PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bonnema, G; Lee, JG; Wang, SH; Lagarrigue, D; Bucher, J; Wehrens, R; de Vos, R; Beekwilder, J				Bonnema, Guusje; Lee, Jun Gu; Wang Shuhang; Lagarrigue, David; Bucher, Johan; Wehrens, Ron; de Vos, Ric; Beekwilder, Jules			Glucosinolate variability between turnip organs during development	PLOS ONE			English	Article							CRUCIFEROUS VEGETABLES; GERMPLASM COLLECTION; INSECT RESISTANCE; DEFENSE COMPOUNDS; ARABIDOPSIS; IDENTIFICATION; BIOSYNTHESIS; CANCER; PATTERNS; GENES	Turnip (Brassica rapa spp. rapa) is an important vegetable species, with a unique physiology. Several plant parts, including both the turnip tubers and leaves, are important for human consumption. During the development of turnip plants, the leaves function as metabolic source tissues, while the tuber first functions as a sink, while later the tuber turns into a source for development of flowers and seeds. In the present study, chemical changes were determined for two genotypes with different genetic background, and included seedling, young leaves, mature leaves, tuber surface, tuber core, stalk, flower and seed tissues, at seven different time points during plant development. As a basis for understanding changes in glucosinolates during plant development, the profile of glucosinolates was analysed using liquid chromatography (LC) coupled to mass spectrometry (MS). This analysis was complemented by a gene expression analysis, focussed on GLS biosynthesis, which could explain part of the observed variation, pointing to important roles of specific gene orthologues for defining the chemical differences. Substantial differences in glucosinolate profiles were observed between aboveground tissues and turnip tuber, reflecting the differences in physiological role. In addition, differences between the two genotypes and between tissues that were harvested early or late during the plant lifecycle. The importance of the observed differences in glucosinolate profile for the ecophysiology of the turnip and for breeding turnips with optimal chemical profiles is discussed.	[Bonnema, Guusje; Wang Shuhang; Lagarrigue, David; Bucher, Johan] Wageningen Univ & Res, Plant Breeding, Wageningen, Netherlands; [Lee, Jun Gu] Chonbuk Natl Univ, Coll Agr & Life Sci, Dept Hort, Jeonju, South Korea; [Wehrens, Ron; de Vos, Ric; Beekwilder, Jules] Wageningen Plant Res, Wageningen, Netherlands; [Lee, Jun Gu] Chonbuk Natl Univ, Dept Hort, Jeonju, South Korea	Wageningen University & Research; Jeonbuk National University; Wageningen University & Research; Jeonbuk National University	Beekwilder, J (corresponding author), Wageningen Plant Res, Wageningen, Netherlands.	jules.beekwilder@wur.nl	Wehrens, Ron/M-8781-2015; Beekwilder, Jules/A-6802-2011	Wehrens, Ron/0000-0002-8798-5599; Beekwilder, Jules/0000-0003-3238-4427	National Agrobiodiversity Centre, Rural Development Administration, Korea	National Agrobiodiversity Centre, Rural Development Administration, Korea	This research was supported by the National Agrobiodiversity Centre, Rural Development Administration, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissani N, 2015, J AGR FOOD CHEM, V63, P6120, DOI 10.1021/acs.jafc.5b02425; Beekwilder J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002068; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Bruce TJA, 2014, ANN APPL BIOL, V164, P348, DOI 10.1111/aab.12128; Burdock GA, 2001, FENAROLIS HANDBOOK O; Burow M, 2017, CURR OPIN PLANT BIOL, V38, P142, DOI 10.1016/j.pbi.2017.04.009; Burow M, 2010, CURR OPIN PLANT BIOL, V13, P348, DOI 10.1016/j.pbi.2010.02.002; CARLSON DG, 1981, J AGR FOOD CHEM, V29, P1235, DOI 10.1021/jf00108a034; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Cheng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036442; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Del Carpio DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019624; Francisco M, 2009, J CHROMATOGR A, V1216, P6611, DOI 10.1016/j.chroma.2009.07.055; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Golicz AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13390; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2008, PLANT PHYSIOL, V148, P2096, DOI 10.1104/pp.108.129981; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Jensen LM, 2014, BIOL CHEM, V395, P529, DOI 10.1515/hsz-2013-0286; Jorgensen ME, 2015, TRENDS PLANT SCI, V20, P508, DOI 10.1016/j.tplants.2015.04.006; Justen VL, 2012, HORTIC ENVIRON BIOTE, V53, P108, DOI 10.1007/s13580-012-0106-3; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kim SJ, 2001, SOIL SCI PLANT NUTR, V47, P167, DOI 10.1080/00380768.2001.10408379; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Klopsch R, 2017, FOOD RES INT, V100, P392, DOI 10.1016/j.foodres.2017.04.016; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lee JG, 2013, J AGR FOOD CHEM, V61, P3984, DOI 10.1021/jf400890p; Li SM, 2007, J AGR FOOD CHEM, V55, P8452, DOI 10.1021/jf070816k; Lin K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-250; Monfort WS, 2007, CROP PROT, V26, P1359, DOI 10.1016/j.cropro.2006.11.008; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Padilla G, 2005, EUPHYTICA, V145, P171, DOI 10.1007/s10681-005-0895-x; Padilla G, 2007, PHYTOCHEMISTRY, V68, P536, DOI 10.1016/j.phytochem.2006.11.017; Pino Del Carpio D, 2014, THESIS; Qiao S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111012; Seo MS, 2016, PLANT MOL BIOL, V90, P503, DOI 10.1007/s11103-016-0437-z; Smilde AK, 2005, ANAL CHEM, V77, P6729, DOI 10.1021/ac051080y; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Song JC, 2015, J EXP BOT, V66, P5067, DOI 10.1093/jxb/erv133; Tang HB, 2012, GENETICS, V190, P1563, DOI 10.1534/genetics.111.137349; Tsunoda T, 2017, J ECOL, V105, P1256, DOI 10.1111/1365-2745.12793; van Dam NM, 2009, PHYTOCHEM REV, V8, P171, DOI 10.1007/s11101-008-9101-9; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Voorrips LE, 2000, AM J EPIDEMIOL, V152, P1081, DOI 10.1093/aje/152.11.1081; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x	55	5	5	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217862	10.1371/journal.pone.0217862	http://dx.doi.org/10.1371/journal.pone.0217862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170222	gold, Green Published, Green Submitted			2022-12-26	WOS:000470263700072
J	Haun, CT; Vann, CG; Osburn, SC; Mumford, PW; Roberson, PA; Romero, MA; Fox, CD; Johnson, CA; Parry, HA; Kavazis, AN; Moon, JR; Badisa, VLD; Mwashote, BM; Ibeanusi, V; Young, KC; Roberts, MD				Haun, Cody T.; Vann, Christopher G.; Osburn, Shelby C.; Mumford, Petey W.; Roberson, Paul A.; Romero, Matthew A.; Fox, Carlton D.; Johnson, Christopher A.; Parry, Hailey A.; Kavazis, Andreas N.; Moon, Jordan R.; Badisa, Veera L. D.; Mwashote, Benjamin M.; Ibeanusi, Victor; Young, Kaelin C.; Roberts, Michael D.			Muscle fiber hypertrophy in response to 6 weeks of high-volume resistance training in trained young men is largely attributed to sarcoplasmic hypertrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; MUSCULAR ADAPTATIONS; EXERCISE; STRENGTH; LOAD; GAINS	Cellular adaptations that occur during skeletal muscle hypertrophy in response to high-volume resistance training are not well-characterized. Therefore, we sought to explore how actin, myosin, sarcoplasmic protein, mitochondrial, and glycogen concentrations were altered in individuals that exhibited mean skeletal muscle fiber cross-sectional area (fCSA) hypertrophy following 6 weeks of high-volume resistance training. Thirty previously resistance-trained, college-aged males (mean +/- standard deviation: 21 +/- 2 years, 5 +/- 3 training years) had vastus lateralis (VL) muscle biopsies obtained prior to training (PRE), at week 3 (W3), and at week 6 (W6). Muscle tissue from 15 subjects exhibiting PRE to W6 VL mean fCSA increases ranging from 320-1600 mu m(2) was further interrogated using various biochemical and histological assays as well as proteomic analysis. Seven of these individuals donated a VL biopsy after refraining from training 8 days following the last training session (W7) to determine how deloading affected biomarkers. The 15 fCSA hypertrophic responders experienced a +23% increase in mean fCSA from PRE to W6 (p<0.001) and, while muscle glycogen concentrations remained unaltered, citrate synthase activity levels decreased by 24% (p<0.001) suggesting mitochondrial volume decreased. Interestingly, repeated measures ANOVAs indicated that p-values approached statistical significance for both myosin and actin (p = 0.052 and p = 0.055, respectively), and forced post hoc tests indicated concentrations for both proteins decreased similar to 30% from PRE to W6 (p<0.05 for each target). Phalloidin-actin staining similarly revealed actin concentrations per fiber decreased from PRE to W6. Proteomic analysis of the sarcoplasmic fraction from PRE to W6 indicated 40 proteins were up-regulated (p<0.05), KEGG analysis indicated that the glycolysis/gluconeogenesis pathway was upregulated (FDR sig. <0.001), and DAVID indicated that the following functionally-annotated pathways were upregulated (FDR value <0.05): a) glycolysis (8 proteins), b) acetylation (23 proteins), c) gluconeogenesis (5 proteins) and d) cytoplasm (20 proteins). At W7, sarcoplasmic protein concentrations remained higher than PRE (+66%, p<0.05), and both actin and myosin concentrations remained lower than PRE (similar to-50%, p<0.05). These data suggest that short-term high-volume resistance training may: a) reduce muscle fiber actin and myosin protein concentrations in spite of increasing fCSA, and b) promote sarcoplasmic expansion coincident with a coordinated up-regulation of sarcoplasmic proteins involved in glycolysis and other metabolic processes related to ATP generation. Interestingly, these effects seem to persist up to 8 days following training.	[Haun, Cody T.] LaGrange Coll, Dept Exercise Sci, La Grange, GA USA; [Vann, Christopher G.; Osburn, Shelby C.; Mumford, Petey W.; Roberson, Paul A.; Romero, Matthew A.; Fox, Carlton D.; Parry, Hailey A.; Kavazis, Andreas N.; Young, Kaelin C.; Roberts, Michael D.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Johnson, Christopher A.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Moon, Jordan R.] Impedimed, Carlsbad, CA USA; [Badisa, Veera L. D.; Mwashote, Benjamin M.; Ibeanusi, Victor] Florida A&M Univ, Sch Environm, Tallahassee, FL 32307 USA; [Young, Kaelin C.; Roberts, Michael D.] Edward Via Coll Osteopath Med Auburn Campus, Dept Cell Biol & Physiol, Auburn, AL 36832 USA	Auburn University System; Auburn University; University of Alabama System; University of Alabama Birmingham; State University System of Florida; Florida A&M University	Roberts, MD (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.; Roberts, MD (corresponding author), Edward Via Coll Osteopath Med Auburn Campus, Dept Cell Biol & Physiol, Auburn, AL 36832 USA.	mdr0024@auburn.edu	Mumford, Petey/GLS-9565-2022; Moon, James/AAA-9905-2020	Moon, James/0000-0001-8071-1491; Mumford, Petey/0000-0002-4946-9702; Fox, Carlton/0000-0001-6142-6062	Impedimed, Inc.; Florida AM University	Impedimed, Inc.; Florida AM University	Funding for subject compensation and certain assays was provided through a contract awarded to KCY and MDR by Impedimed, Inc. The funder provided support in the form of salaries for one author (JRM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for proteomic analysis was provided through a Grant in Aid to MDR and VI from Florida A&M University. Additional funding was provided as a gift in kind to CTH and MDR through Renaissance Periodization by Dr. Mike Israetel and Nick Shaw. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Specific roles of all authors are articulated in the 'Author Contributions' section."	Abe T., 2013, INT J CLIN MED, V4, P114, DOI DOI 10.4236/IJCM.2013.42022; Brentano MA, 2011, J SPORT MED PHYS FIT, V51, P1; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Burd NA, 2013, EUR J APPL PHYSIOL, V113, P267, DOI 10.1007/s00421-012-2527-1; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Damas F, 2015, SPORTS MED, V45, P801, DOI 10.1007/s40279-015-0320-0; Duddy W, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0041-y; Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340; Haun CT, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00247; Haun CT, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00084; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hyatt HW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12619; Jenkins NDM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00331; Jenkins NDM, 2016, J STRENGTH COND RES, V30, P2174, DOI 10.1519/JSC.0000000000001308; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kumar V, 2009, J APPL PHYSIOL, V106, P2026, DOI 10.1152/japplphysiol.91481.2008; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; MACDOUGALL JD, 1982, EUR J APPL PHYSIOL O, V48, P117, DOI 10.1007/BF00421171; Martin JS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13029; Meijer JP, 2015, EXP PHYSIOL, V100, P1331, DOI 10.1113/EP085267; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Mobley CB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090972; Mobley CB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195203; Mobley CB, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00518; Morton RW, 2016, J APPL PHYSIOL, V121, P129, DOI 10.1152/japplphysiol.00154.2016; PENMAN KA, 1969, RES QUART, V40, P764, DOI 10.1080/10671188.1969.10614916; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Qaisar R, 2016, FREE RADICAL BIO MED, V98, P56, DOI 10.1016/j.freeradbiomed.2016.03.025; Reidy PT, 2017, MED SCI SPORT EXER, V49, P1197, DOI 10.1249/MSS.0000000000001224; Reidy PT, 2016, J NUTR, V146, P155, DOI 10.3945/jn.114.203208; Roberts MD, 2018, PEERJ, V6, DOI 10.7717/peerj.5338; Schoenfeld BJ, 2010, J STRENGTH COND RES, V24, P3497, DOI 10.1519/JSC.0b013e3181bac2d7; Schuenke MD, 2012, EUR J APPL PHYSIOL, V112, P3585, DOI 10.1007/s00421-012-2339-3; STARON RS, 1991, J APPL PHYSIOL, V70, P631, DOI 10.1152/jappl.1991.70.2.631; Stone M.H., 1983, STRENGTH COND J, V5, P40; Toth MJ, 2012, J PHYSIOL-LONDON, V590, P1243, DOI 10.1113/jphysiol.2011.219659; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Wilkinson DJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE571, DOI 10.1152/ajpendo.00650.2013	41	30	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0215267	10.1371/journal.pone.0215267	http://dx.doi.org/10.1371/journal.pone.0215267			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166954	Green Submitted, Green Published, gold			2022-12-26	WOS:000470087800005
J	Stawski, D; Nowak, A				Stawski, Dawid; Nowak, Aleksandra			Thermal properties of poly(N,N-dimethylaminoethyl methacrylate)	PLOS ONE			English	Article								Poly(N, N-dimethylaminoethyl methacrylate) (PDMAEMA) is a promising quite new polymer with very interesting properties. The thermal degradation process of PDMAEMA was investigated. The polymer was heated at specific time intervals, then heating was stopped, and infrared analysis was performed to obtain information on the structure of the solid residue. The thermal degradation process has a two-stage character. The limit temperature for the first decomposition step was about 390 degrees C, after which the second stage of sample decomposition began. The order of disintegration of the macromolecules was determined. Activation energy values for the thermal decomposition process have been calculated; they are 89.8 kJ/mol for the first stage and 17.7 kJ/mol for the second stage of the degradation process.	[Stawski, Dawid; Nowak, Aleksandra] Lodz Univ Technol, Dept Mat & Commod Sci & Text Metrol, Div Phys Chem Polymers, Lodz, Poland	Lodz University of Technology	Stawski, D (corresponding author), Lodz Univ Technol, Dept Mat & Commod Sci & Text Metrol, Div Phys Chem Polymers, Lodz, Poland.	dawid.stawski@p.lodz.pl		Stawski, Dawid/0000-0002-7916-0239	Lodz University of Technology, Department of Material and Commodity Sciences and Textile Metrology, Poland [14-148-1-21-28]	Lodz University of Technology, Department of Material and Commodity Sciences and Textile Metrology, Poland	The authors disclose the receipt of the following financial support for the research, authorship, and/or publication of this article: The manuscript was financed from funds assigned for 14-148-1-21-28 statuary activity, by Lodz University of Technology, Department of Material and Commodity Sciences and Textile Metrology, Poland.	Amiji MM, 1999, US Patent US, Patent No. 19970862854; Christy AA, 2010, VIB SPECTROSC, V54, P42, DOI 10.1016/j.vibspec.2010.06.003; COATS AW, 1965, J POLYM SCI POL LETT, V3, P917, DOI 10.1002/pol.1965.110031106; Cunningham V. L., 1978, US Patent, Patent No. [4129534A, 4129534]; Cunningham VL, 1977, US Patent US, Patent No. [4052343A, 4052343]; Fukutomi T, 1996, US Patent, Patent No. [5543045A, 5543045]; Gutarowska B, 2015, TEXT RES J, V85, P1083, DOI 10.1177/0040517514559581; Huang KS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091578; Hurlock JR, 2000, US Patent US, Patent No. 6025426; Jana S, 2007, CHEM COMMUN, P2962, DOI 10.1039/b702067h; Karjalainen E, 2014, MACROMOLECULES, V47, P2103, DOI 10.1021/ma5000706; Nakano H, 1988, US Patent, Patent No. [4787977A, 4787977]; Nita LE, 2018, MAT SCI ENG C-MATER, V87, P22, DOI 10.1016/j.msec.2018.02.016; Orakdogen N, 2012, J POLYM RES, V19, DOI 10.1007/s10965-012-9914-5; Plamper FA, 2007, MACROMOLECULES, V40, P8361, DOI 10.1021/ma071203b; Rawlinson LAB, 2011, J MED MICROBIOL, V60, P968, DOI 10.1099/jmm.0.025619-0; Rawlinson LAB, 2010, BIOMACROMOLECULES, V11, P443, DOI 10.1021/bm901166y; Romano Jr CE, 2000, US Patent, Patent No. [6020032A, 6020032]; Stawski D, 2013, J TEXT I, V104, P883, DOI 10.1080/00405000.2013.764753; Zielinska D, 2016, TEXT RES J, V86, P1837, DOI 10.1177/0040517515617420	20	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217441	10.1371/journal.pone.0217441	http://dx.doi.org/10.1371/journal.pone.0217441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166982	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800029
J	Peach, DAH; Ko, E; Blake, AJ; Gries, G				Peach, Daniel A. H.; Ko, Elton; Blake, Adam J.; Gries, Gerhard			Ultraviolet inflorescence cues enhance attractiveness of inflorescence odour to Culex pipiens mosquitoes	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; AEDES-AEGYPTI; NECTAR SOURCES; DIPTERA; VISION; COMPLEX; LIGHT; EYES; PHYTOCHEMICALS; PHOTORECEPTORS	Inflorescence patterns of ultraviolet (UV) absorption and UV-reflection are attractive to many insect pollinators. To understand whether UV inflorescence cues affect the attraction of nectar-foraging mosquitoes, we worked with the common house mosquito, Culex pipiens and with two plant species exhibiting floral UV cues: the tansy, Tanacetum vulgare, and the common hawkweed Hieraciumm lachenalii. Electroretinograms revealed that Cx. pipiens eyes can sense UV wavelengths, with peak sensitivity at 335 nm. Behavioural bioassays divulged that UV inflorescence cues enhance the attractiveness of inflorescence odour. In the presence of natural floral odour, female Cx. pipiens were attracted to floral patterns of UV-absorption and UV-reflection but preferred uniformly UV-dark inflorescences. Moreover, Cx. pipiens females preferred UV-dark and black inflorescence models to UV-dark and yellow inflorescence models. With feathers and pelts of many avian and mammalian hosts also being UV-dark and dark-coloured, foraging Cx. pipiens females may respond to analogous visual cues when they seek nectar and vertebrate blood resources.	[Peach, Daniel A. H.; Ko, Elton; Blake, Adam J.; Gries, Gerhard] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada	Simon Fraser University	Peach, DAH (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.	dan@danpeach.info	Peach, Daniel AH/C-9323-2019; Blake, Adam/ABE-5234-2020	Peach, Daniel AH/0000-0002-8913-5133; Blake, Adam/0000-0002-4143-6981	Natural Sciences and Engineering Research Council of Canada [NSERC] PGSD; SFU Provost's Prize of Distinction; John H Borden Scholarship; NSERC - Undergraduate Student Research Award; NSERC -Industrial Research Chair; Scotts Canada Ltd.	Natural Sciences and Engineering Research Council of Canada [NSERC] PGSD(Natural Sciences and Engineering Research Council of Canada (NSERC)); SFU Provost's Prize of Distinction; John H Borden Scholarship; NSERC - Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC -Industrial Research Chair(Canada Research Chairs); Scotts Canada Ltd.	The research was supported by scholarships to DP (Natural Sciences and Engineering Research Council of Canada [NSERC; https://www.canada.ca/en/science-engineering-research.html] PGSD; SFU Provost's Prize of Distinction [https://www.sfu.ca/dean-gradstudies/awards/entrance-scholarships/provost-awards/ppd.html]; John H Borden Scholarship [http://esc-sec.ca/student/student-awards/#toggle-id-5]), a scholarship to EK (NSERC - Undergraduate Student Research Award), and by an NSERC -Industrial Research Chair to GG, with Scotts Canada Ltd. as the industrial sponsor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON IH, 1987, MED VET ENTOMOL, V1, P59, DOI 10.1111/j.1365-2915.1987.tb00323.x; Arnold SEJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014287; Bernath B, 2016, J INSECT PHYSIOL, V95, P8, DOI 10.1016/j.jinsphys.2016.08.011; BRANTJES NBM, 1976, ACTA BOT NEERL, V25, P281, DOI 10.1111/j.1438-8677.1976.tb00240.x; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Brodie BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145055; BURKHARDT D, 1989, J COMP PHYSIOL A, V164, P787, DOI 10.1007/BF00616750; Chavez AE, 2003, INVEST OPHTH VIS SCI, V44, P2290, DOI 10.1167/iovs.02-0670; Clements AN., 1999, SENSORY RECEPTION BE; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Dieng H, 2018, ACTA TROP, V185, P230, DOI 10.1016/j.actatropica.2018.05.019; Dinkel T, 2001, J INSECT PHYSIOL, V47, P1111, DOI 10.1016/S0022-1910(01)00080-4; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Foster WA, 2008, J AM MOSQUITO CONTR, V24, P138, DOI 10.2987/8756-971X(2008)24[138:PAPSL]2.0.CO;2; FREE J B, 1970, Behaviour, V37, P269, DOI 10.1163/156853970X00376; Giraldo-Calderon GI, 2017, BMC EVOL BIOL, V17, P1, DOI [10.1186/s12862-016-0855-1, DOI 10.1186/S12862-016-0855-1]; GRIMSTAD PR, 1974, J MED ENTOMOL, V11, P331, DOI 10.1093/jmedent/11.3.331; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10; HAUFE WO, 1964, CAN ENTOMOL, V96, P118, DOI 10.4039/Ent96118-1; HOROVITZ A, 1972, AM J BOT, V59, P706, DOI 10.2307/2441142; Horth L, 2014, BIOL OPEN, V3, P221, DOI 10.1242/bio.20146445; Hu XB, 2014, J EXP BIOL, V217, P1003, DOI 10.1242/jeb.096347; Hu XB, 2012, J NEUROSCI, V32, P13661, DOI 10.1523/JNEUROSCI.1816-12.2012; Hu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023121; Hu XB, 2009, J COMP NEUROL, V516, P334, DOI 10.1002/cne.22114; JEPSON PC, 1988, B ENTOMOL RES, V78, P641, DOI 10.1017/S0007485300015492; Kimura M, 2010, J PARASITOL, V96, P144, DOI 10.1645/GE-2060.1; Kirschfeld K, 1977, NATURE, V267, P192; Koski MH, 2014, FUNCT ECOL, V28, P868, DOI 10.1111/1365-2435.12242; Land MF, 1999, J COMP PHYSIOL A, V185, P91, DOI 10.1007/s003590050369; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; MAGNARELLI LA, 1977, ENVIRON ENTOMOL, V6, P237, DOI 10.1093/ee/6.2.237; MAGNARELLI LA, 1979, ENVIRON ENTOMOL, V8, P949, DOI 10.1093/ee/8.5.949; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; Mellor HE, 1996, MED VET ENTOMOL, V10, P371, DOI 10.1111/j.1365-2915.1996.tb00759.x; Miller BR, 1996, INSECT MOL BIOL, V5, P93, DOI 10.1111/j.1365-2583.1996.tb00044.x; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; MUIR LE, 1992, J MED ENTOMOL, V29, P278, DOI 10.1093/jmedent/29.2.278; Muller H, 1873, BEFRUCHTUNG BLUMEN D; Nyasembe VO, 2014, PHYTOCHEM LETT, V8, P196, DOI 10.1016/j.phytol.2013.10.003; Orban LL, 2014, INSECT SOC, V61, P325, DOI 10.1007/s00040-014-0366-2; Peach DAH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39748-4; Peach DAH, 2016, ARTHROPOD-PLANT INTE, V10, P497, DOI 10.1007/s11829-016-9445-9; PRIMACK R B, 1982, Arnoldia (Jamaica Plain), V42, P139; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; SANDHOLM HOLLACE A., 1962, MOSQUITO NEWS, V22, P346; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; SATO SHOZO, 1957, SCI REPTS TOHOKU UNIV SER 4 BIOL, V23, P83; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; Shekar SN, 2008, PHOTOCHEM PHOTOBIOL, V84, P719, DOI 10.1111/j.1751-1097.2007.00237.x; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Silva IM, 2005, J AM MOSQUITO CONTR, V21, P229, DOI 10.2987/8756-971X(2005)21[229:LEOMTB]2.0.CO;2; SIPPELL WL, 1953, B ENTOMOL RES, V43, P567, DOI 10.1017/S0007485300026651; Song B, 2015, J PLANT ECOL, V8, P173, DOI 10.1093/jpe/rtv012; STADDON BW, 1980, COMP BIOCHEM PHYS A, V65, P371, DOI 10.1016/0300-9629(80)90046-8; Stavenga DG, 2017, J PHYSIOL-LONDON, V595, P5481, DOI 10.1113/JP273674; Stoutamire W, 1968, MICH BOT, V7, P203; THIEN LB, 1969, AM J BOT, V56, P232, DOI 10.2307/2440711; UTECH FH, 1975, BOT MAG TOKYO, V88, P9, DOI 10.1007/BF02498877; van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046; WEISS MR, 1991, NATURE, V354, P227, DOI 10.1038/354227a0; WILTON DP, 1972, J MED ENTOMOL, V9, P301, DOI 10.1093/jmedent/9.4.301; WILTON DP, 1975, MOSQ NEWS, V35, P522	65	16	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217484	10.1371/journal.pone.0217484	http://dx.doi.org/10.1371/journal.pone.0217484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163041	gold, Green Submitted, Green Published			2022-12-26	WOS:000470086200013
J	Ali, B; Zhou, YC; Zhang, QY; Niu, CY; Zhu, ZH				Ali, Bahar; Zhou, Yicheng; Zhang, Qiuyuan; Niu, Changying; Zhu, Zhihui			Development of an easy and cost-effective method for non-invasive genotyping of insects	PLOS ONE			English	Article							DNA; AMPLIFICATION; SEQUENCE; GENES; PCR	Non-invasive genotyping methods provide valuable information on insect populations. However, poor DNA amplification and time-consuming sampling procedures limit these methods, especially for small insects. An efficient and convenient method was developed for non-invasive, non-lethal genotyping of a large insect, Mythimna separata, and a small insect, Drosophila melanogaster, by amplification of endogenous and exogenous, nuclear and mitochondrial genes from insect frass, exuviae, and food waste. For M. separata, the chitin synthesis gene MsCHSB and the COI gene were successfully detected by PCR from exuviae DNA. However, a COI fragment could not be detected directly by PCR from frass, probably due to DNA degradation. To improve the detection rate, DNA from frass was first amplified by Multiple Displacement Amplification with phi29 DNA polymerase, after which the COI fragment was detected from all samples by PCR. For D. melanogaster, second instar larvae were reared individually for three days and then DNA was extracted from food waste of each individual. The endogenous fragment serendipity a (srya), exogenous transgene FC31 integrase, and the kl-5 gene, a Y-chromosome-located male-specific marker gene were successfully detected from most samples. We developed a simple, non-invasive, non-lethal method to determine gender and identify transgenic individuals early in the larval stage. This universal method is applicable to most insects and has potential application in genetic and ecological studies of insects and other arthropods.	[Ali, Bahar; Zhou, Yicheng; Zhang, Qiuyuan; Niu, Changying; Zhu, Zhihui] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Zhu, ZH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Hubei, Peoples R China.	zhihui@mail.hzau.edu.cn		Zhu, Zhihui/0000-0002-6650-1241; Zhou, Yicheng/0000-0003-3659-9951	National Natural Science Foundation of China [31572329]; Fundamental Research Funds for the Central Universities [2012ZYTS046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (grant no. 31572329 to ZZ), Fundamental Research Funds for the Central Universities (Program No. 2012ZYTS046 to ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashfaq M, 1999, S PACIFIC STUDY, V19; Barros EM, 2010, ENTOMOL EXP APPL, V137, P237, DOI 10.1111/j.1570-7458.2010.01058.x; Carvalho GB, 2009, BIOTECHNIQUES, V46, P312, DOI 10.2144/000113088; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Essays UK, 2013, REV LAB REAR DROS ME; Feinstein J, 2004, CONSERV GENET, V5, P103, DOI 10.1023/B:COGE.0000014058.34840.94; Fincke OM, 2001, EVOLUTION, V55, P762, DOI 10.1554/0014-3820(2001)055[0762:UOSITD]2.0.CO;2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fumanal B, 2005, J BIOTECHNOL, V119, P15, DOI 10.1016/j.jbiotec.2005.04.011; Ganbaatar O, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0328-7; Gerken T, 1998, ELECTROPHORESIS, V19, P3069, DOI 10.1002/elps.1150191804; GOLDSTEIN LSB, 1982, P NATL ACAD SCI-BIOL, V79, P7405, DOI 10.1073/pnas.79.23.7405; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hoy MA, 2003, INSECT MOL GENETICS, P737, DOI [10.1016/B978-0-12-357031-4.X5018-3, DOI 10.1016/B978-0-12-357031-4.X5018-3]; IBNSOUDA S, 1993, DEVELOPMENT, V119, P971; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; Kurtz J, 1999, P ROY SOC B-BIOL SCI, V266, P2515, DOI 10.1098/rspb.1999.0954; Lefort M-C, 2015, PEERJ, DOI DOI 10.7287/PEERJ.PREPRINTS.655V3; Lushai G, 2000, BIOL CONSERV, V94, P43, DOI 10.1016/S0006-3207(99)00165-2; Oja R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179463; Rea RV, 2016, J FISH WILDL MANAG, V7, P461, DOI 10.3996/112015-JFWM-115; ROSE OC, 1994, MOL ECOL, V3, P275, DOI 10.1111/j.1365-294X.1994.tb00064.x; Scriven JJ, 2013, MOL ECOL RESOUR, V13, P225, DOI 10.1111/1755-0998.12036; Simmons GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024110; Starks PT, 2002, INSECT SOC, V49, P20, DOI 10.1007/s00040-002-8272-4; Venken KJT, 2016, WIRES DEV BIOL, V5, P233, DOI 10.1002/wdev.214; Watts PC, 2005, ODONATOLOGICA, V34, P183	28	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0216998	10.1371/journal.pone.0216998	http://dx.doi.org/10.1371/journal.pone.0216998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158235	Green Submitted, gold, Green Published			2022-12-26	WOS:000469915700005
J	Loi, F; Laddomada, A; Coccollone, A; Marrocu, E; Piseddu, T; Masala, G; Bandino, E; Cappai, S; Rolesu, S				Loi, Federica; Laddomada, Alberto; Coccollone, Annamaria; Marrocu, Elena; Piseddu, Toni; Masala, Giovanna; Bandino, Ennio; Cappai, Stefano; Rolesu, Sandro			Socio-economic factors as indicators for various animal diseases in Sardinia	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; VIRUS SEROTYPE 8; WEST NILE VIRUS; BLUETONGUE VIRUS; CONTAGIOUS AGALACTIA; CULICOIDES-IMICOLA; CURRENT KNOWLEDGE; RISK-FACTORS; MORTALITY; EPIDEMIOLOGY	The need to consider the role of social factors in the efficacy of farm management and, consequently, in the onset and persistence of diseases typical to animal farms is increasingly being realized increasingly worldwide. Many risk analysis studies have been conducted to assess the role of various factors in the development of animal diseases; however, very few have accounted for the role of social factors. The aim of this work was to bridge this gap, with the main hypothesis that different socio-economic factors could be valid indicators for the occurrence of different animal diseases. A socio-economic analysis was performed using demographic characteristics of the farmers and data from 44 social indicators released by the Italian Statistician National Institute of Statistics (ISTAT) database. African swine fever (ASF) in wild boars (WB) and domestic pigs and other endemic animal diseases and zoonoses in Sardinia were considered, such as cistic echinococcosis (CE), contagious agalactia (CA), trichinellosis, West Nile disease (WND), and bluetongue (BT). Seven different negative binomial regression models were fitted using the number of cases between 2011-2017. Three indicators-cultural demand, employment rate, and legality-showed a statistically significant association with risk for all the diseases considered, but with varying effects. Some indicators, such as the age and sex of the farmer, material deprivation index, number of farms and animals, micro-criminality index, and rate of reported thefts were common to ASF, CA, trichinellosis, and CE cases. Others such as the forest surface and the energy produced from renewable sources were common to BT, WND, and ASF in WB. Tourism in seasons other than summer was a valid predictor of ASF and trichinellosis, while out-of-region hospital use had a statistically significant role in CE risk identification. These results may help understand the social context in which these diseases may occur and thus guide the design and implementation of additional risk management measures that go beyond well-known veterinary measures.	[Loi, Federica; Coccollone, Annamaria; Marrocu, Elena; Cappai, Stefano; Rolesu, Sandro] OEVR Osservatorio Epidemiol Vet Reg Sardegna, Cagliari, Italy; [Laddomada, Alberto; Bandino, Ennio] Ist Zooprofilatt Sperimentale Sardegna G Pegreffi, Sassari, Italy; [Piseddu, Toni; Masala, Giovanna] CeNRE Ctr Nazl Referenza Echinococcosi Idatidosi, Sassari, Italy	IZS Della Sardegna	Loi, F (corresponding author), OEVR Osservatorio Epidemiol Vet Reg Sardegna, Cagliari, Italy.	federica.loi@izs-sardegna.it	LOI, FEDERICA/AAG-2563-2020	LOI, FEDERICA/0000-0003-3045-3150; Piseddu, Toni/0000-0002-1024-5250; , Giovanna Masala/0000-0001-5301-2580				Abbott P., 1994, SOC HLTH ILLNESS, V16, P254; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Albarella U., 2006, ARCHAEOZOOLOGICAL ST, P285; [Anonymous], 6 CENS GEN AGR SARD, P82; [Anonymous], 1985, THEORY PRACTICE ECON; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Barnes AP, 2015, PREV VET MED, V122, P42, DOI 10.1016/j.prevetmed.2015.09.003; Beaudeau F, 1996, PREV VET MED, V25, P327, DOI 10.1016/0167-5877(95)00509-9; Beck JD, 1998, COMMUNITY DENT ORAL, V26, P220, DOI 10.1111/j.1600-0528.1998.tb01954.x; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Bhat H. S., 2010, DERIVATION BAYESIAN; Bishwajit G, SOCIAL DETERMINANTS, V2014, P1, DOI [10.1155/2014/135243, DOI 10.1155/2014/135243]; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brundu D, 2014, ACTA TROP, V140, P91, DOI 10.1016/j.actatropica.2014.08.011; Bulter-Jones D, 2016, CAN COMMUN DIS RE S1, V18; Cadum E, 1999, Epidemiol Prev, V23, P175; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Cappai S, 2018, PREV VET MED, V155, P75, DOI 10.1016/j.prevetmed.2018.04.004; Cappai S, 2018, PREV VET MED, V152, P1, DOI 10.1016/j.prevetmed.2018.01.004; Chenais E, 2017, TRANSBOUND EMERG DIS, V64, P101, DOI 10.1111/tbed.12347; Chenais E, 2017, PREV VET MED, V144, P134, DOI 10.1016/j.prevetmed.2017.06.002; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Conte A, 2003, J VET MED B, V50, P139, DOI 10.1046/j.1439-0450.2003.00632.x; Contini A, 1983, CEC FAO EXPERT CONSU; Costard S, 2009, PREV VET MED, V92, P199, DOI 10.1016/j.prevetmed.2009.08.010; Craddock S, 2015, SOC SCI MED, V129, P1, DOI 10.1016/j.socscimed.2014.11.016; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Djordjevic M, 2003, J PARASITOL, V89, P226, DOI 10.1645/0022-3395(2003)089[0226:SPAEFR]2.0.CO;2; Donkin A, 2002, HLTH STAT Q, V15, P5; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Drewe JA, 2011, PREV VET MED, V101, P113, DOI 10.1016/j.prevetmed.2011.05.006; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Efroymson M. A., 1960, MATH METHODS DIGITAL, P191; Elbers ARW, 2010, VACCINE, V28, P2473, DOI 10.1016/j.vaccine.2010.01.047; Enticott G, 2009, SOCIOL RURALIS, V49, P327, DOI 10.1111/j.1467-9523.2009.00498.x; FAO (Food and Agriculture Organization of the United Nations), 2002, 153 FAO; Firinu A, 1988, QUADERNI I ZOOPROFIL, V5, P179; Gao X, 2017, PREV VET MED, V138, P88, DOI 10.1016/j.prevetmed.2017.01.012; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Gibney KB, 2012, AM J TROP MED HYG, V86, P895, DOI 10.4269/ajtmh.2012.11-0502; Hidano A, 2017, 3 INT C AN HLTH SURV; Hidano A, 2017, IN M ISESSA AV INT S, P91; Hidano A, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00137; Hilbe J., 2011, NEGATIVE BINOMIAL RE; HINCHLIFFE S, 2018, PALGR COMMUN, V4, DOI DOI 10.1057/S41599-018-0113-9; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Hurt LS, 2004, J EPIDEMIOL COMMUN H, V58, P315, DOI 10.1136/jech.2003.007351; ISTAT, 2006, IND DEPR AN DIS TRA; ISTAT, ANN STAT IT 2017; ISTAT, 2013, AGR DAT; Jurado C, 2018, TRANSBOUND EMERG DIS, V65, P557, DOI 10.1111/tbed.12740; King LJ, 2008, JAVMA-J AM VET MED A, V233, P259, DOI 10.2460/javma.233.2.259; Laddomada A, 2019, TRANSBOUND EMERG DIS, P1, DOI [10.1111/tbed.13004, DOI 10.1111/TBED.13004]; Lawrence DH, 1921, SEA SARDINIA; Liu H, 2011, SCI TOTAL ENVIRON, V409, P4235, DOI 10.1016/j.scitotenv.2011.07.012; Loi F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214224; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Madanat A, 2001, ACTA VET BRNO, V70, P403, DOI 10.2754/avb200170040403; Mark J., 2001, APPRAISAL J, V56, P89; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Martinez-Lopez B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00314; Mur L, 2018, TRANSBOUND EMERG DIS, V65, P123, DOI 10.1111/tbed.12636; Mur L., 2014, TRANSBOUND EMERG DIS, V3, P113, DOI DOI 10.1111/TBED.12264; OIE, 2009, MANUAL DIAGNOSTIC TE, V1; OIE, 2014, GUID AN DIS CONTR; Okuthe S., 2012, PIG SECTOR KENYA FAO; Ozdenerol E, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-12; Patterson S, 2017, J ANIM ECOL, V86, P442, DOI 10.1111/1365-2656.12649; Piccolo D., 1998, STATISTICA, P872; Piseddu T, PLOS NEGLECTED TROPI; Pozio E, 2006, VET PARASITOL, V140, P177, DOI 10.1016/j.vetpar.2006.03.012; Proudfoot K, 2015, VET J, V206, P15, DOI 10.1016/j.tvjl.2015.05.024; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Regione Autonoma de la Sardegna (RAS), 2004, AN SBOCCH MERC PROD; Rolesu Sandro, 2007, Vet Ital, V43, P463; Rolesu S, 2018, SMALL RUMINANT RES, V164, P39, DOI 10.1016/j.smallrumres.2018.04.013; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204, 10.3201/eid2204.151073]; Stewart G.W., 1987, STAT SCI, V2, P68, DOI DOI 10.1214/ss/1177013439; Swallow B. M., 2000, PAAT TECHNICAL SCI S; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Vernon MC, 2012, PREV VET MED, V105, P110, DOI 10.1016/j.prevetmed.2011.12.016; WILKINSON PJ, 1984, PREV VET MED, V2, P71, DOI 10.1016/0167-5877(84)90050-3; Wilkinson R.G, 2006, PREV CHRONIC DIS, V3, pA26; World Health Organization, 2008, COMM SOC DET HLTH 20; World Health Organization, 2003, SOCIAL DETERMINANTS; Yu H, 2015, SOC SCI RES, V53, P118, DOI 10.1016/j.ssresearch.2015.04.008	88	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217367	10.1371/journal.pone.0217367	http://dx.doi.org/10.1371/journal.pone.0217367			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158242	Green Submitted, Green Published, gold			2022-12-26	WOS:000469915700013
J	Fultang, N; Illendula, A; Chen, B; Wu, C; Jonnalagadda, S; Baird, N; Klase, Z; Peethambaran, B				Fultang, Norman; Illendula, Abhinav; Chen, Brian; Wu, Chun; Jonnalagadda, Subash; Baird, Nathan; Klase, Zachary; Peethambaran, Bela			Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3 beta activity	PLOS ONE			English	Article							PROTEIN-STRUCTURE; ACCURATE DOCKING; PREDICTION; GLIDE; PHOSPHORYLATION; APOPTOSIS; PATHWAY; ROR1	Triple Negative Breast Cancer (TNBC), the most aggressive subtype of breast cancer, is characterized by the absence of hormone receptors usually targeted by hormone therapies like Tamoxifen. Because therapy success and survival rates for TNBC lag far behind other breast cancer subtypes, there is significant interest in developing novel anti-TNBC agents that can target TNBC specifically, with minimal effects on non-malignant tissue. To this aim, our study describes the anti-TNBC effect of strictinin, an ellagitanin previously isolated from Myrothamnus flabellifolius. Using various in silico and molecular techniques, we characterized the mechanism of action of strictinin in TNBC. Our results suggest strictinin interacts strongly with Receptor Tyrosine Kinase Orphan like 1 (ROR1). ROR1 is an oncofetal receptor highly expressed during development but not in normal adult tissue. It is highly expressed in several human malignancies however, owing to its numerous pro-tumor functions. Via its interaction and inhibition of ROR1, strictinin reduced AKT phosphorylation on ser-473, inhibiting downstream phosphorylation and inhibition of GSK3 beta. The reduction in AKT phosphorylation also correlated with decreased cell survival and activation of the caspase-mediated intrinsic apoptotic cascade. Strictinin treatment also repressed cell migration and invasion in a beta-catenin independent manner, presumably via the reactivated GSK3 beta's repressing effect on microtubule polymerization and focal adhesion turnover. This could be of potential therapeutic interest considering heightened interest in ROR1 and other receptor tyrosine kinases as targets for development of anti-cancer agents. Further studies are needed to validate these findings in other ROR1-expressing malignancies but also in more systemic models of TNBC. Our findings do however underline the potential of strictinin and other ROR1targeting agents as therapeutic tools to reduce TNBC proliferation, survival and motility.	[Fultang, Norman; Illendula, Abhinav; Klase, Zachary; Peethambaran, Bela] Univ Sci Philadelphia, Dept Biol, Philadelphia, PA 19104 USA; [Chen, Brian; Wu, Chun; Jonnalagadda, Subash] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ USA; [Baird, Nathan] Univ Sci Philadelphia, Dept Chem & Biochem, Philadelphia, PA USA	Rowan University	Peethambaran, B (corresponding author), Univ Sci Philadelphia, Dept Biol, Philadelphia, PA 19104 USA.	b.peethambaran@usciences.edu	; Jonnalagadda, Subash/O-3388-2015	Chen, Brian/0000-0002-5401-688X; Fultang, Norman/0000-0002-8115-7231; Peethambaran, Bela/0000-0002-2719-3928; Jonnalagadda, Subash/0000-0001-5234-1235	Milton Lev Faculty Research Fund - University of the Sciences; University of the Sciences	Milton Lev Faculty Research Fund - University of the Sciences; University of the Sciences	Funding was provided through the Milton Lev Faculty Research Fund, an internal grant awarded to Dr. Peethambaran by The University of the Sciences.	Aghebati-Maleki L, 2017, BIOMED PHARMACOTHER, V88, P814, DOI 10.1016/j.biopha.2017.01.070; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Borcherding N, 2014, PROTEIN CELL, V5, P496, DOI 10.1007/s13238-014-0059-7; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Brar J., 2018, Journal of Medicinal Plants Research, V12, P7, DOI 10.5897/jmpr2017.6518; Cao JY, 2018, THERANOSTICS, V8, P2739, DOI 10.7150/thno.21477; Choi MY, 2015, AM SOC HEMATOLOGY; Damodar G, 2014, ANN MED HEALTH SCI R, V4, P74, DOI 10.4103/2141-9248.126619; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fultang N, 2018, INT J APPL RES NAT P, V11, P24; Gentile A, 2011, CANC RES; Gianni L, 2007, CARDIOVASC TOXICOL, V7, P67, DOI 10.1007/s12012-007-0013-5; Gohil S, 2017, LANCET, V389, P40; Grainger S, 2018, PROG MOL BIOL TRANSL, V153, P321, DOI 10.1016/bs.pmbts.2017.11.002; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hojjat-Farsangi M, 2018, LEUKEMIA, V32, P2291, DOI 10.1038/s41375-018-0113-1; Hula KT, 2006, MOL CARCINOGEN, V45, P551, DOI 10.1002/mc.20226; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Min BK, 2012, IEEE INT SYMP SIGNAL, P37, DOI 10.1109/ISSPIT.2012.6621257; Nath O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01254-w; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Tao ZQ, 2015, CELL BIOCHEM BIOPHYS, V72, P333, DOI 10.1007/s12013-014-0459-6; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang X, 2018, ONCOL REP, V39, P2635, DOI 10.3892/or.2018.6379; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Zhang H, 2018, AM SOC HEMATOLOGY; Zhang SP, 2012, AM J PATHOL, V181, P1903, DOI 10.1016/j.ajpath.2012.08.024; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	46	15	15	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217789	10.1371/journal.pone.0217789	http://dx.doi.org/10.1371/journal.pone.0217789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150511	gold, Green Published			2022-12-26	WOS:000469759100110
J	Kim, YO; Chung, CR; Gil, E; Park, CM; Suh, GY; Ryu, JA				Kim, Yong Oh; Chung, Chi Ryang; Gil, Eunmi; Park, Chi-Min; Suh, Gee Young; Ryu, Jeong-Am			Safety and feasibility of ultrasound-guided placement of peripherally inserted central catheter performed by neurointensivist in neurosurgery intensive care unit	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; BLOOD-STREAM INFECTION; LARGE VEIN-THROMBOSIS; INTRAHOSPITAL TRANSPORT; ADVERSE EVENTS; RISK-FACTORS	We evaluated the safety and feasibility of ultrasound-guided peripherally-inserted central venous catheters (PICC) by a neurointensivist at the bedside compared to fluoroscopy-guided PICC and conventional central venous catheter (CCVC). This was a retrospective study of adult patients who underwent central line placement and were admitted to the neurosurgical intensive care unit (ICU) between January 2014 and March 2018. In this study, the primary endpoint was central line-induced complications. The secondary endpoint was initial success of central line placement. Placements of ultrasound-guided PICC and CCVC performed at the bedside if intra-hospital transport was inappropriate. Other patients underwent PICC placement at the interventional radiology suite under fluoroscopic guidance. A total of 191 patients underwent central line placement in the neurosurgery ICU during the study period. Requirement for central line infusion (56.0%) and difficult venous access (28.8%) were the most common reasons for central line placement. The basilic vein (39.3%) and the subclavian vein (35.1%) were the most common target veins among patients who underwent central line placement. The placements of ultrasound-guided PICC and CCVC at the bedside were more frequently performed in patients on mechanical ventilation (p = 0.001) and with hemodynamic instability (p < 0.001) compared to the fluoroscopy-guided PICC placement. The initial success rate of central line placement was better in the fluoroscopy-guided PICC placement than in the placements of ultrasound-guided PICC and CCVC at the bedside (p = 0.004). However, all re-inserted central lines were successful. There was no significant difference in procedure time between the three groups. However, incidence of insertional injuries was higher in CCVC group compared to PICC groups (p = 0.038). Ultrasound-guided PICC placement by a neurointensivist may be safe and feasible compared to fluoroscopy-guided PICC placement by interventional radiologists and CCVC placement for neurocritically ill patients.	[Kim, Yong Oh; Chung, Chi Ryang; Gil, Eunmi; Park, Chi-Min; Suh, Gee Young; Ryu, Jeong-Am] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Crit Care Med, Seoul, South Korea; [Gil, Eunmi; Park, Chi-Min] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Surg, Seoul, South Korea; [Suh, Gee Young] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Pulm & Crit Care Med,Sch Med, Seoul, South Korea; [Ryu, Jeong-Am] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurosurg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Ryu, JA (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Crit Care Med, Seoul, South Korea.; Ryu, JA (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurosurg, Seoul, South Korea.	lamyud.ryu@samsung.com						ANDREWS JC, 1992, AM J ROENTGENOL, V158, P427, DOI 10.2214/ajr.158.2.1729802; Black IH, 2000, CRIT CARE MED, V28, P3833, DOI 10.1097/00003246-200012000-00014; Chittick P, 2013, INFECT CONT HOSP EP, V34, P980, DOI 10.1086/671726; DeLemos C, 2011, CRIT CARE NURSE, V31, P70, DOI 10.4037/ccn2011911; Dillon RC, 2018, J INTENSIVE CARE MED, V33, P48, DOI 10.1177/0885066617702590; Donovan M S, 1996, J Am Board Fam Pract, V9, P235; Evans RS, 2010, CHEST, V138, P803, DOI 10.1378/chest.10-0154; Fletcher JJ, 2011, NEUROCRIT CARE, V15, P454, DOI 10.1007/s12028-011-9554-3; Griffiths Vivien R, 2002, Intensive Crit Care Nurs, V18, P37, DOI 10.1054/iccn.2002.1615; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Lee DS, 2014, J ACUTE CARE SURG, V4, P13; Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001; Park KB, 2008, J VASC INTERV RADIOL, V19, P552, DOI 10.1016/j.jvir.2007.10.010; Parmentier-Decrucq E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-10; Pittiruti M, 2012, CRIT CARE, V16, DOI 10.1186/cc11181; Pittiruti M, 2009, CLIN NUTR, V28, P365, DOI 10.1016/j.clnu.2009.03.015; Potet J, 2015, DIAGN INTERV IMAG, V96, P1147, DOI 10.1016/j.diii.2014.12.012; RYDER MA, 1993, NURS CLIN N AM, V28, P937; Ryu JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138150; Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489; Schwebel C, 2013, CRIT CARE MED, V41, P1919, DOI 10.1097/CCM.0b013e31828a3bbd; Wilson TJ, 2013, CLIN NEUROL NEUROSUR, V115, P879, DOI 10.1016/j.clineuro.2012.08.025; Wilson TJ, 2012, INTENS CARE MED, V38, P272, DOI 10.1007/s00134-011-2418-7	23	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217641	10.1371/journal.pone.0217641	http://dx.doi.org/10.1371/journal.pone.0217641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150465	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100079
J	Klusmann, B; Wessel, I				Klusmann, Birte; Wessel, Ineke			Manipulating the reported age in earliest memories in a Dutch community sample	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY; EXPERIENCES; GENDER; TIME	Background Childhood amnesia in adults can be defined as the relative paucity of autobiographical memories from the first years of life. An earlier study by Wessel, Schweig and Huntjens demonstrated that 'how' we ask for an earliest memory may bias adults' estimations of when the earliest childhood memory actually happened. They suggested that snapshot memories (i.e., mental pictures) were less sensitive to an age manipulation than event memories (i.e. narratives). We aimed at replicating and extending these findings using a Dutch community sample stratified for age, gender and educational level. Method Participants (N = 619) were randomized into one of three experimental conditions. Prior to recalling their earliest memory, participants in the early and late conditions were presented with examples referring to memories from age 1-2 or 5-6, respectively. The example memories in the control group did not contain any age cues. Participants reported the estimated age in their earliest memory and their strategy for arriving at this estimate. They also rated their memory's phenomenology (e.g. vividness). Independent judges rated memory type (e.g., snapshot memories). Results Compared to the control group, participants in the early condition estimated the age in their memory to be significantly earlier. The difference between the late and control conditions was too small to be of interest. We did not observe a statistically significant interaction between memory type and condition. Snapshot memories were from a younger age than event memories and showed differences with respect to phenomenology (e.g., emotional intensity). Conclusion The results of this community study replicate earlier findings that instructions including age cues influence estimates of age in earliest memories. Although snapshot and event memories seem to be qualitatively different, the idea that they respond differently to an age manipulation could not be corroborated.	[Klusmann, Birte] Univ Med Ctr Groningen, Dept Hlth Psychol, Sect Hlth Sci, Groningen, Netherlands; [Wessel, Ineke] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands	University of Groningen; University of Groningen	Klusmann, B (corresponding author), Univ Med Ctr Groningen, Dept Hlth Psychol, Sect Hlth Sci, Groningen, Netherlands.	b.klusmann@rug.nl		Klusmann, Birte/0000-0002-2859-0546; Wessel, Ineke/0000-0001-6312-376X	Department of Psychology, University of Groningen	Department of Psychology, University of Groningen	I.W. received an internal Internet Research Fund grant from the Department of Psychology, University of Groningen, for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S., 2018, FICTIONAL 1 MEMORIES; Arbuthnott KD, 2009, MEMORY, V17, P279, DOI 10.1080/09658210802665829; Bauer P. J., 2014, WILEY BLACKWELL HDB, P519; Bauer PJ, 2014, MEMORY, V22, P907, DOI 10.1080/09658211.2013.854806; Bruce D, 2005, MEM COGNITION, V33, P567, DOI 10.3758/BF03195324; Bruce D, 2007, APPL COGNITIVE PSYCH, V21, P307, DOI 10.1002/acp.1275; Centraal Bureau voor Statistiek / Central Bureau of Statistics, STAND OND, P1; Centraal Bureau voor Statistiek / Central Bureau of Statistics, 2016, BEGR PERS MET NED AC; Cramer AOJ, 2016, PSYCHON B REV, V23, P640, DOI 10.3758/s13423-015-0913-5; Delacre M, 2017, INT REV SOC PSYCHOL, V30, P92, DOI 10.5334/irsp.82; FRIEDMAN WJ, 1993, PSYCHOL BULL, V113, P44, DOI 10.1037/0033-2909.113.1.44; Gelman A, 2014, AM SCI, V102, P460, DOI 10.1511/2014.111.460; George D, 2003, SPSS WINDOWS STEP ST; Greenberg DL, 2017, MEMORY, V25, P1303, DOI 10.1080/09658211.2017.1297833; Howe ML, 2013, NAT REV NEUROSCI, V14, P869, DOI 10.1038/nrn3627; Jack F, 2007, MEMORY, V15, P647, DOI 10.1080/09658210701467087; Janssen SMJ, 2006, MEM COGNITION, V34, P138, DOI 10.3758/BF03193393; KIHLSTROM JF, 1982, J PERS, V50, P134, DOI 10.1111/j.1467-6494.1982.tb01019.x; Kingo OS, 2013, PSYCHOL AGING, V28, P646, DOI 10.1037/a0031356; Kingo OS, 2013, MEMORY, V21, P280, DOI 10.1080/09658211.2012.729598; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Loftus EF, 2006, ANNU REV CLIN PSYCHO, V2, P469, DOI 10.1146/annurev.clinpsy.2.022305.095315; Luchetti M, 2016, MEMORY, V24, P592, DOI 10.1080/09658211.2015.1031679; MacDonald S, 2000, MEMORY, V8, P365, DOI 10.1080/09658210050156822; Malinoski PT, 1999, INT J CLIN EXP HYP, V47, P320, DOI 10.1080/00207149908410040; Peterson T, 2009, APPL COGNITIVE PSYCH, V23, P267, DOI 10.1002/acp.1455; Qualtrics, 2005, COMPUTER SOFTWARE; Scoboria A, 2017, MEMORY, V25, P146, DOI 10.1080/09658211.2016.1260747; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Tustin K, 2010, DEV PSYCHOL, V46, P1049, DOI 10.1037/a0020105; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wang Q, 2004, J PERS, V72, P911, DOI 10.1111/j.0022-3506.2004.00285.x; Wang Q, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02038; Wang Q, 2014, DEV PSYCHOL, V50, P1680, DOI 10.1037/a0036001; Wessel I, 2019, MEMORY, V27, P6, DOI 10.1080/09658211.2017.1396345; West TA, 1999, MEMORY, V7, P257, DOI 10.1080/096582199387913	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217436	10.1371/journal.pone.0217436	http://dx.doi.org/10.1371/journal.pone.0217436			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150431	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100050
J	Lawrence, YA; Guard, BC; Steiner, JM; Suchodolski, JS; Lidbury, JA				Lawrence, Yuri A.; Guard, Blake C.; Steiner, Joerg M.; Suchodolski, Jan S.; Lidbury, Jonathan A.			Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HEPATOCELLULAR-CARCINOMA; PROTEIN-METABOLISM; LIVER; BIOMARKERS; PLATFORM; INSULIN	Chronic hepatic disease can present a diagnostic challenge with different etiologies being associated with similar clinical and laboratory findings. The histopathological assessment of a liver biopsy specimen is usually required in order to make a definitive diagnosis and the availability of non-invasive prognostic biomarkers is limited. The emerging science of me is used to detect changes in endogenous low molecular weight metabolites in biological samples and offers the possibility of identifying noninvasive markers of disease. The objective of this study was to investigate differences in the urine metabolome between healthy dogs, dogs with chronic hepatitis, dogs with hepatocellular carcinoma, and dogs with a congenital portosystemic shunt. Stored urine samples from 10 healthy dogs, 10 dogs with chronic hepatitis, 6 dogs with hepatocellular carcinoma, and 5 dogs with a congenital portosystemic shunt were analyzed. The urine metabolome was analyzed by gas chromatography-quadrupole time of flight mass spectrometry and 220 known metabolites were identified. Principal component analysis and heat dendrogram plots of the metabolomics data showed clustering between groups. Random forest analysis showed differences in the abundance of various metabolites including putrescine, gluconic acid, sorbitol, and valine. Based on univariate statistics, 37 metabolites were significantly different between groups. In, conclusion, the urine metabolome varies between healthy dogs, dogs with chronic hepatitis, dogs with hepatocellular carcinoma, and dogs with a congenital portosystemic shunt. Further targeted assessment of these metabolites is needed to assess their diagnostic utility.	[Lawrence, Yuri A.; Guard, Blake C.; Steiner, Joerg M.; Suchodolski, Jan S.; Lidbury, Jonathan A.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Lawrence, YA (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA.	ylawrence@cvm.tamu.edu	Lawrence, Yuri A/I-3701-2019	Lawrence, Yuri A/0000-0001-9078-2293				Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253; Center SA, 2002, AM J VET RES, V63, P1187, DOI 10.2460/ajvr.2002.63.1187; Charlton MR, 1996, BAILLIERE CLIN ENDOC, V10, P617, DOI 10.1016/S0950-351X(96)80771-3; D'Anjou MA, 2004, VET RADIOL ULTRASOUN, V45, P424, DOI 10.1111/j.1740-8261.2004.04076.x; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Dong S, 2017, WORLD J GASTROENTERO, V23, P2771, DOI 10.3748/wjg.v23.i15.2771; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Gao R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18175; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Gromski PS, 2015, METABOLOMICS, V11, P684, DOI 10.1007/s11306-014-0738-7; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kawaguchi T, 2009, CURR MED CHEM, V16, P4843, DOI 10.2174/092986709789909620; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Liang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep19763; Liu Y, 2014, INT J CANCER, V135, P658, DOI 10.1002/ijc.28706; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; MCCULLOUGH AJ, 1991, SEMIN LIVER DIS, V11, P265, DOI 10.1055/s-2008-1040445; MUNRO HN, 1975, LANCET, V1, P722; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; SCHAEFFER MC, 1991, LIFE SCI, V48, P2215, DOI 10.1016/0024-3205(91)90335-9; Schnackenberg LK, 2017, METABOLITES, V7, DOI 10.3390/metabo7030046; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; STEIN WH, 1954, J CLIN INVEST, V33, P410, DOI 10.1172/JCI102913; Van den Bossche L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186491; van Straten G, 2015, VET J, V204, P282, DOI 10.1016/j.tvjl.2015.04.020; Vigil A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006304; Webster CRL, 2019, J VET INTERN MED, V33, P1173, DOI 10.1111/jvim.15467; Wu H, 2009, ANAL CHIM ACTA, V648, P98, DOI 10.1016/j.aca.2009.06.033; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Zhou LN, 2012, ANAL BIOANAL CHEM, V403, P203, DOI 10.1007/s00216-012-5782-4	40	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217797	10.1371/journal.pone.0217797	http://dx.doi.org/10.1371/journal.pone.0217797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150490	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100113
J	Lee, DH; Cho, JH; Jung, JI; Baik, JM; Jun, DS; Hwang, CJ; Lee, CS				Lee, Dong-Ho; Cho, Jae Hwan; Jung, Jin Il; Baik, Jong-Min; Jun, Deuk Soo; Hwang, Chang Ju; Lee, Choon Sung			Does stopping at C7 in long posterior cervical fusion accelerate the symptomatic breakdown of cervicothoracic junction?	PLOS ONE			English	Article							SPINE; DISEASE; TRENDS; LEVEL	Object To compare the clinical and radiological outcomes between patients with long posterior cervical fusion (PCF) in which fusion stopped at C7 versus patients in which fusion crossed the cervicothoracic junction (CTJ). Methods The patients were divided into 2 groups on the basis of the lower-most instrumented vertebra (LIV); C7 group patients (n = 25) and upper thoracic (UT) group (n = 21). We analyzed the visual analogue scale of arm/neck pain, Japanese Orthopedic Association (JOA) score, and neck disability index (NDI). And we also measured the following parameters: (1) pseudomotion of fused segments; (2) C2-C7 sagittal vertical axis; (3) T1 slope; and (4) C2-C7 lordosis. Results Arm and neck pain were similar in both groups pre- and postoperatively. Interestingly, mean postoperative NDI score in the UT group was significant worse when compared with the C7 group (9.7 +/- 4.6 vs. 14.2 +/- 3.7, p = 0.006). Although UT patients had longer fusion levels, the fusion rates were not significantly different between the C7 and UT groups (96.0% vs. 90.5%; p = 0.577). The radiographic parameters did not show any significant differences between the groups at final follow-up. Conclusions Our study demonstrates that multi-level PCF stopping at C7 does not negatively affect C7-T1 segment failure, fusion rate, neck pain, neurologic outcomes, and global sagittal alignment of the cervical spine. Hence, it is unnecessary to extend the long PCF levels caudally across the healthy CTJ for fear of development of adjacent segmental disease (ASD) at the C7-T1 segment.	[Lee, Dong-Ho; Cho, Jae Hwan; Jung, Jin Il; Hwang, Chang Ju; Lee, Choon Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Orthoped Surg, Seoul, South Korea; [Baik, Jong-Min; Jun, Deuk Soo] Univ Gachon, Coll Med, Gil Med Ctr, Dept Orthoped Surg, Incheon, South Korea	University of Ulsan; Asan Medical Center; Gachon University	Baik, JM (corresponding author), Univ Gachon, Coll Med, Gil Med Ctr, Dept Orthoped Surg, Incheon, South Korea.	bbaik@hanmail.net		Baik, Jong-Min/0000-0002-6646-2449				AN HS, 1994, SPINE, V19, P2557, DOI 10.1097/00007632-199411001-00011; Boyle JJW, 1996, SPINE, V21, P544, DOI 10.1097/00007632-199603010-00003; Bydon Mohamad, 2014, Surg Neurol Int, V5, pS74, DOI 10.4103/2152-7806.130676; Carrier CS, 2013, SPINE J, V13, P1370, DOI 10.1016/j.spinee.2013.05.050; Cheng I, 2015, GLOB SPINE J, V5, P282, DOI 10.1055/s-0035-1546418; Cho SK, 2013, J AM ACAD ORTHOP SUR, V21, P3, DOI 10.5435/JAAOS-21-01-3; Daffner SD, 2002, AM J ORTHOP, V31, P3223; Eck JC, 2002, SPINE, V27, P2431, DOI 10.1097/00007632-200211150-00003; Komotar Ricardo J, 2006, Spine J, V6, p252S, DOI 10.1016/j.spinee.2006.04.029; Lawrence BD, 2012, SPINE, V37, pS52, DOI 10.1097/BRS.0b013e31826d60fb; Schroeder GD, 2016, SPINE, V41, P1845, DOI 10.1097/BRS.0000000000001864; Song KS, 2014, J BONE JOINT SURG AM, V96A, P557, DOI 10.2106/JBJS.M.00167; STANESCU S, 1994, SPINE, V19, P2082, DOI 10.1097/00007632-199409150-00014; Stein BE, 2014, SPINE, V39, P1178, DOI 10.1097/BRS.0000000000000376; Truumees E, 2018, SPINE J, V18, P782, DOI 10.1016/j.spinee.2017.09.010; Wang MC, 2009, SPINE, V34, P955, DOI 10.1097/BRS.0b013e31819e2fd5; Wang VY, 2007, NEUROSURG CLIN N AM, V18, P365, DOI 10.1016/j.nec.2007.02.012	17	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217792	10.1371/journal.pone.0217792	http://dx.doi.org/10.1371/journal.pone.0217792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150496	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100111
J	Ray, DK; West, PC; Clark, M; Gerber, JS; Prishchepov, AV; Chatterjee, S				Ray, Deepak K.; West, Paul C.; Clark, Michael; Gerber, James S.; Prishchepov, Alexander, V; Chatterjee, Snigdhansu			Climate change has likely already affected global food production	PLOS ONE			English	Article							WHEAT YIELDS; RICE YIELDS; TEMPERATURE; MODELS; TRENDS; SCENARIOS; SECURITY; INCREASE; IMPACTS; CROPS	Crop yields are projected to decrease under future climate conditions, and recent research suggests that yields have already been impacted. However, current impacts on a diversity of crops subnationally and implications for food security remains unclear. Here, we constructed linear regression relationships using weather and reported crop data to assess the potential impact of observed climate change on the yields of the top ten global crops-barley, cassava, maize, oil palm, rapeseed, rice, sorghum, soybean, sugarcane and wheat at similar to 20,000 political units. We find that the impact of global climate change on yields of different crops from climate trends ranged from -13.4% (oil palm) to 3.5% (soybean). Our results show that impacts are mostly negative in Europe, Southern Africa and Australia but generally positive in Latin America. Impacts in Asia and Northern and Central America are mixed. This has likely led to similar to 1% average reduction (-3.5 X 10(13) kcal/year) in consumable food calories in these ten crops. In nearly half of food insecure countries, estimated caloric availability decreased. Our results suggest that climate change has already affected global food production.	[Ray, Deepak K.; West, Paul C.; Gerber, James S.] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA; [Clark, Michael] Univ Minnesota, Dept Nat Resources Sci & Management, St Paul, MN 55108 USA; [Clark, Michael] Univ Oxford, Oxford Martin Sch, Oxford, England; [Clark, Michael] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Prishchepov, Alexander, V] Univ Copenhagen, Dept Geosci & Nat Resource Management IGN, Copenhagen, Denmark; [Chatterjee, Snigdhansu] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oxford; University of Oxford; University of Copenhagen; University of Minnesota System; University of Minnesota Twin Cities	Ray, DK (corresponding author), Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA.	dray@umn.edu	West, Paul C./J-1665-2015; Prishchepov, Alexander/H-6708-2012; Ray, Deepak K/F-7720-2012	West, Paul C./0000-0001-9024-1657; Prishchepov, Alexander/0000-0003-2375-1651; Chatterjee, Snigdhansu/0000-0002-7986-0470; Gerber, James/0000-0002-6890-0481; Clark, Michael/0000-0001-7161-7751; Ray, Deepak/0000-0002-2856-9608	Gordon and Betty Moore Foundation; Belmont Forum/FACCE-JPI [NE/M021327/1]; Institute on the Environment; Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP) [205212/Z/16/Z]; National Science Foundation (NSF) [DMS-1622483, DMS-1737918]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Belmont Forum/FACCE-JPI; Institute on the Environment; Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP); National Science Foundation (NSF)(National Science Foundation (NSF))	DKR, PCW and JSG were partially supported by funding from the Gordon and Betty Moore Foundation and the Belmont Forum/FACCE-JPI funded DEVIL project (NE/M021327/1), and the Institute on the Environment. MC was supported by the Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP), award number 205212/Z/16/Z. SC was partially supported by the National Science Foundation (NSF) grants DMS-1622483 and DMS-1737918. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aggarwal PK, 2002, CLIMATIC CHANGE, V52, P331, DOI 10.1023/A:1013714506779; [Anonymous], 2016, GLOBAL HUNGER INDEX; Asseng S, 2015, NAT CLIM CHANGE, V5, P143, DOI [10.1038/nclimate2470, 10.1038/NCLIMATE2470]; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Brown M.E., 2015, CLIMATE CHANGE GLOBA, DOI [10.7930/J0862DC7, DOI 10.7930/J0862DC7]; Butler EE, 2018, P NATL ACAD SCI USA, V115, P11935, DOI 10.1073/pnas.1808035115; Butler EE, 2013, NAT CLIM CHANGE, V3, P68, DOI [10.1038/NCLIMATE1585, 10.1038/nclimate1585]; Deryng D, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003765; Deutsch CA, 2018, SCIENCE, V361, P916, DOI 10.1126/science.aat3466; Donat MG, 2016, NAT CLIM CHANGE, V6, P508, DOI [10.1038/nclimate2941, 10.1038/NCLIMATE2941]; Elliott J., 2015, GEOSCI MODEL DEV, V8, P261, DOI [10.5194/gmd-8-261-2015, DOI 10.5194/gmd-8-261-2015, DOI 10.5194/GMD-8-261-2015]; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Green JK, 2019, NATURE, V565, P476, DOI 10.1038/s41586-018-0848-x; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hochman Z, 2017, GLOBAL CHANGE BIOL, V23, P2071, DOI 10.1111/gcb.13604; Kukal MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21848-2; Licker R, 2013, AGR FOREST METEOROL, V176, P25, DOI 10.1016/j.agrformet.2013.02.010; Liu B, 2016, NAT CLIM CHANGE, V6, P1130, DOI 10.1038/NCLIMATE3115; Lobell DB, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa518a; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Matiu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178339; Meng QF, 2014, CLIMATIC CHANGE, V122, P341, DOI 10.1007/s10584-013-1009-8; Mourtzinis S, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.26, 10.1038/nplants.2014.26]; Muller C, 2017, GEOSCI MODEL DEV, V10, P1403, DOI 10.5194/gmd-10-1403-2017; Muller D, 2016, IMPACT CLIMATE CHANG, V41; Nawrotzki RJ, 2016, POPUL ENVIRON, V38, P164, DOI 10.1007/s11111-016-0260-0; Nelson GC, 2014, AGR ECON-BLACKWELL, V45, P85, DOI 10.1111/agec.12091; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Ray DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6989; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Roshydromet, 2014, 2 ROSH ASS REP CLIM, V54; Schauberger B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13931; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Siebert S., 2017, ENVIRON RES LETT, V12, DOI 10.1088/ 1748-9326/aa702f; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tack J, 2015, P NATL ACAD SCI USA, V112, P6931, DOI 10.1073/pnas.1415181112; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Tao FL, 2017, AGR FOREST METEOROL, V239, P1, DOI 10.1016/j.agrformet.2017.02.033; Tigchelaar M, 2018, P NATL ACAD SCI USA, V115, P6644, DOI 10.1073/pnas.1718031115; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Wang E, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.102; Wiebe K, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085010; Williams A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160974; Zampieri M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa723b; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114; Zhu GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21049	50	229	232	32	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217148	10.1371/journal.pone.0217148	http://dx.doi.org/10.1371/journal.pone.0217148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150427	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100033
J	Takac, M; Collett, J; Blom, KJ; Conduit, R; Rehm, I; De Foe, A				Takac, Marcel; Collett, James; Blom, Kristopher J.; Conduit, Russell; Rehm, Imogen; De Foe, Alexander			Public speaking anxiety decreases within repeated virtual reality training sessions	PLOS ONE			English	Article							SOCIAL PHOBIA; EXPOSURE THERAPY; FEAR; DISORDERS; SYMPTOMS; STATE	Therapy for public speaking phobia using virtual reality exposure (VRE) has focused on distress arousal rather than distress habituation. Understanding habituation will help optimise session duration, making treatment more affordable and accessible. This pilot study utilised within-speech repeated measures to examine distress habituation during three brief public speaking scenarios in a non-clinical sample (n = 19; 18-76 years). VRE elicited significant distress in all three scenarios. Although within-scenario distress habituation was not observed, between-scenario habituation was partially supported. An increase in distress during the second scenario indicated that three consecutive speech performances were critical in achieving habituation. Brief repeated VRE scenarios using an agent audience were effective in eliciting public speaking distress, as well as habituation.	[Takac, Marcel; Collett, James; Conduit, Russell; Rehm, Imogen; De Foe, Alexander] RMIT Univ, Melbourne, Vic, Australia; [Blom, Kristopher J.] Virtual Human Technol, Vinohrady, Czech Republic	Royal Melbourne Institute of Technology (RMIT)	De Foe, A (corresponding author), RMIT Univ, Melbourne, Vic, Australia.	alexander.defoe@rmit.edu.au		Conduit, Russell/0000-0001-9356-6844; Rehm, Imogen/0000-0002-0053-2272				American Psychiatric Association DSMTF, 2013, DIAGNOSTIC STAT MANU; Anderson PL, 2017, COGNITIVE THER RES, V41, P230, DOI 10.1007/s10608-016-9820-y; Anderson PL, 2013, J CONSULT CLIN PSYCH, V81, P751, DOI 10.1037/a0033559; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Botella C, CYBERTHERAPY ADVANTA, P77; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; Crisan LG, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00005; Finn AN, 2009, COMMUN EDUC, V58, P92, DOI 10.1080/03634520802450549; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Freeman A., 2004, CLIN APPL COGNITIVE; Harris SR, 2002, CYBERPSYCHOL BEHAV, V5, P543, DOI 10.1089/109493102321018187; HEIMBERG RG, 1993, COGNITIVE THER RES, V17, P325, DOI 10.1007/BF01177658; Hook JN, 2008, PERS INDIV DIFFER, V44, P1306, DOI 10.1016/j.paid.2007.11.021; Keough ME, 2010, BEHAV THER, V41, P567, DOI 10.1016/j.beth.2010.04.002; Kessler RC, 1998, AM J PSYCHIAT, V155, P613, DOI 10.1176/ajp.155.5.613; Kessler RC, 2003, ACTA PSYCHIAT SCAND, V108, P19, DOI 10.1034/j.1600-0447.108.s417.2.x; Kozasa EH, 1998, J BEHAV THER EXP PSY, V29, P317, DOI 10.1016/S0005-7916(98)00025-1; Krijn M, 2004, CLIN PSYCHOL REV, V24, P259, DOI 10.1016/j.cpr.2004.04.001; Ling Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096144; MacIntyre VA, 2010, COMMUN RES REP, V27, P286, DOI 10.1080/08824096.2010.496323; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; McCullough SC, 2006, COMMUN Q, V54, P101, DOI 10.1080/01463370500270520; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Overholser James C, 2002, J CONTEMP PSYCHOTHER, V32, P125; Owens ME, 2015, J PSYCHOPATHOL BEHAV, V37, P296, DOI 10.1007/s10862-014-9454-x; Paul G. L., 1966, INSIGHT VS DESENSITI; Ponniah K, 2008, PSYCHOL MED, V38, P3, DOI 10.1017/S0033291707000918; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Regenbrecht H, 2002, PRESENCE-TELEOP VIRT, V11, P425, DOI 10.1162/105474602760204318; Reuland E, 2010, CURR ANTHROPOL, V51, pS99, DOI 10.1086/651260; Riva G, 2007, CYBERPSYCHOL BEHAV, V10, P45, DOI 10.1089/cpb.2006.9993; Ruscio AM, 2008, PSYCHOL MED, V38, P15, DOI 10.1017/S0033291707001699; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Shcherbina A, 2017, J PERS MED, V7, DOI 10.3390/jpm7020003; Sheridan T.B., 1992, PRESENCE TELEOPERATO, V1, P120, DOI [10.1162/pres.1992.1.1.120, DOI 10.1162/PRES.1992.1.1.120]; Smith CD, 2005, COMMUN REP, V18, P31, DOI 10.1080/08934210500084206; Stein MB, 1996, ARCH GEN PSYCHIAT, V53, P169; van Minnen A, 2006, J TRAUMA STRESS, V19, P427, DOI 10.1002/jts.20146; Wallach HS, 2011, ISR J PSYCHIATR REL, V48, P91; Wallach HS, 2009, BEHAV MODIF, V33, P314, DOI 10.1177/0145445509331926; Wolpe J., 1990, PRACTICE BEHAV THERA	41	20	21	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216288	10.1371/journal.pone.0216288	http://dx.doi.org/10.1371/journal.pone.0216288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150399	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000469759100017
J	Torrie, LS; Zuccotto, F; Robinson, DA; Gray, DW; Gilbert, IH; De Rycker, M				Torrie, Leah S.; Zuccotto, Fabio; Robinson, David A.; Gray, David W.; Gilbert, Ian H.; De Rycker, Manu			Identification of inhibitors of an unconventional Trypanosoma brucei kinetochore kinase	PLOS ONE			English	Article							DRUG DISCOVERY; MECHANISM	The discovery of 20 unconventional kinetochore proteins in Trypanosoma brucei has opened a new and interesting area of evolutionary research to study a biological process previously thought to be highly conserved in all eukaryotes. In addition, the discovery of novel proteins involved in a critical cellular process provides an opportunity to exploit differences between kinetoplastid and human kinetochore proteins to develop therapeutics for diseases caused by kinetoplastid parasites. Consequently, we identified two of the unconventional kinetochore proteins as key targets (the highly related kinases KKT10 and KKT19). Recombinant T. bruceiKKT19 (TbKKT19) protein was produced, a peptide substrate phosphorylated by TbKKT19 identified (KKLRRTLSVA), Michaelis constants for KKLRRTLSVA and ATP were determined (179 mu M and 102 mu M respectively) and a robust high-throughput compatible biochemical assay developed. This biochemical assay was validated pharmacologically with inhibition by staurosporine and hypothemycin (IC50 values of 288 nM and 65 nM respectively). Surprisingly, a subsequent high-throughput screen of a kinase-relevant compound library (6,624 compounds) yielded few hits (8 hits; final hit rate 0.12%). The low hit rate observed was unusual for a kinase target, particularly when screened against a compound library enriched with kinase hinge binding scaffolds. In an attempt to understand the low hit rate a TbKKT19 homology model, based on human cdc2-like kinase 1 (CLK1), was generated. Analysis of the TbKKT19 sequence and structure revealed no obvious features that could explain the low hit rates. Further work will therefore be necessary to explore this unique kinetochore kinase as well as to assess whether the few hits identified can be developed into tool molecule(s) or new drugs.	[Torrie, Leah S.; Zuccotto, Fabio; Robinson, David A.; Gray, David W.; Gilbert, Ian H.; De Rycker, Manu] Univ Dundee, Wellcome Ctr Antiinfect Res, Sch Life Sci, Drug Discovery Unit, Dundee, Scotland	University of Dundee	Gilbert, IH; De Rycker, M (corresponding author), Univ Dundee, Wellcome Ctr Antiinfect Res, Sch Life Sci, Drug Discovery Unit, Dundee, Scotland.	I.H.Gilbert@dundee.ac.uk; M.DeRycker@dundee.ac.uk	Gray, David W/F-6674-2011; Zuccotto, Fabio/E-7144-2017	Gray, David W/0000-0001-9512-3828; Gilbert, Ian/0000-0002-5238-1314; De Rycker, Manu/0000-0002-3171-3519; Zuccotto, Fabio/0000-0002-3888-7423	Wellcome Trust [092340, 204672]; Wellcome Centre for Anti-Infectives Research (WCAIR)	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Centre for Anti-Infectives Research (WCAIR)	This work was funded by Wellcome Trust (https://wellcome.ac.uk/) awards 092340 and 204672. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bungo Akiyoshi for provision of the TbKKT19 plasmid and helpful discussions. We also acknowledge the support of the Protein Production, Compound Management and Data Management Teams within the Wellcome Centre for Anti-Infectives Research (WCAIR).	Akiyoshi B, 2016, BIOCHEM SOC T, V44, P1201, DOI 10.1042/BST20160112; Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Alves F, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00048-18; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Bullock AN, 2009, STRUCTURE, V17, P352, DOI 10.1016/j.str.2008.12.023; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; Buscher P, 2017, LANCET, V390, P2397, DOI 10.1016/S0140-6736(17)31510-6; Cheeseman IM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015826; Chen GJ, 2000, BIOCHEMISTRY-US, V39, P2079, DOI 10.1021/bi9919495; Cleghorn LAT, 2011, CHEMMEDCHEM, V6, P2214, DOI 10.1002/cmdc.201100344; De Rycker M, 2018, NATURE, V559, P498, DOI 10.1038/s41586-018-0327-4; Glover L, 2015, NAT PROTOC, V10, P106, DOI 10.1038/nprot.2015.005; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kim JH, 2017, JAMA ONCOL, V3, P1001, DOI 10.1001/jamaoncol.2017.0509; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Mackey ZB, 2011, CHEM BIOL DRUG DES, V78, P454, DOI 10.1111/j.1747-0285.2011.01156.x; Menegay HJ, 2000, J CELL SCI, V113, P3241; Moeslein FM, 1999, J BIOL CHEM, V274, P26697, DOI 10.1074/jbc.274.38.26697; Monda JK, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214577; Nerusheva OO, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150206; Nishino M, 2013, ELIFE, V2, DOI 10.7554/eLife.00712; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Prowse CN, 2001, J BIOL CHEM, V276, P99, DOI 10.1074/jbc.M008137200; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; van Hooff JJE, 2017, EMBO REP, V18, P1559, DOI 10.15252/embr.201744102; Woodland A, 2013, CHEMMEDCHEM, V8, P1127, DOI 10.1002/cmdc.201300072; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10115; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217828	10.1371/journal.pone.0217828	http://dx.doi.org/10.1371/journal.pone.0217828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150492	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100119
J	Yamamoto, K				Yamamoto, Kyosuke			Distillation of crop models to learn plant physiology theories using machine learning	PLOS ONE			English	Article							IMAGE-ANALYSIS; DEEP; IDENTIFICATION	Convolutional neural networks (CNNs) can not only classify images but can also generate key features, e.g., the Google neural network that learned to identify cats by simply watching YouTube videos, for the classification. In this paper, crop models are distilled by CNN to evaluate the ability of deep learning to identify the plant physiology knowledge behind such crop models simply by learning. Due to difficulty in collecting big data on crop growth, a crop model was used to generate datasets. The generated datasets were fed into CNN for distillation of the crop model. The models trained by CNN were evaluated by the visualization of saliency maps. In this study, three saliency maps were calculated using all datasets (case 1) and using datasets with spikelet sterility due to either high temperature at anthesis (case 2) or cool summer damage (case 3). The results of case 1 indicated that CNN determined the developmental index of paddy rice, which was implemented in the crop model, simply by learning. Moreover, CNN identified the important individual environmental factors affecting the grain yield. Although CNN had no prior knowledge of spikelet sterility, cases 2 and 3 indicated that CNN realized about paddy rice becoming sensitive to daily mean and maximum temperatures during specific periods. Such deep learning approaches can be used to accelerate the understanding of crop models and make the models more portable. Moreover, the results indicated that CNN can be used to develop new plant physiology theories simply by learning.	[Yamamoto, Kyosuke] SoftBank Corp, Tokyo, Japan		Yamamoto, K (corresponding author), SoftBank Corp, Tokyo, Japan.	kyosuke.yamamoto01@g.softbank.co.jp			PS Solutions Corp; PS Solutions Corp.	PS Solutions Corp; PS Solutions Corp.	The author is an employee of PS Solutions Corp. and SoftBank Corp. This work was supported by PS Solutions Corp and SoftBank Corp. PS Solutions Corp. provided supports in the form of salaries for the author, and funding for computational resources and English corrections. SoftBank Corp. provided fundings for publication. The specific roles of the author are articulated in the "author contributions" section.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2018, CROPSIM; Boniecki P, 2015, COMPUT ELECTRON AGR, V110, P9, DOI 10.1016/j.compag.2014.09.013; Bouman B., 2001, ORYZA2000 MODELING L, V1; da Silva FL, 2015, COMPUT ELECTRON AGR, V114, P68, DOI 10.1016/j.compag.2015.03.012; Delerce S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161620; Ferentinos KP, 2018, COMPUT ELECTRON AGR, V145, P311, DOI 10.1016/j.compag.2018.01.009; Ghosal S, 2018, P NATL ACAD SCI USA, V115, P4613, DOI 10.1073/pnas.1716999115; Gonzalez-Sanchez A, 2014, SPANISH J AGR RES, V12; Guo W, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0047-9; Guo W, 2013, COMPUT ELECTRON AGR, V96, P58, DOI 10.1016/j.compag.2013.04.010; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Heckmann D, 2017, MOL PLANT, V10, P878, DOI 10.1016/j.molp.2017.04.009; Horie T., 03404007 MIN ED SCI; Horie T, 1995, MODELING IMPACT CLIM, P51; Huang SP, 2015, COMPUT ELECTRON AGR, V118, P167, DOI 10.1016/j.compag.2015.08.031; Ishak AJ, 2009, COMPUT ELECTRON AGR, V66, P53, DOI 10.1016/j.compag.2008.12.003; Jimenez D, 2009, COMPUT ELECTRON AGR, V69, P198, DOI 10.1016/j.compag.2009.08.008; Jones J. W., 1998, Understanding options for agricultural production., P157; JONES JW, 1991, T ASAE, V34, P663; Keating BA, 2003, EUROPEAN J AGRONOMY; Kingma DP., 2014, ADAM METHOD STOCHAST; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kurtulmus F, 2014, PRECIS AGRIC, V15, P57, DOI 10.1007/s11119-013-9323-8; Linker R, 2012, COMPUT ELECTRON AGR, V81, P45, DOI 10.1016/j.compag.2011.11.007; Ma JC, 2015, COMPUT ELECTRON AGR, V111, P92, DOI 10.1016/j.compag.2014.12.007; Marko O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184198; McMennamy JA, 1983, IRRI RES PAPER SERIE; Mutka AM, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00734; Ohno H., 2016, CLIMATE BIOSPHERE, V16, P71, DOI 10.2480/cib.J-16-028; Rahman M, 2015, COMPUT ELECTRON AGR, V113, P14, DOI 10.1016/j.compag.2014.12.012; Rahnemoonfar M, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040905; Sa I, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081222; Safa B, 2004, ARTIFICIAL NEURAL NE; Shekoofa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097288; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simonyan K., 2013, DEEP INSIDE CONVOLUT; Sladojevic S, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/3289801; Stockle CO, 2003, EUROPEAN J AGRONOMY; Su YX, 2017, SAUDI J BIOL SCI, V24, P537, DOI 10.1016/j.sjbs.2017.01.024; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tang L, 2009, NJAS WAGENINGEN J LI; Ubbens J, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0273-z; Uehara G, 1987, P INT WORKSH IMP WEA, P271; van Diepen CA, 1989, SOIL USE MANAGEMENT; Venugoban Kanesh, 2014, International Journal of Machine Learning and Computing, V4, P1, DOI 10.7763/IJMLC.2014.V4.376; Yamamoto K., 2019, DISTILLATION CROP MO, DOI [10.5281/zenodo.2582678, DOI 10.5281/ZENODO.2582678]; Yamamoto K, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17112557; Yamamoto K, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071044; Yamamoto K, 2014, SENSORS-BASEL, V14, P12191, DOI 10.3390/s140712191	50	1	1	9	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217075	10.1371/journal.pone.0217075	http://dx.doi.org/10.1371/journal.pone.0217075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141528	Green Submitted, Green Published, gold			2022-12-26	WOS:000469323000039
J	Duan, YH; Zhong, YZ; Xiao, H; Zheng, CB; Song, B; Wang, WL; Guo, QP; Li, YY; Han, H; Gao, J; Xu, K; Li, TJ; Yin, YL; Li, FN; Yin, J; Kong, XF				Duan, Yehui; Zhong, Yinzhao; Xiao, Hao; Zheng, Changbing; Song, Bo; Wang, Wenlong; Guo, Qiuping; Li, Yuying; Han, Hui; Gao, Jing; Xu, Kang; Li, Tiejun; Yin, Yulong; Li, Fengna; Yin, Jie; Kong, Xiangfeng			Gut microbiota mediates the protective effects of dietary beta-hydroxy-beta-methylbutyrate (HMB) against obesity induced by high-fat diets	FASEB JOURNAL			English	Article						insulin resistance; propionic acid; gut microbiota transplantation; lipid metabolism	BODY-MASS INDEX; INSULIN SENSITIVITY; PROTEIN-METABOLISM; IMPROVES GLUCOSE; SKELETAL-MUSCLE; GLOBAL BURDEN; LEUCINE; OVERWEIGHT; EXPRESSION; CANCER	Obesity increases the risk of developing insulin resistance and diabetes and is a major public health concern. Our previous study shows that dietary beta-hydroxy-beta-methylbutyrate (HMB) improves lipid metabolism in a pig model. However, it remains unclear whether HMB blocks obesity through gut microbiota. In this study, we found that HMB reduced body weight, alleviated the whitening of brown adipose tissue, and improved insulin resistance in mice fed a high-fat diet (HFD). High-throughput pyrosequencing of the 16S rRNA demonstrated that HMB administration significantly reversed the gut microbiota dysbiosis in HFD-fed mice, including the diversity of gut microbiota and relative abundances of Bacteroidetes and Firmicutes. Moreover, microbiota transplantation from HMB-treated mice attenuated HFD-induced lipid metabolic disorders. Furthermore, HFD-fed mice showed lower short-chain fatty acids, whereas administration of HMB increased the propionic acid production. Correlation analysis identified a significant correlation between propionic acid production and the relative Bacteroidetes abundance. Sodium propionate treatment also attenuated HFD-induced lipid metabolic disorders. Collectively, our results indicated that HMB might be used as a probiotic agent to reverse HFD-induced obesity, and the potential mechanism was associated with reprogramming gut microbiota and metabolism, especially Bacteroidetes-mediated propionic acid production. In future studies, more efforts should be made to confirm and expand the beneficial effects of HMB to human models.-Duan, Y., Zhong, Y., Xiao, H., Zheng, C., Song, B., Wang, W., Guo, Q., Li, Y., Han, H., Gao, J., Xu, K., Li, T., Yin, Y., Li, F., Yin, J., Kong, X. Gut microbiota mediates the protective effects of dietary beta-hydroxy-beta-methylbutyrate (HMB) against obesity induced by high-fat diets.	[Duan, Yehui; Zhong, Yinzhao; Wang, Wenlong; Guo, Qiuping; Li, Yuying; Han, Hui; Gao, Jing; Xu, Kang; Li, Tiejun; Yin, Yulong; Li, Fengna; Yin, Jie; Kong, Xiangfeng] Chinese Acad Sci, Hunan Prov Key Lab Anim Nutr Physiol & Metab Proc, Hunan Prov Engn Res Ctr Hlth Livestock & Poultry, Key Lab Agroecol Proc Subtrop Reg,Inst Subtrop Ag, Changsha, Hunan, Peoples R China; [Zhong, Yinzhao; Zheng, Changbing; Song, Bo; Yin, Yulong] South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Regulat, Guangzhou, Guangdong, Peoples R China; [Xiao, Hao] Guangdong Acad Agr Sci, Minist Agr, Inst Anim Sci, Key Lab Anim Nutr & Feed Sci South China, Guangzhou, Guangdong, Peoples R China; [Li, Fengna] Hunan Coinnovat Ctr Anim Prod Safety CICAPS, Hunan Collaborat Innovat Ctr Utilizat Bot Funct I, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; South China Agricultural University; Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Li, FN; Yin, J (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, 644 Yuanda Rd, Changsha 410125, Hunan, Peoples R China.	lifengna@isa.ac.cn; yinjie2014@126.com		Han, Hui/0000-0002-8163-8932; Wang, Wenlong/0000-0003-1669-613X	National Natural Science Foundation of China [31802077]; Science and Technology Project of Guangxi Province [2018JJB130239]; National Key R D Program [2018YFD0500405, 2016YFD0501204, 2017YFD0500503]; Youth Innovation Promotion Association of the Chinese Academy of Sciences (CAS) [2016326]; Science and Technology Projects of Hunan Province [2016SK3022, 2017RS3058]; Key Project of Research and Development Plan of Hunan Province [2016NK2170]; Youth Innovation Team Project of the Institute of Subtropical Agriculture (ISA) [2017QNCXTD_ZCS]; Earmarked Fund for China Agriculture Research System [CARS-35]; Special Fund for Ability Construction - Guangdong Academy of Science [2017GDASCX-0702]; Major Project for Changsha City [kq1706147]; Science and Technology Service (STS) regional key project of the CAS [AD17195043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangxi Province; National Key R D Program; Youth Innovation Promotion Association of the Chinese Academy of Sciences (CAS); Science and Technology Projects of Hunan Province; Key Project of Research and Development Plan of Hunan Province; Youth Innovation Team Project of the Institute of Subtropical Agriculture (ISA); Earmarked Fund for China Agriculture Research System; Special Fund for Ability Construction - Guangdong Academy of Science; Major Project for Changsha City; Science and Technology Service (STS) regional key project of the CAS	This study was jointly supported by the National Natural Science Foundation of China (Grant 31802077), the Science and Technology Project of Guangxi Province (Grant 2018JJB130239), the National Key R & D Program (Grants 2018YFD0500405, 2016YFD0501204, and 2017YFD0500503), the Youth Innovation Promotion Association of the Chinese Academy of Sciences (CAS; Grant 2016326), the Science and Technology Projects of Hunan Province (Grants 2016SK3022 and 2017RS3058), the Key Project of Research and Development Plan of Hunan Province (Grant 2016NK2170), the Youth Innovation Team Project of the Institute of Subtropical Agriculture (ISA; Grant 2017QNCXTD_ZCS), the Earmarked Fund for China Agriculture Research System (Grant CARS-35), Special Fund for Ability Construction Supported by Guangdong Academy of Science (Grant 2017GDASCX-0702), the Major Project for Changsha City (Grant kq1706147), the Science and Technology Service (STS) regional key project of the CAS (Grant AD17195043). The authors declare no conflicts of interest.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; [Anonymous], INT J OBES; Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Binder E, 2014, OBESITY, V22, P713, DOI 10.1002/oby.20578; Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Chen H, 2012, J NEUROENDOCRINOL, V24, P1356, DOI 10.1111/j.1365-2826.2012.02339.x; Duan YH, 2018, FOOD FUNCT, V9, P4836, DOI 10.1039/c8fo00898a; Duan YH, 2018, J AGR FOOD CHEM, V66, P170, DOI 10.1021/acs.jafc.7b04841; Duan YH, 2017, NUTRITION, V36, P8, DOI 10.1016/j.nut.2016.10.016; Duan YH, 2015, ANIM NUTR, V1, P30, DOI 10.1016/j.aninu.2015.02.005; Duan YH, 2016, AMINO ACIDS, V48, P41, DOI 10.1007/s00726-015-2067-1; Federico A, 2017, MINERVA GASTROENTERO, V63, P337, DOI 10.23736/S1121-421X.17.02376-5; Fu LZ, 2015, METABOLISM, V64, P1426, DOI 10.1016/j.metabol.2015.07.006; Fu LZ, 2015, DIABET METAB SYND OB, V8, P227, DOI 10.2147/DMSO.S82338; Fu LZ, 2015, METABOLISM, V64, P845, DOI 10.1016/j.metabol.2015.03.007; Gannon NP, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700756; Giron MD, 2016, J CACHEXIA SARCOPENI, V7, P68, DOI 10.1002/jcsm.12032; Guo KY, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-57; HALL TR, 1993, J BIOL CHEM, V268, P3092; Holecek M, 2017, J CACHEXIA SARCOPENI, V8, P529, DOI 10.1002/jcsm.12208; Hsieh LC, 2010, ASIA PAC J CLIN NUTR, V19, P200; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lemieux-Labonte V, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0334-y; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Liu W, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601082; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Morgen CS, 2014, NAT REV ENDOCRINOL, V10, P513, DOI 10.1038/nrendo.2014.124; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nissen SL, 1997, J NUTR BIOCHEM, V8, P300, DOI 10.1016/S0955-2863(97)00048-X; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Slater GJ, 2000, SPORTS MED, V30, P105, DOI 10.2165/00007256-200030020-00004; Smith HJ, 2005, CANCER RES, V65, P277; Stancliffe RA, 2012, FASEB J, V26; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Tong LC, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00253; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Torres-Leal FL, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-62; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; VANKOEVERING M, 1992, AM J PHYSIOL, V262, pE27, DOI 10.1152/ajpendo.1992.262.1.E27; Wang ZY, 2018, EAT WEIGHT DISORD-ST, V23, P267, DOI 10.1007/s40519-017-0428-3; Wheatley SM, 2014, AM J PHYSIOL-ENDOC M, V306, pE91, DOI 10.1152/ajpendo.00500.2013; Wilson GJ, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-1; Xu PF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12399; Yao K, 2016, TRENDS PHARMACOL SCI, V37, P714, DOI 10.1016/j.tips.2016.05.004; Yin J, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12524; Zemel MB, 2012, NUTRIENTS, V4, P529, DOI 10.3390/nu4060529; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	65	44	49	8	54	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					10019	10033		10.1096/fj.201900665RR	http://dx.doi.org/10.1096/fj.201900665RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31167080				2022-12-26	WOS:000482214200025
J	Froula, JM; Castellana-Cruz, M; Anabtawi, NM; Camino, JD; Chen, SW; Thrasher, DR; Freire, J; Yazdi, AA; Fleming, S; Dobson, CM; Kumita, JR; Cremades, N; Volpicelli-Daley, LA				Froula, Jessica M.; Castellana-Cruz, Marta; Anabtawi, Nadia M.; Camino, Jose D.; Chen, Serene W.; Thrasher, Drake R.; Freire, Jennifer; Yazdi, Allen A.; Fleming, Sheila; Dobson, Christopher M.; Kumita, Janet R.; Cremades, Nunilo; Volpicelli-Daley, Laura A.			Defining alpha-synuclein species responsible for Parkinson's disease phenotypes in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein; Parkinson's disease; amyloid; protein aggregation; neurodegenerative disease; cytotoxicity; fibril; Lewy body; motor-behavior defect; oligomer	ANTIPARALLEL BETA-SHEET; LEWY BODY; OLIGOMERS; FIBRILS; SEEDS; NEURODEGENERATION; TRANSMISSION; PROPAGATION; DYSFUNCTION; AGGREGATION	Parkinson's disease (PD) is a neurodegenerative disorder characterized by fibrillar neuronal inclusions composed of aggregated alpha-synuclein (alpha-syn). These inclusions are associated with behavioral and pathological PD phenotypes. One strategy for therapeutic interventions is to prevent the formation of these inclusions to halt disease progression. alpha-Synuclein exists in multiple structural forms, including disordered, nonamyloid oligomers, ordered amyloid oligomers, and fibrils. It is critical to understand which conformers contribute to specific PD phenotypes. Here, we utilized a mouse model to explore the pathological effects of stable beta-amyloid-sheet oligomers compared with those of fibrillar alpha-synuclein. We biophysically characterized these species with transmission EM, atomic-force microscopy, CD spectroscopy, FTIR spectroscopy, analytical ultracentrifugation, and thioflavin T assays. We then injected these different alpha-synuclein forms into the mouse striatum to determine their ability to induce PD-related phenotypes. We found that beta-sheet oligomers produce a small but significant loss of dopamine neurons in the substantia nigra pars compacta (SNc). Injection of small beta-sheet fibril fragments, however, produced the most robust phenotypes, including reduction of striatal dopamine terminals, SNc loss of dopamine neurons, and motor-behavior defects. We conclude that although the beta-sheet oligomers cause some toxicity, the potent effects of the short fibrillar fragments can be attributed to their ability to recruit monomeric alpha-synuclein and spread in vivo and hence contribute to the development of PD-like phenotypes. These results suggest that strategies to reduce the formation and propagation of beta-sheet fibrillar species could be an important route for therapeutic intervention in PD and related disorders.	[Froula, Jessica M.; Thrasher, Drake R.; Freire, Jennifer; Yazdi, Allen A.; Volpicelli-Daley, Laura A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA; [Anabtawi, Nadia M.; Camino, Jose D.; Cremades, Nunilo] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit BIFI IQFR CSIC, Zaragoza 50018, Spain; [Castellana-Cruz, Marta; Chen, Serene W.; Dobson, Christopher M.; Kumita, Janet R.] Univ Cambridge, Ctr Misfolding Dis, Dept Chem, Cambridge CB2 1EW, England; [Fleming, Sheila] Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH 44272 USA	University of Alabama System; University of Alabama Birmingham; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Cambridge; Northeast Ohio Medical University (NEOMED)	Volpicelli-Daley, LA (corresponding author), Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA.; Cremades, N (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit BIFI IQFR CSIC, Zaragoza 50018, Spain.	ncc@unizar.es; lvolpicellidaley@uabmc.edu	Camino, José Daniel/AFR-1589-2022; Kumita, Janet/AAO-5254-2021; Cremades, Nunilo/F-9634-2015	Yazdi, Allen/0000-0002-4536-7346; Chen, Serene W/0000-0001-7084-5621; Cremades, Nunilo/0000-0002-9138-6687; Freire, Jennifer/0000-0002-6811-7438; Froula, Jessica/0000-0003-0738-904X	Michael J. Fox Foundation; Alabama Udall Center [P50NS108675]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS108675] Funding Source: NIH RePORTER	Michael J. Fox Foundation; Alabama Udall Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Michael J. Fox Foundation (to L.V.-D. and N.C.) and Grant P50NS108675 (Alabama Udall Center). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelmotilib H, 2017, NEUROBIOL DIS, V105, P84, DOI 10.1016/j.nbd.2017.05.014; Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Angelova PR, 2016, J CELL SCI, V129, P1792, DOI 10.1242/jcs.180737; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chang E, 2008, ANAL BIOCHEM, V373, P330, DOI 10.1016/j.ab.2007.09.015; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Cremades N, 2018, NEUROBIOL DIS, V109, P178, DOI 10.1016/j.nbd.2017.07.009; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Dirr ER, 2018, BEHAV BRAIN RES, V343, P41, DOI 10.1016/j.bbr.2018.01.029; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Fusco G, 2017, SCIENCE, V358, P1440, DOI 10.1126/science.aan6160; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Hersch SM, 1997, J COMP NEUROL, V388, P211; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Melki R, 2018, NEUROBIOL DIS, V109, P201, DOI 10.1016/j.nbd.2017.03.011; Mor DE, 2017, NAT NEUROSCI, V20, P1560, DOI 10.1038/nn.4641; OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; Pan WXX, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00147; Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Polinski NK, 2018, J PARKINSON DIS, V8, P303, DOI 10.3233/JPD-171248; Popova B, 2015, BIOMOLECULES, V5, P617, DOI 10.3390/biom5020617; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Rey NL, 2016, J EXP MED, V213, P1759, DOI 10.1084/jem.20160368; Rutherford NJ, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0357-9; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shrivastava AN, 2015, EMBO J, V34, P2408, DOI 10.15252/embj.201591397; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tarutani A, 2016, J BIOL CHEM, V291, P18675, DOI 10.1074/jbc.M116.734707; Vargas KJ, 2017, CELL REP, V18, P161, DOI 10.1016/j.celrep.2016.12.023; Volpicelli-Daley Laura, 2018, Handb Clin Neurol, V153, P321, DOI 10.1016/B978-0-444-63945-5.00017-9; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Volpicelli-Daley Laura A, 2004, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0102s25; Weihofen A, 2019, NEUROBIOL DIS, V124, P276, DOI 10.1016/j.nbd.2018.10.016; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xu GL, 2002, ALZ DIS ASSOC DIS, V16, P191, DOI 10.1097/00002093-200207000-00010; Zharikov AD, 2015, J CLIN INVEST, V125, P2721, DOI 10.1172/JCI64502	58	58	58	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10392	10406		10.1074/jbc.RA119.007743	http://dx.doi.org/10.1074/jbc.RA119.007743			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31142553	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000478717100002
J	Zhao, PS; Pattison, LA; Jensen, DD; Jimenez-Vargas, NN; Latorre, R; Lieu, T; Jaramillo, JO; Lopez-Lopez, C; Poole, DP; Vanner, SJ; Schmidt, BL; Bunnett, NW				Zhao, Peishen; Pattison, Luke A.; Jensen, Dane D.; Jimenez-Vargas, Nestor N.; Latorre, Rocco; Lieu, TinaMarie; Jaramillo, Josue O.; Lopez-Lopez, Cintya; Poole, Daniel P.; Vanner, Stephen J.; Schmidt, Brian L.; Bunnett, Nigel W.			Protein kinase D and G beta gamma mediate sustained nociceptive signaling by biased agonists of protease-activated receptor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); Golgi; pain; protease; protein kinase D (PKD); signal transduction; trafficking; F2R-like trypsin receptor; nociception; proteinase-activated receptor-2; G beta gamma	ARRESTIN-DEPENDENT ENDOCYTOSIS; G(Q)-COUPLED RECEPTORS; MEMBRANE-PROTEIN; LOOP SER(744); GOLGI; DOMAIN; TRANSLOCATION; STIMULATION; TRAFFICKING; SELECTIVITY	Proteases sustain hyperexcitability and pain by cleaving protease-activated receptor-2 (PAR(2)) on nociceptors through distinct mechanisms. Whereas trypsin induces PAR(2) coupling to G alpha(q), G alpha(s), and beta-arrestins, cathepsin-S (CS) and neutrophil elastase (NE) cleave PAR(2) at distinct sites and activate it by biased mechanisms that induce coupling to G alpha(s), but not to G alpha(q) or beta-arrestins. Because proteases activate PAR(2) by irreversible cleavage, and activated PAR(2) is degraded in lysosomes, sustained extracellular protease-mediated signaling requires mobilization of intact PAR(2) from the Golgi apparatus or de novo synthesis of new receptors by incompletely understood mechanisms. We found here that trypsin, CS, and NE stimulate PAR(2)-dependent activation of protein kinase D (PKD) in the Golgi of HEK293 cells, in which PKD regulates protein trafficking. The proteases stimulated translocation of the PKD activator G beta gamma to the Golgi, coinciding with PAR(2) mobilization from the Golgi. Proteases also induced translocation of a photoconverted PAR(2)-Kaede fusion protein from the Golgi to the plasma membrane of KNRK cells. After incubation of HEK293 cells and dorsal root ganglia neurons with CS, NE, or trypsin, PAR(2) responsiveness initially declined, consistent with PAR(2) cleavage and desensitization, and then gradually recovered. Inhibitors of PKD, G beta gamma, and protein translation inhibited recovery of PAR(2) responsiveness. PKD and G beta gamma inhibitors also attenuated protease-evoked mechanical allodynia in mice. We conclude that proteases that activate PAR(2) by canonical and biased mechanisms stimulate PKD in the Golgi; PAR(2) mobilization and de novo synthesis repopulate the cell surface with intact receptors and sustain nociceptive signaling by extracellular proteases.	[Zhao, Peishen; Pattison, Luke A.; Lieu, TinaMarie; Poole, Daniel P.; Bunnett, Nigel W.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Zhao, Peishen; Pattison, Luke A.; Lieu, TinaMarie; Poole, Daniel P.; Bunnett, Nigel W.] Monash Univ, Australian Res Council Ctr Excellence Convergent, Parkville, Vic 3052, Australia; [Jensen, Dane D.; Latorre, Rocco] Columbia Univ, Vagelos Coll Phys & Surg, Dept Surg, New York, NY 10032 USA; [Jensen, Dane D.; Latorre, Rocco] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Jimenez-Vargas, Nestor N.; Jaramillo, Josue O.; Lopez-Lopez, Cintya; Vanner, Stephen J.] Queens Univ, Div Gastroenterol, Gastrointestinal Dis Res Unit, Kingston, ON K7L 3N6, Canada; [Schmidt, Brian L.] NYU, Bluestone Ctr Clin Res, Coll Dent, New York, NY 10010 USA	Monash University; Monash University; Columbia University; Columbia University; Queens University - Canada; New York University	Bunnett, NW (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, 21 Audubon Av,Rm 209, New York, NY 10032 USA.	nb2733@cumc.columbia.edu	Zhao, Peishen/AFQ-6840-2022; Poole, Daniel/AET-6645-2022; Lieu, TinaMarie/AAM-7691-2020; Polanco, Josue O Jaramillo/Q-3718-2016	Poole, Daniel/0000-0002-6168-8422; Polanco, Josue O Jaramillo/0000-0002-4444-6149; Jensen, Dane D./0000-0001-6540-2375; Jimenez-Vargas, Nestor N/0000-0001-6595-1884; Bunnett, Nigel W./0000-0003-3367-0644; Zhao, Peishen/0000-0003-0185-0595; Pattison, Luke/0000-0001-8571-3314	National Institutes of Health [NS102722, DE026806, DK118971]; Department of Defense [W81XWH1810431]; National Health and Medical Research Council [63303, 1049682, 1031886]; Takeda Pharmaceuticals Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Takeda Pharmaceuticals Inc.(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants NS102722, DE026806, and DK118971; Department of Defense Grant W81XWH1810431 (to N. W. B. and B. L. S.); and National Health and Medical Research Council Grants 63303, 1049682, and 1031886) (to N. W. B.). Nigel Bunnett is a founding scientist of Endosome Therapeutics Inc. Research in Nigel Bunnett's laboratory was funded in part by Takeda Pharmaceuticals Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Amadesi S, 2009, J COMP NEUROL, V516, P141, DOI 10.1002/cne.22104; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jensen DD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3447; Jensen DD, 2016, J BIOL CHEM, V291, P11285, DOI 10.1074/jbc.M115.710681; Jimenez-Vargas NN, 2018, P NATL ACAD SCI USA, V115, pE7438, DOI 10.1073/pnas.1721891115; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Muniz M, 1997, P NATL ACAD SCI USA, V94, P14461, DOI 10.1073/pnas.94.26.14461; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Poole DP, 2008, AM J PHYSIOL-GASTR L, V294, pG1245, DOI 10.1152/ajpgi.00521.2007; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Coria AS, 2014, BIOL CELL, V106, P30, DOI 10.1111/boc.201300052; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Waldron RT, 2012, CELL SIGNAL, V24, P914, DOI 10.1016/j.cellsig.2011.12.014; Yarwood RE, 2017, P NATL ACAD SCI USA, V114, P12309, DOI 10.1073/pnas.1706656114; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712	43	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10649	10662		10.1074/jbc.RA118.006935	http://dx.doi.org/10.1074/jbc.RA118.006935			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31142616	Green Published, hybrid			2022-12-26	WOS:000478717100023
J	van Rensburg, C; Berhanu, R; Hirasen, K; Evans, D; Rosen, S; Long, L				van Rensburg, Craig; Berhanu, Rebecca; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Long, Lawrence			Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa	PLOS ONE			English	Article								Background Drug resistant-tuberculosis is a growing burden on the South African health care budget. In response the National Department of Health implemented two important strategies in 2011; universal access to drug-sensitivity testing for rifampicin with Xpert MTB/RIF as the first-line diagnostic test for TB; and decentralization of treatment for RR/MDR-TB to improve access and reduce costs of treatment. Objective Estimate the costs by treatment outcome of decentralized care for rifampicin and multi-drug resistant tuberculosis under routine conditions. The study was set at an outpatient drug resistant-tuberculosis treatment facility at a public academic hospital in Johannesburg, South Africa. During the study period 18-24 month long course treatment was offered for rifampicin-resistant and multi-drug-resistant tuberculosis. Methods Data are from a prospective observational cohort study. Costs of treatment were estimated from the provider perspective using bottom-up micro-costing. Costs were estimated as patient-level resource use multiplied by the unit cost of the resource. Clinic visits, drugs, laboratory tests, and total days hospitalized were collected from patients' medical records. Staff time was estimated through a time and motion study. A successful treatment outcome was defined as cure or completion of the regimen. Results We enrolled 124 patients with 52% having a successful outcome. The average total cost/patient for all patients was $3,430 and $4,530 for successfully treated patients. The largest contributors to total cost across all outcomes were drugs (43%) and staff (28%). The average cost to achieve a successful outcome including all patients who started treatment ("production cost") in the cohort is $6,684. Conclusions Decentralized, outpatient RR/MDR-TB care under South Africa's 2011 strategy costs 74% less per patient than the previous strategy of inpatient care. The treatment cost of RR/MDR-TB is primarily driven by drug and staff costs, which are in turn dependant on treatment length.	[van Rensburg, Craig; Berhanu, Rebecca; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Long, Lawrence] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa; [van Rensburg, Craig; Berhanu, Rebecca; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Long, Lawrence] Univ Witwatersrand, Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Berhanu, Rebecca; Rosen, Sydney; Long, Lawrence] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	University of Witwatersrand; University of Witwatersrand; Boston University	van Rensburg, C (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa.; van Rensburg, C (corresponding author), Univ Witwatersrand, Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa.	cvanrensburg@heroza.org		Berhanu, Rebecca/0000-0002-9692-8748; van Rensburg, Craig/0000-0003-0458-3306	President's Emergency Plan for AIDS Relief (PEPFAR) through USAID [AID-674-A-12-00029, 72067419CA00004]; National Institute of Health Fogarty International Center [D43TW009340]; National Institute of Allergy and Infectious Disease [T32A1052074]; FOGARTY INTERNATIONAL CENTER [D43TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052074] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through USAID(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study has been made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through USAID under the terms of Cooperative Agreements AID-674-A-12-00029 and 72067419CA00004 to HE2RO and LL. The contents are the responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID or the United States Government. RB received support from National Institute of Health Fogarty International Center under award number D43TW009340 and the National Institute of Allergy and Infectious Disease under award number T32A1052074.	Berhanu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164974; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Caminero J., 2013, GUIDELINES CLIN OPER, V2013; Cox H, 2015, TROP MED INT HEALTH, V20, P1337, DOI 10.1111/tmi.12544; Department of Health Republic of South Africa, 2011, S AFR NAT TUB MAN GU; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Loveday M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196003; National Department of Health Republic of South Africa, NEW BED DAT SHOWS RE; National Department of Health Republic of South Africa, 2015, INTR NEW DRUGS DRUG; National Institute for Communicable Diseases, 2017, S AFR TUB DRUG RES S; Organization WH, 2016, GLOBAL TUBERCULOSIS; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Republic Of South Africa, 2011, MULT RES TUB POL FRA, P77; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Sinanovic E, 2015, INT J TUBERC LUNG D, V19, P172, DOI 10.5588/ijtld.14.0421; WHO, 2017, GLOB TUB REP	16	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217820	10.1371/journal.pone.0217820	http://dx.doi.org/10.1371/journal.pone.0217820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170207	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700061
J	Jeong, HG; Yoon, JS; Lee, J; Bae, HJ				Jeong, Han-Gil; Yoon, Jae Sun; Lee, Juneyoung; Bae, Hee-Joon			Incidence of neutropenia in patients with ticlopidine/Ginkgo biloba extract combination drug for vascular events: A post-marketing cohort study	PLOS ONE			English	Article							OXIDATIVE STRESS; RECURRENT STROKE; MINOR STROKE; EGB 761; CLOPIDOGREL; ASPIRIN; PREVENTION; EFFICACY; TRIAL; SAFETY	Background and purpose The ticlopidine/Ginkgo biloba ext. combination drug (Yuclid) is used as an antiplatelet agent for prevention of vascular events since its approval in 2008. The purpose of this study is to explore the safety of ticlopidine/Ginkgo biloba combination, mainly regarding the incidence of neutropenia, through a post-marketing surveillance study. Methods From March 2009 to October 2015, a total of 4839 subjects had been enrolled in this study. The enrollments were conducted by 152 doctors of 89 hospitals according to the regulations for post-marketing surveillance programs in Korea. If a subject was administered the drug once, he/she was included in the safety analysis set for any adverse events and bleedings, and the primary safety evaluation regarding neutropenia was conducted in subjects who completed 3-month blood test follow-up. We predefined that 1% reduction in neutropenia incidence by ticlopidine/Ginkgo biloba ext. combination from the previously reported incidence of ticlopidine of 2.3% was clinically meaningful. Results Among the safety analysis set of 4831 patients (99.8% of the enrolled subjects), 3150 (65.1%) completed evaluation for neutropenia at 3 months which is the primary safety endpoint. The major causes of dropout were no follow-up visit at 3 months (n = 1016) and violation of the follow-up period (n = 503). Nine patients experienced neutropenia (Absolute neutrophil count [ANC] <= 1200mm(3)) and the estimated cumulative incidence at 3 months is 0.29% (95% confidence interval, 0.13%-0.54%). Severe neutropenia (ANC <= 450mm(3)) did not occur in any patients. Conclusions The incidence of neutropenia with addition of Ginkgo biloba ext. to ticlopidine may be lower than the previously reported incidence of neutropenia with ticlopidine, which needs to be confirmed in randomized controlled trials.	[Jeong, Han-Gil; Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea; [Jeong, Han-Gil; Bae, Hee-Joon] Seoul Natl Univ, Bundang Hosp, Cerebrovasc Ctr, Seongnam, South Korea; [Yoon, Jae Sun; Lee, Juneyoung] Korea Univ, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea University	Bae, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea.; Bae, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Cerebrovasc Ctr, Seongnam, South Korea.	braindoc@snu.ac.kr		Lee, Juneyoung/0000-0001-8073-9304; Bae, Hee-Joon/0000-0003-0051-1997	YuYu Pharma, Inc., Seoul, South Korea	YuYu Pharma, Inc., Seoul, South Korea	This research was supported by YuYu Pharma, Inc., Seoul, South Korea, which collaborated in the execution of the study and collected the data. Since this study was a postmarketing surveillance study, YuYu Pharma was required to collaborate in the execution of the study and collection of the data including electronic case report system management and participating center recruitment. However, the study design, statistical analysis, preparation of the manuscript and decision to publish were performed independently by the investigators.	Ahn HS, 2007, DONGDUK PHARM RES, V11, P1; Aleil B, 2007, J THROMB HAEMOST, V5, P879, DOI 10.1111/j.1538-7836.2007.02338.x; An AR, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0555-3; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; Brewer T, 1999, JAMA-J AM MED ASSOC, V281, P824, DOI 10.1001/jama.281.9.824; Chung JW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00044; DroyLefaix MT, 1997, AGE, V20, P141, DOI 10.1007/s11357-997-0013-1; Fukuuchi Y, 2008, CEREBROVASC DIS, V25, P40, DOI 10.1159/000111498; GENT M, 1989, LANCET, V1, P1215, DOI 10.1016/S0140-6736(89)92327-1; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gorelick PB, 2003, JAMA-J AM MED ASSOC, V289, P2947, DOI 10.1001/jama.289.22.2947; HARBISON JW, 1992, STROKE, V23, P1723, DOI 10.1161/01.STR.23.12.1723; HASS WK, 1989, NEW ENGL J MED, V321, P501, DOI 10.1056/NEJM198908243210804; Hong JM, 2013, THROMB RES, V131, pE147, DOI 10.1016/j.thromres.2013.01.026; Huang CH, 2013, PHYTOMEDICINE, V20, P303, DOI 10.1016/j.phymed.2012.11.004; Kim BH, 2010, CLIN THER, V32, P380, DOI 10.1016/j.clinthera.2010.01.027; Kim YS, 1998, THROMB RES, V91, P33, DOI 10.1016/S0049-3848(98)00075-9; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Liu ZC, 2000, DRUG METAB DISPOS, V28, P726; Maeda A, 2011, CLIN PHARMACOL THER, V89, P229, DOI 10.1038/clpt.2010.268; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Muller C, 2000, CIRCULATION, V101, P590, DOI 10.1161/01.CIR.101.6.590; Pan YS, 2017, CIRCULATION, V135, P21, DOI 10.1161/CIRCULATIONAHA.116.024913; Rong YG, 1996, FREE RADICAL BIO MED, V20, P121, DOI 10.1016/0891-5849(95)02016-0; Schindowski K, 2001, J NEURAL TRANSM, V108, P969, DOI 10.1007/s007020170016; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Steinhubl SR, 1999, JAMA-J AM MED ASSOC, V281, P806, DOI 10.1001/jama.281.9.806; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Tang YB, 2011, EUR CELLS MATER, V21, P459, DOI 10.22203/eCM.v021a34; Taniuchi M, 2001, CIRCULATION, V104, P539, DOI 10.1161/hc3001.093435; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Wang YL, 2016, JAMA-J AM MED ASSOC, V316, P70, DOI 10.1001/jama.2016.8662; WEISBERG LA, 1993, NEUROLOGY, V43, P27, DOI 10.1212/WNL.43.1_Part_1.27	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217723	10.1371/journal.pone.0217723	http://dx.doi.org/10.1371/journal.pone.0217723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166961	gold, Green Published, Green Submitted			2022-12-26	WOS:000470087800035
J	Nguyen, TMD; Klett, D; Filliatreau, L; Combarnous, Y				Thi Mong Diep Nguyen; Klett, Daniele; Filliatreau, Laura; Combarnous, Yves			Inhibition by fluoxetine of LH-stimulated cyclic AMP synthesis in tumor Leydig cells partly involves AMPK activation	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; PROTEIN-KINASE; ADENOSINE-MONOPHOSPHATE; ADENYLATE-CYCLASE; EXTRACELLULAR ATP; METFORMIN; MECHANISM; PHOSPHODIESTERASE; MODULATION; MEMBRANE	Fluoxetine (FLX), a widely used antidepressant primarily acting as a selective serotonin reuptake inhibitor (SSRI), has been shown to exhibit other mechanisms of action in various cell types. Consequently, it might have unexpected adverse effects not related to its intended use, possibly in the endocrine regulation of reproduction. We show in the present report that after a 1-hour preincubation of MLTC-1 Leydig cells with FLX, the intracellular cyclic adenosine monophosphate (cAMP) responses to Luteinizing Hormone (LH) and forskolin (FSK) are reduced through AMPK-dependent and -independent pathways respectively. FLX at low concentrations (12.5 mu M and 25 mu M) induced this inhibition without triggering AMPK phosphorylation, while higher FLX concentrations (50 mu M and 100 mu M) induced AMPK phosphorylation and lowered ATP concentration similarly to Metformin. Pretreatment with the specific AMPK inhibitor Compound C (CpdC), significantly diminished the inhibition of cAMP synthesis caused by high concentration of FLX. Moreover, as expected FLX also caused a decline of steroidogenesis which is under the control of cAMP. Taken together, these findings demonstrate that the inhibition of cAMP synthesis by FLX is dose-dependent and occurs in MLTC-1 cells through two mechanisms, AMPK-independent and AMPK-dependent, at low and high concentrations, respectively. FLX also inhibited hormone-induced steroidogenesis in MLTC-1 cells and mouse testicular Leydig cells, suggesting similar mechanisms in both cell types.	[Thi Mong Diep Nguyen; Klett, Daniele; Filliatreau, Laura; Combarnous, Yves] INRA, CNRS, Physiol Reprod & Comportements Nouzilly, Nouzilly, France; [Thi Mong Diep Nguyen] Quy Nhon Univ, Fac Biol Agr Engn, Quy Nhon, Vietnam	Centre National de la Recherche Scientifique (CNRS); INRAE; Quy Nhon University	Nguyen, TMD (corresponding author), INRA, CNRS, Physiol Reprod & Comportements Nouzilly, Nouzilly, France.; Nguyen, TMD (corresponding author), Quy Nhon Univ, Fac Biol Agr Engn, Quy Nhon, Vietnam.	diepdhqn@ymail.com	Nguyen, Thi Mong Diep/AAB-3939-2020; Combarnous, Yves/K-4161-2019	Nguyen, Thi Mong Diep/0000-0001-6534-9041; Combarnous, Yves/0000-0002-0574-2025; filliatreau, ghislaine/0000-0001-8789-1704	Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.01-2017.307]; Institut National de Recherche Agronomique, INRA for TMDN internships in France	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); Institut National de Recherche Agronomique, INRA for TMDN internships in France	This research was funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.01-2017.307. This work was also supported by Institut National de Recherche Agronomique, INRA for TMDN internships in France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou HS, 2014, MOL CELL BIOL, V34, P4257, DOI 10.1128/MCB.00734-14; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bell Stewart, 2006, Ann Clin Psychiatry, V18, P19, DOI 10.1080/10401230500464612; Brambilla P, 2005, PHARMACOPSYCHIATRY, V38, P69, DOI 10.1055/s-2005-837806; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Charles E, 2017, ONCOTARGET, V8, P3181, DOI 10.18632/oncotarget.13689; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Curti C, 1999, MOL CELL BIOCHEM, V199, P103, DOI 10.1023/A:1006912010550; Deak F, 2000, NEUROPHARMACOLOGY, V39, P1029, DOI 10.1016/S0028-3908(99)00206-3; Deli T, 2008, PATHOL ONCOL RES, V14, P219, DOI 10.1007/s12253-008-9071-7; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; DUFAU ML, 1980, P NATL ACAD SCI-BIOL, V77, P5837, DOI 10.1073/pnas.77.10.5837; FREEMAN DA, 1981, P NATL ACAD SCI-BIOL, V78, P6309, DOI 10.1073/pnas.78.10.6309; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Green AS, 2011, CELL CYCLE, V10, P2115, DOI 10.4161/cc.10.13.16244; GUZE BH, 1994, J FAM PRACTICE, V38, P49; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Hallows KR, 2005, CURR OPIN NEPHROL HY, V14, P464, DOI 10.1097/01.mnh.0000174145.14798.64; Halls ML, 2017, PHARMACOL THERAPEUT, V172, P171, DOI 10.1016/j.pharmthera.2017.01.001; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Howlett HCS, 1999, DRUG SAFETY, V20, P489, DOI 10.2165/00002018-199920060-00003; Johanns M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10856; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Klett D, 2016, MOL CELL ENDOCRINOL, V434, P144, DOI 10.1016/j.mce.2016.06.028; Kongsuphol P, 2009, PFLUG ARCH EUR J PHY, V457, P1071, DOI 10.1007/s00424-008-0577-3; Lai ZW, 2013, J IMMUNOL, V191, P2236, DOI 10.4049/jimmunol.1301005; Light PE, 2003, CIRCULATION, V107, P1962, DOI 10.1161/01.CIR.0000069269.60167.02; Liu JH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/932414; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Motlagh K.K., 2012, J PHARM BIOMED SCI, V2, P87; Nahon E, 2005, FEBS LETT, V579, P5105, DOI 10.1016/j.febslet.2005.08.020; ODONNELL JM, 1993, J PHARMACOL EXP THER, V264, P1168; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pancrazio JJ, 1998, J PHARMACOL EXP THER, V284, P208; Pantovic A, 2013, BONE, V52, P524, DOI 10.1016/j.bone.2012.10.024; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; QUINN PG, 1981, ENDOCRINOLOGY, V109, P1790, DOI 10.1210/endo-109-5-1790; REBOIS RV, 1982, J CELL BIOL, V94, P70, DOI 10.1083/jcb.94.1.70; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Sonntag T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173013; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Sukhodub A, 2007, J CELL PHYSIOL, V210, P224, DOI 10.1002/jcp.20862; Svechnikov K, 2009, J APPL TOXICOL, V29, P673, DOI 10.1002/jat.1456; Tartarin P, 2012, ENDOCRINOLOGY, V153, P3468, DOI 10.1210/en.2011-1911; Theriault O, 2015, EUR J PHARMACOL, V764, P395, DOI 10.1016/j.ejphar.2015.06.053; Nguyen TMD, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00025; Nguyen TMD, 2018, GEN COMP ENDOCR, V261, P23, DOI 10.1016/j.ygcen.2018.01.018; Tosca L, 2005, ENDOCRINOLOGY, V146, P4500, DOI 10.1210/en.2005-0301; Tosca L, 2007, BIOL REPROD, V76, P368, DOI 10.1095/biolreprod.106.055749; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Walker JMV, 2017, DIABETES OBES METAB, V19, P997, DOI 10.1111/dom.12912; Willoughby D, 2012, J CELL SCI, V125, P5850, DOI 10.1242/jcs.111427; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	59	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217519	10.1371/journal.pone.0217519	http://dx.doi.org/10.1371/journal.pone.0217519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163038	Green Published, gold, Green Submitted			2022-12-26	WOS:000470086200015
J	Masih, J; Belschak, F; Verbeke, JMIW				Masih, Jolly; Belschak, Frank; Verbeke, J. M. I. Willem			Mood configurations and their relationship to immune system responses: Exploring the relationship between moods, immune system responses, thyroid hormones, and social support	PLOS ONE			English	Article							DEPRESSION; STRESS; ANXIETY; INFLAMMATION; LONELINESS; CYTOKINES; PATHOPHYSIOLOGY; EMOTIONS; IL-6	Analyzing data on 2,057 healthy subjects in the Dutch Lifelines database we explore the relationship between immune system responses, thyroid hormone functioning and people's mood that is expected to be moderated by social support. We focus (1) on the innate immune system cell count: monocytes, eosinophil granulocytes, basophilic granulocytes, neutrophil granulocytes; and thrombocytes; and (2) on the adaptive immune system cell count: lymphocytes (T, B and NK cells). Moods were measured on the positive (PA) and negative (NA) dimensions of the PANAS scale, divided in four groups based on their PA and NA median scores: hedonic, positive mood, negative mood and anhedonic. We focus further on (3) thyroid cells: T3 and T4; and (4) on social support. We found significant differences between mood groups and mean cell counts for basophilic granulocytes and thrombocytes but not for monocytes, eosinophil granulocytes and neutrophil granulocytes in the innate immune system. However, in the adaptive immune system we found mean lymphocyte cell counts to be different in all four mood groups. We also found that T3 and T4 levels differ significantly across all mood groups and work in very close association with lymphocytes to activate the adaptive immune system. These differences were most significant in the hedonic and anhedonic groups. The findings allow us to better understand mood groups, especially the hedonic and anhedonic groups, and open up new avenues for intervention.	[Masih, Jolly; Verbeke, J. M. I. Willem] Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands; [Belschak, Frank] Univ Amsterdam, Sch Econ, Amsterdam, Netherlands	Erasmus University Rotterdam; University of Amsterdam	Verbeke, JMIW (corresponding author), Erasmus Univ, Erasmus Sch Econ, Rotterdam, Netherlands.	verbeke@ese.eur.nl						Ashby F. G., 2002, EMOTIONAL COGNITION, V44, P245, DOI DOI 10.1075/AICR.44.11ASH; Berntson GG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P433, DOI 10.1017/CBO9780511546396.019; Bise S, 2011, PREVALENCE CARDIOVAS, V1; Botella-Carretero JI, 2005, EUR J ENDOCRINOL, V153, P223, DOI 10.1530/eje.1.01951; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; CACIOPPO JT, 1992, AM PSYCHOL, V47, P1019, DOI 10.1037/0003-066X.47.8.1019; CARTON S, 1995, J AFFECT DISORDERS, V34, P219, DOI 10.1016/0165-0327(95)00020-N; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Colic L, 2018, EUROPEAN NEUROPSYCHO; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; COUTELIER JP, 1990, J CLIN IMMUNOL, V10, P204, DOI 10.1007/BF00918653; COYNE JC, 1976, PSYCHIATRY, V39, P28, DOI 10.1080/00332747.1976.11023874; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; D'Acquisto F, 2017, DIALOGUES CLIN NEURO, V19, P9; De Vito P, 2011, THYROID, V21, P879, DOI 10.1089/thy.2010.0429; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Elenkov IJ, 2015, NEUROIMMUNOMODULAT, V12, P255; Futterman AD, 1994, PSYCHOSOMATIC MED; Gaspersz R, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0016-3; GLASER R, 1985, J BEHAV MED, V8, P249, DOI 10.1007/BF00870312; Gray EK, 2001, EMOTIONS WORK THEORY, P21; Gurok MG, 2018, PSYCHIAT CLIN PSYCH, P1; Heffner KL, 2014, ANN ALLERG ASTHMA IM, V113, P13, DOI 10.1016/j.anai.2014.03.008; Hendrick V, 1998, PSYCHIAT CLIN N AM, V21, P277, DOI 10.1016/S0193-953X(05)70005-8; Hyttel J, 1994, INT CLIN PSYCHOPHARM; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Kaviani H, 2004, J AFFECT DISORDERS, V83, P21, DOI 10.1016/j.jad.2004.04.007; KNAPP PH, 1992, PSYCHOSOM MED, V54, P133, DOI 10.1097/00006842-199203000-00002; Kostanjsak Lidija, 2017, Alcoholism and Psychiatry Research, V53, P33, DOI 10.20471/apr.2017.53.01.04; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lasselin J, 2016, CURR OPIN PHARMACOL, V29, P34, DOI 10.1016/j.coph.2016.05.003; Lerman C, 2004, PHARMACOGENOMICS J, V4, P184, DOI 10.1038/sj.tpj.6500238; Liu Y, 2012, INT J RHEUM DIS, V15, P183, DOI 10.1111/j.1756-185X.2011.01673.x; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; Mao RZ, 2018, J AFFECT DISORDERS, V237, P65, DOI 10.1016/j.jad.2018.04.115; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Marsland AL, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P761; Mihailova S, 2016, J NEUROIMMUNOL, V293, P123, DOI 10.1016/j.jneuroim.2016.03.005; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Nieboer A, 2005, SOC INDIC RES, V73, P313, DOI 10.1007/s11205-004-0988-2; Nummenmaa L, 2018, BRIT J PHARM, V1; Park JE, 2005, J KOREAN MED SCI, V20, P215, DOI 10.3346/jkms.2005.20.2.215; Pini S, 2014, EUR NEUROPSYCHOPHARM, V24, pS477, DOI 10.1016/S0924-977X(14)70764-3; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Raap U, 2011, CURR OPIN ALLERGY CL, V11, P420, DOI 10.1097/ACI.0b013e32834a41c2; Russell JA, 2009, COGNITION EMOTION, V23, P1259, DOI 10.1080/02699930902809375; Segerstrom S. C., 2010, EUROPEAN HLTH PSYCHO, V12, P36; Segerstrom SC, 2000, ANN BEHAV MED, V22, P180, DOI 10.1007/BF02895112; SOLOMON WR, 1984, J ALLERGY CLIN IMMUN, V74, P449, DOI 10.1016/0091-6749(84)90376-2; Steibliene V, 2012, IMMUNOLOGY, V123, P584, DOI [10.1111/j.1365-2567.2007.02731.x, DOI 10.1111/J.1365-2567.2007.02731.X]; Tor P. C., 2007, SMJ Singapore Medical Journal, V48, P354; Troisi A, 2011, SOC NEUROSCI-UK, V6, P88, DOI 10.1080/17470919.2010.482786; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004; van den Briel T, 2000, AM J CLIN NUTR, V72, P1179; Warden Diane, 2007, Curr Psychiatry Rep, V9, P449, DOI 10.1007/s11920-007-0061-3; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wawrzyniak AJ, 2011, JPN PSYCHOL RES, V53, P121, DOI 10.1111/j.1468-5884.2011.00466.x; Yip J, 2005, IUBMB LIFE, V57, P103, DOI 10.1080/15216540500078962; Zachariae R, 2001, ALLERGY, V56, P734, DOI 10.1034/j.1398-9995.2001.056008734.x	60	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216232	10.1371/journal.pone.0216232	http://dx.doi.org/10.1371/journal.pone.0216232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150403	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100015
J	Royall, DR; Palmer, RF; Pavlik, V; Massman, P; Darby, E; Rodriguear, M; Ansari, AK; DeToledo, JC; Reddy, H; Wilms, H; Johnson, K; Perez, V; Fairchild, T; Knebl, J; O'Bryant, SE; Hall, JR; Johnson, L; Barber, RC; Mains, D; Alvarez, L; Cullum, M; Rosenberg, R; Williams, B; Quiceno, M; Reisch, J; Hynan, LS; Huebinger, R; Smith, J; Nguyen, T; Royall, D; Palmer, R; Polk, M; Stevens, A; Ory, M; Paydarfar, D; Bertelson, J; Woon, M; Ayres, G; Aguirre, A; Wilhelmsen, KC; Tilson, JL				Royall, Donald R.; Palmer, Raymond F.; Pavlik, Valory; Massman, Paul; Darby, Eveleen; Rodriguear, Monica; Ansari, Aisha Khaleeq; DeToledo, John C.; Reddy, Hemachandra; Wilms, Henrick; Johnson, Kim; Perez, Victoria; Fairchild, Thomas; Knebl, Janice; O'Bryant, Sid E.; Hall, James R.; Johnson, Leigh; Barber, Robert C.; Mains, Douglas; Alvarez, Lisa; Cullum, Munro; Rosenberg, Roger; Williams, Benjamin; Quiceno, Mary; Reisch, Joan; Hynan, Linda S.; Huebinger, Ryan; Smith, Janet; Trung Nguyen; Royall, Donald; Palmer, Raymond; Polk, Marsha; Stevens, Alan; Ory, Marcia; Paydarfar, David; Bertelson, John; Woon, Martin; Ayres, Gayle; Aguirre, Alyssa; Wilhelmsen, Kirk C.; Tilson, Jeffrey L.		ADNI; TARCC	Selection for depression-specific dementia cases with replication in two cohorts	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INSTRUMENTAL ACTIVITIES; MISSING DATA; VALIDATION; MILD; ASSOCIATION; PHENOTYPE; DIAGNOSIS; SCALES; STATE	The latent variable "delta" (for "dementia") provides an etiologically "agnostic" omnibus dementia severity metric capable of recognizing the dementing potential of any condition. Depressive symptoms are independent predictors of delta and are thereby implicated as "dementing". Serum resistin levels partially mediate the association between depressive symptoms and delta. We use a novel "off-diagonal" CHI SQ algorithm to demonstrate our ability to select individuals demented solely by depression's effect in both the Texas Alzheimer's Research and Care Consortium (TARCC) (N congruent to 3,500), and the Alzheimer's Disease Neuroimaging Initiative (ADNI (N congruent to 1,750), and demonstrate the higher resistin levels of such cases in TARCC. This approach can be adapted to any delta-related dementia risk factor or biomarker and used identify individuals who might revert back to non-demented states after its successful treatment.	[Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Royall, Donald R.; Palmer, Raymond F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA; [Royall, Donald R.] South Texas Vet Hlth Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Care Ctr, San Antonio, TX 78229 USA; [Pavlik, Valory; Massman, Paul; Darby, Eveleen; Rodriguear, Monica; Ansari, Aisha Khaleeq] Baylor Coll Med, Houston, TX 77030 USA; [DeToledo, John C.; Reddy, Hemachandra; Wilms, Henrick; Johnson, Kim; Perez, Victoria] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79409 USA; [Fairchild, Thomas; Knebl, Janice; O'Bryant, Sid E.; Hall, James R.; Johnson, Leigh; Barber, Robert C.; Mains, Douglas; Alvarez, Lisa] Univ North Texas, Hlth Sci Ctr, Denton, TX 76203 USA; [Cullum, Munro; Rosenberg, Roger; Williams, Benjamin; Quiceno, Mary; Reisch, Joan; Hynan, Linda S.; Huebinger, Ryan; Smith, Janet; Trung Nguyen] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Royall, Donald; Palmer, Raymond; Polk, Marsha] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Stevens, Alan; Ory, Marcia] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX 77843 USA; [Paydarfar, David; Bertelson, John; Woon, Martin; Ayres, Gayle; Aguirre, Alyssa] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA; [Wilhelmsen, Kirk C.; Tilson, Jeffrey L.] Univ N Carolina, Chapel Hill, NC 27515 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; Baylor College of Medicine; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health San Antonio; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill	Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), South Texas Vet Hlth Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Care Ctr, San Antonio, TX 78229 USA.	royall@uthscsa.edu		Royall, Donald/0000-0001-6475-0300	Blue Skies of Texas comprehensive care retirement community (CCRC) through Alzheimer's Care and Research Center Foundation (Freedom House); Darrell K Royal Texas Alzheimer's Initiative; USAMRAA [11551963]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]	Blue Skies of Texas comprehensive care retirement community (CCRC) through Alzheimer's Care and Research Center Foundation (Freedom House); Darrell K Royal Texas Alzheimer's Initiative; USAMRAA; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense)	This analysis was funded by the Blue Skies of Texas comprehensive care retirement community (CCRC) through a grant from the Alzheimer's Care and Research Center Foundation (Freedom House). This project was supported in part by funding provided to the Texas Alzheimer's Research and Care Consortium by the Darrell K Royal Texas Alzheimer's Initiative, directed by the Texas Council on Alzheimer's Disease and Related Disorders. Dr. Royall is funded by USAMRAA GRANT11551963 to construct delta homologs for use in traumatic brain injury. Dr. Palmer has disclosed his co-invention of delta, its homologs and orthologs to UTHSCSA. Dr. Palmer is also funded by USAMRAA GRANT11551963. Some data used in preparation of this article were obtained from the ADNI database (adni.loni.usc.edu). ADNI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, ADNI investigators contributed to the design and implementation of ADNI and/or provided data. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012).	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Andrews SJ, 2019, ALZHEIMER DIS ASS DI; Arbuckle JL, 2006, ANAL MOMENT STRUCTUR; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bishnoi RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117282; Bishnoi RJ, 2015, J ALZHEIMERS DIS, V43, P37, DOI 10.3233/JAD-140042; Bollen K. A., 1993, TESTING STRUCTURAL E; Brendel M, 2018, J ALZHEIMERS DIS, V65, P793, DOI 10.3233/JAD-170387; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; BURKE WJ, 1989, J AM GERIATR SOC, V37, P856, DOI 10.1111/j.1532-5415.1989.tb02266.x; Degenhardt EK, 2016, PSYCHOSOMATICS, V57, P208, DOI 10.1016/j.psym.2015.12.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavett BE, 2016, J ALZHEIMERS DIS, V49, P531, DOI 10.3233/JAD-150252; Gavett BE, 2015, NEUROPSYCHOLOGY, V29, P344, DOI 10.1037/neu0000128; Goodglass H., 1983, BOSTON NAMING TEST; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Huang AR, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1726; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ismail Z, 2017, JAMA PSYCHIAT, V74, P58, DOI 10.1001/jamapsychiatry.2016.3162; John SE, 2016, NEUROPSYCHOLOGY, V30, P946, DOI 10.1037/neu0000315; Juva K, 1997, AGE AGEING, V26, P393, DOI 10.1093/ageing/26.5.393; Kizilarslanoglu MC, 2015, TURK J MED SCI, V45, P1040, DOI 10.3906/sag-1403-55; Koppara A, 2016, J ALZHEIMERS DIS, V49, P547, DOI 10.3233/JAD-150257; Landau SM, 2016, NEUROLOGY, V86, P1377, DOI 10.1212/WNL.0000000000002576; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MAIXNER SM, 1995, AM J GERIAT PSYCHIAT, V3, P60, DOI 10.1097/00019442-199524310-00008; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; O'Bryant SE, 2013, J ALZHEIMERS DIS, V34, P841, DOI 10.3233/JAD-122074; Palmer RF, 2016, J ALZHEIMERS DIS, V49, P521, DOI 10.3233/JAD-150254; Peh CX, 2017, J ALZHEIMERS DIS, V55, P823, DOI 10.3233/JAD-160575; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Royall DR, 2019, J ALZHEIMERS DIS, V67, P67, DOI 10.3233/JAD-171053; Royall DR, 2018, J NEUROPSYCH CLIN N, V30, P202, DOI 10.1176/appi.neuropsych.17060110; Royall DR, 2017, J GERONTOL B-PSYCHOL, V72, P947, DOI 10.1093/geronb/gbw004; Royall DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175790; Royall Donald R, 2017, Alzheimers Dement (Amst), V6, P214, DOI 10.1016/j.dadm.2017.02.002; Royall DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172268; Royall DR, 2016, AGING-US, V8, P3241, DOI 10.18632/aging.101091; Royall Donald R, 2016, Alzheimers Dement (Amst), V3, P35, DOI 10.1016/j.dadm.2016.02.003; Royall DR, 2016, J ALZHEIMERS DIS, V49, P571, DOI 10.3233/JAD-150250; Royall DR, 2015, NEUROPSYCHOLOGY, V29, P683, DOI 10.1037/neu0000153; Royall DR, 2015, J ALZHEIMERS DIS, V43, P275, DOI 10.3233/JAD-140264; Royall DR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00369; Royall DR, 2013, ALZHEIMERS DEMENT, V9, P318, DOI 10.1016/j.jalz.2011.11.009; Royall DR, 2012, J ALZHEIMERS DIS, V30, P639, DOI 10.3233/JAD-2012-120055; Royall DR, 2018, ALZHEIMERS DEMENT, V14, pP649; Royall DR, 2016, J PREV ALZ DIS, V3, P283; Satapathy SK, 2011, MOL MED, V17, P599, DOI 10.2119/molmed.2011.00083; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Teng E, 2010, DEMENT GERIATR COGN, V30, P189, DOI 10.1159/000313540; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weiner MW, 2015, ALZHEIMERS DEMENT, V11, P730, DOI 10.1016/j.jalz.2015.05.007; Wheaton B, 1977, SOCIOLOGY METHODOLOG; White LR, 2016, NEUROLOGY, V86, P1000, DOI 10.1212/WNL.0000000000002480; Witte MM, 2014, J NEUROPSYCH CLIN N, V26, P214, DOI 10.1176/appi.neuropsych.12120402	61	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216413	10.1371/journal.pone.0216413	http://dx.doi.org/10.1371/journal.pone.0216413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150419	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100020
J	Sellars, M; Clayton, JM; Detering, KM; Tong, A; Power, D; Morton, RL				Sellars, Marcus; Clayton, Josephine M.; Detering, Karen M.; Tong, Allison; Power, David; Morton, Rachael L.			Costs and outcomes of advance care planning and end-of-life care for older adults with end-stage kidney disease: A person-centred decision analysis	PLOS ONE			English	Article							RENAL-DISEASE; DIALYSIS; DIRECTIVES; INTERVENTION; WITHDRAWAL; PATIENT; DEATH	Background Economic evaluations of advance care planning (ACP) in people with chronic kidney disease are scarce. However, past studies suggest ACP may reduce healthcare costs in other settings. We aimed to examine hospital costs and outcomes of a nurse-led ACP intervention compared with usual care in the last 12 months of life for older people with end-stage kidney disease managed with haemodialysis. Methods We simulated the natural history of decedents on dialysis, using hospital data, and modelled the effect of nurse-led ACP on end-of-life care. Outcomes were assessed in terms of patients' end-of-life treatment preferences being met or not, and costs included all hospitalbased care. Model inputs were obtained from a prospective ACP cohort study among dialysis patients; renal registries and the published literature. Cost-effectiveness of ACP was assessed by calculating an incremental cost-effectiveness ratio (ICER), expressed in dollars per additional case of end-of-life preferences being met. Robustness of model results was tested through sensitivity analyses. Results The mean cost of ACP was AUD$ 519 per patient. The mean hospital costs of care in last 12 months of life were $ 100,579 for those who received ACP versus $ 87,282 for those who did not. The proportion of patients in the model who received end-of-life care according to their preferences was higher in the ACP group compared with usual care (68% vs. 24%). The incremental cost per additional case of end-of-life preferences being met was $ 28,421. The greatest influence on the cost-effectiveness of ACP was the probability of dying in hospital following dialysis withdrawal, and costs of acute care. Conclusion Our model suggests nurse-led ACP leads to receipt of patient preferences for end-of-life care, but at an increased cost.	[Sellars, Marcus; Clayton, Josephine M.] Univ Sydney, Fac Med, Northern Clin Sch, Kolling Inst, Sydney, NSW, Australia; [Sellars, Marcus; Detering, Karen M.] Advance Care Planning Australia, Austin Hlth, Melbourne, Vic, Australia; [Clayton, Josephine M.] Greenwich Hosp, HammondCare Ctr Learning & Res Palliat Care, Sydney, NSW, Australia; [Detering, Karen M.] Univ Melbourne, Fac Med Dent & Hlth Sci, Parkville, Vic, Australia; [Tong, Allison] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Tong, Allison] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia; [Power, David] Austin Hlth, Dept Nephrol, Melbourne, Vic, Australia; [Morton, Rachael L.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; University of Sydney; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Sydney	Sellars, M (corresponding author), Univ Sydney, Fac Med, Northern Clin Sch, Kolling Inst, Sydney, NSW, Australia.; Sellars, M (corresponding author), Advance Care Planning Australia, Austin Hlth, Melbourne, Vic, Australia.	marcus.sellars@austin.org.au	Morton, Rachael L/AAB-7420-2020	Morton, Rachael L/0000-0001-7834-0572; Clayton, Josephine/0000-0002-9856-5434; Tong, Allison/0000-0001-8973-9538; Sellars, Marcus/0000-0002-8299-0313	University of Sydney Postgraduate Award; Ramsay Health Care Foundation Top-Up Scholarship; Australian National Health and Medical Research Council Fellowship [1054216]; National Health and Medical Research Council Fellowship [1106716]	University of Sydney Postgraduate Award(University of Sydney); Ramsay Health Care Foundation Top-Up Scholarship; Australian National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	MS is supported by a University of Sydney Postgraduate Award and the Ramsay Health Care Foundation Top-Up Scholarship. RM is supported by an Australian National Health and Medical Research Council Fellowship (1054216). AT is supported by a National Health and Medical Research Council Fellowship (1106716). The funders had no role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.	Brinkman-Stoppelenburg A, 2014, PALLIATIVE MED, V28, P1000, DOI 10.1177/0269216314526272; Davison SN, 2006, CLIN J AM SOC NEPHRO, V1, P1023, DOI 10.2215/CJN.01050306; Davison SN, 2006, BRIT MED J, V333, P886, DOI 10.1136/bmj.38965.626250.55; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Dixon J, 2015, PALLIATIVE MED, V29, P869, DOI 10.1177/0269216315586659; Elliott BA, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4010017; Feely MA, 2016, CLIN J AM SOC NEPHRO, V11, P2204, DOI 10.2215/CJN.12131115; Findlay MD, 2016, NEPHROL DIAL TRANSPL, V31, P2041, DOI 10.1093/ndt/gfw074; Goff SL, 2015, CLIN J AM SOC NEPHRO, V10, P390, DOI 10.2215/CJN.07490714; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Houben CHM, 2014, J AM MED DIR ASSOC, V15, P477, DOI 10.1016/j.jamda.2014.01.008; Husereau Don, 2013, Cost Eff Resour Alloc, V11, P6, DOI 10.1186/1478-7547-11-6; Kirchhoff KT, 2012, J AM GERIATR SOC, V60, P946, DOI 10.1111/j.1532-5415.2012.03917.x; Klingler C, 2016, PALLIATIVE MED, V30, P423, DOI 10.1177/0269216315601346; Luckett T, 2014, AM J KIDNEY DIS, V63, P761, DOI 10.1053/j.ajkd.2013.12.007; McDonald S., ANZDATA REGISTRY REP; Morton RL, 2016, CLIN J AM SOC NEPHRO, V11, P2195, DOI 10.2215/CJN.11861115; Morton RL, 2016, CLIN J AM SOC NEPHRO; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; PETITTI DB, 2000, METAANALYSIS DECISIO; Sellars M, 2019, NEPHROLOGY, V24, P148, DOI 10.1111/nep.13230; Sellars M, 2018, AM J KIDNEY DIS, V71, P216, DOI 10.1053/j.ajkd.2017.07.021; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Song MK, 2017, PALLIATIVE MED, V31, P267, DOI 10.1177/0269216316652012; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sudore RL, 2018, J PAIN SYMPTOM MANAG, V55, P245, DOI 10.1016/j.jpainsymman.2017.08.025; Sudore RL, 2017, J PAIN SYMPTOM MANAG, V53, P821, DOI 10.1016/j.jpainsymman.2016.12.331; SWARTZ RD, 1993, J AM SOC NEPHROL, V3, P1623; Tamura MK, 2017, CLIN J AM SOC NEPHRO, V12, P435, DOI 10.2215/CJN.07510716; Weisbord SD, 2003, NEPHROL DIAL TRANSPL, V18, P1345, DOI 10.1093/ndt/gfg105; Wetmore JB, 2018, AM J KIDNEY DIS, V71, P831, DOI 10.1053/j.ajkd.2017.10.025	31	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217787	10.1371/journal.pone.0217787	http://dx.doi.org/10.1371/journal.pone.0217787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150504	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100108
J	Zhang, BB; Yang, J; Qin, ZF; Li, SS; Xu, JJ; Yao, ZH; Zhang, XJ; Gonzalez, FJ; Yao, XS				Zhang, Beibei; Yang, Jing; Qin, Zifei; Li, Shishi; Xu, Jinjin; Yao, Zhihong; Zhang, Xiaojian; Gonzalez, Frank J.; Yao, Xinsheng			Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; BLOOD-BRAIN-BARRIER; REDUCED GLUCURONIDATION; CURCUMIN ANALOGS; IN-VITRO; IDENTIFICATION; METABOLITES; EXPRESSION; ENZYMES; MRP2	Demethoxycurcumin (DMC) is a safe and natural food-coloring additive, as well as an agent with several therapeutic properties. However, extensive glucuronidation in vivo has resulted in its poor bioavailability. In this study, we aimed to investigate the formation of DMC-O-glucuronides by uridine 5'-diphospho-glucuronosyltransferase 1A1 (UGT1A1) and its transport by breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in HeLa cells stably transfected with UGT1A1 (named HeLa1A1 cells). The chemical inhibitors Ko143 (a selective BCRP inhibitor) and MK571 (a pan-MRP inhibitor) both induced an obvious decrease in the excretion rate of DMC-O-glucuronides and a significant increase in intracellular DMC-O-glucuronide concentrations. Furthermore, BCRP knockdown resulted in a marked reduction in the level of excreted DMC-O-glucuronides (maximal 55.6%), whereas MRP1 and MRP4 silencing significantly decreased the levels of excreted DMC-O-glucuronides (a maximum of 42.9% for MRP1 and a maximum of 29.9% for MRP3), respectively. In contrast, neither the levels of excreted DMC-O-glucuronides nor the accumulation of DMC-O-glucuronides were significantly altered in the MRP4 knock-down HeLa cells. The BCRP, MRP1 and MRP3 transporters were identified as the most important contributors to the excretion of DMC-O-glucuronides. These results may significantly contribute to improving our understanding of mechanisms underlying the cellular disposition of DMC via UGT-mediated metabolism.	[Zhang, Beibei; Yang, Jing; Qin, Zifei; Zhang, Xiaojian] Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Qin, Zifei; Li, Shishi; Xu, Jinjin; Yao, Zhihong; Yao, Xinsheng] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Yao, Zhihong; Yao, Xinsheng] Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Zhengzhou University; Jinan University; Jinan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Qin, ZF (corresponding author), Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.; Qin, ZF; Yao, ZH (corresponding author), Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China.; Yao, ZH (corresponding author), Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou, Guangdong, Peoples R China.	qzf1989@163.com; yaozhihong_jnu@163.com	Yao, Zhihong/GQB-4386-2022	Yao, Zhihong/0000-0001-6946-2367; Qin, Zifei/0000-0001-8989-1986	National Major Scientific and Program of Introducing Talents of Discipline to Universities [B13038]; National Natural Science Foundation of China [81630097]; National Natural Science Foundation of Guangdong Province [2018A030310639, 2017A03031387]; Hospital Youth Foundation of the First Affiliated Hospital of Zhengzhou University [YNQN2017200]; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	National Major Scientific and Program of Introducing Talents of Discipline to Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Hospital Youth Foundation of the First Affiliated Hospital of Zhengzhou University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Major Scientific and Program of Introducing Talents of Discipline to Universities (B13038) to XY, State Key Program of National Natural Science Foundation of China (81630097) to XY, National Natural Science Foundation of Guangdong Province (2017A03031387) to ZY, National Natural Science Foundation of Guangdong Province (2018A030310639) to ZQ and Hospital Youth Foundation of the First Affiliated Hospital of Zhengzhou University (YNQN2017200) to BZ.; This study was supported by grants from the National Major Scientific and Program of Introducing Talents of Discipline to Universities (B13038), State Key Program of National Natural Science Foundation of China (81630097), National Natural Science Foundation of Guangdong Province (2017A03031387), National Natural Science Foundation of Guangdong Province (2018A030310639) and Hospital Youth Foundation of the First Affiliated Hospital of Zhengzhou University (YNQN2017200).	Ahlin G, 2009, DRUG METAB DISPOS, V37, P2275, DOI 10.1124/dmd.109.028654; Ahmad N, 2016, DRUG DELIV, V23, P2095, DOI 10.3109/10717544.2014.941076; Ahmed T, 2014, PHYTOTHER RES, V28, P517, DOI 10.1002/ptr.5030; Allen JD, 2002, MOL CANCER THER, V1, P417; Ampasavate C, 2010, PHYTOMEDICINE, V17, P506, DOI 10.1016/j.phymed.2009.09.004; Ansari M, 2012, PHARMACOGENOMICS J, V12, P386, DOI 10.1038/tpj.2011.17; Arshad L, 2017, FUTURE MED CHEM, V9, P605, DOI 10.4155/fmc-2016-0223; Asai A, 2000, LIFE SCI, V67, P2785, DOI 10.1016/S0024-3205(00)00868-7; Bamba Y, 2011, J NAT MED-TOKYO, V65, P583, DOI 10.1007/s11418-011-0507-0; Burapan S, 2017, J AGR FOOD CHEM, V65, P3306, DOI 10.1021/acs.jafc.7b00943; Cao Y, 2014, J CHROMATOGR B, V949, P70, DOI 10.1016/j.jchromb.2013.12.039; Dinkova-Kostova AT, 1999, CARCINOGENESIS, V20, P911, DOI 10.1093/carcin/20.5.911; Fahrmayr C, 2012, BRIT J PHARMACOL, V165, P1836, DOI 10.1111/j.1476-5381.2011.01672.x; Furukawa T, 2009, PHARM RES-DORDR, V26, P469, DOI 10.1007/s11095-008-9752-7; Ge SF, 2016, PHARM RES-DORDR, V33, P590, DOI 10.1007/s11095-015-1812-1; Hoehle SI, 2007, MOL NUTR FOOD RES, V51, P932, DOI 10.1002/mnfr.200600283; HOLDER GM, 1978, XENOBIOTICA, V8, P761, DOI 10.3109/00498257809069589; Hong XD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091983; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Jiang W, 2012, DRUG METAB DISPOS, V40, P336, DOI 10.1124/dmd.111.041467; Karibe T, 2018, DRUG METAB DISPOS, V46, P667, DOI 10.1124/dmd.117.078931; Kaur M, 2017, BRAIN RES, V1654, P9, DOI 10.1016/j.brainres.2016.10.020; Kocher A, 2015, J FUNCT FOODS, V14, P183, DOI 10.1016/j.jff.2015.01.045; Krishnakumar IM, 2015, J FUNCT FOODS, V14, P215, DOI 10.1016/j.jff.2015.01.049; Lee CA, 2015, DRUG METAB DISPOS, V43, P490, DOI 10.1124/dmd.114.062174; Li R, 2011, FOOD CHEM, V126, P1890, DOI 10.1016/j.foodchem.2010.12.014; Li SS, 2018, CHEM-BIOL INTERACT, V296, P45, DOI 10.1016/j.cbi.2018.09.001; Lin EPY, 2018, JCO PRECIS ONCOL, V2, DOI 10.1200/PO.18.00043; Liu YQ, 2018, J PHARMACEUT BIOMED, V154, P31, DOI 10.1016/j.jpba.2018.03.014; Lu XY, 2015, MOL NUTR FOOD RES, V59, P634, DOI 10.1002/mnfr.201400493; Lv X, 2015, DRUG METAB PHARMACOK, V30, P358, DOI 10.1016/j.dmpk.2015.07.001; Maruo Y, 2003, CLIN GENET, V64, P420, DOI 10.1034/j.1399-0004.2003.00136.x; Qin ZF, 2018, FOOD FUNCT, V9, P1410, DOI 10.1039/c7fo01298e; Quan EX, 2015, DRUG METAB DISPOS, V43, P433, DOI 10.1124/dmd.114.061598; Schwabedissen HEUMZ, 2005, AM J PATHOL, V166, P39, DOI 10.1016/S0002-9440(10)62230-4; Sun H, 2015, J AGR FOOD CHEM, V63, P6001, DOI 10.1021/acs.jafc.5b00983; Teymouri M, 2018, J CELL PHYSIOL, V233, P124, DOI 10.1002/jcp.25749; Verma MK, 2013, DARU, V21, DOI 10.1186/2008-2231-21-11; Volak LP, 2008, DRUG METAB DISPOS, V36, P1594, DOI 10.1124/dmd.108.020552; Vulsteke C, 2013, ANN ONCOL, V24, P1513, DOI 10.1093/annonc/mdt008; Wang L, 2018, XENOBIOTICA, V48, P357, DOI 10.1080/00498254.2017.1323139; Wang MF, 2016, MOL NUTR FOOD RES, V60, P1967, DOI 10.1002/mnfr.201500321; Wang XX, 2015, TOXICOL APPL PHARM, V289, P70, DOI 10.1016/j.taap.2015.09.003; Wu BJ, 2012, J PHARM SCI-US, V101, P381, DOI 10.1002/jps.22738; Xin H, 2015, J PHARM PHARMACOL, V67, P1673, DOI 10.1111/jphp.12483; Yang J, 2018, BIOFACTORS, V44, P558, DOI 10.1002/biof.1452; Zeng YC, 2007, DRUG METAB DISPOS, V35, P1564, DOI 10.1124/dmd.107.015008; Zhang XW, 2015, MOL PHARMACEUT, V12, P1268, DOI 10.1021/mp5008019; ZHANG Y, 2016, OXID MED CELL LONGEV, V16, DOI DOI 10.1155/2016/9045736	50	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217695	10.1371/journal.pone.0217695	http://dx.doi.org/10.1371/journal.pone.0217695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150474	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100090
J	Fu, X; Jia, TX; Zhang, XQ; Li, SL; Zhang, YL				Fu, Xiao; Jia, Tianxia; Zhang, Xueqi; Li, Shanlin; Zhang, Yonglin			Do street-level scene perceptions affect housing prices in Chinese megacities? An analysis using open access datasets and deep learning	PLOS ONE			English	Article							BUILT ENVIRONMENT; HEDONIC ANALYSIS; URBAN LANDSCAPE; VIEW; GREENERY; TREES; NEIGHBORHOODS; HEALTH; SKY; GUANGZHOU	Many studies have explored the relationship between housing prices and environmental characteristics using the hedonic price model (HPM). However, few studies have deeply examined the impact of scene perception near residential units on housing prices. This article used house purchasing records from FANacom and open access geolocation data (including massive street view pictures, point of interest (POI) data and road network data) and proposed a framework named "open-access-dataset-based hedonic price modeling (OADB-HPM)" for comprehensive analysis in Beijing and Shanghai, China. A state-of-the-art deep learning framework and massive Baidu street view panoramas were employed to visualize and quantify three major scene perception characteristics (greenery, sky and building view indexes, abbreviated GVI, SVI and BVI, respectively) at the street level. Then, the newly introduced scene perception characteristics were combined with other traditional characteristics in the HPM to calculate marginal prices, and the results for Beijing and Shanghai were explored and compared. The empirical results showed that the greenery and sky perceptual elements at the property level can significantly increase the housing price in Beijing (RMB 39,377 and 6011, respectively) and Shanghai (RMB 21,689 and 2763, respectively), indicating an objectively higher willingness by buyers to pay for houses that provide the ability to perceive natural elements in the surrounding environment. This study developed quantification tools to help decision makers and planners understand and analyze the interaction between residents and urban scene components.	[Fu, Xiao; Jia, Tianxia; Zhang, Xueqi; Zhang, Yonglin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Jia, Tianxia; Zhang, Xueqi; Zhang, Yonglin] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China; [Li, Shanlin] Chinese Acad Sci, Natl Sci Lib, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; National Science Library, CAS	Zhang, YL (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.; Zhang, YL (corresponding author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China.	ylzhang_rcees@foxmail.com		Zhang, Yonglin/0000-0001-5432-8800	National Key Research and Development Program of China [2016YFC0503605]	National Key Research and Development Program of China	All authors were funded by The National Key Research and Development Program of China (2016YFC0503605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair A, 2000, HOUSING STUD, V15, P699, DOI 10.1080/02673030050134565; [Anonymous], ICAL EC, V82, P34, DOI [10.1086/260169, DOI 10.1086/260169]; Asgarzadeh M, 2014, LANDSCAPE URBAN PLAN, V131, P36, DOI 10.1016/j.landurbplan.2014.07.011; Asgarzadeh M, 2012, LANDSCAPE URBAN PLAN, V107, P1, DOI 10.1016/j.landurbplan.2012.04.001; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Bae C., 2003, TRANSPORT POLICY, V10, P85, DOI [10.1016/S0967-070X(02)00048-3, DOI 10.1016/S0967-070X(02)00048-3, 10.1016/s0967-070x(02)00048-3]; Barnett DW, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0558-z; Chen WY, 2008, CITIES, V25, P298, DOI 10.1016/j.cities.2008.06.002; Chen WY, 2018, GEOGR J, V184, P283, DOI 10.1111/geoj.12246; Chen WY, 2010, GEOGR J, V176, P227, DOI 10.1111/j.1475-4959.2010.00358.x; Cheng L, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6090265; Dong RC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071367; Dubey A, 2016, LECT NOTES COMPUT SC, V9905, P196, DOI 10.1007/978-3-319-46448-0_12; Evans GW, 2003, J URBAN HEALTH, V80, P536, DOI 10.1093/jurban/jtg063; Gebru T, 2017, P NATL ACAD SCI USA, V114, P13108, DOI 10.1073/pnas.1700035114; Gong FY, 2018, BUILD ENVIRON, V134, P155, DOI 10.1016/j.buildenv.2018.02.042; Gubbels JS, 2016, HEALTH PLACE, V40, P153, DOI 10.1016/j.healthplace.2016.06.002; HANEY WG, 1978, HUM ECOL, V6, P201, DOI 10.1007/BF00889095; He L, 2017, COMPUT ENVIRON URBAN, V66, P83, DOI 10.1016/j.compenvurbsys.2017.08.001; Hu TY, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020151; Hui ECM, 2007, BUILD ENVIRON, V42, P2333, DOI 10.1016/j.buildenv.2006.05.004; Jackson LE, 2003, LANDSCAPE URBAN PLAN, V64, P191, DOI 10.1016/S0169-2046(02)00230-X; Jim CY, 2007, GEOFORUM, V38, P414, DOI 10.1016/j.geoforum.2006.10.002; Jim CY, 2006, LANDSCAPE URBAN PLAN, V78, P422, DOI 10.1016/j.landurbplan.2005.12.003; Jim CY, 2009, LANDSCAPE URBAN PLAN, V91, P226, DOI 10.1016/j.landurbplan.2009.01.009; Joo Y, 2015, URBAN FOR URBAN GREE, V14, P1088, DOI 10.1016/j.ufug.2015.10.001; Klemm W, 2015, LANDSCAPE URBAN PLAN, V138, P87, DOI 10.1016/j.landurbplan.2015.02.009; Kong FH, 2006, LANDSCAPE URBAN PLAN, V78, P147, DOI 10.1016/j.landurbplan.2005.07.006; Lansford NH, 1995, J AGR RESOUR ECON, V20, P341; Li XJ, 2018, T GIS, V22, P1029, DOI 10.1111/tgis.12472; Li XJ, 2018, LANDSCAPE URBAN PLAN, V169, P81, DOI 10.1016/j.landurbplan.2017.08.011; Li XJ, 2016, URBAN FOR URBAN GREE, V18, P163, DOI 10.1016/j.ufug.2016.06.002; Li XJ, 2015, URBAN FOR URBAN GREE, V14, P675, DOI 10.1016/j.ufug.2015.06.006; Liang JM, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9050411; Liu L, 2017, COMPUT ENVIRON URBAN, V65, P113, DOI 10.1016/j.compenvurbsys.2017.06.003; Liu RQ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061161; Liu XJ, 2016, ENVIRON PLANN B, V43, P341, DOI 10.1177/0265813515604767; Long Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171110; Lu Y, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081576; Lu Y, 2018, SOC SCI MED, V208, P41, DOI 10.1016/j.socscimed.2018.05.022; Luttik J, 2000, LANDSCAPE URBAN PLAN, V48, P161, DOI 10.1016/S0169-2046(00)00039-6; Lynch K., 1982, IMAGEN CITY; Mahan BL, 2000, LAND ECON, V76, P100, DOI 10.2307/3147260; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; Mansfield C, 2005, J FOREST ECON, V11, P177, DOI 10.1016/j.jfe.2005.08.002; Tse RYC, 2002, URBAN STUD, V39, P1165, DOI 10.1080/00420980220135545; Tyrvainen L, 1997, LANDSCAPE URBAN PLAN, V37, P211, DOI 10.1016/S0169-2046(97)80005-9; Tyrvainen L, 2000, J ENVIRON ECON MANAG, V39, P205, DOI 10.1006/jeem.1999.1097; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; Wen HZ, 2017, CITIES, V66, P72, DOI 10.1016/j.cities.2017.03.008; Wen HZ, 2014, HABITAT INT, V42, P155, DOI 10.1016/j.habitatint.2013.12.004; Wolf KL, 2005, J FOREST, V103, P396; Wu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164553; Xiao YX, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6110358; Yin L, 2015, APPL GEOGR, V63, P337, DOI 10.1016/j.apgeog.2015.07.010; Zeng LY, 2018, BUILD ENVIRON, V135, P74, DOI 10.1016/j.buildenv.2018.03.009; Zhang F, 2018, LANDSCAPE URBAN PLAN, V180, P148, DOI 10.1016/j.landurbplan.2018.08.020; Zhang F, 2018, COMPUT ENVIRON URBAN, V71, P153, DOI 10.1016/j.compenvurbsys.2018.05.005; Zhang YL, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7030104; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660; Zhao JZ, 2016, INT J SUST DEV WORLD, V23, P293, DOI 10.1080/13504509.2015.1119215; Zhou BL, 2019, INT J COMPUT VISION, V127, P302, DOI 10.1007/s11263-018-1140-0	62	29	30	10	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217505	10.1371/journal.pone.0217505	http://dx.doi.org/10.1371/journal.pone.0217505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145767	Green Published, gold, Green Submitted			2022-12-26	WOS:000469425500019
J	Meischl, T; Rasoul-Rockenschaub, S; Gyori, G; Sieghart, W; Reiberger, T; Trauner, M; Soliman, T; Berlakovich, G; Pinter, M				Meischl, Tobias; Rasoul-Rockenschaub, Susanne; Gyoeri, Georg; Sieghart, Wolfgang; Reiberger, Thomas; Trauner, Michael; Soliman, Thomas; Berlakovich, Gabriela; Pinter, Matthias			C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; GLASGOW PROGNOSTIC SCORE; POOR-PROGNOSIS; SURVIVAL; IMPACT; INFLAMMATION; BIOMARKER; CRITERIA	Background Serum C-reactive protein (CRP) is a prognostic factor for overall survival (OS) and recurrence of hepatocellular carcinoma (HCC) in patients treated with resection or non-surgical treatment. Here, we investigated the association of elevated CRP (>= 1 vs. < 1 mg/dL) with (i) recurrence of HCC and (ii) OS after liver transplantation (LT). Methods Adult HCC patients undergoing orthotopic deceased donor LT at the Medical University of Vienna between 1997 and 2014 were retrospectively analysed. Results Among 216 patients included, 132 (61.1%) were transplanted within the Milan criteria and forty-two patients (19.4%) had microvascular invasion on explant histology. Seventy patients (32.4%) showed elevated CRP (>= 1 mg/dL). On multivariate analysis, a CRP >= 1 mg/dL was an independent risk factor for HCC recurrence with a 5-year recurrence rate of 27.4% vs. 16.4% (HR 2.33; 95% CI 1.13-4.83; p = 0.022). OS was similar in patients with normal vs. elevated CRP levels. Conclusions Elevated serum CRP is associated with HCC recurrence after LT and may be a marker for more aggressive tumor biology. Future studies should evaluate whether patients with elevated pre-transplant CRP levels benefit from closer monitoring for HCC recurrence.	[Meischl, Tobias; Sieghart, Wolfgang; Reiberger, Thomas; Trauner, Michael; Pinter, Matthias] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Meischl, Tobias; Sieghart, Wolfgang; Pinter, Matthias] Med Univ Vienna, Liver Canc HCC Study Grp Vienna, Vienna, Austria; [Rasoul-Rockenschaub, Susanne; Gyoeri, Georg; Soliman, Thomas; Berlakovich, Gabriela] Med Univ Vienna, Dept Surg, Div Transplantat, Vienna, Austria; [Reiberger, Thomas] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Pinter, M (corresponding author), Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.; Pinter, M (corresponding author), Med Univ Vienna, Liver Canc HCC Study Grp Vienna, Vienna, Austria.	matthias.pinter@meduniwien.ac.at	Reiberger, Thomas/H-7613-2019	Reiberger, Thomas/0000-0002-4590-3583; Meischl, Tobias/0000-0002-1716-9166; Trauner, Michael/0000-0002-1275-6425; Gyoeri, Georg/0000-0002-0863-2876				An HJ, 2012, LIVER TRANSPLANT, V18, P1406, DOI 10.1002/lt.23512; Befeler AS, 2005, GASTROENTEROLOGY, V128, P1752, DOI 10.1053/j.gastro.2005.03.033; Bruix J, 2017, J HEPATOL, V67, P999, DOI 10.1016/j.jhep.2017.06.026; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Cervoni JP, 2012, J HEPATOL, V56, P1299, DOI 10.1016/j.jhep.2011.12.030; Chun JM, 2011, J SURG ONCOL, V103, P148, DOI 10.1002/jso.21786; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Fan WZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119312; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Galle PR, 2018, J HEPATOLOGY; Graziadei I, 2016, WIEN KLIN WOCHENSCHR, V128, P679, DOI 10.1007/s00508-016-1046-1; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Howell JA, 2017, ONCOTARGET, V8, P36161, DOI 10.18632/oncotarget.15322; Hung HC, 2017, J HEPATO-BIL-PAN SCI, V24, P559, DOI 10.1002/jhbp.498; Imai N, 2013, CLIN TRANSL ONCOL, V15, P575, DOI 10.1007/s12094-012-0976-y; Ji F, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2189-1; Kim YK, 2015, TRANSPL P, V47, P686, DOI 10.1016/j.transproceed.2014.11.048; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Li MX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002133; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Lue A, 2017, ONCOTARGET, V8, P103077, DOI 10.18632/oncotarget.21528; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2011, LIVER TRANSPLANT, V17, pS44, DOI 10.1002/lt.22365; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Mori S, 2014, HEPATO-GASTROENTEROL, V61, P2353, DOI 10.5754/hge13322; Na GH, 2014, WORLD J GASTROENTERO, V20, P6594, DOI 10.3748/wjg.v20.i21.6594; Nakanishi H, 2016, LIVER CANCER, V5, P257, DOI 10.1159/000449337; O'Dowd C, 2010, J THORAC ONCOL, V5, P988, DOI 10.1097/JTO.0b013e3181da78f9; Okamura Y, 2016, BRIT J SURG, V103, P891, DOI 10.1002/bjs.10123; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; PENN I, 1991, SURGERY, V110, P726; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042; Polterauer S, 2010, INT J GYNECOL CANCER, V20, P1052, DOI 10.1111/IGC.0b013e3181e64bb1; Qi XS, 2016, ONCOTARGET, V7, P45283, DOI 10.18632/oncotarget.9942; Raj A, 2011, J HEPATOL, V55, P1063, DOI 10.1016/j.jhep.2011.01.052; Rebonato A, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/4164130; Shiba H, 2017, ONCOL LETT, V14, P293, DOI 10.3892/ol.2017.6104; Shimada H, 2003, J SURG ONCOL, V83, P248, DOI 10.1002/jso.10275; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Sprinzl MF, 2018, LIVER CANCER, P1; Wang YJ, 2018, INT J SURG, V55, P73, DOI 10.1016/j.ijsu.2018.05.022; Xiao GQ, 2013, WORLD J GASTROENTERO, V19, P8398, DOI 10.3748/wjg.v19.i45.8398; Xiao W-K, 2014, BMC CANCER, P14, DOI [10.18632/oncotarget.9942, DOI 10.18632/ONCOTARGET.9942]; Yao FY, 2008, AM J TRANSPLANT, V8, P1982, DOI 10.1111/j.1600-6143.2008.02351.x; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563	51	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216677	10.1371/journal.pone.0216677	http://dx.doi.org/10.1371/journal.pone.0216677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141535	Green Submitted, Green Published, gold			2022-12-26	WOS:000469323000018
J	Puchades, MA; Csucs, G; Ledergerber, D; Leergaard, TB; Bjaalie, JG				Puchades, Maja A.; Csucs, Gergely; Ledergerber, Debora; Leergaard, Trygve B.; Bjaalie, Jan G.			Spatial registration of serial microscopic brain images to three-dimensional reference atlases with the QuickNII tool	PLOS ONE			English	Article							WAXHOLM SPACE ATLAS; MOUSE-BRAIN; CONNECTOME; MAPS	Modern high throughput brain wide profiling techniques for cells and their morphology, connectivity, and other properties, make the use of reference atlases with 3D coordinate frameworks essential. However, anatomical location of observations made in microscopic sectional images from rodent brains is typically determined by comparison with 2D anatomical reference atlases. A major challenge in this regard is that microscopic sections often are cut with orientations deviating from the standard planes used in the reference atlases, resulting in inaccuracies and a need for tedious correction steps. Overall, efficient tools for registration of large series of section images to reference atlases are currently not widely available. Here we present QuickNII, a stand-alone software tool for semi-automated affine spatial registration of sectional image data to a 3D reference atlas coordinate framework. A key feature in the tool is the capability to generate user defined cut planes through the reference atlas, matching the orientation of the cut plane of the sectional image data. The reference atlas is transformed to match anatomical landmarks in the corresponding experimental images. In this way, the spatial relationship between experimental image and atlas is defined, without introducing distortions in the original experimental images. Following anchoring of a limited number of sections containing key landmarks, transformations are propagated across the entire series of sectional images to reduce the amount of manual steps required. By having coordinates assigned to the experimental images, further analysis of the distribution of features extracted from the images is greatly facilitated.	[Puchades, Maja A.; Csucs, Gergely; Leergaard, Trygve B.; Bjaalie, Jan G.] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Neural Syst Lab, Oslo, Norway; [Ledergerber, Debora] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NTNU, Trondheim, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU)	Bjaalie, JG (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Neural Syst Lab, Oslo, Norway.	j.g.bjaalie@medisin.uio.no	Bjaalie, Jan G. G./AAW-6445-2021; Puchades, Maja/D-5835-2013	Bjaalie, Jan G. G./0000-0001-7899-906X; Puchades, Maja/0000-0002-4536-8197; Leergaard, Trygve B./0000-0001-5965-8470; Csucs, Gergely/0000-0002-2093-6274	European Union's Horizon 2020 Research and Innovation Programme [720270, 785907]; Research Council of Norway [269774]	European Union's Horizon 2020 Research and Innovation Programme; Research Council of Norway(Research Council of Norway)	This work was supported by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 720270 (HBP SGA1) and Grant Agreement No. 785907 (HBP SGA2), with additional support from The Research Council of Norway, Grant Agreement No. 269774 (INCF National Node) to JGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Bjerke IE, 2018, EUR PSYCHIAT, V50, P70, DOI 10.1016/j.eurpsy.2018.02.004; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Campagnola L, 2014, J NEUROSCI, V34, P2214, DOI 10.1523/JNEUROSCI.4669-13.2014; Dempsey B, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00009; Furth D, 2018, NAT NEUROSCI, V21, P139, DOI 10.1038/s41593-017-0027-7; Ju T, 2006, J NEUROSCI METH, V156, P84, DOI 10.1016/j.jneumeth.2006.02.020; Kim Y, 2017, CELL, V171, P456, DOI 10.1016/j.cell.2017.09.020; Kjonigsen LJ, 2015, NEUROIMAGE, V108, P441, DOI 10.1016/j.neuroimage.2014.12.080; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Majka P, 2013, NEUROINFORMATICS, V11, P507, DOI 10.1007/s12021-013-9199-9; Niedworok CJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11879; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Schubert N, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00051; Shiffman S, 2018, J NEUROSCI METH, V308, P219, DOI 10.1016/j.jneumeth.2018.08.005; Tiesinga P, 2015, CURR OPIN NEUROBIOL, V32, P107, DOI 10.1016/j.conb.2015.02.003; Vandenberghe ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep20958; Zakiewicz IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137571; Zakiewicz IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022669	21	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216796	10.1371/journal.pone.0216796	http://dx.doi.org/10.1371/journal.pone.0216796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141518	Green Published, gold			2022-12-26	WOS:000469323000024
J	Ram, H; Kaur, A; Gandass, N; Singh, S; Deshmukh, R; Sonah, H; Sharma, TR				Ram, Hasthi; Kaur, Amandeep; Gandass, Nishu; Singh, Shweta; Deshmukh, Rupesh; Sonah, Humira; Sharma, Tilak Raj			Molecular characterization and expression dynamics of MTP genes under various spatio-temporal stages and metal stress conditions in rice	PLOS ONE			English	Article							HEAVY-METALS; METABOLISM; TOLERANCE; DATABASE	Metal Tolerance Proteins (MTPs) are the class of membrane proteins involved in the transport of metals, mainly Zn, Mn, Fe, Cd, Co and Ni, and confer metal tolerance in plants. In the present study, a comprehensive molecular analysis of rice MTP genes was performed to understand the evolution, distribution and expression dynamics of MTP genes. Exploration of the whole genome re-sequencing information available for three thousand rice genotypes highlighted the evolution and allelic diversity of MTP genes. Based on the presence of nonsynonymous single nucleotide polymorphism (SNP), MTP1, MTP6, MTP8 and MTP9 were found to be the most conserved genes. Furthermore, results showed localization of MTP1, MTP8.1 and MTP9, and MTP11, respectively with QTLs/m- QTLs for Zn and Cd accumulation, making these genes promising candidates to understand the QTL regulation. Expression profiling of the entire set of 10 MTP genes revealed root and shoot specific expressions of MTP9 and MTP8.1, respectively, under all tested vegetative stages. Expression of seedspecific MTPs increased as seed maturation progressed, which revealed their potential role in transporting metals during seed filling. Upon exposure to harmful heavy metals, expression of most MTP genes decreased in root and increased in shoot, suggests that different mechanisms are being employed by MTPs in different tissues. Contrastingly, only a few MTPs were found to be responsive to Fe and/or Zn starvation conditions. The extensive analysis of MTPs presented here will be helpful in identifying candidate MTP genes for crop biofortification and bioremediation purposes.	[Ram, Hasthi; Kaur, Amandeep; Gandass, Nishu; Singh, Shweta; Deshmukh, Rupesh; Sonah, Humira; Sharma, Tilak Raj] NABI, Dept Agribiotechnol, Sas Nagar Mohali, Punjab, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Sharma, TR (corresponding author), NABI, Dept Agribiotechnol, Sas Nagar Mohali, Punjab, India.	hrmundel84@gmail.com; trsharma@nabi.res.in	Deshmukh, Rupesh Kailasrao/C-6479-2012	Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; Ram, Dr Hasthi/0000-0003-0893-3895; Sonah, Humira/0000-0003-4796-6120; Singh, Shweta/0000-0003-4408-5766	DST-INSPIRE Faculty grant from Department of Science and Technology, Govt. of India [DST/INSPIRE/04/2016/001118]; National Agri-Food Biotechnology Institute (NABI), Department of Biotechnology (DBT), Govt. of India	DST-INSPIRE Faculty grant from Department of Science and Technology, Govt. of India; National Agri-Food Biotechnology Institute (NABI), Department of Biotechnology (DBT), Govt. of India	This research was funded by DST-INSPIRE Faculty grant from Department of Science and Technology, Govt. of India (http://www.dst.gov.in/), awarded to HR with grant no. DST/INSPIRE/04/2016/001118, and core grant from National Agri-Food Biotechnology Institute (NABI) (https://nabi.res.in/), Department of Biotechnology (DBT), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Barker K, 2015, HART STUD PRIV LAW, P3; Bashir K, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00015, 10.3389/fpls.2013.00090]; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; Borrill P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00053; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Chen ZH, 2013, J EXP BOT, V64, P4375, DOI 10.1093/jxb/ert243; Chibuike G.U., 2014, APPL ENVIRON SOIL SC, DOI [10.1155/2014/752708, DOI 10.1155/2014/752708, 10.1155/ 2014/752708]; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Deshmukh RK, 2016, J PLANT BIOCHEM BIOT, V25, P142, DOI 10.1007/s13562-015-0319-5; Deshmukh RK, 2015, PLANT J, V83, P489, DOI 10.1111/tpj.12904; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; Esposito S, 2012, INT J PHYTOREMEDIAT, V14, P443, DOI 10.1080/15226514.2011.620904; dos Santos LMG, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20170202; Gustin JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-76; John Wiley & Sons Ltd, 2001, ENCY LIFE SCI, P287; Li WF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00040; Liu JK, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00345; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackill DJ, 2018, RICE, V11, DOI 10.1186/s12284-018-0208-3; Menguer PK, 2013, J EXP BOT, V64, P2871, DOI 10.1093/jxb/ert136; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Reeves RD, 2018, NEW PHYTOL, V218, P407, DOI 10.1111/nph.14907; Takemoto Y, 2017, PLANT CELL PHYSIOL, V58, P1573, DOI 10.1093/pcp/pcx082; TULCHINSKY TH, 2010, PUBLIC HLTH REV, V32, P243; Ueno D, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.170, 10.1038/nplants.2015.170]; Xia L, 2017, J GENET GENOMICS, V44, P235, DOI 10.1016/j.jgg.2017.05.003; Yuan LY, 2012, PLANT CELL REP, V31, P67, DOI 10.1007/s00299-011-1140-9; Zhang M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174987	31	19	19	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217360	10.1371/journal.pone.0217360	http://dx.doi.org/10.1371/journal.pone.0217360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136613	Green Submitted, Green Published, gold			2022-12-26	WOS:000469224300029
J	Deep, SN; Mitra, S; Rajagopal, S; Paul, S; Poddar, R				Deep, Satya Narayan; Mitra, Sumonto; Rajagopal, Sathyanarayanan; Paul, Surojit; Poddar, Ranjana			GluN2A-NMDA receptor-mediated sustained Ca2+ influx leads to homocysteine-induced neuronal cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homocysteine; N-methyl-D-aspartate receptor (NMDA receptor; NMDAR); glutamate; calcium; extracellular-signal-regulated kinase (ERK); calcium homeostasis; GluN2A-NMDA receptor subunit; hyperhomocysteinemia; kinase signaling; neurotoxicity	METABOTROPIC GLUTAMATE RECEPTORS; EXCITATORY AMINO-ACIDS; ISCHEMIC BRAIN-INJURY; NMDA RECEPTOR; PLASMA HOMOCYSTEINE; DIFFERENTIAL ROLES; TYROSINE PHOSPHATASE; NR2A SUBUNIT; RISK-FACTOR; IN-VITRO	Homocysteine, a metabolite of the methionine cycle, is a known agonist of N-methyl-d-aspartate receptor (NMDAR), a glutamate receptor subtype and is involved in NMDAR-mediated neurotoxicity. Our previous findings have shown that homocysteine-induced, NMDAR-mediated neurotoxicity is facilitated by a sustained increase in phosphorylation and activation of extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK MAPK). In the current study, we investigated the role GluN1/GluN2A-containing functional NMDAR (GluN2A-NMDAR) and GluN1/GluN2B-containing functional NMDAR (GluN2B-NMDAR) in homocysteine-induced neurotoxicity. Our findings revealed that exposing primary cortical neuronal cultures to homocysteine leads to a sustained low-level increase in intracellular Ca2+. We also showed that pharmacological inhibition of GluN2A-NMDAR or genetic deletion of the GluN2A subunit attenuates homocysteine-induced increase in intracellular Ca2+. Our results further established the role of GluN2A-NMDAR in homocysteine-mediated sustained ERK MAPK phosphorylation and neuronal cell death. Of note, the preferential role of GluN2A-NMDAR in homocysteine-induced neurotoxicity was distinctly different from glutamate-NMDAR-induced excitotoxic cell death that involves overactivation of GluN2B-NMDAR and is independent of ERK MAPK activation. These findings indicate a critical role of GluN2A-NMDAR-mediated signaling in homocysteine-induced neurotoxicity.	[Deep, Satya Narayan; Mitra, Sumonto; Rajagopal, Sathyanarayanan; Paul, Surojit; Poddar, Ranjana] Univ New Mexico, Dept Neurol, Hlth Sci Ctr, 1 Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Poddar, R (corresponding author), Univ New Mexico, Dept Neurol, Hlth Sci Ctr, 1 Univ New Mexico, Albuquerque, NM 87131 USA.	rpoddar@salud.unm.edu	Sumonto, Mitra/H-2083-2013	Sumonto, Mitra/0000-0001-6381-5344	National Institutes of Health [RO1 NS083914, RO1 NS059962]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083914, R01NS059962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Grants RO1 NS083914 (to R. P.) and RO1 NS059962 (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansari R, 2014, J CLIN NEUROL, V10, P281, DOI 10.3988/jcn.2014.10.4.281; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Austin RC, 2004, CELL DEATH DIFFER, V11, pS56, DOI 10.1038/sj.cdd.4401451; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; DAXHELET GA, 1989, ANAL BIOCHEM, V179, P401, DOI 10.1016/0003-2697(89)90152-8; DEERAUSQUIN GA, 1990, P NATL ACAD SCI USA, V87, P8017, DOI 10.1073/pnas.87.20.8017; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dingledine R, 1999, PHARMACOL REV, V51, P7; GLAUM SR, 1990, J PHARMACOL EXP THER, V253, P1293; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hankey GJ, 2001, CURR OPIN NEUROL, V14, P95, DOI 10.1097/00019052-200102000-00015; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hyrc K, 1997, J NEUROSCI, V17, P6669; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jara-Prado A, 2003, NEUROTOX RES, V5, P237, DOI 10.1007/BF03033381; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai TW, 2011, TRENDS MOL MED, V17, P266, DOI 10.1016/j.molmed.2010.12.008; Lazarewicz JW, 2003, NEUROCHEM RES, V28, P259, DOI 10.1023/A:1022329317218; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; LINDGREN A, 1995, STROKE, V26, P795, DOI 10.1161/01.STR.26.5.795; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; Martin HGS, 2010, CELL, V140, P174, DOI 10.1016/j.cell.2010.01.014; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Morikawa E, 1998, J NEUROSCI, V18, P9727; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2010, J NEUROCHEM, V114, P1107, DOI 10.1111/j.1471-4159.2010.06835.x; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Poddar R, 2017, J NEUROCHEM, V142, P560, DOI 10.1111/jnc.14078; Poddar R, 2013, J NEUROCHEM, V124, P558, DOI 10.1111/jnc.12102; Poddar R, 2009, J NEUROCHEM, V110, P1095, DOI 10.1111/j.1471-4159.2009.06207.x; RANDALL RD, 1992, J NEUROSCI, V12, P1882; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Riccio A, 2002, NAT NEUROSCI, V5, P389, DOI 10.1038/nn0502-389; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Sharma M, 2015, BASIC CLIN PHARMACOL, V117, P287, DOI 10.1111/bcpt.12424; Shi Q, 2003, J PHARMACOL EXP THER, V305, P131, DOI 10.1124/jpet.102.047092; Sibarov DA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00246; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Terasaki Y, 2010, J CEREBR BLOOD F MET, V30, P1441, DOI 10.1038/jcbfm.2010.18; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tymianski M, 1996, ADV NEUROL, V71, P85; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhou XJ, 2013, J BIOL CHEM, V288, P24151, DOI 10.1074/jbc.M113.482000; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; Zieminska E, 2003, NEUROCHEM INT, V43, P481, DOI 10.1016/S0197-0186(03)00038-X; Zoccolella S, 2010, AMYOTROPH LATERAL SC, V11, P140, DOI 10.3109/17482960902919360; Zoccolella Stefano, 2006, Current Vascular Pharmacology, V4, P237, DOI 10.2174/157016106777698414	69	23	26	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11154	11165		10.1074/jbc.RA119.008820	http://dx.doi.org/10.1074/jbc.RA119.008820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167782	Green Published, hybrid			2022-12-26	WOS:000478717400009
J	Yadav, PK; Vitvitsky, V; Kim, H; White, A; Cho, US; Banerjee, R				Yadav, Pramod K.; Vitvitsky, Victor; Kim, Hanseong; White, Andrew; Cho, Uhn-Soo; Banerjee, Ruma			S-3-Carboxypropyl-l-cysteine specifically inhibits cystathionine gamma-lyase-dependent hydrogen sulfide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; crystal structure; pyridoxal phosphate; hydrogen sulfide; enzyme inhibitor; chemical screen; cystathionine gamma-lyase; cysteine catabolism; PLP enzyme; propargylglycine; transsulfuration pathway	BETA-SYNTHASE; L-AMINOETHOXYVINYLGLYCINE; TRANSSULFURATION PATHWAY; CYSTEINE PERSULFIDES; INDUCED INFLAMMATION; REDOX REGULATION; HEME; AMINOTRANSFERASE; GLUTATHIONE; LIVER	Hydrogen sulfide (H2S) is a gaseous signaling molecule, which modulates a wide range of mammalian physiological processes. Cystathionine gamma-lyase (CSE) catalyzes H2S synthesis and is a potential target for modulating H2S levels under pathophysiological conditions. CSE is inhibited by propargylglycine (PPG), a widely used mechanism-based inhibitor. In this study, we report that inhibition of H2S synthesis from cysteine, but not the canonical cystathionine cleavage reaction catalyzed by CSE in vitro, is sensitive to preincubation of the enzyme with PPG. In contrast, the efficacy of S-3-carboxpropyl-l-cysteine (CPC) a new inhibitor described herein, was not dependent on the order of substrate/inhibitor addition. We observed that CPC inhibited the gamma-elimination reaction of cystathionine and H2S synthesis from cysteine by human CSE with K-i values of 50 +/- 3 and 180 +/- 15 mu m, respectively. We noted that CPC spared the other enzymes involved either directly (cystathionine beta-synthase and mercaptopyruvate sulfurtransferase) or indirectly (cysteine aminotransferase) in H2S biogenesis. CPC also targeted CSE in cultured cells, inhibiting transsulfuration flux by 80-90%, as monitored by the transfer of radiolabel from [S-35]methionine to GSH. The 2.5 angstrom resolution crystal structure of human CSE in complex with the CPC-derived aminoacrylate intermediate provided a structural framework for the molecular basis of its inhibitory effect. In summary, our study reveals a previously unknown confounding effect of PPG, widely used to inhibit CSE-dependent H2S synthesis, and reports on an alternative inhibitor, CPC, which could be used as a scaffold to develop more potent H2S biogenesis inhibitors.	[Yadav, Pramod K.; Vitvitsky, Victor; Kim, Hanseong; Cho, Uhn-Soo; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Sch, Ann Arbor, MI 48109 USA; [White, Andrew] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Sch, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010; Vitvitsky, Victor/ABA-2967-2021	Yadav, Pramod K./0000-0003-0026-1684; Vitvitsky, Victor/0000-0001-6251-6115; cho, uhn-soo/0000-0002-6992-2455; Kim, Hanseong/0000-0001-7518-6936	National Institutes of Health [HL58984, DK111465]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants HL58984 (to R. B.) and DK111465 (to U.-S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABELES RH, 1973, J AM CHEM SOC, V95, P6124, DOI 10.1021/ja00799a053; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKAGI R, 1982, ACTA MED OKAYAMA, V36, P187; Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Banerjee R, 2017, CURR OPIN CHEM BIOL, V37, P115, DOI 10.1016/j.cbpa.2017.02.021; BAXTER CF, 1961, J BIOL CHEM, V236, P3287; BEATTY PW, 1980, ARCH BIOCHEM BIOPHYS, V204, P80, DOI 10.1016/0003-9861(80)90009-0; Capitani G, 2002, J BIOL CHEM, V277, P49735, DOI 10.1074/jbc.M208427200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Kabil O, 2016, J BIOL CHEM, V291, P16418, DOI 10.1074/jbc.C116.742213; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KAWAJI A, 1990, Journal of Toxicological Sciences, V15, P145; LAUINGER C, 1970, BIOCHIM BIOPHYS ACTA, V198, P316, DOI 10.1016/0005-2744(70)90064-1; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; Ohta J, 1997, BBA-GEN SUBJECTS, V1334, P240, DOI 10.1016/S0304-4165(96)00100-6; REJ R, 1977, CLIN CHEM, V23, P1508; Roman HB, 2013, ANTIOXID REDOX SIGN, V19, P1321, DOI 10.1089/ars.2012.5010; SHINOZUKA S, 1982, EUR J BIOCHEM, V124, P377; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Steegborn C, 1999, J BIOL CHEM, V274, P12675, DOI 10.1074/jbc.274.18.12675; Sun QX, 2009, J BIOL CHEM, V284, P3076, DOI 10.1074/jbc.M805459200; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Vitvitsky V, 2015, METHOD ENZYMOL, V554, P111, DOI 10.1016/bs.mie.2014.11.013; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Whiteman M, 2011, CLIN SCI, V121, P459, DOI 10.1042/CS20110267; Whiteman M, 2010, ANN NY ACAD SCI, V1203, P146, DOI 10.1111/j.1749-6632.2010.05556.x; Yadav PK, 2016, J AM CHEM SOC, V138, P289, DOI 10.1021/jacs.5b10494; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yadav PK, 2012, J BIOL CHEM, V287, P43464, DOI 10.1074/jbc.M112.414722; Yadav PK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414706; Yamagata S, 2003, J BIOCHEM, V134, P607, DOI 10.1093/jb/mvg179; Yan YL, 2013, RES VET SCI, V94, P590, DOI 10.1016/j.rvsc.2012.10.009; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	48	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					11011	11022		10.1074/jbc.RA119.009047	http://dx.doi.org/10.1074/jbc.RA119.009047			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31160338	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000478717200022
J	Huang, CY; Chen, YC; Wu-Hsieh, BA; Fang, JM; Chang, ZF				Huang, Chang-Yu; Chen, Yee-Chun; Wu-Hsieh, Betty A.; Fang, Jim-Min; Chang, Zee-Fen			The Ca-loop in thymidylate kinase is critical for growth and contributes to pyrimidine drug sensitivity of Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; drug resistance; nucleoside; nucleotide analogue; DNA damage; substrate specificity; thymidylate kinase	CELL-DIVISION CYCLE; SACCHAROMYCES-CEREVISIAE; GENETIC-CONTROL; 5-FLUOROURACIL; MECHANISMS; RESISTANCE; EXPRESSION; INSIGHTS; SYSTEM; AZOLES	The yeast Candida albicans is the most prevalent opportunistic fungal pathogen in humans. Drug resistance among C. albicans isolates poses a common challenge, and overcoming this resistance represents an unmet need in managing this common pathogen. Here, we investigated CDC8, encoding thymidylate kinase (TMPK), as a potential drug target for the management of C. albicans infections. We found that the region spanning amino acids 106-123, namely the Ca-loop of C. albicans TMPK (CaTMPK), contributes to the hyperactivity of this enzyme compared with the human enzyme (hTMPK) and to the utilization of deoxyuridine monophosphate (dUMP)/deoxy-5-fluorouridine monophosphate (5-FdUMP) as a substrate. Notably, expression of CaTMPK, but not of hTMPK, produced dUTP/5-FdUTP-mediated DNA toxicity in budding yeast (Saccharomyces cerevisiae). CRISPR-mediated deletion of this Ca-loop in C. albicans revealed that the Ca-loop is critical for fungal growth and susceptibility to 5-fluorouridine (5-FUrd). Of note, pathogenic and drug-resistant C. albicans clones were similarly sensitive to 5-FUrd, and we also found that CaTMPK is essential for the growth of C. albicans. In conclusion, these findings not only identified a target site for the development of CaTMPK-selective drugs, but also revealed that 5-FUrd may have potential utility as drug for managing C. albicans infections.	[Huang, Chang-Yu; Chang, Zee-Fen] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Linong St, Taipei 11221, Taiwan; [Huang, Chang-Yu; Chang, Zee-Fen] Natl Taiwan Univ, Coll Med, Inst Mol Med, Jen Ai Rd, Taipei 10051, Taiwan; [Chen, Yee-Chun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei 10002, Taiwan; [Chen, Yee-Chun] Natl Taiwan Univ, Coll Med, Taipei 10002, Taiwan; [Chen, Yee-Chun; Chang, Zee-Fen] Natl Taiwan Univ, Coll Med, Ctr Precis Med, Taipei 10002, Taiwan; [Wu-Hsieh, Betty A.] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Jen Ai Rd, Taipei 10051, Taiwan; [Fang, Jim-Min] Natl Taiwan Univ, Dept Chem, Taipei 10612, Taiwan; [Chang, Zee-Fen] 1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chang, ZF (corresponding author), Natl Taiwan Univ, Coll Med, Inst Mol Med, Jen Ai Rd, Taipei 10051, Taiwan.; Chang, ZF (corresponding author), 1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan.	zfchang@ntu.edu.tw		Huang, Chang Yu/0000-0001-7430-2085	"Center of PrecisionMedicine" from the Fea-of CaTMPK within Ministry of Education (MOE) in Taiwan; Ministry of Science and Technology, Taiwan [MOST 108-3017-F-002-004, MOST 107-2321-B-002-041, MOST 106-2113-M-002-021-MY3]	"Center of PrecisionMedicine" from the Fea-of CaTMPK within Ministry of Education (MOE) in Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the "Center of PrecisionMedicine" from the Fea-of CaTMPK from C. albicans in antifungal drug development. tured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan and by Grants MOST 108-3017-F-002-004, MOST 107-2321-B-002-041, and MOST 106-2113-M-002-021-MY3 from the Ministry of Science and Technology, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Albertson GD, 1996, ANTIMICROB AGENTS CH, V40, P2835, DOI 10.1128/AAC.40.12.2835; Alexander B. D., 2017, M27 CLSI, P1; Belenky P, 2013, CELL REP, V3, P350, DOI 10.1016/j.celrep.2012.12.021; BIRKENMEYER LG, 1984, MOL CELL BIOL, V4, P583, DOI 10.1128/MCB.4.4.583; Chen YC, 2017, MYCOSES, V60, P89, DOI 10.1111/myc.12553; Chen YH, 2016, J MED CHEM, V59, P9906, DOI 10.1021/acs.jmedchem.6b01280; Cui Q, 2013, CURR MED CHEM, V20, P1286, DOI 10.2174/0929867311320100006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ford CB, 2015, ELIFE, V4, DOI 10.7554/eLife.00662; Gabriel F, 2014, ANTIMICROB AGENTS CH, V58, P4476, DOI 10.1128/AAC.00009-14; HARTWELL LH, 1971, J MOL BIOL, V59, P183, DOI 10.1016/0022-2836(71)90420-7; HARTWELL LH, 1973, GENETICS, V74, P267; Hope WW, 2004, ANTIMICROB AGENTS CH, V48, P4377, DOI 10.1128/AAC.48.11.4377-4386.2004; Hu CM, 2012, CANCER CELL, V22, P36, DOI 10.1016/j.ccr.2012.04.038; Hu R, 2005, ANTIMICROB AGENTS CH, V49, P2044, DOI 10.1128/AAC.49.5.2044-2049.2005; Lai WC, 2016, CURR GENET, V62, P213, DOI 10.1007/s00294-015-0526-6; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lockhart S. R., 2016, M59 CLSI, P1; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Martel CM, 2010, ANTIMICROB AGENTS CH, V54, P3578, DOI 10.1128/AAC.00303-10; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Nett JE, 2010, ANTIMICROB AGENTS CH, V54, P3505, DOI 10.1128/AAC.00227-10; Ostermann N, 2000, STRUCTURE, V8, P629, DOI 10.1016/S0969-2126(00)00149-0; POLAK A, 1979, J MED MICROBIOL, V12, P83, DOI 10.1099/00222615-12-1-83; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Shor E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004668; Sinha K, 2017, BIOCHEMISTRY-US, V56, P4360, DOI 10.1021/acs.biochem.7b00498; Su H, 2018, J ANTIBIOT, V71, P978, DOI 10.1038/s41429-018-0100-9; SU JY, 1991, NUCLEIC ACIDS RES, V19, P823, DOI 10.1093/nar/19.4.823; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Toussaint M, 2005, NUCLEIC ACIDS RES, V33, P704, DOI 10.1093/nar/gki219; Turner SA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019778; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092	38	3	3	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10686	10697		10.1074/jbc.RA118.006798	http://dx.doi.org/10.1074/jbc.RA118.006798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31152062	Green Published, hybrid			2022-12-26	WOS:000478717100026
J	Horiike, R; Nakai, H; Itatani, T; Shirai, F; Konishi, K				Horiike, Ryo; Nakai, Hisao; Itatani, Tomoya; Shirai, Fumie; Konishi, Kaoru			Using GIS to simulate tsunami evacuation guidance signs for the hearing impaired	PLOS ONE			English	Article								The Nankai Trough in Japan has been identified as a geological feature that could cause extensive damage in the event of a major earthquake. In this study, we investigated the impact of effective guidance signs for hearing-impaired individuals requiring special care when escaping to a tsunami evacuation building (emergency evacuation location) using geographical information system (GIS) and viewshed analysis. We selected an area we considered would suffer severe damage following a major earthquake and tsunami; we identified difficulties in the provision of escape routes. Using GIS, we determined the time required for escape and tsunami arrival time if effective signs were installed; we undertook such analysis using the height data of buildings in the target area. With effectively installed guidance signs, the average required evacuation time was 36.88 minutes; without such signs (which is currently the case in the target area), the average time was 47.10 minutes: that would result in citizens getting caught by the tsunami. Installing effective guidance signs would allow hearing-impaired individuals to escape to an evacuation building before being hit by the tsunami.	[Horiike, Ryo] Hlth Policy Dept, Med Policy Sect, Kochi, Kochi, Japan; [Nakai, Hisao] Kanazawa Med Univ, Nursing Dept, Kanazawa, Ishikawa, Japan; [Itatani, Tomoya] Kanazawa Univ, Grad Sch Med Pharmaceut & Hlth Sci, Doctoral Course, Div Hlth Sci, Kanazawa, Ishikawa, Japan; [Shirai, Fumie; Konishi, Kaoru] Osaka Univ, Grad Sch Med, Div Hlth Sci, Suita, Osaka, Japan	Kanazawa Medical University; Kanazawa University; Osaka University	Horiike, R (corresponding author), Hlth Policy Dept, Med Policy Sect, Kochi, Kochi, Japan.	spi4949@gmail.com		Horiike, Ryo/0000-0001-9126-3727				Ai FL, 2016, SAFETY SCI, V90, P62, DOI 10.1016/j.ssci.2015.09.022; [Anonymous], 2018, KOUCH BOUS MAP; [Anonymous], 2012, KOCH KEN BAN DAI 2 D; [Anonymous], 2018, CHOUK HYOUK NIYOR JI; [Anonymous], 2013, KOCH TSUN HIN KEIK S; [Anonymous], 2015, KOCH TSUN HIN KEIK; [Anonymous], 2018, KOUCH SUIK JINK; [Anonymous], 2013, NANK TROUGH EARTHQ N; ashie Yasunobu, 2010, HIGH RESOLUTION NUME; Atsushi O, 2007, SEISAN KENKYU, V59, P295; Bradshaw Wayne, 2013, Aust Nurs J, V21, P32; Cabinet Office, SAIG YOUH; Cuckovi Z, 2016, J OPEN SOURCE SOFTW, V1, DOI [DOI 10.21105/JOSS.00032, 10.21105/joss.00032]; Fire and Disaster Management Agency, 1999, YUD OYOB YUD NI KAK; Fire and Disaster Management Agency, 2018, GAIK YA SYOUG GA RIY; Fujiwara Y., 2009, J JPN SOC CIV ENG A1, V65, P757; Geospatial Information Authority of Japan, FUND GEOSP DAT DOWNL; Global Open Data Index, PLAC OV; Hitoshi G, 2009, J JAPAN SOC CIV ENG, V53, P1311; Imamura F, 2009, J EARTHQ TSUNAMI, V3, P59, DOI 10.1142/S1793431109000457; Japan Tourism Agency, 2017, KANK RIKK SUISH KEIK; Japanese Federation of the Deaf, 2011, CHOUK SAIG ANP MAN; Klynman Y., 2007, WORLD DISASTERS REPO; Kwan MP, 2010, COMPUT ENVIRON URBAN, V34, P179, DOI 10.1016/j.compenvurbsys.2010.02.001; Lonergan C, 2015, NAT HAZARDS, V78, P41, DOI 10.1007/s11069-015-1696-8; Mamiooki Naoto T, 2009, J ARCH PLANN, V74, P1523; Manley M, 2012, EXPERT SYST APPL, V39, P8300, DOI 10.1016/j.eswa.2012.01.169; Ministry of Economy T and I, 2014, TSUN EV GUID SAF SIG; Ministry of Internal Affairs and Communications J, 2017, ACT PROM TSUN COUNT; Ministry of Land Infrastructure T and T, 2013, TSUN HIN WO SOUT SIT; Ministry of Land Infrastructure T and T, 2018, KOUK KOTS NO RYOK NI; Minoru A., QGIS2THREEJS PLUGIN; Nakai H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199252; Nippon Signs Association, 2014, GUID TSUN SIGNS; Shekhar S, 2012, INT J GEOGR INF SCI, V26, P2253, DOI 10.1080/13658816.2012.719624; Shinji Y, 2015, AIJ J TECHNOL DES, V21, P873; Tatsuki S, 2012, INT J JPN SOCIOL, V21, P12, DOI 10.1111/j.1475-6781.2012.01158.x; Thi N, 2012, INT J COMPT SCI ARTI, V2, P33; United Nations, SUST DEV GOALS; US Department of Commerce NO and AA, WHAT IS LIDAR; Wood N, 2016, INT J DISAST RISK RE, V18, P41, DOI 10.1016/j.ijdrr.2016.05.010; Yuling LIU MH, 2008, ANN DISAS PREY RES I, V49, P189	42	2	2	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217512	10.1371/journal.pone.0217512	http://dx.doi.org/10.1371/journal.pone.0217512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170210	gold, Green Published, Green Submitted			2022-12-26	WOS:000470263700038
J	Ryu, SJ; Kim, DR; Song, IS; Shin, YU; Seong, M; Cho, H; Kang, MH				Ryu, So Jung; Kim, Du Roo; Song, In Seok; Shin, Yong Un; Seong, Mincheol; Cho, Heeyoon; Kang, Min Ho			The influence of low signal-to-noise ratio of axial length measurement on prediction of target refraction, achieved using IOLMaster	PLOS ONE			English	Article							PARTIAL COHERENCE INTERFEROMETRY; INTRAOCULAR-LENS POSITION; ANTERIOR-CHAMBER DEPTH; ULTRASOUND BIOMETRY; A-SCAN; CLINICAL FEASIBILITY; CATARACT-SURGERY; OPTICAL BIOMETRY; EYES; SEVERITY	Purpose To evaluate the influence of low signal-to-noise ratio (SNR) of axial length measurement, achieved using IOLMaster, on prediction of target refraction. Methods A total of 131 eyes of 131 patients who underwent phacoemulsification with posterior chamber lens implantation were enrolled. Preoperative axial length measurements were performed with the IOLMaster 500 (Carl Zeiss Meditec, Germany); preoperative SNR values were used to divide the eyes into three groups (Group 1; SNR <10, Group 2; 10 <= SNR <50, Group 3; 50 <= SNR <100). One month and 6 months after cataract surgery, the manifest refraction spherical equivalents (MRSE) were measured. The mean numeric errors (MNE), the mean of the difference between postoperative MRSE, and preoperative target refraction, using the various intraocular lens (IOL) formulas, were calculated and compared among the three groups. Results One month after cataract surgery, postoperative MRSE was more hyperopic than preoperative target refraction, calculated by the Haigis formula in group 1, and by the SRK/T formula in group 2. After 6 months, for all formulas in group 1, there were significantly hyperopic results (approximately 0.35 diopter). Upon comparison of MNE among the three groups, group 1 was statistically significantly different from the other groups by Haigis formula. Conclusions When the SNR values in biometry, using IOLMaster, are <10, careful attention should be given to determining IOL power, as postoperative spherical equivalents are more hyperopic than preoperative target refraction by IOL formula.	[Ryu, So Jung; Kim, Du Roo; Shin, Yong Un; Seong, Mincheol; Cho, Heeyoon; Kang, Min Ho] Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Kim, Du Roo; Shin, Yong Un; Seong, Mincheol; Cho, Heeyoon; Kang, Min Ho] Hanyang Univ, Dept Ophthalmol, Guri Hosp, Guri, South Korea; [Song, In Seok; Kang, Min Ho] Seoul Eye Clin, Seoul, South Korea; [Kang, Min Ho] Johns Hopkins Med Inst, Wilmer Eye Inst, Baltimore, MD 21205 USA	Hanyang University; Hanyang University; Johns Hopkins University; Johns Hopkins Medicine	Kang, MH (corresponding author), Hanyang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea.; Kang, MH (corresponding author), Hanyang Univ, Dept Ophthalmol, Guri Hosp, Guri, South Korea.; Kang, MH (corresponding author), Johns Hopkins Med Inst, Wilmer Eye Inst, Baltimore, MD 21205 USA.	ocularimmunity@gmail.com	SHIN, Yong-Un/AAI-9824-2020; Shin, Yong Un/V-7668-2017	Shin, Yong Un/0000-0003-1251-8985				Attas-Fox L, 2007, OPHTHALMOLOGY, V114, P1499, DOI 10.1016/j.ophtha.2006.10.053; Buckhurst PJ, 2009, BRIT J OPHTHALMOL, V93, P949, DOI 10.1136/bjo.2008.156554; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Connors R, 2002, J CATARACT REFR SURG, V28, P235, DOI 10.1016/S0886-3350(01)01179-8; Dietlein TS, 2005, J CATARACT REFR SURG, V31, P1006, DOI 10.1016/j.jcrs.2004.09.049; Drexler W, 1998, AM J OPHTHALMOL, V126, P524, DOI 10.1016/S0002-9394(98)00113-5; Eleftheriadis H, 2003, BRIT J OPHTHALMOL, V87, P960, DOI 10.1136/bjo.87.8.960; Findl O, 2003, J CATARACT REFR SURG, V29, P1950, DOI 10.1016/S0886-3350(03)00243-8; Freeman G, 2005, ACTA OPHTHALMOL SCAN, V83, P439, DOI 10.1111/j.1600-0420.2005.00473.x; Goyal R, 2003, ACTA OPHTHALMOL SCAN, V81, P331, DOI 10.1034/j.1600-0420.2003.00092.x; Haigis W, 2000, GRAEF ARCH CLIN EXP, V238, P765, DOI 10.1007/s004170000188; Hill W, 2008, J CATARACT REFR SURG, V34, P920, DOI 10.1016/j.jcrs.2008.02.021; Hirnschall N, 2011, J CATARACT REFR SURG, V37, P45, DOI 10.1016/j.jcrs.2010.07.023; HOLLADAY JT, 1988, J CATARACT REFR SURG, V14, P17, DOI 10.1016/S0886-3350(88)80059-2; Kiss B, 2002, J CATARACT REFR SURG, V28, P224, DOI 10.1016/S0886-3350(01)01272-X; Kiss B, 2002, J CATARACT REFR SURG, V28, P230, DOI 10.1016/S0886-3350(01)01274-3; Koeppl C, 2005, J CATARACT REFR SURG, V31, P348, DOI 10.1016/j.jcrs.2004.04.063; Nemeth J, 2003, J CATARACT REFR SURG, V29, P85, DOI 10.1016/S0886-3350(02)01500-6; OLSEN T, 1992, J CATARACT REFR SURG, V18, P125, DOI 10.1016/S0886-3350(13)80917-0; Olsen T, 2005, J CATARACT REFR SURG, V31, P1345, DOI 10.1016/j.jcrs.2004.12.066; Packer M, 2002, J CATARACT REFR SURG, V28, P239, DOI 10.1016/S0886-3350(01)01259-7; Petternel V, 2004, J CATARACT REFR SURG, V30, P52, DOI 10.1016/S0886-3350(03)00556-X; Prinz A, 2006, J CATARACT REFR SURG, V32, P1161, DOI 10.1016/j.jcrs.2006.01.101; RETZLAFF JA, 1990, J CATARACT REFR SURG, V16, P333, DOI 10.1016/S0886-3350(13)80705-5; Shammas HJ, 2010, J CATARACT REFR SURG, V36, P1474, DOI 10.1016/j.jcrs.2010.02.027; Stifter E, 2008, J CATARACT REFR SURG, V34, P749, DOI 10.1016/j.jcrs.2007.12.035; Suto C, 2007, J CATARACT REFR SURG, V33, P2062, DOI 10.1016/j.jcrs.2007.07.031; Tehrani M, 2003, J CATARACT REFR SURG, V29, P741, DOI 10.1016/S0886-3350(02)01740-6; Tehrani M, 2003, J CATARACT REFR SURG, V29, P747, DOI 10.1016/S0886-3350(02)01739-X; Wirtitsch MG, 2004, J CATARACT REFR SURG, V30, P45, DOI 10.1016/S0886-3350(03)00459-0	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217584	10.1371/journal.pone.0217584	http://dx.doi.org/10.1371/journal.pone.0217584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170196	gold, Green Published, Green Submitted			2022-12-26	WOS:000470263700043
J	Shamu, S; Kuwanda, L; Farirai, T; Guloba, G; Slabbery, J; Nkhwashu, N				Shamu, Simukai; Kuwanda, Locadiah; Farirai, Thato; Guloba, Geoffrey; Slabbery, Jean; Nkhwashu, Nkhensani			Study on knowledge about associated factors of Tuberculosis (TB) and TB/HIV co-infection among young adults in two districts of South Africa	PLOS ONE			English	Article							HIV; ATTITUDES; MORTALITY; PEOPLE; CARE	South Africa ranks third among 22 high burden countries in the world. TB which remains a leading cause of death causes one in five adult deaths in South Africa. An in-depth understanding of knowledge, attitudes and practices of young people towards TB is required to implement meaningful interventions. We analysed young men and women (18-24 years)'s TB knowledge including TB/HIV coinfections, testing rates and factors associated with them. A cross sectional cluster-based household survey was conducted in two provinces. Participants completed computer-assisted self-interviews on TB knowledge, testing history and TB/HIV coinfections. A participant was regarded as knowledgeable of TB if s/he correctly answered the WHO-adopted TB knowledge questions. We built three multivariate regression models in Stata 13.0 to assess factors associated with knowing TB alone, testing alone and both knowing and testing for TB. 1955 participants were interviewed (89.9% response rate). Their median age was 20 years (IQR19-22). Sixteen percent (16.2%) of the participants were social grant recipients, 55% were enrolled in a school/college and 5% lived in substandard houses. A total of 72% had knowledge of TB, 21% underwent screening tests for TB and 14.7% knew and tested for TB. Factors associated with TB knowledge were being female, younger, a student, social grant recipient, not transacting sex and having positive attitudes towards people living with HIV (PLWH). Factors associated with TB testing were being a student, receiving a social grant, living in OR Tambo district, HIV knowledge and having a family member with TB history. Factors associated with both TB knowledge and testing were being female, a student, using the print media, living in OR Tambo district and having a family member with a TB history. The study demonstrates the importance of demographic factors (gender, economic status, family TB history, and location) and HIV factors in explaining TB knowledge and testing. We recommend extending community TB testing services to increase testing.	[Shamu, Simukai; Kuwanda, Locadiah; Farirai, Thato; Guloba, Geoffrey; Slabbery, Jean; Nkhwashu, Nkhensani] Fdn Profess Dev, Hlth Syst Strengthening Div, Pretoria, South Africa; [Shamu, Simukai] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of Witwatersrand	Shamu, S (corresponding author), Fdn Profess Dev, Hlth Syst Strengthening Div, Pretoria, South Africa.; Shamu, S (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	shamuts@yahoo.com		Shamu, Simukai/0000-0002-2290-0515	KfW; South African National Department of Health; Foundation for professional Development	KfW; South African National Department of Health; Foundation for professional Development	The study was funded by KfW in collaboration with the South African National Department of Health and the Foundation for professional Development. There was no additional external funding received for this study.	Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Bati J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-734; Bell CA, 2011, INT J TUBERC LUNG D, V15, P1005, DOI 10.5588/ijtld.10.0294; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Cramm JM, 2011, J PUBLIC HEALTH AFR, V2, P143, DOI 10.4081/jphia.2011.e34; Friedland G, 2007, J INFECT DIS, V196, pS1, DOI 10.1086/518667; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Harris PA, 2012, BMC BIOINFORMATICS, V13, pA15, DOI DOI 10.1186/1471-2105-13-S12-A15; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HOSMER DW, 2000, WILEY PS TX, P1; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Johnson S, 2013, 3 NATL HIV COMMUNICA; Joint United Nations Programme on HIV AIDS, 2014, GLOB AIDS RESP PROGR; Kanjee Z, 2011, J HOSP INFECT, V79, P333, DOI 10.1016/j.jhin.2011.06.017; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3; Kwambai TK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-134; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Naidoo P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2951-y; National Department of Health, 2017, S AFR NAT STRAT PLAN; Nkuoh GN, 2013, J MIDWIFERY WOM HEAL, V58, P83, DOI 10.1111/j.1542-2011.2012.00208.x; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Sanac, 2017, S AFR NAT AIDS COUNC, V1, P1; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Shisana O., 2014, S AFRICAN NATL HIV P, V2012; StataCorp, 2019, STATA STAT SOFTWARE, DOI [10.2307/2234838, DOI 10.2307/2234838]; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tachfouti N, 2012, PAN AFR MED J, V12; Tasnim S, 2012, PULM MED, V2012, DOI 10.1155/2012/352850; Walzl G, 2005, T ROY SOC TROP MED H, V99, pS15, DOI 10.1016/j.trstmh.2005.06.006; WHO, 2009, GLOB TUB CONTR 2009; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2012, GLOB TUB REP 2012, P258; World Health Organization, 2015, WORLD HLTH ORG, V53, P1689; World Health Organization (WHO), 1994, FRAM EFF TUB CONTR	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217836	10.1371/journal.pone.0217836	http://dx.doi.org/10.1371/journal.pone.0217836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170200	Green Published, gold			2022-12-26	WOS:000470263700065
J	Nakamura, H; Fujii, K; Gupta, V; Hata, H; Koizumu, H; Hoshikawa, M; Naruki, S; Miyata, Y; Takahashi, I; Miyazawa, T; Sakai, H; Tsumoto, K; Takagi, M; Saji, H; Nishimura, T				Nakamura, Haruhiko; Fujii, Kiyonaga; Gupta, Vipul; Hata, Hiroko; Koizumu, Hirotaka; Hoshikawa, Masahiro; Naruki, Saeko; Miyata, Yuka; Takahashi, Ikuya; Miyazawa, Tomoyuki; Sakai, Hiroki; Tsumoto, Kouhei; Takagi, Masayuki; Saji, Hisashi; Nishimura, Toshihide			Identification of key modules and hub genes for small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma by weighted gene co-expression network analysis of clinical tissue-proteomes	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; NECROSIS-FACTOR RECEPTOR; PROGNOSTIC MARKERS; PROTEIN; DATABASE; PATHWAY; CANCER; CLASSIFICATION; TRANSCRIPTION; ORGANIZATION	Small-cell lung carcinoma (SCLC) and large-cell neuroendocrine lung carcinoma (LCNEC) are high-grade lung neuroendocrine tumors (NET). However, comparative protein expression within SCLC and LCNEC remains unclear. Here, protein expression profiles were obtained via mass spectrometry-based proteomic analysis. Weighted gene co-expression network analysis (WGCNA) identified co-expressed modules and hub genes. Of 34 identified modules, six were significant and selected for protein-protein interaction (PPI) network analysis and pathway enrichment. Within the six modules, the activation of cellular processes and complexes, such as alternative mRNA splicing, translation initiation, nucleosome remodeling and deacetylase (NuRD) complex, SWItch/Sucrose Non-Fermentable (SWI/SNF) superfamily-type complex, chromatin remodeling pathway, and mRNA metabolic processes, were significant to SCLC. Modules enriched in processes, including signal recognition particle (SRP)-dependent co-translational protein targeting to membrane, nuclear-transcribed mRNA catabolic process of nonsense-mediated decay (NMD), and cellular macromolecule catabolic process, were characteristically activated in LCNEC. Novel high-degree hub genes were identified for each module. Master and upstream regulators were predicted via causal network analysis. This study provides an understanding of the molecular differences in tumorigenesis and malignancy between SCLC and LCNEC and may help identify potential therapeutic targets.	[Nakamura, Haruhiko; Miyazawa, Tomoyuki; Sakai, Hiroki; Saji, Hisashi] St Marianna Univ, Dept Chest Surg, Sch Med, Kawasaki, Kanagawa, Japan; [Fujii, Kiyonaga; Nishimura, Toshihide] St Marianna Univ, Dept Translat Med Informat, Sch Med, Kawasaki, Kanagawa, Japan; [Gupta, Vipul] Syst Biol Inst, Tokyo, Japan; [Hata, Hiroko; Tsumoto, Kouhei] Univ Tokyo, Med Prote Lab, Inst Med Sci, Tokyo, Japan; [Koizumu, Hirotaka; Hoshikawa, Masahiro; Naruki, Saeko; Takagi, Masayuki] St Marianna Univ Hosp, Dept Pathol, Kawasaki, Kanagawa, Japan; [Miyata, Yuka; Takahashi, Ikuya] NISSHA Co, Corp Technol Res & Dev, Kyoto, Japan	Saint Marianna University; Saint Marianna University; University of Tokyo; Saint Marianna University	Nishimura, T (corresponding author), St Marianna Univ, Dept Translat Med Informat, Sch Med, Kawasaki, Kanagawa, Japan.	t-nisimura@marianna-u.ac.jp		Gupta, Vipul/0000-0003-3345-7288				Asamura H, 2006, J CLIN ONCOL, V24, P70, DOI 10.1200/JCO.2005.04.1202; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bo LJ, 2017, MED SCI MONITOR, V23, P4518, DOI 10.12659/MSM.902953; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Carvalho PC, 2016, NAT PROTOC, V11, P102, DOI 10.1038/nprot.2015.133; Carvalho PC, 2012, PROTEOMICS, V12, P944, DOI 10.1002/pmic.201100529; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Derks JL, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01838-2016; Deutsch EW, 2016, J PROTEOME RES, V15, P3961, DOI 10.1021/acs.jproteome.6b00392; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Esposti DD, 2016, ONCOTARGET, V7, P31862, DOI 10.18632/oncotarget.7364; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fehniger TE, 2010, J PROTEOME RES, V9, P1191, DOI 10.1021/pr1000237; Fujii K, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201800015; Giulietti M, 2017, CELL ONCOL, V40, P181, DOI 10.1007/s13402-017-0315-y; Giulietti M, 2016, CELL ONCOL, V39, P379, DOI 10.1007/s13402-016-0283-7; Guo X, 2017, CANCER GENE THER, V24, P333, DOI 10.1038/cgt.2017.23; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Huang H, 2017, J CANCER RES CLIN, V143, P2571, DOI 10.1007/s00432-017-2497-0; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karp P. D., 2017, BRIEF BIOINFORM; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kotlyar M, 2019, NUCLEIC ACIDS RES, V47, pD581, DOI 10.1093/nar/gky1037; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LaBaer J, GENES DEV EPOT, V11, P847; Lang S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00887; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lejeune F, 2017, BMB REP, V50, P175, DOI 10.5483/BMBRep.2017.50.4.015; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Liao XW, 2017, ONCOTARGETS THER, V10, P4493, DOI 10.2147/OTT.S142557; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Liu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26666-0; Liu XS, 2017, J CELL BIOCHEM, V118, P3953, DOI 10.1002/jcb.26050; Ma CH, 2017, INT J RHEUM DIS, V20, P971, DOI 10.1111/1756-185X.13063; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; McIlwain S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-308; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Nicholson SA, 2002, AM J SURG PATHOL, V26, P1184, DOI 10.1097/00000478-200209000-00009; Nishimura T, 2014, TRANSL BIOINFORM, V6, P69, DOI 10.1007/978-94-017-9202-8_5; Nishimura T, 2010, J PROTEOMICS, V73, P1100, DOI 10.1016/j.jprot.2009.11.010; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Padmavathi G, 2018, CANCER LETT, V432, P260, DOI 10.1016/j.canlet.2018.06.017; Presson AP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-230; Prieto DaRue A, 2005, Biotechniques, VSuppl, P32; Rekhtman N, 2016, CLIN CANCER RES, V22, P3618, DOI 10.1158/1078-0432.CCR-15-2946; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang Y, 2018, J CELL BIOCHEM, V119, P2102, DOI 10.1002/jcb.26372; Travis W, 2004, WHO CLASSIFICATION T; Travis WD, 2010, ANN ONCOL, V21, P65, DOI 10.1093/annonc/mdq380; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Wechsler DS, 1996, GENOMICS, V32, P466, DOI 10.1006/geno.1996.0144; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Zhou Y, 2019, BIOCHEM BIOPH RES CO, V508, P527, DOI 10.1016/j.bbrc.2018.11.157; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	70	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217105	10.1371/journal.pone.0217105	http://dx.doi.org/10.1371/journal.pone.0217105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166966	gold, Green Published, Green Submitted			2022-12-26	WOS:000470087800017
J	Medic, S; Anastassopoulou, C; Milosevic, V; Dragnic, N; Rajcevic, S; Ristic, M; Petrovic, V				Medic, Snezana; Anastassopoulou, Cleo; Milosevic, Vesna; Dragnic, Natasa; Rajcevic, Smiljana; Ristic, Mioljub; Petrovic, Vladimir			Declining seroprevalence of hepatitis A in Vojvodina, Serbia	PLOS ONE			English	Article							VIRAL-HEPATITIS; EPIDEMIOLOGY	To assess the current hepatitis A virus (HAV) endemicity in the Autonomous Province of Vojvodina, Serbia, we examined the seroprevalence and susceptibility profiles of the general population. A serum bank of 3466 residual samples, collected in 2015-16 as per the specifications of the European Sero-Epidemiology Network 2 project (ESEN2), was tested for anti-HAV antibodies with an enzyme immunoassay. Relationships between anti-HAV positivity and demographic features of respondents were examined by univariable and multivariable analyses. Present-day HAV seroprevalence was compared with that obtained in 1978-79. Surveillance data for hepatitis A recorded between 2008 and 2017 were also analyzed. Age was the only demographic variable found to be independently associated with a HAV seropositive status. Seropositivity (17% overall vs. 79% in 1978-79) increased with age to a maximum of 90% in the elderly >= 60 years. Only 5% of subjects <30 years were seropositive, unlike the 44% of seropositives >= 30 years. The estimated age at midpoint of population immunity (AMPI) increased markedly from 14 years in the late 70s to 55 years in 2015-16. Meanwhile, disease incidence decreased noticeably in recent years (from 11 in 2008 to 2 per 100,000 population in 2017). In the ongoing pre-vaccine era, natural infection provides immunity for merely a third (31%) and two thirds (57%) of people in their 40s and 50s, respectively. Hence, the majority of people <= 40 years (94%) and middle-aged adults 40-49 years (69%) are susceptible to HAV. Older susceptible individuals, particularly those >= 50 years (24%), are prone to severe symptoms. Taken together, these changes reflect the epidemiological transition of Vojvodina and Serbia from high to very low HAV endemicity, thereby supporting the current national policy of immunization of only high-risk groups.	[Medic, Snezana; Rajcevic, Smiljana; Ristic, Mioljub; Petrovic, Vladimir] Inst Publ Hlth Vojvodina, Ctr Dis Control & Prevent, Novi Sad, Serbia; [Medic, Snezana; Milosevic, Vesna; Dragnic, Natasa; Rajcevic, Smiljana; Ristic, Mioljub; Petrovic, Vladimir] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Anastassopoulou, Cleo] Univ Patras, Div Genet Cell & Dev Biol, Dept Biol, Patras, Greece; [Milosevic, Vesna] Inst Publ Hlth Vojvodina, Ctr Virol, Novi Sad, Serbia; [Dragnic, Natasa] Inst Publ Hlth Vojvodina, Ctr Informat & Biostat, Novi Sad, Serbia	University of Novi Sad; University of Patras	Medic, S (corresponding author), Inst Publ Hlth Vojvodina, Ctr Dis Control & Prevent, Novi Sad, Serbia.; Medic, S (corresponding author), Univ Novi Sad, Fac Med, Novi Sad, Serbia.	snezana.medic@izjzv.org.rs	Petrovic, Vladimir/L-7149-2018; Ristić, Mioljub/AFI-4237-2022; Anastassopoulou, Cleo/AAO-8539-2020; Ristić, Mioljub/AAF-3754-2022	Petrovic, Vladimir/0000-0002-2052-6232; Anastassopoulou, Cleo/0000-0001-7666-9198; N.Medic, Sneza/0000-0002-5778-9861	Institute of Public Health of Vojvodina	Institute of Public Health of Vojvodina	This study was supported by Institute of Public Health of Vojvodina (SM, VM, ND, SR, MR, VP).	[Anonymous], 2012, Wkly Epidemiol Rec, V87; [Anonymous], 2017, GLOB HEP REP 2017, P2017; Beaute J, 2018, EUROSURVEILLANCE, V23, P11, DOI 10.2807/1560-7917.ES.2018.23.22.1700583; Brinkhof MWG, 2013, VACCINE, V31, P1490, DOI 10.1016/j.vaccine.2013.01.011; Carrillo-Santisteve P, 2017, LANCET INFECT DIS, V17, pE306, DOI 10.1016/S1473-3099(17)30392-4; European Centre for Disease Prevention and Control, 2016, HEP A VIR EU EEA 197, DOI [10.2900/60930, DOI 10.2900/60930]; European Centre for Disease Prevention and Control, 2018, HEP A ANN EP REP 201; Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68; Hanafiah KM, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-57; Institute of Public Health of Serbia, 2018, ANN REP IMM REP SERB; Institute of Public Health of Vojvodina, 2018, ANN REPORT; Itani T, 2014, VACCINE, V32, P6067, DOI 10.1016/j.vaccine.2014.09.006; Jacobsen KH, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031716; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jacobsen KH, 2009, GLOBAL PREVALENCE HE; Koroglu M, 2017, J INFECT PUBLIC HEAL, V10, P513, DOI 10.1016/j.jiph.2016.09.020; Kurkela S, 2012, EPIDEMIOL INFECT, V140, P2172, DOI 10.1017/S0950268812000015; Lanini S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185428; Lazic G, 2015, FOOD ENVIRON VIROL, V7, P149, DOI 10.1007/s12560-015-9187-3; Lemon SM, 2018, J HEPATOL, V68, P167, DOI 10.1016/j.jhep.2017.08.034; Medic S, 2018, EPIDEMIOL INFECT, V146, P1593, DOI 10.1017/S0950268818001619; Mijuskovic P, 1978, Vojnosanit Pregl, V35, P405; Quaglio G, 2008, J MED VIROL, V80, P833, DOI 10.1002/jmv.21141; Ristic Mioljub, 2011, Med Pregl, V64, P570; Sane J, 2015, Euro Surveill, V20, DOI 10.2807/1560-7917.ES2015.20.4.21018; Seguljev Z, 1995, 8 K PREV MED JUG SA; Statistical Office of the Republic of Serbia, 2011, CNES POP HOUS DWELL; Statistical Office of the Republic of Serbia, 2017, DEM YB 2016; Tavoschi L, 2018, VACCINE, V36, P2501, DOI 10.1016/j.vaccine.2018.02.100; Vilibic-Cavlek T, 2011, HEPAT MON, V11, P997, DOI 10.5812/kowsar.1735143X.756; VUKOVIC BS, 1981, J HYG-CAMBRIDGE, V86, P105, DOI 10.1017/S0022172400068790; Wenzel JJ, 2014, FOOD ENVIRON VIROL, V6, P297, DOI 10.1007/s12560-014-9165-1	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217176	10.1371/journal.pone.0217176	http://dx.doi.org/10.1371/journal.pone.0217176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163046	Green Submitted, gold, Green Published			2022-12-26	WOS:000470086200008
J	Rangel, LT; Marden, J; Colston, S; Setubal, JC; Graf, J; Gogarten, JP				Rangel, Luiz Thiberio; Marden, Jeremiah; Colston, Sophie; Setubal, Joao Carlos; Graf, Joerg; Gogarten, Johann Peter			Identification and characterization of putative Aeromonas spp. T3SS effectors	PLOS ONE			English	Article							III SECRETION SYSTEM; HORIZONTAL GENE-TRANSFER; SALMONICIDA SUBSP SALMONICIDA; COMPLETE GENOME SEQUENCE; ADP-RIBOSYLATING TOXIN; TRAVELERS-DIARRHEA; BACTERIAL; PROTEIN; VIRULENCE; AEXT	The genetic determinants of bacterial pathogenicity are highly variable between species and strains. However, a factor that is commonly associated with virulent Gram-negative bacteria, including many Aeromonas spp., is the type 3 secretion system (T3SS), which is used to inject effector proteins into target eukaryotic cells. In this study, we developed a bioinformatics pipeline to identify T3SS effector proteins, applied this approach to the genomes of 105 Aeromonas strains isolated from environmental, mutualistic, or pathogenic contexts and evaluated the cytotoxicity of the identified effectors through their heterologous expression in yeast. The developed pipeline uses a two-step approach, where candidate Aeromonas gene families are initially selected using Hidden Markov Model (HMM) profile searches against the Virulence Factors DataBase (VFDB), followed by strict comparisons against positive and negative control datasets, greatly reducing the number of false positives. This approach identified 21 Aeromonas T3SS likely effector families, of which 8 represent known or characterized effectors, while the remaining 13 have not previously been described in Aeromonas. We experimentally validated our in silico findings by assessing the cytotoxicity of representative effectors in Saccharomyces cerevisiae BY4741, with 15 out of 21 assayed proteins eliciting a cytotoxic effect in yeast. The results of this study demonstrate the utility of our approach, combining a novel in silico search method with in vivo experimental validation, and will be useful in future research aimed at identifying and authenticating bacterial effector proteins from other genera.	[Rangel, Luiz Thiberio; Marden, Jeremiah; Colston, Sophie; Graf, Joerg; Gogarten, Johann Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Rangel, Luiz Thiberio; Setubal, Joao Carlos] Univ Sao Paulo, Interunidades Bioinformat, Sao Paulo, Brazil; [Rangel, Luiz Thiberio; Setubal, Joao Carlos] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Graf, Joerg; Gogarten, Johann Peter] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA; [Rangel, Luiz Thiberio] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Colston, Sophie] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA	University of Connecticut; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Connecticut; Massachusetts Institute of Technology (MIT); United States Department of Defense; United States Navy; Naval Research Laboratory	Graf, J; Gogarten, JP (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.; Graf, J; Gogarten, JP (corresponding author), Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA.	joerg.graf@uconn.edu; gogarten@uconn.edu	Setubal, Joao Carlos/C-7305-2012; Rangel, Luiz Thibério/AAA-4652-2021; Graf, Joerg/ABI-2447-2020	Setubal, Joao Carlos/0000-0001-9174-2816; Graf, Joerg/0000-0001-5320-2712; Gogarten, Johann Peter/0000-0001-6459-6518	JG Agricultural Research Service Agreement [58-1930-4-002]; United States Department of Agriculture JPG JG [1616514]; National Science Foundation JPG [1716046]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/17196-2, 2014/23975-0]; National Science Foundation LTR	JG Agricultural Research Service Agreement; United States Department of Agriculture JPG JG; National Science Foundation JPG; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation LTR	JG Agricultural Research Service Agreement 58-1930-4-002 United States Department of Agriculture JPG JG #1616514 National Science Foundation JPG #1716046 National Science Foundation LTR Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) awards 2012/17196-2 and 2014/23975-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; Andam CP, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-47; Andam CP, 2010, P NATL ACAD SCI USA, V107, P10679, DOI 10.1073/pnas.1001418107; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bansal MS, 2015, BIOINFORMATICS, V31, P1211, DOI 10.1093/bioinformatics/btu806; Bansal MS, 2012, BIOINFORMATICS, V28, pI283, DOI 10.1093/bioinformatics/bts225; Beka L, 2018, MBIO, V9, DOI 10.1128/mBio.01328-18; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bomar L, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00800-13; Braun M, 2002, J BACTERIOL, V184, P1851, DOI 10.1128/JB.184.7.1851-1858.2002; Brown Nat F, 2011, Mob Genet Elements, V1, P118; Burr SE, 2005, MICROBIOL-SGM, V151, P2111, DOI 10.1099/mic.0.27926-0; Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chopra AK, 2009, J WATER HEALTH, V7, pS29, DOI 10.2166/wh.2009.053; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Colston SM, 2014, MBIO, V5, DOI 10.1128/mBio.02136-14; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; CSH Protocols, 2010, COLD SPRING HARB PRO, V2010, DOI [10.1101/pdb.rec12315, DOI 10.1101/PDB.REC12315]; Curak J, 2009, CURR OPIN MICROBIOL, V12, P18, DOI 10.1016/j.mib.2008.11.004; Dacanay A, 2006, MICROBIOL-SGM, V152, P1847, DOI 10.1099/mic.0.28768-0; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; DONG X, 2015, PHYS REV B, V92, DOI DOI 10.1093/DATABASE/BAV064; Ebanks RO, 2006, MICROBIOL-SGM, V152, P1275, DOI 10.1099/mic.0.28485-0; Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1; Eichinger V, 2016, NUCLEIC ACIDS RES, V44, pD669, DOI 10.1093/nar/gkv1269; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fehr D, 2006, MICROBIOL-SGM, V152, P2809, DOI 10.1099/mic.0.28889-0; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; Gori K, 2016, MOL BIOL EVOL, V33, P1590, DOI 10.1093/molbev/msw038; Graf J, 1999, INFECT IMMUN, V67, P1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HANNINEN ML, 1995, J MED MICROBIOL, V42, P26, DOI 10.1099/00222615-42-1-26; Hiransuthikul N, 2005, CLIN INFECT DIS, V41, pE93, DOI 10.1086/497372; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Igbinosa IH, 2012, SCI WORLD J, DOI 10.1100/2012/625023; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; Jones RM, 2012, CELL MICROBIOL, V14, P274, DOI 10.1111/j.1462-5822.2011.01717.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lecuit M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00025; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Lewis PO, 2016, SYST BIOL, V65, P1009, DOI 10.1093/sysbio/syw042; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; MacCannell D., 2016, Clinical Microbiology Newsletter, V38, P169; Mardeni JN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01569; McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x; Merda D, 2017, MOL ECOL, V26, P5939, DOI 10.1111/mec.14343; Mirarab S, 2014, SCIENCE, V346, P1337, DOI 10.1126/science.1250463; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Mulder Nicola, 2007, V396, P59; Naum M, 2009, MICROBIOL-SGM, V155, P3187, DOI 10.1099/mic.0.029892-0; Notti RQ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0004-2015; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Popa O, 2017, ISME J, V11, P543, DOI 10.1038/ismej.2016.116; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; Salomon D, 2010, JOVE-J VIS EXP, DOI [10.3791/1865, DOI 10.3791/1865]; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Silver AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016751; Silver AC, 2009, DNA CELL BIOL, V28, P383, DOI 10.1089/dna.2009.0867; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Van Dongen S. M., 2000, GRAPH CLUSTERING FLO; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; Vanden Bergh P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-44; Vila J, 2003, EMERG INFECT DIS, V9, P552, DOI 10.3201/eid0905.020451; Vilches S, 2008, MICROB PATHOGENESIS, V44, P1, DOI 10.1016/j.micpath.2007.06.004; Wahli T, 2005, J FISH DIS, V28, P141, DOI 10.1111/j.1365-2761.2005.00608.x; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Williams D, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-45; Xiang ZS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r150	95	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0214035	10.1371/journal.pone.0214035	http://dx.doi.org/10.1371/journal.pone.0214035			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163020	Green Submitted, gold, Green Published			2022-12-26	WOS:000470086200002
J	von Hacht, JL; Erdmann, S; Niederstadt, L; Prasad, S; Wagener, A; Exner, S; Beindorff, N; Brenner, W; Grotzinger, C				von Hacht, Jan Lennart; Erdmann, Sarah; Niederstadt, Lars; Prasad, Sonal; Wagener, Asja; Exner, Samantha; Beindorff, Nicola; Brenner, Winfried; Groetzinger, Carsten			Increasing molar activity by HPLC purification improves Ga-68-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model	PLOS ONE			English	Article							STIMULATING HORMONE ANALOG; PET	Purpose Melanocortin receptor 1 (MC1R) is overexpressed in melanoma and may be a molecular target for imaging and peptide receptor radionuclide therapy. (68)Gallium (Ga-68) labeling of DOTA-conjugated peptides is an established procedure in the clinic for use in positron emission tomography (PET) imaging. Aim of this study was to compare a standard labeling protocol against the Ga-68-DOTA peptide purified from the excess of unlabeled peptide. Procedures The MC1R ligand DOTA-NAPamide was labeled with Ga-68 using a standard clinical protocol. Radioactive peptide was separated from the excess of unlabeled DOTA-NAPamide by HPLC. Immediately after the incubation of peptide and Ga-68 (95 degrees C, 15 min), the reaction was loaded on a C18 column and separated by a water/acetonitrile gradient, allowing fractionation in less than 20 minutes. Radiolabeled products were compared in biodistribution studies and PET imaging using nude mice bearing MC1R-expressing B16/F1 xenograft tumors. Results In biodistribution studies, non-purified Ga-68-DOTA-NAPamide did not show significant uptake in the tumor at 1 h post injection (0.78% IA/g). By the additional HPLC step, the molar activity was raised around 10,000-fold by completely removing unlabeled peptide. Application of this rapid purification strategy led to a more than 8-fold increase in tumor uptake (7.0% IA/g). The addition of various amounts of unlabeled DOTA-NAPamide to the purified product led to a blocking effect and decreased specific tumor uptake, similar to the result seen with non-purified radiopeptide. PET imaging was performed using the same tracer preparations. Purified Ga-68-DOTA-NAPamide, in comparison, showed superior tumor uptake. Conclusions We demonstrated that chromatographic separation of radiolabeled from excess unlabeled peptide is technically feasible and beneficial, even for short-lived isotopes such as Ga-68. Unlabeled peptide molecules compete with receptor binding sites in the target tissue. Purification of the radiopeptide therefore improved tumor uptake.	[von Hacht, Jan Lennart; Erdmann, Sarah; Niederstadt, Lars; Wagener, Asja; Exner, Samantha; Groetzinger, Carsten] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany; [Prasad, Sonal; Beindorff, Nicola; Brenner, Winfried] Charite Univ Med Berlin, BERIC, Berlin, Germany; [Prasad, Sonal; Brenner, Winfried] Charite Univ Med Berlin, Dept Nucl Med, Berlin, Germany; [Brenner, Winfried; Groetzinger, Carsten] German Canc Consortium DKTK, Berlin, Germany; [Groetzinger, Carsten] Charite Univ Med Berlin, Mol Canc Res Ctr MKFZ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Grotzinger, C (corresponding author), Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany.; Grotzinger, C (corresponding author), German Canc Consortium DKTK, Berlin, Germany.; Grotzinger, C (corresponding author), Charite Univ Med Berlin, Mol Canc Res Ctr MKFZ, Berlin, Germany.	carsten.groetzinger@charite.de	Grötzinger, Carsten/B-6938-2008	Grötzinger, Carsten/0000-0001-9872-3087; Brenner, Winfried/0000-0003-2478-6004; Prasad, Sonal/0000-0002-9126-855X; Beindorff, Nicola/0000-0001-9126-3356	InnoProfile program of the German Federal Ministry of Education and Research (BMBF) [03IPT614A]; Deutsche Forschungsgemeinschaft (DFG) [INST 335/454-1FUGG]; Sonnenfeld-Stiftung [20161123]	InnoProfile program of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sonnenfeld-Stiftung	This study was supported by grant 03IPT614A in the InnoProfile program of the German Federal Ministry of Education and Research (BMBF; https://www.bmbf.de/) to CG, by grant INST 335/454-1FUGG from Deutsche Forschungsgemeinschaft (DFG; https://www.dfg.de/) to WB and by grant 20161123 from Sonnenfeld-Stiftung to Samantha Exner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes P, 2007, EUR J NUCL MED MOL I, V34, P982, DOI 10.1007/s00259-006-0317-x; BARD DR, 1990, BRIT J CANCER, V62, P919, DOI 10.1038/bjc.1990.409; BREEMAN WAP, 1995, J NUCL MED, V36, P623; Brom M, 2011, MOL IMAGING, V10, P144, DOI 10.2310/7290.2010.00032; Brom M, 2010, EUR J NUCL MED MOL I, V37, P1345, DOI 10.1007/s00259-009-1363-y; Cheng Z, 2007, BIOCONJUGATE CHEM, V18, P765, DOI 10.1021/bc060306g; de Jong M, 1999, EUR J NUCL MED, V26, P693, DOI 10.1007/s002590050439; Exner S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00146; Fani M, 2012, EUR J NUCL MED MOL I, V39, P11, DOI 10.1007/s00259-011-2001-z; Froidevaux S, 2004, J NUCL MED, V45, P116; Gladfelter P, 2017, MELANOMA RES, V27, P403, DOI 10.1097/CMR.0000000000000379; Katsifis A, 2006, APPL RADIAT ISOTOPES, V64, P27, DOI 10.1016/j.apradiso.2005.06.006; Lim SM, 2009, J NUCL MED, V50, P1638, DOI 10.2967/jnumed.109.065870; Notni J, 2016, J NUCL MED, V57, P1618, DOI 10.2967/jnumed.116.173948; Notni J, 2011, CHEM-EUR J, V17, P14718, DOI 10.1002/chem.201103503; Raposinho PD, 2010, BIOPOLYMERS, V94, P820, DOI 10.1002/bip.21490; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Schuhmacher J, 2005, J NUCL MED, V46, P691; SIEGRIST W, 1989, CANCER RES, V49, P6352; Van Laeken N, 2013, APPL RADIAT ISOTOPES, V78, P62, DOI 10.1016/j.apradiso.2013.04.009; Velikyan I, 2008, NUCL MED BIOL, V35, P529, DOI 10.1016/j.nucmedbio.2008.03.002	21	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217883	10.1371/journal.pone.0217883	http://dx.doi.org/10.1371/journal.pone.0217883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163066	Green Published, Green Submitted, gold			2022-12-26	WOS:000470086200042
J	Bundy, JL; Anderson, BR; Francescatto, L; Garrett, ME; Soldano, KL; Telen, MJ; Davis, EE; Ashley-Koch, AE				Bundy, Joseph L.; Anderson, Blair R.; Francescatto, Ludmila; Garrett, Melanie E.; Soldano, Karen L.; Telen, Marilyn J.; Davis, Erica E.; Ashley-Koch, Allison E.			RNA sequencing of isolated cell populations expressing human APOL1 G2 risk variant reveals molecular correlates of sickle cell nephropathy in zebrafish podocytes	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL-DISEASE; GENE; ASSOCIATION; INTERLEUKIN-6; NPHS1	Kidney failure occurs in 5-13% of individuals with sickle cell disease and is associated with early mortality. Two APOL1 alleles (G1 and G2) have been identified as risk factors for sickle cell disease nephropathy. Both risk alleles are prevalent in individuals with recent African ancestry and have been associated with nephropathic complications in other diseases. Despite the association of G1 and G2 with kidney dysfunction, the mechanisms by which these variants contribute to increased risk remain poorly understood. Previous work in zebrafish models suggest that the G2 risk allele functions as a dominant negative, whereas the G1 allele is a functional null. To understand better the cellular pathology attributed to APOL1 G2, we investigated the in vivo effects of the G2 risk variant on distinct cell types using RNA sequencing. We surveyed APOL1 G2 associated transcriptomic alterations in podocytes and vascular endothelial cells isolated from zebrafish larvae expressing cell-type specific reporters. Our analysis identified many transcripts (n = 7,523) showing differential expression between APOL1 G0 (human wild-type) and APOL1 G2 exposed podocytes. Conversely, relatively few transcripts (n = 107) were differentially expressed when comparing APOL1 G0 and APOL1 G2 exposed endothelial cells. Pathway analysis of differentially expressed transcripts in podocytes showed enrichment for autophagy associated terms such as " Lysosome" and " Phagosome", implicating these pathways in APOL1 G2 associated kidney dysfunction. This work provides insight into the molecular pathology of APOL1 G2 nephropathy which may offer new therapeutic strategies for multiple disease contexts such as sickle cell nephropathy.	[Bundy, Joseph L.; Anderson, Blair R.; Garrett, Melanie E.; Soldano, Karen L.; Ashley-Koch, Allison E.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Bundy, Joseph L.; Telen, Marilyn J.; Ashley-Koch, Allison E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Francescatto, Ludmila; Davis, Erica E.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA	Duke University; Duke University; Duke University	Ashley-Koch, AE (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA.; Ashley-Koch, AE (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	allison.ashleykoch@duke.edu		Bundy, Joseph/0000-0002-7631-6197; Davis, Erica/0000-0002-2412-8397; Telen, Marilyn/0000-0003-3809-1780	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) project research grant (R01) [DK110104]; National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant (T32) [HL007057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110104] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) project research grant (R01); National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant (T32); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) project research grant (R01 #DK110104) to AEAK. JLB and LF were supported by a National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant (T32 #HL007057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005349; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Chen TK, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007199; DARGENT B, 1990, P NATL ACAD SCI USA, V87, P5907, DOI 10.1073/pnas.87.15.5907; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duchateau PN, 2001, J LIPID RES, V42, P620; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Granado D, 2017, J AM SOC NEPHROL, V28, P3226, DOI 10.1681/ASN.2016111220; Hashemi M, 2015, IRAN J KIDNEY DIS, V9, P25; Horibe H, 2015, NEPHROLOGY, V20, P273, DOI 10.1111/nep.12381; Hughson MD, 2018, KIDNEY INT REP, V3, P89, DOI 10.1016/j.ekir.2017.08.007; Jones SA, 2015, NEPHROL DIAL TRANSPL, V30, P564, DOI 10.1093/ndt/gfu233; Kiberd BA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014251.87778.01; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kormann R, 2017, BRIT J HAEMATOL, V179, P323, DOI 10.1111/bjh.14842; Kotb AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153768; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Neelofar K, 2017, J CELL BIOCHEM, V118, P1803, DOI 10.1002/jcb.25853; O'Toole JF, 2018, J AM SOC NEPHROL, V29, P869, DOI 10.1681/ASN.2016121322; Olabisi O, 2016, CLIN NEPHROL, V86, pS114, DOI 10.5414/CNP86S116; Olabisi OA, 2017, SEMIN NEPHROL, V37, P546, DOI 10.1016/j.semnephrol.2017.07.008; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Sun ZJ, 2015, AM J TRANSPLANT, V15, P3229, DOI 10.1111/ajt.13378; Tayo BO, 2013, INT UROL NEPHROL, V45, P485, DOI 10.1007/s11255-012-0263-4; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217042	10.1371/journal.pone.0217042	http://dx.doi.org/10.1371/journal.pone.0217042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158233	Green Published, Green Submitted, gold			2022-12-26	WOS:000469915700007
J	Horvath, D; Anderson, JV; Chao, WS; Zheng, PY; Buchwaldt, M; Parkin, IAP; Dorn, K				Horvath, David; Anderson, James, V; Chao, Wun S.; Zheng, Puying; Buchwaldt, Miles; Parkin, Isobel A. P.; Dorn, Kevin			Genes associated with chloroplasts and hormone-signaling, and transcription factors other than CBFs are associated with differential survival after low temperature treatments of Camelina sativa biotypes	PLOS ONE			English	Article							COLD RESPONSE PATHWAY; FREEZING TOLERANCE; ARABIDOPSIS-THALIANA; NETWORK; STRESS; OVEREXPRESSION; EXPRESSION; TRAITS; PIF3	Winter annual biotypes of Camelina sativa regularly survive after winter conditions experienced in northern regions of the U.S., whereas summer annual biotypes do not. To determine potential molecular mechanisms associated with these biotype differences in survival after low temperature treatments, we examined genetic and transcript variations in both a winter (Joelle) and a summer- (CO46) biotype. It was determined that as few as one or two dominant genes may control differential survival after low temperature treatments. Of the 1797 genes that were differentially expressed in response to cold in both the winter and summer biotypes many COR genes were identified, indicating that the CBF regulon is functional in both. However, only 153 and 76 genes from Joelle and CO46, respectively, were either differentially expressed or not expressed at all in one biotype versus the other following cold acclimation. We hypothesize that these 229 genes play a significant role in, or are primarily responsive to, differences in survival after freezing between these two biotypes. Promoter analysis provided few clues as to the regulation or these genes; however, genes that were down-regulated specifically in the winter biotype Joelle were enriched with the sequence TGGCCCTCGCTCAC, which is over-represented among genes associated with chloroplasts in Arabidopsis. Additionally, several genes involved in auxin signaling were down-regulated specifically in Joelle. A transcription factor with strong similarity to MYB47, known to be up-regulated by salt, drought, and jasmonic acid, but not cold in Arabidopsis, was essentially off in the freezing sensitive biotype CO46, but was cold-induced in the winter biotype Joelle. Several other transcription factors genes including three with similarity to WRKY70, that may be involved in SA/JA-dependent responses, a HOMEOBOX 6 gene involved in ABA signaling, and two others (NUCLEAR FACTOR Y and CONSTANS-like 2) known to be implicated in photoperiodic flowering were also differentially expressed between the two biotypes.	[Horvath, David; Anderson, James, V; Chao, Wun S.] USDA ARS, Edward T Schafer Agr Res Ctr, Sunflower & Plant Biol Res Unit, Fargo, ND 58102 USA; [Zheng, Puying] North Dakota State Univ, Dept Plant Sci, Fargo, ND USA; [Buchwaldt, Miles; Parkin, Isobel A. P.] Agr & Agri Food Canada, Saskatoon, SK, Canada; [Dorn, Kevin] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); North Dakota State University Fargo; Agriculture & Agri Food Canada; Kansas State University	Horvath, D (corresponding author), USDA ARS, Edward T Schafer Agr Res Ctr, Sunflower & Plant Biol Res Unit, Fargo, ND 58102 USA.	David.horvath@ars.usda.gov	Parkin, Isobel/AAD-6625-2020; Dorn, Kevin/K-5667-2013	Dorn, Kevin/0000-0003-2722-6221; Parkin, Isobel/0000-0002-5807-9466; Anderson, James/0000-0002-1801-5767; Horvath, David/0000-0002-8458-7691	USDA-ARS CRIS [3060-21220-029-00-D]	USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by USDA-ARS CRIS 3060-21220-029-00-D Novel Weed Management Solutions: Understanding Weed-Crop Interactions in Northern Climates.; This work was funded by USDA-ARS CRIS 3060-21220-029-00-D Novel Weed Management Solutions: Understanding Weed-Crop Interactions in Northern Climates. Significant technical contributions were provided by Wayne Sargent and Brant Bigger.	Agren J, 2012, NEW PHYTOL, V194, P1112, DOI 10.1111/j.1469-8137.2012.04112.x; Anderson J. V., 2018, PLANT DIRECT, V2, P1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berti M, 2016, IND CROP PROD, V94, P690, DOI 10.1016/j.indcrop.2016.09.034; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Dong J, 2017, CURR BIOL, V27, P2420, DOI 10.1016/j.cub.2017.06.062; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gehan MA, 2015, PLANT J, V84, P682, DOI 10.1111/tpj.13027; Gesch RW, 2013, IND CROP PROD, V44, P718, DOI 10.1016/j.indcrop.2012.05.023; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jiang BC, 2017, P NATL ACAD SCI USA, V114, pE6695, DOI 10.1073/pnas.1706226114; Kagale S, 2016, PLANT J, V88, P879, DOI 10.1111/tpj.13302; Kagale S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4706; Kole C, 2002, MOL BREEDING, V9, P201, DOI 10.1023/A:1019759512347; Le MQ, 2015, PLANT MOL BIOL, V87, P1, DOI 10.1007/s11103-014-0256-z; Ledger S, 2001, PLANT J, V26, P14; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Pennycooke JC, 2008, PLANT MOL BIOL, V67, P483, DOI 10.1007/s11103-008-9333-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Savitch LV, 2005, PLANT CELL PHYSIOL, V46, P1525, DOI 10.1093/pcp/pci165; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Thomashow MF, 2001, PHYSIOL PLANTARUM, V112, P171, DOI 10.1034/j.1399-3054.2001.1120204.x; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wilke BJ, 2008, J SCI FOOD AGR, V88, P551, DOI 10.1002/jsfa.3149; Yamasaki Y, 2016, PLANT SCI, V246, P80, DOI 10.1016/j.plantsci.2016.02.007; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Zander M, 2012, MOL PLANT, V5, P831, DOI 10.1093/mp/ssr113; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217692	10.1371/journal.pone.0217692	http://dx.doi.org/10.1371/journal.pone.0217692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150478	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100089
J	Nguiffo, DN; Wondji, CS; Wabo, JP; Mpoame, M				Nguiffo, Daniel Nguete; Wondji, Charles S.; Wabo, Josue Pone; Mpoame, Mbida			Microfilariae infestation of goliath frogs (Conraua goliath) from Cameroon	PLOS ONE			English	Article							PARASITES	The goliath frog (Conraua goliath) is endemic to Equatorial Guinea and Cameroon. It is an endangered species but little information is known about its parasites. To understand the impact of blood parasites on this species, we microscopically examined blood smears from 78 goliath frogs in February and November 2016 (dry and wet seasons) from six localities in Littoral Region of Cameroon, and we sequenced mitochondrial DNA from positive samples. Microfilariae were found in 33/78 (42.3%) goliath frogs at six locations. No other haemoparasite species was detected. Morphological characteristics of microfilariae were also described, and specimens from each frog species were similar. DNA sequencing data from the mitochondrial Cytochrome Oxidases sub unit I (COI) gene revealed a close relationship with Icosiella neglecta, a microfilaria documented in other European, Asian, and African frogs. However, sequences were sufficiently genetically distant (0.118) that they may define a new species of Icosiella. The infection burden of microfilariae varied by site, with season (65% in dry season to 23% in rainy season), and by sex, (male frogs had significantly higher parasite burdens than females (p < 0.0001)). However, this may have been confounded by size as the microfilaria intensity increased with frog weight (p < 0.0001), and males were larger than females. Microfilaria infection intensity varied from 1 to 120 per 50 mu l of blood. Microfilaria induced a significant increase (p < 0.05) in the number of white blood cells (WBC) counted compared to uninfected frogs, but there was no statistically significant variation in red blood cell (RBC) count, plasma cholesterol level (p = 0.210) or plasma glucose level (p = 0.100).	[Nguiffo, Daniel Nguete; Wabo, Josue Pone; Mpoame, Mbida] Univ Dschang, Dept Anim Biol, Fac Sci, Res Unit Biol & Appl Ecol, Dschang, Cameroon; [Nguiffo, Daniel Nguete; Wondji, Charles S.] Ctr Res Infect Dis, Yaounde, Cameroon; [Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine	Nguiffo, DN (corresponding author), Univ Dschang, Dept Anim Biol, Fac Sci, Res Unit Biol & Appl Ecol, Dschang, Cameroon.; Nguiffo, DN (corresponding author), Ctr Res Infect Dis, Yaounde, Cameroon.	danielnguete@yahoo.fr	Wondji, Charles/AAG-1510-2020	Wondji, Charles S./0000-0003-0791-3673				AHO JM, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P157; Al- Bayati O, 2009, IRAQI J VET SCI S1, V23; Allender Matthew C., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P463, DOI 10.1016/j.cvex.2008.03.006; Amiet J, 2004, IUCN 2013 IUCN RED L; ARIKAN H, 2014, N W J ZOOLOGY, V10; Baker D.G., 2008, FLYNNS PARASITES LAB; BARTA J R, 1984, Journal of Wildlife Diseases, V20, P180; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; BERNARD G, 2009, B GEORGIAN NATL ACAD, V3, P129; BLAUSTEIN AR, 1995, SCI AM, V272, P52, DOI 10.1038/scientificamerican0495-52; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Casiraghi M, 2001, PARASITOL RES, V87, P417, DOI 10.1007/s004360000368; Combes C, 1996, BIODIVERS CONSERV, V5, P953, DOI 10.1007/BF00054413; Daniel NN, 2015, GLOB ECOL CONSERV, V4, P146, DOI 10.1016/j.gecco.2015.06.009; Ferguson Laura V., 2012, Insects, V3, P410, DOI 10.3390/insects3020410; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haroun EM, 1996, VET RES COMMUN, V20, P255, DOI 10.1007/BF00366923; Hemmingsen W, 2000, POLAR BIOL, V23, P368, DOI 10.1007/s003000050457; Klaphake Eric, 2009, Vet Clin North Am Exot Anim Pract, V12, P597, DOI 10.1016/j.cvex.2009.06.005; Kudo R., 1922, Transactions of the American Microscopical Society, V41, P59, DOI 10.2307/3221896; Lefoulon E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004233; MAFF, 1984, MANUAL VET INVESTIGA, V2, p[390, 162]; McKenzie VJ, 2008, J PARASITOL, V94, P824, DOI 10.1645/GE-1433.1; McKenzie VJ, 2007, BIOL CONSERV, V137, P102, DOI 10.1016/j.biocon.2007.01.019; Olivry J., 1986, ORSTOM MEMOIRES, V9, P1; Omonona A. O., 2011, Journal of Veterinary Medicine and Animal Health, V3, P14; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Reichenbach-Klinke H, 1965, SCIENCE, V150, P1143; ROESCHLAP, 1974, Z KLIN CHEM KLIN BIO, V12, P226; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105	32	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217539	10.1371/journal.pone.0217539	http://dx.doi.org/10.1371/journal.pone.0217539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141563	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000469323000058
J	Billings, E; Heipertz, RA; Varleva, T; Sanders-Buell, E; O'Sullivan, AM; Bose, M; Howell, S; Kijak, GH; Taskov, H; Elenkov, I; Nenova, M; Popivanova, N; Valenzuela, AB; Myles, O; Bautista, CT; Robb, ML; Michael, NL; Kim, JH; Scott, PT; Tovanabutra, S; Ake, JA				Billings, Erik; Heipertz, Richard A.; Varleva, Tonka; Sanders-Buell, Eric; O'Sullivan, Anne Marie; Bose, Meera; Howell, Shana; Kijak, Gustavo H.; Taskov, Hristo; Elenkov, Ivailo; Nenova, Marina; Popivanova, Nedialka; Valenzuela, Aimee Bolen; Myles, Otha; Bautista, Christian T.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Scott, Paul T.; Tovanabutra, Sodsai; Ake, Julie A.			HIV-1 genetic diversity and demographic characteristics in Bulgaria	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENOTYPING ASSAY; HIGH-THROUGHPUT; TYPE-1; INFECTIONS; RECOMBINANTS; SPREAD	HIV-1 strain diversity in Bulgaria is extensive and includes contributions from nearly all major subtypes and the Circulating Recombinant Forms (CRF): 01_AE, 02_AG, and 05_DF. Prior to this study, HIV-1 sequence information from Bulgaria has been based solely on the pro-RT gene, which represent less than 15% of the viral genome. To further characterize HIV-1 in Bulgaria, assess participant risk behaviors, and strengthen knowledge of circulating strains in the region, the study "Genetic Subtypes of HIV-1 in Bulgaria (RV240)" was conducted. This study employed the real time-PCR based Multi-region Hybridization Assay (MHA) B/non-B and HIV-1 sequencing to survey 215 of the approximately 1100 known HIV-1 infected Bulgarian adults (2008-2009) and determine if they were infected with subtype B HIV-1. The results indicated a subtype B prevalence of 40% and demonstrate the application of the MHA B/non-B in an area containing broad HIV-1 strain diversity. Within the assessed risk behaviors, the proportion of subtype B infection was greatest in men who have sex with men and lowest among those with drug use risk factors. During this study, 15 near full-length genomes and 22 envelope sequences were isolated from study participants. Phylogenetic analysis shows the presence of subtypes A1, B, C, F1, and G, CRF01_AE, CRF02_AG, CRF05_DF, and one unique recombinant form (URF). These sequences also show the presence of two strain groups containing participants with similar risk factors. Previous studies in African and Asian cohorts have shown that co-circulation of multiple subtypes can lead to viral recombination within super-infected individuals and the emergence of new URFs. The low prevalence of URFs in the presence of high subtype diversity in this study, may be the result of successful infection prevention and control programs. Continued epidemiological monitoring and support of infection prevention programs will help maintain control of the HIV-1 epidemic in Bulgaria.	[Billings, Erik; Heipertz, Richard A.; Sanders-Buell, Eric; O'Sullivan, Anne Marie; Bose, Meera; Howell, Shana; Kijak, Gustavo H.; Valenzuela, Aimee Bolen; Myles, Otha; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Scott, Paul T.; Tovanabutra, Sodsai; Ake, Julie A.] US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Billings, Erik; Sanders-Buell, Eric; O'Sullivan, Anne Marie; Bose, Meera; Howell, Shana; Kijak, Gustavo H.; Valenzuela, Aimee Bolen; Bautista, Christian T.; Robb, Merlin L.; Tovanabutra, Sodsai] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Heipertz, Richard A.; Myles, Otha; Bautista, Christian T.; Michael, Nelson L.; Scott, Paul T.; Ake, Julie A.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Varleva, Tonka] Minist Hlth, Dept Prevent & Control AIDS TB&STIs, Sofia, Bulgaria; [Taskov, Hristo] Natl Ctr Infect & Parasit Dis, Sofia, Bulgaria; [Elenkov, Ivailo] Hosp Infect Dis Prof Iv Kirov, Dept Patients Acquired Immune Deficiencies, Sofia, Bulgaria; [Nenova, Marina] Med Univ Hosp, Infect Dis Clin, St Marina, Varna, Bulgaria; [Popivanova, Nedialka] Med Univ Hosp St Georg, Infect Dis Clin, Plovdiv, Bulgaria; [Heipertz, Richard A.] US Army, Off Regulated Activ, Med Res & Materiel Command, Ft Detrick, MD USA; [Kijak, Gustavo H.] GSK Vaccines, Rockville, MD USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Ministry of Health Bulgaria; Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Medical University Varna; Medical University Plovdiv; GlaxoSmithKline; International Vaccine Institute	Tovanabutra, S (corresponding author), US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Tovanabutra, S (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	stovanabutra@hivresearch.org	Varleva, Tonka/AAY-6476-2020	Billings, Erik/0000-0002-8963-0484; Bautista, Christian/0000-0002-1228-0754	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; GlaxoSmithKline (GSK) Vaccines; United States Military HIV Research Program (the Walter Reed Army Institute of Research); United States Military HIV Research Program (Henry M. Jackson Foundation for the Advancement of Military Medicine)	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); GlaxoSmithKline (GSK) Vaccines; United States Military HIV Research Program (the Walter Reed Army Institute of Research); United States Military HIV Research Program (Henry M. Jackson Foundation for the Advancement of Military Medicine)	Authors ESB, AOS, MB, SH, GHK, ABV, CTB, MLB, and ST received funding support in the form of money paid to the institution by cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). Additionally, author GHK is currently a paid employee of GlaxoSmithKline (GSK) Vaccines and receives financial support in the form of a salary. However, his contribution to the research reported on in this paper took place prior to this commercial affiliation. The specific roles of this author are articulated in the ' author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The material has been reviewed by the Walter Reed Army Institute of Research and there is no objection to its presentation and/or publication. The Walter Reed Army Institute of Research Institutional Research Board human use protocol #W1424 (RV240), "Genetic Subtypes of HIV-1 in Bulgaria from 2008-2009'' was funded through the United States Military HIV Research Program (the Walter Reed Army Institute of Research and the Henry M. Jackson Foundation for the Advancement of Military Medicine).	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Alexiev I, 2016, INFECT GENET EVOL, V46, P269, DOI 10.1016/j.meegid.2016.05.029; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bello G, 2012, INFECT GENET EVOL, V12, P1079, DOI 10.1016/j.meegid.2012.03.014; Beloukas A, 2016, INFECT GENET EVOL, V46, P180, DOI 10.1016/j.meegid.2016.06.033; Billings E, 2017, AIDS RES HUM RETROV, V33, P373, DOI [10.1089/aid.2016.0111, 10.1089/AID.2016.0111]; Billings E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135124; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2015, HIV AIDS SURV EUR 20; Frentz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094495; Gaschen B, 2001, BIOINFORMATICS, V17, P415, DOI 10.1093/bioinformatics/17.5.415; Heipertz RA, 2013, AIDS RES HUM RETROV, V29, P1310, DOI [10.1089/aid.2013.0087, 10.1089/AID.2013.0087]; Hierholzer J, 2002, AIDS RES HUM RETROV, V18, P1339, DOI 10.1089/088922202320935410; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Inan D, 2014, J INT AIDS SOC, V17, P126, DOI 10.7448/IAS.17.4.19684; Ivanov IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059666; Kijak GH, 2004, AIDS RES HUM RETROV, V20, P521, DOI 10.1089/088922204323087778; Kijak GH, 2007, VIROLOGY, V358, P178, DOI 10.1016/j.virol.2006.07.055; Kijak GH, 2010, AIDS RES HUM RETROV, V26, P1317, DOI 10.1089/aid.2010.0127; Los Alamos National Laboratory, 2016, HIV SEQ DAT; Paraschiv S, 2012, INFECT GENET EVOL, V12, P1052, DOI 10.1016/j.meegid.2012.03.003; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Siljic M, 2013, INFECT GENET EVOL, V19, P378, DOI 10.1016/j.meegid.2013.06.015; Singer DE, 2010, AIDS RES HUM RETROV, V26, P889, DOI 10.1089/aid.2009.0289; Stanojevic M, 2012, AIDS REV, V14, P28; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; UNAIDS, 2014, GAP REP 2014; US Department of State, 2015, TRAFF PERS REP 2015	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217063	10.1371/journal.pone.0217063	http://dx.doi.org/10.1371/journal.pone.0217063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136611	gold, Green Submitted, Green Published			2022-12-26	WOS:000469224300015
J	Saito, H; Sakakibara, Y; Sakata, A; Kurashige, R; Murakami, D; Kageshima, H; Saito, A; Miyazaki, Y				Saito, Hiroaki; Sakakibara, Yumi; Sakata, Ayumi; Kurashige, Rie; Murakami, Daisuke; Kageshima, Hiroki; Saito, Akira; Miyazaki, Yasunari			Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus	PLOS ONE			English	Article							COLI OUTER-MEMBRANE; ESCHERICHIA-COLI; FUNCTIONAL-PROPERTIES; BACTERICIDAL ACTION; GALACTOMANNAN; MECHANISMS; SUSCEPTIBILITY; DERIVATIVES; INDUSTRIAL; PROTEINS	The recent emergence of antibiotic-resistant bacteria requires the development of new antibiotics or new agents capable of enhancing antibiotic activity. This study evaluated the antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus (MRSA), which should resolve the problem of antibiotic-resistant bacteria. Bactericidal tests showed that LYZOX killed 50% more P. aeruginosa (NBRC 13275), A. baumannii and MRSA than the control treatment after 60 min. In addition, LYZOX was shown to inhibit the growth of P. aeruginosa (NBRC 13275 and PAO1), A. baumannii and MRSA better than its components. To elucidate the antibacterial mechanism of LYZOX, we performed cell membrane integrity assays, N-phenyl-1-naphthylamine assays, 2-nitrophenyl beta-D-galactopyranoside assays and confocal laser scanning microscopy. These results showed that LYZOX affected bacterial cell walls and increased the permeability of the outer membrane and the plasma membrane. Furthermore, each type of bacteria treated with LYZOX was observed by electron microscopy. Electron micrographs revealed that these bacteria had the morphological features of both lysozyme-treated and chitosan oligosaccharide-treated bacteria and that LYZOX destroyed bacterial cell walls, which caused the release of intracellular contents from cells. An acquired drug resistance test revealed that these bacteria were not able to acquire resistance to LYZOX. The hemolytic toxicity test demonstrated the low hemolytic activity of LYZOX. In conclusion, LYZOX exhibited antibacterial activity and low drug resistance in the presence of P. aeruginosa, A. baumannii and MRSA and showed low hemolytic toxicity. LYZOX affected bacterial membranes, leading to membrane disruption and the release of intracellular contents and consequent bacterial cell death. LYZOX may serve as a novel candidate drug that could be used for the control of refractory infections.	[Saito, Hiroaki; Sakakibara, Yumi; Sakata, Ayumi; Kurashige, Rie; Miyazaki, Yasunari] Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan; [Murakami, Daisuke] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka, Fukuoka, Japan; [Kageshima, Hiroki; Saito, Akira] Wako Filter Technol Co Ltd, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Kyushu University	Miyazaki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan.	miyazaki.pilm@tmd.ac.jp	MIYAZAKI, YASUNARI/B-7847-2015	MIYAZAKI, YASUNARI/0000-0002-9073-9815	Wako Filter Technology Co., Ltd.	Wako Filter Technology Co., Ltd.	Y. M. and D. M. are funded by Wako Filter Technology Co., Ltd. A. Saito and H. K. are employees of Wako Filter Technology Co., Ltd. A. Saito and H. K. made lysozyme-chitosan oligosaccharide conjugates (LYZOX) and lysozyme-galactomannan conjugates. H. K. performed SDS-PAGE analysis, heat stability tests, determination of minimal inhibitory concentrations and acquired drug resistance tests. The funders (A. Saito and H. K.) had roles in performing SDS-PAGE analysis, heat stability tests, determination of minimal inhibitory concentrations and acquired drug resistance tests, and producing lysozymechitosan oligosaccharide conjugates (LYZOX) and lysozyme-galactomannan conjugates. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.r We express sincere thanks to the staff of the Research Core in Tokyo Medical and Dental University for photographing the samples using electron microscopy. WAKO FILTER TECHNOLOGY Co. Ltd. provided lysozyme-chitosan oligosaccharide conjugates (LYZOX) and lysozyme-galactomannan conjugates for this study free of charge and supported this study financially.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Aminlari L, 2014, J FOOD SCI, V79, pR1077, DOI 10.1111/1750-3841.12460; [Anonymous], 2016, TACKLING DRUG RESIST; [Anonymous], 2015, M07A10 CLIN LAB STAN; Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4; Chen LC, 2012, FOOD CHEM, V135, P2397, DOI 10.1016/j.foodchem.2012.06.122; Cheung RCF, 2015, MAR DRUGS, V13, P5156, DOI 10.3390/md13085156; Chung YC, 2011, MOLECULES, V16, P8504, DOI 10.3390/molecules16108504; Costa EM, 2017, CARBOHYD POLYM, V178, P347, DOI 10.1016/j.carbpol.2017.09.055; Costa EM, 2017, J APPL MICROBIOL, V122, P1547, DOI 10.1111/jam.13457; Costa EM, 2017, CARBOHYD POLYM, V174, P369, DOI 10.1016/j.carbpol.2017.06.087; Deng JD, 2016, IND CROP PROD, V94, P281, DOI 10.1016/j.indcrop.2016.09.004; DEPAMPHILIS ML, 1971, J BACTERIOL, V105, P1184, DOI 10.1128/JB.105.3.1184-1199.1971; Fernandes MM, 2017, ACS APPL MATER INTER, V9, P15022, DOI 10.1021/acsami.7b00217; Fujimura T, 2005, JPN J CHEMOTHER, V53, P57; Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Hoque J, 2016, MOL PHARMACEUT, V13, P3578, DOI 10.1021/acs.molpharmaceut.6b00764; Kato A, 2002, FOOD SCI TECHNOL RES, V8, P193, DOI 10.3136/fstr.8.193; Kong M, 2008, COLLOID SURFACE B, V65, P197, DOI 10.1016/j.colsurfb.2008.04.003; Kumar ABV, 2005, BIOCHEM J, V391, P167, DOI 10.1042/BJ200580093; Lee Joongjae, 2018, Prev Nutr Food Sci, V23, P60, DOI 10.3746/pnf.2018.23.1.60; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Ma ZX, 2016, ACS APPL MATER INTER, V8, P10700, DOI 10.1021/acsami.6b00894; Mine Y, 2008, J AGR FOOD CHEM, V56, P4874, DOI 10.1021/jf8001153; NAKAMURA K, 1975, BIOCHIM BIOPHYS ACTA, V413, P371, DOI 10.1016/0005-2736(75)90122-4; Nakamura S, 1996, FEBS LETT, V383, P251, DOI 10.1016/0014-5793(96)00260-8; Nakamura S, 2000, NAHRUNG, V44, P201, DOI [10.1002/1521-3803(20000501)44:3<201::AID-FOOD201>3.0.CO;2-S, 10.1002/1521-3803(20000501)44:3&lt;201::AID-FOOD201&gt;3.0.CO;2-S]; Paterson GK, 2014, TRENDS MICROBIOL, V22, P42, DOI 10.1016/j.tim.2013.11.003; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Rahman MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07651-7; Ramezani R, 2008, J SCI FOOD AGR, V88, P2730, DOI 10.1002/jsfa.3400; Ryu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132619; Sahariah P, 2017, BIOMACROMOLECULES, V18, P3846, DOI 10.1021/acs.biomac.7b01058; Saito A, 2003, BIOSCI BIOTECH BIOCH, V67, P2334, DOI 10.1271/bbb.67.2334; Shen SX, 2015, FOOD CONTROL, V47, P196, DOI 10.1016/j.foodcont.2014.07.003; Song Y, 2002, FOOD RES INT, V35, P459, DOI 10.1016/S0963-9969(01)00144-2; Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002; Travis SM, 2001, CURR OPIN IMMUNOL, V13, P89, DOI 10.1016/S0952-7915(00)00187-4; VENTOLA, 2015, J PHARM THERAPEUTICS, V40, P277, DOI DOI 10.5796/ELECTR0CHEMISTRY.82.749; Wang JJ, 2019, MED RES REV, V39, P831, DOI 10.1002/med.21542; WARREN GH, 1955, J BACTERIOL, V70, P614, DOI 10.1128/JB.70.5.614-619.1955; Xing K, 2009, CARBOHYD POLYM, V76, P17, DOI 10.1016/j.carbpol.2008.09.016; Xu C, 2017, FOOD CONTROL, V73, P1445, DOI 10.1016/j.foodcont.2016.10.048; Yang JE, 2017, FOOD CHEM, V227, P149, DOI 10.1016/j.foodchem.2017.01.076	46	34	34	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217504	10.1371/journal.pone.0217504	http://dx.doi.org/10.1371/journal.pone.0217504			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136634	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300047
J	Kim, DY; Park, JA; Kim, Y; Noh, M; Park, S; Lie, E; Kim, E; Kim, YM; Kwon, YG				Kim, Dong Young; Park, Jeong Ae; Kim, Yeomyung; Noh, Minyoung; Park, Songyi; Lie, Eunkyung; Kim, Eunjoon; Kim, Young-Myeong; Kwon, Young-Guen			SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175	FASEB JOURNAL			English	Article						VEGF signaling; endothelial leakage; vascular permeability; ischemia reperfusion	VASCULAR-PERMEABILITY; GROWTH-FACTOR; ISCHEMIC-STROKE; EXPRESSION; FAMILY; INFLAMMATION; INHIBITION; MECHANISMS; SURVIVAL; BIOLOGY	Angiogenesis depends on VEGF-mediated signaling. However, the regulatory mechanisms and functions of individual VEGF receptor 2 (VEGFR2) phosphorylation sites remain unclear. Here, we report that synaptic adhesion-like molecule 4 (SALM4) regulates a specific VEGFR2 phosphorylation site. SALM4 silencing in HUVECs and Salm4 knockout (KO) in lung endothelial cells (ECs) of Salm4(-/-) mice suppressed phosphorylation of VEGFR2 tyrosine (Y) 1175 (Y1173 in mice) and downstream signaling upon VEGF-A stimulation. However, VEGFR2 phosphorylation at Y951 (Y949 in mice) and Y1214 (Y1212 in mice) remained unchanged. Knockdown and KO of SALM4 inhibited VEGF-A-induced angiogenic functions of ECs. SALM4 depletion reduced endothelial leakage, sprouting, and migratory activities. Furthermore, in an ischemia and reperfusion (I/R) model, brain injury was attenuated in Salm4(-/-) mice compared with wild-type (WT) mice. In brain lysates after I/R, VEGFR2 phosphorylation at Y949, Y1173, and Y1212 were induced in WT brains, but only Y1173 phosphorylation of VEGFR2 was reduced in Salm4(-/-) brains. Taken together, our results demonstrate that SALM4 specifically regulates VEGFR2 phosphorylation at Y1175 (Y1173 in mice), thereby fine-tuning VEGF signaling in ECs.-Kim, D. Y., Park, J. A., Kim, Y., Noh, M., Park, S., Lie, E., Kim, E., Kim, Y.-M., Kwon, Y.-G. SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175.	[Kim, Dong Young; Park, Jeong Ae; Kim, Yeomyung; Noh, Minyoung; Park, Songyi; Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, 50 Yonsei Ro, Seoul 03722, South Korea; [Lie, Eunkyung; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chuncheon Si, South Korea	Yonsei University; Korea Advanced Institute of Science & Technology (KAIST); Kangwon National University	Kwon, YG (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, 50 Yonsei Ro, Seoul 03722, South Korea.	ygkwon@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning (MSIP) [NRF-2019R1A2C3007142]; NRF - MSIP [NRF-2015M3A9B6066835]; Korea Health Industry Development Institute (KHIDI) - Korean Ministry of Health and Welfare [HI16C1501]	National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning (MSIP); NRF - MSIP; Korea Health Industry Development Institute (KHIDI) - Korean Ministry of Health and Welfare	This research was supported by the Basic Science Research Program from the National Research Foundation of Korea (NRF), funded by the Ministry of Science, Information and Communications Technology, and Future Planning (MSIP; NRF-2019R1A2C3007142) and the Bio and Medical Technology Development Program of the NRF funded by the MSIP (NRF-2015M3A9B6066835). This work was also supported by a Korea Health Technology Research and Development Project grant from the Korea Health Industry Development Institute (KHIDI), funded by the Korean Ministry of Health and Welfare (Grant HI16C1501). The authors declare no conflicts of interest.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Akarasereenont P, 2002, MEDIAT INFLAMM, V11, P17, DOI 10.1080/09629350210311; Ambesi A, 2014, J CELL SCI, V127, P3805, DOI 10.1242/jcs.150458; Ao R, 2018, J CELL BIOCHEM, V119, P4420, DOI 10.1002/jcb.26524; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Batori R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44698; Chislock EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085231; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Corti F, 2017, PHARMACOL RES, V115, P107, DOI 10.1016/j.phrs.2016.11.022; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Dieterich LC, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.106; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Geiseler SJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051362; Graziani G, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00125; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Guruswamy R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030496; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim JY, 2016, EXP NEUROBIOL, V25, P241, DOI 10.5607/en.2016.25.5.241; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Kuchmiy AA, 2016, J EXP MED, V213, P2851, DOI 10.1084/jem.20160900; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Li XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11017; Lie E, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00105; Lie E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12328; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Mah W, 2010, J NEUROSCI, V30, P5559, DOI 10.1523/JNEUROSCI.4839-09.2010; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Min JK, 2007, BLOOD, V109, P1495, DOI 10.1182/blood-2006-06-029298; Morimura N, 2006, GENE, V380, P72, DOI 10.1016/j.gene.2006.05.014; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Park H, 2015, J CELL BIOL, V211, P619, DOI 10.1083/jcb.201503113; Pedram A, 2002, J BIOL CHEM, V277, P44385, DOI 10.1074/jbc.M202391200; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Pircher A, 2014, ONCOLOGY-BASEL, V86, P46, DOI 10.1159/000356871; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rocha SF, 2014, CIRC RES, V115, P581, DOI 10.1161/CIRCRESAHA.115.304718; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Senis YA, 2018, MOLECULES, V23, DOI 10.3390/molecules23030569; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Smith GA, 2015, J INHERIT METAB DIS, V38, P753, DOI 10.1007/s10545-015-9838-4; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Swanwick CC, 2010, MOL CELL NEUROSCI, V45, P213, DOI 10.1016/j.mcn.2010.06.012; Tai-Nagara I, 2017, DEVELOPMENT, V144, P2392, DOI 10.1242/dev.149757; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Walchli T, 2015, NEURON, V87, P271, DOI 10.1016/j.neuron.2015.06.038; Wang PY, 2008, MOL CELL NEUROSCI, V39, P83, DOI 10.1016/j.mcn.2008.05.019; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Zhang F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13517; Zhang H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0897-3; Zhang X, 2014, ARTERIOSCL THROM VAS, V34, P1831, DOI 10.1161/ATVBAHA.114.303217	57	7	7	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9842	9857		10.1096/fj.201802516RR	http://dx.doi.org/10.1096/fj.201802516RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31170000	Green Published, hybrid			2022-12-26	WOS:000482214200013
J	Wang, SL; Wang, WW; Ma, Q; Shen, ZF; Zhang, MQ; Zhou, NM; Zhang, CX				Wang, Si-Liang; Wang, Wei-Wei; Ma, Qiang; Shen, Zhang-Fei; Zhang, Meng-Qiu; Zhou, Nai-Ming; Zhang, Chuan-Xi			Elevenin signaling modulates body color through the tyrosine-mediated cuticle melanism pathway	FASEB JOURNAL			English	Article						salivary gland; intracellular signaling pathway; Nilarparvata lugens; GPCR	PROTEIN COUPLED RECEPTORS; BROWN PLANTHOPPER; ENCODING NEUROPEPTIDES; PHENOTYPIC PLASTICITY; CALCINEURIN; METABOLISM	Elevenin is a newly discovered novel neuropeptide. Knockdown of either elevenin or orphan receptor NlA42 transcript expression by RNA interference caused severe cuticle melanization in the brown planthopper (BPH). Injection of a synthetic elevenin peptide not only rescued the body color phenotype in dselevenin-pretreated individuals but also suppressed melanization of black insects grown in natural conditions. Real-time quantitative PCR results revealed that elevenin expression levels were highest in the brain and salivary gland. Immunohistochemistry analysis confirmed that a precursor peptide of elevenin was generated in the salivary gland, suggesting that the salivary gland might be an important neurosecretory tissue in addition to the brain in BPH. Furthermore, double-strand RNA-mediated silencing of elevenin and NlA42 resulted in down-regulation of arylalkylamine-N-acetyltransferase and up-regulation of tyrosine hydroxylase, whereas elevenin peptide injection resulted in up-regulation of N-beta-alanyldopamine synthase and aspartate 1-decarboxylase, indicating a complex regulation network for cuticle pigmentation. In addition, functional characterization demonstrated that NlA42 is a cognate receptor for elevenin, and couples to Gq and Gs proteins, triggering both PLC/Ca2+/PKC and AC/cAMP/PKA signaling pathways in response to elevenin treatment. These findings suggest that the elevenin signaling functions control BPH body color through the tyrosine-mediated cuticle melanism pathway.-Wang, S.-L., Wang, W.-W., Ma, Q., Shen, Z.-F., Zhang, M.-Q., Zhou, N.-M., Zhang, C.-X. Elevenin signaling modulates body color through the tyrosine-mediated cuticle melanism pathway.	[Wang, Si-Liang; Zhang, Meng-Qiu; Zhang, Chuan-Xi] Zhejiang Univ, State Key Lab Rice Biol, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Si-Liang; Zhang, Meng-Qiu; Zhang, Chuan-Xi] Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insect Pests, Inst Insect Sci, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Wei-Wei; Ma, Qiang; Shen, Zhang-Fei; Zhou, Nai-Ming] Zhejiang Univ, Inst Biochem, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University	Zhang, CX (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, CX (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insect Pests, Inst Insect Sci, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.; Zhou, NM (corresponding author), Zhejiang Univ, Inst Biochem, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.	zhounaiming@zju.edu.cn; chxzhang@zju.edu.cn	Zhou, Naiming/AHC-1121-2022	shen, zhangfei/0000-0002-3707-2265; Zhang, Chuan-Xi/0000-0002-7784-1188	National Natural Science Foundation of China [31630057, 31871954]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 31630057 and 31871954). The authors declare no conflicts of interest.	Adamson KJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1510-8; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Arakane Y., 2016, EXTRACELLULAR COMPOS; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Bai H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-388; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; Conzelmann M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-906; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; Derst C, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0621-4; Du MF, 2017, MOL CELL PROTEOMICS, V16, P2138, DOI [10.1074/mcp.ra117.000065, 10.1074/mcp.RA117.000065]; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Gibert JM, 2007, PLOS GENET, V3, P266, DOI 10.1371/journal.pgen.0030030; Huang HJ, 2015, INSECT BIOCHEM MOLEC, V66, P77, DOI 10.1016/j.ibmb.2015.10.007; Kim D, 2018, INSECT BIOCHEM MOLEC, V101, P66, DOI 10.1016/j.ibmb.2018.07.005; Lapadula D, 2019, MOL CANCER RES, V17, P963, DOI 10.1158/1541-7786.MCR-18-0574; Liu J, 2016, GENETICS, V203, P403, DOI 10.1534/genetics.115.186684; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Q, 2017, EXPERT OPIN DRUG DIS, V12, P511, DOI 10.1080/17460441.2017.1303473; MASLER EP, 1993, ARCH INSECT BIOCHEM, V22, P87, DOI 10.1002/arch.940220109; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Qiao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042968; Robinson SD, 2017, GEN COMP ENDOCR, V244, P11, DOI 10.1016/j.ygcen.2015.07.012; Tanaka S, 2016, CURR OPIN INSECT SCI, V17, P10, DOI 10.1016/j.cois.2016.05.011; Tanaka Y, 2014, PEPTIDES, V53, P125, DOI 10.1016/j.peptides.2013.07.027; TAUSSIG R, 1984, P NATL ACAD SCI-BIOL, V81, P4988, DOI 10.1073/pnas.81.15.4988; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Nguyen TV, 2016, SCI REP-UK, V6, DOI 10.1038/srep38658; Uchiyama H, 2018, GEN COMP ENDOCR, V258, P33, DOI 10.1016/j.ygcen.2017.07.017; Veenstra JA, 2016, PEERJ, V4, DOI 10.7717/peerj.2043; Veenstra JA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00454; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; Walter MF, 1996, ARCH INSECT BIOCHEM, V31, P219, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;219::AID-ARCH9&gt;3.0.CO;2-U; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Xu HJ, 2013, INSECT MOL BIOL, V22, P635, DOI 10.1111/imb.12051; Xu HJ, 2015, NATURE, V519, P464, DOI 10.1038/nature14286; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020; Yang HP, 2013, INSECT BIOCHEM MOLEC, V43, P1028, DOI 10.1016/j.ibmb.2013.08.011; Yu B, 2016, INSECT MOL BIOL, V25, P778, DOI 10.1111/imb.12262	41	5	5	3	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9731	9741		10.1096/fj.201802786RR	http://dx.doi.org/10.1096/fj.201802786RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162939				2022-12-26	WOS:000482214200004
J	Yan, J; Zhao, WH; Gao, C; Liu, X; Zhao, XL; Wei, T; Gao, ZD				Yan, Jing; Zhao, Wenhui; Gao, Chao; Liu, Xia; Zhao, Xiuliang; Wei, Ting; Gao, Zhaodi			Leucine-rich repeat kinase 2 regulates mouse dendritic cell migration by ORAI2	FASEB JOURNAL			English	Article						SOCE; DC; Ca2+ signaling; sodium-calcium exchanger	NA+/CA2+ EXCHANGER ACTIVITY; STIM2; LRRK2; CRAC; INHIBITION; RELEASE; ENTRY	The leucine-rich repeat kinase 2 (LRRK2) is expressed in various immune cells and involved in regulating inflammatory processes. LRRK2 facilitates calcium extrusion exchanger and sodium-calcium exchanger activity and hence influences intracellular Ca2+ concentration in dendritic cells (DCs). DC maturation and migration are governed by the intracellular Ca2+ concentration, but the related mechanisms whereby LRRK2 regulates DC function and involved Ca2+ channels are still under investigation. In the previous study, we found that LRRK2(-/-) DCs exhibited higher store-operated Ca2+ entry (SOCE) activity than LRRK2(+/+) DCs. Herein, we ascertained the exact SOCE components by using genetic, pharmacological, and fluorescent approaches. Ca2+ imaging showed that LRRK2 kinase activity negatively modulated SOCE activity. Moreover, LRRK2 deficiency resulted in an enhanced migration capacity of DCs but had little effect on the maturation process. SOCE is widely known to regulate DC functions; we wanted to dissect the reason why LRRK2 specifically influenced DC migration and therefore silenced ORAI1, ORAI2, and ORAI3, respectively. Transwell assays showed that both ORAI1 and ORAI2 silencing markedly decreased the migration of DCs, but only ORAI1 deficiency influenced the expression of maturation markers CD11c, CD86, and major histocompatibility complex class II. Of note, LRRK2 deficiency increased ORAI2 expression but not that of ORAI1 and ORAI3. Thus, we suggest that LRRK2 modulates DC migration by interfering with ORAI2.-Yan, J., Zhao, W., Gao, C., Liu, X., Zhao, X., Wei, T., Gao, Z. Leucine-rich repeat kinase 2 regulates mouse dendritic cell migration by ORAI2.	[Yan, Jing; Gao, Chao; Liu, Xia; Zhao, Xiuliang; Wei, Ting; Gao, Zhaodi] Jining Med Univ, Dept Physiol, Hehua Rd 16, Jining 272067, Peoples R China; [Zhao, Wenhui] Huaian Nursing Coll, Dept Pathol, Huaian, Peoples R China; [Yan, Jing; Gao, Chao; Liu, Xia; Zhao, Xiuliang; Wei, Ting; Gao, Zhaodi] Xinxiang Med Univ, Dept Physiol, Xinxiang, Henan, Peoples R China	Jining Medical University; Xinxiang Medical University	Yan, J (corresponding author), Jining Med Univ, Dept Physiol, Hehua Rd 16, Jining 272067, Peoples R China.	jane102@live.cn		Yan, Jing/0000-0002-5202-3146; Yan, Jing/0000-0002-0307-1635	National Natural Science Fund of China [31801172]; Young Talent Project of Henan Province [31]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Young Talent Project of Henan Province	This work was supported by National Natural Science Fund of China (Grant 31801172) and the Young Talent Project (Grant 31) of Henan Province. The authors declare no conflicts of interests.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Clemens RA, 2017, BLOOD, V130, P1565, DOI 10.1182/blood-2016-11-751230; De Wit T, 2018, NEUROSCIENTIST, V24, P486, DOI 10.1177/1073858418756309; Decuypere JP, 2010, CELL CALCIUM, V48, P161, DOI 10.1016/j.ceca.2010.08.003; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; den Haan JMM, 2000, P NATL ACAD SCI USA, V97, P12950, DOI 10.1073/pnas.97.24.12950; Felix R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061595; Feske S, 2011, ANN NY ACAD SCI, V1238, P74, DOI 10.1111/j.1749-6632.2011.06240.x; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Koski GK, 1999, J IMMUNOL, V163, P82; Kuss M, 2014, J NEUROCHEM, V129, P980, DOI 10.1111/jnc.12668; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu ZH, 2012, CELL RES, V22, P1092, DOI 10.1038/cr.2012.42; Lopez E, 2012, J PHYSIOL BIOCHEM, V68, P619, DOI 10.1007/s13105-012-0163-1; Ma JA, 2010, EUR J IMMUNOL, V40, P3028, DOI 10.1002/eji.201040614; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Nunes-Hasler P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01600-6; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Shi YK, 2010, EXP BIOL MED, V235, P317, DOI 10.1258/ebm.2009.009237; Shim AHR, 2015, J MOL BIOL, V427, P77, DOI 10.1016/j.jmb.2014.09.021; Shumilina E, 2011, AM J PHYSIOL-CELL PH, V300, pC1205, DOI 10.1152/ajpcell.00039.2011; Stathopulos PB, 2013, CURR TOP MEMBR, V71, P59, DOI 10.1016/B978-0-12-407870-3.00003-2; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Vaeth M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14714; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Yan J, 2018, BIOCHEM BIOPH RES CO, V503, P1747, DOI 10.1016/j.bbrc.2018.07.108; Yan J, 2016, CELL PHYSIOL BIOCHEM, V40, P982, DOI 10.1159/000453155; Yan J, 2015, CELL PHYSIOL BIOCHEM, V36, P2287, DOI 10.1159/000430192; Yan J, 2015, FASEB J, V29, P1701, DOI 10.1096/fj.14-264028	38	9	9	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9775	9784		10.1096/fj.201802550R	http://dx.doi.org/10.1096/fj.201802550R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31166814				2022-12-26	WOS:000482214200008
J	Stone, JK; Kim, JH; Vukadin, L; Richard, A; Giannini, HK; Lim, STS; Tan, M; Ahn, EYE				Stone, Joshua K.; Kim, Jung-Hyun; Vukadin, Lana; Richard, Alexander; Giannini, Hannah K.; Lim, Ssang-Taek Steve; Tan, Ming; Ahn, Eun-Young Erin			Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; long noncoding RNA (long ncRNA; lncRNA); chromatin structure; histone modification; breast cancer; MALAT1	LONG NONCODING RNA; CHROMOSOME CONFORMATION CAPTURE; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; METASTASIS; REGULATOR; SIGNATURE; ENHANCERS; ELEMENTS; MEDIATOR	Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long noncoding RNA overexpressed in various cancers that promotes cell growth and metastasis. Although hypoxia has been shown to up-regulate MALAT1, only hypoxia-inducible factors (HIFs) have been implicated in activation of the MALAT1 promoter in specific cell types and other molecular mechanisms associated with hypoxia-mediated MALAT1 up-regulation remain largely unknown. Here, we demonstrate that hypoxia induces cancer cell-specific chromatin-chromatin interactions between newly identified enhancer-like cis-regulatory elements present at the MALAT1 locus. We show that hypoxia-mediated up-regulation of MALAT1 as well as its antisense strand TALAM1 occurs in breast cancer cells, but not in nontumorigenic mammary epithelial cells. Our analyses on the MALAT1 genomic locus discovered three novel putative enhancers that are located upstream and downstream of the MALAT1 gene body. We found that parts of these putative enhancers are epigenetically modified to a more open chromatin state under hypoxia in breast cancer cells. Furthermore, our chromosome conformation capture experiment demonstrated that noncancerous cells and breast cancer cells exhibit different interaction profiles under both normoxia and hypoxia, and only breast cancer cells gain specific chromatin interactions under hypoxia. Although the HIF-2 alpha protein can enhance the interaction between the promoter and the putative 3 ' enhancer, the gain of chromatin interactions associated with other upstream elements, such as putative -7 and -20 kb enhancers, were HIF-independent events. Collectively, our study demonstrates that cancer cell-specific chromatin-chromatin interactions are formed at the MALAT1 locus under hypoxia, implicating a novel mechanism of MALAT1 regulation in cancer.	[Stone, Joshua K.; Kim, Jung-Hyun; Vukadin, Lana; Richard, Alexander; Giannini, Hannah K.; Tan, Ming; Ahn, Eun-Young Erin] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Lim, Ssang-Taek Steve; Tan, Ming; Ahn, Eun-Young Erin] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Ahn, EYE (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA.	eahn@health.southalabama.edu	Tan, Ming/ABD-5847-2021; Kim, Jung-Hyun/AAK-8795-2021	Tan, Ming/0000-0003-2007-9898; Kim, Jung-Hyun/0000-0001-7176-409X; Ahn, Eun-Young Erin/0000-0001-8795-7734; Lim, Steve/0000-0003-0323-8607	Mitchell Cancer Institute; National Institutes of Health [R21 CA185818, R01 CA190688, R01 CA149646, R01 HL136432]; NATIONAL CANCER INSTITUTE [R21CA185818, R01CA190688] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136432] Funding Source: NIH RePORTER	Mitchell Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Mitchell Cancer Institute (to E. Y. E. A.) and National Institutes of Health Grants R21 CA185818 (to E. Y. E. A.), R01 CA190688 (to E. Y. E. A.), R01 CA149646 (to M. T.), and R01 HL136432 (to S. T. S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Andersson R, 2015, TRENDS GENET, V31, P426, DOI 10.1016/j.tig.2015.05.007; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Chan HL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05728-x; Chang S, 2016, FEBS LETT, V590, P3407, DOI 10.1002/1873-3468.12375; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Huang ZL, 2015, ONCOL REP, V34, P2403, DOI 10.3892/or.2015.4259; Jeffers Liesl K, 2013, J Cancer Ther, V4, DOI 10.4236/jct.2013.43094; Jen JY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0674-z; Jiao F, 2015, INT J MOL SCI, V16, P6677, DOI 10.3390/ijms16046677; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Kim JH, 2016, MOL CELL, V61, P859, DOI 10.1016/j.molcel.2016.02.024; Kirmes I, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0802-2; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Lelli A, 2015, HYPOXIA, V3, P45, DOI 10.2147/HP.S90555; Li SF, 2015, J CANCER RES CLIN, V141, P1909, DOI 10.1007/s00432-015-1951-0; Luo F, 2016, ONCOTARGET, V7, P5769, DOI 10.18632/oncotarget.6806; Ma XY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1881-x; Medina-Rivera A, 2018, TRENDS BIOCHEM SCI, V43, P452, DOI 10.1016/j.tibs.2018.03.004; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Mikhaylichenko O, 2018, GENE DEV, V32, P42, DOI 10.1101/gad.308619.117; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Niskanen H, 2018, NUCLEIC ACIDS RES, V46, P1724, DOI 10.1093/nar/gkx1214; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Platt JL, 2016, EMBO REP, V17, P1410, DOI 10.15252/embr.201642198; Prickaerts P, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0086-0; Salle-Lefort S, 2016, INT J ONCOL, V49, P1731, DOI 10.3892/ijo.2016.3630; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sexton T, 2012, NAT PROTOC, V7, P1335, DOI 10.1038/nprot.2012.071; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Singh KK, 2016, INT J VASC MED, V2016, DOI 10.1155/2016/2459687; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Tee AE, 2016, ONCOTARGET, V7, P8663, DOI 10.18632/oncotarget.6675; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Wu YS, 2015, INT J ONCOL, V46, P2586, DOI 10.3892/ijo.2015.2976; Wu YT, 2015, TOXICOL APPL PHARM, V289, P163, DOI 10.1016/j.taap.2015.09.028; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yoshimoto R, 2016, BBA-GENE REGUL MECH, V1859, P192, DOI 10.1016/j.bbagrm.2015.09.012; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zeitz MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073974; Zhang RR, 2017, ENDOCR PATHOL, V28, P7, DOI 10.1007/s12022-016-9453-4; Zhao G, 2016, FEBS LETT, V590, P2884, DOI 10.1002/1873-3468.12315; Zhao Y, 2014, CANCER RES, V74, P5103, DOI 10.1158/0008-5472.CAN-14-0427; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zong XY, 2016, NUCLEIC ACIDS RES, V44, P2898, DOI 10.1093/nar/gkw047; Zou A, 2016, NEOPLASMA, V63, P865, DOI 10.4149/neo_2016_605	59	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11213	11224		10.1074/jbc.RA118.006889	http://dx.doi.org/10.1074/jbc.RA118.006889			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167784	hybrid, Green Published			2022-12-26	WOS:000478717400013
J	Zhong, G; Hogarth, C; Snyder, J; Palau, L; Topping, T; Huang, WZ; Czuba, LC; Lafrance, J; Ghiaur, G; Isoherranen, N				Zhong, Guo; Hogarth, Cathryn; Snyder, Jessica; Palau, Laura; Topping, Traci; Huang, Weize; Czuba, Lindsay C.; Lafrance, Jeffrey; Ghiaur, Gabriel; Isoherranen, Nina			The retinoic acid hydroxylase Cyp26a1 has minor effects on postnatal vitamin A homeostasis, but is required for exogenous atRA clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retinoic acid; retinoid; retinol; cytochrome P450; vitamin A; cytochrome; hematopoiesis	INHIBITION; METABOLISM; DIFFERENTIATION; EXPRESSION; ENZYMES; CANCER; ROLES	The all-trans-retinoic acid (atRA) hydroxylase Cyp26a1 is essential for embryonic development and may play a key role in regulating atRA clearance also in adults. We hypothesized that loss of Cyp26a1 activity via inducible knockout in juvenile or adult mice would result in decreased atRA clearance and increased tissue atRA concentrations and atRA-related adverse effects. To test these hypotheses, Cyp26a1 was knocked out in juvenile and adult male and female Cyp26a1 floxed mice using standard Cre-Lox technology and tamoxifen injections. Biochemical and histological methods were used to study the effects of global Cyp26a1 knockout. The Cyp26a1 knockout did not result in consistent histopathological changes in any major organs. Cyp26a1(-/-) mice gained weight normally and exhibited no adverse phenotypes for up to 1 year after loss of Cyp26a1 expression. Similarly, atRA concentrations were not increased in the liver, testes, spleen, or serum of these mice, and the Cyp26a1 knockout did not cause compensatory induction of lecithin:retinol acetyltransferase (Lrat) or retinol dehydrogenase 11 (Rdh11) mRNA or a decrease in aldehyde dehydrogenase 1a1 (Aldh1a1) mRNA in the liver compared with tamoxifen-treated controls. However, the Cyp26a1(-/-) mice showed increased bone marrow cellularity and decreased frequency of erythroid progenitor cells in the bone marrow consistent with a retinoid-induced myeloid skewing of hematopoiesis. In addition, the Cyp26a1 knockout decreased clearance of exogenous atRA by 70% and increased atRA half-life 6-fold. These findings demonstrate that despite lacking a major impact on endogenous atRA signaling, Cyp26a1 critically contributes as a barrier for exogenous atRA exposure.	[Zhong, Guo; Huang, Weize; Czuba, Lindsay C.; Lafrance, Jeffrey; Isoherranen, Nina] Univ Washington, Dept Pharmaceut, Sch Pharm, Hlth Sci Bldg,Rm H-272M,Box 357610, Seattle, WA 98195 USA; [Snyder, Jessica] Univ Washington, Dept Comparat Med, Sch Pharm, Seattle, WA 98195 USA; [Hogarth, Cathryn; Topping, Traci] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Palau, Laura; Ghiaur, Gabriel] Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington State University; Johns Hopkins University	Isoherranen, N (corresponding author), Univ Washington, Dept Pharmaceut, Sch Pharm, Hlth Sci Bldg,Rm H-272M,Box 357610, Seattle, WA 98195 USA.	ni2@uw.edu	Czuba, Lindsay/AAB-2320-2020	Huang, Weize/0000-0001-5903-721X; Ghiaur, Gabriel/0000-0002-3955-7944; Hogarth, Cathryn/0000-0003-2744-7323; Zhong, Guo/0000-0002-6056-9472; Czuba, Lindsay/0000-0001-9142-5706; Isoherranen, Nina/0000-0002-9548-3126	National Institutes of Health [R01GM111772, K08HL127269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL127269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants increases tissue atRA concentrations and retinoid signaling R01GM111772 (to N. I. and C. H.) and K08HL127269 (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Alonso S, 2017, EXP HEMATOL, V54, P17, DOI 10.1016/j.exphem.2017.07.004; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Arnold SLM, 2015, BIOCHEM PHARMACOL, V95, P177, DOI 10.1016/j.bcp.2015.03.001; Beedle MT, 2019, BIOL REPROD, V100, P547, DOI 10.1093/biolre/ioy200; Chenery A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072308; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; GEELEN JAG, 1979, CRC CR REV TOXICOL, V6, P351, DOI 10.3109/10408447909043651; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Grizotte-Lake M, 2018, IMMUNITY, V49, P1103, DOI 10.1016/j.immuni.2018.11.018; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hogarth CA, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129718; Hogarth CA, 2013, CURR OPIN ENDOCRINOL, V20, P217, DOI 10.1097/MED.0b013e32836067cf; Jing J, 2017, J PHARMACOL EXP THER, V361, P246, DOI 10.1124/jpet.117.240523; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; KISTLER A, 1986, BIOCHEM SOC T, V14, P936, DOI 10.1042/bst0140936; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz JD, 2009, BIOCHEM PHARMACOL, V77, P258, DOI 10.1016/j.bcp.2008.10.012; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; Morton JEV, 2016, AM J MED GENET A, V170, P2706, DOI 10.1002/ajmg.a.37804; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nelson CH, 2016, FEBS LETT, V590, P2527, DOI 10.1002/1873-3468.12303; Nelson CH, 2013, CURR TOP MED CHEM, V13, P1402; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Nilsson O, 2016, HORM METAB RES, V48, P737, DOI 10.1055/s-0042-114038; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023; Stevison F, 2017, DRUG METAB DISPOS, V45, P846, DOI 10.1124/dmd.117.075341; Stoppie P, 2000, J PHARMACOL EXP THER, V293, P304; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Tay S, 2010, MOL PHARMACOL, V77, P218, DOI 10.1124/mol.109.059071; Thatcher JE, 2011, MOL PHARMACOL, V80, P228, DOI 10.1124/mol.111.072413; Thatcher JE, 2010, BIOCHEM PHARMACOL, V80, P903, DOI 10.1016/j.bcp.2010.05.023; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Treuting Piper M, 2015, Curr Protoc Mouse Biol, V5, P223, DOI 10.1002/9780470942390.mo140296; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; Zhong G, 2019, J PHARMACOL EXP THER, V370, P92, DOI 10.1124/jpet.119.258517; Zhong G, 2018, MOL PHARMACOL, V93, P489, DOI 10.1124/mol.117.111039	47	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11166	11179		10.1074/jbc.RA119.009023	http://dx.doi.org/10.1074/jbc.RA119.009023			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167781	Green Published, hybrid			2022-12-26	WOS:000478717400010
J	Dekerle, J; Greenhouse-Tucknott, A; Wrightson, JG; Schafer, L; Ansdell, P				Dekerle, Jeanne; Greenhouse-Tucknott, Aaron; Wrightson, James G.; Schafer, Lisa; Ansdell, Paul			Improving the measurement of TMS-assessed voluntary activation in the knee extensors	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; GROUP-III; METHODOLOGICAL ISSUES; NEUROMUSCULAR FATIGUE; STATISTICAL-METHODS; PERIPHERAL FATIGUE; MUSCLE AFFERENTS; EXCITABILITY; RELIABILITY	Purpose To test the accuracy, validity, reliability and sensitivity of an alternative method for the measure of TMS-assessed voluntary activation (VA(TMS)) in the knee extensors. Methods Ten healthy males (24 +/- 5 years) completed a neuromuscular assessment protocol before and after a fatiguing isometric exercise: two sets of five contractions (50%, 62.5%, 75%, 87.5%, 100% Maximal Voluntary Contraction; MVC) with superimposed TMS-evoked twitches for calculation of VATMs using either the first 5 stimulations (1x5C) or all 10 (2x5C). This was performed on two separate occasions (between-day reliability). Accuracy and validity were compared with a routinely used protocol [i.e. 50%, 75%, and 100% of MVC (1x3C) performed three times (3x3C)]. Results 95% confidence interval for estimated resting twitch, a key determinant of VA-rms, was similar between 1x5C, 2x5C, and 3x3C but improved by six-fold when compared to 1x3C (P<0.05). In a fresh state, potentiated twitch force was unchanged following 1x5C but decreased following 2x5C (P<0.05). A recovery was found post-exercise but was smaller for 1x5C compared to 2x5C (P<0.05), with no difference between the latter two (P>0.05). Absolute reliability was strong enough for both 1x5C and 2x5C to depict a true detectable change in the sample's VATMs following the fatiguing exercise (TEM < 3% at rest, <9% post-exercise) but 2x5C was marginally more sensitive to individual's changes from baseline. Conclusion Both 1x5C and 2x5C provide reliable measures of VA-rms. However, 1x5C may hold stronger internal validity. Both protocols allow detection of 'true' changes in sample's means but not individual scores following a fatiguing isometric exercise.	[Dekerle, Jeanne; Greenhouse-Tucknott, Aaron; Wrightson, James G.; Schafer, Lisa; Ansdell, Paul] Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Fatigue & Exercise Tolerance Lab, Eastbourne, England; [Wrightson, James G.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Ansdell, Paul] Northumbria Univ, Fac Hlth & Life Sci, Dept Sport Exercise & Rehabil, Northumbria, England	University of Brighton; University of Calgary; Northumbria University	Dekerle, J (corresponding author), Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Fatigue & Exercise Tolerance Lab, Eastbourne, England.	j.dekerle@brighton.ac.uk	Dekerle, Jeanne/M-8367-2019; Ansdell, Paul/J-2618-2019	Dekerle, Jeanne/0000-0002-4482-4576; Ansdell, Paul/0000-0001-7542-1107; Wrightson, James/0000-0001-7106-7470				Adreani CM, 1997, J APPL PHYSIOL, V82, P1811, DOI 10.1152/jappl.1997.82.6.1811; Armitage P, 2002, STAT METHODS; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bachasson D, 2016, NEUROSCIENCE, V314, P125, DOI 10.1016/j.neuroscience.2015.11.056; Beaulieu LD, 2017, BRAIN STIMUL, V10, P196, DOI 10.1016/j.brs.2016.12.008; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Clark BC, 2007, J ELECTROMYOGR KINES, V17, P90, DOI 10.1016/j.jelekin.2005.11.008; Dekerle J, 2019, EUR J APPL PHYSIOL, V119, P991, DOI 10.1007/s00421-019-04089-7; Folland JP, 2007, J ELECTROMYOGR KINES, V17, P317, DOI 10.1016/j.jelekin.2006.04.008; Froyd C, 2013, J PHYSIOL-LONDON, V591, P1339, DOI 10.1113/jphysiol.2012.245316; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Goodall S, 2009, EXP PHYSIOL, V94, P995, DOI 10.1113/expphysiol.2009.047902; Goodall S, 2018, EXP BRAIN RES, V236, P463, DOI 10.1007/s00221-017-5142-x; Goodall S, 2017, EUR J APPL PHYSIOL, V117, P687, DOI 10.1007/s00421-017-3561-9; Gruet M, 2014, EXP PHYSIOL, V99, P1053, DOI 10.1113/expphysiol.2014.078840; Hamada T, 2000, J APPL PHYSIOL, V88, P2131, DOI 10.1152/jappl.2000.88.6.2131; Hayes SG, 2005, J APPL PHYSIOL, V99, P1891, DOI 10.1152/japplphysiol.00629.2005; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hunter SK, 2006, J APPL PHYSIOL, V101, P1036, DOI 10.1152/japplphysiol.00103.2006; KAUFMAN MP, 1984, CARDIOVASC RES, V18, P663, DOI 10.1093/cvr/18.11.663; Kotan S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00363; Kufel TJ, 2002, MUSCLE NERVE, V25, P438, DOI 10.1002/mus.10047; LORING SH, 1992, J APPL PHYSIOL, V73, P516, DOI 10.1152/jappl.1992.73.2.516; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mira J, 2017, EUR J APPL PHYSIOL, V117, P1845, DOI 10.1007/s00421-017-3678-x; Otieno LA, 2019, J NEUROPHYSIOL, V121, P471, DOI 10.1152/jn.00628.2018; Sidhu SK, 2017, CLIN NEUROPHYSIOL, V128, P44, DOI 10.1016/j.clinph.2016.10.008; Sidhu SK, 2009, J APPL PHYSIOL, V106, P556, DOI 10.1152/japplphysiol.90911.2008; Sidhu SK, 2009, MUSCLE NERVE, V39, P186, DOI 10.1002/mus.21064; Souron R, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00519; Souron R, 2017, J APPL PHYSIOL, V122, P1504, DOI 10.1152/japplphysiol.00793.2016; Tamm AS, 2009, J BIOL RHYTHM, V24, P211, DOI 10.1177/0748730409334135; Taylor JL, 2009, J APPL PHYSIOL, V107, P357; Terwee CB, 2010, SPORTS MED, V40, P525, DOI 10.2165/11531370-000000000-00000; Thomas K, 2016, MED SCI SPORT EXER, V48, P1751, DOI 10.1249/MSS.0000000000000950; Thomas K, 2015, MED SCI SPORT EXER, V47, P537, DOI 10.1249/MSS.0000000000000448; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Todd G, 2016, J APPL PHYSIOL, V121, P678, DOI 10.1152/japplphysiol.00293.2016; Twomey R, 2017, MED SCI SPORT EXER, V49, P2422, DOI 10.1249/MSS.0000000000001371; Yue GH, 2000, MUSCLE NERVE, V23, P376, DOI 10.1002/(SICI)1097-4598(200003)23:3<376::AID-MUS9>3.3.CO;2-U	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216981	10.1371/journal.pone.0216981	http://dx.doi.org/10.1371/journal.pone.0216981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170180	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000470263700013
J	Bartsch, VB; Niehaus, JK; Taylor-Blake, B; Zylka, MJ				Bartsch, Victoria Brings; Niehaus, Jesse K.; Taylor-Blake, Bonnie; Zylka, Mark J.			Enhanced histamine-induced itch in diacylglycerol kinase iota knockout mice	PLOS ONE			English	Article							MAST-CELL DEGRANULATION; SPARED NERVE INJURY; NEUROPATHIC PAIN; DORSAL-ROOT; SPINAL-CORD; RECEPTOR; MOUSE; MODEL; MECHANISMS; EXPRESSION	Subsets of small-diameter dorsal root ganglia (DRG) neurons detect pruritogenic (itch-causing) and algogenic (pain-causing) stimuli and can be activated or sensitized by chemical mediators. Many of these chemical mediators activate receptors that are coupled to lipid hydrolysis and diacylglycerol (DAG) production. Diacylglycerol kinase iota (DGKI) can phosphorylate DAG and is expressed at high levels in small-diameter mouse DRG neurons. Given the importance of these neurons in sensing pruritogenic and algogenic chemicals, we sought to determine if loss of DGKI impaired responses to itch-or pain-producing stimuli. Using male and female Dgki-knockout mice, we found that in vivo sensitivity to histamine-but not other pruritogens-was enhanced. In contrast, baseline pain sensitivity and pain sensitization following inflammatory or neuropathic injury were equivalent between wild type and Dgki(-/-) mice. In vitro calcium responses in DRG neurons to histamine was enhanced, while responses to algogenic ligands were unaffected by Dgki deletion. These data suggest Dgki regulates sensory neuron and behavioral responses to histamine, without affecting responses to other pruritogenic or algogenic agents.	[Bartsch, Victoria Brings; Taylor-Blake, Bonnie; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Niehaus, Jesse K.; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.; Zylka, MJ (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022	Brings, Victoria/0000-0003-2325-6888; Niehaus, Jesse/0000-0002-6800-4134	National Institute of Neurological Disorders and Stroke [R01NS081127, F31NS098600, F31NS105397, T32NS007431, P30NS045892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, T32NS007431, F31NS105397, R01NS081127, F31NS098600] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institute of Neurological Disorders and Stroke, https://www.ninds.nih.gov/, grants R01NS081127 (MJZ), F31NS098600 (VBB), F31NS105397 (JKN), T32NS007431 (JKN), and P30NS045892 (MJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There !!!was no additional external funding received for this study.	Akiyama T, 2013, NEUROSCIENCE, V250, P697, DOI 10.1016/j.neuroscience.2013.07.035; Bartsch VB, 2020, GENES BRAIN BEHAV, V19, DOI 10.1111/gbb.12570; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Brenner DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039765; Carlos D, 2006, EUR J IMMUNOL, V36, P1494, DOI 10.1002/eji.200535464; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; EICHBERG J, 1992, ADV EXP MED BIOL, V318, P413; Elmes SJR, 2004, BRAIN RES, V1022, P205, DOI 10.1016/j.brainres.2004.07.005; Garrison SR, 2012, J NEUROPHYSIOL, V107, P913, DOI 10.1152/jn.00658.2011; Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hockley JRF, 2016, J NEUROSCI, V36, P2364, DOI 10.1523/JNEUROSCI.3369-15.2016; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; JANSSEN PAJ, 1963, ARZNEIMITTEL-FORSCH, V13, P502; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu T, 2013, PFLUG ARCH EUR J PHY, V465, P1671, DOI 10.1007/s00424-013-1284-2; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Michael GJ, 1999, J NEUROSCI, V19, P1844; Moehring F, 2016, J PAIN, V17, P50, DOI 10.1016/j.jpain.2015.08.014; Mogil JS, 2005, J MED GENET, V42, P583, DOI 10.1136/jmg.2004.027698; NISHIHARA I, 1995, BRAIN RES, V677, P138, DOI 10.1016/0006-8993(95)00133-B; Olenchock BA, 2006, IMPAIRED DEGRANULATI, V203, P1471, DOI [10.1084/jem.20052424, DOI 10.1084/JEM.20052424]; Ong CKS, 2007, CLIN MED RES, V5, P17, DOI 10.3121/cmr.2007.698; Pingle S. C., 2007, V179, P155; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Renback K, 2000, MOL BRAIN RES, V75, P350, DOI 10.1016/S0169-328X(99)00333-2; Rittiner JE, 2014, MOL PHARMACOL, V85, P800, DOI 10.1124/mol.113.091280; Sakuma M, 2014, BIOCHEM BIOPH RES CO, V445, P340, DOI 10.1016/j.bbrc.2014.01.197; Sasaki H, 2006, CELL TISSUE RES, V326, P35, DOI 10.1007/s00441-006-0219-z; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Voscopoulos C, 2010, BRIT J ANAESTH, V105, pI69, DOI 10.1093/bja/aeq323; WANG JJ, 1995, ANESTH ANALG, V80, P102, DOI 10.1097/00000539-199501000-00018; Wilkerson JL, 2016, BRIT J PHARMACOL, V173, P1678, DOI 10.1111/bph.13469; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Wright BD, 2014, NEURON, V82, P836, DOI 10.1016/j.neuron.2014.04.006; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang J, 2011, EMBO J, V30, P165, DOI 10.1038/emboj.2010.286	50	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217819	10.1371/journal.pone.0217819	http://dx.doi.org/10.1371/journal.pone.0217819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31167004	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800041
J	You, QH; Fang, N; Liu, LL; Yang, WJ; Zhang, L; Wang, YQ				You, Qinghui; Fang, Na; Liu, Lingling; Yang, Wenjing; Zhang, Li; Wang, Yeqiao			Effects of land use, topography, climate and socio-economic factors on geographical variation pattern of inland surface water quality in China	PLOS ONE			English	Article							DISSOLVED-OXYGEN; RIVER-BASIN; SIERRA-NEVADA; TEMPERATURE; COVER	The deterioration of water quality has become a primary environmental concern worldwide. Understanding the status of water quality and identifying the influencing factors are important for water resources management. However, reported analyses have mostly been conducted in small and focused areas. It is still unclear if factors driving spatial variation in water quality would be different in extended spatial scales. In this paper, we analyzed spatial pattern of inland surface water quality in China using a dataset with four water quality parameters (i.e., pH, DO, NH4+-N and CODMn) and the water quality level. We tested the effects of anthropogenic (i.e., land use and socio-economic) and natural (i.e., climatic and topographic) factors on spatial variation in water quality. The study concluded that the overall inland surface water quality in China was at level III (fair). Water quality level was strongly correlated with CODMn and NH4+-N concentration. In contrast to reported studies that suggested land use patterns were the determinants of inland surface water quality, this study revealed that both anthropogenic and natural factors played important roles in explaining spatial variation of inland surface water quality in China. Among the tested explanatory variables, mean elevation within watershed appeared as the best predictor for pH, while annual precipitation and mean air temperature were the most important explanatory variables for CODMn and DO, respectively. NH4+-N concentration and water quality level were most strongly correlated with the percent of forest cover in watershed. Compared to studies at smaller spatial scales, this study found different influencing factors of surface water quality, suggesting that factors may play different roles at different spatial scales of consideration. Therefore management policies and measures in water quality control must be established and implemented accordingly. Since currently adopted parameters for monitoring of inland surface water quality in China are largely influenced by natural variables, additional physicochemical and biological indicators are needed for a robust assessment of human impacts on water quality.	[You, Qinghui; Fang, Na; Liu, Lingling; Yang, Wenjing; Zhang, Li] Jiangxi Normal Univ, Minist Educ, Key Lab Poyang Lake Wetland & Watershed Res, Nanchang, Jiangxi, Peoples R China; [You, Qinghui] Jiangxi Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China; [Fang, Na; Liu, Lingling; Yang, Wenjing; Zhang, Li] Jiangxi Normal Univ, Coll Geog & Environm, Nanchang, Jiangxi, Peoples R China; [Yang, Wenjing; Zhang, Li] Jiangxi Normal Univ, Jiangxi Prov Key Lab Poyang Lake Comprehens Manag, Nanchang, Jiangxi, Peoples R China; [Wang, Yeqiao] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	Jiangxi Normal University; Jiangxi Normal University; Jiangxi Normal University; Jiangxi Normal University; University of Rhode Island	Yang, WJ (corresponding author), Jiangxi Normal Univ, Minist Educ, Key Lab Poyang Lake Wetland & Watershed Res, Nanchang, Jiangxi, Peoples R China.; Yang, WJ (corresponding author), Jiangxi Normal Univ, Coll Geog & Environm, Nanchang, Jiangxi, Peoples R China.; Yang, WJ (corresponding author), Jiangxi Normal Univ, Jiangxi Prov Key Lab Poyang Lake Comprehens Manag, Nanchang, Jiangxi, Peoples R China.; Wang, YQ (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	yangwenjing@jxnu.edu.cn; yqwang@uri.edu			National Natural Science Foundation of China [41561097, 41701514]; Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation [JXS-EW-00]; Natural Science Foundation of Jiangxi Province [20142BAB213023, 20161BAB213074]; Education Department of Jiangxi Provincial Government [GJJ170199, GJJ150334]; Key Laboratory of Poyang Lake Wetland and Watershed Research (Jiangxi Normal University), Ministry of Education [PK2017004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Education Department of Jiangxi Provincial Government; Key Laboratory of Poyang Lake Wetland and Watershed Research (Jiangxi Normal University), Ministry of Education	This work was supported by National Natural Science Foundation of China (41561097, WY; 41701514, LZ), Collaborative Innovation Center for Major Ecological Security Issues of Jiangxi Province and Monitoring Implementation (JXS-EW-00, YW), Natural Science Foundation of Jiangxi Province (20142BAB213023, WY; 20161BAB213074, LZ), Education Department of Jiangxi Provincial Government (GJJ170199, QY; GJJ150334, WY), and the Key Laboratory of Poyang Lake Wetland and Watershed Research (Jiangxi Normal University), Ministry of Education (PK2017004, WY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bu HM, 2014, ECOL INDIC, V41, P187, DOI 10.1016/j.ecolind.2014.02.003; BUTCHER JB, 1995, J ENVIRON ENG-ASCE, V121, P756, DOI 10.1061/(ASCE)0733-9372(1995)121:10(756); Caldwell P, 2015, HYDROL PROCESS, V29, P2196, DOI 10.1002/hyp.10358; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chapagain AK, 2008, WATER INT, V33, P19, DOI 10.1080/02508060801927812; Chen JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102714; [陈静生 CHEN Jingsheng], 2006, [地学前缘, Earth science frontiers], V13, P74; Delpla I, 2009, ENVIRON INT, V35, P1225, DOI 10.1016/j.envint.2009.07.001; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duncan R, 2014, LAND USE POLICY, V41, P378, DOI 10.1016/j.landusepol.2014.06.003; Dvornic A, 2011, ANN FACULTY ENG HUNE, V9, P79; Ficklin DL, 2013, WATER RESOUR RES, V49, P2765, DOI 10.1002/wrcr.20248; Fukushima T, 2000, HYDROL PROCESS, V14, P593, DOI [10.1002/(SICI)1099-1085(20000228)14:3<593::AID-HYP956>3.0.CO;2-O, 10.1002/(SICI)1099-1085(20000228)14:3&lt;593::AID-HYP956&gt;3.0.CO;2-O]; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; He HS, 2000, LANDSCAPE ECOL, V15, P591, DOI 10.1023/A:1008102521322; Jia K, 2014, GEOCARTO INT, V29, P941, DOI 10.1080/10106049.2014.894586; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kang JH, 2010, WATER RES, V44, P4143, DOI 10.1016/j.watres.2010.05.009; Kawabe M., 1997, J OCEANOGR, V53, P443; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Lee SW, 2009, LANDSCAPE URBAN PLAN, V92, P80, DOI 10.1016/j.landurbplan.2009.02.008; Liu WZ, 2012, HYDROL PROCESS, V26, P570, DOI 10.1002/hyp.8157; Liu WZ, 2010, HYDROBIOLOGIA, V644, P289, DOI 10.1007/s10750-010-0151-9; Luce C, 2014, WATER RESOUR RES, V50, P3428, DOI 10.1002/2013WR014329; Manaspah R, 2006, OCEANOLOGIA, V48, P237; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; Ministry of Environmental Protection of the People''s Republic of China, 2012, STAND METH AN WAT WA; Morrice JA, 2008, ENVIRON MANAGE, V41, P347, DOI 10.1007/s00267-007-9055-5; National Water Quality Monitoring Council, 2002, NAT ENV METH IND; Nezlin NP, 2009, ESTUAR COAST SHELF S, V82, P139, DOI 10.1016/j.ecss.2009.01.004; Nie L, 2014, J JIANGXI NORMAL U N, V38, P429; Nielsen A, 2012, ECOL APPL, V22, P1187, DOI 10.1890/11-1831.1; Olaniran AO, 2008, J ENVIRON MONITOR, V10, P889, DOI 10.1039/b805055d; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; Sahu O, 2014, INT LETT NAT SCI, V13, P1, DOI 10.18052/www.scipress.com/ILNS.13.1; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; St-Hilaire A, 2016, CAN WATER RESOUR J, V41, P273, DOI 10.1080/07011784.2015.1010181; Tu J, 2011, APPL GEOGR, V31, P376, DOI 10.1016/j.apgeog.2010.08.001; WANG P, 2015, J JIANGXI NORMAL U N, V39, P435; Xing X, 2012, ENVIRON CHEM, V31, P804; Yang WJ, 2013, J BIOGEOGR, V40, P1415, DOI 10.1111/jbi.12108; Ye L, 2009, ENVIRON GEOL, V58, P937, DOI 10.1007/s00254-008-1573-9; Zhao J, 2015, LANDSCAPE URBAN PLAN, V137, P20, DOI 10.1016/j.landurbplan.2014.12.010	46	12	13	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217840	10.1371/journal.pone.0217840	http://dx.doi.org/10.1371/journal.pone.0217840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31167003	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800043
J	Beltz, CW; Mobley, ML; Burke, IC				Beltz, Christopher W.; Mobley, Megan L.; Burke, Ingrid C.			Nitrogen addition pulse has minimal effect in big sagebrush (Artemisia tridentata) communities on the Pinedale Anticline, Wyoming (USA)	PLOS ONE			English	Article							TEMPORAL VARIATION; SOIL-NITROGEN; GAS EMISSIONS; ELEVATED CO2; GRASSLAND; PRECIPITATION; DYNAMICS; STEPPE; MINERALIZATION; DECOMPOSITION	Nitrogen additions are known to elicit variable responses in semi-arid ecosystems, with responses increasing with precipitation. The response of semi-arid ecosystems to nitrogen are important to understand due to their large spatial extent worldwide and the global trend of increasingly available nitrogen. In this study, we evaluated the impact of a single nitrogen addition pulse on a semi-arid big sagebrush (Artemisia tridentata) ecosystem in western Wyoming. This is important given that sagebrush ecosystems are poorly understood, despite their prevalence in the western US. In addition, large-scale nitrogen additions have begun on sagebrush landscapes in Wyoming in order to mitigate population declines in mule deer (Odocoileus hemionus). The study objectives were (1) to evaluate the effectiveness of a nitrogen fertilization pulse in increasing sagebrush biomass and forage quality, and (2) to assess effects of nitrogen addition on soil biogeochemistry and vegetation community structure. We fertilized 15 plots across 5 locations in western Wyoming using a single pulse of urea (5.5g N m(-2)). In addition, we immobilized available nitrogen through surface hay treatments (250g hay/m(2)). Nitrogen additions failed to increase growth of sagebrush, alter nitrogen content of sagebrush leaders, or alter greenhouse gas efflux from soils. The plant community also remained unchanged; total cover, species richness, and community composition were all unaffected by our treatment application. Over the two years of this study, we did not find indications of nitrogen limitation of ecosystem processes, despite a wet growing season in 2014. Thus, we have found a general lack of response to nitrogen in sagebrush ecosystems and no treatment effect of a single pulse of N to sagebrush biomass or forage quality.	[Beltz, Christopher W.; Burke, Ingrid C.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Mobley, Megan L.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	Yale University; Oregon State University	Beltz, CW (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	christopher.beltz@yale.edu	Mobley, Megan L/A-5402-2010; Mobley, Megan/AAF-3560-2020; Burke, Ingrid/A-1420-2009	Mobley, Megan L/0000-0002-6046-8380; Mobley, Megan/0000-0002-6046-8380; Burke, Ingrid/0000-0003-4717-6399; Beltz, Christopher/0000-0001-9605-0712	Wyoming Excellence Fund at the University of Wyoming; Yale University	Wyoming Excellence Fund at the University of Wyoming; Yale University	This research was funded by the Wyoming Excellence Fund at the University of Wyoming and by Yale University.	Brooks PD, 1998, BIOGEOCHEMISTRY, V43, P1, DOI 10.1023/A:1005947511910; BURKE IC, 1989, ECOLOGY, V70, P1115, DOI 10.2307/1941380; Burke IC, 1997, ECOLOGY, V78, P1330, DOI 10.1890/0012-9658(1997)078[1330:RATVIN]2.0.CO;2; Chen J, 2015, ECOSYSTEMS, V18, P867, DOI 10.1007/s10021-015-9868-7; Collins SL, 2017, GLOBAL CHANGE BIOL, V23, P1095, DOI 10.1111/gcb.13493; Connelly J.W., 2004, CONSERVATION ASSESSM; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Coskun D, 2016, J PLANT PHYSIOL, V203, P95, DOI 10.1016/j.jplph.2016.05.016; Dahlke J, 2015, 07SC0403657 WGFD SER; Daubenmire RF, 1959, PLANTS ENV TXB PLANT; Davies KW, 2012, RANGELAND ECOL MANAG, V65, P268, DOI 10.2111/REM-D-11-00146.1; Feng S, 2013, ATMOS CHEM PHYS, V13, P10081, DOI 10.5194/acp-13-10081-2013; Frey SD, 2014, BIOGEOCHEMISTRY, V121, P305, DOI 10.1007/s10533-014-0004-0; Frey SD, 2000, SOIL BIOL BIOCHEM, V32, P689, DOI 10.1016/S0038-0717(99)00205-9; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gomez-Casanovas N, 2016, GLOBAL CHANGE BIOL, V22, P1348, DOI 10.1111/gcb.13187; HART SC, 1993, SOIL BIOL BIOCHEM, V25, P431, DOI 10.1016/0038-0717(93)90068-M; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Korfanta NM, 2015, WILDLIFE SOC B, V39, P1, DOI 10.1002/wsb.519; LAUENROTH WK, 1978, OECOLOGIA, V36, P211, DOI 10.1007/BF00349810; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Length R., 2019, EMMEANS ESTIMATED MA; Lowe PN, 2002, J RANGE MANAGE, V55, P94, DOI 10.2307/4003269; Manier D.J., 2013, 20131098 US GEOL SUR, P170; McMurray JA, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1487-3; MILCHUNAS DG, 1995, ECOL APPL, V5, P452, DOI 10.2307/1942035; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING DE; Mobley ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107775; Munn LC, 1998, SOILS WYOMING; Naftz DL, 2011, GEOCHEM T, V12, DOI 10.1186/1467-4866-12-4; National Oceanic and Atmospheric Administration, 1981 2010 CLIM NORM; Norton U, 2008, SOIL BIOL BIOCHEM, V40, P1421, DOI 10.1016/j.soilbio.2007.12.021; Palmquist KA, 2016, ECOLOGY, V97, P2342, DOI 10.1002/ecy.1457; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Sala OE, 2012, PHILOS T R SOC B, V367, P3135, DOI 10.1098/rstb.2011.0347; Samuel MJ, 1998, J RANGE MANAGE, V51, P408, DOI 10.2307/4003325; Sawyer H, 2017, GLOBAL CHANGE BIOL, V23, P4521, DOI 10.1111/gcb.13711; Schlaepfer DR, 2014, RANGELAND ECOL MANAG, V67, P344, DOI 10.2111/REM-D-13-00079.1; SEAGLE SW, 1993, BIOGEOCHEMISTRY, V22, P157, DOI 10.1007/BF00000645; SEASTEDT TR, 1992, CAN J BOT, V70, P384, DOI 10.1139/b92-052; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Sobecki T.M., 2001, POTENTIAL US GRAZING; U.S. Department of the Interior Bureau of Land Management, 2011, WY100EA10303 US DEP; U.S. Department of the Interior Bureau of Land Management, 2011, FIND NO SIGN IMP DEC; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Walston LJ, 2009, ECOGRAPHY, V32, P943, DOI 10.1111/j.1600-0587.2009.05852.x; Wang L, 2012, HYDROL EARTH SYST SC, V16, P2585, DOI 10.5194/hess-16-2585-2012; WEST NE, 1989, N AM TERRESTRIAL VEG, P209; Yandjian L, 2011, J ARID ENVIRON, V75, P675, DOI 10.1016/j.jaridenv.2011.03.003	52	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0206563	10.1371/journal.pone.0206563	http://dx.doi.org/10.1371/journal.pone.0206563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150398	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100002
J	Cokal, D; Zimmerer, V; Turkington, D; Ferrier, N; Varley, R; Watson, S; Hinzen, W				Cokal, Derya; Zimmerer, Vitor; Turkington, Douglas; Ferrier, Nicol; Varley, Rosemary; Watson, Stuart; Hinzen, Wolfram			Disturbing the rhythm of thought: Speech pausing patterns in schizophrenia, with and without formal thought disorder	PLOS ONE			English	Article							LANGUAGE; PAUSES; PREDICTABILITY; IMPAIRMENT; BIOMARKER; DEFICITS; FLUENCY; LENGTH; WORDS	Everyday speech is produced with an intricate timing pattern and rhythm. Speech units follow each other with short interleaving pauses, which can be either bridged by fillers (erm, ah) or empty. Through their syntactic positions, pauses connect to the thoughts expressed. We investigated whether disturbances of thought in schizophrenia are manifest in patterns at this level of linguistic organization, whether these are seen in first degree relatives (FDR) and how specific they are to formal thought disorder (FTD). Spontaneous speech from 15 participants without FTD (SZ-FTD), 15 with FTD (SZ+ FTD), 15 FDRs and 15 neurotypical controls (NC) was obtained from a comic strip retelling task and rated for pauses subclassified by syntactic position and duration. SZ-FTD produced significantly more unfilled pauses than NC in utterance-initial positions and before embedded clauses. Unfilled pauses occurring within clausal units did not distinguish any groups. SZ-FTD also differed from SZ+ FTD in producing significantly more pauses before embedded clauses. SZ+ FTD differed from NC and FDR only in producing longer utterance-initial pauses. FDRs produced significantly fewer fillers than NC. Results reveal that the temporal organization of speech is an important window on disturbances of the thought process and how these relate to language.	[Cokal, Derya] Queen Mary Univ London, Sch Engn & Comp Sci, London, England; [Zimmerer, Vitor; Varley, Rosemary] UCL, Dept Language & Cognit, London, England; [Turkington, Douglas; Ferrier, Nicol; Watson, Stuart] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Turkington, Douglas; Ferrier, Nicol; Watson, Stuart] Northumberland Tyne & Wear NHS Fdn Trust, Newcastle, England; [Hinzen, Wolfram] ICREA, Barcelona, Spain; [Hinzen, Wolfram] Univ Pompeu Fabra, Dept Translat & Language Sci, Barcelona, Spain; [Hinzen, Wolfram] FIDMAG Germanes Hosp Res Fdn, Benito Menni Hosp, Barcelona, Spain	University of London; Queen Mary University London; University of London; University College London; Newcastle University - UK; ICREA; Pompeu Fabra University	Cokal, D (corresponding author), Queen Mary Univ London, Sch Engn & Comp Sci, London, England.	deryacokal@gmail.com	Hinzen, Wolfram/F-2333-2016; Cokal, Derya/AAB-8634-2021; COKAL, DERYA/ABH-2580-2020; watson, stuart/B-8728-2009	Hinzen, Wolfram/0000-0002-6159-4215; COKAL, DERYA/0000-0002-5653-1412; watson, stuart/0000-0002-2558-3367	Northumberland, Tyne and Wear NHS Mental Health Foundation Trust; Arts and Humanities Research Council [AH/L004070/1]; Ministerio de Economia y Competitividad, Spanish Government [FFI2016-77647-C2-1-P]; Generalitat de Catalunya [SGR-1265]; AHRC [AH/L004070/1] Funding Source: UKRI	Northumberland, Tyne and Wear NHS Mental Health Foundation Trust; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Ministerio de Economia y Competitividad, Spanish Government(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was supported by the Northumberland, Tyne and Wear NHS Mental Health Foundation Trust (including Research Capability Funding), the Arts and Humanities Research Council (AH/L004070/1 to W.H.), the Ministerio de Economia y Competitividad, Spanish Government (FFI2016-77647-C2-1-P to W.H.), and Generalitat de Catalunya (SGR-1265 to W.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert M, 1997, SCHIZOPHRENIA BULL, V23, P171, DOI 10.1093/schbul/23.2.171; ANDREASEN NC, 1979, ARCH GEN PSYCHIAT, V36, P1315, DOI 10.1001/archpsyc.1979.01780120045006; Angelopoulou G, 2018, NEUROPSYCHOLOGIA, V114, P41, DOI 10.1016/j.neuropsychologia.2018.04.006; Ballard KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089864; BUTTERWORTH B, 1979, BRAIN LANG, V8, P133, DOI 10.1016/0093-934X(79)90046-4; Campione E, 2002, ISCA C P; Clark HH, 2002, COGNITION, V84, P73, DOI 10.1016/S0010-0277(02)00017-3; CLEMMER EJ, 1980, J PSYCHOLINGUIST RES, V9, P161, DOI 10.1007/BF01067469; Cokal D, 2018, NPJ SCHIZOPHR, V4, DOI 10.1038/s41537-018-0061-9; Crow TJ, 2008, SCHIZOPHR RES, V102, P31, DOI 10.1016/j.schres.2008.03.010; CUESTA MJ, 1995, PSYCHIAT RES, V58, P227, DOI 10.1016/0165-1781(95)02712-6; Dibben CRM, 2009, PSYCHOL MED, V39, P381, DOI 10.1017/S0033291708003887; Engelhardt PE, 2010, MEM COGNITION, V38, P617, DOI 10.3758/MC.38.5.617; FERREIRA F, 1991, J MEM LANG, V30, P210, DOI 10.1016/0749-596X(91)90004-4; FRASER WI, 1986, BRIT J PSYCHIAT, V148, P275, DOI 10.1192/bjp.148.3.275; Goldman Eisler F., 1968, PSYCHOLINGUISTICS EX; GOLDMANEISLER F, 1958, Q J EXP PSYCHOL, V10, P96, DOI 10.1080/17470215808416261; GOLDMANEISLER F, 1958, LANG SPEECH, V1, P226, DOI 10.1177/002383095800100308; Hartsuiker RJ, 2010, EXP PSYCHOL, V57, P169, DOI 10.1027/1618-3169/a000021; Hinzen W, 2016, COGN NEUROPSYCHIATRY, V21, P281, DOI 10.1080/13546805.2016.1190703; Hinzen W, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00971; Howes C, 2017, COGSCI; Kircher TTJ, 2004, NEUROIMAGE, V21, P84, DOI 10.1016/j.neuroimage.2003.09.041; Lake JK, 2011, PSYCHON B REV, V18, P135, DOI 10.3758/s13423-010-0037-x; Levelt W., 1989, SPEAKING INTENTION A; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Mack JE, 2015, NEUROPSYCHOLOGIA, V77, P211, DOI 10.1016/j.neuropsychologia.2015.08.019; Mark H., 1983, STORYLINES PICTURE S; Matsumoto K., 2013, FRONT PSYCHIAT, V4; MORICE R, 1986, SCHIZOPHRENIA BULL, V12, P239, DOI 10.1093/schbul/12.2.239; MORICE RD, 1982, AUST NZ J PSYCHIAT, V16, P11, DOI 10.3109/00048678209161186; O'Leary DS, 2000, J NEUROPSYCH CLIN N, V12, P4, DOI 10.1176/jnp.12.1.4; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Rapcan V, 2010, MED ENG PHYS, V32, P1074, DOI 10.1016/j.medengphy.2010.07.013; Rossi NF, 2011, RES DEV DISABIL, V32, P2957, DOI 10.1016/j.ridd.2011.05.006; Sevilla G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201545; Shriberg E., 2001, J INT PHON ASSOC, V31, P153, DOI [10.1017/S0025100301001128, DOI 10.1017/S0025100301001128]; SILVERMAN G, 1973, BRIT J PSYCHIAT, V122, P407, DOI 10.1192/bjp.122.4.407; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Teichmann M, 2013, BRAIN, V136, P3474, DOI 10.1093/brain/awt266; Toth L, 2018, CURR ALZHEIMER RES, V15, P130, DOI 10.2174/1567205014666171121114930; Zimmerer VC, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00017	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217404	10.1371/journal.pone.0217404	http://dx.doi.org/10.1371/journal.pone.0217404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150442	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100044
J	Ignasiak, NK; Ravi, DK; Orter, S; Nasab, SHH; Taylor, WR; Singh, NB				Ignasiak, Niklas Konig; Ravi, Deepak K.; Orter, Stefan; Nasab, Seyyed Hamed Hosseini; Taylor, William R.; Singh, Navrag B.			Does variability of footfall kinematics correlate with dynamic stability of the centre of mass during walking?	PLOS ONE			English	Article							LATERAL STABILIZATION; LOAD CARRIAGE; OLDER-ADULTS; GAIT; FALLS	A stable walking pattern is presumably essential to avoid falls. Stability of walking is most accurately determined by the short-term local dynamic stability (maximum Lyapunov exponent) of the body centre of mass. In many studies related to fall risk, however, variability of step width is considered to be indicative of the stability of the centre of mass during walking. However, other footfall parameters, in particular variability of stride time, have also been associated with increased risk for falling. Therefore, the aim of this study was to investigate the association between short-term local dynamic stability of the body centre of mass and different measures of footfall variability. Twenty subjects performed unperturbed walking trials on a treadmill and under increased (addition of 40% body weight) and decreased (harness system) demands to stabilise the body centre of mass. Association between stability of the centre of mass and footfall parameters was established using a structural equation model. Walking with additional body weight lead to greater instability of the centre of mass and increased stride time variability, however had no effect on step width variability. Supported walking in the harness system did not increase centre of mass stability further, however, led to a significant decrease of step width and increase in stride time variability. A structural equation model could only predict 8% of the variance of the centre of mass stability after variability of step width, stride time and stride length were included. A model which included only step width variability as exogenous variable, failed to predict centre of mass stability. Because of the failure to predict centre of mass stability in this study, it appears, that the stability of the centre of mass is controlled by more complex interaction of sagittal and frontal plane temporal and spatial footfall parameters, than those observed by standard variability measures. Anyway, this study does not support the application of step width variability as indicator for medio-lateral stability of the centre of mass during walking.	[Ignasiak, Niklas Konig; Ravi, Deepak K.; Orter, Stefan; Nasab, Seyyed Hamed Hosseini; Taylor, William R.; Singh, Navrag B.] Swiss Fed Inst Technol, Inst Biomech, Leopold Ruzicka Weg 4, Zurich, Switzerland; [Ignasiak, Niklas Konig] Chapman Univ, Dept Phys Therapy, Irvine, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Chapman University System; Chapman University	Taylor, WR (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Leopold Ruzicka Weg 4, Zurich, Switzerland.	bt@ethz.ch	Ravi, Deepak Kumar/S-3490-2019; Singh, Navrag/F-5305-2012; Ignasiak, Niklas/F-8617-2014; Taylor, William R./F-8692-2010; Nasab, Seyyed Hamed Hosseini/AAB-3461-2019	Ravi, Deepak Kumar/0000-0002-5015-8901; Singh, Navrag/0000-0001-8074-041X; Ignasiak, Niklas/0000-0001-9065-3344; Taylor, William R./0000-0003-4060-4098; Nasab, Seyyed Hamed Hosseini/0000-0002-3518-3316				Allet L, 2009, GAIT POSTURE, V29, P488, DOI 10.1016/j.gaitpost.2008.11.012; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Bruijn SM, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0816; Dean JC, 2007, IEEE T BIO-MED ENG, V54, P1919, DOI 10.1109/TBME.2007.901031; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; DeMott TK, 2007, AM J PHYS MED REHAB, V86, P125, DOI 10.1097/PHM.0b013e31802ee1d1; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Dragunas AC, 2016, J BIOMECH, V49, P2662, DOI 10.1016/j.jbiomech.2016.05.026; Frenkel-Toledo Silvi, 2005, J Neuroeng Rehabil, V2, P23, DOI 10.1186/1743-0003-2-23; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Gates DH, 2007, J APPL PHYSIOL, V102, P965, DOI 10.1152/japplphysiol.00413.2006; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hamacher D, 2014, GAIT POSTURE, V40, P727, DOI 10.1016/j.gaitpost.2014.07.016; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 1997, ARCH PHYS MED REHAB, V78, P278, DOI 10.1016/S0003-9993(97)90034-4; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hurt CP, 2010, GAIT POSTURE, V31, P461, DOI 10.1016/j.gaitpost.2010.02.001; Konig N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0353; Konig N, 2016, NEUROSCI BIOBEHAV R, V68, P111, DOI 10.1016/j.neubiorev.2016.03.035; Konig N, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00319; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kyvelidou A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-22; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Lhomond O, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00318; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mortaza N, 2014, EUR J PHYS REHAB MED, V50, P677; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Qu XD, 2012, GAIT POSTURE, V36, P325, DOI 10.1016/j.gaitpost.2012.03.004; Qu XD, 2011, J BIOMECH, V44, P1259, DOI 10.1016/j.jbiomech.2011.02.016; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; Reimann H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01271; Stergiou N., 2016, NONLINEAR ANAL HUMAN; Stimpson KH, 2019, GAIT POSTURE, V70, P136, DOI 10.1016/j.gaitpost.2019.03.003; Timar B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154654; TOWNSEND MA, 1985, J BIOMECH, V18, P21, DOI 10.1016/0021-9290(85)90042-9; Wang Y, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0405; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027; Young PMM, 2012, GAIT POSTURE, V35, P472, DOI 10.1016/j.gaitpost.2011.11.010	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217460	10.1371/journal.pone.0217460	http://dx.doi.org/10.1371/journal.pone.0217460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150452	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100053
J	Nair, M; Tripathi, S; Mazumdar, S; Mahajan, R; Harshana, A; Pereira, A; Jimenez, C; Halder, D; Burza, S				Nair, Mohit; Tripathi, Santanu; Mazumdar, Sumit; Mahajan, Raman; Harshana, Amit; Pereira, Alan; Jimenez, Carolina; Halder, Debasish; Burza, Sakib			Knowledge, attitudes, and practices related to antibiotic use in Paschim Bardhaman District: A survey of healthcare providers in West Bengal, India	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; MEDICAL-STUDENTS; NEW-DELHI; PERCEPTIONS; RESISTANCE; BELIEFS; PATIENT; ADULTS	Introduction Antibiotic misuse is widespread and contributes to antibiotic resistance, especially in less regulated health systems such as India. Although informal providers are involved with substantial segments of primary healthcare, their level of knowledge, attitudes, and practices is not well documented in the literature. Objectives This quantitative study systematically examines the knowledge, attitudes, and practices of informal and formal providers with respect to antibiotic use. Methods We surveyed a convenience sample of 384 participants (96 allopathic doctors, 96 nurses, 96 informal providers, and 96 pharmacy shopkeepers) over a period of 8 weeks from December to February using a validated questionnaire developed in Italy. Our team created an equivalent, composite KAP score for each respondent in the survey, which was subsequently compared between providers. We then performed a multivariate logistic regression analysis to estimate the odds of having a low composite score (<80) based on occupation by comparing allopathic doctors (referent category) with all other study participants. The model was adjusted for age (included as a continuous variable) and gender. Results Doctors scored highest in questions assessing knowledge (77.3%) and attitudes (87.3%), but performed poorly in practices (67.6%). Many doctors knew that antibiotics were not indicated for viral infections, but over 87% (n = 82) reported prescribing them in this situation. Nurses, pharmacy shopkeepers, and informal providers were more likely to perform poorly on the survey compared to allopathic doctors (OR: 10.4, 95% CI 5.4, 20.0, p<0.01). 30.8% (n = 118) of all providers relied on pharmaceutical company representatives as a major source of information about antibiotics. Conclusions Our findings indicate poor knowledge and awareness of antibiotic use and functions among informal health providers, and dissonance between knowledge and practices among allopathic doctors. The nexus between allopathic doctors, pharmaceutical company representatives, and informal health providers present promising avenues for future research and intervention.	[Nair, Mohit; Mahajan, Raman; Harshana, Amit; Pereira, Alan; Burza, Sakib] Medecins Sans Frontieres, New Delhi, India; [Tripathi, Santanu; Mazumdar, Sumit] Calcutta Sch Trop Med, Kolkata, India; [Jimenez, Carolina] Medecins Sans Frontieres, Barcelona, Spain; [Halder, Debasish] Pasch Bardhaman Hlth Dist, Bardhaman, W Bengal, India	Calcutta School of Tropical Medicine (CSTM); Doctors Without Borders	Burza, S (corresponding author), Medecins Sans Frontieres, New Delhi, India.	sakib.burza@barcelona.msf.org	Jimenez, Carolina/GYD-8755-2022	de Lima Pereira, Alan/0000-0001-7578-3626; Harshana, Amit Kumar Singh/0000-0003-1272-5087; Burza, Sakib/0000-0001-7886-8633; Mahajan, Raman/0000-0001-6788-2835	MSF fundraising activities	MSF fundraising activities	Funding for the study was provided through normal MSF fundraising activities. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo LM, 2013, CLIN INFECT DIS, V57, P631, DOI 10.1093/cid/cit370; Akkerman AE, 2004, J ANTIMICROB CHEMOTH, V54, P1116, DOI 10.1093/jac/dkh480; Anderson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204878; [Anonymous], 2016, ANT RES GLOB REP SUR; [Anonymous], 2017, CDC ENC SAF ANT PRES; [Anonymous], 2018, FACTS ANT RES; Barker AK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4261-4; Bashir A, 2012, JK PRACTITIONER, V17, P1; Bianco A, 2018, INFECT DRUG RESIST, V11, P2199, DOI 10.2147/IDR.S170349; Bloom G, 2011, HEALTH POLICY PLANN, V26, pi45, DOI 10.1093/heapol/czr025; Briggs GG., 2012, DRUGS PREGNANCY LACT; Centers for Disease Control and Prevention, 2017, ANT PRESCR US DOCT O; Chua KP, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5092; Das J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7384; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Davis ME, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6040023; Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P842, DOI 10.1093/jac/dkt440; Gautham M, 2014, HEALTH POLICY PLANN, V29, pI20, DOI 10.1093/heapol/czt050; George S, 2019, AIDS CARE, V31, P875, DOI 10.1080/09540121.2018.1549720; Hawkings NJ, 2007, J ANTIMICROB CHEMOTH, V59, P1155, DOI 10.1093/jac/dkm103; Hersh AL, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0027; Khan AKA, 2013, J CLIN DIAGN RES, V7, P1613, DOI 10.7860/JCDR/2013/6290.3230; Kotwani A, 2016, INDIAN J PHARMACOL, V48, P365, DOI 10.4103/0253-7613.186208; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Krishna BY, 2015, IOSR J DENT MED SCI, V14, P2279; Lindberg BH, 2017, SCAND J PRIM HEALTH, V35, P178, DOI 10.1080/02813432.2017.1333301; Minen MT, 2010, MICROB DRUG RESIST, V16, P285, DOI 10.1089/mdr.2010.0009; Ministry of Health and Family Welfare (MoHFW) Government of Bangladesh, 2017, NATL ACTION PLAN ANT; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Norris P, 2013, ANTIBIOTICS-BASEL, V2, P465, DOI 10.3390/antibiotics2040465; Omaswa F, 2006, B WORLD HEALTH ORGAN, V84, P83, DOI 10.2471/BLT.05.027979; Padmanabha TS, 2016, INT J BASIC CLIN PHA, V5, P2432, DOI [10.18203/2319-2003.ijbcp20164100, DOI 10.18203/2319-2003.IJBCP20164100]; PULLA P, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I291; Sahoo KC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-629; Sampath S., 2016, SCHOLARS J APPL MED, V4, P3294; Scaioli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122476; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Varghese Joe, 2010, Indian J Med Ethics, V7, P70; WHO, 2015, ANT RES MULT PUBL AW; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005	41	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217818	10.1371/journal.pone.0217818	http://dx.doi.org/10.1371/journal.pone.0217818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150515	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000469759100117
J	Snider, JT; Sullivan, J; van Eijndhoven, E; Hansen, MK; Bellosillo, N; Neslusan, C; O'Brien, E; Riley, R; Seabury, S; Kasiske, BL				Snider, Julia Thornton; Sullivan, Jeffrey; van Eijndhoven, Emma; Hansen, Michael K.; Bellosillo, Nobel; Neslusan, Cheryl; O'Brien, Ellen; Riley, Ralph; Seabury, Seth; Kasiske, Bertram L.			Lifetime benefits of early detection and treatment of diabetic kidney disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; TNF RECEPTORS 1; UNITED-STATES; HEALTH; RISK; PREVALENCE; MORTALITY; ADULTS; TRENDS; ESRD	Objectives Diabetic kidney disease (DKD) is a frequent complication of diabetes with potentially devastating consequences that may be prevented or delayed. This study aimed to estimate the health and economic benefit of earlier diagnosis and treatment of DKD. Methods Life expectancy and medical spending for people with diabetes were modeled using The Health Economics Medical Innovation Simulation (THEMIS). THEMIS uses data from the Health and Retirement Study to model cohorts of individuals over age 50 to project population-level lifetime health and economic outcomes. DKD status was imputed based on diagnoses and laboratory values in the National Health and Nutrition Examination Survey. We simulated the implementation of a new biomarker identifying people with diabetes at an elevated risk of DKD and DKD patients at risk of rapid progression. Results Compared to baseline, the prevalence of DKD declined 5.1% with a novel prognostic biomarker test, while the prevalence of diabetes with stage 5 chronic kidney disease declined 3.0%. Consequently, people with diabetes gained 0.2 years in life expectancy, while per-capita annual medical spending fell by 0.3%. The estimated cost was $12,796 per life-year gained and $25,842 per quality-adjusted life-year. Conclusions A biomarker test that allows earlier treatment reduces DKD prevalence and slows DKD progression, thereby increasing life expectancy among people with diabetes while raising healthcare spending by less than one percent.	[Snider, Julia Thornton; Sullivan, Jeffrey; van Eijndhoven, Emma; Seabury, Seth] Precis Hlth Econ, Los Angeles, CA 90025 USA; [Hansen, Michael K.] Janssen Res & Dev, Spring House, PA USA; [Bellosillo, Nobel] Janssen Diagnost, Raritan, NJ USA; [Neslusan, Cheryl; O'Brien, Ellen; Riley, Ralph] Janssen Global Serv, Raritan, NJ USA; [Kasiske, Bertram L.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA	Johnson & Johnson; Janssen Pharmaceuticals; Hennepin County Medical Center	Snider, JT (corresponding author), Precis Hlth Econ, Los Angeles, CA 90025 USA.	julia.snider@precisionhealtheconomics.com			Janssen Diagnostics, LLC; Janssen	Janssen Diagnostics, LLC; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Financial support for this research was provided by Janssen Diagnostics, LLC, to Precision Health Economics (PHE). Dr. Snider, Mr. Sullivan, and Ms. van Eijndhoven are employees of PHE, which provides consulting services to life science firms. Dr. Snider holds equity in PHE. Dr. Kasiske and Dr. Seabury are consultants for PHE. Mr. Riley, Dr. Hansen, Dr. Neslusan, Dr. O'Brien, and Dr. Bellosillo are employees of Janssen, which provided financial support to PHE for this study. Janssen's website can be found here: https://www.janssen.com/us/.Janssen played a role in the study design, decision to publish, and review of the manuscript.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; AstraZeneca, 2017, STUD EV EFF DAP REN; Atkins RC, 2005, KIDNEY INT, V67, pS14, DOI 10.1111/j.1523-1755.2005.09403.x; Bhattacharya J., 2005, HLTH AFFAIRS S2, V24; Boehringer Ingelheim, 2018, EMPA KIDNEY STUD HEA; Carlsson AC, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0359-8; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Chernew M. E., 2005, HLTH AFFAIRS S2, V24; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Colombo M, 2019, DIABETOLOGIA, V62, P156, DOI 10.1007/s00125-018-4741-9; Congressional Budget Office (CBO), 2012, RAIS EXC TAX CIG EFF; Critselis E, 2018, NEPHROL DIAL TRANSPL, V33, P441, DOI 10.1093/ndt/gfx068; Dzau VJ, 2015, LANCET, V385, P2118, DOI 10.1016/S0140-6736(15)60722-X; Forsblom C, 2014, DIABETES CARE, V37, P2334, DOI 10.2337/dc14-0225; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Goldman Dana E., 2006, FORUM HLTH EC POLICY, V9; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; Goldman DP, 2009, AM J PUBLIC HEALTH, V99, P2096, DOI 10.2105/AJPH.2009.172627; Goldman DP, 2005, HEALTH AFFAIR, V24, pW5R5; Hayes A, 2016, VALUE HEALTH, V19, P36, DOI 10.1016/j.jval.2015.10.010; Hodes R. J., 2007, GROWING OLDER AM HLT; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Lakdawalla Darius N, 2005, Health Aff (Millwood), V24 Suppl 2, pW5R30; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Michaud PC, 2012, J HEALTH ECON, V31, P630, DOI 10.1016/j.jhealeco.2012.04.006; Muehrer RJ, 2011, CLIN J AM SOC NEPHRO, V6, P489, DOI 10.2215/CJN.02550310; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; National Kidney Foundation, 2007, AM J KIDNEY DIS S2, V49; National Research Council, 2010, IMPR HLTH CAR COST P; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Ozieh MN, 2015, DIABETES RES CLIN PR, V109, P185, DOI 10.1016/j.diabres.2015.04.011; Paykov ME, 2015, KIDNEY INT, V87, P812, DOI 10.1038/ki.2014.330; Perkovic V, 2019, NEW ENGLAND J MED; Pontillo C, 2017, CLIN KIDNEY J, V10, P192, DOI 10.1093/ckj/sfx002; Radcliffe NJ, 2017, J DIABETES INVEST, V8, P6, DOI 10.1111/jdi.12533; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Shekelle PG, 2005, HLTH AFFAIRS S2, V24; Slabaugh SL, 2015, J MED ECON, V18, P106, DOI 10.3111/13696998.2014.979292; Stanton RC, 2014, AM J KIDNEY DIS, V63, pS3, DOI 10.1053/j.ajkd.2013.10.050; Szczech LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110535; U. S. Senate Committee on Health E Labor and Pensions, EX DIS PREV PUBL HLT; United States Renal Data System, 2015, ANN DAT REP 2015 EP; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Wetmore J, 2017, DIABETES, V66, pA438; WHO, 2016, GLOB REP PSOR; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017	51	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217487	10.1371/journal.pone.0217487	http://dx.doi.org/10.1371/journal.pone.0217487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150444	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100056
J	Carvalho, F; Brown, KA; Waller, MP; Bunting, MJ; Boom, A; Leng, MJ				Carvalho, Fabio; Brown, Kerry A.; Waller, Martyn P.; Bunting, M. Jane; Boom, Arnoud; Leng, Melanie J.			A method for reconstructing temporal changes in vegetation functional trait composition using Holocene pollen assemblages	PLOS ONE			English	Article							RICH-FEN SYSTEMS; LITTER DECOMPOSITION RATES; PLANT-COMMUNITIES; QUANTITATIVE RECONSTRUCTION; LAND-COVER; DIVERSITY; ECOSYSTEMS; ENGLAND; CLIMATE; WALES	Methods of reconstructing changes in plant traits over long time scales are needed to understand the impact of changing environmental conditions on ecosystem processes and services. Although Holocene pollen have been extensively used to provide records of vegetation history, few studies have adopted a functional trait approach that is pertinent to changes in ecosystem processes. Here, for woody and herbaceous fen peatland communities, we use modern pollen and vegetation data combined with pollen records from Holocene deposits to reconstruct vegetation functional dynamics. The six traits chosen (measures of leaf area-to-mass ratio and leaf nutrient content) are known to modulate species' fitness and to vary with changes in ecosystem processes. We fitted linear mixed effects models between community weighted mean (CWM) trait values of the modern pollen and vegetation to determine whether traits assigned to pollen types could be used to reconstruct traits found in the vegetation from pollen assemblages. We used relative pollen productivity (RPP) correction factors in an attempt to improve this relationship. For traits showing the best fit between modern pollen and vegetation, we applied the model to dated Holocene pollen sequences from Fenland and Romney Marsh in eastern and southern England and reconstructed temporal changes in trait composition. RPP adjustment did not improve the linear relationship between modern pollen and vegetation. Leaf nutrient traits (leaf C and N) were generally more predictable from pollen data than mass-area traits. We show that inferences about biomass accumulation and decomposition rates can be made using Holocene trait reconstructions. While it is possible to reconstruct community-level trends for some leaf traits from pollen assemblages preserved in sedimentary archives in wetlands, we show the importance of testing methods in modern systems first and encourage further development of this approach to address issues concerning the pollen-plant abundance relationship and pollen source area.	[Carvalho, Fabio; Brown, Kerry A.; Waller, Martyn P.] Kingston Univ London, Dept Geog & Geol, Kingston Upon Thames, Surrey, England; [Bunting, M. Jane] Univ Hull, Sch Environm Sci, Kingston Upon Hull, N Humberside, England; [Boom, Arnoud] Univ Leicester, Sch Geog Geol & Environm, Leicester, Leics, England; [Leng, Melanie J.] British Geol Survey, NERC Isotope Geosci Lab, Nottingham, England; [Leng, Melanie J.] Univ Nottingham, Sch Biosci, Ctr Environm Geochem, Loughborough, Leics, England	Kingston University; University of Hull; University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Nottingham	Carvalho, F (corresponding author), Kingston Univ London, Dept Geog & Geol, Kingston Upon Thames, Surrey, England.	fabiocgs@yahoo.com	Brown, Kerry/U-5082-2019; Carvalho, Fabio/AAB-5806-2020	Carvalho, Fabio/0000-0002-6305-5602; BROWN, KERRY/0000-0002-6342-8966; Boom, Arnoud/0000-0003-1299-691X	Faculty of Sciences, Engineering and Computing at Kingston University London	Faculty of Sciences, Engineering and Computing at Kingston University London	F.C. was funded through a PhD studentship from the Faculty of Sciences, Engineering and Computing at Kingston University London. Field work and laboratory analyses were supported by the Department of Geography and Geology at Kingston University London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alan Bowley and Craig Bellwood at Natural England and Debs Kershaw at the Norfolk Wildlife Trust for access to and information about Woodwalton Fen and Upton Broad, respectively. Jim Innes and Antony Long are thanked for giving us permission to use the data from Brookland. F.C. was funded through a PhD studentship from the Faculty of Sciences, Engineering and Computing at Kingston University London. Field work and laboratory analyses were supported by the Department of Geography and Geology at Kingston University London.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Birks HJB, 2016, REV PALAEOBOT PALYNO, V228, P1, DOI 10.1016/j.revpalbo.2015.12.011; Birks HJB, 2014, VEG HIST ARCHAEOBOT, V23, P309, DOI 10.1007/s00334-013-0430-2; Brussel T, 2018, J VEG SCI, V29, P450, DOI 10.1111/jvs.12654; Bunting MJ, 2005, HOLOCENE, V15, P459, DOI 10.1191/0959683605hl821rr; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Davis BAS, 2015, VEG HIST ARCHAEOBOT, V24, P303, DOI 10.1007/s00334-014-0476-9; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dorrepaal E, 2005, J ECOL, V93, P817, DOI 10.1111/j.1365-2745.2005.01024.x; Dunn C, 2011, CARBON MANAG, V2, P289, DOI 10.4155/CMT.11.23; Fyfe RM, 2009, VEG HIST ARCHAEOBOT, V18, P417, DOI 10.1007/s00334-009-0215-9; Gaillard MJ, 2010, CLIM PAST, V6, P483, DOI 10.5194/cp-6-483-2010; Gaillard MJ, 2008, VEG HIST ARCHAEOBOT, V17, P415, DOI [10.1007/s00334-008-0170-x, 10.1007/s00334-008-0169-3]; Garnier E., 2016, PLANT FUNCTIONAL DIV, V1st, DOI DOI 10.1093/ACPROF:OSO/9780198757368.001.0001; Grant MJ, 2017, MICROPALEAEONTOLOGIC, P103; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hagemann U, 2015, SOIL BIOL BIOCHEM, V87, P10, DOI 10.1016/j.soilbio.2015.04.002; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Jeffers ES, 2015, QUATERNARY SCI REV, V112, P17, DOI 10.1016/j.quascirev.2014.12.018; Jeffers ES, 2015, J ECOL, V103, P459, DOI 10.1111/1365-2745.12365; Keddy PA, 2010, WETLAND ECOLOGY PRIN, Vxvi; Lacourse T, 2009, ECOLOGY, V90, P2149, DOI 10.1890/08-1136.1; Laughlin DC, 2011, J ECOL, V99, P1091, DOI 10.1111/j.1365-2745.2011.01856.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lavorel S, 2013, J ECOL, V101, P4, DOI 10.1111/1365-2745.12031; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Marquer L, 2014, QUATERNARY SCI REV, V90, P199, DOI 10.1016/j.quascirev.2014.02.013; Mazier F, 2012, REV PALAEOBOT PALYNO, V187, P38, DOI 10.1016/j.revpalbo.2012.07.017; Moor H., 2017, Journal of Ecology (Oxford), V105, P1623, DOI 10.1111/1365-2745.12734; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nielsen AB, 2012, QUATERNARY SCI REV, V47, P131, DOI 10.1016/j.quascirev.2012.05.011; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pillar VD, 1999, J VEG SCI, V10, P631, DOI 10.2307/3237078; Pirzamanbein B, 2014, ECOL COMPLEX, V20, P127, DOI 10.1016/j.ecocom.2014.09.005; Prentice IC, 2009, CLIM PAST, V5, P297, DOI 10.5194/cp-5-297-2009; Prentice IC, 1996, CLIM DYNAM, V12, P185, DOI 10.1007/BF00211617; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; R Development Core Team, 2018, R LANG ENV STAT COMP; Reitalu T, 2015, J VEG SCI, V26, P911, DOI 10.1111/jvs.12300; Skiba MW, 2011, BIOCHEM SOC T, V39, P275, DOI 10.1042/BST0390275; Sokal R.R., 2012, BIOMETRY PRINCIPLES; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; Sugita S, 2007, HOLOCENE, V17, P229, DOI 10.1177/0959683607075837; Sugita S, 2007, HOLOCENE, V17, P243, DOI 10.1177/0959683607075838; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vincens A, 2007, REV PALAEOBOT PALYNO, V145, P135, DOI 10.1016/j.revpalbo.2006.09.004; Waller M., 1994, E ANGLIAN ARCHAEOLOG, V70, P353; Waller M, 2017, REV PALAEOBOT PALYNO, V238, P15, DOI 10.1016/j.revpalbo.2016.11.007; Waller MP, 2005, REV PALAEOBOT PALYNO, V133, P179, DOI 10.1016/j.revpalbo.2004.10.001; Waller MP, 1999, QUATERNARY SCI REV, V18, P1419, DOI 10.1016/S0277-3791(98)00072-9; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; WHEELER BD, 1982, J ECOL, V70, P179, DOI 10.2307/2259872; WHEELER BD, 1980, J ECOL, V68, P365, DOI 10.2307/2259411; WHEELER BD, 1980, J ECOL, V68, P761, DOI 10.2307/2259455; WHEELER BD, 1993, BIODIVERS CONSERV, V2, P490, DOI 10.1007/BF00056744; WHEELER BD, 1980, J ECOL, V68, P405, DOI 10.2307/2259413; Willis KJ, 2006, SCIENCE, V314, P1261, DOI 10.1126/science.1122667; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yu ZC, 2012, BIOGEOSCIENCES, V9, P4071, DOI 10.5194/bg-9-4071-2012	67	13	13	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216698	10.1371/journal.pone.0216698	http://dx.doi.org/10.1371/journal.pone.0216698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141538	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000469323000019
J	Oyeniran, AA; Bello, FA; Oluborode, B; Awowole, I; Loto, OM; Irinyenikan, TA; Fabamwo, AO; Olutayo, L; Ganatra, B; Guest, P; Fawole, B				Oyeniran, Agnes A.; Bello, Folasade A.; Oluborode, Babawale; Awowole, Ibraheem; Loto, Olabisi M.; Irinyenikan, Theresa A.; Fabamwo, Adetokunbo O.; Olutayo, Lanre; Ganatra, Bela; Guest, Philip; Fawole, Bukola			Narratives of women presenting with abortion complications in Southwestern Nigeria: A qualitative study	PLOS ONE			English	Article							SERVICES	Unsafe abortion continues to impact negatively on women's health in countries with restrictive abortion laws. It remains one of the leading causes of maternal mortality and morbidity. Paradoxically, modern contraceptive prevalence remains low and the unmet need for contraception continues to mirror unwanted pregnancy rates in many countries within subSaharan Africa. This qualitative study assessed women's knowledge; their expectation and experiences of the methods employed for abortion; and their health care-seeking decisions following a complicated abortion. Women who presented with abortion complications were purposively sampled from seven health facilities in south-west Nigeria. In-depth interviews were conducted by social scientists with the aid of a semi-structured interview guide. Coding schemes were developed and content analysis was performed with WEFTQDA software. Thirty-one women were interviewed. Misoprostol was used by 16 women; 15 women used other methods. About one-fifth of respondents were aged. 20 years; almost one-third were students. Common reasons for terminating a pregnancy were: " too young/still in school/ training"; "has enough number of children"; "last baby too young" and "still breastfeeding". Women had little knowledge about methods used. Friends, nurses or pharmacists were the commonest sources of information. Awareness about use of misoprostol for abortion among women was high. Women used misoprostol to initiate an abortion and were often disappointed if misoprostol did not complete the abortion process. Given its clandestine manner, women were financially exploited by the abortion providers and only presented to hospitals for post-abortion care as a last resort. Women's narratives of their abortion experience highlight the difficulties and risks women encounter to safeguard and protect their sexual and reproductive health. To reduce unsafe abortion therefore, urgent and synergized efforts are required to promote prompt access to family planning and post-abortion care services.	[Oyeniran, Agnes A.] Univ Ibadan, Dept Hlth Promot & Educ, Coll Med, Ibadan, Nigeria; [Bello, Folasade A.; Fawole, Bukola] Univ Ibadan, Dept Obstet & Gynaecol, Coll Med, Ibadan, Nigeria; [Oluborode, Babawale; Awowole, Ibraheem; Loto, Olabisi M.] Obafemi Awolowo Univ, Dept Obstet & Gynaecol, Ife, Nigeria; [Irinyenikan, Theresa A.] State Specialist Hosp, Dept Obstet & Gynaecol, Akure, Nigeria; [Fabamwo, Adetokunbo O.] Lagos State Univ, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria; [Olutayo, Lanre] Univ Ibadan, Dept Sociol, Fac Social Sci, Ibadan, Nigeria; [Ganatra, Bela] WHO, World Bank Special Programme Res Dev & Res Traini, UNICEF, UNFPA,UNDP, Geneva, Switzerland; [Guest, Philip] Inst Populat & Social Res, Bangkok, Thailand	University of Ibadan; University of Ibadan; Obafemi Awolowo University; Lagos State University; University of Ibadan; The World Bank; United Nations Population Fund; World Health Organization	Bello, FA (corresponding author), Univ Ibadan, Dept Obstet & Gynaecol, Coll Med, Ibadan, Nigeria.	dr.nikebello@yahoo.com		Bello, Folasade Adenike/0000-0002-3337-3335; Awowole, Ibraheem/0000-0001-7006-0824; Ganatra, Bela/0000-0002-4812-4577	World Health Organization	World Health Organization(World Health Organization)	The study was supported with a grant from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinma ED, 2012, SE ASIAN J TROP MED, V43, P471; Adinma ED, 2012, PRECONCEPTION POSTPA, P125; Adinma JIB, 2010, SE ASIAN J TROP MED, V41, P696; Adinma JI, 2010, INT J GYNECOL OBSTET, V111, P53, DOI 10.1016/j.ijgo.2010.06.003; Aniteye Patience, 2011, Afr J Reprod Health, V15, P47; [Anonymous], UNWANTED PREGNANCY I; Awoyemi BO, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0003-9; Bankole A, 2015, INT PERSPECT SEX R H, V41, P170, DOI 10.1363/4117015; Barot S, 2011, GUTTMACHER POLICY RE, V14, P24; Bello FA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209415; Centre for Reproductive Rights, 2018, NIG AB PROV; Centre for Reproductive Rights, 1998, WOM REPR RIGHTS NIG; Emechebe C, 2016, SAUDI J HLTH SCI, V5, P34; Ganatra B, 2004, INFORMAL PROVIDERS A; Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4; Government of the Federal Republic of Nigeria, 2015, MILL DEV GOALS END P; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Ilobinso LO, 2007, POLICY ABORTION NIGE; International Consortium, 2012, EM CONTR PILLS MED S; Kaluarachchi Athula, 2018, J Family Med Prim Care, V7, P1521, DOI 10.4103/jfmpc.jfmpc_188_18; Kumar R, 2013, AM J PUBLIC HEALTH, V103, P400, DOI 10.2105/AJPH.2012.301154; Lamina M A, 2015, Ghana Med J, V49, P187, DOI 10.4314/gmj.v49i3.10; Mya WW, 2016, RCOG WORLD C 2016; Okonofua FE, 2005, ACTA OBSTET GYN SCAN, V84, P270, DOI 10.1111/j.0001-6349.2005.00405.x; Omokhodion FO, 2017, AFR J REPROD HEALTH, V21, P114, DOI 10.29063/ajrh2017/v21i1.11; ONU, 2015, RESOLUTION ADOPTED G, DOI DOI 10.1007/S13398-014-0173-7.2; Orisaremi TC, 2012, AFR SOCIOL REV, V16, P61; Oye-Adeniran BA, 2002, REPROD HEALTH MATTER, V10, P18, DOI 10.1016/S0968-8080(02)00024-1; Oye-Adeniran Boniface A, 2004, Afr J Reprod Health, V8, P103, DOI 10.2307/3583397; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Soe YY, 2016, RCOG WORLD C 2016; Tayo A, 2014, INT J MED MED SCI, V4, P47; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Warriner IK., 2006, PREVENTING UNSAFE AB; WHO, 2006, RED UNS AB; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2014, CLIN PRACT HDB SAF A	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217616	10.1371/journal.pone.0217616	http://dx.doi.org/10.1371/journal.pone.0217616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141550	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000067
J	Belmonte, FR; Dedousis, N; Sipula, I; Desai, NA; Singhi, AD; Chu, YX; Zhang, YZ; Bannwarth, S; Paquis-Flucklinger, V; Harrington, L; Shiva, S; Jurczak, MJ; O'Doherty, RM; Kaufman, BA				Belmonte, Frances R.; Dedousis, Nikolaos; Sipula, Ian; Desai, Nikita A.; Singhi, Aatur D.; Chu, Yanxia; Zhang, Yingze; Bannwarth, Sylvie; Paquis-Flucklinger, Veronique; Harrington, Lea; Shiva, Sruti; Jurczak, Michael J.; O'Doherty, Robert M.; Kaufman, Brett A.			Petite Integration Factor 1 (PIF1) helicase deficiency increases weight gain in Western diet-fed female mice without increased inflammatory markers or decreased glucose clearance	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; HEPATIC STEATOSIS; PPAR-GAMMA; ADIPOSE-TISSUE; FATTY LIVER; OBESITY; GENE; INACTIVATION; CONTRIBUTES	Petite Integration Factor 1 (PIF1) is a multifunctional helicase present in nuclei and mitochondria. PIF1 knock out (KO) mice exhibit accelerated weight gain and decreased wheel running on a normal chow diet. In the current study, we investigated whether Pif1 ablation alters whole body metabolism in response to weight gain. PIF1 KO and wild type (WT) C57BL/6J mice were fed a Western diet (WD) rich in fat and carbohydrates before evaluation of their metabolic phenotype. Compared with weight gain-resistant WT female mice, WD-fed PIF1 KO females, but not males, showed accelerated adipose deposition, decreased locomotor activity, and reduced whole-body energy expenditure without increased dietary intake. Surprisingly, PIF1 KO females did not show obesity-induced alterations in fasting blood glucose and glucose clearance. WD-fed PIF1 KO females developed mild hepatic steatosis and associated changes in liver gene expression that were absent in weight-matched, WD-fed female controls, linking hepatic steatosis to Pif1 ablation rather than increased body weight. WD-fed PIF1 KO females also showed decreased expression of inflammation-associated genes in adipose tissue. Collectively, these data separated weight gain from inflammation and impaired glucose homeostasis. They also support a role for Pif1 in weight gain resistance and liver metabolic dysregulation during nutrient stress.	[Belmonte, Frances R.; Desai, Nikita A.; Shiva, Sruti; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Div Cardiol, Ctr Metab & Mitochondria Med, Pittsburgh, PA 15260 USA; [Belmonte, Frances R.; Desai, Nikita A.; Shiva, Sruti; Kaufman, Brett A.] Vasc Med Inst, Pittsburgh, PA 15260 USA; [Dedousis, Nikolaos; Sipula, Ian; Jurczak, Michael J.; O'Doherty, Robert M.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Biomed Sci Tower, Pittsburgh, PA USA; [Singhi, Aatur D.] Univ Pittsburgh, Dept Pathol, Scaife Hall, Pittsburgh, PA USA; [Singhi, Aatur D.] Univ Pittsburgh, Pittsburgh Liver Res Ctr, Scaife Hall, Pittsburgh, PA USA; [Chu, Yanxia; Zhang, Yingze] UPMC Montefiore Hosp, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA USA; [Bannwarth, Sylvie; Paquis-Flucklinger, Veronique] Univ Cote dAzur, CHU Nice, INSERM, CNRS,IRCAN, Nice, France; [Harrington, Lea] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montreal	Kaufman, BA (corresponding author), Univ Pittsburgh, Sch Med, Div Cardiol, Ctr Metab & Mitochondria Med, Pittsburgh, PA 15260 USA.; Kaufman, BA (corresponding author), Vasc Med Inst, Pittsburgh, PA 15260 USA.	bkauf@pitt.edu		Zhang, YIngze/0000-0001-8042-6105; Belmonte, Frances/0000-0002-3402-8744	NIGMS [R01GM110424]; NIDDK [T32DK007052, R01DK102839]; Center for Metabolism and Mitochondrial Medicine (C3M); Stimulating Pittsburgh Research in Geroscience (SPRIG) Award; Pittsburgh Liver Research Center (PLRC); C3M; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007052, R01DK102839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110424] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Metabolism and Mitochondrial Medicine (C3M); Stimulating Pittsburgh Research in Geroscience (SPRIG) Award; Pittsburgh Liver Research Center (PLRC); C3M; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BAK was supported by NIGMS (R01GM110424). RMO was supported by NIDDK (R01DK102839) and the Center for Metabolism and Mitochondrial Medicine (C3M) funding. FB was supported by NIDDK (T32DK007052) and the animal costs were supported by NIGMS and Stimulating Pittsburgh Research in Geroscience (SPRIG) Award. ND was supported by C3M. ADS was supported by Pittsburgh Liver Research Center (PLRC).	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; [Anonymous], 2010, ASSESSMENT FEEDING B; Bannwarth S, 2016, MITOCHONDRION, V30, P126, DOI 10.1016/j.mito.2016.02.005; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347; Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038; Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llewellyn CH, 2013, INT J OBESITY, V37, P1506, DOI 10.1038/ijo.2013.30; Mangahas JL, 2001, MOL BIOL CELL, V12, P4078, DOI 10.1091/mbc.12.12.4078; Mateyak MK, 2006, CELL CYCLE, V5, P2796, DOI 10.4161/cc.5.23.3524; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schuldt A, 2011, NAT REV MOL CELL BIO, V12, DOI 10.1038/nrm3142; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Twig G, 2014, DIABETES CARE, V37, P2989, DOI 10.2337/dc14-0869; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738; Vega LR, 2007, PLOS GENET, V3, P1065, DOI 10.1371/journal.pgen.0030105; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0203101	10.1371/journal.pone.0203101	http://dx.doi.org/10.1371/journal.pone.0203101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136580	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300001
J	Czech, L; Stamatakis, A				Czech, Lucas; Stamatakis, Alexandros			Scalable methods for analyzing and visualizing phylogenetic placement of metagenomic samples	PLOS ONE			English	Article							COMPOSITIONAL DATA; DIVERSITY; SEQUENCE; IDENTIFICATION; COMMUNITIES; ANNOTATION; SEARCH; READS; SILVA; VIEW	Background The exponential decrease in molecular sequencing cost generates unprecedented amounts of data. Hence, scalable methods to analyze these data are required. Phylogenetic (or Evolutionary) Placement methods identify the evolutionary provenance of anonymous sequences with respect to a given reference phylogeny. This increasingly popular method is deployed for scrutinizing metagenomic samples from environments such as water, soil, or the human gut. Novel methods Here, we present novel and, more importantly, highly scalable methods for analyzing phylogenetic placements of metagenomic samples. More specifically, we introduce methods for (a) visualizing differences between samples and their correlation with associated meta-data on the reference phylogeny, (b) clustering similar samples using a variant of the k-means method, and (c) finding phylogenetic factors using an adaptation of the Phylofactorization method. These methods enable to interpret metagenomic data in a phylogenetic context, to find patterns in the data, and to identify branches of the phylogeny that are driving these patterns. Results To demonstrate the scalability and utility of our methods, as well as to provide exemplary interpretations of our methods, we applied them to 3 publicly available datasets comprising 9782 samples with a total of approximately 168 million sequences. The results indicate that new biological insights can be attained via our methods.	[Czech, Lucas; Stamatakis, Alexandros] Heidelberg Inst Theoret Studies, Computat Mol Evolut Grp, Heidelberg, Germany; [Stamatakis, Alexandros] Karlsruhe Inst Technol, Inst Theoret Informat, Karlsruhe, Germany	Heidelberg Institute for Theoretical Studies; Helmholtz Association; Karlsruhe Institute of Technology	Czech, L; Stamatakis, A (corresponding author), Heidelberg Inst Theoret Studies, Computat Mol Evolut Grp, Heidelberg, Germany.; Stamatakis, A (corresponding author), Karlsruhe Inst Technol, Inst Theoret Informat, Karlsruhe, Germany.	lucas.czech@h-its.org; alexandros.stamatakis@h-its.org	Stamatakis, Alexandros/B-8740-2009; Czech, Lucas/AAF-8722-2021	Stamatakis, Alexandros/0000-0003-0353-0691; Czech, Lucas/0000-0002-1340-9644	Klaus Tschira Stiftung gGmbH	Klaus Tschira Stiftung gGmbH	This work was financially supported by the Klaus Tschira Stiftung gGmbH (https://www.klaus-tschira-stiftung.de) in Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2018, INTRO CATEGORICAL DA; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Arthur D., 2006, Proceedings of the Twenty-Second Annual Symposium on Computational Geometry (SCG'06), P144, DOI 10.1145/1137856.1137880; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Barbera P, 2018, SYSTEMATIC BIOL; Berger SA, 2011, BIOINFORMATICS, V27, P2068, DOI 10.1093/bioinformatics/btr320; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bischof H, 1999, PATTERN ANAL APPL, V2, P59, DOI 10.1007/s100440050015; Bottou L., 1995, Advances in Neural Information Processing Systems 7, P585; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Czech L, 2018, BIOINFORMATICS; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Dunthorn M, 2014, MOL BIOL EVOL, V31, P993, DOI 10.1093/molbev/msu055; Dupont AOC, 2016, ENVIRON MICROBIOL, V18, P2010, DOI 10.1111/1462-2920.13220; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards David J, 2013, Microb Inform Exp, V3, P2, DOI 10.1186/2042-5783-3-2; Egozcue JJ, 2005, MATH GEOL, V37, P795, DOI 10.1007/s11004-005-7381-9; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Escobar-Zepeda A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00348; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Everitt B.S., 2010, CAMBRIDGE DICT STAT, DOI DOI 10.1017/CBO9780511779633; Giner CR, 2016, APPL ENVIRON MICROB, V82, P4757, DOI 10.1128/AEM.00560-16; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Gloor GB, 2016, AUST J STAT, V45, P73, DOI 10.17713/ajs.v45i4.122; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; GOOD IJ, 1956, J ROY STAT SOC B, V18, P113; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grant S.G, 2017, J MOL CANC, P1; Guidi L, 2016, NATURE, V532, P465, DOI 10.1038/nature16942; Hamerly G, 2004, ADV NEUR IN, V16, P281; Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jackson DA, 1997, ECOLOGY, V78, P929; Egozcue JJ, 2016, AUST J STAT, V45, P25, DOI 10.17713/ajs.v45i4.126; Kanungo T., 2003, 18 ANN S COMP GEOM S, V28, P89; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kelley DR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-544; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kozlov AM, 2016, NUCLEIC ACIDS RES, V44, P5022, DOI 10.1093/nar/gkw396; Kriegel HP, 2011, WIRES DATA MIN KNOWL, V1, P231, DOI 10.1002/widm.30; Krzanowski W.J., 1994, MULTIVARIATE ANAL; Lamp D, 2012, ACHIEVING REAL-TIME IN DISTRIBUTED COMPUTING: FROM GRIDS TO CLOUDS, P200, DOI 10.4018/978-1-60960-827-9.ch011; Legendre P., 1998, NUMERICAL ECOLOGY DE, V20; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Levina E, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P251, DOI 10.1109/ICCV.2001.937632; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Logares R, 2012, J MICROBIOL METH, V91, P106, DOI 10.1016/j.mimet.2012.07.017; Lovell D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004075; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mahe F., 2014, PEERJ, V2014, P1, DOI [10.7717/peerj.593, DOI 10.7717/PEERJ.593]; Mahe F, 2017, NAT ECOL EVOL, V1, DOI [10.1038/s41559-017-00911, 10.1038/s41559-017-0091]; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; MALLOWS CL, 1972, ANN MATH STAT, V43, P508, DOI 10.1214/aoms/1177692631; MARDIA KV, 1978, COMMUN STAT A-THEOR, V7, P1233, DOI 10.1080/03610927808827707; Matsen F. A., 2011, PLOS ONE, V8, P1; Matsen FA, 2011, EDGE PRINCIPAL COMPO; Matsen FA, 2015, SYST BIOL, V64, pE26, DOI 10.1093/sysbio/syu053; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; MCCuLLAGH P., 1989, GEN LINEAR MODELS, V37; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Mignardi M, 2014, GENOME MED, V6, DOI 10.1186/gm548; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Morton JT, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00162-16; Nguyen NP, 2014, BIOINFORMATICS, V30, P3548, DOI 10.1093/bioinformatics/btu721; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Pawlowsky-Glahn V., 2015, MODELLING ANAL COMPO, DOI DOI 10.1002/9781119003144; PawlowskyGlahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P1, DOI 10.1002/9781119976462; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Potapova M., 2011, PATTERNS DIATOM DIST; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RACHEV ST, 1985, THEOR PROBAB APPL+, V29, P647, DOI 10.1137/1129093; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shah N, 2018, BIOINFORMATICS; Silverman JD, 2017, ELIFE, V6, DOI 10.7554/eLife.21887; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thorndike RL., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tsilimigras MCB, 2016, ANN EPIDEMIOL, V26, P330, DOI 10.1016/j.annepidem.2016.03.002; Villani C., 2008, OPTIMAL TRANSPORT OL; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Washburne AD, 2018, BIORXIV; Washburne AD, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1353; Washburne AD, 2017, PEERJ, V5, DOI 10.7717/peerj.2969; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	110	44	45	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217050	10.1371/journal.pone.0217050	http://dx.doi.org/10.1371/journal.pone.0217050			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136592	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300014
J	Tavares, TD; de Oliveira, BR; Silva, VD; da Silva, RP; dos Santos, AF; Okida, ES				Tavares, Tiago de Oliveira; de Oliveira, Bruno Rocca; Silva, Vantuir de Albuquerque; da Silva, Rouverson Pereira; dos Santos, Adao Felipe; Okida, Estela Silva			The times, movements and operational efficiency of mechanized coffee harvesting in sloped areas	PLOS ONE			English	Article								Coffee farms have been adopting the microterraces system, a technique that reduces the effect of the slope by moving the soil between the crop lines. In this way, all the mechanized operations can be carried out normally, except for harvesting, due to the work limitation of the harvesters, who work in areas with a maximum slope of 20%. One option is to use unilateral harvesters, which crop one side at a time; however, there has been no research on these microterrace machines to evaluate their performance and to compare it with those of the other harvesting methods in those regions. This study aimed to compare the mechanized harvest performance in the microterraces with the manual and semimechanized harvesting methods. The study was carried out in an agricultural area of the municipality of Ouro Fino / MG, Brazil, in a crop production site where the microterraces were built six years before the experiment. The treatments were assigned to a split-block design with seven repetitions and consisted of mechanized harvest-unilateral harvester with bag storage; manual harvest-regionally experienced workers; and semimechanized harvest-with portable breakers. Through an analysis of the times and movements, the operational efficiency and operational and effective field capabilities were measured. The adoption of microterraces allows the efficient mechanization of areas previously impossible to mechanize. The unilateral harvester is a potential tool for the partial replacement of manual labor in the harvest, performing a service equivalent to that of 23.68 manual workers and 10.55 manual workers in the semimechanized system.	[Tavares, Tiago de Oliveira; de Oliveira, Bruno Rocca; Silva, Vantuir de Albuquerque; da Silva, Rouverson Pereira; dos Santos, Adao Felipe; Okida, Estela Silva] Sao Paulo State Univ, Lab Agr Machinery & Mechanizat, Dept Agr Engn, Jaboticabal, SP, Brazil	Universidade Estadual Paulista	de Oliveira, BR (corresponding author), Sao Paulo State Univ, Lab Agr Machinery & Mechanizat, Dept Agr Engn, Jaboticabal, SP, Brazil.	brunorocca1@outlook.com	dos Santos, Adão Felipe/P-7312-2019; da Silva, Rouverson Pereira/ABG-7394-2021; de Oliveira, Bruno Rocca/V-7521-2019	dos Santos, Adão Felipe/0000-0003-3405-5360; da Silva, Rouverson Pereira/0000-0001-8852-2548; de Oliveira, Bruno Rocca/0000-0002-1364-4548; Santos, Felipe/0000-0001-7264-3396				[Anonymous], 2008, THESIS; [Anonymous], 1996, MAQUINAS AGRICOLAS E; Arnaez J, 2015, CATENA, V128, P122, DOI 10.1016/j.catena.2015.01.021; ASABE, 2011, AGR MACH MAN DAT; Cirillo EJ, 2007, REV CIENTIFICA ELETR, V6; CONAB-Companhia Nacional De Abastecimento, 2018, CANA DEACUCAR, V5, P1; Cunha J. P. B., 2016, Coffee Science, V11, P87; Oliveira Ezequiel de, 2007, Cienc. Rural, V37, P1466, DOI 10.1590/S0103-84782007000500041; Embrapa Solos, 2013, SISTEMA BRASILEIRO C; Japiassu L. B., 2010, Coffee Science, V5, P28; Madeira PBF, 2014, 40 C BRAS PESQ CAF S; MATIELLO J. B., 2010, CULTURA CAFE BRASIL; Matiello JB, 2007, 33 C BRAS PESQ CAF L; MIALHE L. G., 1974, MANUAL MECANIZACAO A; Molin J. P., 2002, Engenharia Agricola, V22, P83; Nuintin AA, 2014, CUSTOS AGRONEGOCIO, V10; Paula M, 2013, ENGENHARIA AMBIENTAL, V10, P90; Pedro FC, 2010, MONOGRAFIA ESPECIALI; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Santinato F, 2015, CIENC RURAL, V45, P1809, DOI 10.1590/0103-8478cr20140801; Silva F. M., 2003, Engenharia Agricola, V23, P309; Silva FM, 2000, 26 C BRAS PESQ CAF M, P345; Silva FM, 2013, S PESQ CAF BRAS; Silva RP, 2008, CIENCIA RURAL, P1286; Sousa Filho GR, 2013, AVALIACAO COLHEITA M; Tarolli P, 2015, LAND DEGRAD DEV, V26, P92, DOI 10.1002/ldr.2311; Tarolli P, 2014, ANTHROPOCENE, V6, P10, DOI 10.1016/j.ancene.2014.03.002; Zonta MV, 2016, THESIS, P2016	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217286	10.1371/journal.pone.0217286	http://dx.doi.org/10.1371/journal.pone.0217286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136595	Green Submitted, gold, Green Published			2022-12-26	WOS:000469224300024
J	Garside, K; Henderson, R; Makarenko, I; Masoller, C				Garside, Kathryn; Henderson, Robin; Makarenko, Irina; Masoller, Cristina			Topological data analysis of high resolution diabetic retinopathy images	PLOS ONE			English	Article								Diabetic retinopathy is a complication of diabetes that produces changes in the blood vessel structure in the retina, which can cause severe vision problems and even blindness. In this paper, we demonstrate that by identifying topological features in very high resolution retinal images, we can construct a classifier that discriminates between healthy patients and those with diabetic retinopathy using summary statistics of these features. Topological data analysis identifies the features as connected components and holes in the images and describes the extent to which they persist across the image. These features are encoded in persistence diagrams, summaries of which can be used to discrimate between diabetic and healthy patients. The method has the potential to be an effective automated screening tool, with high sensitivity and specificity.	[Garside, Kathryn; Henderson, Robin; Makarenko, Irina] Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne, Tyne & Wear, England; [Masoller, Cristina] Univ Politecn Cataluna, Dept Phys, Barcelona, Spain	Newcastle University - UK; Universitat Politecnica de Catalunya	Garside, K (corresponding author), Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne, Tyne & Wear, England.	K.A.Garside2@newcastle.ac.uk	Masoller, Cristina/M-3696-2014	Masoller, Cristina/0000-0003-0768-2019; Garside, Kathryn/0000-0001-5727-0405	Spanish MINECO [FIS2015-66503, FIS2015-66503-C3-2-P]; program ICREA ACADEMIA of Generalitat de Catalunya	Spanish MINECO(Spanish Government); program ICREA ACADEMIA of Generalitat de Catalunya	C.M. is supported in part by the Spanish MINECO (FIS2015-66503 and FIS2015-66503-C3-2-P) and the program ICREA ACADEMIA of Generalitat de Catalunya. K.G, R.H and I.M received no specific funding for this work.	Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Antal B, 2014, KNOWL-BASED SYST, V60, P20, DOI 10.1016/j.knosys.2013.12.023; Biscio C, 2016, ACCUMULATED PERSISTE, P1; Bubenik P, 2015, J MACH LEARN RES, V16, P77; Budai A, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/154860; Decenciere E, 2014, IMAGE ANAL STEREOL, V33, P231, DOI 10.5566/ias.1155; Gargeya R, 2017, OPHTHALMOLOGY, V124, P962, DOI 10.1016/j.ophtha.2017.02.008; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Henderson R, 2017, STAT TOPOLOGY RANDOM, P1; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Kirkizlar E, 2013, OPHTHALMOLOGY, V120, P2604, DOI 10.1016/j.ophtha.2013.06.029; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075699; Niemeijer M, 2010, IEEE T MED IMAGING, V29, P185, DOI 10.1109/TMI.2009.2033909; Phan ADT, 2014, DIABETES CARE, V37, pE252, DOI 10.2337/dc14-0929; Sandhu HS, 2018, INVEST OPHTH VIS SCI, V59, P3155, DOI 10.1167/iovs.17-23677; Solomon SD, 2017, DIABETES CARE, V40, P412, DOI 10.2337/dc16-2641; Soomro TA, 2017, PATTERN ANAL APPL, V20, P927, DOI 10.1007/s10044-017-0630-y; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Takahashi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179790	20	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217413	10.1371/journal.pone.0217413	http://dx.doi.org/10.1371/journal.pone.0217413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125372	Green Published, gold, Green Submitted			2022-12-26	WOS:000468865700038
J	Zhou, XM; Wu, Q; Lu, Y; Zhang, XS; Lv, SY; Shao, J; Zhou, Y; Chen, JG; Hou, LJ; Huang, CG; Zhang, X				Zhou, Xiaoming; Wu, Qi; Lu, Yue; Zhang, Xiangsheng; Lv, Shengyin; Shao, Jiang; Zhou, Yuan; Chen, Jigang; Hou, Lijun; Huang, Chengguang; Zhang, Xin			Crosstalk between soluble PDGF-BB and PDGFR beta promotes astrocytic activation and synaptic recovery in the hippocampus after subarachnoid hemorrhage	FASEB JOURNAL			English	Article						SAH; neurovascular unit; astrocytic PDGFR beta; neuroprotection	MOUSE MODEL	Platelet-derived growth factor receptor beta (PDGFR beta) dynamically changes after brain injury, possibly mediating the neuroprotective role of soluble homodimers of the platelet-derived growth factor beta subunit (PDGF-BB) that is secreted by microcirculation cells. The aim of this study was to determine whether binding of PDGF-BB to astrocytic PDGFR beta enhanced crosstalk among the various components of the neurovascular unit, leading to synaptic recovery after subarachnoid hemorrhage (SAH). The soluble PDGF-BB from the cerebrospinal fluid (CSF) of patients with SAH was measured. The relationship between PDGF-BB treatment and astrocytic PDGFR beta signaling was further explored in vivo and in vitro in experimental SAH models. Compared with the levels in the control samples, the PDGF-BB protein levels in the CSF of patients with SAH were significantly increased. After the generation of experimental SAH, astrocyte activation markers were markedly induced by the binding of PDGF-BB to astrocytic PDGFR beta, accompanied by improved levels of synaptic recovery and cognitive function. Soluble PDGF-BB and astrocytic PDGFR beta signaling are essential for the neuroprotective effect in the hippocampus and the coculture system in vitro after SAH that otherwise leads to cognitive dysfunction and neuronal damage.-Zhou, X., Wu, Q., Lu, Y., Zhang, X., Lv, S., Shao, J., Zhou, Y., Chen, J., Hou, L., Huang, C., Zhang, X. Crosstalk between soluble PDGF-BB and PDGFR beta promotes astrocytic activation and synaptic recovery in the hippocampus after subarachnoid hemorrhage.	[Zhou, Xiaoming; Chen, Jigang; Hou, Lijun; Huang, Chengguang] Second Mil Med Univ, Dept Neurosurg, Changzheng Hosp, Shanghai 200003, Peoples R China; [Wu, Qi; Zhang, Xiangsheng; Zhou, Yuan; Zhang, Xin] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Lu, Yue] Nanjing Univ, Drum Tower Hosp, Dept Neurosurg, Sch Med, Nanjing, Jiangsu, Peoples R China; [Lv, Shengyin; Shao, Jiang] Southern Med Univ, Jinling Hosp, Dept Neurosurg, Sch Med, Nanjing, Jiangsu, Peoples R China	Naval Medical University; Nanjing University; Nanjing University; Southern Medical University - China	Huang, CG (corresponding author), Second Mil Med Univ, Dept Neurosurg, Changzheng Hosp, Shanghai 200003, Peoples R China.; Zhang, X (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.	huang64@163.com; zhangxsp@163.com			National Natural Science Foundation, China [81171130, 81671206, 81471183]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation, China (81171130, 81671206, and 81471183). The authors declare that there are no conflicts of interest that could be perceived as prejudicing the impartiality of the reported research.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arango-Lievano M, 2018, CELL REP, V23, P1045, DOI 10.1016/j.celrep.2018.03.110; Cabezas R, 2018, MOL NEUROBIOL, V55, P3085, DOI 10.1007/s12035-017-0567-6; Cai Y, 2016, J CELL BIOL, V215, P245, DOI 10.1083/jcb.201605065; Chen Q, 2016, J NEUROL SCI, V369, P126, DOI 10.1016/j.jns.2016.08.017; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; Gaceb A, 2018, J CEREBR BLOOD F MET, V38, P45, DOI 10.1177/0271678X17719645; Jones EV, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/321209; Klinkhammer BM, 2018, MOL ASPECTS MED, V62, P44, DOI 10.1016/j.mam.2017.11.008; Kyyriainen J, 2017, GLIA, V65, P322, DOI 10.1002/glia.23094; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Luo C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.63; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Miners JS, 2018, J CEREBR BLOOD F MET, V38, P103, DOI 10.1177/0271678X17690761; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P1825, DOI 10.1038/jcbfm.2013.173; Oztop-Cakmak O, 2017, CURR DRUG TARGETS, V18, P1386, DOI 10.2174/1389450117666160613104523; Padel T, 2016, NEUROBIOL DIS, V94, P95, DOI 10.1016/j.nbd.2016.06.002; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Shen J, 2012, J CEREBR BLOOD F MET, V32, P353, DOI 10.1038/jcbfm.2011.136; Sompol P, 2017, J NEUROSCI, V37, P6132, DOI 10.1523/JNEUROSCI.0877-17.2017; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294	24	16	18	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9588	9601		10.1096/fj.201900195R	http://dx.doi.org/10.1096/fj.201900195R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162947				2022-12-26	WOS:000478832900069
J	Kelly, SD; Clarke, BR; Ovchinnikova, OG; Sweeney, RP; Williamson, ML; Lowary, TL; Whitfield, C				Kelly, Steven D.; Clarke, Bradley R.; Ovchinnikova, Olga G.; Sweeney, Ryan P.; Williamson, Monica L.; Lowary, Todd L.; Whitfield, Chris			Klebsiella pneumoniae O1 and O2ac antigens provide prototypes for an unusual strategy for polysaccharide antigen diversification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gram-negative bacteria; Klebsiella pneumonia; lipopolysaccharide (LPS); glycosyltransferase; polysaccharide; antigenic diversity; cell surface; enzyme complex; O-antigen; serotyping	D-GALACTAN-I; ESCHERICHIA-COLI; CHAIN-LENGTH; SEROTYPE O1-K20; LIPOPOLYSACCHARIDE; BINDING; BIOSYNTHESIS; PROTEIN; IDENTIFICATION; MEMBRANE	A limited range of different structures is observed in O-antigenic polysaccharides (OPSs) from Klebsiella pneumoniae lipopolysaccharides. Among these, several are based on modifications of a conserved core element of serotype O2a OPS, which has a disaccharide repeat structure [-> 3)-alpha-d-Galp-(1 -> 3)-beta-d-Galf-(1 ->]. Here, we describe the enzymatic pathways for a highly unusual modification strategy involving the attachment of a second glycan repeat-unit structure to the nonreducing terminus of O2a. This occurs by the addition of the O1 [-> 3)-alpha-d-Galp-(1 -> 3)-beta-d-Galp-(1 ->] or O2c [-> 3)-beta-d-GlcpNAc-(1 -> 5)-beta-d-Galf-(1 ->] antigens. The organization of the enzyme activities performing these modifications differs, with the enzyme WbbY possessing two glycosyltransferase catalytic sites solely responsible for O1 antigen polymerization and forming a complex with the O2a glycosyltransferase WbbM. In contrast, O2c polymerization requires glycosyltransferases WbmV and WbmW, which interact with one another but apparently not with WbbM. Using defined synthetic acceptors and site-directed mutants to assign the activities of the WbbY catalytic sites, we found that the C-terminal WbbY domain is a UDP-Galp-dependent GT-A galactosyltransferase adding beta-(1 -> 3)-linked d-Galp, whereas the WbbY N terminus includes a GT-B enzyme adding alpha-(1 -> 3)-linked d-Galp. These activities build the O1 antigen on a terminal Galp in the O2a domain. Using similar approaches, we identified WbmV as the UDP-GlcNAc transferase and noted that WbmW represents a UDP-Galf-dependent enzyme and that both are GT-A members. WbmVW polymerizes the O2c antigen on a terminal Galf. Our results provide mechanistic and conceptual insights into an important strategy for polysaccharide antigen diversification in bacteria.	[Kelly, Steven D.; Clarke, Bradley R.; Ovchinnikova, Olga G.; Williamson, Monica L.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Sweeney, Ryan P.; Lowary, Todd L.] Univ Alberta, Alberta Glycom Ctr, Edmonton, AB T6G 2G2, Canada; [Sweeney, Ryan P.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Lowary, Todd L/F-9608-2019	Lowary, Todd L/0000-0002-8331-8211; Sweeney, Ryan/0000-0003-4022-3041; Whitfield, Chris/0000-0002-5267-7027; Kelly, Steven/0000-0003-1250-7055	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (to T. L. L. and C. W.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, ANT RES THREATS; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; CLARKE BR, 1995, J BACTERIOL, V177, P5411, DOI 10.1128/jb.177.19.5411-5418.1995; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; CLARKE BR, 1992, J BACTERIOL, V174, P4614, DOI 10.1128/JB.174.14.4614-4621.1992; Clarke BR, 2018, J BIOL CHEM, V293, P4666, DOI 10.1074/jbc.RA117.000646; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Follador R, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000073; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Guachalla LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06682-2; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Hegerle N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203143; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hsieh PF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00608; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KELLY RF, 1995, J ENDOTOXIN RES, V0002; KELLY RF, 1993, MOL MICROBIOL, V10, P615, DOI 10.1111/j.1365-2958.1993.tb00933.x; KOL O, 1992, CARBOHYD RES, V236, P339, DOI 10.1016/0008-6215(92)85028-X; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Kubler-Kielb J, 2013, CARBOHYD RES, V378, P144, DOI 10.1016/j.carres.2013.03.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Liston SD, 2017, BBA-MOL CELL BIOL L, V1862, P1394, DOI 10.1016/j.bbalip.2016.10.008; Mann E, 2016, J BIOL CHEM, V291, P9748, DOI 10.1074/jbc.M116.719344; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; MCCALLUM KL, 1989, INFECT IMMUN, V57, P3816, DOI 10.1128/IAI.57.12.3816-3822.1989; Miller J. H., 1972, EXPT MOL GENETICS, P432; Mostowy RJ, 2018, TRENDS MICROBIOL, V26, P1008, DOI 10.1016/j.tim.2018.06.006; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Ovchinnikova OG, 2016, J BIOL CHEM, V291, P21519, DOI 10.1074/jbc.M116.751115; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Pan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15573; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Stojkovic K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00684; Szijarto V, 2017, VIRULENCE, V8, P1203, DOI 10.1080/21505594.2017.1279778; Szijarto V, 2016, INT J MED MICROBIOL, V306, P89, DOI 10.1016/j.ijmm.2015.12.002; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Thomason Lynn C, 2014, Curr Protoc Mol Biol, V106, DOI 10.1002/0471142727.mb0116s106; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trautmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P550, DOI 10.1128/CDLI.4.5.550-555.1997; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Williams DM, 2017, P NATL ACAD SCI USA, V114, pE1215, DOI 10.1073/pnas.1613609114; Yates LE, 2021, ADV BIOCHEM ENG BIOT, V175, P167, DOI 10.1007/10_2018_72	58	9	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10863	10876		10.1074/jbc.RA119.008969	http://dx.doi.org/10.1074/jbc.RA119.008969			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138653	Green Published, hybrid			2022-12-26	WOS:000478717200011
J	Rey, EG; Finkelstein, JL; Erickson, D				Rey, Elizabeth G.; Finkelstein, Julia L.; Erickson, David			Fluorescence lateral flow competitive protein binding assay for the assessment of serum folate concentrations	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; FOLIC-ACID; OPPORTUNITIES; PREVENTION	Folate is a micronutrient required for the production of new cells, making it a key factor in early fetal development and ensuring normal growth and maintenance of health. The increase in consumption of folate due to increased periconceptional supplementation and fortification of grains in many countries has led to a decrease in occurrence of folate deficiency and a class of birth defects called neural tube defects. However, an opportunity remains to further improve folate status of populations in areas with limited access to fortified foods and supplementation. Screening of women of reproductive age and other vulnerable populations for folate status would increase our understanding of the magnitude of the burden of folate deficiency and inform monitoring of public health programs. Current gold standard methods for folate assessment are time-intensive and require cold chain, sophisticated laboratory infrastructure, and highly-trained personnel. Our lateral flow assay is lowcost, easy to use, and allows a user to assess folate insufficiency at the point of care in less than 40 minutes. We evaluated the sensitivity and specificity of our assay in 24 human serum samples, including 8 samples with folate concentrations less than 10.0 nmol/L and 14 samples less than 13.4 nmol/L using the Immulite 2000 commercial assay as a reference standard. The sensitivity and specificity were found to be 93% (95% CI: 54.7-100.0) and 91% (95% CI: 80.0-100.0), respectively, when using our test to determine folate insufficiency based on a cutoff of 13.4 nmol/L. Our point-of-care diagnostic test for folate concentrations could inform screening and public health programs in at-risk populations.	[Rey, Elizabeth G.; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Finkelstein, Julia L.; Erickson, David] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Erickson, D (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.; Finkelstein, JL; Erickson, D (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	jfinkelstein@cornell.edu; de54@cornell.edu		Rey, Elizabeth/0000-0003-1445-9982	U.S. Department of Health & Human Services \ National Institutes of Health (NIH) - Indo-US [R03 EB 023190]; Cornell University Institute for Biotechnology Center for Advanced Technology Grant; National Science Foundation (NSF) [CBET-1343058]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB023190] Funding Source: NIH RePORTER	U.S. Department of Health & Human Services \ National Institutes of Health (NIH) - Indo-US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell University Institute for Biotechnology Center for Advanced Technology Grant; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge the funding support from the following: U.S. Department of Health & Human Services vertical bar National Institutes of Health (NIH) - Indo-US R03 EB 023190 [J.L.F.] https://www.nih.gov/ Cornell University Institute for Biotechnology Center for Advanced Technology Grant [J.L.F.] http://www.biotech.cornell.edu/cat/funding/cat-awards National Science Foundation (NSF) - CBET-1343058 [D.E.] https://www.nsf.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Laboratories, 2010, ARCH FOL ASS; Anagnostis P, 2013, INT J CLIN PRACT, V67, P225, DOI 10.1111/ijcp.12031; Bailey LB, BIOMARKERS NUTR DEV, DOI [10.3945/jn.114.206599, DOI 10.3945/JN.114.206599]; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; CDC, 2003, LAB PROC MAN FOL VIT; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P362; CHEN TS, 1979, J FOOD SCI, V44, P713, DOI 10.1111/j.1365-2621.1979.tb08483.x; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P980; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Farrell CJL, 2013, CLIN CHEM LAB MED, V51, P555, DOI 10.1515/cclm-2012-0639; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GIVAS JK, 1975, CLIN CHEM, V21, P427; Holm J, 2014, BBA-PROTEINS PROTEOM, V1844, P512, DOI 10.1016/j.bbapap.2013.12.009; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; HORNE DW, 1988, CLIN CHEM, V34, P2357; JENSEN EV, 1950, J BIOL CHEM, V185, P411; Jones ML, 2002, J NUTR, V132, P2690, DOI 10.1093/jn/132.9.2690; Lee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28237; Lu ZD, 2017, P NATL ACAD SCI USA, V114, P13513, DOI 10.1073/pnas.1711464114; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Pfeiffer CM, 2015, J NUTR, V145, P520, DOI 10.3945/jn.114.201210; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Qu Q, 2009, J MICROBIOL METH, V79, P121, DOI 10.1016/j.mimet.2009.07.015; Rey E G, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3906, DOI 10.1109/EMBC.2018.8513377; Rey EG, 2017, ANAL CHEM, V89, P5095, DOI 10.1021/acs.analchem.7b00638; Selhub J, 2016, BIOCHIMIE, V126, P71, DOI 10.1016/j.biochi.2016.04.010; Vemulapati S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13044-5; Vitale SG, 2016, OBSTET GYNECOL SURV, V71, P721, DOI 10.1097/OGX.0000000000000369; WALD N, 1991, LANCET, V338, P131; WAXMAN S, 1975, BRIT J HAEMATOL, V29, P23, DOI 10.1111/j.1365-2141.1975.tb01796.x; Waxman S, 1973, BLOOD, V42; WHO, 2012, STATE SCI ENDOCRINE, P1; World Health Organization, 2015, GUID OPT SER RED BLO, P38; Yan ZQ, 2006, SENSOR ACTUAT B-CHEM, V119, P656, DOI 10.1016/j.snb.2006.01.029; Zhang H-Y, 2008, NEURAL TUBE DEFECTS, DOI [10.1016/j.expneurol.2008.04.044, DOI 10.1016/J.EXPNEUROL.2008.04.044]	37	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217403	10.1371/journal.pone.0217403	http://dx.doi.org/10.1371/journal.pone.0217403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166978	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800026
J	Serrano, ME; Bartholome, O; Van den Ackerveken, P; Ferrara, A; Rogister, B; Plenevaux, A; Tirelli, E				Serrano, Maria Elisa; Bartholome, Odile; Van den Ackerveken, Priscilla; Ferrara, Andre; Rogister, Bernard; Plenevaux, Alain; Tirelli, Ezio			Anxiety-like features and spatial memory problems as a consequence of hippocampal SV2A expression	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; TEMPORAL-LOBE EPILEPSY; PILOCARPINE MODEL; SEX-DIFFERENCES; NEUROBEHAVIORAL COMORBIDITIES; IMPROVES COGNITION; ANTIEPILEPTIC DRUG; BINDING-SITE; WATER-MAZE; PLUS-MAZE	The Synaptic Vesicle Protein 2A (SV2A) is a transmembrane protein whose presence is reduced both in animal models and in patients with chronic epilepsy. Besides its implication in the epileptic process, the behavioural consequences of the changes in its expression remain unclear. The purpose of our research is to better understand the possible role(s) of this protein through the phenotype of cKO (Grik4 Cre+/-, SV2A lox/lox) mice, male and female, which present a specific decrease of SV2A expression levels in the hippocampal glutamatergic neurons but without any epileptic seizures. In this study, we compare the cKO mice with cHZ (Grik4 Cre+/-, SV2A lox/+) and WT (Grik4 Cre+/+, SV2A lox/lox) mice through a battery of tests, used to evaluate different features: the anxiety-related features (Elevated Plus Maze), the locomotor activity (Activity Chambers), the contextual fear-related memory (Contextual Fear Conditioning), and the spatial memory (Barnes Maze). Our results showed statistically significant differences in the habituation to a new environment, an increase in the anxiety levels and spatial memory deficit in the cHZ and cKO groups, compared to the WT group. No statistically significant differences due to the genotype appeared in the spontaneous locomotor activity or the fear-linked memory. However, sexual differences were observed in this last feature. These results highlight not only an important role of the SV2A protein in the cognitive and anxiety problems typically encountered in epileptic patients, but also a possible role in the symptomatology of other neurodegenerative diseases, such as the Alzheimer's disease.	[Serrano, Maria Elisa; Plenevaux, Alain] Univ Liege, GIGA CRC Vivo Imaging, Liege, Belgium; [Bartholome, Odile; Van den Ackerveken, Priscilla; Rogister, Bernard] Univ Liege, GIGA Neurosci, Liege, Belgium; [Ferrara, Andre; Tirelli, Ezio] Univ Liege, Dept Psychol, Liege, Belgium; [Rogister, Bernard] Univ Liege, Acad Hosp, CHU, Dept Neurol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Serrano, ME (corresponding author), Univ Liege, GIGA CRC Vivo Imaging, Liege, Belgium.	maelisaserranon@gmail.com	Rogister, Bernard/AAJ-9591-2020	Serrano Navacerrada, Maria Elisa/0000-0003-0880-6183; Plenevaux, Alain/0000-0003-3011-4984; Van Den Ackerveken, Priscilla/0000-0001-5913-6293	Action de Recherches Concertees (ARC) [13/17-07]; la Communaute Francaise de Belgique; FNRS	Action de Recherches Concertees (ARC); la Communaute Francaise de Belgique; FNRS(Fonds de la Recherche Scientifique - FNRS)	This work has been supported by Action de Recherches Concertees (ARC, grant number 13/17-07) (AP, MES, OB, BR), la Communaute Francaise de Belgique (BR) and by the FNRS (BR). AP is research director from Fonds De La Recherche Scientifique - FNRS Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Bakker A, 2015, NEUROIMAGE-CLIN, V7, P688, DOI 10.1016/j.nicl.2015.02.009; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bartholome O, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00148; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Berkiks I, 2019, PHYSIOL BEHAV, V199, P386, DOI 10.1016/j.physbeh.2018.11.037; Brabant C, 2007, PSYCHOPHARMACOLOGY, V190, P251, DOI 10.1007/s00213-006-0603-0; Bragina L, 2012, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00032; Celikyurt IK, 2012, LIFE SCI, V90, P185, DOI 10.1016/j.lfs.2011.11.003; Chaaya N, 2018, NEUROSCI BIOBEHAV R, V92, P43, DOI 10.1016/j.neubiorev.2018.05.013; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Charlier Y, 2013, BEHAV BRAIN RES, V253, P121, DOI 10.1016/j.bbr.2013.07.016; Chatzikonstantinou A, 2014, FRONT NEUROL NEUROSC, V34, P121, DOI 10.1159/000356435; Clary HMM, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0445-9; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colon L, 2018, LEARN MEMORY, V25, P230, DOI 10.1101/lm.047159.117; Crevecoeur J, 2014, NEUROPATH APPL NEURO, V40, P191, DOI 10.1111/nan.12054; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Dardou D, 2013, BRAIN RES, V1507, P61, DOI 10.1016/j.brainres.2013.02.041; Desgent S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042622; Devi L, 2013, NEUROBIOL LEARN MEM, V102, P7, DOI 10.1016/j.nlm.2013.02.001; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Ge YX, 2016, NEUROSCI LETT, V628, P194, DOI 10.1016/j.neulet.2016.06.043; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Helmstaedter C, 2017, SEIZURE-EUR J EPILEP, V49, P83, DOI 10.1016/j.seizure.2017.02.017; Hermann B, 2008, LANCET NEUROL, V7, P151, DOI 10.1016/S1474-4422(08)70018-8; Holler Y, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00058; Holmes G.L., 2012, JASPERS BASIC MECH E; Isiegas C, 2006, J NEUROSCI, V26, P12700, DOI 10.1523/JNEUROSCI.2743-06.2006; Izquierdo A, 2017, NEUROSCIENCE, V345, P12, DOI 10.1016/j.neuroscience.2016.03.021; Jacoby A, 2015, EPILEPSY BEHAV, V43, P149, DOI 10.1016/j.yebeh.2014.09.071; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Kanner AM, 2012, EPILEPSY BEHAV, V24, P156, DOI 10.1016/j.yebeh.2012.01.007; Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238; Keiser AA, 2017, NEUROPSYCHOPHARMACOL, V42, P397, DOI 10.1038/npp.2016.174; Kesby JP, 2016, BEHAV BRAIN RES, V311, P131, DOI 10.1016/j.bbr.2016.05.034; Kesby JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140034; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Klein P, 2018, CLIN PHARMACOL-ADV A, V10, P1, DOI 10.2147/CPAA.S114072; Kochli DE, 2015, LEARN MEMORY, V22, P92, DOI 10.1101/lm.034918.114; Koh MT, 2018, SCHIZOPHR RES, V193, P119, DOI 10.1016/j.schres.2017.06.027; Korczyn AD, 2013, EPILEPSY BEHAV, V28, P283, DOI 10.1016/j.yebeh.2013.03.012; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Krabbe S, 2018, BIOL PSYCHIAT, V83, P800, DOI 10.1016/j.biopsych.2017.10.006; Lamberty Y, 2009, BEHAV BRAIN RES, V198, P329, DOI 10.1016/j.bbr.2008.11.005; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lopes MW, 2016, EPILEPSY BEHAV, V55, P92, DOI 10.1016/j.yebeh.2015.12.001; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Magalhaes JC, 2015, CLIN PSYCHOPHARM NEU, V13, P83, DOI 10.9758/cpn.2015.13.1.83; Majak K, 2004, EPILEPSY BEHAV, V5, pS35, DOI 10.1016/j.yebeh.2003.11.012; McDonald CR, 2011, EPILEPSY BEHAV, V22, P69, DOI 10.1016/j.yebeh.2011.06.004; Menten-Dedoyart C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166525; Merz CJ, 2017, J NEUROSCI RES, V95, P93, DOI 10.1002/jnr.23811; Minjarez B, 2017, NEUROSCI BIOBEHAV R, V83, P373, DOI 10.1016/j.neubiorev.2017.10.016; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Paul CM, 2009, BEHAV BRAIN RES, V203, P151, DOI 10.1016/j.bbr.2009.05.022; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; PITKANEN A, ANN N Y ACAD SCI, V911, P369; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Roelofs K, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0206; Rozeske RR, 2018, CURR OPIN NEUROBIOL, V52, P60, DOI 10.1016/j.conb.2018.04.017; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Savic I, 2014, EXP NEUROL, V259, P38, DOI 10.1016/j.expneurol.2014.04.009; Sen A, 2018, BRAIN, V141, P1592, DOI 10.1093/brain/awy022; Sendrowski K, 2013, PHARMACOL REP, V65, P555, DOI 10.1016/S1734-1140(13)71033-8; Serajee FJ, 2015, PEDIATR NEUROL, V52, P642, DOI 10.1016/j.pediatrneurol.2015.02.011; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Simone JJ, 2018, INT J DEV NEUROSCI, V69, P119, DOI 10.1016/j.ijdevneu.2018.07.011; Soukupova M, 2015, NEUROSCIENCE, V301, P246, DOI 10.1016/j.neuroscience.2015.06.013; Soukupova M, 2014, EXP NEUROL, V257, P39, DOI 10.1016/j.expneurol.2014.04.014; Toering ST, 2009, EPILEPSIA, V50, P1409, DOI 10.1111/j.1528-1167.2008.01955.x; Tokudome K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27420; van Vliet EA, 2009, EPILEPSIA, V50, P422, DOI 10.1111/j.1528-1167.2008.01727.x; Venkatesan K, 2012, J NEUROSCI RES, V90, P2317, DOI 10.1002/jnr.23111; von Rosenstiel P, 2007, NEUROTHERAPEUTICS, V4, P84, DOI 10.1016/j.nurt.2006.11.004; Wiglusz MS, 2018, EPILEPSY BEHAV, V79, P1, DOI 10.1016/j.yebeh.2017.11.025; Wilson YM, 2009, LEARN MEMORY, V16, P357, DOI 10.1101/lm.1361509; Xiang XJ, 2011, BEHAV BRAIN RES, V222, P326, DOI 10.1016/j.bbr.2011.03.068; Zhang J, 2018, NEUROBIOL LEARN MEM	89	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217882	10.1371/journal.pone.0217882	http://dx.doi.org/10.1371/journal.pone.0217882			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166988	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800048
J	Yaney-Keller, A; Tomillo, PS; Marshall, JM; Paladino, FV				Yaney-Keller, Adam; Santidrian Tomillo, Pilar; Marshall, Jordan M.; Paladino, Frank V.			Using Unmanned Aerial Systems (UAS) to assay mangrove estuaries on the Pacific coast of Costa Rica	PLOS ONE			English	Article							LEAF-AREA INDEX; VEHICLE UAV; ABOVEGROUND BIOMASS; AVICENNIA-GERMINANS; VEGETATION INDEXES; CANOPY COVER; FOREST; IMAGERY; FIELD; NDVI	Mangrove forests, one of the world's most endangered ecosystems, are also some of the most difficult to access. This is especially true along the Pacific coast of Costa Rica, where 99% of the country's mangroves occur. Unmanned Aerial Systems (UAS), or drones, have become a convenient tool for natural area assessment, and offer a solution to the problems of remote mangrove monitoring. This study is the first to use UAS to analyze the structure of a mangrove forests within Central America. Our goals were to (1) determine the forest structure of two estuaries in northwestern Costa Rica through traditional ground measurements, (2) assess the accuracy of UAS measurements of canopy height and percent coverage and (3) determine whether the normalized difference vegetation index (NDVI) could discriminate between the most abundant mangrove species. We flew a UAS equipped with a single NDVI sensor during the peak wet (Sept-Nov) and dry (Jan-Feb) seasons. The structure and species composition of the estuaries showed a possible transition between the wet mangroves of southern Costa Rica and the drier northern mangroves. UAS-derived measurements at 100 cm/pixel resolution of percent canopy coverage and maximum and mean canopy height were not statistically different from ground measurements (p > 0.05). However, there were differences in mean canopy height at 10 cm/pixel resolution (p = 0.043), indicating diminished returns in accuracy as resolution becomes extremely fine. Mean NDVI values of Avicennia germinans (most abundant species) changed significantly between seasons (p < 0.001). Mean NDVI of Rhizophora racemosa (second most abundant species) was significantly different from A. germinans and dry forest dominant plots during the dry season (p < 0.001), demonstrating NDVI's capability of discriminating mangrove species. This study provides the first structural assessment of the studied estuaries and a framework for future studies of mangroves using UAS.	[Yaney-Keller, Adam; Marshall, Jordan M.; Paladino, Frank V.] Purdue Univ Ft Wayne, Ft Wayne, IN 46805 USA; [Santidrian Tomillo, Pilar; Paladino, Frank V.] Leatherback Trust, Goldring Gund Marine Biol Stn, Playa Grande, Costa Rica		Yaney-Keller, A (corresponding author), Purdue Univ Ft Wayne, Ft Wayne, IN 46805 USA.	yaneam01@pfw.edu	Marshall, Jordan/AAF-9692-2021; Yaney-Keller, Adam/ABE-7576-2020; Santidrián Tomillo, Pilar/N-5406-2014; Marshall, Jordan/B-1934-2009	Santidrián Tomillo, Pilar/0000-0002-6895-7218; Marshall, Jordan/0000-0001-6024-3758; Paladino, Frank V./0000-0002-6452-0086; Yaney-Keller, Adam/0000-0003-1538-664X	Leatherback Trust; Fort Wayne Children's Zoo; Mary Margaret Stucky Testament Trust, under Purdue Fort Wayne Grant [8000078286]	Leatherback Trust; Fort Wayne Children's Zoo; Mary Margaret Stucky Testament Trust, under Purdue Fort Wayne Grant	Funding for this study was provided to FVP by The Leatherback Trust, (https://www.leatherback.org), Fort Wayne Children's Zoo, (https://kidszoo.org/), Mary Margaret Stucky Testament Trust, (https://www.manta.com/c/mr4rpd3/mary-margaret-stucky-testament-trust), under Purdue Fort Wayne Grant #8000078286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BM, 2015, FRONT ECOL ENVIRON, V13, P354, DOI 10.1890/15.WB.015; Andersen HE, 2006, CAN J REMOTE SENS, V32, P355, DOI 10.5589/m06-030; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; [Anonymous], 2000, ELEMENTS PHOTOGRAMME; Navarro JA, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11010077; Baena S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188714; Ballaria D, 2016, ISPRS INT ARCH PHOTO, P41, DOI DOI 10.5194/ISPRS-ARCHIVES-XLI-B1-1105-2016; Becker C, 2018, PHOTOGRAMM ENG REM S, V84, P287, DOI 10.14358/PERS.84.5.287; Cao JJ, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010089; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; Carreiras JMB, 2006, FOREST ECOL MANAG, V223, P45, DOI 10.1016/j.foreco.2005.10.056; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Cordoba Munoz R, 1998, INVENTARIO HUMEDALES; Cortes J., 2014, REV BIOL TROPICAL S4, V62, P151; Cruzan MB, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600041; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Dandois JP, 2010, REMOTE SENS-BASEL, V2, P1157, DOI 10.3390/rs2041157; Diaz BM, 2003, INT J REMOTE SENS, V24, P53, DOI 10.1080/01431160305012; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ellison A, 2010, IUCN RED LIST THREAT, DOI [10. 2305/IUCN. UK. 2010-2. RLTS. T178833A7621318. en, DOI 10.2305/IUCN.UK.2010-2.RLTS.T178833A7621318.EN]; Flores-de-Santiago F, 2013, WETL ECOL MANAG, V21, P193, DOI 10.1007/s11273-013-9290-x; Flores-De-Santiago F, 2012, MAR ECOL PROG SER, V444, P57, DOI 10.3354/meps09474; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Garcia-Ruiz F, 2013, COMPUT ELECTRON AGR, V91, P106, DOI 10.1016/j.compag.2012.12.002; Gross J, 2014, WETLANDS, V34, P55, DOI 10.1007/s13157-013-0482-1; Guo Q, 2017, INT J REMOTE SENS, V38, P2954, DOI 10.1080/01431161.2017.1285083; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Heenkenda MK, 2015, PHOTOGRAMM ENG REM S, V81, P471, DOI 10.14358/PERS.81.6.471; Huete AR, 1997, INT GEOSCI REMOTE SE, P1966, DOI 10.1109/IGARSS.1997.609169; Jensen JR, 1986, INTRO DIGITAL IMAGE, P379; Jiang ZY, 2006, REMOTE SENS ENVIRON, V101, P366, DOI 10.1016/j.rse.2006.01.003; JIMENEZ JA, 1985, REV BIOL TROP, V33, P25; Jimenez Jorge A., 2004, P136; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kauffman J. B., 2012, CIFOR Working Paper; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Kovacs JM, 2009, ENVIRON MONIT ASSESS, V157, P137, DOI 10.1007/s10661-008-0523-z; Kovacs JM, 2004, AQUAT BOT, V80, P13, DOI 10.1016/j.aquabot.2004.06.001; Lee SY, 2014, GLOBAL ECOL BIOGEOGR, V23, P726, DOI 10.1111/geb.12155; Lee TM, 2009, ECOL ENG, V35, P487, DOI 10.1016/j.ecoleng.2008.01.007; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lewis RR, 2005, ECOL ENG, V24, P403, DOI 10.1016/j.ecoleng.2004.10.003; Li QS, 2017, INT ARCH PHOTOGRAMM, V42-2, P209, DOI 10.5194/isprs-archives-XLII-2-W6-209-2017; Lin H, 1991, GEOCARTO INT, V6, P13, DOI DOI 10.1080/10106049109354302; Lisein J, 2013, FORESTS, V4, P922, DOI 10.3390/f4040922; Liu XH, 2018, REMOTE SENS LETT, V9, P1040, DOI [10.1080/2150704X.2018.1504339, 10.1080/2150704x.2018.1504339]; Loria-Naranjo M., 2014, REV BIOL TROP, V62, P33, DOI [10.15517/rbt.v62i4.20030, DOI 10.15517/RBT.V62I4.20030]; Luther DA, 2009, BIOSCIENCE, V59, P602, DOI 10.1525/bio.2009.59.7.11; Manfreda S, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040641; Matese A, 2015, REMOTE SENS-BASEL, V7, P2971, DOI 10.3390/rs70302971; McKee KL, 1996, TREE PHYSIOL, V16, P883; Mendez-Alonzo R, 2008, BIOTROPICA, V40, P449, DOI 10.1111/j.1744-7429.2008.00397.x; Messinger M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8080615; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myeong S., 2001, URBAN ECOSYST, V5, P243, DOI [DOI 10.1016/j.ufug.2017.05.012, 10.1023/A:1025687711588, DOI 10.1023/A:1025687711588]; Ota T, 2015, FORESTS, V6, P3882, DOI 10.3390/f6113882; Otero V, 2018, FOREST ECOL MANAG, V411, P35, DOI 10.1016/j.foreco.2017.12.049; Panagiotidis D, 2017, INT J REMOTE SENS, V38, P2392, DOI 10.1080/01431161.2016.1264028; Pereira JMC, 1995, EARSEL ADV REMOTE SE, V4, P14; Polania J., 1993, CONSERVATION SUSTAIN, P129; POOL DJ, 1977, BIOTROPICA, V9, P195, DOI 10.2307/2387881; Primicerio J, 2012, PRECIS AGRIC, V13, P517, DOI 10.1007/s11119-012-9257-6; Vo QT, 2013, REMOTE SENS-BASEL, V5, P183, DOI 10.3390/rs5010183; R Core Team, 2021, R LANGUAGE ENV STAT; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Ruwaimana M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200288; Samper-Villarreal J, 2012, REV BIOL TROP, V60, P109; Satyanarayana B, 2011, INT J REMOTE SENS, V32, P1635, DOI 10.1080/01431160903586781; Savage NH, 2013, GEOSCI MODEL DEV, V6, P353, DOI 10.5194/gmd-6-353-2013; Smith AMS, 2009, CAN J REMOTE SENS, V35, P447, DOI 10.5589/m09-038; Smith NF, 2009, MAR BIOL, V156, P2255, DOI 10.1007/s00227-009-1253-7; Sobrado MA, 1999, TREES-STRUCT FUNCT, V13, P125, DOI 10.1007/s004680050196; SOTO R, 1982, REV BIOL TROP, V30, P161; Tian JY, 2017, INT J APPL EARTH OBS, V61, P22, DOI 10.1016/j.jag.2017.05.002; Tomlinson PB, 2016, CAMBRIDGE TROPICAL B; Trout TJ, 2008, HORTSCIENCE, V43, P333, DOI 10.21273/HORTSCI.43.2.333; Turner D, 2012, REMOTE SENS-BASEL, V4, P1392, DOI 10.3390/rs4051392; Unger M, 2009, LECT NOTES COMPUT SC, V5876, P1119, DOI 10.1007/978-3-642-10520-3_107; Wallace L, 2016, FORESTS, V7, DOI 10.3390/f7030062; Wang L, 2004, REMOTE SENS ENVIRON, V91, P432, DOI 10.1016/j.rse.2004.04.005; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; Yu X, 2017, INT J REMOTE SENS, V38, P3101, DOI 10.1080/01431161.2016.1230291; Zahawi RA, 2015, BIOL CONSERV, V186, P287, DOI 10.1016/j.biocon.2015.03.031; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004	88	15	15	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217310	10.1371/journal.pone.0217310	http://dx.doi.org/10.1371/journal.pone.0217310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166979	gold, Green Published, Green Submitted			2022-12-26	WOS:000470087800024
J	Cumsille, P; Godoy, M; Gerdtzen, ZP; Conca, C				Cumsille, Patricio; Godoy, Matias; Gerdtzen, Ziomara P.; Conca, Carlos			Parameter estimation and mathematical modeling for the quantitative description of therapy failure due to drug resistance in gastrointestinal stromal tumor metastasis to the liver	PLOS ONE			English	Article							IDENTIFIABILITY	In this work we develop a general mathematical model and devise a practical identifiability approach for gastrointestinal stromal tumor (GIST) metastasis to the liver, with the aim of quantitatively describing therapy failure due to drug resistance. To this end, we have modeled metastatic growth and therapy failure produced by resistance to two standard treatments based on tyrosine kinase inhibitors (Imatinib and Sunitinib) that have been observed clinically in patients with GIST metastasis to the liver. The parameter identification problem is difficult to solve, since there are no general results on this issue for models based on ordinary differential equations (ODE) like the ones studied here. We propose a general modeling framework based on ODE for GIST metastatic growth and therapy failure due to drug resistance and analyzed five different model variants, using medical image observations (CT scans) from patients that exhibit drug resistance. The associated parameter estimation problem was solved using the Nelder-Mead simplex algorithm, by adding a regularization term to the objective function to address model instability, and assessing the agreement of either an absolute or proportional error in the objective function. We compared the goodness of fit to data for the proposed model variants, as well as evaluated both error forms in order to improve parameter estimation results. From the model variants analyzed, we identified the one that provides the best fit to all the available patient data sets, as well as the best assumption in computing the objective function (absolute or proportional error). This is the first work that reports mathematical models capable of capturing and quantitatively describing therapy failure due to drug resistance based on clinical images in a patient-specific manner.	[Cumsille, Patricio] Univ Bio Bio, Basic Sci Dept, Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Grp Invest Tumor Angiogenesis GIANT, Chillan, Chile; [Cumsille, Patricio; Godoy, Matias; Gerdtzen, Ziomara P.; Conca, Carlos] Ctr Biotechnol & Bioengn CeBiB, Santiago, Chile; [Gerdtzen, Ziomara P.] Univ Chile, Dept Chem Engn Biotechnol & Mat, Santiago, Chile; [Conca, Carlos] Univ Chile, CNRS, UMI 2807, Dept Math Engn DIM, Santiago, Chile; [Conca, Carlos] Univ Chile, CNRS, UMI 2807, CMM, Santiago, Chile	Universidad del Bio-Bio; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universidad de Chile	Cumsille, P (corresponding author), Univ Bio Bio, Basic Sci Dept, Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Grp Invest Tumor Angiogenesis GIANT, Chillan, Chile.; Cumsille, P (corresponding author), Ctr Biotechnol & Bioengn CeBiB, Santiago, Chile.	pcumsille@ubiobio.cl	Conca, Carlos/E-8985-2010; Cumsille, Patricio/AAE-7493-2020	Conca, Carlos/0000-0003-3891-0846; GODOY, Matias/0000-0003-1100-0340	Centre for Biotechnology and Bioengineering (CeBiB) [PIA-CONICYT FB-01]; Group of Investigation in Tumor Angiogenesis (GIANT) [DIUBB-GI 171709/VC, DIUBB 193409 3/R]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico [ID18I10308]	Centre for Biotechnology and Bioengineering (CeBiB); Group of Investigation in Tumor Angiogenesis (GIANT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico	Funding was provided by Centre for Biotechnology and Bioengineering (CeBiB), grant no. PIA-CONICYT FB-01, to PC, MG, ZG, and CC; Group of Investigation in Tumor Angiogenesis (GIANT), grant no. DIUBB-GI 171709/VC, and regular research project DIUBB 193409 3/R, to PC; and Fondo de Fomento al Desarrollo Cientifico y Tecnologico, grant no. ID18I10308 to ZG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks HI., 2009, MATH STAT ESTIMATION, P249, DOI [10.1007/978-90-481-2313-1_11, DOI 10.1007/978-90-481-2313-1_11]; Blay JY, 2011, CANCER TREAT REV, V37, P373, DOI 10.1016/j.ctrv.2010.11.003; Cumsille P, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0009-y; Engl HW, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123014; Greene H., 2003, ECONOMETRIC ANAL; Hartung N, 2014, J MATH BIOL, V68, P41, DOI 10.1007/s00285-013-0724-0; Lefebvre G, 2017, MATH MED BIOL, V34, P151, DOI 10.1093/imammb/dqw002; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Muller S, 2008, PARAMETER IDENTIFICA; Olufsen MS, 2013, J MATH BIOL, V67, P39, DOI 10.1007/s00285-012-0535-8; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Tanveer Adil M, 2016, EUR MED J ONCOL, V4, P113; Wu HL, 2008, B MATH BIOL, V70, P785, DOI 10.1007/s11538-007-9279-9	14	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217332	10.1371/journal.pone.0217332	http://dx.doi.org/10.1371/journal.pone.0217332			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145737	Green Published, gold, Green Submitted			2022-12-26	WOS:000469425500016
J	Zhu, L; Liao, SE; Ai, YW; Fukunaga, R				Zhu, Li; Liao, Susan E.; Ai, Yiwei; Fukunaga, Ryuya			RNA methyltransferase BCDIN3D is crucial for female fertility and miRNA and mRNA profiles in Drosophila ovaries	PLOS ONE			English	Article							PRE-MIRNA; GENE; DICER-2; BINDING; EXPRESSION; EFFICIENT; DOMAIN; LENGTH; PIRNA; SIRNA	RNA methyltransferases post-transcriptionally add methyl groups to RNAs, which can regulate their fates and functions. Human BCDIN3D (Bicoid interacting 3 domain containing RNA methyltransferase) has been reported to specifically methylate the 5'-monophosphates of pre-miR-145 and cytoplasmic tRNA(His). Methylation of the 5'-monophosphate of pre-miR-145 blocks its cleavage by the miRNA generating enzyme Dicer, preventing generation of miR-145. Elevated expression of BCDIN3D has been associated with poor prognosis in breast cancer. However, the biological functions of BCDIN3D and its orthologs remain unknown. Here we studied the biological and molecular functions of CG1239, a Drosophila ortholog of BCDIN3D. We found that ovary-specific knockdown of Drosophila BCDIN3D causes female sterility. High-throughput sequencing revealed that miRNA and mRNA profiles are dysregulated in BCDIN3D knockdown ovaries. Pathway analysis showed that many of the dysregulated genes are involved in metabolic processes, ribonucleoprotein complex regulation, and translational control. Our results reveal BCDIN3D's biological role in female fertility and its molecular role in defining miRNA and mRNA profiles in ovaries.	[Zhu, Li; Liao, Susan E.; Ai, Yiwei; Fukunaga, Ryuya] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Fukunaga, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	fukunaga@jhmi.edu	Zhu, Li/S-7517-2018; Ai, Yiwei/AAU-7620-2021; Fukunaga, Ryuya/AAK-8609-2020	Zhu, Li/0000-0002-4919-1894; Fukunaga, Ryuya/0000-0002-5814-8206	National Institutes of Health [R01GM116841]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grant from the National Institutes of Health [R01GM116841] to RF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Fukunaga R, 2018, BIOCHEM BIOPH RES CO, V498, P1022, DOI 10.1016/j.bbrc.2018.03.108; Fukunaga R, 2014, EMBO J, V33, P371, DOI 10.1002/embj.201387176; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264; Han BW, 2015, BIOINFORMATICS, V31, P593, DOI 10.1093/bioinformatics/btu647; Harcourt EM, 2017, NATURE, V541, P339, DOI 10.1038/nature21351; Helm M, 2017, NAT REV GENET, V18, P275, DOI 10.1038/nrg.2016.169; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jonkhout N, 2017, RNA, V23, P1754, DOI 10.1261/rna.063503.117; Kandasamy SK, 2017, RNA, V23, P1139, DOI 10.1261/rna.059915.116; Kandasamy SK, 2016, P NATL ACAD SCI USA, V113, P14031, DOI 10.1073/pnas.1612393113; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Liao SE, 2019, RNA, V25, P825, DOI 10.1261/rna.070268.118; Liao SE, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00706; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151930; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez A, 2017, NUCLEIC ACIDS RES, V45, P5423, DOI 10.1093/nar/gkx051; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Sergiev PV, 2018, NAT CHEM BIOL, V14, P226, DOI [10.1038/nchembio.2569, 10.1038/NCHEMBIO.2569]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vakrou S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94493; Xhemalce B, 2012, CELL, V151, P278, DOI 10.1016/j.cell.2012.08.041; Yao L, 2016, ONCOTARGET, V7, P53895, DOI 10.18632/oncotarget.9656; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhu L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06404-w; Zhu L, 2018, NUCLEIC ACIDS RES, V46, P3726, DOI 10.1093/nar/gky043	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217603	10.1371/journal.pone.0217603	http://dx.doi.org/10.1371/journal.pone.0217603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145769	Green Published, gold, Green Submitted			2022-12-26	WOS:000469425500026
J	Harris, CM; Albaeni, A; Thorpe, RJ; Norris, KC; Abougergi, MS				Harris, Che Matthew; Albaeni, Aiham; Thorpe, Roland J.; Norris, Keith C.; Abougergi, Marwan S.			Racial factors and inpatient outcomes among patients with diabetes hospitalized with foot ulcers and foot infections, 2003-2014	PLOS ONE			English	Article							AMPUTATION RATES; DISPARITIES; MORTALITY; DISEASE; RACE; INSURANCE; IMPACT; RISK	Background In patients with diabetes, foot amputations among Black patients have been historically higher compared with White patients. Using the National Inpatient Sample database, we sought to determine if disparities in foot amputations and resource utilization have improved over time. We hypothesized there would be improvements and reduced differences in foot amputations between the two races as quality of care and access to healthcare has improved. Methods and findings Patients over 18 years old with a principal diagnosis of diabetic foot complications and secondary diagnosis of Diabetes Mellitus were selected. We compared the primary outcome of foot amputations between Black and White patients. Adjusted rates, odds ratios (aOR) and trends of foot amputations among Black and White patients were studied. Healthcare utilization was measured via length of hospital stay (LOS). Of 262,924 patients, 18% were Black. Following adjustment for confounders, major foot amputations decreased among Whites (1.5% in 2003 to 1.1% in 2014) and Blacks (2.1% in 2003 to 0.9% in 2014). On pooled analysis, Black patients had higher adjusted odds of major foot amputations in 2003-2004 [aOR 1.7; (1.16-2.57), p< 0.01]. Disparities in major foot amputations disappeared in 2013-2014 [aOR: 0.92 (0.58-1.44), p = 0.70]. Black patients had declining but persistently longer LOS (adjusted mean difference (aMD): 1.1 days (0.52-1.6) p< 0.01 in 2003-2004 and 0.46 days (0.18-0.73) p< 0.01 in 2013-2014). The main limitation of the study was that the NIS uses ICD-9 and ICD-10 CM codes, and hence prone to incorrect or missing codes. Conclusions Major foot amputations declined among Black and White patients hospitalized with Diabetic foot complications between 2003 and 2014. The observed difference for amputations in 2003-2004 was absent by 2013-2014. Future research to determine specific contributors for this reduction in health disparities is needed for ongoing improvements and sustainability.	[Harris, Che Matthew] Johns Hopkins Sch Med, Johns Hopkins Bayview Med Ctr, Dept Gen Internal Med, Div Hosp Med, Baltimore, MD 21205 USA; [Albaeni, Aiham] Univ Cent Florida, Dept Med, Ocala, FL USA; [Thorpe, Roland J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Norris, Keith C.] Univ Calif Los Angeles, Dept Internal Med, David Geffen Sch Med, Los Angeles, CA USA; [Abougergi, Marwan S.] Univ South Carolina, Sch Med, Dept Internal Med, Div Gastroenterol, Columbia, SC 29208 USA; [Abougergi, Marwan S.] Catalyst Med Consulting, Simpsonville, SC USA	Johns Hopkins University; Johns Hopkins Medicine; State University System of Florida; University of Central Florida; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of South Carolina System; University of South Carolina Columbia	Harris, CM (corresponding author), Johns Hopkins Sch Med, Johns Hopkins Bayview Med Ctr, Dept Gen Internal Med, Div Hosp Med, Baltimore, MD 21205 USA.	charri21@jhmi.edu		Norris, Keith/0000-0003-3071-0700	National Heart, Lung, and Blood Institute to the University of Mississippi Medical Center;  [1R25HL126145-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL126145] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute to the University of Mississippi Medical Center; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant from the National Heart, Lung, and Blood Institute to the University of Mississippi Medical Center. KN received Grant #1R25HL126145-01. No-The funders did not play a role in formulating the study or manuscript. NHLBI URL: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts.Catalyst Medical Consulting company did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and only provided financial support in the form of Marwan Abougergi's salary and/or research materials. Catalyst Medical Consulting company provided support in the form of salary for Marwan Abougergi but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007425; Ashry H R, 1998, J Foot Ankle Surg, V37, P186; Boyko EJ, 1996, DIABETIC MED, V13, P967, DOI 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K; Brown DA, 2018, NEURO-ONCOLOGY, V20, P1374, DOI 10.1093/neuonc/noy102; Burton BN, 2018, J CARDIOTHOR VASC AN; Centers for Disease Control and Prevention, CDC REP FINDS LARG D; Chammas NK, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2879809; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dietrich I, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0680-z; Geiss LS, 2018, DIABETES CARE; Goldberg JB, 2012, J VASC SURG, V56, P1663, DOI 10.1016/j.jvs.2012.05.100; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hashimoto Robin E, 2014, Evid Based Spine Care J, V5, P74, DOI 10.1055/s-0034-1390027; Hicks CW, 2016, ANN VASC SURG, V33, P149, DOI 10.1016/j.avsg.2015.11.025; Hoffmann M, 2015, DIABETES VASC DIS RE, V12, P265, DOI 10.1177/1479164115579005; Hughes K, 2014, VASC ENDOVASC SURG, V48, P402, DOI 10.1177/1538574414543276; Hunt NA, 2011, PLAST RECONSTR SURG, V127, p289S, DOI 10.1097/PRS.0b013e3181fbe2a6; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kominski GF, 2017, ANNU REV PUBL HEALTH, V38, P489, DOI 10.1146/annurev-publhealth-031816-044555; Loehrer AP, 2016, ANN SURG, V263, P705, DOI 10.1097/SLA.0000000000001310; Mehtsun WT, 2017, HEALTH AFFAIR, V36, P1057, DOI 10.1377/hlthaff.2017.0061; Muhlestein WE, 2017, WORLD NEUROSURG, V104, P24, DOI 10.1016/j.wneu.2017.04.061; Newhall K, 2016, ANN VASC SURG, V30, P292, DOI 10.1016/j.avsg.2015.07.040; Noor S, 2017, DIABETES METAB SYND, V11, P149, DOI 10.1016/j.dsx.2016.06.023; Rice JB, 2013, DIABETES CARE; Rinkel WD, 2017, DIABETES RES CLIN PR, V132, P68, DOI 10.1016/j.diabres.2017.07.029; Robbins JM, 2008, J AM PODIAT MED ASSN, V98, P489, DOI 10.7547/0980489; Romano PS, SELECTING QUALITY RE; Skrepnek GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134914; Smedley BD, 2009, UNEQUAL TREATMENT CO; Suckow BD, 2016, ANN VASC SURG, V36, P208, DOI 10.1016/j.avsg.2016.03.035; Wukich DK, 2016, PLAST RECONSTR SURG, V138, p188S, DOI 10.1097/PRS.0000000000002713	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216832	10.1371/journal.pone.0216832	http://dx.doi.org/10.1371/journal.pone.0216832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141534	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000025
J	Holtkamp, C; Koos, B; Unterberg, M; Rahmel, T; Bergmann, L; Bazzi, Z; Bazzi, M; Bukhari, H; Adamzik, M; Rump, K				Holtkamp, Caroline; Koos, Bjoern; Unterberg, Matthias; Rahmel, Tim; Bergmann, Lars; Bazzi, Zainab; Bazzi, Maha; Bukhari, Hassan; Adamzik, Michael; Rump, Katharina			A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes	PLOS ONE			English	Article							DELIRIUM; ANESTHESIA; TERM; ACETYLCHOLINESTERASE; NEUROINFLAMMATION; PATHOPHYSIOLOGY; DYSFUNCTION; EXPRESSION; PATHWAYS; SYSTEM	Background Propofol is a widely used anaesthetic drug with advantageous operating conditions and recovery profile. However, propofol could have long term effects on neuronal cells and is associated with post-operative delirium (POD). In this context, one of the contributing factors to the pathogenesis of POD is a reduction of cholinesterase activity. Accordingly, we investigated the effects of propofol on the methylation, expression and activity of cholinergic genes and proteins in an in-vitro model. Results We found that propofol indeed reduced the activity of AChE/BChE in our in-vitro model, without affecting the protein levels. Furthermore, we could show that propofol reduced the methylation of a repressor region of the CHRNA7 gene without changing the secretion of pro-or anti-inflammatory cytokines. Lastly, propofol changed the expression patterns of genes responsible for maintaining the epigenetic status of the cell and accordingly reduced the tri-methylation of H3 K27. Conclusion In conclusion we found a possible functional link between propofol treatment and POD, due to a reduced cholinergic activity. In addition to this, propofol changed the expression of different maintenance genes of the epigenome that also affected histone methylation. Thus, propofol treatment may also induce strong, long lasting changes in the brain by potentially altering the epigenetic landscape.	[Holtkamp, Caroline; Koos, Bjoern; Unterberg, Matthias; Rahmel, Tim; Bergmann, Lars; Bazzi, Zainab; Bazzi, Maha; Adamzik, Michael; Rump, Katharina] Ruhr Univ Bochum, Univ Klinikum Knappschaftskrankenhaus Bochum Lang, Klin Anasthesiol Intens Med & Schmerztherapie, Bochum, Germany; [Bukhari, Hassan] Ruhr Univ Bochum, Med Proteomctr MPC, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Rump, K (corresponding author), Ruhr Univ Bochum, Univ Klinikum Knappschaftskrankenhaus Bochum Lang, Klin Anasthesiol Intens Med & Schmerztherapie, Bochum, Germany.	katharina.k.rump@rub.de	Bukhari, Hassan/GZK-6477-2022; Rump, Katharina/AAJ-9090-2020; Rahmel, Tim/AAI-1566-2020; Adamzik, Michael/HGE-9286-2022	Bukhari, Hassan/0000-0003-3328-8234; Rump, Katharina/0000-0003-2220-519X; Rahmel, Tim/0000-0002-7039-6288; Unterberg, Matthias/0000-0002-1500-1984	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; Sophia and Frizu Heinemann-Stiftung of the RUHR-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; Sophia and Frizu Heinemann-Stiftung of the RUHR-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum and the Sophia and Frizu Heinemann-Stiftung of the RUHR-Universitat Bochum. (www.rub.de) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Cascella M, 2018, MINERVA ANESTESIOL, V84, P246, DOI 10.23736/S0375-9393.17.12146-2; Cerejeira J, 2012, J AM GERIATR SOC, V60, P669, DOI 10.1111/j.1532-5415.2011.03883.x; Cerejeira J, 2011, AGE AGEING, V40, P621, DOI 10.1093/ageing/afr053; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Ferreira GK, 2012, NEUROCHEM INT, V61, P1370, DOI 10.1016/j.neuint.2012.09.017; FULTON B, 1995, DRUGS, V50, P636, DOI 10.2165/00003495-199550040-00006; Inoue N, 2018, EMBO REP, V19, DOI 10.15252/embr.201744860; Inouye SK, 2016, ALZHEIMERS DEMENT, V12, P766, DOI 10.1016/j.jalz.2016.03.005; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Ji MH, 2014, MOL NEUROBIOL, V50, P937, DOI 10.1007/s12035-014-8659-z; Koskderelioglu A, 2017, GERIATR GERONTOL INT, V17, P919, DOI 10.1111/ggi.12806; Lauzon MA, 2018, MOL CELL NEUROSCI, V88, P83, DOI 10.1016/j.mcn.2018.01.003; Maldonado JR, 2017, CRIT CARE CLIN, V33, P461, DOI 10.1016/j.ccc.2017.03.013; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Mei B, 2018, CLIN J PAIN, V34, P811, DOI 10.1097/AJP.0000000000000605; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Milanovic D, 2017, NEUROTOX RES, V32, P247, DOI 10.1007/s12640-017-9730-0; Mori K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087319; Nakaizumi K, 2018, J ALZHEIMERS DIS, V61, P1355, DOI [10.3233/JAD.170591, 10.3233/JAD-170591]; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; Reddy Siddareddygari Velayudha, 2017, J Anaesthesiol Clin Pharmacol, V33, P291, DOI 10.4103/joacp.JOACP_180_16; Rump K, 2013, SHOCK, V40, P430, DOI 10.1097/SHK.0000000000000035; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Sall JW, 2013, ANESTH ANALG, V117, P65, DOI 10.1213/ANE.0b013e318292f32e; Shaltiel G, 2013, BRAIN STRUCT FUNCT, V218, P59, DOI 10.1007/s00429-011-0376-z; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P622, DOI 10.1097/00000542-200703000-00026; Umholtz M, 2017, IMMUNOL INVEST, V46, P805, DOI 10.1080/08820139.2017.1373898; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WHITTAKER M, 1980, ANAESTHESIA, V35, P174, DOI 10.1111/j.1365-2044.1980.tb03800.x; Xu R, 2018, GENE, V657, P9, DOI 10.1016/j.gene.2018.03.010; Yadav R, 2017, NEUROSCIENCE, V349, P106, DOI 10.1016/j.neuroscience.2017.02.041; Zujalovic Benedikt, 2015, Case Rep Crit Care, V2015, P793015, DOI 10.1155/2015/793015	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217269	10.1371/journal.pone.0217269	http://dx.doi.org/10.1371/journal.pone.0217269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141559	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000047
J	Ray, K; Banerjee, H; Dutta, S; Hazra, AK; Majumdar, K				Ray, Krishnendu; Banerjee, Hirak; Dutta, Sudarshan; Hazra, Alok Kumar; Majumdar, Kaushik			Macronutrients influence yield and oil quality of hybrid maize (Zea mays L.)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; NUTRITIONAL QUALITY; NITROGEN; POTASSIUM; PHOSPHORUS; PROTEIN; SEED; FERTILIZATION; PROFILE; GROWTH	In the present two-year study, an attempt was made to estimate the grain yield, grain nutrient uptake, and oil quality of three commonly grown maize (Zea mays L.) hybrids fertilized with varied levels of nitrogen (N), phosphorus (P) and potassium (K). Results obtained from both the experimental years indicated that application of 125% of recommended dose of fertilizer (RDF) recorded maximum grain yield (10.37 t ha -1; 124% higher than control). When compared with 100% RDF, grain yield reduction with nutrient omission was 44% for N omission, 17% for P omission, and 27% for K omission. Nitrogen uptake was increased with increasing NPK levels up to 150% RDF that was statistically at par (p. 0.01) with 125% RDF. Increasing trend in P and K uptake was observed with successive increase in NPK levels up to 125% RDF, above which it declined. The protein content was significantly higher in grains of var. P 3396 with 125% RDF. Nutrient management has significant (p. 0.01) role in the grain oil content. Saturated fatty acids (palmitic, stearic and arachidic acid) content decreased, and unsaturated fatty acid (oleic, linoleic and linolenic acid) increased with increasing NPK levels. The average oleic acid desaturation and linoleic acid desaturation ratios were increased with increasing NPK levels up to 100 and 125% RDF, respectively. However, average monounsaturated fatty acids (MUFA): poly-unsaturated fatty acids (PUFA), saturated: unsaturated as well as linoleic: linolenic acid ratios were increased on receiving 75% RDF, and beyond that it showed decreasing trend. The omission of K had the highest inhibitory effect on corn oil quality followed by N and P omission.	[Ray, Krishnendu] Sasya Shyamala Krishi Vigyan Kendra, Ramakrishna Mission Vivekananda Educ & Res Inst, Kolkata, W Bengal, India; [Banerjee, Hirak] Bidhan Chandra Krishi Viswavidyalaya, Reg Res Stn CSZ, Kakdwip, W Bengal, India; [Dutta, Sudarshan] Int Plant Nutr Inst, South Asia Program, Kolkata, W Bengal, India; [Dutta, Sudarshan; Majumdar, Kaushik] African Plant Nutr Inst, Benguerir, Morocco; [Hazra, Alok Kumar] Ramakrishna Mission Ashrama, IRDM Fac Ctr, Kolkata, W Bengal, India; [Majumdar, Kaushik] Int Plant Nutr Inst, Asia Africa & Middle East Program, Gurgaon, Haryana, India	Bidhan Chandra Agricultural University; Mohammed VI Polytechnic University	Dutta, S (corresponding author), Int Plant Nutr Inst, South Asia Program, Kolkata, W Bengal, India.; Dutta, S (corresponding author), African Plant Nutr Inst, Benguerir, Morocco.	sudarshandutta@gmail.com	; Ray, Krishnendu/H-8605-2018	MAJUMDAR, KAUSHIK/0000-0001-6931-8170; Ray, Krishnendu/0000-0001-6825-8129				Ahmad A, 2000, J AGRON CROP SCI, V185, P49, DOI 10.1046/j.1439-037X.2000.00401.x; Ahmad Alias, 2003, International Journal of Agriculture and Biology, V5, P632; Ahmad R., 1999, INT J AGRIC BIOL, V1, P325; Ali A, 2012, CHIL J AGR RES, V72, P564, DOI 10.4067/S0718-58392012000400016; Ali J., 2002, ASIAN J PLANT SCI, V1, P367; Alipatra A., 2017, THESIS; AOAC, 1960, OFF TENT METH AN; AOAC, 2016, OFFICIAL METHODS ANA, VII, P20; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Ashraf M, 2006, J SCI FOOD AGR, V86, P871, DOI 10.1002/jsfa.2426; Aytac Z, 2017, J CHEM, P1; Bilgin O, 2010, CEREAL RES COMMUN, V38, P233, DOI 10.1556/CRC.38.2010.2.9; Blumenthal J., 2008, IMPORTANCE EFFECT NI; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Brady N.C., 1996, NATURE PROPERTIES SO; Chaudhary DP, 2012, INDIAN J AGR SCI, V82, P681; Chen YL, 2014, FIELD CROP RES, V159, P1, DOI 10.1016/j.fcr.2014.01.002; Ciampitti IA, 2013, AGRON J, V105, P783, DOI 10.2134/agronj2012.0467; Dag A, 2009, J SCI FOOD AGR, V89, P1871, DOI 10.1002/jsfa.3664; Dibaba D. H., 2013, Karnataka Journal of Agricultural Sciences, V26, P194; DUPONT J, 1990, J AM COLL NUTR, V9, P438, DOI 10.1080/07315724.1990.10720403; Echarte L, 2008, CROP SCI, V48, P656, DOI 10.2135/cropsci2007.06.0366; Fageria VD, 2001, J PLANT NUTR, V24, P1269, DOI 10.1081/PLN-100106981; FAOSTAT, 2017, STAT DAT DAT SETS FO; Genet T, 2004, J SCI FOOD AGR, V84, P1663, DOI 10.1002/jsfa.1856; Goffman FD, 2001, J AGR FOOD CHEM, V49, P4990, DOI 10.1021/jf010156y; Hanway J.J., 1952, IOWA AGR, V57, P1, DOI DOI 10.12691/AJWR-7-1-5; Haq MU, 2005, AGRON J, V97, P910, DOI 10.2134/agronj2004.0215; Iqbal S., 2013, Cercetari Agronomice in Moldova, V46, P39; Israel DW, 2007, CROP SCI, V47, P2036, DOI 10.2135/cropsci2006.11.0691; Jackson M.L, 1973, CONSTABLE CO, P38, DOI [DOI 10.1002/JPLN.19590850311, 10.1002/jpln.19590850311]; Jackson ML., 1963, SOIL CHEM ANAL; JELLUM MD, 1970, J AGR FOOD CHEM, V18, P365, DOI 10.1021/jf60169a032; Kaplan M, 2017, GRASAS ACEITES, V68, DOI 10.3989/gya.0222171; Khan M. B., 2003, International Journal of Agriculture and Biology, V5, P17; Kostik V., 2013, Journal of Hygienic Engineering and Design, V4, P112; Krueger K, 2013, CROP SCI, V53, P602, DOI 10.2135/cropsci2012.06.0372; Lambert RJ, 2000, SPECIALTY CORN, P154; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Mehta S, 2011, INDIAN J AGR SCI, V81, P50; Mengel K., 2006, PRINCIPLES PLANT NUT, V5th; Moreau RA, 2005, J AM OIL CHEM SOC, V82, P851, DOI 10.1007/s11746-005-1154-6; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Oikeh SO, 1998, CROP SCI, V38, P1056, DOI 10.2135/cropsci1998.0011183X003800040029x; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Patra BC, 2000, INDIAN J AGR SCI, V70, P203; Pepo P, 2017, CEREAL RES COMMUN, V45, P699, DOI 10.1556/0806.45.2017.046; Pettigrew WT, 1999, AGRON J, V91, P962, DOI 10.2134/agronj1999.916962x; Prodhan HS, 2001, INDIAN J AGR SCI, V71, P55; Ray K, 2017, EXPT AGR, V52, P434; Rehman A, 2011, CHIL J AGR RES, V71, P586, DOI 10.4067/S0718-58392011000400014; Sadasivam S., 1996, BIOCH METHODS, P34; SALAMA AM, 1987, NOVENYTERMELES, V36, P191; Sanjeev P, 2014, J AM OIL CHEM SOC, V91, P1001, DOI 10.1007/s11746-014-2429-y; Sawan ZM, 2007, GRASAS ACEITES, V58, P243; Sawan Z. M., 2006, World Journal of Agricultural Sciences, V2, P56; Seebauer JR, 2004, PLANT PHYSIOL, V136, P4326, DOI 10.1104/pp.104.043778; Seo G. S., 1986, Korean Journal of Crop Science, V31, P24; Sharma N.K., 2012, ISRN AGRON, V2012, DOI [10.5402/2012/359673, DOI 10.5402/2012/359673]; STROMBERGER JA, 1994, J PLANT NUTR, V17, P19, DOI 10.1080/01904169409364707; SUBBIAH B. V., 1956, CURRENT SCI, V25, P259; THOMPSON DL, 1973, J AM OIL CHEM SOC, V50, P540, DOI 10.1007/BF02640529; TSAI CY, 1983, J SCI FOOD AGR, V34, P255, DOI 10.1002/jsfa.2740340309; Velasco L, 1998, GENET RESOUR CROP EV, V45, P371, DOI 10.1023/A:1008628624867; WELCH LF, 1969, AGRON J, V61, P890, DOI 10.2134/agronj1969.00021962006100060017x; Yin XinHua, 2016, American Journal of Plant Sciences, V7, P1975; Zheljazkov VD, 2012, IND CROP PROD, V36, P28, DOI 10.1016/j.indcrop.2011.08.002	67	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216939	10.1371/journal.pone.0216939	http://dx.doi.org/10.1371/journal.pone.0216939			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141543	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000030
J	Stowie, A; Ellis, I; Adams, K; Castanon-Cervantes, O; Davidson, AJ				Stowie, Adam; Ellis, Ivory; Adams, Kandis; Castanon-Cervantes, Oscar; Davidson, Alec J.			A reductionist, in vitro model of environmental circadian disruption demonstrates SCN-independent and tissue-specific dysregulation of inflammatory responses	PLOS ONE			English	Article							REV-ERB-ALPHA; SHIFT-WORK; SUPRACHIASMATIC NUCLEUS; JET-LAG; CLOCK; MISALIGNMENT; RHYTHMS; MACROPHAGES; BEHAVIOR; PROTEIN	Environmental circadian disruption (ECD), characterized by repeated or long-term disruption in environmental timing cues which require the internal circadian clock to change its phase to resynchronize with the environment, is associated with numerous serious health issues in humans. While animal and isolated cell models exist to study the effects of destabilizing the relationship between the circadian system and the environment, neither approach provides an ideal solution. Here, we developed an in vitro model which incorporates both elements of a reductionist cellular model and disruption of the clock/environment relationship using temperature as an environmental cue, as occurs in vivo. Using this approach, we have demonstrated that some effects of in vivo ECD can be reproduced using only isolated peripheral oscillators. Specifically, we report exaggerated inflammatory responses to endotoxin following repeated environmental circadian disruption in explanted spleens. This effect requires a functional circadian clock but not the master brain clock, the suprachiasmatic nucleus (SCN). Further, we report that this is a result of cumulative, rather than acute, circadian disruption as has been previously observed in vivo. Finally, such effects appear to be tissue specific as it does not occur in lung, which is less sensitive to the temperature cycles employed to induce ECD. Taken together, the present study suggests that this model could be a valuable tool for dissecting the causes and effects of circadian disruption both in isolated components of physiological systems as well as the aggregated interactions of these systems that occur in vivo.	[Stowie, Adam; Ellis, Ivory; Adams, Kandis; Castanon-Cervantes, Oscar; Davidson, Alec J.] Morehouse Sch Med, Neurosci Inst, Dept Neurobiol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Davidson, AJ (corresponding author), Morehouse Sch Med, Neurosci Inst, Dept Neurobiol, Atlanta, GA 30310 USA.	adavidson@msm.edu		Stowie, Adam/0000-0002-7007-9135	National Institute of General Medical Sciences of the National Institute of Health [SC1GM112567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM125493, SC1GM112567] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R25MD007589] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institute of General Medical Sciences of the National Institute of Health (https://www.nigms.nih.gov/) grant number SC1GM112567 to Alec J Davidson. The funding agency played no role in study design, data collection or analysis, decision to publish, or preparation of this manuscript.	Adams KL, 2013, J BIOL RHYTHM, V28, P272, DOI 10.1177/0748730413494561; Beker MC, 2018, MOL NEUROBIOL, V55, P2565, DOI 10.1007/s12035-017-0524-4; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Brager AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063752; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gossan N, 2013, ARTHRITIS RHEUM-US, V65, P2334, DOI 10.1002/art.38035; Guerrero-Vargas NN, 2015, J BIOL RHYTHM, V30, P318, DOI 10.1177/0748730415586482; Guerrero-Vargas NN, 2014, J NEUROIMMUNOL, V273, P22, DOI 10.1016/j.jneuroim.2014.05.012; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kervezee L, 2018, P NATL ACAD SCI USA, V115, P5540, DOI 10.1073/pnas.1720719115; Knutsson A, 1999, OCCUP ENVIRON MED, V56, P46, DOI 10.1136/oem.56.1.46; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Magrini A, 2006, Int J Immunopathol Pharmacol, V19, P31; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morales-Nebreda L, 2015, EUR RESPIR REV, V24, P505, DOI 10.1183/16000617.0031-2015; Morikawa Y, 2005, SCAND J WORK ENV HEA, V31, P179, DOI 10.5271/sjweh.867; Morris CJ, 2017, J BIOL RHYTHM, V32, P154, DOI 10.1177/0748730417697537; Morris CJ, 2016, P NATL ACAD SCI USA, V113, pE1402, DOI 10.1073/pnas.1516953113; Morris CJ, 2016, J CLIN ENDOCR METAB, V101, P1066, DOI 10.1210/jc.2015-3924; Nakazato R, 2017, GLIA, V65, P198, DOI 10.1002/glia.23087; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; RUSAK B, 1977, J COMP PHYSIOL, V118, P145, DOI 10.1007/BF00611819; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sato S, 2014, J IMMUNOL, V192, P407, DOI 10.4049/jimmunol.1301982; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Sender Vicky, 2014, Commun Integr Biol, V7, pe29053, DOI 10.4161/cib.29053; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004; Wright KP, 2013, SLEEP MED REV, V17, P41, DOI 10.1016/j.smrv.2012.02.002; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	45	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217368	10.1371/journal.pone.0217368	http://dx.doi.org/10.1371/journal.pone.0217368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136603	Green Published, gold, Green Submitted			2022-12-26	WOS:000469224300031
J	Du, H; Wang, PC; Li, L; Wang, YS				Du, Hua; Wang, Pengcheng; Li, Lin; Wang, Yinsheng			Repair and translesion synthesis of O-6-alkylguanine DNA lesions in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA replication; mutagenesis; mutagenesis mechanism; carcinogenesis; DNA adduct; MS; O-6-alkylguanine lesion; translesion synthesis	ERROR-FREE BYPASS; Y-FAMILY; ALKYLTRANSFERASE ACTIVITY; POLYMERASE-KAPPA; MAMMALIAN-CELLS; N-NITROSOUREA; POL-KAPPA; RAT-LIVER; B-FAMILY; REPLICATION	O-6-alkyl-2 '-deoxyguanosine (O-6-alkyl-dG) lesions are among the most mutagenic and prevalent alkylated DNA lesions that are associated with cancer initiation and progression. In this study, using a shuttle vector-based strand-specific PCR-competitive replication and adduct bypass assay in conjunction with tandem MS for product identification, we systematically assessed the repair and replicative bypass of a series of O-6-alkyl-dG lesions, with the alkyl group being a Me, Et, nPr, iPr, nBu, iBu, or sBu, in several human cell lines. We found that the extent of replication-blocking effects of these lesions is influenced by the size of the alkyl groups situated on the O-6 position of the guanine base. We also noted involvement of distinct DNA repair pathways and translesion synthesis polymerases (Pols) in ameliorating the replication blockage effects elicited by the straight- and branched-chain O-6-alkyl-dG lesions. We observed that O-6-methylguanine DNA methyltransferase is effective in removing the smaller alkyl groups from the O-6 position of guanine, whereas repair of the branched-chain lesions relied on nucleotide excision repair. Moreover, these lesions were highly mutagenic during cellular replication and exclusively directed G -> A mutations; Pol eta and Pol zeta participated in error-prone bypass of the straight-chain lesions, whereas Pol kappa preferentially incorporated the correct dCMP opposite the branched-chain lesions. Together, these results uncover key cellular proteins involved in repair and translesion synthesis of O-6-alkyl-dG lesions and provide a better understanding of the roles of these types of lesions in the etiology of human cancer.	[Du, Hua; Wang, Pengcheng; Li, Lin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 ES025121. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIROLDI L, 1994, CARCINOGENESIS, V15, P2297, DOI 10.1093/carcin/15.10.2297; Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136; Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; BOYLE JM, 1987, J CELL SCI, P147; BRONSTEIN SM, 1992, CANCER RES, V52, P2008; BRONSTEIN SM, 1991, CANCER RES, V51, P5188; CHITTENDEN T, 1991, J VIROL, V65, P5944, DOI 10.1128/JVI.65.11.5944-5951.1991; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; CHUEH LL, 1992, CARCINOGENESIS, V13, P837; DOLAN ME, 1985, CANCER RES, V45, P6413; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Du H, 2018, J BIOL CHEM, V293, P11100, DOI 10.1074/jbc.RA118.003477; ELLISON KS, 1989, MUTAT RES, V220, P93, DOI 10.1016/0165-1110(89)90014-6; ELLISON KS, 1989, P NATL ACAD SCI USA, V86, P8620, DOI 10.1073/pnas.86.22.8620; Esteller M, 1999, CANCER RES, V59, P793; Friedberg E. C., 2006, DNA REPAIR MUTAGENES, P1; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Groth P, 2010, J MOL BIOL, V402, P70, DOI 10.1016/j.jmb.2010.07.010; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Hendel A, 2008, DNA REPAIR, V7, P1636, DOI 10.1016/j.dnarep.2008.06.008; Jalal S, 2011, CLIN CANCER RES, V17, P6973, DOI 10.1158/1078-0432.CCR-11-0761; Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; Johnson RE, 2003, GENE DEV, V17, P77, DOI 10.1101/gad.1048303; Johnson RE, 2006, MOL CELL BIOL, V26, P6435, DOI 10.1128/MCB.00851-06; KAINA B, 1991, CARCINOGENESIS, V12, P1857; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kirouac KN, 2011, P NATL ACAD SCI USA, V108, P3210, DOI 10.1073/pnas.1013909108; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Lupari E, 2012, DNA REPAIR, V11, P579, DOI 10.1016/j.dnarep.2012.03.004; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; MORIMOTO K, 1985, CARCINOGENESIS, V6, P1027, DOI 10.1093/carcin/6.7.1027; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; ORTLIEB H, 1980, CARCINOGENESIS, V1, P849, DOI 10.1093/carcin/1.10.849; Pauly GT, 2001, CHEM RES TOXICOL, V14, P894, DOI 10.1021/tx010032f; PEGG AE, 1992, FASEB J, V6, P2302, DOI 10.1096/fasebj.6.6.1544541; PEGG AE, 1990, MUTAT RES, V233, P165, DOI 10.1016/0027-5107(90)90160-6; PEGG AE, 1984, CANCER RES, V44, P3806; PEGG AE, 1990, CANCER RES, V50, P6119; PEGG AE, 1985, ENVIRON HEALTH PERSP, V62, P109, DOI 10.2307/3430101; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Peterson LA, 2001, CANCER RES, V61, P5757; PETERSON LA, 1991, CANCER RES, V51, P5557; Raz MH, 2016, CHEM RES TOXICOL, V29, P1493, DOI 10.1021/acs.chemrestox.6b00168; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Samson L, 1997, CARCINOGENESIS, V18, P919, DOI 10.1093/carcin/18.5.919; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SOULIOTIS VL, 1989, CANCER RES, V49, P6997; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Takenaka K, 2006, J BIOL CHEM, V281, P2000, DOI 10.1074/jbc.M506153200; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Wang PC, 2018, J BIOL CHEM, V293, P15033, DOI 10.1074/jbc.RA118.004676; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Williams HL, 2012, MOL CELL, V47, P140, DOI 10.1016/j.molcel.2012.05.001; Wu J, 2018, J BIOL CHEM, V293, P8638, DOI 10.1074/jbc.RA118.003133; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yoon JH, 2015, GENE DEV, V29, P2588, DOI 10.1101/gad.272229.115; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b	77	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11144	11153		10.1074/jbc.RA119.009054	http://dx.doi.org/10.1074/jbc.RA119.009054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167778	Green Published, hybrid			2022-12-26	WOS:000478717400008
J	Naldiga, S; Ji, SF; Thomforde, J; Nicolae, CM; Lee, M; Zhang, ZT; Moldovan, GL; Tretyakova, NY; Basu, AK				Naldiga, Spandana; Ji, Shaofei; Thomforde, Jenna; Nicolae, Claudia M.; Lee, Marietta; Zhang, Zhongtao; Moldovan, George-Lucian; Tretyakova, Natalia Y.; Basu, Ashis K.			Error-prone replication of a 5-formylcytosine-mediated DNA-peptide cross-link in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; DNA polymerase; mutagenesis; mutagenesis mechanism; 5-formylcytosine; DNA-peptide cross-link; translesion synthesis	REPAIR; ROLES; POLYMERASES; MECHANISM; THYMINE; MUTAGENICITY; MUTAGENESIS; INDUCTION; PROTEINS; REVEALS	DNA-protein cross-links can interfere with chromatin architecture, block DNA replication and transcription, and interfere with DNA repair. Here we synthesized a DNA 23-mer containing a site-specific DNA-peptide cross-link (DpC) by cross-linking an 11-mer peptide to the DNA epigenetic mark 5-formylcytosine in synthetic DNA and used it to generate a DpC-containing plasmid construct. Upon replication of the DpC-containing plasmid in HEK 293T cells, approximately 9% of progeny plasmids contained targeted mutations and 5% semitargeted mutations. Targeted mutations included C -> T transitions and C deletions, whereas semitargeted mutations included several base substitutions and deletions near the DpC lesion. To identify DNA polymerases involved in DpC bypass, we comparatively studied translesion synthesis (TLS) efficiency and mutagenesis of the DpC in a series of cell lines with TLS polymerase knockouts or knockdowns. Knockdown of either hPol iota or hPol zeta reduced the mutation frequency by nearly 50%. However, the most significant reduction in mutation frequency (50%-70%) was observed upon simultaneous knockout of hPol eta and hPol kappa with knockdown of hPol zeta, suggesting that these TLS polymerases play a critical role in error-prone DpC bypass. Because TLS efficiency of the DpC construct was not significantly affected in TLS polymerase-deficient cells, we examined a possible role of replicative DNA polymerases in their bypass and determined that hPol delta and hPol E can accurately bypass the DpC. We conclude that both replicative and TLS polymerases can bypass this DpC lesion in human cells but that mutations are induced mainly by TLS polymerases.	[Naldiga, Spandana; Basu, Ashis K.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Ji, Shaofei] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Thomforde, Jenna; Tretyakova, Natalia Y.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Thomforde, Jenna; Tretyakova, Natalia Y.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Nicolae, Claudia M.; Moldovan, George-Lucian] Penn State Univ, Coll Med, Hershey, PA 17033 USA; [Lee, Marietta; Zhang, Zhongtao] New York Med Coll, Valhalla, NY 10595 USA	University of Connecticut; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; New York Medical College	Basu, AK (corresponding author), Univ Connecticut, Dept Chem, Storrs, CT 06269 USA.	ashis.basu@uconn.edu	Ji, Shaofei/K-3555-2019	Ji, Shaofei/0000-0003-0013-0617; Naldiga, Spandana/0000-0003-1289-2897; zhang, zhongtao/0000-0002-1910-4753; George-Lucian, Moldovan/0000-0003-3825-149X	NIEHS, National Institutes of Health [R01 ES-023350, R01 ES-026184]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023350, R01ES026184] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIEHS, National Institutes of Health Grants R01 ES-023350 (to N. Y. T. and A. K. B.) and R01 ES-026184 (to G-L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachman M, 2015, NAT CHEM BIOL, V11, P555, DOI 10.1038/nchembio.1848; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Basu AK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040970; Chesner LN, 2018, DNA REPAIR, V62, P18, DOI 10.1016/j.dnarep.2018.01.004; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; COHEN MD, 1992, MUTAT RES, V269, P141, DOI 10.1016/0027-5107(92)90169-3; CRAFT TR, 1987, MUTAT RES, V176, P147, DOI 10.1016/0027-5107(87)90262-4; DIZDAROGLU M, 1989, BIOCHEMISTRY-US, V28, P3625, DOI 10.1021/bi00434a071; DIZDAROGLU M, 1989, CANCER RES, V49, P3463; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Izzotti A, 1999, MUTAT RES-GEN TOX EN, V446, P215, DOI 10.1016/S1383-5718(99)00189-8; Ji SF, 2018, NUCLEIC ACIDS RES, V46, P6455, DOI 10.1093/nar/gky444; Ji SF, 2017, ANGEW CHEM INT EDIT, V56, P14130, DOI 10.1002/anie.201708286; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Li FC, 2017, J AM CHEM SOC, V139, P10617, DOI 10.1021/jacs.7b05495; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Merk O, 1998, ENVIRON MOL MUTAGEN, V32, P260, DOI 10.1002/(SICI)1098-2280(1998)32:3<260::AID-EM9>3.0.CO;2-M; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Minko IG, 2008, MUTAT RES-FUND MOL M, V637, P161, DOI 10.1016/j.mrfmmm.2007.08.001; NACKERDIEN Z, 1991, BIOCHEMISTRY-US, V30, P4873, DOI 10.1021/bi00234a006; Pande P, 2017, CHEM RES TOXICOL, V30, P669, DOI 10.1021/acs.chemrestox.6b00397; Pande P, 2014, BIOCHEMISTRY-US, V53, P5323, DOI 10.1021/bi5007805; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Sanchez AM, 2003, CHEM RES TOXICOL, V16, P1019, DOI 10.1021/tx034066u; Singer B., 1981, MOLECULAR BIOLOGY OF; SMITH KC, 1966, BIOCHIM BIOPHYS ACTA, V114, P1, DOI 10.1016/0005-2787(66)90248-6; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Speit G, 2000, MUTAGENESIS, V15, P85, DOI 10.1093/mutage/15.1.85; Stingele J, 2017, NAT REV MOL CELL BIO, V18, P563, DOI 10.1038/nrm.2017.56; Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031; Tretyakova NY, 2015, ACCOUNTS CHEM RES, V48, P1631, DOI 10.1021/acs.accounts.5b00056; Tretyakova NY, 2013, BIOCHEMISTRY-US, V52, P3171, DOI 10.1021/bi400273m; Vaisman A, 2017, CRIT REV BIOCHEM MOL, V52, P274, DOI 10.1080/10409238.2017.1291576; Voitkun V, 1999, MUTAT RES-FUND MOL M, V424, P97, DOI 10.1016/S0027-5107(99)00011-1; Wickramaratne S, 2016, J BIOL CHEM, V291, P23589, DOI 10.1074/jbc.M116.745257; Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Wu FY, 2002, CANCER EPIDEM BIOMAR, V11, P287; Wu FY, 2002, MUTAT RES-FUND MOL M, V501, P69, DOI 10.1016/S0027-5107(02)00006-4; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; ZWELLING LA, 1979, MUTAT RES, V67, P271, DOI 10.1016/0165-1218(79)90021-1	48	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10619	10627		10.1074/jbc.RA119.008879	http://dx.doi.org/10.1074/jbc.RA119.008879			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138652	hybrid, Green Published			2022-12-26	WOS:000478717100020
J	Saralamba, N; Nosten, F; Sutherland, CJ; Arez, AP; Snounou, G; White, NJ; Day, NPJ; Dondorp, AM; Imwong, M				Saralamba, Naowarat; Nosten, Francois; Sutherland, Colin J.; Arez, Ana Paula; Snounou, Georges; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Imwong, Mallika			Genetic dissociation of three antigenic genes in Plasmodium ovale curtisi and Plasmodium ovale wallikeri	PLOS ONE			English	Article							DIVERSITY; MALARIAE; PVMSP1	Plasmodium ovale curtisi and Plasmodium ovale wallikeri are two sympatric human malaria species prevalent in Africa, Asia and Oceania. The reported prevalence of both P. ovale spp. was relatively low compared to other malaria species, but more sensitive molecular detection techniques have shown that asymptomatic low-density infections are more common than previously thought. Whole genome sequencing of both P. ovale spp. revealed genetic dissociation between P. ovale curtisi and P. ovale wallikeri suggesting a species barrier. In this study we further evaluate such a barrier by assessing polymorphisms in the genes of three vaccine candidate surface protein: circumsporozoite protein/ thrombospondin-related anonymous-related protein (ctrp), circumsporozoite surface protein (csp) and merozoite surface protein 1 (msp1). The complete coding sequence of ctrp and csp, and a partial fragment of msp1 were isolated from 25 P. ovale isolates and compared to previously reported reference sequences. A low level of nucleotide diversity (Pi = 0.02-0.10) was observed in all three genes. Various sizes of tandem repeats were observed in all ctrp, csp and msp1 genes. Both tandem repeat unit and nucleotide polymorphism in all three genes exhibited clear dimorphism between P. ovale curtisi and P. ovale wallikeri, supporting evidence of non-recombination between these two species.	[Saralamba, Naowarat; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Saralamba, Naowarat; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Imwong, Mallika] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Bangkok, Thailand; [Sutherland, Colin J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Immunol Unit, London, England; [Arez, Ana Paula] Univ Nova Lisboa, IHMT, GHTM, Lisbon, Portugal; [Snounou, Georges] Univ Paris Sud 11, Immunol Viral Infect & Autoimmune Dis IMVA, IDMIT Dept, CEA,INSERM U1184,IBFJ,DRF, Fontenay Aux Roses, France; [White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of London; London School of Hygiene & Tropical Medicine; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Saralamba, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand.; Saralamba, N (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	naowarat.sar@mahidol.ac.th	Nosten, Francois/AAC-5509-2019; Sutherland, Colin/AAN-3939-2020; White, Nick/AAC-6527-2019; Arez, Ana Paula/I-1729-2012; Imwong, Mallika/ABE-6493-2020; Snounou, Georges/F-3352-2011	Nosten, Francois/0000-0002-7951-0745; Sutherland, Colin/0000-0003-1592-6407; White, Nick/0000-0002-1897-1978; Arez, Ana Paula/0000-0002-0497-6532; Snounou, Georges/0000-0002-6133-6398	Mahidol University; Wellcome Trust of Great Britain	Mahidol University; Wellcome Trust of Great Britain(Wellcome Trust)	This research project is supported by Mahidol University, and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the patients and the other support staff for the samples from Shoklo Malaria Research Unit, Tak, Thailand. This research project is supported by Mahidol University, and was part of the Wellcome Trust Mahidol University-Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain.	Ansari HR, 2016, INT J PARASITOL, V46, P685, DOI 10.1016/j.ijpara.2016.05.009; Garrido-Cardenas JA, 2019, PARASITOL RES, V118, P1, DOI 10.1007/s00436-018-6127-9; Bonilla JA, 2006, AM J TROP MED HYG, V75, P830, DOI 10.4269/ajtmh.2006.75.830; Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Chen JT, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2611-z; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Fong MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137734; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Le HG, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2513-0; Imwong M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-20; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lo E, 2017, EMERG INFECT DIS, V23, P601, DOI 10.3201/eid2304.161245; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; Nabarro LEB, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1204-6; Nolder D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002711; Oguike MC, 2015, INT J PARASITOL, V45, P449, DOI 10.1016/j.ijpara.2015.02.004; Oguike MC, 2011, INT J PARASITOL, V41, P677, DOI 10.1016/j.ijpara.2011.01.004; Putaporntip C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058962; Rojo-Marcos G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2544-6; Roucher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087169; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saralamba N, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2413-3; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Tanomsing N, 2013, J CLIN MICROBIOL, V51, P4213, DOI 10.1128/JCM.01527-13; Tanomsing N, 2010, J CLIN MICROBIOL, V48, P3735, DOI 10.1128/JCM.00898-10; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430	31	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217795	10.1371/journal.pone.0217795	http://dx.doi.org/10.1371/journal.pone.0217795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170213	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000470263700056
J	Pinto, M; Langer, TM; Huffer, T; Hofmann, T; Herndl, GJ				Pinto, Maria; Langer, Teresa M.; Hueffer, Thorsten; Hofmann, Thilo; Herndl, Gerhard J.			The composition of bacterial communities associated with plastic biofilms differs between different polymers and stages of biofilm succession	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; MARINE PLASTICS; SURFACE; DEGRADATION; RADIATION; COLONIZATION; HITCHHIKERS; ASSEMBLAGES; DIVERSITY; DYNAMICS	Once in the ocean, plastics are rapidly colonized by complex microbial communities. Factors affecting the development and composition of these communities are still poorly understood. Additionally, whether there are plastic-type specific communities developing on different plastics remains enigmatic. We determined the development and succession of bacterial communities on different plastics under ambient and dim light conditions in the coastal Northern Adriatic over the course of two months using scanning electron microscopy and 16S rRNA gene analyses. Plastics used were low-and high-density polyethylene (LDPE and HDPE, respectively), polypropylene (PP) and polyvinyl chloride with two typical additives (PVC DEHP and PVC DINP). The bacterial communities developing on the plastics clustered in two groups; one group was found on PVC and the other group on all the other plastics and on glass, which was used as an inert control. Specific bacterial taxa were found on specific surfaces in essentially all stages of biofilm development and in both ambient and dim light conditions. Differences in bacterial community composition between the different plastics and light exposures were stronger after an incubation period of one week than at the later stages of the incubation. Under both ambient and dim light conditions, one part of the bacterial community was common on all plastic types, especially in later stages of the biofilm development, with families such as Flavobacteriaceae, Rhodobacteraceae, Planctomycetaceae and Phyllobacteriaceae presenting relatively high relative abundances on all surfaces. Another part of the bacterial community was plastic-type specific. The plastic- type specific fraction was variable among the different plastic types and was more abundant after one week of incubation than at later stages of the succession.	[Pinto, Maria; Langer, Teresa M.; Herndl, Gerhard J.] Univ Vienna, Dept Limnol & Biooceanog, Ctr Funct Ecol, Vienna, Austria; [Pinto, Maria; Hueffer, Thorsten; Hofmann, Thilo; Herndl, Gerhard J.] Univ Vienna, Res Platform Plast Environm & Soc, Vienna, Austria; [Hueffer, Thorsten; Hofmann, Thilo] Univ Vienna, Dept Environm Geosci, Ctr Microbiol & Environm Syst Sci, Vienna, Austria; [Herndl, Gerhard J.] Univ Utrecht, NIOZ, Dept Marine Microbiol & Biogeochem, Royal Netherlands Inst Sea Res, Den Burg, Netherlands	University of Vienna; University of Vienna; University of Vienna; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Pinto, M (corresponding author), Univ Vienna, Dept Limnol & Biooceanog, Ctr Funct Ecol, Vienna, Austria.; Pinto, M (corresponding author), Univ Vienna, Res Platform Plast Environm & Soc, Vienna, Austria.	maria.pinto@univie.ac.at	Herndl, Gerhard J./B-1513-2013; Herndl, Gerhard J./S-3011-2019; Hüffer, Thorsten/M-5017-2013; Hofmann, Thilo/A-8927-2008	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Hofmann, Thilo/0000-0001-8929-6933	DOC from the OAW (Austrian Academy of Sciences) [24446]; Austrian Science Fund (FWF) project [P28781-B21]; research platform PLENTY (Plastics in the Environment and Society) - University of Vienna [326400]	DOC from the OAW (Austrian Academy of Sciences); Austrian Science Fund (FWF) project(Austrian Science Fund (FWF)); research platform PLENTY (Plastics in the Environment and Society) - University of Vienna	This work was supported by a doctoral grant DOC from the OAW (Austrian Academy of Sciences) awarded to M.P. (Grant number 24446), an Austrian Science Fund (FWF) project to G.J.H. (Project number P28781-B21), and by the research platform PLENTY (Plastics in the Environment and Society) financed by the University of Vienna (Project number 326400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2005, APPL ENVIRON MICROB, V71, P5282, DOI 10.1128/AEM.71.9.5282-5289.2005; Amaral-Zettler LA, 2015, FRONT ECOL ENVIRON, V13, P541, DOI 10.1890/150017; Bacosa HP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01325; Bengtsson MM, 2018, MOL ECOL, V27, P2913, DOI 10.1111/mec.14696; Benner R, 1998, LIMNOL OCEANOGR, V43, P1373, DOI 10.4319/lo.1998.43.6.1373; Characklis W.G., 1990, PHYSL ECOLOGY BIOFIL; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; Datta MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11965; Davidson A, 2002, AQUAT MICROB ECOL, V27, P159, DOI 10.3354/ame027159; De Tender C, 2017, ENVIRON SCI TECHNOL, V51, P7350, DOI 10.1021/acs.est.7b00697; Debeljak P, 2017, ANAL METHODS-UK, V9, P1521, DOI 10.1039/c6ay03119f; Debroas D, 2017, SCI TOTAL ENVIRON, V599, P1222, DOI 10.1016/j.scitotenv.2017.05.059; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dussud C, 2018, ENVIRON POLLUT, V236, P807, DOI 10.1016/j.envpol.2017.12.027; Dussud C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01571; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Elasri MO, 1999, APPL ENVIRON MICROB, V65, P2025; Fazey FMC, 2016, ENVIRON POLLUT, V210, P354, DOI 10.1016/j.envpol.2016.01.026; Golyshin PN, 2002, INT J SYST EVOL MICR, V52, P901, DOI 10.1099/ijs.0.01890-0; Harrison JP., 2018, HDB ENV CHEM, V58, P181, DOI [10.1007/978-3-319-61615-5_9, DOI 10.1007/978-3-319-61615-5_9]; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; HERNDL GJ, 1993, NATURE, V361, P717, DOI 10.1038/361717a0; Hoellein TJ, 2017, FRESHW SCI, V36, P491, DOI 10.1086/693012; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Iwaki H, 2012, WORLD J MICROB BIOT, V28, P1321, DOI 10.1007/s11274-011-0925-x; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kapanen A, 2007, CHEMOSPHERE, V67, P2201, DOI 10.1016/j.chemosphere.2006.12.023; Kettner MT, 2017, ENVIRON MICROBIOL, V19, P4447, DOI 10.1111/1462-2920.13891; Khanna ND, 2010, J APPL POLYM SCI, V118, P1476, DOI 10.1002/app.32434; Kirstein IV, 2018, MAR ENVIRON RES, V142, P147, DOI 10.1016/j.marenvres.2018.09.028; Kirstein IV, 2016, MAR ENVIRON RES, V120, P1, DOI 10.1016/j.marenvres.2016.07.004; Lee JW, 2008, J MICROBIOL, V46, P174, DOI 10.1007/s12275-008-0032-3; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Lorite GS, 2011, J COLLOID INTERF SCI, V359, P289, DOI 10.1016/j.jcis.2011.03.066; McCormick AR, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1556; Miao LZ, 2019, SCI TOTAL ENVIRON, V650, P2395, DOI 10.1016/j.scitotenv.2018.09.378; Oberbeckmann S, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02709; Oberbeckmann S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159289; Oberbeckmann S, 2014, FEMS MICROBIOL ECOL, V90, P478, DOI 10.1111/1574-6941.12409; Obernosterer I, 1999, LIMNOL OCEANOGR, V44, P1645, DOI 10.4319/lo.1999.44.7.1645; Ogonowski M, 2018, ENVIRON MICROBIOL, V20, P2796, DOI 10.1111/1462-2920.14120; Paluselli A, 2019, ENVIRON SCI TECHNOL, V53, P166, DOI 10.1021/acs.est.8b05083; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Rodrigues EM, 2018, MICROB ECOL, V75, P688, DOI 10.1007/s00248-017-1078-8; Roling WFM, 2002, APPL ENVIRON MICROB, V68, P5537, DOI 10.1128/AEM.68.11.5537-5548.2002; Romani AM, 1999, FRESHWATER BIOL, V41, P729, DOI 10.1046/j.1365-2427.1999.00413.x; Romera-Castillo C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03798-5; Royer SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200574; Rummel CD, 2017, ENVIRON SCI TECH LET, V4, P258, DOI 10.1021/acs.estlett.7b00164; Salta M, 2013, ENVIRON MICROBIOL, V15, P2879, DOI 10.1111/1462-2920.12186; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Singh B, 2008, POLYM DEGRAD STABIL, V93, P561, DOI 10.1016/j.polymdegradstab.2007.11.008; Staples CA, 2009, ENVIRON TOXICOL CHEM, V16, P875; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Van Cauwenberghe L, 2013, ENVIRON POLLUT, V182, P495, DOI 10.1016/j.envpol.2013.08.013; Wagner K, 2017, J GEOPHYS RES-BIOGEO, V122, P1806, DOI 10.1002/2016JG003727; Wagner K, 2015, ENVIRON MICROBIOL, V17, P5036, DOI 10.1111/1462-2920.12913; WHO (World Health Organisation), 1994, ULTR RAD; Zenoff VF, 2006, APPL ENVIRON MICROB, V72, P7857, DOI 10.1128/AEM.01333-06; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	60	104	106	14	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217165	10.1371/journal.pone.0217165	http://dx.doi.org/10.1371/journal.pone.0217165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166981	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800018
J	Nah, K; Magpantay, FMG; Bede-Fazekas, A; Rost, G; Trajer, AJ; Wu, XT; Zhang, X; Wu, JH				Nah, Kyeongah; Magpantay, Felicia Maria G.; Bede-Fazekas, Akos; Rost, Gergely; Trajer, Attila Janos; Wu, Xiaotian; Zhang, Xue; Wu, Jianhong			Assessing systemic and non-systemic transmission risk of tick-borne encephalitis virus in Hungary	PLOS ONE			English	Article							SEASONAL POPULATION-DYNAMICS; IXODES-RICINUS TICKS; LYME-DISEASE; INFECTION; BORRELIOSIS; PATHOGENS; EUROPE; EPIDEMIOLOGY; INFESTATION; TEMPERATURE	Estimating the tick-borne encephalitis (TBE) infection risk under substantial uncertainties of the vector abundance, environmental condition and human-tick interaction is important for evidence-informed public health intervention strategies. Estimating this risk is computationally challenging since the data we observe, i.e., the human incidence of TBE, is only the final outcome of the tick-host transmission and tick-human contact processes. The challenge also increases since the complex TBE virus (TBEV) transmission cycle involves the non-systemic route of transmission between co-feeding ticks. Here, we describe the hidden Markov transition process, using a novel TBEV transmission-human case reporting cascade model that couples the susceptible-infected compartmental model describing the TBEV transmission dynamics among ticks, animal hosts and humans, with the stochastic observation process of human TBE reporting given infection. By fitting human incidence data in Hungary to the transmission model, we estimate key parameters relevant to the tick-host interaction and tick-human transmission. We then use the parametrized cascade model to assess the transmission potential of TBEV in the enzootic cycle with respect to the climate change, and to evaluate the contribution of non-systemic transmission. We show that the TBEV transmission potential in the enzootic cycle has been increasing along with the increased temperature though the TBE human incidence has dropped since 1990s, emphasizing the importance of persistent public health interventions. By demonstrating that non-systemic transmission pathway is a significant factor in the transmission of TBEV in Hungary, we conclude that the risk of TBE infection will be highly underestimated if the non-systemic transmission route is neglected in the risk assessment.	[Nah, Kyeongah; Wu, Jianhong] York Univ, Dept Math & Stat, Toronto, ON, Canada; [Magpantay, Felicia Maria G.] Queens Univ, Dept Math & Stat, Kingston, ON, Canada; [Bede-Fazekas, Akos] MTA Ctr Ecol Res, Inst Ecol & Bot, Vacratot, Hungary; [Bede-Fazekas, Akos] MTA Ctr Ecol Res, GINOP Sustainable Ecosyst Grp, Tihany, Hungary; [Rost, Gergely] Univ Oxford, Wolfson Ctr Math Biol, Oxford, England; [Rost, Gergely] Univ Szeged, Bolyai Inst, Szeged, Hungary; [Trajer, Attila Janos] Univ Pannonia, Dept Limnol, Veszprem, Hungary; [Trajer, Attila Janos] Univ Pannonia, Inst Environm Engn, Veszprem, Hungary; [Wu, Xiaotian] Shanghai Maritime Univ, Coll Arts & Sci, Shanghai, Peoples R China; [Zhang, Xue] Northeastern Univ, Dept Math, Shenyang, Liaoning, Peoples R China	York University - Canada; Queens University - Canada; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Oxford; Szeged University; University of Pannonia; University of Pannonia; Shanghai Maritime University; Northeastern University - China	Wu, JH (corresponding author), York Univ, Dept Math & Stat, Toronto, ON, Canada.	wujh@mathstat.yorku.ca	Wu, Jian/AAU-5221-2020; Trájer, Attila J/GVS-3713-2022; Bede-Fazekas, Ákos/J-1636-2012; Rost, Gergely/L-9376-2016; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Trájer, Attila J/0000-0003-3248-6474; Bede-Fazekas, Ákos/0000-0002-2905-338X; Rost, Gergely/0000-0001-9476-3284; Wu, Jian/0000-0002-3394-1507; Nah, Kyeongah/0000-0002-7708-1019	GlaxoSmithKline SA [HO-17-18014]; Nemzetgazdasagi Miniszterium (English: Ministry for National Economy, Hungary) [GINOP-2.3.2-15-2016-00019]; National Natural Science Foundation of China [11701072, 11501358]; Natural Sciences and Engineering Research Council of Canada [105588-2011]	GlaxoSmithKline SA(GlaxoSmithKline); Nemzetgazdasagi Miniszterium (English: Ministry for National Economy, Hungary); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research is part of the project entitled "Estimating risk of tick-borne encephalitis with changes in climate, habitation and recreational activities" which received funding from GlaxoSmithKline SA (HO-17-18014 (K.N., X.Z., J.W.) https://www.gsk.com.GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The project was also supported by Nemzetgazdasagi Miniszterium (English: Ministry for National Economy, Hungary) (GINOP-2.3.2-15-2016-00019 [A.B., A.T.] http://www.kormany.hu/en/ministry-for-national-economy), National Natural Science Foundation of China (11701072 [X.Z.]), 11501358 (X.W.) http://www.nsfc.gov.cn/english/site_1/index.html and Natural Sciences and Engineering Research Council of Canada (105588-2011 [J.W.]) http://www.nserc-crsng.gc.ca/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2009, EN DEL FUT, P16; Balogh Z, 2010, J VIROL METHODS, V163, P481, DOI 10.1016/j.jviromet.2009.10.003; Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430; Bolzoni L, 2012, INT J PARASITOL, V42, P373, DOI 10.1016/j.ijpara.2012.02.006; Brockmann SO, 2018, EUROSURVEILLANCE, V23, P8, DOI 10.2807/1560-7917.ES.2018.23.15.17-00336; Campbell JA, 1948, THESIS; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Daniel M, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00090; Dobson ADM, 2011, J APPL ECOL, V48, P1017, DOI 10.1111/j.1365-2664.2011.02003.x; Donoso-Mantke O., 2011, FLAVIVIRUS ENCEPHALI; DUSBABEK F, 1995, MED VET ENTOMOL, V9, P133, DOI 10.1111/j.1365-2915.1995.tb00169.x; ECDC, 2020, IX RIC FACTSH EXP; Egyed L, 2012, TICKS TICK-BORNE DIS, V3, P90, DOI 10.1016/j.ttbdis.2012.01.002; Eisen L, 2016, J MED ENTOMOL, V53, P1050, DOI 10.1093/jme/tjw092; European Centre for Disease Prevention and Control, 2012, EP SIT TICK BORN ENC; European Centre for Disease Prevention and Control, 2018, ANN EP REP 2015 TICK; European Centre for Disease Prevention and Control, FACTSH TICK BORN ENC; Ferenczi E, 2005, NATO SCI SER I LIFE, V370, P43; Ghosh M, 2004, B MATH BIOL, V66, P1659, DOI 10.1016/j.bulm.2004.03.007; GRAY JS, 1981, B ENTOMOL RES, V71, P533, DOI 10.1017/S0007485300008543; Greenfield B.P.J., 2011, Bioscience Horizons, V4, P140; Hancock PA, 2011, INT J PARASITOL, V41, P513, DOI 10.1016/j.ijpara.2010.12.012; Harrison A, 2012, PARASITOLOGY, V139, P1605, DOI 10.1017/S0031182012000893; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Heinz FX, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.es2015.20.13.21077; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184; Khasnatinov MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158105; King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347; Kollaritsch H, 2011, VACCINE, V29, P4556, DOI 10.1016/j.vaccine.2011.04.061; LABUDA M, 1993, MED VET ENTOMOL, V7, P339, DOI 10.1111/j.1365-2915.1993.tb00702.x; Magpantay FMG, 2016, PARASITOLOGY, V143, P835, DOI 10.1017/S0031182015000979; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; MATUSCHKA FR, 1991, AM J TROP MED HYG, V44, P100, DOI 10.4269/ajtmh.1991.44.100; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Mogl C, 2011, ACTA ZOOL BULGAR, V63, P301; MOLNAR E, 1982, Geographia Medica, V12, P78; Nonaka E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011745; Ogden NH, 2005, INT J PARASITOL, V35, P375, DOI 10.1016/j.ijpara.2004.12.013; Ogden NH, 1997, PARASITOLOGY, V115, P591, DOI 10.1017/S0031182097001868; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Pettersson JHO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-102; PRETZMAN.G, 1964, ZENTBL BAKTERIOLOG P, V194, P431; Qviller L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-179; R Core Team, 2018, R LANG ENV STAT COMP; Randolph SE, 2008, MICROBES INFECT, V10, P209, DOI 10.1016/j.micinf.2007.12.005; Randolph SE, 2011, TICKS TICK-BORNE DIS, V2, P179, DOI 10.1016/j.ttbdis.2011.07.004; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; REHACEK J, 1962, ACTA VIROL, V6, P220; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rosa R, 2007, MATH BIOSCI, V208, P216, DOI 10.1016/j.mbs.2006.10.002; Sikutova S, 2009, VET MICROBIOL, V135, P267, DOI 10.1016/j.vetmic.2008.09.082; Sixl W, 1971, EINFLUSS TEMPERATUR; Sonenshine D. E., 1994, ECOLOGICAL DYNAMICS; Trajer A, 2014, INT J ENVIRON HEAL R, V24, P226, DOI 10.1080/09603123.2013.807329; Trajer A, 2013, ANN AGR ENV MED, V20, P245; Voordouw MJ, 2015, PARASITOLOGY, V142, P290, DOI 10.1017/S0031182014001486; Wilhelmsson P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-362; Wu XT, 2013, J THEOR BIOL, V319, P50, DOI 10.1016/j.jtbi.2012.11.014; Zavadska D, 2013, HUM VACC IMMUNOTHER, V9, P362, DOI 10.4161/hv.22766; Zeman P, 2004, INT J MED MICROBIOL, V293, P48, DOI 10.1016/S1433-1128(04)80008-1; Zhang X, 2017, J BIOL SYST, V25, P657, DOI 10.1142/S0218339017400083; Zoldi V, 2015, ECOHEALTH, V12, P174, DOI 10.1007/s10393-014-0969-0; Zoldi V, 2015, INFECT DIS-NOR, V47, P178, DOI 10.3109/00365548.2014.975743; Zoldi V, 2013, VECTOR-BORNE ZOONOT, V13, P256, DOI 10.1089/vbz.2011.0905; ZOLOTOV PE, 1981, PARAZITOLOGIYA+, V15, P469	69	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217206	10.1371/journal.pone.0217206	http://dx.doi.org/10.1371/journal.pone.0217206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163042	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000470086200009
J	Pees, M; Schmidt, V; Papp, T; Gellert, A; Abbas, M; Starck, M; Neul, A; Marschang, RE				Pees, Michael; Schmidt, Volker; Papp, Tibor; Gellert, Akos; Abbas, Maha; Starck, Matthias; Neul, Annkatrin; Marschang, Rachel E.			Three genetically distinct ferlaviruses have varying effects on infected corn snakes (Pantherophis guttatus)	PLOS ONE			English	Article							PARAMYXOVIRUS FUSION; OPHIDIAN PARAMYXOVIRUS; DIFFUSION CAPACITY; PROTEIN-STRUCTURE; SEQUENCE; PREDICTION; LIZARDS; ACTIVATION; EXPRESSION; PNEUMONIA	Ferlaviruses are important pathogens in snakes and other reptiles. They cause respiratory and neurological disease in infected animals and can cause severe disease outbreaks. Isolates from this genus can be divided into four genogroups-A, B, and C, as well as a more distantly related sister group, "tortoise". Sequences from large portions (5.3 kb) of the genomes of a variety of ferlavirus isolates from genogroups A, B, and C, including the genes coding the surface glycoproteins F and HN as well as the L protein were determined and compared. In silico analyses of the glycoproteins of genogroup A, B, and C isolates were carried out. Three isolates representing these three genogroups were used in transmission studies with corn snakes (Pantherophis guttatus), and clinical signs, gross and histopathology, electronmicroscopic changes in the lungs, and isolation of bacteria from the lungs were evaluated. Analysis of the sequences supported the previous categorization of ferlaviruses into four genogroups, and criteria for definition of ferlavirus genogroups and species were established based on sequence identities (80% resp. 90%). Analysis of the ferlavirus glycoprotein models showed parallels to corresponding regions of other paramyxoviruses. The transmission studies showed clear differences in the pathogenicities of the three virus isolates used. The genogroup B isolate was the most and the group A virus the least pathogenic. Reasons for these differences were not clear based on the differences in the putative structures of their respective glycoproteins, although e.g. residue and consequential structure variation of an extended cleavage site or changes in electrostatic charges at enzyme binding sites could play a role. The presence of bacteria in the lungs of the infected animals also clearly corresponded to increased pathogenicity. This study contributes to knowledge about the structure and phylogeny of ferlaviruses and lucidly demonstrates differences in pathogenicity between strains of different genogroups.	[Pees, Michael; Schmidt, Volker; Neul, Annkatrin] Univ Leipzig, Univ Teaching Hosp, Dept Birds & Reptiles, Leipzig, Germany; [Papp, Tibor; Gellert, Akos] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, Budapest, Hungary; [Abbas, Maha] Univ Hohenheim, Inst Environm & Anim Hyg, Stuttgart, Germany; [Starck, Matthias] LMU Munchen, Bioctr, Dept Biol 2, Munich, Germany; [Marschang, Rachel E.] Laboklin, Bad Kissingen, Germany; [Abbas, Maha] Al Qasim Green Univ, Dept Biotechnol, Coll Biotechnol, Hilla, Iraq	Leipzig University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; University Hohenheim; University of Munich; Al Qasim Green University	Pees, M (corresponding author), Univ Leipzig, Univ Teaching Hosp, Dept Birds & Reptiles, Leipzig, Germany.	pees@uni-leipzig.de	Papp, Tibor/A-6437-2011; Schmidt, Volker/I-7708-2019; Starck, Matthias/K-5713-2014	Papp, Tibor/0000-0002-6402-3864; Schmidt, Volker/0000-0002-6001-9542; Gellert, Akos/0000-0002-1455-8879; Starck, Matthias/0000-0001-7882-9482; Marschang, Rachel/0000-0002-0578-8963; abbas, maha/0000-0001-9313-3192; Pees, Michael/0000-0002-7244-9697	German Research Foundation (DFG) [PE 877/2-2]; Bolyai Research Fellowship of the Hungarian Academy of Sciences [BO/00569/15]	German Research Foundation (DFG)(German Research Foundation (DFG)); Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The work was supported by a grant from the German Research Foundation (DFG, PE 877/2-2 to MP), and the Bolyai Research Fellowship of the Hungarian Academy of Sciences (BO/00569/15 to TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Maha Diekan, 2012, Journal of Herpetological Medicine and Surgery, V22, P86, DOI 10.5818/1529-9651-22.3.86; Abbas MD, 2011, VET MICROBIOL, V150, P70, DOI 10.1016/j.vetmic.2011.01.010; Ahne W, 1999, VIRUS RES, V63, P65, DOI 10.1016/S0168-1702(99)00059-3; Ahne W, 1991, 2ND P INT S VIR LOW, P203; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berjanskii M, 2010, NUCLEIC ACIDS RES, V38, pW633, DOI 10.1093/nar/gkq375; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; CLARK HF, 1979, J GEN VIROL, V44, P405, DOI 10.1099/0022-1317-44-2-405; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Essbauer S, 2001, J VET MED B, V48, P403, DOI 10.1046/j.1439-0450.2001.00473.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferrando RE, 2003, J ALLERGY CLIN IMMUN, V112, P1243, DOI 10.1016/j.jaci.2003.09.038; FOELSCH DW, 1976, TIERAERZTL PRAX, V4, P527; Franke J, 2006, ARCH VIROL, V151, P449, DOI 10.1007/s00705-005-0663-1; Franke J, 2001, VIRUS RES, V80, P67, DOI 10.1016/S0168-1702(01)00353-7; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Golubchik T, 2007, MOL BIOL EVOL, V24, P2433, DOI 10.1093/molbev/msm176; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyndman TH, 2013, VET MICROBIOL, V165, P200, DOI 10.1016/j.vetmic.2013.04.002; International Committee on Taxonomy of Viruses, VIRUS TAXONOMY; JACOBSON E, 1980, J AM VET MED ASSOC, V177, P796; Jacobson Elliott R., 2007, P395, DOI 10.1201/9781420004038.ch9; Jacobson ER, 2001, J VET DIAGN INVEST, V13, P143, DOI 10.1177/104063870101300208; JACOBSON ER, 1992, J ZOO WILDLIFE MED, V23, P318; Jacobson ER, 1997, VET PATHOL, V34, P450, DOI 10.1177/030098589703400509; Junqueira de Azevedo ILM, 2001, ARCH VIROL, V146, P51, DOI 10.1007/s007050170190; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kindermann J, 2001, ARCH VIROL, V146, P1021, DOI 10.1007/s007050170133; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kurath G, 2004, J VIROL, V78, P2045, DOI 10.1128/JVI.78.4.2045-2056.2004; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luque LE, 2007, J VIROL, V81, P3130, DOI 10.1128/JVI.02464-06; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 2009, VIRUS RES, V144, P272, DOI 10.1016/j.virusres.2009.05.011; Marschang RE, 2002, J ZOO WILDLIFE MED, V33, P317, DOI 10.1638/1042-7260(2002)033[0317:PARIIW]2.0.CO;2; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Neul A, 2017, AM J VET RES, V78, P482, DOI 10.2460/ajvr.78.4.482; Papp T., 2010, Journal of Herpetological Medicine and Surgery, V20, P64, DOI 10.5818/1529-9651-20.2.64; Papp T, 2013, VET MICROBIOL, V162, P195, DOI 10.1016/j.vetmic.2012.08.010; Papp T, 2010, VET MICROBIOL, V144, P466, DOI 10.1016/j.vetmic.2010.02.002; Pees M, 2016, VET MICROBIOL, V182, P213, DOI 10.1016/j.vetmic.2015.11.024; PERRY SF, 1981, MIKROSKOPIE, V38, P278; Plenz B, 2015, VET REC, V176, P285, DOI 10.1136/vr.102580; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Schmidt V, 2013, VET REC, V172, DOI 10.1136/vr.100972; Schrodinger L, 2016, SCHRODINGER SUITE; Starck JM, 2017, J COMP PATHOL, V156, P419, DOI 10.1016/j.jcpa.2017.02.001; Starck JM, 2015, J COMP PATHOL, V153, P333, DOI 10.1016/j.jcpa.2015.07.004; Starck JM, 2012, ZOOLOGY, V115, P245, DOI [10.1016/j.zool.2012.02.003, 10.1016/j.zoo1,2012.02.003]; Terrell Scott P., 2007, P219; Tian S, 2009, BIOCHEM INSIGHTS, V2, P9, DOI 10.4137/BCI.S2049; Tian S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00261; Wang L.-F., 2011, VIRUS TAXONOMY CLASS; Welch BD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003534; West G, 2001, J ZOO WILDLIFE MED, V32, P360, DOI 10.1638/1042-7260(2001)032[0360:MIABSP]2.0.CO;2; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Woo PCY, 2014, J CLIN MICROBIOL, V52, P3614, DOI 10.1128/JCM.01653-14; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108	70	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217164	10.1371/journal.pone.0217164	http://dx.doi.org/10.1371/journal.pone.0217164			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163032	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000470086200007
J	Shamali, M; Konradsen, H; Stas, L; Ostergaard, B				Shamali, Mahdi; Konradsen, Hanne; Stas, Lara; Ostergaard, Birte			Dyadic effects of perceived social support on family health and family functioning in patients with heart failure and their nearest relatives: Using the Actor-Partner Interdependence Mediation Model	PLOS ONE			English	Article							QUALITY-OF-LIFE; SELF-CARE; IMPACT	Background Social support, family functioning and family health are essential elements in the treatment of heart failure, yet most heart failure studies focus on the pharmacological interventions. This study aimed to examine whether perceived social support from nurses is associated with better family functioning of patients with heart failure and their nearest relatives and to examine whether family health mediates this relationship. Methods and findings A sample of 312 patients with heart failure and 312 of their nearest relatives were included in the study. The Family Functioning, Health and Social Support questionnaire was used to collect the data. Dyadic data were analysed by the Actor-Partner Interdependence Mediation Model with distinguishable dyads using structural equation modelling. Patients and nearest relatives who perceived more social support had a higher level of family health and functioned better within the family. One partner effect was found, indicating that the higher the level of family health of the nearest relative, the better the family functioning of the patient (p <0.001). Family health partially (in the patient) and completely (in the nearest relative) mediated the association between social support and family functioning. Conclusion This study indicated that patients with heart failure and their nearest relatives who perceived more social support from nurses were more likely to have high level of family health and function better within the family. The interdependent relationships found in our study highlight a dyadic and family-oriented approach to improve family functioning in patients with heart failure.	[Shamali, Mahdi; Ostergaard, Birte] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Konradsen, Hanne] Herlev & Gentofte Univ Hosp, Dept Gastroenterol, Copenhagen, Denmark; [Konradsen, Hanne] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Konradsen, Hanne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Stas, Lara] Univ Ghent, Dept Data Anal, Ghent, Belgium; [Ostergaard, Birte] Univ Southern Denmark, OPEN, Odense, Denmark	University of Southern Denmark; Karolinska Institutet; University of Copenhagen; Ghent University; University of Southern Denmark	Shamali, M (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	mshamali@health.sdu.dk	Shamali, Mahdi/A-2087-2017	Shamali, Mahdi/0000-0001-7628-0887; Konradsen, Hanne/0000-0002-7477-125X; Ostergaard, Birte/0000-0002-9094-8123; Stas, Lara/0000-0003-1567-2881	Novo Nordisk Foundation [NNF17OC0027968]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was funded by the Novo Nordisk Foundation (http://novonordiskfonden.dk) under grant Number NNF17OC0027968.	Al-Rawashdeh SY, 2017, WESTERN J NURS RES, V39, P492, DOI 10.1177/0193945916672647; Astedt-Kurki P, 2004, J ADV NURS, V48, P115, DOI 10.1111/j.1365-2648.2004.03178.x; Astedt-Kurki P, 2009, INT J NURS STUD, V46, P350, DOI 10.1016/j.ijnurstu.2008.01.008; Buck HG, 2015, J PALLIAT MED, V18, P1026, DOI 10.1089/jpm.2015.0086; Cameron J, 2017, J CLIN NURS, V26, P4804, DOI 10.1111/jocn.13836; Campbell L., 2015, ENCY CLIN PSYCHOL, P1, DOI [10.1002/9781118625392.wbecp467, DOI 10.1002/9781118625392.WBECP467]; Chung ML, 2009, J PSYCHOSOM RES, V67, P29, DOI 10.1016/j.jpsychores.2009.01.009; Dalteg T, 2016, J FAM NURS, V22, P368, DOI 10.1177/1074840716656815; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Dunbar SB, 2008, J CARDIOVASC NURS, V23, P258, DOI 10.1097/01.JCN.0000305093.20012.b8; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fritz MS, 2008, BEHAV RES METHODS, V40, P55, DOI 10.3758/BRM.40.1.55; Hasanpour-Dehkordi A, 2016, APPL NURS RES, V31, P165, DOI 10.1016/j.apnr.2016.03.005; Hautsalo K, 2013, J CLIN NURS, V22, P2953, DOI 10.1111/j.1365-2702.2012.04335.x; Kenny DA, 1999, PERS RELATIONSHIP, V6, P433, DOI 10.1111/j.1475-6811.1999.tb00202.x; Kenny DA, 2010, J FAM PSYCHOL, V24, P359, DOI 10.1037/a0019651; Ledermann T, 2011, STRUCT EQU MODELING, V18, P595, DOI 10.1080/10705511.2011.607099; Luttik ML, 2007, J CARDIOVASC NURS, V22, P131, DOI 10.1097/00005082-200703000-00010; Mansourian BP, 2009, GLOBAL PERSPECTIVES, VI; Molloy GJ, 2005, EUR J HEART FAIL, V7, P592, DOI 10.1016/j.ejheart.2004.07.008; Ostergaard B, 2018, SCAND J CARING SCI, V32, P554, DOI 10.1111/scs.12479; Paavilainen Eija, 2006, Eur J Cardiovasc Nurs, V5, P54, DOI 10.1016/j.ejcnurse.2005.10.002; Pedersen S, 2005, J FAM PSYCHOL, V19, P404, DOI 10.1037/0893-3200.19.3.404; Pischke CR, 2007, EUR J HEART FAIL, V9, P928, DOI 10.1016/j.ejheart.2007.05.009; Riegel B, 2011, NAT REV CARDIOL, V8, P644, DOI 10.1038/nrcardio.2011.95; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; ROSS CE, 1990, J MARRIAGE FAM, V52, P1059, DOI 10.2307/353319; Schmidt M, 2016, EUR J HEART FAIL, V18, P490, DOI 10.1002/ejhf.486; Shamali M, 2018, SCAND J CARING SCI, V32, P1247, DOI 10.1111/scs.12541; Tarkka MT, 2003, J CLIN NURS, V12, P736, DOI 10.1046/j.1365-2702.2003.00771.x; Vellone E, 2014, J FAM NURS, V20, P120, DOI 10.1177/1074840713510205	31	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217970	10.1371/journal.pone.0217970	http://dx.doi.org/10.1371/journal.pone.0217970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163068	Green Published, gold, Green Submitted			2022-12-26	WOS:000470086200049
J	Dahms, I; Bailey-Hall, E; Sylvester, E; Parenteau, A; Yu, SG; Karagiannis, A; Roos, F; Wilson, J				Dahms, Irina; Bailey-Hall, Eileen; Sylvester, Erin; Parenteau, Audrey; Yu, Shiguang; Karagiannis, Alexios; Roos, Franz; Wilson, Jon			Safety of a novel feed ingredient, Algal Oil containing EPA and DHA, in a gestation-lactation-growth feeding study in Beagle dogs	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ETHYL-ESTER; FISH OILS; PLASMA; OMEGA-3-FATTY-ACIDS; BLOOD	An Algal Oil Containing EPA and DHA (AOCED) at similar to 50% was developed as a sustainable source of omega-3 fatty acids. AOCED was incorporated into extruded dry foods for dogs at 0, 0.75%, 1.5% and 3.0% levels (equivalent to 0, 7.5, 15 and 30 g/kg diet) on dry matter basis at the expense of chicken fat and fed to healthy female Beagle dogs starting at mating and throughout gestation and lactation. The offspring were fed their maternal corresponding diets for 26 weeks after weaning. AOCED-enriched diets were well tolerated by dogs in both generations and did not affect their overall health, physiological parameters, food consumption, body weights and body weight gains. There were no changes in hematology, clinical chemistry, and coagulation parameters in both generations of dogs fed the AOCED diets when compared to those in the control group. Plasma levels of DHA and EPA increased significantly and generally dose-dependently in both generations. The study demonstrated the safety of AOCED in dogs during gestation, lactation, and growth periods at dietary levels up to 3.0wt%, equivalent to 30 g/kg diet. AOCED's bioavailability as a source of DHA and EPA in dogs was demonstrated by the increased plasma concentrations of these nutritional lipids.	[Dahms, Irina; Karagiannis, Alexios; Roos, Franz] DSM Nutr Prod, Kaiseraugst, Switzerland; [Bailey-Hall, Eileen; Sylvester, Erin; Yu, Shiguang; Wilson, Jon] DSM Nutr Prod, Columbia, MD USA; [Parenteau, Audrey] Citoxlab North Amer, Laval, PQ, Canada	DSM NV; DSM NV	Dahms, I (corresponding author), DSM Nutr Prod, Kaiseraugst, Switzerland.	irina.dahms@dsm.com						Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Bauer JE, 2011, JAVMA-J AM VET MED A, V239, P1441, DOI 10.2460/javma.239.11.1441; BROWN SA, 1999, COMPENDIUM CONTINU S, V21, P11, DOI DOI 10.1111/J.1939-1676.1998.TB02148.X; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; CARLSON SE, 1992, LIPIDS, V27, P901, DOI 10.1007/BF02535870; CARLSON SE, 1992, J PEDIATR-US, V120, pS159, DOI 10.1016/S0022-3476(05)81251-X; CRAWFORD MA, 1993, AM J CLIN NUTR, V57, P703; Dahms I, 2016, PROSTAG LEUKOTR ESS, V113, P1, DOI 10.1016/j.plefa.2016.08.001; Dahms I, 2016, FOOD CHEM TOXICOL, V92, P50, DOI 10.1016/j.fct.2016.03.024; Fedorova-Dahms I, 2011, FOOD CHEM TOXICOL, V49, P70, DOI 10.1016/j.fct.2010.09.033; Freeman LM, 2006, J VET INTERN MED, V20, P1116, DOI 10.1892/0891-6640(2006)20[1116:EODMID]2.0.CO;2; Freeman LM, 1998, J VET INTERN MED, V12, P440, DOI 10.1111/j.1939-1676.1998.tb02148.x; Hall JA, 1999, AM J VET RES, V60, P319; Hall JA, 1996, COMP CONT EDUC PRACT, V18, P879; HARRIS WS, 1989, J LIPID RES, V30, P785; HOLUB BJ, 1987, ATHEROSCLEROSIS, V66, P11, DOI 10.1016/0021-9150(87)90174-2; Laurent G, 2008, CARDIOVASC RES, V77, P89, DOI 10.1093/cvr/cvm024; Lenox CE, 2013, J VET INTERN MED, V27, P217, DOI 10.1111/jvim.12033; Logas Dawn, 1994, Vet Dermatol, V5, P99, DOI 10.1111/j.1365-3164.1994.tb00020.x; MARSEN TA, 1992, PROSTAG LEUKOTR ESS, V46, P191, DOI 10.1016/0952-3278(92)90069-U; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; National Research Council (NRC), 2006, NUTR REQ DOGS CATS, P81; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Pinheiro J, R PACKAGE VERSION; R Core Team, 2021, R LANGUAGE ENV STAT; Raatz SK, 2012, NUTR RES, V32, P1, DOI 10.1016/j.nutres.2011.12.006; SALEM N, 1989, ADV PROSTAG THROMB L, V19, P618; Salem N. Jr., 1986, Health effects of polyunsaturated fatty acids in seafoods, P263; Sargent JR, 1999, P NUTR SOC, V58, P377, DOI 10.1017/S0029665199001366	29	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217794	10.1371/journal.pone.0217794	http://dx.doi.org/10.1371/journal.pone.0217794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158258	Green Submitted, gold, Green Published			2022-12-26	WOS:000469915700027
J	Kazim, N; Adhikari, A; Davie, J				Kazim, Noor; Adhikari, Abhinav; Davie, Judith			The transcription elongation factor TCEA3 promotes the activity of the myogenic regulatory factors	PLOS ONE			English	Article							ANNEXIN A1; MOUSE; DIFFERENTIATION; EXPRESSION; APOPTOSIS; TARGET; GENES; MYOD; CELL	The transcription elongation factor TFIIS is encoded by a three member gene family in vertebrates. Here we show that one member of this family, TCEA3, is upregulated during skeletal muscle differentiation and acts to promote gene activation by the myogenic regulatory family of transcription factors, which includes MyoD and myogenin. We show that myogenin is a direct regulator of Tcea3. Myogenin binds to the Tcea3 promoter and is required to recruit RNA polymerase II. TCEA3 can bind to both myogenin and MyoD and is co-recruited with the MRFs to promoters dependent on the MRFs. Depletion of myogenin inhibits the recruitment of TCEA3, suggesting that the interaction of TCEA3 with the MRFs serves to aid in recruitment to target promoters. Like TFIIS, we show that TCEA3 interacts with RNA polymerase II. TCEA3 travels with the elongating RNA polymerase II in the coding region of genes and depletions of TCEA3 inhibit the recruitment of RNA polymerase II to promoters. In proliferating cells, TCEA3 expressed at low levels and is present in both the nucleus and cytoplasm. However, upon differentiation, TCEA3 is upregulated and transported exclusively to the nucleus. Thus, our data show that TCEA3 is a required co-factor for MRF driven gene expression during myogenesis.	[Kazim, Noor; Adhikari, Abhinav; Davie, Judith] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; [Kazim, Noor; Adhikari, Abhinav; Davie, Judith] Southern Illinois Univ, Sch Med, Simmons Canc Inst, Carbondale, IL 62901 USA; [Kazim, Noor] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Cornell University	Davie, J (corresponding author), Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	jdavie@siumed.edu	Adhikari, Abhinav/J-5224-2019; Kazim, Noor/AAJ-4824-2021	Adhikari, Abhinav/0000-0002-9228-480X; Kazim, Noor/0000-0001-7313-0875	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [RAR068622]	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health, grant no. RAR068622 (to JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Cha Y, 2013, GENE EXPRESSION, V16, P25, DOI 10.3727/105221613X13776146743343; Cha Y, 2013, CELL SIGNAL, V25, P1245, DOI 10.1016/j.cellsig.2013.01.016; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Ge Y, 2019, J CELL PHYSIOL, V234, P10554, DOI 10.1002/jcp.27726; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; Kablar B, 2000, HISTOL HISTOPATHOL, V15, P649, DOI 10.14670/HH-15.649; Labhart P, 1998, GENOMICS, V52, P278, DOI 10.1006/geno.1998.5449; Li J, 2015, MED SCI MONITOR, V21, P3241, DOI 10.12659/MSM.895860; Liao JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23542; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Park KS, 2013, STEM CELLS, V31, P282, DOI 10.1002/stem.1284; Shimasaki NB, 2000, J BIOL CHEM, V275, P36541, DOI 10.1074/jbc.M005834200; Yang TM, 2018, EXP CELL RES, V370, P551, DOI 10.1016/j.yexcr.2018.07.020; You S, 2018, AM J CANCER RES, V8, P2076; Zhu Y, 2017, BIOCHEM BIOPH RES CO, V484, P827, DOI 10.1016/j.bbrc.2017.01.182	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217680	10.1371/journal.pone.0217680	http://dx.doi.org/10.1371/journal.pone.0217680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158246	gold, Green Published, Green Submitted			2022-12-26	WOS:000469915700021
J	Keyel, AC; Timm, OE; Backenson, PB; Prussing, C; Quinones, S; McDonough, KA; Vuille, M; Conn, JE; Armstrong, PM; Andreadis, TG; Kramer, LD				Keyel, Alexander C.; Timm, Oliver Elison; Backenson, P. Bryon; Prussing, Catharine; Quinones, Sarah; McDonough, Kathleen A.; Vuille, Mathias; Conn, Jan E.; Armstrong, Philip M.; Andreadis, Theodore G.; Kramer, Laura D.			Seasonal temperatures and hydrological conditions improve the prediction of West Nile virus infection rates in Culex mosquitoes and human case counts in New York and Connecticut	PLOS ONE			English	Article							UNITED-STATES; PIPIENS DIPTERA; SUFFOLK COUNTY; OVIPOSITION PREFERENCES; TRANSMISSION DYNAMICS; FEATURE-SELECTION; RISK-ASSESSMENT; BRIDGE VECTOR; LAND-COVER; CULICIDAE	West Nile virus (WNV; Flaviviridae: Flavivirus) is a widely distributed arthropod-borne virus that has negatively affected human health and animal populations. WNV infection rates of mosquitoes and human cases have been shown to be correlated with climate. However, previous studies have been conducted at a variety of spatial and temporal scales, and the scale-dependence of these relationships has been understudied. We tested the hypothesis that climate variables are important to understand these relationships at all spatial scales. We analyzed the influence of climate on WNV infection rate of mosquitoes and number of human cases in New York and Connecticut using Random Forests, a machine learning technique. During model development, 66 climate-related variables based on temperature, precipitation and soil moisture were tested for predictive skill. We also included 20-21 non-climatic variables to account for known environmental effects (e.g., land cover and human population), surveillance related information (e.g., relative mosquito abundance), and to assess the potential explanatory power of other relevant factors (e.g., presence of wastewater treatment plants). Random forest models were used to identify the most important climate variables for explaining spatial-temporal variation in mosquito infection rates (abbreviated as MLE). The results of the cross-validation support our hypothesis that climate variables improve the predictive skill for MLE at county-and trap-scales and for human cases at the county-scale. Of the climate-related variables selected, mean minimum temperature from July-September was selected in all analyses, and soil moisture was selected for the mosquito county-scale analysis. Models demonstrated predictive skill, but still over-and under-estimated WNV MLE and numbers of human cases. Models at fine spatial scales had lower absolute errors but had greater errors relative to the mean infection rates.	[Keyel, Alexander C.; McDonough, Kathleen A.; Conn, Jan E.; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12203 USA; [Keyel, Alexander C.; Timm, Oliver Elison; Quinones, Sarah; Vuille, Mathias] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA; [Backenson, P. Bryon] New York State Dept Hlth, Bur Communicable Dis Control, Albany, NY USA; [Prussing, Catharine; McDonough, Kathleen A.] SUNY Albany, Dept Biomed Sci, Albany, NY USA; [Armstrong, Philip M.; Andreadis, Theodore G.] Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, Dept Environm Sci, New Haven, CT 06504 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Connecticut Agricultural Experiment Station	Keyel, AC (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12203 USA.; Keyel, AC (corresponding author), SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA.	akeyel@albany.edu	Armstrong, Philip/GWU-8253-2022; Vuille, Mathias/O-8128-2019; Vuille, Mathias/S-3906-2019; Prussing, Catharine/AAB-4546-2019	Vuille, Mathias/0000-0002-9736-4518; Prussing, Catharine/0000-0001-6425-6839; Keyel, Alexander C./0000-0001-5256-6274; Conn, Jan/0000-0002-5301-7020	Centers for Disease Control and Prevention [1U01CK000509-01]; University at Albany Vice President for Research Office	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University at Albany Vice President for Research Office	This publication was supported by cooperative agreement 1U01CK000509-01, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. Initial funding supporting this collaboration was provided by the University at Albany Vice President for Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DLJ, 2015, J CHEM INF MODEL, V55, P1316, DOI 10.1021/acs.jcim.5b00206; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; Andreadis TG, 2012, J AM MOSQUITO CONTR, V28, P137, DOI 10.2987/8756-971X-28.4s.137; Bernard KA, 2001, VIRAL IMMUNOL, V14, P319, DOI 10.1089/08828240152716574; Biggerstaff B. J., 2009, POOLEDINFRATE VERSIO; BirdLife International, 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22705874A94039098.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22705874A94039098.EN]; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Bowen RA, 2007, CURR OPIN INFECT DIS, V20, P293, DOI 10.1097/QCO.0b013e32816b5cad; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown H, 2008, VECTOR-BORNE ZOONOT, V8, P197, DOI 10.1089/vbz.2007.0154; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287; Carpenter S. J., 1955, MOSQUITOES N AM N ME; CDC, 2017, FIN CUM MAPS DAT 199; CDC, 2017, SPEC DEAD BIRDS WHIC; Census Bureau U. S, 2010, 2010 CENS COUNT CONN; CHIANG CL, 1962, AM J HYG, V75, P377, DOI 10.1093/oxfordjournals.aje.a120259; Ciota AT, 2013, VIRUSES-BASEL, V5, P3021, DOI 10.3390/v5123021; Clark MP, 2006, J HYDROMETEOROL, V7, P3, DOI 10.1175/JHM474.1; Cohen JM, 2016, P NATL ACAD SCI USA, V113, pE3359, DOI 10.1073/pnas.1521657113; Connecticut Agricultural Experimental Station, 2018, CONN MOSQ TRAP DAT T; Connecticut State Department of Public Health, 2018, W NIL VIR STAT; Darsie R.F.J., 1981, IDENTIFICATION GEOGR; DeFelice NB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006047; DeFelice NB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14592; DeGroote JP, 2012, VECTOR-BORNE ZOONOT, V12, P657, DOI 10.1089/vbz.2011.0786; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; EPA, 2013, EPA FAC REG SERV FRS; Farnsworth George L., 2005, U S Forest Service General Technical Report PSW, V191, P736; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Gates MC, 2009, PREV VET MED, V89, P134, DOI 10.1016/j.prevetmed.2008.12.004; Gehlke CE, 1934, J AM STAT ASSOC, V29, P169, DOI 10.2307/2277827; George TL, 2015, P NATL ACAD SCI USA, V112, P14290, DOI 10.1073/pnas.1507747112; Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Jackson BT, 2005, J AM MOSQUITO CONTR, V21, P360, DOI 10.2987/8756-971X(2006)21[360:OPOCRA]2.0.CO;2; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Klenk K, 2004, EMERG INFECT DIS, V10, P2150, DOI 10.3201/eid1012.040264; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2005, AM J TROP MED HYG, V73, P1031, DOI 10.4269/ajtmh.2005.73.1031; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Kostyukov M. A., 1986, MED PARAZITOL MOSK, V6, P76; Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; KVALSETH TO, 1985, AM STAT, V39, P279, DOI 10.2307/2683704; LACHENBR.PA, 1968, TECHNOMETRICS, V10, P1, DOI 10.2307/1266219; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lampman RL, 1996, J AM MOSQUITO CONTR, V12, P23; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Lawler JJ, 2006, CONDOR, V108, P47, DOI 10.1650/0010-5422(2006)108[0047:AVATIM]2.0.CO;2; Little E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1720-1; Liu A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-67; Manore CA, 2014, PLOS CURR, V6; Means R, 1979, NY STATE MUS B A, V430, P1; Means RG., 1987, NEW YORK STATE MUSEU, V430B, P1; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Mongoh MN, 2008, TROP ANIM HEALTH PRO, V40, P69, DOI 10.1007/s11250-007-9055-8; Montgomery RR, 2017, CLIN EXP IMMUNOL, V187, P26, DOI 10.1111/cei.12863; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Myer MH, 2019, SCI TOTAL ENVIRON, V650, P2818, DOI 10.1016/j.scitotenv.2018.09.397; Myer MH, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1854; New York State Department of Health, 2018, NEW YORK MOSQ TRAP D; Newman AJ, 2015, J HYDROMETEOROL, V16, P2481, DOI 10.1175/JHM-D-15-0026.1; Nilsson R, 2007, J MACH LEARN RES, V8, P589; Niu GY, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015139; NYSDOH, 2018, COMM DIS ANN REP REL; Openshaw S., 1979, STAT APPL SPATIAL SC, V21, P127; Paull SH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2078; Paz S, 2008, ECOHEALTH, V5, P40, DOI 10.1007/s10393-007-0150-0; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pimentel RS, 2015, STAT PROBABIL LETT, V96, P61, DOI 10.1016/j.spl.2014.09.002; Python Software Foundation, 2016, PYTH LANG REF VERS 2; R Core Team, 2021, R LANGUAGE ENV STAT; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; REITER P, 1983, MOSQ NEWS, V43, P496; Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101; Rochlin I, 2008, J MED ENTOMOL, V45, P563, DOI 10.1603/0022-2585(2008)45[563:CAODAA]2.0.CO;2; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; Rochlin I, 2009, AM J TROP MED HYG, V80, P661, DOI 10.4269/ajtmh.2009.80.661; Root JJ, 2006, AM J TROP MED HYG, V75, P697, DOI 10.4269/ajtmh.2006.75.697; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; SCHMIDT JR, 1963, ANN TROP MED PARASIT, V57, P415, DOI 10.1080/00034983.1963.11686194; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Shaman J, 2011, J MED ENTOMOL, V48, P867, DOI 10.1603/ME10269; Simpson JE, 2012, P ROY SOC LOND B BIO, V279; Spielman A, 2001, ANN NY ACAD SCI, V951, P220; Stojanovich CJ, 1961, ILLUSTRATED KEY COMM; Tebaldi C, 2006, CLIMATIC CHANGE, V79, P185, DOI 10.1007/s10584-006-9051-4; Tonjes DJ, 2008, J VECTOR ECOL, V33, P293, DOI 10.3376/1081-1710-33.2.293; Trawinski PR, 2008, VECTOR-BORNE ZOONOT, V8, P505, DOI 10.1089/vbz.2007.0202; Trawinski PR, 2010, VECTOR-BORNE ZOONOT, V10, P515, DOI 10.1089/vbz.2008.0063; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Vanderhoff N, 2016, BIRDS N AM, DOI [10.2173/bna.462, DOI 10.2173/BNA.462]; Vitart F, 2017, B AM METEOROL SOC, V98, P163, DOI 10.1175/BAMS-D-16-0017.1; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; WALTER SD, 1980, AM J EPIDEMIOL, V112, P124, DOI 10.1093/oxfordjournals.aje.a112961; WHITTAKER J, 1984, J R STAT SOC C-APPL, V33, P52; Williams AP, 2017, J GEOPHYS RES-ATMOS, V122, P10888, DOI 10.1002/2017JD027523; Williams CJ, 2005, J AQUAT ANIM HEALTH, V17, P386, DOI 10.1577/H04-066.1; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; Xia YL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016048; Young SG, 2013, APPL GEOGR, V45, P241, DOI 10.1016/j.apgeog.2013.09.022	118	17	17	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217854	10.1371/journal.pone.0217854	http://dx.doi.org/10.1371/journal.pone.0217854			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158250	gold, Green Published, Green Submitted			2022-12-26	WOS:000469915700030
J	Hussein, NR; Balatay, AA; Saleem, ZSM; Hassan, SM; Assafi, MS; Sheikhan, RS; Amedi, FR; Hafzullah, SS; Hafzullah, MS; Xedr, AM; Zebary, MT; Aqrawi, HA				Hussein, Nawfal R.; Balatay, Amer A.; Saleem, Zana S. M.; Hassan, Shiraz M.; Assafi, Mande S.; Sheikhan, Ramzy Sh; Amedi, Farasheen R.; Hafzullah, Shivan S.; Hafzullah, Mahmood S.; Xedr, Abdulkareem M.; Zebary, Mohamed T.; Aqrawi, Hindreen A.			A clinical study of cutaneous leishmaniasis in a new focus in the Kurdistan region, Iraq	PLOS ONE			English	Article								Leishmaniasis is caused by protozoan parasites of the genus Leishmania and is a major health problem in various parts of the world. Cutaneous leishmaniasis (CL) occurs, among others, in unpredictable outbreaks after wars and disasters. After the last war in Iraq, the collapse of the health system led to the spread of infectious diseases, including CL. Between September 2016 and November 2017, all patients with confirmed CL having one or more skin lesion(s) were referred to a regional health center in Musol City within the Rabeea District. During this period, 1539 patients visited the clinic. A total of 190 patients were excluded from the study because of poor follow-up. The treatment success rate was 97.7% (1319/1349). Statistically significant associations were found between number of lesions and treatment failure (p = 0.0018; OR = 1.4430; CI = 1.1466-1.8161), number of doses and number of lesions (Pearson's correlation coefficient = 0.095; p = 0.001), and the lack of municipality services and number of doses used for the treatment (p = 0.008; OR = 1.0629; CI = 1.0158-1.1122). To conclude, the highest number of patients with CL in the city of Musol was recorded after the war in Iraq. The treatment success rate was high, which reflected the strict treatment and follow-up program. An urgent plan is needed to stop the spread of infection.	[Hussein, Nawfal R.] Univ Zakho, Coll Med, Zakho, Kurdistan Regio, Iraq; [Balatay, Amer A.] Univ Duhok, Coll Pharm, Duhok, Iraq; [Saleem, Zana S. M.; Hassan, Shiraz M.] Univ Duhok, Coll Med, Dept Internal Med, Duhok, Iraq; [Assafi, Mande S.] Univ Duhok, Coll Sci, Dept Biol, Duhok, Iraq; [Sheikhan, Ramzy Sh; Hafzullah, Shivan S.; Hafzullah, Mahmood S.; Xedr, Abdulkareem M.; Zebary, Mohamed T.; Aqrawi, Hindreen A.] Azadi Hosp, Infect Dis Unit, Directorate Hlth, Duhok, Iraq; [Amedi, Farasheen R.] Duhok Cent Lab, Dept Pathol, Duhok, Iraq	University of Duhok; University of Duhok; University of Duhok	Hussein, NR (corresponding author), Univ Zakho, Coll Med, Zakho, Kurdistan Regio, Iraq.	nawfal.hussein@yahoo.com		assafi, Mahde/0000-0002-4863-282X; Hussein, Nawfal/0000-0002-7813-9198	International Organization of Migration (IOM) - Duhok Suboffice - Medical Department	International Organization of Migration (IOM) - Duhok Suboffice - Medical Department	The role of the International Organization of Migration (IOM) - Duhok Suboffice - Medical Department should be acknowledged for supporting both the Rabeea medical team and researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004835; Alam E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004426; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; de Vries HJC, 2015, AM J CLIN DERMATOL, V16, P99, DOI 10.1007/s40257-015-0114-z; Fakoorziba MR, 2012, INT J INFECT DIS, V16, pE158, DOI 10.1016/j.ijid.2012.05.689; Hashiguchi Y, 2018, ACTA TROP, V177, P135, DOI 10.1016/j.actatropica.2017.09.028; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; Kobets T, 2012, PLOS NEGLECT TROP D, V6, P1; Llanos-Cuentas A, 2008, CLIN INFECT DIS, V46, P223, DOI 10.1086/524042; Machado P, 2002, CLIN INFECT DIS, V34, pE69, DOI 10.1086/340526; Munir M, 2002, GUIDELINES TREATMENT; Norouzinezhad F, 2016, ASIAN PAC J TROP BIO, V6, P614, DOI 10.1016/j.apjtb.2016.05.005; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Salam N, 2014, PLOS NEGLECT TROP D, V8, P1	14	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217683	10.1371/journal.pone.0217683	http://dx.doi.org/10.1371/journal.pone.0217683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150485	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100085
J	Wiatrowska, K; Komisarek, J				Wiatrowska, Katarzyna; Komisarek, Jolanta			Role of the light fraction of soil organic matter in trace elements binding	PLOS ONE			English	Article							METALLURGICAL FALLOUT; METAL ENRICHMENT; ARABLE SOILS; HEAVY-METALS; COPPER; CARBON; CADMIUM; ZINC; PB; BIOAVAILABILITY	The light fraction of soil organic matter (LF) has a rapid turnover and may be potentially metal-enriched, but the interaction between this pool of organic matter and trace elements has not been well studied. The present study aimed to investigate changes in LF content and its effect on heavy metals distribution and extractability in long-term contaminated soil by smelting activity. An incubation experiment was conducted on a surface horizon of Brunic Arenosol sampled from the previously-existing sanitary zone of Gtogow smelter, for 450 days. The contaminated soil was divided into three combinations: with the addition of either triticate straw (at the dose of 4.5 Mg ha(-1)) or pig manure (at the dose of 40 Mg ha(-1)) or without any "foreign" organic materials (nil). The LF (rho > 1.7 g cm(-3)) occurred to be metal-enriched and despite its low content (5.49%-nil, 7.18-straw and 7.29%-manure combination) in the bulk soil, it was observed that initially Cd, Cu, Pb and Zn stock reached 16.2%, 11.9%, 18.0% and 32.3%, respectively. Incubation conditions where mineralization processes dominate led to a decrease in the LF share by about 12.6% in nil and 31.4-39.8% in the combinations with organic amendments. In consequence, the DOC (dissolved organic carbon) concentration doubled and metal distribution had changed. The increase in water-soluble (F1) fraction was observed for all metals, additionally for Cu, Pb, Zn in exchangeable fraction (F2) and in carbonate bound (F3) fraction for Cd and Zn. These results support the view that changes in the LF content may play a key role in controlling trace metals mobility, especially in long-term contaminated soil.	[Wiatrowska, Katarzyna; Komisarek, Jolanta] Poznan Univ Life Sci, Dept Soil Sci & Land Reclamat, Poznan, Poland	Poznan University of Life Sciences	Wiatrowska, K (corresponding author), Poznan Univ Life Sci, Dept Soil Sci & Land Reclamat, Poznan, Poland.	kawiatr@up.poznan.pl		Komisarek, Jolanta/0000-0002-2986-0229; Wiatrowska, Katarzyna/0000-0002-5467-7952	Ministry of Science and Higher Education programme as "Regional Initiative Excellence" in years 2019-2022 [005/RID/2018/19];  [N N305 371 638]	Ministry of Science and Higher Education programme as "Regional Initiative Excellence" in years 2019-2022; 	Grant No. N N305 371 638; The work was founded by the Polish Ministry of Science and Higher Education and the publication was co-financed within the framework of Ministry of Science and Higher Education programme as "Regional Initiative Excellence" in years 2019-2022, Project No. 005/RID/2018/19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, 14841999 PNE; Balabane M, 1999, ENVIRON POLLUT, V105, P45, DOI 10.1016/S0269-7491(98)00209-7; Balabane M, 2002, SOIL BIOL BIOCHEM, V34, P1513, DOI 10.1016/S0038-0717(02)00066-4; Beckett P. H. T., 1989, Advances in Soil Science, V9, P143; Berardi R, 1998, WASTE MANAGE, V17, P535, DOI 10.1016/S0956-053X(97)10061-7; CAMBARDELLA CA, 1993, SOIL SCI SOC AM J, V57, P1071, DOI 10.2136/sssaj1993.03615995005700040032x; Chen W, 2015, ENVIRON SCI TECHNOL, V49, P2052, DOI 10.1021/es5049495; Chen Y, 2006, NATO SCI S SS IV EAR, V69, P275; Chlopecka A, 1996, J ENVIRON QUAL, V25, P69, DOI 10.2134/jeq1996.00472425002500010009x; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; DALAL RC, 1986, AUST J SOIL RES, V24, P293, DOI 10.1071/SR9860293; Du HH, 2018, ENVIRON POLLUT, V243, P444, DOI 10.1016/j.envpol.2018.08.087; Du HH, 2016, ENVIRON POLLUT, V218, P168, DOI 10.1016/j.envpol.2016.08.022; Dumat C, 2006, ENVIRON POLLUT, V142, P521, DOI 10.1016/j.envpol.2005.10.027; FAO. IUSS Working Group WRB, 2015, WORLD SOIL RESOURCES, V106; Gregorich E., 1993, SOIL SAMPLING METHOD, P397; Gregorich EG, 2006, SOIL SCI SOC AM J, V70, P975, DOI 10.2136/sssaj2005.0116; Grzebisz W, 2001, POL J ENVIRON STUD, V10, P269; Guo XJ, 2015, J SOIL SEDIMENT, V15, P1473, DOI 10.1007/s11368-015-1113-7; Hammer D, 2002, J ENVIRON QUAL, V31, P1561, DOI 10.2134/jeq2002.1561; Hu SH, 2016, J SOIL SEDIMENT, V16, P327, DOI 10.1007/s11368-015-1226-z; Jenkinson D. S., SOIL SCI, V197, P298; Kabala C., 2006, Polish Journal of Environmental Studies, V15, P90; Kabala C, 2001, J ENVIRON QUAL, V30, P485, DOI 10.2134/jeq2001.302485x; Kabata-Pendias A., 1992, TRACE ELEMENT SOILS; Kabata-Pendias A., 1995, BIBLIOTEKA MONITORIN, P28; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Komisarek J, 2009, POL J ENVIRON STUD, V18, P1029; Labanowski J, 2007, ENVIRON POLLUT, V149, P59, DOI 10.1016/j.envpol.2006.12.019; Li ZB, 1997, ENVIRON POLLUT, V95, P227, DOI 10.1016/S0269-7491(96)00074-7; Lindsay W.L., 1979, CHEM EQUILIBRIA SOIL; Liu BL, 2017, SCI TOTAL ENVIRON, V609, P822, DOI 10.1016/j.scitotenv.2017.07.215; MA QL, 1997, J ENVIRON QUAL, V26, P259; Magid J, 2010, EUR J SOIL SCI, V61, P539, DOI 10.1111/j.1365-2389.2010.01247.x; McBride M. B., 1989, Advances in Soil Science, V10, P1; Mohamed I, 2010, J SOIL SEDIMENT, V10, P973, DOI 10.1007/s11368-010-0199-1; Muller T, 2004, SOIL BIOL BIOCHEM, V36, P877, DOI 10.1016/S0038-0717(04)00047-1; Oades JM, 1995, DAHL WS ENV, V16, P293; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Przewocka M., 2011, INZYNIERIA SRODOWISK, V144, P103; Sherene T., 2009, NAT ENV POLLUT TECHN, V8, P817; Shi WJ, 2018, ECOTOX ENVIRON SAFE, V154, P59, DOI 10.1016/j.ecoenv.2018.02.013; Song B, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-3; Soriano-Disla JM, 2008, FRESEN ENVIRON BULL, V17, P1839; Szwed M, 2010, NAT HAZARD EARTH SYS, V10, P1725, DOI 10.5194/nhess-10-1725-2010; Thomas G. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P159; Tiller K. G., 1989, Advances in Soil Science, V9, P113; Wiatrowska K, 2013, FRESEN ENVIRON BULL, V22, P3424; Wiatrowska K, 2011, FRESEN ENVIRON BULL, V20, P2193; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Zhou T, 2018, ENVIRON POLLUT, V232, P514, DOI 10.1016/j.envpol.2017.09.081	51	8	9	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217077	10.1371/journal.pone.0217077	http://dx.doi.org/10.1371/journal.pone.0217077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145729	Green Published, gold, Green Submitted			2022-12-26	WOS:000469425500010
J	Deshpande, NG; Saxena, J; Pesaresi, TG; Carrell, CD; Ashby, GB; Liao, MK; Freeman, LR				Deshpande, Nikita Girish; Saxena, Juhi; Pesaresi, Tristan G.; Carrell, Casey Dylan; Ashby, Grayson Breneman; Liao, Min-Ken; Freeman, Linnea Ruth			High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats	PLOS ONE			English	Article							HIGH SATURATED FAT; INDUCED DYSBIOSIS; CHOLESTEROL DIET; OBESITY; BRAIN; SUGAR; IMPAIRMENT; MECHANISMS; EXPOSURE; MARKERS	As the global population ages, and rates of dementia rise, understanding lifestyle factors that play a role in the development and acceleration of cognitive decline is vital to creating therapies and recommendations to improve quality of later life. Obesity has been shown to increase risk for dementia. However, the specific mechanisms for obesity-induced cognitive decline remain unclear. One potential contributor to diet-induced cognitive changes is neuroinflammation. Furthermore, a source of diet-induced inflammation to potentially increase neuroinflammation is via gut dysbiosis. We hypothesized that a high fat diet would cause gut microbe dysbiosis, and subsequently: neuroinflammation and cognitive decline. Using 7-month old male Sprague Dawley rats, this study examined whether 8 weeks on a high fat diet could impact performance on the water radial arm maze, gut microbe diversity and abundance, and microgliosis. We found that a high fat diet altered gut microbe populations compared to a low fat, control diet. However, we did not observe any significant differences between dietary groups on maze performance (a measure of spatial working memory) or microgliosis. Our data reveal a significant change to the gut microbiome without subsequent effects to neuroinflammation (as measured by microglia characterization and counts in the cortex, hippocampus, and hypothalamus) or cognitive performance under the parameters of our study. However, future studies that explore duration of the diet, composition of the diet, age of animal model, and strain of animal model, must be explored.	[Deshpande, Nikita Girish; Saxena, Juhi; Pesaresi, Tristan G.; Freeman, Linnea Ruth] Furman Univ, Neurosci, Greenville, SC 29613 USA; [Carrell, Casey Dylan; Ashby, Grayson Breneman; Liao, Min-Ken; Freeman, Linnea Ruth] Furman Univ, Dept Biol, 3300 Poinsett Highway, Greenville, SC 29613 USA		Freeman, LR (corresponding author), Furman Univ, Neurosci, Greenville, SC 29613 USA.; Freeman, LR (corresponding author), Furman Univ, Dept Biol, 3300 Poinsett Highway, Greenville, SC 29613 USA.	linnea.freeman@furman.edu			National Institute of General Medical Sciences of the National Institutes of Health [P20GM103499]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103499 (LRF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilharz JE, 2018, MOL PSYCHIATR, V23, P351, DOI 10.1038/mp.2017.38; Beilharz JE, 2016, BEHAV BRAIN RES, V306, P1, DOI 10.1016/j.bbr.2016.03.018; Beilharz JE, 2016, BRAIN BEHAV IMMUN, V57, P304, DOI 10.1016/j.bbi.2016.07.151; Beilharz JE, 2015, NUTRIENTS, V7, P6719, DOI 10.3390/nu7085307; Beilharz JE, 2014, BRAIN BEHAV IMMUN, V37, P134, DOI 10.1016/j.bbi.2013.11.016; Bengmark S, 2013, PHARMACOL RES, V69, P87, DOI 10.1016/j.phrs.2012.09.002; Borre YE, 2014, ADV EXP MED BIOL, V817, P373, DOI 10.1007/978-1-4939-0897-4_17; Bruce-Keller AJ, 2016, BIOL PSYCHIAT, V80, pE5, DOI 10.1016/j.biopsych.2015.11.006; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cope EC, 2018, J NEUROSCI, V38, P8889, DOI 10.1523/JNEUROSCI.0789-18.2018; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Dorfman MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14556; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Freeman LR, 2014, NUTR NEUROSCI, V17, P241, DOI 10.1179/1476830513Y.0000000092; Freeman LR, 2012, J CEREBR BLOOD F MET, V32, P643, DOI 10.1038/jcbfm.2011.168; Freeman LR, 2011, NUTR NEUROSCI, V14, P32, DOI 10.1179/174313211X12966635733358; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; GREENWOOD CE, 1990, BEHAV NEURAL BIOL, V53, P74, DOI 10.1016/0163-1047(90)90831-P; Hargrave SL, 2016, BEHAV NEUROSCI, V130, P123, DOI 10.1037/bne0000110; Khan MZH, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/7869080; Ledreux A, 2016, BEHAV BRAIN RES, V312, P294, DOI 10.1016/j.bbr.2016.06.012; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Magnusson KR, 2015, NEUROSCIENCE, V300, P128, DOI 10.1016/j.neuroscience.2015.05.016; Marques C, 2016, BIOL PSYCHIAT, V80, pE3, DOI 10.1016/j.biopsych.2015.10.027; McNeilly AD, 2012, DIABETOLOGIA, V55, P3061, DOI 10.1007/s00125-012-2686-y; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1015, DOI 10.1016/j.jalz.2015.04.011; Morrison CD, 2010, J NEUROCHEM, V114, P1581, DOI 10.1111/j.1471-4159.2010.06865.x; Myles IA, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-61; Ogden CL, 2014, JAMA-J AM MED ASSOC, V312, P2; Singh-Manoux A, 2018, ALZHEIMERS DEMENT, V14, P178, DOI 10.1016/j.jalz.2017.06.2637; Smith P J, 2016, J Prev Alzheimers Dis, V3, P53; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322	39	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217553	10.1371/journal.pone.0217553	http://dx.doi.org/10.1371/journal.pone.0217553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141574	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000061
J	Mills, D; Fattebert, J; Hunter, L; Slotow, R				Mills, David; Fattebert, Julien; Hunter, Luke; Slotow, Rob			Maximising camera trap data: Using attractants to improve detection of elusive species in multi-species surveys	PLOS ONE			English	Article							ESTIMATING POPULATION-SIZE; CARNIVORE COMMUNITY; GRIZZLY BEARS; GOLDEN CAT; OCCUPANCY; LANDSCAPE; CAPTURE; FOREST; PATTERNS; PREY	Camera traps are a key tool in ecological studies, and are increasingly being used to understand entire communities. However, robust inferences continue to be hampered by low detection of rare and elusive species. Attractants can be used to increase detection rates, but may also alter behaviour, and little research has evaluated short-term, localized response to the presence of attractants. We conducted three camera trap surveys in Kibale National Park, Uganda, using food baits and scent lures (" attractants") at each camera station to entice small carnivores to pass in front of camera stations. To examine the interrelationship between scavenging and response to attractants, we also placed camera traps at five food refuse pits. We modelled the effect of attractant and duration of trap placement on the detection probability of small carnivores and selected African golden cat Caracal aurata prey items. We examine transient site response of each species, by comparing our observed likelihood of detection in each 24 h period from 1-7 d following refreshing of attractants to randomly generated capture histories. African civet Civettictis civetta, rusty-spotted genet Genetta maculata, African palm civet Nandinia binotata, and marsh mongoose Atilax paludinosus detection probabilities were highest and Weyns's red duiker Cephalophus wenysi detection probability was lowest immediately after attractants were placed. Within 24 h after attractant was placed, rusty-spotted genet and African palm civet were more likely to be detected and African golden cat, red duiker, and blue duiker Philantomba monticola were less likely to be detected. Our results suggest that attractants can increase detection of small-bodied species and include some arboreal species in terrestrial camera trap sampling. However, attractants may also alter short-term visitation rates of some species, with potentially cascading effects on others. Community level and intraguild interaction studies should control for the potentially confounding effects of attractants on spatial activity patterns.	[Mills, David; Fattebert, Julien; Hunter, Luke; Slotow, Rob] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Mills, David; Hunter, Luke] Panthera, New York, NY 10018 USA; [Slotow, Rob] UCL, Dept Genet Evolut & Environm, London, England	University of Kwazulu Natal; University of London; University College London	Mills, D (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.; Mills, D (corresponding author), Panthera, New York, NY 10018 USA.	africanleopard@gmail.com	Fattebert, Julien/I-8126-2019; Mills, David/GXF-1821-2022; Slotow, Rob/AAM-9053-2020	Fattebert, Julien/0000-0001-5510-6804; 	Panthera's Kaplan Graduate Award; Small Cat Action Fund; John D. and Catherine T. MacArthur Foundation Grant through the Wildlife Conservation Society (WCS), Uganda	Panthera's Kaplan Graduate Award; Small Cat Action Fund; John D. and Catherine T. MacArthur Foundation Grant through the Wildlife Conservation Society (WCS), Uganda	This work was supported by Panthera's Kaplan Graduate Award (DM) and Small Cat Action Fund (DM) https://www.panthera.org/grants-and-fellowships.Additional funding was provided through a John D. and Catherine T. MacArthur Foundation Grant through the Wildlife Conservation Society (WCS), Uganda. (DM). https://www.macfound.org/info-grantseekers/.https://uganda.wcs.org. Luke Hunter was both President of Panthera and co-supervisor of this work, which is part of a PhD thesis. He participated in discussions on survey locations and design, did not participate in data collection or analysis, approved our decision to publish, and provided comments on the manuscript. Since the mission of Panthera is to increase our knowledge and promote conservation of the worlds cats, we do not feel this is a conflict of interest.	Ahumada JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073707; Alexander JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134815; [Anonymous], 2012, HDB WILDLIFE MONITOR; Bahaa-el-din L, 2015, MAMMAL REV, V45, P63, DOI 10.1111/mam.12033; Balme G, 2014, BIOL CONSERV, V179, P144, DOI 10.1016/j.biocon.2014.09.021; Beaudrot L, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002357; Belbachir F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115136; Braczkowski AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151033; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Chapman CA, 2000, AM J PRIMATOL, V50, P169, DOI 10.1002/(SICI)1098-2345(200003)50:3&lt;169::AID-AJP1&gt;3.0.CO;2-P; Chapman CA, 2012, AM J PRIMATOL, V74, P510, DOI 10.1002/ajp.20992; CHARLESDOMINIQUE P, 1978, TERRE VIE-REV ECOL A, V32, P477; Cove M, 2014, HYSTRIX, V25, P113, DOI 10.4404/hystrix-25.2-9945; Cusack JJ, 2017, OIKOS, V126, P812, DOI 10.1111/oik.03403; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Di Bitetti Mario S, 2014, Mastozool. neotrop., V21, P37; du Preez BD, 2014, BIOL CONSERV, V176, P153, DOI 10.1016/j.biocon.2014.05.021; Echeverria-Londono S, 2016, DIVERS DISTRIB, V22, P1099, DOI 10.1111/ddi.12478; Edwards S, 2018, AFR J ECOL, V56, P885, DOI 10.1111/aje.12511; Edwards S, 2016, J ARID ENVIRON, V124, P304, DOI 10.1016/j.jaridenv.2015.09.009; Efford MG, 2016, ECOGRAPHY, V39, P676, DOI 10.1111/ecog.01511; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Farris ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136456; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Galvez N, 2016, BIOL CONSERV, V204, P350, DOI 10.1016/j.biocon.2016.10.019; Gerber BD, 2012, J MAMMAL, V93, P667, DOI 10.1644/11-MAMM-A-265.1; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Gompper ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146055; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hart JA, 1996, AFR J ECOL, V34, P364, DOI 10.1111/j.1365-2028.1996.tb00632.x; Hearn AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151046; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Kilshaw K, 2015, ORYX, V49, P207, DOI 10.1017/S0030605313001154; Kingdon J., 2013, MAMMALS AFRICA, Vv; Kittle AM, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0082-9; Laundre JW, 2014, ECOLOGY, V95, P1141, DOI 10.1890/13-1083.1; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Michalski F, 2010, ORYX, V44, P300, DOI 10.1017/S0030605309990871; Moreira-Arce D, 2016, FOREST ECOL MANAG, V369, P135, DOI 10.1016/j.foreco.2016.03.024; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Nagy-Reis MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168441; Noss A, 2013, EVALUATING JAGUAR DE; O'Connor KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175684; Ososky JJ, 1998, DIET LEOPARDS GOLDEN; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Rich LN, 2017, GLOBAL ECOL BIOGEOGR, V26, P918, DOI 10.1111/geb.12600; Rocha DG, 2016, J ZOOL, V300, P205, DOI 10.1111/jzo.12372; Ryan AM, 2013, AFR J ECOL, V51, P1, DOI 10.1111/j.1365-2028.2012.01346.x; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Srbek-Araujo AC, 2013, BIOTA NEOTROP, V13, P51, DOI 10.1590/S1676-06032013000200005; Steenweg R, 2016, BIOL CONSERV, V201, P192, DOI 10.1016/j.biocon.2016.06.020; Suraci JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10698; Swanson A, 2016, ECOL EVOL, V6, P8534, DOI 10.1002/ece3.2569; Theimer TC, 2015, URBAN ECOSYST, V18, P895, DOI 10.1007/s11252-015-0436-x; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tobler MW, 2015, J APPL ECOL, V52, P413, DOI 10.1111/1365-2664.12399; Van Rompaey H, 2013, MAMMALS AFRICA CARNI, V5, P140; Vargas LEP, 2016, BIODIVERS CONSERV, V25, P739, DOI 10.1007/s10531-016-1089-7; Weckel M, 2006, J ZOOL, V270, P25, DOI 10.1111/j.1469-7998.2006.00106.x; Wilting A, 2012, ORYX, V46, P423, DOI 10.1017/S0030605311001694	65	29	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216447	10.1371/journal.pone.0216447	http://dx.doi.org/10.1371/journal.pone.0216447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141506	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000012
J	Ning, K; Ding, CJ; Huang, QJ; Zhang, WX; Yang, CC; Liang, DJ; Fan, RT; Su, XH				Ning, Kun; Ding, Changjun; Huang, Qinjun; Zhang, Weixi; Yang, Chengchao; Liang, Dejun; Fan, Ruting; Su, Xiaohua			Transcriptome profiling revealed diverse gene expression patterns in poplar (Populus x euramericana) under different planting densities	PLOS ONE			English	Article							NITROGEN ASSIMILATION; GLUTAMINE-SYNTHETASE; BIOMASS PRODUCTION; YIELD; AUXIN; MAIZE; LIGHT; DEFENSE; GROWTH; RESISTANCE	Certain plant genotypes can achieve optimal growth under appropriate environmental conditions. Under high planting density conditions, plants undergo competition for uptake and utilization of light and nutrients. However, the relationship between whole-genome expression patterns and the planting density in perennial woody plants remains unknown. In this study, whole-genome RNA sequencing of poplar (Populus x euramericana) was carried out at three different sampling heights to determine gene expression patterns under high (HD) and low (LD) planting densities. As a result, 4,004 differentially expressed genes (DEGs) were detected between HD and LD, of which 2,300, 701, and 1,003 were detected at the three positions, upper, middle and bottom, respectively. Function annotation results further revealed that a large number of the DEGs were involved in distinct biological functions. There were significant changes in the expression of metabolism-related and stimulusrelated genes in response to planting density. There were 37 DEGs that were found at all three positions and were subsequently screened. Several DEGs related to plant light responses and photosynthesis were observed at different positions. Meanwhile, numbers of genes related to auxin/indole-3-acetic acid, and carbon and nitrogen metabolism were also revealed, displaying overall trends of upregulation under HD. These findings provide a basis for identifying candidate genes related to planting density and could increase our molecular understanding of the effect of planting density on gene expression.	[Ning, Kun; Ding, Changjun; Huang, Qinjun; Zhang, Weixi; Su, Xiaohua] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Ning, Kun; Ding, Changjun; Huang, Qinjun; Zhang, Weixi; Su, Xiaohua] State Forestry & Grassland Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China; [Yang, Chengchao; Liang, Dejun] Liaoning Prov Inst Poplar, Gaizhou, Liaoning, Peoples R China; [Fan, Ruting] Annoroad Gene Technol Co Ltd, Beijing, Peoples R China; [Su, Xiaohua] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Nanjing Forestry University	Su, XH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.; Su, XH (corresponding author), State Forestry & Grassland Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China.; Su, XH (corresponding author), Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.	suxh@caf.ac.cn	fan, ru/GYQ-7323-2022; Ning, Kun/GWQ-4538-2022	Ning, Kun/0000-0002-9086-128X; yang, chengchao/0000-0001-9765-987X	National Key Research and Development program of China [2016YFD0600401]	National Key Research and Development program of China	This work was supported by the National Key Research and Development program of China [Grant No. 2016YFD0600401 to XS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah HM, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0555-5; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alboresi A, 2005, PLANT CELL ENVIRON, V28, P500, DOI 10.1111/j.1365-3040.2005.01292.x; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Benomar L, 2012, TREES-STRUCT FUNCT, V26, P939, DOI 10.1007/s00468-011-0671-6; Bouguyon E, 2012, SEMIN CELL DEV BIOL, V23, P648, DOI 10.1016/j.semcdb.2012.01.004; Chen ChuanYong, 2010, Acta Agronomica Sinica, V36, P871, DOI 10.3724/SP.J.1006.2010.00871; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Cominelli E, 2009, CELL RES, V19, P1231, DOI 10.1038/cr.2009.123; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Estrada-Campuzano G, 2008, EUR J AGRON, V28, P597, DOI 10.1016/j.eja.2008.01.003; GERAKIS PA, 1980, AGR METEOROL, V21, P129, DOI 10.1016/0002-1571(80)90059-X; Gonzalez-Grandio E, 2013, PLANT CELL, V25, P834, DOI 10.1105/tpc.112.108480; Grassini P, 2011, FIELD CROP RES, V120, P142, DOI 10.1016/j.fcr.2010.09.012; Guo D, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02001; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hecht VL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00944; Jansson G, 2017, SCAND J FOREST RES, V32, P273, DOI 10.1080/02827581.2016.1242770; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Johnson DM, 2005, AM J BOT, V92, P1425, DOI 10.3732/ajb.92.9.1425; Kang M, 2015, BIOGEOSCIENCES, V12, P4245, DOI 10.5194/bg-12-4245-2015; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Karve AA, 2012, NEW PHYTOL, V196, P726, DOI 10.1111/j.1469-8137.2012.04288.x; Khan S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00532; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Knauss S, 2003, J BIOL CHEM, V278, P23936, DOI 10.1074/jbc.M212585200; Ku LX, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0483-x; Kusano M, 2011, PLANT J, V66, P456, DOI 10.1111/j.1365-313X.2011.04506.x; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Li F, 2010, PLANT CELL REP, V29, P977, DOI 10.1007/s00299-010-0883-z; Li HW, 2010, EUR J AGRON, V33, P267, DOI 10.1016/j.eja.2010.07.002; Liu HZ, 2008, PLANT MOL BIOL, V68, P17, DOI 10.1007/s11103-008-9349-x; Lockhart J, 2013, PLANT CELL, V25, P1483, DOI 10.1105/tpc.113.250510; Lutter R, 2017, SCAND J FOREST RES, V32, P688, DOI 10.1080/02827581.2017.1278784; Mao K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00480; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Moroney JV, 2001, PLANT CELL ENVIRON, V24, P141, DOI 10.1111/j.1365-3040.2001.00669.x; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Raey Y, 2009, NEW ZEAL J CROP HORT, V37, P141, DOI 10.1080/01140670909510259; Ren BZ, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1445-9; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Roig-Villanova I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00236; Ryu H, 2015, J PLANT BIOL, V58, P147, DOI 10.1007/s12374-015-0103-z; Sanchez-Rodriguez E, 2011, J PLANT PHYSIOL, V168, P816, DOI 10.1016/j.jplph.2010.11.018; Sawers RJH, 2005, TRENDS PLANT SCI, V10, P138, DOI 10.1016/j.tplants.2005.01.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; St Pierre S, 2011, PLANT GENOME-US, V4, P47, DOI 10.3835/plantgenome2010.08.0020; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Suga M, 2016, CURR OPIN STRUC BIOL, V39, P46, DOI 10.1016/j.sbi.2016.04.004; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tian Q, 2001, J PLANT GROWTH REGUL, V20, P274, DOI 10.1007/s003440010022; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tun TN, 2018, SCAND J FOREST RES, V33, P464, DOI 10.1080/02827581.2018.1457711; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; van Ittersum MK, 2013, FIELD CROP RES, V143, P1, DOI 10.1016/j.fcr.2012.12.012; Vanselow C, 2009, BBA-BIOENERGETICS, V1787, P46, DOI 10.1016/j.bbabio.2008.10.004; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang NY, 2015, PLANT PHYSIOL, V168, P575, DOI 10.1104/pp.15.00025; Zhao HS, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0720-9; Zhao SQ, 2013, MOL PLANT, V6, P174, DOI 10.1093/mp/sss064	68	6	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217066	10.1371/journal.pone.0217066	http://dx.doi.org/10.1371/journal.pone.0217066			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141527	Green Published, Green Submitted, gold			2022-12-26	WOS:000469323000038
J	Rai, P; Bharati, M; Subba, A; Saha, D				Rai, Priyanka; Bharati, Minu; Subba, Abhisekh; Saha, Dhiraj			Insecticide resistance mapping in the vector of lymphatic filariasis, Culex quinquefasciatus Say from northern region of West Bengal, India	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; PYRETHROID RESISTANCE; CARBAMATE RESISTANCE; AEDES-AEGYPTI; HARRIS COUNTY; MECHANISMS; MOSQUITOS; DIPTERA; CULICIDAE; ORGANOPHOSPHATE	Culex quinquefasciatus is a vector of lymphatic filariasis and vector control strategies normally involve the use of synthetic insecticides targeted against them. Extensive and uncontrolled use of these synthetic insecticides has led to the development of insecticide resistance in the mosquito vectors. In this context, to study the resistance status of Cx. quinquefasciatus, field populations were collected from three districts of Northern part of West Bengal and tested against insecticides ( 5% malathion, 0.05% deltamethrin, 0.05% lambdacyhalothrin, 0.75% permethrin, 0.1% propoxur, 4% DDT and Temephos). Qualitative and quantitative enzyme assay was also conducted in order to find the role of detoxifying enzymes behind the development of insecticide resistance. This study revealed the presence of widespread resistance amongst the field populations of Cx. quinquefasciatus throughout the studied regions. Moreover, the result of native PAGE and biochemical enzyme assay may be linked to some extent in the involvement of the detoxifying enzymes in conferring resistance against insecticides in most of the tested Cx. quinquefasciatus populations. The present study involving the survey of resistance status may be of immense help during the implementation of vector control strategies throughout this region.	[Rai, Priyanka; Bharati, Minu; Subba, Abhisekh; Saha, Dhiraj] Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, Raja Rammohanpur, W Bengal, India	University of North Bengal	Saha, D (corresponding author), Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, Raja Rammohanpur, W Bengal, India.	dhirajsaha.nbu@gmail.com	Saha, Dhiraj/AEB-7986-2022	Saha, Dhiraj/0000-0002-2309-4068	University Grants Commission (UGC), New Delhi, India [2061630607, 19/06/2016 (ii) EU-V]	University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	The first author expresses sincere gratitude to University Grants Commission (UGC), New Delhi, India for providing financial assistance through Junior Research Fellowship (JRF) award letter Sr. no. 2061630607, Ref no.: 19/06/2016 (ii) EU-V, Dated 23/01/2017. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], 2006, PESTICIDES THEIR APP; [Anonymous], 2014, ADV ENTOMOL, DOI DOI 10.4236/ae.2014.23019; Atoni E, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010030; Balabanidou V, 2018, CURR OPIN INSECT SCI, V27, P68, DOI 10.1016/j.cois.2018.03.001; Bharati M., 2017, VECTOR BORNE DIS TRE, P1; Bharati M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203207; Bharati M, 2018, ACTA TROP, V187, P78, DOI 10.1016/j.actatropica.2018.07.004; BISSET JA, 1990, B ENTOMOL RES, V80, P245, DOI 10.1017/S0007485300050434; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; CARVALHO VM, 2003, GENET MOL BIOL, V26, P195, DOI DOI 10.1590/S1415-47572003000200013; Chandre F, 1998, MED VET ENTOMOL, V12, P359, DOI 10.1046/j.1365-2915.1998.00120.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; Delannay C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199615; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x; Gordon JR, 2012, J ECON ENTOMOL, V105, P971, DOI 10.1603/EC11224; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayes J.D., 1988, GLUTATHIONE CONJUGAT, P3150; HEMINGWAY J, 1990, MED VET ENTOMOL, V4, P275, DOI 10.1111/j.1365-2915.1990.tb00440.x; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; KARUNARATNE SHPP, 1993, BIOCHEM J, V294, P575, DOI 10.1042/bj2940575; Kudom AA, 2015, ACTA TROP, V150, P122, DOI 10.1016/j.actatropica.2015.07.009; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NVBDCP, 2018, FIL MAGN DIS; Pietrantonio PV, 2000, J VECTOR ECOL, V25, P74; Rai P, 2018, VECTOR BORNE DIS TRE, VII, P1; Skovmand O, 2018, MED RES ARCH, V6, DOI [10.18103/mra.v6i4.1773, DOI 10.18103/MRA.V6I4.1773]; Stark PM, 2017, J VECTOR ECOL, V42, P279, DOI 10.1111/jvec.12268; Sudomo M, 2010, ADV PARASIT, V72, P205, DOI 10.1016/S0065-308X(10)72008-X; Thavaselvam D., 1993, Indian Journal of Malariology, V30, P75; Tyagi BK., 2015, INT J MOSQ RES, V50, P50; VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4; WHO, TEST PROC INREMO; World Health Organization, 2005, GUIDELINES LAB FIELD; Yadouleton A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0638-3	43	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217706	10.1371/journal.pone.0217706	http://dx.doi.org/10.1371/journal.pone.0217706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141548	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000075
J	Xu, Y; Sun, FY; Ji, C; Hu, QW; Wang, CY; Wu, DX; Sun, GL				Xu, Yi; Sun, Fang-Yao; Ji, Chun; Hu, Quan-Wen; Wang, Cheng-Yu; Wu, De-Xiang; Sun, Genlou			Nucleotide diversity patterns at the DREB1 transcriptional factor gene in the genome donor species of wheat (Triticum aestivum L)	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; BINDING DOMAIN; WILD RELATIVES; DNA; POLYMORPHISM; EVOLUTION; TOLERANCE; EXPRESSION; AEGILOPS; DROUGHT	Bread wheat (AABBDD) originated from the diploid progenitor Triticum urartu (AA), a relative of Aegilops speltoides (BB), and Ae. tauschii (DD). The DREB1 transcriptional factor plays key regulatory role in low-temperature tolerance. The modern breeding strategies resulted in serious decrease of the agricultural biodiversity, which led to a loss of elite genes underlying abiotic stress tolerance in crops. However, knowledge of this gene's natural diversity is largely unknown in the genome donor species of wheat. We characterized the dehydration response element binding protein 1 (DREB1) gene-diversity pattern in Ae. speltoides, Ae. tauschii, T. monococcum and T. urartu. The highest nucleotide diversity value was detected in Ae. speltoides, followed by Ae. tauschii and T. monococcum. The lowest nucleotide diversity value was observed in T. urartu. Nucleotide diversity and haplotype data might suggest no reduction of nucleotide diversity during T. monococcum domestication. Alignment of the 68 DREB1 sequences found a large-size (70 bp) insertion/deletion in the accession PI486264 of Ae. speltoides, which was different from the copy of sequences from other accessions of Ae. speltoides, suggesting a likely existence of two different ancestral Ae. speltoides forms. Implication of sequences variation of Ae. speltoides on origination of B genome in wheat was discussed.	[Xu, Yi; Sun, Fang-Yao; Ji, Chun; Hu, Quan-Wen; Wang, Cheng-Yu; Wu, De-Xiang; Sun, Genlou] Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China; [Sun, Genlou] St Marys Univ, Biol Dept, Halifax, NS, Canada	Anhui Agricultural University; Saint Marys University - Canada	Wu, DX; Sun, GL (corresponding author), Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China.; Sun, GL (corresponding author), St Marys Univ, Biol Dept, Halifax, NS, Canada.	dexiangwu198@163.com; genlou.sun@smu.ca			National Key Research and Development Program of China [2017YFD0301304]; Research Foundation for Talented Scholars from Anhui Agricultural University; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05817, RGPIN-2018-05433]; Senate Research Grant at Saint Mary's University; introduced leading talent research team for Universities in Anhui Province	National Key Research and Development Program of China; Research Foundation for Talented Scholars from Anhui Agricultural University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Senate Research Grant at Saint Mary's University; introduced leading talent research team for Universities in Anhui Province	This project was supported in part by the National Key Research and Development Program of China (2017YFD0301304), a Research Foundation for Talented Scholars from Anhui Agricultural University and the introduced leading talent research team for Universities in Anhui Province, the Natural Sciences and Engineering Research Council of Canada (grant No: RGPIN-2017-05817 and RGPIN-2018-05433) and a Senate Research Grant at Saint Mary's University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Burke EJ, 2006, J HYDROMETEOROL, V7, P1113, DOI 10.1175/JHM544.1; Challam C, 2015, J GENET, V94, P231, DOI 10.1007/s12041-015-0507-z; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Alves GSC, 2018, TROP PLANT BIOL, V11, P31, DOI 10.1007/s12042-018-9199-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; DVORAK J, 1990, P NATL ACAD SCI USA, V87, P9640, DOI 10.1073/pnas.87.24.9640; Dwivedi SL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01461; Edae EA, 2013, PLANT GEN, V6, P2, DOI DOI 10.3835/PLANTGEN0ME2013.04.0010; El Baidouri M, 2017, NEW PHYTOL, V213, P1477, DOI 10.1111/nph.14113; El-Shazly H, 2012, J GENET ENG BIOTECHN, V10, P1, DOI [10.1016/j.jgeb.2011.08.002, DOI 10.1016/J.JGEB.2011.08.002]; FAO (Food Agriculture Organization of the United Nations), 2004, FAO PROD YB; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Filiz E, 2014, APPL BIOCHEM BIOTECH, V174, P1272, DOI 10.1007/s12010-014-1093-x; FU YX, 1993, GENETICS, V133, P693; Ganeva G., 2000, Genetika, V36, P71; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Golovnina KA, 2007, PLANT SYST EVOL, V264, P195, DOI 10.1007/s00606-006-0478-x; Gulbitti-Onarici S, 2007, BOT J LINN SOC, V153, P67, DOI 10.1111/j.1095-8339.2007.00585.x; Haider N, 2013, Genetika, V49, P303; Harmon LJ, 2005, EVOLUTION, V59, P2705; Heidarvand L, 2010, ACTA PHYSIOL PLANT, V32, P419, DOI 10.1007/s11738-009-0451-8; Hirosawa S, 2004, GENES GENET SYST, V79, P271, DOI 10.1266/ggs.79.271; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jadhao KR, 2014, HEREDITARY GENET, V3, P3; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Kurahashi Y, 2009, INT J MOL SCI, V10, P2733, DOI 10.3390/ijms10062733; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02163; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu FF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31706; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Luo GB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0322-3; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Morrell PL, 2014, J HERED, V105, P253, DOI 10.1093/jhered/est083; Munoz-Amatriain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-653; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Qi PF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-168; Roorkiwal M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00248; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Salina EA, 2006, GENOME, V49, P1023, DOI 10.1139/G06-050; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Sasanuma T, 2002, EUPHYTICA, V127, P81, DOI 10.1023/A:1019941817057; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAJIMA F, 1989, GENETICS, V123, P585; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Wang GZ, 1997, P NATL ACAD SCI USA, V94, P14570, DOI 10.1073/pnas.94.26.14570; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei B, 2009, MOL BREEDING, V23, P13, DOI 10.1007/s11032-008-9209-z; Wiens JJ, 1998, SYST BIOL, V47, P228, DOI 10.1080/106351598260897; Wu DX, 2014, GENE, V546, P11, DOI 10.1016/j.gene.2014.05.049; Xu ZS, 2009, J PLANT RES, V122, P121, DOI 10.1007/s10265-008-0195-3	65	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217081	10.1371/journal.pone.0217081	http://dx.doi.org/10.1371/journal.pone.0217081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136598	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300017
J	da Silva, CA; Callegari, MA; Dias, CP; Bridi, AM; Pierozan, CR; Foppa, L; Martins, CCD; Dias, FTF; Passos, A; Hermes, R				da Silva, Caio Abercio; Callegari, Marco Aurelio; Dias, Cleandro Pazinato; Bridi, Ana Maria; Pierozan, Carlos Rodolfo; Foppa, Luciana; da Silva Martins, Claudia Cassimira; Falleiros Dias, Francine Taniguchi; Passos, Adsos; Hermes, Rafael			Increasing doses of phytase from Citrobacter braakii in diets with reduced inorganic phosphorus and calcium improve growth performance and lean meat of growing and finishing pigs	PLOS ONE			English	Article							TRACT NUTRIENT DIGESTIBILITY; SOYBEAN-MEAL; AMINO-ACIDS; MINERAL DIGESTIBILITY; ILEAL DIGESTIBILITY; PLASMA METABOLITES; MICROBIAL PHYTASE; 6-PHYTASE; AVAILABILITY; DEPOSITION	The objective of this study was to evaluate the effect of increasing doses of bacterial phytase (RONOZYME HiPhos) on performance and carcass characteristics of growing and finishing pigs. The study included 120 castrated males with initial weight of 23.21 +/- 1.91 kg and 68 days of age, distributed in a randomized block design with five treatments and eight replicates with three animals each. The pigs were fed five corn-soybean meal-based diets: positive control (PC), supplemented with inorganic phosphorus and calcium; negative control (NC), with 0.13% reduction in available phosphorus and 0.11% in calcium; and three NC diets supplemented with 1,000, 2,000, and 3,000 phytase units (FYT)/kg in the feed. Compared with the NC diets without phytase, diets with 1,000, 2,000, and 3,000 FYT/kg inclusion increased the daily weight gain by +12% (quadratic, p<0.05) during the growing I period; +2.9, +2.9, and +10.5% (linear, p<0.01), respectively, during the growing II period; and +4.1, +5.1, and +8.2% (linear, p<0.001), respectively, over the entire experimental period. The daily feed intake increased by 0, +2.8, and +4.3% (linear, p<0.05), respectively, considering the entire experimental period; and the final live weight increased by +3.2, +4.2, and +6.1% (linear, p<0.001), respectively. The phytase treatments did not influence feed conversion ratio, carcass weight and yield, backfat thickness, loin depth and carcass lean meat. According to the European Carcass Classification (SEUROP), however, the animals fed the PC diet and the three phytase levels had more carcasses classified as E (between 55-60% lean meat) when compared to carcasses of pigs fed the NC. Supplementing increasing levels of phytase to a corn-and soybean meal-based diet with inorganic P and Ca reduction improved daily weight gain and feed intake of growing pigs, and such effects were maintained until slaughter age.	[da Silva, Caio Abercio; Callegari, Marco Aurelio; Bridi, Ana Maria; Pierozan, Carlos Rodolfo; Foppa, Luciana] Univ Estadual Londrina, Ctr Agrarian Sci, Dept Zootechnol, Londrina, Parana, Brazil; [Dias, Cleandro Pazinato] Akei Anim Res, Fartura, SP, Brazil; [da Silva Martins, Claudia Cassimira; Falleiros Dias, Francine Taniguchi; Passos, Adsos; Hermes, Rafael] DSM Nutr Prod Ltda, Jaguare, SP, Brazil	Universidade Estadual de Londrina	da Silva, CA; Pierozan, CR (corresponding author), Univ Estadual Londrina, Ctr Agrarian Sci, Dept Zootechnol, Londrina, Parana, Brazil.	casilva@uel.br; carlospierozan@hotmail.com	BRIDI, ANA/ABC-5253-2021	Silva, Claudia/0000-0003-3822-5611; Foppa, Luciana/0000-0002-8353-6470; Pierozan, Carlos Rodolfo/0000-0003-2703-1387				Adeola O, 2011, J ANIM SCI, V89, P3189, DOI 10.2527/jas.2010-3715; Almeida FN, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-8; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2527; Brady SM, 2003, IRISH J AGR FOOD RES, V42, P101; Brana DV, 2006, J ANIM SCI, V84, P1839, DOI 10.2527/jas.2005-565; Cowieson AJ, 2017, ANIM FEED SCI TECH, V225, P182, DOI 10.1016/j.anifeedsci.2017.01.008; Cowieson A, 2016, ANIM FEED SCI TECH, V222, P180, DOI 10.1016/j.anifeedsci.2016.10.016; Cowieson AJ, 2011, WORLD POULTRY SCI J, V67, P225, DOI 10.1017/S0043933911000250; Cowieson AJ, 2017, BRIT J NUTR, V118, P897, DOI [10.1017/s0007114517003026, 10.1017/S0007114517003026]; Dersjant-Li YueMing, 2017, Journal of Applied Animal Nutrition, V5, pe4, DOI 10.1017/JAN.2017.3; Dersjant-Li Y, 2015, J SCI FOOD AGR, V95, P878, DOI 10.1002/jsfa.6998; Fandrejewski H, 1999, J ANIM FEED SCI, V8, P533; Goncalves MAD, 2016, J SWINE HEALTH PROD, V24, P97; Guggenbuhl P, 2007, LIVEST SCI, V109, P261, DOI 10.1016/j.livsci.2007.01.110; Guggenbuhl P, 2016, J ANIM SCI, V94, P286, DOI 10.2527/jas.2015-9806; Guggenbuhl P, 2016, J ANIM SCI, V94, P307, DOI 10.2527/jas.2015-9807; Guggenbuhl P, 2012, J ANIM SCI, V90, P182, DOI 10.2527/jas.53892; Guggenbuhl P., 2012, J ANIM SCI ADV, V2, P438; Haefner S, 2005, APPL MICROBIOL BIOT, V68, P588, DOI 10.1007/s00253-005-0005-y; Johnston SL, 2004, J ANIM SCI, V82, P705; Jongbloed AW, 2004, LIVEST PROD SCI, V91, P143, DOI 10.1016/j.livprodsci.2004.07.017; Kerr BJ, 2010, J ANIM SCI, V88, P238, DOI 10.2527/jas.2009-2146; KETAREN PP, 1993, BRIT J NUTR, V70, P289, DOI 10.1079/BJN19930123; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Lozano A.P., 2011, Arch. zootec., V60, P839, DOI 10.4321/s0004-05922011000400001; Madrid J, 2013, LIVEST SCI, V154, P144, DOI 10.1016/j.livsci.2013.03.003; Menezes-Blackburn D, 2015, J AGR FOOD CHEM, V63, P6142, DOI 10.1021/acs.jafc.5b01996; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Romero LF, 2016, POULTR SCI ASS P 1 L; Rostagno H.S., 2011, COMPOSICAO ALIMENTOS, V2, P186; Saraiva A, 2009, REV BRAS ZOOTECN, V38, P1279, DOI 10.1590/S1516-35982009000700017; Schmeisser J, 2017, J ANIM PHYSIOL AN N, V101, P563, DOI 10.1111/jpn.12482; Selle PH, 2008, LIVEST SCI, V113, P99, DOI 10.1016/j.livsci.2007.05.014; Selle PH, 2012, NUTR RES REV, V25, P1, DOI 10.1017/S0954422411000151; Selle PH, 2009, LIVEST SCI, V124, P126, DOI 10.1016/j.livsci.2009.01.006; Shelton JL, 2003, J ANIM SCI, V81, P2053; Silva CA, 2014, PRODUCAO SUINOS TEOR, P707; Traylor SL, 2001, J ANIM SCI, V79, P2634; Velayudhan DE, 2015, ANIM FEED SCI TECH, V210, P217, DOI 10.1016/j.anifeedsci.2015.10.005; Wiseman TG, 2007, J ANIM SCI, V85, P1825, DOI 10.2527/jas.2006-407; Wu F, 2017, KANS AES RES PUBL, V3, P19	41	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217490	10.1371/journal.pone.0217490	http://dx.doi.org/10.1371/journal.pone.0217490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125379	Green Published, gold, Green Submitted			2022-12-26	WOS:000468865700044
J	Melendez, DM; Marti, S; Pajor, EA; Sidhu, PK; Gellatly, D; Janzen, ED; Schwinghamer, TD; Coetzee, JF; Schwartzkopf-Genswein, KS				Melendez, Daniela M.; Marti, Sonia; Pajor, Edmond A.; Sidhu, Pritam K.; Gellatly, Desiree; Janzen, Eugene D.; Schwinghamer, Timothy D.; Coetzee, Johann F.; Schwartzkopf-Genswein, Karen S.			Pharmacokinetics of oral and subcutaneous meloxicam: Effect on indicators of pain and inflammation after knife castration in weaned beef calves	PLOS ONE			English	Article							SURGICAL CASTRATION; SUBSTANCE-P; PLASMA-CORTISOL; ADULT GOATS; BEHAVIOR; PERFORMANCE; BAND; ANESTHESIA; MITIGATION; BIOMARKERS	Oral meloxicam is labelled for reducing pain and inflammation associated with castration in cattle in Canada, however, subcutaneous meloxicam is only labelled for pain associated with dis-budding and abdominal surgery. The aim of this project was to determine the pharmacokinetic profile of oral (PO; 1.0 mg/kg BW) and subcutaneous meloxicam (SC; 0.5 mg/kg BW), and to assess the effect of meloxicam on physiological and behavioural indicators of pain associated with knife castration in 7-8 month old calves. Twenty-three Angus crossbred beef calves (328 +/- 4.4 kg BW) were randomly assigned to two treatments: PO n = 12 or SC n = 11 administration of meloxicam immediately before knife castration. Physiological parameters included salivary and hair cortisol, substance P, haptoglobin, serum amyloid-A, weight, complete blood count, scrotal and rectal temperature. Behavioural parameters included standing and lying behaviour, pen behaviour and feeding behaviour. Data were analyzed using PROC GLIMMIX (SAS), with repeated measures using mixed procedures including treatment as a fixed effect and animal and pen as a random effect. The pharmacokinetic profile of the drug including area under the curve, volume of distribution and clearance was greater (P < 0.05) in PO than SC calves. After surgery, substance P concentrations, white blood cell counts (WBC), weight and lying duration were greater (P < 0.05) in PO than SC calves, while scrotal circumference was lower (P < 0.05) in PO calves than SC calves. Although statistical differences were observed for pharmacokinetic, physiological and behavioural parameters differences were small and may lack biological relevance.	[Melendez, Daniela M.; Marti, Sonia; Gellatly, Desiree; Schwinghamer, Timothy D.; Schwartzkopf-Genswein, Karen S.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Marti, Sonia] IRTA, Dept Ruminant Prod, Barcelona, Spain; [Pajor, Edmond A.; Janzen, Eugene D.] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada; [Sidhu, Pritam K.; Coetzee, Johann F.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	Agriculture & Agri Food Canada; IRTA; University of Calgary; Kansas State University	Schwartzkopf-Genswein, KS (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	Karen.genswein@agr.gc.ca	Marti, Sonia/S-1799-2019; Coetzee, Hans/GOK-3477-2022; MartÍ, Sonia/P-9800-2016; Meléndez, Daniela/AAT-9279-2020	Coetzee, Hans/0000-0003-1802-3991; MartÍ, Sonia/0000-0002-8115-0582; Meléndez, Daniela/0000-0002-0153-9708; Schwinghamer, Timothy/0000-0001-7727-7284	Agriculture and Agri-Food Canada; Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster [ANH.21.13AIP-CL01]; CERCA program from Generalitat de Catalunya	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster; CERCA program from Generalitat de Catalunya	Funding was provided by Agriculture and Agri-Food Canada (http://www.agr.gc.ca/eng/home/?id=1395690825741) and the Beef Cattle Research Council (http://www.beefresearch.ca/) through the Canadian Beef Cattle Industry Science Cluster (ANH.21.13AIP-CL01). The co-author Sonia Marti was partly supported by the CERCA program from Generalitat de Catalunya. This is Lethbridge Research Centre contribution #38719006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou MA, 2013, VET IMMUNOL IMMUNOP, V151, P285, DOI 10.1016/j.vetimm.2012.11.018; Barrier AC, 2014, APPL ANIM BEHAV SCI, V155, P28, DOI 10.1016/j.applanim.2014.02.015; Brown AC, 2015, J ANIM SCI, V93, P2460, DOI 10.2527/jas.2014-8695; CCAC, 2009, CCAC GUID AN US PROT; CHASE CC, 1995, J ANIM SCI, V73, P975; Coetzee JF, 2008, AM J VET RES, V69, P751, DOI 10.2460/ajvr.69.6.751; Coetzee JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-153; Coetzee JF, 2009, VET THER, V10; Currah JM, 2009, CAN VET J, V50, P375; de Grauw JC, 2009, EQUINE VET J, V41, P693, DOI 10.2746/042516409X436286; DeVane CL, 2001, PHARMACOTHERAPY, V21, P1061, DOI 10.1592/phco.21.13.1061.34612; Dockweiler JC, 2013, J DAIRY SCI, V96, P4340, DOI 10.3168/jds.2012-6274; Fisher AD, 1996, J ANIM SCI, V74, P2336; Gonzalez LA, 2010, J ANIM SCI, V88, P802, DOI 10.2527/jas.2008-1752; Ingvast-Larsson C, 2011, J VET PHARMACOL THER, V34, P64, DOI 10.1111/j.1365-2885.2010.01195.x; Karademir U, 2016, NEW ZEAL VET J, V64, P165, DOI 10.1080/00480169.2015.1124811; Kreuder AJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-85; Lees P, 2004, J VET PHARMACOL THER, V27, P479, DOI 10.1111/j.1365-2885.2004.00617.x; Marti S, 2018, CANADIAN J ANIMAL SC, V21, P1; Marti S, 2018, J ANIM SCI, V96, P4136, DOI 10.1093/jas/sky291; Marti S, 2017, CAN VET J, V58, P1081; Martin P., 2007, RECORDING METHODS ME, V3rd, P48; McFarlane D., 2008, LARGE ANIMAL INTERNA, V4th, P1478; Melendez DM, 2018, J ANIM SCI, V96, P1268, DOI 10.1093/jas/sky034; Melendez DM, 2017, J ANIM SCI, V95, P5218, DOI 10.2527/jas2017.1978; Melendez DM, 2017, J ANIM SCI, V95, P4352, DOI 10.2527/jas2017.1762; Melendez DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207289; Melendez DM, 2018, J ANIM SCI, V96, P3606, DOI 10.1093/jas/sky245; Molony V, 1995, APPL ANIM BEHAV SCI, V46, P33, DOI 10.1016/0168-1591(95)00635-4; Moya D, 2014, J ANIM SCI, V92, P1684, DOI 10.2527/jas.2013-7298; Moya D, 2013, LIVEST SCI, V158, P138, DOI 10.1016/j.livsci.2013.10.007; NFACC, 2013, COD PRACT CAR HANDL; NICOL GD, 1992, J NEUROSCI, V12, P1917; NRC (National Research Council), 2016, NUTR REQ BEEF CATTL; PERRIER D, 1982, J PHARM SCI, V71, P372, DOI 10.1002/jps.2600710332; Repenning PE, 2013, J ANIM SCI, V91, P4975, DOI 10.2527/jas.2012-6061; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Roberts SL, 2015, J ANIM SCI, V93, P4123, DOI 10.2527/jas.2015-9160; Schwartzkopf-Genswein KS, 2003, CAN J ANIM SCI, V83, P29, DOI 10.4141/A02-027; SEIDEMAN SC, 1982, J ANIM SCI, V55, P826, DOI 10.2527/jas1982.554826x; Shukla M, 2007, COMP BIOCHEM PHYS C, V145, P528, DOI 10.1016/j.cbpc.2007.01.020; Sowell BF, 1998, APPL ANIM BEHAV SCI, V59, P277, DOI 10.1016/S0168-1591(98)00110-5; Stock ML, 2013, AM J VET RES, V74, P779, DOI 10.2460/ajvr.74.5.779; Theurer ME, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-48; Toutain PL, 2004, J VET PHARMACOL THER, V27, P415, DOI 10.1111/j.1365-2885.2004.00605.x; Toutain PL, 2004, AM J VET RES, V65, P1542, DOI 10.2460/ajvr.2004.65.1542; Tripathi K., 2013, ESSENTIALS MED PHARM, P5; UBC AWP (University of British Columbia Animal Welfare Program), 2013, UBC AN WELF PROGR SO, P1; Van Engen NK, 2014, J ANIM SCI, V92, P498, DOI 10.2527/jas.2013-6857; White BJ, 2008, AM J VET RES, V69, P1005, DOI 10.2460/ajvr.69.8.1005	50	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217518	10.1371/journal.pone.0217518	http://dx.doi.org/10.1371/journal.pone.0217518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125384	Green Published, gold, Green Submitted			2022-12-26	WOS:000468865700047
J	Ortega, FJ; Moreno-Navarrete, JM; Mercader, JM; Gomez-Serrano, M; Garcia-Santos, E; Latorre, J; Lluch, A; Sabater, M; Caballano-Infantes, E; Guzman, R; Macias-Gonzalez, M; Buxo, M; Girones, J; Vilallonga, R; Naon, D; Botas, P; Delgado, E; Corella, D; Burcelin, R; Fruhbeck, G; Ricart, W; Simo, R; Castrillon-Rodriguez, I; Tinahones, FJ; Bosch, F; Vidal-Puig, A; Malagon, MM; Peral, B; Zorzano, A; Fernandez-Real, JM				Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Mercader, Josep M.; Gomez-Serrano, Maria; Garcia-Santos, Eva; Latorre, Jessica; Lluch, Aina; Sabater, Monica; Caballano-Infantes, Estefania; Guzman, Rocio; Macias-Gonzalez, Manuel; Buxo, Maria; Girones, Jordi; Vilallonga, Ramon; Naon, Deborah; Botas, Patricia; Delgado, Elias; Corella, Dolores; Burcelin, Remy; Fruhbeck, Gema; Ricart, Wifredo; Simo, Rafael; Castrillon-Rodriguez, Ignacio; Tinahones, Francisco J.; Bosch, Fatima; Vidal-Puig, Antonio; Malagon, Maria M.; Peral, Belen; Zorzano, Antonio; Fernandez-Real, Jose M.			Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function	FASEB JOURNAL			English	Article						cytoskeleton; adipocytes; inflammation; obesity	ACTIN CYTOSKELETON; GENE POLYMORPHISMS; LIPID DROPLETS; ASSOCIATION; OBESITY; CELLS; ADIPOGENESIS; SENSITIVITY; PLASTICITY; SOFTWARE	During adipogenesis, preadipocytes' cytoskeleton reorganizes in parallel with lipid accumulation. Failure to do so may impact the ability of adipose tissue (AT) to shift between lipid storage and mobilization. Here, we identify cytoskeletal transgelin 2 (TAGLN2) as a protein expressed in AT and associated with obesity and inflammation, being normalized upon weight loss. TAGLN2 was primarily found in the adipose stromovascular cell fraction, but inflammation, TGF-beta, and estradiol also prompted increased expression in human adipocytes. Tagln2 knockdown revealed a key functional role, being required for proliferation and differentiation of fat cells, whereas transgenic mice overexpressing Tagln2 using the adipocyte protein 2 promoter disclosed remarkable sex-dependent variations, in which females displayed healthy obesity and hypertrophied adipocytes but preserved insulin sensitivity, and males exhibited physiologic changes suggestive of defective AT expandability, including increased number of small adipocytes, activation of immune cells, mitochondrial dysfunction, and impaired metabolism together with decreased insulin sensitivity. The metabolic relevance and sexual dimorphism of TAGLN2 was also outlined by genetic variants that may modulate its expression and are associated with obesity and the risk of ischemic heart disease in men. Collectively, current findings highlight the contribution of cytoskeletal TAGLN2 to the obese phenotype in a gender-dependent manner.-Ortega, F. J., Moreno-Navarrete, J. M., Mercader, J. M., Gomez-Serrano, M., Garcia-Santos, E., Latorre, J., Lluch, A., Sabater, M., Caballano-Infantes, E., Guzman, R., Macias-Gonzalez, M., Buxo, M., Girones, J., Vilallonga, R., Naon, D., Botas, P., Delgado, E., Corella, D., Burcelin, R., Fruhbeck, G., Ricart, W., Simo, R., Castrillon-Rodriguez, I., Tinahones, F. J., Bosch, F., Vidal-Puig, A., Malagon, M. M., Peral, B., Zorzano, A., Fernandez-Real, J. M. Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function.	[Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Sabater, Monica; Caballano-Infantes, Estefania; Guzman, Rocio; Macias-Gonzalez, Manuel; Corella, Dolores; Fruhbeck, Gema; Ricart, Wifredo; Tinahones, Francisco J.; Malagon, Maria M.; Fernandez-Real, Jose M.] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Naon, Deborah; Simo, Rafael; Castrillon-Rodriguez, Ignacio; Bosch, Fatima; Zorzano, Antonio] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Metab Asociadas CIBERDEM, Madrid, Spain; [Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Latorre, Jessica; Lluch, Aina; Sabater, Monica; Caballano-Infantes, Estefania; Buxo, Maria; Ricart, Wifredo; Fernandez-Real, Jose M.] Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr UDEN, Girona, Spain; [Girones, Jordi] Inst Invest Biomed Girona IdIBGi, Dept Surg, Girona, Spain; [Mercader, Josep M.] Barcelona Supercomp Ctr BSC, Joint BSC CRG IRB Res Program Computat Biol, Barcelona, Spain; [Gomez-Serrano, Maria; Garcia-Santos, Eva; Peral, Belen] CSIC, Dept Endocrinol Physiopathol & Nervous Syst, Inst Invest Biomed Alberto Sols IIBM, Madrid, Spain; [Guzman, Rocio; Malagon, Maria M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain; [Macias-Gonzalez, Manuel; Tinahones, Francisco J.] Hosp Clin Univ Virgen Victoria Malaga, Serv Endocrinol & Nutr, Malaga, Spain; [Vilallonga, Ramon] Hosp Univ Vall dHebron, European Ctr Excellence EAC BS, Unidad Cirugia Endocrina Bariatr & Metab, Serv Cirugia Gen, Barcelona, Spain; [Naon, Deborah; Castrillon-Rodriguez, Ignacio; Zorzano, Antonio] Univ Barcelona, Inst Res Biomed IRB Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Botas, Patricia; Delgado, Elias] Univ Oviedo, Hosp Univ Cent Asturias HUCA, Dept Med, Endocrinol & Nutr Serv, Oviedo, Spain; [Botas, Patricia; Delgado, Elias] Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain; [Corella, Dolores] Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Genet & Mol Epidemiol Unit, Valencia, Spain; [Burcelin, Remy] Univ Paul Sabatier, INSERM, Unite 858, Inst Med Mol Ranguil,IFR31, Toulouse, France; [Fruhbeck, Gema] Clin Univ Navarra IdiSNA, Dept Endocrinol & Nutr, Pamplona, Spain; [Simo, Rafael] Vall dHebron Res Inst, Diabet & Metab Res Unit, Barcelona, Spain; [Bosch, Fatima] Autonomous Univ Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, Ctr Anim Biotechnol & Gene Therapy, Barcelona, Spain; [Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Cambridge, England	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Cordoba; Hospital Universitari Vall d'Hebron; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Central University Hospital Asturias; University of Oviedo; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA); University of Valencia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Autonomous University of Barcelona; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ortega, FJ; Fernandez-Real, JM (corresponding author), Hosp Girona Dr Josep Trueta, Dept Diabet Endocrinol & Nutr UDEN, Inst Invest Biomed Girona IDIBGI, Carretera Franca S-N, Girona 17007, Spain.	fortega@idibgi.org; jmfreal@idibgi.org	Malagon, Maria M/L-5386-2014; , VILALLONGA/AAO-5437-2020; Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/H-9772-2015; Gómez-Serrano, María/AAZ-3953-2021; Moreno-Navarrete, José María/ABG-5548-2021; Delgado, Elias/B-2634-2013; Balaña, Aina Lluch/A-5098-2019; Ortega, Francisco José J/F-3883-2016; Caballano-Infantes, Estefanía/AAA-5547-2020; Zorzano, Antonio/R-5479-2018; Tinahones, Francisco José/AAB-2882-2020; PERAL, BELEN/F-4562-2015	Malagon, Maria M/0000-0002-2419-2727; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Gómez-Serrano, María/0000-0002-9669-091X; Moreno-Navarrete, José María/0000-0002-2883-511X; Delgado, Elias/0000-0001-6114-9712; Balaña, Aina Lluch/0000-0003-4216-4436; Ortega, Francisco José J/0000-0003-2111-769X; Caballano Infantes, Estefania/0000-0001-8269-9158; BOSCH, FATIMA/0000-0002-7705-5515; Tinahones, Francisco J/0000-0001-6871-4403; PERAL, BELEN/0000-0003-4984-4020; Naon, Deborah Paola/0000-0002-9726-4664; Latorre Luque, Jessica/0000-0002-7603-1458; Simo Canonge, Rafael/0000-0003-0475-3096	Ministerio de Educacion y Ciencia [GEN2001-4758, SAF2008-02073, SAF2009-10461, SAF2012-33014]; Instituto de Salud Carlos III (ISCIII) [PI15/01934, PI18/00550]; Instituto de Salud Carlos III (CIBEROBN); Instituto de Salud Carlos III (CIBERDEM); Pla estrategic de recerca i innovacio en salut and the Govern de la Generalitat (PERIS 2016); Agencia de Gestio d'Ajuts Universitaris de Recerca (AGAUR, FI-DGR 2015); Universidad Autonoma de Madrid (FPI-UAM); Fondo Europeo de Desarrollo Regional (FEDER); AGAUR; Agence Nationale de la Recherche; Institute Nationale du Diabete; MRC [MC_UU_12012/2, G0600717, G0802051, MC_UU_00014/2, G0400192] Funding Source: UKRI	Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (CIBEROBN)(Instituto de Salud Carlos III); Instituto de Salud Carlos III (CIBERDEM)(Instituto de Salud Carlos III); Pla estrategic de recerca i innovacio en salut and the Govern de la Generalitat (PERIS 2016); Agencia de Gestio d'Ajuts Universitaris de Recerca (AGAUR, FI-DGR 2015); Universidad Autonoma de Madrid (FPI-UAM); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institute Nationale du Diabete; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of all the members of the Multidisciplinary Obesity Team of the Clinica Universitaria de Navarra is gratefully acknowledged. The authors are indebted to the Institut d'Investigacio Biomedica de Girona (IDIBGI) Biobank, integrated in the Spanish National Biobank Network, for the sample and data procurement. GenDiab Consortium was constituted with funds from the Ministerio de Educacion y Ciencia (Grant GEN2001-4758). This work was also supported by research funds from the Instituto de Salud Carlos III (ISCIII; PI15/01934 to J.M.F-R., and PI18/00550 to F.J.O.) and the Ministerio de Educacion y Ciencia (SAF2008-02073 to J.M.F.-R., SAF2009-10461 and SAF2012-33014 to B.P.), the Instituto de Salud Carlos III (CIBEROBN and CIBERDEM), the Pla estrategic de recerca i innovacio en salut and the Govern de la Generalitat (PERIS 2016 to F.J.O.), the Agencia de Gestio d'Ajuts Universitaris de Recerca (AGAUR, FI-DGR 2015 to J.L.), the Universidad Autonoma de Madrid (FPI-UAM to M.G.-S.), and the Fondo Europeo de Desarrollo Regional (FEDER). J.M.M. was supported by a Beatriu de Pinos fellowship from the AGAUR. R.B. is recipient of funding from the Agence Nationale de la Recherche (Florinflam and Floradip programs) and the Institute Nationale du Diabete. The authors declare no conflicts of interest.	Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Bupp MRG, 2015, CELL IMMUNOL, V294, P102, DOI 10.1016/j.cellimm.2015.02.002; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005; Cutolo M, 2014, EXPERT REV CLIN IMMU, V10, P31, DOI 10.1586/1744666X.2014.863149; Feizi S, 2013, NAT BIOTECHNOL, V31, P726, DOI 10.1038/nbt.2635; Fong TH, 2001, BIOCHEM BIOPH RES CO, V289, P1168, DOI 10.1006/bbrc.2001.6080; Frances R, 2006, MOL IMMUNOL, V43, P2124, DOI 10.1016/j.molimm.2005.12.011; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Fu YP, 2000, J APPL PHYSIOL, V89, P1985, DOI 10.1152/jappl.2000.89.5.1985; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jo S, 2018, J LEUKOCYTE BIOL, V104, P903, DOI 10.1002/JLB.MR1117-470R; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; Kim HR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23816-2; Kim HR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09144-x; Kim IG, 2018, CANCER SCI, V109, P3519, DOI 10.1111/cas.13791; Lancha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098398; Latorre J, 2018, CELL PHYSIOL BIOCHEM, V51, P1051, DOI 10.1159/000495487; Leung WKC, 2011, ONCOGENE, V30, P4464, DOI 10.1038/onc.2011.161; Liang XL, 2019, FASEB J, V33, P5667, DOI 10.1096/fj.201802158RRR; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Fernandez-Real JM, 2010, EUR J CLIN INVEST, V40, P600, DOI 10.1111/j.1365-2362.2010.02306.x; Moreno-Navarrete JM, 2008, CLIN CHEM, V54, P301, DOI 10.1373/clinchem.2007.095943; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Meng T, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317702650; Moreno-Castellanos N, 2017, DIABETOLOGIA, V60, P324, DOI 10.1007/s00125-016-4155-5; Na BR, 2015, J CELL BIOL, V209, P143, DOI 10.1083/jcb.201407130; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; Ortega FJ, 2015, J CLIN ENDOCR METAB, V100, pE1467, DOI 10.1210/jc.2015-2357; Ortega FJ, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0083-3; Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082; Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Sotos-Prieto M, 2013, BRIT J NUTR, V109, P193, DOI 10.1017/S0007114512000918; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Valdes S, 2007, DIABETES CARE, V30, P2258, DOI 10.2337/dc06-2461; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Verstraeten VLRM, 2011, HISTOCHEM CELL BIOL, V135, P251, DOI 10.1007/s00418-011-0792-4; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang WL, 2013, BIOCHEM J, V449, P605, DOI 10.1042/BJ20121121	58	3	3	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9656	9671		10.1096/fj.201900479R	http://dx.doi.org/10.1096/fj.201900479R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145872	Bronze			2022-12-26	WOS:000478832900074
J	Shi, E; Shi, KB; Qiu, SF; Sheth, KN; Lawton, MT; Ducruet, AF				Shi, Elaine; Shi, Kaibin; Qiu, Shenfeng; Sheth, Kevin N.; Lawton, Michael T.; Ducruet, Andrew F.			Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage	FASEB JOURNAL			English	Article						microglia; delayed cognitive impairment; LTP	MOUSE MODEL; INJURY; SPHINGOSINE-1-PHOSPHATE; NEUROINFLAMMATION; NEUROGENESIS; FINGOLIMOD; ACTIVATION; MEDIATORS; MEMORY; DAMAGE	Delayed cognitive decline commonly occurs following intracerebral hemorrhage (ICH), but the mechanisms underlying this phenomenon remain obscure. We therefore investigated the potential mechanisms responsible for impaired cognitive function in a mouse collagenase model of ICH. Following recovery of motor and sensory deficits in the chronic phase of ICH, we noted significant cognitive impairment, which was assessed by the Morris water maze. This finding was accompanied by reduced dendrite spine density of ipsilateral hippocampal CA1 neurons. Reduced synaptic plasticity, manifested by impaired long-term potentiation in hippocampal neurons, was also evident in both ipsilateral and contralateral hemispheres, suggesting that ICH also induces functional alterations in distal brain regions remote from the site of injury. In addition, the accumulation of microglia, infiltration of peripheral immune cells, and generation of reactive oxygen species were observed in both contralateral and ipsilateral hemispheres up to 5 wk post-ICH. Furthermore, depletion of microglia using PLX3397, which inhibits colony stimulating factor 1 receptor, ameliorated this delayed cognitive impairment. Collectively, these results suggest that persistent and diffuse brain inflammation may contribute to cognitive impairment in the chronic stage of ICH recovery.-Shi, E., Shi, K., Qiu, S., Sheth, K. N., Lawton, M. T., Ducruet, A. F. Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage.	[Shi, Elaine; Shi, Kaibin; Lawton, Michael T.; Ducruet, Andrew F.] St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, 350 W Thomas Rd,NRC 220, Phoenix, AZ 85013 USA; [Shi, Elaine; Shi, Kaibin; Lawton, Michael T.; Ducruet, Andrew F.] St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, 350 W Thomas Rd,NRC 220, Phoenix, AZ 85013 USA; [Qiu, Shenfeng] Univ Arizona, Dept Basic Med Sci, Coll Med, Phoenix, AZ USA; [Sheth, Kevin N.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Arizona; Yale University	Ducruet, AF (corresponding author), St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, 350 W Thomas Rd,NRC 220, Phoenix, AZ 85013 USA.; Ducruet, AF (corresponding author), St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, 350 W Thomas Rd,NRC 220, Phoenix, AZ 85013 USA.	andrew.ducruet@barrowbrainandspine.com			Barrow Neurological Foundation	Barrow Neurological Foundation	The authors thank Dr. Jie Wu (Barrow Neurological Institute) for technical support. This study was supported by the Barrow Neurological Foundation. The authors declare no conflicts of interest.	Barratt HE, 2014, J CEREBR BLOOD F MET, V34, P1463, DOI 10.1038/jcbfm.2014.107; Biffi A, 2016, JAMA NEUROL, V73, P969, DOI 10.1001/jamaneurol.2016.0955; Chang CF, 2017, NEUROBIOL DIS, V103, P54, DOI 10.1016/j.nbd.2017.03.016; Chen Z, 2011, STROKE, V42, P465, DOI 10.1161/STROKEAHA.110.602755; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dendrou CA, 2016, NAT REV NEUROL, V12, P685, DOI 10.1038/nrneurol.2016.171; Doyle KP, 2015, J NEUROSCI, V35, P2133, DOI 10.1523/JNEUROSCI.4098-14.2015; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Fu Y, 2014, JAMA NEUROL, V71, P1092, DOI 10.1001/jamaneurol.2014.1065; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Hartman R, 2009, BRAIN RES, V1280, P148, DOI 10.1016/j.brainres.2009.05.038; He P, 2012, FASEB J, V26, P334, DOI 10.1096/fj.11-192716; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Kim DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035476; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Li MS, 2017, J CEREBR BLOOD F MET, V37, P2383, DOI 10.1177/0271678X16666551; Li YJ, 2015, NEUROSCI BULL, V31, P755, DOI 10.1007/s12264-015-1532-2; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2009, BEHAV BRAIN RES, V198, P321, DOI 10.1016/j.bbr.2008.11.004; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Shi KB, 2018, STROKE VASC NEUROL, V3, P34, DOI 10.1136/svn-2017-000123; Shi KB, 2016, J IMMUNOL, V197, P3471, DOI 10.4049/jimmunol.1600135; Sun GZ, 2017, CNS NEUROSCI THER, V23, P748, DOI 10.1111/cns.12720; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Wu H, 2010, NEUROCHEM INT, V57, P248, DOI 10.1016/j.neuint.2010.06.002; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yang Y, 2015, NEUROSCI LETT, V599, P133, DOI 10.1016/j.neulet.2015.05.049; Zhang J, 2018, FASEB J, V32, P220, DOI 10.1096/fj.201700324R; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; Zhao XR, 2015, J NEUROCHEM, V133, P144, DOI 10.1111/jnc.12974	39	28	28	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9616	9626		10.1096/fj.201900257R	http://dx.doi.org/10.1096/fj.201900257R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145859	Bronze			2022-12-26	WOS:000478832900071
J	Rosell-Garcia, T; Paradela, A; Bravo, G; Dupont, L; Bekhouche, M; Colige, A; Rodriguez-Pascual, F				Rosell-Garcia, Tamara; Paradela, Alberto; Bravo, Gema; Dupont, Laura; Bekhouche, Mourad; Colige, Alain; Rodriguez-Pascual, Fernando			Differential cleavage of lysyl oxidase by the metalloproteinases BMP1 and ADAMTS2/14 regulates collagen binding through a tyrosine sulfate domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; collagen; lysyl oxidase; proteolysis; post-translational modification (PTM); connective tissue; ADAMTS; tyrosine sulfation; metalloproteinase	CROSS-LINKING; ENZYME-ACTIVITY; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; ACCUMULATION; ORGANIZATION; INSIGHTS; MUTATION; FIBRILS	Collagens are the main structural component of the extracellular matrix and provide biomechanical properties to connective tissues. A critical step in collagen fibril formation is the proteolytic removal of N- and C-terminal propeptides from procollagens by metalloproteinases of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) and BMP1 (bone morphogenetic protein 1)/Tolloid-like families, respectively. BMP1 also cleaves and activates the lysyl oxidase (LOX) precursor, the enzyme catalyzing the initial step in the formation of covalent collagen cross-links, an essential process for fibril stabilization. In this study, using murine skin fibroblasts and HEK293 cells, along with immunoprecipitation, LOX enzymatic activity, solid-phase binding assays, and proteomics analyses, we report that the LOX precursor is proteolytically processed by the procollagen N-proteinases ADAMTS2 and ADAMTS14 between Asp-218 and Tyr-219, 50 amino acids downstream of the BMP1 cleavage site. We noted that the LOX sequence between the BMP1- and ADAMTS-processing sites contains several conserved tyrosine residues, of which some are post-translationally modified by tyrosine O-sulfation and contribute to binding to collagen. Taken together, these findings unravel an additional level of regulation in the formation of collagen fibrils. They point to a mechanism that controls the binding of LOX to collagen and is based on differential BMP1- and ADAMTS2/14-mediated cleavage of a tyrosine-sulfated domain.	[Rosell-Garcia, Tamara; Rodriguez-Pascual, Fernando] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severn Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain; [Paradela, Alberto; Bravo, Gema] Univ Autonoma Madrid, Prote Facil, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Dupont, Laura; Bekhouche, Mourad; Colige, Alain] Univ Liege, Lab Connect Tissues Biol, GIGA, B-4000 Sart Taman, Belgium	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Liege	Rodriguez-Pascual, F (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severn Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain.	frodriguez@cbm.csic.es	Bekhouche, Mourad/ABA-6557-2020; Bekhouche, Mourad/ABA-7355-2020; Rosell-Garcia, Tamara/E-7212-2015; Paradela, Alberto/H-2113-2015	Bekhouche, Mourad/0000-0003-3786-2563; Rosell-Garcia, Tamara/0000-0001-8784-2769; Rodriguez-Pascual, Fernando/0000-0002-9765-9578; Paradela, Alberto/0000-0001-6837-7056	 [PT17/0019]		We thank Victor L. Ruiz-Perez (Instituto de Investigaciones Biomedicas "Alberto Sols," Madrid, Spain) for providing the plasmid pBabe-BMP1. Proteomic analysis was carried out at the CBMSO and CNB Protein Chemistry Facilities, which belong to the Spanish Proteomics Network ProteoRed, PRB3-ISCIII, supported by Grant PT17/0019.	Atsawasuwan P, 2011, CONNECT TISSUE RES, V52, P479, DOI 10.3109/03008207.2011.564337; Bekhouche M, 2016, FASEB J, V30, P1741, DOI 10.1096/fj.15-279869; Bekhouche M, 2015, MATRIX BIOL, V44-46, P46, DOI 10.1016/j.matbio.2015.04.001; Blouin S., 2010, BONE, V47, pS80, DOI [10.1016/j.bone.2010.04.159, DOI 10.1016/J.BONE.2010.04.159]; BOAK AM, 1994, AM J RESP CELL MOL, V11, P751, DOI 10.1165/ajrcmb.11.6.7946403; Busnadiego O, 2013, MOL CELL BIOL, V33, P2388, DOI 10.1128/MCB.00036-13; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Dupont L, 2018, MATRIX BIOL, V70, P140, DOI 10.1016/j.matbio.2018.04.002; Engel J, 2011, BIOL EXTRACELL MATR, P1, DOI 10.1007/978-3-642-16555-9_1; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Grau-Bove X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10568; Guo DC, 2016, CIRC RES, V118, P928, DOI 10.1161/CIRCRESAHA.115.307130; Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; KAGAN HM, 1979, BIOCHEM J, V177, P203, DOI 10.1042/bj1770203; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kanan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105409; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; KUIVANIEMI H, 1985, BIOCHEM J, V230, P639, DOI 10.1042/bj2300639; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; Lee VS, 2016, P NATL ACAD SCI USA, V113, P8759, DOI 10.1073/pnas.1601442113; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Marini JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.52; Martinez-Glez V, 2012, HUM MUTAT, V33, P343, DOI 10.1002/humu.21647; Moali C, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P539; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Mould A. Paul, 2009, V522, P195, DOI 10.1007/978-1-59745-413-1_13; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Puig M, 2015, MOL CANCER RES, V13, P161, DOI 10.1158/1541-7786.MCR-14-0155; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodriguez-Pascual F, 2003, CIRC RES, V92, P1288, DOI 10.1161/01.RES.0000078491.79697.7F; Rodriguez-Pascual Fernando, 2018, J Glaucoma, V27 Suppl 1, pS15, DOI 10.1097/IJG.0000000000000910; Rodriguez-Pascual F, 2016, SCI REP-UK, V6, DOI 10.1038/srep37374; Rosini S, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar2566; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tillgren V, 2016, J BIOL CHEM, V291, P23744, DOI 10.1074/jbc.M116.730325; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Uzel MI, 2000, J BONE MINER RES, V15, P1189, DOI 10.1359/jbmr.2000.15.6.1189; VIDAL GP, 1975, BIOCHEM BIOPH RES CO, V64, P989, DOI 10.1016/0006-291X(75)90145-X; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang YS, 2015, MOLECULES, V20, P2138, DOI 10.3390/molecules20022138; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]	55	25	25	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11087	11100		10.1074/jbc.RA119.007806	http://dx.doi.org/10.1074/jbc.RA119.007806			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31152061	Green Published, hybrid			2022-12-26	WOS:000478717400004
J	Samson, SC; Elliott, A; Mueller, BD; Kim, Y; Carney, KR; Bergman, JP; Blenis, J; Mendoza, MC				Samson, Shiela C.; Elliott, Andrew; Mueller, Brian D.; Kim, Yung; Carney, Keith R.; Bergman, Jared P.; Blenis, John; Mendoza, Michelle C.			p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular-signal-regulated kinase (ERK); myosin; cell migration; cell signaling; cytoskeleton; cell motility; myosin phosphatase targeting subunit (MYPT1); p90 ribosomal S6 kinase (RSK); Rho kinase (ROCK)	REGULATORY SUBUNIT; SERINE PHOSPHORYLATION; ADHESION DYNAMICS; ACTIVATES RAF-1; DISTINCT ROLES; ERK ACTIVATION; RAS-ERK; F-ACTIN; RHO; PROTRUSION	Cell migration is essential to embryonic development, wound healing, and cancer cell dissemination. Cells move via leading-edge protrusion, substrate adhesion, and retraction of the cell's rear. The molecular mechanisms by which extracellular cues signal to the actomyosin cytoskeleton to control these motility mechanics are poorly understood. The growth factor-responsive and oncogenically activated protein extracellular signal-regulated kinase (ERK) promotes motility by signaling in actin polymerization-mediated edge protrusion. Using a combination of immunoblotting, co-immunoprecipitation, and myosin-binding experiments and cell migration assays, we show here that ERK also signals to the contractile machinery through its substrate, p90 ribosomal S6 kinase (RSK). We probed the signaling and migration dynamics of multiple mammalian cell lines and found that RSK phosphorylates myosin phosphatase-targeting subunit 1 (MYPT1) at Ser-507, which promotes an interaction of Rho kinase (ROCK) with MYPT1 and inhibits myosin targeting. We find that by inhibiting the myosin phosphatase, ERK and RSK promote myosin II-mediated tension for lamella expansion and optimal edge dynamics for cell migration. These findings suggest that ERK activity can coordinately amplify both protrusive and contractile forces for optimal cell motility.	[Samson, Shiela C.; Elliott, Andrew; Mueller, Brian D.; Kim, Yung; Carney, Keith R.; Bergman, Jared P.; Mendoza, Michelle C.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Blenis, John; Mendoza, Michelle C.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Blenis, John] Weill Cornell Med Coll, Meyer Canc Ctr, 1300 York Ave,F-113, New York, NY 10065 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Cornell University	Mendoza, MC (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	Michelle.Mendoza@hci.utah.edu		Kim, Yung/0000-0002-5732-3017; Mendoza, Michelle/0000-0002-6490-1794; Mueller, Brian/0000-0002-6525-7101	National Institutes of Health [K01CA168850, R01CA046595]; American Lung Association Research Grant; American Cancer Society [RSG CSM130435]; NATIONAL CANCER INSTITUTE [F32CA236428, K01CA168850, R01CA046595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Research Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants K01CA168850 (to M. C. M.) and R01CA046595 (to J. B.), an American Lung Association Research Grant (to M. C. M.), and American Cancer Society Grant RSG CSM130435 (to M. C. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JC, 1997, MOL BIOL CELL, V8, P2345, DOI 10.1091/mbc.8.11.2345; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aronchik I, 2014, MOL CANCER RES, V12, P803, DOI 10.1158/1541-7786.MCR-13-0595; Artamonov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058703; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; BAZZI MD, 1989, BIOCHEMISTRY-US, V28, P3577, DOI 10.1021/bi00434a064; BAZZI MD, 1988, BIOCHEMISTRY-US, V27, P7589, DOI 10.1021/bi00420a003; Boeckeler K, 2010, J CELL SCI, V123, P2725, DOI 10.1242/jcs.062299; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; Cell Signalling Technology, 2019, PHOSPH MYPT1 SER668; Chao A, 2012, J PROTEOMICS, V75, P3342, DOI 10.1016/j.jprot.2012.03.043; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Galan JA, 2014, P NATL ACAD SCI USA, V111, pE2918, DOI 10.1073/pnas.1405601111; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gawecka JE, 2012, J BIOL CHEM, V287, P43424, DOI 10.1074/jbc.M112.423046; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang JS, 2004, CELL SIGNAL, V16, P521, DOI 10.1016/j.cellsig.2003.10.008; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Khasnis M, 2014, BIOCHEMISTRY-US, V53, P2701, DOI 10.1021/bi5001728; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Krens SFG, 2008, DEV BIOL, V319, P370, DOI 10.1016/j.ydbio.2008.04.032; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Li D, 2013, J BIOL CHEM, V288, P32528, DOI 10.1074/jbc.M113.500561; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Markwardt ML, 2018, CELL REP, V24, P1060, DOI 10.1016/j.celrep.2018.06.088; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Melak M, 2017, J CELL SCI, V130, P525, DOI 10.1242/jcs.189068; Mendoza MC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8859; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sayyad WA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07842; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shi GX, 2018, P NATL ACAD SCI USA, V115, pE190, DOI 10.1073/pnas.1708584115; Shutova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040814; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Sommese RF, 2016, J BIOL CHEM, V291, P21963, DOI 10.1074/jbc.M116.737601; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905; Zhang XM, 2014, J PROTEOMICS, V109, P63, DOI 10.1016/j.jprot.2014.06.010; Zhou Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8679	92	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10846	10862		10.1074/jbc.RA119.007431	http://dx.doi.org/10.1074/jbc.RA119.007431			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138649	hybrid, Green Published			2022-12-26	WOS:000478717200010
J	Tao, T; Sun, J; Peng, YJ; Li, YQ; Wang, P; Chen, X; Zhao, W; Zheng, YY; Wei, LS; Wang, W; Zhou, YW; Liu, JH; Shi, YS; Zhu, MS				Tao, Tao; Sun, Jie; Peng, Yajing; Li, Yeqiong; Wang, Pei; Chen, Xin; Zhao, Wei; Zheng, Yan-Yan; Wei, Lisha; Wang, Wei; Zhou, Yuwei; Liu, Jianghuai; Shi, Yun Stone; Zhu, Min-Sheng			Golgi-resident TRIO regulates membrane trafficking during neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurite outgrowth; membrane trafficking; neurodevelopment; guanine nucleotide exchange factor (GEF); Rho (Rho GTPase); Rab; signal transduction	RHO-GTPASES; INTELLECTUAL DISABILITY; RAB GTPASES; ACTIVATION; TRANSPORT; KINASE; CELL; IDENTIFICATION; POLARIZATION; MUTATIONS	Neurite outgrowth requires coordinated cytoskeletal rearrangements in the growth cone and directional membrane delivery from the neuronal soma. As an essential Rho guanine nucleotide exchange factor (GEF), TRIO is necessary for cytoskeletal dynamics during neurite outgrowth, but its participation in the membrane delivery is unclear. Using co-localization studies, live-cell imaging, and fluorescence recovery after photobleaching analysis, along with neurite outgrowth assay and various biochemical approaches, we here report that in mouse cerebellar granule neurons, TRIO protein pools at the Golgi and regulates membrane trafficking by controlling the directional maintenance of both RAB8 (member RAS oncogene family 8)- and RAB10-positive membrane vesicles. We found that the spectrin repeats in Golgi-resident TRIO confer RAB8 and RAB10 activation by interacting with and activating the RAB GEF RABIN8. Constitutively active RAB8 or RAB10 could partially restore the neurite outgrowth of TRIO-deficient cerebellar granule neurons, suggesting that TRIO-regulated membrane trafficking has an important functional role in neurite outgrowth. Our results also suggest cross-talk between Rho GEF and Rab GEF in controlling both cytoskeletal dynamics and membrane trafficking during neuronal development. They further highlight how protein pools localized to specific organelles regulate crucial cellular activities and functions. In conclusion, our findings indicate that TRIO regulates membrane trafficking during neurite outgrowth in coordination with its GEF-dependent function in controlling cytoskeletal dynamics via Rho GTPases.	[Tao, Tao; Sun, Jie; Li, Yeqiong; Wang, Pei; Chen, Xin; Zhao, Wei; Zheng, Yan-Yan; Wei, Lisha; Wang, Wei; Zhou, Yuwei; Liu, Jianghuai; Shi, Yun Stone; Zhu, Min-Sheng] Nanjing Univ, Med Sch, Affiliated Nanjing Drum Tower Hosp,Dept Neurol, Model Anim Res Ctr State,Key Lab Pharmaceut Biote, Nanjing 210061, Jiangsu, Peoples R China; [Peng, Yajing] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	Nanjing University; University of Wisconsin System; University of Wisconsin Madison	Zhu, MS (corresponding author), Nanjing Univ, Med Sch, Affiliated Nanjing Drum Tower Hosp,Dept Neurol, Model Anim Res Ctr State,Key Lab Pharmaceut Biote, Nanjing 210061, Jiangsu, Peoples R China.	zhums@nju.edu.cn	Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009	Shi, Yun/0000-0002-8842-9818; Chen, Xin/0000-0003-3304-8943; Liu, Jianghuai/0000-0002-2382-9140	National Natural Science Foundation of China [31272311, 31330034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31272311 and 31330034 (to M.-S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Ba W, 2016, HUM MOL GENET, V25, P892, DOI 10.1093/hmg/ddv618; Backer S, 2007, J NEUROSCI, V27, P10323, DOI 10.1523/JNEUROSCI.1102-07.2007; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, J CELL SCI, V114, P1973; Beck KA, 2005, BBA-MOL CELL RES, V1744, P374, DOI 10.1016/j.bbamcr.2005.04.008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Campa CC, 2018, NAT CHEM BIOL, V14, P801, DOI 10.1038/s41589-018-0086-4; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Deng CY, 2014, J NEUROSCI, V34, P1710, DOI 10.1523/JNEUROSCI.4496-13.2014; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Gartner A, 2014, J CELL SCI, V127, P4409, DOI 10.1242/jcs.149815; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Herring BE, 2016, P NATL ACAD SCI USA, V113, P2264, DOI 10.1073/pnas.1600179113; Homma Y, 2016, MOL BIOL CELL, V27, P2107, DOI 10.1091/mbc.E16-02-0091; HUBER LA, 1995, MOL CELL BIOL, V15, P918; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Katrancha SM, 2017, HUM MOL GENET, V26, P4728, DOI 10.1093/hmg/ddx355; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; McPherson CE, 2005, GENE, V347, P125, DOI 10.1016/j.gene.2004.12.028; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neumann S, 2017, TRAFFIC, V18, P71, DOI 10.1111/tra.12456; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Pellegrin S., 2008, RHO GTPASE ACTIVATIO; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Pengelly RJ, 2016, J MED GENET, V53, P735, DOI 10.1136/jmedgenet-2016-103942; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; Qi Yaoyao, 2015, Methods Mol Biol, V1298, P259, DOI 10.1007/978-1-4939-2569-8_22; Sadybekov A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00472-0; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Tojima T, 2015, DEV GROWTH DIFFER, V57, P291, DOI 10.1111/dgd.12218; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Villarroel-Campos D, 2016, CYTOSKELETON, V73, P498, DOI 10.1002/cm.21303; Wang JF, 2015, P NATL ACAD SCI USA, V112, P148, DOI 10.1073/pnas.1412089112; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Wojnacki J, 2016, DEV NEUROBIOL, V76, P1185, DOI 10.1002/dneu.22390; Zeitvogel F., 2016, J OPEN RES SOFTWARE, V4, pe5, DOI DOI 10.5334/J0RS.89; Zheng CY, 2011, JOVE-J VIS EXP, DOI 10.3791/2568; Zheng CG, 2016, P NATL ACAD SCI USA, V113, P6973, DOI 10.1073/pnas.1607179113; Zong W, 2015, BRAIN RES, V1608, P82, DOI 10.1016/j.brainres.2015.02.040	59	14	15	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10954	10968		10.1074/jbc.RA118.007318	http://dx.doi.org/10.1074/jbc.RA118.007318			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31152060	Green Published, hybrid			2022-12-26	WOS:000478717200018
J	Vissers, T; Koumakis, N; Hermes, M; Brown, AT; Schwarz-Linek, J; Dawson, A; Poon, WCK				Vissers, Teun; Koumakis, Nick; Hermes, Michiel; Brown, Aidan T.; Schwarz-Linek, Jana; Dawson, Angela; Poon, Wilson C. K.			Dynamical analysis of bacteria in microscopy movies	PLOS ONE			English	Article							ESCHERICHIA-COLI; ADHESION; BIOFILMS; CHEMOTAXIS; MOTILITY; FLOW	Recent advances in microscopy, computing power and image processing have enabled the analysis of ever larger datasets of movies of microorganisms to study their behaviour. However, techniques for analysing the dynamics of individual cells from such datasets are not yet widely available in the public domain. We recently demonstrated significant phenotypic heterogeneity in the adhesion of Escherichia coli bacteria to glass surfaces using a new method for the high-throughput analysis of video microscopy data. Here, we present an in-depth analysis of this method and its limitations, and make public our algorithms for following the positions and orientations of individual rod-shaped bacteria from time-series of 2D images to reconstruct their trajectories and characterise their dynamics. We demonstrate in detail how to use these algorithms to identify different types of adhesive dynamics within a clonal population of bacteria sedimenting onto a surface. The effects of measurement errors in cell positions and of limited trajectory durations on our results are discussed.	[Vissers, Teun; Koumakis, Nick; Hermes, Michiel; Brown, Aidan T.; Schwarz-Linek, Jana; Dawson, Angela; Poon, Wilson C. K.] Univ Edinburgh, SUPA, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland; [Vissers, Teun; Koumakis, Nick; Hermes, Michiel; Brown, Aidan T.; Schwarz-Linek, Jana; Dawson, Angela; Poon, Wilson C. K.] Univ Edinburgh, Sch Phys & Astron, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland; [Hermes, Michiel] Univ Utrecht, Debye Inst Nanomat Sci, Soft Condensed Matter, Dept Phys, Princetonpl 5, NL-3584 CC Utrecht, Netherlands	University of Edinburgh; University of Edinburgh; Utrecht University	Vissers, T (corresponding author), Univ Edinburgh, SUPA, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland.; Vissers, T (corresponding author), Univ Edinburgh, Sch Phys & Astron, Peter Guthrie Tait Rd, Edinburgh EH9 3FD, Midlothian, Scotland.	t.vissers@ed.ac.uk	Brown, Aidan T/M-4897-2017; Poon, Wilson/V-3495-2019; Poon, Wilson C K/B-5960-2013	Brown, Aidan T/0000-0002-6898-4021; Poon, Wilson/0000-0003-0760-7940; Poon, Wilson C K/0000-0003-0760-7940	FP7-PEOPLE-2013-IEF Marie Curie fellowship LivPaC [623364]; Marie Curie fellowship H2020-MSCA-IF-2014 ActiDoC [654688]; ERC Advanced Grant [GA 340877-PHYSAPS]; EPSRC programme [EP/J007404/1]; National Physical Laboratory; SUPA; UK EPSRC [EP/S001255/1]; BBSRC [BB/R012415/1] Funding Source: UKRI; EPSRC [EP/S001255/1, EP/J007404/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/R012415/1] Funding Source: researchfish	FP7-PEOPLE-2013-IEF Marie Curie fellowship LivPaC; Marie Curie fellowship H2020-MSCA-IF-2014 ActiDoC; ERC Advanced Grant(European Research Council (ERC)); EPSRC programme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Physical Laboratory; SUPA; UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided through FP7-PEOPLE-2013-IEF Marie Curie fellowship LivPaC, 623364 (TV), Marie Curie fellowship H2020-MSCA-IF-2014 ActiDoC, 654688 (NK), ERC Advanced Grant GA 340877-PHYSAPS (TV, NK) and an EPSRC programme grant EP/J007404/1 (AD, WP, JSL). JSL was also funded by the National Physical Laboratory and SUPA. ATB received funding from UK EPSRC (EP/S001255/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 1990, BIOPHYS J, V58, P919, DOI 10.1016/S0006-3495(90)82436-X; Besseling TH, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/19/194109; Bianchi S, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062705; Burov S, 2013, P NATL ACAD SCI USA, V110, P19689, DOI 10.1073/pnas.1319473110; Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006; Chan J, 2010, POLLUT SCI TECHNOL A, P1; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DEWITT SK, 1962, GENETICS, V47, P577; Ducret A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.77, 10.1038/nmicrobiol.2016.77]; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Duvernoy MC, 2017, BIORXIV; El-Kirat-Chatel S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01399; Leptos KC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198103; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Ping LY, 2010, J MOL BIOL, V397, P906, DOI 10.1016/j.jmb.2010.02.008; Prakash B, 2003, CURR SCI INDIA, V85, P1299; Schlafer S, 2017, J MICROBIOL METH, V138, P50, DOI 10.1016/j.mimet.2016.03.002; Schluter J, 2015, ISME J, V9, P139, DOI 10.1038/ismej.2014.174; Schwarz-Linek J, 2016, COLLOID SURFACE B, V137, P2, DOI 10.1016/j.colsurfb.2015.07.048; Sharma S, 2016, LANGMUIR, V32, P5422, DOI 10.1021/acs.langmuir.6b00883; Sharma S, 2014, LANGMUIR, V30, P11147, DOI 10.1021/la502313y; Spengler C, 2017, NANOSCALE, V9, P10084, DOI 10.1039/c7nr02297b; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Vissers T, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1170; Wang J, 2017, IEEE IMAGE PROC, P330; Weaver WM, 2014, CURR OPIN BIOTECH, V25, P114, DOI 10.1016/j.copbio.2013.09.005	29	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217823	10.1371/journal.pone.0217823	http://dx.doi.org/10.1371/journal.pone.0217823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170194	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700062
J	Han, SY; Ogawa, A; Osada, T; Suda, A; Tanaka, M; Nanjo, H; Shimo, Y; Hattori, N; Konishi, S				Han, Shuyan; Ogawa, Akitoshi; Osada, Takahiro; Suda, Akimitsu; Tanaka, Masaki; Nanjo, Hitoshi; Shimo, Yasushi; Hattori, Nobutaka; Konishi, Seiki			More subjects are required for ventrolateral than dorsolateral prefrontal TMS because of intolerability and potential drop-out	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; MEMORY-GUIDED SACCADES; COGNITIVE NEUROSCIENCE; MOTOR THRESHOLD; FRONTAL-CORTEX; SAFETY; DISRUPTION; PERTURBATION; CHRONOMETRY	Transcranial magnetic stimulation (TMS) of the human lateral prefrontal cortex, particularly the ventral region, often causes considerable discomfort to subjects. To date, in contrast to abundant literature on stimulations to the dorsolateral prefrontal cortex, the ventrolateral prefrontal cortex has been less frequently stimulated, partly because some subjects are intolerable of stimulation to the ventrolateral prefrontal cortex. To predict the additional number of subjects required for the stimulation of the dorsolateral and ventrolateral prefrontal cortices, 20 young healthy subjects reported two evaluation scores: the discomfort caused by TMS and the resulting intolerability to complete the TMS experiments. Single-pulse stimulation (SPS) or theta-burst stimulation (TBS) was administered to the lateral prefrontal cortex. The high-resolution extended 10-20 system was used to provide accurate estimation of the voxelwise scores. The discomfort ratings with the SPS and TBS were relatively higher in the ventrolateral prefrontal cortex than those in the dorsolateral prefrontal cortex. Both the SPS and TBS elicited maximal discomfort at the stimulation position F8. The SPS and TBS to F8 under the standard TMS protocols were intolerable for approximately one half (11 and 10, respectively) of the subjects. The intolerability was further calculated for all voxels in the lateral prefrontal cortex, which enabled us to estimate the additional number of subjects required for specific target areas. These results suggest that prior knowledge of subjects' discomfort during stimulation of the lateral prefrontal cortex can be of practical use in the experimental planning of the appropriate number of recruited subjects and provide the database for the probability of intolerability that can be used to predict the additional number of subjects.	[Han, Shuyan; Ogawa, Akitoshi; Osada, Takahiro; Suda, Akimitsu; Tanaka, Masaki; Nanjo, Hitoshi; Konishi, Seiki] Juntendo Univ, Dept Neurophysiol, Sch Med, Tokyo, Japan; [Suda, Akimitsu; Shimo, Yasushi; Hattori, Nobutaka] Juntendo Univ, Dept Neurol, Sch Med, Tokyo, Japan; [Konishi, Seiki] Juntendo Univ, Res Inst Dis Old Age, Sch Med, Tokyo, Japan; [Konishi, Seiki] Juntendo Univ, Sportol Ctr, Sch Med, Tokyo, Japan; [Konishi, Seiki] Juntendo Univ, Adv Res Inst Hlth Sci, Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Konishi, S (corresponding author), Juntendo Univ, Dept Neurophysiol, Sch Med, Tokyo, Japan.; Konishi, S (corresponding author), Juntendo Univ, Res Inst Dis Old Age, Sch Med, Tokyo, Japan.; Konishi, S (corresponding author), Juntendo Univ, Sportol Ctr, Sch Med, Tokyo, Japan.; Konishi, S (corresponding author), Juntendo Univ, Adv Res Inst Hlth Sci, Sch Med, Tokyo, Japan.	skonishi@juntendo.ac.jp	Hattori, Nobutaka/ACR-0069-2022; Osada, Takahiro/GLU-9088-2022; Ogawa, Akitoshi/D-6287-2011; Ogawa, Akitoshi/AAB-6930-2020	Osada, Takahiro/0000-0002-3743-3200; Ogawa, Akitoshi/0000-0003-1247-445X	JSPS KAKENHI [16K16076]; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI to A.O. (grant number 16K16076) and a grant from Takeda Science Foundation to S.K.	Abler B, 2005, BRAIN TOPOGR, V17, P193, DOI 10.1007/s10548-005-6028-y; Anderson BS, 2009, BRAIN STIMUL, V2, P88, DOI 10.1016/j.brs.2008.09.001; Arana AB, 2008, BRAIN STIMUL, V1, P44, DOI 10.1016/j.brs.2007.08.006; Basso D, 2010, NEUROPSYCHOLOGIA, V48, P3282, DOI 10.1016/j.neuropsychologia.2010.07.011; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Borckardt JJ, 2013, BRAIN STIMUL, V6, P925, DOI 10.1016/j.brs.2013.04.009; Cai WD, 2012, J NEUROSCI METH, V204, P238, DOI 10.1016/j.jneumeth.2011.11.020; CHATRIAN GE, 1988, J CLIN NEUROPHYSIOL, V5, P183, DOI 10.1097/00004691-198804000-00005; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Chung SW, 2018, HUM BRAIN MAPP, V39, P783, DOI 10.1002/hbm.23882; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; De Dreu CKW, 2016, SOC COGN AFFECT NEUR, V11, P1236, DOI 10.1093/scan/nsw045; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Duecker F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00210; Duecker F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073813; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Gogulski J, 2017, CEREB CORTEX, V27, P5343, DOI 10.1093/cercor/bhx219; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; Grossheinrich N, 2009, BIOL PSYCHIAT, V65, P778, DOI 10.1016/j.biopsych.2008.10.029; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hartwigsen G, 2013, P NATL ACAD SCI USA, V110, P16402, DOI 10.1073/pnas.1310190110; Hartwright CE, 2016, HUM BRAIN MAPP, V37, P3502, DOI 10.1002/hbm.23255; Herwig U, 2010, NEUROSCI LETT, V471, P30, DOI 10.1016/j.neulet.2010.01.003; Holmes NP, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01989; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jimura K, 2014, NEUROSCIENCE, V274, P383, DOI 10.1016/j.neuroscience.2014.05.058; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kahn I, 2005, J NEUROPHYSIOL, V94, P688, DOI 10.1152/jn.01335.2004; Loo CK, 2008, INT J NEUROPSYCHOPH, V11, P131, DOI 10.1017/S1461145707007717; Machii K, 2006, CLIN NEUROPHYSIOL, V117, P455, DOI 10.1016/j.clinph.2005.10.014; Maizey L, 2013, CLIN NEUROPHYSIOL, V124, P536, DOI 10.1016/j.clinph.2012.07.024; Meteyard L, 2018, J NEUROSCI METH, V299, P34, DOI 10.1016/j.jneumeth.2018.02.008; Miyashita Y., 2016, JUNTENDO MED J, V62, P6; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Mottaghy FM, 2003, NEUROIMAGE, V18, P565, DOI 10.1016/S1053-8119(03)00010-7; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; Muri RM, 2000, NEUROPSYCHOLOGIA, V38, P1105, DOI 10.1016/S0028-3932(00)00030-0; Narayana S, 2015, J CHILD NEUROL, V30, P1111, DOI 10.1177/0883073814553274; Nyffeler T, 2004, EXP BRAIN RES, V154, P109, DOI 10.1007/s00221-003-1663-6; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Osada T, 2019, J NEUROSCI, V39, P2509, DOI 10.1523/JNEUROSCI.2244-18.2019; Ott DVM, 2011, NEUROIMAGE, V57, P617, DOI 10.1016/j.neuroimage.2011.04.038; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Peterchev AV, 2017, BRAIN STIMUL, V10, P99, DOI 10.1016/j.brs.2016.09.007; Poreisz C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-54; Rahnev D, 2016, P NATL ACAD SCI USA, V113, P6059, DOI 10.1073/pnas.1522551113; Ro T, 1997, J COGNITIVE NEUROSCI, V9, P433, DOI 10.1162/jocn.1997.9.4.433; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Sagliano L, 2016, SOC COGN AFFECT NEUR, V11, P1992, DOI 10.1093/scan/nsw105; Schabrun SM, 2018, PAIN MED, V19, P608, DOI 10.1093/pm/pnx099; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smalle EHM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14547-x; Smittenaar P, 2013, NEURON, V80, P914, DOI 10.1016/j.neuron.2013.08.009; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Suppa A, 2016, BRAIN STIMUL, V9, P323, DOI 10.1016/j.brs.2016.01.006; Tame L, 2016, NEUROIMAGE, V138, P184, DOI 10.1016/j.neuroimage.2016.05.056; Tarapore PE, 2016, CLIN NEUROPHYSIOL, V127, P1895, DOI 10.1016/j.clinph.2015.11.042; Thapa T, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/6207508; Thapa T, 2018, CLIN NEUROPHYSIOL, V129, P1090, DOI 10.1016/j.clinph.2018.01.060; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Ueno T, 2018, CEREB CORTEX, V28, P3035, DOI 10.1093/cercor/bhy131; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Watanabe T, 2015, J NEUROSCI, V35, P4813, DOI 10.1523/JNEUROSCI.3761-14.2015; Watanabe T, 2014, HUM BRAIN MAPP, V35, P1896, DOI 10.1002/hbm.22300; Yamasaki T, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00208; Yi X, 2014, EXP BRAIN RES, V232, P545, DOI 10.1007/s00221-013-3763-2; Zhao D, 2018, CEREB CORTEX, V28, P3468, DOI 10.1093/cercor/bhx213	72	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217826	10.1371/journal.pone.0217826	http://dx.doi.org/10.1371/journal.pone.0217826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158248	gold, Green Published, Green Submitted			2022-12-26	WOS:000469915700028
J	Schindler, P; Helfen, A; Wildgruber, M; Heindel, W; Schulke, C; Masthoff, M				Schindler, Philipp; Helfen, Anne; Wildgruber, Moritz; Heindel, Walter; Schuelke, Christoph; Masthoff, Max			Intraosseous contrast administration for emergency computed tomography: A case-control study	PLOS ONE			English	Article							VASCULAR ACCESS; ANGIOGRAPHY; INFUSION	Objective The aim of the study was to evaluate the feasibility of intraosseous (i. o.) contrast media injection (CMI) for emergency computed tomography (CT) of severe trauma and the associated image quality compared to intravenous (i.v.) CMI. Materials and methods The authors retrospectively analysed objective (contrast-to-noise ratio (CNR)) and subjective (4-point Likert scale) image quality of CTs after i.o. (n = 4, mean age (y) 57.0 +/- 11.0) versus i.v. (n = 20, mean age (y) 58.8 +/- 4.4) CMI. All patients underwent a native head CT scan, a cerebral CT angiography (CTA) and CTA of the supra-aortic vasculature as well as a chest and abdominal CT scan in the venous phase; one patient with an i.o. access additionally received a CTA of the lower limbs. Electronic patient records have been reviewed to determine i.o. access related complications. Results Both groups were consistent in age, heart rate, scan parameters including the flow rate of the contrast agent, resulting in comparable radiation dose levels. The image noise and CNR had no significant difference between the two groups. Scoring the delineation of the main vessels after i.o. CMI showed no significant difference to the i.v. group. There were no CT or i.o. access related complications observed. Conclusion The i.o. access is a safe and suitable alternative for emergency CMI in CT. Using established protocols good to very good image quality can be achieved, comparable to i.v. CMI. We show for the first time, that i.o. CMI is also feasible for CTA imaging of the head and neck region as well as of pelvic and leg vessels.	[Schindler, Philipp; Helfen, Anne; Wildgruber, Moritz; Heindel, Walter; Schuelke, Christoph; Masthoff, Max] Univ Hosp Muenster, Inst Clin Radiol, Munster, Germany	University of Munster	Schindler, P (corresponding author), Univ Hosp Muenster, Inst Clin Radiol, Munster, Germany.	Philipp.Schindler@ukmuenster.de		Schindler, Philipp/0000-0002-8098-9853; Masthoff, Max/0000-0001-5338-9193				Ahrens KL, 2013, J EMERG MED, V45, P182, DOI 10.1016/j.jemermed.2012.11.091; Baadh AS, 2016, AM J ROENTGENOL, V207, P241, DOI 10.2214/AJR.15.15784; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Budach NM, 2017, EMERG RADIOL, V24, P105, DOI 10.1007/s10140-016-1438-6; Cambray EJ, 1997, PEDIATR RADIOL, V27, P892, DOI 10.1007/s002470050264; Cohen J, 2015, J EMERG MED, V49, P771, DOI 10.1016/j.jemermed.2014.06.036; Feuchtner GM, 2010, EUR J RADIOL, V75, pE51, DOI 10.1016/j.ejrad.2009.07.012; FISER DH, 1990, NEW ENGL J MED, V322, P1579; Fowler RL, 2008, ANN EMERG MED, V52, pS152, DOI 10.1016/j.annemergmed.2008.06.389; Fowler R, 2007, PREHOSP EMERG CARE, V11, P63, DOI 10.1080/10903120601021036; Geller E, 1999, PEDIATR EMERG CARE, V15, P328, DOI 10.1097/00006565-199910000-00007; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Kleinman ME, 2010, PEDIATRICS, V126, pE1361, DOI 10.1542/peds.2010-2972D; ORLOWSKI JP, 1989, ANN EMERG MED, V18, P1062, DOI 10.1016/S0196-0644(89)80932-1; Petitpas F, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1277-6; Schueller G, 2015, RADIOL MED, V120, P641, DOI 10.1007/s11547-015-0500-x; Winkler M, 2017, J CARDIOVASC COMPUT, V11, P203, DOI 10.1016/j.jcct.2017.03.001	17	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217629	10.1371/journal.pone.0217629	http://dx.doi.org/10.1371/journal.pone.0217629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150466	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100075
J	Kiguen, AX; Marrama, M; Ruiz, S; Estofan, P; Venezuela, RF; Mosmann, JP; Monetti, MS; Rivero, V; Cuffini, CG				Ximena Kiguen, Ana; Marrama, Marcela; Ruiz, Susana; Estofan, Patricia; Fernando Venezuela, Raul; Paola Mosmann, Jessica; Soledad Monetti, Marina; Rivero, Virginia; Gabriela Cuffini, Cecilia			Prevalence, risk factors and molecular characterization of Chlamydia trachomatis in pregnant women from Cordoba, Argentina: A prospective study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS	Background Chlamydia trachomatis causes the most prevalent bacterial Sexual Transmitted Infection. In pregnant women, untreated chlamydial infections are associated with abortions, premature rupture of membranes, postpartum endometritis, low birth weight and transmission to the newborn. In Cordoba, Argentina, there is little knowledge about the prevalence of Chlamydia trachomatis in women in their third trimester of pregnancy, so, the aim of this study was to evaluate Chlamydia trachomatis prevalence and genotypes present in Cordovan pregnant women with different age and socioeconomic status. Methods and findings Design: prospective study. Settings: Women population from Cordoba city, Argentina. Population: Pregnant women having 35 to 37 weeks of gestation. Methods: Five hundred and nine cervical swabs were collected. Each sample was subjected to DNA extraction and PCR for Chlamydia trachomatis using primers NRO/NLO and CTP1/CTP2. Positives samples were sequenced to determine genotype. Main outcome measures: Demographic data of the patients were collected to detect a population at risk for this infection. Results A prevalence of 6.9% (35/509) for Chlamydia trachomatis infection was detected, with 32/295 and 3/214 from pregnant women with low or better economic resources respectively (p = 0,0001). Results showed a significantly increased rate of 11.6% (30/258) in women under 25 years compared with 2% (5/251) in patients over that age (p = 0,00003). Genotype E was the most prevalent. Conclusions With these results, we can say that pregnant women under 25 years old and low economic resources are one of the populations in which the screening programs of Chlamydia trachomatis should focus.	[Ximena Kiguen, Ana; Fernando Venezuela, Raul; Paola Mosmann, Jessica; Soledad Monetti, Marina; Gabriela Cuffini, Cecilia] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Doctor Jose Maria Vanella, Cordoba, Argentina; [Marrama, Marcela] Municipalidad Cordoba, Direcc Especialidades Med, Cordoba, Argentina; [Ruiz, Susana] Labs Lace Soc Anonima, Cordoba, Argentina; [Estofan, Patricia] CIGOR, Cordoba, Argentina; [Rivero, Virginia] Univ Nacl Cordoba, Ctr Invest Bioquim Clin & Inmunol CIBICI, CONICET, Dept Bioquim Clin,Fac Ciencias Quim, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Kiguen, AX (corresponding author), Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Doctor Jose Maria Vanella, Cordoba, Argentina.	ximenakiguen@gmail.com	Mosmann, Jessica Paola/ABC-9690-2020	Mosmann, Jessica Paola/0000-0002-0839-6324; Venezuela, Raul Fernando/0000-0002-4325-8998	Fundacion Roemmers 2014; Secyt 2014 [Res Secyt UNC 203/2014. RHCD: 1565/2014]; Secyt 2016 [Res Secyt UNC 202/2016. RHCD: 1634/2016]	Fundacion Roemmers 2014; Secyt 2014; Secyt 2016	This study was supported by AXKiguen: Fundacion Roemmers 2014, AXKiguen: Secyt 2014 (Res Secyt UNC 203/2014. RHCD: 1565/2014), and AXKiguen: Secyt 2016 (Res Secyt UNC 202/2016. RHCD: 1634/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional support was provided by Laboratorios LACE Sociedad Anonima (https://www.laboratoriolace.com.ar/) in the form of salary for Susana Ruiz, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Adachi K, 2016, BIOMED RES INT; Andersen B, 2006, SEX TRANSM DIS, V33, P407, DOI 10.1097/01.olq.0000200609.77577.3f; [Anonymous], 1994, EP INF VERS 7; Bilardi JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-505; Blatt AJ, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.027; Brunelle BW, 2006, INFECT IMMUN, V74, P578, DOI 10.1128/IAI.74.1.578-585.2006; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Cabeza J, 2015, SEX TRANSM INFECT, V91, P7, DOI 10.1136/sextrans-2014-051531; Crichton J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2069-7; Cuffini C, 2012, J MICROBIOL RES, V2, P114; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; de Borborema-Alfaia APB, 2013, BRAZ J INFECT DIS, V17, P545, DOI 10.1016/j.bjid.2013.01.014; de Vries R, 2006, VALUE HEALTH, V9, P1, DOI 10.1111/j.1524-4733.2006.00075.x; Eng T, 2003, HIDDEN EPIDEMIC CONF; Farinati A, 2008, REV PANAM INFECTOL, V10, P8; Gallo Vaulet Lucia, 2010, BMC Res Notes, V3, P34, DOI 10.1186/1756-0500-3-34; Gencay M, 2001, APMIS, V109, P636, DOI 10.1034/j.1600-0463.2001.d01-186.x; Head MG, 2015, J GLOB HEALTH, V5, P89, DOI 10.7189/jogh.05.020405; Kakar S, 2010, INDIAN J MED MICROBI, V28, P45, DOI 10.4103/0255-0857.58728; Lagergard T, 2010, EUR J CLIN MICROBIOL, V29, P609, DOI 10.1007/s10096-010-0887-1; Lee V, 2006, J FAM PLAN REPROD H, V32, P104, DOI 10.1783/147118906776276440; Lopez-Hurtado M, 2002, PERINATOL REPROD HUM, V16, P140; Lutter EI, 2010, INFECT IMMUN, V78, P3678, DOI 10.1128/IAI.00515-10; Monetti M., 2013, INT J VIROL MOL BIOL, V2, P1; Murray PR, 2006, MICROBIOLOGIA MED, P463; Nonato DR, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.07.003; Ovalle A, 2012, REV CHIL INFECTOL, V29, P517, DOI 10.4067/S0716-10182012000600006; Schmidt R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141367; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vidwan NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034794; Welte R, 2000, SEX TRANSM DIS, V27, P518, DOI 10.1097/00007435-200010000-00005; World Health Organization, 2016, ESTR MUND SECT SAL I; Zucotti Agostina, 2018, Rev Fac Cien Med Univ Nac Cordoba, V75, P183, DOI 10.31053/1853.0605.v75.n3.19810	34	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217245	10.1371/journal.pone.0217245	http://dx.doi.org/10.1371/journal.pone.0217245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150440	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100036
J	Krebs, E; Enns, B; Wang, L; Zang, X; Panagiotoglou, D; Rio, C; Dombrowski, J; Feaster, DJ; Golden, M; Granich, R; Marshall, B; Mehta, SH; Metsch, L; Schackman, BR; Strathdee, SA; Nosyk, B; Gebo, K; Kerr, T; Kirk, G; Montaner, J; Shoptaw, S; Small, W				Krebs, Emanuel; Enns, Benjamin; Wang, Linwei; Zang, Xiao; Panagiotoglou, Dimitra; Del Rio, Carlos; Dombrowski, Julia; Feaster, Daniel J.; Golden, Matthew; Granich, Reuben; Marshall, Brandon; Mehta, Shruti H.; Metsch, Lisa; Schackman, Bruce R.; Strathdee, Steffanie A.; Nosyk, Bohdan; Gebo, Kelly; Kerr, Thomas; Kirk, Gregory; Montaner, Julio; Shoptaw, Steven; Small, William		Localized HIV Modeling Study Grp	Developing a dynamic HIV transmission model for 6 US cities: An evidence synthesis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DECISION-ANALYTIC MODELS; HEALTH STATE UTILITIES; INJECTING DRUG-USERS; PLASMA VIRAL LOAD; QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; HETEROSEXUAL TRANSMISSION; ECONOMIC EVALUATIONS	Background Dynamic HIV transmission models can provide evidence-based guidance on optimal combination implementation strategies to treat and prevent HIV/AIDS. However, these models can be extremely data intensive, and the availability of good-quality data characterizing regional microepidemics varies substantially within and across countries. We aim to provide a comprehensive and transparent description of an evidence synthesis process and reporting framework employed to populate and calibrate a dynamic, compartmental HIV transmission model for six US cities. Methods We executed a mixed-method evidence synthesis strategy to populate model parameters in six categories: (i) initial HIV-negative and HIV-infected populations; (ii) parameters used to calculate the probability of HIV transmission; (iii) screening, diagnosis, treatment and HIV disease progression; (iv) HIV prevention programs; (v) the costs of medical care; and (vi) health utility weights for each stage of HIV disease progression. We identified parameters that required city-specific data and stratification by gender, risk group and race/ethnicity a priori and sought out databases for primary analysis to augment our evidence synthesis. We ranked the quality of each parameter using context- and domain-specific criteria and verified sources and assumptions with our scientific advisory committee. Findings To inform the 1,667 parameters needed to populate our model, we synthesized evidence from 59 peer-reviewed publications and 24 public health and surveillance reports and executed primary analyses using 11 data sets. Of these 1,667 parameters, 1,517 (91%) were city-specific and 150 (9%) were common for all cities. Notably, 1,074 (64%), 201 (12%) and 312 (19%) parameters corresponded to categories (i), (ii) and (iii), respectively. Parameters ranked as best-to moderate-quality evidence comprised 39% of the common parameters and ranged from 56%-60% across cities for the city-specific parameters. We identified variation in parameter values across cities as well as within cities across risk and race/ethnic groups. Conclusions Better integration of modelling in decision making can be achieved by systematically reporting on the evidence synthesis process that is used to populate models, and by explicitly assessing the quality of data entered into the model. The effective communication of this process can help prioritize data collection of the most informative components of local HIV prevention and care services in order to reduce decision uncertainty and strengthen model conclusions.	[Krebs, Emanuel; Enns, Benjamin; Wang, Linwei; Zang, Xiao; Panagiotoglou, Dimitra; Nosyk, Bohdan] British Columbia Ctr Excellence HIV AIDS, Hlth Econ Res Unit, Vancouver, BC, Canada; [Zang, Xiao; Nosyk, Bohdan; Small, William] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Emory Ctr AIDS Res, Atlanta, GA 30322 USA; [Dombrowski, Julia; Golden, Matthew] Univ Washington, Dept Med, Div Allergy & Infect Dis Adjunct Epidemiol, Seattle, WA USA; [Feaster, Daniel J.] Univ Miami, Ctr Family Studies, Leonard M Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL USA; [Granich, Reuben] Int Assoc Providers AIDS Care, Washington, DC USA; [Marshall, Brandon] Brown Sch Publ Hlth, Dept Epidemiol, Providence, RI USA; [Mehta, Shruti H.; Gebo, Kelly; Kirk, Gregory] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Metsch, Lisa] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; [Schackman, Bruce R.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Emory Ctr AIDS Res, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Kerr, Thomas] British Columbia Ctr Substance Use, Vancouver, BC, Canada; [Kerr, Thomas; Montaner, Julio] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Nosyk, Bohdan; Montaner, Julio; Small, William] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Shoptaw, Steven] Univ Calif Los Angeles, Sch Med, Ctr HIV Identificat Prevent & Treatment Serv, Los Angeles, CA 90024 USA	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Emory University; Rollins School Public Health; University of Washington; University of Washington Seattle; University of Miami; Brown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; Cornell University; University of California System; University of California San Diego; Emory University; Rollins School Public Health; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nosyk, B (corresponding author), British Columbia Ctr Excellence HIV AIDS, Hlth Econ Res Unit, Vancouver, BC, Canada.; Nosyk, B (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	bnosyk@cfenet.ubc.ca	Enns, Benjamin/GYU-3276-2022; Gebo, Kelly/AHA-7533-2022; Golden, Matthew/AAE-4314-2020; Strathdee, Steffanie A/B-9042-2009	Enns, Benjamin/0000-0002-4865-1510; Gebo, Kelly/0000-0003-4010-398X; Krebs, Emanuel/0000-0002-6590-8728	National Institutes on Drug Abuse (NIDA) [R01-DA041747]; NIDA [DA12568, DA036297]; Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV [P30DA040500]; NIDA Method to Extend Research in Time (MERIT) award [R37-DA019829]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA019829, R01DA041747, P30DA040500] Funding Source: NIH RePORTER	National Institutes on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV; NIDA Method to Extend Research in Time (MERIT) award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institutes on Drug Abuse (NIDA), grant no. R01-DA041747 (BN), and received additional support from NIDA grants DA12568 and DA036297. BRS received additional support from the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (P30DA040500). SAS is supported by a NIDA Method to Extend Research in Time (MERIT) award (R37-DA019829). The funders had no direct role in the conduct of the analysis or the decision to submit the manuscript. NIDA - https://www.drugabuse.gov/. CHERISH - https://cherishresearch.org/.	Administration. DoHaMHVS, 2010, MAR VIT STAT ANN REP; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], 2017, GEORGIA HLTH NEWS; [Anonymous], 2019, HIV SURVEILL REP SPE; [Anonymous], 2018, HIV SURV REP 2017; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Baser O, 2011, AM J MANAG CARE, V17, pS6; Bellan SE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001801; Bernard CL, 2016, ANN INTERN MED, V26, pM15; Blair JM, 2014, BEHAV CLIN CHARACTER; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Center for HIV Surveillance-Epidemiology and Evaluation-Department of Health and Mental Hygiene-Baltimore-MD, 2015, BALT CIT ANN HIV EP; Centers for Disease Control and Prevention, 2014, PUBL US DAT FIL DOC; Centers for Disease Control and Prevention, 2021, HIV SURVEILLANCE SUP; Centers for Disease Control and Prevention, 2015, 11 CDCP; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI; Centers for Disease Control and Prevention, 2015, SYR SERV PROGR PERS; Centers for Disease Control and Prevention, 2014, 15 CDCP; Centers for Disease Control and Prevention, 2013, 13 CDCP; Centers for Disease Control and Prevention (CDC), 2014, BEH RISK FACT SURV S; Centers for Medicare and Medicaid Services, 2017, CLIN LAB FEE SCHED; Centers for Medicare and Medicaid Services, 2017, PHYS FEE SCHED SEARC; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; City of Baltimore, 2016, BALT CIT SYR EXCH PR; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Cleary S, 2009, HEALTH ECON, V19, P1166; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper NJ, 2007, HEALTH ECON, V16, P1277, DOI 10.1002/hec.1297; Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187; County of Los Angeles, 2011, 2010 ANN HIV SURV RE; Critchlow S, 2017, J MED ECON, V20, P129, DOI 10.1080/13696998.2016.1229671; Cuadros DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09464-y; DEGRUTTOLA V, 1989, J CLIN EPIDEMIOL, V42, P849, DOI 10.1016/0895-4356(89)90098-X; Delva W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001239; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Dombrowski JC, 2014, JAIDS-J ACQ IMM DEF, V67, P323, DOI 10.1097/QAI.0000000000000302; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Emanuel EJ, 2016, JAMA-J AM MED ASSOC, V316, P2604, DOI 10.1001/jama.2016.16739; Enns B, 2019, AIDS, V3; Evans E, 2015, ADDICTION, V110, P996, DOI 10.1111/add.12863; Florida Department of Health, 2018, ALL CAUS CRUD DEATH; Florida Department of Health, 2016, HIV SURV MIAM FL2015; Frieden TR, 2017, NEW ENGL J MED, V377, P465, DOI 10.1056/NEJMra1614394; Fujimoto K, 2015, AM J PUBLIC HEALTH, V105, P1128, DOI 10.2105/AJPH.2014.302474; Gaines TL, 2016, AIDS CARE, V28, P554, DOI 10.1080/09540121.2015.1131968; Ganz ML, 2015, J MED ECON, V18, P366, DOI 10.3111/13696998.2014.1001848; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Georgia Department of Public Health, 2018, AG ADJ DEATH RAT 201; Georgia Department of Public Health. HIV, 2014, HIV AIDS EP PROGR HI; Goodreau SM, 2017, LANCET HIV, V4, pE311, DOI 10.1016/S2352-3018(17)30067-X; Granich RM, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60648-6; GRANT RM, 1987, J INFECT DIS, V156, P189, DOI 10.1093/infdis/156.1.189; Greenberg AE, 2015, JAIDS-J ACQ IMM DEF, V69, pS1, DOI 10.1097/QAI.0000000000000569; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Hall HI, 2015, MMWR-MORBID MORTAL W, V64, P657; Hansen HB, 2013, J BEHAV HEALTH SER R, V40, P367, DOI 10.1007/s11414-013-9341-3; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Hudgens MG, 2002, AM J EPIDEMIOL, V155, P159, DOI 10.1093/aje/155.2.159; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Joyce VR, 2009, JAIDS-J ACQ IMM DEF, V50, P27, DOI 10.1097/QAI.0b013e31818ce6f3; KAPLAN EH, 1990, J ACQ IMMUN DEF SYND, V3, P55; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Karnon J, 2011, PHARMACOECONOMICS, V29, P51, DOI 10.2165/11584610-000000000-00000; Kato M, 2013, JAIDS-J ACQ IMM DEF, V63, pE142, DOI 10.1097/QAI.0b013e31829b535b; Katz IT, 2017, LANCET HIV, V4, pE324, DOI 10.1016/S2352-3018(17)30086-3; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095735; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Los Angeles County Department of Public Health, 2013, MORT LOS ANG COUNT 2; Low AJ, 2016, CLIN INFECT DIS, V63, P1094, DOI 10.1093/cid/ciw416; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mangal TD, 2017, AIDS, V31, P1073, DOI 10.1097/QAD.0000000000001437; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marmor M, 2001, J ACQ IMMUN DEF SYND, V27, P472, DOI 10.1097/00126334-200108150-00009; McCollister K, 2017, J SUBST ABUSE TREAT, V81, P25, DOI 10.1016/j.jsat.2017.07.008; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nachega JB, 2014, CLIN INFECT DIS, V59, pS21, DOI 10.1093/cid/ciu299; Neumann P. J., 2016, Cost-effectiveness in health and medicine; New York City Department of Health and Mental Hygiene, 2011, NEW YORK CIT HIV AID; New York City Department of Health and Mental Hygiene, 2011, SUMM VIT STAT 2010 C; New York State Department of Health AIDS Institute, 2014, COMPR HARM RED REV T; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Nosyk B, 2015, DRUG ALCOHOL DEPEN, V146, pe53, DOI DOI 10.1016/J.DRUGALCDEP.2014.09.516; Nosyk B, 2015, LANCET HIV, V2; Nosyk B, 2018, CLIN INFECT DIS, V66, P765, DOI 10.1093/cid/cix832; Nosyk B, 2017, LANCET HIV, V4, pE303, DOI 10.1016/S2352-3018(17)30045-0; Nosyk B, 2015, LANCET HIV, V2, pE393, DOI 10.1016/S2352-3018(15)00127-7; OBRIEN TR, 1994, J ACQ IMMUN DEF SYND, V7, P705; Oxford Centre for Evidence-Based Medicine, 2009, LEVELS EVIDENCE; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Paisley S, 2016, PHARMACOECONOMICS, V34, P597, DOI 10.1007/s40273-015-0372-x; Paisley S, 2010, INT J TECHNOL ASSESS, V26, P458, DOI 10.1017/S026646231000098X; Panagiotoglou D, 2017, AIDS BEHAV; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; PETERMAN TA, 1988, JAMA-J AM MED ASSOC, V259, P55, DOI 10.1001/jama.259.1.55; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Praditsitthikorn N, 2013, INFLUENZA OTHER RESP, V7, P59, DOI 10.1111/irv.12091; Public Health-Seattle and King County, HIV AIDS ANN Q REP 2; Public Health-Seattle & King County, 2017, HIV STD PROGR 2017; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; Rebeiro PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146119; Rodger A, 2014, 21 C RETR OPP INF 3; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Saloner B, 2017, MED CARE, V55, P669, DOI 10.1097/MLR.0000000000000727; SAMHSA, 2017, NUMB DATA CERT PHYS; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schiller-Fruthwirth IC, 2017, APPL HEALTH ECON HEA, V15, P333, DOI 10.1007/s40258-017-0312-3; Shepherd K, 2015, NATURE, V523, P152, DOI 10.1038/523152a; Shiboski SC, 1998, J ACQ IMMUN DEF SYND, V19, P527, DOI 10.1097/00042560-199812150-00013; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; Song DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116694; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Substance Abuse and Mental Health Services Administration, 2020, TREATM EP DAT SET TE; Suen Sze-Chuan, 2017, J Theor Biol, V428, P1, DOI 10.1016/j.jtbi.2017.06.004; Sutton AJ, 2012, EPIDEMICS-NETH, V4, P48, DOI 10.1016/j.epidem.2011.12.001; Taylor DCA, 2010, PHARMACOECONOMICS, V28, P995, DOI 10.2165/11538660-000000000-00000; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Timko C, 2016, J ADDICT DIS, V35, P22, DOI 10.1080/10550887.2016.1100960; Tookes H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129360; Truven Health Analytics, 2018, RED BOOK AV WHOL PRI; Hoang VP, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1368-8; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406; Wand H, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-28; Wang L, 2019, LANCET HIV; Washington State Department of Health, 2011, AG ADJ MORT RAT; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; Wiseman V, 2016, HEALTH ECON, V25, P140, DOI 10.1002/hec.3299; World Health Organization, 2011, PREVENTION TREATMENT; Zang X, 2019, DEV CALIBRATIO UNPUB; Zang X, 2019, STRUCTURAL DESIGN DA; Zechmeister-Koss I, 2014, MED DECIS MAKING, V34, P288, DOI 10.1177/0272989X13509406	153	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217559	10.1371/journal.pone.0217559	http://dx.doi.org/10.1371/journal.pone.0217559			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145752	Green Published, gold, Green Submitted			2022-12-26	WOS:000469425500022
J	Rodriguez-Flores, EM; Mata-Espinosa, D; Barrios-Payan, J; Marquina-Castillo, B; Castanon-Arreola, M; Hernandez-Pando, R				Rodriguez-Flores, Eden M.; Mata-Espinosa, Dulce; Barrios-Payan, Jorge; Marquina-Castillo, Brenda; Castanon-Arreola, Mauricio; Hernandez-Pando, Rogelio			A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ANTITUBERCULOSIS AGENTS; INDUCED HEPATOTOXICITY; NATURAL-PRODUCTS; MILK THISTLE; SILIBININ; INHIBITION; ACTIVATION; EXPRESSION	For many years, tuberculosis (TB) has been a major public health problem worldwide. Advances for treatment and eradication have been very limited. Silymarin (Sm) is a natural product with antioxidant and hepatoprotective activities that has been proposed as a complementary medicine to reduce the liver injury produced by the conventional anti-TB chemotherapy. Sm also has immunoregulatory and microbicide properties. In this study, we determined the effect of Sm on the growth control of mycobacteria. In vitro studies showed that Sm and Silibinin (the principal active compound of Sm) have microbicidal activity against drug-sensitive and multidrug-resistant (MDR) mycobacteria, induce the production of protective cytokines from infected macrophages, and improve the growth control of mycobacteria (p <= 0.0001). Studies in vivo using a model of progressive pulmonary TB in BALB/c mice infected with drug-sensitive or MDR mycobacteria have shown that Sm induces significant expression of Th-1 cytokines such as IFN-gamma and IL-12 as well as TNF alpha, which produce significant therapeutic activity when administered alone and apparently have a synergistic effect with chemotherapy. These results suggest that Sm has a bactericidal effect and can contribute to the control and establishment of a T(H)1 protective immune response against mycobacterial infection. Thus, it seems that this flavonoid has a promising potential as adjuvant therapy in the treatment of TB.	[Rodriguez-Flores, Eden M.; Mata-Espinosa, Dulce; Barrios-Payan, Jorge; Marquina-Castillo, Brenda; Hernandez-Pando, Rogelio] Natl Inst Med Sci & Nutr Salvador Zubiran, Expt Pathol Sect, Dept Pathol, Mexico City, DF, Mexico; [Rodriguez-Flores, Eden M.; Castanon-Arreola, Mauricio] Autonomous Univ Mexico City, Genom Sci Program, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Hernandez-Pando, R (corresponding author), Natl Inst Med Sci & Nutr Salvador Zubiran, Expt Pathol Sect, Dept Pathol, Mexico City, DF, Mexico.	rhdezpando@hotmail.com		Hernandez-Pando, Rogelio/0000-0003-1292-3833	National Council of Science and Technology (CONACYT); Rogelio Hernandez Pando [180990]	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Rogelio Hernandez Pando	This work was supported by the National Council of Science and Technology (CONACYT), grant Fon. Inst./58/2016 to Rogelio Hernandez Pando and No. 180990 to Mauricio Castanon-Arreola.	Abate G, 2016, IMMUNOTARGETS THER, V5, P37, DOI 10.2147/ITT.S81892; Abenavoli L, 2010, PHYTOTHER RES, V24, P1423, DOI 10.1002/ptr.3207; Arbex MA, 2010, J BRAS PNEUMOL, V36, P641, DOI 10.1590/S1806-37132010000500017; Bahmani M, 2015, J EVID-BASED INTEGR, V20, P292, DOI 10.1177/2156587215571116; Biedermann D, 2014, NAT PROD REP, V31, P1138, DOI 10.1039/c3np70122k; Bijak M, 2017, NUTRIENTS, V9; Bloom BR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2944; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Casas-Grajales Sael, 2015, World J Gastrointest Pharmacol Ther, V6, P59, DOI 10.4292/wjgpt.v6.i3.59; Chiang CY, 2013, INT J TUBERC LUNG D, V17, P714, DOI 10.5588/ijtld.12.0989; Cristofalo R, 2013, FREE RADICAL RES, V47, P268, DOI 10.3109/10715762.2013.765951; Cronje L, 2005, FEMS IMMUNOL MED MIC, V45, P103, DOI 10.1016/j.femsim.2005.02.007; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; de Oliveira DR, IN VITRO ANTIMICROBI; Dooley KE, 2016, ADV DRUG DELIVER REV, V102, P116, DOI 10.1016/j.addr.2016.01.014; Eminzade S, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-18; Fordham JB, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/938712; Forget EJ, 2006, EXPERT OPIN DRUG SAF, V5, P231, DOI 10.1517/14740338.5.2.231; Garcia A, 2012, EUR J MED CHEM, V49, P1, DOI 10.1016/j.ejmech.2011.12.029; Gharagozloo M, 2013, BASIC CLIN PHARMACOL, V113, P209, DOI 10.1111/bcpt.12088; Hackett ES, 2013, J VET INTERN MED, V27, P10, DOI 10.1111/jvim.12002; Hernandez Pando R, 1996, IMMUNOLOGY, V89, P26; Hoagland DT, 2016, ADV DRUG DELIVER REV, V102, P55, DOI 10.1016/j.addr.2016.04.026; Jahan S, 2015, J PAK MED ASSOC, V65, P620; Jeong DH, 2005, WORLD J GASTROENTERO, V11, P1141, DOI 10.3748/wjg.v11.i8.1141; Jiang RH, 2015, COMPLEMENT THER MED, V23, P544, DOI 10.1016/j.ctim.2015.06.006; Jnawali H., 2013, 1 2 LINE DRUGS DRUG; Kang HK, 2011, BIOTECHNOL J, V6, P1397, DOI 10.1002/biot.201000422; Kang JS, 2002, J PHARMACOL EXP THER, V302, P138, DOI 10.1124/jpet.302.1.138; Keni RS, 2015, EUR J MED CHEM, V100, P257, DOI 10.1016/j.ejmech.2015.06.017; Kim EJ, 2015, KOREAN J PHYSIOL PHA, V19, P211, DOI 10.4196/kjpp.2015.19.3.211; Kumar D, 2015, FUTURE MED CHEM, V7, P1981, DOI 10.4155/fmc.15.128; Lee DG, 2003, ARCH PHARM RES, V26, P597, DOI 10.1007/BF02976707; Lee H, 2016, J IND MICROBIOL BIOT, V43, P205, DOI 10.1007/s10295-015-1709-3; Lee JS, 2007, J CELL PHYSIOL, V210, P385, DOI 10.1002/jcp.20852; Lima MM, 2015, CURR CLIN PHARMACOL, V10, P242, DOI 10.2174/1574884708666131229124215; Luangchosiri C, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0861-7; Manna SK, 1999, J IMMUNOL, V163, P6800; Marjani M, 2016, IRAN J PHARM RES, V15, P247; Mascarello A, 2016, CURR PHARM DESIGN, V22, P1561, DOI 10.2174/1381612822666160112130539; Matteelli A, 2017, PRESSE MED, V46, pE13, DOI 10.1016/j.lpm.2017.01.015; Meeran SM, 2006, MOL CANCER THER, V5, P1660, DOI 10.1158/1535-7163.MCT-06-0095; Metushi I, 2016, BRIT J CLIN PHARMACO, V81, P1030, DOI 10.1111/bcp.12885; MIADONNA A, 1987, BRIT J CLIN PHARMACO, V24, P747, DOI 10.1111/j.1365-2125.1987.tb03241.x; Molina-Salinas GM, 2006, ARCH MED RES, V37, P45, DOI 10.1016/j.arcmed.2005.04.010; Nairz M, 2018, J TRACE ELEM MED BIO, V48, P118, DOI 10.1016/j.jtemb.2018.03.007; O'Donnell MR, 2016, INT J TUBERC LUNG D, V20, P430, DOI 10.5588/ijtld.15.0360; odany AT, 2016, F1000RES, P5, DOI [10.12688/f1000research.7403.1, DOI 10.12688/F1000RESEARCH.7403.1]; Oosthuizen C, 2017, J MED FOOD, DOI [10.1016/j.ctim.2015.06.006, DOI 10.1016/J.CTIM.2015.06.006]; Ordonez AA, 2014, CURR MOL MED, V14, P385, DOI 10.2174/1566524013666131118112431; Owatari MS, 2018, FISH SHELLFISH IMMUN, V82, P565, DOI 10.1016/j.fsi.2018.08.061; Papackova Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191353; Parida SK, 2015, J INTERN MED, V277, P388, DOI 10.1111/joim.12264; Parveen R, 2015, J PHARM BIOALLIED SC, V7, P321, DOI 10.4103/0975-7406.168037; Rangaka MX, 2015, LANCET, V386, P1, DOI 10.1016/S0140-6736(15)00323-2; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Raviglione M, 2016, INFECT DIS REP, V8, P33, DOI 10.4081/idr.2016.6570; Rawal T, 2016, INDIAN J PHARM SCI, V78, P8, DOI 10.4103/0250-474X.180243; Rayasaml GV, 2015, TRENDS PHARMACOL SCI, V36, P506, DOI 10.1016/j.tips.2015.05.005; Rennie Robert P, 2012, Handb Exp Pharmacol, P45, DOI 10.1007/978-3-642-28951-4_4; Saller R, 2007, FORSCH KOMP KLAS NAT, V14, P70, DOI 10.1159/000100581; Salomon CE, 2012, CURR TOP MED CHEM, V12, P735; Senousy BE, 2010, NAT REV GASTRO HEPAT, V7, P543, DOI 10.1038/nrgastro.2010.134; Silva JP, 2016, BIOTECHNOL ADV, V34, P924, DOI 10.1016/j.biotechadv.2016.05.007; Singh M, 2012, HUM EXP TOXICOL, V31, P788, DOI 10.1177/0960327111433901; Sonika Ujjwal, 2012, Trop Gastroenterol, V33, P102; Surai PF, 2015, ANTIOXIDANTS-BASEL, V4, P204, DOI 10.3390/antiox4010204; Vaid M, 2013, BIOCHEM PHARMACOL, V85, P1066, DOI 10.1016/j.bcp.2013.01.026; Vargas-Mendoza N, 2014, WORLD J HEPATOL, V6, P144, DOI 10.4254/wjh.v6.i3.144; Vivekanandan L, 2018, BIOMED PHARMACOTHER, V108, P1303, DOI 10.1016/j.biopha.2018.09.133; Wang M, 2015, TUBERCULOSIS, V95, P364, DOI 10.1016/j.tube.2015.03.003; Wu JW, 2007, DRUG METAB DISPOS, V35, P1603, DOI 10.1124/dmd.107.014894; Wu SS, 2015, J GASTROEN HEPATOL, V30, P540, DOI 10.1111/jgh.12717; Zhang SM, 2016, J GASTROEN HEPATOL, V31, P409, DOI 10.1111/jgh.13070; Zumla A, 2016, LANCET INFECT DIS, V16, P396, DOI 10.1016/S1473-3099(16)00086-4; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	76	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217457	10.1371/journal.pone.0217457	http://dx.doi.org/10.1371/journal.pone.0217457			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145751	Green Submitted, gold, Green Published			2022-12-26	WOS:000469425500018
J	Aloni, I; Markman, S; Ziv, Y				Aloni, Irith; Markman, Shai; Ziv, Yaron			Autumn temperatures at African wintering grounds affect body condition of two passerine species during spring migration	PLOS ONE			English	Article							BLACKCAPS SYLVIA-ATRICAPILLA; SWALLOWS HIRUNDO-RUSTICA; ENVIRONMENTAL-CONDITIONS; HABITAT QUALITY; BIRD MIGRATION; RAINFALL; ARRIVAL	Most papers on the physical condition of birds during spring migration focused on food availability preceding migratory take-off. Only a few studies examined the effect of climate conditions at the wintering grounds upon autumn arrival on bird physical condition later on. Here, we hypothesized that environmental conditions upon arrival at the wintering grounds, and not necessarily upon departure, have a crucial carry-over effect on bird spring migration. Using 29,000 observations of the lesser whitethroat, Sylvia curruca, and the eastern Bonelli's warbler, Phylloscopus orientalis, we found temperatures upon arrival at the African wintering grounds to be the only climatic variable correlated with birds' body state upon spring stopover in Israel, six months later. Two different mechanisms could explain these results. One possibility is that high temperatures create favorable conditions for insect activity, which allows rapid recovery from autumn migration and hence successful winter survival and maintenance. Another possible scenario is that harsh conditions, due to the heat and dry environment, cause high mortality, permitting survival of larger individuals which, then, enjoy reduced inter-and intra-specific competition. Whatever the mechanism is, our findings suggest that conditions upon autumn arrival, and not necessarily at the end of winter as traditionally thought, may have a major impact on migrating birds.	[Aloni, Irith; Ziv, Yaron] Ben Gurion Univ Negev, Dept Life Sci, Spatial Ecol Lab, Beer Sheva, Israel; [Markman, Shai] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Haifa, Israel	Ben Gurion University; University of Haifa	Aloni, I (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Spatial Ecol Lab, Beer Sheva, Israel.	irital@post.bgu.ac.il		Aloni, Irith/0000-0002-7777-3365; Markman, Shai/0000-0002-0484-3801; Ziv, Yaron/0000-0002-6369-9803				Aloni I, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160755; Bairlein F, 2004, ADV ECOL RES, V35, P33, DOI 10.1016/S0065-2504(04)35002-6; Bairlein F, 2006, HDB BIRDS WORLD, V11, p[652, 695]; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; BirdLife International, 2017, SPEC FACTSH PHYLL OR; BirdLife International, 2016, SPEC FACTSH SYLV CUR; Cooper NW, 2015, ECOLOGY, V96, P1933, DOI 10.1890/14-1365.1; DICK WJA, 1979, ORNIS SCAND, V10, P117, DOI 10.2307/3676351; Evans KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034542; Finch T, 2014, BIODIVERS CONSERV, V23, P2427, DOI 10.1007/s10531-014-0731-5; FRUMKIN R, 1995, J ORNITHOL, V136, P127, DOI 10.1007/BF01651235; Gonzalez-Prieto AM, 2013, J ORNITHOL, V154, P1067, DOI 10.1007/s10336-013-0975-y; Goodenough AE, 2017, BIRD STUDY, V64, P433, DOI 10.1080/00063657.2017.1408566; Goodman SM, 1989, BIRDS EGYPT, P429; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Izhaki I, 1998, IBIS, V140, P234, DOI 10.1111/j.1474-919X.1998.tb04384.x; Jones PD, 2008, CLIMATIC RES UNIT CR; Karasov WH, 2004, PHYSIOL BIOCHEM ZOOL, V77, P149, DOI 10.1086/381465; Kiat Y, 2015, J ISRAELI RINGIN FAL, P7; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Kutner M. H., 2004, APPL LINEAR REGRESSI; Moreau R., 1972, PALAEARCTIC AFRICAN; Ockendon N, 2014, J ORNITHOL, V155, P905, DOI 10.1007/s10336-014-1073-5; R Development Core Team, 2016, R LANG ENV STAT COMP; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2007, CLIM RES, V35, P123, DOI 10.3354/cr00719; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Schaub M, 2008, BEHAV ECOL, V19, P657, DOI 10.1093/beheco/arn023; Schlaich AE, 2016, J ANIM ECOL, V85, P1491, DOI 10.1111/1365-2656.12583; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; Shirihai H., 2001, SYLVIA WARBLERS IDEN; Shirihai H., 1996, BIRDS ISRAEL; Sicurella B, 2016, POPUL ECOL, V58, P135, DOI 10.1007/s10144-015-0529-7; Smith JAM, 2010, ECOLOGY, V91, P2874, DOI 10.1890/09-2212.1; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Svensson L., 1992, IDENTIFICATION GUIDE; van den Brink B, 2000, OSTRICH, V71, P198, DOI 10.1080/00306525.2000.9639911; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Zduniak P, 2012, J ARID ENVIRON, V77, P32, DOI 10.1016/j.jaridenv.2011.09.002; Zwarts L., 2009, LIVING EDGE WETLAND	43	5	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217619	10.1371/journal.pone.0217619	http://dx.doi.org/10.1371/journal.pone.0217619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141573	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000069
J	Nagel, S; Uphoff, CC; Dirks, WG; Pommerenke, C; Meyer, C; Drexler, HG				Nagel, Stefan; Uphoff, Cord C.; Dirks, Wilhelm G.; Pommerenke, Claudia; Meyer, Corinna; Drexler, Hans G.			Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL	PLOS ONE			English	Article							B-CELL LYMPHOMA; DOWN-REGULATION; EXPRESSION; DIFFERENTIATION; SURVIVAL; RECEPTOR; PROLIFERATION; TRANSCRIPTION; PATHOGENESIS; INFECTION	NKL homeobox genes encode developmental transcription factors regulating basic processes in cell differentiation. According to their physiological expression pattern in early hematopoiesis and lymphopoiesis, particular members of this homeobox gene subclass constitute an NKL-code. B-cell specific NKL-code genes generate a regulatory network and their deregulation is implicated in B-cell lymphomagenesis. Epstein-Barr virus (EBV) infects B-cells and influences the activity of signalling pathways including JAK/STAT and several genes encoding developmental regulators. Therefore, EBV-infection impacts the pathogenesis and the outcome of B-cell malignancies including Hodgkin lymphoma and diffuse large B-cell lymphoma (DLBCL). Here, we isolated EBV-positive and EBV-negative subclones from the DLBCL derived cell line DOHH-2. These subclones served as models to investigate the role of EBV in deregulation of the B-cell specific NKL-code members HHEX, HLX, MSX1 and NKX6-3. We showed that the EBV-encoded factors LMP1 and LMP2A activated the expression of HLX via STAT3. HLX in turn repressed NKX6-3, SPIB and IL4R which normally mediate plasma cell differentiation. In addition, HLX repressed the pro-apoptotic factor BCL2L11/BIM and hence supported cell survival. Thus, EBV aberrantly activated HLX in DLBCL, thereby disturbing both B-cell differentiation and apoptosis. The results of our study appreciate the pathogenic role of EBV in NKL homeobox gene deregulation and B-cell malignancies.	[Nagel, Stefan; Uphoff, Cord C.; Dirks, Wilhelm G.; Pommerenke, Claudia; Meyer, Corinna; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de		Dirks, Wilhelm/0000-0001-9781-0998				Alanentalo T, 2006, GENE EXPR PATTERNS, V6, P162, DOI 10.1016/j.modgep.2005.06.012; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Bavi P, 2011, J PATHOL, V224, P355, DOI 10.1002/path.2864; CUOMO L, 1992, INT J CANCER, V51, P949, DOI 10.1002/ijc.2910510619; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Demetriades C, 2009, J VIROL, V83, P5269, DOI 10.1128/JVI.00097-09; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Dijkstra D, 2017, J IMMUNOL, V198, P229, DOI 10.4049/jimmunol.1601144; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Drexler HG, 2016, LEUKEMIA LYMPHOMA, V57, P1015, DOI 10.3109/10428194.2015.1108414; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; El-Sharkawy A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00265; Garrido JL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-231; Guasparri L, 2008, BLOOD, V111, P3813, DOI 10.1182/blood-2007-03-080309; Gupta M, 2012, LEUKEMIA, V26, P1356, DOI 10.1038/leu.2011.340; Hannan JP, 2016, CURR PROTEIN PEPT SC, V17, P463, DOI 10.2174/1389203717666151201192124; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Igarashi K, 2014, IMMUNOL REV, V261, P116, DOI 10.1111/imr.12201; Incrocci R, 2017, VIROLOGY, V500, P96, DOI 10.1016/j.virol.2016.10.015; Kato H, 2014, CANCER SCI, V105, P537, DOI 10.1111/cas.12389; Kook SH, 2005, J BIOCHEM MOL BIOL, V38, P755; Kung CP, 2008, J VIROL, V82, P5486, DOI 10.1128/JVI.00125-08; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Kuze T, 2000, JPN J CANCER RES, V91, P1233, DOI 10.1111/j.1349-7006.2000.tb00909.x; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; Li XF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01052; Longnecker R, 2013, FIELDS VIROLOGY, V2, P1898; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mikhalkevich N, 2006, J IMMUNOL, V176, P1553, DOI 10.4049/jimmunol.176.3.1553; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Nagel Stefan, 2018, Oncotarget, V9, P37480, DOI 10.18632/oncotarget.26459; Nagel S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205537; Nagel Stefan, 2018, Oncotarget, V9, P14338, DOI 10.18632/oncotarget.24512; Nagel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171164; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061447; Nagy M, 2002, BRIT J HAEMATOL, V116, P429, DOI 10.1046/j.1365-2141.2002.03271.x; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Noujima-Harada M, 2017, CANCER SCI, V108, P1071, DOI 10.1111/cas.13213; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Paschos K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000492; Pei YG, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006500; Robles EF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11889; Rosenthal A, 2017, BLOOD REV, V31, P37, DOI 10.1016/j.blre.2016.09.004; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Shannon-Lowe C, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0271; Song S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02026; Styles CT, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001992; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Teng Y, 2007, EUR J CELL BIOL, V86, P581, DOI 10.1016/j.ejcb.2007.05.006; Tisi MC, 2016, LEUKEMIA LYMPHOMA, V57, P628, DOI 10.3109/10428194.2015.1072766; Uphoff CC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210404; Uphoff CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/904767; Vrzalikova K, 2011, BLOOD, V117, P5907, DOI 10.1182/blood-2010-09-307710; WANG D, 1988, J VIROL, V62, P4173, DOI 10.1128/JVI.62.11.4173-4184.1988; Wang L, 2017, ONCOGENE, V36, P2265, DOI 10.1038/onc.2016.380; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yin QY, 2010, J VIROL, V84, P6318, DOI 10.1128/JVI.00635-10; Yoon JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02901-y; Zhang LW, 2004, VIROLOGY, V323, P141, DOI 10.1016/j.virol.2004.03.007; Zhang ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108337	66	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216898	10.1371/journal.pone.0216898	http://dx.doi.org/10.1371/journal.pone.0216898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141539	Green Published, Green Submitted, gold			2022-12-26	WOS:000469323000027
J	Recharla, N; Kim, D; Ramani, S; Song, M; Park, J; Balasubramanian, B; Puligundla, P; Park, S				Recharla, Neeraja; Kim, Duwan; Ramani, Sivasubramanian; Song, Minho; Park, Juncheol; Balasubramanian, Balamuralikrishnan; Puligundla, Pradeep; Park, Sungkwon			Dietary multi-enzyme complex improves In Vitro nutrient digestibility and hind gut microbial fermentation of pigs	PLOS ONE			English	Article							WHEAT-BASED DIETS; GROWTH-PERFORMANCE; SOYBEAN-MEAL; NONSTARCH POLYSACCHARIDES; ENZYME SUPPLEMENTATION; BETA-GLUCANASE; GASTROINTESTINAL-TRACT; BLOOD CHARACTERISTICS; BROILER-CHICKENS; HULLESS BARLEY	This study was conducted in two stages to investigate the potential of multi-enzyme supplementation on the nutrient digestibility, growth performance, and gut microbial composition of pigs. In stage 1, effects of multi-enzyme complex (xylanase, alpha-amylase, beta-glucanase, and protease) supplementation on the ileal and total tract dry matter (DM) digestibility of feedstuffs were investigated with in vitro two-stage and three-stage enzyme incubation methods. A wide range of feed ingredients, namely, corn meal, wheat meal, soybean meal, fish meal, Oriental herbal extract, Italian rye-grass (IRG) and peanut hull were used as substrates. Supplementation of the multi-enzyme complex increased (P < 0.05) the digestibility of the Oriental herbal extract and corn meal. In stage 2, in vivo animal studies were performed to further investigate the effects of the dietary multi-enzyme complex on the nutrient utilization, growth performance, and fecal microbial composition of pigs. A total of 36 weaned pigs were fed corn- and soybean meal-based diets without (control) and with the multi-enzyme complex (treatment) for 6 weeks. Fecal samples were collected from 12 pigs to analyze the microbial communities by using DNA sequencing and bioinformatics tools. Multi-enzyme supplementation had no effect on apparent digestibility of nutrients and growth performance of pigs compared to control. Taxonomic analysis of the fecal samples indicated that the bacteria in both control and treatment samples predominantly belonged to Firmicutes and Bacteroidetes. In addition, the proportion of the phylum Firmicutes was slightly higher in the treatment group. At the genus level, the abundance of Treponema and Barnesiella increased in the treatment group; whereas the numbers of the genera including Prevotella, Butyricicoccus, Ruminococcus and Succinivibrio decreased in the treatment group. These results suggest that multi-enzyme supplementation with basal diets have the potential to improve nutrient digestibility and modify microbial communities in the hind-gut of pigs.	[Recharla, Neeraja; Ramani, Sivasubramanian; Balasubramanian, Balamuralikrishnan; Park, Sungkwon] Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea; [Kim, Duwan; Park, Juncheol] RDA, Natl Inst Anim Sci, Swine Div, Sunghwan, South Korea; [Song, Minho] Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea; [Puligundla, Pradeep] Gachon Univ, Dept Food Sci & Biotechnol, Seongnam, South Korea	Sejong University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Chungnam National University; Gachon University	Park, S (corresponding author), Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea.	sungkwonpark@sejong.ac.kr	Ramani, Sivasubramanian/P-6080-2017; Balasubramanian, Balamuralikrishnan/K-6132-2019; Puligundla, Pradeep/C-3895-2012; Recharla, Neeraja/P-2776-2019; Balasubramanian, Balamuralikrishnan/AAB-1199-2020	Ramani, Sivasubramanian/0000-0001-9370-6552; Balasubramanian, Balamuralikrishnan/0000-0001-6938-1495; Puligundla, Pradeep/0000-0002-2457-0273; Recharla, Neeraja/0000-0001-9343-7436; Balasubramanian, Balamuralikrishnan/0000-0001-6938-1495; park, sungkwon/0000-0002-7684-9719	"Cooperative Research Program for Agriculture science Technology Development Rural Development" Administration and Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future planning, South [PJ012615, 2015R1C1A1A01051767]	"Cooperative Research Program for Agriculture science Technology Development Rural Development" Administration and Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future planning, South	This work was carried out with the support of "Cooperative Research Program for Agriculture science & Technology Development (Project No. PJ012615)" Rural Development Administration and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future planning 2015R1C1A1A01051767), South Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeola O, 2004, BRIT J NUTR, V92, P87, DOI 10.1079/BJN20041180; Adeola O., 2001, SWINE NUTR, VLewis, P903, DOI DOI 10.1201/9781420041842.CH40; ANDERSON DC, 1973, J ANIM SCI, V37, P148, DOI 10.2527/jas1973.371148x; AOAC, 2000, OFFICIAL METHODS ANA; Bakker GCM, 1998, VET QUART, V20, pS59; BEDFORD MR, 1992, CAN J ANIM SCI, V72, P97, DOI 10.4141/cjas92-011; Boisen S, 1997, ANIM FEED SCI TECH, V68, P277, DOI 10.1016/S0377-8401(97)00058-8; BOISEN S, 1995, ANIM FEED SCI TECH, V51, P29, DOI 10.1016/0377-8401(94)00686-4; Choct M, 2010, ASIAN AUSTRAL J ANIM, V23, P1386, DOI 10.5713/ajas.2010.90222; Choct M., 1997, FEED MILLING INT, V191, P13; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Hogberg A, 2004, ANIM FEED SCI TECH, V116, P113, DOI 10.1016/j.anifeedsci.2004.03.010; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Jha R, 2015, ANIMAL, V9, P1441, DOI 10.1017/S1751731115000919; Jha R., 2016, P NZ POULTR IND C, V13, P84; Jo JK, 2012, J ANIM SCI, V90, P3041, DOI 10.2527/jas.2010-3430; KERR TJ, 1986, J SCI FOOD AGR, V37, P632, DOI 10.1002/jsfa.2740370706; Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014; Kim S. W, 2014, 6 C LAT AM NUTR AN S; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1; Kong C, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1060-1; KORNEGAY ET, 1995, J ANIM SCI, V73, P1381; l'Anson KA, 2013, ANIM PROD SCI, V53, P531, DOI 10.1071/AN12256; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li S, 1996, J ANIM SCI, V74, P1649; LINDEMANN MD, 1986, J ANIM SCI, V62, P412, DOI 10.2527/jas1986.622412x; Liu HY, 2012, APPL ENVIRON MICROB, V78, P4102, DOI 10.1128/AEM.07702-11; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Meng X, 2005, POULTRY SCI, V84, P1242, DOI 10.1093/ps/84.8.1242; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Nortey TN, 2007, J ANIM SCI, V85, P1432, DOI 10.2527/jas.2006-613; O'Neill HVM, 2014, ASIAN AUSTRAL J ANIM, V27, P290, DOI 10.5713/ajas.2013.13261; Omogbenigun FO, 2004, J ANIM SCI, V82, P1053; Owusu-Asiedu A, 2010, LIVEST SCI, V134, P76, DOI 10.1016/j.livsci.2010.06.102; Park KR, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2194-5; Pryde SE, 1999, APPL ENVIRON MICROB, V65, P5372; Prykhodko O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116947; Ramayo-Caldas Y, 2016, ISME J, V10, P2973, DOI 10.1038/ismej.2016.77; Ravindran V, 2013, J APPL POULTRY RES, V22, P628, DOI 10.3382/japr.2013-00739; Regmi PR, 2009, J ANIM SCI, V87, P3620, DOI 10.2527/jas.2008-1739; ROBINSON IM, 1984, APPL ENVIRON MICROB, V48, P964, DOI 10.1128/AEM.48.5.964-969.1984; Ruan YF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1272-3; Shim YH, 2003, ASIAN AUSTRAL J ANIM, V16, P1339, DOI 10.5713/ajas.2003.1339; Sieo CC, 2005, POULTRY SCI, V84, P734, DOI 10.1093/ps/84.5.734; Slominski BA, 2011, POULTRY SCI, V90, P2013, DOI 10.3382/ps.2011-01372; Tactacan GB, 2016, ASIAN AUSTRAL J ANIM, V29, P998, DOI 10.5713/ajas.15.0886; Toscano M, 2017, DIGEST LIVER DIS, V49, P261, DOI 10.1016/j.dld.2016.11.011; Upadhaya SD, 2016, ANIM FEED SCI TECH, V216, P281, DOI 10.1016/j.anifeedsci.2016.04.003; Vahjen W, 2007, ARCH ANIM NUTR, V61, P90, DOI 10.1080/17450390701203881; Wang H, 2008, ANIM FEED SCI TECH, V140, P376, DOI 10.1016/j.anifeedsci.2007.04.003; Ward NE, 2008, POULTRY SCI, V87, P91; Willamil J, 2012, J ANIM SCI, V90, P824, DOI 10.2527/jas.2010-3766; WILLIAMS CH, 1962, J AGR SCI, V59, P381, DOI 10.1017/S002185960001546X; Yang Y, 2010, J ANIM SCI, V88, P3304, DOI 10.2527/jas.2009-2318; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin YL, 2001, LIVEST PROD SCI, V71, P97, DOI 10.1016/S0301-6226(01)00214-7; Yuan L, 2017, P 50 HAW INT C SYST, P12, DOI DOI 10.24251/HICSS.2017; Zhang YJ, 2018, LIVEST SCI, V207, P105, DOI 10.1016/j.livsci.2017.11.017	63	10	10	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217459	10.1371/journal.pone.0217459	http://dx.doi.org/10.1371/journal.pone.0217459			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136616	Green Published, gold, Green Submitted			2022-12-26	WOS:000469224300041
J	Wieghaus, A; Prufer, D; Gronover, CS				Wieghaus, Annika; Pruefer, Dirk; Gronover, Christian Schulze			Loss of function mutation of the Rapid Alkalinization Factor (RALF1)-like peptide in the dandelion Taraxacum koksaghyz entails a high-biomass taproot phenotype	PLOS ONE			English	Article							RUSSIAN DANDELION; ALTERNATIVE SOURCES; SILENCING AFFECTS; NATURAL-RUBBER; PLANT-GROWTH; L. RODIN; RALF; INULIN; PROTEINS; HORMONE	The Russian dandelion (Taraxacum koksaghyz) is a promising source of inulin and natural rubber because large amounts of both feedstocks can be extracted from its roots. However, the domestication of T. koksaghyz requires the development of stable agronomic traits such as higher yields of inulin and natural rubber, a higher root biomass, and an agronomically preferable root morphology which is more suitable for cultivation and harvesting. Arabidopsis thaliana Rapid Alkalinisation Factor 1 (RALF1) has been shown to suppress root growth. We identified the T. koksaghyz orthologue TkRALF-like 1 and knocked out the corresponding gene (TkRALFL1) using the CRISPR/Cas9 system to determine its impact on root morphology, biomass, and inulin and natural rubber yields. The TkRALFL1 knockout lines more frequently developed a taproot phenotype which is easier to cultivate and harvest, as well as a higher root biomass and greater yields of both inulin and natural rubber. The TkRALFL1 gene could therefore be suitable as a genetic marker to support the breeding of profitable new dandelion varieties with improved agronomic traits. To our knowledge, this is the first study addressing the root system of T. koksaghyz to enhance the agronomic performance.	[Wieghaus, Annika; Pruefer, Dirk] Univ Munster, Inst Plant Biol & Biotechnol, Munster, Germany; [Pruefer, Dirk; Gronover, Christian Schulze] Fraunhofer Inst Mol Biol & Appl Ecol IME, Munster, Germany	University of Munster; Fraunhofer Gesellschaft	Gronover, CS (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Munster, Germany.	christian.schulze.gronover@ime.fraunhofer.de		Schulze Gronover, Christian/0000-0001-6398-2265	Federal Ministry of Education and Research [031A285A]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Annika Wieghaus was financed by a grant from the Federal Ministry of Education and Research (grant no. 031A285A).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arias M, 2016, IND CROP PROD, V83, P316, DOI 10.1016/j.indcrop.2016.01.023; Bedinger PA, 2010, PLANT SIGNAL BEHAV, V5, P1342, DOI 10.4161/psb.5.11.12954; Bergonci T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.976146; Bergonci T, 2014, J EXP BOT, V65, P2219, DOI 10.1093/jxb/eru099; Campbell L, 2017, FRONT PLANT SCI, V8, P1, DOI [10.3389/fpls.2017.00001, DOI 10.3389/FPLS.2017.00001]; Cao J, 2012, EVOL BIOINFORM, V8, P271, DOI 10.4137/EBO.S9652; Chandler PM, 1999, PLANT PHYSIOL, V120, P623, DOI 10.1104/pp.120.2.623; do Canto AM, 2014, PLANT PHYSIOL BIOCH, V75, P45, DOI 10.1016/j.plaphy.2013.12.005; Dressano K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007053; Du CQ, 2016, P NATL ACAD SCI USA, V113, pE8326, DOI 10.1073/pnas.1609626113; Eggert M, 2018, EUR J AGRON, V93, P126, DOI 10.1016/j.eja.2017.12.003; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ge ZX, 2017, SCIENCE, V358, P1596, DOI 10.1126/science.aao3642; Grienenberger E, 2015, CURR OPIN PLANT BIOL, V23, P8, DOI 10.1016/j.pbi.2014.09.013; Gronover CS, 2011, BIOTECHNOLOGY OF BIOPOLYMERS, P75; Haruta M, 2008, BIOCHEMISTRY-US, V47, P6311, DOI 10.1021/bi8001488; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Javorsky L., 1944, TROPENPFLANZER, V1, P1; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Kreuzberger M, 2016, EUR J AGRON, V80, P66, DOI 10.1016/j.eja.2016.06.011; KROTKOV G, 1945, BOT REV, V11, P417, DOI 10.1007/BF02861139; Laibach N, 2015, PLANT J, V82, P609, DOI 10.1111/tpj.12836; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lin T, 2018, NATL SCI REV, V5, P78, DOI 10.1093/nsr/nwx101; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; Matos JL, 2008, FEBS LETT, V582, P3343, DOI 10.1016/j.febslet.2008.08.025; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Mecchia MA, 2017, SCIENCE, V358, P1600, DOI 10.1126/science.aao5467; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627; Morre DJ, 2000, J APPL TOXICOL, V20, P157, DOI 10.1002/(SICI)1099-1263(200003/04)20:2<157::AID-JAT648>3.0.CO;2-9; Munt O, 2012, IND CROP PROD, V36, P289, DOI 10.1016/j.indcrop.2011.10.014; Murphy E, 2016, J EXP BOT, V67, P4863, DOI 10.1093/jxb/erw281; Murphy E, 2014, TRENDS PLANT SCI, V19, P664, DOI 10.1016/j.tplants.2014.06.005; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; OHTA K, 1993, APPL ENVIRON MICROB, V59, P729, DOI 10.1128/AEM.59.3.729-733.1993; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Pearce G, 2010, PEPTIDES, V31, P1973, DOI 10.1016/j.peptides.2010.08.012; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Putter KM, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1036-0; Ramirez-Cadavid DA, 2017, IND CROP PROD, V107, P624, DOI 10.1016/j.indcrop.2017.05.043; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt T, 2010, PLANT MOL BIOL REP, V28, P277, DOI 10.1007/s11105-009-0145-9; Sharma A, 2016, PLANT PHYSIOL BIOCH, V106, P82, DOI 10.1016/j.plaphy.2016.03.037; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shih HW, 2014, CURR BIOL, V24, P1887, DOI 10.1016/j.cub.2014.06.064; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; Stolze A, 2017, PLANT BIOTECHNOL J, V15, P740, DOI 10.1111/pbi.12672; Uhlmann M., 1951, WERTVOLLE KAUTSCHUKP; van Beilen JB, 2007, CRIT REV BIOTECHNOL, V27, P217, DOI 10.1080/07388550701775927; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Van den Ende W, 2004, TRENDS PLANT SCI, V9, P523, DOI 10.1016/j.tplants.2004.09.008; Wahler D, 2009, PLANT PHYSIOL, V151, P334, DOI 10.1104/pp.109.138743; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x; Wu Xuebing, 2014, Quant Biol, V2, P59; Yu YQ, 2018, PLANT PHYSIOL, V176, P2426, DOI 10.1104/pp.17.01277	61	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217454	10.1371/journal.pone.0217454	http://dx.doi.org/10.1371/journal.pone.0217454			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125376	gold, Green Submitted, Green Published			2022-12-26	WOS:000468865700043
J	LeBlanc, ME; Saez-Torres, KL; Cano, I; Hu, ZP; Saint-Geniez, M; Ng, YS; D'Amore, PA				LeBlanc, Michelle E.; Saez-Torres, Kahira L.; Cano, Issahy; Hu, Zhengping; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.			Glycocalyx regulation of vascular endothelial growth factor receptor 2 activity	FASEB JOURNAL			English	Article						endothelium; angiogenesis; VEGF; endocytosis	VEGFR2; CADHERIN; INTERNALIZATION; COLOCALIZATION; ANGIOGENESIS; TRAFFICKING; ENDOCYTOSIS; EXPRESSION	We have previously shown that knockdown of endomucin (EMCN), an integral membrane glycocalyx glycoprotein, prevents VEGF-induced proliferation, migration, and tube formation in vitro and angiogenesis in vivo. In the endothelium, VEGF mediates most of its angiogenic effects through VEGF receptor 2 (VEGFR2). To understand the role of EMCN, we examined the effect of EMCN depletion on VEGFR2 endocytosis and activation. Results showed that although VEGF stimulation promoted VEGFR2 internalization in control endothelial cells (ECs), loss of EMCN prevented VEGFR2 endocytosis. Cell surface analysis revealed a decrease in VEGFR2 following VEGF stimulation in control but not siRNA directed against EMCN-transfected ECs. EMCN depletion resulted in heightened phosphorylation following VEGF stimulation with an increase in total VEGFR2 protein. These results indicate that EMCN modulates VEGFR2 endocytosis and activity and point to EMCN as a potential therapeutic target.-LeBlanc, M. E., Saez-Torres, K. L., Cano, I., Hu, Z., Saint-Geniez, M., Ng, Y.-S., D'Amore, P. A. Glycocalyx regulation of vascular endothelial growth factor receptor 2 activity.	[LeBlanc, Michelle E.; Saez-Torres, Kahira L.; Cano, Issahy; Hu, Zhengping; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.] Massachusetts Eye & Ear, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA; [LeBlanc, Michelle E.; Saez-Torres, Kahira L.; Cano, Issahy; Hu, Zhengping; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [D'Amore, Patricia A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	D'Amore, PA (corresponding author), Massachusetts Eye & Ear, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	patricia_damore@meei.harvard.edu	Ng, Wing Yin/HHN-1743-2022; D'Amore, Patricia/G-5660-2017	Hu, Zhengping/0000-0001-7369-1314; Ng, Yin Shan/0000-0002-4982-1999; D'Amore, Patricia/0000-0001-9652-8974	U.S. National Institutes of Health/National Eye Institute (NIH/NEI) Grant [R01EY026539]; Vitreo Retinal Surgery Foundation; Training Program in the Molecular Bases of Eye Diseases Grant [2T32EY007145]; NIH/NEI Core Grant for Vision Research [P30 EY003790]; NATIONAL EYE INSTITUTE [P30EY003790, T32EY007145, R01EY026539] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute (NIH/NEI) Grant; Vitreo Retinal Surgery Foundation; Training Program in the Molecular Bases of Eye Diseases Grant; NIH/NEI Core Grant for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Jinling Yang for design and use of the tagged endomucin construct and Dr. Ashley Mackey for technical assistance on the cell surface protein biotinylation assay (both from Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA, USA). The study was supported by U.S. National Institutes of Health/National Eye Institute (NIH/NEI) Grant R01EY026539 (to P.A.D.), the Vitreo Retinal Surgery Foundation (to M.E.L.), and the Training Program in the Molecular Bases of Eye Diseases Grant 2T32EY007145 (to M.E.L.). The authors acknowledge the NIH/NEI Core Grant for Vision Research P30 EY003790. The authors declare no conflicts of interest.	Basagiannis D, 2016, J CELL SCI, V129, P4091, DOI 10.1242/jcs.188219; Becker PM, 2005, CIRC RES, V96, P1257, DOI 10.1161/01.RES.0000171756.13554.49; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Clegg LW, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004158; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; D'Amore PA, 2007, AM J PATHOL, V171, P14, DOI 10.2353/ajpath.2007.070385; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Kinoshita M, 2001, FEBS LETT, V499, P121, DOI 10.1016/S0014-5793(01)02520-0; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Park-Windhol C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16852-x; Pasula S, 2012, J CLIN INVEST, V122, P4424, DOI 10.1172/JCI64537; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Salikhova A, 2008, CIRC RES, V103, pE71, DOI 10.1161/CIRCRESAHA.108.183327; Samulowitz U, 2002, AM J PATHOL, V160, P1669, DOI 10.1016/S0002-9440(10)61114-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tian HY, 2018, FASEB J, V32, P2934, DOI 10.1096/fj.201700867RR; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Yadav L, 2015, J CLIN DIAGN RES, V9, pXE1, DOI 10.7860/JCDR/2015/12016.6135; Zhu WQ, 2017, J CLIN INVEST, V127, P4569, DOI 10.1172/JCI91770	31	14	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9362	9373		10.1096/fj.201900011R	http://dx.doi.org/10.1096/fj.201900011R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31141406	Green Published, Bronze			2022-12-26	WOS:000478832900052
J	Yoo, W; Cho, EB; Kim, S; Yoon, JB				Yoo, Wonjin; Cho, Eun-Bee; Kim, Sungjoo; Yoon, Jong-Bok			The E3 ubiquitin ligase MARCH2 regulates ERGIC3-dependent trafficking of secretory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; protein degradation; intracellular trafficking; ubiquitin; protein secretion; alpha 1-antitrypsin; cargo receptor; endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3); haptoglobin; membrane-associated ring-CH-type finger 2 (MARCH2)	GOLGI INTERMEDIATE COMPARTMENT; ENDOPLASMIC-RETICULUM; TRANSPORT; COMPLEX; DEGRADATION; RECEPTOR; ERV41P; EXIT; ER	The E3 ubiquitin ligase membrane-associated ring-CH-type finger 2 (MARCH2) is known to be involved in intracellular vesicular trafficking, but its role in the early secretory pathway between the endoplasmic reticulum (ER) and Golgi compartments is largely unknown. Human ER-Golgi intermediate compartment protein 2 (ERGIC2) and ERGIC3 are orthologs of Erv41 and Erv46 in yeast, proteins that form a heteromeric complex, cycle between the ER and Golgi, and function as cargo receptors in both anterograde and retrograde protein trafficking. Here, we report that MARCH2 directs ubiquitination and subsequent degradation of ERGIC3 and that MARCH2 depletion increases endogenous ERGIC3 levels. We provide evidence that the lysine residues at positions 6 and 8 of ERGIC3 are the major sites of MARCH2-mediated ubiquitination. Of note, MARCH2 did not significantly decrease the levels of an ERGIC3 variant with lysine-to-arginine substitutions at residues 6 and 8. We also show that ERGIC3 binds to itself or to ERGIC2, whereas ERGIC2 is unable to interact with itself. Our results indicate that alpha(1)-antitrypsin and haptoglobin are likely to be cargo proteins of ERGIC3. We further observed that alpha(1)-antitrypsin and haptoglobin specifically bind to ERGIC3 and that ERGIC3 depletion decreases their secretion. Moreover, MARCH2 reduced secretion of alpha(1)-antitrypsin and haptoglobin, and coexpression of the ubiquitination-resistant ERGIC3 variant largely restored their secretion, suggesting that MARCH2-mediated ERGIC3 ubiquitination is the major cause of the decrease in trafficking of ERGIC3-binding secretory proteins. Our findings provide detailed insights into the regulation of the early secretory pathway by MARCH2 and into ERGIC3 function.	[Yoo, Wonjin; Yoon, Jong-Bok] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea; [Cho, Eun-Bee; Kim, Sungjoo] Catholic Univ Korea, Dept Med Lifesci, Seoul 06591, South Korea	Yonsei University; Catholic University of Korea	Yoon, JB (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea.	yoonj@yonsei.ac.kr		Yoo, Wonjin/0000-0002-3779-4348; Kim, Sungjoo/0000-0003-2497-729X	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT (MSIT)) [NRF-2019R1A2C1010777, NRF-2018R1A2B6003455]; Brain Korea 21 (BK21) PLUS Program	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT (MSIT)); Brain Korea 21 (BK21) PLUS Program	This work was supported by the National Research Foundation of Korea (NRF) Grants NRF-2019R1A2C1010777 and NRF-2018R1A2B6003455 funded by the Korea government (Ministry of Science and ICT (MSIT)) and the Brain Korea 21 (BK21) PLUS Program (to J.-B. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Biterova EI, 2013, J MOL BIOL, V425, P2208, DOI 10.1016/j.jmb.2013.03.024; Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200; Cao ZF, 2008, CELL SIGNAL, V20, P73, DOI 10.1016/j.cellsig.2007.08.019; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068001; Cho EB, 2018, BBA-MOL BASIS DIS, V1864, P2199, DOI 10.1016/j.bbadis.2018.04.001; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Deshar R, 2019, NUCLEIC ACIDS RES, V47, P762, DOI 10.1093/nar/gky1166; Deshar R, 2016, FEBS J, V283, P4583, DOI 10.1111/febs.13947; Geva Y, 2014, CURR BIOL, V24, pR130, DOI 10.1016/j.cub.2013.12.008; Gomez-Navarro N, 2016, J CELL BIOL, V215, P769, DOI 10.1083/jcb.201610031; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Lee H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143107; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Noda Y, 2014, BIOL OPEN, V3, P209, DOI 10.1242/bio.20146312; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Orci L, 2003, P NATL ACAD SCI USA, V100, P4586, DOI 10.1073/pnas.0730885100; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Shibuya A, 2015, J CELL BIOL, V208, P197, DOI 10.1083/jcb.201408024; Xia D, 2016, AUTOPHAGY, V12, P1614, DOI 10.1080/15548627.2016.1192752; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	25	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10900	10912		10.1074/jbc.RA119.007435	http://dx.doi.org/10.1074/jbc.RA119.007435			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31142615	Green Published, hybrid			2022-12-26	WOS:000478717200014
J	Chen, Y; Cramer, P				Chen, Ying; Cramer, Patrick			Structure of the super-elongation complex subunit AFF4 C-terminal homology domain reveals requirements for AFF homo- and heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription elongation factor; phosphorylation; X-ray crystallography; dimerization; RNA polymerase II; gene regulation; AF4; FMR2 family member 4 (AFF4); C-terminal homology domain (CHD); super elongation complex	LIGATION-INDEPENDENT CLONING; POISSON-BOLTZMANN EQUATION; RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION; PHOSPHORYLATION SITES; SEC FAMILY; P-TEFB; KINASE; GPS; ACTIVATION	AF4/FMR2 family member 4 (AFF4) is the scaffold protein of the multisubunit super-elongation complex, which plays key roles in the release of RNA polymerase II from promoter-proximal pausing and in the transactivation of HIV-1 transcription. AFF4 consists of an intrinsically disordered N-terminal region that interacts with other super-elongation complex subunits and a C-terminal homology domain (CHD) that is conserved among AF4/FMR2 family proteins, including AFF1, AFF2, AFF3, and AFF4. Here, we solved the X-ray crystal structure of the CHD in human AFF4 (AFF4-CHD) to 2.2 angstrom resolution and characterized its biochemical properties. The structure disclosed that AFF4-CHD folds into a novel domain that consists of eight helices and is distantly related to tetratrico peptide repeat motifs. Our analyses further revealed that AFF4-CHD mediates the formation of an AFF4 homodimer or an AFF1-AFF4 heterodimer. Results from fluorescence anisotropy experiments suggested that AFF4-CHD interacts with both RNA and DNA in vitro. Furthermore, we identified a surface loop region in AFF4-CHD as a substrate for the P-TEFb kinase cyclin-dependent kinase 9, which triggers release of polymerase II from promoter-proximal pausing sites. In conclusion, the AFF-CHD structure and biochemical analyses reported here reveal the molecular basis for the homo- and heterodimerization of AFF proteins and implicate the AFF4-CHD in nucleic acid interactions. The high conservation of the CHD among several other proteins suggests that our results are also relevant for understanding other CHD-containing proteins and their dimerization behavior.	[Chen, Ying; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de			Deutsche Forschungsgemeinschaft [SFB860, SPP1935]; European Research Council Advanced Investigator Grant TRANSREGULON [693023]; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced Investigator Grant TRANSREGULON; Volkswagen Foundation(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB860 and SPP1935, by European Research Council Advanced Investigator Grant TRANSREGULON under Agreement 693023, and by the Volkswagen Foundation (to P. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; ASLANIDIS C, 1994, PCR METH APPL, V4, P172; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou S, 2013, P NATL ACAD SCI USA, V110, pE123, DOI 10.1073/pnas.1216971110; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Gu JY, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28756; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; He NH, 2011, J NEUROIMMUNE PHARM, V6, P260, DOI 10.1007/s11481-011-9267-6; Hill CP, 2013, ELIFE, V2, DOI 10.7554/eLife.00577; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kuzmina A, 2017, TRANSCR-AUSTIN, V8, P133, DOI 10.1080/21541264.2017.1295831; Leach BI, 2013, STRUCTURE, V21, P176, DOI 10.1016/j.str.2012.11.011; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lu HS, 2015, NUCLEIC ACIDS RES, V43, P5868, DOI 10.1093/nar/gkv541; Lu HS, 2014, P NATL ACAD SCI USA, V111, pE15, DOI 10.1073/pnas.1318503111; Lu XD, 2016, NUCLEIC ACIDS RES, V44, P6853, DOI 10.1093/nar/gkw571; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Melko M, 2011, HUM MOL GENET, V20, P1873, DOI 10.1093/hmg/ddr069; Muck F, 2016, AM J BLOOD RES, V6, P28; OBEROI H, 1993, BIOPHYS J, V65, P48, DOI 10.1016/S0006-3495(93)81032-4; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Okuda H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9869; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Pan Z, 2013, STRUCTURE, V21, P1007, DOI 10.1016/j.str.2013.04.005; Qi SQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14076; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Schulze-Gahmen U, 2018, P NATL ACAD SCI USA, V115, P12973, DOI 10.1073/pnas.1806438115; Schulze-Gahmen U, 2016, ELIFE, V5, DOI 10.7554/eLife.15910; Schulze-Gahmen U, 2014, ELIFE, V3, DOI 10.7554/eLife.02375; Schulze-Gahmen U, 2013, ELIFE, V2, DOI 10.7554/eLife.00327; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Smidova A, 2018, FEBS J, V285, P4196, DOI 10.1111/febs.14670; Stevers LM, 2018, J AM CHEM SOC, V140, P14498, DOI 10.1021/jacs.8b09618; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Vos SM, 2016, ELIFE, V5, DOI 10.7554/eLife.14981; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winters AC, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00004; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	68	16	17	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10663	10673		10.1074/jbc.RA119.008577	http://dx.doi.org/10.1074/jbc.RA119.008577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31147444	hybrid, Green Published			2022-12-26	WOS:000478717100024
J	Jung, JS; Park, SJ; Kim, EY; Na, KS; Kim, YJ; Kim, KG				Jung, Jun Su; Park, Sung Jin; Kim, Eun Young; Na, Kyoung-Sae; Kim, Young Jae; Kim, Kwang Gi			Prediction models for high risk of suicide in Korean adolescents using machine learning techniques	PLOS ONE			English	Article							BEHAVIORS; IDEATION; THOUGHTS	Objective Suicide in adolescents is a major problem worldwide and previous history of suicide ideation and attempt represents the strongest predictors of future suicidal behavior. The aim of this study was to develop prediction model to identify Korean adolescents of high risk suicide (= who have history of suicide ideation/attempt in previous year) using machine learning techniques. Methods A nationally representative dataset of Korea Youth Risk Behavior Web-based Survey (KYRBWS) was used (n = 59,984 of middle and high school students in 2017). The classification process was performed using machine learning techniques such as logistic regression (LR), random forest (RF), support vector machine (SVM), artificial neural network (ANN), and extreme gradient boosting (XGB). Results A total of 7,443 adolescents (12.4%) had a previous history of suicidal ideation/attempt. In the multivariable analysis, sadness (odds ratio [OR], 6.41; 95% confidence interval [95% CI], 6.08-6.87), violence (OR, 2.32; 95% CI, 2.01-2.67), substance use (OR, 1.93; 95% CI, 1.52-2.45), and stress (OR, 1.63; 95% CI, 1.40-1.86) were associated factors. Taking into account 26 variables as predictors, the accuracy of models of machine learning techniques to predict the high-risk suicidal was comparable with that of LR; the accuracy was best in XGB (79.0%), followed by SVM (78.7%), LR (77.9%), RF (77.8%), and ANN (77.5%). Conclusions The machine leaning techniques showed comparable performance with LR to classify adolescents who have previous history of suicidal ideation/attempt. This model will hopefully serve as a foundation for decreasing future suicides as it enables early identification of adolescents at risk of suicide and modification of risk factors.	[Jung, Jun Su] Gachon Univ, Sch Med, Coll Med, Incheon, South Korea; [Park, Sung Jin; Kim, Young Jae; Kim, Kwang Gi] Gachon Univ, Coll Med, Dept Biomed Engn, Incheon, South Korea; [Kim, Eun Young] Korea Natl Open Univ, Dept Informat & Stat, Seoul, South Korea; [Kim, Eun Young] Gachon Univ, Coll Med, Dept Radiol, Gil Med Ctr, Incheon, South Korea; [Na, Kyoung-Sae] Gachon Univ, Coll Med, Gil Med Ctr, Dept Psychiat, Incheon, South Korea	Gachon University; Gachon University; Korea National Open University; Gachon University; Gachon University	Kim, KG (corresponding author), Gachon Univ, Coll Med, Dept Biomed Engn, Incheon, South Korea.; Kim, EY (corresponding author), Korea Natl Open Univ, Dept Informat & Stat, Seoul, South Korea.; Kim, EY (corresponding author), Gachon Univ, Coll Med, Dept Radiol, Gil Med Ctr, Incheon, South Korea.	oneshot0229@gmail.com; kimkg@gachon.ac.kr	Na, Kyoung-Sae/W-1317-2019	Na, Kyoung-Sae/0000-0002-0148-9827; Kim, Young Jae/0000-0003-0443-0051; Kim, Eun Young/0000-0002-2101-7982	MD-PhD research through the Korea Research-Driven Hospital [2018-5287]; Future Innovation Challenges through the Gachon University [2018-0669]	MD-PhD research through the Korea Research-Driven Hospital; Future Innovation Challenges through the Gachon University	This research was supported by MD-PhD research through the Korea Research-Driven Hospital (grant 2018-5287) and Future Innovation Challenges through the Gachon University (grant 2018-0669).	Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Burke TA, 2019, J AFFECT DISORDERS, V245, P869, DOI 10.1016/j.jad.2018.11.073; Byeon KH, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018046; Choi SB, 2018, J AFFECT DISORDERS, V231, P8, DOI 10.1016/j.jad.2018.01.019; Choi SB, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4491-5; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Jordan P, 2018, GEN HOSP PSYCHIAT, V51, P106, DOI 10.1016/j.genhosppsych.2018.02.002; Kim YJ, 2018, CRISIS, V39, P4, DOI 10.1027/0227-5910/a000438; McArdle JJ, 2014, CONTEMPORARY ISSUES; Oh J, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00192; Passos IC, 2016, J AFFECT DISORDERS, V193, P109, DOI 10.1016/j.jad.2015.12.066	12	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217639	10.1371/journal.pone.0217639	http://dx.doi.org/10.1371/journal.pone.0217639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170212	Green Submitted, Green Published, gold			2022-12-26	WOS:000470263700045
J	Qin, L; Xie, YD; Zhang, XG; Wu, SX; Xu, WM; Zuo, T				Qin Lang; Xie Yidong; Zhang Xueguang; Wu Sixian; Xu Wenming; Zuo Tao			ETA-mediated anti-TNF-alpha therapy ameliorates the phenotype of PCOS model induced by letrozole	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; GENE-EXPRESSION; INFLAMMATION; ETANERCEPT; RECEPTOR; ANDROGENS	Chronic inflammation is a typical characteristic of polycystic ovary syndrome (PCOS), in which, tumor necrosis factor (TNF)-alpha plays an important role. We investigated whether anti-TNF-alpha therapy can alleviate the core phenotypes of PCOS. In pubertal female Wistar rats, release pellets of letrozole (LET) were administered continuously for 90 days to induce PCOS-like phenotypes, followed by treatment with etanercept (ETA), a TNF-alpha inhibitor. ETA significantly inhibited increases in body weight and androgen, TNF-alpha, and MCP-1 levels, excessive recruitment of lipid droplets, altered levels of pre-adipose differentiation markers, and abnormal development of follicles. In addition, TNF-alpha and testosterone (T) levels in the rat sera were significantly positively correlated. Further experiments were performed to investigate the relationship between TNF-alpha and androgen. Persistent exposure of the RAW 264.7 cell line to low doses of testosterone significantly enhanced TNF-alpha expression and activated the NF-KB signaling pathway, which were blocked by ETA. Furthermore, treatment with TNF-alpha promoted the production of testosterone in KGN granulosa cells by reducing CYP19A1 expression, whereas ETA treatment blocked this process. In conclusion, anti-TNF-alpha therapy with ETA may be an efficient method to alleviate PCOS, whose underlying mechanism may be associated with its ability to reduce excessive androgen levels.	[Qin Lang; Xie Yidong] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Reprod Med Ctr, Chengdu, Sichuan, Peoples R China; [Zhang Xueguang; Wu Sixian; Xu Wenming; Zuo Tao] Sichuan Univ, West China Univ Hosp 2, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu, Sichuan, Peoples R China; [Zhang Xueguang; Xu Wenming; Zuo Tao] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Sichuan, Peoples R China; [Wu Sixian] Sichuan Univ, West China Sch Pharm, Chengdu, Sichuan, Peoples R China	Sichuan University; Chinese University of Hong Kong; Sichuan University; Sichuan University; Sichuan University	Xu, WM; Zuo, T (corresponding author), Sichuan Univ, West China Univ Hosp 2, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu, Sichuan, Peoples R China.; Xu, WM; Zuo, T (corresponding author), Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Sichuan, Peoples R China.	xuwenming1973@163.com; zuotaoxy@163.com		Xu, wenming/0000-0002-3686-229X; Wu, Sixian/0000-0001-9396-9635	Science and Technology Support Project of Science and Technology Bureau of Sichuan Province [2016FZ0061]; Sichuan Province Science and Technology Support Project [2016-16ZC1659]	Science and Technology Support Project of Science and Technology Bureau of Sichuan Province; Sichuan Province Science and Technology Support Project	This work was supported by the Science and Technology Support Project of Science and Technology Bureau of Sichuan Province (grant number 2016FZ0061) to LQ. This work was also supported by Sichuan Province Science and Technology Support Project (2016-16ZC1659). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytan AN, 2016, GYNECOL ENDOCRINOL, V32, P709, DOI 10.3109/09513590.2016.1155208; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Comim FV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080416; Debelec-Butuner B, 2014, MOL CARCINOGEN, V53, P85, DOI 10.1002/mc.21948; Delfino FJ, 2003, MOL CELL ENDOCRINOL, V201, P1, DOI 10.1016/S0303-7207(03)00005-4; Dewailly D, 2014, HUM REPROD UPDATE, V20, P334, DOI 10.1093/humupd/dmt061; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gao LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164021; Gonzalez F, 2012, STEROIDS, V77, P300, DOI 10.1016/j.steroids.2011.12.003; Goodarzi MO, 2015, J STEROID BIOCHEM, V145, P213, DOI 10.1016/j.jsbmb.2014.06.003; Joham AE, 2015, J WOMENS HEALTH, V24, P299, DOI 10.1089/jwh.2014.5000; Kauffman AS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131631; Liao CH, 2012, STEROIDS, V77, P756, DOI 10.1016/j.steroids.2012.03.014; Liu MM, 2015, CLIN ENDOCRINOL, V83, P913, DOI 10.1111/cen.12951; Maliqueo M, 2013, ENDOCRINOLOGY, V154, P434, DOI 10.1210/en.2012-1693; Marotte H, 2014, EXPERT OPIN BIOL TH, V14, P569, DOI 10.1517/14712598.2014.896334; Morisset AS, 2013, J MATERN-FETAL NEO M, V26, P513, DOI 10.3109/14767058.2012.735725; Morooka N, 2016, BIOCHEM BIOPH RES CO, V477, P895, DOI 10.1016/j.bbrc.2016.06.155; Ojeda-Ojeda M, 2013, CURR PHARM DESIGN, V19, P5775, DOI 10.2174/1381612811319320012; Prizant H, 2014, J ENDOCRINOL, V222, pR141, DOI 10.1530/JOE-14-0296; Repaci A, 2011, MOL CELL ENDOCRINOL, V335, P30, DOI 10.1016/j.mce.2010.08.002; Scott LJ, 2014, DRUGS, V74, P1379, DOI 10.1007/s40265-014-0258-9; Shannon M, 2012, J MIDWIFERY WOM HEAL, V57, P221, DOI 10.1111/j.1542-2011.2012.00161.x; Sinagra E, 2013, EUR J INTERN MED, V24, P385, DOI 10.1016/j.ejim.2012.12.015; Spritzer PM, 2015, REPRODUCTION, V149, pR219, DOI 10.1530/REP-14-0435; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Tannus S, 2015, WOMENS HEALTH, V11, P901, DOI 10.2217/whe.15.40; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Walters KA, 2015, REPRODUCTION, V149, pR193, DOI 10.1530/REP-14-0517; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Yu J, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/670743; Zuo T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8589318	35	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217495	10.1371/journal.pone.0217495	http://dx.doi.org/10.1371/journal.pone.0217495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170164	Green Submitted, Green Published, gold			2022-12-26	WOS:000470263700037
J	Chung, YS; Choi, JY; Yoo, MS; Seong, JH; Choi, BS; Kang, C				Chung, Yoon-Seok; Choi, Ju-Yeon; Yoo, Myoung-Su; Seong, Jae Hyun; Choi, Byeong-Sun; Kang, Chun			Phylogenetic transmission clusters among newly diagnosed antiretroviral drug-naive patients with human immunodeficiency virus-1 in Korea: A study from 1999 to 2012	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC-VARIATION; RESISTANT HIV-1; NATIONAL-SURVEY; SEX; MEN; POPULATION; DIVERSITY; EMERGENCE; EVOLUTION	Population-level phylogenetic patterns reflect both transmission dynamics and genetic changes, which accumulate because of selection or drift. In this study, we determined whether a longitudinally sampled dataset derived from human immunodeficiency virus (HIV)-1-infected individuals over a 14-year period (1999-2012) could shed light on the transmission processes involved in the initiation of the HIV-1 epidemic in Korea. In total, 927 sequences were acquired from 1999 to 2012; each sequence was acquired from an individual patient who had not received treatment. Sequences were used for drug resistance and phylogenetic analyses. Phylogenetic and other analyses were conducted using MEGA version 6.06 based on the GTR G+I parameter model and SAS. Of the 927 samples, 863 (93.1%) were classified as subtype B and 64 were classified as other subtypes. Phylogenetic analysis demonstrated that 104 of 927 patient samples (11.2%) were grouped into 37 clusters. Being part of a transmission cluster was significantly associated with subtype-B viruses, infection via sexual contact, and the infection of young males. Of all clusters, three (similar to 8.1%) that comprised 10 individual samples (22.2% of 45 individuals) included at least one member with total transmitted drug resistance (TDR). In summary, HIV transmission cluster analyses can integrate laboratory data with behavioral data to enable the identification of key transmission patterns to develop tailored interventions aimed at interrupting transmission chains.	[Chung, Yoon-Seok; Choi, Ju-Yeon; Kang, Chun] Korea Ctr Dis Control & Prevent, Div Viral Dis, Ctr Lab Control & Infect Dis, Cheongju, South Korea; [Yoo, Myoung-Su; Seong, Jae Hyun; Choi, Byeong-Sun] Korea Ctr Dis Control & Prevent, Div Viral Dis Res, Ctr Res Infect Dis, Natl Inst Hlth, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH)	Kang, C (corresponding author), Korea Ctr Dis Control & Prevent, Div Viral Dis, Ctr Lab Control & Infect Dis, Cheongju, South Korea.	kangchun@korea.kr	Chung, Yoon-Seok/GQA-3042-2022	Chung, Yoon-Seok/0000-0003-4562-5533	STI Prevention Study [4800-4842-304-210]; Korea Centers for Disease Control and Prevention	STI Prevention Study; Korea Centers for Disease Control and Prevention	This study was supported by a grant for the AIDS and STI Prevention Study (grant number 4800-4842-304-210) from the Korea Centers for Disease Control and Prevention.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Abubakar YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080487; Alpsar D, 2013, MED MICROBIOL IMMUN, V202, P251, DOI 10.1007/s00430-012-0285-7; Antoniadou ZA, 2014, AIDS RES HUM RETROV, V30, P225, DOI [10.1089/AID.2013.0166, 10.1089/aid.2013.0166]; Bao YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114764; Bielejec F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-133; Bolivar H, 2009, JAIDS-J ACQ IMM DEF, V52, P659, DOI 10.1097/QAI.0b013e3181b72539; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brenner BG, 2011, J MED VIROL, V83, P751, DOI 10.1002/jmv.22047; Chan PA, 2014, INFECT GENET EVOL, V28, P358, DOI 10.1016/j.meegid.2014.03.027; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093130; Chen YJ, 2012, JAIDS-J ACQ IMM DEF, V59, P438, DOI 10.1097/QAI.0b013e3182454ea3; Chen YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091104; Chijiwa K, 1999, MICROBIOL IMMUNOL, V43, P271, DOI 10.1111/j.1348-0421.1999.tb02403.x; Choi JY, 2008, JAIDS-J ACQ IMM DEF, V49, P237, DOI 10.1097/QAI.0b013e318188a919; Ciccozzi M, 2013, AIDS RES HUM RETROV, V29, P404, DOI [10.1089/AID.2012.0209, 10.1089/aid.2012.0209]; Cohen J, 2015, SCIENCE, V348, P1188, DOI 10.1126/science.348.6240.1188; da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Pina-Araujo IIM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096201; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Fabeni L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135325; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Gui T, 2016, CURR HIV RES, V14, P148, DOI 10.2174/1570162X13666150929094555; Hattori J, 2016, JAIDS-J ACQ IMM DEF, V71, P367, DOI 10.1097/QAI.0000000000000861; Hattori J, 2010, ANTIVIR RES, V88, P72, DOI 10.1016/j.antiviral.2010.07.008; Huang SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128266; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Jiao Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0689-7; Kim GJ, 2008, JAIDS-J ACQ IMM DEF, V48, P127, DOI 10.1097/QAI.0b013e31816b6ae6; Kim GJ, 2012, AIDS RES HUM RETROV, V28, P880, DOI [10.1089/aid.2011.0267, 10.1089/AID.2011.0267]; Kim JY, 2011, CLIN MICROBIOL INFEC, V17, P1155, DOI 10.1111/j.1469-0691.2010.03392.x; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Kusagawa S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00196-15; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li Xi, 2014, Trust and Trustworthy Computing. 7th International Conference, TRUST 2014. Proceedings: LNCS 8564, P1, DOI 10.1007/978-3-319-08593-7_1; Lubelchek RJ, 2015, JAIDS-J ACQ IMM DEF, V68, P46, DOI 10.1097/QAI.0000000000000404; Ng KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067286; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Shiino T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102633; Takebe Y, 2014, J VIROL, V88, P9864, DOI 10.1128/JVI.01354-14; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wu JJ, 2015, AIDS RES HUM RETROV, V31, P926, DOI [10.1089/AID.2015.0107, 10.1089/aid.2015.0107]; Zhang WQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099693	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217817	10.1371/journal.pone.0217817	http://dx.doi.org/10.1371/journal.pone.0217817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166970	gold, Green Submitted, Green Published			2022-12-26	WOS:000470087800040
J	Peng, LY; Cui, ZQ; Wu, ZM; Fu, BD; Yi, PF; Shen, HQ				Peng, Lu-Yuan; Cui, Zhen-Qiang; Wu, Zong-Mei; Fu, Ben-Dong; Yi, Peng-Fei; Shen, Hai-Qing			RNA-seq profiles of chicken type II pneumocyte in response to Escherichia coli infection	PLOS ONE			English	Article							NF-KAPPA-B; SALMONELLA-INDUCED APOPTOSIS; ALVEOLAR EPITHELIAL-CELLS; T-CELLS; VIRULENCE; ANTIGEN; DIFFERENTIATION; INFLAMMATION; INHIBITION; SEQUENCE	Avian pathogenic Escherichia coli (APEC) causes great economic loss to the poultry industry worldwide. Chicken type II pneumocytes (CP II cells) secrete surfactants and modulate lung immunity to decrease the infection of the invading pathogen. Nevertheless, the pathogenesis of CP II cells to APEC infection remains poorly understood. Therefore, we conducted global gene expression profiling of CP II cells after APEC-O78 infection to explore the host-pathogen interaction. The differentially expressed genes of CP II cells to APEC infection were characterized by RNA-seq with EB-seq algorithm. In consequence, the mRNA of 18996 genes was identified, and CP II cells responded to APEC infection with marked changes in the expression of 1390 genes. Among them, there are 803 down-regulated mRNAs and 587 upregulated mRNAs. The KEGG prediction and Gene Ontology terms analysis revealed that the major enriched pathways were related to NF-kappa B signaling pathway, apoptosis pathway, tight junction, and cytokine-cytokine receptor interaction and other pathways. We adopted qRT-PCR to verify the validity of the selected gene expression. The fold induction of qPCR was similar to the RNA-seq results. These results provide a better understanding of the pathogenesis of APEC, especially apoptosis pathway involved in APEC infection.	[Peng, Lu-Yuan; Cui, Zhen-Qiang; Wu, Zong-Mei; Fu, Ben-Dong; Yi, Peng-Fei; Shen, Hai-Qing] Jilin Univ, Dept Clin Vet Med, Coll Vet Med, Changchun, Jilin, Peoples R China	Jilin University	Fu, BD; Shen, HQ (corresponding author), Jilin Univ, Dept Clin Vet Med, Coll Vet Med, Changchun, Jilin, Peoples R China.	fubendong96@163.com; 510055813@qq.com			National Natural Science Foundation of China [31372470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 31372470).	Bastiani M, 2005, FEMS MICROBIOL LETT, V253, P133, DOI 10.1016/j.femsle.2005.09.024; Bjornstad S, 2014, NEONATOLOGY, V105, P112, DOI 10.1159/000355346; Carneiro NVQ, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920170831; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Dou XH, 2016, GENE, V576, P244, DOI 10.1016/j.gene.2015.10.012; Drago-Serrano ME, 2006, FEMS MICROBIOL LETT, V265, P35, DOI 10.1111/j.1574-6968.2006.00463.x; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Frode-Saleh TS, 2000, INFLAMM RES, V49, P330, DOI 10.1007/PL00000213; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Gao QX, 2012, VET MICROBIOL, V160, P395, DOI 10.1016/j.vetmic.2012.06.009; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Green SR, 2010, BRIT J CANCER, V103, P1391, DOI 10.1038/sj.bjc.6605922; Horn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041031; Johnson JR, 2006, MICROBES INFECT, V8, P1702, DOI 10.1016/j.micinf.2006.02.007; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kamble NM, 2016, VET IMMUNOL IMMUNOP, V169, P96, DOI 10.1016/j.vetimm.2015.11.002; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Lai JL, 2017, INFLAMMATION, V40, P1, DOI 10.1007/s10753-016-0447-7; Lavric M, 2008, VET MICROBIOL, V126, P111, DOI 10.1016/j.vetmic.2007.06.011; Li PC, 2011, BIOCHEM BIOPH RES CO, V409, P142, DOI 10.1016/j.bbrc.2011.04.131; Liang CJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/305149; Liang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145001; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Maina JN, 2006, BIOL REV, V81, P545, DOI 10.1017/S1464793106007111; Nie QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041645; Oliveira A, 2009, J APPL MICROBIOL, V106, P1919, DOI 10.1111/j.1365-2672.2009.04145.x; Paesold G, 2002, CELL MICROBIOL, V4, P771, DOI 10.1046/j.1462-5822.2002.00233.x; Qin M, 2014, IMMUNOPHARM IMMUNOT, V36, P251, DOI 10.3109/08923973.2013.861481; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Remppis A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/194896; Salik E, 1999, AM J RESP CELL MOL, V21, P365, DOI 10.1165/ajrcmb.21.3.3529; Salmond RJ, 2002, EUR J IMMUNOL, V32, P1737, DOI 10.1002/1521-4141(200206)32:6<1737::AID-IMMU1737>3.0.CO;2-J; Sandford Erin E, 2012, Results Immunol, V2, P44, DOI 10.1016/j.rinim.2012.02.003; Scott O, 2019, J ALLERGY CLIN IMMUN, V143, P1688, DOI 10.1016/j.jaci.2019.03.016; Sun HY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1850-4; Szmolka A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127708; Varasteh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138975; Vasanthakumar A, 2017, CELL REP, V20, P2906, DOI 10.1016/j.celrep.2017.08.068; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilbur JS, 2015, INFECT IMMUN, V83, P1139, DOI 10.1128/IAI.02876-14; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058; Zhang LY, 2014, VET IMMUNOL IMMUNOP, V159, P50, DOI 10.1016/j.vetimm.2014.02.005	45	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217438	10.1371/journal.pone.0217438	http://dx.doi.org/10.1371/journal.pone.0217438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166969	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800028
J	Puig-Divi, A; Escalona-Marfil, C; Padulles-Riu, JM; Busquets, A; Padulles-Chando, X; Marcos-Ruiz, D				Puig-Divi, Albert; Escalona-Marfil, Carles; Maria Padulles-Riu, Josep; Busquets, Albert; Padulles-Chando, Xavier; Marcos-Ruiz, Daniel			Validity and reliability of the Kinovea program in obtaining angles and distances using coordinates in 4 perspectives	PLOS ONE			English	Article							LOW-COST; CONCURRENT VALIDITY; ANALYSIS SOFTWARE; VIDEO ANALYSIS; WALKING; MOTION; QUANTIFICATION; PARTICIPANTS; VALIDATION; CHILDREN	An objective analysis of the human movement can help both clinical assessment and sports performance. Kinovea is a free 2D motion analysis software that can be used to measure kinematic parameters. This low-cost technology has been used in sports sciences, as well as in the clinical and research fields. One interesting tool is that it can measure an object (or person) passing in front of the camera, taking into account the perspective between the camera and the recorded object. Although it has been validated as a tool to assess time-related variables, few studies assessed its validity compared to a Gold Standard; furthermore, its reliability in different perspectives has not been previously assessed. The main objective of this study is to determine the validity of the Kinovea software compared to AutoCAD, and its intra and inter-rater reliability in obtaining coordinates data; a second objective is to compare their results at 4 different perspectives (90 degrees, 75 degrees, 60 degrees and 45 degrees) and to assess the inter and intra rater reliability at each perspective. For this purpose, a wire structure figure in the shape of a human lower limb was designed and measured in AutoCAD; it was then recorded during a pendular motion with a video-camera placed at distance of 5 m and analyzed with Kinovea in the 4 perspectives (90 degrees, 75 degrees, 60 degrees and 45 degrees). Each frame was examined by three observers who made two attempts. A multiple approach was applied involving the analysis of the systematic error, with a two-way ANOVA 2x4; the relative reliability with Intraclass Correlation Coefficient (ICC) and the Coefficient of Variance (CV) (95% confidence interval); and the absolute reliability with the Standard Error (SE). The results indicate that the Kinovea software is a valid and reliable tool that is able to measure accurately at distances up to 5 m from the object and at an angle range of 90 degrees-45 degrees. Nevertheless, for optimum results an angle of 90 degrees is suggested.	[Puig-Divi, Albert] Ramon Llull Univ, Blanquerna Sch Hlth Sci, Barcelona, Catalunya, Spain; [Escalona-Marfil, Carles] Univ Cent Catalunya, Fac Ciencies Salut Manresa, Univ Vic, Catalunya, Barcelona, Spain; [Escalona-Marfil, Carles; Marcos-Ruiz, Daniel] Univ Girona, Dept Phys Therapy, EUSES, Catalunya, Girona, Spain; [Maria Padulles-Riu, Josep; Busquets, Albert; Padulles-Chando, Xavier] Natl Inst Phys Educ Catalonia INEFC, Barcelona, Catalunya, Spain	Universitat Ramon Llull; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universitat de Girona	Escalona-Marfil, C (corresponding author), Univ Cent Catalunya, Fac Ciencies Salut Manresa, Univ Vic, Catalunya, Barcelona, Spain.; Escalona-Marfil, C (corresponding author), Univ Girona, Dept Phys Therapy, EUSES, Catalunya, Girona, Spain.	cescalona@umanresa.cat	Busquets, Albert/I-5544-2015; Padullés, Josep M/AAB-2723-2019; Escalona Marfil, Carles/P-1982-2017	Busquets, Albert/0000-0002-8879-1577; Padullés, Josep M/0000-0002-0531-7459; Escalona Marfil, Carles/0000-0003-3028-9557; Puig-Divi, Albert/0000-0002-1778-0803				Aguilar LM, 2015, 2015 CHILEAN Conference on Electrical, Electronics Engineering, Information and Communication Technologies (CHILECON), P205, DOI 10.1109/Chilecon.2015.7400376; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Balsalobre-Fernandez C, 2014, J STRENGTH COND RES, V28, P528, DOI 10.1519/JSC.0b013e318299a52e; Baude M, 2015, BIOMED RES INT, V2015, P1; Damsted C, 2015, GAIT POSTURE, V42, P32, DOI 10.1016/j.gaitpost.2015.01.029; Damsted C, 2015, INT J SPORTS PHYS TH, V10, P147; Dias JA, 2011, J STRENGTH COND RES, V25, P2034, DOI 10.1519/JSC.0b013e3181e73f6e; Ditroilo M, 2011, J SPORT SCI, V29, P1675, DOI 10.1080/02640414.2011.614270; Elnahhas A, 2014, TRENDS APPL SCI RES, V9, P503, DOI DOI 10.3923/tasr.2014.503.511; Eltoukhy M, 2012, IJSER, V3, P1; Candido PEF, 2012, WORK, V41, P2506, DOI 10.3233/WOR-2012-0490-2506; Grigore V, 2015, 4TH INTERNATIONAL CONGRESS OF PHYSICAL EDUCATION, SPORT AND KINETOTHERAPY (ICPESK 2014), P125; Hernandez-Gervilla O, 2016, APUNTS-MED ESPORT, V51, P115, DOI 10.1016/j.apunts.7016.03.001; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Ismail SI, 2014, PROCEDIA ENGINEER, V72, P186, DOI 10.1016/j.proeng.2014.06.031; Krishnan C, 2015, J BIOMECH, V48, P544, DOI 10.1016/j.jbiomech.2014.11.048; Maas JC, 2014, CLIN REHABIL, V28, P1025, DOI 10.1177/0269215514542355; Macleod CA, 2014, MED ENG PHYS, V36, P541, DOI 10.1016/j.medengphy.2013.11.011; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Moral-Munoz JA, 2015, J STRENGTH COND RES, V29, P2661, DOI 10.1519/JSC.0000000000000896; Norris Beth S., 2011, Physiotherapy Theory and Practice, V27, P521, DOI 10.3109/09593985.2010.533745; Northeast L, 2018, GAIT POSTURE, V64, P114, DOI 10.1016/j.gaitpost.2018.06.001; Nuzzo JL, 2011, J STRENGTH COND RES, V25, P2580, DOI 10.1519/JSC.0b013e3181fee650; Olper L, 2011, PHYS THER, V91, P566, DOI 10.2522/ptj.20100156; Padulo J, 2015, BIOL SPORT, V32, P53, DOI 10.5604/20831862.1127282; Pontes LF, 2015, EUR J ORTHODONT, V37, P435, DOI 10.1093/ejo/cju055; Potop V, 2014, ELEARN SOFTW EDUC, P177; Potov V, 2015, 4TH INTERNATIONAL CONGRESS OF PHYSICAL EDUCATION, SPORT AND KINETOTHERAPY (ICPESK 2014), P477; Quieregatto PR, 2014, ACTA CIR BRAS, V29, P688, DOI 10.1590/S0102-8650201400160010; Suarez GR, 2016, VIREF-REV EDUC FIS, V5, P1; Ramos-Ortega J, 2014, CLIN J SPORT MED, V24, P251, DOI 10.1097/JSM.0000000000000027; Rebolledo Uribe JP, 2012, REV FAC ODONTOL U AN, V24, P76; Rozan M, 2016, J HUM KINET, V50, P115, DOI 10.1515/hukin-2015-0148; Sanudo B, 2016, J STRENGTH COND RES, V30, P2934, DOI 10.1519/JSC.0000000000000563; Thewlis D, 2013, J APPL BIOMECH, V29, P112, DOI 10.1123/jab.29.1.112; Torralba Jordán Miguel Angel, 2016, CPD, V16, P69; Torres-Luque G, 2015, INT J PERF ANAL SPOR, V15, P1135, DOI 10.1080/24748668.2015.11868857; Ugbolue UC, 2013, GAIT POSTURE, V38, P483, DOI 10.1016/j.gaitpost.2013.01.018; Valdivia C., 2013, INT J SOFT COMPUT EN, V3, P359; Vitorio R, 2012, GAIT POSTURE, V35, P175, DOI 10.1016/j.gaitpost.2011.09.002; Webber SC, 2010, PHYS THER, V90, P1165, DOI 10.2522/ptj.20090394; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Youssef AR, 2016, INT J PHYSIOTHER, V3, P326, DOI 10.15621/ijphy/2016/v3i3/100838	43	91	91	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216448	10.1371/journal.pone.0216448	http://dx.doi.org/10.1371/journal.pone.0216448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166989	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800009
J	Yamaguchi, A; Yamamoto, Y				Yamaguchi, Atsuko; Yamamoto, Yasunori			Split4Blank: Maintaining consistency while improving efficiency of loading RDF data with blank nodes	PLOS ONE			English	Article								In life sciences, accompanied by the rapid growth of sequencing technology and the advancement of research, vast amounts of data are being generated. It is known that as the size of Resource Description Framework (RDF) datasets increases, the more efficient loading to triple stores is crucial. For example, UniProt's RDF version contains 44 billion triples as of December 2018. PubChem also has an RDF dataset with 137 billion triples. As data sizes become extremely large, loading them to a triple store consumes time. To improve the efficiency of this task, parallel loading has been recommended for several stores. However, with parallel loading, dataset consistency must be considered if the dataset contains blank nodes. By definition, blank nodes do not have global identifiers; thus, pairs of identical blank nodes in the original dataset are recognized as different if they reside in separate files after the dataset is split for parallel loading. To address this issue, we propose the Split4Blank tool, which splits a dataset into multiple files under the condition that identical blank nodes are not separated. The proposed tool uses connected component and multiprocessor scheduling algorithms and satisfies the above condition. Furthermore, to confirm the effectiveness of the proposed approach, we applied Split4Blank to two life sciences RDF datasets. In addition, we generated synthetic RDF datasets to evaluate scalability based on the properties of various graphs, such as a scale-free and random graph.	[Yamaguchi, Atsuko; Yamamoto, Yasunori] Res Org Informat & Syst, Database Ctr Life Sci DBCLS, Kashiwa, Chiba, Japan	Research Organization of Information & Systems (ROIS)	Yamaguchi, A (corresponding author), Res Org Informat & Syst, Database Ctr Life Sci DBCLS, Kashiwa, Chiba, Japan.	atsuko@dbcls.rois.ac.jp		Yamaguchi, Atsuko/0000-0001-7538-5337	NBDC; National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST)	NBDC; National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST)	NBDC (https://biosciencedbc.jp/en/) financially supported our work and there is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Bioscience Database Center (NBDC) of the Japan Science and Technology Agency (JST).	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beckett D, RDF 1 1 N TRIPLES; Beckett D, RDF 1 1 TURTLE; Chen R, 2011, APPL MECH MAT, V145, P460, DOI [10.4028/www.scientific.net/AMM.145.460, DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.145.460]; Cheung KH, 2005, BIOINFORMATICS, V21, pI85, DOI 10.1093/bioinformatics/bti1026; Cyganiak R., RDF 1 1 CONCEPTS ABS; Gandon F., RDF 1 1 XML SYNTAX; Garey M.R., 1979, COMPUTERS INTRACTABI; GRAHAM RL, 1969, SIAM J APPL MATH, V17, P416, DOI 10.1137/0117039; Hayes P.J., RDF 1 1 SEMANTICS; Hey T., 2009, 4 PARADIGM DATA INTE; HOCHBAUM DS, 1987, J ACM, V34, P144, DOI 10.1145/7531.7535; Hogan A, 2014, J WEB SEMANT, V27-28, P42, DOI 10.1016/j.websem.2014.06.004; Kumar R., 2015, TOPC, V2, p14:1, DOI DOI 10.1145/2809814; Lam HYK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S4; Mallea A, 2011, LECT NOTES COMPUT SC, V7031, P421, DOI 10.1007/978-3-642-25073-6_27; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; O'Driscoll A, 2015, J BIOMED INFORM, V54, P58, DOI 10.1016/j.jbi.2015.01.008; Stolpe A, 2017, SEMANT WEB, V8, P1001, DOI 10.3233/SW-160250; Yamamoto Yasunori, 2011, Database (Oxford), V2011, pbar013, DOI 10.1093/database/bar013	20	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217852	10.1371/journal.pone.0217852	http://dx.doi.org/10.1371/journal.pone.0217852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163073	Green Published, gold, Green Submitted			2022-12-26	WOS:000470086200041
J	Jasoliya, M; Sacca, F; Sahdeo, S; Chedin, F; Pane, C; Morra, VB; Filla, A; Pook, M; Cortopassi, G				Jasoliya, Mittal; Sacca, Francesco; Sahdeo, Sunil; Chedin, Frederic; Pane, Chiara; Morra, Vincenzo Brescia; Filla, Alessandro; Pook, Mark; Cortopassi, Gino			Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia	PLOS ONE			English	Article							MITOCHONDRIAL BIOGENESIS; EPIGENETIC CHANGES; R-LOOPS; DEFICIENCY; REPEATS; GENE; MODELS; CELLS; MICE	Friedreich's Ataxia (FA) is an inherited neurodegenerative disorder resulting from decreased expression of the mitochondrial protein frataxin, for which there is no approved therapy. High throughput screening of clinically used drugs identified Dimethyl fumarate (DMF) as protective in FA patient cells. Here we demonstrate that DMF significantly increases frataxin gene (FXN) expression in FA cell model, FA mouse model and in DMF treated humans. DMF also rescues mitochondrial biogenesis deficiency in FA-patient derived cell model. We further examined the mechanism of DMF's frataxin induction in FA patient cells. It has been shown that transcription-inhibitory R-loops form at GAA expansion mutations, thus decreasing FXN expression. In FA patient cells, we demonstrate that DMF significantly increases transcription initiation. As a potential consequence, we observe significant reduction in both R-loop formation and transcriptional pausing thereby significantly increasing FXN expression. Lastly, DMF dosed Multiple Sclerosis (MS) patients showed significant increase in FXN expression by similar to 85%. Since inherited deficiency in FXN is the primary cause of FA, and DMF is demonstrated to increase FXN expression in humans, DMF could be considered for Friedreich's therapy.	[Jasoliya, Mittal; Sahdeo, Sunil; Cortopassi, Gino] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Sacca, Francesco; Pane, Chiara; Morra, Vincenzo Brescia; Filla, Alessandro] Univ Federico II, Dept Neurosci Odontostomatol & Reprod Sci, Naples, Italy; [Chedin, Frederic] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Pook, Mark] Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, Uxbridge, Middx, England	University of California System; University of California Davis; University of Naples Federico II; University of California System; University of California Davis; Brunel University	Cortopassi, G (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	gcortopassi@ucdavis.edu		Pane, Chiara/0000-0002-3459-2644; Chedin, Frederic/0000-0002-1306-5335	FARA (Friedreich's ataxia Research Alliance); NIH [NS-077777]	FARA (Friedreich's ataxia Research Alliance); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the FARA (Friedreich's ataxia Research Alliance) and the NIH NS-077777, and a gift from the Packer-Wentz foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A part of Sunil Sahdeo and Mittal Jasoliya's salaries were supported by these grants.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Albano Lilian Maria José, 2002, Arq. Bras. Cardiol., V78, P448, DOI 10.1590/S0066-782X2002000500002; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Condo I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200; Cory SA, 2017, P NATL ACAD SCI USA; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Hayashi G, 2017, HUM MOL GENET, V26, P2864, DOI 10.1093/hmg/ddx167; Indelicato E, 2018, EXPERT OPIN ORPHAN D, V6, P57, DOI 10.1080/21678707.2018.1409109; Jasoliya MJ, 2017, HUM MOL GENET, V26, P2627, DOI 10.1093/hmg/ddx141; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Li YJ, 2015, HUM MOL GENET, V24, P6932, DOI 10.1093/hmg/ddv397; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Oglesbee D, 2013, CLIN CHEM CLINCHEM; Pandolfo M, 2002, ADV EXP MED BIOL, V516, P99; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sacca F, 2013, J NEUROL, V260, P1116, DOI 10.1007/s00415-012-6770-5; Sacca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017627; Sahdeo S, 2014, HUM MOL GENET, V23, P6848, DOI 10.1093/hmg/ddu408; Sandi C, 2013, GENET RES INT, V2013, DOI 10.1155/2013/852080; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Strawser C, 2017, EXPERT REV NEUROTHER, V17, P895, DOI 10.1080/14737175.2017.1356721; Tai G, 2018, NEUROLOGIA NEUROCHIR; Venci JV, 2013, ANN PHARMACOTHER, V47, P1697, DOI 10.1177/1060028013509232	32	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217776	10.1371/journal.pone.0217776	http://dx.doi.org/10.1371/journal.pone.0217776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158268	Green Submitted, Green Published, gold			2022-12-26	WOS:000469915700025
J	Lovato, CV; Lovato, TL; Cripps, RM				Lovato, Candice, V; Lovato, TyAnna L.; Cripps, Richard M.			Crossveinless is a direct transcriptional target of Trachealess and Tango in Drosophila tracheal precursor cells	PLOS ONE			English	Article							BHLH-PAS PROTEIN; CNS MIDLINE; GENE ENCODES; GASTRULATION; EXPRESSION; MIGRATION; DRIFTER; BINDING; FAMILY	Understanding the transcriptional pathways controlling tissue-specific gene expression is critical to unraveling the complex regulatory networks that underlie developmental mechanisms. Here, we assessed how the Drosophila crossveinless (cv) gene, that encodes a BMP-binding factor, is transcriptionally regulated in the developing embryonic tracheal system. We identify an upstream regulatory region of cv that promotes reporter gene expression in the tracheal precursors. We further demonstrate that this promoter region is directly responsive to the basic, helix-loop-helix-PAS domain factors Trachealess (Trh) and Tango (Tgo), that function to specify tracheal fate. Moreover, cv expression in embryos is lost in trh mutants, and the integrity of the Trh/ Tgo binding sites are required for promoter-lacZ expression. These findings for the first time elucidate the transcriptional regulation of one member of a family of BMP binding proteins, that have diverse functions in animal development.	[Lovato, Candice, V; Lovato, TyAnna L.; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Cripps, Richard M.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of New Mexico; California State University System; San Diego State University	Cripps, RM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.; Cripps, RM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	rcripps@sdsu.edu			NIH [R01 GM061738]; NIH from the Institute Development Award (IDeA) Program of the National Center for Research Resources [P20 RR018754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the Institute Development Award (IDeA) Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R01 GM061738, awarded by the NIH to RMC. We acknowledge technical support from the Department of Biology's Molecular Biology Facility, supported by NIH grant P20 RR018754 from the Institute Development Award (IDeA) Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 1996, DEVELOPMENT, V122, P4169; Arias A.M., 1993, DEV DROSOPHILA, P609; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Chen CK, 1998, DEVELOPMENT, V125, P4959; Chung S, 2011, DEV BIOL, V360, P160, DOI 10.1016/j.ydbio.2011.09.014; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Jiang L, 2010, MECH DEVELOP, V127, P265, DOI 10.1016/j.mod.2010.03.003; Jin J, 2001, DEV CELL, V1, P817, DOI 10.1016/S1534-5807(01)00090-9; Junell A, 2010, MOL CELL BIOL, V30, P3672, DOI 10.1128/MCB.00223-10; Morozova T, 2010, DEV GENES EVOL, V220, P191, DOI 10.1007/s00427-010-0339-z; Ohshiro T, 1997, DEVELOPMENT, V124, P3975; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; Patel NH, METHODS CELL BIOL, V44, P445; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; Sedaghat Y, 2002, DEVELOPMENT, V129, P2591; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571; Tanaka KKK, 2008, MOL CELL BIOL, V28, P1616, DOI 10.1128/MCB.01169-07; Thummel CS, 1992, DROS INF SERV, V71, P150; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vilmos P, 2005, EMBO REP, V6, P262, DOI 10.1038/sj.embor.7400347; Vincent S, 1997, DEVELOPMENT, V124, P2741; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Zelzer E, 2000, MECH DEVELOP, V91, P163, DOI 10.1016/S0925-4773(99)00295-6	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217906	10.1371/journal.pone.0217906	http://dx.doi.org/10.1371/journal.pone.0217906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158257	Green Published, gold, Green Submitted			2022-12-26	WOS:000469915700033
J	Hultin, E; Muhr, LSA; Lagheden, C; Dillner, J				Hultin, Emilie; Muhr, Laila Sara Arroyo; Lagheden, Camilla; Dillner, Joakim			HPV transcription in skin tumors	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-DNA; TRANSPLANT RECIPIENTS; CANCER; BETAPAPILLOMAVIRUSES; PREVALENCE; HEAD	Background Although more than 95% of viral sequences found in skin tumors typically belong to human papillomaviruses (HPVs), HPV transcription has so far not been detected. As current technology allows very deep transcriptome sequencing, we examined skin tumors and precursor lesions for HPV transcription. Method Fresh frozen biopsies from 12 skin specimens (11/12 were positive for HPV DNA) were subjected to total RNA sequencing. The cervical cancer cell line CaSki was included as a positive control for HPV transcription. Results HPV RNA was detected and confirmed in 1/12 skin lesions at a median depth of 66 million reads per sample. One specimen was positive for HPV 110 transcripts mapping to E6, E7, E2/E4 and L2 open reading frames, as well as to a spliced E1<^>E4 transcript. Conclusion In conclusion, the study revealed that a minority of skin lesions contains HPV transcripts and that HPV DNA detection does not predict HPV transcriptional activity.	[Hultin, Emilie; Muhr, Laila Sara Arroyo; Lagheden, Camilla; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Dillner, Joakim] Karolinska Univ Hosp, Karolinska Univ Lab, Clin Pathol Cytol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Hultin, E (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	Emilie.Hultin@ki.se		Hultin, Emilie/0000-0003-2169-0840; Arroyo Muhr, Laila Sara/0000-0003-2498-5206	Swedish Cancer Society [CAN 2017/459]; Swedish Research Council [2017-01841_3]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Swedish Cancer Society (author: JD, grant number: CAN 2017/459, url: https://www.cancerfonden.se) and by the Swedish Research Council (author: JD, grant number: 2017-01841_3, url: https://www.vr.se).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ALP, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-262; Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Arroyo LS, 2013, J CLIN VIROL, V58, P437, DOI 10.1016/j.jcv.2013.07.013; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Braakhuis BJM, 2004, JNCI-J NATL CANCER I, V96, P998, DOI 10.1093/jnci/djh183; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Bzhalava D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05807; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; Chen JM, 2014, VIROLOGY, V462, P14, DOI 10.1016/j.virol.2014.05.026; de Jong SJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01222; de Koning MNC, 2007, J GEN VIROL, V88, P1489, DOI 10.1099/vir.0.82732-0; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Ekstrom J, 2013, VIROLOGY, V447, P300, DOI 10.1016/j.virol.2013.09.010; Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Ganzenmueller T, 2012, INT J CANCER, V131, pE1173, DOI 10.1002/ijc.27581; Graham SV, 2017, VIRUS RES, V231, P83, DOI 10.1016/j.virusres.2016.11.016; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hortlund M, 2017, INT J CANCER, V140, P1091, DOI 10.1002/ijc.30531; Kullander J, 2008, INT J CANCER, V122, P477, DOI 10.1002/ijc.23115; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Muhr LSA, 2015, INT J CANCER, V136, P2546, DOI 10.1002/ijc.29325; Muhr LSA, 2017, INT J CANCER, V141, P2498, DOI 10.1002/ijc.31017; Muhr LSA, 2015, VIROLOGY, V485, P283, DOI 10.1016/j.virol.2015.07.023; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pfister H, 1997, CLIN DERMATOL, V15, P335, DOI 10.1016/S0738-081X(96)00162-9; Plasmeijer EI, 2009, CANCER RES, V69, P8926, DOI 10.1158/0008-5472.CAN-09-1186; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Walboomers JMM, 1997, J PATHOL, V181, P253, DOI 10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217942	10.1371/journal.pone.0217942	http://dx.doi.org/10.1371/journal.pone.0217942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150522	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100130
J	Lorenz, TK; Cheng, H; Heiman, JR				Lorenz, Tierney K.; Cheng, Hu; Heiman, Julia R.			Neural correlates of emotion processing comparing antidepressants and exogenous oxytocin in postpartum depressed women: An exploratory study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; AMYGDALA RESPONSE; MATERNAL BRAIN; SEXUAL DYSFUNCTION; GESTATIONAL STRESS; SSRI TREATMENT; PREGNANCY; PLASTICITY; SEROTONIN; INFANT	Despite common use of antidepressants to treat postpartum depression, little is known about the impact of antidepressant use on postpartum brain activity. Additionally, although oxytocin has been investigated as a potential treatment for postpartum depression, the interaction between antidepressants and exogenous oxytocin on brain activity is unknown. We explored postpartum depressed women's neural activation in areas identified as important to emotion and reward processing and potentially, antidepressant response: the amygdala, nucleus accumbens and ventral tegmental area. We conducted a secondary analysis of a functional imaging study of response to sexual, crying infant and smiling infant images in 23 postpartum depressed women with infants under six months (11 women taking antidepressants, 12 unmedicated). Participants were randomized to receive a single dose of oxytocin or placebo nasal spray. There was significantly higher amygdala activation to sexual stimuli than either neutral or infant-related stimuli among women taking antidepressants or receiving oxytocin nasal spray. Among unmedicated women receiving placebo, amygdala activation was similar across stimuli types. There were no significant effects of antidepressants nor oxytocin nasal spray on reward area processing (i.e., in the nucleus accumbens or ventral tegmental area). Among postpartum women who remain depressed, there may be significant interactions between the effects of antidepressant use and exogenous oxytocin on neural activity associated with processing emotional information. Observed effect sizes were moderate to large, strongly suggesting the need for further replication with a larger sample.	[Lorenz, Tierney K.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Lorenz, Tierney K.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE USA; [Cheng, Hu; Heiman, Julia R.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Indiana University System; Indiana University Bloomington	Heiman, JR (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	jheiman@indiana.edu	Lorenz, Tierney/ABB-8558-2021; Cheng, Hu/AAS-3076-2021; Lorenz, Tierney/AAF-2531-2020	Lorenz, Tierney/0000-0002-4999-1584; 	National Institutes of Health [NIMH R21MH082925, NICHD T32HD049336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by National Institutes of Health grants NIMH R21MH082925 (JRH; Co-PI) and NICHD T32HD049336 (TKL; trainee), https://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzil S, 2011, NEUROPSYCHOPHARMACOL, V36, P2603, DOI 10.1038/npp.2011.172; Borrow AP, 2012, HORM BEHAV, V61, P266, DOI 10.1016/j.yhbeh.2011.11.001; Briceno EM, 2013, PSYCHOL MED, V43, P1433, DOI 10.1017/S0033291712002176; Brown RSE, 2015, J NEUROENDOCRINOL, V27, P708, DOI 10.1111/jne.12297; Brunton PJ, 2010, BRAIN RES, V1364, P198, DOI 10.1016/j.brainres.2010.09.062; Carceller H, 2018, NEUROSCIENCE, V386, P205, DOI 10.1016/j.neuroscience.2018.06.041; Carter CS, 2014, ANNU REV PSYCHOL, V65, P17, DOI 10.1146/annurev-psych-010213-115110; Chase HW, 2014, SOC COGN AFFECT NEUR, V9, P1069, DOI 10.1093/scan/nst083; Clarici A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00426; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cox EQ, 2015, PSYCHONEUROENDOCRINO, V55, P164, DOI 10.1016/j.psyneuen.2015.02.009; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; Emiliano ABF, 2007, NEUROPSYCHOPHARMACOL, V32, P977, DOI 10.1038/sj.npp.1301206; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Feldman R, 2011, DEVELOPMENTAL SCI, V14, P752, DOI 10.1111/j.1467-7687.2010.01021.x; Galbally M, 2018, PSYCHONEUROENDOCRINO, V90, P1, DOI 10.1016/j.psyneuen.2018.01.004; Gemmel M, 2016, NEUROSCIENCE, V327, P32, DOI 10.1016/j.neuroscience.2016.03.068; Godlewska BR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.130; Godlewska BR, 2012, PSYCHOL MED, V42, P2609, DOI 10.1017/S0033291712000591; Godlewska B, 2017, BIOL PSYCHIAT, V81, pS57, DOI 10.1016/j.biopsych.2017.02.148; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Graf H, 2014, PHARMACOL BIOCHEM BE, V121, P138, DOI 10.1016/j.pbb.2013.12.003; Gregory R, 2015, HORM BEHAV, V69, P82, DOI 10.1016/j.yhbeh.2014.12.009; Gu V, 2015, BIRTH; Haim A, 2017, BRAIN BEHAV IMMUN, V59, P67, DOI 10.1016/j.bbi.2016.09.026; Haim A, 2016, HORM BEHAV, V77, P124, DOI 10.1016/j.yhbeh.2015.05.005; Hillerer KM, 2011, ENDOCRINOLOGY, V152, P3930, DOI 10.1210/en.2011-1091; Joshi SH, 2016, BIOL PSYCHIAT, V79, P282, DOI 10.1016/j.biopsych.2015.02.029; Julian MM, 2017, ARCH WOMEN MENT HLTH, P1; Keers R, 2010, INT REV PSYCHIATR, V22, P485, DOI 10.3109/09540261.2010.496448; Kim K, 2016, J AFFECT DISORDERS, V191, P222, DOI 10.1016/j.jad.2015.11.050; Kim P, 2016, HORM BEHAV, V77, P113, DOI 10.1016/j.yhbeh.2015.08.001; Kim P, 2011, J CHILD PSYCHOL PSYC, V52, P907, DOI 10.1111/j.1469-7610.2011.02406.x; Kim P, 2010, BEHAV NEUROSCI, V124, P695, DOI 10.1037/a0020884; Kim S, 2016, NEW DIR CHILD ADOLES, V153, P59, DOI 10.1002/cad.20170; Kim S, 2014, BRAIN RES, V1580, P219, DOI 10.1016/j.brainres.2013.11.009; Klimes-Dougan B, 2018, PROG NEURO-PSYCHOPH, V81, P194, DOI 10.1016/j.pnpbp.2017.10.015; Kokras N, 2017, J NEUROSCI RES, V95, P731, DOI 10.1002/jnr.23861; Kroll-Desrosiers AR, 2017, DEPRESS ANXIETY, V34, P137, DOI 10.1002/da.22599; Lang P. J., 2005, INT AFFECTIVE PICTUR; Langevin JP, 2016, BIOL PSYCHIAT, V79, pE82, DOI 10.1016/j.biopsych.2015.09.003; Leng G, 2016, BIOL PSYCHIAT, V79, P243, DOI 10.1016/j.biopsych.2015.05.003; Leuner B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089912; Levy F, 2016, ANN ENDOCRINOL-PARIS, V77, P114, DOI 10.1016/j.ando.2016.04.002; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Macoveanu J, 2014, BRAIN RES, V1556, P19, DOI 10.1016/j.brainres.2014.02.003; Mah BL, 2017, CHILD PSYCHIAT HUM D, V48, P308, DOI 10.1007/s10578-016-0642-7; Mah BL, 2016, HARVARD REV PSYCHIAT, V24, P1, DOI 10.1097/HRP.0000000000000093; Mah BL, 2013, PROG NEURO-PSYCHOPH, V40, P267, DOI 10.1016/j.pnpbp.2012.10.005; Massey SH, 2016, DEPRESS ANXIETY, V33, P316, DOI 10.1002/da.22467; McDonald E, 2017, MIDWIFERY, V55, P60, DOI 10.1016/j.midw.2017.09.002; McQuaid RJ, 2014, NEUROSCI BIOBEHAV R, V45, P305, DOI 10.1016/j.neubiorev.2014.07.005; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mottolese R, 2014, P NATL ACAD SCI USA, V111, P8637, DOI 10.1073/pnas.1319810111; Outhred T, 2014, J PSYCHIATR NEUROSCI, V39, P267, DOI 10.1503/jpn.130118; Ozsoy S, 2009, PSYCHIAT RES, V169, P249, DOI 10.1016/j.psychres.2008.06.034; Pawluski JL, 2017, TRENDS NEUROSCI, V40, P106, DOI 10.1016/j.tins.2016.11.009; Pawluski JL, 2016, HORM BEHAV, V77, P86, DOI 10.1016/j.yhbeh.2015.06.004; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Pratt M, 2015, DEPRESS ANXIETY, V32, P635, DOI 10.1002/da.22392; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rantala MJ, 2017, BEHAV IMMUNITY DEPRE; Rupp HA, 2014, SOC COGN AFFECT NEUR, V9, P48, DOI 10.1093/scan/nss100; Rupp HA, 2013, HORM BEHAV, V63, P114, DOI 10.1016/j.yhbeh.2012.10.007; Rupp HA, 2009, ARCH SEX BEHAV, V38, P417, DOI 10.1007/s10508-008-9402-5; Sabihi S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00258; Scantamburlo G, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.08.007; Serretti A, 2009, J CLIN PSYCHOPHARM, V29, P259, DOI 10.1097/JCP.0b013e3181a5233f; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Striepens N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03440; Uvnas-Moberg K, 1999, PSYCHOPHARMACOLOGY, V142, P95, DOI 10.1007/s002130050867; Walsh EC, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00547; Wang T, 2018, BEHAV BRAIN RES, V336, P236, DOI 10.1016/j.bbr.2017.09.012; Williams LM, 2015, NEUROPSYCHOPHARMACOL, V40, P2398, DOI 10.1038/npp.2015.89; Wonch KE, 2016, SOC NEUROSCI-UK, V11, P600, DOI 10.1080/17470919.2015.1131193; Yang JC, 2008, J SEX MED, V5, P602, DOI 10.1111/j.1743-6109.2007.00737.x; Yang JC, 2012, PSYCHIAT INVEST, V9, P379, DOI 10.4306/pi.2012.9.4.379; Yip SH, 2019, CELL REP, V26, P1787, DOI 10.1016/j.celrep.2019.01.067; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]; Zelkowitz P, 2014, HORM BEHAV, V66, P351, DOI 10.1016/j.yhbeh.2014.06.014	83	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217764	10.1371/journal.pone.0217764	http://dx.doi.org/10.1371/journal.pone.0217764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150502	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100101
J	Spaggiari, D; Desfontaine, V; Cruchon, S; Guinchard, S; Vocat, A; Blattes, E; Pitteloud, J; Ciullini, L; Bardinet, C; Ivanyuk, A; Makarov, V; Ryabova, O; Buclin, T; Cole, ST; Decosterd, LA				Spaggiari, Deny; Desfontaine, Vincent; Cruchon, Sandra; Guinchard, Sylvie; Vocat, Anthony; Blattes, Emilyne; Pitteloud, Jeff; Ciullini, Lorenzo; Bardinet, Carine; Ivanyuk, Anton; Makarov, Vadim; Ryabova, Olga; Buclin, Thierry; Cole, Stewart T.; Decosterd, Laurent A.			Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma	PLOS ONE			English	Article							QUANTITATIVE ANALYTICAL PROCEDURES; CHROMATOGRAPHY-MASS-SPECTROMETRY; MYCOBACTERIUM-TUBERCULOSIS; SFSTP PROPOSAL; COMBINATION THERAPY; STRATEGIES; BENZOTHIAZINONES; HARMONIZATION; IDENTIFICATION; BIOANALYSIS	The emergence of Mycobacterium tuberculosis strains resistant to current first-line antibiotic regimens constitutes a major global health threat. New treatments against multidrug-resistant tuberculosis (MDR-TB) are thus eagerly needed in particular in countries with a high MDR-TB prevalence. In this context, macozinone (PBTZ169), a promising drug candidate with an unique mode of action and highly potent in vitro tuberculocidal properties against MDR Mycobacterium strains, has now reached the clinical phase and has been notably tested in healthy male volunteers in Switzerland. To that endeavor, a multiplex UHPLC-MS/MS method has been developed for the sensitive and accurate human plasma levels determination of PBTZ169 along with five metabolites retaining in vitro anti-TB activity. Plasma protein precipitation with methanol was carried out as a simplified sample clean-up procedure followed by direct injection of the undiluted supernatant for the bioanalysis of the six analytes within 5 min, using 1.8 mu m reversed-phase chromatography coupled to triple quadrupole mass spectrometry employing electrospray ionization in the positive mode. Stable isotopically-labelled PBTZ169 was used as internal standard (ISTD), while metabolites could be reliably quantified using two unlabeled chemical analogues selected as ISTD from a large in-house analogous compounds library. The overall methodology was fully validated according to current recommendations (FDA, EMEA) for bioanalytical methods, which include selectivity, carryover, qualitative and quantitative matrix effect, extraction recovery, process efficiency, trueness, precision, accuracy profiles, method and instrument detection limits, integrity to dilution, anticoagulant comparison and short-and long-term stabilities. Stability studies on the reduced metabolite H-2-PBTZ169 have shown no significant impact on the actual PBTZ169 concentrations determined with the proposed assay. This simplified, rapid, sensitive and robust methodology has been applied to the bioanalysis of human plasma samples collected within the frame of a phase I clinical study in healthy volunteers receiving PBTZ169.	[Spaggiari, Deny; Desfontaine, Vincent; Cruchon, Sandra; Guinchard, Sylvie; Pitteloud, Jeff; Ciullini, Lorenzo; Bardinet, Carine; Ivanyuk, Anton; Buclin, Thierry; Decosterd, Laurent A.] Univ Hosp Lausanne, Dept Labs, Lab & Serv Clin Pharmacol, Lausanne, Switzerland; [Spaggiari, Deny; Desfontaine, Vincent; Cruchon, Sandra; Guinchard, Sylvie; Pitteloud, Jeff; Ciullini, Lorenzo; Bardinet, Carine; Ivanyuk, Anton; Buclin, Thierry; Decosterd, Laurent A.] Univ Lausanne, Lausanne, Switzerland; [Vocat, Anthony; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland; [Blattes, Emilyne; Makarov, Vadim; Cole, Stewart T.] Innovat Med TB IM4TB, Lausanne, Switzerland; [Makarov, Vadim; Ryabova, Olga] Fundamentals Biotechnol RAS, Fed Res Ctr, Moscow, Russia; [Spaggiari, Deny] Debiopharm Int SA, Lausanne, Switzerland; [Cole, Stewart T.] Pasteur Inst, Paris, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Research Center of Biotechnology RAS; Debiopharm; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Decosterd, LA (corresponding author), Univ Hosp Lausanne, Dept Labs, Lab & Serv Clin Pharmacol, Lausanne, Switzerland.; Decosterd, LA (corresponding author), Univ Lausanne, Lausanne, Switzerland.	laurentarthur.decosterd@chuv.ch	Riabova, Olga/K-6030-2015; Makarov, Vadim/HGB-7756-2022; Buclin, Thierry/P-1640-2014; Makarov, Vadim/AAE-5483-2021; Decosterd, Laurent/E-8494-2019	Riabova, Olga/0000-0002-3794-6495; Makarov, Vadim/0000-0001-8746-2694; Buclin, Thierry/0000-0003-0639-5536; Makarov, Vadim/0000-0001-8746-2694; Decosterd, Laurent/0000-0002-9840-1325	Bill and Melinda Gates Foundation through the im4TB [OPP1164837]; Swiss National Science Foundation (SNF) [SNF 324730-165956]; REQUIP grant SNF [326000-121314/1]	Bill and Melinda Gates Foundation through the im4TB; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); REQUIP grant SNF	This research program is supported by the Bill and Melinda Gates Foundation (grant OPP1164837) through the study sponsor im4TB (EB). Support for this work and part of the salaries of DS were also provided by a grant from the Swiss National Science Foundation (SNF) No SNF 324730-165956 to LAD. This analytical project performed at the Laboratory of Clinical Pharmacology also benefits from the REQUIP grant SNF No 326000-121314/1 to LAD and from a donation of the Loterie Romande for the acquisition of LC-MS/MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, AB SCIEX PUBLICATION; [Anonymous], GLOB TUB REP; Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.3.CO;2-S; Bylda C, 2014, ANALYST, V139, P2265, DOI 10.1039/c4an00094c; Chetty S, 2017, BIOORG MED CHEM LETT, V27, P370, DOI 10.1016/j.bmcl.2016.11.084; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; De Nicolo A, 2017, BIOANALYSIS, V9, P1093, DOI 10.4155/bio-2017-0059; EMEA, 2011, GUID BIOAN METH VAL; Feinberg M, 2007, J CHROMATOGR A, V1158, P174, DOI 10.1016/j.chroma.2007.02.021; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Hoagland DT, 2016, ADV DRUG DELIVER REV, V102, P55, DOI 10.1016/j.addr.2016.04.026; Hoffman D, 2007, PHARM RES, V24, P1157, DOI 10.1007/s11095-007-9242-3; Hubert P, 1999, ANAL CHIM ACTA, V391, P135, DOI 10.1016/S0003-2670(99)00106-3; Hubert P, 2004, J PHARMACEUT BIOMED, V36, P579, DOI 10.1016/j.jpba.2004.07.027; Hubert P, 2008, J PHARMACEUT BIOMED, V48, P760, DOI 10.1016/j.jpba.2008.07.018; Hubert P, 2007, J PHARMACEUT BIOMED, V45, P70, DOI 10.1016/j.jpba.2007.06.013; Hubert P, 2007, J PHARMACEUT BIOMED, V45, P82, DOI 10.1016/j.jpba.2007.06.032; Kloss F, 2014, ANGEW CHEM INT EDIT, V56, P2187; Law RA, 2016, TN10494EN0816S THERM; Lechartier B, 2015, ANTIMICROB AGENTS CH, V59, P4457, DOI 10.1128/AAC.00395-15; Lechartier B, 2012, ANTIMICROB AGENTS CH, V56, P5790, DOI 10.1128/AAC.01476-12; Lupien A, 2018, ANTIMICROB AGENTS CH; Lv K, 2017, ACS MED CHEM LETT, V8, P636, DOI 10.1021/acsmedchemlett.7b00106; Makarov V, 2015, ANTIMICROB AGENTS CH, V59, P4446, DOI 10.1128/AAC.00778-15; Makarov V, 2014, EMBO MOL MED, V6, P372, DOI 10.1002/emmm.201303575; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Matuszewski BK, 1998, ANAL CHEM, V70, P882, DOI 10.1021/ac971078+; Neres J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004395; Panuwet P, 2016, CRIT REV ANAL CHEM, V46, P93, DOI 10.1080/10408347.2014.980775; Parra NPT, 2014, 59914089EN AG TECHN; Pasca MR, 2010, ANTIMICROB AGENTS CH, V54, P1616, DOI 10.1128/AAC.01676-09; Peters FT, 2012, ANAL BIOANAL CHEM, V403, P2155, DOI 10.1007/s00216-012-6035-2; Richter A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31316-6; Rozet E, 2007, J CHROMATOGR A, V1158, P126, DOI 10.1016/j.chroma.2007.03.102; Rozet E, 2007, J CHROMATOGR A, V1158, P111, DOI 10.1016/j.chroma.2007.03.111; Sheehan T.L., 2015, SPECTROSCOPY-US, V13, P16; Singh V, 2017, DRUG DISCOV TODAY, V22, P503, DOI 10.1016/j.drudis.2016.09.010; Spaggiari D, 2017, C PRINT SOC SUISS ME; Stepanova ES, 2018, PHARM CHEM J+, V52, P248, DOI 10.1007/s11094-018-1801-x; Stokvis E, 2005, RAPID COMMUN MASS SP, V19, P401, DOI 10.1002/rcm.1790; Taylor PJ, 2005, CLIN BIOCHEM, V38, P328, DOI 10.1016/j.clinbiochem.2004.11.007; Trefzer C, 2012, J AM CHEM SOC, V134, P912, DOI 10.1021/ja211042r; Trefzer C, 2010, J AM CHEM SOC, V132, P13663, DOI 10.1021/ja106357w; US Department of Health and Human Services Food and Drug Administration, GUID IND BIOAN METH; US Food and Drug Administration, 2016, GUID IND SAF TEST DR; Viswanathan CT, 2007, PHARM RES, V24, P1962, DOI 10.1007/s11095-007-9291-7; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; Wells G., 2011, 59907651EN AG TECHN; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	50	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217139	10.1371/journal.pone.0217139	http://dx.doi.org/10.1371/journal.pone.0217139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150423	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100032
J	Wu, LF; Fan, JL				Wu, Lifeng; Fan, Junliang			Comparison of neuron-based, kernel-based, tree-based and curve-based machine learning models for predicting daily reference evapotranspiration	PLOS ONE			English	Article							SUPPORT-VECTOR-MACHINE; GLOBAL SOLAR-RADIATION; LIMITED CLIMATIC DATA; ARPS DECLINE MODEL; EMPIRICAL EQUATIONS; REGRESSION; NETWORK; ANFIS; TEMPERATURE; SVM	Accurately predicting reference evapotranspiration (ET0) with limited climatic data is crucial for irrigation scheduling design and agricultural water management. This study evaluated eight machine learning models in four categories, i.e. neuron-based (MLP, GRNN and ANFIS), kernel-based (SVM, KNEA), tree-based (M5Tree, XGBoost) and curve-based (MARS) models, for predicting daily ET0 with maximum/maximum temperature and precipitation data during 2001-2015 from 14 stations in various climatic regions of China, i.e., arid desert of northwest China (NWC), semi-arid steppe of Inner Mongolia (IM), Qinghai-Tibetan Plateau (QTP), (semi-)humid cold-temperate northeast China (NEC), semi-humid warm-temperate north China (NC), humid subtropical central China (CC) and humid tropical south China (SC). The results showed machine learning models using only temperature data obtained satisfactory daily ET0 estimates (on average R-2 = 0.829, RMSE = 0.718 mm day(-1), NRMSE = 0.250 and MAE = 0.508 mm day(-1)). The prediction accuracy was improved by 7.6% across China when information of precipitation was further considered, particularly in (sub) tropical humid regions (by 9.7% in CC and 12.4% in SC). The kernel-based SVM, KNEA and curve-based MARS models generally outperformed the others in terms of prediction accuracy, with the best performance by KNEA in NWC and IM, by SVM in QTP, CC and SC, and very similar performance by them in NEC and NC. SVM (1.9%), MLP (2.0%), MARS (2.6%) and KNEA (6.4%) showed relatively small average increases in RMSE during testing compared with training RMSE. SVM is highly recommended for predicting daily ET0 across China in light of best accuracy and stability, while KNEA and MARS are also promising powerful models.	[Wu, Lifeng] Nanchang Inst Technol, Sch Hydraul & Ecol Engn, Nanchang, Jiangxi, Peoples R China; [Fan, Junliang] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China	Nanchang Institute Technology; Northwest A&F University - China	Fan, JL (corresponding author), Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China.	nwwfjl@163.com	Fan, Junliang/E-2534-2017	Fan, Junliang/0000-0002-7687-9109; Wu, Lifeng/0000-0002-1210-5411	Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CAAS) [FIRI2018-01]; National Natural Science Foundation of China [51709144]	Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CAAS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CAAS, FIRI2018-01), the National Natural Science Foundation of China (No. 51709144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah SS, 2015, J HYDROL, V527, P184, DOI 10.1016/j.jhydrol.2015.04.073; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Antonopoulos VZ, 2017, COMPUT ELECTRON AGR, V132, P86, DOI 10.1016/j.compag.2016.11.011; Baba APA, 2013, HYDROL RES, V44, P131, DOI 10.2166/nh.2012.074; Chen T., 2015, XGBOOST EXTREME GRAD, V1, P1; Fan JL, 2019, RENEW SUST ENERG REV, V105, P168, DOI 10.1016/j.rser.2019.01.040; Fan JL, 2019, RENEW SUST ENERG REV, V100, P186, DOI 10.1016/j.rser.2018.10.018; Fan JL, 2018, AGR FOREST METEOROL, V263, P225, DOI 10.1016/j.agrformet.2018.08.019; Fan JL, 2018, ENERG CONVERS MANAGE, V164, P102, DOI 10.1016/j.enconman.2018.02.087; Fan JL, 2016, J HYDROL, V542, P923, DOI 10.1016/j.jhydrol.2016.09.060; Fan JL, 2014, J HYDROL, V519, P1120, DOI 10.1016/j.jhydrol.2014.08.039; Feng Y, 2017, AGR WATER MANAGE, V193, P163, DOI 10.1016/j.agwat.2017.08.003; Feng Y, 2017, COMPUT ELECTRON AGR, V136, P71, DOI 10.1016/j.compag.2017.01.027; Feng Y, 2016, J HYDROL, V536, P376, DOI 10.1016/j.jhydrol.2016.02.053; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gocic M, 2015, COMPUT ELECTRON AGR, V113, P164, DOI 10.1016/j.compag.2015.02.010; Guo XH, 2011, HYDROL RES, V42, P268, DOI 10.2166/nh.2011.072; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hassan MA, 2017, APPL ENERG, V203, P897, DOI 10.1016/j.apenergy.2017.06.104; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Jovic S, 2018, COMPUT ELECTRON AGR, V150, P1, DOI 10.1016/j.compag.2018.04.003; Karbasi M, 2018, WATER RESOUR MANAG, V32, P1035, DOI 10.1007/s11269-017-1853-9; Karimi S, 2017, INT J CLIMATOL, V37, P3238, DOI 10.1002/joc.4911; Keshtegar B, 2018, WATER RESOUR MANAG, V32, P1101, DOI 10.1007/s11269-017-1857-5; Kisi O, 2008, HYDROL PROCESS, V22, P2449, DOI 10.1002/hyp.6837; Kisi O, 2016, THEOR APPL CLIMATOL, V126, P413, DOI 10.1007/s00704-015-1582-z; Kisi O, 2016, AGR WATER MANAGE, V169, P162, DOI 10.1016/j.agwat.2016.02.026; Kisi O, 2015, J HYDROL, V528, P312, DOI 10.1016/j.jhydrol.2015.06.052; Kisi O, 2014, WATER RESOUR MANAG, V28, P4045, DOI 10.1007/s11269-014-0726-8; Landeras G, 2008, AGR WATER MANAGE, V95, P553, DOI 10.1016/j.agwat.2007.12.011; Ma X, 2019, APPL MATH MODEL, V70, P402, DOI 10.1016/j.apm.2019.01.039; Ma X, 2019, J GREY SYST-UK, V31, P1; Ma X, 2018, NEURAL COMPUT APPL, V29, P579, DOI 10.1007/s00521-016-2721-x; Ma X, 2017, J GREY SYST-UK, V29, P122; Mehdizadeh S, 2017, COMPUT ELECTRON AGR, V139, P103, DOI 10.1016/j.compag.2017.05.002; Pal M, 2009, HYDROL PROCESS, V23, P1437, DOI 10.1002/hyp.7266; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Rahimikhoob A, 2014, WATER RESOUR MANAG, V28, P657, DOI 10.1007/s11269-013-0506-x; Sanikhani H, 2019, THEOR APPL CLIMATOL, V135, P449, DOI 10.1007/s00704-018-2390-z; Shiri J, 2018, J HYDROL, V561, P737, DOI 10.1016/j.jhydrol.2018.04.042; Shiri J, 2017, AGR WATER MANAGE, V188, P101, DOI 10.1016/j.agwat.2017.04.009; Shiri J, 2014, COMPUT ELECTRON AGR, V108, P230, DOI 10.1016/j.compag.2014.08.007; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Tabari H, 2013, IRRIGATION SCI, V31, P107, DOI 10.1007/s00271-011-0295-z; Tabari H, 2012, J HYDROL, V444, P78, DOI 10.1016/j.jhydrol.2012.04.007; Trabert W., 1896, METEOROL Z, V13, P261; Traore S, 2016, AGR WATER MANAGE, V163, P363, DOI 10.1016/j.agwat.2015.10.009; Vapnik V, 2003, NATURE STAT LEARNING; Wang LC, 2017, INT J CLIMATOL, V37, P1076, DOI 10.1002/joc.5064; Wang LC, 2017, J HYDROL, V544, P407, DOI 10.1016/j.jhydrol.2016.11.059; Wang LC, 2016, RENEW SUST ENERG REV, V61, P384, DOI 10.1016/j.rser.2016.04.024; Wang XK, 2019, ADV AGRON, V153, P121, DOI 10.1016/bs.agron.2018.08.003; Wang Y., 1997, P POST PAP EUR C MAC; Wen XH, 2015, WATER RESOUR MANAG, V29, P3195, DOI 10.1007/s11269-015-0990-2; Wu LF, 2019, ENERG CONVERS MANAGE, V183, P280, DOI 10.1016/j.enconman.2018.12.103; Yao N, 2018, SCI TOTAL ENVIRON, V616, P73, DOI 10.1016/j.scitotenv.2017.10.327; Yin ZL, 2017, HYDROL RES, V48, P1177, DOI 10.2166/nh.2016.205; Zhao S., 1983, ACTA GEOGRAPH SIN, V38, P1	59	37	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217520	10.1371/journal.pone.0217520	http://dx.doi.org/10.1371/journal.pone.0217520			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150448	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100062
J	He, S; Joseph, N; Luo, X; Raston, CL				He, Shan; Joseph, Nikita; Luo, Xuan; Raston, Colin L.			Vortex fluidic mediated food processing	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PROTEIN HYDROLYSATE; MILK; ENCAPSULATION; OPTIMIZATION; STABILITY; CURCUMIN	The high heat and mass transfer, and controlled mechanoenergy, in angled vortex fluidics has been applied in chemical and material sciences and allied fields, but its utility in food processing remains largely unexplored. Herein we report three models of food processing incorporating such vortex fluidics, including enzymatic hydrolysis, raw milk pasteurization and encapsulation. The processing times of enzymatic hydrolysis was reduced from about 2-3 hours to 20 minutes, with the processing time of raw milk pasteurization reduced from 30 to 10 minutes, and an encapsulated particle size reduced approximately 10-fold, from micro meters to hundreds of nanometers. These findings highlight exciting possibilities, in exploiting the value of vortex fluidic mediated processing in the food industry.	[He, Shan] Guangzhou Univ, Sch Chem & Chem Engn, Dept Food Sci, Guangzhou, Guangdong, Peoples R China; [He, Shan; Joseph, Nikita; Luo, Xuan; Raston, Colin L.] Flinders Univ S Australia, Coll Sci & Engn, Flinders Inst NanoScale Sci & Technol, Bedford Pk, SA, Australia	Guangzhou University; Flinders University South Australia	He, S (corresponding author), Guangzhou Univ, Sch Chem & Chem Engn, Dept Food Sci, Guangzhou, Guangdong, Peoples R China.; He, S; Raston, CL (corresponding author), Flinders Univ S Australia, Coll Sci & Engn, Flinders Inst NanoScale Sci & Technol, Bedford Pk, SA, Australia.	he0091@gmail.com; colin.raston@flinders.edu.au		Luo, Xuan/0000-0002-8811-3143	Australian Research Council (ARC) [DP170100453]	Australian Research Council (ARC)(Australian Research Council)	The authors acknowledge support from the Australian Research Council (ARC Discovery Grant DP170100453) and Flinders Analytical Facility for MALDI measurements, and acknowledge the provision of in kind by Bd farm Paris Creek PTY LTD (9/7 Paris Creek Rd, Paris Creek SA 5201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shamsi KA, 2018, J DAIRY SCI, V101, P47, DOI 10.3168/jds.2017-13194; Awad S, 2016, J DAIRY SCI, V99, P8499, DOI 10.3168/jds.2015-10626; Betoret E, 2015, TRENDS FOOD SCI TECH, V46, P1, DOI 10.1016/j.tifs.2015.07.006; Britton J, 2016, ANGEW CHEM INT EDIT, V55, P11387, DOI 10.1002/anie.201604014; Britton J, 2015, CHEM-EUR J, V21, P10660, DOI 10.1002/chem.201501785; Britton J, 2014, RSC ADV, V4, P49850, DOI 10.1039/C4RA10317C; Chemat F, 2017, INNOV FOOD SCI EMERG, V41, P357, DOI 10.1016/j.ifset.2017.04.016; He S, 2019, LWT-FOOD SCI TECHNOL, V103, P88, DOI 10.1016/j.lwt.2018.12.066; He S, 2015, J FOOD SCI, V80, pE108, DOI 10.1111/1750-3841.12684; He S, 2012, INT J FOOD SCI TECH, V47, P2397, DOI 10.1111/j.1365-2621.2012.03115.x; Honary S, 2014, PHARM DEV TECHNOL, V19, P987, DOI 10.3109/10837450.2013.846375; Kaur K, 2015, J MOL LIQ, V209, P62, DOI 10.1016/j.molliq.2015.05.018; Liu G, 2016, BIOPROC BIOSYST ENG, V39, P133, DOI 10.1007/s00449-015-1497-1; Luo X, 2016, ACS SUSTAIN CHEM ENG, V4, P3905, DOI 10.1021/acssuschemeng.6b00756; Majumdar S., 2017, ANGEW CHEM, V129, P2336, DOI DOI 10.1002/ange.201610821; Ming Y, 2015, INT J BIOL MACROMOL, V79, P201, DOI [10.1016/j.ijbiomac.2015.04.057, DOI 10.1016/J.IJBIOMAC.2015.04.057]; Shoabargh S, 2014, J IND ENG CHEM, V20, P3150, DOI 10.1016/j.jiec.2013.11.058; Valle BCS, 2015, AQUACULT NUTR, V21, P105, DOI 10.1111/anu.12149; Wu Y, 2017, INT J FOOD PROP, V20, P3295, DOI 10.1080/10942912.2017.1286505; Zhang YD, 2014, FOOD CONTROL, V36, P238, DOI 10.1016/j.foodcont.2013.08.012; Zhang Z, 2017, ANGEW CHEM, V129, P9518, DOI DOI 10.1002/ANGE.201608673	21	8	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0216816	10.1371/journal.pone.0216816	http://dx.doi.org/10.1371/journal.pone.0216816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145727	gold, Green Published, Green Submitted			2022-12-26	WOS:000469425500006
J	Kaur, N; Sinha, PK; Sahni, G				Kaur, Navneet; Sinha, Prakash Kumar; Sahni, Girish			Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL MODIFICATION; PROTEIN PEGYLATION; ANTIBODY FRAGMENTS; MOLECULAR-WEIGHT; PEG; MICROPLASMIN; SUBSTRATE; CHEMISTRY; PEPTIDE; DOMAIN	The relatively rapid inhibition of microplasmin by alpha(2)-AP leads to short functional half-life of the molecule in vivo, causing inefficient clot dissolution, even after site-specific, local catheter-based delivery. Here, we describe a PEGylation approach for improving the therapeutic potential via improving the survival of microplasmin in presence of its cognate inhibitor, alpha(2)-AP, wherein a series of strategically designed cysteine analogs of micro-plasminogen were prepared and expressed in E. coli, and further modified by covalent grafting in vitro with PEG groups of different molecular sizes so as to select single or double PEG chains that increase the molecular weight and hydrodynamic radii of the conjugates, but with a minimal discernible effect on intrinsic plasmin activity and structural framework, as explored by amidolytic activity and CD-spectroscopy, respectively. Interestingly, some of the purified PEG-coupled proteins after conversion to their corresponding proteolytically active forms were found to exhibit significantly reduced inhibition rates (up to 2-fold) by alpha(2)-AP relative to that observed with wild-type microplasmin. These results indicate an interesting, and not often observed, effect of PEG groups through reduced/altered dynamics between protease and inhibitor, likely through a steric hindrance mechanism. Thus, the present study successfully identifies single- and double-site PEGylated muteins of microplasmin with significantly enhanced functional half-life through enhanced resistance to inactivation by its in vivo plasma inhibitor. Such an increased survival of bioactivity in situ, holds unmistakable potential for therapeutic exploitation, especially in ischemic strokes where a direct, catheter-based deposition within the cranium has been shown to be promising, but is currently limited by the very short in vivo bioactive half-life of the fibrin dissolving agent/s.	[Kaur, Navneet; Sinha, Prakash Kumar; Sahni, Girish] CSIR Inst Microbial Technol, Chandigarh, India; [Kaur, Navneet; Sinha, Prakash Kumar] Panjab Univ, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Panjab University	Sahni, G (corresponding author), CSIR Inst Microbial Technol, Chandigarh, India.	girishsahni@gmail.com	Sinha, Prakash Kumar/K-6048-2013	Sinha, Prakash Kumar/0000-0002-2067-5676	Council of Scientific and Industrial Research (CSIR), New Delhi, India; ICMR Junior Research fellowship	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); ICMR Junior Research fellowship	R and D funding was provided by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. GS is a Bhatnagar Research Fellow of the CSIR and a Honorary Professor, Punjab University, Chandigarh, India. NK was supported by ICMR Junior Research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582; Adivitiya, 2017, BIOENGINEERED, V8, P331, DOI 10.1080/21655979.2016.1229718; AMBRUS JL, 1957, ANN NY ACAD SCI, V68, P97, DOI 10.1111/j.1749-6632.1957.tb42616.x; Aneja R, 2009, J BIOL CHEM, V284, P32642, DOI 10.1074/jbc.M109.046573; Aoki N, 2005, J THROMB HAEMOST, V3, P623, DOI 10.1111/j.1538-7836.2004.01055.x; Bailon P, 1998, PHARM SCI TECHNOL TO, V1, P352, DOI 10.1016/S1461-5347(98)00086-8; BOYLES PW, 1960, AM J CARDIOL, V6, P439, DOI 10.1016/0002-9149(60)90337-4; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; CLIFFTON EE, 1957, ANN NY ACAD SCI, V68, P209, DOI 10.1111/j.1749-6632.1957.tb42627.x; Collen D, 2000, CIRCULATION, V102, P1766; COLLEN D, 1991, BLOOD, V78, P3114; Crumrine R Christian, 2012, Exp Transl Stroke Med, V4, P10, DOI 10.1186/2040-7378-4-10; DELGADO C, 1992, CRIT REV THER DRUG, V9, P249; Doherty DH, 2005, BIOCONJUGATE CHEM, V16, P1291, DOI 10.1021/bc050172r; Dong XB, 2018, MEMBRANES-BASEL, V8, DOI 10.3390/membranes8020023; DREBORG S, 1990, CRIT REV THER DRUG, V6, P315; Erel O, 2014, CLIN BIOCHEM, V47, P326, DOI 10.1016/j.clinbiochem.2014.09.026; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Gaberc-Porekar V, 2008, CURR OPIN DRUG DISC, V11, P242; GEIER GE, 1979, J BIOL CHEM, V254, P1408; Gladysheva IP, 2002, J BIOL CHEM, V277, P26846, DOI 10.1074/jbc.M202999200; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Hao Y, 2006, BIODRUGS, V20, P357, DOI 10.2165/00063030-200620060-00006; Harris JM, 2003, ADV DRUG DELIVER REV, V55, P1259, DOI 10.1016/S0169-409X(03)00107-8; Harris JM, 1997, ACS SYM SER, P680; Hoefer IE, 2009, J VASC INTERV RADIOL, V20, P951, DOI 10.1016/j.jvir.2009.03.043; Hu Y, 2007, J CONTROL RELEASE, V118, P7, DOI 10.1016/j.jconrel.2006.11.028; Hunt JA, 2008, THROMB HAEMOSTASIS, V100, P413, DOI 10.1160/TH08-04-0225; Jahan R, 2008, STROKE, V39, P1613, DOI 10.1161/STROKEAHA.107.507376; Jensen VJ, 1976, US patent, Patent No. 3950513; Joshi KK, 2010, PROCESS BIOCHEM, V45, P1251, DOI 10.1016/j.procbio.2010.04.014; KATRE NV, 1993, ADV DRUG DELIVER REV, V10, P91, DOI 10.1016/0169-409X(93)90005-O; Kerwin BA, 2002, PROTEIN SCI, V11, P1825, DOI 10.1110/ps.0208102; Kubetzko S, 2005, MOL PHARMACOL, V68, P1439, DOI 10.1124/mol.105.014910; Kusterle M, 2008, ACTA CHIM SLOV, V55, P594; Lapchak PA, 2002, STROKE, V33, P2279, DOI 10.1161/01.STR.0000028267.09604.7B; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; Lawrence PB, 2016, CURR OPIN CHEM BIOL, V34, P88, DOI 10.1016/j.cbpa.2016.08.006; Lee P, 2015, MACROMOL BIOSCI, V15, P1332, DOI 10.1002/mabi.201500143; Lin XT, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-2; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Marder VJ, 2011, J THROMB HAEMOST, V9, P364, DOI 10.1111/j.1538-7836.2011.04370.x; Marder VJ, 2010, J THROMB HAEMOST, V8, P433, DOI 10.1111/j.1538-7836.2009.03701.x; MAXFIELD J, 1975, POLYMER, V16, P505, DOI 10.1016/0032-3861(75)90008-7; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Morgenstern J, 2017, INT J PHARMACEUT, V519, P408, DOI 10.1016/j.ijpharm.2017.01.040; Mu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068559; Nagai N, 2003, J THROMB HAEMOST, V1, P307, DOI 10.1046/j.1538-7836.2003.00078.x; Nagai N, 2001, BLOOD, V97, P3086, DOI 10.1182/blood.V97.10.3086; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Neffendorf JE, 2018, ACTA OPHTHALMOL, V96, P685, DOI 10.1111/aos.13547; Ozbakir HF, 2018, AICHE J, V64, P12, DOI 10.1002/aic.15893; PETERSEN TE, 1990, J BIOL CHEM, V265, P6104; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Rodriguez-Martinez JA, 2008, BIOTECHNOL BIOENG, V101, P1142, DOI 10.1002/bit.22014; Sadeghi S, 2003, J THROMB HAEMOST, V1, P2621, DOI 10.1046/j.1538-7836.2003.00441.x; Sawhney P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155831; SEHON AH, 1991, ADV DRUG DELIVER REV, V6, P203, DOI 10.1016/0169-409X(91)90041-A; Suzuki Y, 2004, STROKE, V35, P2402, DOI 10.1161/01.STR.0000140628.00927.1a; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Turecek PL, 2016, J PHARM SCI-US, V105, P460, DOI 10.1016/j.xphs.2015.11.015; Turner RB, 2002, J BIOL CHEM, V277, P33068, DOI 10.1074/jbc.M203782200; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wang XQ, 2000, J MOL BIOL, V295, P903, DOI 10.1006/jmbi.1999.3397; WIMAN B, 1978, EUR J BIOCHEM, V87, P143, DOI 10.1111/j.1432-1033.1978.tb12360.x; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WIMAN B, 1979, J BIOL CHEM, V254, P9291; WU HL, 1987, P NATL ACAD SCI USA, V84, P8292, DOI 10.1073/pnas.84.23.8292; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yang C, 2011, BIOCHEMISTRY-US, V50, P2585, DOI 10.1021/bi101926u; Yang K, 2003, PROTEIN ENG, V16, P761, DOI 10.1093/protein/gzg093; ZALIPSKY S, 1995, ADV DRUG DELIVER REV, V16, P157, DOI 10.1016/0169-409X(95)00023-Z; Zheng JC, 2012, IMMUNOPHARM IMMUNOT, V34, P866, DOI 10.3109/08923973.2012.666979	78	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217234	10.1371/journal.pone.0217234	http://dx.doi.org/10.1371/journal.pone.0217234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141522	Green Published, Green Submitted, gold			2022-12-26	WOS:000469323000045
J	Somma, F; Stoia, V; Serra, N; D'Angelo, R; Gatta, G; Fiore, F				Somma, Francesco; Stoia, Vincenzo; Serra, Nicola; D'Angelo, Roberto; Gatta, Gianluca; Fiore, Francesco			Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-TRANSPLANTATION; MICROSPHERES; CANCER; TERM; SORAFENIB; BRACHYTHERAPY; DESIGN; SAFETY	Purpose Portal vein thrombosis (PVT) is generally recognized as a prognostic factor in HCC. Our purpose is to assess and compare the survival of patients with PVT and without PVT, after Y-90 Trans-Arterial Radio-Embolization (TARE) of unresectable HCC, unresponsive to other loco-regional treatments. Materials and methods Between November 2005 and November 2012, Y-90 resin-based TARE was performed in an IRB-approved prospective protocol, on 89 patients with unresectable HCC. 33/89 patients had PVT, the remaining 56 were resistant-to-cTACE or underwent TARE as a downstaging therapy. All patients were studied with Multi-Detector Computed Tomography (MDCT), angiography, 99m Tc-MAA-scintigraphy and liver biopsy. Gastro-duodenal artery was embolized in most cases. Proton-Pump Inhibitors were administered to prevent gastritis and ulcers..2 test with Yates correction and log rank test were used to compare the two proportions and Kaplan-Meier survival curves, respectively. Results The average activity administered was 1.7 +/- 0.4 GBq. After the treatment, CTCAE grade 2 adverse events occurred in 46% (41/89) patients: in particular, fever and abdominal pain were found in 25 and 16 patients, respectively. No major side-effect was observed. According to mRECIST criteria, partial response or complete response was found in 70% of patient three months after the treatment, and in 90.5% nine months after the treatment. No significant difference was found in survival of patients with PVT compared to those without PVT (p-value = 0.672). A complete regression of PVT was observed in almost half patients (13/27, 48.1%). Conclusions Portal vein invasion does not affect survival in advanced stage HCC-patients undergoing TARE using Y-90 resin-based microspheres. Y90 procedure is associated with regression of portal vein tumor thrombus.	[Somma, Francesco; Stoia, Vincenzo; Serra, Nicola; D'Angelo, Roberto; Gatta, Gianluca; Fiore, Francesco] Ist Nazl Tumori IRCCS Fdn G Pascale, Dipartimento Radiol Interventist, Naples, Italy	IRCCS Fondazione Pascale	Somma, F (corresponding author), Ist Nazl Tumori IRCCS Fdn G Pascale, Dipartimento Radiol Interventist, Naples, Italy.	fra1585@hotmail.it	Somma, Francesco/AAA-9462-2021; , vincenzo/AAY-6364-2021	, vincenzo/0000-0002-8919-861X; GATTA, Gianluca/0000-0003-0874-8294; Somma, Francesco/0000-0002-8193-3050				Barbier L, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/791013; BREEDIS C, 1954, AM J PATHOL, V30, P969; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Carr BI, 2016, ONCOLOGY-BASEL, V90, P215, DOI 10.1159/000444394; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chow P, 2017, P AN M AM SOC CLIN, V35, P4002, DOI DOI 10.1200/JC0.201735.15.3UPPL.4002; Chung GE, 2011, RADIOLOGY, V258, P627, DOI 10.1148/radiol.10101058; Clayton D, 1993, STAT MODELS EPIDEMIO, p[27, 146]; Costentin CE, 2017, LIVER CANCER, V6, P360, DOI 10.1159/000481315; D'Avola D, 2009, HEPATO-GASTROENTEROL, V56, P1683; Dai QS, 2014, MOL CLIN ONCOL, V2, P1047, DOI 10.3892/mco.2014.391; FARMER DG, 1994, ANN SURG, V219, P236, DOI 10.1097/00000658-199403000-00003; Fiore F, 2014, ENDOCRINE; Gondolesi GE, 2004, ANN SURG, V239, P142, DOI 10.1097/01.sla.0000109022.32391.eb; Hilgard P, 2010, HEPATOLOGY, V52, P1741, DOI 10.1002/hep.23944; Ho S, 1997, BRIT J RADIOL, V70, P823, DOI 10.1259/bjr.70.836.9486047; Ho S, 1996, EUR J NUCL MED, V23, P947, DOI 10.1007/BF01084369; Jeong SW, 2013, GUT LIVER, V7, P696, DOI 10.5009/gnl.2013.7.6.696; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kennedy AS, 2006, INT J RADIAT ONCOL, V65, P412, DOI 10.1016/j.ijrobp.2005.12.051; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Lau WY, 2013, ONCOLOGY-BASEL, V84, P311, DOI 10.1159/000348325; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Lewandowski RJ, 2009, AM J TRANSPLANT, V9, P1920, DOI 10.1111/j.1600-6143.2009.02695.x; Lewandowski RJ, 2007, CARDIOVASC INTER RAD, V30, P571, DOI 10.1007/s00270-007-9064-z; Lewandowski RJ, 2010, RADIOLOGY, V255, P955, DOI 10.1148/radiol.10091473; Liapi E, 2007, J CLIN ONCOL, V25, P978, DOI 10.1200/JCO.2006.09.8657; Liu DM, 2005, J VASC INTERV RADIOL, V16, P911, DOI 10.1097/01.RVI.0000164324.79242.B2; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Manghisi G, 1998, HEPATOLOGY, V28, P751; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2013, HEPATOLOGY, V57, P1826, DOI 10.1002/hep.26014; Memon K, 2012, CURR TREAT OPTION ON, V13, P403, DOI 10.1007/s11864-012-0200-x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pinter M, 2012, RADIOLOGY, V263, P590, DOI 10.1148/radiol.12111550; Pirisi M, 1998, J CANCER RES CLIN, V124, P397, DOI 10.1007/s004320050189; Salem R, 2002, J VASC INTERV RADIOL, V13, pS223, DOI 10.1016/S1051-0443(07)61790-4; Salem R, 2007, TECH VASC INTERV RAD, V10, P12, DOI 10.1053/j.tvir.2007.08.001; Salem R, 2006, J VASC INTERV RADIOL, V17, P1251, DOI 10.1097/01.RVI.0000233785.75257.9A; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; Sangro B, 2012, J HEPATOL, V56, P464, DOI 10.1016/j.jhep.2011.07.012; Sangro B, 2011, HEPATOLOGY, V54, P868, DOI 10.1002/hep.24451; Sato K, 2006, CARDIOVASC INTER RAD, V29, P522, DOI 10.1007/s00270-005-0171-4; Shi J, 2010, ANN SURG ONCOL, V17, P2073, DOI 10.1245/s10434-010-0940-4; SOKAL RR, 1995, BIOMETRY PRINCIPLES, P724; Somma F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129573; Syha R, 2012, EUR J GASTROEN HEPAT, V24, P1325, DOI 10.1097/MEG.0b013e32835724bc; Vilgrain V, 2017, J HEPATOL, V66, pS85, DOI 10.1016/S0168-8278(17)30436-1	57	20	21	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216935	10.1371/journal.pone.0216935	http://dx.doi.org/10.1371/journal.pone.0216935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141552	Green Published, Green Submitted, gold			2022-12-26	WOS:000469323000029
J	Mustafa, HMJ; Ayob, M; Nazri, MZA; Kendall, G				Mustafa, Hossam M. J.; Ayob, Masri; Nazri, Mohd Zakree Ahmad; Kendall, Graham			An improved adaptive memetic differential evolution optimization algorithms for data clustering problems	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; HYBRIDIZATION; STABILITY; SEARCH	The performance of data clustering algorithms is mainly dependent on their ability to balance between the exploration and exploitation of the search process. Although some data clustering algorithms have achieved reasonable quality solutions for some datasets, their performance across real-life datasets could be improved. This paper proposes an adaptive memetic differential evolution optimisation algorithm (AMADE) for addressing data clustering problems. The memetic algorithm (MA) employs an adaptive differential evolution (DE) mutation strategy, which can offer superior mutation performance across many combinatorial and continuous problem domains. By hybridising an adaptive DE mutation operator with the MA, we propose that it can lead to faster convergence and better balance the exploration and exploitation of the search. We would also expect that the performance of AMADE to be better than MA and DE if executed separately. Our experimental results, based on several real-life benchmark datasets, shows that AMADE outperformed other compared clustering algorithms when compared using statistical analysis. We conclude that the hybridisation of MA and the adaptive DE is a suitable approach for addressing data clustering problems and can improve the balance between global exploration and local exploitation of the optimisation algorithm.	[Mustafa, Hossam M. J.; Ayob, Masri; Nazri, Mohd Zakree Ahmad] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Data Min & Optimizat Res Grp, Bangi, Malaysia; [Kendall, Graham] Univ Nottingham Malaysia, Asap Res Grp, Semenyih, Selangor, Malaysia	Universiti Kebangsaan Malaysia; University of Nottingham Malaysia	Mustafa, HMJ (corresponding author), Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Ctr Artificial Intelligence Technol, Data Min & Optimizat Res Grp, Bangi, Malaysia.	hasa.mustafa@gmail.com	Ayob, Masri/AAH-9732-2019; Kendall, Graham/B-8249-2008	Mustafa, Hossam/0000-0003-2015-7497; Kendall, Graham/0000-0003-2006-5103	FRGS of Ministry of Higher Education, Malaysia [FRGS/1/2018/ICT02/UKM/01/1]; Universiti Kebangsaan Malaysia grant Dana Impak Perdana [DIP-2014-039]	FRGS of Ministry of Higher Education, Malaysia; Universiti Kebangsaan Malaysia grant Dana Impak Perdana	This work was supported by the FRGS of Ministry of Higher Education, Malaysia. Ref. No: FRGS/1/2018/ICT02/UKM/01/1. Additionally, this work was supported by Universiti Kebangsaan Malaysia grant Dana Impak Perdana [DIP-2014-039].	Abbasi AA, 2007, COMPUT COMMUN, V30, P2826, DOI 10.1016/j.comcom.2007.05.024; Abdeyazdan M, 2014, J SUPERCOMPUT, V68, P574, DOI 10.1007/s11227-013-1053-1; Abualigah LM, 2017, APPL SOFT COMPUT, V60, P423, DOI 10.1016/j.asoc.2017.06.059; Ali MZ, 2017, IEEE T CYBERNETICS, V47, P2768, DOI 10.1109/TCYB.2016.2617301; Arivudainambi D, 2014, IEEE INT C NETW SENS, P261, DOI 10.1109/ICNSC.2014.6819636; Bouyer A, 2018, APPL SOFT COMPUT, V67, P172, DOI 10.1016/j.asoc.2018.03.011; Chandrasekar P, 2014, 2014 INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING APPLICATIONS (ICICA 2014), P138, DOI 10.1109/ICICA.2014.38; Das S, 2008, IEEE T SYST MAN CY A, V38, P218, DOI 10.1109/TSMCA.2007.909595; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng J, 2016, INT J PROD RES, V54, P3561, DOI 10.1080/00207543.2015.1084063; Esfandiari N, 2014, EXPERT SYST APPL, V41, P4434, DOI 10.1016/j.eswa.2014.01.011; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Fan QQ, 2015, EXPERT SYST APPL, V42, P1551, DOI 10.1016/j.eswa.2014.09.046; Gong A., 2016, INT J CONTROL AUTOM, V9, P107, DOI [10.14257/ijca.2016.9.4.11, DOI 10.14257/IJCA.2016.9.4.11]; Gu XP, 2015, INT J ELEC POWER, V64, P664, DOI 10.1016/j.ijepes.2014.07.070; Gupta T., 2014, INT J ADV RES COMPUT, V4, P491; Han XH, 2017, ENG APPL ARTIF INTEL, V61, P1, DOI 10.1016/j.engappai.2016.11.003; Han Y, 2017, ENERGIES, V10, DOI 10.3390/en10010136; Hatamlou A, 2013, INFORM SCIENCES, V222, P175, DOI 10.1016/j.ins.2012.08.023; Hatamlou A, 2011, LECT NOTES ARTIF INT, V6954, P337, DOI 10.1007/978-3-642-24425-4_44; Holland J. H., 1992, ADAPTATION NATURAL A; Jaddi NS, 2013, 2013 INTERNATIONAL CONFERENCE ON INFORMATICS AND CREATIVE MULTIMEDIA (ICICM), P278, DOI 10.1109/ICICM.2013.54; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jamil NA, 2015, PROCEEDINGS 5TH IEEE INTERNATIONAL CONFERENCE ON CONTROL SYSTEM, COMPUTING AND ENGINEERING (ICCSCE 2015), P287, DOI 10.1109/ICCSCE.2015.7482199; Jaradat G, 2016, APPL SOFT COMPUT, V44, P45, DOI 10.1016/j.asoc.2016.01.002; Jiang B, 2013, COMMUN NONLINEAR SCI, V18, P3134, DOI 10.1016/j.cnsns.2013.03.011; Kheng CW, 2012, INT J SYST SCI, V43, P1193, DOI 10.1080/00207721.2011.617526; Khurana R, 2013, ADV E-BUS RES, P1, DOI 10.4018/978-1-4666-4209-6; Kumar Y, 2015, SOFT COMPUT, V19, P3621, DOI 10.1007/s00500-015-1719-0; Kushwaha N, 2018, PATTERN RECOGN LETT, V115, P59, DOI 10.1016/j.patrec.2017.10.031; Langdon W, 2002, FDN GENETIC PROGRAMM, DOI [10.1162/evco.1998.6.3.253, DOI 10.1162/EVCO.1998.6.3.253]; Li Y, 2018, ENERGY, V162, P237, DOI 10.1016/j.energy.2018.07.200; Li Y, 2018, ENERGY, V147, P286, DOI 10.1016/j.energy.2018.01.036; Li YY, 2014, NEUROCOMPUTING, V134, P132, DOI 10.1016/j.neucom.2012.12.068; Lin JB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203071; Miller B. L., 1995, Complex Systems, V9, P193; Muller H, 2014, FOOD QUAL PREFER, V34, P70, DOI 10.1016/j.foodqual.2013.12.004; Mustafa HMJ, 2019, J INF COMMUN TECHNOL, V18, P77; Mustafi D, 2017, ADV INTELL SYST, V509, P123, DOI 10.1007/978-981-10-2525-9_12; Neri F, 2012, STUD COMPUT INTELL, V379, P3; Nikbakht H, 2015, IRAN CONF ELECTR ENG, P662, DOI 10.1109/IranianCEE.2015.7146297; Niu B, 2017, NAT COMPUT, V16, P45, DOI 10.1007/s11047-016-9542-9; Pandey AC, 2017, 2016 9 INT C CONT  C; Piotrowski AP, 2013, INFORM SCIENCES, V241, P164, DOI 10.1016/j.ins.2013.03.060; Popoola E., 2017, INT J NETW SECUR, V19, P660; Ramadan RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193142; Renders J. M., 1994, P 1 IEEE C EV COMP, P312, DOI DOI 10.1109/ICEC.1994.349948; Rodriguez-Lopez M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178528; Sabar NR, 2017, IEEE T EVOLUT COMPUT, V21, P315, DOI 10.1109/TEVC.2016.2602860; Sabar NR, 2013, P 6 MULTIDISCIPLINAR, P549; Sheng WG, 2014, IEEE T EVOLUT COMPUT, V18, P721, DOI 10.1109/TEVC.2013.2283513; Shi H, 2013, PROCEEDINGS OF THE 9TH INTERNATIONAL PIPELINE CONFERENCE - 2012, VOL 1, P139; Sivanandam S., 2008, INTRO GENETIC ALGORI, DOI DOI 10.1007/978-3-540-73190-0; Smith MR, 2014, MACH LEARN, V95, P225, DOI 10.1007/s10994-013-5422-z; Sorensen K, 2006, COMPUT OPER RES, V33, P1214, DOI 10.1016/j.cor.2004.09.011; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Taguchi G., 1987, SYSTEM EXPT DESIGN E; Talbi E., 2013, HYBRID METAHEURISTIC, DOI [10.1007/978-3-642-30671-6, DOI 10.1007/978-3-642-30671-6]; Tanabe R, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P71; Venkatakrishnan GR, 2018, LECT NOTES ELECTR EN, V446, P153, DOI 10.1007/978-981-10-4852-4_14; Wang C, 2018, SOFT COMPUT, V22, P1263, DOI 10.1007/s00500-016-2413-6; Wang HB, 2018, SOFT COMPUT, V22, P1313, DOI 10.1007/s00500-016-2418-1; Wang ZR, 2015, APPL SOFT COMPUT, V37, P572, DOI 10.1016/j.asoc.2015.08.003; Wangchamhan T, 2017, EXPERT SYST APPL, V90, P146, DOI 10.1016/j.eswa.2017.08.004; Wu M., 2012, INT J INNOV MANAG IN, V3, P99; Xiang WL, 2015, NEUROCOMPUTING, V158, P144, DOI 10.1016/j.neucom.2015.01.058; Yassen Esam Taha, 2015, Journal of Theoretical and Applied Information Technology, V73, P43; Yassen ET, 2017, COMPUT IND ENG, V113, P382, DOI 10.1016/j.cie.2017.09.034; Zhang CP, 2017, IOP C SER EARTH ENV, V63, DOI 10.1088/1755-1315/63/1/012020; Zhang CM, 2013, APPL SOFT COMPUT, V13, P2947, DOI 10.1016/j.asoc.2012.02.028; Zhang YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206832; Zhu ZX, 2011, IEEE T EVOLUT COMPUT, V15, P643, DOI 10.1109/TEVC.2011.2160399	72	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216906	10.1371/journal.pone.0216906	http://dx.doi.org/10.1371/journal.pone.0216906			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31137034	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300011
J	Nakakura, S; Nagata, Y; Shimizu, Y; Kawai, A; Tabuchi, H; Kiuchi, Y				Nakakura, Shunsuke; Nagata, Yuki; Shimizu, Yukiko; Kawai, Akiko; Tabuchi, Hitoshi; Kiuchi, Yoshiaki			Determination of iris thickness development in children using swept-source anterior-segment optical coherence tomography	PLOS ONE			English	Article							CHOROIDAL THICKNESS; OCULAR COMPONENTS; REFRACTIVE ERROR; ANGLE	Purpose The uvea comprises the iris, ciliary body, and choroid. However, the development of the anterior part (iris and ciliary body) in children is not yet fully elucidated. We investigated the iris thickness (IT) in children using swept-source anterior-segment optical coherence tomography (ASOCT). Methods In this retrospective, clinic-based study, we enrolled 41 children (mean +/- standard deviation: 6.8 +/- 3.3 years; range: 3-16; 17 males) with normal or mild refractive error. Horizontal scanning images of swept-source ASOCT were analyzed in temporal and nasal angle areas. The ITs at 1 and 2 mm from the pupil edge were measured using swept-source ASOCT. The association between IT and age, sex, and ocular morphological parameters (i.e., axial length, average corneal curvature, central corneal thickness, inter-scleral spur distance, and anterior chamber depth) was assessed using Pearson's correlation coefficient (r) and linear regression analysis. Results The average IT (temporal and nasal) at 1 and 2 mm were 0.432 +/- 0.060 (0.302-0.569 mm) and 0.337 +/- 0.045 (0.229-0.414 mm), respectively. There was a significant correlation between age and average IT (r = 0.45, P = 0.002 at 1 mm and r = 0.31, P = 0.042 at 2 mm). Multiple linear regression analysis revealed that age (coefficient: 0.01), axial length (-0.02), average corneal curvature (0.01), and anterior chamber depth (0.01) at 1 mm as well as age (0.00), average corneal curvature (0.09), anterior chamber depth (0.06), and male (-0.02) at 2 mm were identified as predictors of IT. Conclusions IT in children increases with age. Additionally, IT was thinner with longer axial length and in males, thicker in eyes with deeper anterior chamber and flatter corneal curvature. Our study may partly explain the development of eyeball structures in children.	[Nakakura, Shunsuke; Nagata, Yuki; Shimizu, Yukiko; Kawai, Akiko; Tabuchi, Hitoshi] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Tabuchi, Hitoshi; Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	Hiroshima University	Nakakura, S (corresponding author), Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	shunsukenakakura@yahoo.co.jp		Nakakura, Shunsuke/0000-0002-1094-1862				Akkaya S, 2018, INT OPHTHALMOL, V38, P2239, DOI 10.1007/s10792-017-0666-4; Bailey MD, 2008, INVEST OPHTH VIS SCI, V49, P4353, DOI 10.1167/iovs.08-2008; Batur M, 2017, CURR EYE RES, V42, P1445, DOI 10.1080/02713683.2017.1338349; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cheung CMG, 2019, EYE, V33, P14, DOI 10.1038/s41433-018-0158-4; GOTO H, 1990, INT OPHTHALMOL CLIN, V30, P279, DOI 10.1097/00004397-199030040-00014; Gupta V, 2007, J AAPOS, V11, P546, DOI 10.1016/j.jaapos.2007.06.014; Hashemi H, 2015, ACTA OPHTHALMOL, V93, pE74, DOI 10.1111/aos.12498; Invernizzi A, 2015, INVEST OPHTH VIS SCI, V56, P4796, DOI 10.1167/iovs.15-16483; Invernizzi A, 2014, BRIT J OPHTHALMOL, V98, P1245, DOI 10.1136/bjophthalmol-2013-304481; Jin PY, 2016, J GLAUCOMA, V25, P692, DOI 10.1097/IJG.0000000000000404; Jin PY, 2016, AM J OPHTHALMOL, V168, P164, DOI 10.1016/j.ajo.2016.05.008; Kobayashi Y, 2018, CASE REP OPHTHALM, V9, P449, DOI 10.1159/000493418; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Nakakura S, 2018, J GLAUCOMA, V27, P415, DOI 10.1097/IJG.0000000000000921; Phasukkijwatana N, 2018, RETINA-J RET VIT DIS, V38, P1652, DOI 10.1097/IAE.0000000000001907; Pucker AD, 2013, INVEST OPHTH VIS SCI, V54, P4710, DOI 10.1167/iovs.13-11658; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P7578, DOI 10.1167/iovs.13-12772; Shimizu Y, 2016, J AAPOS, V21, P57, DOI 10.1016/j.jaapos.2016.10.005; Sng CC, 2013, INVEST OPHTH VIS SCI, V54, P2829, DOI 10.1167/iovs.12-11250; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Twelker JD, 2009, OPTOMETRY VISION SCI, V86, P918, DOI 10.1097/OPX.0b013e3181b2f903; Xiong SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45059	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217656	10.1371/journal.pone.0217656	http://dx.doi.org/10.1371/journal.pone.0217656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136628	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300054
J	Liu, H; Zhao, YL; Zou, YC; Huang, WT; Zhu, LY; Liu, F; Wang, DX; Guo, KM; Hu, J; Chen, J; Ye, LX; Li, XK; Lin, L				Liu, Huan; Zhao, Yeli; Zou, Yuchi; Huang, Wenting; Zhu, Liyun; Liu, Fei; Wang, Dongxue; Guo, Kaiming; Hu, Jian; Chen, Jun; Ye, Lixia; Li, Xiaokun; Lin, Li			Heparin-poloxamer hydrogel-encapsulated rhFGF21 enhances wound healing in diabetic mice	FASEB JOURNAL			English	Article						biomaterial; skin wound; T2DM; sustained release	FACTOR 21 PROTECTS; CHITOSAN SCAFFOLD; MOUSE MODEL; STEM-CELLS; FIBROBLAST; PROLIFERATION; REGENERATION; COLLAGEN; NANOPARTICLES; INFLAMMATION	Wound healing, especially for diabetic wounds, is a lengthy and complicated process involving interactions and responses at the protein, cell, and tissue levels. Loading of growth factors into a hydrogel to construct a sustained-release system is considered a promising approach to improve wound healing. The present study investigates the effect of thermosensitive heparin-poloxamer (HP) hydrogel-encapsulated recombinant human fibroblast growth factor 21 (rhFGF21) on wound healing in mice with streptozotocin-induced diabetes mellitus. First, we studied the in vitro release of rhFGF21 from the rhFGF21-HP coacervate. The results showed that HP might control the release of rhFGF21. Next, we examined the effect of rhFGF21-HP on skin wound healing in diabetic mice. Our data showed that rhFGF21-HP significantly improved wound closure; promoted granulation, collagen deposition, and re-epithelialization; and enhanced the expression of CD31. Moreover, rhFGF21-HP had obvious advantages in diabetic wound healing. Therefore, the results suggest that the rhFGF21-HP hydrogel polymer plays an important role in skin wound healing. This work provides a suitable sustained-release delivery system that can continuously release rhFGF21 and presents a promising therapeutic strategy for wound healing in patients with diabetes.-Liu, H., Zhao, Y., Zou, Y., Huang, W., Zhu, L., Liu, F., Wang, D., Guo, K., Hu, J., Chen, J., Ye, L., Li, X., Lin, L. Heparin-poloxamer hydrogel-encapsulated rhFGF21 enhances wound healing in diabetic mice.	[Liu, Huan; Zhao, Yeli; Zhu, Liyun; Liu, Fei; Wang, Dongxue; Guo, Kaiming; Hu, Jian; Chen, Jun; Li, Xiaokun; Lin, Li] Wenzhou Med Univ, Affiliated Hosp 2, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China; [Huang, Wenting] Wenzhou Med Univ, Affiliated Hosp 2, Sch Clin Med Sci 1, Wenzhou, Zhejiang, Peoples R China; [Ye, Lixia] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neonatol, Wenzhou, Zhejiang, Peoples R China; [Ye, Lixia] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Zou, Yuchi] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Li, XK; Lin, L (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Chashan High Educ Pk Ctr North Rd, Wenzhou 325035, Zhejiang, Peoples R China.	profxiaokunli@163.com; linliwz@163.com	Guo, Kaiming/AAI-3702-2020		National Key R&D Program of China [2017YFA0506000]; National Natural Science Foundation of China [81771284]; Public Welfare Technology Application Research Foundation of Zhejiang Province [2017C33080]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Technology Application Research Foundation of Zhejiang Province	This study was supported by research grants from the National Key R&D Program of China (Grant 2017YFA0506000), the National Natural Science Foundation of China (Grant 81771284), and the Public Welfare Technology Application Research Foundation of Zhejiang Province (Grant 2017C33080). The authors declare no conflicts of interest.	Amini A, 2018, J PHOTOCH PHOTOBIO B, V182, P42, DOI 10.1016/j.jphotobiol.2018.03.010; Attia ABE, 2011, CURR OPIN COLLOID IN, V16, P182, DOI 10.1016/j.cocis.2010.10.003; Benomar Y, 2016, DIABETES, V65, P913, DOI 10.2337/db15-1029; Cerqueira MT, 2016, ADV WOUND CARE, V5, P164, DOI 10.1089/wound.2014.0607; Chang EI, 2011, NAT MED, V17, P1147, DOI 10.1038/nm.2424; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4; CLARK RAF, 1993, J DERMATOL SURG ONC, V19, P693, DOI 10.1111/j.1524-4725.1993.tb00413.x; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dong YX, 2014, ACTA BIOMATER, V10, P2076, DOI 10.1016/j.actbio.2013.12.045; Edwards N, 2018, J BIOMATER APPL, V33, P553, DOI 10.1177/0885328218803754; El Masry MS, 2019, FASEB J, V33, P2144, DOI 10.1096/fj.201800352R; Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Fu ZJ, 2018, DIABETES, V67, P974, DOI 10.2337/db17-0830; Gao SQ, 2018, DRUG DELIV, V25, P1779, DOI 10.1080/10717544.2018.1513608; [龚琦 Gong Qi], 2015, [中国细胞生物学学报, Chinese Journal of Cell Biology], V37, P460; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Houreld NN, 2014, SCI WORLD J, DOI 10.1155/2014/398412; Huang YW, 2019, FASEB J, V33, P953, DOI 10.1096/fj.201800337R; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jin LG, 2016, DIABETES METAB J, V40, P22, DOI 10.4093/dmj.2016.40.1.22; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Li R, 2018, BIOMATERIALS, V168, P24, DOI 10.1016/j.biomaterials.2018.03.044; Li SB, 2018, DIABETES RES CLIN PR, V143, P215, DOI 10.1016/j.diabres.2018.07.014; Liang YK, 2014, ACTA BIOMATER, V10, P1588, DOI 10.1016/j.actbio.2013.07.031; Lorz LR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051043; Lu YF, 2019, J CELL MOL MED, V23, P497, DOI 10.1111/jcmm.13952; Nath S, 2017, J PHARMACOL TOX MET, V84, P20, DOI 10.1016/j.vascn.2016.10.007; Razdan N, 2018, AGING CELL, V17, DOI 10.1111/acel.12838; Rezaii M, 2019, MAT SCI ENG C-MATER, V98, P347, DOI 10.1016/j.msec.2018.12.143; Schmidt A, 2019, THERANOSTICS, V9, P1066, DOI 10.7150/thno.29754; Shi Q, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00904; Shi YC, 2019, INT J BIOL SCI, V15, P138, DOI 10.7150/ijbs.28873; Shibata S, 2012, J IMMUNOL, V189, P3231, DOI 10.4049/jimmunol.1101739; Torres P, 2017, FASEB J, V31, P4946, DOI 10.1096/fj.201700085R; Wu HJ, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020501; Wu J, 2016, ACS APPL MATER INTER, V8, P18710, DOI 10.1021/acsami.6b06047; Wu J, 2016, BIOMACROMOLECULES, V17, P2168, DOI 10.1021/acs.biomac.6b00398; Wu XJ, 2015, WOUND REPAIR REGEN, V23, P104, DOI 10.1111/wrr.12258; Xu HL, 2018, INT J NANOMED, V13, P681, DOI 10.2147/IJN.S152246; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yang CT, 2019, MOL CELL ENDOCRINOL, V480, P74, DOI 10.1016/j.mce.2018.10.013; Yang H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0307-5; Yong CS, 2001, INT J PHARM, V226, P195, DOI 10.1016/S0378-5173(01)00809-2; Yu ZY, 2019, MOL NEUROBIOL, V56, P2314, DOI 10.1007/s12035-018-1234-2; Zhang C, 2018, BRIT J PHARMACOL, V175, P4218, DOI 10.1111/bph.14482; Zhang C, 2015, DIABETOLOGIA, V58, P1937, DOI 10.1007/s00125-015-3630-8; Zhang SS, 2017, INT J NANOMED, V12, P5643, DOI 10.2147/IJN.S137237; Zhang X, 2019, J DIABETES, V11, P418, DOI 10.1111/1753-0407.12871; Zhao YZ, 2016, ACTA BIOMATER, V29, P71, DOI 10.1016/j.actbio.2015.10.014	52	15	17	3	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9858	9870		10.1096/fj.201802600RR	http://dx.doi.org/10.1096/fj.201802600RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31166803				2022-12-26	WOS:000482214200014
J	Delfarah, A; Parrish, S; Junge, JA; Yang, J; Seo, F; Li, S; Mac, J; Wang, P; Fraser, SE; Graham, NA				Delfarah, Alireza; Parrish, Sydney; Junge, Jason A.; Yang, Jesse; Seo, Frances; Li, Si; Mac, John; Wang, Pin; Fraser, Scott E.; Graham, Nicholas A.			Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						systems biology; metabolomics; nucleoside; nucleotide biosynthesis; epithelial cell; cellular senescence; aging; cell stress; growth arrest; ribonucleotide reductase regulatory subunit M2 (RRM2)	PLASMINOGEN-ACTIVATOR INHIBITOR-1; CELLULAR SENESCENCE; INCREASED GLYCOLYSIS; DNA-DAMAGE; METABOLISM; P53; STRESS; METABOLOMICS; HOMEOSTASIS; EXPRESSION	Cellular senescence is a mechanism by which cells permanently withdraw from the cell cycle in response to stresses including telomere shortening, DNA damage, or oncogenic signaling. Senescent cells contribute to both age-related degeneration and hyperplastic pathologies, including cancer. In culture, normal human epithelial cells enter senescence after a limited number of cell divisions, known as replicative senescence. Here, to investigate how metabolic pathways regulate replicative senescence, we used LC-MS-based metabolomics to analyze senescent primary human mammary epithelial cells (HMECs). We did not observe significant changes in glucose uptake or lactate secretion in senescent HMECs. However, analysis of intracellular metabolite pool sizes indicated that senescent cells exhibit depletion of metabolites from nucleotide synthesis pathways. Furthermore, stable isotope tracing with C-13-labeled glucose or glutamine revealed a dramatic blockage of flux of these two metabolites into nucleotide synthesis pathways in senescent HMECs. To test whether cellular immortalization would reverse these observations, we expressed telomerase in HMECs. In addition to preventing senescence, telomerase expression maintained metabolic flux from glucose into nucleotide synthesis pathways. Finally, we investigated whether inhibition of nucleotide synthesis in proliferating HMECs is sufficient to induce senescence. In proliferating HMECs, both pharmacological and genetic inhibition of ribonucleotide reductase regulatory subunit M2 (RRM2), a rate-limiting enzyme in dNTP synthesis, induced premature senescence with concomitantly decreased metabolic flux from glucose into nucleotide synthesis. Taken together, our results suggest that nucleotide synthesis inhibition plays a causative role in the establishment of replicative senescence in HMECs.	[Delfarah, Alireza; Parrish, Sydney; Yang, Jesse; Seo, Frances; Li, Si; Mac, John; Wang, Pin; Graham, Nicholas A.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Junge, Jason A.; Fraser, Scott E.] Univ Southern Calif, Translat Imaging Ctr, Mol & Computat Biol, Los Angeles, CA 90089 USA; [Graham, Nicholas A.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Graham, NA (corresponding author), Univ Southern Calif, 3710 McClintock Ave,RTH 509, Los Angeles, CA 90089 USA.	nagraham@usc.edu	Graham, Nicholas/GYD-5066-2022; Delfarah, Alireza/AAN-2110-2020; Graham, Nicholas A./X-2738-2019	Graham, Nicholas/0000-0002-6811-1941; Graham, Nicholas A./0000-0002-6811-1941; Fraser, Scott/0000-0002-5377-0223; Delfarah, Alireza/0000-0002-3192-5941; Yang, Jesse/0000-0002-6487-1652; Junge, Jason/0000-0002-9886-1751	Rose Hills Foundation; University of Southern California (USC) Provost's Office; USC Translational Imaging Center; Viterbi School of Engineering	Rose Hills Foundation; University of Southern California (USC) Provost's Office; USC Translational Imaging Center; Viterbi School of Engineering	This work was supported by the Rose Hills Foundation, the University of Southern California (USC) Provost's Office, the USC Translational Imaging Center, and the Viterbi School of Engineering. The authors declare that they have no conflicts of interest with the contents of this article.	Aird KM, 2015, CELL REP, V11, P893, DOI 10.1016/j.celrep.2015.04.014; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; BITTLES AH, 1984, BIOSCIENCE REP, V4, P751, DOI 10.1007/BF01128816; Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen QM, 2000, J CELL SCI, V113, P4087; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cordes T, 2016, CURR OPIN CHEM ENG, V14, P72, DOI 10.1016/j.coche.2016.08.019; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dikovskaya D, 2015, CELL REP, V12, P1483, DOI 10.1016/j.celrep.2015.07.055; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Eren M, 2014, SEMIN THROMB HEMOST, V40, P645, DOI 10.1055/s-0034-1387883; Foskolou IP, 2017, MOL CELL, V66, P206, DOI 10.1016/j.molcel.2017.03.005; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Graham NA, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167159; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hsu CW, 2017, J CANCER, V8, P1378, DOI 10.7150/jca.17478; James EL, 2015, J PROTEOME RES, V14, P1854, DOI 10.1021/pr501221g; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kim J, 2017, NATURE, V546, P168, DOI 10.1038/nature22359; Knecht H, 2009, LEUKEMIA, V23, P565, DOI 10.1038/leu.2008.314; Kondoh H, 2005, CANCER RES, V65, P177; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kuo ML, 2012, SCI REP-UK, V2, DOI 10.1038/srep00822; Lamm N, 2015, EMBO MOL MED, V7, P1138, DOI 10.15252/emmm.201404824; Leikam C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.71; Li MX, 2013, PROTEOMICS, V13, P2585, DOI 10.1002/pmic.201200298; Mannava S, 2013, AM J PATHOL, V182, P142, DOI 10.1016/j.ajpath.2012.09.011; Mazurek S, 2001, ONCOGENE, V20, P6891, DOI 10.1038/sj.onc.1204792; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mirzayans R, 2018, CANCERS, V10, DOI 10.3390/cancers10040118; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Moseley HNB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-139; Pai CC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020057; Popovic-Bijelic A, 2011, J INORG BIOCHEM, V105, P1422, DOI 10.1016/j.jinorgbio.2011.07.003; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stampfer MR, 2013, CELL MOL BIOL BREAST, P323, DOI [10.1007/978-1-62703-634-4_15, DOI 10.1007/978-1-62703-634-4_15]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Vaughan DE, 2017, ARTERIOSCL THROM VAS, V37, P1446, DOI 10.1161/ATVBAHA.117.309451; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816	61	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10564	10578		10.1074/jbc.RA118.005806	http://dx.doi.org/10.1074/jbc.RA118.005806			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138644	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000478717100016
J	Demitto, FO; Schmaltz, CAS; Sant'Anna, FM; Arriaga, MB; Andrade, BB; Rolla, VC				Demitto, Fernanda O.; Schmaltz, Carolina A. S.; Sant'Anna, Flavia M.; Arriaga, Maria B.; Andrade, Bruno B.; Rolla, Valeria C.			Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; RIO-DE-JANEIRO; CASE DEFINITIONS; TUBERCULOSIS; RIFAMPICIN; ACCESS; HAART	Background The implementation of antiretroviral (ARV) therapy caused a significant decrease in HIV-associated mortality worldwide. Nevertheless, mortality is still high among people living with HIV/AIDS and tuberculosis (TB). ARV-naive HIV patients coinfected with tuberculosis (TB) have more options to treat both diseases concomitantly. Nevertheless, some TB-HIV patients undertaking ARVs (ARV-experienced) are already failing the first line efavirenz-based regimen and seem to display different response to second line ARV therapy and exhibit other predictors of mortality. Methods We performed a retrospective cohort study including 273 patients diagnosed with TB-HIV and treated at a referral center in Rio de Janeiro, Brazil, between 2008 and 2016. Multivariate analysis and Cox regression models were used to evaluate the effectiveness of ARV therapy regimens (viral load [VL] <80 copies from the 4th to 10th months after TB therapy introduction) and to identify predictors of early mortality (100 days after TB therapy initiation) considering ARV-naive and ARV-experienced patients adjusting for sociodemographic, clinical and therapeutic covariates. Findings Survival analysis included 273 patients, out of whom 154 (56.4%) were ARV-naive and 119 (43.6%) were ARV-experienced. Seven deaths occurred within 6 months of anti-TB treatment, 4 in ARV-naive and 3 in ARV-experienced patients. Multivariate analysis revealed that in ARV-naive patients, the chance of death was substantially higher in patients who developed immune reconstitution inflammatory syndrome during the study follow up (HR = 40.6, p<0.01). For ARV-experienced patients, similar analyses failed to identify factors significantly associated with mortality. Variables independently associated with treatment failure for the ARV-naive group were previous TB (adjusted OR [aOR] = 6.1 p = 0.03) and alcohol abuse (aOR = 3.7 p = 0.01). For ARV-experienced patients, a ritonavir boosted. Protease Inhibitor-based regimen resulted in a 2.6 times higher risk of treatment failure compared to the use of efavirenz based ARV regimens (p = 0.03) and High baseline HIV VL (p = 0.03) were predictors of treatment failure. Conclusions Risk factors for mortality and ARV failure were different for ARV-naive and ARV-experienced patients. The latter patient group should be targeted for trials with less toxic and rifampicin-compatible drugs to improve TB-HIV treatment outcomes and prevent death.	[Demitto, Fernanda O.; Rolla, Valeria C.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Programa Posgrad Pesquisa Clin Doencas Infecciosa, Rio De Janeiro, Brazil; [Schmaltz, Carolina A. S.; Sant'Anna, Flavia M.; Rolla, Valeria C.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Micobacterioses LAPCLIN TB, Rio De Janeiro, Brazil; [Arriaga, Maria B.; Andrade, Bruno B.] Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil; [Andrade, Bruno B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Andrade, Bruno B.] EBMSP, Salvador, BA, Brazil; [Andrade, Bruno B.] Laureate Univ, Univ Salvador UNIFACS, Salvador, BA, Brazil; [Andrade, Bruno B.] Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Andrade, Bruno B.] Vanderbilt Univ, Dept Med, Div Infect Dis, Sch Med, Nashville, TN 37232 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Salvador (UNIFACS); University of Cape Town; Vanderbilt University	Andrade, BB (corresponding author), Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Andrade, BB (corresponding author), EBMSP, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Laureate Univ, Univ Salvador UNIFACS, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa.; Andrade, BB (corresponding author), Vanderbilt Univ, Dept Med, Div Infect Dis, Sch Med, Nashville, TN 37232 USA.	bruno.andrade@bahia.fiocruz.br	Rolla, Valeria Cavalcanti/AAI-6078-2021; Andrade, Bruno/AAI-2248-2020	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; de Oliveira Demitto Tamogami, Fernanda/0000-0002-0939-9615; Andrade, Bruno/0000-0001-6833-3811; Arriaga Gutierrez, Maria Belen/0000-0001-6883-8422	Ministry of Heath UNODC (Escritorio das Nacoes Unidas sobre Drogas e Crime) [113/2013]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]; FIOCRUZ; National Institutes of Health [U01AI115940]; Fundacao de Amparo a Pesquisa da Bahia (FAPESB); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI115940] Funding Source: NIH RePORTER	Ministry of Heath UNODC (Escritorio das Nacoes Unidas sobre Drogas e Crime); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FIOCRUZ; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of V.C.R. was supported by the Ministry of Heath UNODC (Escritorio das Nacoes Unidas sobre Drogas e Crime; agreement 113/2013). Fernanda Demitto was also supported as a post graduate student by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (finance code: 001). The work from BBA was supported by intramural research program from FIOCRUZ and from the National Institutes of Health (U01AI115940). MBA received a fellowship from the Fundacao de Amparo a Pesquisa da Bahia (FAPESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud Michael, 2018, ADV TB CRYPTOCOCCAL; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulanger C, 2017, MED CORRECTOS DOSIS; Brasil. Ministerio da Saude, 2009, NOT TECN MUD TRAT TU; Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867; Campos DP, 2005, AIDS, V19, pS22, DOI 10.1097/01.aids.0000191486.92285.1c; da Silva TP, 2017, BMC INFECT DIS, P17, DOI [10.1186/s1287901727006, DOI 10.1186/S1287901727006]; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Greco DB, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000279705.24428.a3; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P459, DOI 10.1016/S1473-3099(14)70711-X; Haddow LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040623; Johnson LF, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002468; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Ministerio da saude, 2008, GUIA TRAT REC TER AN; Ministerio da Saude, 2012, 4212012CQVDDSTAIDSHV; Robertson J, 2006, CLIN INFECT DIS, V42, P1639, DOI 10.1086/503903; Rolla VC, 2006, CLIN DRUG INVEST, V26, P469, DOI 10.2165/00044011-200626080-00005; Sant'Anna FM, 2009, BRAZ J INFECT DIS, V13, P362, DOI 10.1590/S1413-86702009000500010; Schmaltz C. A. S., 2014, Journal of AIDS and Clinical Research, V5, P358; Serra FC, 2007, BRAZ J INFECT DIS, V11, P462, DOI 10.1590/S1413-86702007000500004; Schmaltz CAS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045704; Schmaltz CAS, 2009, JAIDS-J ACQ IMM DEF, V52, P623, DOI 10.1097/QAI.0b013e3181b31e56; Walker NF, 2015, HIV AIDS-RES PALLIAT, V7, P49, DOI 10.2147/HIV.S42328; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization,, 2008, NEW LAB DIAGN TOOLS	26	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217014	10.1371/journal.pone.0217014	http://dx.doi.org/10.1371/journal.pone.0217014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170171	gold, Green Published, Green Submitted			2022-12-26	WOS:000470263700014
J	Taniuchi, K; Furihata, M; Naganuma, S; Sakaguchi, M; Saibara, T				Taniuchi, Keisuke; Furihata, Mutsuo; Naganuma, Seiji; Sakaguchi, Masahiko; Saibara, Toshiji			Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; POOR-PROGNOSIS; OPEN-LABEL; PROMOTES; GEMCITABINE; INVASIVENESS; RESECTION; INVASION; MULTICENTER; FOLFIRINOX	We previously reported that overexpression of PODXL, BCL7B, and ARHGEF4 in pancreatic cancer tissue is correlated with pancreatic cancer-related survival. The aim of this study was to investigate the use of PODXL, BCL7B, ARHGEF4, and the integrin family member ITGB1 as useful markers for the prognosis of postoperative pancreatic cancer patients in comparison with tumor size and the tumor node metastasis (TNM) staging system. Immunohistochemistry was performed using an anti-ITGB1 antibody on 102 samples of pancreatic cancer tissue surgically resected at the University of Kochi Medical School Hospital and the Matsuyama Shimin Hospital. Univariate Cox proportional hazards regression analysis showed that TNM stage and overexpression of PODXL, BCL7B, and ITGB1 were correlated with postoperative survival. However, tumor size was not significantly associated with postoperative prognosis of pancreatic cancer compared to these features. Multivariate Cox proportional hazards regression analysis showed that the overexpression of both PODXL and ITGB1 and overexpression of both BCL7B and ITGB1 increased the hazard ratio (6.27, 95% confidence interval [CI] 2.58-15.21; and 3.93, 95% CI 1.74-8.91, respectively) compared to that of TNM stage (IIA and IIB vs. III and IV; 3.05, 95% CI 1.25-7.42). These results imply that the combination of PODXL with ITGB1 and the combination of BCL7B with ITGB1 accurately predicted the postoperative outcomes of pancreatic cancer patients, and they were superior compared to the TNM staging system. The combination of PODXL with ITGB1 would be particularly useful, as it was the most highly correlated with postoperative outcomes. Importantly, the present results are useful to determine which adjuvant therapy should be selected.	[Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan; [Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Nankoku, Kochi, Japan; [Furihata, Mutsuo; Naganuma, Seiji] Kochi Univ, Kochi Med Sch, Dept Pathol, Nankoku, Kochi, Japan; [Sakaguchi, Masahiko] Kochi Univ, Kochi Med Sch, Integrated Ctr Adv Med Technol, Nankoku, Kochi, Japan; [Sakaguchi, Masahiko] Kanagawa Canc Ctr Res Inst, Canc Prevent & Control Div, Yokohama, Kanagawa, Japan	Kochi University; Kochi University; Kochi University; Kochi University; Kanagawa Prefectural Cancer Center	Taniuchi, K (corresponding author), Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan.; Taniuchi, K (corresponding author), Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Nankoku, Kochi, Japan.	ktaniuchi@kochi-u.ac.jp			 [24591013];  [15K14396];  [17K09463]	; ; 	This research was supported by the Grants-in-Aid for Scientific Research (KAKENHI; 24591013, 15K14396, and 17K09463 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andea A, 2003, MODERN PATHOL, V16, P996, DOI 10.1097/01.MP.0000087422.24733.62; Arao S, 2000, PANCREAS, V20, P129, DOI 10.1097/00006676-200003000-00004; Callery MP, 2009, ANN SURG ONCOL, V16, P1727, DOI 10.1245/s10434-009-0408-6; Conroy T, 2018, NEW ENGL J MED, V379, P2395, DOI 10.1056/NEJMoa1809775; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Japan Pancreatic Society, 2003, CLASS PANCR CARC; Khushman M, 2015, PANCREATOLOGY, V15, P667, DOI 10.1016/j.pan.2015.08.010; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Marchegiani G, 2017, ANN SURG, V266, P142, DOI 10.1097/SLA.0000000000001837; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Morganti AG, 2014, INT J RADIAT ONCOL, V90, P911, DOI 10.1016/j.ijrobp.2014.07.024; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Philip Philip A, 2009, Gastrointest Cancer Res, V3, P37; Royall NA, 2015, TRANSL CANCER RES, V4, P641, DOI 10.3978/j.issn.2218-676X.2015.11.04; Shaul YD, 2016, NUCLEIC ACIDS RES, V44, pD560, DOI 10.1093/nar/gkv1337; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sinn M, 2017, J CLIN ONCOL, V35, P3330, DOI 10.1200/JCO.2017.72.6463; Sobin LH, 2009, TNM CLASSIFICATION M, P132; Taniuchi K, 2018, INT J ONCOL, V53, P2224, DOI 10.3892/ijo.2018.4549; Taniuchi K, 2018, AM J CANCER RES, V8, P387; Taniuchi K, 2016, CANCER SCI, V107, P1430, DOI 10.1111/cas.13018; Taniuchi K, 2014, NEOPLASIA, V16, P1082, DOI 10.1016/j.neo.2014.10.007; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Tsuboi M, 2016, PANCREATOLOGY, V16, P905, DOI 10.1016/j.pan.2016.07.002; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9; Van den Broeck A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-68; Xu JB, 2017, ONCOTARGET, V8, P81419, DOI 10.18632/oncotarget.19082	30	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217920	10.1371/journal.pone.0217920	http://dx.doi.org/10.1371/journal.pone.0217920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166991	gold, Green Published, Green Submitted			2022-12-26	WOS:000470087800052
J	Hawkes, VC; Gerwing, TG				Hawkes, Virgil C.; Gerwing, Travis G.			Wildlife usage indicates increased similarity between reclaimed upland habitat and mature boreal forest in the Athabasca Oil Sands Region of Alberta, Canada	PLOS ONE			English	Article							LANDSCAPES; FRAGMENTATION; BIOINDICATORS; RECLAMATION; SELECTION; SOILS; BATS	While there is no denying that oil sands development in the Athabasca Oil Sands Region (AOSR) has large impacts upon the habitat it disturbs, developers are legally required to return this land to "an equivalent land capability." While still early in the process of reclamation, land undergoing reclamation offers an opportunity to study factors influencing reclamation success, as well as how reclaimed ecosystems function. As such, an Early Successional Wildlife Dynamics (ESWD) program was created to study how wildlife return to and use reclaimed upland boreal habitat in the AOSR. Wildlife data comprising 182 taxa of mammals, birds, and amphibians, collected between 2011 and 2017 and from five oil sands leases, were compared from multiple habitat types (burned [BRN], cleared [CLR], compensation lakes [COMP], logged [LOG], mature forest [MF], and reclaimed sites [REC]). Overall, similarity of wildlife communities in REC and MF plots varied greatly, even at 33 years since reclamation (31-62% with an average of 52%). However, an average community similarity of 52% so early in the successional process suggests that current reclamation efforts are progressing towards increased similarity compared to mature forest plots. Conversely, our data suggest that REC plots are recovering differently than plots impacted by natural (BRN) or other anthropogenic disturbances (LOG), which is likely due to differences associated with soil reconstruction and development on reclaimed plots. Regardless of the developmental trajectory of reclaimed habitats, progression towards increased wildlife community similarity at REC and MF plots is apparent in our data. While there is no expectation that reclaimed upland habitats will resemble or function identically to naturally occurring boreal forest, the degree of similarity observed in our study suggests that comparable ecological functionality is possible, increasing the probability that oil sands operators will be able to fulfill their regulatory requirements and duty to reclaim regarding wildlife and wildlife habitat.	[Hawkes, Virgil C.; Gerwing, Travis G.] LGL Ltd Environm Res Associates, Sidney, BC, Canada; [Gerwing, Travis G.] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Gerwing, Travis G.] Univ British Columbia, Ecosyst Sci & Management Program, Prince George, BC, Canada	University of Victoria; University of British Columbia	Hawkes, VC (corresponding author), LGL Ltd Environm Res Associates, Sidney, BC, Canada.	vhawkes@lgl.com	Gerwing, Travis/AAU-6569-2020	Gerwing, Travis/0000-0002-4433-1843	Canadian Natural Resources Limited; Horizon Oil Sands [806448]; Shell Canada Energy [UA54615]; Suncor Energy Services Inc. [POs 4501376479, 4502047284, 45022884647]; Fort Hills Energy [PO 4502244761]	Canadian Natural Resources Limited; Horizon Oil Sands; Shell Canada Energy; Suncor Energy Services Inc.; Fort Hills Energy	This project was completed under contract to Canadian Natural Resources Limited, Horizon Oil Sands (Contract #806448); Shell Canada Energy (Agreement Number UA54615), Suncor Energy Services Inc. (POs 4501376479, 4502047284, and 45022884647) and Fort Hills Energy (PO 4502244761) to LGL Limited environmental research associates. Some data (i.e., those collected on Syncrude's Mildred Lake Lease) used in this report were obtained under contract to the Cumulative Environmental Management Association (CEMA) in 2010, 2011, and 2012. These data used with permission. LGL provided support in the form of salaries for authors [VCH, and TGG] and field technicians, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AE. Alberta Energy, 2018, OIL SANDS; Alberta Environment, 2010, GUID RECL FOR VEG AT, V2nd ed.; Allen EW, 2008, J ENVIRON ENG SCI, V7, P123, DOI 10.1139/S07-038; Andersen AN, 1999, J INSECT CONSERV, V3, P61; Anderson M.J., 2008, PERMANOVA PRIMER GUI; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Asif N, 2018, POLLUTION, V4, P111, DOI 10.22059/poll.2017.237440.296; Audet P, 2015, CAN J FOREST RES, V45, P364, DOI 10.1139/cjfr-2014-0330; Beckingham JD, 1996, FIELD GUIDE ECOSITES, V5; BERGERON Y, 1989, VEGETATIO, V79, P51, DOI 10.1007/BF00044848; Burger Joanna, 2006, Environmental Bioindicators, V1, P136, DOI 10.1080/15555270600701540; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Charchuk C, 2018, FOREST ECOL MANAG, V407, P9, DOI 10.1016/j.foreco.2017.10.033; Chase Mary K., 2005, U S Forest Service General Technical Report PSW, V191, P130; Chen HYH, 2018, J APPL ECOL, V55, P926, DOI 10.1111/1365-2664.13018; Choi YD, 2008, ECOSCIENCE, V15, P53, DOI 10.2980/1195-6860(2008)15[53:ERFFSI]2.0.CO;2; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; COGBILL CV, 1985, CAN J FOREST RES, V15, P252, DOI 10.1139/x85-043; Cristescu B, 2016, ENVIRON CONSERV, V43, P327, DOI 10.1017/S0376892916000217; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feinsinger P., 2001, DESIGNING FIELD STUD; Foster KR, 2017, RESTOR ECOL, V25, P532, DOI 10.1111/rec.12478; Giesy JP, 2010, P NATL ACAD SCI USA, V107, P951, DOI 10.1073/pnas.0912880107; Gosselin P., 2010, ENV HLTH IMPACTS CAN; Hammond JHE, 2018, J INSECT CONSERV, P1; Hawkes VC, 2013, EA3248 LGL CEMA RWG; Hawkes VC, 2012, MINE CLOSURE 2012, P717; Hawkes VC, 2014, YEAR 2 2013 2014 ANN; Hawkes VC, 2018, REGIONAL EARLY UNPUB; Johnson EA, 2008, ANN NY ACAD SCI, V1134, P120, DOI 10.1196/annals.1439.007; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Keim JL, 2019, J ANIMAL ECOLOGY; Litvak M, 2003, J GEOPHYS RES-ATMOS, V108, P1; Martiniakova M, 2012, J ENVIRON SCI HEAL A, V47, P1202, DOI 10.1080/10934529.2012.672062; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Moreno Claudia E., 2007, International Journal of Environment and Health, V1, P71, DOI 10.1504/IJENVH.2007.012225; Padoa-Schioppa E, 2006, ECOL INDIC, V6, P83, DOI 10.1016/j.ecolind.2005.08.006; Patriquin KJ, 2003, J APPL ECOL, V40, P646, DOI 10.1046/j.1365-2664.2003.00831.x; Pezya J-P, 2018, ECOLOGICAL INDICATOR, V91, P2320; Pickard D, 2013, LONG TERM PLOT NETWO; Pinno BD, 2015, FORESTS, V6, P2109, DOI 10.3390/f6062109; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Ralph C. J, 1995, PSWGTR149 USDA FOR S, V187, P149; Robataille R, 2010, EARLY SUCCESSI UNPUB; Rogers VV, 2002, TOXICOL SCI, V66, P347, DOI 10.1093/toxsci/66.2.347; Rooney RC, 2012, P NATL ACAD SCI USA, V109, P4933, DOI 10.1073/pnas.1117693108; Rowland SM, 2009, J ENVIRON QUAL, V38, P1580, DOI 10.2134/jeq2008.0317; Salafsky N., 2001, ADAPTIVE MANAGEMENT; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Scopel LC, 2017, CANADIAN J FISHERIES, P1; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Stefani F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20783-6; Sullivan RM, 1997, J MAMMAL, V78, P798, DOI 10.2307/1382937; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, J EXPT MARINE BIOL E, V250, P97; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	63	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217556	10.1371/journal.pone.0217556	http://dx.doi.org/10.1371/journal.pone.0217556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163043	gold, Green Published, Green Submitted			2022-12-26	WOS:000470086200017
J	Wojcik, E; Szostek, M				Wojcik, Ewa; Szostek, Malgorzata			Assessment of genome stability in various breeds of cattle	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGE; COMMON FRAGILE SITE; CHROMOSOME FRAGILITY; MOLECULAR-MECHANISMS; INSTABILITY; LOCALIZATION; SCE; COWS; SEX; IDENTIFICATION	Chromosomal instability is a type of genome instability involving changes in genetic information at the chromosomal level. The basic tests used to identify this form of instability are sister chromatid exchange (SCE) tests and identification of fragile sites (FS). SCE is the process by which sister chromatids become fragmented as a result of DNA strand breakage and reassembly, followed by exchange of these fragments. FS can be observed in the form of breaks, gaps or constrictions on chromosomes, which often result from multiple nucleotide repeats in DNA that are difficult to replicate. The research material was the peripheral blood of ten breeds of cattle raised in Poland, including four native breeds covered by a genetic resources conservation programme, i.e. Polish Red, Polish Red-and-White, White-Backed, and Polish Black-and-White, as well as Polish Holstein-Friesian, Simmental, Montbeliarde, Jersey, Limousine and Danish Red. Two tests were performed on chromosomes obtained from in vitro cultures: SCE and FS. The average frequency of SCE was 5.08 +/- 1.31, while the incidence of FS was 3.45 +/- 0.94. Differences in the incidence of SCE and FS were observed between breeds. The least damage was observed in the Polish Red and White-Backed breeds, and the most in Polish Holstein-Friesians. The most damage was observed in the interstitial part of the chromosomes. Age was shown to significantly affect the incidence of SCE and FS. Younger cows showed less damage than older ones (SCE: 4.84 +/- 1.25; 5.34 +/- 1.24; FS: 3.10 +/- 0.88, 3.80 +/- 0.92).	[Wojcik, Ewa; Szostek, Malgorzata] Siedlce Univ Nat Sci & Humanities, Inst Bioengn & Anim Breeding, Siedlce, Poland		Wojcik, E (corresponding author), Siedlce Univ Nat Sci & Humanities, Inst Bioengn & Anim Breeding, Siedlce, Poland.	ewa.wojcik@uph.edu.pl		Wojcik, Ewa/0000-0002-9446-7132				Albarella S, 2009, MUTAGENESIS, V24, P471, DOI 10.1093/mutage/gep030; Ali A, 2008, J GENET, V87, P219, DOI 10.1007/s12041-008-0035-1; Ansari HA, 1999, CYTOGENET CELL GENET, V87, P134, DOI 10.1159/000015380; Arias E, 2000, HEREDITAS, V133, P263, DOI 10.1111/j.1601-5223.2000.00263.x; Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Band MR, 2000, GENOME RES, V10, P1359, DOI 10.1101/gr.145900; Blagoev KB, 2010, AGING-US, V2, P727, DOI 10.18632/aging.100206; CATALAN J, 1995, MUTAT RES-FUND MOL M, V331, P205, DOI 10.1016/0027-5107(95)00077-V; Ciotola F, 2005, VET RES COMMUN, V29, P359, DOI 10.1007/s11259-005-0081-6; Conrad S, 2011, CELL CYCLE, V10, P222, DOI 10.4161/cc.10.2.14639; Danielak-Czech B, 2004, J ANIM FEED SCI, V13, P257, DOI 10.22358/jafs/67410/2004; Danielak-Czech B., 2012, Annales Universitatis Mariae Curie-Sklodowska. Sectio EE Zootechnica, V30, P18; Danielak-Czech B., 2011, Annales Universitatis Mariae Curie-Sklodowska. Sectio EE Zootechnica, V29, P28, DOI 10.2478/v10083-011-0015-4; Dezfouli SMA, 2012, IRAN J VET RES, V13, P161; Di Berardino D, 2001, CYTOGENET CELL GENET, V92, P284; Di Meo GP, 2008, CYTOGENET GENOME RES, V120, P127, DOI 10.1159/000118751; Di Meo GP, 2011, MUTAGENESIS, V26, P269, DOI 10.1093/mutage/geq082; DIBERARDINO D, 1983, CARYOLOGIA, V36, P285, DOI 10.1080/00087114.1983.10797668; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Freudenreich CH, 2007, FRONT BIOSCI-LANDMRK, V12, P4911, DOI 10.2741/2437; Garrick DJ, 2015, CYTOGENETICS CHROMOS, P103; Gaymes TJ, 2002, ONCOGENE, V21, P2525, DOI 10.1038/sj.onc.1205331; Genualdo V, 2012, J APPL GENET, V53, P221, DOI 10.1007/s13353-012-0092-2; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Gonzalez-Barrera S, 2003, MOL CELL, V11, P1661, DOI 10.1016/S1097-2765(03)00183-7; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; HUSUM B, 1986, HEREDITAS, V105, P17, DOI 10.1111/j.1601-5223.1986.tb00635.x; IANNUZZI L, 1991, HEREDITAS, V114, P201, DOI 10.1111/j.1601-5223.1991.tb00325.x; IANNUZZI L, 1991, CARYOLOGIA, V44, P145, DOI 10.1080/00087114.1991.10797179; Iannuzzi L, 1996, CHROMOSOME RES, V4, P448, DOI 10.1007/BF02265052; Iannuzzi L, 2004, MUTAGENESIS, V19, P355, DOI 10.1093/mutage/geh041; Iannuzzi L, 2007, ITAL J ANIM SCI, V6, P713, DOI DOI 10.4081/IJAS.2007.1S.23; Khatun MR, 2011, ASIAN J ANIM VET ADV, V6, P117, DOI 10.3923/ajava.2011.117.125; Kuchta-Gladysz M, 2016, FOLIA BIOL-KRAKOW, V64, P89, DOI 10.3409/fb64_2.89; Kuchta-Gladysz M, 2015, CAN J ANIM SCI, V95, P543, DOI 10.4141/CJAS-2015-073; Kumar A, 2014, INDIAN J DAIRY SCI, V67, P1; LATT SA, 1974, SCIENCE, V185, P74, DOI 10.1126/science.185.4145.74; LAZUTKA JR, 1994, MUTAT RES, V306, P173, DOI 10.1016/0027-5107(94)90028-0; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEIBENGUTH F, 1986, Archivos de Zootecnia, V35, P301; Litwinczuk Z, 2012, ANN ANIM SCI, V12, P423; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Nagasawa H, 2017, RADIAT RES, V187, P259, DOI 10.1667/RR14679.1; Neja W., 2013, Journal of Central European Agriculture, V14, P91, DOI 10.5513/JCEA01/14.1.1161; Nicodemo D, 2008, CYTOGENET GENOME RES, V120, P178, DOI 10.1159/000118760; Nicolae I., 2009, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V42, P64; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Peretti V, 2007, MUTAGENESIS, V22, P317, DOI 10.1093/mutage/gem019; Peretti V, 2005, ITAL J ANIM SCI, V4, P97; Peretti V, 2006, HEREDITAS, V143, P113, DOI 10.1111/j.2006.0018-0661.01937.x; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Prasanthi GS, 2004, INTAS POLIVET, V5, P87; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; RangelFigueiredo MT, 1995, HEREDITAS, V123, P25, DOI 10.1111/j.1601-5223.1995.t01-1-00025.x; RIGGS PK, 1993, CYTOGENET CELL GENET, V62, P110, DOI 10.1159/000133452; Rodriguez V, 2002, GENET SEL EVOL, V34, P649, DOI [10.1051/gse:2002029, 10.1186/1297-9686-34-6-649]; Rodriguez-Reyes R, 2003, MUTAGENESIS, V18, P65, DOI 10.1093/mutage/18.1.65; RONNE M, 1995, HEREDITAS, V122, P153, DOI 10.1111/j.1601-5223.1995.00153.x; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Schoket B, 1999, MUTAT RES-FUND MOL M, V424, P143, DOI 10.1016/S0027-5107(99)00015-9; Seppa N., 1998, SCI NEWS, V154, P317; SINHA AK, 1985, CELL BIOL TOXICOL, V1, P333, DOI 10.1007/BF00118198; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sram RJ, 1999, MUTAT RES-FUND MOL M, V428, P203, DOI 10.1016/S1383-5742(99)00048-4; Stults DM, 2014, METHODS MOL BIOL, V1105, P439, DOI 10.1007/978-1-62703-739-6_32; VIJH RK, 1992, INDIAN J ANIM SCI, V62, P473; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Wnuk M, 2011, MECH AGEING DEV, V132, P257, DOI 10.1016/j.mad.2011.04.009; Wojcik E, 2014, BRIT POULTRY SCI, V55, P435, DOI 10.1080/00071668.2014.929637; Wojcik E, 2013, POULTRY SCI, V92, P84, DOI 10.3382/ps.2012-02564; Wojcik E, 2012, POULTRY SCI, V91, P2424, DOI 10.3382/ps.2012-02327; Wojcik E, 2018, CAN J ANIM SCI, V98, P818, DOI 10.1139/cjas-2017-0078; Wojcik E, 2013, FOLIA BIOL-KRAKOW, V61, P199, DOI 10.3409/fb61_3-4.199; Wojcik E, 2012, FOLIA BIOL-KRAKOW, V60, P141, DOI 10.3409/fb60_3-4.141-146; Wojcik E, 2012, CAN J ANIM SCI, V92, P49, DOI 10.4141/CJAS2011-112; Wojcik E, 2011, ARCH TIERZUCHT, V54, P107, DOI 10.5194/aab-54-107-2011; WOLFF S, 1974, CHROMOSOMA, V48, P341, DOI 10.1007/BF00290991; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	83	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217799	10.1371/journal.pone.0217799	http://dx.doi.org/10.1371/journal.pone.0217799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163060	gold, Green Published, Green Submitted			2022-12-26	WOS:000470086200036
J	Semites, K; Kolilekas, L; Vamvakaris, I; Gkogkou, C; Filippousis, P; Gaga, M; Zervas, E				Semites, Konstantinos; Kolilekas, Lykourgos; Vamvakaris, Ioannis; Gkogkou, Charalampos; Filippousis, Petros; Gaga, Mina; Zervas, Eleftherios			Introducing transbronchial cryobiopsies in diagnosing diffuse parenchymal lung diseases in Greece: Implementing training into clinical practice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; BIOPSY; YIELD; STATEMENT; SAFETY; STANDARDIZATION; COMPLICATIONS; GUIDELINES	Introduction Diffuse parenchymal lung diseases (DPLD) constitute a heterogeneous group of disorders, sometimes requiring surgical lung biopsies (SLB) to obtain a definite diagnosis. Transbronchial cryobiopsy (TBCB) is a new promising interventional bronchoscopic method of obtaining lung tissue that is gaining ground against SLB. Methods Fifty consecutive patients with indeterminate DPLD (definite/possible UIP excluded), after expert panel review referral, were retrospectively analyzed from January 2016 to August 2018. Patients underwent TBCB under deep sedation with endotracheal intubation and spontaneous breathing at a single, tertiary-care, reference hospital. Results A total of 110 TBCBs (2.7 per patient, range 1 to 4) were performed. Frequent complications included mild pneumothorax in 5 patients (10%), requiring only oxygen supplementation, and bleeding in 31 patients (62%) that was mild in 19 patients and moderate in 12 patients. No serious bleeding was observed. There was zero mortality and no serious adverse events. Adequate samples for diagnostic purposes were obtained in 46 patients (92%) and pathologic histologic diagnosis was reached in 40 patients (80%). The most frequent histopathological patterns were organizing pneumonia (OP) (25%) and non-specific interstitial pneumonia (NSIP) (15%). After an expert panel review of all cases a final diagnosis was achieved in 38 patients, corresponding to a diagnostic yield of 76% for TBCB. Conclusion Our single center cohort demonstrates that establishing TBCBs as a new technique is safe and feasible after proper training in specialized centers, resulting in low complication rates and adequate diagnostic yields.	[Semites, Konstantinos; Kolilekas, Lykourgos; Gaga, Mina; Zervas, Eleftherios] Athens Chest Hosp Sotiria, Resp Med Dept, Athens, Greece; [Semites, Konstantinos; Kolilekas, Lykourgos; Gaga, Mina; Zervas, Eleftherios] Athens Chest Hosp Sotiria, Asthma Ctr, Athens, Greece; [Semites, Konstantinos; Gaga, Mina; Zervas, Eleftherios] Athens Chest Hosp Sotiria, Cent Bronchoscopy Unit, Athens, Greece; [Vamvakaris, Ioannis] Athens Chest Hosp Sotiria, Pathol Dept, Athens, Greece; [Gkogkou, Charalampos] HistoBioDiag Lab, Pathol Dept, Athens, Greece; [Filippousis, Petros] Athens Chest Hosp Sotiria, Dept Med Imaging & Intervent Radiol, Athens, Greece		Zervas, E (corresponding author), Athens Chest Hosp Sotiria, Resp Med Dept, Athens, Greece.; Zervas, E (corresponding author), Athens Chest Hosp Sotiria, Asthma Ctr, Athens, Greece.; Zervas, E (corresponding author), Athens Chest Hosp Sotiria, Cent Bronchoscopy Unit, Athens, Greece.	lefzervas@yahoo.gr	Gaga, Mina/AAP-8348-2020	Zervas, Eleftherios/0000-0001-7436-4550				Aragaki-Nakahodo AA, 2017, RESP MED, V131, P65, DOI 10.1016/j.rmed.2017.08.003; Babiak A, 2009, RESPIRATION, V78, P203, DOI 10.1159/000203987; Bango-Alvarez Antonio, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00148-2016; Baron TH, 2013, NEW ENGL J MED, V368, P2113, DOI 10.1056/NEJMra1206531; Berbescu EA, 2006, CHEST, V129, P1126, DOI 10.1378/chest.129.5.1126; Bondue B, 2017, PULM MED, V2017, DOI 10.1155/2017/6794343; Casoni GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086716; Colby TV, 2017, ARCH PATHOL LAB MED, V141, P891, DOI 10.5858/arpa.2016-0233-RA; DiBardino DM, 2017, ANN AM THORAC SOC, V14, P851, DOI 10.1513/AnnalsATS.201610-829OC; Drakopanagiotakis F, 2011, CHEST, V139, P893, DOI 10.1378/chest.10-0883; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Ganganah O, 2016, RESPIROLOGY, V21, P834, DOI 10.1111/resp.12770; Griff S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-171; Hagmeyer L, 2016, CLIN RESPIR J, V10, P589, DOI 10.1111/crj.12261; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; Hernandez-Gonzalez F, 2015, ARCH BRONCONEUMOL, V51, P261, DOI 10.1016/j.arbres.2014.09.009; Hetzel J, 2018, RESPIRATION, V95, P188, DOI 10.1159/000484055; Hohberger LA, 2014, RESPIRATION, V88, P521, DOI 10.1159/000368616; Huang Steven K, 2008, Expert Opin Med Diagn, V2, P183, DOI 10.1517/17530059.2.2.183; Hutchinson JP, 2016, EUR RESPIR J, V48, P1453, DOI 10.1183/13993003.00378-2016; Iftikhar IH, 2017, ANN AM THORAC SOC, V14, P1197, DOI 10.1513/AnnalsATS.201701-086SR; Kreider ME, 2007, ANN THORAC SURG, V83, P1140, DOI 10.1016/j.athoracsur.2006.10.002; Kronborg-White S, 2017, EUR CLIN RESPIR J, V4, P1, DOI 10.1080/20018525.2016.1274099; Kropski JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078674; Lentz RJ, 2017, J THORAC DIS, V9, P2186, DOI 10.21037/jtd.2017.06.96; Lynch DA, 2018, LANCET RESP MED, V6, P138, DOI 10.1016/S2213-2600(17)30433-2; Marcoa R, 2017, REV PORT PNEUMOL, V23, P296, DOI 10.1016/j.rppnen.2017.07.002; MILMAN N, 1994, RESP MED, V88, P749, DOI 10.1016/S0954-6111(05)80197-0; MOLIN LJ, 1994, ANN THORAC SURG, V58, P1595, DOI 10.1016/0003-4975(94)91638-1; Pajares V, 2014, RESPIROLOGY, V19, P900, DOI 10.1111/resp.12322; Poletti V, 2016, CURR OPIN PULM MED, V22, P289, DOI 10.1097/MCP.0000000000000272; Poletti V, 2015, RESPIRATION, V90, P275, DOI 10.1159/000439313; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Raj R, 2016, AM J RESP CRIT CARE, V193, P1082, DOI 10.1164/rccm.201512-2488ED; Raparia K, 2016, ARCH PATHOL LAB MED, V140, P1281, DOI 10.5858/arpa.2016-0258-SA; Ravaglia C, 2017, RESPIRATION, V93, P285, DOI 10.1159/000456671; Ravaglia C, 2016, RESPIRATION, V91, P215, DOI 10.1159/000444089; Riario Sforza Gian Galeazzo, 2017, Clin Mol Allergy, V15, P6, DOI 10.1186/s12948-017-0062-7; Sharp C, 2017, CHEST, V151, P512, DOI 10.1016/j.chest.2016.10.060; Thomeer M, 2001, EUR RESPIR J, V32, P114, DOI DOI 10.1016/S1010-7940(01)00915-0; Tomassetti S, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-96; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217554	10.1371/journal.pone.0217554	http://dx.doi.org/10.1371/journal.pone.0217554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158264	gold, Green Submitted, Green Published			2022-12-26	WOS:000469915700020
J	Foster, KL; Kern, KD; Chambers, TM; Lupo, PJ; Kamdar, KY; Scheurer, ME; Brown, AL				Foster, Kayla L.; Kern, Kathleen D.; Chambers, Tiffany M.; Lupo, Philip J.; Kamdar, Kala Y.; Scheurer, Michael E.; Brown, Austin L.			Weight trends in a multiethnic cohort of pediatric acute lymphoblastic leukemia survivors: A longitudinal analysis	PLOS ONE			English	Article							BODY-MASS INDEX; ADULT SURVIVORS; CHILDHOOD-CANCER; UNITED-STATES; OBESITY; CHILDREN; PREVALENCE; OVERWEIGHT; PREDICTORS; ADOLESCENTS	Background As survival rates for childhood acute lymphoblastic leukemia (ALL) continue to improve, there is growing concern over the chronic health conditions that survivors face. Given that survivors of childhood ALL are at increased risk of cardiovascular complications and obesity, we sought to characterize BMI trends from diagnosis through early survivorship in a multi-ethnic, contemporary cohort of childhood ALL patients and determine if early weight change was predictive of long-term weight status. Methods The study population consisted of ALL patients aged 2-15 years at diagnosis who were treated with chemotherapy alone at Texas Children's Hospital. Each patient had BMI z-scores collected at diagnosis, 30-days post-diagnosis, and annually for five years. Linear regression models were estimated to evaluate the association between: 1) BMI z-score change in the first 30 days and BMI z-scores at five-years post-diagnosis; and 2) BMI zscore change in the first year post-diagnosis and BMI z-scores at five-years post-diagnosis. Results This retrospective cohort study included longitudinal data from 121 eligible patients. The mean BMI z-scores for the population increased significantly (p-value< 0.001) from baseline (mean = 0.25) to 30 days post-diagnosis (mean = 1.17) before plateauing after one year post-diagnosis (mean = 0.99). Baseline BMI z-scores were statistically significant predictors to five year BMI z-scores (p < 0.001). Independent of baseline BMI z-score and other clinical factors, the BMI z-score at one year post-diagnosis was significantly associated with BMI z-score at five-years post-diagnosis (beta = 0.63, p < 0.001), while BMI z-score at 30 days postdiagnosis was not (beta = 0.10, p = 0.23). Conclusion Our results suggest that weight gain within the first year after diagnosis is more strongly associated with long-term BMI than early weight gain (within 30 days). If confirmed, this information may help identify a window of time during therapy when ALL patients would benefit most from weight management directed interventions.	[Foster, Kayla L.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kern, Kathleen D.; Chambers, Tiffany M.; Lupo, Philip J.; Kamdar, Kala Y.; Scheurer, Michael E.; Brown, Austin L.] Baylor Coll Med, Houston, TX 77030 USA; [Kern, Kathleen D.; Chambers, Tiffany M.; Lupo, Philip J.; Kamdar, Kala Y.; Scheurer, Michael E.; Brown, Austin L.] Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA	St Jude Children's Research Hospital; Baylor College of Medicine; Texas Children's Cancer Center	Brown, AL (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.; Brown, AL (corresponding author), Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA.	Austin.Brown@bcm.edu	Lupo, Philip/R-8314-2019	Lupo, Philip/0000-0003-0978-5863; Scheurer, Michael/0000-0002-8379-6088	National Institutes of Health National Cancer Institute [K07 CA218362]; Leukemia & Lymphoma Society Translational Research Program [6314-11]; Leukemia Research Foundation Hollis Brownstein Research Grants Program; St. Baldrick's Foundation Consortium Grant; NATIONAL CANCER INSTITUTE [K07CA218362] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia & Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Leukemia Research Foundation Hollis Brownstein Research Grants Program; St. Baldrick's Foundation Consortium Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Institutes of Health National Cancer Institute (K07 CA218362 to A.L.B.); Leukemia & Lymphoma Society Translational Research Program (6314-11 to K.Y.K.); Leukemia Research Foundation Hollis Brownstein Research Grants Program (to A.L.B); St. Baldrick's Foundation Consortium Grant (to P.J.L). The funders listed had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Belle FN, 2018, CANCER-AM CANCER SOC, V124, P3576, DOI 10.1002/cncr.31599; Brown AL, 2016, J PEDIAT HEMATOL ONC, V38, P429, DOI 10.1097/MPH.0000000000000555; Browne EK, 2018, CANCER-AM CANCER SOC, V124, P4248, DOI 10.1002/cncr.31736; Butturini AM, 2007, J CLIN ONCOL, V25, P2063, DOI 10.1200/JCO.2006.07.7792; Chow EJ, 2007, CANCER-AM CANCER SOC, V110, P2313, DOI 10.1002/cncr.23050; Collins L, 2010, J PEDIAT HEMATOL ONC, V32, pE304, DOI 10.1097/MPH.0b013e3181ece2bb; Dores GM, 2012, BLOOD, V119, P34, DOI 10.1182/blood-2011-04-347872; Esbenshade AJ, 2013, PEDIATR BLOOD CANCER, V60, P1287, DOI 10.1002/pbc.24489; Esbenshade AJ, 2011, PEDIATR BLOOD CANCER, V56, P372, DOI 10.1002/pbc.22782; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Irizarry KA, 2014, PEDIATR ANN, V43, P210, DOI 10.3928/00904481-20140825-07; Jansen H, 2009, SUPPORT CARE CANCER, V17, P103, DOI 10.1007/s00520-008-0531-0; Love E, 2011, PEDIATR BLOOD CANCER, V57, P1204, DOI 10.1002/pbc.23010; Ness KK, 2015, BLOOD, V125, P3411, DOI 10.1182/blood-2015-01-621680; Ness KK, 2009, CANCER-AM CANCER SOC, V115, P1984, DOI 10.1002/cncr.24209; Nottage KA, 2014, BRIT J HAEMATOL, V165, P364, DOI 10.1111/bjh.12754; Oeffinger KC, 2003, J CLIN ONCOL, V21, P1359, DOI 10.1200/JCO.2003.06.131; Ogden CL, 2018, JAMA-J AM MED ASSOC, V319, P2410, DOI 10.1001/jama.2018.5158; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Orgel E, 2016, AM J CLIN NUTR, V103, P808, DOI 10.3945/ajcn.115.124586; Pakakasama S, 2010, INT J HEMATOL, V91, P850, DOI 10.1007/s12185-010-0594-9; Prevention CfDCa, 2010, 2000 CDC GROWTH CHAR; Prevention CfDCa, 2011, OV OB; Razzouk BI, 2007, J CLIN ONCOL, V25, P1183, DOI 10.1200/JCO.2006.07.8709; Reilly JJ, 2001, J CLIN ENDOCR METAB, V86, P3742, DOI 10.1210/jc.86.8.3742; Sklar CA, 2000, MED PEDIATR ONCOL, V35, P91, DOI 10.1002/1096-911X(200008)35:2<91::AID-MPO1>3.0.CO;2-G; United States Cancer Statistics, 2017, 1999 2014 INC MORT W; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Withycombe JS, 2009, PEDIATR BLOOD CANCER, V53, P1249, DOI 10.1002/pbc.22237; Zhang F. F., 2015, PEDIAT BLOOD CANC; Zhang FF, 2014, PEDIATR BLOOD CANCER, V61, P1263, DOI 10.1002/pbc.24960; Zhang FF, 2014, PEDIATRICS, V133, pE704, DOI 10.1542/peds.2013-3332	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							0217932	10.1371/journal.pone.0217932	http://dx.doi.org/10.1371/journal.pone.0217932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150521	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100129
J	Ksenofontov, AL; Fedorova, NV; Badun, GA; Serebryakova, MV; Nikitin, NA; Evtushenko, EA; Chernysheva, MG; Bogacheva, EN; Dobrov, EN; Baratova, LA; Atabekov, JG; Karpova, OV				Ksenofontov, Alexander L.; Fedorova, Natalia, V; Badun, Gennady A.; Serebryakova, Marina, V; Nikitin, Nikolai A.; Evtushenko, Ekaterina A.; Chernysheva, Maria G.; Bogacheva, Elena N.; Dobrov, Eugeny N.; Baratova, Ludmila A.; Atabekov, Joseph G.; Karpova, Olga, V			Surface characterization of the thermal remodeling helical plant virus	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; POTATO-VIRUS; COAT PROTEIN; SPHERICAL-PARTICLES; SPATIAL-ORGANIZATION; TRITIUM PLANIGRAPHY; BACTERIORHODOPSIN; TRANSITION; VIRIONS; VACCINE	Previously, we have reported that spherical particles (SPs) are formed by the thermal remodeling of rigid helical virions of native tobacco mosaic virus (TMV) at 94 degrees C. SPs have remarkable features: stability, unique adsorption properties and immunostimulation potential. Here we performed a comparative study of the amino acid composition of the SPs and virions surface to characterize their properties and take an important step to understanding the structure of SPs. The results of tritium planigraphy showed that thermal transformation of TMV leads to a significant increase in tritium label incorporation into the following sites of SPs protein: 41-71 .a. and 93-122 a.a. At the same time, there was a decrease in tritium label incorporation into the N- and C-terminal region (1-15 a.a., 142-158 a.a). The use of complementary physico-chemical methods allowed us to carry out a detailed structural analysis of the surface and to determine the most likely surface areas of SPs. The obtained data make it possible to consider viral protein thermal rearrangements, and to open new opportunities for biologically active complex design using information about SPs surface amino acid composition and methods of non-specific adsorption and bioconjugation.	[Ksenofontov, Alexander L.; Fedorova, Natalia, V; Serebryakova, Marina, V; Dobrov, Eugeny N.; Baratova, Ludmila A.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Badun, Gennady A.; Chernysheva, Maria G.] Lomonosov Moscow State Univ, Dept Chem, Moscow, Russia; [Nikitin, Nikolai A.; Evtushenko, Ekaterina A.; Atabekov, Joseph G.; Karpova, Olga, V] Lomonosov Moscow State Univ, Dept Virol, Moscow, Russia; [Bogacheva, Elena N.] Russian Acad Sci, Semenov Inst Chem Phys, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences	Ksenofontov, AL (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.; Nikitin, NA (corresponding author), Lomonosov Moscow State Univ, Dept Virol, Moscow, Russia.	ksenofon@belozersky.msu.ru; nikitin@mail.bio.msu.ru	Chernysheva, Maria G/L-5404-2018; Badun, Gennadii A/D-3492-2015; Ksenofontov, Alexander L/D-6747-2012; Evtushenko, Ekaterina A./H-6989-2013; Ksenofontov, Alexander/AAH-1774-2021; Karpova, Olga V/H-2475-2013; Serebryakova, Marina/E-2986-2012; Chernysheva, Maria G./J-2945-2013; Nikitin, Nikolai/D-6520-2013	Chernysheva, Maria G/0000-0001-5040-9937; Badun, Gennadii A/0000-0002-9792-8432; Ksenofontov, Alexander L/0000-0003-1585-7907; Evtushenko, Ekaterina A./0000-0002-0679-6818; Ksenofontov, Alexander/0000-0003-1585-7907; Karpova, Olga V/0000-0002-0605-9033; Serebryakova, Marina/0000-0002-5402-8215; Chernysheva, Maria G./0000-0001-5040-9937; Nikitin, Nikolai/0000-0001-9626-2336	Russian Science Foundation [18-1400044]; Russian Foundation for Basic Research (RFBR) [RFBR-18-04-00525-a]; Russian Science Foundation [18-14-00044] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The work was supported in part by Russian Science Foundation project No. 18-1400044, https://grant.rscf.ru, (N.A.N., E.A.E., J.G.A, O.V.K); Russian Foundation for Basic Research (RFBR) project No. RFBR-18-04-00525-a, https://kias.rfbr.ru, (A.L.K., N.V.F., G.A.B., E.N.B., E.N.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov DE, 1997, P NATL ACAD SCI USA, V94, P12892, DOI 10.1073/pnas.94.24.12892; Atabekov JG, 2016, MOSCOW U BIOL SCI B, V70, P177, DOI [10.3103/s0096392515040045, DOI 10.3103/S0096392515040045]; Atabekov J, 2011, J GEN VIROL, V92, P453, DOI 10.1099/vir.0.024356-0; BARATOVA LA, 1992, VIROLOGY, V188, P175, DOI 10.1016/0042-6822(92)90747-D; Baratova LA, 2001, J VIROL, V75, P9696, DOI 10.1128/JVI.75.20.9696-9702.2001; Bruckman MA, 2016, J CONTROL RELEASE, V231, P103, DOI 10.1016/j.jconrel.2016.02.045; Dobrov EN, 2003, EUR J BIOCHEM, V270, P3300, DOI 10.1046/j.1432-1033.2003.03680.x; Dobrov EN, 2014, J BIOMOL STRUCT DYN, V32, P701, DOI 10.1080/07391102.2013.788983; Fraenkel-Conrat H, 1999, PHILOS T ROY SOC B, V354, P583, DOI 10.1098/rstb.1999.0409; Gol'danskii V I, 1982, Mol Biol (Mosk), V16, P528; GOLDANSKII VI, 1988, J MOL BIOL, V201, P567, DOI 10.1016/0022-2836(88)90638-9; Karpova O, 2012, J GEN VIROL, V93, P400, DOI 10.1099/vir.0.036293-0; Kondakova O. A., 2017, Sel'skokhozyaistvennaya Biologiya, P731, DOI 10.15389/agrobiology.2017.4.731rus; Kordyukova LV, 2001, BIOSCIENCE REP, V21, P711, DOI 10.1023/A:1015572321508; Ksenofontov AL, 2018, J BIOMOL STRUCT DYN, V36, P1728, DOI 10.1080/07391102.2017.1333457; Ksenofontov AL, 2016, J BIOMOL STRUCT DYN, V34, P250, DOI 10.1080/07391102.2015.1022604; Ksenofontov AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067830; Lukashina E, 2012, MOL PLANT PATHOL, V13, P38, DOI 10.1111/j.1364-3703.2011.00725.x; McCormick AA, 2008, EXPERT REV VACCINES, V7, P33, DOI 10.1586/14760584.7.1.33; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; Nikitin NA, 2018, DATA BRIEF, V21, P1504, DOI 10.1016/j.dib.2018.10.102; Nikitin NA, 2018, DATA BRIEF, V21, P742, DOI 10.1016/j.dib.2018.10.030; Nikitin NA, 2018, REGUL TOXICOL PHARM, V97, P127, DOI 10.1016/j.yrtph.2018.06.010; Nikitin N. A., 2016, Moscow University Biological Sciences Bulletin, V71, P128, DOI 10.3103/S0096392516030081; Nikitin N, 2016, FEBS LETT, V590, P1543, DOI 10.1002/1873-3468.12184; Nikitin N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142415; Nikitin N, 2013, MICROSC MICROANAL, V19, P808, DOI 10.1017/S1431927613000597; Shishkov A, 2011, FEBS J, V278, P4905, DOI 10.1111/j.1742-4658.2011.08392.x; Shishkov AV, 1999, P NATL ACAD SCI USA, V96, P7827, DOI 10.1073/pnas.96.14.7827; Shishkov AV, 2002, BIOELECTROCHEMISTRY, V56, P147, DOI 10.1016/S1567-5394(02)00018-X; Trifonova EA, 2016, MOSCOW U BIOL SCI B, V70, P194, DOI [10.3103/s0096392515040094, DOI 10.3103/S0096392515040094]; Trifonova E, 2014, J BIOMOL STRUCT DYN, V32, P1193, DOI 10.1080/07391102.2013.816868; Trifonova EA, 2017, ANTIVIR RES, V144, P27, DOI 10.1016/j.antiviral.2017.05.006; Trofimova L, 2016, CURR ANAL CHEM, V12, P349, DOI 10.2174/1573411011666151006220356; TSETLIN VI, 1988, EUR J BIOCHEM, V178, P123, DOI 10.1111/j.1432-1033.1988.tb14437.x; TSUGITA A, 1982, EUR J BIOCHEM, V124, P585, DOI 10.1111/j.1432-1033.1982.tb06634.x	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216905	10.1371/journal.pone.0216905	http://dx.doi.org/10.1371/journal.pone.0216905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150411	gold, Green Published			2022-12-26	WOS:000469759100026
J	Lee, GB; Woo, H; Lee, SY; Cheon, SM; Kim, JW				Lee, Geum-Bong; Woo, Hyunhee; Lee, Su-Yoon; Cheon, Sang-Myung; Kim, Jae Woo			The burden of care and the understanding of disease in Parkinson's disease	PLOS ONE			English	Article							PATIENT EDUCATION-PROGRAM; QUALITY-OF-LIFE; NONMOTOR SYMPTOMS; CAREGIVER BURDEN; KNOWLEDGE; ATTITUDES	Background and objective Education of disease plays an important role in management of Parkinson's disease (PD). However, little is known about the link between the understanding of disease and the burden of care. This study was carried out to find the correlation between the burden of care and the understanding of disease in caregivers for PD patients. Methods Non-demented patients with PD and their caregivers participated in structured interviews. Understanding of patients and caregivers was evaluated through newly-devised questions. The caregiver burden inventory was used to assess the burden of care. Results A total of 142 pairs of patients and their caregivers were recruited. A correlation analysis showed that the burden of care was positively associated with low understanding of the disease by the caregiver. Daily care time and female patients were revealed to be independently associated with the burden of care through a multivariate analysis. Further analyses were performed in the caregiver group according to relationship with patients. The spouse group showed an increased burden of care and poor understanding compared to the offspring group. A multivariate analysis revealed that daily care time and understanding were independent predictors for the burden of care in the spouse group. There was no significant association in the offspring group. Conclusion The burden of care was associated with higher daily caregiving time and female gender of the patient, and was significantly increased in the spouse of the patient. In the spouse group, better understanding of the caregiver correlated with less burden of care.	[Lee, Geum-Bong; Cheon, Sang-Myung; Kim, Jae Woo] Dong A Univ, Dept Neurol, Sch Med, Busan, South Korea; [Woo, Hyunhee] Dongju Coll, Dept Nursing, Busan, South Korea; [Lee, Su-Yoon] Pohang S Hosp, Dept Neurol, Pohang, South Korea	Dong A University	Cheon, SM (corresponding author), Dong A Univ, Dept Neurol, Sch Med, Busan, South Korea.	smcheon@dau.ac.kr			Dong-A University Research Fund	Dong-A University Research Fund	This study was supported by Dong-A University Research Fund to SMC. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	A'Campo LEI, 2011, INT J CLIN PRACT, V65, P1173, DOI 10.1111/j.1742-1241.2011.02765.x; A'Campo LEI, 2010, PARKINSONISM RELAT D, V16, P89, DOI 10.1016/j.parkreldis.2009.07.009; Baik JS, 2017, J MOV DISORD, V10, P109, DOI 10.14802/jmd.17053; Bhidayasiri R, 2014, NEUROLOGY, V82, P2238, DOI 10.1212/WNL.0000000000000515; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Cheon SM, 2008, PARKINSONISM RELAT D, V14, P286, DOI 10.1016/j.parkreldis.2007.09.002; Dahodwala N, 2018, NEUROLOGY, V90, pE48, DOI 10.1212/WNL.0000000000004764; Gallagher DA, 2010, MOVEMENT DISORD, V25, P2493, DOI 10.1002/mds.23394; Grun D, 2016, J AM MED DIR ASSOC, V17, P626, DOI 10.1016/j.jamda.2016.03.004; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jitkritsadakul O, 2017, J NEUROL SCI, V374, P69, DOI 10.1016/j.jns.2016.12.063; Lim SY, 2010, MOVEMENT DISORD, V25, pS123, DOI 10.1002/mds.22786; Macht M, 2007, PATIENT EDUC COUNS, V65, P245, DOI 10.1016/j.pec.2006.08.005; Martinez-Martin P, 2012, EXPERT REV PHARM OUT, V12, P221, DOI [10.1586/erp.11.106, 10.1586/ERP.11.106]; Mosley PE, 2017, J GERIATR PSYCH NEUR, V30, P235, DOI 10.1177/0891988717720302; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Pan S, 2014, J CROSS-CULT GERONTO, V29, P339, DOI 10.1007/s10823-014-9233-x; Santos-Garcia D, 2013, J NEUROL SCI, V332, P136, DOI 10.1016/j.jns.2013.07.005; Shin H, 2012, EUR NEUROL, V67, P292, DOI 10.1159/000335577; Terayama H, 2018, PSYCHOGERIATRICS, V18, P327, DOI 10.1111/psyg.12337; Walton E., 2003, J FAMILY SOCIAL WORK, V7, P1	21	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217581	10.1371/journal.pone.0217581	http://dx.doi.org/10.1371/journal.pone.0217581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150470	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100069
J	Parigi, A; Porter, C; Cermak, M; Pitchers, WR; Dworkin, I				Parigi, Abhijna; Porter, Cody; Cermak, Megan; Pitchers, William R.; Dworkin, Ian			The behavioral repertoire of Drosophila melanogaster in the presence of two predator species that differ in hunting mode	PLOS ONE			English	Article							JUMPING SPIDERS; TENODERA-ARIDIFOLIA; FORAGING BEHAVIOR; PRAYING-MANTIS; ARANEAE; PREY; SALTICIDAE; ECOLOGY; RISK; COMMUNITIES	The fruit fly, Drosophila melanogaster, has proven to be an excellent model organism for genetic, genomic and neurobiological studies. However, relatively little is known about the natural history of D. melanogaster. In particular, neither the natural predators faced by wild populations of D. melanogaster, nor the anti-predatory behaviors they may employ to escape and avoid their enemies have been documented. Here we observe and describe the influence of two predators that differ in their mode of hunting: zebra jumping spiders, Salticus scenicus (active hunters) and Chinese praying mantids, Tenodera sinensis (ambush predators) on the behavioral repertoire of Drosophila melanogaster. We documented three particularly interesting behaviors: abdominal lifting, stopping, and retreat-which were performed at higher frequency by D. melanogaster in the presence of predators. While mantids had only a modest influence on the locomotory activity of D. melanogaster, we observed a significant increase in the overall activity of D. melanogaster in the presence of jumping spiders. Finally, we observed considerable among-individual behavioral variation in response to both predators.	[Parigi, Abhijna; Pitchers, William R.; Dworkin, Ian] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Parigi, Abhijna; Porter, Cody; Cermak, Megan; Dworkin, Ian] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Parigi, Abhijna; Pitchers, William R.; Dworkin, Ian] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Parigi, Abhijna] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Porter, Cody] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Cermak, Megan] Nationwide Childrens Hosp, Columbus, OH USA; [Pitchers, William R.] Univ Melbourne, Microbiol Diagnost Unit, Publ Hlth Lab, Melbourne, Vic, Australia; [Dworkin, Ian] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Michigan State University; Michigan State University; Michigan State University; University of California System; University of California Davis; University of Wyoming; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Melbourne; McMaster University	Parigi, A (corresponding author), Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.; Parigi, A (corresponding author), Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA.; Parigi, A (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.; Parigi, A (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	abhijna.parigi@gmail.com		Dworkin, Ian/0000-0002-2874-287X	BEACON via the National Science Foundation [DBI-0939454]	BEACON via the National Science Foundation	The funding was awarded to ID by BEACON via the National Science Foundation under Cooperative Agreement No. DBI-0939454. https://nsf. gov/; https://www3.beacon-center.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMAN GC, 1993, ANIM BEHAV, V46, P233, DOI 10.1006/anbe.1993.1185; Bakeman R., 1997, OBSERVING INTERACTIO; Bidaye SS, 2014, SCIENCE, V344, P97, DOI 10.1126/science.1249964; BLEST AD, 1981, J COMP PHYSIOL, V145, P227, DOI 10.1007/BF00605035; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Brown GE, 1999, ANIM BEHAV, V58, P469, DOI 10.1006/anbe.1999.1173; Brown GE, 2009, BEHAV ECOL SOCIOBIOL, V63, P699, DOI 10.1007/s00265-008-0703-4; Ceccarelli FS, 2008, J ARACHNOL, V36, P344, DOI 10.1636/CSt07-114.1; Chabaud MA, 2009, CURR BIOL, V19, P1654, DOI 10.1016/j.cub.2009.08.017; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; DILL LM, 1975, CAN J ZOOL, V53, P1284, DOI 10.1139/z75-153; Edmunds M., 1974, DEFENCE ANIMALS; ESCALANTE A, 1990, BIOTROPICA, V22, P48, DOI 10.2307/2388718; FITZGIBBON CD, 1988, BEHAV ECOL SOCIOBIOL, V23, P69, DOI 10.1007/BF00299889; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; FORSTER LM, 1979, NEW ZEAL J ZOOL, V6, P79, DOI 10.1080/03014223.1979.10428351; FREED AN, 1984, J ZOOL, V203, P49; Gosline AK, 2008, AQUAT ECOL, V42, P693, DOI 10.1007/s10452-007-9138-7; Harland DP, 1999, J ZOOL, V247, P357, DOI 10.1111/j.1469-7998.1999.tb00998.x; Harrington B., 2004, INKSCAPE; Herberholz J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00125; HILL D, 1988, J WILDLIFE MANAGE, V52, P446, DOI 10.2307/3801588; HOLLDOBLER B, 1983, BIOTROPICA, V15, P241, DOI 10.2307/2387648; HORNER NV, 1988, J ARACHNOL, V16, P260; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; IWASAKI T, 1990, J ETHOL, V8, P75, DOI 10.1007/BF02350277; Iwasaki Taku, 1998, Entomological Science, V1, P529; Jackson CH, 2011, J STAT SOFTW, V38, P1; JACKSON RR, 1982, J EXP BIOL, V97, P441; JACKSON RR, 1982, ZOOL J LINN SOC-LOND, V76, P293, DOI 10.1111/j.1096-3642.1982.tb02185.x; Jensen P, 2014, ANNU REV ANIM BIOSCI, V2, P85, DOI 10.1146/annurev-animal-022513-114135; Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; KOHLER SL, 1989, ECOLOGY, V70, P1811, DOI 10.2307/1938114; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; LAND MF, 1971, J EXP BIOL, V54, P119; Langerhans R. Brian, 2007, P177, DOI 10.1007/978-3-540-46046-6_10; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Lefranc A, 2001, CR ACAD SCI III-VIE, V324, P219, DOI 10.1016/S0764-4469(00)01297-X; Levine JD, 2004, CURR OPIN CELL BIOL, V16, P210, DOI 10.1016/j.ceb.2004.02.009; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mercier JL, 1997, BEHAV PROCESS, V41, P39, DOI 10.1016/S0376-6357(97)00026-0; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Okuyama T, 2007, APPL ENTOMOL ZOOL, V42, P663, DOI 10.1303/aez.2007.663; Polak M, 1998, P ROY SOC B-BIOL SCI, V265, P2197, DOI 10.1098/rspb.1998.0559; Preisser EL, 2007, ECOLOGY, V88, P2744, DOI 10.1890/07-0260.1; PRETE FR, 1990, J INSECT PHYSIOL, V36, P561, DOI 10.1016/0022-1910(90)90024-A; Prete FR, 1991, PRAYING MANTIDS 93 1, P93; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reaume CJ, 2006, CURR BIOL, V16, pR623, DOI 10.1016/j.cub.2006.07.042; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Sansom A, 2009, BEHAV ECOL, V20, P1168, DOI 10.1093/beheco/arp110; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCHROTH KE, 1991, ORNIS SCAND, V22, P249, DOI 10.2307/3676598; SPIETH HT, 1952, B AM MUS NAT HIST, V99, P401; Wilfert L, 2014, MOL ECOL, V23, P2093, DOI 10.1111/mec.12709; Wong BBM, 2005, BEHAV ECOL SOCIOBIOL, V58, P345, DOI 10.1007/s00265-005-0955-1; WORTHEN WB, 1989, ECOL ENTOMOL, V14, P117, DOI 10.1111/j.1365-2311.1989.tb00761.x; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103	65	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216860	10.1371/journal.pone.0216860	http://dx.doi.org/10.1371/journal.pone.0216860			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150415	gold, Green Submitted, Green Published			2022-12-26	WOS:000469759100025
J	Lino, VTS; Rodrigues, NCP; Andrade, MKD; Reis, IND; Lopes, LAE; Atie, S				Saraiva Lino, Valeria Teresa; Pinheiro Rodrigues, Nadia Cristina; de Noronha Andrade, Monica Kramer; de Carvalho Reis, Ines Nascimento; Elias Lopes, Lucilia Almeida; Atie, Soraya			Association between visual problems, insufficient emotional support and urinary incontinence with disability in elderly people living in a poor district in Rio de Janeiro, Brazil: A six-year follow-up study	PLOS ONE			English	Article							METROPOLITAN BELO-HORIZONTE; MENTAL-STATE-EXAMINATION; MINAS-GERAIS STATE; OLDER-ADULTS; FUNCTIONAL DISABILITY; SOCIAL SUPPORT; RISK-FACTORS; INCIDENT DISABILITY; GENDER-DIFFERENCES; HEALTH	Introduction Disability follows the rapid rate of population ageing, imposing a huge burden on society. Functional assessment in older people can identify predictors of disability. Objective Analyze the incidence and the risk factors for disability in activities of daily living (ADL) and instrumental activities of daily living (IADL) in older adults over six years. Methods Six year-follow up study initiated in 2010. The baseline non-probabilistic sample consisted of 180 independent community dwelling individuals aged 60 and over. The procedures comprised an interview with sociodemographic data, questions about falls, urinary incontinence, self-rated health, and assessment of ADL, IADL, mobility, depression, vision, hearing, cognition, nutrition, grip strength and social support. The second research was carried out by telephone and assessed ADL and IADL. Logistic regression models calculated the odds of disability in ADL and IADL according to the age, sex and all other variables. Results At six-year follow-up, 118 participants were still alive (65.6%), 31 died (17%) and other 31 were missed (17%). The incidence of disability to performADL and IADL were 25.4% and 32.3%, respectively. The regression logistic models revealed thaturinary incontinence (OR = 3.2; P = 0.03) and insufficient emotional support (OR = 3.8; P = 0.04) were associated with ADL disability, while visual problems (OR: 2.9; P = 0.03) and insufficient emotional support (OR: 5.6; P = 0.01) were associated with IADL disability. Conclusion The current study has identified that insufficient emotional support, visual problems and urinary incontinence are associated with disability in older adults. The routine assessment of these problems in the primary care clinics enable the implementation of strategies aimed at reducing or postponing disability. Educating patients and families will also enable better choices to reduce the risk of functional decline.	[Saraiva Lino, Valeria Teresa; Pinheiro Rodrigues, Nadia Cristina; de Noronha Andrade, Monica Kramer; de Carvalho Reis, Ines Nascimento; Elias Lopes, Lucilia Almeida; Atie, Soraya] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Lino, VTS (corresponding author), Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Rio De Janeiro, Brazil.	valerialino@ensp.fiocruz.br	Lino, Valeria/ADI-4254-2022	Saraiva Lino, Valeria Teresa/0000-0002-3087-5778	Rio de Janeiro's Municipal Health Secretariat [ENSP-043-PPE-14-2-12]	Rio de Janeiro's Municipal Health Secretariat	This research was funded by Rio de Janeiro's Municipal Health Secretariat, grant number: ENSP-043-PPE-14-2-12. The grant in this research was aimed only at paying scholarships to the field work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Navarro S, 2012, J GERONTOL A-BIOL, V67, P1266, DOI 10.1093/gerona/gls152; Alexandre TD, 2012, ARCH GERONTOL GERIAT, V55, P431, DOI 10.1016/j.archger.2012.04.001; Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Balzi D, 2010, AGE AGEING, V39, P92, DOI 10.1093/ageing/afp209; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bravo FV, 2012, ARQUIVOS BRASILEIROS, V75, P4; Carvalho M, 2012, INTEGRATED TERRITORY; Cherry N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-379; Rosa TEDC, 2007, CAD SAUDE PUBLICA, V23, P2982, DOI 10.1590/S0102-311X2007001200019; de Souza ER, 2008, CIENC SAUDE COLETIVA, V13, P1153, DOI 10.1590/S1413-81232008000400011; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; den Ouden MEM, 2013, EXP GERONTOL, V48, P437, DOI 10.1016/j.exger.2013.02.002; Eisenberger NI, 2013, CURR OPIN NEUROBIOL, V23, P407, DOI 10.1016/j.conb.2013.01.006; Erekson EA, 2015, FEMALE PELVIC MED RE, V21, P170, DOI 10.1097/SPV.0000000000000136; Figueiredo CS, 2013, BRAZ J PHYS THER, V17, P297, DOI 10.1590/S1413-35552012005000094; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fuentes-Garcia A, 2013, GAC SANIT, V27, P226, DOI 10.1016/j.gaceta.2012.11.005; Giacomin KC, 2008, CAD SAUDE PUBLICA, V24, P1260, DOI 10.1590/S0102-311X2008000600007; Griep R., 2003, CONFIABILIDADE VALID; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hosseinpoor AR, 2013, AM J PUBLIC HEALTH, V103, P1278, DOI 10.2105/AJPH.2012.301115; IBGE, 2015, IND DES SUST GIN DIS; IBGE, 2010, 2010 POP CENS DIS PE; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; Lino VTS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071712; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; Mangione C., 2000, COMPREHENSIVE GERIAT, P285; McLaughlin D, 2010, J HEALTH PSYCHOL, V15, P671, DOI 10.1177/1359105310368177; Moreira PL, 2016, ARCH GERONTOL GERIAT, V66, P140, DOI 10.1016/j.archger.2016.05.013; Nagarkar A, 2017, ARCH GERONTOL GERIAT, V69, P151, DOI 10.1016/j.archger.2016.11.015; Okabe T, 2017, GERIATR GERONTOL INT, V17, P1096, DOI 10.1111/ggi.12834; Parahyba MI, 2009, AM J PUBLIC HEALTH, V99, P81, DOI 10.2105/AJPH.2007.130708; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pirozzo S, 2003, BRIT MED J, V327, P967, DOI 10.1136/bmj.327.7421.967; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rosso AL, 2013, J AM GERIATR SOC, V61, P371, DOI 10.1111/jgs.12147; Saarela M., 2018, ARTIFINTELL MED 1003; Lino VTS, 2008, CAD SAUDE PUBLICA, V24, P103, DOI 10.1590/S0102-311X2008000100010; Lino VTS, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00086715; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Tas U, 2007, BRIT J GEN PRACT, V57, P319; Teo N, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.04.015; Torres JL, 2014, CAD SAUDE PUBLICA, V30, P1018, DOI 10.1590/0102-311X00102013; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; van der Vorst A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165127; WINPEPI J A., 2009, PEPI FOR WINDOWS COM; World Health Organization, 2001, ICF INT CLASFUNCT	52	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217456	10.1371/journal.pone.0217456	http://dx.doi.org/10.1371/journal.pone.0217456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150450	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100052
J	Tu, CF; Chuang, CK; Hsiao, KH; Chen, CH; Chen, CM; Peng, SH; Su, YH; Chiou, MT; Yen, CH; Hung, SW; Yang, TS; Chen, CM				Tu, Ching-Fu; Chuang, Chin-kai; Hsiao, Kai-Hsuan; Chen, Chien-Hong; Chen, Chi-Min; Peng, Su-Hei; Su, Yu-Hsiu; Chiou, Ming-Tang; Yen, Chon-Ho; Hung, Shao-Wen; Yang, Tien-Shuh; Chen, Chuan-Mu			Lessening of porcine epidemic diarrhoea virus susceptibility in piglets after editing of the CMP-N-glycolylneuraminic acid hydroxylase gene with CRISPR/Cas9 to nullify N-glycolylneuraminic acid expression	PLOS ONE			English	Article							ISOLATE US/IOWA/18984/2013; AMINOPEPTIDASE-N; SIALIC ACIDS; EDITED PIGS; INFECTION; RECEPTOR; CORONAVIRUS; OUTBREAK; BINDING; SWINE	The porcine epidemic diarrhoea virus (PEDV) devastates the health of piglets but may not infect piglets whose CMP-N-glycolylneuraminic acid hydroxylase (CMAH) gene is mutated (knockouts, KO) by using CRISPR/Cas9 gene editing techniques. This hypothesis was tested by using KO piglets that were challenged with PEDV. Two single-guide RNAs targeting the CMAH gene and Cas9 mRNA were microinjected into the cytoplasm of newly fertilized eggs. Four live founders generated and proven to be biallelic KO, lacking detectable N-glycolylneuraminic acid (NGNA). The founders were bred, and homozygous offspring were obtained. Two-day-old (in exps. I, n = 6, and III, n = 15) and 3-day-old (in exp. II, n = 9) KO and wild- type (WT, same ages in respective exps.) piglets were inoculated with TCID50 1x10(3) PEDV and then fed 20 mL of infant formula (in exps. I and II) or sow's colostrum (in exp. III) every 4 hours. In exp. III, the colostrum was offered 6 times and was then replaced with Ringer/5% glucose solution. At 72 hours post-PEDV inoculation (hpi), the animals either deceased or euthanized were necropsied and intestines were sampled. In all 3 experiments, the piglets showed apparent outward clinical manifestations suggesting that infection occurred despite the CMAH KO. In exp. I, all 6 WT piglets and only 1 of 6 KO piglets died at 72 hpi. Histopathology and immunofluorescence staining showed that the villus epithelial cells of WT piglets were severely exfoliated, but only moderate exfoliation and enterocyte vacuolization was observed in KO piglets. In exp. II, delayed clinical symptoms appeared, yet the immunofluorescence staining/histopathologic inspection (I/H) scores of the two groups differed little. In exp. III, the animals exhibited clinical and pathological signs after inoculation similar to those in exp. II. These results suggest that porcine CMAH KO with nullified NGNA expression are not immune to PEDV but that this KO may lessen the severity of the infection and delay its occurrence.	[Tu, Ching-Fu; Chuang, Chin-kai; Hsiao, Kai-Hsuan; Chen, Chien-Hong; Peng, Su-Hei; Su, Yu-Hsiu; Yen, Chon-Ho; Yang, Tien-Shuh] Agr Technol Res Inst, Anim Technol Labs, Div Anim Technol, Hsinchu, Taiwan; [Hsiao, Kai-Hsuan; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Chen, Chi-Min] Agr Technol Res Inst, Div Anim Med, Anim Technol Labs, Hsinchu, Taiwan; [Chiou, Ming-Tang] Natl Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung, Taiwan; [Hung, Shao-Wen] Agr Technol Res Inst, Anim Technol Labs, Div Anim Ind, Hsinchu, Taiwan; [Yang, Tien-Shuh] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Yilan, Taiwan; [Chen, Chuan-Mu] Natl Chung Hsinh Univ, iEGG & Anim Biotechnol Ctr, Taichung, Taiwan; [Chen, Chien-Hong] Lee Womens Hosp, Reprod Med Ctr, Taichung, Taiwan; [Chen, Chi-Min] Chao Kun Biotech Ltd, Taipei, Taiwan	Agricultural Technology Research Institute; National Chung Hsing University; Agricultural Technology Research Institute; Agricultural Technology Research Institute; National Ilan University	Tu, CF (corresponding author), Agr Technol Res Inst, Anim Technol Labs, Div Anim Technol, Hsinchu, Taiwan.	cftu@mail.atri.org.tw	Chen, Chien-Hong/GOP-2714-2022; Chen, Chuan-Mu/K-7049-2013	Chen, Chien-Hong/0000-0002-6352-3437; Chen, Chuan-Mu/0000-0003-2461-9150	Ministry of Science and Technology, Executive Yuan, Taiwan, ROC [MOST 104-2321-B-866-001, MOST 105-2321-B-886-002, MOST 106-2321-B-866-002]	Ministry of Science and Technology, Executive Yuan, Taiwan, ROC	The financial assistances (MOST 104-2321-B-866-001, MOST 105-2321-B-886-002 and MOST 106-2321-B-866-002, all to CFT) were provided by the Ministry of Science and Technology, Executive Yuan, Taiwan, ROC to support the research and salaries for the author of [YHS]. After approval, the granting institution has no any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisson-Silva F, 2016, MOL ASPECTS MED, V51, P16, DOI 10.1016/j.mam.2016.07.002; Annamalai T, 2015, VET IMMUNOL IMMUNOP, V168, P193, DOI 10.1016/j.vetimm.2015.09.006; Burkard C, 2018, J VIROL, V92, DOI [10.1128/JVI.00415-18, 10.1128/jvi.00415-18]; Burkard C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006206; Chae C, 2000, VET REC, V147, P606, DOI 10.1136/vr.147.21.606; Chen C., 2017, CONTROL PEDV TAIWAN; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Chuang CK, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2321; Chuang CK, 2017, ANIM BIOTECHNOL, V28, P174, DOI 10.1080/10495398.2016.1246453; Chuang Ck, 2016, J CHIN ANIM SCI, V45, P223; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong YY, 2015, VIROLOGY, V478, P1, DOI 10.1016/j.virol.2015.01.020; Cooper DKC, 2016, J PATHOL, V238, P288, DOI 10.1002/path.4635; Council N.R., 2012, NUTR REQ SWIN; Deng F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030055; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; Hernaez B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005595; Ju XD, 2018, J CELL BIOCHEM, V119, P52, DOI 10.1002/jcb.26154; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kamau AN, 2017, VIRUS RES, V227, P150, DOI 10.1016/j.virusres.2016.10.004; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li BX, 2007, VIROLOGY, V365, P166, DOI 10.1016/j.virol.2007.03.031; Lin CN, 2014, J VET MED SCI, V76, P1297, DOI 10.1292/jvms.14-0098; Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15; Madson DM, 2016, VET PATHOL, V53, P44, DOI 10.1177/0300985815591080; Madson DM, 2014, VET MICROBIOL, V174, P60, DOI 10.1016/j.vetmic.2014.09.002; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Oh J, 2014, ARCH VIROL, V159, P2977, DOI 10.1007/s00705-014-2163-7; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Popescu L, 2017, VIROLOGY, V501, P102, DOI 10.1016/j.virol.2016.11.012; Prather RS, 2013, J VIROL, V87, P9538, DOI 10.1128/JVI.00177-13; RHOADS JM, 1986, PEDIATR RES, V20, P879, DOI 10.1203/00006450-198609000-00015; Schultze B, 1996, J VIROL, V70, P5634, DOI 10.1128/JVI.70.8.5634-5637.1996; Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Su YH, 2015, ANIM BIOTECHNOL, V26, P279, DOI 10.1080/10495398.2015.1027774; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Sun RQ, 2014, SCI WORLD J, DOI 10.1155/2014/208439; Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XY, 2019, ARCH VIROL, V164, P83, DOI 10.1007/s00705-018-4061-x; Whitworth KM, 2019, TRANSGENIC RES, V28, P21, DOI 10.1007/s11248-018-0100-3; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Yang HQ, 2018, ANTIVIR RES, V151, P63, DOI 10.1016/j.antiviral.2018.01.004	52	13	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217236	10.1371/journal.pone.0217236	http://dx.doi.org/10.1371/journal.pone.0217236			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141512	Green Submitted, gold, Green Published			2022-12-26	WOS:000469323000046
J	Kashiyama, N; Miyagawa, S; Fukushima, S; Kawamura, T; Kawamura, A; Yoshida, S; Nakamura, Y; Harada, A; Masuda, H; Toda, K; Asahara, T; Sawa, Y				Kashiyama, Noriyuki; Miyagawa, Shigeru; Fukushima, Satsuki; Kawamura, Takuji; Kawamura, Ai; Yoshida, Shohei; Nakamura, Yuki; Harada, Akima; Masuda, Haruchika; Toda, Koichi; Asahara, Takayuki; Sawa, Yoshiki			Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts	PLOS ONE			English	Article							REGULATORY T-CELLS; TRANSPLANTATION; IMMUNOSUPPRESSION; SURVIVAL; THERAPY	Allogeneic transplantation of induced pluripotent stem cell (iPSC)-derived cardiomyocytes is a promising treatment for cardiac diseases, although immune rejection by the recipient poses a concern. In this study, we aimed to investigate whether concomitant transplantation of vasculogenically conditioned peripheral blood mononuclear cells, which are otherwise immunosuppressive, may enhance graft survival. Luciferase-transduced, iPSC-derived cardiomyocytes from C57BL/6 mice were transplanted to the dorsal subcutaneous space of syngeneic C57BL/6 mice (n = 19), allogeneic Balb/c mice treated with (n = 20) or without (n = 20) immunosuppressants, and those injected with vasculogenically conditioned peripheral blood mononuclear cells (n = 20). Although graft survival, assessed by bioluminescence, was comparable among the groups initially, it improved significantly at days 7 and 10 in allogeneic transplanted mice treated with vasculogenically conditioned peripheral blood mononuclear cells than in others (P < 0.01). Our results proved that cell-based immunosuppression may boost clinical outcomes from allogeneic cell therapy.	[Kashiyama, Noriyuki; Miyagawa, Shigeru; Fukushima, Satsuki; Kawamura, Takuji; Kawamura, Ai; Yoshida, Shohei; Nakamura, Yuki; Harada, Akima; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Masuda, Haruchika; Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa, Japan	Osaka University; Tokai University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Miyagawa, Shigeru/0000-0003-0015-6569	AMED Japan Regenerative Medicine Project [15bk0104012h003]	AMED Japan Regenerative Medicine Project	This work was supported by AMED Japan Regenerative Medicine Project Grant numbers 15bk0104012h003 (https://www.amed.go.jp/en/index.html) to T.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Shinya Yamanaka and Keisuke Okita of the Center for iPS Cell Research and Application, Kyoto University, Japan who kindly provided murine iPSCs. We also thank Seiko Eiraku and Hitomi Nishinaka for technical assistance. This work was supported by AMED Japan Regenerative Medicine Project (Grant 15bk0104012h003).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Cai JC, 2010, TRANSPLANTATION, V90, P1511, DOI 10.1097/TP.0b013e3181fecfcb; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hotta K, 2018, TRANSPLANTATION, V102, pE128, DOI 10.1097/TP.0000000000002078; Ichise H, 2017, STEM CELL REP, V9, P853, DOI 10.1016/j.stemcr.2017.07.020; Kashiyama N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165748; Katabathina V, 2016, RADIOL CLIN N AM, V54, P303, DOI 10.1016/j.rcl.2015.09.009; Kawamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19464; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kawamura T, 2016, STEM CELL REP, V6, P312, DOI 10.1016/j.stemcr.2016.01.012; Kawamura T, 2015, STEM CELL TRANSL MED, V4, P1258, DOI 10.5966/sctm.2015-0029; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Manilay JO, 1998, TRANSPLANTATION, V66, P96, DOI 10.1097/00007890-199807150-00015; Masuda H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000743; Masuda H, 2012, STEM CELL TRANSL MED, V1, P160, DOI 10.5966/sctm.2011-0023; Michael M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/608951; Mizukami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098319; Morizane A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00926-5; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Sasaki H, 2015, TRANSPLANTATION, V99, P2301, DOI 10.1097/TP.0000000000000875; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Shiba Y, 2016, NATURE, V538, P388, DOI 10.1038/nature19815; Soares MA, 2018, AM J TRANSPLANT, V18, P1657, DOI 10.1111/ajt.14668; Sugita S, 2016, STEM CELL REP, V7, P635, DOI 10.1016/j.stemcr.2016.08.010	28	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217076	10.1371/journal.pone.0217076	http://dx.doi.org/10.1371/journal.pone.0217076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136599	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300016
J	Ruggieri, M; Berini, C; Ducasa, N; Malkovsky, M; Fisch, P; Biglione, M				Ruggieri, Matias; Berini, Carolina; Ducasa, Nicolas; Malkovsky, Miroslav; Fisch, Paul; Biglione, Mirna			Molecular detection of human T-lymphotropic virus type 1 infection among oncology patients in Germany: A retrospective view	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HTLV-II INFECTIONS; BLOOD-DONORS; DIFFERENTIAL-DIAGNOSIS; MULTIPLEX PCR; EPIDEMIOLOGY; PREVALENCE; TRANSMISSION; MYELOPATHY; ASSAY	Human T-cell lymphotropic virus (HTLV) belongs to a larger group of primate T-cell lymphotropic viruses (PTLVs) within the family Retroviridae. It is estimated that 10 to 20 million people worldwide may be infected with HTLV-1. Although most of them are asymptomatic, around 5% of infected individuals may develop either HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) or Adult T-cell Leukaemia/Lymphoma (ATLL). Public Health authorities in many countries have implemented routine blood-donor tests for HTLV-specific antibodies; but this is not the case for Germany since the reported prevalence is very low (7/100,000). With the aim to evaluate retrospectively the presence of HTLV-1 among oncology patients in this country, samples stored at the Universitatsklinikum Freiburg, were analyzed. For this purpose, two different nested-PCR (n-PCR) protocols have been modified and set up for HTLV-1 detection. One positive case was detected by n-PCR among 406 samples (0,25%) in a period of 5 years (2008-2012) corresponding to a T-Cell Lymphoma. Despite the low prevalence, this virus is circulating in Germany, probably due to the increasing numbers of immigrants in these last years. Physicians should consider HTLV-1 infection and suspect it taking in account the ethnic and relation to endemic regions regardless the patient's residence.	[Ruggieri, Matias; Fisch, Paul] Univ Klinikum Freiburg, Inst Klin Pathol, Freiburg, Germany; [Berini, Carolina; Ducasa, Nicolas; Biglione, Mirna] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Malkovsky, Miroslav] UW Sch Med & Publ Hlth, Madison, WI USA	University of Freiburg; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Wisconsin System	Ruggieri, M (corresponding author), Univ Klinikum Freiburg, Inst Klin Pathol, Freiburg, Germany.	matias.ruggieri@uniklinik-freiburg.de		Malkovsky, Miroslav/0000-0002-5056-5224; Ruggieri, Matias/0000-0002-5959-9092	International Cooperation Project MINCYT-BMBF 2014 (Bilateral project ArgentinaGermany) [AL/14/08-01DN15025]; National Scientific and Technical Research Council [CONICET: PICT 20161033]; German Academic Exchange Service (DAAD); University of Freiburg; German Research Foundation (DFG)	International Cooperation Project MINCYT-BMBF 2014 (Bilateral project ArgentinaGermany); National Scientific and Technical Research Council; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Freiburg; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors are grateful for the funding support by the International Cooperation Project MINCYT-BMBF 2014 (Bilateral project ArgentinaGermany AL/14/08-01DN15025) (MB and PF); National Scientific and Technical Research Council (CONICET: PICT 20161033) (MB) and German Academic Exchange Service (DAAD) for the scholarship (MR). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding program Open Access Publishing. The funders had no role in the study design, the collection, analysis and interpretation of the data, nor in the decision to publish, or preparation of the manuscript.	Biglione MM, 2005, AIDS RES HUM RETROV, V21, P1, DOI 10.1089/aid.2005.21.1; Canepa C, 2015, VIRUSES-BASEL, V7, P5643, DOI 10.3390/v7112897; ec. europa. eu [Internet], EUR COMM MAPP MOR ST; Egan JF, 1999, AIDS RES HUM RETROV, V15, P699, DOI 10.1089/088922299310782; Einsiedel L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006281; Einsiedel L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3366-5; Ellerbrok H, 1998, AIDS RES HUM RETROV, V14, P1199, DOI 10.1089/aid.1998.14.1199; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; eur- lex. europa. eu [Internet], EUROPEAN UNION LAW; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Glowacka I, 2013, CLIN INFECT DIS, V57, P1417, DOI 10.1093/cid/cit545; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; Heneine W, 1996, J ACQ IMMUN DEF SYND, V13, pS236, DOI 10.1097/00042560-199600001-00035; HENEINE W, 1992, J CLIN MICROBIOL, V30, P1605, DOI 10.1128/JCM.30.6.1605-1607.1992; HENRARD DR, 1995, J CLIN MICROBIOL, V33, P1735, DOI 10.1128/JCM.33.7.1735-1738.1995; Heredia A, 1996, CLIN DIAGN VIROL, V7, P85, DOI 10.1016/S0928-0197(96)00255-3; Hitzler W, PREVALENCE HTLV 1 2, P211; Hohn O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183496; Karimi G, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0693-9; KITZE B, 1992, CLIN INVESTIGATOR, V70, P1013; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Tagaya Y, 2019, F1000RESEARCH, P8, DOI [10.12688/f1000research.17047.1, DOI 10.12688/F1000RESEARCH.17047.1]; Toro C, 2003, TRANSPLANTATION, V75, P102, DOI 10.1097/00007890-200301150-00019; TUKE PW, 1992, J VIROL METHODS, V40, P163, DOI 10.1016/0166-0934(92)90065-L; Umeki K, 2017, CLIN LAB, V63, P227, DOI 10.7754/Clin.Lab.2016.160501; VANDAMME AM, 1994, VIROLOGY, V202, P212, DOI 10.1006/viro.1994.1337; Vrielink H, 2004, TRANSFUS MED REV, V18, P46, DOI 10.1016/j.tmrv.2003.10.004; WATTEL E, 1992, J INFECT DIS, V165, P369, DOI 10.1093/infdis/165.2.369	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217560	10.1371/journal.pone.0217560	http://dx.doi.org/10.1371/journal.pone.0217560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136642	Green Published, gold, Green Submitted			2022-12-26	WOS:000469224300050
J	Zhu, QJ; Zhu, M; Xu, XX; Meng, XM; Wu, YG				Zhu, Qi-Jin; Zhu, Mei; Xu, Xing-Xin; Meng, Xiao-Ming; Wu, Yong-Gui			Exosomes from high glucose-treated macrophages activate glomerular mesangial cells via TGF-beta 1/Smad3 pathway in vivo and in vitro	FASEB JOURNAL			English	Article						diabetic nephropathy; activation; proliferation; fibrosis	KIDNEY-DISEASE; EXTRACELLULAR VESICLES; DIABETIC-NEPHROPATHY; INJURY; PROTEINURIA; PROGRESSION; MECHANISMS; INSIGHTS; PODOCYTE	Diabetes nephropathy (DN) is characterized by abnormal interactions between kidney-infiltrating macrophages and glomerular mesangial cells. Recently, a novel cell-cell communication mediated by exosomes has gained attention. Exosomes are membrane-bound vesicles that contain a variety of molecules such as proteins, lipids, DNA, mRNA, and microRNAs. Exosomes play an important role in the pathogenesis of DN. In this study, we show that high glucose (HG) led to increased excretion of exosomes from macrophages. Mesangial cells took up exosomes in vitro, which resulted in the activation and proliferation of mesangial cells and the secretion of extracellular matrix and inflammatory cytokines. In addition, C57BL/6 mice injected with exosomes from HG-treated macrophages showed morphologic and functional changes. We then showed that exosomes from HG-treated TGF-beta 1 knockdown macrophages induced less extracellular matrix and fewer inflammatory factors in mesangial cells compared with vector control. Our findings suggest that TGF-beta 1 mRNA in exosomes serves a role between macrophages and mesangial cells by activating the TGF-beta 1/ mothers against decapentaplegic homolog 3 pathway.-Zhu, Q.-J., Zhu, M., Xu, M.-X., Meng, X.-M., Wu, Y.-G. Exosomes from high glucose-treated macrophages activate glomerular mesangial cells via TGF-beta 1/Smad3 pathway in vivo and in vitro.	[Zhu, Qi-Jin; Zhu, Mei; Xu, Xing-Xin; Wu, Yong-Gui] Anhui Med Univ, Affiliated Hosp 1, Dept Nephrol, 218 Jixi Rd, Hefei 230032, Anhui, Peoples R China; [Meng, Xiao-Ming] Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Wu, YG (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Nephrol, 218 Jixi Rd, Hefei 230032, Anhui, Peoples R China.; Meng, XM (corresponding author), Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	mengxiaoming@ahmu.edu.cn; wuyonggui@medmail.com.cn			National Natural Science Foundation of China [81770722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by National Natural Science Foundation of China (No. 81770722). The authors declare no conflicts of interest.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Badal SS, 2014, AM J KIDNEY DIS, V63, pS63, DOI 10.1053/j.ajkd.2013.10.047; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Fan Z, 2018, IMMUNOL INVEST, V47, P303, DOI 10.1080/08820139.2018.1428199; Hickey FB, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-0984-6; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Krause M, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00065; Kumar A, 2018, PHARMACOL REP, V70, P614, DOI 10.1016/j.pharep.2017.12.008; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Li YC, 2018, EXP THER MED, V15, P4067, DOI 10.3892/etm.2018.5993; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lv LL, 2018, J CELL MOL MED, V22, P728, DOI 10.1111/jcmm.13407; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Pavenstadt H, 2000, AM J PHYSIOL-RENAL, V278, pF173, DOI 10.1152/ajprenal.2000.278.2.F173; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Sagoo MK, 2018, FREE RADICAL BIO MED, V116, P50, DOI 10.1016/j.freeradbiomed.2017.12.040; Sasaki M, 2011, ACTA MED OKAYAMA, V65, P81; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Tesch GH, 2017, CLIN SCI, V131, P2183, DOI 10.1042/CS20160636; Tesch GH, 2010, SEMIN NEPHROL, V30, P290, DOI 10.1016/j.semnephrol.2010.03.007; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Vikram A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/679754; Wang YY, 2018, EUR J PHARMACOL, V824, P185, DOI 10.1016/j.ejphar.2018.01.034; Wu CC, 2011, EXP DIABETES RES, DOI 10.1155/2011/514738; Wu CC, 2010, CLIN CHIM ACTA, V411, P700, DOI 10.1016/j.cca.2010.01.036; Yan YM, 2018, ONCOL LETT, V15, P7479, DOI 10.3892/ol.2018.8348; Yu SMW, 2018, ADV CHRONIC KIDNEY D, V25, P166, DOI 10.1053/j.ackd.2017.12.005; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469	33	42	46	6	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9279	9290		10.1096/fj.201802427RRR	http://dx.doi.org/10.1096/fj.201802427RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162940				2022-12-26	WOS:000478832900046
J	Cong, XY; Yuan, ZL; Du, YJ; Wu, B; Lu, DF; Wu, XJ; Zhang, YJ; Li, F; Wei, B; Li, J; Wu, JQ; Xu, SJ; Wang, JB; Qi, J; Shang, GJ; Gu, LC				Cong, Xiaoyan; Yuan, Zenglin; Du, Yijun; Wu, Bo; Lu, Defen; Wu, Xiangju; Zhang, Youjia; Li, Feng; Wei, Bin; Li, Jun; Wu, Jiaqiang; Xu, Sujuan; Wang, Jinbao; Qi, Jing; Shang, Guijun; Gu, Lichuan			Crystal structures of porcine STING(CBD)-CDN complexes reveal the mechanism of ligand recognition and discrimination of STING proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signaling; pathogen-associated molecular pattern (PAMP); pattern recognition receptor (PRR); cyclic diadenosine monophosphate (c-di-AMP); interferon	CYCLIC DI-GMP; ENDOGENOUS 2ND-MESSENGER; AMP; RECEPTORS; TRANSLOCATION; ACTIVATION; BINDING	The cyclic dinucleotide (CDN)-stimulator of interferon genes (STING) pathway plays an important role in the detection of viral and bacterial pathogens in animals. Previous studies have shown that the metazoan second messenger cyclic [G(2 ',5 ')pA(3 ',5 ')p] (2 ',3 '-cGAMP) generated by cyclic GMP-AMP synthase cGAS binds STING with high affinity compared with bacterial CDNs such as c-di-GMP, c-di-AMP, and 3 ',3 '-cGAMP. Despite recent progress indicating that the CDN-binding domain (CBD) of dimeric STING binds asymmetric 2 ',3 '-cGAMP preferentially over symmetric 3 ',3 '-CDNs, it remains an open question whether STING molecules, such as human STING, adopt a symmetric dimeric conformation to efficiently engage its asymmetric ligand. Here, structural studies of the CBD from porcine STING (STING(CBD)) in complex with CDNs at 1.76-2.6 angstrom resolution revealed that porcine STING(CBD), unlike its human and mouse counterparts, can adopt an asymmetric ligand-binding pocket to accommodate the CDNs. We observed that the extensive interactions and shape complementarity between asymmetric 2 ',3 '-cGAMP and the ligand-binding pocket make it the most preferred ligand for porcine STING and that geometry constraints limit the binding between symmetric 3 ',3 '-CDN and porcine STING. The ligand-discrimination mechanism of porcine STING observed here expands our understanding of how the CDN-STING pathway is activated and of its role in antiviral defense.	[Cong, Xiaoyan; Yuan, Zenglin; Lu, Defen; Xu, Sujuan; Wang, Jinbao; Shang, Guijun; Gu, Lichuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Cong, Xiaoyan; Du, Yijun; Wu, Xiangju; Li, Jun; Wu, Jiaqiang; Qi, Jing] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Sangyuan Rd 8, Jinan 250100, Shandong, Peoples R China; [Wu, Bo; Zhang, Youjia] Chinese Acad Sci, Hefei Inst Phys Sci, Magnet Field Lab, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230026, Anhui, Peoples R China; [Li, Feng] South Dakota State Univ, Dept Biol & Microbiol, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Wei, Bin] Shandong Asia Pacific Highharve Organisms Sci & T, 1 Jinneng Rd, Qihe 251100, Shandong, Peoples R China	Shandong University; Shandong Academy of Agricultural Sciences; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; South Dakota State University	Shang, GJ; Gu, LC (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.; Qi, J (corresponding author), Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Sangyuan Rd 8, Jinan 250100, Shandong, Peoples R China.	qj-happy2008@163.com; gjshang@gmail.com; lcgu@sdu.edu.cn	; Yuan, Zenglin/M-8378-2016	Wu, Bo/0000-0003-4556-0477; Yuan, Zenglin/0000-0003-0517-8249; Du, Yijun/0000-0001-9215-4637	National Natural Science Foundation of China [31470732, 31502051, 31672609, 21673244]; National Key Research and Development Program of China [2016YFD0501505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China Grants 31470732 (to L. G.), 31502051 (to X. C.), 31672609 (to J. Q.) and 21673244 (to Bo. W.) and the National Key Research and Development Program of China Grant 2016YFD0501505 (to Y. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chin KH, 2013, ACTA CRYSTALLOGR D, V69, P352, DOI 10.1107/S0907444912047269; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Denessiouk KA, 2001, PROTEINS, V44, P282, DOI 10.1002/prot.1093; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shi HP, 2015, P NATL ACAD SCI USA, V112, P8947, DOI 10.1073/pnas.1507317112; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Walsh D, 2013, CYTOKINE GROWTH F R, V24, P91, DOI 10.1016/j.cytogfr.2012.09.003; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep18035; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	36	14	14	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11420	11432		10.1074/jbc.RA119.007367	http://dx.doi.org/10.1074/jbc.RA119.007367			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31167783	Green Published, hybrid			2022-12-26	WOS:000478717600007
J	Hashimoto, N; Ito, S; Tsuchida, A; Bhuiyan, RH; Okajima, T; Yamamoto, A; Furukawa, K; Ohmi, Y; Furukawa, K				Hashimoto, Noboru; Ito, Shizuka; Tsuchida, Akiko; Bhuiyan, Robiul H.; Okajima, Tetsuya; Yamamoto, Akihito; Furukawa, Keiko; Ohmi, Yuhsuke; Furukawa, Koichi			The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ganglioside; glycolipid structure; fatty acid; ceramide; membrane; cancer-associated carbohydrate; glycosphingolipid; hydroxylation; immunity; silica acid-binding Ig-like lectin 7 (Siglec-7)	GANGLIOSIDE G(D2); EXPRESSION; GROWTH; ACTIVATION; SYNTHASE; RECEPTOR; COMPLEX; LIGAND	To analyze the binding specificity of a sialic acid-recognizing lectin, sialic acid-binding Ig-like lectin 7 (SIGLEC7), to disialyl gangliosides (GD3s), here we established GD3-expressing cells by introducing GD3 synthase (GD3S or ST8SIA1) cDNA into a colon cancer cell line, DLD-1, that expresses no ligands for the recombinant protein SIGLEC7-Fc. SIGLEC7-Fc did not recognize newly-expressed GD3 on DLD-1 cells, even though GD3 was highly expressed, as detected by an anti-GD3 antibody. Because milk-derived GD3 could be recognized by this fusion protein when incorporated onto the surface of DLD-1 cells, we compared the ceramides in DLD-1-generated and milk-derived GD3s to identify the SIGLEC7-specific GD3 structures on the cell membrane, revealing that SIGLEC7 recognizes only GD3-containing regular ceramides but not phytoceramides. This was confirmed by knockdown/knockout of the sphingolipid delta(4)-desaturase/C4-monooxygenase (DES2) gene, involved in phytoceramide synthesis, disclosing that DES2 inhibition confers SIGLEC7 binding. Furthermore, knocking out fatty acid 2-hydroxylase also resulted in the emergence of SIGLEC7 binding to the cell surface. To analyze the effects of binding between SIGLEC7 and various GD3 species on natural killer function, we investigated cytotoxicity of peripheral blood mononuclear cells from healthy donors toward GD3S-transfected DLD-1 (DLD-1-GD3S) cells and DLD-1-GD3S cells with modified ceramides. We found that cytotoxicity is suppressed in DLD-1-GD3S cells with dehydroxylated GD3s. These results indicate that the ceramide structures in glycosphingolipids affect SIGLEC7 binding and distribution on the cell surface and influence cell sensitivity to killing by SIGLEC7-expressing effector cells.	[Hashimoto, Noboru; Ito, Shizuka; Tsuchida, Akiko; Bhuiyan, Robiul H.; Okajima, Tetsuya; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan; [Bhuiyan, Robiul H.; Furukawa, Keiko; Ohmi, Yuhsuke; Furukawa, Koichi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan; [Hashimoto, Noboru; Yamamoto, Akihito] Tokushima Univ, Grad Sch Biomed Sci, Dept Tissue Regenerat, 3-18-5 Kuramoto Cho, Tokushima 7708504, Japan	Nagoya University; Chubu University; Tokushima University	Furukawa, K (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan.	koichi@isc.chubu.ac.jp		Furukawa, Koichi/0000-0002-3321-9784	Ministry of Education, Culture, Sports and Technology of Japan (MEXT) [15H04696, 15K15080, 25670141, 24390078, 26860320]; Yokoyama Rinsho Yakuri Foundation	Ministry of Education, Culture, Sports and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokoyama Rinsho Yakuri Foundation(Yokoyama Foundation for Clinical Pharmacology)	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports and Technology of Japan (MEXT) 15H04696, 15K15080, 25670141, and 24390078, Grant-in-aid for Young Scientists (B) 26860320, and by a grant from Yokoyama Rinsho Yakuri Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Attrill H, 2006, J BIOL CHEM, V281, P32774, DOI 10.1074/jbc.M601714200; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Crocker PR, 1996, BIOCHEM SOC T, V24, P150, DOI 10.1042/bst0240150; Dan P, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-84; Furukawa K, 2008, J NEUROCHEM, V105, P1057, DOI 10.1111/j.1471-4159.2008.05232.x; Furukawa K, 2012, GLYCOCONJUGATE J, V29, P579, DOI 10.1007/s10719-012-9423-0; Guo L, 2010, J BIOL CHEM, V285, P25438, DOI 10.1074/jbc.M110.119933; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Iwabuchi Kazuhisa, 2008, Glycoconj J, V25, P357, DOI 10.1007/s10719-007-9084-6; Kaneko K, 2016, J BIOL CHEM, V291, P16630, DOI 10.1074/jbc.M115.708834; Karlsson KA, 1998, ACTA BIOCHIM POL, V45, P429, DOI 10.18388/abp.1998_4237; Kawasaki Y, 2015, TOHOKU J EXP MED, V236, P1, DOI 10.1620/tjem.236.1; Kondo Y, 2013, P NATL ACAD SCI USA, V110, P4714, DOI 10.1073/pnas.1218508110; Kota Venkatesh, 2014, Advances in Biological Regulation, V54, P223, DOI 10.1016/j.jbior.2013.09.012; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mito M, 2016, METHODS, V98, P158, DOI 10.1016/j.ymeth.2015.11.007; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Nicoll G, 2003, EUR J IMMUNOL, V33, P1642, DOI 10.1002/eji.200323693; O'Reilly MK, 2010, METHOD ENZYMOL, V478, P343, DOI 10.1016/S0076-6879(10)78017-4; Ohkawa Y, 2015, J BIOL CHEM, V290, P16043, DOI 10.1074/jbc.M114.635755; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Yeh SC, 2016, P NATL ACAD SCI USA, V113, P5592, DOI 10.1073/pnas.1604721113; Yoshida S, 2001, CANCER RES, V61, P4244	27	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10833	10845		10.1074/jbc.RA118.007083	http://dx.doi.org/10.1074/jbc.RA118.007083			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138648	hybrid, Green Published			2022-12-26	WOS:000478717200009
J	Park, EJ; Kwon, YM; Lee, JW; Kang, HY; Oh, JI				Park, Eun-Jin; Kwon, Yu-Mi; Lee, Jin-Won; Kang, Ho-Young; Oh, Jeong-Il			Dual control of RegX3 transcriptional activity by SenX3 and PknB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; Mycobacterium smegmatis; Mycobacterium tuberculosis; serine; threonine protein kinase; signal transduction; transcription regulation; SenX3-RegX3; two-component system	MYCOBACTERIUM-TUBERCULOSIS PKNB; 2-COMPONENT REGULATORY SYSTEM; SERINE/THREONINE KINASES; RESPONSE REGULATOR; GENE-REGULATION; HISTIDINE KINASES; PROTEIN-PHOSPHORYLATION; STAPHYLOCOCCUS-AUREUS; CONSERVED ASPARTATE; SIGNAL-TRANSDUCTION	The mycobacterial SenX3-RegX3 two-component system consists of the SenX3 sensor histidine kinase and its cognate RegX3 response regulator. This system is a phosphorelay-based regulatory system involved in sensing environmental P-i levels and induction of genes required for P-i acquisition under P-i-limiting conditions. Here we demonstrate that overexpression of the kinase domain of Mycobacterium tuberculosis PknB (PknB-KDMtb) inhibits the transcriptional activity of RegX3 of both M. tuberculosis and Mycobacterium smegmatis (RegX3(Mtb) and RegX3(Ms), respectively). Mass spectrometry results, along with those of in vitro phosphorylation and complementation analyses, revealed that PknB kinase activity inhibits the transcriptional activity of RegX3(Mtb) through phosphorylation events at Thr-100, Thr-191, and Thr-217. Electrophoretic mobility shift assays disclosed that phosphorylation of Thr-191 and Thr-217 abolishes the DNA-binding ability of RegX3(Mtb) and that Thr-100 phosphorylation likely prevents RegX3(Mtb) from being activated through conformational changes induced by SenX3-mediated phosphorylation. We propose that the convergence of the PknB and SenX3-RegX3 signaling pathways might enable mycobacteria to integrate environmental P-i signals with the cellular replication state to adjust gene expression in response to P-i availability.	[Park, Eun-Jin; Kang, Ho-Young; Oh, Jeong-Il] Pusan Natl Univ, Dept Microbiol, Busan 46241, South Korea; [Kwon, Yu-Mi] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 02792, South Korea; [Kwon, Yu-Mi; Lee, Jin-Won] Hanyang Univ, Dept Life Sci & Res Inst Nat Sci, Seoul 04763, South Korea	Pusan National University; Korea Institute of Science & Technology (KIST); Hanyang University	Oh, JI (corresponding author), Pusan Natl Univ, Dept Microbiol, Busan 46241, South Korea.	joh@pusan.ac.kr		Oh, Jeong-Il/0000-0002-9250-2627; Kwon, Yumi/0000-0003-0523-6197	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [NRF-2014R1A2A1A11051572]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (NRF-2014R1A2A1A11051572). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal S, 2012, INFECT IMMUN, V80, P1361, DOI 10.1128/IAI.06311-11; Agarwal S, 2011, J BIOL CHEM, V286, P41368, DOI 10.1074/jbc.M111.286690; Bae HJ, 2017, MOL CELLS, V40, P632, DOI 10.14348/molcells.2017.0076; Baek JH, 2007, FEMS MICROBIOL LETT, V277, P254, DOI 10.1111/j.1574-6968.2007.00965.x; Baer CE, 2014, J BIOL CHEM, V289, P20422, DOI 10.1074/jbc.M114.559054; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; Brokaw AM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02523; Canova MJ, 2014, BIOCHEM BIOPH RES CO, V447, P165, DOI 10.1016/j.bbrc.2014.03.128; Carette X, 2018, MBIO, V9, DOI 10.1128/mBio.02333-17; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cousin C, 2013, FEMS MICROBIOL LETT, V346, P11, DOI 10.1111/1574-6968.12189; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Fridman M, 2013, BIOCHEMISTRY-US, V52, P7975, DOI 10.1021/bi401177n; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gardner SG, 2014, J BACTERIOL, V196, P1741, DOI 10.1128/JB.00029-14; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Horstmann N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004088; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Khan MZ, 2018, IUBMB LIFE, V70, P889, DOI 10.1002/iub.1871; Kim MJ, 2010, J BACTERIOL, V192, P4868, DOI 10.1128/JB.00550-10; Kriakov J, 2003, J BACTERIOL, V185, P4983, DOI 10.1128/JB.185.16.4983-4991.2003; Kundu M, 2018, IUBMB LIFE, V70, P710, DOI 10.1002/iub.1872; Lee HN, 2018, MOL MICROBIOL, V108, P661, DOI 10.1111/mmi.13956; Lee HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111680; Lee HN, 2012, J MICROBIOL, V50, P270, DOI 10.1007/s12275-012-2050-4; Lefevre P, 1997, J BACTERIOL, V179, P2900, DOI 10.1128/jb.179.9.2900-2906.1997; Libby EA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005275; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; Manuse S, 2016, FEMS MICROBIOL REV, V40, P41, DOI 10.1093/femsre/fuv041; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Mouncey NJ, 1998, J BACTERIOL, V180, P5612, DOI 10.1128/JB.180.21.5612-5618.1998; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Namugenyi SB, 2017, MBIO, V8, DOI 10.1128/mBio.00494-17; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Ogawara H, 2016, J ANTIBIOT, V69, P660, DOI 10.1038/ja.2015.138; Oh JI, 1999, BIOCHEMISTRY-US, V38, P2688, DOI 10.1021/bi9825100; Ortega C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001746; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Parish T, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0010-2013; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Richard-Greenblatt M, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0005-2015; Rickman L, 2004, BIOCHEM BIOPH RES CO, V314, P259, DOI 10.1016/j.bbrc.2003.12.082; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh N, 2015, ANTIOXID REDOX SIGN, V22, P603, DOI 10.1089/ars.2014.6020; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sridhar R, 2000, PHARM RES-DORDR, V17, P1345, DOI 10.1023/A:1007507224529; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tischler AD, 2013, INFECT IMMUN, V81, P317, DOI 10.1128/IAI.01136-12; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; White DW, 2018, MBIO, V9, DOI 10.1128/mBio.00778-18; Wright DP, 2014, VIRULENCE, V5, P863, DOI 10.4161/21505594.2014.983404; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	73	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					11023	11034		10.1074/jbc.RA119.008232	http://dx.doi.org/10.1074/jbc.RA119.008232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31160336	Green Published, hybrid			2022-12-26	WOS:000478717200023
J	Arshad, R; Sohail, MF; Sarwar, HS; Saeed, H; Ali, I; Akhtar, S; Hussain, SZ; Afzal, I; Jahan, S; Anees-ur-Rehman; Shahnaz, G				Arshad, Rabia; Sohail, Muhammad Farhan; Sarwar, Hafiz Shoaib; Saeed, Hamid; Ali, Imran; Akhtar, Sohail; Hussain, Syed Zajif; Afzal, Iqra; Jahan, Sarwat; Anees-ur-Rehman; Shahnaz, Gul			ZnO-NPs embedded biodegradable thiolated bandage for postoperative surgical site infection: In vitro and in vivo evaluation	PLOS ONE			English	Article							RISK-FACTORS; CHITOSAN NANOPARTICLES; DRUG-RELEASE; MECHANISMS; POLYMERS; MUCIN	Post-operative surgical site infections (SSI) present a serious threat and may lead to complications. Currently available dressings for SSI lack mucoadhesion, safety, efficacy and most importantly patient compliance. We aimed to address these concerns by developing a bioactive thiolated chitosan-alginate bandage embedded with zinc oxide nanoparticles (ZnO-NPs) for localized topical treatment of SSI. The FTIR, XRD, DSC and TGA of bandage confirmed the compatibility of ingredients and modifications made. The porosity, swelling index and lysozyme degradation showed good properties for wound healing and biodegradation. Moreover, in-vitro antibacterial activity showed higher bactericidal effect as compared to ZnO-NPs free bandage. In-vivo wound healing in murine model showed significant improved tissue generation and speedy wound healing as compared to positive and negative controls. Over all, thiolated bandage showed potential as an advanced therapeutic agent for treating surgical site infections, meeting the required features of an ideal surgical dressing.	[Arshad, Rabia; Sohail, Muhammad Farhan; Sarwar, Hafiz Shoaib; Afzal, Iqra; Anees-ur-Rehman; Shahnaz, Gul] Quaid I Azam Univ, Fac Biol Sci, Dept Pharm, Islamabad, Pakistan; [Sohail, Muhammad Farhan; Sarwar, Hafiz Shoaib] Riphah Int Univ, RIPS, Lahore Campus, Lahore, Pakistan; [Saeed, Hamid] Univ Punjab, Univ Coll Pharm, Lahore, Pakistan; [Ali, Imran] Islamia Univ, Univ Coll Agr & Environm Sci, Dept Entomol, Bahawalpur, Pakistan; [Akhtar, Sohail] Victoria Hosp, Bahawalpur, Pakistan; [Hussain, Syed Zajif] LUMS, SBA SSE, Dept Chem & Chem Engn, Lahore, Pakistan; [Jahan, Sarwat] Quaid I Azam Univ, Dept Anim Sci, Islamabad, Pakistan; [Anees-ur-Rehman] USM, Sch Pharmaceut Sci, George Town, Malaysia	Quaid I Azam University; University of Punjab; Lahore University of Management Sciences; Quaid I Azam University; Universiti Sains Malaysia	Sohail, MF; Shahnaz, G (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Pharm, Islamabad, Pakistan.; Sohail, MF (corresponding author), Riphah Int Univ, RIPS, Lahore Campus, Lahore, Pakistan.	farmacist.pk@gmail.com; gshahnaz@qau.edu.pk	Shahnaz, Gul/I-7041-2019; Hussain, Syed Zajif/AAZ-3250-2021	Shahnaz, Gul/0000-0003-0736-2277; Hussain, Syed Zajif/0000-0002-3834-6061; Sohail, Farhan/0000-0002-3970-5003; Arshad, Rabia/0000-0001-7654-3456; ur Rehman, Anees/0000-0002-6502-8464				Afzal I, 2019, NANOMEDICINE; Alfonso-Sanchez JL, 2017, CAN J SURG, V60, P155, DOI 10.1503/cjs.017916; Amna Sirelkhatim DM, 2015, REV ZINC OXIDE NANOP; Anitha A, 2011, CARBOHYD POLYM, V83, P66, DOI 10.1016/j.carbpol.2010.07.028; [Anonymous], INT J MED MED SCI; [Anonymous], AAPS PHARMSCITECH; Archana D, 2013, CARBOHYD POLYM, V95, P530, DOI 10.1016/j.carbpol.2013.03.034; Asija R., 2013, J DRUG DISCOVERY THE, V1; Azoury SC, 2015, CHRONIC WOUND CARE M, V2, P137, DOI 10.2147/CWCMR.S62514; Ball R., 2012, BIOMATERIALS; Begam T, 2003, J APPL POLYM SCI, V89, P779, DOI 10.1002/app.12270; Bernkop-Schnurch A, 2005, ADV DRUG DELIVER REV, V57, P1569, DOI 10.1016/j.addr.2005.07.002; Boateng J, 2015, J PHARM SCI-US, V104, P3653, DOI 10.1002/jps.24610; Carbinatto FM, 2014, ASIAN J PHARM SCI, V9, P27, DOI 10.1016/j.ajps.2013.12.002; Catanzano Ovidio D R, 2017, CARBOHYDRATE POLYM; Cherng J.-H., 2018, STRATEGIES NATURAL P; Chhabra H, 2016, RSC ADV, V6, P1428, DOI 10.1039/c5ra21821g; Davis FM, 2016, J VASC SURG, V64, P870, DOI 10.1016/j.jvs.2016.07.017; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; Dizaj SM, 2014, MAT SCI ENG C-MATER, V44, P278, DOI 10.1016/j.msec.2014.08.031; Doillon CJ, 1987, J BIOMATER APPL, V2, P562, DOI [10.1177/088532828700200404, DOI 10.1177/088532828700200404]; Dragostin Oana Maria S SK, 2016, NEW ANTIMICROBIAL CH; Fernandez-Flores A, 2016, J CUTAN PATHOL, V43, P1005, DOI 10.1111/cup.12782; Florman S, 2001, CLIN INFECT DIS; Gopikrishnan R, 2010, NANO-MICRO LETT, V2, P31, DOI 10.1007/BF03353614; GU JM, 1988, CRC CR REV THER DRUG, V5, P21; Hassan S, 2017, NANO TODAY, V15, P91, DOI 10.1016/j.nantod.2017.06.008; Herning Linn Kira Kolsrud, 2009, THESIS; Hira S, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00945; Idrees A, 2014, ACTA POL PHARM, V71, P287; Iqbal J, 2012, EUR J PHARM BIOPHARM, V80, P95, DOI 10.1016/j.ejpb.2011.09.010; Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v; Kumar PTS, 2013, PHARM RES-DORDR, V30, P523, DOI 10.1007/s11095-012-0898-y; Lee Seung Moon, 2016, Biomater Res, V20, P15, DOI 10.1186/s40824-016-0063-5; Mishra Renuka P N, 2012, REV MINERAL GEOCHEM, V23, P177; Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015; Mohandas Annapoorna, 2015, Int J Nanomedicine, V10 Suppl 1, P53, DOI 10.2147/IJN.S79981; Naz Kiran S G, 2016, AAPS PHARM SCI TECH; Nimesh S, 2006, INT J PHARMACEUT, V323, P146, DOI 10.1016/j.ijpharm.2006.05.065; PEPPAS N A, 1985, Journal of Controlled Release, V2, P257, DOI 10.1016/0168-3659(85)90050-1; Ribeiro Maximiano P., 2009, THESIS; Roy S., 2016, ASIAN J BIOMEDICAL P, V6; Saboktakin MR., 2010, J PHARM ED RES, V1, P62; Safferling K, 2013, J CELL BIOL, V203, P691, DOI 10.1083/jcb.201212020; Saremi S, 2011, INT J NANOMED, V6, P119, DOI 10.2147/IJN.S15500; Siddiqi KS, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2532-3; Smart JD, 2005, ADV DRUG DELIVER REV, V57, P1556, DOI 10.1016/j.addr.2005.07.001; Sohail MF, 2016, J MATER CHEM B, V4, P6240, DOI 10.1039/c6tb01348a; Sriamornsak P, 2008, CARBOHYD POLYM, V74, P458, DOI 10.1016/j.carbpol.2008.03.022; Yu J, 2011, J PHYS C SERIES	50	39	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217079	10.1371/journal.pone.0217079	http://dx.doi.org/10.1371/journal.pone.0217079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170179	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700018
J	Edwards, KL; Miller, MA; Carlstead, K; Brown, JL				Edwards, Katie L.; Miller, Michele A.; Carlstead, Kathy; Brown, Janine L.			Relationships between housing and management factors and clinical health events in elephants in North American zoos	PLOS ONE			English	Article							LOXODONTA-AFRICANA; SERUM PROLACTIN; ANIMAL-WELFARE; ENRICHMENT; MAXIMUS; DISEASE; CORTISOL; BEHAVIOR; PIG; STEREOTYPIES	Elephants experience a number of health issues that can contribute to their well-being and survival. In managed populations, housing conditions and management practices can influence individual health, so potential risk factors associated with morbidity or mortality should be identified to ensure the best possible standards of care. The goal of this study was to determine if the number of clinical events experienced could be a useful welfare indicator in zoo elephants, and to determine factors associated with key pathologies. We used an epidemiological approach to investigate how intrinsic (species, sex, age) and extrinsic (housing, management) factors were associated with both the total number of clinical events, and each of the four most prevalent pathology types (gastrointestinal issues, skin lesions, lameness, foot lesions), over a 12-month period. The study included 220 (127 African; 93 Asian) elephants housed at 61 facilities across North America. More than 1100 clinical events were identified. Species and sex differences were apparent in the types of pathology encountered, and unsurprisingly, the number of clinical events was positively correlated with age. Factors relating to housing (percent time with indoor/outdoor choice, space experience inside, number of unique environments an elephant was housed in, percent time on soft substrate) and management (enrichment diversity, spread of feeding opportunities) were also related to the number of clinical events. However, relationships were often counter to our initial hypotheses, highlighting caution in assuming cause and effect from correlational analyses such as these. Other welfare indicators such as serum and fecal glucocorticoids and serum prolactin were also associated with health status, being higher or more variable in individuals with a greater number of events. This approach provides insight into housing and management factors related to the health of these species in zoos, and in some cases, may reflect management changes that have already been made to mitigate existing or anticipated health concerns.	[Edwards, Katie L.; Carlstead, Kathy; Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA; [Miller, Michele A.] Stellenbosch Univ, Nat Res Fdn Ctr Excellence Biomed TB Res, South African Med Res Council,Ctr TB Res, Dept Sci & Technol,Div Mol Biol & Human Genet,Fac, Cape Town, South Africa	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; South African Medical Research Council; Stellenbosch University	Edwards, KL (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA.	edwardskl@si.edu	Miller, Michele/ABA-1332-2020; Edwards, Katie/K-5559-2015	Miller, Michele/0000-0002-5883-6076; Edwards, Katie/0000-0001-6736-1183	Institute of Museum and Library Services [LG-25-10-0033-10]; Morris Animal Foundation [D15Z0-403]	Institute of Museum and Library Services; Morris Animal Foundation	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Funding support was also provided by a Morris Animal Foundation Training Fellowship Grant (https://www.morrisanimalfoundation.org/) to KLE (Grant number: D15Z0-403). Employers provided financial support in the form of authors' salaries as follows: Smithsonian National Zoological Park and Conservation Biology Institute (KLE, JLB); Honolulu Zoo (KC); Palm Beach Zoo (MAM). The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZA, 2018, AZA STAND EL MAN CAR; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bechert U, 2008, J ZOO WILDLIFE MED, V39, P188, DOI 10.1638/2007-0139R.1; Bedore M. P., 1982, ELEPHANT, V2, P3, DOI DOI 10.22237/ELEPHANT/1521731887; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Brown JL, 1997, ZOO BIOL, V16, P149, DOI 10.1002/(SICI)1098-2361(1997)16:2<149::AID-ZOO5>3.0.CO;2-A; BROWN JL, 2016, PLOS ONE, V11; Carlstead K, 2005, ZOO BIOL, V24, P215, DOI 10.1002/zoo.20050; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Cavallotti CAP., 2008, AGE RELATED CHANGES, DOI 10.1007/978-1-59745-507-7; Chadwick CL, 2017, ANIM WELFARE, V26, P461, DOI 10.7120/09627286.26.4.461; Clauss M, 2007, EUR J WILDLIFE RES, V53, P68, DOI 10.1007/s10344-006-0064-0; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; Csuti B, 2001, ELEPHANTS FOOT PREVE; D'Agata M, 2009, MEAT SCI, V83, P691, DOI 10.1016/j.meatsci.2009.08.005; Das B. K., 2002, Indian Journal of Pediatrics, V69, P663; de Boer SF, 2017, NEUROSCI BIOBEHAV R, V74, P401, DOI 10.1016/j.neubiorev.2016.07.008; Dierenfeld Ellen S., 2006, P57, DOI 10.1002/9780470344484.ch6; Dow TL, 2012, REPROD FERT DEVELOP, V24, P1019, DOI 10.1071/RD11302; DUNLAP KD, 1995, PHYSIOL ZOOL, V68, P608, DOI 10.1086/physzool.68.4.30166347; Edwards KL, 2019, CONSERV PHYSIOL, V7, DOI 10.1093/conphys/coy077; Edwards KL, 2016, GEN COMP ENDOCR, V225, P104, DOI 10.1016/j.ygcen.2015.09.011; El-Khateeb EA, 2011, INT J DERMATOL, V50, P693, DOI 10.1111/j.1365-4632.2010.04752.x; Elsherif NA, 2015, J DERMATOL DERMATOL, V19, P104, DOI 10.1016/j.jdds.2015.03.002; Fagan D. A., 2001, Zoologische Garten, V71, P281; Fazio JM, 2016, ASSESSMENT ADRENAL A; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fernandez LT, 2008, ZOO BIOL, V27, P200, DOI 10.1002/zoo.20180; Foitzik K, 2009, J INVEST DERMATOL, V129, P1071, DOI 10.1038/jid.2008.348; Fowler M, 2006, BIOL MED SURG ELEPHA; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; French F, 2014, P 50 CONV ART INT SI; Gage L, 2001, ELEPHANT'S FOOT, P117; Ganswindt A, 2010, WILDLIFE BIOL, V16, P323, DOI 10.2981/09-081; Gillis-Germitsch N, 2017, ZOO BIOL, V36, P40, DOI 10.1002/zoo.21341; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Godagama W. K., 1999, Ceylon Journal of Science, Biological Sciences, V27, P47; Gold JR, 2012, J VET INTERN MED, V26, P654, DOI 10.1111/j.1939-1676.2012.00910.x; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; Greco BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144276; Greco BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152490; Grindrod JAE, 2001, ANIM WELFARE, V10, P53; Guy JH, 2002, LIVEST PROD SCI, V75, P233, DOI 10.1016/S0301-6226(01)00327-X; Harris M., 2008, WELFARE HOUSING HUSB; Haspeslagh M, 2013, ANIM WELFARE, V22, P437, DOI 10.7120/09627286.22.4.437; Hatt J. -M., 2006, International Zoo Yearbook, V40, P88, DOI 10.1111/j.1748-1090.2006.00088.x; Henderson JV, 2001, ANIM WELFARE, V10, P73; Hermes R, 2004, ANIM REPROD SCI, V82-3, P49, DOI 10.1016/j.anireprosci.2004.05.015; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150331; Holdgate MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153301; Kapur G, 2004, J TROP PEDIATRICS, V50, P37, DOI 10.1093/tropej/50.1.37; Karlen J, 2015, PEDIATRICS, V135, pE1450, DOI 10.1542/peds.2014-2561; Kaufman G, 2009, AN ELEPHANT IN THE R, P69; Kim YS, 2014, WORLD J GASTROENTERO, V20, P10577, DOI 10.3748/wjg.v20.i30.10577; Knierim U, 2006, NJAS-WAGEN J LIFE SC, V54, P133, DOI 10.1016/S1573-5214(06)80017-5; Kottwitz J, 2016, J ZOO WILDLIFE MED, V47, P301, DOI 10.1638/2015-0195.1; Leach MC, 2008, ANIM WELFARE, V17, P171; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; LOBIE PE, 1993, J ENDOCRINOL, V139, P371, DOI 10.1677/joe.0.1390371; Long SY, 2015, ILAR J, V56, P283, DOI 10.1093/ilar/ilv041; Magda S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0438-1; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Maslow JN, 2015, VET PATHOL, V52, P437, DOI 10.1177/0300985814568357; MCCAIN G A, 1989, Journal of Rheumatology, V16, P154; Meehan CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158124; Meehan CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146703; Mikota S.K., 1994, W BLOOMFIELD; Mikota Susan K., 2006, P211, DOI 10.1002/9780470344484.ch15; Miller David, 2015, Veterinary Medicine International, P614690, DOI 10.1155/2015/614690; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Montgomery D.C., 2012, INTRO LINEAR REGRESS; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; NEECK G, 1990, J RHEUMATOL, V17, P24; Nielsen AMW, 2012, J ZOO WILDLIFE MED, V43, P744, DOI 10.1638/2011-0059R2.1; ORTON RK, 1985, EQUINE VET J, V17, P386, DOI 10.1111/j.2042-3306.1985.tb02530.x; PAHUJA DN, 1981, SCIENCE, V214, P1038, DOI 10.1126/science.7302575; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; PILLAI NP, 1981, EUR J PHARMACOL, V72, P11; Powell David M., 2016, Zoo Biology, V35, P298, DOI 10.1002/zoo.21289; Prado-Oviedo NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154750; R Core Team, 2021, R LANGUAGE ENV STAT; Ramanathan A, 2008, J ZOO WILDLIFE MED, V39, P148, DOI 10.1638/2007-0008R1.1; RAMSEY DH, 1972, J ENDOCRINOL, V53, P453, DOI 10.1677/joe.0.0530453; Ruis M, 2004, P 38 ISAE C HELS FIN; Samuelson MM, 2017, J APPL ANIM WELF SCI, V20, P75, DOI 10.1080/10888705.2016.1246362; SCHAPIRO SJ, 1994, ANIM WELFARE, V3, P25; Schoeman JP, 2007, JAVMA-J AM VET MED A, V231, P1534, DOI 10.2460/javma.231.10.1534; SCHOEN RT, 1989, AM J MED, V86, P449, DOI 10.1016/0002-9343(89)90344-6; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Stoinski TS, 2000, ZOO BIOL, V19, P485, DOI 10.1002/1098-2361(2000)19:6&lt;485::AID-ZOO1&gt;3.0.CO;2-5; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; Swaisgood RR, 2001, ANIM BEHAV, V61, P447, DOI 10.1006/anbe.2000.1610; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; Ullrey DE., 1997, ELEPHANTS NUTR DIETA; von Houwald F., 1998, EAZWV SCI M, V2, P323; von Houwald FF, 2001, FOOT PROBLEMS INDIAN; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; West G., 2006, BIOL MED SURG ELEPHA; Whittle BJR, 2003, FUND CLIN PHARMACOL, V17, P301, DOI 10.1046/j.1472-8206.2003.00135.x; Wiedenmayer C, 1998, APPL ANIM BEHAV SCI, V56, P77, DOI 10.1016/S0168-1591(97)00091-9; Wiedner EB, 2012, J ZOO WILDLIFE MED, V43, P125, DOI 10.1638/2011-0088.1; Williams E, 2018, ANIM WELFARE, V27, P235, DOI 10.7120/09627286.27.3.235; Wyss F, 2014, ANIM WELFARE, V23, P57, DOI 10.7120/09627286.23.1.057; Yoshikawa TT, 2000, CLIN INFECT DIS, V30, P931, DOI 10.1086/313792	108	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217774	10.1371/journal.pone.0217774	http://dx.doi.org/10.1371/journal.pone.0217774			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170219	Green Published, Green Submitted, gold			2022-12-26	WOS:000470263700055
J	Zhao, R; Wang, Q; Hu, XX; Nie, TY; Yang, XY; Li, CR; Lu, X; Wang, XK; Jiang, JD; Pang, J; You, XF				Zhao, Rui; Wang, Qing; Hu, Xin-Xin; Nie, Tong-Ying; Yang, Xin-Yi; Li, Cong-Ran; Lu, Xi; Wang, Xiukun; Jiang, Jian-Dong; Pang, Jing; You, Xue-Fu			Microdialysis combined with liquid chromatography-tandem mass spectrometry for the quantitation of gemifloxacin and its application to a muscle penetration study in healthy and MRSA-infected rats	PLOS ONE			English	Article							PHARMACOKINETICS; PHARMACODYNAMICS; LUNG; SUSCEPTIBILITY; GATIFLOXACIN; MOXIFLOXACIN; EFFICACY; FUTURE; TISSUE	Pharmacological efficacy is based on the drug concentration in target tissues, which usually cannot be represented by the plasma concentration. The purpose of this study was to compare the pharmacokinetic characteristics of gemifloxacin in plasma and skeletal muscle and evaluate its tissue penetration in both healthy and MRSA (methicillin-resistant Staphylococcus aureus)-infected rats. A microdialysis (MD) combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated to determine free gemifloxacin concentrations in rat plasma and skeletal muscle simultaneously. The in vivo recoveries of MD were 23.21% +/- 3.42% for skeletal muscle and 20.62% +/- 3.19% for plasma, and were concentration independent. We provided evidence that the method developed here meets FDA requirements. Additionally, this method was successfully applied to the determination of free gemifloxacin in rats. Muscle and blood dialysates were collected after an 18 mg/kg intravenous bolus dose. The mean areas under the concentration-time curves (AUCs) from 0 to 9 h for skeletal muscle and plasma were 3641.50 +/- 915.65 h*ng/mL and 7068.32 +/- 1964.19 h*ng/mL in MRSA-infected rats and 3774.72 +/- 700.36 h*ng/mL and 6927.49 +/- 1714.86 h*ng/mL in healthy rats, respectively. There was no significant difference (P>0.05) in gemifloxacin exposure between healthy rats and MRSA-infected rats for plasma or muscle. The low ratio of AUC(0-9) muscle to AUC(0-9) plasma suggested lower drug exposure in skeletal muscle than in plasma for both healthy and MRSA-infected rats. Our study suggested that the administration of gemifloxacin according to drug levels in plasma to treat local infection is unreasonable and might result in an inadequate dose regimen.	[Zhao, Rui; Wang, Qing; Hu, Xin-Xin; Nie, Tong-Ying; Yang, Xin-Yi; Li, Cong-Ran; Lu, Xi; Wang, Xiukun; Jiang, Jian-Dong; Pang, Jing; You, Xue-Fu] Chinese Acad Med Sci, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China; [Zhao, Rui; Wang, Qing; Hu, Xin-Xin; Nie, Tong-Ying; Yang, Xin-Yi; Li, Cong-Ran; Lu, Xi; Wang, Xiukun; Jiang, Jian-Dong; Pang, Jing; You, Xue-Fu] Chinese Acad Med Sci, Dept Pharmacol, Inst Med Biotechnol, Beijing, Peoples R China; [Zhao, Rui; Wang, Qing; Hu, Xin-Xin; Nie, Tong-Ying; Yang, Xin-Yi; Li, Cong-Ran; Lu, Xi; Wang, Xiukun; Jiang, Jian-Dong; Pang, Jing; You, Xue-Fu] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Pang, J; You, XF (corresponding author), Chinese Acad Med Sci, Beijing Key Lab Antimicrobial Agents, Inst Med Biotechnol, Beijing, Peoples R China.; Pang, J; You, XF (corresponding author), Chinese Acad Med Sci, Dept Pharmacol, Inst Med Biotechnol, Beijing, Peoples R China.	pangjing.pangjing@163.com; xuefuyou@imb.pumc.edu.cn			National Natural Science Foundation of China [81621064, 81361138020]; Beijing Science and Technology Projects [Z141102004414065, Z151100000315029]; CAMS Initiative for Innovative Medicine [2016-I2M-3-014, 2017-I2M-1-012, 2016-I2M-2-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Projects; CAMS Initiative for Innovative Medicine	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, 81621064 and 81361138020 received by XFY), Beijing Science and Technology Projects (http://kw.beijing.gov.cn/, Z141102004414065 and Z151100000315029 received by XFY), CAMS Initiative for Innovative Medicine (http://www.pumc.edu.cn/%/E9%A6%96%E9%A1%B5% 2016-I2M-3-014 received by XFY, 2017-I2M-1-012 received by JP, and 2016-I2M-2-002 received by XW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose PG, 2006, PHARMACOTHERAPY, V26, P129, DOI 10.1592/phco.2006.26.1.129; Araki Harumi, 2002, Drug Metab Pharmacokinet, V17, P237, DOI 10.2133/dmpk.17.237; Azeredo FJ, 2014, CLIN PHARMACOKINET, V53, P205, DOI 10.1007/s40262-014-0131-8; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; Bernardi PM, 2017, J PHARMACEUT BIOMED, V134, P340, DOI 10.1016/j.jpba.2016.10.023; Brunner M, 1999, ANTIMICROB AGENTS CH, V43, P1307, DOI 10.1128/AAC.43.5.1307; Bush K, 2000, CURR OPIN CHEM BIOL, V4, P433, DOI 10.1016/S1367-5931(00)00106-X; Chaurasia CS, 2007, J CLIN PHARMACOL, V47, P589, DOI 10.1177/0091270006299091; Clinical and Laboratory Standards Institute Wayne PA, 2012, M07A10 CLIN LAB STAN, P27; de Araujo BV, 2013, J CHROMATOGR B, V919, P62, DOI 10.1016/j.jchromb.2013.01.006; de Carvalho JF, 2017, ACTA CIR BRAS, V32, P46, DOI 10.1590/s0102-865020170106; FDA, 2013, GUID IND BIOAN METH; Fulzele SV, 2007, TOXICOLOGY, V237, P77, DOI 10.1016/j.tox.2007.05.005; Hutschala D, 2008, INTENS CARE MED, V34, P1827, DOI 10.1007/s00134-008-1122-8; Islinger F, 2004, ANTIMICROB AGENTS CH, V48, P4246, DOI 10.1128/AAC.48.11.4246-4249.2004; Jin HE, 2013, XENOBIOTICA, V43, P355, DOI 10.3109/00498254.2012.720740; Kaiser M, 2011, J CHROMATOGR B, V879, P3639, DOI 10.1016/j.jchromb.2011.09.011; Labreche MJ, 2012, AM J HEALTH-SYST PH, V69, P1863, DOI 10.2146/ajhp110464; Marino A, 2016, INT J ANTIMICROB AG, V48, P395, DOI 10.1016/j.ijantimicag.2016.06.026; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; Muller M, 2004, ANTIMICROB AGENTS CH, V48, P1441, DOI 10.1128/AAC.48.5.1441-1453.2004; Muller M, 1999, ANTIMICROB AGENTS CH, V43, P2345, DOI 10.1128/AAC.43.10.2345; Nix DE, 2004, ANTIMICROB AGENTS CH, V48, P3419, DOI 10.1128/AAC.48.9.3419-3424.2004; Ramji JV, 2001, DRUG METAB DISPOS, V29, P435; Roberts DJ, 2008, EXPERT OPIN DRUG MET, V4, P1245, DOI 10.1517/17425255.4.10.1245 ; Roberts JA, 2012, BRIT J CLIN PHARMACO, V73, P27, DOI 10.1111/j.1365-2125.2011.04080.x; Saravolatz LD, 2003, CLIN INFECT DIS, V37, P1210, DOI 10.1086/378809; Segreti J, 2012, J OCUL PHARMACOL TH, V28, P3, DOI 10.1089/jop.2011.0072; Tasso L, 2008, INT J PHARMACEUT, V358, P96, DOI 10.1016/j.ijpharm.2008.02.023; Wagdy HA, 2019, TURK J PHARM SCI, V16, P8, DOI 10.4274/tjps.04934	30	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217573	10.1371/journal.pone.0217573	http://dx.doi.org/10.1371/journal.pone.0217573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170198	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700042
J	Chang, CL; Hsu, SYT				Chang, Chia Lin; Hsu, Sheau Yu Teddy			Development of chimeric and bifunctional antagonists for CLR/RAMP receptors	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; CGRP RECEPTOR; CALCITONIN-RECEPTOR; ADRENOMEDULLIN-RAMP2 SYSTEM; THERAPEUTIC TARGET; CANCER CURRENT; GROWTH-FACTOR; KEY RESIDUE; ALPHA-CGRP; IN-VITRO	CGRP, adrenomedullin (ADM), and adrenomedullin 2 (ADM2) family peptides are important neuropeptides and hormones for the regulation of neurotransmission, vasotone, cardiovascular morphogenesis, vascular integrity, and feto-placental development. These peptides signal through CLR/RAMP1, 2 and 3 receptor complexes. CLR/RAMP1, or CGRP receptor, antagonists have been developed for the treatment of migraine headache and osteoarthritis pain; whereas CLR/RAMP2, or ADM receptor, antagonists are being developed for the treatment of tumor growth/metastasis. Based on the finding that an acylated chimeric ADM/ADM2 analog potently stimulates CLR/RAMP1 and 2 signaling, we hypothesized that the binding domain of this analog could have potent inhibitory activity on CLR/RAMP receptors. Consistent with this hypothesis, we showed that acylated truncated ADM/ADM2 analogs of 27-31 residues exhibit potent antagonistic activity toward CLR/RAMP1 and 2. On the other hand, nonacylated analogs have minimal activity. Further truncation at the junctional region of these chimeric analogs led to the generation of CLR/RAMP1-selective antagonists. A 17-amino-acid analog (Antagonist 2-4) showed 100-fold selectivity for CLR/RAMP1 and was >100-fold more potent than the classic CGRP receptor antagonist CGRP8-37. In addition, we showed (1) a lysine residue in the Antagonist 2-4 is important for enhancing the antagonistic activity, (2) an analog consisted of an ADM sequence motif and a 12-amino-acid binding domain of CGRP exhibits potent CLR/RAMP1-inhibitory activity, and (3) a chimeric analog consisted of a somatostatin analog and an ADM antagonist exhibits dual activities on somatostatin and CLR/RAMP receptors. Because the blockage of CLR/RAMP signaling prevents migraine pain and suppresses tumor growth/metastasis, further studies of these analogs, which presumably have better access to the tumor microenvironment and nerve endings at the trigeminal ganglion and synovial joints as compared to antibody-based therapies, may lead to the development of better anti-CGRP therapy and alternative antiangiogenesis therapy. Likewise, the use of bifunctional somatostatin-ADM antagonist analogs could be a promising strategy for the treatment of high-grade neuroendocrine tumors by targeting an antiangiogenesis agent to the neuroendocrine tumor microenvironment.	[Chang, Chia Lin] Chang Gung Univ, Dept Obstet & Gynecol, Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan; [Hsu, Sheau Yu Teddy] Adepthera LLC, San Jose, CA 95035 USA	Chang Gung Memorial Hospital; Chang Gung University	Hsu, SYT (corresponding author), Adepthera LLC, San Jose, CA 95035 USA.	SYT.HSU@adepthera.com			Eunice Kennedy Shriver National Institute of Child Health and Human Development SBIR awards [1R43HD078056-01A1, 1R41HD082698-01]; National Heart, Lung, and Blood Institute SBIR award [1R43HL127808-01]; Adepthera LLC	Eunice Kennedy Shriver National Institute of Child Health and Human Development SBIR awards; National Heart, Lung, and Blood Institute SBIR award; Adepthera LLC	This study was partly supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development SBIR awards (1R43HD078056-01A1 and 1R41HD082698-01, SYTH), National Heart, Lung, and Blood Institute SBIR award (1R43HL127808-01, SYTH), and Adepthera LLC. The funders provided support in the form of salaries for SYTH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa J, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0864-8; Aiyar N, 2001, J PHARMACOL EXP THER, V296, P768; Albertin G, 2010, INT J MOL MED, V26, P289, DOI 10.3892/ijmm_00000464; Andreassen KV, 2014, AM J PHYSIOL-ENDOC M, V307, pE24, DOI 10.1152/ajpendo.00121.2014; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Benschop RJ, 2014, OSTEOARTHR CARTILAGE, V22, P578, DOI 10.1016/j.joca.2014.01.009; Berenguer-Daize C, 2013, CLIN CANCER RES, V19, P6138, DOI 10.1158/1078-0432.CCR-13-0691; Bigal ME, 2015, BRIT J CLIN PHARMACO, V79, P886, DOI 10.1111/bcp.12591; Boeglin D, 2007, J MED CHEM, V50, P1401, DOI 10.1021/jm061343w; Boulanger Y, 1996, INT J PEPT PROT RES, V47, P477; Bradley J, 2009, METHODS MOL BIOL, V552, P171, DOI 10.1007/978-1-60327-317-6_12; BREEZE AL, 1991, BIOCHEMISTRY-US, V30, P575, DOI 10.1021/bi00216a036; Bullock CM, 2014, ARTHRITIS RHEUMATOL, V66, P2188, DOI 10.1002/art.38656; Carpenter KA, 2001, BIOCHEMISTRY-US, V40, P8317, DOI 10.1021/bi0102860; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; CHOY M, 2018, P & T, V43, P462; Conner AC, 2002, BIOCHEM SOC T, V30, P451, DOI 10.1042/bst0300451; Conteduca V, 2014, CRIT REV ONCOL HEMAT, V92, P11, DOI 10.1016/j.critrevonc.2014.05.008; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Cornish J, 2001, J ENDOCRINOL, V170, P251, DOI 10.1677/joe.0.1700251; D'Angelillo RM, 2014, TUMORI, V100, P249, DOI 10.1700/1578.17192; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Deen M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0807-1; DENNIS T, 1990, J PHARMACOL EXP THER, V254, P123; Deville JL, 2010, EXPERT OPIN THER TAR, V14, P1059, DOI 10.1517/14728222.2010.522328; Dong YL, 2003, MOL HUM REPROD, V9, P481, DOI 10.1093/molehr/gag058; Dong YL, 2007, BIOL REPROD, V76, P892, DOI 10.1095/biolreprod.106.059089; Doods H, 2000, BRIT J PHARMACOL, V129, P420, DOI 10.1038/sj.bjp.0703110; Dunworth WP, 2008, PEPTIDES, V29, P2243, DOI 10.1016/j.peptides.2008.09.009; Durham PL, 2010, CNS DRUGS, V24, P539, DOI 10.2165/11534920-000000000-00000; Edvinsson L, 2008, BRIT J PHARMACOL, V155, P967, DOI 10.1038/bjp.2008.346; Edvinsson L, 2008, LANCET, V372, P2089, DOI 10.1016/S0140-6736(08)61710-9; Erdener SE, 2014, BRIT J PHARMACOL, V171, P4575, DOI 10.1111/bph.12651; Feistel S, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-93; Fernandez AP, 2010, ENDOCRINOLOGY, V151, P4908, DOI 10.1210/en.2010-0121; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Hendrikse ER, 2019, CEPHALALGIA, V39, P403, DOI 10.1177/0333102418765787; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Holmes D, 2013, CURR PROTEIN PEPT SC, V14, P294, DOI 10.2174/13892037113149990049; Howitt SG, 2003, BRIT J PHARMACOL, V138, P325, DOI 10.1038/sj.bjp.0705040; Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; Jacobs B, 2016, NEUROSCIENCE, V338, P130, DOI 10.1016/j.neuroscience.2016.06.012; Jin Y, 2018, OSTEOARTHR CARTILAGE, V26, P1609, DOI 10.1016/j.joca.2018.08.019; Jin Y, 2016, OSTEOARTHR CARTILAGE, V24, pS50, DOI 10.1016/j.joca.2016.01.114; Kaafarani I, 2009, FASEB J, V23, P3424, DOI 10.1096/fj.08-127852; Khalfaoui-Bendriss G, 2015, ONCOTARGET, V6, P7536, DOI 10.18632/oncotarget.3167; KITAMURA K, 1994, FEBS LETT, V341, P288, DOI 10.1016/0014-5793(94)80474-5; Korner C, 2014, PEPTIDES, V62, P49, DOI 10.1016/j.peptides.2014.09.022; Koyama T, 2015, J ATHEROSCLER THROMB, V22, P647, DOI 10.5551/jat.29967; Koyama T, 2013, CIRCULATION, V127, P842, DOI 10.1161/CIRCULATIONAHA.112.000756; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Lang M, 2006, J MED CHEM, V49, P616, DOI 10.1021/jm050613s; Larrayoz IM, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0339-2; Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628; Li CC, 2015, BRIT J CLIN PHARMACO, V79, P831, DOI 10.1111/bcp.12547; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Lv Y, 2016, J BIOL CHEM, V291, P23390, DOI 10.1074/jbc.M116.735563; Ma WY, 2006, P NATL ACAD SCI USA, V103, P16027, DOI 10.1073/pnas.0602488103; Maas D, 2013, PROCEEDINGS OF THE 2013 38TH ANNUAL IEEE CONFERENCE ON LOCAL COMPUTER NETWORKS WORKSHOPS (LCN WORKSHOPS), P203, DOI 10.1109/LCNW.2013.6758520; MAGGI CA, 1995, PROG NEUROBIOL, V45, P1, DOI 10.1016/0301-0082(94)E0017-B; Marinoni E, 2011, EUR J OBSTET GYN R B, V154, P146, DOI 10.1016/j.ejogrb.2010.10.013; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Michibata H, 1998, KIDNEY INT, V53, P979, DOI 10.1111/j.1523-1755.1998.00855.x; Michot B, 2015, EUR J PAIN, V19, P281, DOI 10.1002/ejp.616; Minatani A, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0460-4; Miranda LP, 2008, J MED CHEM, V51, P7889, DOI 10.1021/jm8009298; Moore EL, 2012, BRIT J PHARMACOL, V166, P66, DOI 10.1111/j.1476-5381.2011.01633.x; Muff R, 1998, FEBS LETT, V441, P366, DOI 10.1016/S0014-5793(98)01587-7; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Negro A, 2012, EXPERT OPIN INV DRUG, V21, P807, DOI 10.1517/13543784.2012.681044; Nouguerede E, 2013, CANCER MED-US, V2, P196, DOI 10.1002/cam4.51; Ochoa-Callejero L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17573-x; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Perez-Castells J, 2012, BIOPOLYMERS, V97, P45, DOI 10.1002/bip.21700; Poyner DR, 1998, BRIT J PHARMACOL, V124, P1659, DOI 10.1038/sj.bjp.0702032; Qian SJ, 2005, CHINESE J ASTRON AST, V5, P27, DOI 10.1088/1009-9271/5/1/004; Recober A, 2009, J NEUROSCI, V29, P8798, DOI 10.1523/JNEUROSCI.1727-09.2009; Rist B, 1998, J MED CHEM, V41, P117, DOI 10.1021/jm970533r; Roehrkasse AM, 2018, J BIOL CHEM, V293, P15840, DOI 10.1074/jbc.RA118.005062; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; ROVERO P, 1992, PEPTIDES, V13, P1025, DOI 10.1016/0196-9781(92)90067-D; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Russo AF, 2015, BRIT J CLIN PHARMACO, V80, P403, DOI 10.1111/bcp.12686; Russo AF, 2015, ANNU REV PHARMACOL, V55, P533, DOI 10.1146/annurev-pharmtox-010814-124701; Schou WS, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0741-2; Schuster NM, 2016, NAT REV NEUROL, V12, P635, DOI 10.1038/nrneurol.2016.143; Shi LC, 2016, J PHARMACOL EXP THER, V356, P223, DOI 10.1124/jpet.115.227793; Smith DD, 2003, J MED CHEM, V46, P2427, DOI 10.1021/jm020507f; Smith RS, 2009, AM J PHYSIOL-HEART C, V297, pH1040, DOI 10.1152/ajpheart.00404.2009; Storer RJ, 2004, BRIT J PHARMACOL, V142, P1171, DOI 10.1038/sj.bjp.0705807; Takano S, 2017, J PAIN RES, V10, P1099, DOI 10.2147/JPR.S135939; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Taniguchi A, 2015, INT J CLIN EXP PATHO, V8, P12967; Taylor CK, 2007, CHEM BIOL DRUG DES, V70, P216, DOI 10.1111/j.1747-0285.2007.00558.x; Taylor CK, 2006, J PHARMACOL EXP THER, V319, P749, DOI 10.1124/jpet.106.108316; Tepper SJ, 2018, HEADACHE, V58, P238, DOI 10.1111/head.13379; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Thakur MK, 2018, CLIN GENITOURIN CANC, V16, pE695, DOI 10.1016/j.clgc.2018.01.019; Tsatsaris V, 2002, J CLIN ENDOCR METAB, V87, P4383, DOI 10.1210/jc.2002-020138; Tso AR, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0463-4; Tsuchiya K, 2010, INT J ONCOL, V36, P1379, DOI 10.3892/ijo_00000622; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Verheggen R, 2002, BRIT J PHARMACOL, V136, P120, DOI 10.1038/sj.bjp.0704682; Walsh DA, 2015, BRIT J CLIN PHARMACO, V80, P965, DOI 10.1111/bcp.12669; Wang BC, 2017, J THERM SCI TECH-JPN, V12, DOI 10.1299/jtst.2017jtst0008; Wang DM, 2011, BEHAV BRAIN RES, V221, P83, DOI 10.1016/j.bbr.2011.02.046; Wang LJ, 2014, INT J CANCER, V134, P2041, DOI 10.1002/ijc.28542; Watkins HA, 2013, BRIT J PHARMACOL, V169, P143, DOI 10.1111/bph.12118; Watkins HA, 2013, BRIT J PHARMACOL, V170, P1308, DOI 10.1111/bph.12072; Williams ET, 2018, ANGEW CHEM INT EDIT, V57, P11640, DOI 10.1002/anie.201805208; Woolley MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0589; Yu DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077824; Zeller J, 2008, BRIT J PHARMACOL, V155, P1093, DOI 10.1038/bjp.2008.334; Zeng X, 2014, EUR J PAIN, V18, P1323, DOI 10.1002/j.1532-2149.2014.493.x; Zheng SA, 2010, AM J PHYSIOL-CELL PH, V299, pC1485, DOI 10.1152/ajpcell.00173.2010	117	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216996	10.1371/journal.pone.0216996	http://dx.doi.org/10.1371/journal.pone.0216996			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150417	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100028
J	Cheng, YW; Chang, YC; Chen, YL; Chen, RC; Chou, CT				Cheng, Yi-Wen; Chang, Ya-Chien; Chen, Yao-Li; Chen, Ran-Chou; Chou, Chen-Te			Feasibility of measuring spleen stiffness with MR elastography and splenic volume to predict hepatic fibrosis stage	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; LIVER FIBROSIS; PORTAL-HYPERTENSION; DIAGNOSTIC PERFORMANCE; NONINVASIVE ASSESSMENT; ESOPHAGEAL-VARICES; REPEATABILITY; SIZE	Aim The aim of this study was to investigate the relationship between spleen stiffness value, splenic volume and the liver fibrosis stages. Materials and methods This retrospective study was approved by the institutional review board of our institute. We enrolled 109 patients that had undergone abdominal MR imaging and histopathological examination. The preoperative MR imaging, MR elastography and laboratory data were reviewed. Liver stiffness and spleen stiffness were determined with MR elastography, and splenic volume was calculated. Liver fibrosis stage was determined using surgical pathology. Results The correlation coefficient between the liver stiffness and the fibrosis stage was r = 0.72 and r = 0.62 when the passive driver was on right chest wall and the left chest wall, respectively. The correlation coefficient between the spleen stiffness and the fibrosis stage was r = 0.63 and r = 0.18 when the passive driver was on the left chest wall and the right chest wall, respectively. The correlation coefficient between the splenic volume and the fibrosis stage was r = 0.31. The diagnostic performance of spleen stiffness was similar to liver stiffness in prediction of advanced liver fibrosis. The combination of spleen stiffness and liver stiffness provided greater sensitivity in prediction of advanced fibrosis than spleen or liver stiffness alone, but no significant difference was found. Conclusion According to our study, the spleen stiffness value was useful in staging liver fibrosis. The combination of spleen stiffness and liver stiffness could provide higher diagnostic sensitivity than liver stiffness alone in prediction of advanced fibrosis.	[Cheng, Yi-Wen; Chen, Ran-Chou] Natl Yang Ming Med Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Chang, Ya-Chien; Chou, Chen-Te] Changhua Christian Hosp, Dept Radiol, Changhua, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Chou, Chen-Te] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chou, Chen-Te] Dayeh Univ, Coll Biotechnol & Bioresources, Dept Mol Biotechnol, Changhua, Taiwan	National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; Kaohsiung Medical University; Da Yeh University	Chou, CT (corresponding author), Changhua Christian Hosp, Dept Radiol, Changhua, Taiwan.; Chou, CT (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.; Chou, CT (corresponding author), Dayeh Univ, Coll Biotechnol & Bioresources, Dept Mol Biotechnol, Changhua, Taiwan.	96888@cch.org.tw		Chou, Chen-Te/0000-0003-1879-8105				Bensamoun SF, 2008, J MAGN RESON IMAGING, V28, P1287, DOI 10.1002/jmri.21523; Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chang W, 2016, RADIOLOGY, V280, P88, DOI 10.1148/radiol.2016150397; Chen XL, 2013, J MAGN RESON IMAGING, V38, P540, DOI 10.1002/jmri.24007; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Hines CDG, 2010, J MAGN RESON IMAGING, V31, P725, DOI 10.1002/jmri.22066; Hirsch S, 2014, J MAGN RESON IMAGING, V39, P298, DOI 10.1002/jmri.24165; Ichikawa S, 2017, J MAGN RESON IMAGING, V46, P375, DOI 10.1002/jmri.25551; Ichikawa S, 2012, MAGN RESON MED SCI, V11, P291, DOI 10.2463/mrms.11.291; Kim D, 2013, RADIOLOGY, V268, P411, DOI 10.1148/radiol.13121193; Lee YJ, 2014, J MAGN RESON IMAGING, V39, P326, DOI 10.1002/jmri.24147; Liu P, 2009, WORLD J GASTROENTERO, V15, P3298, DOI 10.3748/wjg.15.3298; Mannelli L, 2010, AM J ROENTGENOL, V195, P387, DOI 10.2214/AJR.09.3390; Mariappan YK, 2009, MAGN RESON MED, V61, P678, DOI 10.1002/mrm.21885; Morisaka H, 2018, J MAGN RESON IMAGING, V47, P1268, DOI 10.1002/jmri.25868; Morisaka H, 2017, J MAGN RESON IMAGING, V45, P1163, DOI 10.1002/jmri.25425; Morisaka H, 2015, J MAGN RESON IMAGING, V41, P117, DOI 10.1002/jmri.24505; Nedredal GI, 2011, J MAGN RESON IMAGING, V34, P79, DOI 10.1002/jmri.22610; Runge JH, 2014, ABDOM IMAGING, V39, P283, DOI 10.1007/s00261-013-0063-z; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Shi Y, 2014, RADIOLOGY, V273, P88, DOI 10.1148/radiol.14132592; Shin SU, 2014, RADIOLOGY, V272, P143, DOI 10.1148/radiol.14130916; Simon TG, 2015, J HEPATOL, V62, P18, DOI 10.1016/j.jhep.2014.08.013; Singh S, 2015, CLIN GASTROENTEROL H, V13, P440, DOI 10.1016/j.cgh.2014.09.046; Sporea I, 2010, WORLD J GASTROENTERO, V16, P4832, DOI 10.3748/wjg.v16.i38.4832; Sun HY, 2014, J MAGN RESON IMAGING, V39, P559, DOI 10.1002/jmri.24186; Takuma Y, 2017, CLIN GASTROENTEROL H, V15, P1782, DOI 10.1016/j.cgh.2016.10.041; Talwalkar JA, 2009, AM J ROENTGENOL, V193, P122, DOI 10.2214/AJR.07.3504; TARAO K, 1989, HEPATOLOGY, V9, P589, DOI 10.1002/hep.1840090413; Wagner M, 2018, J MAGN RESON IMAGING, V48, P1091, DOI 10.1002/jmri.26026; Yin M, 2013, J MAGN RESON IMAGING, V38, P809, DOI 10.1002/jmri.24049; Yin M, 2011, AM J ROENTGENOL, V197, P64, DOI 10.2214/AJR.10.5989	33	7	10	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217876	10.1371/journal.pone.0217876	http://dx.doi.org/10.1371/journal.pone.0217876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150508	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100124
J	Felix, TF; Lapa, RML; de Carvalho, M; Bertoni, N; Tokar, T; Oliveira, RA; Rodrigues, MAM; Hasimoto, CN; Oliveira, WK; Pelafsky, L; Spadella, CT; Llanos, JC; Silva, GF; Lam, WL; Rogatto, SR; Amorim, LS; Drigo, SA; Carvalho, RF; Reis, PP				Felix, Tainara F.; Lopez Lapa, Rainer M.; de Carvalho, Marcio; Bertoni, Natalia; Tokar, Tomas; Oliveira, Rogerio A.; Rodrigues, Maria A. M.; Hasimoto, Claudia N.; Oliveira, Walmar K.; Pelafsky, Leonardo; Spadella, Cesar T.; Llanos, Juan C.; Silva, Giovanni F.; Lam, Wan L.; Rogatto, Silvia Regina; Amorim, Luciana Schultz; Drigo, Sandra A.; Carvalho, Robson F.; Reis, Patricia P.			MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CANCER; SUBTYPES; IMMUNOTHERAPY; INTERLEUKIN-6; LEUKOPLAKIA; COMPLEXITY; SIGNATURE; CARCINOMA; DATABASE	Despite progress in treatment strategies, only similar to 24% of pancreatic ductal adenocarcinoma (PDAC) patients survive > 1 year. Our goal was to elucidate deregulated pathways modulated by microRNAs (miRNAs) in PDAC and Vater ampulla (AMP) cancers. Global miRNA expression was identified in 19 PDAC, 6 AMP and 25 paired, histologically normal pancreatic tissues using the GeneChip 4.0 miRNA arrays. Computational approaches were used for miRNA target prediction/identification of miRNA-regulated pathways. Target gene expression was validated in 178 pancreatic cancer and 4 pancreatic normal tissues from The Cancer Genome Atlas (TCGA). 20 miRNAs were significantly deregulated (FC >= 2 and p< 0.05) (15 down-and 5 up-regulated) in PDAC. miR-216 family (miR-216a-3p, miR-216a5p, miR-216b-3p and miR-216b-5p) was consistently down-regulated in PDAC. miRNA-modulated pathways are associated with innate and adaptive immune system responses in PDAC. AMP cancers showed 8 down-and 1 up-regulated miRNAs (FDR p< 0.05). Most enriched pathways (p< 0.01) were RAS and Nerve Growth Factor signaling. PDAC and AMP display different global miRNA expression profiles and miRNA regulated networks/tumorigenesis pathways. The immune response was enriched in PDAC, suggesting the existence of immune checkpoint pathways more relevant to PDAC than AMP.	[Felix, Tainara F.; Bertoni, Natalia; Hasimoto, Claudia N.; Oliveira, Walmar K.; Pelafsky, Leonardo; Spadella, Cesar T.; Llanos, Juan C.; Drigo, Sandra A.; Reis, Patricia P.] Sao Paulo State Univ UNESP, Fac Med, Dept Surg & Orthoped, Botucatu, SP, Brazil; [Felix, Tainara F.; Lopez Lapa, Rainer M.; Bertoni, Natalia; Drigo, Sandra A.; Reis, Patricia P.] Sao Paulo State Univ UNESP, Fac Med, Expt Res Unity UNIPEX, Botucatu, SP, Brazil; [Lopez Lapa, Rainer M.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Genet, Botucatu, SP, Brazil; [de Carvalho, Marcio] Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Vet Clin, Botucatu, SP, Brazil; [Tokar, Tomas] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Oliveira, Rogerio A.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil; [Rodrigues, Maria A. M.] Sao Paulo State Univ UNESP, Fac Med, Dept Pathol, Botucatu, SP, Brazil; [Silva, Giovanni F.] Sao Paulo State Univ UNESP, Fac Med, Dept Clin & Gastroenterol, Botucatu, SP, Brazil; [Lam, Wan L.] British Columbia Canc Ctr, Genet Unity, Integrat Oncol, Vancouver, BC, Canada; [Rogatto, Silvia Regina] Univ Southern Denmark, Vejle Hosp, Inst Reg Hlth Res, Dept Clin Genet, Odense, Denmark; [Amorim, Luciana Schultz] Inst Pathol Anat, Piracicaba, SP, Brazil; [Carvalho, Robson F.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; British Columbia Cancer Agency; University of Southern Denmark; Lillebaelt Hospital; Universidade Estadual Paulista	Reis, PP (corresponding author), Sao Paulo State Univ UNESP, Fac Med, Dept Surg & Orthoped, Botucatu, SP, Brazil.; Reis, PP (corresponding author), Sao Paulo State Univ UNESP, Fac Med, Expt Res Unity UNIPEX, Botucatu, SP, Brazil.	patricia.reis@unesp.br	Drigo, Sandra A/I-6514-2012; LINDE, SANDRA/S-3128-2019; Amorim, Luciana Schultz/AAR-3947-2020; Bertoni, Natália/B-7053-2018; dos Reis, Patricia Pintor/F-4701-2012; Carvalho, Robson Francisco/AAE-4134-2020; Felix, Tainara Francini/V-3420-2017	Drigo, Sandra A/0000-0001-6747-6642; LINDE, SANDRA/0000-0001-6747-6642; Amorim, Luciana Schultz/0000-0002-9134-0216; Bertoni, Natália/0000-0002-8623-0573; dos Reis, Patricia Pintor/0000-0003-3775-3797; Carvalho, Robson Francisco/0000-0002-4901-7714; Rogatto, Silvia/0000-0003-4637-5687; Lopez Lapa, Rainer Marco/0000-0002-2879-5138; Felix, Tainara Francini/0000-0003-3155-9088	Sao Paulo Research Foundation (FAPESP) [2016/03905-2]; Coordination for the Improvement of Higher Level Education (CAPES); FAPESP [2014/00367-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Level Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Research funds were obtained from Sao Paulo Research Foundation (FAPESP) (grant #2016/03905-2 to P. P. Reis). T.F.F. was funded, in separate time periods, through the Coordination for the Improvement of Higher Level Education (CAPES) and FAPESP -fellowship #2014/00367-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Daniel H, 2014, Am Soc Clin Oncol Educ Book, P112, DOI 10.14694/EdBook_AM.2014.34.112; Askew J, 2013, HPB, V15, P829, DOI 10.1111/hpb.12038; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bellone G, 2006, CANCER IMMUNOL IMMUN, V55, P684, DOI 10.1007/s00262-005-0047-0; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Birnbaum DJ, 2018, BBA-REV CANCER, V1869, P248, DOI 10.1016/j.bbcan.2018.02.001; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, 2017, Cancer Cell, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Cervigne NK, 2014, HUM MOL GENET, V23, P2618, DOI 10.1093/hmg/ddt657; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Chae YK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19454-3; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Cid-Arregui A, 2015, WORLD J GASTROENTERO, V21, P9297, DOI 10.3748/wjg.v21.i31.9297; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Cortesini R, 2007, J PANCREAS, V8, P697; Curtale G, 2013, INT J MOL SCI, V14, P17347, DOI 10.3390/ijms140917347; Dalla Venezia N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051226; de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947; DeVita VTJ, 2011, CANC PRINCIPLES PRAC, P961; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Forstmeier W, 2017, BIOL REV, V92, P1941, DOI 10.1111/brv.12315; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gigliozzi A, 2004, GASTROENTEROLOGY, V127, P1198, DOI 10.1053/j.gastro.2004.06.023; Kao YH, 2010, J HEPATOL, V52, P96, DOI 10.1016/j.jhep.2009.10.002; Kellermeyer R, 2018, J DEV BIOL, V6, DOI 10.3390/jdb6040024; Kotlyar M, 2016, NUCLEIC ACIDS RES, V44, pD536, DOI 10.1093/nar/gkv1115; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Mao YX, 2017, ONCOTARGET, V8, P42537, DOI 10.18632/oncotarget.16451; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; Martinez-Bosch N, 2018, CANCERS, V10, DOI 10.3390/cancers10010006; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Mazza T, 2017, ONCOTARGET, V8, P105320, DOI 10.18632/oncotarget.22184; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mikhitarian K, 2014, MODERN PATHOL, V27, P665, DOI 10.1038/modpathol.2013.185; Mitsunaga S, 2013, BRIT J CANCER, V108, P2063, DOI 10.1038/bjc.2013.174; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Morrison AH, 2018, TRENDS CANCER, V4, P418, DOI 10.1016/j.trecan.2018.04.001; Nugent M, 2017, CALCIFIED TISSUE INT, V101, P355, DOI 10.1007/s00223-017-0296-x; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; Okada S, 1998, JPN J CLIN ONCOL, V28, P12, DOI 10.1093/jjco/28.1.12; Paladini L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0375-2; Pauken KE, 2014, CANCER CELL, V26, P785, DOI 10.1016/j.ccell.2014.11.016; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Puleo F, 2018, GASTROENTEROLOGY, V155, P1999, DOI 10.1053/j.gastro.2018.08.033; Retamales-Ortega R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030507; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Schultz NA, 2012, MODERN PATHOL, V25, P1609, DOI 10.1038/modpathol.2012.122; Shibuya KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096565; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Starruy J, 2014, BIOINFORMATICS, V30, P1331, DOI 10.1093/bioinformatics/btt772; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Thomas D, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0927-5; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; Tu TC, 2015, J EXP MED, V212, P415, DOI 10.1084/jem.20131601; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Varricchi G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00424; Wang J, 2015, CANCER LETT, V356, P404, DOI 10.1016/j.canlet.2014.09.029; Wang LJ, 2015, ONCOTARGET, V6, P33805, DOI 10.18632/oncotarget.5668; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wormann SM, 2014, ONCOGENE, V33, P2956, DOI 10.1038/onc.2013.257; Xing HB, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3195025; Yako YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154016; Yonemori K, 2017, ONCOTARGET, V8, P70097, DOI 10.18632/oncotarget.19591; Yuan HL, 2018, ONCOTARGETS THER, V11, P3891, DOI 10.2147/OTT.S156921; Zhang L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21573-w; Zhou L, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0745-9	70	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217421	10.1371/journal.pone.0217421	http://dx.doi.org/10.1371/journal.pone.0217421			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150430	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100048
J	Gong, H; Wu, WQ; Xu, JJ; Yu, DN; Qiao, B; Liu, H; Yang, B; Li, YZ; Ling, Y; Kuang, HB				Gong, Han; Wu, Weiqi; Xu, Jingjie; Yu, Dainan; Qiao, Bo; Liu, Hui; Yang, Bei; Li, Yuezhen; Ling, Yan; Kuang, Haibin			Flutamide ameliorates uterine decidualization and angiogenesis in the mouse hyperandrogenemia model during mid-pregnancy	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; POLYCYSTIC-OVARY-SYNDROME; EXPRESSION; PROLIFERATION; DEFECTS	Background/Aim Patients with polycystic ovary syndrome (PCOS), characterized by anovulation, hyperandrogenemia and polycystic ovaries, are still vulnerable to undergo recurrent pregnancy loss and premature labor even though the ovulatory process is pharmacologically recovered. However, its potential mechanism remains unknown. Thus, our aim was to investigate the effect and mechanism of hyperandrogenemia and flutamide (a non-steroidal anti-androgen) on the embryo implantation and pregnancy during mid-pregnancy. Methods We used a mouse model in which PCOS-like hyperandrogenemia was induced by subcutaneous injection of testosterone propionate. In this model, we observed the effect of hyperandrogenemia and flutamide on the decidualization, angiogenesis and uNK cells by methods of immunohistochemistry, quantitative PCR, western blotting and Dolichos biflorus agglutinin (DBA) lectin staining. Results Testosterone and flutamide treatment did not significantly influence the numbers of implanted embryo compared with the control group. However, different doses of testosterone significantly increased the ratio of resorbed/implanted embryo, decreased the level of prl8a2 mRNA and cyclin D3 protein, inhibited the uterine angiogenesis and reduced the numbers of uNK cells, but combined treatment with flutamide markedly decreased the resorbed embryos, increased expressions of prl8a2 mRNA and cyclin D3 protein and angiogenesis and numbers of uNK cells. Conclusion Flutamide treatment can efficiently ameliorate the hyperandrogenemia-induced the disorders in aspects of decidualization, angiogenesis and uNK cells, which further improve the poor endometrial receptivity in PCOS patients.	[Gong, Han; Wu, Weiqi; Xu, Jingjie; Yu, Dainan; Qiao, Bo; Liu, Hui; Yang, Bei; Kuang, Haibin] Nanchang Univ, Basic Med Coll, Dept Physiol, Nanchang, Jiangxi, Peoples R China; [Gong, Han] Sichuan Univ, West China Hosp, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China; [Li, Yuezhen; Kuang, Haibin] Nanchang Univ, Med Expt Teaching Ctr, Jiangxi Prov Key Lab Reprod Physiol & Pathol, Nanchang, Jiangxi, Peoples R China; [Ling, Yan] Jiangxi Prov Peoples Hosp, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Sichuan University; Nanchang University	Kuang, HB (corresponding author), Nanchang Univ, Basic Med Coll, Dept Physiol, Nanchang, Jiangxi, Peoples R China.; Kuang, HB (corresponding author), Nanchang Univ, Med Expt Teaching Ctr, Jiangxi Prov Key Lab Reprod Physiol & Pathol, Nanchang, Jiangxi, Peoples R China.; Ling, Y (corresponding author), Jiangxi Prov Peoples Hosp, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China.	lingyan1205@163.com; kuanghaibin@ncu.edu.cn		Kuang, haibin/0000-0003-4711-5449	National Natural Science Foundation of China [81860283, 81671486, 81270668, 31260248]; 555 project of Jiangxi Province Gan Po Excellence	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 555 project of Jiangxi Province Gan Po Excellence	This work was supported by the National Natural Science Foundation of China (81860283, 81671486, 81270668 and 31260248 to HK) and The 555 project of Jiangxi Province Gan Po Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khalifah RA, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0105-4; Auble B, 2013, J PEDIATR ADOL GYNEC, V26, P234, DOI 10.1016/j.jpag.2013.03.007; Bilinski MJ, 2008, REPROD BIOMED ONLINE, V16, P218, DOI 10.1016/S1472-6483(10)60577-9; Cermik D, 2003, J CLIN ENDOCR METAB, V88, P238, DOI 10.1210/jc.2002-021072; Degaki KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052037; Dosiou C, 2005, ENDOCR REV, V26, P44, DOI 10.1210/er.2003-0021; Dragamestianos C, 2018, GYNECOL OBSTET INVES, P1; Freis A, 2017, ARCH GYNECOL OBSTET, V295, P1005, DOI 10.1007/s00404-017-4295-y; Fu XF, 2018, CELL PHYSIOL BIOCHEM, V48, P670, DOI 10.1159/000491894; Gibson DA, 2015, HUM REPROD, V30, P1290, DOI 10.1093/humrep/dev067; Gong H, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0290-1; Hugar AL, 2017, ENDOCR METAB IMMUNE, V17, P317, DOI 10.2174/1871530317666170912153934; Kim M, 2013, EMBO MOL MED, V5, P1415, DOI 10.1002/emmm.201302618; Kuang HB, 2010, J MOL HISTOL, V41, P1, DOI 10.1007/s10735-010-9256-8; Mokhtar HM, 2014, INT J CLIN EXP PATHO, V7, P1967; Patel S, 2018, J STEROID BIOCHEM, V182, P27, DOI 10.1016/j.jsbmb.2018.04.008; Ratsep MT, 2015, REPRODUCTION, V149, pR91, DOI 10.1530/REP-14-0271; Rahman MA, 2006, DEV BIOL, V290, P105, DOI 10.1016/j.ydbio.2005.11.016; Roe Andrea Hsu, 2011, Rev Obstet Gynecol, V4, P45; Spanos N, 2012, OBESITY FACTS, V5, P495, DOI 10.1159/000341579; Sroga JM, 2012, ENDOCRINOLOGY, V153, P5575, DOI 10.1210/en.2012-1528; Tal R, 2015, SEMIN REPROD MED, V33, P195, DOI 10.1055/s-0035-1552582; Tanbo T, 2018, ACTA OBSTET GYN SCAN, V97, P1162, DOI 10.1111/aogs.13395; Zhang YH, 2017, EBIOMEDICINE, V18, P157, DOI 10.1016/j.ebiom.2017.03.023; Zhao DM, 2018, MOL MED REP, V17, P414, DOI 10.3892/mmr.2017.7890; Zong T, 2015, J HAZARD MATER, V297, P25, DOI 10.1016/j.jhazmat.2015.04.065; Zou WY, 2016, ACUPUNCT MED, V34, P114, DOI 10.1136/acupmed-2015-010788	27	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217095	10.1371/journal.pone.0217095	http://dx.doi.org/10.1371/journal.pone.0217095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150416	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100030
J	Nowack, S; Bauch, CT; Anand, M				Nowack, Shane; Bauch, Chris T.; Anand, Madhur			A local optimization framework for addressing conservation conflicts in mosaic ecosystems	PLOS ONE			English	Article							LAND-USE; FOREST EXPANSION; ATLANTIC FOREST; BIODIVERSITY CONSERVATION; ARAUCARIA FOREST; NATURAL FOREST; GRASSLAND; FRAGMENTATION; INFORMATION; MANAGEMENT	An effective strategy to resolve conservation conflicts on lands outside of nature reserves is to consider the spatial arrangement of agricultural and native vegetation parcels such that the ecological value of the landscape is improved without reducing the amount of land used for agricultural production. Global optimization methods have been used to identify the best spatial arrangement of land parcels for a given project goal, but these methods are not designed to provide pathways to reach the optimum from the initial landscape. Here we describe how local search algorithms can be used to develop land parcel rearrangement pathways to obtain a landscape that sustains greater species richness than the initial landscape without changing the amount of land used for agricultural production. To demonstrate how the local optimization framework can be applied, an ecological setting based on a forest-grassland mosaic ecosystem in Rio Grande do Sul, Brazil was constructed. Plant samples collected from this region were used to construct species area curves. Multiple locally optimal solutions that improved the modeled species richness of the landscape almost to globally optimal levels were identified. To support the results, the algorithm was also applied to a 306,250 ha forest-grassland region of Rio Grande do Sul. The case study results suggested that conservation polices solely based on landowners satisfying a legal reserve percentage on their property should be revised to consider landscape-level connectivity. Providing multiple possible solutions for landscape configurations using local optimization methods may improve managerial flexibility for decision-makers, compared to global optimization approaches providing a single solution. Furthermore, the algorithm details the parcel exchange pathways that are required to reach the optimal land state. We conclude that local and global optimization approaches can be used in combination to improve land use decision-making for conservation, in mosaic ecosystems as well as other terrestrial ecosystems.	[Nowack, Shane; Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada; [Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON, Canada	University of Guelph; University of Waterloo	Nowack, S (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON, Canada.	spnowack@gmail.com		Nowack, Shane/0000-0002-8265-6366	James S. McDonnell Foundation Complex Systems Scholar Award; Natural Sciences and Engineering Research Council of Canada; NSERC Discovery Grants; James S. McDonnell Complex Systems Scholar Award	James S. McDonnell Foundation Complex Systems Scholar Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); James S. McDonnell Complex Systems Scholar Award	This research was supported by a James S. McDonnell Foundation Complex Systems Scholar Award to MA, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to MA and CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Gerhard Overbeck and his students at Universidade Federal do Rio Grande do Sul, Brazil, for collecting samples in Aparados da Serra National Park and sharing the corresponding data. Permission to sample in the area of the National Park was granted by the ICMBio (Instituto Chico Mendes de Conservac [comma] ao da Biodiversidade), which administrates the National Park. This research was supported by NSERC Discovery Grants to MA and CTB and a James S. McDonnell Complex Systems Scholar Award to MA.	Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; Aguiar L., 1986, IHERINGIA BOT, V34, P3; Aguilar J, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0136580; Anand M, 2005, CONSERV BIOL, V19, P955, DOI 10.1111/j.1523-1739.2005.00571.x; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Blake J., 1999, LOCAL ENVIRON, V4, P257, DOI [10.1080/13549839908725599, DOI 10.1080/13549839908725599]; Cao K, 2013, STOCH ENV RES RISK A, V27, P1133, DOI 10.1007/s00477-012-0649-y; Carothers NL, 2000, REAL ANAL; Chopard B., 1998, CELLULAR AUTOMATA MO; Cordeiro JLP., 2009, CAMPOS SULINOS CONSE, P285; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Duarte LDS, 2006, AUSTRAL ECOL, V31, P520, DOI 10.1111/j.1442-9993.2006.01602.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faith DP, 1996, BIODIVERS CONSERV, V5, P431, DOI 10.1007/BF00056389; Fisher B, 2007, ECOL ECON, V62, P93, DOI 10.1016/j.ecolecon.2006.05.020; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Furst C, 2012, J ENVIRON PLANN MAN, V55, P855, DOI 10.1080/09640568.2011.630067; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Hasenack H., 2006, MAPEAMENTO COBERTURA; Henderson KA, 2016, P NATL ACAD SCI USA, V113, P14552, DOI 10.1073/pnas.1604987113; Henderson KA, 2016, SUSTAIN SCI, V11, P321, DOI 10.1007/s11625-015-0319-3; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Kelley C.T., 1999, ITERATIVE METHODS OP; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Kumm Karl-Ivar, 2004, Journal for Nature Conservation (Jena), V12, P213, DOI 10.1016/j.jnc.2004.07.001; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Matte ALL, 2015, AUSTRAL ECOL, V40, P21, DOI 10.1111/aec.12178; Lira PK, 2012, FOREST ECOL MANAG, V278, P80, DOI 10.1016/j.foreco.2012.05.008; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Matthews KB, 1999, COMPUT ELECTRON AGR, V23, P9, DOI 10.1016/S0168-1699(99)00005-8; Moilanen A, 2005, AM NAT, V165, P695, DOI 10.1086/430011; Moilanen A, 2009, SPATIAL CONSERVATION; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N., 1997, Nature's services: societal dependence on natural ecosystems., P255; Natuhara Y, 1999, ECOL RES, V14, P105, DOI 10.1046/j.1440-1703.1999.00287.x; Overbeck G. E., 2006, Braz. J. Biol., V66, P1073, DOI 10.1590/S1519-69842006000600015; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Pagnutti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075890; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Prugh T., 2000, LOCAL POLITICS GLOBA; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues C, 2007, IEEE PART ACC CONF, P713; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Schindler S, 2013, ECOL INDIC, V31, P41, DOI 10.1016/j.ecolind.2012.04.012; Silva LCR, 2011, ECOSYSTEMS, V14, P1354, DOI 10.1007/s10021-011-9486-y; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Venema HD, 2005, EUR J OPER RES, V164, P423, DOI 10.1016/j.ejor.2003.11.011; Virkkala R, 2004, ECOGRAPHY, V27, P273, DOI 10.1111/j.0906-7590.2004.03810.x; Westphal MI, 2003, CONSERV BIOL, V17, P327, DOI 10.1046/j.1523-1739.2003.01594.x	57	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217812	10.1371/journal.pone.0217812	http://dx.doi.org/10.1371/journal.pone.0217812			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150510	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100116
J	Patinha, D; Carvalho, C; Abreu, C; Cunha, OM; Mota, MC; Afonso, J; Albino-Teixeira, A; Diniz, C; Morato, M				Patinha, Daniela; Carvalho, Carla; Abreu, Carla; Cunha, Olga M.; Mota, Mariana C.; Afonso, Joana; Albino-Teixeira, Antonio; Diniz, Carmen; Morato, Manuela			Diabetes downregulates renal adenosine A(2A) receptors in an experimental model of hypertension	PLOS ONE			English	Article							GLOMERULAR MESANGIAL CELLS; CHRONIC KIDNEY-DISEASE; CHLORIDE SECRETION; GENE-EXPRESSION; A(1) RECEPTORS; IMAGE-ANALYSIS; RAT; ACTIVATION; HYPERFILTRATION; NEPHROPATHY	Studies on diabetic nephropathy rarely take into account that the co-existence of diabetes and hypertension is frequent and further aggravates the prognosis of renal dysfunction. Adenosine can activate four subtypes of adenosine receptors (A(1), A(2A), A(2B) and A(3)) and has been implicated in diabetic nephropathy. However, it is not known if, in hypertensive conditions, diabetes alters the presence/distribution profile of renal adenosine receptors. The aim of this work was to describe the presence/distribution profile of the four adenosine receptors in six renal structures (superficial/deep glomeruli, proximal/distal tubules, loop of Henle, collecting tubule) of the hypertensive kidney and to evaluate whether it is altered by diabetes. Immunoreactivities against the adenosine receptors were analyzed in six renal structures from spontaneously hypertensive rats (SHR, the control group) and from SHR rats with diabetes induced by streptozotocyin (SHR-STZ group). Data showed, for the first time, that all adenosine receptors were present in the kidney of SHR rats, although the distribution pattern was specific for each adenosine receptor subtype. Also, induction of diabetes in the SHR was associated with downregulation of adenosine A(2A) receptors, which might be relevant for the development of hypertensive diabetic nephropathy. This study highlights the adenosine A(2A) receptors as a potential target to explore to prevent and/or treat early diabetes-induced hyperfiltration, at least in hypertensive conditions.	[Patinha, Daniela; Afonso, Joana; Albino-Teixeira, Antonio] Univ Porto, Fac Med, Dept Biomed, Pharmacol & Therapeut Unit, Porto, Portugal; [Carvalho, Carla; Abreu, Carla; Cunha, Olga M.; Mota, Mariana C.; Diniz, Carmen; Morato, Manuela] Univ Porto, Fac Pharm, Dept Drug Sci, LAQV REQUIMTE,Lab Pharmacol, Porto, Portugal; [Afonso, Joana; Albino-Teixeira, Antonio] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Porto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Diniz, C; Morato, M (corresponding author), Univ Porto, Fac Pharm, Dept Drug Sci, LAQV REQUIMTE,Lab Pharmacol, Porto, Portugal.	cdiniz@ff.up.pt; mmorato@ff.up.pt	Morato, Manuela/D-7563-2013; , CDiniz/D-6293-2013; Abreu, Carla/AAY-7760-2020	Morato, Manuela/0000-0002-9509-0613; , CDiniz/0000-0003-4668-9360; Abreu, Carla/0000-0003-2026-9595; Patinha, Daniela/0000-0003-1150-0046	Portuguese Foundation for Science and Technology (FCT); Fundo Europeu de Desenvolvimento Regional (FEDER); Programa Operacional Factores de Competitividade (POFC-COMPETE) [PTDC/SAU-FCF/67764/2006, UID/QUI/50006/2013 - POCI/01/0145/FEDER/007265]; FCT [SFRH/BD/43187/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional Factores de Competitividade (POFC-COMPETE); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank the financial support from the Portuguese Foundation for Science and Technology (FCT, https://www.fct.pt/), Fundo Europeu de Desenvolvimento Regional (FEDER), and Programa Operacional Factores de Competitividade (POFC-COMPETE): projects PTDC/SAU-FCF/67764/2006 and UID/QUI/50006/2013 - POCI/01/0145/FEDER/007265. DP thanks FCT for the PhD fellowship SFRH/BD/43187/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas D., 2021, IDF DIABETES ATLAS, V10th edn; Awad AS, 2008, J AM SOC NEPHROL, V19, P59, DOI 10.1681/ASN.2007030276; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; Bell TD, 2009, KIDNEY INT, V75, P769, DOI 10.1038/ki.2009.18; Cardenas A, 2013, LAB INVEST, V93, P135, DOI 10.1038/labinvest.2012.143; Carreira MC, 2006, J ENDOCRINOL, V191, P147, DOI 10.1677/joe.1.06714; CHURCHILL PC, 1985, J PHARMACOL EXP THER, V232, P589; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Diniz C., 2010, MICROSCOPY SCI TECHN, V2; Dousdampanis P, 2014, HEMODIAL INT, V18, P730, DOI 10.1111/hdi.12159; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Dubey RK, 2005, HYPERTENSION, V46, P628, DOI 10.1161/01.HYP.0000178464.63393.88; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Faulhaber-Walter R, 2008, J AM SOC NEPHROL, V19, P722, DOI 10.1681/ASN.2007060721; Giunti S, 2006, HYPERTENSION, V48, P519, DOI 10.1161/01.HYP.0000240331.32352.0c; Guirado R, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00669; Hansen PB, 2005, J PHARMACOL EXP THER, V315, P1150, DOI 10.1124/jpet.105.091017; Imai G, 2003, HYPERTENS RES, V26, P339, DOI 10.1291/hypres.26.339; JACKSON EK, 1991, ANNU REV PHARMACOL, V31, P1; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kang HS, 2001, AM J PHYSIOL-RENAL, V281, pF1141, DOI 10.1152/ajprenal.2001.281.6.F1141; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kost CK, 2000, J PHARMACOL EXP THER, V292, P752; Kretschmar C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147430; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Laforest S, 2018, HISTOCHEM CELL BIOL, V149, P209, DOI 10.1007/s00418-018-1635-3; Leal S, 2008, MICROSC RES TECHNIQ, V71, P703, DOI 10.1002/jemt.20609; Leal S, 2006, ANAL BIOCHEM, V357, P137, DOI 10.1016/j.ab.2006.07.017; Lee J, 2013, AM J PATHOL, V183, P1488, DOI 10.1016/j.ajpath.2013.07.010; Lu Z, 2018, COMPUT METH PROG BIO, V155, P179, DOI 10.1016/j.cmpb.2017.12.014; Ma HP, 1996, AM J PHYSIOL-RENAL, V270, pF798, DOI 10.1152/ajprenal.1996.270.5.F798; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Mozaffari MS, 2000, CAN J PHYSIOL PHARM, V78, P428, DOI 10.1139/cjpp-78-5-428; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; OLIVERA A, 1989, KIDNEY INT, V35, P1300, DOI 10.1038/ki.1989.126; Palm F, 2004, DIABETES-METAB RES, V20, P452, DOI 10.1002/dmrr.472; Palm F, 2001, UPSALA J MED SCI, V106, P175, DOI 10.3109/2000-1967-147; Patinha D, 2014, LIFE SCI, V108, P71, DOI 10.1016/j.lfs.2014.05.011; Patinha D, 2014, UPSALA J MED SCI, V119, P10, DOI 10.3109/03009734.2013.851748; Patinha D, 2013, AM J PHYSIOL-RENAL, V304, pF614, DOI 10.1152/ajprenal.00285.2012; Pawelczyk T, 2005, AM J PATHOL, V167, P315, DOI 10.1016/S0002-9440(10)62977-X; Quezada C, 2013, CURR DRUG TARGETS, V14, P490; Rajagopal M, 2010, HYPERTENSION, V55, P1123, DOI 10.1161/HYPERTENSIONAHA.109.143404; Reshkin SJ, 2000, J MEMBRANE BIOL, V178, P103, DOI 10.1007/s002320010018; Roa H, 2009, FEBS LETT, V583, P3192, DOI 10.1016/j.febslet.2009.09.003; Smith JA, 2001, BIOCHEM PHARMACOL, V61, P237, DOI 10.1016/S0006-2952(00)00532-3; Sousa-Oliveira A, 2018, HISTOCHEM CELL BIOL; Stockand JD, 1998, PHYSIOL REV, V78, P723, DOI 10.1152/physrev.1998.78.3.723; Szczepanska-Konkel M, 2003, J PHYSIOL PHARMACOL, V54, P109; Thakur S, 2010, J BIOL CHEM, V285, P40104, DOI 10.1074/jbc.M110.184606; Tomohiro T, 2007, LIFE SCI, V80, P1364, DOI 10.1016/j.lfs.2006.11.054; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309; Valladares D, 2008, BIOCHEM BIOPH RES CO, V366, P180, DOI 10.1016/j.bbrc.2007.11.113; Vallon V, 2006, PHYSIOL REV, V86, P901, DOI 10.1152/physrev.00031.2005; Vallon Volker, 2009, Handb Exp Pharmacol, P443, DOI 10.1007/978-3-540-89615-9_15; Vitzthum H, 2004, KIDNEY INT, V65, P1180, DOI 10.1111/j.1523-1755.2004.00490.x; WEAVER DR, 1992, AM J PHYSIOL, V263, pF991, DOI 10.1152/ajprenal.1992.263.6.F991; Wengert M, 2005, INT J BIOCHEM CELL B, V37, P155, DOI 10.1016/j.biocel.2004.06.006; WHO, 2016, GLOB REP PSOR; Wilcox CS, 1999, J AM SOC NEPHROL, V10, P714; Wilkinson PF, 2016, ANN CLIN LAB SCI, V46, P339; YAMAGUCHI S, 1995, HYPERTENSION, V26, P1181, DOI 10.1161/01.HYP.26.6.1181; Zhao ZH, 2002, KIDNEY INT, V61, P1276, DOI 10.1046/j.1523-1755.2002.00256.x; Zizzo MG, 2009, LIFE SCI, V84, P772, DOI 10.1016/j.lfs.2009.03.006	65	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217552	10.1371/journal.pone.0217552	http://dx.doi.org/10.1371/journal.pone.0217552			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150459	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100065
J	Zhu, ZJ; Li, QX; Li, P; Xun, XJ; Zheng, LY; Ning, DD; Su, M				Zhu, Zhijun; Li, Qingxuan; Li, Ping; Xun, Xiaojie; Zheng, Liyuan; Ning, Dandan; Su, Ming			Surface charge controlled nucleoli selective staining with nanoscale carbon dots	PLOS ONE			English	Article							GRAPHENE QUANTUM DOTS; HIGHLY LUMINESCENT; REAL-TIME; C-DOTS; DELIVERY; ACID; MECHANISM; NANODOTS; CELLS; GREEN	Organelle selective imaging can reveal structural and functional characters of cells undergoing external stimuli, and is considered critical in revealing biological fundamentals, designing targeted delivery system, and screening potential drugs and therapeutics. This paper describes the nucleoli targeting ability of nanoscale carbon dots (including nanodiamond) that are hydrothermally made with controlled surface charges. The surface charges of carbon dots are controlled in the range of -17.9 to -2.84 mV by changing the molar ratio of two precursors, citric acid (CA) and ethylenediamine (EDA). All carbon dots samples show strong fluorescence under wide excitation wavelength, and samples with both negative and positve charges show strong fluorescent contrast from stained nucleoli. The nucleoli selective imaging of live cell has been confirmed with Hoechst staining and nucleoli specific staining (SYTO RNA-select green), and is explained as surface charge heterogeneity on carbon dots. Carbon dots with both negative and positive charges have better ability to penetrate cell and nucleus membranes, and the charge heterogeneity helps carbon dots to bind preferentially to nucleoli, where the electrostatic environment is favored.	[Zhu, Zhijun; Li, Qingxuan; Li, Ping; Xun, Xiaojie; Zheng, Liyuan; Ning, Dandan; Su, Ming] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Xun, Xiaojie; Zheng, Liyuan; Ning, Dandan; Su, Ming] Wenzhou Med Univ, Wenzhou Inst Biomat & Engn, Wenzhou, Zhejiang, Peoples R China; [Xun, Xiaojie; Zheng, Liyuan; Ning, Dandan; Su, Ming] Chinese Acad Sci, Ningbo, Zhejiang, Peoples R China; [Li, Ping] Ningde Normal Univ, Sch Chem & Mat, Ningde, Fujian, Peoples R China	Northeastern University; Wenzhou Medical University; Chinese Academy of Sciences; Ningde Normal University	Su, M (corresponding author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.; Su, M (corresponding author), Wenzhou Med Univ, Wenzhou Inst Biomat & Engn, Wenzhou, Zhejiang, Peoples R China.; Su, M (corresponding author), Chinese Acad Sci, Ningbo, Zhejiang, Peoples R China.	m.su@northeastern.edu	Zhu, Zhijun/E-5394-2016		National Institute of Health [1DP2EB016572]; Ningde Normal University [2016Q46]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ningde Normal University	This project was supported by a Director's New Innovator Award from National Institute of Health (no. 1DP2EB016572) to MS, a Young Teacher Specific Project from Ningde Normal University (no. 2016Q46) to PL.	Barbosa CDDS, 2015, CHEM-EUR J, V21, P5055, DOI 10.1002/chem.201406330; Bhunia SK, 2016, CHEMBIOCHEM, V17, P614, DOI 10.1002/cbic.201500694; Cao L, 2007, J AM CHEM SOC, V129, P11318, DOI 10.1021/ja073527l; Du FY, 2017, BIOMATERIALS, V121, P109, DOI 10.1016/j.biomaterials.2016.07.008; Feng T, 2016, ACS NANO, V10, P4410, DOI 10.1021/acsnano.6b00043; Fowley C, 2012, CHEM COMMUN, V48, P9361, DOI 10.1039/c2cc34962k; Gupta V, 2011, J AM CHEM SOC, V133, P9960, DOI 10.1021/ja2036749; He H, 2016, ACS APPL MATER INTER, V8, P28529, DOI 10.1021/acsami.6b10737; Hola K, 2014, NANO TODAY, V9, P590, DOI 10.1016/j.nantod.2014.09.004; Hu F, 2016, ORG BIOMOL CHEM, V14, P9931, DOI 10.1039/c6ob01414c; Hu LM, 2014, CARBON, V67, P508, DOI 10.1016/j.carbon.2013.10.023; Huang P, 2012, ADV MATER, V24, P5104, DOI 10.1002/adma.201200650; Jiang D., 2016, PLOS ONE, V10; Jiang K, 2015, ANGEW CHEM INT EDIT, V54, P5360, DOI 10.1002/anie.201501193; Jung YK, 2015, SCI REP-UK, V5, DOI 10.1038/srep18807; Kim J, 2013, BIOMATERIALS, V34, P7168, DOI 10.1016/j.biomaterials.2013.05.072; Kong B, 2012, ADV MATER, V24, P5844, DOI 10.1002/adma.201202599; Kong WQ, 2014, J MATER CHEM B, V2, P5077, DOI 10.1039/c4tb00579a; LeCroy GE, 2014, ACS NANO, V8, P4522, DOI 10.1021/nn406628s; Lim SY, 2015, CHEM SOC REV, V44, P362, DOI 10.1039/c4cs00269e; Liu WJ, 2016, J MATER CHEM B, V4, P5772, DOI 10.1039/c6tb00976j; Liu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep31100; Luo PJG, 2013, J MATER CHEM B, V1, P2116, DOI 10.1039/c3tb00018d; Magde D, 1999, PHOTOCHEM PHOTOBIOL, V70, P737, DOI 10.1111/j.1751-1097.1999.tb08277.x; Mewada A, 2014, J MATER CHEM B, V2, P698, DOI 10.1039/c3tb21436b; Mosquera J, 2018, ACCOUNTS CHEM RES, V51, P2305, DOI 10.1021/acs.accounts.8b00292; Pierrat P, 2015, BIOMATERIALS, V51, P290, DOI 10.1016/j.biomaterials.2015.02.017; Qu KG, 2013, CHEM-EUR J, V19, P7243, DOI 10.1002/chem.201300042; Saini AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34807; Salinas-Castillo A, 2013, CHEM COMMUN, V49, P1103, DOI 10.1039/c2cc36450f; Senthilnathan N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11293-y; Sharma V, 2017, J MATER CHEM B, V5, P8904, DOI 10.1039/c7tb02484c; Shen R, 2010, J AM CHEM SOC, V132, P8627, DOI 10.1021/ja1002668; Song YB, 2015, J MATER CHEM C, V3, P5976, DOI 10.1039/c5tc00813a; Tao HQ, 2012, SMALL, V8, P281, DOI 10.1002/smll.201101706; Vazquez-Gonzalez M, 2017, ACS NANO, V11, P3247, DOI 10.1021/acsnano.7b00352; Wang CI, 2013, ANAL CHEM, V85, P3263, DOI 10.1021/ac303613d; Wang F, 2011, ADV FUNCT MATER, V21, P1027, DOI 10.1002/adfm.201002279; Wang L, 2017, BIOMATERIALS, V145, P192, DOI 10.1016/j.biomaterials.2017.08.039; Wang L, 2014, LANGMUIR, V30, P14270, DOI 10.1021/la5031813; Wang SS, 2017, BIOMATERIALS, V141, P29, DOI 10.1016/j.biomaterials.2017.05.040; Wang XJ, 2017, ACS APPL MATER INTER, V9, P17799, DOI 10.1021/acsami.7b04576; Wu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep21170; Yan FY, 2014, SENSOR ACTUAT B-CHEM, V192, P488, DOI 10.1016/j.snb.2013.11.041; Yang GM, 2012, ADV FUNCT MATER, V22, P736, DOI 10.1002/adfm.201101764; Yang ST, 2009, J AM CHEM SOC, V131, P11308, DOI 10.1021/ja904843x; Yang Y, 2014, SENSOR ACTUAT B-CHEM, V199, P121, DOI 10.1016/j.snb.2014.03.064; Zeng QH, 2016, J MATER CHEM B, V4, P5119, DOI 10.1039/c6tb01259k; Zhu H, 2016, ACCOUNTS CHEM RES, V49, P2115, DOI 10.1021/acs.accounts.6b00292; Zhu SJ, 2015, NANO RES, V8, P355, DOI 10.1007/s12274-014-0644-3	50	16	16	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216230	10.1371/journal.pone.0216230	http://dx.doi.org/10.1371/journal.pone.0216230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150413	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100014
J	Bedri, SK; Nilsson, OB; Fink, K; Manberg, A; Hamsten, C; Ayoglu, B; Manouchehrinia, A; Nilsson, P; Olsson, T; Hillert, J; Gronlund, H; Glaser, A				Bedri, Sahl Khalid; Nilsson, Ola B.; Fink, Katharina; Manberg, Anna; Hamsten, Carl; Ayoglu, Burcu; Manouchehrinia, Ali; Nilsson, Peter; Olsson, Tomas; Hillert, Jan; Gronlund, Hans; Glaser, Anna			Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; NATALIZUMAB; EXPRESSION; CLONING; KINASE	Multiple sclerosis (MS) treatment options have improved significantly over the past decades, but the consequences of MS can still be devastating and the needs for monitoring treatment surveillance are considerable. In the current study we used affinity proteomics technology to identify potential biomarkers which could ultimately be used to as facilitate treatment decisions. We profiled the intra-individual changes in the levels of 59 target proteins using an antibody suspension bead array in serial plasma samples from 44 MS patients during treatment with natalizumab followed by fingolimod. Nine proteins showed decreasing plasma levels during natalizumab treatment, with PEBP1 and RTN3 displaying the most significant changes. Protein levels remained stable during fingolimod treatment for both proteins. The decreasing PEBP1 levels during natalizumab treatment could be validated using ELISA and replicated in an independent cohort. These results support the use of this technology as a high throughput method of identifying potentially useful biomarkers of MS treatment.	[Bedri, Sahl Khalid; Nilsson, Ola B.; Fink, Katharina; Manouchehrinia, Ali; Olsson, Tomas; Hillert, Jan; Gronlund, Hans; Glaser, Anna] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Bedri, Sahl Khalid; Nilsson, Ola B.; Fink, Katharina; Manouchehrinia, Ali; Olsson, Tomas; Hillert, Jan; Gronlund, Hans; Glaser, Anna] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Nilsson, Ola B.] Advice Foretagsassistans & Stockholm AB, TCER AB, Stockholm, Sweden; [Fink, Katharina] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Manberg, Anna; Ayoglu, Burcu; Nilsson, Peter] KTH Royal Inst Technol, Sch Engn Sci Chem Biotechnol & Hlth, Affin Prote, SciLifeLab, Stockholm, Sweden; [Hamsten, Carl] Karolinska Inst, Dept Med, Immunol & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology; SciLifeLab; Karolinska Institutet	Bedri, SK (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Bedri, SK (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.	sahl.bedri@ki.se	Manouchehrinia, Ali/AAD-4898-2022	Manouchehrinia, Ali/0000-0003-4857-5762; /0000-0001-7843-2960; Bedri, Sahl Khalid/0000-0002-7750-5723; Olsson, Tomas/0000-0002-2938-1877	Sanofi Genzyme [GZ-2014-11150]; Swedish Research Council [K2014-61X-11220-20-4]	Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	JH received funding from Sanofi Genzyme [(grant number GZ-2014-11150] and the Swedish Research Council [grant number K2014-61X-11220-20-4]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2014, BASIC IMMUNOLOGY FUN, pix; Ayoglu B, 2014, EMBO MOL MED, V6, P918, DOI 10.15252/emmm.201303724; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bystrom S, 2014, J PROTEOME RES, V13, P4607, DOI 10.1021/pr500609e; Chiurchiu V, NEUROMOLECULAR MED, P3; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Deng M, 2013, INCREASED EXPRESSION, V1, DOI [10.1074/jbc.M113.480079, DOI 10.1074/JBC.M113.480079]; Drobin Kimi, 2013, Methods Mol Biol, V1023, P137, DOI 10.1007/978-1-4614-7209-4_8; Forsberg L, ECTRIMS2016; Frisell T, 2016, MULT SCLER J, V22, P85, DOI 10.1177/1352458515579216; Haggmark A, 2014, ANN CLIN TRANSL NEUR, V1, P544, DOI 10.1002/acn3.83; Haggmark A, 2013, PROTEOMICS, V13, P2256, DOI 10.1002/pmic.201200580; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Heath JE, 2010, NEUROPATHOLOGY, V30, P574, DOI 10.1111/j.1440-1789.2010.01107.x; Holmen C, 2011, MULT SCLER J, V17, P708, DOI 10.1177/1352458510394701; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Iaffaldano P, 2015, BRAIN, V138, DOI 10.1093/brain/awv260; Kuznetsova A., 2012, LMERTEST TESTS RANDO; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Lundstrom W, 2014, MULT SCLER J, V20, P1727, DOI 10.1177/1352458514532700; Maki M, 2002, J NEUROPATH EXP NEUR, V61, P176, DOI 10.1093/jnen/61.2.176; Moreira EF, 1999, GENOMICS, V58, P73, DOI 10.1006/geno.1999.5807; Neiman M, 2011, J PROTEOME RES, V10, P4925, DOI 10.1021/pr200286c; Ojika K, 2000, PROG NEUROBIOL, V60, P37, DOI 10.1016/S0301-0082(99)00021-0; Pabarcus MK, 2005, PROTEIN EXPRES PURIF, V44, P39, DOI 10.1016/j.pep.2005.04.013; Pollard K. S., 2005, BIOINFORMATICS COMPU, DOI DOI 10.1007/0-387-29362-0_23; Prosperini L, 2017, J NEUROL, V264, P284, DOI 10.1007/s00415-016-8343-5; Rudloff I, 2015, ARTHRITIS RHEUMATOL, V67, P3219, DOI 10.1002/art.39328; Schwenk JM, 2008, J PROTEOME RES, V7, P3168, DOI 10.1021/pr700890b; Sevastou I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157754; Sundqvist E, 2012, GENES IMMUN, V13, P14, DOI 10.1038/gene.2011.42; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; Tsugu Y, 1998, EUR J NEUROL, V5, P561, DOI 10.1046/j.1468-1331.1998.560561.x; Tykhomyrov AA, 2016, NEUROPHYSIOLOGY+, V48, P54, DOI 10.1007/s11062-016-9568-8; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vostry Michal, 2010, EJIFCC, V20, P162; World Health Organization (WHO), 2008, ATL MULT SCLER RES W; Wu YM, 2009, ACTA MED OKAYAMA, V63, P305; Yamout BI, 2018, SEMIN NEUROL, V38, P212, DOI 10.1055/s-0038-1649502; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Yu Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04389-0	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217208	10.1371/journal.pone.0217208	http://dx.doi.org/10.1371/journal.pone.0217208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141529	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000044
J	Gomez-Gallego, M; Gommers, R; Bader, MKF; Williams, NM; Adeyrmi, JO				Gomez-Gallego, Mireia; Gommers, Ralf; Bader, Martin Karl-Friedrich; Williams, Nari Michelle; Adeyrmi, Jerry O.			Modelling the key drivers of an aerial Phytophthora foliar disease epidemic, from the needles to the whole plant	PLOS ONE			English	Article							PATHOGEN; RESISTANCE	Understanding the epidemiology of infectious diseases in a host population is a major challenge in forestry. Radiata pine plantations in New Zealand are impacted by a foliar disease, red needle cast (RNC), caused by Phytophthora pluvialis. This pathogen is dispersed by water splash with polycyclic infection affecting the lower part of the tree canopy. In this study, we extended an SI (Susceptible-Infectious) model presented for RNC to analyse the key epidemiological drivers. We conducted two experiments to empirically fit the extended model: a detached-needle assay and an in vivo inoculation. We used the detached-needle assay data to compare resistant and susceptible genotypes, and the in vivo inoculation data was used to inform sustained infection of the whole plant. We also compared isolations and real-time quantitative PCR (qPCR) to assess P. pluvialis infection. The primary infection rate and the incubation time were similar for susceptible and resistant genotypes. The pathogen death rate was 2.5 times higher for resistant than susceptible genotypes. Further, external proliferation of mycelium and sporangia were only observed on 28% of the resistant ramets compared to 90% of the susceptible ones. Detection methods were the single most important factor influencing parameter estimates of the model, giving qualitatively different epidemic outputs. In the early stages of infection, qPCR proved to be more efficient than isolations but the reverse was true at later points in time. Isolations were not influenced by the presence of lesions in the needles, while 19% of lesioned needle maximized qPCR detection. A primary infection peak identified via qPCR occurred at 4 days after inoculation (dai) with a secondary peak observed 22 dai. Our results have important implications to the management of RNC, by highlighting the main differences in the response of susceptible and resistant genotypes, and comparing the most common assessment methods to detect RNC epidemics.	[Gomez-Gallego, Mireia; Bader, Martin Karl-Friedrich] Auckland Univ Technol, Sch Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand; [Gomez-Gallego, Mireia; Gommers, Ralf; Williams, Nari Michelle; Adeyrmi, Jerry O.] New Zealand Forest Res Inst Scion, Rotorua, New Zealand	Auckland University of Technology	Gomez-Gallego, M (corresponding author), Auckland Univ Technol, Sch Sci, Inst Appl Ecol New Zealand, Auckland, New Zealand.; Gomez-Gallego, M (corresponding author), New Zealand Forest Res Inst Scion, Rotorua, New Zealand.	mireia.gomez@scionresearch.com		Bader, Martin Karl-Friedrich/0000-0002-3742-9762; Gomez-Gallego, Mireia/0000-0001-6713-1708; Williams, Nari/0000-0003-0493-4954	Forest Owners Association [C04X1305]; Ministry of Business Innovation and Employment	Forest Owners Association; Ministry of Business Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was supported by the Forest Owners Association, C04X1305 (https://www.nzfoa.org.nz/) and Ministry of Business Innovation and Employment (https://www.mbie.govt.nz/) to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RN, 1973, T BRIT MYCOL SOC, V61, P287, DOI 10.1016/S0007-1536(73)80152-4; [Anonymous], 2014, P 13 PYTHON SCI C, DOI DOI 10.25080/MAJORA-14BD3278-00E; Australian Bureau of Agricultural and Resource Economics and Sciences, 2018, AUSTR FOR WOOD PROD; Beets P. N., 2013, IMPACT RED NEEDLE CA; CAIRNS AJG, 1990, IMA J MATH APPL MED, V7, P219; Cara M, 2018, PLANT DIS, V102, P253, DOI 10.1094/PDIS-03-17-0353-PDN; Chettri P, 2012, FUNGAL GENET BIOL, V49, P141, DOI 10.1016/j.fgb.2011.11.009; Cunniffe NJ, 2012, PHYTOPATHOLOGY, V102, P365, DOI 10.1094/PHYTO-12-10-0338; Dick MA, 2014, NEW ZEAL J FOR SCI, V44, DOI 10.1186/s40490-014-0006-7; Duran A, 2008, PLANT PATHOL, V57, P715, DOI 10.1111/j.1365-3059.2008.01893.x; Erwin DC, 1996, AM PHYTOPATHOLOGICAL, DOI [10.1016/S0261-2194(97)83220-6, DOI 10.1016/S0261-2194(97)83220-6]; Fawke S, 2015, MICROBIOL MOL BIOL R, V79, P263, DOI 10.1128/MMBR.00010-15; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gilligan CA, 1997, PHILOS T R SOC B, V352, P591, DOI 10.1098/rstb.1997.0040; Gomez-Gallego M, 2017, PLANT DIS, V101, P1259, DOI 10.1094/PDIS-12-16-1738-RE; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Graham NJ, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-018-1266-9; Hader DP, 1999, ADV SPACE RES-SERIES, V24, P843, DOI 10.1016/S0273-1177(99)00965-5; Hansen EM, 2015, PLANT DIS, V99, P727, DOI 10.1094/PDIS-09-14-0943-PDN; Hurley BP, 2017, BIOL INVASIONS, V19, P3273, DOI 10.1007/s10530-017-1488-z; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Latif NSA, 2014, J THEOR BIOL, V347, P144, DOI 10.1016/j.jtbi.2013.12.023; Leclerc M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086568; Mammeri Y, 2014, ECOL MODEL, V290, P178, DOI 10.1016/j.ecolmodel.2014.02.017; Manter DK, 2003, ECOL MODEL, V164, P211, DOI 10.1016/S0304-3800(03)00026-7; Matthiesen RL, 2016, PLANT DIS, V100, P1424, DOI 10.1094/PDIS-08-15-0916-RE; O'Neill R, 2018, NZ PLANT PROTECTION, V71, P30843; Otten W, 2003, ECOLOGY, V84, P3232, DOI 10.1890/02-0564; Reeser P., 2013, North American Fungi, V8, P1; Rolando C, 2014, NZ J FORESTRY SCI, V44, DOI 10.1186/s40490-014-0008-5; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Salas C, 2016, J FOREST, V114, P562, DOI 10.5849/jof.14-062; Vergu E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009371; Wake G, 2018, ANZIAM J, V59, P1; Wingfield MJ, 2015, SCIENCE, V349, P832, DOI 10.1126/science.aac6674; Wingfield MJ, 2003, AUSTRALAS PLANT PATH, V32, P133, DOI 10.1071/AP03024; Wood S., 2017, GAMM4 GEN ADDITIVE M; Young GK, 2018, PLANT PATHOL, V67, P1539, DOI 10.1111/ppa.12856; Zangerl AR, 1979, PLANT RESISTANCE HER, P363	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216161	10.1371/journal.pone.0216161	http://dx.doi.org/10.1371/journal.pone.0216161			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136583	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300004
J	Guo, LS; Carraro, M; Carrer, A; Minervini, G; Urbani, A; Masgras, I; Tosatto, SCE; Szabo, I; Bernardi, P; Lippe, G				Guo, Lishu; Carraro, Michela; Carrer, Andrea; Minervini, Giovanni; Urbani, Andrea; Masgras, Ionica; Tosatto, Silvio C. E.; Szabo, Ildiko; Bernardi, Paolo; Lippe, Giovanna			Arg-8 of yeast subunit e contributes to the stability of F-ATP synthase dimers and to the generation of the full-conductance mitochondrial megachannel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; ATP synthase; yeast; dimerization; mitochondrial permeability transition (MPT); molecular motor; high-conductance channel; megachannel	MEMBRANE-SPANNING SEGMENT; PERMEABILITY TRANSITION; F1F0-ATP SYNTHASE; SACCHAROMYCES-CEREVISIAE; CHANNEL FORMATION; GXXXG MOTIF; IDENTIFICATION; RESOLUTION; F1-ATPASE; COMPLEX	The mitochondrial F-ATP synthase is a complex molecular motor arranged in V-shaped dimers that is responsible for most cellular ATP synthesis in aerobic conditions. In the yeast F-ATP synthase, subunits e and g of the F-O sector constitute a lateral domain, which is required for dimer stability and cristae formation. Here, by using site-directed mutagenesis, we identified Arg-8 of subunit e as a critical residue in mediating interactions between subunits e and g, most likely through an interaction with Glu-83 of subunit g. Consistent with this hypothesis, (i) the substitution of Arg-8 in subunit e (eArg-8) with Ala or Glu or of Glu-83 in subunit g (gGlu-83) with Ala or Lys destabilized the digitonin-extracted F-ATP synthase, resulting in decreased dimer formation as revealed by blue-native electrophoresis; and (ii) simultaneous substitution of eArg-8 with Glu and of gGlu-83 with Lys rescued digitonin-stable F-ATP synthase dimers. When tested in lipid bilayers for generation of Ca2+-dependent channels, WT dimers displayed the high-conductance channel activity expected for the mitochondrial megachannel/permeability transition pore, whereas dimers obtained at low digitonin concentrations from the Arg-8 variants displayed currents of strikingly small conductance. Remarkably, double replacement of eArg-8 with Glu and of gGlu-83 with Lys restored high-conductance channels indistinguishable from those seen in WT enzymes. These findings suggest that the interaction of subunit e with subunit g is important for generation of the full-conductance megachannel from F-ATP synthase.	[Guo, Lishu; Carraro, Michela; Carrer, Andrea; Minervini, Giovanni; Urbani, Andrea; Masgras, Ionica; Tosatto, Silvio C. E.; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Szabo, Ildiko; Bernardi, Paolo] Univ Padua, Dept Biol, Padua, Italy; [Tosatto, Silvio C. E.; Szabo, Ildiko] Consiglio Nazl Ric Inst Neurosci, I-35131 Padua, Italy; [Lippe, Giovanna] Univ Udine, Dept Agr Food Environm & Anim Sci, I-33100 Udine, Italy	University of Padua; University of Padua; University of Udine	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.; Lippe, G (corresponding author), Univ Udine, Dept Agr Food Environm & Anim Sci, I-33100 Udine, Italy.	bernardi@bio.unipd.it; giovanna.lippe@uniud.it	Tosatto, Silvio/B-2840-2009; Masgras, Ionica/ABG-9245-2021; Szabo, Ildiko/AAW-5972-2021; Bernardi, Paolo/C-3656-2008; Minervini, Giovanni/D-1200-2013	Tosatto, Silvio/0000-0003-4525-7793; Masgras, Ionica/0000-0002-9768-460X; Szabo, Ildiko/0000-0002-3637-3947; Bernardi, Paolo/0000-0001-9187-3736; Minervini, Giovanni/0000-0001-7013-5785; Urbani, Andrea/0000-0002-3935-6907	AIRC [IG17067]; Fondation Leducq Grant [16CVD04]	AIRC(Fondazione AIRC per la ricerca sul cancro); Fondation Leducq Grant(Leducq Foundation)	This work was supported in part by AIRC Grant IG17067 (to P. B.) and Fondation Leducq Grant 16CVD04 (to P. B.). This work is in partial fulfillment of the requirements for the Ph.D. at the Department of Biomedical Sciences, University of Padova (L. G.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Anselmi C, 2018, J GEN PHYSIOL, V150, P763, DOI 10.1085/jgp.201812033; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arnold I, 1997, FEBS LETT, V411, P195, DOI 10.1016/S0014-5793(97)00691-1; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Bernardi P, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01543; Bernardi P, 2018, CURR OPIN PHYSIOL, V3, P1, DOI 10.1016/j.cophys.2017.12.006; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Bradshaw PC, 2013, YEAST, V30, P471, DOI 10.1002/yea.2984; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Carraro M, 2018, CELL PHYSIOL BIOCHEM, V50, P1840, DOI 10.1159/000494864; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Everard-Gigot V, 2005, EUKARYOT CELL, V4, P346, DOI 10.1128/EC.4.2.346-355.2005; Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004; Giorgio V, 2017, EMBO REP, V18, P1065, DOI 10.15252/embr.201643354; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815; Guo LS, 2018, J BIOL CHEM, V293, P14632, DOI 10.1074/jbc.RA118.004495; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; Hahn A, 2016, MOL CELL, V63, P445, DOI 10.1016/j.molcel.2016.05.037; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Klusch N, 2017, ELIFE, V6, DOI 10.7554/eLife.33274; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; Neginskaya MA, 2019, CELL REP, V26, P11, DOI 10.1016/j.celrep.2018.12.033; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Saddar S, 2005, J BIOL CHEM, V280, P24435, DOI 10.1074/jbc.M502804200; Soubannier V, 1999, BIOCHEMISTRY-US, V38, P15017, DOI 10.1021/bi9916067; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; Srivastava AP, 2018, SCIENCE, V360, DOI 10.1126/science.aas9699; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Velours J, 2011, J BIOL CHEM, V286, P35477, DOI 10.1074/jbc.M111.275776; von Stockum S, 2015, J BIOL CHEM, V290, P4537, DOI 10.1074/jbc.C114.629766; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	45	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10987	10997		10.1074/jbc.RA119.008775	http://dx.doi.org/10.1074/jbc.RA119.008775			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31160339	Green Published, hybrid			2022-12-26	WOS:000478717200020
J	Yang, XJ; Zhu, H; Mu, SR; Wei, WJ; Yuan, X; Wang, M; Liu, YC; Hui, JY; Huang, Y				Yang, Xiao-Juan; Zhu, Hong; Mu, Shi-Rong; Wei, Wen-Juan; Yuan, Xun; Wang, Meng; Liu, Yanchao; Hui, Jingyi; Huang, Ying			Crystal structure of a Y-box binding protein 1 (YB-1)-RNA complex reveals key features and residues interacting with RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; post-transcriptional regulation; gene expression; structural biology; cancer; oncogene; cold shock domain (CSD); single-stranded RNA binding; splicing regulation; Y-box binding protein 1 (YB-1)	COLD-SHOCK DOMAIN; SINGLE STRANDS BIND; MESSENGER-RNA; BREAST-CANCER; TRANSLATIONAL ACTIVATION; YB-1 PROMOTES; DNA-BINDING; GROWTH; RECOGNITION; ASSOCIATION	The Y-box binding protein 1 (YB-1) is a member of the cold shock domain (CSD) protein family and is recognized as an oncogenic factor in several solid tumors. By binding to RNA, YB-1 participates in several steps of posttranscriptional regulation of gene expression, including mRNA splicing, stability, and translation; microRNA processing; and stress granule assembly. However, the mechanisms in YB-1-mediated regulation of RNAs are unclear. Previously, we used both systematic evolution of ligands by exponential enrichment (SELEX) and individual-nucleotide resolution UV cross-linking and immunoprecipitation coupled RNA-Seq (iCLIP-Seq) analyses, which defined the RNA-binding consensus sequence of YB-1 as CA(U/C)C. We also reported that through binding to its core motif CAUC in primary transcripts, YB-1 regulates the alternative splicing of a CD44 variable exon and the biogenesis of miR-29b-2 during both Drosha and Dicer steps. To elucidate the molecular basis of the YB-1-RNA interactions, we report high-resolution crystal structures of the YB-1 CSD in complex with different RNA oligos at 1.7 angstrom resolution. The structure revealed that CSD interacts with RNA mainly through pi-pi stacking interactions assembled by four highly conserved aromatic residues. Interestingly, YB-1 CSD forms a homodimer in solution, and we observed that two residues, Tyr-99 and Asp-105, at the dimer interface are important for YB-1 CSD dimerization. Substituting these two residues with Ala reduced CSD's RNA-binding activity and abrogated the splicing activation of YB-1 targets. The YB-1 CSD-RNA structures presented here at atomic resolution provide mechanistic insights into gene expression regulated by CSD-containing proteins.	[Yang, Xiao-Juan; Zhu, Hong; Mu, Shi-Rong; Wei, Wen-Juan; Wang, Meng; Hui, Jingyi] CAS Ctr Excellence Mol Cell Sci, Shanghai 200031, Peoples R China; [Yang, Xiao-Juan; Zhu, Hong; Mu, Shi-Rong; Wei, Wen-Juan; Yuan, Xun; Wang, Meng; Liu, Yanchao; Hui, Jingyi; Huang, Ying] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Yang, Xiao-Juan; Yuan, Xun; Liu, Yanchao; Huang, Ying] Shanghai Key Lab Mol Androl, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Hui, JY; Huang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	jyhui@sibcb.ac.cn; huangy@sibcb.ac.cn	Huang, Ying/AFM-0838-2022	Huang, Ying/0000-0002-2806-2874; , Yanchao/0000-0002-6647-8491; Hui, Jingyi/0000-0002-1999-4776	National Natural Science Foundation of China [91640102, 31870741, 31570820, 31661143035, 31770881]; National Key Research and Development Program of China [2017YFA0504400]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010202, XDB19000000]; Chinese Academy of Sciences Facility-based Open Research Program; State Key Laboratory of Molecular Biology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences Facility-based Open Research Program; State Key Laboratory of Molecular Biology	This work was supported by National Natural Science Foundation of China Grants 91640102 and 31870741 (to Y. H.) and 31570820, 31661143035, and 31770881 (to J. H.), National Key Research and Development Program of China Grant 2017YFA0504400 (to J. H.), Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDB08010202 (to Y. H.) and XDB19000000 (to J. H.), the Chinese Academy of Sciences Facility-based Open Research Program, and the State Key Laboratory of Molecular Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Abrakhi S, 2017, ACS NANO, V11, P7189, DOI 10.1021/acsnano.7b03071; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allemand E, 2007, NAT STRUCT MOL BIOL, V14, P630, DOI 10.1038/nsmb1257; Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; BOUVET P, 1995, J BIOL CHEM, V270, P28297; Chen CY, 2000, GENE DEV, V14, P1236; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; Feracci M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10355; Ferreira AR, 2017, J BONE ONCOL, V6, P16, DOI 10.1016/j.jbo.2017.01.002; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Guryanov SG, 2013, BBA-PROTEINS PROTEOM, V1834, P559, DOI 10.1016/j.bbapap.2012.11.007; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Hinze F, 2018, RNA BIOL, V15, P359, DOI 10.1080/15476286.2017.1384120; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Kosnopfel C, 2014, EUR J CELL BIOL, V93, P61, DOI 10.1016/j.ejcb.2013.11.007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindquist JA, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0274-6; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Manival X, 2001, NUCLEIC ACIDS RES, V29, P2223, DOI 10.1093/nar/29.11.2223; Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706; Maurya PK, 2017, J CANCER, V8, P1900, DOI 10.7150/jca.17689; Max KEA, 2007, FEBS J, V274, P1265, DOI 10.1111/j.1742-4658.2007.05672.x; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; Mayr F, 2012, NUCLEIC ACIDS RES, V40, P7492, DOI 10.1093/nar/gks355; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Ohga T, 1998, J BIOL CHEM, V273, P5997, DOI 10.1074/jbc.273.11.5997; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Rohr I, 2016, CYTOKINE, V85, P157, DOI 10.1016/j.cyto.2016.06.021; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Shurtleff MJ, 2017, P NATL ACAD SCI USA, V114, pE8987, DOI 10.1073/pnas.1712108114; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; To K, 2010, CANCER RES, V70, P2840, DOI 10.1158/0008-5472.CAN-09-3155; van Zalen S, 2012, BLOOD, V119, P1045, DOI 10.1182/blood-2011-10-387316; Wei WJ, 2012, NUCLEIC ACIDS RES, V40, P8622, DOI 10.1093/nar/gks579; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Wu SL, 2015, NUCLEIC ACIDS RES, V43, P8516, DOI 10.1093/nar/gkv779	52	31	31	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10998	11010		10.1074/jbc.RA119.007545	http://dx.doi.org/10.1074/jbc.RA119.007545			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31160337	Green Published, hybrid			2022-12-26	WOS:000478717200021
J	Singh, S; Goswami, N; Tyagi, AK; Khare, G				Singh, Swati; Goswami, Nikita; Tyagi, Anil K.; Khare, Garima			Unraveling the role of the transcriptional regulator VirS in low pH-induced responses of Mycobacterium tuberculosis and identification of VirS inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; gene microarray; transcription factor; tuberculosis; inhibitor; AraC; XylS type transcription factor; immune evasion; site-directed mutagenesis; VirS; virtual screening	MICROTITER ASSAY PLATE; DNA-BINDING DOMAIN; INTRAPHAGOSOMAL SURVIVAL; 3-DIMENSIONAL STRUCTURES; GENE-EXPRESSION; PROTEIN MODELS; MYMA OPERON; ACID; SEQUENCE; REVEALS	The ability of Mycobacterium tuberculosis to respond and adapt to various stresses such as oxygen/nitrogen radicals and low pH inside macrophages is critical for the persistence of this human pathogen inside its host. We have previously shown that an AraC/XylS-type transcriptional regulator, VirS, which is induced in low pH, is involved in remodeling the architecture of the bacterial cell envelope. However, how VirS influences gene expression to coordinate these pH responses remains unclear. Here, using a genetic biosensor of cytoplasmic pH, we demonstrate that VirS is required for the intracellular pH maintenance in response to acidic stress and inside acidified macrophages. Furthermore, we observed that VirS plays an important role in blocking phagosomal-lysosomal fusions. Transcriptomics experiments revealed that VirS affects the expression of genes encoding metabolic enzymes, cell-wall envelope proteins, efflux pumps, ion transporters, detoxification enzymes, and transcriptional regulators expressed under low-pH stress. Employing electrophoretic mobility-shift assays, DNA footprinting, and in silico analysis, we identified a DNA sequence to which VirS binds and key residues in VirS required for its interaction with DNA. A significant role of VirS in M. tuberculosis survival in adverse conditions suggested it as a potential anti-mycobacterial drug target. To that end, we identified VirS inhibitors in a virtual screen; the top hit compounds inhibited its DNA-binding activity and also M. tuberculosis growth in vitro and inside macrophages. Our findings establish that VirS mediates M. tuberculosis responses to acidic stress and identify VirS-inhibiting compounds that may form the basis for developing more effective anti-mycobacterial agents.	[Singh, Swati; Goswami, Nikita; Tyagi, Anil K.; Khare, Garima] Univ Delhi South Campus, Dept Biochem, Benito Juarez Rd, New Delhi 110021, India; [Tyagi, Anil K.] Guru Gobind Singh Indraprastha Univ, Sect 16-C, New Delhi 110078, India	University of Delhi; GGS Indraprastha University	Tyagi, AK; Khare, G (corresponding author), Univ Delhi South Campus, Dept Biochem, Benito Juarez Rd, New Delhi 110021, India.	aniltyagi@south.du.ac.in; garima1822@yahoo.co.in			Department of Biotechnology, Government of India [BT/01/COE/05/06-II, BT/07/IYBA/2013-5]; Department of Science and Technology, Government of India, J.C. Bose Fellowship [SR/S2/JCB-39/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India, J.C. Bose Fellowship	This work was supported by Department of Biotechnology, Government of India, Grant BT/01/COE/05/06-II (to A.K.T.); Department of Science and Technology, Government of India, J.C. Bose Fellowship SR/S2/JCB-39/2009 (to A.K.T.), and Department of Biotechnology, Government of India, Innovative Young Bio-technologist Award BT/07/IYBA/2013-5 (to G.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Athmann C, 2000, J CLIN INVEST, V106, P339, DOI 10.1172/JCI9351; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Baker JJ, 2014, MOL MICROBIOL, V94, P56, DOI 10.1111/mmi.12688; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chauhan S, 2009, FEBS J, V276, P3428, DOI 10.1111/j.1742-4658.2009.07066.x; Cholo MC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/608682; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dangi B, 2004, MOL MICROBIOL, V54, P45, DOI 10.1111/j.1365-2958.2004.04250.x; Dassault Systemes, 2016, BIOVIA DISC STUD MOD; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Desriac N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00284; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Gupta S, 1999, FEMS MICROBIOL LETT, V172, P137, DOI 10.1016/S0378-1097(99)00028-2; GUPTA S, 1993, GENE, V126, P157, DOI 10.1016/0378-1119(93)90607-5; Healy C, 2016, TUBERCULOSIS, V97, P154, DOI 10.1016/j.tube.2015.10.003; Khare G, 2013, SCI REP-UK, V3, DOI 10.1038/srep03527; Khare G, 2013, ANTIMICROB AGENTS CH, V57, P6372, DOI 10.1128/AAC.01444-13; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Lopez M, 2018, ARCH MICROBIOL, V200, P483, DOI 10.1007/s00203-017-1465-z; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marcus EA, 2013, HELICOBACTER, V18, P363, DOI 10.1111/hel.12055; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; Martin-Galiano AJ, 2001, MOL MICROBIOL, V41, P1327, DOI 10.1046/j.1365-2958.2001.02597.x; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Mols M, 2010, ENVIRON MICROBIOL, V12, P873, DOI 10.1111/j.1462-2920.2009.02132.x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ni L, 2013, NUCLEIC ACIDS RES, V41, P1998, DOI 10.1093/nar/gks1207; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Raimunda D, 2012, MOL MICROBIOL, V84, P1139, DOI 10.1111/j.1365-2958.2012.08082.x; Raynaud C, 2002, MOL MICROBIOL, V46, P191, DOI 10.1046/j.1365-2958.2002.03152.x; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Rodgers ME, 2009, PROTEINS, V77, P202, DOI 10.1002/prot.22431; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohilla A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04748-9; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Singh S, 2018, DRUG DES DEV THER, V12, P1065, DOI 10.2147/DDDT.S144240; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Stincone A, 2011, NUCLEIC ACIDS RES, V39, P7512, DOI 10.1093/nar/gkr338; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Yao MD, 2013, J BIOL CHEM, V288, P31019, DOI 10.1074/jbc.M113.473611	59	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2019	294	26					10055	10075		10.1074/jbc.RA118.005312	http://dx.doi.org/10.1074/jbc.RA118.005312			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IH4EW	31126988	Green Published, hybrid			2022-12-26	WOS:000474445600003
J	Weinroth, MD; Britton, BC; McCullough, KR; Martin, JN; Geornaras, I; Knight, R; Belk, KE; Metcalf, JL				Weinroth, Margaret D.; Britton, Brianna C.; McCullough, Kathryn R.; Martin, Jennifer N.; Geornaras, Ifigenia; Knight, Rob; Belk, Keith E.; Metcalf, Jessica L.			Ground beef microbiome changes with antimicrobial decontamination interventions and product storage	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; LACTIC-ACID; BACTERIAL SPOILAGE; SODIUM-SULFATE; SULFURIC-ACID; MEAT; CONTAMINATION; SALMONELLA; TEMPERATURE; REDUCTION	Ground beef makes up more than half of the beef consumed in the U.S. market. Although numerous studies have been conducted on microbial safety and shelf life of ground beef limited work has been done using a culture-independent approach. While past studies have allowed for the evaluation of a few organisms of interest, there is limited work on the microbial community associated with fresh ground beef. In order to have a more complete picture of the microbial ecology of the product, a culture-independent approach utilizing 16S rRNA gene amplicon sequencing was used. The objectives of this study were to characterize the fresh ground beef microbiome and the effect that antimicrobial interventions and antioxidants, applied to beef trim before grinding, and product storage have on community composition using 16S rRNA gene amplicon sequencing. Beef trimmings were treated with antimicrobials and an antioxidant. Samples were ground, loafed, and overwrapped before being packaged in modified-atmosphere packaging. Samples were in dark storage for 21 days followed by five days in retail display. Periodically during storage, samples were collected for microbiological analysis and DNA isolation. Due to low microbial biomass, only 52 of 210 samples were included in the final analysis. These samples represented two antimicrobial treatments (peroxyacetic acid, and a sulfuric acid and sodium sulfate blend) and a control, from day-15 of dark storage and day-5 of retail display. As sample age increased, so did the number of raw reads (P < 0.001) and aerobic plate counts (P < 0.001), which were correlated (r = 0.94, P = 0.017). Across all samples, lactic acid bacteria were most abundant followed by Enterobacteriaceae; several rare taxa were also identified (namely Geobacillus, Thermus, and Sporosarcina). Antimicrobial treatment altered the bacterial alpha (P < 0.001) and beta (P = 0.001) diversity, while storage day altered alpha (P = 0.001) diversity. Enterobacteriaceae relative abundance differed (P < 0.05) among treatments and was highest in control samples. In addition to confirming previously described dominant microbial differences in culture-dependent results, these data identified genera not typically associated with ground beef and allowed for study of shifts in the entire microbiome and not just a subset of indicator organisms.	[Weinroth, Margaret D.; Martin, Jennifer N.; Geornaras, Ifigenia; Belk, Keith E.; Metcalf, Jessica L.] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA; [Britton, Brianna C.] Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA; [McCullough, Kathryn R.] North Amer Meat Inst, Washington, DC USA; [Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA	Colorado State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Metcalf, JL (corresponding author), Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA.	Jessica.Metcalf@colostate.edu	Geornaras, Ifigenia/S-3828-2017	Knight, Rob/0000-0002-0975-9019; Weinroth, Margaret/0000-0001-8351-395X; Geornaras, Ifigenia/0000-0002-2384-2628				Ali NH, 2010, J INFECT DEV COUNTR, V4, P382, DOI 10.3855/jidc.599; ANDERSON ME, 1990, J FOOD SAFETY, V10, P181, DOI 10.1111/j.1745-4565.1989.tb00019.x; Arthur TM, 2004, J FOOD PROTECT, V67, P658, DOI 10.4315/0362-028X-67.4.658; Borch E, 1996, INT J FOOD MICROBIOL, V33, P103, DOI 10.1016/0168-1605(96)01135-X; Brooks JC, 2008, J FOOD PROTECT, V71, P293, DOI 10.4315/0362-028X-71.2.293; Brown MH, 2000, INT J FOOD MICROBIOL, V62, P7, DOI 10.1016/S0168-1605(00)00408-6; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHURCH N, 1994, TRENDS FOOD SCI TECH, V5, P345, DOI 10.1016/0924-2244(94)90211-9; Close D., 2014, RABOBANK AGFOCUS; Crim SM, 2015, MMWR-MORBID MORTAL W, V64, P495; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doulgeraki AI, 2010, FOOD MICROBIOL, V27, P1028, DOI 10.1016/j.fm.2010.07.004; Earth Microbiome Project, 2018, 16S ILL AMPL SEQ; Economic Research Service, 2018, Q RED MEAT POULTR EG; Ercolini D, 2006, APPL ENVIRON MICROB, V72, P4663, DOI 10.1128/AEM.00468-06; Griffiths E, 2004, J BACTERIOL, V186, P3097, DOI 10.1128/JB.186.10.3097-3107.2004; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Holzapfel WH, 1998, GRAM POSTIVE BACTERI, P35; Karre L, 2013, MEAT SCI, V94, P220, DOI 10.1016/j.meatsci.2013.01.007; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koutsoumanis K, 2006, APPL ENVIRON MICROB, V72, P124, DOI 10.1128/AEM.72.1.124-134.2006; Laufer AS, 2015, EPIDEMIOL INFECT, V143, P2003, DOI 10.1017/S0950268814003112; Lavieri N, 2014, MEAT SCI, V97, P534, DOI 10.1016/j.meatsci.2014.02.014; Mancini RA, 2005, MEAT SCI, V71, P100, DOI 10.1016/j.meatsci.2005.03.003; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; NASSOS PS, 1983, APPL ENVIRON MICROB, V46, P894, DOI 10.1128/AEM.46.4.894-900.1983; Nissen H, 2000, INT J FOOD MICROBIOL, V59, P211, DOI 10.1016/S0168-1605(00)00373-1; Nychas G. J. E., 2005, Improving the safety of fresh meat, P461, DOI 10.1533/9781845691028.2.461; Osman KM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29932-3; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rajkovic A, 2010, INT J FOOD MICROBIOL, V141, pS29, DOI 10.1016/j.ijfoodmicro.2009.12.019; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Ransom J. R., 2003, Food Protection Trends, V23, P24; Scott-Bullard BR, 2017, J FOOD PROTECT, V80, P1987, DOI 10.4315/0362-028X.JFP-17-022; Stanbridge L. H., 1998, MICROBIOLOGY MEAT PO, P175; USDA-FSIS, 2012, SHIG TOX PROD ESCH C; USDA- FSIS, 2018, PATH RED SALM CAMP P; Wheeler TL, 2014, MEAT SCI, V98, P372, DOI 10.1016/j.meatsci.2014.06.026; Yang XA, 2017, J FOOD PROTECT, V80, P809, DOI 10.4315/0362-028X.JFP-16-317; Yoon Lee, 2009, GENUS 8 SPOROSARCINA, P377; Zeigler DR, 2014, MICROBIOL-SGM, V160, P1, DOI 10.1099/mic.0.071696-0	44	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217947	10.1371/journal.pone.0217947	http://dx.doi.org/10.1371/journal.pone.0217947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166992	gold, Green Published, Green Submitted			2022-12-26	WOS:000470087800053
J	He, MJ; Yao, YW; Li, YN; Yang, M; Li, Y; Wu, B; Yu, DZ				He, Meijun; Yao, Yiwei; Li, Yanni; Yang, Meng; Li, Yu; Wu, Bin; Yu, Dazhao			Comprehensive transcriptome analysis reveals genes potentially involved in isoflavone biosynthesis in Pueraria thomsonii Benth	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; PROTEIN; EXPRESSION; CLASSIFICATION; INHIBITION; MICRORNAS; ACCURACY; PROGRAM; MIRNAS	Pueraria thomsonii Benth is an important medicinal plant. Transcriptome sequencing, unigene assembly, the annotation of transcripts and the study of gene expression profiles play vital roles in gene function research. However, the full-length transcriptome of P. thomsonii remains unknown. Here, we obtained 44,339 nonredundant transcripts of P. thomsonii by using the PacBio RS II Isoform and Illumina sequencing platforms, of which 43,195 were annotated genes. Compared with the expression levels in the plant roots, those of transcripts with a vertical bar fold change vertical bar >= 4 and FDR < 0.01 in the leaves or stems were assigned as differentially expressed transcripts (DETs). In total, we found 9,225 DETs, 32 of which came from structural genes that were potentially involved in isoflavone biosynthesis. The expression profiles of 8 structural genes from the RNA-Seq data were validated by qRT-PCR. We identified 437 transcription factors (TFs) that were positively or negatively correlated with at least 1 of the structural genes involved in isoflavone biosynthesis using Pearson correlation coefficients (r) (r > 0.8 or r < -0.8). We also identified a total of 32 microRNAs (miRNAs), which targeted 805 transcripts. These miRNAs caused enriched function in 'ATP binding', 'defense response', 'ADP binding', and 'signal transduction'. Interestingly, MIR156a potentially promoted isoflavone biosynthesis by repressing SBP, and MIR319 promoted isoflavone biosynthesis by repressing TCP and HB-HD-ZIP. Finally, we identified 2,690 alternative splicing events, including that of the structural genes of trans-cinnamate 4-mono-oxygenase and pullulanase, which are potentially involved in the biosynthesis of isoflavone and starch, respectively, and of three TFs potentially involved in isoflavone biosynthesis. Together, these results provide us with comprehensive insight into the gene expression and regulation of P. thomsonii.	[He, Meijun; Yu, Dazhao] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [He, Meijun; Li, Yu] Hubei Acad Agr Sci, Inst Chinese Med Mat, Enshi, Peoples R China; [Yao, Yiwei; Li, Yanni; Yang, Meng; Wu, Bin] Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing, Peoples R China; [Yao, Yiwei; Li, Yanni; Yang, Meng; Wu, Bin] Peking Union Med Coll, Beijing, Peoples R China	Wuhan University; Hubei Academy of Agricultural Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yu, DZ (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China.; Wu, B (corresponding author), Chinese Acad Med Sci, Ctr Bioinformat, Inst Med Plant Dev, Beijing, Peoples R China.; Wu, B (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	bwu@implad.ac.cn; dazhaoyu@china.com		Wu, Bin/0000-0001-5042-8345	Natural Science Foundation of China [81274015]; Research and development of science and technology project of Enshi [XYJ2017000305]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and development of science and technology project of Enshi	This work was supported by Natural Science Foundation of China (81274015) to Bin Wu (https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and Research and development of science and technology project of Enshi (XYJ2017000305) to Meijun He (http://kjj.enshi.gov.cn/2017/1026/595024.shtml).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamancos GP, 2015, RNA, V21, P1521, DOI 10.1261/rna.051557.115; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2005, CHINESE PHARMACOPOEI, P203; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chu SS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006770; Dai XB, 2018, NUCLEIC ACIDS RES, V46, pW49, DOI 10.1093/nar/gky316; Deng Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092476; Du G, 2010, J CHROMATOGR A, V1217, P705, DOI 10.1016/j.chroma.2009.12.017; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Gong P, 2017, EXP THER MED, V14, P4431, DOI 10.3892/etm.2017.5049; Gordon SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132628; Hackl T, 2014, BIOINFORMATICS, V30, P3004, DOI 10.1093/bioinformatics/btu392; Han RC, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00426; He L, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100257; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00861; Li J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00793; Li J, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.31; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li XW, 2013, GENE, V532, P72, DOI 10.1016/j.gene.2013.09.015; Lin RC, 1996, ALCOHOL CLIN EXP RES, V20, P659, DOI 10.1111/j.1530-0277.1996.tb01668.x; Liu XQ, 2013, PLANT BIOTECHNOL REP, V7, P445, DOI 10.1007/s11816-013-0283-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Qu JZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30411-y; Reddy CK, 2017, INT J BIOL MACROMOL, V105, P354, DOI 10.1016/j.ijbiomac.2017.07.052; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Wang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066417, 10.1371/journal.pone.0068894]; Wang X, 2017, PLANT J, V90, P535, DOI 10.1111/tpj.13510; Wang X, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00387; Wu B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2151-7; Wu B, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034588, 10.1371/journal.pone.0044385]; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Xu ZC, 2015, PLANT J, V82, P951, DOI 10.1111/tpj.12865; Yang X, 2017, CURR MOL MED, V17, P488, DOI 10.2174/1566524018666171219101142; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014	45	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217593	10.1371/journal.pone.0217593	http://dx.doi.org/10.1371/journal.pone.0217593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163077	Green Published, gold, Green Submitted			2022-12-26	WOS:000470086200022
J	Oldenburg, M; Jensen, HJ				Oldenburg, Marcus; Jensen, Hans-Joachim			Stress and strain among merchant seafarers differs across the three voyage episodes of port stay, river passage and sea passage	PLOS ONE			English	Article							SLEEP; EXPERIENCE; SAFETY; WORK; LIFE	Background A sea voyage is characterized by a variety of work requirements for the ship's crew, basically reflected in three voyage episodes: port stay, river passage and sea passage. The primary aim of this study was to compare stress and strain amongst a sample of merchant seafarers across these three voyage episodes. Methods In a cross-sectional maritime field study, 323 sailors on 22 container ships were biometrically surveyed and completed a questionnaire. In addition, a survey of energy expenditure and heart rate (variability) was carried out in parallel with 236 participants with the Sense-Wear armband monitor and the RS 800 polar watch. Results Port stay and sea passage each accounted for the largest proportion of the ships' journeys, each at around 40%. The study participants rated port stay with 37.8% as the voyage episode with the highest strain, followed by the river passage (24.8%) and then the sea passage (13.0%). The working time during the sea passage was on average shorter than during port stay or the river passage (p<0.001)-as a result, seafarers had more spare time to spend on leisure and sleep. Total energy turnover and, by trend, work energy turnover were notably at the lowest during the sea passage. In particular, the crew had a significantly lower heart rate during the sea passage than during the other two voyage episodes (p = 0.001). Furthermore, there was no difference in the seafarers' heart rate variability between the voyage episodes. Conclusion In the present study, it becomes clear that an accumulation of psychophysical stress takes place during port stay and leads to a subjectively and objectively higher strain level. In contrast, seafarers are more likely to recover during the sea passage. This knowledge should be used to offer ships' crews targeted health measures, in particular during the sea passage.	[Oldenburg, Marcus; Jensen, Hans-Joachim] Univ Med Ctr Hamburg Eppendorf UKE, Inst Occupat & Maritime Med Hamburg ZfAM, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Oldenburg, M (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Inst Occupat & Maritime Med Hamburg ZfAM, Hamburg, Germany.	marcus.oldenburg@bgv.hamburg.de			Berufsgenossenschaft fur Transport und Verkehrswirtschaft ("BG Verkehr"), Hamburg	Berufsgenossenschaft fur Transport und Verkehrswirtschaft ("BG Verkehr"), Hamburg	This study was funded by the Berufsgenossenschaft fur Transport und Verkehrswirtschaft ("BG Verkehr"), Hamburg. Both authors received funding. The funder has no involvement in the study design, the collection, analysis and interpretation of data, the writing of the report or the decision to submit the paper for publication.	Ambrosino D, 2004, TRANSPORT RES A-POL, V38, P81, DOI 10.1016/j.tra.2003.09.002; [Anonymous], 2017, 1007512017 ISO; [Anonymous], 2015, CONNECTING YOU CREW; Arafat MT, 2009, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION 2008, VOL 2, P3; BG BAU, 2018, ERG FACH BEGR DAUERL; Carotenuto A, 2012, INT MARIT HEALTH, V63, P188; Carter Tim, 2005, Travel Med Infect Dis, V3, P61, DOI 10.1016/j.tmaid.2004.09.005; Cezar-Vaz MR, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.1347.2837; Comperatore CA, 2005, AVIAT SPACE ENVIR MD, V76, pB108; Doyle N, 2016, INT ARCH OCC ENV HEA, V89, P199, DOI 10.1007/s00420-015-1063-9; Eagles AN, 2016, J SPORT MED PHYS FIT, V56, P565; Fan JJ, 2016, PAPERS LANGUAGE TEST, P2; Forsell K, 2017, INT ARCH OCC ENV HEA, V90, P161, DOI 10.1007/s00420-016-1180-0; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Gruwez A, 2017, INT J MED INFORM, V102, P87, DOI 10.1016/j.ijmedinf.2017.03.008; Haka M, 2011, INT MARIT HEALTH, V62, P20; Jepsen JR, 2015, INT MARIT HEALTH, V66, P106, DOI 10.5603/IMH.2015.0024; Karan C., 2016, GUIDELINES MARINE IN; Kunte M, 2017, INDIAN J PSYCHOL MED, V39, P590, DOI 10.4103/0253-7176.217022; Lodde B, 2008, INT MARIT HEALTH, V59, P53; Manfredini F, 2007, G Ital Med Lav Ergon, V29, P722; McVeigh J, 2019, MAR POLICY, V99, P283, DOI 10.1016/j.marpol.2018.10.012; Oldenburg M, 2012, OCCUP ENVIRON MED, V69, P685, DOI 10.1136/oemed-2011-100619; Oldenburg M, 2010, J OCCUP HEALTH, V52, P249, DOI 10.1539/joh.K10004; Oldenburg M, 2009, INT J PUBLIC HEALTH, V54, P96, DOI 10.1007/s00038-009-7067-z; Papachristou A, 2015, WMU J MARIT AFF, V14, P159, DOI 10.1007/s13437-015-0085-1; Pauksztat B, 2017, MARIT POLICY MANAG, V44, P899, DOI 10.1080/03088839.2017.1371347; Pitta F, 2006, EUR RESPIR J, V27, P1040, DOI 10.1183/09031936.06.00064105; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Radespiel-Troger M, 2003, CLIN AUTON RES, V13, P99, DOI 10.1007/s10286-003-0085-7; Ross J., 2006, PRACTICAL ASSESSMENT, V11, P2; Sampson Helen, 2003, Int Marit Health, V54, P58; Simkuva H, 2016, OPTIMIZATION WORK RE; Sliskovic A., 2017, MARITIME PSYCHOL RES, P99, DOI DOI 10.1007/978-3-319-45430-6_5; Sonnentag S, 2007, J OCCUP HEALTH PSYCH, V12, P204, DOI 10.1037/1076-8998.12.3.204; Teo STT, 2013, J NURS MANAGE, V21, P878, DOI 10.1111/jonm.12120	36	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217904	10.1371/journal.pone.0217904	http://dx.doi.org/10.1371/journal.pone.0217904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163071	Green Published, gold, Green Submitted			2022-12-26	WOS:000470086200045
J	Ryoo, SM; Ahn, R; Shin, TG; Jo, YH; Chung, SP; Beom, JH; Choi, SH; Yoon, YH; Ko, BS; Lee, HJ; Suh, GJ; Kim, WY; Park, YS; Kim, K; Shin, JH; Lee, SW; Kang, GH; Lim, TH; Choi, HS				Ryoo, Seung Mok; Ahn, Ryeok; Shin, Tae Gun; Jo, You Hwan; Chung, Sung Phil; Beom, Jin Ho; Choi, Sung-Hyuk; Yoon, Young-Hoon; Ko, Byuk Sung; Lee, Hui Jai; Suh, Gil Joon; Kim, Won Young; Park, Yoo Seok; Kim, Kyuseok; Shin, Jong Hwan; Lee, Sung Woo; Kang, Gu Hyun; Lim, Tae Ho; Choi, Han Sung		Korean Shock Soc KoSS Investigator	Lactate normalization within 6 hours of bundle therapy and 24 hours of delayed achievement were associated with 28-day mortality in septic shock patients	PLOS ONE			English	Article							GOAL-DIRECTED RESUSCITATION; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; CLEARANCE; DEFINITIONS	This study evaluated the prognostic ability of lactate normalization achieved within 6 and 24 h from septic shock recognition. Data from a septic shock registry from October 2015 to February 2017 were reviewed. The study included 2,102 eligible septic shock patients to analyze the prognostic ability of lactate normalization, defined as a follow-up lactate level <2 mmol/L within six hours of bundle therapy and within 24 hours of delayed normalization. The primary outcome was 28-day mortality. The overall 28-day mortality rate was 21.4%. The rates of lactate normalization within 6 and 24 h were significantly higher in the survivor groups than in the non-survivor group (42.4% vs. 23.4% and 60.2% vs. 31.2%; P<0.001, respectively). Multivariate logistic regression analysis showed that both 6-and 24-h lactate normalization were independent predictors (odds ratio [ OR] 0.58, 95% confidence interval [ CI] 0.45-0.75, p<0.001 and OR 0.42, 95% CI 0.33-0.54, p<0.001, respectively). When we could not achieve the lactate normalization, the sensitivity, specificity, positive, and negative predictive value to predict mortality were 76.6%, 42.4%, 26.5% and 87.0% respectively for 6-h normalization, and 68.8%, 60.2%, 32.0% and 87.7% respectively for 24-h normalization. Besides 6-h lactate normalization, 24-h delayed lactate normalization was associated with decreasing mortality in septic shock patients. Lactate normalization may have a role in early risk stratification and as a therapeutic target.	[Ryoo, Seung Mok; Kim, Won Young] Univ Ulsan, Asan Med Ctr, Dept Emergency Med, Coll Med, Seoul, South Korea; [Ahn, Ryeok] Univ Ulsan, Ulsan Univ Hosp, Dept Emergency Med, Coll Med, Ulsan, South Korea; [Shin, Tae Gun] Sungkyunkwan Univ, Samsung Med Ctr, Dept Emergency Med, Sch Med, Seoul, South Korea; [Jo, You Hwan] Seoul Natl Univ, Dept Emergency Med, Bundang Hosp, Seongnam, South Korea; [Chung, Sung Phil; Beom, Jin Ho] Yonsei Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Choi, Sung-Hyuk; Yoon, Young-Hoon] Korea Univ, Guro Hosp, Dept Emergency Med, Med Ctr, Seoul, South Korea; [Ko, Byuk Sung] Hanyang Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Lee, Hui Jai] Seoul Natl Univ, Dept Emergency Med, Boramae Med Ctr, Seoul, South Korea; [Suh, Gil Joon] Seoul Natl Univ, Dept Emergency Med, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Ulsan University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, WY (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Emergency Med, Coll Med, Seoul, South Korea.	wonpia73@naver.com	Shin, Tae Gun/GSD-5866-2022; YOON, Young-Hoon/ABA-8810-2020	Yoon, Young-Hoon/0000-0002-1916-2080; Ryoo, Seung Mok/0000-0002-2436-3311; Choi, Sung-Hyuk/0000-0002-6686-6937	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2018-0409]	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	This study was supported by a grant (2018-0409) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [http://ails.amc.seoul.kr/ailsk/main.do].The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Hernandez G, 2019, JAMA-J AM MED ASSOC, V321, P654, DOI 10.1001/jama.2019.0071; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Jung C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030374; Kim JS, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120554; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lyu Xiaochun, 2015, Zhonghua Yi Xue Za Zhi, V95, P496; Masyuk M, 2019, INTENS CARE MED, V45, P55, DOI 10.1007/s00134-018-5475-3; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Puskarich MA, 2013, CHEST, V143, P1548, DOI 10.1378/chest.12-0878; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Ryoo SM, 2018, AM J MED SCI, V356, P97, DOI 10.1016/j.amjms.2018.05.002; Scott HF, 2016, J PEDIATR-US, V170, P149, DOI 10.1016/j.jpeds.2015.11.071; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sterling SA, 2015, CLIN EXP EMERG MED, V2, P197, DOI 10.15441/ceem.15.025; Tian Huan-huan, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P42; Yu Bin, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P578, DOI 10.3760/cma.j.issn.2095-4352.2013.10.002; Zhang ZH, 2014, CRIT CARE MED, V42, P2118, DOI 10.1097/CCM.0000000000000405; Zhang ZH, 2014, J THORAC DIS, V6, P995, DOI 10.3978/j.issn.2072-1439.2014.07.01	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217857	10.1371/journal.pone.0217857	http://dx.doi.org/10.1371/journal.pone.0217857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158247	Green Published, gold, Green Submitted			2022-12-26	WOS:000469915700031
J	Arteni, AA; LaFountain, AM; Alexandre, MTA; Fradot, M; Mendes-Pinto, MM; Sahel, JA; Picaud, S; Franke, HA; Robert, B; Pascal, AA				Arteni, Ana-Andreea; LaFountain, Amy M.; Alexandre, Maxime T. A.; Fradot, Mathias; Mendes-Pinto, Maria M.; Sahel, Jose-Alain; Picaud, Serge; Franke, Harry A.; Robert, Bruno; Pascal, Andrew A.			Carotenoid composition and conformation in retinal oil droplets of the domestic chicken	PLOS ONE			English	Article								Carotenoid-containing oil droplets in the avian retina act as cut-off filters to enhance colour discrimination. We report a confocal resonance Raman investigation of the oil droplets of the domestic chicken, Gallus gallus domesticus. We show that all carotenoids present are in a constrained conformation, implying a locus in specific lipid binding sites. In addition, we provide proof of a recent conclusion that all carotenoid-containing droplets contain a mixture of all carotenoids present, rather than only a subset of them-a conclusion that diverges from the previously-held view. Our results have implications for the mechanism(s) giving rise to these carotenoid mixtures in the differently-coloured droplets.	[Arteni, Ana-Andreea; Alexandre, Maxime T. A.; Mendes-Pinto, Maria M.; Robert, Bruno; Pascal, Andrew A.] Univ Paris Saclay, CNRS, CEA, I2BC, Gif Sur Yvette, France; [LaFountain, Amy M.; Franke, Harry A.] Univ Connecticut, Dept Chem, U-60, Storrs, CT USA; [Fradot, Mathias; Sahel, Jose-Alain; Picaud, Serge] Sorbonne Univ, Inst Vis, CNRS, INSERM, Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Connecticut; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pascal, AA (corresponding author), Univ Paris Saclay, CNRS, CEA, I2BC, Gif Sur Yvette, France.	andrew.pascal@i2bc.paris-saclay.fr	Pinto, Maria Manuela Mendes/M-2804-2013; Robert, Bruno/D-1264-2012; Arteni, Ana Andreea/AAK-8561-2020; pascal, andrew/B-6186-2014; Picaud, Serge/H-4012-2014	Robert, Bruno/0000-0001-5999-4538; pascal, andrew/0000-0002-1844-6065; ARTENI, Ana Andreea/0000-0001-6462-905X; Mendes Pinto, Maria Manuela/0000-0001-7541-7335; Picaud, Serge/0000-0002-0548-5145	European Research Council through the Advanced Grant PHOTPROT [267333]; French Agence Nationale de la Recherche through contract BIOPHYSMEMBPROT [ANR-07-CEX-009-0]; French Agence Nationale de la Recherche through contract CYANOPROTECT (Blanc SVSE 8 2011); CEA interdisciplinary program Technology for Health (MEDIASPEC project); French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INBS-05]	European Research Council through the Advanced Grant PHOTPROT; French Agence Nationale de la Recherche through contract BIOPHYSMEMBPROT; French Agence Nationale de la Recherche through contract CYANOPROTECT (Blanc SVSE 8 2011); CEA interdisciplinary program Technology for Health (MEDIASPEC project); French Infrastructure for Integrated Structural Biology (FRISBI)	This work was supported by the European Research Council (http://erc.europa.eu) through the Advanced Grant PHOTPROT (contract No. 267333, to BR); the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr) through contracts BIOPHYSMEMBPROT (contract No. ANR-07-CEX-009-0, to BR) and CYANOPROTECT (Blanc SVSE 8 2011, to BR); the CEA (http://www.cea.fr) interdisciplinary program Technology for Health (MEDIASPEC project, to BR); and The French Infrastructure for Integrated Structural Biology (FRISBI; http://frisbi.eu) ANR-10-INBS-05 (to BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhosale P, 2007, BIOCHEMISTRY-US, V46, P9050, DOI 10.1021/bi700558f; BOWMAKER JK, 1977, VISION RES, V17, P755, DOI 10.1016/0042-6989(77)90117-1; Christensen RL, 2004, ARCH BIOCHEM BIOPHYS, V430, P30, DOI 10.1016/j.abb.2004.02.026; Cobbs C, 2013, MOL PHYLOGENET EVOL, V68, P221, DOI 10.1016/j.ympev.2013.03.012; GOLDSMITH TH, 1984, VISION RES, V24, P1661, DOI 10.1016/0042-6989(84)90324-9; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hill G.E., 2006, BIRD COLOURATION FUN; Ho JM, 2017, P NATL ACAD SCI USA, V114, pE5513, DOI 10.1073/pnas.1614857114; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Osorio D, 1999, J EXP BIOL, V202, P2951; Phillip D, 1996, P NATL ACAD SCI USA, V93, P1492, DOI 10.1073/pnas.93.4.1492; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Subramanian B, 2015, ANALYST, V140, P7423, DOI [10.1039/C5AN01261A, 10.1039/c5an01261a]; Toomey MB, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00097; Toomey MB, 2016, ELIFE, V5, DOI 10.7554/eLife.15675; Toomey MB, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0563; Toomey MB, 2009, FUNCT ECOL, V23, P321, DOI 10.1111/j.1365-2435.2008.01498.x; Wilby D, 2017, J EXP BIOL, V220, P1997, DOI 10.1242/jeb.152918	19	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217418	10.1371/journal.pone.0217418	http://dx.doi.org/10.1371/journal.pone.0217418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150434	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100047
J	Ekakoro, JE; Caldwell, M; Strand, EB; Okafor, CC				Ekakoro, John E.; Caldwell, Marc; Strand, Elizabeth B.; Okafor, Chika C.			Perceptions of Tennessee cattle producers regarding the Veterinary Feed Directive	PLOS ONE			English	Article							ANTIMICROBIAL USE; RESISTANCE; ANIMALS; PRODUCTIVITY; HEALTH	Since January 1, 2017, the United States Food and Drug Administration (FDA) has fully implemented the Veterinary Feed Directive (VFD) final rule aimed at facilitating the judicious use of medically important antimicrobials in food-producing animals. The objective of this study was to identify the common perceptions of Tennessee (TN) cattle producers regarding the VFD. We used a combination of focus groups and survey questionnaires to explore TN cattle producers' perceptions regarding the VFD. Preliminary findings from seven focus groups of 62 producers were used in the development of the questionnaire sent both online and in-print to rest of cattle producers in TN. The beef focus group participants perceived the VFD: to be a top-down policy; to have led to unregulated access to in-feed antimicrobials; a regulation that has limited the producers' ability to prevent disease and leading to economic losses; to negatively affect small producers; and to be affected by challenges related to prescription writing and disposal of un-used medicines. The dairy focus group participants perceived the VFD as unnecessary and burdensome, to have affected small producers, and introduced additional costs. Among the survey questionnaire respondents, 35 (15.4%) beef producers and 6 (13.6%) dairy producers respectively were not familiar at all with the VFD. Forty-eight (21.1%) beef producers and 11 (25%) dairy producers were slightly familiar with VFD. Gender was significantly associated (P = 0.02) with the beef producers' belief in the usefulness of the VFD. Similarly, for dairy producers, herd size was significantly associated (P = 0.002) with their perceptions regarding the usefulness of the VFD. The findings of this study could inform future VFD policy review processes. More awareness regarding the VFD and its benefits is needed among both beef and dairy producers in TN.	[Ekakoro, John E.; Strand, Elizabeth B.; Okafor, Chika C.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Caldwell, Marc] Univ Tennessee, Coll Vet Med, Dept Large Anim Clin Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Okafor, CC (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	okaforch@utk.edu		Ekakoro, John Eddie/0000-0002-8148-753X; Okafor, Chika/0000-0002-2895-8347	U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture [2016-36100-04715]; Center of Excellence in Livestock Diseases and Human Health (COE) at The University of Tennessee Institute of Agriculture [2016-36100-04715, 12-2209]	U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Center of Excellence in Livestock Diseases and Human Health (COE) at The University of Tennessee Institute of Agriculture	This research received major funding from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (Award number: 2016-36100-04715) and supplemented funding from the Center of Excellence in Livestock Diseases and Human Health (COE) at The University of Tennessee Institute of Agriculture (Project number: 12-2209; Award number: 2016-36100-04715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Aidara-Kane A, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0294-9; [Anonymous], 2017, FRONT MICROBIOL, DOI DOI 10.3389/FMICB.2017.02124; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Ciesinski L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191660; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Coyne LA, 2014, VET REC, V175, P593, DOI 10.1136/vr.102686; Debski B, 2016, POL J VET SCI, V19, P917, DOI 10.1515/pjvs-2016-0113; Dohoo IR, 2003, VET EPIDEMIOLOGIC RE; Duane S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008894; Ekakoro John E, 2018, Vet Med Int, V2018, P1836836, DOI 10.1155/2018/1836836; Ekakoro JE, 2019, BMC VET RES, V15, DOI 10.1186/s12917-018-1731-6; FDA, FACT SHEET VET FEED; FDA, CVM RESP VFD QUEST; FDA, 2012, GUID IND 209 JUD US; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Laxminarayan R, EC COSTS WITHDRAWING; Lee T., 2017, KANSAS AGR EXPT STAT, P1, DOI [10.4148/2378-5977.1341, DOI 10.4148/2378-5977.1341]; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; May AM, 2018, KYKLOS, V71, P162, DOI 10.1111/kykl.12166; May AM, 2014, CONTEMP ECON POLICY, V32, P111, DOI 10.1111/coep.12004; McEwen SA, 2017, WHO GUIDELINES USE M; McEwen SA, 2018, LANCET PLANET HEALTH, V2, pE279, DOI 10.1016/S2542-5196(18)30138-4; Olsen R., 2008, ENCY SURVEY RES METH, P809, DOI DOI 10.4135/9781412963947; Robinson TP, 2016, T ROY SOC TROP MED H, V110, P377, DOI 10.1093/trstmh/trw048; Speksnijder D., 2017, ANTIBIOTIC USE FARM; Speksnijder DC, 2018, ANIM FRONT, V8, P4, DOI 10.1093/af/vfy006; Taylor N, 2005, ANTHROZOOS, V18, P18, DOI 10.2752/089279305785594342; The Dairy Alliance, 2017, 2017 TENN DAIR FACTS; The Pew Charitable trusts, 2018, TRENDS US ANT US; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turnidge J, 2005, LANCET, V365, P548; Vahjen W, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0071-3; van Duijkeren E, 2014, J ANTIMICROB CHEMOTH, V69, P2022, DOI 10.1093/jac/dku123; Wierup M, 2001, MICROB DRUG RESIST, V7, P183, DOI 10.1089/10766290152045066; World Organization for Animal Health, OIE STAND GUID RES A; World Organization for Animal Health (OIE), OIE LIST ANT AG VET	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217773	10.1371/journal.pone.0217773	http://dx.doi.org/10.1371/journal.pone.0217773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150500	gold, Green Submitted, Green Published			2022-12-26	WOS:000469759100103
J	Sarker, S; Lim, UT				Sarker, Souvic; Lim, Un Taek			Development and fecundity performance of Grapholita molesta and Grapholita dimorpha (Lepidoptera: Tortricidae) on different immature fruits	PLOS ONE			English	Article							HOST-PLANT QUALITY; MOTH LEPIDOPTERA; SEX-PHEROMONE; APPLE; LARVAE; PEACH; PARAMETERS; SHOOTS; BEETLE	Both Grapholita molesta (Busck) and Grapholita dimorpha Komai (Lepidoptera: Tortricidae) are important pests of pome and stone fruits. Mature fruits of peach and plum have been tested as food sources for G. molesta, but no studies have examined the suitability of immature fruits, which are the fruit stage more likely to be available for the spring populations of both G. molesta and G. dimorpha. Thus, we evaluated immature fruits of peach, plum, and apple as food sources by assessing their effects on biological and behavioral attributes of these moths in the laboratory. Immature fruits were collected in May and June of 2016 and again in 2017. The first-instar larvae of G. molesta preferred either peach or plum, which showed exit rates of mature larvae of 81.0 and 100.0% for the two fruits, respectively. On peach, development time was shorter, and fecundity was lower than plum. However, G. dimorpha preferred plum and apple, showing the lowest fruit-boring rate and lowest mature larval exit rate on peach, from which only one female moth emerged but produced no eggs. In conclusion, it seems that at the immature fruit stage, plum and apple are better food sources for both G. molesta and G. dimorpha than is peach.	[Sarker, Souvic; Lim, Un Taek] Andong Natl Univ, Dept Plant Med, Andong, South Korea	Andong National University	Lim, UT (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	utlim@andong.ac.kr		Lim, Un Taek/0000-0002-6704-0627; Sarker, Souvic/0000-0001-6346-9656	R&D Program for Forest Science Technology by Korea Forest Service (Korea Forestry Promotion Institute) [2017064A00-1720-AB02]	R&D Program for Forest Science Technology by Korea Forest Service (Korea Forestry Promotion Institute)	This study was carried out with the support of R&D Program for Forest Science Technology (Project No. 2017064A00-1720-AB02) provided by Korea Forest Service (Korea Forestry Promotion Institute).	Atachi P., 2000, WALP INSECT SCI APPL, V20, P117, DOI [10.1017/S1742758400018750, DOI 10.1017/S1742758400018750]; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Beljaev E.A., 2005, Far Eastern Entomologist, V155, P1; Bellerose S, 2007, CAN ENTOMOL, V139, P292, DOI 10.4039/N06-058; BRANSON TF, 1982, ENTOMOL EXP APPL, V31, P303, DOI 10.1111/j.1570-7458.1982.tb03149.x; CATES RG, 1980, OECOLOGIA, V46, P22, DOI 10.1007/BF00346961; CHEW FS, 1980, OECOLOGIA, V46, P347, DOI 10.1007/BF00346263; Du J, 2015, ENVIRON ENTOMOL, V44, P1522, DOI 10.1093/ee/nvv124; Il'ichev AL, 2007, J APPL ENTOMOL, V131, P368, DOI 10.1111/j.1439-0418.2007.01201.x; Ishihara M, 2006, ENVIRON ENTOMOL, V35, P524, DOI 10.1603/0046-225X-35.2.524; Jung CR, 2014, GENOMICS, V103, P308, DOI 10.1016/j.ygeno.2014.02.009; Jung CR, 2013, J ASIA-PAC ENTOMOL, V16, P189, DOI 10.1016/j.aspen.2013.01.008; Jung Chung Ryul, 2012, Korean Journal of Applied Entomology, V51, P479, DOI 10.5656/KSAE.2012.10.0.049; KOMAI F, 1979, APPL ENTOMOL ZOOL, V14, P133, DOI 10.1303/aez.14.133; Komai Furumi, 1999, Entomologica Scandinavica Supplement, V55, P1; Leskey TC, 2001, J CHEM ECOL, V27, P1, DOI 10.1023/A:1005667430877; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Masante-Roca I, 2007, ENTOMOL EXP APPL, V122, P239, DOI 10.1111/j.1570-7458.2006.00510.x; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; MORRIS R. F., 1954, CANADIAN JOUR ZOOL, V32, P283, DOI 10.1139/z54-027; Murakami Y, 2005, APPL ENTOMOL ZOOL, V40, P521, DOI 10.1303/aez.2005.521; Myers CT, 2007, J ECON ENTOMOL, V100, P421, DOI 10.1603/0022-0493(2007)100[421:EOOHPA]2.0.CO;2; Myers CT, 2006, J ECON ENTOMOL, V99, P1299, DOI 10.1603/0022-0493-99.4.1299; Myers CT, 2006, J ECON ENTOMOL, V99, P349, DOI 10.1603/0022-0493-99.2.349; Myers CT, 2006, J ENTOMOL SCI, V41, P65, DOI 10.18474/0749-8004-41.1.65; Najar-Rodriguez A, 2013, PHYSIOL ENTOMOL, V38, P63, DOI 10.1111/phen.12003; Naseri B, 2009, ENTOMOL SCI, V12, P147, DOI 10.1111/j.1479-8298.2009.00310.x; Natale D, 2003, B ENTOMOL RES, V93, P335, DOI 10.1079/BER2003250; OKU T, 1988, Bulletin of the Fruit Tree Research Station Series C (Morioka), P49; Park K.-T., 1986, Korean Journal of Plant Protection, V25, P77; Rothschild G. H. L., 1991, TORTRICID PESTS THEI, V5, P389; Singh A.K., 1997, Indian Journal of Entomology, V59, P209; Timm AE, 2008, ANN ENTOMOL SOC AM, V101, P197, DOI 10.1603/0013-8746(2008)101[197:PGSOGM]2.0.CO;2; Tremblay E., 1990, ENTOMOLOGIA APPL, P170; Walter AJ, 2010, BIOL INVASIONS, V12, P1133, DOI 10.1007/s10530-009-9531-3; WILLS RBH, 1983, J SCI FOOD AGR, V34, P1383, DOI 10.1002/jsfa.2740341211; Yan S., 1999, FOR PEST DIS, V18, P15; Yoshizawa E., 2008, PLANT PROT JAPAN, V62, P556; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhang WX, 2010, ECOLOGY, V91, P2070, DOI 10.1890/09-0979.1; 최경희, 2009, [Korean Journal of Applied Entomology, 한국응용곤충학회지], V48, P417	41	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217492	10.1371/journal.pone.0217492	http://dx.doi.org/10.1371/journal.pone.0217492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150441	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100058
J	Pan, FD; Zhang, L; Ou, YH; Zhang, XN				Pan, Fada; Zhang, Li; Ou, Yuhong; Zhang, Xinni			The audio-visual integration effect on music emotion: Behavioral and physiological evidence	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; CROSSMODAL BINDING; SPEECH-PERCEPTION; VISUAL-ATTENTION; TIME-COURSE; RESPONSES; VOICE; BRAIN; INFORMATION; CONFLICT	Previous research has indicated that, compared to audio-only presentation, audio-visual congruent presentation can lead to a more intense emotional response. In the present study, we investigated the audio-visual integration effect on emotions elicited by positive or negative music and the role of visual information presentation durations. The participants were presented with audio-only condition, audio-visual congruent condition, and audiovisual incongruent condition and then required to judge the intensity of emotional experience elicited by the music. Their emotional responses to the music were measured using self-ratings and physiological aspects, including heart rate, skin temperature, EMG root mean square and prefrontal EEG. Relative to the audio-only presentation, the audio-visual congruent presentation led to a more intense emotional response. More importantly, the audiovisual integration occurred both in the positive music and in the negative music. Furthermore, the audio-visual integration effect was larger for positive music than for negative music; meanwhile the audio-visual integration effect was strongest with the visual information presented within 80s for negative music, which indicated that this integration effect was more likely to occur in the negative music. These results suggest that when the music was positive, the effect of audio-visual integration was greater. When the music was negative, the modulation effect of the presentation durations of visual information on the music induced emotion was more significant.	[Pan, Fada; Zhang, Li; Ou, Yuhong; Zhang, Xinni] Nantong Univ, Sch Educ Sci, Nantong, Peoples R China	Nantong University	Pan, FD (corresponding author), Nantong Univ, Sch Educ Sci, Nantong, Peoples R China.	psyc_lee2015@126.com	Campailla, Jasmin/AAK-2420-2021		Social Sciences Foundation of Jiangsu Province, China [14SHC006]; Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China [C-a/2013/01/003]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX18_2389]	Social Sciences Foundation of Jiangsu Province, China; Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China; Postgraduate Research & Practice Innovation Program of Jiangsu Province	Fada Pan was supported by Grant number: 14SHC006, The Social Sciences Foundation of Jiangsu Province, China. http://jspopss.jschina.com.cn/; and Grant number: C-a/2013/01/003, The Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China. http://www.jssghb.cn/.Li Zhang was supported by Grant number: KYCX18_2389, Postgraduate Research & Practice Innovation Program of Jiangsu Province. http://jyt.jiangsu.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Bigand E, 2005, COGNITION EMOTION, V19, P1113, DOI 10.1080/02699930500204250; Bigand E, 2005, ANN NY ACAD SCI, V1060, P429, DOI 10.1196/annals.1360.036; Brett-Green BA, 2008, BRAIN RES, V1242, P283, DOI 10.1016/j.brainres.2008.03.090; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Chapados C, 2008, COGNITION, V108, P639, DOI 10.1016/j.cognition.2008.05.008; Chen MC, 2013, BRAIN INJURY, V27, P75, DOI 10.3109/02699052.2012.722255; Chen XH, 2016, INT J PSYCHOPHYSIOL, V106, P14, DOI 10.1016/j.ijpsycho.2016.05.009; Conrey B, 2006, J ACOUST SOC AM, V119, P4065, DOI 10.1121/1.2195091; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Gao YL, 2014, NEUROREPORT, V25, P668, DOI 10.1097/WNR.0000000000000155; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Jeong JW, 2011, NEUROIMAGE, V54, P2973, DOI 10.1016/j.neuroimage.2010.11.017; Jessen S, 2011, NEUROIMAGE, V58, P665, DOI 10.1016/j.neuroimage.2011.06.035; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Marin MM, 2012, EMOTION, V12, P618, DOI 10.1037/a0025020; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1986, BRAIN RES, V365, P350; Park JY, 2010, CORTEX, V46, P161, DOI 10.1016/j.cortex.2008.06.008; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Platz F, 2012, MUSIC PERCEPT, V30, P71, DOI 10.1525/MP.2012.30.1.71; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Pourtois G, 2005, CORTEX, V41, P49, DOI 10.1016/S0010-9452(08)70177-1; Santangelo V, 2010, NEUROIMAGE, V49, P2717, DOI 10.1016/j.neuroimage.2009.10.061; Senkowski D, 2005, EXP BRAIN RES, V166, P411, DOI 10.1007/s00221-005-2381-z; Stevenson RA, 2010, NEUROIMAGE, V49, P3308, DOI 10.1016/j.neuroimage.2009.12.001; Szycik GR, 2008, BRAIN RES, V1220, P142, DOI 10.1016/j.brainres.2007.08.027; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Tang XY, 2016, NEUROSCI BIOBEHAV R, V61, P208, DOI 10.1016/j.neubiorev.2015.11.002; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vines BW, 2011, COGNITION, V118, P157, DOI 10.1016/j.cognition.2010.11.010; Vuoskoski J. K., 2016, PSYCHOMUSICOLOGY MUS, V26, P179, DOI DOI 10.1037/PMU0000142; Vuoskoski JK, 2014, ATTEN PERCEPT PSYCHO, V76, P591, DOI 10.3758/s13414-013-0582-2; Watson R, 2014, J NEUROSCI, V34, P6813, DOI 10.1523/JNEUROSCI.4478-13.2014; Weijkamp J, 2017, PSYCHOL MUSIC, V45, P204, DOI 10.1177/0305735616654216; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Yu HT, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P1965, DOI 10.1109/ICMA.2016.7558867; Zimmer U, 2010, NEUROIMAGE, V52, P606, DOI 10.1016/j.neuroimage.2010.04.245	47	14	14	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217040	10.1371/journal.pone.0217040	http://dx.doi.org/10.1371/journal.pone.0217040			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145745	Green Published, Green Submitted, gold			2022-12-26	WOS:000469425500009
J	Bessat, M; Dewair, A				Bessat, Mohamed; Dewair, Amira			Assessment of the inhibitory effects of disinfectants on the embryonation of Ascaridia columbae eggs	PLOS ONE			English	Article							SUUM EGGS; INACTIVATION; LUMBRICOIDES; PRESSURE; IODINE; FECES; SOIL	This study was set out with the aim of assessing the effects of the most commonly available commercial disinfectants on embryogenesis of A. columbae eggs. In addition to the distilled water treatment as a control group, four disinfectants were tested that included formalin, povidone iodide, TH4, and Virkon-S, in three independent experiments. In the first experiment, an overnight incubation with the working concentration of disinfectants resulted in significant inhibition of 80%, 85%, and 98% of embryonic development at day 9 post-treatment with formalin, povidone iodide, and TH4, respectively. This inhibition was continued through days 12 and 15 with the three tested disinfectants. Virkon-S did not affect embryogenesis with larval development comparable to that of the control group. In the second more dissected experiment, contact times of 10, 20, 30, and 60 minutes were set out for each disinfectant with embryogenesis inhibition results echoed that of the first experiment, with all disinfectants but Virkon-S inhibited larval development in significant proportions of eggs. Again, Virkon-S was very neutral in its effect on embryogenesis. When pigeon fecal matters were mixed with eggs and were subjected to disinfectants, discrepancies to results of the first two experiments were observed with only formalin inhibited embryogenesis in considerable proportion of eggs. Thus, and with the exception of Virkon-S, disinfectants tested at levels similar to those applicable in poultry in-houses and farms exhibited potent ovicidal activities on free eggs. To our knowledge, this is the first study involving the application of the commonly used in-poultry houses disinfectants to inactivate or delay the embryogenesis of bird Ascarids. The future perspective will potentially involve the in-field applications of the efficient disinfectants to eliminate or reduce the dissemination of infections with bird Ascarids in the chicken, turkey, pigeons, and other poultry houses.	[Bessat, Mohamed; Dewair, Amira] Alexandria Univ, Dept Parasitol, Fac Vet Med, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University	Bessat, M (corresponding author), Alexandria Univ, Dept Parasitol, Fac Vet Med, Alexandria, Egypt.	mohamed.bessat@alexu.edu.eg	bessat, mohamed/W-6396-2019	bessat, mohamed/0000-0002-4583-1604	Vmerge FP7 grant from EU [613996]	Vmerge FP7 grant from EU	The study was in-part supported financially by the Vmerge FP7 grant (613996) from EU. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT J, 1976, PARASITOLOGY, V73, P109, DOI 10.1017/S0031182000051374; Boado E., 1992, Revista Cubana de Ciencia Avicola, V19, P74; Brownell SA, 2006, APPL ENVIRON MICROB, V72, P2178, DOI 10.1128/AEM.72.3.2178-2184.2006; Butkus MA, 2011, APPL ENVIRON MICROB, V77, P363, DOI 10.1128/AEM.01675-10; Feachem RG, 1983, SANITATION DIS HLTH, Vxxvii; GASPARINI R, 1995, EUR J EPIDEMIOL, V11, P193, DOI 10.1007/BF01719487; Hernandez A, 2000, J HOSP INFECT, V46, P203, DOI 10.1053/jhin.2000.0818; Labare MP, 2013, AM J INFECT CONTROL, V41, P360, DOI 10.1016/j.ajic.2012.05.013; Mandarino-Pereira A, 2010, VET PARASITOL, V170, P176, DOI 10.1016/j.vetpar.2010.02.007; McMullin P, 2004, APOCKET GUIDE POULTR, DOI [10.1016/j.ajic.2012.05.013, DOI 10.1016/J.AJIC.2012.05.013]; MELENDEZ RD, 1979, J PARASITOL, V65, P85, DOI 10.2307/3280207; Msoffe PLMM, 2010, AFRJAGRICRES, V5, P564; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; Oh KS, 2016, KOREAN J PARASITOL, V54, P103, DOI 10.3347/kjp.2016.54.1.103; Pecson BM, 2005, ENVIRON SCI TECHNOL, V39, P7909, DOI 10.1021/es050659a; RAO TB, 2006, ZOOS PRINT J, V21, P2377; Rosypal AC, 2007, VET PARASITOL, V145, P86, DOI 10.1016/j.vetpar.2006.11.001; Sari BK B., 2008, B VET I PULAWY, V52, P20; SINNIAH B, 1982, PARASITOLOGY, V84, P167, DOI 10.1017/S0031182000051763; Soulsby EJL., 1968, HELMINTHS ARTHROPODS; Soulsby EJL, 1983, HELMINTHS ARTHROPODS, Vxix; Taylor M. A., 2015, VET PARASITOL; Thomas Divyamol, 2014, Journal of Parasitic Diseases, V38, P174, DOI 10.1007/s12639-012-0217-x; Tietz Marques Sandra Marcia, 2007, Parasitologia Latinoamericana, V62, P183; vd Burg W P, 1987, Tijdschr Diergeneeskd, V112, P769; WATTAL C, 1985, J PARASITOL, V71, P518, DOI 10.2307/3281551; WEHR EE, 1964, J PARASITOL, V50, P131, DOI 10.2307/3276047; Yu YM, 2014, KOREAN J PARASITOL, V52, P111, DOI 10.3347/kjp.2014.52.1.111; ZAMAN V, 1967, T ROY SOC TROP MED H, V61, P443, DOI 10.1016/0035-9203(67)90026-0	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217551	10.1371/journal.pone.0217551	http://dx.doi.org/10.1371/journal.pone.0217551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141572	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000060
J	Garcia, NA; Gonzalez-King, H; Grueso, E; Sanchez, R; Martinez-Romero, A; Javega, B; O'Connor, JE; Simons, PJ; Handberg, A; Sepulveda, P				Garcia, N. A.; Gonzalez-King, H.; Grueso, E.; Sanchez, R.; Martinez-Romero, A.; Javega, B.; O'Connor, J. E.; Simons, P. J.; Handberg, A.; Sepulveda, P.			Circulating exosomes deliver free fatty acids from the bloodstream to cardiac cells: Possible role of CD36	PLOS ONE			English	Article							NILE-RED; METABOLISM; PLASMA; MUSCLE	Regulation of circulating free fatty acid (FFA) levels and delivery is crucial to maintain tissue homeostasis. Exosomes are nanomembranous vesicles that are released from diverse cell types and mediate intercellular communication by delivering bioactive molecules. Here, we sought to investigate the uptake of FFAs by circulating exosomes, the delivery of FFAloaded exosomes to cardiac cells and the possible role of the FFA transporter CD36 in these processes. Circulating exosomes were purified from the serum of healthy donors after an overnight fast (F) or 20 minutes after a high caloric breakfast (postprandial, PP). Western blotting, Immunogold Electron Microscopy and FACS analysis of circulating exosomes showed that CD36 was expressed under both states, but was higher in postprandial-derived exosomes. Flow cytometry analysis showed that circulating exosomes were able to take-up FFA directly from serum. Importantly, preincubation of exosomes with a blocking CD36 antibody significantly impeded uptake of the FFA analogue BODIPY, pointing to the role of CD36 in FFA exosomal uptake. Finally, we found that circulating exosomes could delivery FFA analogue BODIPY into cardiac cells ex vivo and in vivo in a mice model. Overall, our results suggest a novel mechanism in which circulating exosomes can delivery FFAs from the bloodstream to cardiac tissue. Further studies will be necessary to understand this mechanism and, in particular, its potential involvement in metabolic pathologies such as obesity, diabetes and atherosclerosis.	[Garcia, N. A.] GECORP, Buenos Aires, DF, Argentina; [Gonzalez-King, H.; Grueso, E.; Sanchez, R.; Sepulveda, P.] Inst Invest Sanitaria La Fe, Regenerat Med & Heart Transplantat Unit, Valencia, Spain; [Gonzalez-King, H.; Grueso, E.; Sanchez, R.; O'Connor, J. E.; Sepulveda, P.] Joint Res Unit Cardiovasc Repair IISLAFE CIPF, Valencia, Spain; [Martinez-Romero, A.; O'Connor, J. E.] Joint Res Unit Cytom CIPF UVEG, Valencia, Spain; [Javega, B.] Univ Valencia, Dept Biochem, Valencia, Spain; [Simons, P. J.] Bioceros BV, Utrecht, Netherlands; [Handberg, A.] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Handberg, A.] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg, Denmark	University of Valencia; Bioceros B.V.; Aalborg University; Aalborg University Hospital; Aalborg University	Garcia, NA (corresponding author), GECORP, Buenos Aires, DF, Argentina.; Sepulveda, P (corresponding author), Inst Invest Sanitaria La Fe, Regenerat Med & Heart Transplantat Unit, Valencia, Spain.; Sepulveda, P (corresponding author), Joint Res Unit Cardiovasc Repair IISLAFE CIPF, Valencia, Spain.	gecorpinfo@gmail.com; pilar.sepulveda.sanchis@gmail.com	Sepúlveda, Pilar/GWN-0626-2022; Sepulveda, Pilar/AAA-6636-2022; Jávega, Beatriz/AAE-6298-2022; Martínez-Romero, Alicia/ABH-3160-2020	Sepulveda, Pilar/0000-0001-6071-7431; Martínez-Romero, Alicia/0000-0002-5197-0635; Garcia, Nahuel/0000-0001-6903-9972; Grueso Navarro, Elena/0000-0002-5384-9978; O'Connor, Jose-Enrique/0000-0002-8792-5780; Javega, Beatriz/0000-0001-9585-0080; Handberg, Aase/0000-0001-5719-203X	Instituto de Salud Carlos III - FEDER "una manera de hacer Europa [PI16/0107, (RD16/0011/0004) 354]	Instituto de Salud Carlos III - FEDER "una manera de hacer Europa	This work was supported by grants PI16/0107 and RETICS Program (RD16/0011/0004) 354 from Instituto de Salud Carlos III cofunded by FEDER "una manera de hacer Europa. GECORP provided support in the form of salaries for author [NAG] and Bioceros BV provided support in the form of salaries for author [PJS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatatbeh MJ, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.1; ANDRES R, 1956, J CLIN INVEST, V35, P671, DOI 10.1172/JCI103324; BASSO L V, 1970, Journal of Clinical Investigation, V49, P537, DOI 10.1172/JCI106264; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Evans K, 2002, DIABETES, V51, P2684, DOI 10.2337/diabetes.51.9.2684; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Garcia NA, 2016, CARDIOVASC RES, V109, P397, DOI 10.1093/cvr/cvv260; GOLD M, 1964, AM J PHYSIOL, V206, P153, DOI 10.1152/ajplegacy.1964.206.1.153; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kimura K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02406-2; Miles JM, 2007, HORM METAB RES, V39, P726, DOI 10.1055/s-2007-990273; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rumin J, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0220-4; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Susztak K CE, 2005, PLOS MED; Tanaka T, 2001, J LIPID RES, V42, P751; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	23	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217546	10.1371/journal.pone.0217546	http://dx.doi.org/10.1371/journal.pone.0217546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141569	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000059
J	Nuss, H; Altazan, A; Zabaleta, J; Sothern, M; Redman, L				Nuss, Henry; Altazan, Abby; Zabaleta, Jovanny; Sothern, Melinda; Redman, Leanne			Maternal pre-pregnancy weight status modifies the influence of PUFAs and inflammatory biomarkers in breastmilk on infant growth	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; INSULIN-RESISTANCE; DEPRESSIVE SYMPTOMS; ADIPOSE-TISSUE; BODY-WEIGHT; TNF-ALPHA; OBESITY; PREGNANCY; LEPTIN; MARKERS	Background Human breastmilk contains pro- and anti-inflammatory compounds and hormones that can influence infant growth. However, little is known about the specific interrelationships between these compounds and whether their effects on infant growth may be influenced by pre-pregnancy weight status. Objective The purpose of this novel, prospective cohort study was to assess the interrelationships between pro- inflammatory cytokines (TNF-alpha, IL-6), hormones (insulin, leptin) and PUFAs (n-6, n-3) in blood and breastmilk in early postpartum between women with normal BMI (Group 1, n = 18; 18.5<BMI <= 24.9 kg/m(2)) and with overweight/obesity (Group 2, n = 15; BMI >= 25.0 kg/m(2)) befor e pregnancy to determine if these components correlated to infant growth measures at age 4-8 weeks. Methods Participants were robustly phenotyped along with their infants at 4-8 weeks postpartum. TNF-alpha, IL-6, insulin, leptin, and n-3 and n-6 PUFAs measured in blood and breastmilk and compared between pre-pregnancy BMI groups and with infant weight, length, head circumference and % fat mass. Results Group 1 women had higher serum leptin (p< 0.01) and breastmilk leptin (p< 0.001) compared to Group 2. Other inflammatory markers, hormones, and total n-6, n-3 and n-6/n-3 ratio PUFAs were similar between pre-pregnancy BMI groups. No relationships were observed between whey inflammatory markers, hormones, PUFAs and growth measures in infants born to Group 2 women. However, TNF-alpha was positively related and, IL-6, leptin, insulin, total n-6, n-3 and n-6/n-3 PUFAs in whey breastmilk were negatively correlated to infant growth measures in infants born to Group 1 women (p< 0.01). Conclusions Pro-inflammatory qualities of breastmilk were associated with infant growth measures regardless of maternal pre-pregnancy BMI. However, infants born to women with overweight or obesity demonstrated less responsive growth to breastmilk contents. More studies are needed to assess longitudinal effects of this impact.	[Nuss, Henry; Sothern, Melinda] Louisiana State Univ Hlth, Sch Publ Hlth, Behav & Community Hlth Sci, New Orleans, LA 70112 USA; [Altazan, Abby; Sothern, Melinda; Redman, Leanne] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Zabaleta, Jovanny; Sothern, Melinda] Louisiana State Univ Hlth, Sch Med, Dept Pediat, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Nuss, H (corresponding author), Louisiana State Univ Hlth, Sch Publ Hlth, Behav & Community Hlth Sci, New Orleans, LA 70112 USA.	hnussj@lsuhsc.edu			Louisiana/Pennington Nutrition Obesity Research Center [P30DK072476]; Lifestyle Interventions for Expectant Moms (LIFE-Moms); National Institutes of Health through the NIDDK [U01 DK094418, U01 DK094463, U01 DK094416, 5U01 DK094466]; National Heart, Lung, and Blood Institute [U01 HL114344, U01 HL114377]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 HD072834]; National Center for Complementary and Integrative Health; National Institutes of Health Office of Research in Women's Health; Office of Behavioral and Social Science Research; Indian Health Service; Intramural Research Program of the NIDDK; Louisiana Clinical and Translational Science Center [U54 GM104940];  [P30 DK089503];  [U24 DK097153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL114344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, U24DK097153, U01DK094466, U01DK094416, P30DK072476, U01DK094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	Louisiana/Pennington Nutrition Obesity Research Center; Lifestyle Interventions for Expectant Moms (LIFE-Moms); National Institutes of Health through the NIDDK; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary and Integrative Health; National Institutes of Health Office of Research in Women's Health; Office of Behavioral and Social Science Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Health Service(United States Department of Health & Human Services); Intramural Research Program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Louisiana Clinical and Translational Science Center; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the Louisiana/Pennington Nutrition Obesity Research Center (P30DK072476) (HN, AA), the Lifestyle Interventions for Expectant Moms (LIFE-Moms), supported by the National Institutes of Health through the NIDDK (U01 DK094418 [LR; Expecting Success], U01 DK094463, U01 DK094416, 5U01 DK094466), the National Heart, Lung, and Blood Institute (U01 HL114344, U01 HL114377), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01 HD072834), the National Center for Complementary and Integrative Health, the National Institutes of Health Office of Research in Women's Health, the Office of Behavioral and Social Science Research, the Indian Health Service, and the Intramural Research Program of the NIDDK (HN, LR). The study was supported by cores and services including biostatistics by Louisiana Clinical and Translational Science Center (U54 GM104940) and the lipid analyses at the University of Michigan, supported by grant P30 DK089503 and U24 DK097153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MM, 2017, BRIT J NUTR, V118, P788, DOI 10.1017/S0007114517002884; Andreas NJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010778; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackmore ER, 2014, J PSYCHOSOM OBST GYN, V35, P8, DOI 10.3109/0167482X.2013.868879; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosviel R, 2017, FREE RADICAL BIO MED, V103, P146, DOI 10.1016/j.freeradbiomed.2016.12.018; Calder PC, 2017, BIOCHEM SOC T, V45, P1105, DOI 10.1042/BST20160474; Calder PC, 2013, P NUTR SOC, V72, P326, DOI 10.1017/S0029665113001031; Cao YL, 2008, DIABETES RES CLIN PR, V79, P214, DOI 10.1016/j.diabres.2007.08.030; Chan D, 2018, INT J OBESITY, V42, P36, DOI 10.1038/ijo.2017.189; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Desai M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.025; Eriksson B, 2010, BRIT J NUTR, V103, P50, DOI 10.1017/S0007114509991371; Fields DA, 2017, PEDIATR OBES, V12, P78, DOI 10.1111/ijpo.12182; Fields DA, 2012, PEDIATR OBES, V7, P304, DOI 10.1111/j.2047-6310.2012.00059.x; Fields DA, 2016, OBESITY, V24, P1213, DOI 10.1002/oby.21519; Flock MR, 2014, PROSTAG LEUKOTR ESS, V91, P161, DOI 10.1016/j.plefa.2014.07.006; Fujimori M, 2017, BIOFACTORS, V43, P243, DOI 10.1002/biof.1339; Gomes RM, 2018, J NUTR BIOCHEM, V61, P24, DOI 10.1016/j.jnutbio.2018.07.006; Hales Craig M, 2017, NCHS Data Brief, P1; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Huang YS, 2011, MOL CELL BIOCHEM, V358, P85, DOI 10.1007/s11010-011-0924-0; Kramer MS, 2012, EPIDEMIOLOGY, V23, P790, DOI 10.1097/EDE.0b013e31826cc0e9; Lindholm ES, 2013, PROSTAG LEUKOTR ESS, V88, P211, DOI 10.1016/j.plefa.2012.11.007; Mastroeni MF, 2017, PUBLIC HEALTH NUTR, V20, P2537, DOI [10.1017/s1368980017001239, 10.1017/S1368980017001239]; Murabayashi N, 2013, EUR J OBSTET GYN R B, V169, P39, DOI 10.1016/j.ejogrb.2013.02.003; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Panagos PG, 2016, J PERINATOL, V36, P284, DOI 10.1038/jp.2015.199; Perichart-Perera O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180874; Rudolph MC, 2017, INT J OBESITY, V41, P510, DOI 10.1038/ijo.2016.211; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schuster S, 2011, PEDIATR RES, V70, P633, DOI 10.1203/PDR.0b013e31823214ea; Sergeant S, 2016, EUR J PHARMACOL, V785, P77, DOI 10.1016/j.ejphar.2016.04.020; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simpson W, 2016, REV BRAS PSIQUIATR, V38, P190, DOI 10.1590/1516-4446-2015-1899; Skinner AC, 2016, OBESITY, V24, P1116, DOI 10.1002/oby.21497; Steffen BT, 2012, INT J OBESITY, V36, P797, DOI 10.1038/ijo.2011.157; Sutton EF, 2017, OBSTET GYNECOL, V129, P554, DOI 10.1097/AOG.0000000000001900; Vahamiko S, 2013, BRIT J NUTR, V110, P1098, DOI 10.1017/S0007114513000214; Vaidya H, 2018, PEDIATR OBES, V13, P285, DOI 10.1111/ijpo.12215; Vidakovic AJ, 2016, AM J CLIN NUTR, V103, P1017, DOI 10.3945/ajcn.115.112847; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Young BE, 2018, PEDIATR OBES, V13, P598, DOI 10.1111/ijpo.12394; Young BE, 2017, MATERN CHILD HLTH J, V21, P1367, DOI 10.1007/s10995-016-2243-2	47	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217085	10.1371/journal.pone.0217085	http://dx.doi.org/10.1371/journal.pone.0217085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141526	Green Published, Green Submitted, gold			2022-12-26	WOS:000469323000040
J	Pontes, TA; Barbosa, AD; Silva, RD; Melo, MR; Silva, RO				Pontes, T. A.; Barbosa, A. D.; Silva, R. D.; Melo-Junior, M. R.; Silva, R. O.			Osteopenia-osteoporosis discrimination in postmenopausal women by H-1 NMR-based metabonomics	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SPECTROSCOPY; DIAGNOSIS; CANCER; PLASMA; SERUM	This is a report on how H-1 NMR-based metabonomics was employed to discriminate osteopenia from osteoporosis in postmenopausal women, identifying the main metabolites associated to the separation between the groups. The Assays were performed using seventyeight samples, being twenty-eight healthy volunteers, twenty-six osteopenia patients and twenty-four osteoporosis patients. PCA, LDA, PLS-DA and OPLS-DA formalisms were used. PCA discriminated the samples from healthy volunteers from diseased patient samples. Osteopenia-osteoporosis discrimination was only obtained using Analysis Discriminants formalisms, as LDA, PLS-DA and OPLS-DA. The metabonomics model using LDA formalism presented 88.0% accuracy, 88.5% specificity and 88.0% sensitivity. Cross-Validation, however, presented some problems as the accuracy of modeling decreased. LOOCV resulted in 78.0% accuracy. The OPLS-DA based model was better: R2Y and Q2 values equal to 0.871 (p< 0.001) and 0.415 (p< 0.001). LDA and OPLS-DA indicated the important spectral regions for discrimination, making possible to assign the metabolites involved in the skeletal system homeostasis, as follows: VLDL, LDL, leucine, isoleucine, allantoin, taurine and unsaturated lipids. These results indicate that H-1 NMR-based metabonomics can be used as a diagnosis tool to discriminate osteoporosis from osteopenia using a single serum sample.	[Pontes, T. A.; Barbosa, A. D.; Melo-Junior, M. R.] Univ Fed Pernambuco, Biol Appl Hlth Postgrad Program, LIKA, Ave Prof Luis Freire S-N,Cidade Univ, Recife, PE, Brazil; [Silva, R. D.; Silva, R. O.] Univ Fed Pernambuco, Fundamental Chem Dept, CCEN, Chem Postgrad Program, Ave Jornalista Anibal Fernandes S-N,Cidade Univ, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Pontes, TA (corresponding author), Univ Fed Pernambuco, Biol Appl Hlth Postgrad Program, LIKA, Ave Prof Luis Freire S-N,Cidade Univ, Recife, PE, Brazil.	tiagoarrudatg@gmail.com	Silva, Ricardo Oliveira/ABF-2093-2021; Silva, Ricardo O/A-9461-2013	Silva, Ricardo Oliveira/0000-0001-8090-7320; Silva, Ricardo O/0000-0001-8090-7320; Pontes, Tiago/0000-0002-1080-7460	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (BR) [APQ-0765-1.06/14]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (BR)	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior to T. A. Pontes and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (BR) (APQ-0765-1.06/14) to R. O. Silva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista AD, 2018, WORLD J HEPATOL, V10, P105, DOI 10.4254/wjh.v10.i1.105; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106559; Chubb SAP, 2015, J CLIN ENDOCR METAB, V100, P90, DOI 10.1210/jc.2014-2646; da Silva RA, 2018, MOL CELL ENDOCRINOL, V478, P151, DOI 10.1016/j.mce.2018.08.008; Dixon SJ, 2000, DRUG DEVELOP RES, V49, P187, DOI 10.1002/(SICI)1098-2299(200003)49:3<187::AID-DDR9>3.0.CO;2-F; Duarte IF, 2012, PROG NUCL MAG RES SP, V62, P51, DOI 10.1016/j.pnmrs.2011.11.002; Gao HC, 2009, CANCER SCI, V100, P782, DOI 10.1111/j.1349-7006.2009.01086.x; Godoy MMG, 2010, J VIRAL HEPATITIS, V17, P854, DOI 10.1111/j.1365-2893.2009.01252.x; Gouveia LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182196; Hanaa HA, 2009, REP OPIN, V1, DOI [10.7537/marsroj010609.05, DOI 10.7537/MARSROJ010609.05]; IOF, 2018, OST MUSC DIS; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373; Lindon JC, 2003, ANAL CHEM, V75, p384A, DOI 10.1021/ac031386+; Liu YR, 2014, MOL CELL ENDOCRINOL, V387, P19, DOI 10.1016/j.mce.2014.02.007; Long Wei-Fu, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P843; Lv HH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122018; Ma B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054965; Maritz FJ, 2001, ARTERIOSCL THROM VAS, V21, P1636, DOI 10.1161/hq1001.097781; Orozco P, 2004, EUR J EPIDEMIOL, V19, P1105, DOI 10.1007/s10654-004-1706-8; Parhami F, 2000, ARTERIOSCL THROM VAS, V20, P2346, DOI 10.1161/01.ATV.20.11.2346; Poiana C, 2013, BONE RES, V1, P275, DOI 10.4248/BR201303004; Prentice RL, 2014, SEMIN REPROD MED, V32, P419, DOI 10.1055/s-0034-1384624; Qiao Y, 2016, NEUROSCI LETT, V617, P270, DOI 10.1016/j.neulet.2016.02.031; Rosen, 2000, ENDOTEXT; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Tanko LB, 2003, BONE, V32, P8, DOI 10.1016/S8756-3282(02)00918-3; Tella SH, 2014, J STEROID BIOCHEM, V142, P155, DOI 10.1016/j.jsbmb.2013.09.008; Varga F, 1997, CALCIFIED TISSUE INT, V61, P404, DOI 10.1007/s002239900356; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Vasikaran Samuel D, 2014, Clin Biochem Rev, V35, P237; Xue LM, 2011, INT J MOL SCI, V12, P7635, DOI 10.3390/ijms12117635; You L, 2011, ACTA PHARMACOL SIN, V32, P1498, DOI 10.1038/aps.2011.135	34	19	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217348	10.1371/journal.pone.0217348	http://dx.doi.org/10.1371/journal.pone.0217348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141566	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000051
J	van Zyl, FJ; Marais, J; Nieuwoudt, M; Niesler, TR				van Zyl, Floris J.; Marais, Johan; Nieuwoudt, Martin; Niesler, Thomas R.			Computer simulation and physical phantom models for estimating the dielectric properties of rhinoceros tissue	PLOS ONE			English	Article								In vivo and ex vivo sensors have the potential to aid tracking and anti-poaching endeavours and provide new insights into rhinoceros physiology and environment. However, the propagation of electromagnetic signals in rhinoceros tissue is currently not known. We present simulation and agar models of the rhinoceros that allow the investigation of electromagnetic propagation by in vivo and ex vivo devices without the need for surgery. Since the dielectric properties of rhinoceros tissue have not been documented, the conductivity and permittivity of the skin, fat, muscle, blood and other organs are first approximated by means of a meta-analysis that includes animals with similar physical properties. Subsequently, we develop anatomical models that include dermal layers, internal organs and a skeleton. We also develop a flank model that serves as an approximation of the anatomical model in certain situations. These models are used to determine the viability of communication between an in vivo device and an ex vivo device attached to the hind leg of the animal. Two types of antenna (microstrip- fed planar elliptical monopole antenna and printed inverted-F antenna) and three feasible implant locations (back, neck and chest) are considered. In addition to the computer models, phantom recipes using salt, sugar and agar are developed to match the dielectric properties of each tissue type at the industrial, scientific and medical (ISM) frequencies of 403MHz, 910MHz and 2.4GHz. The average error between the measured and theoretically predicted dielectric values was 6.22% over all recipes and 4.49% for the 2.4 GHz recipe specifically. When considering the predicted efficiency of the transmitting and receiving antennas, an agreement of 67.38% was demonstrated between the computer simulations and laboratory measurements using the agar rhinoceros flank models. Computer simulations using the anatomical model of the rhinoceros indicate that the chest is the optimal implant location and that best signal propagation is achieved using the planar inverted-F antenna (PIFA). Using this configuration, the simulations indicate that communication between the implant and an ex vivo device attached to the hind leg is challenging but possible. Furthermore, we find that the inclusion of factors such as the density and temperature of the phantom materials were found to be critical to the achievement of good agreement between practice and simulation.	[van Zyl, Floris J.; Niesler, Thomas R.] Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa; [Marais, Johan] Univ Pretoria, Fac Vet Sci, Pretoria, Gauteng, South Africa; [Nieuwoudt, Martin] Stellenbosch Univ, IBE, Stellenbosch, Western Cape, South Africa	Stellenbosch University; University of Pretoria; Stellenbosch University	Niesler, TR (corresponding author), Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa.	trn@sun.ac.za		Nieuwoudt, Martin/0000-0002-6354-799X	South African National Research Foundation (NRF); South African Centre for Epidemiological Modelling and Analysis (SACEMA)	South African National Research Foundation (NRF)(National Research Foundation - South Africa); South African Centre for Epidemiological Modelling and Analysis (SACEMA)	The work was supported in part by grants from the South African National Research Foundation (NRF) and the South African Centre for Epidemiological Modelling and Analysis (SACEMA). National Research Foundation (NRF): www.nrf.ac.za; South African Centre for Epidemiological Modelling and Analysis (SACEMA): www.sacema.org.The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearcraft W, 1958, EPIDERMAL STRUCTURES, V182, P196; Dabbagh A, 2014, ULTRASONIC IMAGING, V36, P291, DOI 10.1177/0161734614526372; Duan Q, 2014, MED PHYS, V41, DOI 10.1118/1.4895823; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Huang J., 2016, SENSORS, V16, P1; International Rhino Foundation, 2016, RHIN FACT SHEET; MALMBERG CG, 1956, J RES NAT BUR STAND, V56, P1, DOI 10.6028/jres.056.001; SHADWICK RE, 1992, PHILOS T ROY SOC B, V337, P419, DOI 10.1098/rstb.1992.0118; TOMASELL.VP, 1973, BIOPOLYMERS, V12, P353, DOI 10.1002/bip.1973.360120212	10	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216595	10.1371/journal.pone.0216595	http://dx.doi.org/10.1371/journal.pone.0216595			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141536	Green Submitted, Green Published, gold			2022-12-26	WOS:000469323000017
J	Callahan, RL; Brunie, A; Mackenzie, ACL; Wayack-Pambe, M; Guiella, G; Kibira, SPS; Makumbi, F				Callahan, Rebecca L.; Brunie, Aurelie; Mackenzie, Amelia C. L.; Wayack-Pambe, Madeleine; Guiella, Georges; Kibira, Simon P. S.; Makumbi, Fredrick			Potential user interest in new long-acting contraceptives: Results from a mixed methods study in Burkina Faso and Uganda	PLOS ONE			English	Article							ACCEPTABILITY; PREVENTION; HIV	Method-related concerns represent an important cause of contraceptive non-use and discontinuation. User preferences must be incorporated into the design of new contraceptive technologies to ensure product success and improve family planning outcomes. We assessed preferences among potential users in Burkina Faso and Uganda for six contraceptive methods currently under development or ready for introduction: a new copper intra-uterine device (IUD), a levonorgestrel intra-uterine system, a new single-rod implant, a biodegradable implant, a longer-acting injectable, and a method of non-surgical permanent contraception. Questions were added to nationally-representative PMA2020 household surveys that asked 2,743 and 2,403 women in Burkina Faso and Uganda, respectively, their interest in using each new method. We assessed factors associated with interest through multivariable logistic regression models. We conducted qualitative interviews and focus groups with 398 women, 78 men, and 52 family planning providers and key informants to explore perceived advantages and disadvantages of the methods. Respondents expressed interest in using all new methods, with greatest interest in the longer-acting injectable (77% in Burkina Faso, 61% in Uganda), followed by a new single-rod implant. Least interest was expressed in a new copper IUD (26% Burkina Faso, 15% in Uganda). In both countries, women with less education had higher odds of interest in a longer-acting injectable. Interest in most new methods was associated with desiring a method lasting longer than one year and acceptance of lack of menstrual bleeding as a contraceptive side effect. Perceived advantages and disadvantages were similar between countries, including concerns about menstrual side effects and fear of the biodegradable nature of the biodegradable implant. Potential users, their partners, and providers are interested in new longer-acting methods, however, familiar forms including the injectable and implant may be the most immediately acceptable. A biodegradable implant will require clear counseling messages to allay potential fears.	[Callahan, Rebecca L.; Mackenzie, Amelia C. L.] Contracept Technol Innovat, Durham, NC 27701 USA; [Brunie, Aurelie] Hlth Serv Res, Washington, DC USA; [Wayack-Pambe, Madeleine; Guiella, Georges] Univ Ouagadougou, Inst Super Sci Populat, Ouagadougou, Burkina Faso; [Kibira, Simon P. S.; Makumbi, Fredrick] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	Makerere University	Callahan, RL (corresponding author), Contracept Technol Innovat, Durham, NC 27701 USA.	rcallahan@fhi360.org		Mackenzie, Amelia/0000-0003-1721-805X; Kibira, Simon Peter Sebina/0000-0002-7385-423X; Brunie, Aurelie/0000-0002-9515-1420	Bill & Melinda Gates Foundation [OPP1055878]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the Bill & Melinda Gates Foundation through grant #OPP1055878. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, POPULATION COUNCIL F; Bailey MJ, 2013, BROOKINGS PAP ECO AC, P341; Bill and Melinda Gates Foundation, FAM PLANN STRAT OV; Brauner-Otto SR, 2013, POPUL RES POLICY REV, V32, P1, DOI 10.1007/s11113-012-9261-6; Brunie A, DEV ACCEPTABLE CONTR; Casterline J, 2009, UNWANTED FERTILITY L; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Darroch JacquelineE., 2011, CONTRACEPTIVE TECHNO; FHI 360, CONTR TECHN INN IN; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P90, DOI 10.1363/3909007; Guthrie KM, 2018, PHARM DEV TECHNOL, V23, P311, DOI 10.1080/10837450.2017.1339085; Heise L, 1997, ACCEPTABILITY USERS, P6; Moran M, 2014, REPROD HLTH R D DEV; Nass SJ, 2004, NAT REV DRUG DISCOV, V3, P885, DOI 10.1038/nrd1526; Performance Monitoring and Accountability 2020, SAMPL OV; Performance Monitoring and Accountability 2020, SURVEY METHODOLOGY; Performance Monitoring and Accountability 2020, UG ROUND 4 FAM PLANN; Performance Monitoring and Accountability 2020, BURK FAS ROUND 4 FAM; Polis CB, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0561-0; Ross J, 2013, GLOB HEALTH-SCI PRAC, V1, P203, DOI 10.9745/GHSP-D-13-00010; Sedgh G., 2016, UNMET NEED CONTRACEP; Singh S, 2015, ADD COSTS BEN INV SE; Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374; Tolley EE, 2013, ANTIVIR RES, V100, pS54, DOI 10.1016/j.antiviral.2013.09.029; Van Lith LM, 2013, GLOB HEALTH-SCI PRAC, V1, P97, DOI 10.9745/GHSP-D-12-00036; Woodsong C, 2015, ADV DRUG DELIVER REV, V92, P146, DOI 10.1016/j.addr.2015.02.004	26	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217333	10.1371/journal.pone.0217333	http://dx.doi.org/10.1371/journal.pone.0217333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136612	gold, Green Submitted, Green Published			2022-12-26	WOS:000469224300027
J	Baker, CA; De, J; Bertoldi, B; Dunn, L; Chapin, T; Jay-Russell, M; Danyluk, MD; Schneider, KR				Baker, Christopher A.; De, Jaysankar; Bertoldi, Bruna; Dunn, Laurel; Chapin, Travis; Jay-Russell, Michele; Danyluk, Michelle D.; Schneider, Keith R.			Prevalence and concentration of stx plus E. coli and E. coli O157 in bovine manure from Florida farms	PLOS ONE			English	Article							ESCHERICHIA-COLI; SHIGA TOXIN; UNITED-STATES; CATTLE FECES; BEEF-CATTLE; PRODUCE; GENES; ENUMERATION; SALMONELLA; QUANTIFICATION	Fresh produce outbreaks due to Shiga toxin-producing Escherichia coli (STEC) continue to occur in the United States (US). Manure-amended soils can pose a public health risk when used for growing raw agricultural commodities. Knowing the prevalence and concentration of STEC in untreated biological soil amendments of animal origin (BSAAO) is important to help guide the most appropriate pre-harvest interval(s) following application to limit risks from these soil amendments. Bovine manure samples were collected from 12 farms in Florida, including samples from piles, lagoons, barns, and screened solids. Two methods were used to detect stx1/2 and rfbE genes in samples. A prevalence rate of 9% for stx1 and/or stx2 and 19% for rfbE was observed from the 518 bovine manure samples evaluated. A most probable number (MPN) assay was performed on stx+ samples when applicable. The geometric mean for stx+ samples (n = 20) was 3.37 MPN g(-1) (0.53 log MPN g(-1)) with a maximum value of 6,800 MPN g(-1) (3.83 log MPN g(-1)). This research was part of a larger nationwide geographical study on the prevalence and concentration of STEC in bovine manure to help guide regulations on feasible pre-harvest intervals for the application of untreated BSAAO.	[Baker, Christopher A.; De, Jaysankar; Bertoldi, Bruna; Danyluk, Michelle D.; Schneider, Keith R.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Dunn, Laurel; Chapin, Travis; Danyluk, Michelle D.] Univ Florida, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Jay-Russell, Michele] Univ Calif Davis, Western Ctr Food Safety, Davis, CA 95616 USA; [Dunn, Laurel] Univ Georgia, Dept Food Sci & Technol, Athens, GA 30602 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Davis; University System of Georgia; University of Georgia	Schneider, KR (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	keiths29@ufl.edu	Baker, Christopher/AAG-7217-2019; De, Jaysankar/G-8386-2011	De, Jaysankar/0000-0001-9799-9401; Dunn, Laurel/0000-0003-0786-5253	Western Center for Food Safety from the U.S. Food and Drug Administration [U19-FD004995]; FOOD AND DRUG ADMINISTRATION [U19FD004995] Funding Source: NIH RePORTER	Western Center for Food Safety from the U.S. Food and Drug Administration; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	This work was supported by the Western Center for Food Safety contract U19-FD004995 from the U.S. Food and Drug Administration. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminabadi P, ANN INT ASS FOOD PRO; Arthur TM, 2010, MEAT SCI, V86, P32, DOI 10.1016/j.meatsci.2010.04.019; Atwill ER, 2015, J FOOD PROTECT, V78, P240, DOI 10.4315/0362-028X.JFP-14-277; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; Benjamin LA, 2015, EPIDEMIOL INFECT, V143, P81, DOI 10.1017/S0950268814000521; Besser TE, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.EHEC-0021-2013, 10.1128/microbiolspec.EHEC-0021]; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brichta-Harhay DM, 2007, J APPL MICROBIOL, V103, P1657, DOI 10.1111/j.1365-2672.2007.03405.x; Callejon RM, 2015, FOODBORNE PATHOG DIS, V12, P32, DOI 10.1089/fpd.2014.1821; Centers for Disease Control and Prevention, 2006, MULT OUTBR E COL O15; Centers for Disease Control and Prevention, 2018, MULT OUTBR E COL O15; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Desmarchelier PM, 1998, J CLIN MICROBIOL, V36, P1801, DOI 10.1128/JCM.36.6.1801-1804.1998; Dewey-Mattia D, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6710a1; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Fegan N, 2004, J APPL MICROBIOL, V97, P362, DOI 10.1111/j.1365-2672.2004.02300.x; Fegan N, 2004, LETT APPL MICROBIOL, V38, P56, DOI 10.1046/j.1472-765X.2003.01439.x; Fox JT, 2008, J FOOD PROTECT, V71, P1761, DOI 10.4315/0362-028X-71.9.1761; Fox JT, 2007, APPL ENVIRON MICROB, V73, P5253, DOI 10.1128/AEM.00554-07; Franz E, 2007, APPL ENVIRON MICROB, V73, P2180, DOI 10.1128/AEM.01950-06; Gutierrez-Rodriguez E, 2019, FOOD MICROBIOL, V77, P173, DOI 10.1016/j.fm.2018.08.013; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Himathongkham S, 1999, FEMS MICROBIOL LETT, V178, P251, DOI 10.1111/j.1574-6968.1999.tb08684.x; Hirvonen JJ, 2012, J CLIN MICROBIOL, V50, P3586, DOI 10.1128/JCM.01754-12; Hutchison ML, 2004, LETT APPL MICROBIOL, V39, P207, DOI 10.1111/j.1472-765X.2004.01564.x; Jacob ME, 2012, FOODBORNE PATHOG DIS, V9, P79, DOI 10.1089/fpd.2011.0947; Jay-Russell MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113433; Joris MA, 2011, TOXINS, V3, P672, DOI 10.3390/toxins3060672; KARCH H, 1992, INFECT IMMUN, V60, P3464, DOI 10.1128/IAI.60.8.3464-3467.1992; Karmali MA, 2017, CLIN INFECT DIS, V64, P371, DOI 10.1093/cid/ciw708; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; LeJeune JT, 2006, J CLIN MICROBIOL, V44, P872, DOI 10.1128/JCM.44.3.872-875.2006; Li M, 2018, J FOOD PROTECT, V81, P1171, DOI [10.4315/0362-028X.JFP-17-465, 10.4315/0362-028x.jfp-17-465]; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Matthews L, 2006, EPIDEMIOL INFECT, V134, P131, DOI 10.1017/S0950268805004590; Mir RA, 2015, VET MICROBIOL, V175, P325, DOI 10.1016/j.vetmic.2014.12.016; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Noll LW, 2015, FOODBORNE PATHOG DIS, V12, P787, DOI 10.1089/fpd.2015.1951; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Parsons BD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00478; Preussel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078180; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Robinson SE, 2004, J APPL MICROBIOL, V97, P581, DOI 10.1111/j.1365-2672.2004.02339.x; Sargeant JM, 2000, AM J VET RES, V61, P1375, DOI 10.2460/ajvr.2000.61.1375; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sharma M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.PFS-0010-2015; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; U. S. Food and Drug Administration (FDA) Department of Health and Human Services, 2015, STAND GROW HARV PACK; US Food and Drug Administration (FDA), 2017, BACT AN MAN CHAPT 4A; US Food and Drug Administration (FDA), 2016, RAW MAN FSMA FIN RUL; US Food and Drug Administration (FDA), 2009, DRAFT GUID IND GUID; Wallace JS, 1996, J APPL BACTERIOL, V81, P663; Wetzel AN, 2007, LETT APPL MICROBIOL, V45, P504, DOI 10.1111/j.1472-765X.2007.02228.x; Wylie JL, 2013, J CLIN MICROBIOL, V51, P466, DOI 10.1128/JCM.02329-12; Zelyas N, 2016, DIAGN MICR INFEC DIS, V85, P302, DOI 10.1016/j.diagmicrobio.2016.03.013; ZHAO T, 1995, APPL ENVIRON MICROB, V61, P1290, DOI 10.1128/AEM.61.4.1290-1293.1995	58	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217445	10.1371/journal.pone.0217445	http://dx.doi.org/10.1371/journal.pone.0217445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125367	Green Published, gold, Green Submitted			2022-12-26	WOS:000468865700042
J	Singh, S; Gupta, K; Shukla, S; Sampathkumar, SG; Roy, RP				Singh, Shikha; Gupta, Kanchan; Shukla, Shagun; Sampathkumar, Srinivasa-Gopalan; Roy, Rajendra P.			Sortase-click strategy for defined protein conjugation on a heptavalent cyclodextrin scaffold	PLOS ONE			English	Article							SCHARDINGER DEXTRIN; BETA-CYCLODEXTRIN; PEPTIDE; LIGATION; SYSTEM	Multivalent proteins or protein dendrimers are useful for clinical and biotechnological applications. However, assembly of chemically defined protein dendrimers is a challenging endeavor. In the past, majority of protein dendrimers have been developed on branched lysine scaffolds and are usually limited to a valency of two to four. The naturally occurring cyclodextrin (CD) scaffold composed of 6-8 glucose units offers the possibility of expanding the valency. Here we have adapted a chemoenzymatic-click strategy for displaying heptavalent peptides and large proteins on the beta-cyclodextrin (beta-CD) scaffold. We demonstrate that recombinant proteins (engineered with a LPXTG pentapeptide motif at the carboxy terminus), labeled with an alkyne moiety by sortase-mediated ligation, can be easily clicked on to the azide-derivatized beta-cyclodextrin through the Huisgen cycloaddition reaction yielding a well-defined heptavalent display of proteins.	[Singh, Shikha; Gupta, Kanchan; Shukla, Shagun; Sampathkumar, Srinivasa-Gopalan; Roy, Rajendra P.] Natl Inst Immunol, Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Roy, RP (corresponding author), Natl Inst Immunol, Delhi, India.	rproy@nii.ac.in	Singh, Shikha/AAM-4407-2021; shukla, shagun/AAZ-7923-2021; Sampathkumar, Srinivasa-Gopalan/C-9951-2017	Sampathkumar, Srinivasa-Gopalan/0000-0002-0616-8977; gupta, kanchan/0000-0002-8411-881X; Roy, Rajendra/0000-0002-7796-7047	J. C. Bose Fellowship grant [SB/S2/JCB-016/2016]; National Institute of Immunology from Department of Biotechnology (Government of India)	J. C. Bose Fellowship grant; National Institute of Immunology from Department of Biotechnology (Government of India)	This work was supported by J. C. Bose Fellowship grant (#SB/S2/JCB-016/2016) to RPR (Department of Science and Technology, Government of India) and intramural grants of National Institute of Immunology from Department of Biotechnology (Government of India). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggelidou C, 2014, BEILSTEIN J ORG CHEM, V10, P2414, DOI 10.3762/bjoc.10.251; Alt K, 2015, ANGEW CHEM INT EDIT, V54, P7515, DOI 10.1002/anie.201411507; Ashton PR, 1996, J ORG CHEM, V61, P903, DOI 10.1021/jo951396d; Bertolla C, 2008, BIOORG MED CHEM LETT, V18, P1855, DOI 10.1016/j.bmcl.2008.02.017; Boykins RA, 2000, PEPTIDES, V21, P9, DOI 10.1016/S0196-9781(99)00172-2; Freudenberg K, 1939, NATURWISSENSCHAFTEN, V27, P850, DOI 10.1007/BF01489430; Freudenberg K, 1935, LIEBIGS ANN CHEM, V518, P102; Freudenberg K, 1938, BER DTSCH CHEM GES, V71, P1596, DOI 10.1002/cber.19380710809; Garcia YR, 2015, ORG BIOMOL CHEM, V13, P5273, DOI 10.1039/c5ob00609k; Gupta K, 2012, CHEMBIOCHEM, V13, P2489, DOI 10.1002/cbic.201200559; Helms BA, 2009, J AM CHEM SOC, V131, P11683, DOI 10.1021/ja902285m; Jiang RJ, 2014, CARBOHYD RES, V400, P19, DOI 10.1016/j.carres.2014.08.018; Joshi A, 2011, BIOMACROMOLECULES, V12, P791, DOI 10.1021/bm101396u; KARUPPIAH N, 1995, BIOCHEM BIOPH RES CO, V211, P60, DOI 10.1006/bbrc.1995.1778; Loftsson T., 2004, AM J DRUG DELIV, V2, P261, DOI [10.2165/00137696-200402040-00006, DOI 10.2165/00137696-200402040-00006]; Ma D, 2013, J COLLOID INTERF SCI, V405, P305, DOI 10.1016/j.jcis.2013.05.017; Maciollek A, 2013, BEILSTEIN J ORG CHEM, V9, P827, DOI 10.3762/bjoc.9.94; Motoyama K, 2014, J DRUG TARGET, V22, P211, DOI 10.3109/1061186X.2013.856012; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; van Baal I, 2005, ANGEW CHEM INT EDIT, V44, P5052, DOI 10.1002/anie.200500635; Wang YW, 2010, MACROMOLECULES, V43, P1651, DOI 10.1021/ma902377g; Werlen RC, 1996, CANCER RES, V56, P809; Xiao JP, 2009, ORG LETT, V11, P4144, DOI 10.1021/ol9016468	26	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217369	10.1371/journal.pone.0217369	http://dx.doi.org/10.1371/journal.pone.0217369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125361	Green Submitted, gold, Green Published			2022-12-26	WOS:000468865700031
J	Guo, HZ; Niu, LT; Qiang, WT; Chen, J; Wang, J; Yang, H; Zhang, W; Zhu, J; Yu, SH				Guo, He-Zhou; Niu, Li-Ting; Qiang, Wan-Ting; Chen, Juan; Wang, Juan; Yang, Hui; Zhang, Wu; Zhu, Jiang; Yu, Shan-He			Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance	FASEB JOURNAL			English	Article						AML; IL-17B-IL-17RB signaling; cytokines; drug resistance	ACUTE MYELOID-LEUKEMIA; MESSENGER-RNA EXPRESSION; NF-KAPPA-B; FAMILY CYTOKINES; IDENTIFICATION; INFLAMMATION; METASTASIS; PROGRAM; PATHWAY; PLAYERS	Secreted proteins provide crucial signals that have been implicated in the development of acute myeloid leukemia (AML) in the bone marrow microenvironment. Here we identify aberrant expressions of inflammatory IL-17B and its receptor (IL-17RB) in human and mouse mixed lineage leukemia-rearranged AML cells, which were further increased after exposure to chemotherapy. Interestingly, silencing of IL-17B or IL-17RB led to significant suppression of leukemic cell survival and disease progression in vivo. Moreover, the IL-17B-IL-17RB axis protected leukemic cells from chemotherapeutic agent-induced apoptotic effects. Mechanistic studies revealed that IL-17B promoted AML cell survival by enhancing ERK, NF-kappa B phosphorylation, and the expression of antiapoptotic protein B-cell lymphoma 2, which were reversed by small-molecule inhibitors. Thus, the inhibition of the IL-17B-IL-17RB axis may be a valid strategy to enhance sensitivity and therapeutic benefit of AML chemotherapy.-Guo, H.-Z., Niu, L.-T., Qiang, W.-T., Chen, J., Wang, J., Yang, H., Zhang, W., Zhu, J., Yu, S.-H. Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance.	[Guo, He-Zhou; Niu, Li-Ting; Qiang, Wan-Ting; Chen, Juan; Yang, Hui; Zhang, Wu; Zhu, Jiang; Yu, Shan-He] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, 197 Rui Jin Rd 2,Room 806,Sci & Educ Plaza, Shanghai, Peoples R China; [Guo, He-Zhou; Niu, Li-Ting; Qiang, Wan-Ting; Chen, Juan; Yang, Hui; Zhang, Wu; Zhu, Jiang; Yu, Shan-He] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Wang, Juan] Penn State Univ, Bioinformat & Genom Program, Huck Inst Life Sci, University Pk, PA 16802 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Guo, HZ; Yu, SH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, 197 Rui Jin Rd 2,Room 806,Sci & Educ Plaza, Shanghai, Peoples R China.	redd22@sjtu.edu.cn; 2005150107@sjtu.edu.cn		Yu, Shanhe/0000-0002-0268-7374	National Scientific Foundation of China [81430002, 81770206, 81800099]; Chinese National Key Basic Research Project [2013CB966803]; National Major Scientific and Technological Special Project [2018ZX09101001]; Samuel Waxman Cancer Research Foundation	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Basic Research Project(National Basic Research Program of China); National Major Scientific and Technological Special Project; Samuel Waxman Cancer Research Foundation	This work was supported by grants from the National Scientific Foundation of China (81430002, 81770206, and 81800099), the Chinese National Key Basic Research Project (2013CB966803), the National Major Scientific and Technological Special Project (2018ZX09101001), and Samuel Waxman Cancer Research Foundation. The authors declare no conflicts of interest.	Agger K, 2016, GENE DEV, V30, P1278, DOI 10.1101/gad.280495.116; Al-Samadi A, 2016, TUMOR BIOL, V37, P1609, DOI 10.1007/s13277-015-3941-x; Alinejad V, 2017, BIOMED PHARMACOTHER, V88, P795, DOI 10.1016/j.biopha.2017.01.120; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Anstee N. S., 2018, CELL DEATH DIFFER; Bagger FO, 2013, NUCLEIC ACIDS RES, V41, pD1034, DOI 10.1093/nar/gks1021; Benatar T, 2010, CANCER IMMUNOL IMMUN, V59, P805, DOI 10.1007/s00262-009-0802-8; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bie QL, 2017, MOL IMMUNOL, V90, P50, DOI 10.1016/j.molimm.2017.07.004; Bie QL, 2017, ONCOTARGET, V8, P18914, DOI 10.18632/oncotarget.14835; Bie QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25447; Carey A, 2017, CELL REP, V18, P3204, DOI 10.1016/j.celrep.2017.03.018; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; de Boer J, 2013, LEUKEMIA, V27, P1224, DOI 10.1038/leu.2013.78; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; El Rassi F, 2013, CLIN MED INSIGHTS-ON, V7, P181, DOI 10.4137/CMO.S8528; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fabre J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091433; Furuta S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001374; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hemmati S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00265; Huang CK, 2014, ONCOGENE, V33, P2968, DOI 10.1038/onc.2013.268; Iida T, 2014, ONCOL REP, V31, P605, DOI 10.3892/or.2013.2911; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kohlmann A, 2008, BRIT J HAEMATOL, V142, P802, DOI 10.1111/j.1365-2141.2008.07261.x; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Mitchell K, 2018, J EXP MED, V215, P1709, DOI 10.1084/jem.20180147; Nakamura A, 2016, J NEUROSCI, V36, P5448, DOI 10.1523/JNEUROSCI.4247-15.2016; Naumenko VS, 2015, NEUROSCIENCE, V284, P730, DOI 10.1016/j.neuroscience.2014.10.045; Ofengeim D, 2012, NAT NEUROSCI, V15, P574, DOI 10.1038/nn.3054; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Park HA, 2018, MOLECULES, V23, DOI 10.3390/molecules23113019; Prange KHM, 2017, ONCOGENE, V36, P3346, DOI 10.1038/onc.2016.488; Ren L, 2017, MOL IMMUNOL, V90, P126, DOI 10.1016/j.molimm.2017.06.034; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Song XY, 2013, CELL SIGNAL, V25, P2335, DOI 10.1016/j.cellsig.2013.07.021; Teh TC, 2018, LEUKEMIA, V32, P303, DOI 10.1038/leu.2017.243; Tian EM, 2000, ONCOGENE, V19, P2098, DOI 10.1038/sj.onc.1203577; Turzanski J, 2004, LEUKEMIA, V18, P1662, DOI 10.1038/sj.leu.2403457; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Winters AC, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00004; Wong SHK, 2015, CANCER CELL, V28, P198, DOI 10.1016/j.ccell.2015.06.003; Wu HH, 2015, J EXP MED, V212, P333, DOI 10.1084/jem.20141702; Yu SH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05548-z; Zhu N, 2016, J CLIN INVEST, V126, P997, DOI 10.1172/JCI82978	54	5	6	6	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9565	9576		10.1096/fj.201900099R	http://dx.doi.org/10.1096/fj.201900099R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31136196	Bronze			2022-12-26	WOS:000478832900067
J	Furusawa, K; Takasugi, T; Chiu, YW; Hori, Y; Tomita, T; Fukuda, M; Hisanaga, S				Furusawa, Kotaro; Takasugi, Toshiyuki; Chiu, Yung-Wen; Hori, Yukiko; Tomita, Taisuke; Fukuda, Mitsunori; Hisanaga, Shin-ichi			CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein (APP); Rab; endosome; membrane trafficking; protein degradation; Alzheimer disease; CD2AP; CIN85; Rab7	ALZHEIMERS-DISEASE; COMMON VARIANTS; CAPPING PROTEIN; TRAFFICKING; ASSOCIATION; LOCALIZATION; DISABLED-1; AUTOPHAGY; SECRETASE; INTERACT	A hallmark of Alzheimer's disease (AD) pathology is the appearance of senile plaques, which are composed of beta-amyloid (A beta) peptides. A beta is produced by sequential cleavages of amyloid precursor protein (APP) by beta- and gamma-secretases. These cleavages take place in endosomes during intracellular trafficking of APP through the endocytic and recycling pathways. Genome-wide association studies have identified several risk factors for late-onset AD, one of which is CD2-associated protein (CD2AP), an adaptor molecule that regulates membrane trafficking. Although CD2AP's involvement in APP trafficking has recently been reported, how APP trafficking is regulated remains unclear. We sought to address this question by investigating the effect of CD2AP overexpression or knockdown on the intracellular APP distribution and degradation of APP in cultured COS-7 and HEK293 cells. We found that overexpression of CD2AP increases the localization of APP to Rab7-positive late endosomes, and decreases its localization to Rab5-positive early endosomes. CD2AP overexpression accelerated the onset of APP degradation without affecting its degradation rate. Furthermore, nutrient starvation increased the localization of APP to Rab7-positive late endosomes, and CD2AP overexpression stimulated starvation-induced lysosomal APP degradation. Moreover, the effect of CD2AP on the degradation of APP was confirmed by CD2AP overexpression and knockdown in primary cortical neurons from mice. We conclude that CD2AP accelerates the transfer of APP from early to late endosomes. This transfer in localization stimulates APP degradation by reducing the amount of time before degradation initiation. Taken together, these results may explain why impaired CD2AP function is a risk factor for AD.	[Furusawa, Kotaro; Takasugi, Toshiyuki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Chiu, Yung-Wen; Hori, Yukiko; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Integrat Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Furusawa, Kotaro] Univ Tokyo, Bunkyo Ku, Tokyo 1130033, Japan	Tokyo Metropolitan University; University of Tokyo; Tohoku University; University of Tokyo	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp	Fukuda, MItsunori/I-1511-2015; Tomita, Taisuke/L-5427-2015	Fukuda, MItsunori/0000-0002-8620-5853; Hisanaga, Shin-ichi/0000-0002-7572-472X; Tomita, Taisuke/0000-0002-0075-5943	MEXT of Japan [26117004]; MEXT [16K07060, 18J01378]	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by MEXT Grant-in-aid project, Scientific Research on Innovation Area (Brain Protein Aging and Dementia Control) of Japan Grant 26117004 (to S. H.) and MEXT Grant-in-aid numbers 16K07060 (to S. H.) and 18J01378 (to K. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Colacurcio DJ, 2018, FREE RADICAL BIO MED, V114, P40, DOI 10.1016/j.freeradbiomed.2017.10.001; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437; Dikic I, 2002, FEBS LETT, V529, P110, DOI 10.1016/S0014-5793(02)03188-5; Eggert S, 2018, CELL MOL LIFE SCI, V75, P301, DOI 10.1007/s00018-017-2625-7; Fuchigami T, 2013, GENES CELLS, V18, P410, DOI 10.1111/gtc.12045; Furusawa K, 2017, J NEUROSCI, V37, P790, DOI 10.1523/JNEUROSCI.2197-16.2016; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hernandez-Valladares M, 2010, NAT STRUCT MOL BIOL, V17, P497, DOI 10.1038/nsmb.1792; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Jaeger PA, 2010, ARCH NEUROL-CHICAGO, V67, P1181, DOI 10.1001/archneurol.2010.258; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kuchitsu Y, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215442; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lambert JC, 2013, MOL PSYCHIATR, V18, P461, DOI 10.1038/mp.2012.14; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lefebvre C, 2018, SEMIN CELL DEV BIOL, V74, P21, DOI 10.1016/j.semcdb.2017.08.014; Liao F, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0006-y; Minami SS, 2011, J NEUROCHEM, V118, P879, DOI 10.1111/j.1471-4159.2011.07296.x; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Musardo S, 2013, EUR J PHARMACOL, V719, P84, DOI 10.1016/j.ejphar.2013.07.019; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; Naumann N, 2010, HIPPOCAMPUS, V20, P971, DOI 10.1002/hipo.20693; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nizzari M, 2007, J BIOL CHEM, V282, P13833, DOI 10.1074/jbc.M610146200; Orhon I, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6030020; Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Sato Y, 2007, GENES CELLS, V12, P1315, DOI 10.1111/j.1365-2443.2007.01139.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shulman JM, 2013, JAMA NEUROL, V70, P1150, DOI 10.1001/jamaneurol.2013.2815; Siemes C, 2006, EXP CELL RES, V312, P1939, DOI 10.1016/j.yexcr.2006.02.025; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sullivan SE, 2014, J BIOL CHEM, V289, P15374, DOI 10.1074/jbc.M113.541003; Tanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092291; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Toh WH, 2017, TRAFFIC, V18, P159, DOI 10.1111/tra.12465; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; Wang X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00294; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Yoon SY, 2008, J NEUROSCI RES, V86, P3230, DOI 10.1002/jnr.21760; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zhao JP, 2013, MOL CELL BIOL, V33, P38, DOI 10.1128/MCB.00734-12	57	18	18	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10886	10899		10.1074/jbc.RA118.005385	http://dx.doi.org/10.1074/jbc.RA118.005385			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31138646	hybrid, Green Published			2022-12-26	WOS:000478717200013
J	Li, J; Jia, YH; Lin, AY; Hanna, M; Chelico, L; Xiao, W; Moore, SA				Li, Jia; Jia, Yunhua; Lin, Aiyang; Hanna, Michelle; Chelico, Linda; Xiao, Wei; Moore, Stanley A.			Structure of Ddi2, a highly inducible detoxifying metalloenzyme from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; enzyme structure; enzyme mechanism; metalloenzyme; yeast physiology; active site; cyanamide; HD domain; hydratase; urea	ALDEHYDE DEHYDROGENASE; CYANAMIDE HYDRATION; NATURAL CYANAMIDE; CRYSTAL-STRUCTURE; MECHANISM; REVEALS; PROTEIN; INHIBITION; ENZYME	Cyanamide (H2N-CN) is used to break bud dormancy in woody plants and to deter alcohol use in humans. The biological effects of cyanamide in both these cases require the enzyme catalase. We previously demonstrated that Saccharomyces cerevisiae exposed to cyanamide resulted in strong induction of DDI2 gene expression. Ddi2 enzymatically hydrates cyanamide to urea and belongs to the family of HD-domain metalloenzymes (named after conserved active-site metal-binding His and Asp residues). Here, we report the X-ray structure of yeast Ddi2 to 2.6 angstrom resolution, revealing that Ddi2 is a dimeric zinc metalloenzyme. We also confirm that Ddi2 shares structural similarity with other known HD-domain proteins. HD residues His-55, His-88, and Asp-89 coordinate the active-site zinc, and the fourth zinc ligand is a water/hydroxide molecule. Other HD domain enzymes have a second aspartate metal ligand, but in Ddi2 this residue (Thr-157) does not interact with the zinc ion. Several Ddi2 active-site point mutations exhibited reduced catalytic activity. We kinetically and structurally characterized H137N and T157V mutants of Ddi2. A cyanamide soak of the Ddi2-T157V enzyme revealed cyanamide bound directly to the Zn2+ ion, having displaced the zinc-bound water molecule. The mode of cyanamide binding to Ddi2 resembles cyanamide binding to the active-site zinc of carbonic anhydrase, a known cyanamide hydratase. Finally, we observed that the sensitivity of ddi2 Delta ddi3 Delta to cyanamide was not rescued by plasmids harboring ddi2-H137N or ddi2-TI57V variants, demonstrating that yeast cells require a functioning cyanamide hydratase to overcome cyanamide-induced growth defects.	[Li, Jia; Jia, Yunhua; Lin, Aiyang; Hanna, Michelle; Chelico, Linda; Xiao, Wei; Moore, Stanley A.] Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada; [Lin, Aiyang; Xiao, Wei] Capital Normal Univ, Coll Life Sci, Beijing Key Lab DNA Damage Responses, Beijing 100048, Peoples R China	University of Saskatchewan; Capital Normal University	Xiao, W; Moore, SA (corresponding author), Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.; Xiao, W (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing Key Lab DNA Damage Responses, Beijing 100048, Peoples R China.	wei.xiao@usask.ca; stan.moore@usask.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04580, RGPIN-2019-05604, RGPIN-2011-262138, MOP-126155]; Canadian Institutes for Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grants RGPIN-2014-04580 and RGPIN-2019-05604 (to W.X.) and RGPIN-2011-262138 (to S.A.M.) and by Operating Grant MOP-126155 from the Canadian Institutes for Health Research (to S.A.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Briganti F, 1999, J BIOL INORG CHEM, V4, P528, DOI 10.1007/s007750050375; Buijnsters P, 2014, ACS MED CHEM LETT, V5, P1049, DOI 10.1021/ml500262u; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; DEMASTER EG, 1984, BIOCHEM BIOPH RES CO, V122, P358, DOI 10.1016/0006-291X(84)90483-2; DeMaster EG, 1998, BIOCHEM PHARMACOL, V55, P2007, DOI 10.1016/S0006-2952(98)00080-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Guerri A, 2000, BIOCHEMISTRY-US, V39, P12391, DOI 10.1021/bi000937c; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Ionescu IA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01233; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jeon YJ, 2016, J STRUCT BIOL, V195, P113, DOI 10.1016/j.jsb.2016.04.002; Kamo T, 2003, J CHEM ECOL, V29, P275, DOI 10.1023/A:1022621709486; Kamo T, 2008, PHYTOCHEMISTRY, V69, P1166, DOI 10.1016/j.phytochem.2007.11.004; Kamo T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10527; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2015, J BIOL CHEM, V290, P12664, DOI 10.1074/jbc.M115.645408; MAIERGREINER UH, 1991, P NATL ACAD SCI USA, V88, P4260, DOI 10.1073/pnas.88.10.4260; Maninang JS, 2015, NAT PROD COMMUN, V10, P743; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez FJ, 2005, J PLANT PHYSIOL, V162, P301, DOI 10.1016/j.jplph.2004.07.011; Rinaldo S, 2015, J BACTERIOL, V197, P1525, DOI 10.1128/JB.02606-14; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shirota FN, 1996, BIOCHEM PHARMACOL, V52, P141, DOI 10.1016/0006-2952(96)00174-8; Singh D, 2015, J BIOL CHEM, V290, P10418, DOI 10.1074/jbc.M115.636936; Tamames B, 2007, PROTEINS, V69, P466, DOI 10.1002/prot.21536; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thorsell AG, 2008, J BIOL CHEM, V283, P15209, DOI 10.1074/jbc.M800348200; van Staalduinen LM, 2014, P NATL ACAD SCI USA, V111, P5171, DOI 10.1073/pnas.1320039111; Weeks JT, 2000, CROP SCI, V40, P1749, DOI 10.2135/cropsci2000.4061749x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu X, 2014, METHODS MOL BIOL, V1163, P183, DOI 10.1007/978-1-4939-0799-1_13; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	44	4	4	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10674	10685		10.1074/jbc.RA118.006394	http://dx.doi.org/10.1074/jbc.RA118.006394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31152065	hybrid, Green Published			2022-12-26	WOS:000478717100025
J	Ren, H; Xin, GW; Jia, MK; Zhu, SC; Lin, QY; Wang, XY; Jiang, Q; Zhang, CM				Ren, He; Xin, Guangwei; Jia, Mingkang; Zhu, Shicong; Lin, Qiaoyu; Wang, Xiangyang; Jiang, Qing; Zhang, Chuanmao			Postmitotic annulate lamellae assembly contributes to nuclear envelope reconstitution in daughter cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; nuclear envelope; nuclear pore; endoplasmic reticulum (ER); nuclear membrane; chromatin; AL pore complex (ALPC); annulate lamellae; Drosophila; intracellular membrane; nucleoporin	IMPORTIN-BETA; PORE; COMPLEX; SIZE; MEMBRANES; RAN; PHOSPHORYLATION; PROTEINS; DNA	In higher eukaryotic cells, the nuclear envelope (NE) is composed of double nuclear membranes studded with nuclear pore complexes (NPCs) and undergoes dynamic disassembly and reassembly during the cell cycle. However, how the NE and NPC reassemble remains largely unclear. Here, using HeLa, HEK293, and Drosophila cells, along with immunofluorescence microscopy and transmission EM methods, we found that postmitotic annulate lamellae (AL) assembly contributes to NE and NPC assembly. We observed that the AL are parallel membrane-pair stacks and possess regularly spaced AL pore complexes (ALPCs) that are morphologically similar to the NPCs. We found that the AL assemble in the cytoplasm during mitotic exit simultaneously with NE re-formation in daughter cells. Then, the assembled AL either bound the decondensing chromatin to directly transform into the NE or bound and fused with the outer nuclear membrane to join the assembling NE. The AL did not colocalize with sheet and tubular endoplasmic reticulum (ER) marker proteins on the ER or the lamin B receptor-localized membrane in the cytoplasm, suggesting that postmitotic AL assembly occurs independently of the chromatin and ER. Collectively, our results indicate that postmitotic AL assembly is a common cellular event and an intermediate step in NE and NPC assembly and in NE expansion in higher eukaryotic cells.	[Ren, He; Xin, Guangwei; Jia, Mingkang; Zhu, Shicong; Lin, Qiaoyu; Wang, Xiangyang; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China; [Ren, He; Xin, Guangwei; Jia, Mingkang; Zhu, Shicong; Lin, Qiaoyu; Wang, Xiangyang; Jiang, Qing; Zhang, Chuanmao] Peking Univ, State Key Lab Membrane Biol, Coll Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, CM (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China.	zhangcm@pku.edu.cn		Zhang, Chuanmao/0000-0003-1359-6475; Ren, He/0000-0003-0660-3657	Ministry of Science and Technology of China; National Natural Science Foundation of China [31520103906, 2016YFA0500201, 2016YFA0100501, 31430051]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China and National Natural Science Foundation of China Grants 31520103906, 2016YFA0500201, 2016YFA0100501, and 31430051. The authors declare that they have no conflicts of interest with the contents of this article.	Blow JJ, 2016, INT J DEV BIOL, V60, P202, DOI 10.1387/ijdb.160142jb; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Bodoor K, 1999, J CELL SCI, V112, P2253; Boulware MJ, 2008, J PHYSIOL-LONDON, V586, P2873, DOI 10.1113/jphysiol.2008.153379; CHEN TY, 1988, J CELL BIOL, V107, P1299, DOI 10.1083/jcb.107.4.1299; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Goldberg MW, 1997, J CELL SCI, V110, P409; Good MC, 2015, DEV CELL, V33, P496, DOI 10.1016/j.devcel.2015.05.015; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hampoelz B, 2016, CELL, V166, P664, DOI 10.1016/j.cell.2016.06.015; Hara Y, 2015, DEV CELL, V33, P562, DOI 10.1016/j.devcel.2015.04.016; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; HUTCHISON CJ, 1987, EMBO J, V6, P2003, DOI 10.1002/j.1460-2075.1987.tb02464.x; Jevtic P, 2015, CURR BIOL, V25, P45, DOI 10.1016/j.cub.2014.10.051; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; Kosinski J, 2016, SCIENCE, V352, P363, DOI 10.1126/science.aaf0643; LaJoie D, 2017, CURR OPIN CELL BIOL, V46, P39, DOI 10.1016/j.ceb.2016.12.008; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Lenart P, 2003, CURR OPIN CELL BIOL, V15, P88, DOI 10.1016/S0955-0674(02)00011-X; Levy DL, 2010, CELL, V143, P288, DOI 10.1016/j.cell.2010.09.012; Lu QL, 2012, CELL RES, V22, P1562, DOI 10.1038/cr.2012.113; Lu XL, 2010, J BIOL CHEM, V285, P33281, DOI 10.1074/jbc.M110.102368; Lusk CP, 2016, CELL, V166, P534, DOI 10.1016/j.cell.2016.07.011; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; Raghunayakula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144508; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; Schooley A, 2012, CHROMOSOMA, V121, P539, DOI 10.1007/s00412-012-0388-3; STAFSTROM JP, 1984, J CELL BIOL, V98, P699, DOI 10.1083/jcb.98.2.699; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 1996, J CELL SCI, V109, P2275; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5	38	5	5	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10383	10391		10.1074/jbc.AC119.008171	http://dx.doi.org/10.1074/jbc.AC119.008171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31152066	Green Published, hybrid			2022-12-26	WOS:000478717100001
J	Gonzalez-Rodriguez, R; Campbell, E; Naumov, A				Gonzalez-Rodriguez, Roberto; Campbell, Elizabeth; Naumov, Anton			Multifunctional graphene oxide/iron oxide nanoparticles for magnetic targeted drug delivery dual magnetic resonance/fluorescence imaging and cancer sensing	PLOS ONE			English	Article							IRON-OXIDE; CONTRAST AGENTS; SYNERGISTIC ENHANCEMENT; CONTROLLED-RELEASE; DOXORUBICIN; GADOLINIUM; DESIGN; SIZE; INTERNALIZATION; ACCUMULATION	Graphene Oxide (GO) has recently attracted substantial attention in biomedical field as an effective platform for biological sensing, tissue scaffolds and in vitro fluorescence imaging. However, the targeting modality and the capability of its in vivo detection have not been explored. To enhance the functionality of GO, we combine it with superparamagnetic iron oxide nanoparticles (Fe3O4 NPs) serving as a biocompatible magnetic drug delivery addends and magnetic resonance contrast agent for MRI. Synthesized GO-Fe3O4 conjugates have an average size of 260 nm and show low cytotoxicity comparable to that of GO. Fe3O4 nanoparticles provide superparamagnetic properties for magnetic targeted drug delivery allowing simple manipulation by the magnetic field and magnetic resonance imaging with high r2/r1 relaxivity ratios of similar to 10.7. GO-Fe3O4 retains pH-sensing capabilities of GO used in this work to detect cancer versus healthy environments in vitro and exhibits fluorescence in the visible for bioimaging. As a drug delivery platform GO-Fe3O4 shows successful fluorescence-tracked transport of hydrophobic doxorubicin non-covalently conjugated to GO with substantial loading and 2.5-fold improved efficacy. As a result, we propose GO-Fe3O4 nanoparticles as a novel multifunctional magnetic targeted platform for high efficacy drug delivery traced in vitro by GO fluorescence and in vivo via MRI capable of optical cancer detection.	[Gonzalez-Rodriguez, Roberto; Campbell, Elizabeth; Naumov, Anton] Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA	Texas Christian University	Gonzalez-Rodriguez, R (corresponding author), Texas Christian Univ, Dept Phys & Astron, Ft Worth, TX 76129 USA.	r.ganzalezrodriguez@tcu.edu		Naumov, Anton/0000-0001-6427-7277; Gonzalez Rodriguez, Roberto/0000-0001-6849-1799	INFOR (Initiative for Oncology Research Grant); TCU Invests in Scholarship grant	INFOR (Initiative for Oncology Research Grant); TCU Invests in Scholarship grant	This work was supported with INFOR (Initiative for Oncology Research Grant), and TCU Invests in Scholarship grant.	Ahmad T, 2011, J NANOSCI NANOTECHNO, V11, P5645, DOI 10.1166/jnn.2011.4502; Ahmed MSU, 2017, INT J NANOMED, V12, P6973, DOI 10.2147/IJN.S139011; Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; Allier C, 2017, CYTOM PART A, V91A, P433, DOI 10.1002/cyto.a.23079; Balcioglu M, 2013, J MATER CHEM B, V1, P6187, DOI 10.1039/c3tb20992j; Bjornerud A, 2002, MAGNET RESON MED, V47, P461, DOI 10.1002/mrm.10066; Campbell E., 2018, SCI REPORTS; Chung C, 2013, ACCOUNTS CHEM RES, V46, P2211, DOI 10.1021/ar300159f; Cormode DP, 2011, BIOCONJUGATE CHEM, V22, P353, DOI 10.1021/bc1003179; Eiblmaier M, 2008, J NUCL MED, V49, P1472, DOI 10.2967/jnumed.108.052316; Espinosa A, 2016, ACS NANO, V10, P2436, DOI 10.1021/acsnano.5b07249; Galande C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00085; GILLES MA, 1990, ANAL BIOCHEM, V184, P244, DOI 10.1016/0003-2697(90)90675-Y; Goncalves G, 2014, SCI REP-UK, V4, DOI 10.1038/srep06735; Gossuin Y, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/15/155706; Granitzer P, 2015, NANOSCALE, V7, P20220, DOI 10.1039/c5nr05232g; Granitzer P, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-413; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Guo L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23091-1; Hasan MT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06107-0; Hope TA, 2012, RADIOLOGY, V264, P423, DOI 10.1148/radiol.12112453; Hu FQ, 2012, NANOSCALE, V4, P6235, DOI 10.1039/c2nr31865b; Hu W, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4796602; Huang A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40772; Huang J, 2013, ACS APPL MATER INTER, V5, P4632, DOI 10.1021/am400713j; Hurley KR, 2013, CHEM MATER, V25, P1968, DOI 10.1021/cm400711h; Ishikawa R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21273; Jarockyte G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081193; Jiang B, 2017, GENES DIS, V4, P25, DOI 10.1016/j.gendis.2017.02.003; Jiao TF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12451; Justin R, 2016, CARBON, V97, P54, DOI 10.1016/j.carbon.2015.06.070; Justino CIL, 2017, TRAC-TREND ANAL CHEM, V91, P53, DOI 10.1016/j.trac.2017.04.003; Kim BH, 2011, J AM CHEM SOC, V133, P12624, DOI 10.1021/ja203340u; Larsen EKU, 2009, ACS NANO, V3, P1947, DOI 10.1021/nn900330m; Lee CS, 2017, EUR J MED CHEM, V142, P416, DOI 10.1016/j.ejmech.2017.08.063; Li D, 2008, SCIENCE, V320, P1170, DOI 10.1126/science.1158180; Li HJ, 2016, P NATL ACAD SCI USA, V113, P4164, DOI 10.1073/pnas.1522080113; Liu Z, 2014, SMALL, V10, P2429, DOI 10.1002/smll.201303909; Liu Z, 2009, ANGEW CHEM INT EDIT, V48, P7668, DOI 10.1002/anie.200902612; Lu YJ, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8040193; Luo HN, 2017, J APPL PHYS, V122, DOI 10.1063/1.4991967; Ma XX, 2012, NANO RES, V5, P199, DOI 10.1007/s12274-012-0200-y; Wettstein CM, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4953172; Matsumoto Y., 2015, CARBON N Y, V87, P463, DOI DOI 10.1016/J.CARB0N.2015.02.032; Mkhoyan KA, 2009, NANO LETT, V9, P1058, DOI 10.1021/nl8034256; Montes-Navajas P, 2013, LANGMUIR, V29, P13443, DOI 10.1021/la4029904; O'Neal Stefanie L, 2015, Curr Environ Health Rep, V2, P315, DOI 10.1007/s40572-015-0056-x; Papageorgiou DG, 2017, PROG MATER SCI, V90, P75, DOI 10.1016/j.pmatsci.2017.07.004; Paquet C, 2011, ACS NANO, V5, P3104, DOI 10.1021/nn2002272; Perazella MA, 2008, CURR DRUG SAF, V3, P67, DOI 10.2174/157488608783333989; Pereira C, 2015, J MATER CHEM B, V3, P6261, DOI 10.1039/c5tb00789e; Qin J, 2007, ADV MATER, V19, P1874, DOI [10.1002/adma.200602326, 10.1002/adma.200790066]; Rogosnitzky M, 2016, BIOMETALS, V29, P365, DOI 10.1007/s10534-016-9931-7; Ruan YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21682; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x; Shadjou N, 2018, BIOENGINEERED, V9, P38, DOI 10.1080/21655979.2017.1373539; Shang JZ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00792; Shang L, 2017, RSC ADV, V7, P47715, DOI 10.1039/c7ra08348c; Shen ZY, 2017, MOL PHARMACEUT, V14, P1352, DOI 10.1021/acs.molpharmaceut.6b00839; Shi CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8449; Shi Y, 2013, BIOMACROMOLECULES, V14, P1826, DOI 10.1021/bm400234c; Shibata H, 2015, DRUG DEV IND PHARM, V41, P1376, DOI 10.3109/03639045.2014.954582; Shin DS, 2017, RSC ADV, V7, P13979, DOI 10.1039/c7ra00114b; Singh R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42771; Tong S, 2017, ACS NANO, V11, P6808, DOI 10.1021/acsnano.7b01762; Tong S, 2010, NANO LETT, V10, P4607, DOI 10.1021/nl102623x; Tukmachev D, 2015, NANOSCALE, V7, P3954, DOI 10.1039/c4nr05791k; Tuoek J, 2014, ACS NANO, V8, P7571, DOI [10.1021/m501836x, DOI 10.1021/M501836X]; van Vlerken Lilian E, 2006, Expert Opin Drug Deliv, V3, P205, DOI 10.1517/17425247.3.2.205; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Wang Y, 2011, TRENDS BIOTECHNOL, V29, P205, DOI 10.1016/j.tibtech.2011.01.008; Yan H, 2014, ACS APPL MATER INTER, V6, P9871, DOI 10.1021/am502377n; Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k; Yathindranath V, 2013, LANGMUIR, V29, P10850, DOI 10.1021/la402007d; Zhang F, 2012, BIOCHEM BIOPH RES CO, V425, P886, DOI 10.1016/j.bbrc.2012.07.168; Zhang HZ, 2016, J COLLOID INTERF SCI, V471, P94, DOI 10.1016/j.jcis.2016.03.015; Zhang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11129; Zhang ZY, 2015, SMALL, V11, P3000, DOI 10.1002/smll.201403459; Zhou T, 2014, BIOMATERIALS, V35, P4185, DOI 10.1016/j.biomaterials.2014.01.044; Zhou ZJ, 2014, ACS NANO, V8, P7976, DOI 10.1021/nn5038652; Zhu XL, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/36/365103	82	58	58	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217072	10.1371/journal.pone.0217072	http://dx.doi.org/10.1371/journal.pone.0217072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170197	gold, Green Published, Green Submitted			2022-12-26	WOS:000470263700017
J	Yu, K; Rodriguez, MD; Paul, Z; Gordon, E; Rice, K; Triplett, EW; Keller-Wood, M; Wood, CE				Yu, Kevin; Rodriguez, Michelle D.; Paul, Zubin; Gordon, Elizabeth; Rice, Kelly; Triplett, Eric W.; Keller-Wood, Maureen; Wood, Charles E.			Proof of principle: Physiological transfer of small numbers of bacteria from mother to fetus in late-gestation pregnant sheep	PLOS ONE			English	Article							BREAST-MILK; FETAL; MICROBIOTA; INFANT	Fetal development is thought to proceed in a sterile environment. Recent reports of the presence of bacterial DNA in human placenta, the transfer of live bacteria from mother to fetus after hypoxia in the pregnant sheep, and the presence of bacteria in the meconium of newborn infants have suggested that the fetus might be exposed to bacteria in utero. The present experiments were designed to test the hypothesis that small numbers of bacteria introduced into the maternal bloodstream (too few to induce fever or changes in maternal food consumption), can be found in the fetus days later. We injected 100 colony forming units of green-, red- and far red- fluorescent protein (GFP, RFP, FRFP) expressing S. aureus into late-gestation pregnant sheep intravenously. Five to 7 days later, the animals were euthanized and tissues collected for analysis of GFP. The inoculations did not cause any fever or other measurable behavioral response in the ewes, but did result in the appearance of GFP DNA, and protein in various tissues within the fetuses. Immunohistochemical analysis reveals GFP protein-containing bacteria that appear to be mostly contained within other cells. We were unable to recover any live GFP-expressing bacteria from the fetal tissues. We conclude that S. aureus, and perhaps other bacteria, gain access to the fetus, although it is not clear from these experiments that they survive in the fetus. It is possible that these low inocula and their progeny were effectively cleared by the fetal immune system.	[Yu, Kevin; Paul, Zubin; Gordon, Elizabeth; Wood, Charles E.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Rodriguez, Michelle D.; Rice, Kelly; Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Keller-Wood, Maureen] Univ Florida, Coll Pharm, Dept Pharmacodynam, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wood, CE (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	woodc@ufl.edu		Keller-Wood, Maureen/0000-0002-1443-9212	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD33053]; National Institute of Allergy and Infectious Diseases [AI120195]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the following grants: HD33053 (CEW) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov), AI120195 (CEW and ET) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov).None of the sponsors or funders played any role in the study design, data collection or analysis, decision to publish, or in preparation of this manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ahmed S, 2015, AM J REPROD IMMUNOL, V73, P232, DOI 10.1111/aji.12299; APPLEBY P, 1983, J REPROD IMMUNOL, V5, P203, DOI 10.1016/0165-0378(83)90236-X; Ardissone A. N., 2014, PLOS ONE, V9; Brocklehurst P, 1999, BRIT MED J, V318, P548, DOI 10.1136/bmj.318.7183.548; Burton GJ, 1997, REV MED VIROL, V7, P219, DOI 10.1002/(SICI)1099-1654(199712)7:4<219::AID-RMV205>3.0.CO;2-E; Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007; Chang EI, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12741; Chang EI, 2016, J PHYSIOL-LONDON, V594, P1295, DOI 10.1113/JP271066; Clawson AB, 1928, AMERICAN JOURNAL OF, V85, P20; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; ESCHERICH T, 1989, REV INFECT DIS, V11, P352; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; HAY FC, 1971, CLIN EXP IMMUNOL, V9, P355; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Purinton SC, 2002, J PHYSIOL-LONDON, V544, P919, DOI 10.1113/jphysiol.2002.025635; Rabaglino MB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1001; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Rodriguez MD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02491; Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018; Tissier H., 1900, RECHERCHES FLORE INT; Zar JH, 1999, BIOSTATISTICAL ANAL; Zarate MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06789-6; Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217211	10.1371/journal.pone.0217211	http://dx.doi.org/10.1371/journal.pone.0217211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170184	Green Submitted, gold, Green Published			2022-12-26	WOS:000470263700021
J	Panmanee, W; Su, SC; Schurr, MJ; Lau, GW; Zhu, XT; Ren, ZW; McDaniel, CT; Lu, LJ; Ohman, DE; Muruve, DA; Panos, RJ; Ye, HD; Thompson, TB; Tseng, BS; Hassett, DJ				Panmanee, Warunya; Su, Shengchang; Schurr, Michael J.; Lau, Gee W.; Zhu, Xiaoting; Ren, Zhaowei; McDaniel, Cameron T.; Lu, Long J.; Ohman, Dennis E.; Muruve, Daniel A.; Panos, Ralph J.; Ye, Hongwei D.; Thompson, Thomas B.; Tseng, Boo Shan; Hassett, Daniel J.			The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a Delta mucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS LUNG; ELECTRON-PARAMAGNETIC-RESONANCE; HYDROGEN-PEROXIDE; S-NITROSYLATION; ALGINATE BIOSYNTHESIS; OXYGEN LIMITATION; MUCOID CONVERSION; NITRATE REDUCTASE; GENE-EXPRESSION; REGULATED GENES	Mucoid mucA22 Pseudomonas aeruginosa (PA) is an opportunistic lung pathogen of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients that is highly sensitive to acidified nitrite (A-NO2-). In this study, we first screened PA mutant strains for sensitivity or resistance to 20 mM A-NO2- under anaerobic conditions that represent the chronic stages of the aforementioned diseases. Mutants found to be sensitive to A-NO2- included PA0964 (pmpR, PQS biosynthesis), PA4455 (probable ABC transporter permease), katA (major catalase, KatA) and rhlR (quorum sensing regulator). In contrast, mutants lacking PA0450 (a putative phosphate transporter) and PA1505 (moaA2) were A-NO2- resistant. However, we were puzzled when we discovered that mucA22 mutant bacteria, a frequently isolated mucA allele in CF and to a lesser extent COPD, were more sensitive to A-NO2- than a truncated Delta mucA deletion (Delta 157-194) mutant in planktonic and biofilm culture, as well as during a chronic murine lung infection. Subsequent transcriptional profiling of anaerobic, ANO(2)(-) -treated bacteria revealed restoration of near wild-type transcript levels of protective NO2- and nitric oxide (NO) reductase (nirS and norCB, respectively) in the Delta mucA mutant in	[Panmanee, Warunya; Su, Shengchang; McDaniel, Cameron T.; Thompson, Thomas B.; Hassett, Daniel J.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Schurr, Michael J.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Lau, Gee W.] Univ Illinois, Coll Vet Med, Urbana, IL USA; [Zhu, Xiaoting; Ren, Zhaowei; Lu, Long J.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Med Ctr, Richmond, VA 23298 USA; [Ohman, Dennis E.] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Panos, Ralph J.] Cincinnati Vet Affairs Med Ctr, Dept Med, Cincinnati, OH USA; [Panos, Ralph J.] Univ Cincinnati, Coll Med, Dept Med, Pulm Crit Care & Sleep Div, Cincinnati, OH USA; [Ye, Hongwei D.] Marshall Univ, Dept Biochem & Microbiol, Huntington, WV USA; [Tseng, Boo Shan] Univ Nevada Las Vegas, Dept Life Sci, Las Vegas, NV USA	University System of Ohio; University of Cincinnati; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Illinois System; University of Illinois Urbana-Champaign; Cincinnati Children's Hospital Medical Center; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; University of Calgary; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Marshall University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Hassett, DJ (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	Daniel.Hassett@UC.Edu	Schurr, Michael/I-2481-2013; Tseng, Boo Shan/M-6279-2018; Schurr, Michael/AAX-6596-2020; Lau, Gee W/H-4073-2018	Schurr, Michael/0000-0003-2585-0477; Tseng, Boo Shan/0000-0001-7563-0232; Yu, Hongwei/0000-0002-8546-0158	Cincinnati Veteran's Administration Medical Center, U.S. Department of Veterans Affairs (US) [5I01BX000845-03]	Cincinnati Veteran's Administration Medical Center, U.S. Department of Veterans Affairs (US)	This study was funded by the Merit Award from the Cincinnati Veteran's Administration Medical Center, U.S. Department of Veterans Affairs (US) (5I01BX000845-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgent MA, 2012, FREE RADICAL BIO MED, V53, P951, DOI 10.1016/j.freeradbiomed.2012.06.003; Almagro P, 2012, RESPIRATION, V84, P36, DOI 10.1159/000331224; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Arai H, 2005, J BACTERIOL, V187, P3960, DOI 10.1128/JB.187.12.3960-3968.2005; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Borrero-de Acuna JM, 2015, J BACTERIOL, V197, P3066, DOI 10.1128/JB.00415-15; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Borrill Zoe L, 2008, Int J Chron Obstruct Pulmon Dis, V3, P171; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Boucher JC, 1996, J BACTERIOL, V178, P511, DOI 10.1128/jb.178.2.511-523.1996; Boucher JC, 1997, MICROBIOL-UK, V143, P3473, DOI 10.1099/00221287-143-11-3473; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; CAETANOANOLLES G, 1993, PCR METH APPL, V3, P85; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Corradi M, 2010, AM J RESP CRIT CARE, V181, P3, DOI 10.1164/rccm.200908-1279ED; Crespo A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14051-2; Crespo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00688; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dotsch J, 2002, EUR ARCH OTO-RHINO-L, V259, P222, DOI 10.1007/s00405-001-0436-8; Field TR, 2005, EUR J CLIN MICROBIOL, V24, P677, DOI 10.1007/s10096-005-0031-9; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; Frisk A, 2004, INFECT IMMUN, V72, P5433, DOI 10.1128/IAI.72.9.5433-5438.2004; Fung C, 2010, J MED MICROBIOL, V59, P1089, DOI 10.1099/jmm.0.019984-0; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; GODFREY C, 1987, BIOCHEM J, V243, P241, DOI 10.1042/bj2430241; GODFREY C, 1984, BIOCHEM J, V224, P601, DOI 10.1042/bj2240601; GOLDBERG JB, 1993, J BACTERIOL, V175, P1303, DOI 10.1128/JB.175.5.1303-1308.1993; GOLDBERG JB, 1984, J BACTERIOL, V158, P1115, DOI 10.1128/JB.158.3.1115-1121.1984; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grasemann H, 1998, ARCH DIS CHILD, V78, P49, DOI 10.1136/adc.78.1.49; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hasegawa N, 2001, BIOCHEM BIOPH RES CO, V288, P1223, DOI 10.1006/bbrc.2001.5919; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hassett DJ, 1996, J BACTERIOL, V178, P7322, DOI 10.1128/jb.178.24.7322-7325.1996; Hassett DJ, 2004, STRICT AND FACULTATIVE ANAEROBES: MEDICAL AND ENVIRONMENTAL ASPECTS, P87; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hayashi NR, 1998, BBA-GEN SUBJECTS, V1381, P347, DOI 10.1016/S0304-4165(98)00045-2; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Hogardt M, 2007, J INFECT DIS, V195, P70, DOI 10.1086/509821; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jassem Ewa, 1996, Medycyna Doswiadczalna i Mikrobiologia, V48, P49; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Koskenkorva T, 2008, ARCH MICROBIOL, V189, P385, DOI 10.1007/s00203-007-0329-3; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; Liang HH, 2008, J BACTERIOL, V190, P6217, DOI 10.1128/JB.00428-08; Liu J, 2007, RESPIRATION, V74, P617, DOI 10.1159/000106379; Lizewski SE, 2004, J BACTERIOL, V186, P5672, DOI 10.1128/JB.186.17.5672-5684.2004; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Ma S, 1998, J BACTERIOL, V180, P956, DOI 10.1128/JB.180.4.956-968.1998; Major TA, 2010, ANTIMICROB AGENTS CH, V54, P4671, DOI 10.1128/AAC.00379-10; Maniatis T., 1982, MOL CLONING; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; McDaniel C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00291; McGrath LT, 1999, THORAX, V54, P518, DOI 10.1136/thx.54.6.518; Morici LA, 2007, J BACTERIOL, V189, P7752, DOI 10.1128/JB.01797-06; O'Toole GA, 2003, J BACTERIOL, V185, P2687, DOI 10.1128/JB.185.9.2687-2689.2003; OCHSNER UA, 1994, J BACTERIOL, V176, P2044, DOI 10.1128/jb.176.7.2044-2054.1994; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; PEDERSEN SS, 1992, THORAX, V47, P6, DOI 10.1136/thx.47.1.6; Platt MD, 2008, J BACTERIOL, V190, P2739, DOI 10.1128/JB.01683-07; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; Roche N, 2007, REV MAL RESPIR, V24, P803, DOI 10.1016/S0761-8425(07)91159-6; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Schurr MJ, 1996, J BACTERIOL, V178, P4997, DOI 10.1128/jb.178.16.4997-5004.1996; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Silo-Suh LA, 2015, GENOME ANNOUNCEMENTS, V3, DOI [10.1128/genomea.00153-15, 10.1128/genomeA.00153-15]; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stapley R, 2012, BIOCHEM J, V446, P499, DOI 10.1042/BJ20120675; Storey DG, 1997, INFECT IMMUN, V65, P4061, DOI 10.1128/IAI.65.10.4061-4067.1997; Su S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091813; Su SC, 2012, EXPERT OPIN THER TAR, V16, P859, DOI 10.1517/14728222.2012.708025; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Valderrey AD, 2010, DIAGN MICR INFEC DIS, V68, P20, DOI 10.1016/j.diagmicrobio.2010.04.008; Wang D, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00376-15; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wood LF, 2006, J BACTERIOL, V188, P3134, DOI 10.1128/JB.188.8.3134-3137.2006; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Worlitzsch D, 1998, EUR RESPIR J, V11, P377, DOI 10.1183/09031936.98.11020377; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Yorgey P, 2001, MOL MICROBIOL, V41, P1063, DOI 10.1046/j.1365-2958.2001.02580.x; Zhang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041202	108	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0216401	10.1371/journal.pone.0216401	http://dx.doi.org/10.1371/journal.pone.0216401			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158231	Green Published, gold			2022-12-26	WOS:000469915700002
J	Badiea, EA; Sayed, AA; Maged, M; Fouad, WM; Seid, MM; Esmat, AY				Badiea, Elham A.; Sayed, Ahmed A.; Maged, Mohamad; Fouad, Walid M.; Seid, Mahmoud M.; Esmat, Amr Y.			A novel thermostable and halophilic thioredoxin reductase from the Red Sea Atlantis II hot brine pool	PLOS ONE			English	Article							MAMMALIAN THIOREDOXIN; SALT BRIDGES; SYSTEM; IDENTIFICATION; PROTEINS; PURIFICATION; ACID; DIVERSITY; SEQUENCES; ALIGNMENT	The highly extreme conditions of the lower convective layer in the Atlantis II (ATII) Deep brine pool of the Red Sea make it an ideal environment for the search for novel enzymes that can function under extreme conditions. In the current study, we isolated a novel sequence of a thioredoxin reductase (TrxR) enzyme from the metagenomic dataset established from the microbial community that resides in the lower convective layer of Atlantis II. The gene was cloned, expressed and characterized for redox activity, halophilicity, and thermal stability. The isolated thioredoxin reductase (ATII-TrxR) was found to belong to the high-molecular-weight class of thioredoxin reductases. A search for conserved domains revealed the presence of an extra domain (Crp) in the enzyme sequence. Characterization studies of ATII-TrxR revealed that the enzyme was halophilic (maintained activity at 4 M NaCl), thermophilic (optimum temperature was 65 degrees C) and thermostable (60% of its activity was retained at 70 degrees C). Additionally, the enzyme utilized NADH in addition to NADPH as an electron donor. In conclusion, a novel thermostable and halophilic thioredoxin reductase has been isolated with a unique sequence that adapts to the harsh conditions of the brine pools making this protein a good candidate for biological research and industrial applications.	[Badiea, Elham A.; Sayed, Ahmed A.; Seid, Mahmoud M.; Esmat, Amr Y.] Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt; [Badiea, Elham A.; Fouad, Walid M.] Amer Univ Cairo, Sch Sci & Engn, Dept Biol, New Cairo, Egypt; [Sayed, Ahmed A.] Children Canc Hosp, Cairo, Egypt; [Maged, Mohamad] October Univ Modern Sci & Arts, Fac Biotechnol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); American University Cairo; Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA)	Esmat, AY (corresponding author), Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt.	amryesmat@yahoo.com	Fouad, Walid/AAO-5236-2020; Said, Mahmoud/AAJ-6553-2020; Maged, Mohamed/AAY-9724-2021; Maged, Mohamad/AAE-4190-2021	Maged, Mohamad/0000-0001-6967-9793; Esmat, Amr/0000-0002-6360-2354				Adel M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32704; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrei AS, 2012, FEMS MICROBIOL LETT, V330, P1, DOI 10.1111/j.1574-6968.2012.02526.x; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Behzad H, 2016, GENE, V576, P717, DOI 10.1016/j.gene.2015.10.034; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Brown DM, 1996, MOL BIOCHEM PARASIT, V83, P211, DOI 10.1016/S0166-6851(96)02776-4; Cha MK, 1995, BIOCHEM BIOPH RES CO, V217, P900, DOI 10.1006/bbrc.1995.2856; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; COHEN G, 1993, J BACTERIOL, V175, P5159, DOI 10.1128/JB.175.16.5159-5167.1993; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; DasSarma S, 2015, CURR OPIN MICROBIOL, V25, P120, DOI 10.1016/j.mib.2015.05.009; Eckenroth BE, 2007, BIOCHEMISTRY-US, V46, P4694, DOI 10.1021/bi602394p; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; Gamal M M., 2014, THESIS; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gomes E, 2016, FUNG BIOL-US, P459, DOI 10.1007/978-3-319-27951-0_21; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Kashima Y, 2003, ARCH BIOCHEM BIOPHYS, V418, P179, DOI 10.1016/j.abb.2003.08.002; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lacey BM, 2006, BIOCHEM BIOPH RES CO, V346, P629, DOI 10.1016/j.bbrc.2006.05.095; Lam KN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01196; Laurila TE, 2015, GEOCHEM GEOPHY GEOSY, V16, P4449, DOI 10.1002/2015GC006010; Lee CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084597; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; Mick E, 2014, NAT BIOTECHNOL, V32, P750, DOI 10.1038/nbt.2962; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mohamed YM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03358; Ngugi DK, 2015, ISME J, V9, P396, DOI 10.1038/ismej.2014.137; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Oren A, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P81; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Reith F, 2010, GEOLOGY, V38, P843, DOI 10.1130/G31052.1; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Saccoccia F, 2014, CURR PROTEIN PEPT SC, V15, P621, DOI 10.2174/1389203715666140530091910; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sayed A, 2014, J BIOL CHEM, V289, P1675, DOI 10.1074/jbc.M113.493429; Seo HJ, 2010, J MICROBIOL, V48, P637, DOI 10.1007/s12275-010-0283-7; Siam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042872; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; SILVA OF, 2012, BMC BIOINFORMATICS, V13, P124, DOI DOI 10.1186/1471-2105-13-124; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ufarte L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00563; Watabe S, 1999, EUR J BIOCHEM, V264, P74, DOI 10.1046/j.1432-1327.1999.00578.x; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; WILLIAMS CH, EUROPEAN J BIOCH, V267, P6110; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang XQ, 2010, J BACTERIOL, V192, P1370, DOI 10.1128/JB.01035-09; Yu HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143001; Zhao SR, 2016, PARASITOL RES, V115, P3219, DOI 10.1007/s00436-016-5084-4	63	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217565	10.1371/journal.pone.0217565	http://dx.doi.org/10.1371/journal.pone.0217565			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150456	gold, Green Submitted, Green Published			2022-12-26	WOS:000469759100067
J	Holgado, D; Zabala, M; Sanabria, D				Holgado, Darias; Zabala, Mikel; Sanabria, Daniel			No evidence of the effect of cognitive load on self-paced cycling performance	PLOS ONE			English	Article							DUAL-TASK INTERFERENCE; PHYSICAL PERFORMANCE; EXECUTIVE FUNCTION; ATTENTIONAL FOCUS; WORKING-MEMORY; EXERCISE; SPORT; INHIBITION; FATIGUE; BRAIN	Objectives To test the hypothesis that cognitive load (low vs. high load) during a 20 min self-paced cycling exercise affects physical performance. Design A pre-registered (https://osf.io/qept5/), randomized, within-subject design experiment. Methods 28 trained and experienced male cyclists completed a 20 min self-paced cycling time-trial exercise in two separate sessions, corresponding to two working memory load conditions: 1-back or 2-back. We measured power output, heart rate, RPE and mental fatigue. Results Bayes analyses revealed extreme evidence for the 2-back task being more demanding than the 1-back task, both in terms of accuracy (BF10 = 4490) and reaction time (BF = 1316). The data only showed anecdotal evidence for the alternative hypothesis for the power output (BF10 = 1.52), moderate evidence for the null hypothesis for the heart rate (BF10 = 0.172), anecdotal evidence for RPE (BF10 = 0.72) and anecdotal evidence for mental fatigue (BF10 = 0.588). Conclusions Our data seem to challenge the idea that self-paced exercise is regulated by top-down processing, given that we did not show clear evidence of exercise impairment (at the physical, physiological and subjective levels) in the high cognitive load condition task with respect to the low working memory load condition. The involvement of top-down processing in self-pacing the physical effort, however, cannot be totally discarded. Factors like the duration of the physical and cognitive tasks, the potential influence of dual-tasking, and the participants' level of expertise, should be taken into account in future attempts to investigate the role of top-down processing in self-paced exercise.	[Holgado, Darias; Zabala, Mikel] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Holgado, Darias; Sanabria, Daniel] Univ Granada, Mind Brain & Behav Res Ctr, Dept Expt Psychol, Granada, Spain	University of Granada; University of Granada	Holgado, D (corresponding author), Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain.; Holgado, D (corresponding author), Univ Granada, Mind Brain & Behav Res Ctr, Dept Expt Psychol, Granada, Spain.	dariashn@ugr.es	Zabala, Mikel/AAE-8977-2021; Holgado, Darias/I-3101-2015; Sanabria, Daniel/C-3409-2012	Holgado, Darias/0000-0003-3211-8006; Sanabria, Daniel/0000-0002-4164-7607	Ministerio de Economia, Industria y Competitividad [PSI2016-75956-P]; Ministerio de Educacion, Cultura y Deporte [FPU14/06229]	Ministerio de Economia, Industria y Competitividad; Ministerio de Educacion, Cultura y Deporte	This project was supported by grant PSI2016-75956-P from Ministerio de Economia, Industria y Competitividad, awarded to DS and MZ, and grant FPU14/06229 from Ministerio de Educacion, Cultura y Deporte, awarded to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Baron B, 2011, BRIT J SPORT MED, V45, P511, DOI 10.1136/bjsm.2009.059964; Blakely MJ, 2016, IISE T OCCUP ERG HUM, V4, P104, DOI 10.1080/21577323.2015.1055864; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brick N, 2015, PSYCHOL SPORT EXERC, V19, P1, DOI 10.1016/j.psychsport.2015.02.003; Brick N, 2014, INT REV SPORT EXER P, V7, P106, DOI 10.1080/1750984X.2014.885554; Brick NE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00159; Caramia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185825; Ciria LF, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13326; Ciria LF, 2018, NEUROIMAGE, V181, P203, DOI 10.1016/j.neuroimage.2018.07.009; Daniels GL, 2003, BIOL PSYCHOL, V63, P163, DOI 10.1016/S0301-0511(03)00024-3; Darling KA, 2014, EXP BRAIN RES, V232, P1367, DOI 10.1007/s00221-014-3855-7; Dietrich A, 2011, NEUROSCI BIOBEHAV R, V35, P1305, DOI 10.1016/j.neubiorev.2011.02.001; Edwards AM, 2013, SPORTS MED, V43, P1057, DOI 10.1007/s40279-013-0091-4; Epling SL, 2016, EXP BRAIN RES, V234, P2979, DOI 10.1007/s00221-016-4700-y; Holgado D, 2018, J SCI MED SPORT, V21, P654, DOI 10.1016/j.jsams.2017.10.032; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Luque-Casado A, 2016, MED SCI SPORT EXER, V48, P887, DOI 10.1249/MSS.0000000000000857; Malcolm BR, 2018, J NEUROPHYSIOL, V120, P2246, DOI 10.1152/jn.00079.2018; Martin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159907; McMorris T, 2018, PHYSIOL BEHAV, V188, P103, DOI 10.1016/j.physbeh.2018.01.029; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pageaux B, 2018, PROG BRAIN RES, V240, P291, DOI 10.1016/bs.pbr.2018.10.004; Pageaux B, 2014, EUR J APPL PHYSIOL, V114, P1095, DOI 10.1007/s00421-014-2838-5; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pashler H, 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Robertson CV, 2016, J APPL PHYSIOL, V120, P464, DOI 10.1152/japplphysiol.00363.2015; Rooks CR, 2010, PROG NEUROBIOL, V92, P134, DOI 10.1016/j.pneurobio.2010.06.002; Schaefer S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01167; Schneider S, 2010, MED SCI SPORT EXER, V42, P600, DOI 10.1249/MSS.0b013e3181b76ac8; Tempest GD, 2017, BRAIN COGNITION, V113, P133, DOI 10.1016/j.bandc.2017.02.001; Van Cutsem J, 2017, SPORTS MED, V47, P1569, DOI 10.1007/s40279-016-0672-0; Vera J, 2018, J SPORT SCI, V36, P2521, DOI 10.1080/02640414.2018.1466848; Verhaeghen P, 2005, Q J EXP PSYCHOL-A, V58, P134, DOI 10.1080/02724980443000241; Verhoeven K, 2011, EUR J PAIN, V15, P866, DOI 10.1016/j.ejpain.2011.01.009; Walsh V, 2014, CURR BIOL, V24, pR859, DOI 10.1016/j.cub.2014.08.003; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	41	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217825	10.1371/journal.pone.0217825	http://dx.doi.org/10.1371/journal.pone.0217825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150517	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100118
J	Armstrong, MJ; Alliance, S; Taylor, A; Corsentino, P; Galvin, JE				Armstrong, Melissa J.; Alliance, Slande; Taylor, Angela; Corsentino, Pamela; Galvin, James E.			End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregivers	PLOS ONE			English	Article							PALLIATIVE CARE; BODY DEMENTIA; MANAGEMENT; DIAGNOSIS; SURVIVAL; DISEASE; RESIDENTS; MORTALITY; PEOPLE; NEEDS	Background Dementia caregivers describe knowing what to expect as an unmet need and many are unaware that dementia can be a terminal condition. Dementia with Lewy bodies (DLB) is a common neurodegenerative dementia with unique features which may affect the end of life (EOL). Given the paucity of data on EOL experiences in dementia and unique aspects of DLB affecting EOL, we investigated EOL experiences as reported by caregivers of individuals with DLB. Method We conducted telephone interviews with caregivers and family members of individuals who died with DLB in the last 5 years using a semi-structured questionnaire to identify and describe EOL experiences. We used a qualitative descriptive approach to analyze interview transcripts and identify common themes. Results Thirty individuals participated in interviews. Key themes included lack of knowledge regarding what to expect, end-of-life time course (including end-of-life symptoms, declines after hospitalization and falls, and varied EOL trajectories), advance care planning, lack of family understanding, hospice, views regarding right-to-die, medications at the end of life, approaching end of life, the death experience, and activities that enhanced end of life. Lack of communication between health care teams and families and difficulty predicting death timing were two frequently expressed challenges. Conclusions Study results emphasize the need for improved EOL counseling in DLB, recognition of EOL symptoms, earlier hospice involvement, tailoring EOL care to DLB-specific needs, and clinician-family communication. Suggestions for patient and family education are provided. Further research should confirm predictors of approaching EOL in DLB, identify strategies to improve physician recognition of EOL, and develop tools to aid communication and quality EOL care.	[Armstrong, Melissa J.; Alliance, Slande] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Armstrong, Melissa J.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Taylor, Angela; Corsentino, Pamela] Lewy Body Dementia Assoc, Lilburn, GA USA; [Galvin, James E.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Comprehens Ctr Brain Hlth, Boca Raton, FL 33431 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; Florida Atlantic University	Armstrong, MJ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.; Armstrong, MJ (corresponding author), Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA.	melissa.armstrong@neurology.ufl.edu	Galvin, James/AAM-7492-2021	Armstrong, Melissa/0000-0002-2163-1907; Alliance, Slande/0000-0003-1290-8422	ARHQ K08 career development award [K08HS24159]; 1Florida ADRC pilot grant [AG047266]; Michael J. Fox Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS024159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS100610, R01NS088040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG057681, R01AG054425, R01AG056531, R01AG056610, R01AG040211] Funding Source: NIH RePORTER	ARHQ K08 career development award; 1Florida ADRC pilot grant; Michael J. Fox Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MJA is supported by an ARHQ K08 career development award (K08HS24159), a 1Florida ADRC (AG047266) pilot grant, and as the local PI of a Lewy Body Dementia Association Research Center of Excellence. Staff from the LBDA participated in data collection, analysis, and preparation of the manuscript. MJA previously received research support from the Michael J. Fox Foundation. MJA receives royalties from the publication of the book Parkinson's Disease: Improving Patient Care. MJA receives compensation from the American Academy of Neurology for work as an evidence-based medicine methodology consultant and has participated as faculty in the annual meeting of the American Academy of Neurology and for Medscape CME. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's A., 2017, ALZHEIMERS DEMENT, V13, P325, DOI DOI 10.1016/J.JALZ.2017.02.001; Armstrong MJ, 2019, J AM GERIATR SOC, V67, P67, DOI 10.1111/jgs.15608; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Beernaert K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137251; Biola H, 2007, J AM GERIATR SOC, V55, P846, DOI 10.1111/j.1532-5415.2007.01179.x; Bostrom F, 2007, ALZ DIS ASSOC DIS, V21, P150, DOI 10.1097/WAD.0b013e318065c4a9; Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171; de Beaufort ID, 2016, J NEUROL, V263, P1463, DOI 10.1007/s00415-016-8095-2; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; Dionne-Odom JN, 2019, PALLIAT SUPPORT CARE, V17, P643, DOI 10.1017/S1478951519000154; Erel M, 2017, ANN PALLIAT MED, V6, P365, DOI 10.21037/apm.2017.06.13; Galvin JE, 2010, PARKINSONISM RELAT D, V16, P388, DOI 10.1016/j.parkreldis.2010.03.007; Galvin JE, 2010, ALZ DIS ASSOC DIS, V24, P177, DOI 10.1097/WAD.0b013e3181c72b5d; Garcia-Ptacek S, 2016, J AM GERIATR SOC, V64, pE137, DOI 10.1111/jgs.14421; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hennings J, 2010, REV CLIN GERONTOL, V20, P114, DOI 10.1017/S0959259810000092; Jennings LA, 2015, J AM GERIATR SOC, V63, P282, DOI 10.1111/jgs.13251; Klapwijk MS, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-99; Lee RP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179355; Lewis LF, 2014, QUAL HEALTH RES, V24, P1221, DOI 10.1177/1049732314545888; MCKEITH I, 1992, BRIT MED J, V305, P673, DOI 10.1136/bmj.305.6855.673; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Millenaar JK, 2016, INT J GERIATR PSYCH, V31, P1261, DOI 10.1002/gps.4502; Mitchell SL, 2015, NEW ENGL J MED, V372, P2533, DOI [10.1056/NEJMcp1412652, 10.1056/NEJMc1509349]; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Moscovich M, 2017, PARKINSONISM RELAT D, V41, P99, DOI 10.1016/j.parkreldis.2017.05.022; Price A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017504; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Sanders AE, 2017, NEUROLOGY, V88, P1951, DOI 10.1212/WNL.0000000000003917; Toles M, 2018, J AM MED DIR ASSOC, V19, P879, DOI 10.1016/j.jamda.2018.05.015; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; van der Steen JT, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-105; Vandervoort A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091130; Walker Z, 2000, INT J GERIATR PSYCH, V15, P267, DOI 10.1002/(SICI)1099-1166(200003)15:3<267::AID-GPS107>3.0.CO;2-7; Williams MM, 2006, NEUROLOGY, V67, P1935, DOI 10.1212/01.wnl.0000247041.63081.98	37	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217039	10.1371/journal.pone.0217039	http://dx.doi.org/10.1371/journal.pone.0217039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145749	gold, Green Published, Green Submitted			2022-12-26	WOS:000469425500008
J	Lakes, KD; Vaughan, J; Radom-Aizik, S; Lucas, CT; Stehli, A; Cooper, D				Lakes, Kimberley D.; Vaughan, Jessica; Radom-Aizik, Shlomit; Lucas, Candice Taylor; Stehli, Annamarie; Cooper, Dan			Development of the Parent Perceptions of Physical Activity Scale (PPPAS): Results from two studies with parents of infants and toddlers	PLOS ONE			English	Article								Physical activity (PA) is important from birth to promote health and motor development. Parents of young children are gatekeepers of opportunities for PA, yet little is known about their perceptions of PA. We describe the development of the Parent Perceptions of Physical Activity Scale (PPPAS) across two studies (N = 241 parents). In Study 1, 143 parents of infants and toddlers recruited from neonatal intensive care units (NICUs) and childcare centers completed a 48-item PPPAS. In Study 2, 98 parents of premature infants completed the revised 34-item PPPAS. Study 1 principal components analysis (PCA) identified three components (benefits of, barriers to, and perceived influence on PA), and the scale was reduced. Scores for Perceived Barriers to PA were significantly different between groups, U = 1,108, z = -4.777, p <.0001, with NICU parents reporting more barriers to PA than childcare parents. In Study 2, PCA revealed the same components, and the scale was further reduced to 25 items. Three subscales measuring perceived benefits of, barriers to, and influence over an infant's PA produced Cronbach's alphas of .93,.85,.81, respectively. Results demonstrated sufficient construct validity and internal consistency of PPPAS scores, supporting its use in future PA research.	[Lakes, Kimberley D.] Univ Calif Riverside, Sch Med, Dept Psychiat & Neurosci, Riverside, CA 92521 USA; [Lakes, Kimberley D.; Vaughan, Jessica; Radom-Aizik, Shlomit; Lucas, Candice Taylor; Stehli, Annamarie; Cooper, Dan] Univ Calif Irvine, Dept Pediat, Pediat Exercise & Genom Res Ctr PERC, Irvine, CA 92717 USA; [Vaughan, Jessica] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of California System; University of California Riverside; University of California System; University of California Irvine; Children's Hospital Los Angeles	Lakes, KD (corresponding author), Univ Calif Riverside, Sch Med, Dept Psychiat & Neurosci, Riverside, CA 92521 USA.; Lakes, KD (corresponding author), Univ Calif Irvine, Dept Pediat, Pediat Exercise & Genom Res Ctr PERC, Irvine, CA 92717 USA.	klakes@medsch.ucr.edu	Cooper, Dan/AAA-6699-2022	Lakes, Kimberley/0000-0003-3698-274X	National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000153]; National Heart Lung and Blood Institute, National Institutes of Health [RO1 HL110163NIH]; National Institutes of Health [L60 MD002127]; Memorial Care Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110163] Funding Source: NIH RePORTER	National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health; National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Care Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000153, National Heart Lung and Blood Institute, National Institutes of Health, through RO1 HL110163NIH, National Institutes of Health, through L60 MD002127 and the Memorial Care Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000153, National Heart Lung and Blood Institute, National Institutes of Health, through RO1 HL110163NIH, National Institutes of Health, through L60 MD002127 and the Memorial Care Foundation.	Alderman BL, 2010, J PHYS ACT HEALTH, V7, P60, DOI 10.1123/jpah.7.1.60; American Academy of Pediatrics, 2002, CAR OUR CHILDR NAT H; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Clark JE, 2002, ACT START STAT PHYS, P304; Gravern D, 2009, JOGNN-J OBST GYN NEO, V38, P527, DOI 10.1111/j.1552-6909.2009.01055.x; Ho M, 2012, PEDIATRICS; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Laerd Statistics, 2015, PRINC COMP AN PCA US; McQueen D, 2013, J PERINAT NEONAT NUR, V27, P184, DOI 10.1097/JPN.0b013e31828b244a; Olshansky Ellen, 2012, Int J Educ Psychol Assess, V10, P36; Patrick K, 2001, BRIGHT FUTURES PRACT; Ponterotto JG, 2007, PERCEPT MOTOR SKILL, V105, P997, DOI 10.2466/PMS.105.3.997-1014; Saunders RP, 1997, PREV MED, V26, P241, DOI 10.1006/pmed.1996.0134; Shea Catherine, 2010, Can J Diet Pract Res, V71, pe87, DOI 10.3148/71.3.2010.e87; Thurstone LL, MULTIPLE FACTOR ANAL; Zecevic CA, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/468526; Zhao J, 2013, FAM COMMUNITY HEALTH, V36, P77, DOI 10.1097/FCH.0b013e31826d7601	20	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0213570	10.1371/journal.pone.0213570	http://dx.doi.org/10.1371/journal.pone.0213570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141511	gold, Green Submitted, Green Published			2022-12-26	WOS:000469323000002
J	Zhang, XM; Nie, YP; Cai, SF; Ding, SY; Fu, BQ; Wei, H; Chen, LX; Liu, XH; Liu, MG; Yuan, RQ; Qiu, BQ; He, ZY; Cong, PQ; Chen, YS; Mo, DL				Zhang, Xumeng; Nie, Yaping; Cai, Shufang; Ding, Suying; Fu, Bingqiang; Wei, Hong; Chen, Luxi; Liu, Xiaohong; Liu, Minggui; Yuan, Renqiang; Qiu, Boqin; He, Zuyong; Cong, Peiqing; Chen, Yaosheng; Mo, Delin			Earlier demethylation of myogenic genes contributes to embryonic precocious terminal differentiation of myoblasts in miniature pigs	FASEB JOURNAL			English	Article						DNA methylation; WGBS; embryonic myogenesis; Tet1; Swine	ACTIVE DNA DEMETHYLATION; METHYLATION; MYOD; EXPRESSION; GENOME; FIBROBLASTS; METHYLOME; 5-METHYLCYTOSINE; IDENTIFICATION; TRANSCRIPTION	Here, we performed whole-genome bisulfite sequencing of longissimus dorsi muscle from Landrace and Wuzhishan (WZS) miniature pigs during 18, 21, and 28 d postcoitum. It was uncovered that in regulatory regions only around transcription start sites (TSSs), gene expression and methylation showed negative correlation, whereas in gene bodies, positive correlation occurred. Furthermore, earlier myogenic gene demethylation around TSSs and earlier hypermethylation of myogenic genes in gene bodies were considered to trigger their earlier expression in miniature pigs. Furthermore, by analyzing the methylation pattern of the myogenic differentiation 1(MyoD) promoter and distal enhancer, we found that earlier demethylation of the MyoD distal enhancer in WZSs contributes to its earlier expression. Moreover, DNA demethylase Tet1 was found to be involved in the demethylation of the myogenin promoter and promoted immortalized mouse myoblast cell line (C2C12) and porcine embryonic myogenic cell differentiation. This study reveals that earlier demethylation of myogenic genes contributes to precocious terminal differentiation of myoblasts in miniature pigs.-Zhang, X., Nie, Y., Cai, S., Ding, S., Fu, B., Wei, H., Chen, L., Liu, X., Liu, M., Yuan, R., Qiu, B., He, Z., Cong, P., Chen, Y., Mo, D. Earlier demethylation of myogenic genes contributes to embryonic precocious terminal differentiation of myoblasts in miniature pigs.	[Zhang, Xumeng; Nie, Yaping; Cai, Shufang; Ding, Suying; Fu, Bingqiang; Chen, Luxi; Liu, Xiaohong; Yuan, Renqiang; Qiu, Boqin; He, Zuyong; Cong, Peiqing; Chen, Yaosheng; Mo, Delin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Zhang, Xumeng; Wei, Hong] Shenzhen Kingsino Technol Co Ltd, Shenzhen, Peoples R China; [Liu, Minggui] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Mo, DL (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Higher Educ Mega Ctr, North Third Rd, Guangzhou 510006, Guangdong, Peoples R China.	modelin@mail.sysu.edu.cn	He, Zuyong/AAU-9430-2021	Mo, Delin/0000-0002-8738-4486	National Natural Science Foundation of China [31772565]; Sail Plan [2014YT02H042]; Science and Technology Project of Guangdong Province [2014B020202001]; Ministry of Science and Technology of China [2014FY120800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sail Plan; Science and Technology Project of Guangdong Province; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The authors thank Gene Denovo (Guangzhou, China) for providing us with technical assistance and bioinformatic analyses. This research was supported by the National Natural Science Foundation of China (31772565), Sail Plan (2014YT02H042), the Science and Technology Project of Guangdong Province (2014B020202001), and the Ministry of Science and Technology of China (2014FY120800). The authors declare no conflicts of interest.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; Bar-Nur O, 2018, STEM CELL REP, V10, P1505, DOI 10.1016/j.stemcr.2018.04.009; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; Congras A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119610; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1992, SCIENCE, V256, P1027, DOI 10.1126/science.1317057; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Harada A, 2015, NUCLEIC ACIDS RES, V43, P775, DOI 10.1093/nar/gku1346; Hayatsu Hikoya, 2008, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0610s33; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Hyldig SMW, 2011, BIOL REPROD, V84, P1087, DOI 10.1095/biolreprod.110.086082; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koch A, 2018, NAT REV CLIN ONCOL, V15, P459, DOI 10.1038/s41571-018-0004-4; Koh KP, 2013, CURR OPIN CELL BIOL, V25, P152, DOI 10.1016/j.ceb.2013.02.014; L'honore A, 2007, MOL BIOL CELL, V18, P1992, DOI 10.1091/mbc.E06-09-0867; Leikina E, 2018, DEV CELL, V46, P767, DOI 10.1016/j.devcel.2018.08.006; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Li QN, 2018, REPROD FERT DEVELOP, V30, P1713, DOI 10.1071/RD18002; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Y, 2010, PROCEEDINGS OF 2010 ASIA-PACIFIC YOUTH CONFERENCE ON COMMUNICATION, VOLS 1 AND 2, P10, DOI 10.1371/journal.pbio.1000533; Luo W, 2015, INT J MOL SCI, V16, P26186, DOI 10.3390/ijms161125946; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Rao YS, 2016, POULTRY SCI, V95, P1750, DOI 10.3382/ps/pew136; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Reizel Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04456-6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothschild MF, 2004, GENET RES, V83, P1, DOI 10.1017/S0016672303006621; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Slieker RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005583; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Song MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29390; STICKLAND NC, 1986, J ANAT, V147, P181; Sun Q, 2014, ANIMAL, V8, P1851, DOI 10.1017/S1751731114001700; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Wang KY, 2014, EPIGENOMICS-UK, V6, P353, DOI [10.2217/EPI.14.21, 10.2217/epi.14.21]; Wang XL, 2006, J REPROD DEVELOP, V52, P639, DOI 10.1262/jrd.18048; Womack JE, 2005, GENOME RES, V15, P1699, DOI 10.1101/gr.3809105; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamashita M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.157412; Yang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016229; Yang YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39883; Yuan XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20005; Zhang XM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2464-1; Zhao YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1580-7; Zhong X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43539	70	7	8	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9638	9655		10.1096/fj.201900388R	http://dx.doi.org/10.1096/fj.201900388R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145867	Bronze			2022-12-26	WOS:000478832900073
J	Bradberry, MM; Bao, H; Lou, XC; Chapman, ER				Bradberry, Mazdak M.; Bao, Huan; Lou, Xiaochu; Chapman, Edwin R.			Phosphatidylinositol 4,5-bisphosphate drives Ca2+-independent membrane penetration by the tandem C2 domain proteins synaptotagmin-1 and Doc2 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						synaptotagmin; synapse; exocytosis; calcium-binding protein; membrane biophysics; membrane protein; calcium sensor; phosphatidylinositol (4; 5)-bisphosphate (PIP2); poly-anionic phospholipid; tandem C2 domain protein	CA2+ SENSOR; SECRETION; DOC2B; EXOCYTOSIS; INCREASES; AFFINITY; RELEASE; FUSION; DEPTH; CELLS	Exocytosis mediates the release of neurotransmitters and hormones from neurons and neuroendocrine cells. Tandem C2 domain proteins in the synaptotagmin (syt) and double C2 domain (Doc2) families regulate exocytotic membrane fusion via direct interactions with Ca2+ and phospholipid bilayers. Syt1 is a fast-acting, low-affinity Ca2+ sensor that penetrates membranes upon binding Ca2+ to trigger synchronous vesicle fusion. The closely related Doc2 beta is a slow-acting, high-affinity Ca2+ sensor that triggers spontaneous and asynchronous vesicle fusion, but whether it also penetrates membranes is unknown. Both syt1 and Doc2 beta bind the dynamically regulated plasma membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2), but it is unclear whether PIP2 serves only as a membrane contact or enables specialized membrane-binding modes by these Ca2+ sensors. Furthermore, it has been shown that PIP2 uncaging can trigger rapid, syt1-dependent exocytosis in the absence of Ca2+ influx, suggesting that current models for the action of these Ca2+ sensors are incomplete. Here, using a series of steady-state and time-resolved fluorescence measurements, we show that Doc2 beta, like syt1, penetrates membranes in a Ca2+-dependent manner. Unexpectedly, we observed that PIP2 can drive membrane penetration by both syt1 and Doc2 beta in the absence of Ca2+, providing a plausible mechanism for Ca2+-independent, PIP2-dependent exocytosis. Quantitative measurements of penetration depth revealed that, in the presence of Ca2+, PIP2 drives Doc2 beta, but not syt1, substantially deeper into the membrane, defining a biophysical regulatory mechanism specific to this high-affinity Ca2+ sensor. Our results provide evidence of a novel role for PIP2 in regulating, and under some circumstances triggering, exocytosis.	[Bradberry, Mazdak M.; Bao, Huan; Lou, Xiaochu; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Bradberry, Mazdak M.; Bao, Huan; Lou, Xiaochu; Chapman, Edwin R.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53706 USA; [Bradberry, Mazdak M.] Univ Wisconsin, Sch Med & Publ Hlth, Med Scientist Training Program, Madison, WI 53705 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Dept Neurosci, 1111 Highland Ave, Madison, WI 53705 USA.; Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1111 Highland Ave, Madison, WI 53705 USA.	chapman@wisc.edu		Bao, Huan/0000-0002-4301-4627	National Institute of Mental Health [R01 MH061876, R35 NS097362, F30 MH116580]; Howard Hughes Medical Institute investigator grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH116580, R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097362] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute investigator grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Mental Health Grants R01 MH061876, R35 NS097362 (to E. R. C.), and F30 MH116580 (to M. M. B.) and a Howard Hughes Medical Institute investigator grant (to E. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAMS FS, 1993, BIOCHEMISTRY-US, V32, P10826, DOI 10.1021/bi00091a038; Bai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10971; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; COTMAN C, 1969, BIOCHEMISTRY-US, V8, P4606, DOI 10.1021/bi00839a056; Courtney NA, 2018, NEURON, V98, P977, DOI 10.1016/j.neuron.2018.04.022; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Evans CS, 2015, J NEUROSCI, V35, P11769, DOI 10.1523/JNEUROSCI.1694-15.2015; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giladi M, 2013, J MOL BIOL, V425, P4629, DOI 10.1016/j.jmb.2013.08.017; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hille B, 1999, J PHYSIOL-LONDON, V520, P23, DOI 10.1111/j.1469-7793.1999.00023.x; Houy S, 2017, ELIFE, V6, DOI 10.7554/eLife.27000; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; Kochubey O, 2011, NEURON, V69, P736, DOI 10.1016/j.neuron.2011.01.013; Kyrychenko A, 2013, J PHYS CHEM B, V117, P5875, DOI 10.1021/jp4026706; Li J, 2014, DIABETOLOGIA, V57, P2173, DOI 10.1007/s00125-014-3312-y; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Michaeli L, 2017, TRAFFIC, V18, P825, DOI 10.1111/tra.12528; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Perez-Lara A, 2016, ELIFE, V5, DOI 10.7554/eLife.15886; Pinheiro PS, 2013, J NEUROSCI, V33, P16459, DOI 10.1523/JNEUROSCI.2656-13.2013; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; van den Bogaart G, 2012, J BIOL CHEM, V287, P16447, DOI 10.1074/jbc.M112.343418; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Vyleta NP, 2011, J NEUROSCI, V31, P4593, DOI 10.1523/JNEUROSCI.6398-10.2011; Waltert AM, 2017, ELIFE, V6, DOI 10.7554/eLife.30203; Wang P, 2005, MOL CELL BIOL, V25, P8693, DOI 10.1128/MCB.25.19.8693-8702.2005; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Xue RH, 2018, P NATL ACAD SCI USA, V115, pE5605, DOI 10.1073/pnas.1802104115; Yao J, 2011, CELL, V147, P666, DOI 10.1016/j.cell.2011.09.046	54	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10942	10953		10.1074/jbc.RA119.007929	http://dx.doi.org/10.1074/jbc.RA119.007929			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31147445	Green Published, hybrid			2022-12-26	WOS:000478717200017
J	Iwelunmor, J; Ezechi, O; Obiezu-Umeh, C; Gbajabiamila, T; Musa, AZ; Oladele, D; Idigbe, I; Ohihoin, A; Gyamfi, J; Aifah, A; Salako, B; Ogedegbe, O				Iwelunmor, Juliet; Ezechi, Oliver; Obiezu-Umeh, Chisom; Gbajabiamila, Titilola; Musa, Adesola Z.; Oladele, David; Idigbe, Ifeoma; Ohihoin, Aigbe; Gyamfi, Joyce; Aifah, Angela; Salako, Babatunde; Ogedegbe, Olugbenga			Capabilities, opportunities and motivations for integrating evidence-based strategy for hypertension control into HIV clinics in Southwest Nigeria	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HEALTH-CARE; INTERVENTIONS; FACILITIES; SERVICES	Background Given the growing burden of cardiovascular diseases in sub-Saharan Africa, global donors and governments are exploring strategies for integrating evidence-based cardiovascular diseases prevention into HIV clinics. We assessed the capabilities, motivations and opportunities that exist for HIV clinics to apply evidence-based strategies for hypertension control among people living with HIV (PLHIV) in Nigeria. Methods We used a concurrent Quan-Qual-study approach (a quantitative first step using structured questionnaires followed by a qualitative approach using stakeholder meetings).We invited key stakeholders and representatives of HIV and non-communicable disease organizations in Lagos, Nigeria to 1) assess the capacity of HIV clinics (n = 29) to, and; 2) explore their attitudes and perceptions towards implementing evidence-based strategies for hypertension management in Lagos, Nigeria (n = 19)The quantitative data were analyzed using SPSS whereas responses from the stakeholders meeting were coded and analyzed using thematic approach and an implementation science framework, the COM-B (Capabilities, Opportunities, Motivations and Behavior) model, guided the mapping and interpretation of the data. Results Out of the 29 HIV clinics that participated in the study, 28 clinics were public, government owned facilities with 394 HIV patients per month with varying capabilities, opportunities and motivations for integrating evidence-based hypertension interventions within their services for PLHIV. Majority of the clinics (n = 26) rated medium-to-low on the psychological capability domains, while most of the clinics (n = 25) rated low on the physical capabilities of integrating evidence-based hypertension interventions within HIV clinics. There was high variability in the ratings for the opportunity domains, with physical opportunities rated high in only eight HIV clinics, two clinics with a medium rating and nineteen clinics with a low rating. Social opportunity domain tended to be rated low in majority of the HIV clinics (n = 21). Lastly, almost all the HIV clinics (n = 23) rated high on the reflective motivation domain although automatic motivations tended to be rated low across the HIV clinics. Conclusion In this study, we found that with the exception of motivations, the relative capabilities whether physical or psychological and the relative opportunities for integrating evidence based hypertension intervention within HIV clinics in Nigeria were minimal. Thus, there is need to strengthen the HIV clinics in Lagos for the implementation of evidence-based hypertension interventions within HIV clinics to improve patient outcomes and service delivery in Southwest Nigeria.	[Iwelunmor, Juliet] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO USA; [Ezechi, Oliver; Gbajabiamila, Titilola; Musa, Adesola Z.; Oladele, David; Idigbe, Ifeoma; Ohihoin, Aigbe; Salako, Babatunde] Nigerian Inst Med Res, Lagos, Nigeria; [Obiezu-Umeh, Chisom] NYU, Coll Global Publ Hlth, New York, NY USA; [Gyamfi, Joyce; Aifah, Angela; Ogedegbe, Olugbenga] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Obiezu-Umeh, Chisom] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA	Saint Louis University; New York University; New York University; Saint Louis University	Ezechi, O (corresponding author), Nigerian Inst Med Res, Lagos, Nigeria.	oezechi@yahoo.co.uk	Ohihoin, Aigbe/GPC-8137-2022	Musa, Adesola Z./0000-0002-6533-2984; Aifah, Angela/0000-0002-2811-8487				Aregbeshola BS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00048; Atkins L, 2015, P NUTR SOC, V74, P164, DOI 10.1017/S0029665115000075; Bintabara D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192942; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; DIMALA CA, 2016, PLOS ONE, V11; EHRHART MG, 2014, IMPLEMENT SCI, V9; Ekrikpo UE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019664; Ezechi OC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-46; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; IWELUNMOR J, 2016, IMPLEMENT SCI, V11; Iwuala SO, 2015, NIGER J CLIN PRACT, V18, P626, DOI 10.4103/1119-3077.154208; Kemp CG, 2018, AIDS, V32, pS93, DOI 10.1097/QAD.0000000000001897; Kerschberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046988; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kumakech E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-810; LEEMAN J, 2017, IMPLEMENT SCI, V12; Leung C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3661-1; Mall S, 2012, AIDS CARE, V24, P319, DOI 10.1080/09540121.2011.608790; Michie S., 2011, IMPLEMENT SCI, V6; Moon TD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17406; Moore JE, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0160-6; Mwagomba BLM, 2018, AIDS, V32, pS21, DOI 10.1097/QAD.0000000000001885; Njuguna B, 2018, AIDS, V32, pS33, DOI 10.1097/QAD.0000000000001887; Odafe Solomon, 2013, Niger Med J, V54, P176, DOI 10.4103/0300-1652.114590; Ojo T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212296; Onovo A, 2016, OPEN FORUM INFECT S1, V3, P483, DOI DOI 10.1093/ofid/ofw172.346(Abstract); Owiti P, 2015, PUBLIC HEALTH ACTION, V5, P36, DOI 10.5588/pha.14.0092; Oyekale AS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2112-8; Patel P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002523; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Rabkin M, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/137460; Shelton RC, 2018, ANNU REV PUBL HEALTH, V39, P55, DOI 10.1146/annurev-publhealth-040617-014731; Temu F, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.202.4086; Todowede OO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016602; UNICEF LSMoHa, 2012, RED HLTH DISP LAG ST	35	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217703	10.1371/journal.pone.0217703	http://dx.doi.org/10.1371/journal.pone.0217703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170220	Green Submitted, Green Published, gold			2022-12-26	WOS:000470263700049
J	Maczynska, B; Secewicz, A; Smutnicka, D; Szymczyk, P; Dudek-Wicher, R; Junka, A; Bartoszewicz, M				Maczynska, Beata; Secewicz, Anna; Smutnicka, Danuta; Szymczyk, Patrycja; Dudek-Wicher, Ruth; Junka, Adam; Bartoszewicz, Marzenna			In vitro efficacy of gentamicin released from collagen sponge in eradication of bacterial biofilm preformed on hydroxyapatite surface	PLOS ONE			English	Article							ENTEROBACTERIACEAE; RESISTANCE; AMINOGLYCOSIDES; INFECTIONS; DELIVERY; ANTIBIOTICS; MANAGEMENT; SURGERY; EUROPE; SYSTEM	Biofilm-related infections of bones pose a significant therapeutic issue. In this article we present in vitro results of the efficacy of gentamicin released from a collagen sponge carrier against Staphylococcus aureus, Pseudomonas aeruginosa and Klebsiella pneumoniae biofilms preformed on hydroxyapatite surface. The results indicate that high local concentrations of gentamicin released from a sponge eradicate the biofilm formed not only by gentamicin-sensitive strains but, to some extent, also by those that display a resistance pattern in routine diagnostics. The data presented in this paper is of high clinical translational value and may find application in the treatment of bone infections.	[Maczynska, Beata; Secewicz, Anna; Smutnicka, Danuta; Dudek-Wicher, Ruth; Junka, Adam; Bartoszewicz, Marzenna] Wroclaw Med Univ, Dept Pharmaceut Microbiol & Parasitol, Wroclaw, Poland; [Szymczyk, Patrycja] Wroclaw Univ Sci & Technol, Fac Mech Engn, Ctr Adv Mfg Technol CAMT FPC, Wroclaw, Poland	Wroclaw Medical University; Wroclaw University of Science & Technology	Junka, A (corresponding author), Wroclaw Med Univ, Dept Pharmaceut Microbiol & Parasitol, Wroclaw, Poland.	adam.junka@umed.wroc.pl	Dudek-Wicher, Ruth/AAY-4191-2020	Dudek-Wicher, Ruth/0000-0001-8033-3531; Maczynska, Beata/0000-0001-6388-7970; BARTOSZEWICZ, MARZENNA/0000-0002-6542-2525; Szymczyk-Ziolkowska, Patrycja/0000-0001-7742-7182; Junka, Adam/0000-0002-7559-8903				Andersson RE, 2010, WORLD J SURG, V34, P3042, DOI 10.1007/s00268-010-0763-2; Baraniak A, 2016, ANTIMICROB AGENTS CH, V60, P1912, DOI 10.1128/AAC.02756-15; Bartoszewicz M, 2012, LECZENIE RAN, V9, P147; Brehant O, 2013, INT J COLORECTAL DIS, V28, P119, DOI 10.1007/s00384-012-1557-9; Bueno MFC, 2013, ANTIMICROB AGENTS CH, V57, P2397, DOI 10.1128/AAC.02108-12; Chang WK, 2013, ANN SURG, V258, P59, DOI 10.1097/SLA.0b013e3182895b8c; Chew LC, 2006, ANN ACAD MED SINGAP, V35, P100; CIERNY III G, 1985, CONT ORTHOP, V10, P17, DOI DOI 10.1097/01.BLO.0000088564.81746.62; Deshpande Payal, 2010, J Assoc Physicians India, V58, P147; DIRSCHL DR, 1993, DRUGS, V45, P29, DOI 10.2165/00003495-199345010-00004; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Dowd SE, 2010, RHOADS POLYMICROBIAL; Flemming HC, 2008, BIOFILM HIGHLIGHTS, V5; Fritsche TR, 2008, ANTIMICROB AGENTS CH, V52, P1843, DOI 10.1128/AAC.01477-07; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gentry LO, 1997, INT J ANTIMICROB AG, V9, P37, DOI 10.1016/S0924-8579(97)00375-0; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hayes G, 2013, VET COMP ORTHOPAED, V26, P251, DOI 10.3415/VCOT-12-05-0065; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Humphrey JS, 1998, CLIN ORTHOP RELAT R, P218; Jung YG, 2015, APPL ENVIRON MICROB, V81, P211, DOI 10.1128/AEM.02311-14; Knaepler H, 2012, INT J SURG, V10, pS15, DOI 10.1016/j.ijsu.2012.05.020; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Kowalewski M, 2015, J THORAC CARDIOV SUR, V149, P1631, DOI 10.1016/j.jtcvs.2015.01.034; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Koziol M, 2014, KARDIOCHIR TORAKOCHI, V11, P21, DOI 10.5114/kitp.2014.41925; Ktari S, 2006, ANTIMICROB AGENTS CH, V50, P4198, DOI 10.1128/AAC.00663-06; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lee GC, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-32; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Lindemann PC, 2012, APMIS, V120, P495, DOI 10.1111/j.1600-0463.2011.02856.x; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P48, DOI 10.1093/jac/dkq408; Lovering AM, 2012, INT J SURG, V10, pS2, DOI 10.1016/j.ijsu.2012.05.013; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Mehta S, 1996, J ORTHOPAED RES, V14, P749, DOI 10.1002/jor.1100140511; Nevozhay Dmitry, 2007, Postepy Hig Med Dosw (Online), V61, P350; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Overstreet D, 2015, CLIN ORTHOP RELAT R, V473, P337, DOI 10.1007/s11999-014-3935-9; Rathbone CR, 2011, J ORTHOP RES, V29, P1070, DOI 10.1002/jor.21343; Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007; Sobczak A, 2007, CZASOPISMO TECHNICZN, P149; Stemberger A, 1997, EUR J SURG, V163, P17; Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf; Tada T, 2013, ANTIMICROB AGENTS CH, V57, P96, DOI 10.1128/AAC.01105-12; Wolcott R D, 2008, J Wound Care, V17, P145; Wolcott RD, 2010, ADV WOUND CARE-SER, V1, P311, DOI 10.1089/awc.2009.0104; Zacharczuk K, 2011, J MED MICROBIOL, V60, P1306, DOI 10.1099/jmm.0.024026-0; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07	50	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217769	10.1371/journal.pone.0217769	http://dx.doi.org/10.1371/journal.pone.0217769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163049	Green Submitted, gold, Green Published			2022-12-26	WOS:000470086200033
J	Alizadeh, E; Xu, WL; Castle, J; Foss, J; Prasad, A				Alizadeh, Elaheh; Xu, Wenlong; Castle, Jordan; Foss, Jacqueline; Prasad, Ashok			TISMorph: A tool to quantify texture, irregularity and spreading of single cells	PLOS ONE			English	Article							IMAGE-ANALYSIS; SHAPE; MECHANICS; ACTIN	A number of recent studies have shown that cell shape and cytoskeletal texture can be used as sensitive readouts of the physiological state of the cell. However, utilization of this information requires the development of quantitative measures that can describe relevant aspects of cell shape. In this paper we develop a toolbox, TISMorph, that calculates a set of quantitative measures to address this need. Some of the measures introduced here have been used previously, while others are new and have desirable properties for shape and texture quantification of cells. These measures, broadly classifiable into the categories of textural, irregularity and spreading measures, are tested by using them to discriminate between osteosarcoma cell lines treated with different cytoskeletal drugs. We find that even though specific classification tasks often rely on a few measures, these are not the same between all classification tasks, thus requiring the use of the entire suite of measures for classification and discrimination. We provide detailed descriptions of the measures, as well as the TISMorph package to implement them. Quantitative morphological measures that capture different aspects of cell morphology will help enhance large-scale image-based quantitative analysis, which is emerging as a new field of biological data.	[Alizadeh, Elaheh; Xu, Wenlong; Prasad, Ashok] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA; [Castle, Jordan] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Foss, Jacqueline; Prasad, Ashok] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA; [Foss, Jacqueline] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA; [Alizadeh, Elaheh] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University; University of Arizona	Prasad, A (corresponding author), Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.; Prasad, A (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.	ashok.prasad@colostate.edu	Prasad, Ashok/HDN-5956-2022; Xu, Wenlong/G-9744-2017	Xu, Wenlong/0000-0002-2906-4724; Prasad, Ashok/0000-0002-0832-8153; Alizadeh, Elaheh/0000-0003-4742-7186	National Science Foundation [PHY-1151454]	National Science Foundation(National Science Foundation (NSF))	We acknowledge support from an National Science Foundation (www.nsf.gov) CAREER grant (PHY-1151454) to Ashok Prasad.	Alizadeh E, 2016, INTEGR BIOL-UK, V8, P1183, DOI 10.1039/c6ib00100a; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Cooper S, 2015, MOL BIOL CELL, V26, P4163, DOI 10.1091/mbc.E15-06-0382; Costa A, 2013, HAUSDORFF BOX COUNTI; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Ingber DE, 1994, SCIENCE, V7, DOI [10.1016/S0092-8674(03)00120-X, DOI 10.1016/S0092-8674(03)00120-X]; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Lyons SM, 2016, BIOL OPEN, V5, P289, DOI 10.1242/bio.013409; Marklein RA, 2018, TRENDS BIOTECHNOL, V36, P105, DOI 10.1016/j.tibtech.2017.10.007; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Pasqualato A, 2012, EXP CELL RES, V318, P835, DOI 10.1016/j.yexcr.2012.01.022; Pasqualato A, 2013, CELL ADHES MIGR, V7, P450, DOI 10.4161/cam.26765; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Prasad A, 2019, TRENDS BIOTECHNOL, V37, P347, DOI 10.1016/j.tibtech.2018.09.007; Ren Z., 2015, BIOSCIENCE REP, V35, P1; Sailem HZ, 2017, GENOME RES, V27, P196, DOI 10.1101/gr.202028.115; Sero JE, 2017, CELL SYST, V4, P84, DOI 10.1016/j.cels.2016.11.015; Sero JE, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145644; Slater JH, 2015, ACS NANO, V9, P6128, DOI 10.1021/acsnano.5b01366; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Tahmasbi A, 2011, COMPUT BIOL MED, V41, P726, DOI 10.1016/j.compbiomed.2011.06.009; Uppuluri A., 2010, GCLM FEATURE CALCULA; Villanueva JD, 2015, DESIGN IMPLEMENTATIO; Welzl E, 2014, COMPUTATIONAL GEOMET	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217346	10.1371/journal.pone.0217346	http://dx.doi.org/10.1371/journal.pone.0217346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158241	Green Published, Green Submitted, gold			2022-12-26	WOS:000469915700012
J	Chang, YS; Park, H; Hong, SH; Chung, WH; Cho, YS; Moon, I				Chang, Young-Soo; Park, Heesung; Hong, Sung Hwa; Chung, Won-Ho; Cho, Yang-Sun; Moon, Il Joon			Predicting cochlear dead regions in patients with hearing loss through a machine learning-based approach: A preliminary study	PLOS ONE			English	Article							EQUALIZING NOISE TEST; THRESHOLD; PREVALENCE; ADULTS; MECHANISMS; DAMAGE; AIDS	We propose a machine learning (ML)-based model for predicting cochlear dead regions (DRs) in patients with hearing loss of various etiologies. Five hundred and fifty-five ears from 380 patients (3,770 test samples) diagnosed with sensorineural hearing loss (SNHL) were analyzed. A threshold-equalizing noise (TEN) test was applied to detect the presence of DRs. Data were collected on sex, age, side of the affected ear, hearing loss etiology, word recognition scores (WRS), and pure-tone thresholds at each frequency. According to the cause of hearing loss as diagnosed by the physician, we categorized the patients into six groups: 1) SNHL with unknown etiology; 2) sudden sensorineural hearing loss (SSNHL); 3) vestibular schwannoma (VS); 4) Meniere's disease (MD); 5) noise-induced hearing loss (NIHL); or 6) presbycusis or age-related hearing loss (ARHL). To develop a predictive model, we performed recursive partitioning and regression for classification, logistic regression, and random forest. The overall prevalence of one or more DRs in test ears was 20.36% (113 ears). Among the 3,770 test samples, the overall frequency-specific prevalence of DR was 6.7%. WRS, pure-tone thresholds at each frequency, disease type (VS or MD), and frequency information were useful for predicting DRs. Sex and age were not associated with detecting DRs. Based on these results, we suggest possible predictive factors for determining the presence of DRs. To improve the predictive power of the model, a more flexible model or more clinical features, such as the duration of hearing loss or risk factors for developing DRs, may be needed.	[Chang, Young-Soo] Korea Univ, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Ansan, South Korea; [Chang, Young-Soo] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul, South Korea; [Park, Heesung] Samsung Med Ctr, Hearing Res Lab, Seoul, South Korea; [Hong, Sung Hwa] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Chang Won, South Korea; [Chung, Won-Ho; Cho, Yang-Sun; Moon, Il Joon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Moon, I (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea.	moonij@skku.edu		MOON, IL JOON/0000-0002-3613-0734				Aazh H, 2007, J AM ACAD AUDIOL, V18, P97, DOI 10.3766/jaaa.18.2.2; Ahadi M, 2015, INT J PEDIATR OTORHI, V79, P1362, DOI 10.1016/j.ijporl.2015.06.013; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carhart R, 1959, J SPEECH HEAR DISORD; Choi JE, 2016, OTOL NEUROTOL, V37, P1503, DOI 10.1097/MAO.0000000000001202; Cox RM, 2012, EAR HEARING, V33, P573, DOI 10.1097/AUD.0b013e31824d8ef3; Cox RM, 2011, EAR HEARING, V32, P339, DOI 10.1097/AUD.0b013e318202e982; Gopinath B, 2009, ARCH INTERN MED, V169, P415, DOI 10.1001/archinternmed.2008.597; Gordo Angela, 2007, Braz J Otorhinolaryngol, V73, P299; Gouveris HT, 2007, LARYNGOSCOPE, V117, P680, DOI 10.1097/MLG.0b013e31803146c5; Halpin C, 2009, OTOLARYNG HEAD NECK, V140, P629, DOI 10.1016/j.otohns.2008.12.020; Halpin C, 2009, OTOLARYNG HEAD NECK, V140, P473, DOI 10.1016/j.otohns.2008.12.021; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kang S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21754-7; Kim DW, 2018, BONE; Kim J, 2015, J AUDIOL OTOL, V19, P68, DOI 10.7874/jao.2015.19.2.68; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lee HY, 2015, J AUDIOL OTOL, V19, P20, DOI 10.7874/jao.2015.19.1.20; Lin CY, 2010, HEARING RES, V269, P42, DOI 10.1016/j.heares.2010.07.005; Lin WY, 2018, INT J MED INFORM, V111, P159, DOI 10.1016/j.ijmedinf.2018.01.002; Lopez-Escamez JA, 2015, J VESTIBUL RES-EQUIL, V25, P1, DOI 10.3233/VES-150549; Mackersie Carol L, 2004, J Am Acad Audiol, V15, P498, DOI 10.3766/jaaa.15.7.4; Mahmud MR, 2003, ANN OTO RHINOL LARYN, V112, P979, DOI 10.1177/000348940311201111; Moore BCJ, 2000, BRIT J AUDIOL, V34, P205, DOI 10.3109/03005364000000131; Moore BCJ, 2004, EAR HEARING, V25, P478, DOI 10.1097/01.aud.0000145992.31135.89; Pepler A, 2014, EAR HEARING, V35, pE99, DOI 10.1097/AUD.0000000000000011; PRASHER DK, 1995, ACTA OTO-LARYNGOL, V115, P375, DOI 10.3109/00016489509139332; Soares VYR, 2016, NEURO-ONCOLOGY, V18, P1498, DOI 10.1093/neuonc/now099; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Tillman T W, 1966, Tech Rep SAM-TR, P1; Vinay, 2007, EAR HEARING, V28, P231; Wang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158285; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec	33	6	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217790	10.1371/journal.pone.0217790	http://dx.doi.org/10.1371/journal.pone.0217790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158267	Green Submitted, Green Published, gold			2022-12-26	WOS:000469915700026
J	Anandapadamanaban, M; Kyriakidis, NC; Csizmok, V; Wallenhammar, A; Espinosa, AC; Ahlner, A; Round, AR; Trewhella, J; Moche, M; Wahren-Herlenius, M; Sunnerhagen, M				Anandapadamanaban, Madhanagopal; Kyriakidis, Nikolaos C.; Csizmok, Veronika; Wallenhammar, Amelie; Espinosa, Alexander C.; Ahlner, Alexandra; Round, Adam R.; Trewhella, Jill; Moche, Martin; Wahren-Herlenius, Marie; Sunnerhagen, Maria			E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin-conjugating enzyme (E2 enzyme); substrate specificity; E3 ubiquitin ligase; ubiquitin; allosteric regulation	AUTOANTIGEN RO52; CATALYTIC ACTIVATION; STRUCTURAL BASIS; TRIM FAMILY; ENZYMES; MECHANISM; COMPLEX; INTERFERON; INSIGHTS; AUTOIMMUNITY	The E3 ubiquitin-protein ligase TRIM21, of the RING-containing tripartite motif (TRIM) protein family, is a major autoantigen in autoimmune diseases and a modulator of innate immune signaling. Together with ubiquitin-conjugating enzyme E2 E1 (UBE2E1), TRIM21 acts both as an E3 ligase and as a substrate in autoubiquitination. We here report a 2.82-angstrom crystal structure of the human TRIM21 RING domain in complex with the human E2-conjugating UBE2E1 enzyme, in which a ubiquitin-targeted TRIM21 substrate lysine was captured in the UBE2E1 active site. The structure revealed that the direction of lysine entry is similar to that described for human proliferating cell nuclear antigen (PCNA), a small ubiquitin-like modifier (SUMO)-targeted substrate, and thus differs from the canonical SUMO-targeted substrate entry. In agreement, we found that critical UBE2E1 residues involved in the capture of the TRIM21 substrate lysine are conserved in ubiquitin-conjugating E2s, whereas residues critical for SUMOylation are not conserved. We noted that coordination of the acceptor lysine leads to remodeling of amino acid side-chain interactions between the UBE2E1 active site and the E2-E3 direct interface, including the so-called linchpin residue conserved in RING E3s and required for ubiquitination. The findings of our work support the notion that substrate lysine activation of an E2-E3-connecting allosteric path may trigger catalytic activity and contribute to the understanding of specific lysine targeting by ubiquitin-conjugating E2s.	[Anandapadamanaban, Madhanagopal; Csizmok, Veronika; Wallenhammar, Amelie; Ahlner, Alexandra; Trewhella, Jill; Sunnerhagen, Maria] Linkoping Univ, Div Chem, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden; [Kyriakidis, Nikolaos C.; Espinosa, Alexander C.; Wahren-Herlenius, Marie] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Unit Expt Rheumatol, S-17176 Stockholm, Sweden; [Round, Adam R.] Grenoble Outstn, European Mol Biol Lab, 6 Rue Jules Horowitz, F-38042 Grenoble, France; [Trewhella, Jill] Univ Sydney, Sch Life & Environm Sci SoLES, Sydney, NSW 2006, Australia; [Moche, Martin] Karolinska Inst, Prot Sci Facil, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Kyriakidis, Nikolaos C.] UDLA, Grp Invest Biotecnol Aplicada Biomed BIOMED, Escuela Med, Fac Ciencias Salud, EC-170504 Ouito, Ecuador; [Round, Adam R.] European XFEL GmbH, Holzkoppel 4, D-22869 Schenefeld, Germany	Linkoping University; Karolinska Institutet; Karolinska University Hospital; European Molecular Biology Laboratory (EMBL); University of Sydney; Karolinska Institutet; European XFEL	Sunnerhagen, M (corresponding author), Linkoping Univ, Div Chem, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden.	maria.sunnerhagen@liu.se	Wahren-Herlenius, Marie/AAN-6942-2021	Wahren-Herlenius, Marie/0000-0002-0915-7245; Kyriakidis, Nikolaos C/0000-0003-1382-5661; Anandapadamanaban, Madhanagopal/0000-0002-4237-0048; Wallenhammar, Amelie/0000-0002-2867-8249; Moche, Martin/0000-0002-4834-7076	Swedish Research Council; Swedish Rheumatism Association; Swedish Heart-Lung Foundation; Stockholm County Council; King Gustaf the Vth 80-year foundation; Karolinska Institutet; Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Child Cancer Foundation; Swedish Cancer Foundation; Carl Trygger Foundation; Linkoping University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); King Gustaf the Vth 80-year foundation; Karolinska Institutet(Karolinska Institutet); Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Child Cancer Foundation; Swedish Cancer Foundation; Carl Trygger Foundation; Linkoping University	This work was supported by funding from the Swedish Research Council (to M. S., J. T., and M. W.-H.); The Swedish Rheumatism Association, The Swedish Heart-Lung Foundation, The Stockholm County Council, the King Gustaf the Vth 80-year foundation, and Karolinska Institutet (to M. W.-H.); and the Swedish Foundation for International Cooperation in Research and Higher Education, the Swedish Child Cancer Foundation, the Swedish Cancer Foundation, the Carl Trygger Foundation, and Linkoping University (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Banka PA, 2015, J MOL BIOL, V427, P2290, DOI 10.1016/j.jmb.2015.04.011; Benirschke RC, 2010, STRUCTURE, V18, P955, DOI 10.1016/j.str.2010.04.017; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Campbell EM, 2016, J VIROL, V90, P1849, DOI 10.1128/JVI.01948-15; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chakrabarti KS, 2017, STRUCTURE, V25, P794, DOI 10.1016/j.str.2017.03.016; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinosa A, 2006, J IMMUNOL, V176, P6277, DOI 10.4049/jimmunol.176.10.6277; Espinosa A, 2011, J BIOL CHEM, V286, P36478, DOI 10.1074/jbc.M111.241786; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Espinosa A, 2008, EXP CELL RES, V314, P3605, DOI 10.1016/j.yexcr.2008.09.011; Fletcher AJ, 2015, P NATL ACAD SCI USA, V112, P10014, DOI 10.1073/pnas.1507534112; Fletcher AJ, 2015, EMBO J, V34, P2078, DOI 10.15252/embj.201490361; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hillje AL, 2011, STEM CELLS, V29, P1437, DOI 10.1002/stem.687; Kar G, 2012, J PROTEOME RES, V11, P1196, DOI 10.1021/pr2009143; Koliopoulos MG, 2016, EMBO J, V35, P1204, DOI 10.15252/embj.201593741; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Li Y, 2014, CELL RES, V24, P762, DOI 10.1038/cr.2014.46; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Niklasson M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004022; Oke V, 2012, J AUTOIMMUN, V39, P77, DOI 10.1016/j.jaut.2012.01.014; Orthaber D, 2000, CHEM PHYS LIPIDS, V107, P179, DOI 10.1016/S0009-3084(00)00171-7; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Qin YF, 2016, CELL RES, V26, P613, DOI 10.1038/cr.2016.27; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Reddy BA, 2014, MOL CELL, V53, P458, DOI 10.1016/j.molcel.2013.12.017; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Sanchez JG, 2016, CELL REP, V16, P1315, DOI 10.1016/j.celrep.2016.06.070; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Strandberg L, 2008, J CLIN IMMUNOL, V28, P220, DOI 10.1007/s10875-007-9157-0; Streich FC, 2016, NATURE, V536, P304, DOI 10.1038/nature19071; Taherbhoy AM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8621; Tickle I.J., 2018, STARANISO; Valimberti I, 2015, SCI REP-UK, V5, DOI 10.1038/srep14849; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; van Wijk SJL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002754; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P415, DOI 10.1016/j.bbrc.2005.11.029; Wada K, 2009, J BIOCHEM, V146, P821, DOI 10.1093/jb/mvp127; Wagner JM, 2016, ELIFE, V5, DOI [10.7554/elife.16309, 10.7554/eLife.16309]; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wheaton K, 2017, J BIOL CHEM, V292, P2893, DOI 10.1074/jbc.M116.749564; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaguchi M, 2016, MOL CELL, V63, P593, DOI 10.1016/j.molcel.2016.07.003; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yudina Z, 2015, CELL REP, V12, P788, DOI 10.1016/j.celrep.2015.06.072; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492	80	10	10	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11404	11419		10.1074/jbc.RA119.008485	http://dx.doi.org/10.1074/jbc.RA119.008485			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31160341	Green Published, hybrid			2022-12-26	WOS:000478717600006
J	Lee, AW; Deruaz, M; Lynch, C; Davies, G; Singh, K; Alenazi, Y; Eaton, JRO; Kawamura, A; Shaw, J; Proudfoot, AEI; Dias, JM; Bhattacharya, S				Lee, Angela W.; Deruaz, Maud; Lynch, Christopher; Davies, Graham; Singh, Kamayani; Alenazi, Yara; Eaton, James R. O.; Kawamura, Akane; Shaw, Jeffrey; Proudfoot, Amanda E., I; Dias, Joao M.; Bhattacharya, Shoumo			A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; chemotaxis; crystal structure; inflammation; protein-protein interaction; host-pathogen interaction; evasin; immune response; knottin; tick	PROTEIN; REFINEMENT; NEUTRALIZATION; IMPROVEMENTS; PREDICTION; RECEPTORS; PEPTIDES; OPINION; DISPLAY; FAMILY	Tick evasins (EVAs) bind either CC- or CXC-chemokines by a poorly understood promiscuous or one-to-many mechanism to neutralize inflammation. Because EVAs potently inhibit inflammation in many preclinical models, highlighting their potential as biological therapeutics for inflammatory diseases, we sought to further unravel the CXC-chemokine-EVA interactions. Using yeast surface display, we identified and characterized 27 novel CXC-chemokine-binding evasins homologous to EVA3 and defined two functional classes. The first, which included EVA3, exclusively bound ELR+ CXC-chemokines, whereas the second class bound both ELR+ and ELR- CXC-chemokines, in several cases including CXC-motif chemokine ligand 10 (CXCL10) but, surprisingly, not CXCL8. The X-ray crystal structure of EVA3 at a resolution of 1.79 angstrom revealed a single antiparallel beta-sheet with six conserved cysteine residues forming a disulfide-bonded knottin scaffold that creates a contiguous solvent-accessible surface. Swapping analyses identified distinct knottin scaffold segments necessary for different CXC-chemokine-binding activities, implying that differential ligand positioning, at least in part, plays a role in promiscuous binding. Swapping segments also transferred chemokine-binding activity, resulting in a hybrid EVA with dual CXCL10- and CXCL8-binding activities. The solvent-accessible surfaces of the knottin scaffold segments have distinctive shape and charge, which we suggest drives chemokine-binding specificity. These studies provide structural and mechanistic insight into how CXC-chemokine-binding tick EVAs achieve class specificity but also engage in promiscuous binding.	[Lee, Angela W.; Lynch, Christopher; Davies, Graham; Singh, Kamayani; Alenazi, Yara; Eaton, James R. O.; Kawamura, Akane; Bhattacharya, Shoumo] Univ Oxford, Radcliffe Dept Med Div Cardiovasc Med, Oxford OX3 78N, England; [Deruaz, Maud; Shaw, Jeffrey; Proudfoot, Amanda E., I; Dias, Joao M.] Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland; [Eaton, James R. O.; Kawamura, Akane] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford; University of Oxford	Dias, JM (corresponding author), Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland.; Bhattacharya, S (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Oxford OX3 7BN, England.	jmdias@pfizer.com; sbhattac@well.ox.ac.uk	Bhattacharya, Shoumo/F-4127-2010	Bhattacharya, Shoumo/0000-0002-5571-0478; Lynch, Christopher/0000-0002-4534-4865; Lee, Angela/0000-0002-7591-825X	Saudi Arabian Cultural Bureau; Oxford BHF Centre of Research Excellence; Royal Society Dorothy Hodgkin fellowship; MRC [MC_PC_16056] Funding Source: UKRI	Saudi Arabian Cultural Bureau; Oxford BHF Centre of Research Excellence; Royal Society Dorothy Hodgkin fellowship(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a studentship from the Saudi Arabian Cultural Bureau.; Supported by a studentship from the Oxford BHF Centre of Research Excellence.; Supported by a Royal Society Dorothy Hodgkin fellowship.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Alenazi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24568-9; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bonvin P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00208; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Denisov SS, 2019, CHEM COMMUN, V55, P1374, DOI 10.1039/c8cc08777f; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Eaton JRO, 2018, J BIOL CHEM, V293, P6134, DOI 10.1074/jbc.RA117.000487; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Hayward J, 2017, J BIOL CHEM, V292, P15670, DOI 10.1074/jbc.M117.807255; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Kintzing JR, 2016, CURR OPIN CHEM BIOL, V34, P143, DOI 10.1016/j.cbpa.2016.08.022; Kufareva I, 2017, ANNU REV BIOPHYS, V46, P175, DOI 10.1146/annurev-biophys-051013-022942; Kufareva I, 2016, CURR OPIN PHARMACOL, V30, P27, DOI 10.1016/j.coph.2016.07.006; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lavergne V, 2015, RSC DRUG DISCOV, V42, P37; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lua RC, 2014, PROG BIOPHYS MOL BIO, V116, P194, DOI 10.1016/j.pbiomolbio.2014.05.004; Nava S, 2009, FRONT BIOSCI-LANDMRK, V14, P2857, DOI 10.2741/3418; Nomiyama H, 2013, GENES CELLS, V18, P1, DOI 10.1111/gtc.12013; Postic G, 2018, NUCLEIC ACIDS RES, V46, pD454, DOI 10.1093/nar/gkx1084; Proudfoot AEI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00183; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Scholle MD, 2004, PROTEIN EXPRES PURIF, V37, P243, DOI 10.1016/j.pep.2004.05.012; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Singh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05204-4; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Sommerstein R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005276; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Szekanecz Z, 2016, NAT REV RHEUMATOL, V12, P5, DOI 10.1038/nrrheum.2015.157; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Vancova I, 2010, VET PARASITOL, V167, P274, DOI 10.1016/j.vetpar.2009.09.029; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	62	14	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11199	11212		10.1074/jbc.RA119.008817	http://dx.doi.org/10.1074/jbc.RA119.008817			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167786	Green Published, hybrid			2022-12-26	WOS:000478717400012
J	Le Mauff, F; Bamford, NC; Alnabelseya, N; Zhang, YZ; Baker, P; Robinson, H; Codee, JDC; Howell, PL; Sheppard, DC				Le Mauff, Francois; Bamford, Natalie C.; Alnabelseya, Noor; Zhang, Yongzhen; Baker, Perrin; Robinson, Howard; Codee, Jeroen D. C.; Howell, P. Lynne; Sheppard, Donald C.			Molecular mechanism of Aspergillus fumigatus biofilm disruption by fungal and bacterial glycoside hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus; biofilm; glycoside hydrolase; extracellular matrix; protein structure; virulence factor; substrate specificity; galactosaminogalactan; lung infection	GALACTOSAMINOGALACTAN; IDENTIFICATION; RESIDUES; SEQUENCE; SYSTEM; PEL	During infection, the fungal pathogen Aspergillus fumigatus forms biofilms that enhance its resistance to antimicrobials and host defenses. An integral component of the biofilm matrix is galactosaminogalactan (GAG), a cationic polymer of alpha-1,4-linked galactose and partially deacetylated N-acetylgalactosamine (GalNAc). Recent studies have shown that recombinant hydrolase domains from Sph3, an A. fumigatus glycoside hydrolase involved in GAG synthesis, and PelA, a multifunctional protein from Pseudomonas aeruginosa involved in Pel polysaccharide biosynthesis, can degrade GAG, disrupt A. fumigatus biofilms, and attenuate fungal virulence in a mouse model of invasive aspergillosis. The molecular mechanisms by which these enzymes disrupt biofilms have not been defined. We hypothesized that the hydrolase domains of Sph3 and PelA (Sph3(h) and PelA(h), respectively) share structural and functional similarities given their ability to degrade GAG and disrupt A. fumigatus biofilms. MALDI-TOF enzymatic fingerprinting and NMR experiments revealed that both proteins are retaining endo-alpha-1,4-N-acetylgalactosaminidases with a minimal substrate size of seven residues. The crystal structure of PelA(h) was solved to 1.54 angstrom and structure alignment to Sph3(h) revealed that the enzymes share similar catalytic site residues. However, differences in the substrate-binding clefts result in distinct enzyme-substrate interactions. PelA(h) hydrolyzed partially deacetylated substrates better than Sph3(h), a finding that agrees well with PelA(h)'s highly electronegative binding cleft versus the neutral surface present in Sph3(h). Our insight into PelA(h)'s structure and function necessitate the creation of a new glycoside hydrolase family, GH166, whose structural and mechanistic features, along with those of GH135 (Sph3), are reported here.	[Le Mauff, Francois; Sheppard, Donald C.] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3A 284, Canada; [Le Mauff, Francois; Sheppard, Donald C.] McGill Univ, Hlth Ctr, Res Inst, Infect Dis & Immun Global Hlth, Montreal, PQ H4A 3J1, Canada; [Le Mauff, Francois; Sheppard, Donald C.] McGill Interdisciplinary Initiat Infect & Immun, Montreal, PQ H3A 1Y2, Canada; [Bamford, Natalie C.; Alnabelseya, Noor; Baker, Perrin; Howell, P. Lynne] Hosp Sick Children, Vogram Mol Med, Toronto, ON MSG 1X8, Canada; [Bamford, Natalie C.; Alnabelseya, Noor; Howell, P. Lynne] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON MSS 1A8, Canada; [Zhang, Yongzhen; Codee, Jeroen D. C.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Alnabelseya, Noor] Diassess Inc, 1412 62nd St, Emeryville, CA 94608 USA; [Robinson, Howard] Covalon Technol Ltd, 660 Tech Ave 5, Mississauga, ON L4W 5S7, Canada	McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Leiden University; Leiden University - Excl LUMC; United States Department of Energy (DOE); Brookhaven National Laboratory	Sheppard, DC (corresponding author), McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3A 284, Canada.; Sheppard, DC (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Infect Dis & Immun Global Hlth, Montreal, PQ H4A 3J1, Canada.; Sheppard, DC (corresponding author), McGill Interdisciplinary Initiat Infect & Immun, Montreal, PQ H3A 1Y2, Canada.	howell@sickkids.ca; donald.sheppard@mcgill.ca	Sheppard, Donald/B-4637-2008; Le Mauff, Francois/L-3453-2019	Sheppard, Donald/0000-0001-8877-880X; Le Mauff, Francois/0000-0003-0712-5837; Bamford, Natalie/0000-0003-1959-856X	United States Department of Energy Office; National Center for Research Resources Grant [P41RR012408]; NIGMS from the National Institutes of Health [P41GM103473]; BBSRC [BB/R012415/1] Funding Source: UKRI	United States Department of Energy Office(United States Department of Energy (DOE)); National Center for Research Resources Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Dr. Todd Lowary, Department of Chemistry, University of Alberta, for assistance in the design and interpretation of the NMR spectra. We thank the Drug Discovery platform of the Research Institute of the McGill Health Center for use of the MALDI-TOF mass spectrometer and NMR equipment. Beam Line X29 at the National Synchrotron Light Source is supported by the United States Department of Energy Office and National Center for Research Resources Grant P41RR012408 and NIGMS Grant P41GM103473 from the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; [Anonymous], 2012, INT J MICROBIOL, DOI DOI 10.1155/2012/528521; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker P, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501632; Bamford NC, 2015, J BIOL CHEM, V290, P27438, DOI 10.1074/jbc.M115.679050; Briard B, 2016, MYCOLOGIA, V108, P572, DOI 10.3852/15-312; Cecchini DA, 2015, FEBS LETT, V589, P3098, DOI 10.1016/j.febslet.2015.08.012; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Kernien JF, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01968; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Le Mauff F, 2017, PLANT BIOTECHNOL J, V15, P285, DOI 10.1111/pbi.12607; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Lee MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00252-16; Lee MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005187; Lee MJ, 2014, J BIOL CHEM, V289, P1243, DOI 10.1074/jbc.M113.522516; Little DJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006998; Loussert C, 2010, CELL MICROBIOL, V12, P405, DOI 10.1111/j.1462-5822.2009.01409.x; Mehrad B, 1999, J IMMUNOL, V162, P1633; Moracci M, 1996, PROTEIN ENG, V9, P1191, DOI 10.1093/protein/9.12.1191; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muller FMC, 2011, MED MYCOL, V49, pS96, DOI 10.3109/13693786.2010.502190; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce CG, 2013, CURR OPIN PHARMACOL, V13, P726, DOI 10.1016/j.coph.2013.08.008; Reichhardt C, 2015, EUKARYOT CELL, V14, P1064, DOI 10.1128/EC.00050-15; Seidler MJ, 2008, ANTIMICROB AGENTS CH, V52, P4130, DOI 10.1128/AAC.00234-08; Sheppard DC, 2016, J BIOL CHEM, V291, P12529, DOI 10.1074/jbc.R116.720995; Sheppard DC, 2011, CURR OPIN MICROBIOL, V14, P375, DOI 10.1016/j.mib.2011.07.006; Snarr BD, 2017, P NATL ACAD SCI USA, V114, P7124, DOI 10.1073/pnas.1702798114; Taccone FS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0722-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van de Veerdonk FL, 2017, NAT REV MICROBIOL, V15, P661, DOI 10.1038/nrmicro.2017.90; Yang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17585; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418	51	26	26	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10760	10772		10.1074/jbc.RA119.008511	http://dx.doi.org/10.1074/jbc.RA119.008511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31167793	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000478717200004
J	Li, M; Havelaar, AH; Hoffmann, S; Hald, T; Kirk, MD; Torgerson, PR; Devieesschauwer, B				Li, Min; Havelaar, Arie H.; Hoffmann, Sandra; Hald, Tine; Kirk, Martyn D.; Torgerson, Paul R.; Devieesschauwer, Brecht			Global disease burden of pathogens in animal source foods, 2010	PLOS ONE			English	Article							CHILDREN; NUTRITION; HEALTH	Animal source foods (ASF) such as dairy, eggs, fish and meat are an important source of high-quality nutrients. Lack of ASF in diets can result in developmental disorders including stunting, anemia, poor cognitive and motor development. ASF are more effective in preventing stunting than other foods and promoting ASF consumption in low- and middle-income countries could help improve health, particularly among pregnant women and young children. Production and consumption of ASF are, however, also associated with potential food safety risks. Strengthening of food control systems, informed by quantitative assessments of the disease burden associated with ASF is necessary to meet global nutrition goals. We present the human disease burden associated with 13 pathogens (bacteria and parasites) in ASF, based on an analysis of global burden of foodborne disease (FBD) estimates of the WHO Foodborne Disease Burden Epidemiology Reference Group (FERG). The FBD burden of these pathogens was combined with estimates of the proportion of disease transmitted by eight main groups of ASF. Uncertainty in all estimates was accounted for by Monte Carlo simulation. In 2010, the global burden of ASF was 168 (95% uncertainty interval (UI 137-219) Disability Adjusted Life Years (DALYs) per 100,000 population, which is approximately 35% of the estimated total burden of FBD. Main pathogens contributing to this burden included non-typhoidal Salmonella enterica, Taenia solium, and Campylobacterspp. The proportion of FBD burden associated with ASF varied considerably between subregions and between countries within subregions. Likewise, the contribution of different pathogens and ASF groups varied strongly between subregions. Pathogens with a localized distribution included T. solium and fishborne trematodes. Pathogens with a global distribution included non-typhoidal S. enterica, Campylobacterspp., Toxoplasma gondii, and Mycobacterium bovis. Control methods exist for many hazards associated with ASF, and their implementation is linked to economic development and effective food safety systems.	[Li, Min; Havelaar, Arie H.] Univ Florida, Inst Sustainable Food Syst, Feed Future Innovat Lab Livestock Syst, Emerging Pathogens Inst,Dept Anim Sci, Gainesville, FL 32611 USA; [Hoffmann, Sandra] USDA, Econ Res Serv, Washington, DC USA; [Hald, Tine] Danish Tech Univ, Unit Genom Epidemiol, Lyngby, Denmark; [Kirk, Martyn D.] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Torgerson, Paul R.] Univ Zurich, Vetsuisse Fac, Sect Epidemiol, Zurich, Switzerland; [Devieesschauwer, Brecht] Sciensano, Dept Epidemiol & Publ Hlth, Brussels, Belgium; [Devieesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium	State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Technical University of Denmark; Australian National University; University of Zurich; Sciensano; Ghent University	Havelaar, AH (corresponding author), Univ Florida, Inst Sustainable Food Syst, Feed Future Innovat Lab Livestock Syst, Emerging Pathogens Inst,Dept Anim Sci, Gainesville, FL 32611 USA.	ariehavelaar@ufl.edu	Havelaar, Arie H./P-8495-2014; Hald, Tine/B-5477-2016; Torgerson, Paul R/M-4447-2013	Havelaar, Arie H./0000-0002-6456-5460; Hald, Tine/0000-0002-1115-9792; Torgerson, Paul R/0000-0003-4277-9983; Kirk, Martyn/0000-0001-5432-5984; Hoffmann, Sandra/0000-0003-2537-8731	World Bank; intramural research program of the U.S. Department of Agriculture, Economic Research Service; National Health and Medical Research Council, Australia [GNT1145997]	World Bank(The World Bank India); intramural research program of the U.S. Department of Agriculture, Economic Research Service; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was in part funded by a grant from the World Bank (https://www.worldbank.org/) to the University of Florida. In addition, this research was supported in part by the intramural research program of the U.S. Department of Agriculture, Economic Research Service. MDK is supported by a Career Development Fellowship (GNT1145997) from the National Health and Medical Research Council, Australia (https://nhmrc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour C, 2016, CLIN INFECT DIS, V63, P1171, DOI 10.1093/cid/ciw542; [Anonymous], INFL FOOD ENV HLTH D; Bank World, 2017, RED IN WAT SUPPL SAN; Batz MB, 2005, EMERG INFECT DIS, V11, P993, DOI 10.3201/eid1107.040634; Chan M, 2014, LANCET, V384, P1910, DOI 10.1016/S0140-6736(14)62037-7; Devleesschauwer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142498; Dror DK, 2011, FOOD NUTR BULL, V32, P227, DOI 10.1177/156482651103200307; Enahoro D, 2018, GLOB FOOD SECUR-AGR, V19, P1, DOI 10.1016/j.gfs.2018.08.002; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FAO, 2016, STAT FOOD SEC NUTR W; FAO, 2007, FOOD SAF RISK AN GUI; FAO/WHO, 2014, 2 INT C NUTR FRAM AC; FAO WHO, 2014, 2 INT C NUTR DECL NU; Hald T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145839; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hoffmann S, 2007, J FOOD PROTECT, V70, P1220, DOI 10.4315/0362-028X-70.5.1220; Hoffmann S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183641; Iannotti LL, 2017, AM J CLIN NUTR, V106, P1482, DOI 10.3945/ajcn.117.160515; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208; Platts-Mills JA, 2018, LANCET GLOB HEALTH, V6, pE1309, DOI [10.1016/s2214-109x(18)30349-8, 10.1016/S2214-109X(18)30349-8]; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; R Core Team, 2018, R LANG ENV STAT COMP; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Stevens MP, 2009, PHILOS T R SOC B, V364, P2709, DOI 10.1098/rstb.2009.0094; Troeger C, 2018, LANCET GLOB HEALTH, V6, pE255, DOI 10.1016/S2214-109X(18)30045-7; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	30	36	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216545	10.1371/journal.pone.0216545	http://dx.doi.org/10.1371/journal.pone.0216545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170162	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000470263700006
J	Sundbakk, LM; Wood, M; Gran, JM; Nordeng, H				Sundbakk, Lene Maria; Wood, Mollie; Gran, Jon Michael; Nordeng, Hedvig			Impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age: A study from the Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							PREGNANT-WOMEN; BRAIN-DEVELOPMENT; PROPENSITY SCORE; DIAZEPAM; POPULATION; MEDICATION; PROFILE; DRUGS; BIAS	Many women experience anxiety or sleep disorders during pregnancy and require pharmacological treatment with benzodiazepines (BZDs) or z-hypnotics. Limited information is currently available on how prenatal exposure to these medications affects behavioral problems in children over the long term. Therefore, from a public health perspective, this issue is highly important. The present study aimed to determine whether prenatal exposure to BZDs and z-hypnotics affected externalizing and internalizing behavior problems in children at age 5 years. This study was based on The Norwegian Mother and Child Cohort Study and The Medical Birth Registry of Norway. The final study population included data for 36 401 children, from questionnaires completed by the mothers throughout the 5-year follow up. Children's behaviors were measured at age 5, based on parental responses to The Child Behavior Checklist. Children T-scores of 63 or above were considered to indicate clinically relevant behavior problems. We applied inverse probability of treatment weighting (IPTW) and log-binomial regression models to estimate risk ratios (RRs) and bootstrapped 95% confidence intervals (CIs) with censoring weights to account for loss during follow-up. Several sensitivity analyses were performed to assess the robustness of the main results. The final sample included 273 (0.75%) children that were exposed to BZDs and/or z-hypnotics during pregnancy. The main, IPTW and censoring weighted analyses showed that prenatal exposure to BZD and/or z-hypnotics increased the risks of internalizing behavioral problems (RR: 1.35, 95% CI: 0.73-2.49) and externalizing behavioral problems (RR: 1.51, 95% CI: 0.86-2.64). However, based on sensitivity analyses, we concluded that the risks of displaying externalizing and internalizing problems at 5 years of age did not significantly increase after prenatal exposure to BZDs and/or z-hypnotics. Instead, the sensitivity analyses suggested that residual confounding and selection bias might explain the increased risks observed in the main analyses.	[Sundbakk, Lene Maria; Wood, Mollie; Nordeng, Hedvig] Univ Oslo, Fac Math & Nat Sci, Dept Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway; [Sundbakk, Lene Maria; Wood, Mollie; Nordeng, Hedvig] Univ Oslo, Fac Math & Nat Sci, PharmaTox Strateg Initiat, Oslo, Norway; [Wood, Mollie] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Gran, Jon Michael] Univ Oslo, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Nordeng, Hedvig] Norwegian Inst Publ Hlth, Dept Child Dev & Hlth, Oslo, Norway	University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; Norwegian Institute of Public Health (NIPH)	Sundbakk, LM (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway.; Sundbakk, LM (corresponding author), Univ Oslo, Fac Math & Nat Sci, PharmaTox Strateg Initiat, Oslo, Norway.	l.m.sundbakk@farmasi.uio.no			Ministry of Health and Care Services; Ministry of Education and Research; NIH/NIEHS [N01-ES-75558]; NIH/NINDS [U01 NS 04753701, U01 NS 047537-06A1]; HN's H2020 European Research Council Starting Grant, "DrugslnPregnancy" [639377]; PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway	Ministry of Health and Care Services; Ministry of Education and Research; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HN's H2020 European Research Council Starting Grant, "DrugslnPregnancy"; PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway	The Norwegian Mother and Child Cohort Study (MoBa) is supported by the Ministry of Health and Care Services and the Ministry of Education and Research https://www.regjeringen.no/en/id4/, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no.1 U01 NS 04753701 and grant no.2 U01 NS 047537-06A1). Primary investigator of MoBa is Center director Per Magnus, Center for Fertility and Health, Norway (www.fhi.no/en/more/research-centres/Centre-for-fertility-and-health/employees/per-magnus/).This study was funded by HN's H2020 European Research Council Starting Grant, "DrugslnPregnancy" (grant no. 639377). LMS and MW are funded by the PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; [Anonymous], 1996, BRUK BENZODIAZEPINER; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Brandlistuen RE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181042; Bromley RL, 2017, SEIZURE-EUR J EPILEP, V44, P225, DOI 10.1016/j.seizure.2016.10.006; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Dennis CL, 2017, BRIT J PSYCHIAT, V210, P315, DOI 10.1192/bjp.bp.116.187179; DESALVIA MA, 1990, DEV PHARMACOL THERAP, V15, P173; Flower R., 2016, RANG DALES PHARM; GAI N, 1982, PSYCHOPHARMACOLOGY, V78, P225, DOI 10.1007/BF00428155; Gidai J, 2008, TOXICOL IND HEALTH, V24, P61, DOI 10.1177/0748233708089016; GUERREMILLO M, 1979, EUR J CLIN PHARMACOL, V15, P171, DOI 10.1007/BF00563101; Hanley GE, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-242; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; KELLOGG C, 1980, SCIENCE, V207, P205, DOI 10.1126/science.7350658; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P863; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Lacroix I, 2009, EUR J CLIN PHARMACOL, V65, P839, DOI 10.1007/s00228-009-0647-2; Lash TL, 2009, APPL QUANTITATIVE BI; Leite W., 2016, PRACTICAL PROPENSITY; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2016, SURVEY ANAL COMPLEX, DOI [10.1016/j.jfma.2016.08.004, DOI 10.1016/J.JFMA.2016.08.004]; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; MANDELLI M, 1975, CLIN PHARMACOL THER, V17, P564; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nordeng H., 2016, DRUG UTILIZATION RES; Novik TS, 1999, EUR CHILD ADOLES PSY, V8, P247, DOI 10.1007/s007870050098; Oerbeck B, 2017, J ATTEN DISORD, DOI [10.1177/1087054212696265, DOI 10.1177/1087054212696265]; Organization WH, 2012, THE ANATOMICAL THERA; R Core Team, 2018, R LANG ENV STAT COMP; Radojcic MR, 2017, NEUROTOXICOL TERATOL, V61, P58, DOI 10.1016/j.ntt.2017.02.005; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P697, DOI 10.1002/pds.2256; Riska BS, 2014, EUR J CLIN PHARMACOL, V70, P1367, DOI 10.1007/s00228-014-1744-4; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; SCHLUMPF M, 1989, NEUROTOXICOLOGY, V10, P501; SHADER RI, 1993, NEW ENGL J MED, V328, P1398; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; STIKA L, 1990, PHARM WEEKBLAD, V12, P252; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; VanderWeele TJ, 2007, AM J EPIDEMIOL, V166, P1096, DOI 10.1093/aje/kwm179; VIGGEDAL G, 1993, J CHILD PSYCHOL PSYC, V34, P295, DOI 10.1111/j.1469-7610.1993.tb00993.x; Wood ME, 2018, PHARMACOEPIDEM DR S, V27, P140, DOI 10.1002/pds.4336; Wu C, 2015, METAB BRAIN DIS, V30, P367, DOI 10.1007/s11011-014-9560-1; Zachrisson HD, 2013, CHILD DEV, V84, P1152, DOI 10.1111/cdev.12040	51	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217830	10.1371/journal.pone.0217830	http://dx.doi.org/10.1371/journal.pone.0217830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170221	Green Published, Green Submitted, gold			2022-12-26	WOS:000470263700063
J	Byun, YS; Kim, SE; Paik, JS; Yang, SW				Byun, Yong-Soo; Kim, Sung-Eun; Paik, Ji-Sun; Yang, Suk-Woo			Increased pupillary constriction velocity in benign essential blepharospasm associated with photophobia	PLOS ONE			English	Article							BOTULINUM-TOXIN; GANGLION-CELLS; SHEDDING LIGHT; MECHANISM; DISEASE	We evaluated whether the pupillary light reflex is altered in benign essential blepharospasm patients. Twenty-three patients with benign essential blepharospasm, 47 with reflex blepharospasm, and 29 dry eye disease controls were included. Pupillary light reflex-related parameters were measured under mesopic (10 lux) and photopic illuminance (200 lux) using an infrared pupillometer. Additionally, we assessed photophobia grade, eyelid function, and dry eye disease-related parameters. There were no differences in age, sex predominance, or dry eye disease-related parameters among the three groups, or in photophobia grade and eyelid function between benign essential blepharospasm and reflex groups. Constriction velocity and maximum constriction velocity in the mesopic condition were significantly greater in the benign essential blepharospasm group (3.26 +/- 0.56 and 5.27 +/- 0.90 mm/s) than in reflex (2.86 +/- 0.62 and 4.59 +/- 1.00 mm/s) or dry eye disease groups (2.96 +/- 0.46 and 4.72 +/- 0.67 mm/s). Constriction velocity and maximum constriction velocity in the mesopic condition positively correlated with photophobia grade (r = 0.525 and 0.617, P = 0.025 and 0.006) in the benign essential blepharospasm group. Pupillary light reflex may be related to the pathophysiology of benign essential blepharospasm with photophobia. Further studies are required to reveal connections among pupillary light reflex, photophobia, and focal dystonia in benign essential blepharospasm patients with photophobia.	[Byun, Yong-Soo; Kim, Sung-Eun; Paik, Ji-Sun; Yang, Suk-Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Yang, SW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	yswoph@catholic.ac.kr		Yang, Suk-Woo/0000-0003-3984-9506; Byun, Yong-Soo/0000-0002-7264-0723	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A1A01054947]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	BYS was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A01054947) (URL: https://ernd.nrf.re.kr).The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RL, 1998, OPHTHALMIC PLAST REC, V14, P305, DOI 10.1097/00002341-199809000-00002; Blackburn MK, 2009, OPHTHALMOLOGY, V116, P997, DOI 10.1016/j.ophtha.2008.12.031; Bussa M, 2015, ACTA ANAESTH SCAND, V59, P685, DOI 10.1111/aas.12489; Conte A, 2017, MOV DISORD CLIN PRAC, V4, P733, DOI 10.1002/mdc3.12499; Coscarelli JM, 2010, SEMIN OPHTHALMOL, V25, P104, DOI 10.3109/08820538.2010.488564; Defazio G, 2017, PARKINSONISM RELAT D, V40, P64, DOI 10.1016/j.parkreldis.2017.04.014; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Ferrazzano G, 2015, J NEUROL NEUROSUR PS, V86, P336, DOI 10.1136/jnnp-2014-307821; FISHER CM, 1963, NEUROLOGY, V13, P77, DOI 10.1212/WNL.13.1.77; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; GRANDAS F, 1988, J NEUROL NEUROSUR PS, V51, P767, DOI 10.1136/jnnp.51.6.767; Hallett M, 2002, NEUROLOGY, V59, P1306, DOI 10.1212/01.WNL.0000027361.73814.0E; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hyon Joon Young, 2014, Korean J Ophthalmol, V28, P197, DOI 10.3341/kjo.2014.28.3.197; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Judd RA, 2007, NEURO-OPHTHALMOLOGY, V31, P49, DOI 10.1080/01658100701247646; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; LEMP MA, 1970, ARCH OPHTHALMOL-CHIC, V83, P89, DOI 10.1001/archopht.1970.00990030091017; Liang H, 2015, INVEST OPHTH VIS SCI, V56, P3218, DOI 10.1167/iovs.15-16499; Lu R, 2014, AM J OPHTHALMOL, V157, P591, DOI 10.1016/j.ajo.2013.11.014; Matynia A, 2012, EXP EYE RES, V105, P60, DOI 10.1016/j.exer.2012.09.012; McCann JD, 1999, OPHTHALMIC PLAST REC, V15, P384, DOI 10.1097/00002341-199911000-00003; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Park DI, 2013, ACTA OPHTHALMOL, V91, pe108, DOI 10.1111/aos.12002; Peckham EL, 2011, EUR J NEUROL, V18, P382, DOI 10.1111/j.1468-1331.2010.03161.x; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Valls-Sole J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00045; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Yoon Jin Sook, 2009, Korean J Ophthalmol, V23, P137, DOI 10.3341/kjo.2009.23.3.137	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217924	10.1371/journal.pone.0217924	http://dx.doi.org/10.1371/journal.pone.0217924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163059	Green Published, Green Submitted, gold			2022-12-26	WOS:000470086200046
J	De Marco, F; Willer, K; Gromann, LB; Andrejewski, J; Hellbach, K; Bahr, A; Dmochewitz, M; Koehler, T; Maack, HI; Pfeiffer, F; Herzen, J				De Marco, Fabio; Willer, Konstantin; Gromann, Lukas B.; Andrejewski, Jana; Hellbach, Katharina; Baehr, Andrea; Dmochewitz, Michaels; Koehler, Thomas; Maack, Hanns-Ingo; Pfeiffer, Franz; Herzen, Julia			Contrast-to-noise ratios and thickness-normalized, ventilation-dependent signal levels in dark-field and conventional in vivo thorax radiographs of two pigs	PLOS ONE			English	Article							X-RAY; MECHANICAL VENTILATION; VISIBILITY-CONTRAST; DIAGNOSIS; LUNG; VISUALIZATION	Lung tissue causes significant small-angle X-ray scattering, which can be visualized with grating-based X-ray dark-field imaging. Structural lung diseases alter alveolar microstructure, which often causes a dark-field signal decrease. The imaging method provides benefits for diagnosis of such diseases in small-animal models, and was successfully used on porcine and human lungs in a fringe-scanning setup. Micro-and macroscopic changes occur in the lung during breathing, but their individual effects on the dark-field signal are unknown. However, this information is important for quantitative medical evaluation of dark-field thorax radiographs. To estimate the effect of these changes on the dark-field signal during a clinical examination, we acquired in vivo dark-field chest radiographs of two pigs at three ventilation pressures. Pigs were used due to the high degree of similarity between porcine and human lungs. To analyze lung expansion separately, we acquired CT scans of both pigs at comparable posture and ventilation pressures. Segmentation, masking, and forward-projection of the CT datasets yielded maps of lung thickness and logarithmic lung attenuation signal in registration with the dark-field radiographs. Upon correlating this data, we discovered approximately linear relationships between the logarithmic dark-field signal and both projected quantities for all scans. Increasing ventilation pressure strongly decreased dark-field extinction coefficients, whereas the ratio of lung dark-field and attenuation signal changed only slightly. Furthermore, we investigated ratios of dark-field and attenuation noise levels at realistic signal levels via calculations and phantom measurements. Dark-field contrast-tonoise ratio (CNR) per lung height was 5 to 10% of the same quantity in attenuation. We conclude that better CNR performance in the dark-field modality is typically due to greater anatomical noise in the conventional radiograph. Given the high physiological similarity of human and porcine lungs, the presented thickness-normalized, ventilation-dependent values allow estimation of dark-field activity of human lungs of variable size and inspiration, which facilitates the design of suitable clinical imaging setups.	[De Marco, Fabio; Willer, Konstantin; Gromann, Lukas B.; Andrejewski, Jana; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Chair Biomed Phys, Garching, Germany; [De Marco, Fabio; Willer, Konstantin; Gromann, Lukas B.; Andrejewski, Jana; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Sch BioMed Engn, Garching, Germany; [Hellbach, Katharina] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany; [Baehr, Andrea; Dmochewitz, Michaels] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Oberschleissheim, Germany; [Koehler, Thomas] Philips GmbH Innovat Technol, Res Labs, Hamburg, Germany; [Koehler, Thomas; Pfeiffer, Franz] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Maack, Hanns-Ingo] Philips Med Syst DMC GmbH, Hamburg, Germany; [Pfeiffer, Franz] Tech Univ Munich, Sch Med, Dept Diagnost & Intervent Radiol, Munich, Germany; [Pfeiffer, Franz] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich; University of Munich; Philips; Philips Research; Technical University of Munich; Philips; Philips Healthcare; Technical University of Munich; Technical University of Munich	De Marco, F (corresponding author), Tech Univ Munich, Chair Biomed Phys, Garching, Germany.	fabio.de.marco@tum.de		De Marco, Fabio/0000-0002-3561-7305; Koehler, Thomas/0000-0002-1986-0057	Deutsche Forschungsgemeinschaft Gottfried Wilhelm Leibniz program; European Research Council [AdG 695045]; Deutsche Forschungsgemeinschaft [DFG EXC-158]	Deutsche Forschungsgemeinschaft Gottfried Wilhelm Leibniz program; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Deutsche Forschungsgemeinschaft Gottfried Wilhelm Leibniz program to FP, the European Research Council (AdG 695045), and the Deutsche Forschungsgemeinschaft (DFG EXC-158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bachche S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07032-y; Bech M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03209; Endrizzi M, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/50/505102; Gromann LB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05101-w; Hauke C, 2018, MED PHYS, V45, P2565, DOI 10.1002/mp.12889; Hellbach K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20985-y; Hellbach K, 2015, INVEST RADIOL, V50, P430, DOI 10.1097/RLI.0000000000000147; Horn F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19482-z; Judge EP, 2014, AM J RESP CELL MOL, V51, P334, DOI 10.1165/rcmb.2013-0453TR; Koehler T, 2015, MED PHYS, V42, P1959, DOI 10.1118/1.4914420; Kottler C, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2723064; Krause C, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4975826; Lynch SK, 2011, APPL OPTICS, V50, P4310, DOI 10.1364/AO.50.004310; Malecki A, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/48001; McLaughlin RA, 2014, PHYSIOLOGY, V29, P369, DOI 10.1152/physiol.00002.2014; Meinel FG, 2014, INVEST RADIOL, V49, P653, DOI 10.1097/RLI.0000000000000067; Michel T, 2013, PHYS MED BIOL, V58, P2713, DOI 10.1088/0031-9155/58/8/2713; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Namati E, 2013, BIOMED OPT EXPRESS, V4, P2492, DOI 10.1364/BOE.4.002492; Olivo A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772193; Pelzer G, 2016, MED PHYS, V43, P2774, DOI 10.1118/1.4948671; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Pfeiffer F, 2012, AIP CONF PROC, V1466, P2, DOI 10.1063/1.4742261; Prade F, 2015, CEMENT CONCRETE RES, V74, P19, DOI 10.1016/j.cemconres.2015.04.003; Proschek P, 2011, DIAGNOSTISCHE INTERV, P503, DOI [10.1007/978-3-540-87668-7, DOI 10.1007/978-3-540-87668-7]; Punnoose J, 2016, MED PHYS, V43, P4711, DOI 10.1118/1.4955438; Revol V, 2013, NDT&E INT, V58, P64, DOI 10.1016/j.ndteint.2013.04.012; Revol V, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3465334; Roan E, 2011, AM J PHYSIOL-LUNG C, V301, pL625, DOI 10.1152/ajplung.00105.2011; Scherer K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00489-x; Scherer K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130776; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schleede S, 2012, P NATL ACAD SCI USA, V109, P17880, DOI 10.1073/pnas.1206684109; Seifert M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38030-3; Stampanoni M, 2011, INVEST RADIOL, V46, P801, DOI 10.1097/RLI.0b013e31822a585f; Vignero J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206302; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willer K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204565; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; Yaroshenko A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24269; Yaroshenko A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17492; Yashiro W, 2010, OPT EXPRESS, V18, P16890, DOI 10.1364/OE.18.016890; Yashiro W, 2015, OPT EXPRESS, V23, P23462, DOI 10.1364/OE.23.023462	46	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217858	10.1371/journal.pone.0217858	http://dx.doi.org/10.1371/journal.pone.0217858			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158251	Green Published, gold			2022-12-26	WOS:000469915700032
J	Rodriguez-Osorio, I; Mena, A; Meijide, H; Morano, L; Delgado, M; Cid, P; Margusino, L; Pedreira, JD; Castro, A				Rodriguez-Osorio, Iria; Mena, Alvaro; Meijide, Hector; Morano, Luis; Delgado, Manuel; Cid, Purificacion; Margusino, Luis; Pedreira, Jose Domingo; Castro, Angeles			Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; HEPATOCELLULAR-CARCINOMA; COST-EFFECTIVENESS; THERAPY; LEDIPASVIR/SOFOSBUVIR; EPIDEMIOLOGY; INFECTION; AGENTS; RISK	Background Direct-acting antivirals (DAAs) are effective in patients aged >= 65 years. However, little is known about the effects of DAAs on survival, liver decompensation and development of hepatocellular carcinoma (HCC). Objective To compare the incidence of liver-related events and mortality between patients aged. 65 and < 65 years. Methods Prospective study comparing patients aged >= 65 and < 65 years treated with DAAs. The incidence of liver-related events and mortality, and HCC was compared between age groups. Results Five hundred patients (120 aged >= 65 and 380 aged < 65 years) were included. The incidence of liver-related events was 2.62 per 100 patient-years (py) in older and 1.41/100 py in younger patients. All-cause mortality was 3.89 and 1.27/100 py in older and younger patients, respectively. The respective liver-related mortality rates were 1.12 and 0.31/100 py. In patients with cirrhosis (stage F4), all-cause mortality (P = 0.283) and liver-related mortality (P = 0.254) did not differ between groups. All five liver-related deaths were related to multifocal HCC. The incidence of HCC was 1.91 and 1.43 per 100 py in the older and younger groups, respectively (P = 0.747). The diagnosis of HCC was 8 months after the end of treatment. Conclusions The incidence of liver-related events and liver-related mortality was low in older people treated with DAAs and was similar to that in younger patients. The extra mortality in people aged >= 65 years treated with DAAs seems to be secondary to non-liver-related causes. These results support the utilization of DAAs in patients aged >= 65 years.	[Rodriguez-Osorio, Iria; Mena, Alvaro; Meijide, Hector; Delgado, Manuel; Cid, Purificacion; Margusino, Luis; Pedreira, Jose Domingo; Castro, Angeles] Univ Coruna UDC, CHUAC, Grp Virol Clin, Inst Invest Biomed A Coruna INIBIC,Sergas, La Coruna, Spain; [Rodriguez-Osorio, Iria; Mena, Alvaro; Castro, Angeles] CHUAC, Serv Med Interna, Unidad Enfermedades Infecciosas, Sergas, La Coruna, Spain; [Meijide, Hector] Hosp Quironsalud, Serv Med Interna, La Coruna, Spain; [Morano, Luis] Complexo Hosp Univ Vigo, Hosp Alvaro Cunqueiro, Serv Med Interna, Unidad Patol Infecciosa, Vigo, Spain; [Delgado, Manuel] CHUAC, Serv Aparato Digest, Sergas, La Coruna, Spain; [Cid, Purificacion; Margusino, Luis] CHUAC, Serv Farm, Sergas, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; quironsalud Group; Complexo Hospitalario Universitario de Vigo; Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna	Mena, A (corresponding author), Univ Coruna UDC, CHUAC, Grp Virol Clin, Inst Invest Biomed A Coruna INIBIC,Sergas, La Coruna, Spain.; Mena, A (corresponding author), CHUAC, Serv Med Interna, Unidad Enfermedades Infecciosas, Sergas, La Coruna, Spain.	alvaro.mena.de.cea@sergas.es		Morano Amado, Luis Enrique/0000-0002-0560-3260; Mena, Alvaro/0000-0002-9165-6798; CID-SILVA, PURIFICACION/0000-0002-3227-8002	Fondo de Investigacion Sanitaria [JR17/00028]; Fundacion Profesor Novoa Santos, A Coruna	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Profesor Novoa Santos, A Coruna	This work was supported in part by grants from Fondo de Investigacion Sanitaria (JR17/00028), and Fundacion Profesor Novoa Santos, A Coruna.	Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Bachofner JA, 2017, LIVER INT, V37, P369, DOI 10.1111/liv.13256; Backus LI, 2019, HEPATOLOGY, V69, P487, DOI 10.1002/hep.29408; El-Serag HB, 2016, J VIRAL HEPATITIS, V23, P687, DOI 10.1111/jvh.12533; Fabrizio C, 2017, DIGEST LIVER DIS, V49, P1036, DOI 10.1016/j.dld.2017.05.019; Facciorusso A, 2018, J GASTROEN HEPATOL, V33, P942, DOI 10.1111/jgh.14008; Guo H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184160; He T, 2017, ALIMENT PHARM THER, V46, P711, DOI 10.1111/apt.14271; Ioannou GN, 2016, GASTROENTEROLOGY, V151, P457, DOI 10.1053/j.gastro.2016.05.049; Kondili LA, 2017, HEPATOLOGY, V66, P1814, DOI 10.1002/hep.29399; Kozbial K, 2016, J HEPATOL, V65, P856, DOI 10.1016/j.jhep.2016.06.009; Lens S, 2017, AM J GASTROENTEROL, V112, P1400, DOI 10.1038/ajg.2017.157; McCombs J, 2014, JAMA INTERN MED, V174, P204, DOI 10.1001/jamainternmed.2013.12505; Rodriguez-Osorio I, 2017, J CLIN VIROL, V88, P58, DOI 10.1016/j.jcv.2017.01.003; Saab S, 2016, HEPATOLOGY, V63, P1112, DOI 10.1002/hep.28425; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vespasiani-Gentilucci U, 2015, WORLD J GASTROENTERO, V21, P7412, DOI 10.3748/wjg.v21.i24.7412; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yang JD, 2016, J HEPATOL, V65, P859, DOI 10.1016/j.jhep.2016.06.023	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217052	10.1371/journal.pone.0217052	http://dx.doi.org/10.1371/journal.pone.0217052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158237	gold, Green Published, Green Submitted			2022-12-26	WOS:000469915700008
J	Azevedo, AS; Sousa, IM; Fernandes, RM; Azevedo, NF; Almeida, C				Azevedo, Andreia S.; Sousa, Inds M.; Fernandes, Ricardo M.; Azevedo, Nuno F.; Almeida, Carina			Optimizing locked nucleic acid/2 '-O-methyl-RNA fluorescence in situ hybridization (LNA/2 ' OMe-FISH) procedure for bacterial detection	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; TARGETED OLIGONUCLEOTIDE PROBES; RESPONSE-SURFACE METHODOLOGY; PNA-FISH; ESCHERICHIA-COLI; PHYLOGENETIC IDENTIFICATION; HIGHLY EFFICIENT; MESSENGER-RNA; ACID; DNA	Despite the successful application of LNA/2'OMe-FISH procedures for bacteria detection, there is a lack of knowledge on the properties that affect hybridization. Such information is crucial for the rational design of protocols. Hence, this work aimed to evaluate the effect of three essential factors on the LNA/2'OMe hybridization step-hybridization temperature, NaCl concentration and type and concentration of denaturant (formamide, ethylene carbonate and urea). This optimization was performed for 3 Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa and Citrobacter freundii) and 2 Gram-positive bacteria (Enterococcus faecalis and Staphylococcus epidermidis), employing the response surface methodology and a Eubacteria probe. In general, it was observed that a high NaCl concentration is beneficial (from 2 M to 5 M), regardless of the denaturant used. Urea, formamide and ethylene carbonate are suitable denaturants for LNA/2'OMe-FISH applications; but urea provides higher fluorescence intensities among the different bacteria, especially for gram-positive bacteria and for P. aeruginosa. However, a unique optimal protocol was not found for all tested bacteria. Despite this, the results indicate that a hybridization solution with 2 M of urea and 4 M of NaCl would be a proper starting point. Furthermore, a hybridization temperature around 62 degrees C, for 14 bp probes with LNA monomers at every third position of 2'OMe and 64% of GC content, should be use in initial optimization of new LNA/2'OMe-FISH protocols.	[Azevedo, Andreia S.; Fernandes, Ricardo M.; Almeida, Carina] Univ Minho, CEB Ctr Biol Engn, Braga, Portugal; [Azevedo, Andreia S.; Sousa, Inds M.; Fernandes, Ricardo M.; Azevedo, Nuno F.; Almeida, Carina] Univ Porto, Fac Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, Porto, Portugal; [Azevedo, Andreia S.] Univ Porto, i3S, Porto, Portugal; [Azevedo, Andreia S.] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, Porto, Portugal; [Fernandes, Ricardo M.; Almeida, Carina] IP Natl Inst Agrarian & Vet Res, INIAV, Rua Lagidos, Vairao, Vila Do Conde, Portugal	Universidade do Minho; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Instituto Nacional de Investigacao Agraria e Veterinaria, IP (INIAV)	Almeida, C (corresponding author), Univ Minho, CEB Ctr Biol Engn, Braga, Portugal.; Almeida, C (corresponding author), Univ Porto, Fac Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, Porto, Portugal.; Almeida, C (corresponding author), IP Natl Inst Agrarian & Vet Res, INIAV, Rua Lagidos, Vairao, Vila Do Conde, Portugal.	carina.almeida@iniav.pt	Azevedo, Nuno/I-4915-2013	Almeida, Carina/0000-0002-0175-1119; Azevedo, Andreia Sofia/0000-0002-0521-2841; Azevedo, Nuno/0000-0001-5864-3250	European Regional Development Fund (ERDF) through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) [POCI-01-0145-FEDER-006939, UID/EQU/00511/2013, POCI-01-0145-FEDER-006684, UID/BIO/04469]; national funds (PIDDAC) through FCT - Fundaccao para a Ciencia e a Tecnologia/MCTES [POCI-01-0145-FEDER-006939, UID/EQU/00511/2013, POCI-01-0145-FEDER-006684, UID/BIO/04469]; European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte [NORTE-01-0145-FEDER-000004]; FCT - Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/121601/2016, SFRH/BD/118860/2016]; FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) [PTDC/DTP-PIC/4562/2014 - POCI-01-0145-FEDER-016678, POCI-01-0145-FEDER-030431]; FCT - Fundacao para a Ciencia e a Tecnologia, I.P. [PTDC/DTP-PIC/4562/2014 - POCI-01-0145-FEDER-016678, POCI-01-0145-FEDER-030431]	European Regional Development Fund (ERDF) through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); national funds (PIDDAC) through FCT - Fundaccao para a Ciencia e a Tecnologia/MCTES; European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte; FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT - Fundacao para a Ciencia e a Tecnologia, I.P.	This work was financially supported by project POCI-01-0145-FEDER-006939 (Laboratory for Process Engineering, Environment, Biotechnology and Energy - UID/EQU/00511/2013), POCI-01-0145-FEDER-006684 (Center of Biological Engineering - UID/BIO/04469) funded by European Regional Development Fund (ERDF) through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI), and by national funds (PIDDAC) through FCT - Fundaccao para a Ciencia e a Tecnologia/MCTES; NORTE-01-0145-FEDER-000004 - BioTecNorte operation, funded by the European Regional Development Fund under the scope of Norte2020 - Programa Operacional Regional do Norte; Post-Doctoral Fellowship SFRH/BPD/121601/2016 (Andreia S. Azevedo) and PhD Fellowship SFRH/BD/118860/2016 (Ricardo M. Fernandes) supported by national funds through FCT - Fundacao para a Ciencia e a Tecnologia; Project PTDC/DTP-PIC/4562/2014 - POCI-01-0145-FEDER-016678 (Coded-FISH) and Project POCI-01-0145-FEDER-030431 (CLASInVivo), funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) and by national funds through FCT - Fundacao para a Ciencia e a Tecnologia, I.P.	Almeida C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014786; Amann R, 2001, CURR OPIN BIOTECH, V12, P231, DOI 10.1016/S0958-1669(00)00204-4; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Arora Amit, 2008, Nucleic Acids Symp Ser (Oxf), P417, DOI 10.1093/nass/nrn212; Azevedo AS, 2015, BIOCHEM ENG J, V104, P64, DOI 10.1016/j.bej.2015.04.024; Barrero-Canosa J, 2017, ENVIRON MICROBIOL, V19, P70, DOI 10.1111/1462-2920.13432; Behrens S, 2003, APPL ENVIRON MICROB, V69, P4935, DOI 10.1128/AEM.69.8.4935-4941.2003; Berndt A, 1996, ACTA HISTOCHEM, V98, P79, DOI 10.1016/S0065-1281(96)80053-5; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bond PL, 2001, MICROBIAL ECOL, V41, P149; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Carr EL, 2005, J MICROBIOL METH, V61, P47, DOI 10.1016/j.mimet.2004.10.023; Cerqueira L, 2008, INT J MOL SCI, V9, P1944, DOI 10.3390/ijms9101944; Cerqueira L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-101; Danilevich VN, 2008, CHEM ENG TECHNOL, V31, P904, DOI 10.1002/ceat.200800024; Fontenete S, 2017, METHODS MOL BIOL, V1616, P137, DOI 10.1007/978-1-4939-7037-7_8; Fontenete S, 2016, APPL MICROBIOL BIOT, V100, P5897, DOI 10.1007/s00253-016-7429-4; Fontenete S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148353; Fontenete S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125494; Fontenete S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081230; Griffin TJ, 1998, ANAL BIOCHEM, V260, P56, DOI 10.1006/abio.1998.2686; Haruta S, 2017, MICROBES ENVIRON, V32, P142, DOI 10.1264/jsme2.ME16186; Hoshino T, 2008, APPL ENVIRON MICROB, V74, P5068, DOI 10.1128/AEM.00208-08; Huang EY, 2011, DEV BIOL, V358, P137, DOI 10.1016/j.ydbio.2011.07.017; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kubota K, 2006, APPL ENVIRON MICROB, V72, P5311, DOI 10.1128/AEM.03039-05; Lambert D, 2012, BIOCHEMISTRY-US, V51, P9014, DOI 10.1021/bi301103j; Lima JF, 2018, BMC MOL BIOL, V19, DOI 10.1186/s12867-018-0107-6; Lopes SP, 2017, BIOTECHNOL BIOENG, V114, P355, DOI 10.1002/bit.26085; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Matthiesen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040675; Mendes L, 2016, MICROBIOL RES, V192, P185, DOI 10.1016/j.micres.2016.07.002; Moreno PMD, 2018, MOL THER-NUCL ACIDS, V11, P393, DOI 10.1016/j.omtn.2018.03.009; Myers R., 2009, RESPONSE SURFACE MET, V38, P705; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Perry-O'Keefe H, 2001, J MICROBIOL METH, V47, P281, DOI 10.1016/S0167-7012(01)00303-7; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Priyakumar UD, 2009, J AM CHEM SOC, V131, P17759, DOI 10.1021/ja905795v; Rocha R, 2016, J BIOTECHNOL, V226, P1, DOI 10.1016/j.jbiotec.2016.03.047; Santos RS, 2017, LWT-FOOD SCI TECHNOL, V80, P27, DOI 10.1016/j.lwt.2017.01.077; Santos RS, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.46; Santos RS, 2014, J BIOTECHNOL, V187, P16, DOI 10.1016/j.jbiotec.2014.06.023; Silahtaroglu A, 2004, CYTOGENET GENOME RES, V107, P32, DOI 10.1159/000079569; Silvia F, 2015, APPL MICROBIOL BIOT, V99, P3961, DOI 10.1007/s00253-015-6389-4; Soe MJ, 2011, J HISTOCHEM CYTOCHEM, V59, P661, DOI 10.1369/0022155411409411; Tang YZ, 2005, APPL ENVIRON MICROB, V71, P8157, DOI 10.1128/AEM.71.12.8157-8164.2005; Thomsen R, 2005, RNA, V11, P1745, DOI 10.1261/rna.2139705; Veedu RN, 2009, RNA BIOL, V6, P321, DOI 10.4161/rna.6.3.8807; Volpi EV, 2017, SPRINGER PROTOC HAND, P135, DOI 10.1007/978-3-662-52959-1_12; Wagner M, 1998, FEMS MICROBIOL LETT, V160, P159, DOI 10.1016/S0378-1097(97)00570-3; Wahlestedt C, 2000, P NATL ACAD SCI USA, V97, P5633, DOI 10.1073/pnas.97.10.5633; Yamaguchi T, 2015, SYST APPL MICROBIOL, V38, P400, DOI 10.1016/j.syapm.2015.06.007; Yilmaz LS, 2006, APPL ENVIRON MICROB, V72, P733, DOI 10.1128/AEM.72.1.733-744.2006; Yilmaz LS, 2004, APPL ENVIRON MICROB, V70, P7126, DOI 10.1128/AEM.70.12.7126-7139.2004	59	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217689	10.1371/journal.pone.0217689	http://dx.doi.org/10.1371/journal.pone.0217689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150460	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100087
J	Kraft, AJ; Robinson, DT; Evans, IS; Rooney, RC				Kraft, Adam J.; Robinson, Derek T.; Evans, Ian S.; Rooney, Rebecca C.			Concordance in wetland physicochemical conditions, vegetation, and surrounding land cover is robust to data extraction approach	PLOS ONE			English	Article							PRAIRIE WETLANDS; MANTEL TEST; SPATIAL AUTOCORRELATION; WATER-QUALITY; CATCHMENTS; CULTIVATION; MACROPHYTES; INDICATORS; DIVERSITY; ECOSYSTEM	Concordance among wetland physicochemical conditions, vegetation, and surrounding land cover may result from the influence of land cover on the sources of plant propagules, on physicochemical conditions, and their subsequent determination of growing conditions. Alternatively, concordance may result if differences in climate, soils, and species pools are spatially confounded with differences in human population density and land conversion. Further, we expect that land cover within catchment boundaries will be more predictive than land cover in symmetrical buffers if runoff is a major pathway. We measured concordance between land cover, wetland vegetation and physicochemical conditions in 48 prairie pothole wetlands, controlling for inter-wetland distance. We contrasted land-cover data collected over a four-year period by multiple extraction approaches including topographically-delineated catchments and nested 30 m to 5,000 m radius buffers. After factoring out inter-wetland distance, physiochemical conditions were significantly concordant with land cover. Vegetation was not significantly concordant with land cover, though it was strongly and significantly concordant with physicochemical conditions. More, concordance was as strong when land cover was extracted from buffers <500 m in radius as from catchments, indicating the mechanism responsible is not topographically constrained. We conclude that local landscape structure does not directly influence wetland vegetation composition, but rather that vegetation depends on 1) physicochemical conditions in the wetland that are affected by surrounding land cover and on 2) regional factors such as the vegetation species pool and geographic gradients in climate, soil type, and land use.	[Kraft, Adam J.; Rooney, Rebecca C.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada; [Robinson, Derek T.; Evans, Ian S.] Univ Waterloo, Dept Geog & Environm Management, Waterloo, ON, Canada	University of Waterloo; University of Waterloo	Rooney, RC (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON, Canada.	rrooney@uwaterloo.ca	Robinson, Derek/B-6076-2011	Robinson, Derek/0000-0002-4293-1095; Rooney, Rebecca/0000-0002-3956-7210	Alberta Innovates [2094A]	Alberta Innovates	RCR received award 2094A from Alberta Innovates (https://albertainnovates.ca/).Funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAFC, 2013, ANN CROP INV 2011; AAFC, 2013, ANN CROP INV 2012; AAFC, 2015, ANN CROP INV 2014; AEP, 2014, ALB MERG WETL INV; Agriculture and Agri-Food Canada (AAFC), 2013, ANN CROP INV 2013; Akasaka M, 2010, FRESHWATER BIOL, V55, P909, DOI 10.1111/j.1365-2427.2009.02334.x; [Anonymous], 2012, INT J ADV RES COMPUT; BARKO JW, 1982, CAN J BOT, V60, P877, DOI 10.1139/b82-113; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bremer DJ, 2001, AGRON J, V93, P338, DOI 10.2134/agronj2001.932338x; Capers RS, 2010, FRESHWATER BIOL, V55, P952, DOI 10.1111/j.1365-2427.2009.02328.x; Cronk J, 2001, WETLAND PLANTS BIOL; Downing D. J., 2006, PUBLICATIONS, VT/852; Dutilleul P, 2000, J AGRIC BIOL ENVIR S, V5, P131, DOI 10.2307/1400528; ESRI, 2011, ARCPAD 10 0; ESRI (Environmental Systems Resource Institute), 2015, ARCMAP 10 3 1; Euliss NH, 2004, WETLANDS, V24, P448, DOI 10.1672/0277-5212(2004)024[0448:TWCACF]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fisette T, 2014, INT GEOSCI REMOTE SE, P5095, DOI 10.1109/IGARSS.2014.6947643; Freeland JA, 1999, WETLANDS, V19, P56, DOI 10.1007/BF03161733; Galatowitsch SM, 2000, ENVIRON MONIT ASSESS, V60, P121, DOI 10.1023/A:1006159028274; Gleason RA, 1998, GREAT PLAINS RES, V8, P97; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Hayashi M, 1998, J HYDROL, V207, P56, DOI 10.1016/S0022-1694(98)00099-7; Hayashi M, 2016, WETLANDS, V36, pS237, DOI 10.1007/s13157-016-0797-9; Houlahan JE, 2006, WETLANDS, V26, P79, DOI 10.1672/0277-5212(2006)26[79:TEOALU]2.0.CO;2; Houlahan JE, 2004, LANDSCAPE ECOL, V19, P677, DOI 10.1023/B:LAND.0000042912.87067.35; Howard RJ, 1999, AM J BOT, V86, P785, DOI 10.2307/2656700; JACKSON DA, 1989, CAN J ZOOL, V67, P766, DOI 10.1139/z89-108; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Kraft AJ, 2016, THESIS; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P, 2015, METHODS ECOL EVOL, V6, P1239, DOI 10.1111/2041-210X.12425; Lopez RD, 2002, LANDSCAPE ECOL, V17, P43, DOI 10.1023/A:1015203802047; Lougheed VL, 2001, CAN J FISH AQUAT SCI, V58, P1603, DOI 10.1139/cjfas-58-8-1603; Main AR, 2016, AGR ECOSYST ENVIRON, V215, P76, DOI 10.1016/j.agee.2015.09.011; MARTIN DB, 1987, WATER AIR SOIL POLL, V34, P45; Martinez C, 2010, INT J REMOTE SENS, V31, P6239, DOI 10.1080/01431160903403060; McCauley LA, 2014, WETLANDS, V34, P1123, DOI 10.1007/s13157-014-0571-9; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mikulyuk A, 2011, CAN J FISH AQUAT SCI, V68, P1778, DOI [10.1139/F2011-095, 10.1139/f2011-095]; Moss E.H., 1983, FLORA ALBERTA; Novikmec M, 2016, HYDROBIOLOGIA, V774, P155, DOI 10.1007/s10750-015-2514-8; Queen's Printer for Ontario, 2014, ONTARIO WETLAND EVAL; R Core Team, 2013, R LANG ENV STAT COMP; Rooney RC, 2015, J BIOGEOGR, V42, P439, DOI 10.1111/jbi.12400; Rooney RC, 2012, LANDSCAPE ECOL, V27, P1321, DOI 10.1007/s10980-012-9784-6; Rooney RC, 2011, LANDSCAPE ECOL, V26, P1023, DOI 10.1007/s10980-011-9629-8; Shaw DA, 2012, HYDROL PROCESS, V26, P3147, DOI 10.1002/hyp.8390; Stewart R. E., 1971, RESOURCE PUBLICATION, V92; Tanner CC, 2001, WATER SCI TECHNOL, V44, P9, DOI 10.2166/wst.2001.0804; Tavernia BG, 2010, LANDSCAPE ECOL, V25, P1085, DOI 10.1007/s10980-010-9482-1; van der Kamp G, 1999, HYDROLOG SCI J, V44, P387, DOI 10.1080/02626669909492234; Werner KJ, 2002, WETLANDS, V22, P451, DOI 10.1672/0277-5212(2002)022[0451:HSMSMA]2.0.CO;2; Yang P, 2014, ENVIRON MODELL SOFTW, V58, P48, DOI 10.1016/j.envsoft.2014.04.005; Zobel M, 2001, ENCY LIFE SCI ELS, DOI [10.1002/9780470015902.a0022549, DOI 10.1002/9780470015902.A0022549]	60	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216343	10.1371/journal.pone.0216343	http://dx.doi.org/10.1371/journal.pone.0216343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150421	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100019
J	Nakayama, C; Sato, O; Sugita, M; Nakayama, T; Kuroda, Y; Orui, M; Iwasa, H; Yasumura, S; Rudd, RE				Nakayama, Chihiro; Sato, Osamu; Sugita, Minoru; Nakayama, Takeo; Kuroda, Yujiro; Orui, Masatsugu; Iwasa, Hajime; Yasumura, Seiji; Rudd, Rima E.			Lingering health-related anxiety about radiation among Fukushima residents as correlated with media information following the accident at Fukushima Daiichi Nuclear Power Plant	PLOS ONE			English	Article							SOCIAL AMPLIFICATION; RISK; JAPAN; CHERNOBYL; LITERACY; DISTRESS	Following the March 2011 accident at Fukushima Daiichi Nuclear Power Plant, many residents of Fukushima have faced anxieties about the health impacts of radiation exposure. Considering that source of information may influence resident anxiety, this study aimed to elucidate the correlation between the two. In addition, a health literacy query was included to examine a possible relationship between anxiety and health literacy skills. A mail survey was conducted in August 2016 among 2000 residents of Fukushima Prefecture aged 20 to 79 years. Survey items included questions about current health anxieties caused by radiation, trusted sources of information about radiation, and media used to obtain information on radiation. The survey valid response rate was 43.4%. Results of multiple linear regression analysis revealed that anxiety was significantly higher for the groups indicating "trust in citizen groups" and "use of internet sites." Anxiety was significantly lower for the groups indicating "trust in government ministries," "trust in local government," and "use of local broadcast television." Also anxiety was significantly lower for groups with higher health literacy. It was found that the significant relationship to anxiety varies depending on the sources of trust and media used. There is a possibility that this was caused by the difference between the contents of each information and media reports. In preparation for any future nuclear accident, government may consider action to improve the media literacy of residents. In addition, improving health literacy of both the recipient and the sender of information can improve access to information and thereby safeguard the health and well-being of the public.	[Nakayama, Chihiro; Kuroda, Yujiro; Orui, Masatsugu; Iwasa, Hajime; Yasumura, Seiji] Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan; [Sato, Osamu] Fukushima Coll, Childrens Dept, Welf Fac, Fukushima, Japan; [Sugita, Minoru] Toho Univ, Sch Med, Dept Environm & Occupat Hlth, Tokyo, Japan; [Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Rudd, Rima E.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Fukushima Medical University; Toho University; Kyoto University; Harvard University; Harvard T.H. Chan School of Public Health	Nakayama, C (corresponding author), Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan.	nakac@fmu.ac.jp	Iwasa, Hajime/AFQ-6399-2022; NAKAYAMA, Takeo/HCH-0537-2022	Nakayama, Chihiro/0000-0002-0049-9628; Nakayama, Takeo/0000-0002-7918-6252; Kuroda, Yujiro/0000-0003-0587-5423	 [15K08810]		This work was supported by Grant-in-Aid for Scientific Research (C) (No. 15K08810, SY, TN, MS, and OS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, J RISK RES, DOI [10.1080/136698700376699, DOI 10.1080/136698700376699]; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Dordevic M, 2016, LECT NOTES COMPUT SC, V9844, P442, DOI 10.1007/978-3-319-45234-0_40; Endo K., 2013, JAPAN SCI SUPPORT FD, V1, P15; Friedman SM, 2011, B ATOM SCI, V67, P55, DOI 10.1177/0096340211421587; Fukasawa M, 2017, SSM-POPUL HLTH, V3, P740, DOI 10.1016/j.ssmph.2017.09.002; HANDFORD HA, 1986, J AM ACAD CHILD PSY, V25, P409, DOI 10.1016/S0002-7138(09)60264-8; Havenaar JM, 1997, AM J PSYCHIAT, V154, P1605, DOI 10.1176/ajp.154.11.1605; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; HOBBS R., 2009, J MEDIA LITERACY ED, V1, P1; Ishikawa H, 2008, HEALTH PROMOT INT, V23, P269, DOI 10.1093/heapro/dan017; Ishikawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12712; Kanda R, 2014, JAPAN HLTH PHYS SOC, V49, P77, DOI [10.5453/jhps.49.68, DOI 10.5453/JHPS.49.68]; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Kuroda Y, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071463; Maeda M., 2018, Journal of the National Institute of Public Health, V67, P50; Murakami M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165594; Nakagawa K, 2016, RAYONNEMENTS IONISAN, P18; Ochi S., 2017, ASIA PACIFIC J PUB S, V29, p83S, DOI [10.1177/1010539516681841, DOI 10.1177/1010539516681841]; Ohmori M., 2016, Annals of the ICRP, V45, P33, DOI 10.1177/0146645316666757; Perko T, 2015, MASS COMMUNICATION J, V5, P1, DOI [DOI 10.4172/2165-7912.1000252, 10.4172/2165-7912.1000252]; Perko T, 2016, INTEGR ENVIRON ASSES, V12, P683, DOI 10.1002/ieam.1832; RENN O, 1992, J SOC ISSUES, V48, P137, DOI 10.1111/j.1540-4560.1992.tb01949.x; Rubin GJ, 2012, BRIT J PSYCHIAT, V201, P400, DOI 10.1192/bjp.bp.112.111575; Sato O, 2013, J RADIOL PROT, V33, P823, DOI 10.1088/0952-4746/33/4/823; Science Council of Japan Committee on Clinical Medicine Housyasen bougo risk management bunka-kai, 2017, HOUK KOD HOUS HIB EI; Shin H, 2017, ENERG ENVIRON-UK, V28, P518, DOI 10.1177/0958305X17706179; Shineha R., 2017, RESILIENCE NEW PARAD, P111, DOI DOI 10.1007/978-3-319-58768-4; Sugimoto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065331; Tanaka K., 2012, EIZOU MEDIA GAKKAISI, V66, P891; Tateno S., 2013, J SCI COMMUNICATION, V12, P1; Thoman E, 2004, AM BEHAV SCI, V48, P18, DOI 10.1177/0002764204267246; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Uno K., 2013, TEISENRYOU HOUSYASEN, P140; Vasterman P, 2005, EPIDEMIOL REV, V27, P107, DOI 10.1093/epirev/mxi002; Vyncke B, 2017, RISK ANAL, V37, P570, DOI 10.1111/risa.12618; Yasumura S., 2014, PUBLIC HLTH NUCL DIS, P401	39	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217285	10.1371/journal.pone.0217285	http://dx.doi.org/10.1371/journal.pone.0217285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150483	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100038
J	Quanjel, TCC; Spreeuwenberg, MD; Struijs, JN; Baan, CA; Ruwaard, D				Quanjel, Tessa C. C.; Spreeuwenberg, Marieke D.; Struijs, Jeroen N.; Baan, Caroline A.; Ruwaard, Dirk			Substituting hospital-based outpatient cardiology care: The impact on quality, health and costs	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUADRUPLE AIM CARE; OUTREACH CLINICS; GENERAL-PRACTICE; SPECIALISTS; SYSTEMS; TRIPLE	Background Many Western countries face the challenge of providing high-quality care while keeping the healthcare system accessible and affordable. In an attempt to deal with this challenge a new healthcare delivery model called primary care plus (PC+) was introduced in the Netherlands. Within the PC+ model, medical specialists perform consultations in a primary care setting. PC+ aims to support the general practitioners in gatekeeping and prevent unnecessary referrals to hospital care. The aim of this study was to examine the effects of a cardiology PC+ intervention on the Triple Aim outcomes, which were operationalized by patient-perceived quality of care, health-related quality of life (HRQoL) outcomes, and healthcare costs per patient. Methods This is a quantitative study with a longitudinal observational design. The study population consisted of patients, with non-acute and low-complexity cardiology-related health complaints, who were referred to the PC+ centre (intervention group) or hospital-based outpatient care (control group; care-as-usual). Patient-perceived quality of care and HRQoL (EQ-5D-5L, EQ-VAS and SF-12) were measured through questionnaires at three different time points. Healthcare costs per patient were obtained from administrative healthcare data and patients were followed for nine months. Chi-square tests, independent t-tests and multilevel linear models were used to analyse the data. Results The patient-perceived quality of care was significantly higher within the intervention group for 26 out of 27 items. HRQoL outcomes did significantly increase in both groups (P < 0.05) but there was no significant interaction between group and time. At baseline and also at three, six and nine months' follow-up the healthcare costs per patient were significantly lower for patients in the intervention group (P<0.001). Conclusions While this study showed no improvements on HRQoL outcomes, PC+ seemed to be promising as it results in improved quality of care as experienced by patients and lower healthcare costs per patient.	[Quanjel, Tessa C. C.; Spreeuwenberg, Marieke D.; Ruwaard, Dirk] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst, Dept Hlth Serv Res, Maastricht, Netherlands; [Spreeuwenberg, Marieke D.] Zuyd Univ Appl Sci, Res Ctr Technol Care, Heerlen, Netherlands; [Struijs, Jeroen N.; Baan, Caroline A.] Natl Inst Publ Hlth & Environm, Prevent & Hlth Serv, Dept Qual Care & Hlth Econ, Ctr Nutr, Bilthoven, Netherlands; [Struijs, Jeroen N.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Baan, Caroline A.] Univ Tilburg, Sci Ctr Transformat Care & Welf Tranzo, Tilburg, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tilburg University	Quanjel, TCC (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst, Dept Hlth Serv Res, Maastricht, Netherlands.	t.quanjel@maastrichtuniversity.nl	Struijs, Jeroen/AAQ-9872-2020; Struijs, Jeroen/AAX-6827-2020; Struijs, Jeroen/AAA-8057-2022	Struijs, Jeroen/0000-0002-7493-6720; Ruwaard, Dirk/0000-0003-4887-8413; Quanjel, Tessa/0000-0001-6103-363X	Province of Limburg, the Netherlands; cooperative named: 'Versterking Eerstelijn Zuid-Nederland' (VEZN) (translated in English: 'Reinforcing Primary Care South of the Netherlands'); CZ; VGZ	Province of Limburg, the Netherlands(Netherlands Government); cooperative named: 'Versterking Eerstelijn Zuid-Nederland' (VEZN) (translated in English: 'Reinforcing Primary Care South of the Netherlands'); CZ; VGZ	We received funding from non-commercial companies, namely from the non-commercial private health insurers CZ and VGZ and the Province of Limburg, the Netherlands. The insurers funded this project via the cooperative named: 'Versterking Eerstelijn Zuid-Nederland' (VEZN) (translated in English: 'Reinforcing Primary Care South of the Netherlands'). VEZN is a cooperative for project funding, focused on regional projects which aim to keep healthcare sustainable and affordable. The funding sources of this study have been checked and approved by the Medical Research and Ethics Committee. They approved that there were no competing interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OPEN DATA NEDERLANDS; Atun R, 2004, WHAT ARE ADVANTAGES; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Bond M, 2000, J EPIDEMIOL COMMUN H, V54, P149, DOI 10.1136/jech.54.2.149; Bowling A, 2001, BRIT J GEN PRACT, V51, P264; Bowling A, 1997, J EPIDEMIOL COMMUN H, V51, P52, DOI 10.1136/jech.51.1.52; Gruen RL, 2003, COCHRANE DB SYST REV, P1; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Kessler R, 2011, AM J PREV MED, V40, P637, DOI 10.1016/j.amepre.2011.02.023; Kringos DS, 2013, HEALTH AFFAIR, V32, P686, DOI 10.1377/hlthaff.2012.1242; Kringos DS, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-65; Ma X., 2010, INT ENCYCLOP ED, V3, P757, DOI [10.1016/B978-0-08-044894-7.01611-0, DOI 10.1016/B978-0-08-044894-7.01611-0]; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Maris E, 1998, PSYCHOL METHODS, V3, P309, DOI 10.1037/1082-989X.3.3.309; Meuwissen LE, 2008, CONSUMER QUALITY IND; Ministerie van Volksgezondheid Welzijn en Sport, 2013, OND MED SPEC ZORG 20; Ministerie van Volksgezondheid Welzijn en Sport, 2013, OND 1 LIJN 2014 MET; Mols F, 2009, QUAL LIFE RES, V18, P403, DOI 10.1007/s11136-009-9455-5; Ovretveit J, 2017, INT J QUAL HEALTH C, V29, P874, DOI 10.1093/intqhc/mzx108; Peiro S, 2015, EUR J PUBLIC HEALTH, V25, P1, DOI 10.1093/eurpub/cku223; Porter ME, 2013, HARVARD BUS REV, V91, P50; Powell John, 2002, J Health Serv Res Policy, V7, P177, DOI 10.1258/135581902760082490; Quanjel TCC, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0734-5; Quanjel TCC, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2580-x; Sandager M, 2016, J PATIENT EXP, V3, P63; Sanson-Fisher RW, 2007, AM J PREV MED, V33, P155, DOI 10.1016/j.amepre.2007.04.007; Schulpen GJC, 2003, ANN RHEUM DIS, V62, P159, DOI 10.1136/ard.62.2.159; Schut FT, 2017, HEALTH POLICY, V121, P126, DOI 10.1016/j.healthpol.2016.11.002; Sibbald B, 2008, J HEALTH SERV RES PO, V13, P233, DOI 10.1258/jhsrp.2008.008049; Sikka R, 2015, BMJ QUAL SAF, V24, P608, DOI 10.1136/bmjqs-2015-004160; Steenbakkers M., 2014, NIEUWE KIJK GEZONDHE; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; van Hoof SJM, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0498-8; van Hoof SJM, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2446; van Poucke A, 2018, WIE DOET MET WIE TIJ; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003; Vlek JFM, 2003, BRIT J GEN PRACT, V53, P108; WHO, 2008, PHARMAFORUM 0121; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1; Wiering B, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2582-8; Winpenny EM, 2017, J HEALTH SERV RES PO, V22, P53, DOI 10.1177/1355819616648982; Zarbailov N, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0653-x	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217923	10.1371/journal.pone.0217923	http://dx.doi.org/10.1371/journal.pone.0217923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150520	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100128
J	Auwal, SM; Abidin, NZ; Zarei, M; Tan, CP; Saari, N				Auwal, Shehu Muhammad; Abidin, Najib Zainal; Zarei, Mohammad; Tan, Chin Ping; Saari, Nazamid			Identification, structure-activity relationship and in silico molecular docking analyses of five novel angiotensin I-converting enzyme (ACE)-inhibitory peptides from stone fish (Actinopyga lecanora) hydrolysates	PLOS ONE			English	Article							ACE INHIBITORY PEPTIDE; BIOACTIVE PEPTIDES; ANTIHYPERTENSIVE PEPTIDES; ANTIOXIDANT ACTIVITIES; PURIFICATION; COMPONENTS; PRODUCTS	Stone fish is an under-utilized sea cucumber with many health benefits. Hydrolysates with strong ACE-inhibitory effects were generated from stone fish protein under the optimum conditions of hydrolysis using bromelain and fractionated based on hydrophobicity and isoelectric properties of the constituent peptides. Five novel peptide sequences with molecular weight (mw) < 1000 daltons (Da) were identified using LC-MS/MS. The peptides including Ala-Leu-Gly-Pro-Gln-Phe-Tyr (794.44 Da), Lys-Val-Pro-Pro-Lys-Ala (638.88 Da), Leu-Ala-Pro-Pro-Thr-Met (628.85 Da), Glu-Val-Leu-lle-Gln (600.77 Da) and Glu-His-Pro-Val-Leu (593.74 Da) were evaluated for ACE-inhibitory activity and showed IC50 values of 0.012 mM, 0.980 mM, 1.310 mM, 1.440 mM and 1.680 mM, respectively. The ACE-inhibitory effects of the peptides were further verified using molecular docking study. The docking results demonstrated that the peptides exhibit their effect mainly via hydrogen and electrostatic bond interactions with ACE. These findings provide evidence about stone fish as a valuable source of raw materials for the manufacture of antihypertensive peptides that can be incorporated to enhance therapeutic relevance and commercial significance of formulated functional foods.	[Auwal, Shehu Muhammad; Abidin, Najib Zainal; Saari, Nazamid] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Sci, Serdang, Selangor, Malaysia; [Auwal, Shehu Muhammad] Bayero Univ, Fac Basic Med Sci, Dept Biochem, Kano, Nigeria; [Zarei, Mohammad] Univ Teknol MARA, Fac Sci Appl, Sch Ind Technol, Dept Food Sci & Technol, Shah Alam, Selangor, Malaysia; [Tan, Chin Ping] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Technol, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Bayero University; Universiti Teknologi MARA; Universiti Putra Malaysia	Saari, N (corresponding author), Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Sci, Serdang, Selangor, Malaysia.	nazamid@upm.edu.my	Tan, Chin-Ping/A-8130-2008; Auwal, Shehu/GYQ-5993-2022; Zarei, Mohammad/B-8556-2014	Tan, Chin-Ping/0000-0003-4177-4072; Zarei, Mohammad/0000-0003-1573-347X	 [02-01-04-SF 2309]		This work was supported by Grant No. 02-01-04-SF 2309; https://ernd.mosti.gov.my.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhedi O, 2018, FOOD CHEM, V239, P453, DOI 10.1016/j.foodchem.2017.06.112; Aluko RE, 2015, CURR OPIN FOOD SCI, V4, P44, DOI 10.1016/j.cofs.2015.05.002; Asoodeh A, 2016, J FOOD DRUG ANAL, V24, P332, DOI 10.1016/j.jfda.2015.11.010; Auwal SM, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4765463; Auwal SM, 2017, MAR DRUGS, V15, DOI 10.3390/md15040104; Bordbar S, 2011, MAR DRUGS, V9, P1761, DOI 10.3390/md9101761; Chay SY, 2018, FOOD FUNCT, V9, P1657, DOI [10.1039/c7fo01769c, 10.1039/C7FO01769C]; CHEUNG HS, 1980, J BIOL CHEM, V255, P401; Chowdhuri AK, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2013, VOL 8A; Ngo DH, 2016, PROCESS BIOCHEM, V51, P1622, DOI 10.1016/j.procbio.2016.07.006; Daskaya-Dikmen C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040316; Datta A, 2016, J BIOL CHEM, V291, P13301, DOI 10.1074/jbc.M116.719575; DEDDISH PA, 1994, P NATL ACAD SCI USA, V91, P7807, DOI 10.1073/pnas.91.16.7807; Rocha GF, 2017, FOOD CHEM, V237, P350, DOI 10.1016/j.foodchem.2017.05.112; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghanbari R, 2015, INT J MOL SCI, V16, P28870, DOI 10.3390/ijms161226140; Girgih AT, 2014, J AGR FOOD CHEM, V62, P4135, DOI 10.1021/jf5002606; Hartmann R, 2007, CURR OPIN BIOTECH, V18, P163, DOI 10.1016/j.copbio.2007.01.013; He R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091051; Hu FJ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0904-3; Ibrahim HR, 2017, J ADV RES, V8, P63, DOI 10.1016/j.jare.2016.12.002; Iwaniak A, 2014, COMPR REV FOOD SCI F, V13, P114, DOI 10.1111/1541-4337.12051; Jimsheena VK, 2010, PEPTIDES, V31, P1165, DOI 10.1016/j.peptides.2010.02.022; Jimsheena VK, 2009, ANAL CHEM, V81, P9388, DOI 10.1021/ac901775h; Kim SK, 2013, MARINE BIOMATERIALS: CHARACTERIZATION, ISOLATION AND APPLICATIONS, P1, DOI 10.1201/b14723; Kim SK, 2001, J AGR FOOD CHEM, V49, P2992, DOI 10.1021/jf001119u; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; Lee JK, 2012, ADV FOOD NUTR RES, V65, P47, DOI 10.1016/B978-0-12-416003-3.00004-4; Lee SY, 2017, FOOD CHEM, V228, P506, DOI 10.1016/j.foodchem.2017.02.039; Li Y, 2012, J AGR FOOD CHEM, V60, P1320, DOI 10.1021/jf204118n; Li Y, 2016, MAR DRUGS, V14, DOI 10.3390/md14060110; Manoharan Sivananthan, 2017, Afr J Tradit Complement Altern Med, V14, P383, DOI 10.21010/ajtcam.v14i2.39; Meena J, 2018, INDIAN J TRADIT KNOW, V17, P162; Meresa A., 2017, CLIN EXP PHARM INTER, V7, P1, DOI [DOI 10.4172/2161-1459.1000228, 10.4172/2161-1459.1000228]; Moayedi A, 2017, APPL BIOCHEM BIOTECH, V181, P48, DOI 10.1007/s12010-016-2198-1; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nollet L. M. L., 2012, HDB ANAL ACTIVE COMP; Norris R., 2013, BIOACTIVE FOOD PEPTI, P45, DOI [10.1146/annurev-food-022814-015520, DOI 10.5772/32009]; Pan DD, 2012, FOOD CHEM, V130, P121, DOI 10.1016/j.foodchem.2011.07.011; Pihlanto-Leppala A, 1998, INT DAIRY J, V8, P325, DOI 10.1016/S0958-6946(98)00048-X; Qiao LS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122099; Amado IR, 2014, MAR DRUGS, V12, P1390, DOI 10.3390/md12031390; Schrodinger Software Team, 2015, PROT PREP GUID SCHRO; Segura-Campos M, 2011, FOOD REV INT, V27, P213, DOI 10.1080/87559129.2011.563395; Sheih IC, 2009, FOOD CHEM, V115, P279, DOI 10.1016/j.foodchem.2008.12.019; Shi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111188; Shrikant Sharma, 2011, International Journal BIOAutomation, V15, P223; Sturrock ED, 2004, CELL MOL LIFE SCI, V61, P2677, DOI 10.1007/s00018-004-4239-0; Sun LX, 2017, MAR DRUGS, V15, DOI 10.3390/md15020029; Udenigwe CC, 2012, J FOOD SCI, V77, pR11, DOI 10.1111/j.1750-3841.2011.02455.x; Viator JA, 2004, LASER SURG MED, P9; Wang XQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9746720; Wu YQ, 2017, PROTEOMICS IN FOOD SCIENCE: FROM FARM TO FORK, P17, DOI 10.1016/B978-0-12-804007-2.00002-3; Yea CS, 2014, FOOD FUNCT, V5, P1007, DOI 10.1039/c3fo60667h; Yousr M, 2015, INT J MOL SCI, V16, P29161, DOI 10.3390/ijms161226155; Zarei M, 2015, IND CROP PROD, V76, P112, DOI 10.1016/j.indcrop.2015.06.040; Zhu CZ, 2013, J AGR FOOD CHEM, V61, P1265, DOI 10.1021/jf3044764	57	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0197644	10.1371/journal.pone.0197644	http://dx.doi.org/10.1371/journal.pone.0197644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145747	Green Submitted, Green Published, gold			2022-12-26	WOS:000469425500001
J	Ahedo, V; Caro, J; Bortolini, E; Zurro, D; Madella, M; Galan, JM				Ahedo, Virginia; Caro, Jorge; Bortolini, Eugenio; Zurro, Debora; Madella, Marco; Manuel Galan, Jose			Quantifying the relationship between food sharing practices and socio-ecological variables in small-scale societies: A cross-cultural multi-methodological approach	PLOS ONE			English	Article							HUMAN BEHAVIORAL ECOLOGY; WILCOXON-MANN-WHITNEY; NICHE CONSTRUCTION; EVOLUTIONARY; DISTANCE; DIVERSITY; TESTS; CLASSIFICATION; POPULATIONS; COOPERATION	This article presents a cross-cultural study of the relationship among the subsistence strategies, the environmental setting and the food sharing practices of 22 modern small-scale societies located in America (n = 18) and Siberia (n = 4). Ecological, geographical and economic variables of these societies were extracted from specialized literature and the publicly available D-PLACE database. The approach proposed comprises a variety of quantitative methods, ranging from exploratory techniques aimed at capturing relationships of any type between variables, to network theory and supervised-learning predictive modelling. Results provided by all techniques consistently show that the differences observed in food sharing practices across the sampled populations cannot be explained just by the differential distribution of ecological, geographical and economic variables. Food sharing has to be interpreted as a more complex cultural phenomenon, whose variation over time and space cannot be ascribed only to local adaptation.	[Ahedo, Virginia; Caro, Jorge] Univ Burgos, Dept Ingn Civil, Escuela Politecn Super, Area Org Empresas, Burgos, Spain; [Ahedo, Virginia; Caro, Jorge; Bortolini, Eugenio; Zurro, Debora; Madella, Marco] CSIC, Inst Mila & Fontanals, CaSEs Culture & Socioecol Syst Res Grp, Dept Arqueol & Antropol, Barcelona, Spain; [Ahedo, Virginia; Caro, Jorge; Bortolini, Eugenio; Zurro, Debora; Madella, Marco] UPF, Dept Humanidades, Barcelona, Spain; [Bortolini, Eugenio] Univ Bologna, Dept Cultural Heritage, Ravenna, Italy; [Madella, Marco] ICREA, Barcelona, Spain; [Madella, Marco] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Manuel Galan, Jose] Univ Burgos, Escuela Politecn Super, Dept Ingn Civil, INSISOC,Area Org Empresas, Burgos, Spain	Universidad de Burgos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); Pompeu Fabra University; University of Bologna; ICREA; University of Witwatersrand; Universidad de Burgos	Ahedo, V (corresponding author), Univ Burgos, Dept Ingn Civil, Escuela Politecn Super, Area Org Empresas, Burgos, Spain.; Ahedo, V (corresponding author), CSIC, Inst Mila & Fontanals, CaSEs Culture & Socioecol Syst Res Grp, Dept Arqueol & Antropol, Barcelona, Spain.; Ahedo, V (corresponding author), UPF, Dept Humanidades, Barcelona, Spain.	vahedo@ubu.es	Madella, Marco/M-3320-2014; Galán, José Manuel/B-9782-2009; Ahedo, Virginia/U-6406-2017; Zurro, Debora/L-3965-2014	Madella, Marco/0000-0002-9324-1545; Galán, José Manuel/0000-0003-3360-7602; Ahedo, Virginia/0000-0002-9812-388X; Zurro, Debora/0000-0003-2498-9338; BORTOLINI, EUGENIO/0000-0001-6751-5680; Caro Saiz, Jorge/0000-0002-5065-4841	Spanish Ministry of Science, Innovation and Universities [CSD2010-00034 CONSOLIDER-INGENIO 2010, HAR2017-90883-REDC, HAR2016-77672-P]; European Social Fund; Department of Education of Junta de Castilla y Leon	Spanish Ministry of Science, Innovation and Universities; European Social Fund(European Social Fund (ESF)); Department of Education of Junta de Castilla y Leon	The authors acknowledge support from the Spanish Ministry of Science, Innovation and Universities: SimulPast Project (CSD2010-00034 CONSOLIDER-INGENIO 2010), (VA, JC, EB, DZ, MM, JMG), Consolider Excellence Network (HAR2017-90883-REDC) (VA, JC, EB, DZ, MM, JMG), and CULM Project (HAR2016-77672-P) (DZ, JC, MM). In addition, this work was partially supported by the European Social Fund, as the corresponding author is the recipient of a predoctoral grant from the Department of Education of Junta de Castilla y Leon (VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr Stefano Biagetti for his advice and insightful suggestions, as well as the two reviewers of the article (Dr Sandrine Gallois and the anonymous reviewer) for their constructive comments, which helped us to improve the manuscript significantly. The authors especially appreciate the help and support provided by the Human Relations Area Files (HRAF), that gave free access to the eHRAF World Cultures database to Dr Jorge Caro during part of his PhD.	Abdi H., 2007, ENCY MEAS STAT, P1, DOI DOI 10.4135/9781412952644; Adem TA, 2012, CULTURE SUMMARY SAMO; Andersen Raol, 1970, ETHNOHISTORY, VXVII, P49; ANDERSON DG, 1991, ARCTIC, V44, P12; Anderssen E, 2006, CHEMOMETR INTELL LAB, V84, P69, DOI 10.1016/j.chemolab.2006.04.021; [Anonymous], 1996, NATURE SOC ANTHR PER; Arhem K., 1981, MAKUNA SOCIAL ORG ST; Austerlitz R., 2010, CULTURE SUMMARY NIVK; Basak D., 2007, NEURAL INF PROCESS L, V11; Basehart H.W., 1974, MESCALERO APACHE SUB; BASEHART HW, 1970, SOUTHWEST J ANTHROP, V26, P87, DOI 10.1086/soutjanth.26.1.3629272; Beierle J., 2002, CULTURE SUMMARY STON; Beierle J., 1998, CULTURE SUMMARY TUKA; Beierle J., 2012, CULTURE SUMMARY CHIR; Beierle John, 2006, CULTURE SUMMARY JIVA; Benz M., 2010, P S HELD 29 31 JAN 2, P330; Berkman E.T., 2012, CONCEPTUAL GUIDE STA; Bhanu B. A., 2014, E ANTHR, V67, P325; Binford L.R., 2001, CONSTRUCTING FRAMES; Bird RLB, 1997, CURR ANTHROPOL, V38, P49, DOI 10.1086/204581; BODENHORN B, 2000, SENRI ETHNOLOGICAL S, V53, P27, DOI DOI 10.15021/00002844; BOHANNAN P, 1963, SOCIAL ANTHR; Borgerhoff Mulder M, 2012, HUMAN BEHAV ECOLOGY, DOI [10.1002/9780470015902.a0003671.pub2, DOI 10.1002/9780470015902.A0003671.PUB2]; Bortolini E, 2017, P NATL ACAD SCI USA, V114, P9140, DOI 10.1073/pnas.1614395114; Boyd R., 1985, CULTURE EVOLUTIONARY; Brown Gillian R., 2014, Journal of Bioeconomics, V16, P105, DOI 10.1007/s10818-013-9166-4; CARACO T, 1986, J THEOR BIOL, V118, P379, DOI 10.1016/S0022-5193(86)80160-6; Caro J., 2017, NORMAS REPARTO RECUR; CASHDAN EA, 1980, AM ANTHROPOL, V82, P116, DOI 10.1525/aa.1980.82.1.02a00100; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Chagnon N., 2000, ADAPTATION HUMAN BEH, P27; Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34; Collings P, 1998, ARCTIC, V51, P301; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Creanza N, 2015, P NATL ACAD SCI USA, V112, P1265, DOI 10.1073/pnas.1424033112; Creanza N, 2014, P NATL ACAD SCI USA, V111, P10830, DOI 10.1073/pnas.1400824111; Crema ER, 2014, J ARCHAEOL SCI, V43, P289, DOI 10.1016/j.jas.2014.01.002; Damas D., 1972, HUNTERS GATHERERS TO, P3; Damas David, 1996, CULTURE SUMMARY COPP; David F., 2010, MAGDALENIAN HOUSEHOL, P245; Davies NB, 2012, INTRO BEHAV ECOLOGY; Delaney HD, 2002, PSYCHOL METHODS, V7, P485, DOI 10.1037//1082-989X.7.4.485; Dyble M, 2016, CURR BIOL, V26, P2017, DOI 10.1016/j.cub.2016.05.064; Ember C.R., 2001, CROSS CULTURAL RES M; Ember CR, 2018, EVOL HUM BEHAV, V39, P380, DOI 10.1016/j.evolhumbehav.2018.03.001; Ember M, 2000, ETHNOLOGY, V39, P349, DOI 10.2307/3774051; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Enloe J., 2003, FARMING, V21, P1, DOI [10.3828/bfarm.2003.1.1, DOI 10.3828/BFARM.2003.1.1]; Evans-Pritchard E.E., 1940, NUER DESCRIPTION MOD; Ewers JC, 1955, HORSE BLACKFOOT INDI, Vxv, P374; Fagerland MW, 2009, STAT MED, V28, P1487, DOI 10.1002/sim.3561; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Feltovich N., 2003, Experimental Economics, V6, P273, DOI 10.1023/A:1026273319211; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Flannery K.V., 1972, ANNU REV ECOL SYST, V3, P399, DOI 10.1146/annurev.es.03.110172.002151; FOLEY R, 1985, MAN, V20, P222, DOI 10.2307/2802382; Fort J, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0166; Fort J, 2012, P NATL ACAD SCI USA, V109, P18669, DOI 10.1073/pnas.1200662109; Fortier J, 2001, ETHNOLOGY, V40, P193, DOI 10.2307/3773965; Franzen M, 2007, ECOL ECON, V63, P776, DOI 10.1016/j.ecolecon.2007.02.001; Frey R., 2014, CULTURE SUMMARY CROW; Garfield ZH., 2016, SOCIAL LEARNING INNO, P19; Godoy R, 2005, ANNU REV ANTHROPOL, V34, P121, DOI 10.1146/annurev.anthro.34.081804.120412; Goldman I., 1963, CUBEO INDIANS NW AMA; Gorfine M., 2015, SCIENCE, P1; Grafen A, 2006, J THEOR BIOL, V238, P541, DOI 10.1016/j.jtbi.2005.06.009; Greenfield PJ, 2002, CULTURE SUMMARY W AP; Gregory Christopher, 2015, GIFTS COMMODITIES, VSecond; Grier Colin, 2000, Hierarchies in Action: Cui Bono?, P264; Grinnell GB., 1892, AM ANTHROPOL, V5, P153; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Gurven M, 2000, HUM ECOL, V28, P171, DOI 10.1023/A:1007067919982; GUY J, 1987, J S AFR STUD, V14, P18, DOI 10.1080/03057078708708158; Hames R, 2007, HUM NATURE-INT BIOS, V18, P1, DOI 10.1007/BF02820843; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harder MNC, 2012, GAMMA RADIATION, P305; Harner Michael J., 1984, JIVARO PEOPLE SACRED; Hastie T., 2009, ELEMENTS STAT LEARNI, P520, DOI DOI 10.1007/978-0-387-84858-7; Heinen HD, 1973, ADAPTIVE CHANGES TRI; Heinen HD, 2001, CULTURE SUMMARY WARA; Heinen HD, 1974, J ANTHROPOL RES, V30, P116; Heller R, 2013, BIOMETRIKA, V100, P503, DOI 10.1093/biomet/ass070; Henriksen G., 1973, HUNTERS BARRENS NASK; Honigmann J.J.B., 1948, CULTURE ETHOS KASKA; Honigmann JJ, 2012, CULTURE SUMMARY KASK; Horne C, 2002, RATION SOC, V14, P285, DOI 10.1177/1043463102014003002; Horne Christine., 2009, REWARDS PUNISHMENT R; Hunt RC, 2000, SENRI ETHNOL STUD, DOI [10.15021/00002843, DOI 10.15021/00002843]; Ihara Y, 2004, THEOR POPUL BIOL, V65, P105, DOI 10.1016/j.tpb.2003.07.003; Ikeya K., 2013, SENRI ETHNOL STUD NA, P121, DOI [10.15021/00002440, DOI 10.15021/00002440]; Jaeggi AV, 2013, EVOL ANTHROPOL, V22, P186, DOI 10.1002/evan.21364; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7; Kameda T, 2005, CURR DIR PSYCHOL SCI, V14, P331, DOI 10.1111/j.0963-7214.2005.00392.x; Kaplan H., 2005, MORAL SENTIMENTS MAT; Karsten R., 1935, COMMENTATIONES HUMAN, V598, pxvi; Kirby KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158391; Kishigami N, 2004, J ANTHROPOL RES, V60, P341, DOI 10.1086/jar.60.3.3630754; Kitanishi K., 2000, SENRI ETHNOL STUD, V53, P149; Krebs J.R., 1996, BEHAV ECOLOGY EVOLUT; KRUPNIK II, 1987, ARCTIC, V40, P16; Kuncheva LI, 2014, COMBINING PATTERN CLASSIFIERS: METHODS AND ALGORITHMS, 2ND EDITION, P1; Laland KN, 2006, EVOL ANTHROPOL, V15, P95, DOI 10.1002/evan.20093; Laland KN, 2010, J ARCHAEOL METHOD TH, V17, P303, DOI 10.1007/s10816-010-9096-6; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Laland KN, 2001, J EVOLUTION BIOL, V14, P22, DOI 10.1046/j.1420-9101.2001.00262.x; Lancelotti C, 2016, ECOL SOC, V21, DOI 10.5751/ES-08757-210408; Lenoir JD, 1997, PARAMACCA MAROONS ST; LIa Shternberg, 1933, GILYAK OROCHI GOLDI; Loterman G, 2012, INT J FORECASTING, V28, P161, DOI 10.1016/j.ijforecast.2011.01.006; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Macdonald Gaynor, 2000, SOCIAL EC SHARING RE, V53, P87, DOI DOI 10.15021/00002846; Mace R, 2011, PHILOS T R SOC B, V366, P402, DOI 10.1098/rstb.2010.0238; Malinowski B., 1961, ARGONAUTS W PACIFIC; Marlowe FW, 2004, RES ECON ANTHROPOL, V23, P69, DOI 10.1016/S0190-1281(04)23003-7; Mauss M., 1954, AM SOCIOLOGICAL REV; Morgan LH, 1959, INDIAN J 1859 62; MURDOCK GP, 1967, ETHNOLOGY, V6, P109, DOI 10.2307/3772751; Murphy RF, 1960, SOCIAL EC CHANGE MUN; Murphy Yolanda, 1985, WOMEN FOREST; NEIMAN FD, 1995, AM ANTIQUITY, V60, P7, DOI 10.2307/282074; Nettle D, 2013, BEHAV ECOL, V24, P1031, DOI 10.1093/beheco/ars222; Nettle D, 2009, TRENDS ECOL EVOL, V24, P618, DOI 10.1016/j.tree.2009.05.013; NUGENT D, 1993, AM ETHNOL, V20, P336, DOI 10.1525/ae.1993.20.2.02a00070; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Opler M. E., 1941, APACHE LIFE WAY EC S; Orquera L.A., 1999, ARQUEOLOGIA REGION C; Pardo C, 2013, APPL MATH COMPUT, V219, P9914, DOI 10.1016/j.amc.2013.03.139; Patton JQ, 2005, EVOL HUM BEHAV, V26, P137, DOI 10.1016/j.evolhumbehav.2004.08.008; Pereda M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45574; Perry RJ., 1993, APACHE RESERVATION I; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pinhasi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006747; Polanyi K, 1957, TRADE MARKET EARLY E, P243; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Reed Richard K., 1995, PROPHETS AGROFORESTR; Reed RK, 1998, CULTURE SUMMARY GUAR; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reid GF, 2009, CULTURE SUMMARY INNU; Ren Y, 2016, IEEE COMPUT INTELL M, V11, P41, DOI 10.1109/MCI.2015.2471235; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Reyes-Garcia V, 2016, CURR ANTHROPOL, V57, P761, DOI 10.1086/689307; Rodnick D., 1938, FORT BELKNAP ASSINIB; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Rousset F, 1997, GENETICS, V145, P1219; Sahlins M., 1972, STONE AGE EC; Santos JI, 2015, PLOS ONE, DOI [10.2307/282074, DOI 10.2307/282074]; Sharp HS, 1994, INVERTED SACRIFICE, P253; Sharp HS, 1981, NULL CASE CHIPEWYAN, P221; Shennan SJ, 2015, EVOL HUM BEHAV, V36, P103, DOI 10.1016/j.evolhumbehav.2014.09.006; Simon N, 2014, COMMENT DETECTING NO; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Smith BD., 2009, COMMUNICATIVE INTEGR, V2, P533, DOI DOI 10.4161/cib.2.6.9613; Smith EA, 2001, TRENDS ECOL EVOL, V16, P128, DOI 10.1016/S0169-5347(00)02077-2; SMITH EA, 1983, CURR ANTHROPOL, V24, P625, DOI 10.1086/203066; SMITH EA, 2007, MODEL BASED ARCHAEOL; SMITH EF, 1981, KANS AES BULL, P1; Smith EA, 2011, PHILOS T R SOC B, V366, P325, DOI 10.1098/rstb.2010.0233; Snow J., 1977, THESE MOUNTAINS ARE; Sorokowska A, 2017, APPETITE, V116, P291, DOI 10.1016/j.appet.2017.05.015; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Trudeau N., 2002, SUSTAINABLE FOOD SEC, P103; Turchin Peter, 2015, CLIODYNAMICS J QUANT, V6, DOI [10.21237/C7clio6127917, DOI 10.21237/C7CLIO6127917]; van Wetering W, 1999, CULTURE SUMMARY NDYU; VanStone JW, 1963, SNOWDRIFT CHIPEWYAN, V2, P4; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Voget Fred, 1980, POLITICAL ORG NATIVE, P14163; Voget FW, 2001, HDB N AM INDIANS, P695; Widlok T, 2013, HAU-J ETHNOGR THEORY, V3, P11, DOI 10.14318/hau3.2.003; WINTERHALDER B, 1986, J ANTHROPOL ARCHAEOL, V5, P369, DOI 10.1016/0278-4165(86)90017-6; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Witherspoon G., 1975, NAVAJO KINSHIP MARRI; Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341; Woodburn James, 1998, PROPERTY RELATIONS R; Wright S, 1943, GENETICS, V28, P114; Zhornitskaya M, 1996, CULTURE SUMMARY CHUK; Ziker J. P., 2002, PEOPLES TUNDRA NO SI; Ziker JP, 2007, ECOL FOOD NUTR, V46, P445, DOI 10.1080/03670240701486743; Ziker JP, 2014, EXPT SOCIAL NORMS FA	182	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216302	10.1371/journal.pone.0216302	http://dx.doi.org/10.1371/journal.pone.0216302			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141510	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000005
J	Xue, YF; Guo, CZ; Hu, F; Zhu, WY; Mao, SY				Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong			Maternal undernutrition induces fetal hepatic lipid metabolism disorder and affects the development of fetal liver in a sheep model	FASEB JOURNAL			English	Article						fetus; fatty acid; triglyceride; cell cycle; DNA replication	CELL-CYCLE PROGRESSION; FATTY-ACID SYNTHASE; LATE PREGNANCY; GROWTH-RATE; APOPTOSIS; RESTRICTION; PLASMA; BIRTH; EWES; PHOSPHATIDYLETHANOLAMINE	Undernutrition accelerates body fat mobilization to alleviate negative energy balance, which disrupts homeostasis of lipid metabolism in maternal liver. However, little is known about its effect on fetal metabolism and development. Here, a sheep model was used to explore whether maternal undernutrition induces fetal lipid metabolism disorder and further inhibits fetal hepatic development. Twenty pregnant ewes were either fed normally or restricted to 30% level for 15 d, after which fetal hepatic samples were collected to conduct transcriptome, metabolome, histomorphology, and biochemical analysis. Results showed that maternal undernutrition altered the general transcriptome profile and metabolic mode in fetal liver. Fatty acid oxidation and ketogenesis were enhanced in fetal livers of undernourished ewes, which might be promoted by the activated peroxisome proliferator-activated receptor alpha signaling pathway, whereas cholesterol, steroid, and fatty acid synthesis were repressed. Maternal undernutrition increased triglyceride synthesis, decreased triglyceride degradation, and inhibited phospholipid degradation and synthesis in fetal liver. In addition, our data revealed that maternal undernutrition extremely inhibited DNA replication, cell cycle progression, and antiapoptosis and broke the balance between cell proliferation and apoptosis in fetal liver, indicating that maternal undernutrition affects the growth and development of fetal liver. Generally, these findings provide evidence that maternal undernutrition during pregnancy disturbs fetal lipid metabolism and inhibits fetal hepatic development in sheep, which greatly contribute to the further study of fetal metabolism and development in human beings.-Xue, Y., Guo, C., Hu, F., Zhu, W., Mao, S. Maternal undernutrition induces fetal hepatic lipid metabolism disorder and affects the development of fetal liver in a sheep model.	[Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Lab Gastrointestinal Microbiol, Nanjing, Jiangsu, Peoples R China; [Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Natl Expt Teaching Demonstrat Ctr Anim Sci, Natl Ctr Int Res Anim Gut Nutr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Mao, SY (corresponding author), Nanjing Agr Univ, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China.	maoshengyong@njau.edu.cn			National Key Research and Development Program of China [2016YFD0501200]	National Key Research and Development Program of China	The present study was supported by the National Key Research and Development Program of China (Grant 2016YFD0501200). The authors declare no conflicts of interest.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Artwohl M, 2004, FASEB J, V18, P146, DOI 10.1096/fj.03-0301fje; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Cal L, 2009, ARQ BRAS MED VET ZOO, V61, P306, DOI 10.1590/S0102-09352009000200004; Cal-Pereyra L, 2015, NEW ZEAL VET J, V63, P141, DOI 10.1080/00480169.2014.971083; Cavanaugh SE, 2015, ALCOHOL ALCOHOLISM, V50, P251, DOI 10.1093/alcalc/agu108; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Grover Z, 2009, PEDIATR CLIN N AM, V56, P1055, DOI 10.1016/j.pcl.2009.07.001; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Ismail ZAB, 2008, VET CLIN PATH, V37, P434, DOI 10.1111/j.1939-165X.2008.00076.x; Jobgen WS, 2008, J ANIM SCI, V86, P820, DOI 10.2527/jas.2007-0624; Kwon H, 2004, BIOL REPROD, V71, P901, DOI 10.1095/biolreprod.104.029645; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Martinez-Botas J, 1999, FASEB J, V13, P1359, DOI 10.1096/fasebj.13.11.1359; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MELLOR DJ, 1983, BRIT VET J, V139, P307, DOI 10.1016/S0007-1935(17)30436-0; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Pizer ES, 1998, CANCER RES, V58, P4611; POND WG, 1969, J NUTR, V99, P61, DOI 10.1093/jn/99.1.61; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; Stein AD, 2004, INT J EPIDEMIOL, V33, P831, DOI 10.1093/ije/dyh083; Suarez Y, 2002, EUR J BIOCHEM, V269, P1761, DOI 10.1046/j.1432-1327.2002.02822.x; Surette ME, 1999, CARCINOGENESIS, V20, P757, DOI 10.1093/carcin/20.5.757; Swanson AM, 2015, PLACENTA, V36, P623, DOI 10.1016/j.placenta.2015.03.003; Vance D. E., 1991, BIOCH LIPIDS LIPOPRO; Wang M., 2014, AGR SCI TECHNOL, V15, P470; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wellner N, 2013, BBA-MOL CELL BIOL L, V1831, P652, DOI 10.1016/j.bbalip.2012.08.019; WHO/FAO UNU, 1985, WHO TECHN REP SER, V724, P220; WILLIAMS.DH, 1968, BIOCHEM J, V108, P353, DOI 10.1042/bj1080353; Williamson D H, 1978, Biochem Soc Symp, P137; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Wu GY, 2012, PAEDIATR PERINAT EP, V26, P4, DOI 10.1111/j.1365-3016.2012.01291.x; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xue YF, 2019, ANIMAL, V13, P992, DOI 10.1017/S1751731118002136; Xue YF, 2018, METABOLITES, V8, DOI 10.3390/metabo8040085; Zhang CZ, 2015, CZECH J ANIM SCI, V60, P557, DOI 10.17221/8598-CJAS	48	17	18	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9990	10004		10.1096/fj.201900406R	http://dx.doi.org/10.1096/fj.201900406R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31167079				2022-12-26	WOS:000482214200023
J	Zhou, L; Kohncke, C; Hu, ZY; Roepke, TK; Abbott, GW				Zhou, Leng; Koehncke, Clemens; Hu, Zhaoyang; Roepke, Torsten K.; Abbott, Geoffrey W.			The KCNE2 potassium channel beta subunit is required for normal lung function and resilience to ischemia and reperfusion injury	FASEB JOURNAL			English	Article						KCNQ1; MiRP1; pulmonary; K-v channel; epithelial	GENOME-WIDE ASSOCIATION; K+ CHANNEL; ANION SECRETION; KCNQ1; EXPRESSION; DELETION; MINK; PROTEINS; ISK; SENSITIVITY	The KCNE2 single transmembrane-spanning voltage-gated potassium (K-v) channel beta subunit is ubiquitously expressed and essential for normal function of a variety of cell types, often via regulation of the KCNQ1 K-v channel. A polymorphism upstream of KCNE2 is associated with reduced lung function in human populations, but the pulmonary consequences of KCNE2 gene disruption are unknown. Here, germline deletion of mouse Kcne2 reduced pulmonary expression of potassium channel alpha subunits Kcnq1 and Kcnb1 but did not alter expression of other Kcne genes. Kcne2 colocalized and coimmunoprecipitated with Kcnq1 in mouse lungs, suggesting the formation of pulmonary Kcnq1-Kcne2 potassium channel complexes. Kcne2 deletion reduced blood O-2, increased CO2, increased pulmonary apoptosis, and increased inflammatory mediators TNF-alpha, IL-6, and leukocytes in bronchoalveolar lavage (BAL) fluids. Consistent with increased pulmonary vascular leakage, Kcne2 deletion increased plasma, BAL albumin, and the BAL:plasma albumin concentration ratio. Kcne2(-/-) mouse lungs exhibited baseline induction of the reperfusion injury salvage kinase pathway but were less able to respond via this pathway to imposed pulmonary ischemia/reperfusion injury (IRI). We conclude that KCNE2 regulates KCNQ1 in the lungs and is required for normal lung function and resistance to pulmonary IRI. Our data support a causal relationship between KCNE2 gene disruption and lung dysfunction.-Zhou, L., Kohncke, C., Hu, Z., Roepke, T. K., Abbott, G. W. The KCNE2 potassium channel beta subunit is required for normal lung function and resilience to ischemia and reperfusion injury.	[Zhou, Leng] Sichuan Univ, Dept Anesthesiol, Translat Neurosci Ctr, West China Hosp, Chengdu, Sichuan, Peoples R China; [Hu, Zhaoyang] Sichuan Univ, Lab Anesthesiol & Crit Care Med, Translat Neurosci Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China; [Koehncke, Clemens; Roepke, Torsten K.] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Roepke, Torsten K.] Charite Berlin Univ Med, Campus Mitte, Clin Cardiol & Angiol, Berlin, Germany; [Roepke, Torsten K.] Klinikum Niederlausitz, Clin Internal Med & Cardiol, Senftenberg, Germany; [Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Bioelect Lab, Dept Physiol & Biophys, D337 Med Sci 1, Irvine, CA 92697 USA	Sichuan University; Sichuan University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Irvine	Hu, ZY (corresponding author), Sichuan Univ, Lab Anesthesiol & Crit Care Med, Translat Neurosci Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China.; Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Bioelect Lab, Dept Physiol & Biophys, D337 Med Sci 1, Irvine, CA 92697 USA.	zyhu@hotmail.com; abbottg@uci.edu			National Natural Science Foundation of China [81700074, 81670300]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM115189, GM130377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115189, R35GM130377] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Siegfried Breitling (Charite Universitatsmedizin, Berlin), Angele de Silva (University of California-Irvine), and Dr. Maria Papanikolaou (University of California-Irvine) for technical assistance. This study was supported by Grants 81700074 (to L.Z.) and 81670300 (to Z.H.) from the National Natural Science Foundation of China and GM115189 and GM130377 from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (to G.W.A.). The authors declare no conflicts of interest.	Abbott GW, 2016, GENE, V593, P249, DOI 10.1016/j.gene.2016.07.069; Abbott GW, 2016, GENE, V576, P1, DOI 10.1016/j.gene.2015.09.059; Abbott GW, 2015, GENE, V569, P162, DOI 10.1016/j.gene.2015.06.061; Abbott GW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005025; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Alzamora R, 2011, J PHYSIOL-LONDON, V589, P5091, DOI 10.1113/jphysiol.2011.215772; Anantharam Arun, 2005, V266, P100; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Boini KM, 2009, AM J PHYSIOL-REG I, V296, pR1695, DOI 10.1152/ajpregu.90839.2008; Brueggemann LI, 2014, AM J PHYSIOL-LUNG C, V306, pL476, DOI 10.1152/ajplung.00253.2013; Choi E, 2010, FASEB J, V24, P1518, DOI 10.1096/fj.09-145219; Cowley EA, 2002, J PHYSIOL-LONDON, V543, P201, DOI 10.1113/jphysiol.2002.022400; Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1113/jphysiol.2001.013300; Cuthbert AW, 2003, BRIT J PHARMACOL, V140, P81, DOI 10.1038/sj.bjp.0705403; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Demolombe S, 2001, AM J PHYSIOL-CELL PH, V280, pC359, DOI 10.1152/ajpcell.2001.280.2.C359; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; Franco D, 2001, CARDIOVASC RES, V52, P65, DOI 10.1016/S0008-6363(01)00349-2; Gordon E, 2008, CARDIOVASC RES, V77, P98, DOI 10.1093/cvr/cvm030; Grahammer F, 2001, J BIOL CHEM, V276, P42268, DOI 10.1074/jbc.M105014200; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Hausenloy DJ, 2005, TRENDS CARDIOVAS MED, V15, P69, DOI 10.1016/j.tcm.2005.03.001; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Heitzmann D, 2007, CELL PHYSIOL BIOCHEM, V19, P21, DOI 10.1159/000099189; Hu ZY, 2016, CARDIOVASC RES, V110, P227, DOI 10.1093/cvr/cvw048; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KELLEY J, 1990, AM REV RESPIR DIS, V141, P765, DOI 10.1164/ajrccm/141.3.765; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kroncke BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501228; Kundu P, 2008, MOL CELL ENDOCRINOL, V292, P50, DOI 10.1016/j.mce.2008.06.003; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Lee SM, 2017, FASEB J, V31, P2674, DOI 10.1096/fj.201601347; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Lee SM, 2015, J MOL CELL CARDIOL, V87, P148, DOI 10.1016/j.yjmcc.2015.08.013; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Pan Q, 2010, MOL BIOL REP, V37, P1329, DOI 10.1007/s11033-009-9511-9; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Rapetti-Mauss R, 2013, J PHYSIOL-LONDON, V591, P2813, DOI 10.1113/jphysiol.2013.251678; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2011, FASEB J, V25, P4264, DOI 10.1096/fj.11-187609; Roepke TK, 2011, FASEB J, V25, P727, DOI 10.1096/fj.10-173682; Roepke TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011451; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sabater-Lleal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104082; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Wakil SM, 2016, ATHEROSCLEROSIS, V245, P62, DOI 10.1016/j.atherosclerosis.2015.11.019	58	4	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9762	9774		10.1096/fj.201802519R	http://dx.doi.org/10.1096/fj.201802519R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162977	Green Published			2022-12-26	WOS:000482214200007
J	Naito, Y; Yamamoto, Y; Sakamoto, N; Shimomura, I; Kogure, A; Kumazaki, M; Yokoi, A; Yashiro, M; Kiyono, T; Yanagihara, K; Takahashi, RU; Hirakawa, K; Yasui, W; Ochiya, T				Naito, Yutaka; Yamamoto, Yusuke; Sakamoto, Naoya; Shimomura, Iwao; Kogure, Akiko; Kumazaki, Minami; Yokoi, Akira; Yashiro, Masakazu; Kiyono, Tohru; Yanagihara, Kazuyoshi; Takahashi, Ryou-u; Hirakawa, Kosei; Yasui, Wataru; Ochiya, Takahiro			Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts	ONCOGENE			English	Article							TGF-BETA; CELLS; RECRUITMENT; EXPRESSION; CARCINOMA; GROWTH; CXCL1; CHEMORESISTANCE; INTERLEUKIN-8; LOCALIZATION	Cancer-associated fibroblasts (CAFs), one of the major components of a tumour microenvironment, comprise heterogeneous populations involved in tumour progression. However, it remains obscure how CAF heterogeneity is governed by cancer cells. Here, we show that cancer extracellular vesicles (EVs) induce a series of chemokines in activated fibroblasts and contribute to the formation of the heterogeneity. In a xenograft model of diffuse-type gastric cancer, we showed two distinct fibroblast subpopulations with alpha-smooth muscle actin (alpha-SMA) expression or chemokine expression. MicroRNAs (miRNAs) profiling of the EVs and the transfection experiment suggested that several miRNAs played a role in the induction of chemokines such as CXCL1 and CXCL8 in fibroblasts, but not for the myofibroblastic differentiation. Clinically, aberrant activation of CXCL1 and CXCL8 in CAFs correlated with poorer survival in gastric cancer patients. Thus, this link between chemokine expression in CAFs and tumour progression may provide novel targets for anticancer therapy.	[Naito, Yutaka; Yamamoto, Yusuke; Shimomura, Iwao; Kogure, Akiko; Kumazaki, Minami; Yokoi, Akira; Takahashi, Ryou-u; Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Tokyo, Japan; [Sakamoto, Naoya; Yasui, Wataru] Hiroshima Univ, Dept Mol Pathol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Yashiro, Masakazu; Hirakawa, Kosei] Osaka City Univ, Mol Oncol & Therapeut, Grad Sch Med, Osaka, Japan; [Kiyono, Tohru] Natl Canc Ctr, Div Carcinogenesis & Canc Prevent, Tokyo, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Div Biomarker Discovery, Exploratory Oncol & Clin Trial Ctr, Chiba, Japan; [Takahashi, Ryou-u] Hiroshima Univ, Dept Cellular & Mol Biol, Div Integrated Med Sci, Grad Sch Biomed Sci, Hiroshima, Japan; [Ochiya, Takahiro] Tokyo Med Univ, Dept Mol & Cellular Med, Inst Med Sci, Tokyo, Japan	National Cancer Center - Japan; Hiroshima University; Osaka Metropolitan University; National Cancer Center - Japan; National Cancer Center - Japan; Hiroshima University; Tokyo Medical University	Ochiya, T (corresponding author), Natl Canc Ctr, Div Mol & Cellular Med, Tokyo, Japan.; Ochiya, T (corresponding author), Tokyo Med Univ, Dept Mol & Cellular Med, Inst Med Sci, Tokyo, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019; Asada, Akiko/ABF-7324-2020		JSPS KAKENHI Grant [15K21646, 17H04991, 17K19625]; JSPS [15J10473]; Center of Open Innovation Network for Smart Health (COINS); Council for Science; Japan Agency for Medical Research and development, AMED; Naito foundation	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Open Innovation Network for Smart Health (COINS); Council for Science; Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Naito foundation(Naito Memorial Foundation)	We thank Mr. Shinichi Norimura in Hiroshima University for his excellent technical assistance. This work was supported by JSPS KAKENHI Grant Number 15K21646, 17H04991 and 17K19625, and JSPS Fellows 15J10473 and in part by a Grant-in-Aid for the Japan Science and Technology Agency (JST) through the Center of Open Innovation Network for Smart Health (COINS) initiated by the Council for Science, a Grant-in-Aid for the Project for Cancer Research And Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and development, AMED; and the research grant from Naito foundation.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Al-Alwan LA, 2013, J IMMUNOL, V191, P2731, DOI 10.4049/jimmunol.1203421; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Asfaha S, 2013, GASTROENTEROLOGY, V144, P155, DOI 10.1053/j.gastro.2012.09.057; Baroni S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.224; Belli C, 2018, CANCER TREAT REV, V65, P22, DOI 10.1016/j.ctrv.2018.02.004; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Cheng WL, 2011, ANN ONCOL, V22, P2267, DOI 10.1093/annonc/mdq739; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Eck M, 2003, CLIN EXP IMMUNOL, V134, P508, DOI 10.1111/j.1365-2249.2003.02305.x; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Givel AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03348-z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kasashima H, 2016, AM J PATHOL, V186, P3028, DOI 10.1016/j.ajpath.2016.07.024; Kawajiri H, 2008, CLIN CANCER RES, V14, P2850, DOI 10.1158/1078-0432.CCR-07-1634; Kitadai Y, 1998, AM J PATHOL, V152, P93; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MIZOI T, 1993, CANCER RES, V53, P183; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Paggetti J, 2015, BLOOD, V126, P1106, DOI 10.1182/blood-2014-12-618025; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; Raja UM, 2017, CYTOKINE, V89, P82, DOI 10.1016/j.cyto.2016.08.032; Roswall P, 2018, NAT MED, V24, P463, DOI 10.1038/nm.4494; Shinto O, 2010, BRIT J CANCER, V102, P844, DOI 10.1038/sj.bjc.6605561; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Sugimoto H, 2014, CANCER BIOL THER, V5, P1640; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Verbeke H, 2011, CANCER LETT, V302, P54, DOI 10.1016/j.canlet.2010.12.013; Webber JP, 2015, ONCOGENE, V34, P319, DOI 10.1038/onc.2013.560; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Wu RF, 2018, J CLIN INVEST, V128, P2551, DOI 10.1172/JCI97426; Yamaguchi H, 2015, CANCERS, V7, P2054, DOI 10.3390/cancers7040876; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yanagihara K, 2006, CANCER RES, V66, P7532, DOI 10.1158/0008-5472.CAN-05-3259; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042	48	53	54	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 11	2019	38	28					5566	5579		10.1038/s41388-019-0832-4	http://dx.doi.org/10.1038/s41388-019-0832-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IH9RW	31147602	Green Published, hybrid			2022-12-26	WOS:000474845100002
J	Guan, JH; Hsieh, F; Koehl, P				Guan, Jiahui; Hsieh, Fushing; Koehl, Patrice			DCG plus plus : A data-driven metric for geometric pattern recognition	PLOS ONE			English	Article							STRUCTURE DEFINITION; HARMONIC-ANALYSIS; CONNECTIVITY; DIFFUSIONS; MODEL; TOOL	Clustering large and complex data sets whose partitions may adopt arbitrary shapes remains a difficult challenge. Part of this challenge comes from the difficulty in defining a similarity measure between the data points that captures the underlying geometry of those data points. In this paper, we propose an algorithm, DCG++ that generates such a similarity measure that is data-driven and ultrametric. DCG++ uses Markov Chain Random Walks to capture the intrinsic geometry of data, scans possible scales, and combines all this information using a simple procedure that is shown to generate an ultrametric. We validate the effectiveness of this similarity measure within the context of clustering on synthetic data with complex geometry, on a real-world data set containing segmented audio records of frog calls described by mel-frequency cepstral coefficients, as well as on an image segmentation problem. The experimental results show a significant improvement on performance with the DCG-based ultrametric compared to using an empirical distance measure.	[Guan, Jiahui; Hsieh, Fushing] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Koehl, P (corresponding author), Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA.; Koehl, P (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	koehl@cs.ucdavis.edu	Koehl, Patrice/K-5708-2013	Koehl, Patrice/0000-0002-0908-068X				Anderberg M. R., 1973, CLUSTER ANAL APPL; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Bader D.A., 2012, 10 DIMACS IMPLEMENTA; Blatt M, 1997, NEURAL COMPUT, V9, P1805, DOI 10.1162/neco.1997.9.8.1805; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Carlsson G, 2014, ACTA NUMER, V23, P289, DOI 10.1017/S0962492914000051; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chang H, 2008, PATTERN RECOGN, V41, P191, DOI 10.1016/j.patcog.2007.04.010; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7432, DOI 10.1073/pnas.0500896102; Cole EM, 2014, GLOB ECOL CONSERV, V1, P60, DOI 10.1016/j.gecco.2014.06.002; Colonna JG, 2016, LECT NOTES ARTIF INT, V9956, P198, DOI 10.1007/978-3-319-46307-0_13; DONATH WE, 1973, IBM J RES DEV, V17, P420, DOI 10.1147/rd.175.0420; FIEDLER M, 1973, CZECH MATH J, V23, P298; Fischer B, 2004, ADV NEUR IN, V16, P89; Fischer B, 2003, IEEE T PATTERN ANAL, V25, P513, DOI 10.1109/TPAMI.2003.1190577; FORTUIN CM, 1972, PHYSICA, V57, P536, DOI 10.1016/0031-8914(72)90045-6; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Franti P, 2016, LECT NOTES COMPUT SC, V10029, P207, DOI 10.1007/978-3-319-49055-7_19; Fu LM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-3; Fukunaga K., 2013, INTRO STAT PATTERN R; Fushing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056259; Fushing H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061110; Hartuv E, 2000, INFORM PROCESS LETT, V76, P175, DOI 10.1016/S0020-0190(00)00142-3; Horn D, 2002, ADV NEUR IN, V14, P769; Horn D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018702; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Jain AK, 2005, LECT NOTES COMPUT SC, V3776, P1, DOI 10.1145/1083091.1083101; LANCZOS C, 1950, J RES NAT BUR STAND, V45, P255, DOI 10.6028/jres.045.026; Lawson C. L., 1979, ACM Transactions on Mathematical Software, V5, P324, DOI [10.1145/355841.355847, 10.1145/355841.355848]; Lehoucq R.B., 1998, ARPACK USERS GUIDE S; Li DW, 2018, NEURAL NETWORKS, V105, P447, DOI 10.1016/j.neunet.2018.06.003; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; MATULA DW, 1972, SIAM J APPL MATH, V22, P459, DOI 10.1137/0122040; Matula DW., 1977, CLASSIFICATION CLUST; Nadler B, 2006, ADV NEURAL INFORM PR, V19, P1117; Ng AY, 2002, ADV NEUR IN, V14, P849; POTTS RB, 1952, P CAMB PHILOS SOC, V48, P106, DOI 10.1017/S0305004100027419; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Singh Gurjeet, 2007, EUR S POINT BAS GRAP, DOI [10.2312/SPBG/SPBG07/091-100, DOI 10.2312/SPBG/SPBG07/091-100]; STRASSEN V, 1969, NUMER MATH, V13, P354, DOI 10.1007/BF02165411; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tsaparas, 2007, ACM T KNOWL DISCOV D, V1, P4, DOI [10.1145/1217299.1217303, DOI 10.1145/1217299.1217303]; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang F, 2015, DATA MIN KNOWL DISC, V29, P534, DOI 10.1007/s10618-014-0356-z; Weinstein M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066117; WU Z, 1993, IEEE T PATTERN ANAL, V15, P1101, DOI 10.1109/34.244673; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; ZAHN CT, 1971, IEEE T COMPUT, VC 20, P68, DOI 10.1109/T-C.1971.223083; Zelnik-Manor L., 2005, ADV NEURAL INFORM PR, V17, P1601	55	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217838	10.1371/journal.pone.0217838	http://dx.doi.org/10.1371/journal.pone.0217838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170208	Green Submitted, gold, Green Published			2022-12-26	WOS:000470263700066
J	Fechner, C; Greiner, M; Heseker, H; Lindtner, O				Fechner, Carolin; Greiner, Matthias; Heseker, Helmut; Lindtner, Oliver			Dietary exposure assessment of aluminium and cadmium from cocoa in relation to cocoa origin	PLOS ONE			English	Article							TRACE-ELEMENTS; CACAO BEANS; FOOD; SOIL; CHOCOLATE; LEAD; FRACTIONATION; POWDER	Cocoa contains aluminium and cadmium as environmental contaminants while concentrations are supposed to be country of origin-related. Integrating origin in dietary exposure assessment could refine calculations. Averages or higher percentiles of concentrations in cocoa powder from German Food Monitoring (GFM) and cocoa consumption from the German National Nutrition Survey II (NVS II) were combined in standard scenarios. Additional origin-related scenarios used concentration data grouped into origin A (lower concentrations) and origin B (higher concentrations) as plausible origin information was rare. The most conservative standard scenario resulted in the highest intake estimates for aluminium and cadmium with 0.152 mg/week/kg BW and 0.363 mu g/week/kg BW and covered the origin influence calculated in origin-related scenarios. Having plausible origin information would help to refine exposure assessment as it is exemplarily shown here that origin-related lower intake estimates are possible. Using the Eurostat database and the Mintel Global New Product Database (GNPD) generated more origin information for products available on the German market. For Germany, cocoa beans, cocoa powder and cocoa mass were mainly sourced in Cote d'Ivoire, while the Netherlands was the main distributor. Packages of cocoa powders were sourced from different origins.	[Fechner, Carolin; Greiner, Matthias; Lindtner, Oliver] German Fed Inst Risk Assessment, Exposure, Berlin, Germany; [Greiner, Matthias] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Lower Saxony, Germany; [Heseker, Helmut] Paderborn Univ, Dept Sports & Hlth, Paderborn, North Rhine Wes, Germany; [Fechner, Carolin] Norwegian Inst Publ Hlth, Norwegian Sci Comm Food & Environm, Oslo, Norway	Federal Institute for Risk Assessment; University of Veterinary Medicine Hannover, Foundation; University of Paderborn; Norwegian Institute of Public Health (NIPH)	Fechner, C (corresponding author), German Fed Inst Risk Assessment, Exposure, Berlin, Germany.; Fechner, C (corresponding author), Norwegian Inst Publ Hlth, Norwegian Sci Comm Food & Environm, Oslo, Norway.	fechner.carolin@gmail.com		Fechner, Carolin/0000-0002-6586-8826				Abt E, 2018, FOOD ADDIT CONTAM B, V11, P92, DOI 10.1080/19393210.2017.1420700; Aguilar F, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.754; Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2197; [Anonymous], 2018, GLOB NEW PROD DAT GN; Arnich N, 2012, FOOD CHEM TOXICOL, V50, P2432, DOI 10.1016/j.fct.2012.04.016; Bertoldi D, 2016, FOOD CONTROL, V65, P46, DOI 10.1016/j.foodcont.2016.01.013; Blume K, 2010, ARZTEMANGEL KRANKENH, P1; Boateng DO., 2014, INT J ADV AGR RES, V2, P89; Brombach C, 2006, ERNAHRUNGS UMSCHAU, V53, P4; BVL Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit, 2012, BER LEB HEIT 2012 MO, P3; BVL Bundesamt fur Verbraucherschutz und Lebensmittelsicherheit, 2018, MON PROGR; Chavez E, 2015, SCI TOTAL ENVIRON, V533, P205, DOI 10.1016/j.scitotenv.2015.06.106; D'Elia G., 2011, Annali della Facolta di Medicina Veterinaria, Universita di Parma, V31, P65; Duku MH, 2011, RENEW SUST ENERG REV, V15, P3539, DOI 10.1016/j.rser.2011.05.010; European Food Safety Authority, 2012, EFSA J, V10, DOI [10.2903/j.efsa.2012.2551, 10.2903/j.efsa.2012.2831]; FAO, 2017, STAT FOOD AGR LEV FO, P1; Fechner C, 2020, J EXPO SCI ENV EPID, V30, P492, DOI 10.1038/s41370-019-0117-6; Fold N., 2001, J ECON GEOGR, V1, P405, DOI DOI 10.1093/JEG/1.4.405; Frankowski M, 2013, J ENVIRON MANAGE, V127, P1, DOI 10.1016/j.jenvman.2013.04.033; Frey HC, 2002, RISK ANAL, V22, P553; Heinemeyer G, 2015, GUIDANCE DOCUMENT UN; Husband C, 2009, ALUMINUM IND W CENTR; ICCO, 2017, ANN REP 2014 2015; ICCO International Cocoa Organization, 2008, ANN REP 2006 07; Kaplinsky R., 2004, UN C TRAD DEV UNCTAD; Krems C, 2006, ERNAHRUNGS-UMSCHAU, V53, P44; Kruszewski B, 2018, J FOOD COMPOS ANAL, V66, P127, DOI 10.1016/j.jfca.2017.12.012; Lindtner O, 2013, TOTAL DIET STUDIES, P521; Lo Dico GM, 2018, FOOD CHEM, V245, P1163, DOI 10.1016/j.foodchem.2017.11.052; Mora ML, 2006, SOIL USE MANAGE, V22, P95, DOI 10.1111/j.1475-2743.2006.00011.x; Mounicou S, 2003, FOOD ADDIT CONTAM A, V20, P343, DOI 10.1080/0265203031000077888; Muller M, 1998, FOOD CHEM, V61, P419, DOI 10.1016/S0308-8146(97)00085-X; Nordlokken M, 2015, SCI TOTAL ENVIRON, V502, P391, DOI 10.1016/j.scitotenv.2014.09.038; Ofori-Frimpong K, 1999, GHANA J AGR SCI, V32, P101; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Porter SD, 2016, REG ENVIRON CHANGE, V16, P2279, DOI 10.1007/s10113-015-0783-4; Sarvan I, 2017, BUNDESGESUNDHEITSBLA, V60, P689, DOI 10.1007/s00103-017-2566-1; Schneider K, 2014, FOOD ADDIT CONTAM A, V31, P1052, DOI 10.1080/19440049.2014.905875; Schwarz MA, 2014, FOOD ADDIT CONTAM A, V31, P688, DOI 10.1080/19440049.2013.878041; Sieke C, 2008, DEUT LEBENSM-RUNDSCH, V104, P271; Stahl Thorsten, 2011, Environmental Sciences Europe, V23, P38, DOI 10.1186/2190-4715-23-38; Uras U, 2012, J ANAL APPL PYROL, V98, P207, DOI 10.1016/j.jaap.2012.08.007; Vitola V., 2016, Rural Sustainability Research, V35, P19, DOI 10.1515/plua-2016-0003; Yaman M, 2006, ENVIRON MONIT ASSESS, V115, P279, DOI 10.1007/s10661-006-6554-4; Yanus RL, 2014, TALANTA, V119, P1, DOI 10.1016/j.talanta.2013.10.048	45	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217990	10.1371/journal.pone.0217990	http://dx.doi.org/10.1371/journal.pone.0217990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166999	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800056
J	Madrazo-Moya, CF; Cancino-Munoz, I; Cuevas-Cordoba, B; Gonzalez-Covarrubias, V; Barbosa-Amezcua, M; Soberon, X; Muniz-Salazar, R; Martinez-Guarneros, A; Backer, C; Zarrabal-Meza, J; Sampieri-Ramirez, C; Enciso-Moreno, A; Lauzardo, M; Comas, I; Zenteno-Cuevas, R				Francisco Madrazo-Moya, Carlos; Cancino-Munoz, Irving; Cuevas-Cordoba, Betzaida; Gonzalez-Covarrubias, Vanessa; Barbosa-Amezcua, Martin; Soberon, Xavier; Muniz-Salazar, Raquel; Martinez-Guarneros, Armando; Backer, Claudia; Zarrabal-Meza, Jose; Sampieri-Ramirez, Clara; Enciso-Moreno, Antonio; Lauzardo, Michael; Comas, Inaki; Zenteno-Cuevas, Roberto			Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico	PLOS ONE			English	Article							MGIT 960 SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; MUTATIONS; SUSCEPTIBILITY; PYRAZINAMIDE; VERACRUZ; RIFAMPIN; STRAINS; INDIA	Background Whole genome sequencing (WGS) has been proposed as a tool for diagnosing drug resistance in tuberculosis. However, reports of its effectiveness in endemic countries with important numbers of drug resistance are scarce. The goal of this study was to evaluate the effectiveness of this procedure in isolates from a tuberculosis endemic region in Mexico. Methods WGS analysis was performed in 81 tuberculosis positive clinical isolates with a known phenotypic profile of resistance against first-line drugs (isoniazid, rifampin, ethambutol, pyrazinamide and streptomycin). Mutations related to drug resistance were identified for each isolate; drug resistant genotypes were predicted and compared with the phenotypic profile. Genotypes and transmission clusters based on genetic distances were also characterized. Findings Prediction by WGS analysis of resistance against isoniazid, rifampicin, ethambutol, pyrazinamide and streptomycin showed sensitivity values of 84%, 96%, 71%, 75% and 29%, while specificity values were 100%, 94%, 90%, 90% and 98%, respectively. Prediction of multidrug resistance showed a sensitivity of 89% and specificity of 97%. Moreover, WGS analysis revealed polymorphisms related to second-line drug resistance, enabling classification of eight and two clinical isolates as pre- and extreme drug-resistant cases, respectively. Lastly, four lineages were identified in the population (L1, L2, L3 and L4). The most frequent of these was L4, which included 90% (77) of the isolates. Six transmission clusters were identified; the most frequent was TC6, which included 13 isolates with a L4.1.1 and a predominantly multidrug-resistant condition. Conclusions The results illustrate the utility of WGS for establishing the potential for prediction of resistance against first and second line drugs in isolates of tuberculosis from the region. They also demonstrate the feasibility of this procedure for use as a tool to support the epidemiological surveillance of drug-and multidrug-resistant tuberculosis.	[Francisco Madrazo-Moya, Carlos; Sampieri-Ramirez, Clara; Zenteno-Cuevas, Roberto] Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico; [Francisco Madrazo-Moya, Carlos; Zenteno-Cuevas, Roberto] Univ Veracruzana, Programa Maestria Ciencias Salud, Inst Ciencias Salud, Xalapa, Veracruz, Mexico; [Cancino-Munoz, Irving; Comas, Inaki] CSIC, Biomed Inst Valencia IBV, Valencia, Spain; [Cuevas-Cordoba, Betzaida; Gonzalez-Covarrubias, Vanessa; Barbosa-Amezcua, Martin; Soberon, Xavier] Inst Nacl Med Genom, Lab Farmacogenom, Mexico City, DF, Mexico; [Muniz-Salazar, Raquel] Univ Autonoma Baja Calif, Lab Epidemiol & Ecol & Mol, Escuela Ciencias Salud, Ensenada, Baja California, Mexico; [Martinez-Guarneros, Armando; Backer, Claudia] Inst Nacl Diagnost & Referencia Epidemiol, Lab Micobacterias, Mexico City, DF, Mexico; [Zarrabal-Meza, Jose] Secretaria Salud, Lab Estatal Salud Publ, Xalapa, Veracruz, Mexico; [Enciso-Moreno, Antonio] IMSS, Unidad Invest Biomed Zacatecas, Zacatecas, Zacatecas, Mexico; [Lauzardo, Michael] Univ Florida, Coll Med, Div Infect Dis & Global Med, Gainesville, FL USA; [Comas, Inaki] CIBER Epidemiol & Publ Hlth, Madrid, Spain	Universidad Veracruzana; Universidad Veracruzana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Instituto Nacional de Medicina Genomica; Universidad Autonoma de Baja California; State University System of Florida; University of Florida; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Zenteno-Cuevas, R (corresponding author), Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico.; Zenteno-Cuevas, R (corresponding author), Univ Veracruzana, Programa Maestria Ciencias Salud, Inst Ciencias Salud, Xalapa, Veracruz, Mexico.	robzencue@gmail.com	GUARNEROS, JOSE ARMANDO MARTINEZ/I-7475-2019; ZENTENO-CUEVAS, ROBERTO/A-7152-2012; Cancino-Muñoz, Irving/AAJ-2761-2020; Comas, Iñaki/AAA-1155-2019; Cuevas-Córdoba, Betzaida/C-4103-2014; Gonzalez-Covarrubias, Vanessa/AAG-3675-2020	ZENTENO-CUEVAS, ROBERTO/0000-0001-9597-127X; Cancino-Muñoz, Irving/0000-0002-5261-1634; Comas, Iñaki/0000-0001-5504-9408; Cuevas-Córdoba, Betzaida/0000-0002-6528-9998; Madrazo Moya, Carlos Francisco/0000-0002-1131-481X; Muniz-Salazar, Raquel/0000-0001-5528-7772; Sampieri, Clara Luz/0000-0001-7495-426X; Martinez-Guarneros, Armando/0000-0003-4042-9680	CONACyT-Problemas nacionales grant [2015-01-147]; GACD-FONCICYT Conacyt [264693];  [I-COOP-2017-COOPB2032]	CONACyT-Problemas nacionales grant; GACD-FONCICYT Conacyt; 	CFM-M was a CONACYT fellow of the Maestria en Ciencias de la Salud of the Instituto de Ciencias de la Salud Universidad Veracruzana. RZC and IC were partially funded by I-COOP-2017-COOPB2032. RMS was funded by CONACyT-Problemas nacionales grant no. 2015-01-147. XS was funded by GACD-FONCICYT Conacyt No. 264693.	Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117771; Aung HL, 2016, J GLOB ANTIMICROB RE, V6, P113, DOI 10.1016/j.jgar.2016.04.008; Castellanos-Joya M., 2014, ACTUAL SITUATION TUB; Chatterjee A, 2017, TUBERCULOSIS, V107, P63, DOI 10.1016/j.tube.2017.08.002; Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Coll F, 2018, NAT GENET, V50, P307, DOI 10.1038/s41588-017-0029-0; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cuevas-Cordoba B, 2015, ANTIMICROB AGENTS CH, V59, P5455, DOI 10.1128/AAC.00117-15; Cuevas-Cordoba B, 2013, INFECT GENET EVOL, V19, P330, DOI 10.1016/j.meegid.2012.12.013; Cuevas-Cordoba B, 2013, J MICROBIOL IMMUNOL, V46, P30, DOI 10.1016/j.jmii.2012.08.020; Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77; Eldholm V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8119; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Flores-Lopez CA, 2017, INFECT GENET EVOL, V55, P378, DOI 10.1016/j.meegid.2016.07.001; Flores-Trevino S, 2014, SALUD PUBLICA MEXICO, V56, P63; Grandjean L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126271; Holt KE, 2018, NAT GENET, V50, P849, DOI 10.1038/s41588-018-0117-9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mahomed S, 2017, TUBERCULOSIS, V107, P137, DOI 10.1016/j.tube.2017.09.005; Manson AL, 2017, CLIN INFECT DIS, V64, P1494, DOI 10.1093/cid/cix169; Juarez-Eusebio DM, 2017, INFECT GENET EVOL, V55, P384, DOI 10.1016/j.meegid.2016.09.012; Martinez-Guarneros A, 2013, INFECT GENET EVOL, V14, P434, DOI 10.1016/j.meegid.2012.12.024; Miotto P, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01599-17, 10.1128/JCM.01599-17]; Perez-Navarro LM, 2011, GAC MED MEX, V147, P219; Munro-Rojas D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193626; Pan American Health Organization, 2018, TUB AM 2018; Papaventsis D, 2017, CLIN MICROBIOL INFEC, V23, P61, DOI 10.1016/j.cmi.2016.09.008; Piersimoni C, 2013, J CLIN MICROBIOL, V51, P291, DOI 10.1128/JCM.01838-12; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Senghore M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184510; Serra A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37411-y; Shea J, 2017, J CLIN MICROBIOL, V55, P1871, DOI 10.1128/JCM.00298-17; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Stop TB Partnership W, 2016, GLOB PLAN STOP TB 20, V2020, P1; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; The CRyPTIC Consortium and the 100 000 Genomes Project, 2018, NEW ENGL J MED; Trauer J., 2016, THESIS U MELBOURNE; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Walker TM, 2017, CLIN MICROBIOL INFEC, V23, P161, DOI 10.1016/j.cmi.2016.10.014; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Witney AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0598-2; Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; World Health Organization, 2017, GLOB TUB REP, V2017, P1; Zenteno-Cuevas R, 2009, MEM I OSWALDO CRUZ, V104, P468, DOI 10.1590/S0074-02762009000300012; Zenteno-Cuevas R, 2015, INT J ANTIMICROB AG, V45, P671, DOI 10.1016/j.ijantimicag.2015.02.006; Zenteno-Cuevas R, 2015, APMIS, V123, P116, DOI 10.1111/apm.12312; Zenteno-Cuevas R, 2012, CAN J MICROBIOL, V58, P318, DOI [10.1139/W11-127, 10.1139/w11-127]; Zenteno-Cuevas R, 2011, REV SOC BRAS MED TRO, V44, P282, DOI 10.1590/S0037-86822011005000034; Zhang Y, 2015, INT J TUBERC LUNG D, P1276	56	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0213046	10.1371/journal.pone.0213046	http://dx.doi.org/10.1371/journal.pone.0213046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166945	gold, Green Published, Green Submitted			2022-12-26	WOS:000470087800001
J	Heiss, AG; Antolin, F; Azorin, MB; Biederer, B; Erlach, R; Gail, N; Griebl, M; Linke, R; Lochner, M; Marinova, E; Oberndorfer, D; Stika, HP; Valamoti, SM				Heiss, Andreas G.; Antolin, Ferran; Azorin, Marian Berihuete; Biederer, Benedikt; Erlach, Rudolf; Gail, Niki; Griebl, Monika; Linke, Robert; Lochner, Michaela; Marinova, Elena; Oberndorfer, Daniel; Stika, Hans-Peter; Valamoti, Soultana Maria			The Hoard of the Rings. "Odd" annular bread-like objects as a case study for cereal-product diversity at the Late Bronze Age hillfort site of Stillfried (Lower Austria)	PLOS ONE			English	Article							TEMPERATURE; PYROLYSIS; FOOD; MICROSTRUCTURE; ARCHAEOLOGY; BAKING	Cereals, in addition to being a major ingredient in daily meals, also play a role in the preparation of foodstuffs for ritual purposes. This paper deals with finds that may correspond to such ritual preparations retrieved from the hillfort site of Stillfried an der March. The site, spreading across an area of ca. 23 ha, held a very important position among settlements of Late Urnfield period (particularly during the 10th-9thc. BCE), acting as a central place where large scale storage of grain as well as textile and metal production took place under the control of local elites. Three incomplete ring-shaped charred organic objects, found together with 14 rings and ring fragments made of clay were discovered in a secondary filled silo pit, excavated among a total of about 100 pits of this kind at the site. The overall good state of preservation of the organic ring fragments suggests that they were deposited intact on the bottom of the pit and covered well so that no re-deposition or damage occurred. This could be indicate their intentional placement in this position. Light and scanning electron microscopy revealed that the charred organic rings are cereal products containing hulled barley and a wheat species. Indications that the objects were shaped from a wet cereal mixture and had been subsequently dried without baking are discussed, as well as the possible significance of the find assemblage. The annular objects are put in context with the contemporary cereal spectrum as well as other cereal preparations from Stillfried, outlining their different chaines operatoires for handling cereal food.	[Heiss, Andreas G.; Gail, Niki; Oberndorfer, Daniel] Austrian Acad Sci OAW, Austrian Archaeol Inst OAI, Vienna, Austria; [Antolin, Ferran] Univ Basel, Integrat Prehist & Archaeol Sci IPAS IPNA, Basel, Switzerland; [Azorin, Marian Berihuete; Stika, Hans-Peter] Univ Hohenheim, Inst Bot 210, Stuttgart, Germany; [Biederer, Benedikt; Griebl, Monika; Lochner, Michaela] Austrian Acad Sci OAW, Inst Oriental & European Archaeol OREA, Vienna, Austria; [Erlach, Rudolf] Univ Appl Arts Vienna, Inst Art & Technol, Vienna, Austria; [Linke, Robert] Fed Monuments Author Austria BDA, Referat Nat Wissensch Lab, Vienna, Austria; [Marinova, Elena] State Off Cultural Heritage Baden Wurttemberg, Lab Archaeobot, Gaienhofen Hemmenhofen, Germany; [Valamoti, Soultana Maria] Aristotle Univ Thessaloniki, Lira Lab, Dept Archaeol, Sch Hist & Archaeol, Thessaloniki, Greece; [Valamoti, Soultana Maria] Aristotle Univ Thessaloniki, Ctr Interdisciplinary Res & Innovat CIRI AUTH, Thessaloniki, Greece	Austrian Academy of Sciences; University of Basel; University Hohenheim; Austrian Academy of Sciences; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Heiss, AG (corresponding author), Austrian Acad Sci OAW, Austrian Archaeol Inst OAI, Vienna, Austria.	andreas.heiss@oeai.at	Berihuete Azorín, Marian/H-9833-2015; Heiss, Andreas/K-5393-2013; Marinova, Elena/E-9935-2010; Antolin, Ferran/I-1489-2015	Berihuete Azorín, Marian/0000-0002-6248-1562; Heiss, Andreas/0000-0002-2989-7259; Marinova, Elena/0000-0003-3793-3317; Antolin, Ferran/0000-0002-0533-5788	ERC-CoG-2015 [GA 682529]; backaldrin - The Kornspitz Company; Austrian Science Fund [FWF P28005]; Austrian Science Fund (FWF) project "Resource management, power and cult in Stillfried?" [P 28005]; European Research Council within European Union's Horizon 2020 Research and Innovation Program [682529]	ERC-CoG-2015; backaldrin - The Kornspitz Company; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF) project "Resource management, power and cult in Stillfried?"; European Research Council within European Union's Horizon 2020 Research and Innovation Program	AGH, HPS, MBA, SMV, FA were supported by: ERC-CoG-2015, GA 682529 (PI: SMV) https://cordis.europa.eu/project/rcn/202606/factsheet/en.AGH was supported by: backaldrin - The Kornspitz Company https://www.backaldrin.com/.ML, MG, BB were supported by: Austrian Science Fund FWF P28005 (PI: ML) https://www.fwf. ac. at/. Evaluation of the archaeological context is funded by the Austrian Science Fund (FWF) project "Resource management, power and cult in Stillfried?" (P 28005, PI Michaela Lochner, 2015-2019), based at OAW-OREA. Analysis of the bread-like objects was partly funded by the European Research Council within the framework of the project 'PLANTCULT': Identifying the Food Cultures of Ancient Europe, under the European Union's Horizon 2020 Research and Innovation Program (Grant Agreement No. 682529, Consolidator Grant 2016-2021. PI Soultana Maria Valamoti). Radiocarbon dating of the annular objects (sample ST 12050.4 B/Beta-486379) was funded by backaldrin - The Kornspitz Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg A, 1990, TRIERER Z, V53, P225; Adams W.Y., 1991, ARCHAEOLOGICAL TYPOL; [Anonymous], 2009, GEBACK MOCKBA MMI IV; [Anonymous], 2017, MAHL SCHALPR MITT CO; [Anonymous], [No title captured]; [Anonymous], 2017, BALKAN DIALOGUES NEG; Antolin F, 2016, JB ARCHAOL SCHWEIZ, V99, P143, DOI DOI 10.5281/3888318.894128; Antolin F, 2018, JAHR AG ARCH AK VEG; Arnold P, 2005, BANDKERAMIKER 1 STEI, P99; Arranz-Otaegui A, 2017, QUATERN INT, V457, P60, DOI 10.1016/j.quaint.2016.06.030; Arranz-Otaegui A, 2018, P NATL ACAD SCI USA, V115, P7925, DOI 10.1073/pnas.1801071115; Auerbock CF, 2009, AUSSEER FASCHING ETH; Bahn P., 2005, ARCHAEOLOGY KEY CONC, P18; Bahn PaulG., 2016, ARCHAEOLOGY THEORIES; Balinska M, 2008, BAGEL SURPRISING HIS; Balme J., 2007, ENCY ARCHAEOLOGY, V1-3, P508; Berihuete Azorin M., FRESH OVEN EXPT TRIT; Boateng AA, 2007, FUEL, V86, P735, DOI 10.1016/j.fuel.2006.08.024; Braun T, 1995, FOOD IN ANTIQUITY, P25; Brock F, 2018, RADIOCARBON, V60, P35, DOI 10.1017/RDC.2017.68; BUCHANAN KJ, 1980, EUR POLYM J, V16, P309, DOI 10.1016/0014-3057(80)90074-9; Cafarelli B, 2014, J FOOD ENG, V124, P64, DOI 10.1016/j.jfoodeng.2013.10.002; Campbell G.M., 2008, PROVING BAKING, P337, DOI [10.1016/B978-1-891127-59-5.50037-7, DOI 10.1016/B978-1-891127-59-5.50037-7]; Cappers R.T.J., 2016, DIGITAL ATLAS TRADIT DIGITAL ATLAS TRADIT; Cappers RTJ., 2018, DIGITAL ATLAS TRADIT; Carretero LG, 2017, VEG HIST ARCHAEOBOT, V26, P415, DOI 10.1007/s00334-017-0602-6; Cash JR, 2013, CHARITY REMEMBRANCE; Chevalier A, 2014, PLANTS PEOPLE CHOICE; Chevalier A., 2014, PLANTS PEOPLE CHOICE, P3, DOI DOI 10.2307/J.CTVH1DWFP; Ciaraldi, 1998, ACCORDIA RES PAP, V7, P75; Cohn-Sherbok D., 2005, JUDAISM HIST BELIEF; College S., 1988, SCANNING ELECT MICRO, P225; Cronyn J.M., 1990, ELEMENTS ARCHAEOLOGI; Crowther A, 2012, ARCHAEOL ANTHROP SCI, V4, P221, DOI 10.1007/s12520-012-0097-0; Cruz-Garcia G.S., 2014, PLANTS PEOPLE CHOICE, P42; Das Beilke-Voigt I., 2007, OPFER ARCHAOLOGISCHE; Davison S., 2008, CONSERVATION RESTORA; Dee MW, 2011, RADIOCARBON, V53, P705, DOI 10.1017/S0033822200039151; DELLACASA N, 1984, FOLKLORE, V95, P30, DOI 10.1080/0015587X.1984.9716294; Di Giovine MA, 2014, HERIT CULT INDENT, P77; Dickson C., 1987, CIRCAEA, V4, P95; Dietler M., 1997, FOOD STATUS QUEST IN, P87; Domenech-Carbo A, 2014, J SOLID STATE ELECTR, V18, P399, DOI 10.1007/s10008-013-2232-y; Falcone PM, 2005, J FOOD SCI, V70, pE265, DOI 10.1111/j.1365-2621.2005.tb07182.x; Felgenhauer F., 1980, FORSCHUNGEN STILLFRI, V4, P177; Fu P, 2011, BIORESOURCE TECHNOL, V102, P8211, DOI 10.1016/j.biortech.2011.05.083; Fuller D.Q., 2006, MILLET ATLAS SOME ID; Fuller DQ, 2018, ARCHAEOL INT, V21, P109, DOI 10.5334/ai-391; Fuller DQ., 2014, ANCIENT PLANTS PEOPL, P174; Galanidou-Balphousia E., 1999, PONTIAN FOLKLORE 4 S; Gale R., 2000, PLANTS ARCHAEOLOGY; Gansicke S, 2003, J AM INST CONSERV, V42, P193, DOI 10.2307/3180070; Garnsey P., 1999, FOOD SOC CLASSICAL A; Garrow D, 2012, ARCHAEOL DIALOG, V19, P85, DOI 10.1017/S1380203812000141; Gassner G., 1989, MIKROSKOPISCHE UNTER; Greenwood C T, 1967, Adv Carbohydr Chem Biochem, V22, P483; Griebl M, SPEICHERGRUBEN SPATU; Griebl M, 2017, BEITRAGE ZUM TAG NIE, P195; Griebl M., 2008, ARCHAOLOGIE OSTERREI, V19, P13; Griebl M, 2015, ARCHAEOLOGIA AUSTRIA, V99, P179; GRIEBL M., 2013, KOLLOQUIEN VOR FRUHG, V19, P327; Hahn H., 1996, MIKROSKOPISCHE DIAGN; Hansson A.-M., 1994, LAB ARKEOL, V7, P5; Hansson A-M, 1996, LABORATIV ARKEOLOGI, V9, P61; Hansson A-M., 1994, LAB ARKEOL, V7, P21; Hansson Ann-Marie, 2014, PLANTS PEOPLE CHOICE, V1, P311; Hastorf C., 2016, SOCIAL ARCHAEOLOGY F; Hayden Brian, 1997, FOOD STATUS QUEST IN, P127; Heiss AG, 2007, UNTERSUCHUNG LATENEZ, V2006, P70; Heiss AG., 2014, PLANTS PEOPLE CHOICE, P343; Heiss AG, 2008, OPFERBROTE ARCHAOBOT; Heiss AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182401; Heiss AG, 2015, J ARCHAEOL SCI, V55, P71, DOI 10.1016/j.jas.2014.12.014; Hellerschmid I, 2015, ARCHAEOL AUSTRIACA, P203, DOI 10.1553/archaeologia99s203; Himmelstein P, 1977, J AM INT CONSERV, V17, P37, DOI 10.1179/019713677806029211; Hofmann E., 1924, SITZUNGSBERICHTE MN, V133, P379; Horie V, 2010, ACRYLIC POLYM MAT CO, P153; JOHNSON JS, 1994, J FIELD ARCHAEOL, V21, P221, DOI 10.1179/009346994791547661; Jones G, 2000, VEG HIST ARCHAEOBOT, V9, P133, DOI 10.1007/BF01299798; Kohler-Schneider M, 2003, VEG HIST ARCHAEOBOT, V12, P105, DOI 10.1007/s00334-003-0010-y; Kohler-Schneider M., 1999, ARCHAOLOGIE OSTERREI, V10, P64; Kohler-Schneider M., 2001, VERKOHLTE KULTUR WIL; Koob, 1984, STUDIES CONSERVATI S, V29, P103, DOI DOI 10.1179/SIC.1984.29.SUPPLEMENT-1.103; Koob S.P., 1984, ADHESIVES CONSOLIDAN, P98; KORBERGROHNE U, 1980, FLORA, V170, P189; Kozub D, 2000, HELICON FOCUS 7 0 1; Kroll H, 2016, ARCHAOBOTANIK FEUDVA; Kubiak-Martens L, 2015, VEG HIST ARCHAEOBOT, V24, P47, DOI 10.1007/s00334-014-0485-8; Kuhn E., 2013, THESIS; Lannoy S., 2002, PAIN, P119; Lemke H., 2004, AUFKLARUNG KRITIK, V11, P117; Levi-Strauss C., 1965, FOOD HIST, V2, P7, DOI [10.1484/j.Food.2.300271, DOI 10.1484/J.FOOD.2.300271]; Linke R., 2019, BDA00061SB0002ARSENA; Linke R., 2019, BDA00061SB0001ARSENA; LUND D, 1984, CRC CR REV FOOD SCI, V20, P249, DOI 10.1080/10408398409527391; Lundstrom-Baudais K., 2002, MOUDRE BROYER INTERP, V1, P181; Maier U, 2001, BOT PEDOLOGISCHE UNT; Marchylo B. A., 2001, CEREALS PROCESSING T, P109, DOI [10.1533/ 9781855736283.2.109, DOI 10.1533/9781855736283.2.109]; Martinez Straumann S., 2004, JUNGSTEINZEITLICHE S, P277; Mayeske B. J., 1972, THESIS; Mesnil M, 2002, BREAD OVEN HEARTHS P, P101; Metcalfe CR, 1960, ANATOMY MONOCOTYLEDO, V1; Metheny K.B., 2015, ARCHAEOLOGY FOOD ENC, VVolume 1, P70; Miedaner T, 2012, UNTERSCHATZTE GETREI; Miller D., 1982, SYMBOLIC STRUCTURAL, P17; Mintz SW, 2002, ANNU REV ANTHROPOL, V31, P99, DOI 10.1146/annurev.anthro.32.032702.131011; Mondal A, 2008, J FOOD ENG, V86, P465, DOI 10.1016/j.jfoodeng.2007.11.014; Montanari M., 2017, FAME ABBONDANZA STOR; Montoya J, 2016, J ANAL APPL PYROL, V122, P106, DOI 10.1016/j.jaap.2016.10.010; Morehart CT, 2015, J ARCHAEOL METHOD TH, V22, P483, DOI 10.1007/s10816-013-9183-6; Netolitzky F., 1914, SITZUNGSBERICHTE MN, V123, P725; Odegaard N., 2007, HUMAN REMAINS GUIDE, P77; OUDEMANS TFM, 1991, J ANAL APPL PYROL, V20, P197, DOI 10.1016/0165-2370(91)80073-H; Palmer Carol, 2002, Acta Palaeobotanica, V42, P195; PEACOCK E, 1991, J FIELD ARCHAEOL, V18, P345, DOI 10.1179/009346991791548645; Peto A, 2013, J ARCHAEOL SCI, V40, P58, DOI 10.1016/j.jas.2012.08.027; Phelan W.H., 1971, B AM GROUP INT I CON, V11, P58; Pleterski A., 2015, REKONSTRUKTION MITTE, P123; Popova T., 2016, SE EUROPE ANATOLIA P; Popovtschak M, URNENFELDERKUL UNPUB; Primavera M, 2019, ARCHAEOL ANTHROP SCI, V11, P1273, DOI 10.1007/s12520-018-0605-y; Pucher E., 2018, BEITRAGE ARCHAOZOOLO, V11, P71; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasband W., 2006, IMAGEJ; Razavi P., 2013, REZEPT BILD BRONZEZE, P72; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rivers S, 2003, CONSERVATION FURNITU; Rodgers B. A., 2004, ARCHAEOLOGISTS MANUA; Saleem Q, 2005, J FOOD ENG, V68, P19, DOI 10.1016/j.jfoodeng.2004.05.020; Samuel D., 1994, THESIS; SCHIERER I., 1987, ARCHAEOLOGICA AUSTRI, V71, P29; Schmidt L., 1966, VOLKSKUNDE NIEDEROST; Schneider M., 1991, ACTA INTERDISCIPLINA, P295; Seibel W., 2005, WARENKUNDE GETREIDE; Seifert O, 2004, PANIS ANGELORUM BROT; Sherratt AG., 1991, PALEOECOLOGIA ARQUEO, P221; Simit Roth A., 2012, GASTRONOMICA, V12, P31, DOI [10.1525/gfc.2012.12.4.31, DOI 10.1525/GFC.2012.12.4.31]; Sperber L., 2017, STUDIEN SPATBRONZEZE; Stapel A., 1999, BRONZEZEITLICHE DEPO; Stika H.-P., 2013, OXFORD HDB EUROPEAN, P348, DOI DOI 10.1093/OXFORDHB/9780199572861.013.0019; Stika H-P., 2013, SIEDLUNGEN LTEREN BR, P189; Stillfried Felgenhauer F., 1996, FORSCHUNGEN STILLFRI, V9, P9; Szilvassy J, 1991, Anthropol Anz, V49, P303; Teper J.H., 2011, BPGA, V30, P131; Valamoti SM, 2019, J ARCHAEOL SCI, V104, P97, DOI 10.1016/j.jas.2018.11.004; Valamoti SM, 2011, ARCHAEOL ANTHROP SCI, V3, P19, DOI 10.1007/s12520-011-0058-z; Valamoti SM, 2017, ANTIQUITY, V91, DOI 10.15184/aqy.2017.130; Valamoti SM, 2008, VEG HIST ARCHAEOBOT, V17, pS265, DOI 10.1007/s00334-008-0190-6; vonGroller-Mildensee M., 1902, ROMISCHE LIMES OSTER, V3, P31; Wagner GE., 1988, CURRENT PALEOETHNOBO, P17; Wahren M, 1990, FUNDE AUSGRABUNGEN B, V22, P13; Wahren M., 1990, TRIERER Z, V53, P195; Wahren M., 1984, ARCHAOLOGIE SCHWEIZ, V7, P2, DOI 10.5169/seals-6409; Wang S, 2011, J CEREAL SCI, V54, P203, DOI 10.1016/j.jcs.2011.05.004; WANG SS, 1991, J FOOD SCI, V56, P121, DOI 10.1111/j.1365-2621.1991.tb07990.x; Weikart S., 2002, THESIS; Wilkins J., 2005, HLTH ANTIQUITY, P136; WINTON A. L., 1932, STRUCTURE COMPOSITIO; Wollstonecroft MM, 2011, ARCHAEOL ANTHROP SCI, V3, P141, DOI 10.1007/s12520-011-0062-3; Zapata Pena L., 2014, PLANTS PEOPLE CHOICE, P15; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	161	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216907	10.1371/journal.pone.0216907	http://dx.doi.org/10.1371/journal.pone.0216907			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166950	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000470087800014
J	van Minde, MRC; Blanchette, LMG; Raat, H; Steegers, EAP; de Kroon, MLA				van Minde, Minke R. C.; Blanchette, Lyne M. G.; Raat, Hein; Steegers, Eric A. P.; de Kroon, Marlou L. A.			Reducing growth and developmental problems in children: Development of an innovative postnatal risk assessment	PLOS ONE			English	Article							ADVERSE BIRTH OUTCOMES; LOW SOCIOECONOMIC-STATUS; WEIGHT-GAIN; CATCH-UP; POPULATION; HEALTH; BORN; NEIGHBORHOODS; CHECKLIST; BEHAVIOR	Introduction Globally, awareness of the relevance of both medical and non-medical risk factors influencing growth and development of children has been increasing. The aim of our study was to develop an innovative postnatal risk assessment to be used by the Preventive Child Healthcare (PCHC) to identify at an early stage children at risk for growth (catch-up growth, overweight and obesity) and developmental problems (such as motor, cognitive, psychosocial and language/speech problems). Methods We used the first four steps of the Intervention Mapping process. Step 1: Review of the literature and focus group discussions. Step 2: Identification of program objectives on how to develop and implement a risk assessment in PCHC daily practice. Step 3: Application of the ASE model to initiate behavioral change in the target group. Step 4: Development of the postnatal R4U and a program plan for the implementation in PCHC organizations. Results Subsequently in 2015, the 41 item postnatal R4U (the postnatal Rotterdam Reproduction Risk Reduction checklist) was developed according to steps one until four of the Intervention Mapping process and was implemented in four PCHC organizations. Conclusions It was feasible to design and implement a postnatal risk assessment identifying both medical and non-medical risks for growth and developmental problems, using the Intervention Mapping process.	[van Minde, Minke R. C.; Steegers, Eric A. P.] Erasmus Univ, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Med Ctr, Rotterdam, Netherlands; [van Minde, Minke R. C.; Raat, Hein; de Kroon, Marlou L. A.] Erasmus Univ, Dept Publ Hlth, Div Child & Youth, Med Ctr, Rotterdam, Netherlands; [Blanchette, Lyne M. G.] Municipal City Rotterdam, Dept Social Dev, Rotterdam, Netherlands; [de Kroon, Marlou L. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen	van Minde, MRC (corresponding author), Erasmus Univ, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Med Ctr, Rotterdam, Netherlands.; van Minde, MRC (corresponding author), Erasmus Univ, Dept Publ Hlth, Div Child & Youth, Med Ctr, Rotterdam, Netherlands.	m.vanminde@erasmusmc.nl	de Kroon, Marlou MLA/M-4040-2014	van Minde, Minke/0000-0003-3316-336X; de Kroon, Marlou/0000-0003-1730-4994	Dutch government, Ministry of Welfare and Sports (VWS) [323911]	Dutch government, Ministry of Welfare and Sports (VWS)	The HP4All-2 program has been funded by the Dutch government, Ministry of Welfare and Sports (VWS), grant 323911 to EAPS. The study sponsor had no role in the study design, writing the report and the decision to submit the report for publication.	Arpi E, 2013, DEV MED CHILD NEUROL, V55, P788, DOI 10.1111/dmcn.12142; Bartholomew Eldridge L.K., 2016, PLANNING HLTH PROMOT; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; BRUG J, 1995, APPETITE, V25, P285, DOI 10.1006/appe.1995.0062; cie- de Winter, 2013, RAPP STEV FUND EV BA; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; de Waal CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041302; DEVRIES H, 1995, J APPL SOC PSYCHOL, V25, P237; Dua T, 2016, LANCET GLOB HEALTH, V4, pE887, DOI 10.1016/S2214-109X(16)30218-2; Dunger DB, 2006, MOL CELL ENDOCRINOL, V254, P140, DOI 10.1016/j.mce.2006.04.003; Fishbein, 2010, PREDICTION CHANGE HL; Garba RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174438; Heppe DHM, 2013, PEDIATR RES, V73, P120, DOI 10.1038/pr.2012.145; Holmbeck GN, 2009, J PEDIATR PSYCHOL, V34, P691, DOI 10.1093/jpepsy/jsp046; Kerstjens JM, 2013, OBSTET GYNECOL, V121, P727, DOI 10.1097/AOG.0b013e3182860c52; Metcalfe A, 2011, PAEDIATR PERINAT EP, V25, P236, DOI 10.1111/j.1365-3016.2011.01192.x; Moore GF, 2017, SSM-POPUL HLTH, V3, P132, DOI 10.1016/j.ssmph.2016.12.005; Morandi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049919; Pereira SMP, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011044; Polk S, 2016, PUBLIC HEALTH NUTR, V19, P1777, DOI 10.1017/S1368980015003201; Posthumus AG, 2016, MIDWIFERY, V38, P78, DOI 10.1016/j.midw.2015.11.006; Potijk MR, 2015, EUR CHILD ADOLES PSY, V24, P787, DOI 10.1007/s00787-014-0623-y; Potijk MR, 2013, J PEDIATR-US, V163, P1289, DOI 10.1016/j.jpeds.2013.07.001; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Razaz N, 2016, ARCH DIS CHILD-FETAL, V101, pF114, DOI 10.1136/archdischild-2015-308458; Scholte RS, 2015, J HEALTH ECON, V39, P17, DOI 10.1016/j.jhealeco.2014.10.002; Schouten MCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165641; Sittig JS, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-91; Staal IIE, 2015, PREV MED, V81, P236, DOI 10.1016/j.ypmed.2015.09.003; Steegers-Theunissen RPM, 2015, REPROD FERT DEVELOP, V27, P712, DOI 10.1071/RD14386; Taal HR, 2013, OBESITY, V21, P1261, DOI 10.1002/oby.20116; van der Kooy J, 2011, OBSTET GYNECOL, V118, P1037, DOI 10.1097/AOG.0b013e3182319737; van Stel HF, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-71; van Veen MJ, 2015, MIDWIFERY, V31, P147, DOI 10.1016/j.midw.2014.08.002; Vos AA, 2015, INT J INTEGR CARE, V15; Vos AA, 2014, ACTA OBSTET GYN SCAN, V93, P727, DOI 10.1111/aogs.12430; Waelput AJM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1425-2; Weigl M, 2017, OCCUP MED-OXFORD, V67, P7, DOI 10.1093/occmed/kqw151; Wells NM, 2010, AM J PUBLIC HEALTH, V100, P2507, DOI 10.2105/AJPH.2009.184291; Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR; Zeitlin J, 2013, J EPIDEMIOL COMMUN H, V67, P983, DOI 10.1136/jech-2013-203291; Zimmerman E, 2018, J SPEECH LANG HEAR R, V61, P53, DOI 10.1044/2017_JSLHR-L-16-0150	44	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217261	10.1371/journal.pone.0217261	http://dx.doi.org/10.1371/journal.pone.0217261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166964	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800020
J	Zar, G; Smith, JG; Smith, ML; Andersson, B; Nilsson, J				Zar, Gustav; Smith, J. Gustav; Smith, Maya Landenhed; Andersson, Bodil; Nilsson, Johan			Whole-genome sequencing based on formalin-fixed paraffin-embedded endomyocardial biopsies for genetic studies on outcomes after heart transplantation	PLOS ONE			English	Article							DNA METHYLATION; INTERNATIONAL SOCIETY; FRAMEWORK; ACCURATE; REGISTRY	Background Whole-genome sequencing (WGS) of heart transplant recipient-and donor-derived cardiac biopsies may facilitate organ matching, graft failure prediction, and immunotolerance research. The objective of this study was to determine the feasibility of WGS based on formalin-fixed paraffin-embedded endomyocardial biopsies. Methods and results The study included serial donor-and recipient samples from patients who had undergone heart transplantation at Skane University Hospital, Lund, Sweden, between 1988 and 2009. DNA extraction and WGS were conducted. Additional WGS sequencing quality metrics and coverage were obtained with the Genome Analysis Toolkit (GATK). 455 endomyocardial samples from 37 heart transplant recipients were acquired from routine rejection monitoring and stored as formalin-fixed paraffin-embedded samples. They were analyzed after 3-26 years of storage. DNA was extracted from 114 samples and WGS was run on 85 samples. DNA extraction yielded 313 ng (IQR 96-601) for all samples. A coverage of 11.3x (IQR 9.0-15.9) was recorded for all WGS samples. Three samples stored for > 25 years yielded a coverage of > 25x. Data were generated for 1.7 billion reads per sample (IQR 1.42.7). A Transition/Transversion (TiTv) ratio of 2.09 +/- 0.05 was calculated for all WGS samples. No associations were found among storage time, DNA yield, or sequencing quality metrics. Conclusions The present study demonstrated the feasibility of whole-genome sequencing based on endomyocardial biopsies. This process could enable large-scale retrospective genomic studies using stored histopathological samples.	[Zar, Gustav; Smith, Maya Landenhed; Nilsson, Johan] Lund Univ, Dept Clin Sci Lund, Cardiothorac Surg, Lund, Sweden; [Zar, Gustav; Smith, J. Gustav; Smith, Maya Landenhed; Andersson, Bodil; Nilsson, Johan] Skane Univ Hosp, Lund, Sweden; [Smith, J. Gustav] Lund Univ, Dept Clin Sci, Cardiol, Lund, Sweden; [Smith, J. Gustav] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden; [Andersson, Bodil] Lund Univ, Dept Clin Sci Lund, Surg, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University	Nilsson, J (corresponding author), Lund Univ, Dept Clin Sci Lund, Cardiothorac Surg, Lund, Sweden.; Nilsson, J (corresponding author), Skane Univ Hosp, Lund, Sweden.	johan.nilsson@med.lu.se	Nilsson, Johan/A-4742-2011	Nilsson, Johan/0000-0001-6860-6090; Zar, Gustav/0000-0002-5791-6496	Swedish Heart-Lung Foundation; Swedish Society of Medicine; Anna-Lisa and Sven Eric Lundgrens Foundation; Crafoord Foundation; Region Skane Research Funds	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society of Medicine; Anna-Lisa and Sven Eric Lundgrens Foundation; Crafoord Foundation; Region Skane Research Funds	This study was funded by the Swedish Heart-Lung Foundation, the Swedish Society of Medicine, a government grant for clinical research, Region Skane Research Funds, Donation Funds from Skane University Hospital, the Anna-Lisa and Sven Eric Lundgrens Foundation, and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Baudhuin LM, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001844; Bonnet E, 2018, PLOS ONE, V13, pR1, DOI [10.1186/gb-2011-12-1-r1, DOI 10.1186/GB-2011-12-1-R1]; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Carrick DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127353; Crespo-Leiro MG, 2008, AM J TRANSPLANT, V8, P1031, DOI 10.1111/j.1600-6143.2008.02196.x; Dallol A, 2011, METHODS MOL BIOL, V724, P191, DOI 10.1007/978-1-61779-055-3_13; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Illumina, 2014, SEQ COV CALC METH HU, P1; KapaBiosystems, 2016, KAPA HUM GEN DNA QUA, P1; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lund LH, 2017, J HEART LUNG TRANSPL, V36, P1037, DOI 10.1016/j.healun.2017.07.019; Lund LH, 2013, J HEART LUNG TRANSPL, V32, P951, DOI 10.1016/j.healun.2013.08.006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meynert AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-247; Moran B, 2017, ONCOTARGET, V8, P48126, DOI 10.18632/oncotarget.18296; Peters FS, 2016, J HEART LUNG TRANSPL, V35, P843, DOI 10.1016/j.healun.2016.02.007; Robbe P, 2018, GENET MED, V20, P1196, DOI 10.1038/gim.2017.241; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Wang J, 2015, BIOINFORMATICS, V31, P318, DOI 10.1093/bioinformatics/btu668	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217747	10.1371/journal.pone.0217747	http://dx.doi.org/10.1371/journal.pone.0217747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166960	gold, Green Published, Green Submitted			2022-12-26	WOS:000470087800037
J	Agbemabiese, CA; Nakagomi, T; Damanka, SA; Dennis, FE; Laney, BL; Armah, GE; Nakagomi, O				Agbemabiese, Chantal Ama; Nakagomi, Toyoko; Damanka, Susan Afua; Dennis, Francis Ekow; Laney, Belinda Larteley; Armah, George Enyimah; Nakagomi, Osamu			Sub-genotype phylogeny of the non-G, non-P genes of genotype 2 Rotavirus A strains	PLOS ONE			English	Article							EQUINE-LIKE; REASSORTANT ROTAVIRUS; ACUTE GASTROENTERITIS; MOLECULAR CHARACTERIZATION; GENOME CHARACTERIZATION; DS-1-LIKE; CHILDREN; EMERGENCE; EVOLUTION; JAPAN	Recent increase in the detection of unusual G1P[8], G3P[8], G8P[8], and G9P[4] Rotavirus A (RVA) strains bearing the DS-1-like constellation of the non-G, non-P genes (hereafter referred to as the genotype 2 backbone) requires better understanding of their evolutionary relationship. However, within a genotype, there is lack of a consensus lineage designation framework and a set of common sequences that can serve as references. Phylogenetic analyses were carried out on over 8,500 RVA genotype 2 genes systematically retrieved from the rotavirus database within the NCBI Virus Variation Resource. In line with previous designations, using pairwise comparison of cogent nucleotide sequences and stringent bootstrap support, reference lineages were defined. This study proposes a lineage framework and provides a dataset ranging from 34 to 145 sequences for each genotype 2 gene for orderly lineage designation of global genotype 2 genes of RVAs detected in human and animals. The framework identified five to 31 lineages depending on the gene. The least number of lineages (five to seven) were observed in genotypes A2 (NSP1), T2 (NSP3) and H2 (NSP5) which are limited to human RVA whereas the most number of lineages (31) was observed in genotype E2 (NSP4). Sharing of the same lineage constellations of the genotype 2 backbone genes between recently-emerging, unusual G1P[8], G3P[8], G8P[8] and G9P[4] reassortants and many contemporary G2P[4] strains provided strong support to the hypothesis that unusual genotype 2 strains originated primarily from reassortment events in the recent past involving contemporary G2P[4] strains as one parent and ordinary genotype 1 strains or animal RVA strains as the other. The lineage framework with selected reference sequences will help researchers to identify the lineage to which a given genotype 2 strain belongs, and trace the evolutionary history of common and unusual genotype 2 strains in circulation.	[Agbemabiese, Chantal Ama; Damanka, Susan Afua; Dennis, Francis Ekow; Laney, Belinda Larteley; Armah, George Enyimah] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Accra, Ghana; [Agbemabiese, Chantal Ama; Nakagomi, Toyoko; Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Epidemiol, Nagasaki, Japan	University of Ghana; Nagasaki University	Agbemabiese, CA (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Electron Microscopy & Histopathol, Legon, Accra, Ghana.; Agbemabiese, CA (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Epidemiol, Nagasaki, Japan.	chagbem@gmail.com		Agbemabiese, Chantal/0000-0003-1862-9408				Agbemabiese CA, 2015, J GEN VIROL, V96, P2219, DOI 10.1099/vir.0.000174; Agbemabiese CA, 2017, MICROBIOL IMMUNOL, V61, P328, DOI 10.1111/1348-0421.12501; Agbemabiese CA, 2016, INFECT GENET EVOL, V45, P122, DOI 10.1016/j.meegid.2016.08.024; Agbemabiese CA, 2015, INFECT GENET EVOL, V35, P184, DOI 10.1016/j.meegid.2015.07.033; Aida S, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00168; Arana A, 2016, INFECT GENET EVOL, V44, P137, DOI 10.1016/j.meegid.2016.06.048; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Do LP, 2015, MICROBIOL IMMUNOL, V59, P605, DOI 10.1111/1348-0421.12323; Doan YH, 2017, INFECT GENET EVOL, V54, P417, DOI 10.1016/j.meegid.2017.07.025; Doan YH, 2015, INFECT GENET EVOL, V34, P423, DOI 10.1016/j.meegid.2015.05.026; Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0; Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065; Heylen E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14658; Hoa-Tran TN, 2016, ARCH VIROL, V161, P479, DOI 10.1007/s00705-015-2682-x; Ianiro G, 2018, INFECT GENET EVOL, V64, P57, DOI 10.1016/j.meegid.2018.06.017; Jere KC, 2018, J VIROL, V92, DOI 10.1128/JVI.01246-17; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kikuchi W, 2018, ARCH VIROL, V163, P791, DOI 10.1007/s00705-017-3668-7; Komoto S, 2018, J MED VIROL, V90, P890, DOI 10.1002/jmv.25016; Komoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148416; Komoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141739; Kondo K., 2014, JAPAN EMERG INFECT D, V23, P968; Lewis J, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01284-14; Luchs A, 2019, J GEN VIROL, V100, P7, DOI 10.1099/jgv.0.001171; Malasao R, 2015, VIRUS GENES, V50, P129, DOI 10.1007/s11262-014-1135-z; Matthijnssens J, 2008, J GEN VIROL, V89, P2630, DOI 10.1099/vir.0.2008/003780-0; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Nakagomi T, 2017, ARCH VIROL, V162, P213, DOI 10.1007/s00705-016-3103-5; Nakagomi T, 2017, ARCH VIROL, V162, P739, DOI 10.1007/s00705-016-3155-6; Nakagomi T, 2013, J GEN VIROL, V94, P1273, DOI 10.1099/vir.0.050625-0; Ndze VN, 2014, INFECT GENET EVOL, V28, P537, DOI 10.1016/j.meegid.2014.10.009; Nordgren J, 2012, EMERG INFECT DIS, V18, P589, DOI 10.3201/eid1804.110973; Perkins C, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01341-17; Pietsch C, 2018, INFECT GENET EVOL, V57, P46, DOI 10.1016/j.meegid.2017.11.007; Pradhan GN, 2016, J GEN VIROL, V97, P3139, DOI 10.1099/jgv.0.000650; Guerra SFS, 2016, J GEN VIROL, V97, P3131, DOI 10.1099/jgv.0.000626; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tacharoenmuang R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165826; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran T N Hoa, 2013, Trop Med Health, V41, P13, DOI 10.2149/tmh.2012-29; Yamamoto D, 2017, New Microbes New Infect, V18, P54, DOI 10.1016/j.nmni.2017.04.001; Yamamoto SP, 2015, J MED VIROL, V87, P1311, DOI 10.1002/jmv.24121; Yodmeeklin A, 2018, ARCH VIROL, V163, P2165, DOI 10.1007/s00705-018-3848-0	50	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217422	10.1371/journal.pone.0217422	http://dx.doi.org/10.1371/journal.pone.0217422			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150425	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100049
J	Duranti, S; Mancabelli, L; Mancino, W; Anzalone, R; Longhi, G; Statello, R; Carnevali, L; Sgoifo, A; Bernasconi, S; Turroni, F; Ventura, M				Duranti, Sabrina; Mancabelli, Leonardo; Mancino, Walter; Anzalone, Rosaria; Longhi, Giulia; Statello, Rosario; Carnevali, Luca; Sgoifo, Andrea; Bernasconi, Sergio; Turroni, Francesca; Ventura, Marco			Exploring the effects of COLOSTRONONI on the mammalian gut microbiota composition	PLOS ONE			English	Article							MORINDA-CITRIFOLIA NONI; BOVINE COLOSTRUM; TNF-ALPHA; CELLS; CONSTITUENTS; THERAPY; FRUIT; JUICE	COLOSTRONONI is a dietary supplement consisting of bovine colostrum and Morinda citrifolia fruit (Noni). In this study, we tested the capability of COLOSTRONONI to influence gut microbiota composition using an in vivo evaluation in rats. Furthermore, we analyzed the effect of COLOSTRONONI on the systemic inflammatory responses as well as on the gut permeability of the animals. Altogether, our analyses supported the concept of COLOSTRONONI as a natural food supplement that doesn't affect (neither negatively nor positively) gut microbiota homeostasis in healthy conditions. Moreover, COLOSTRONONI highlighted a lower effect in the expression of genes coding for IL-10, Il-12 and TNF-alpha response allowing us to hypothesize an immunomodulatory activity of this dietary supplement.	[Duranti, Sabrina; Mancabelli, Leonardo; Mancino, Walter; Turroni, Francesca; Ventura, Marco] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Lab Probiogen, Parma, Italy; [Anzalone, Rosaria; Longhi, Giulia] GenProbio Srl Parma, Parma, Italy; [Statello, Rosario; Carnevali, Luca; Sgoifo, Andrea] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Stress Physiol Lab, Parma, Italy; [Sgoifo, Andrea; Bernasconi, Sergio; Turroni, Francesca; Ventura, Marco] Univ Parma, Microbiome Res Hub, Parma, Italy	University of Parma; University of Parma; University of Parma	Ventura, M (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Lab Probiogen, Parma, Italy.; Ventura, M (corresponding author), Univ Parma, Microbiome Res Hub, Parma, Italy.	marco.ventura@unipr.it	Duranti, Sabrina/AAI-7916-2020; Sgoifo, Andrea/AAC-6278-2022; Mancabelli, Leonardo/AAV-5147-2021; Turroni, Francesca/K-9660-2016; ventura, marco/M-8230-2015; Bernasconi, Sergio/AAA-9419-2021; Carnevali, Luca/E-5322-2017	Duranti, Sabrina/0000-0002-7724-5669; Sgoifo, Andrea/0000-0002-9428-6198; Mancabelli, Leonardo/0000-0002-1744-2214; Turroni, Francesca/0000-0001-5363-0231; Carnevali, Luca/0000-0001-9053-7976; Statello, Rosario/0000-0002-0644-2454	GenProbio srl	GenProbio srl	GenProbio srl supports the Laboratory of Probiogenomics. The funder provided support in the form of salaries for R.A. and G.L. and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Assi R, 2017, ARAB J CHEM, V10, P691, DOI 10.1016/j.arabjc.2015.06.018; Campbell HK, 2017, EXP CELL RES, V358, P39, DOI 10.1016/j.yexcr.2017.03.061; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardani D, 2014, Minerva Gastroenterol Dietol, V60, P71; Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferrario C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01749; Filipescu IE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202929; Furusawa E, 2003, PHYTOTHER RES, V17, P1158, DOI 10.1002/ptr.1307; Gad M, 2011, FEMS IMMUNOL MED MIC, V63, P93, DOI 10.1111/j.1574-695X.2011.00835.x; Gorska S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37613; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Kamiya K, 2004, J AGR FOOD CHEM, V52, P5843, DOI 10.1021/jf040114k; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Leppkes M, 2014, INT IMMUNOL, V26, P509, DOI 10.1093/intimm/dxu051; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Pakkanen R, 1997, INT DAIRY J, V7, P285, DOI 10.1016/S0958-6946(97)00022-8; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rathe M, 2014, NUTR REV, V72, P237, DOI 10.1111/nure.12089; Saludes JP, 2002, PHYTOTHER RES, V16, P683, DOI 10.1002/ptr.1003; Shen YJ, 2017, AM J PHYSIOL-GASTR L, V312, pG123, DOI 10.1152/ajpgi.00316.2016; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Sponseller JK, 2015, J INFECT DIS, V211, P1334, DOI 10.1093/infdis/jiu605; Uruakpa FO, 2002, NUTR RES, V22, P755, DOI 10.1016/S0271-5317(02)00373-1; Yang J, 2007, FOOD CHEM, V102, P302, DOI 10.1016/j.foodchem.2006.05.020; Zin ZM, 2006, FOOD CHEM, V94, P169, DOI 10.1016/j.foodchem.2004.08.048	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217609	10.1371/journal.pone.0217609	http://dx.doi.org/10.1371/journal.pone.0217609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150516	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100070
J	Nagoshi, RN; Dhanani, I; Asokan, R; Mahadevaswamy, HM; Kalleshwaraswamy, CM; Sharanabasappa; Meagher, RL				Nagoshi, Rodney N.; Dhanani, Isabel; Asokan, R.; Mahadevaswamy, H. M.; Kalleshwaraswamy, Chicknayakanahalli M.; Sharanabasappa; Meagher, Robert L.			Genetic characterization of fall armyworm infesting South Africa and India indicate recent introduction from a common source population	PLOS ONE			English	Article							SMITH LEPIDOPTERA-NOCTUIDAE; HOST STRAINS; UNITED-STATES; MIGRATION; IDENTIFICATION; DIVERGENCE; PATTERNS; MEXICO; TEXAS	The invasion of the Western Hemisphere native fall armyworm (Spodoptera frugiperda; J. E. Smith) (Lepidoptera: Noctuidae) into the Eastern Hemisphere has been notable for the rapidity and geographical breadth of new detections. In the year following the first discovery in western sub-Saharan Africa in 2016, infestations have been documented in most sub-Saharan maize growing regions and has now expanded beyond Africa with populations recently reported in India. These observations could indicate a remarkable capacity for rapid establishment and long-distance dissemination. However, while fall armyworm does exhibit extended migration in North America where it annually traverses thousands of kilometers, this behavior is known to be dependent on highly favorable wind patterns and so can't be assumed to occur in all locations. An alternative possibility is that the species has long been present in Africa, and perhaps the rest of the hemisphere, but was undetected until the enhanced monitoring that resulted after its initial discovery. Determining whether the fall armyworm in the Eastern Hemisphere is newly arrived or long pre-existing is important for assessing the risks of significant economic impacts, as the former indicates a change in pest composition while the latter does not. This study examined this issue by comparing collections from two geographically distant locations, South Africa and India. Sequence comparisons were used to quantify differences between the South Africa and India collections, assess the likelihood of their sharing a common source population, and their possible relationship with previously characterized fall armyworm from other regions of Africa. The results indicate genetic homogeneity between the South African and Indian fall armyworm populations tested and substantial similarities between these and collections from eastern Africa. The implications of these findings on fall armyworm population behavior and composition are discussed.	[Nagoshi, Rodney N.; Meagher, Robert L.] USDA, Ctr Med Agr & Vet Entomol, ARS, Gainesville, FL 32608 USA; [Dhanani, Isabel] Plant Hlth Diagnost Serv, DAFF, Stellenbosch, South Africa; [Asokan, R.; Mahadevaswamy, H. M.; Kalleshwaraswamy, Chicknayakanahalli M.] Indian Inst Hort Res, Div Biotechnol, Hessaraghatta Lake PO, Bangalore, Karnataka, India; [Sharanabasappa] Univ Agr & Hort Sci, Dept Entomol, Shivamogga, Karnataka, India	United States Department of Agriculture (USDA); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research	Nagoshi, RN (corresponding author), USDA, Ctr Med Agr & Vet Entomol, ARS, Gainesville, FL 32608 USA.	rodney.nagoshi@ars.usda.gov	, Kalleshwaraswamy/Z-2891-2019	Meagher, Robert/0000-0003-2769-1043	United States Department of Agriculture Agricultural Research Service (CRIS) [6615-22000-016-00D]; National Institute of Food and Agriculture [2011-67003-30209]; Agricultural Research Service of the United States Department of Agriculture, USAID; United States Department of Agriculture National Institutes for Food and Agriculture [2011-67003-30209]	United States Department of Agriculture Agricultural Research Service (CRIS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Agricultural Research Service of the United States Department of Agriculture, USAID(United States Agency for International Development (USAID)); United States Department of Agriculture National Institutes for Food and Agriculture	R.N.N. and R.L.M. received funding from the United States Department of Agriculture Agricultural Research Service (CRIS # 6615-22000-016-00D, https://www.ars.usda.gov/) and the National Institute of Food and Agriculture (2011-67003-30209, https://nifa.usda.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. J.M.G. Thomas for technical assistance and together with Dr. D. Dixon for comments about the manuscript. Support came from the Agricultural Research Service of the United States Department of Agriculture, USAID, and the United States Department of Agriculture National Institutes for Food and Agriculture (2011-67003-30209). The use of trade, firm, or corporation names in this publication is for the information and convenience of the reader. Such use does not constitute an official endorsement or approval by the United States Department of Agriculture or the Agricultural Research Service of any product or service to the exclusion of others that may be suitable.	Cock MJW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04238-y; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Ganiger PC, 2018, CURR SCI INDIA, V115, P621, DOI 10.18520/cs/v115/i4/621-623; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052594; Jacobs A, 2018, AFR ENTOMOL, V26, P45, DOI 10.4001/003.026.0045; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kost S, 2016, EVOLUTION, V70, P1418, DOI 10.1111/evo.12940; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; MITCHELL ER, 1991, J ENTOMOL SCI, V26, P39, DOI 10.18474/0749-8004-26.1.39; Nagoshi RN, 2016, INSECT MOL BIOL, V25, P324, DOI 10.1111/imb.12223; Nagoshi RN, 2006, ENVIRON ENTOMOL, V35, P561, DOI 10.1603/0046-225X-35.2.561; Nagoshi RN, 2004, FLA ENTOMOL, V87, P440, DOI 10.1653/0015-4040(2004)087[0440:BADOTT]2.0.CO;2; Nagoshi RN, 2017, J EC ENTOMOL; Nagoshi RN, 2007, J ECON ENTOMOL, V100, P954, DOI 10.1603/0022-0493(2007)100[954:COHFDF]2.0.CO;2; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208966; Nagoshi RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21954-1; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175076; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171743; Nagoshi RN, 2015, J ECON ENTOMOL, V108, P135, DOI 10.1093/jee/tou044; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2012, ANN ENTOMOL SOC AM, V105, P351, DOI 10.1603/AN11138; Nagoshi RN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.15401; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; Nagoshi RN, 2009, ENVIRON ENTOMOL, V38, P1546, DOI 10.1603/022.038.0605; Otim MH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194571; PASHLEY DP, 1988, EVOLUTION, V42, P93, DOI 10.1111/j.1558-5646.1988.tb04110.x; Rosenberg J., 1999, AEROBIOLOGIA, V15, P167; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Sharanabasappa Kalleshwaraswamy CM, 2018, PEST MANAGE HORTIC E, V24, P23; Shylesha A. N., 2018, Journal of Biological Control, V32, P145, DOI 10.18311/jbc/2018/21707; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Srinivasan R, 2018, CURR SCI INDIA, V114, P27, DOI 10.18520/cs/v114/i01/27-28; Swamy H.M. Mahadeva, 2018, Indian Journal of Entomology, V80, P544, DOI 10.5958/0974-8172.2018.00239.0; Unbehend M, 2013, J CHEM ECOL, V39, P364, DOI 10.1007/s10886-013-0263-6; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Westbrook JK, 2016, INT J BIOMETEOROL, V60, P255, DOI 10.1007/s00484-015-1022-x	43	26	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217755	10.1371/journal.pone.0217755	http://dx.doi.org/10.1371/journal.pone.0217755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150493	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100098
J	Chandler, TL; White, HM				Chandler, Tawny L.; White, Heather M.			Glucose metabolism is differentially altered by choline and methionine in bovine neonatal hepatocytes	PLOS ONE			English	Article							RUMEN-PROTECTED CHOLINE; MESSENGER-RNA EXPRESSION; DAIRY-COWS; PYRUVATE-CARBOXYLASE; FATTY LIVER; TRANSITION PERIOD; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HEPATIC GLUCONEOGENESIS; FEED RESTRICTION	Choline and methionine serve essential roles in the liver that may interact with glucose metabolism. Our objectives were to quantify glucose export, cellular glycogen, and expression of genes controlling oxidation and gluconeogenesis in primary bovine neonatal hepatocytes exposed to increasing concentrations of choline chloride (CC) and D, L-methionine (DLM) with or without fatty acids (FA). Primary hepatocytes isolated from 3 Holstein calves were maintained as monolayer cultures for 24 h before treatment with CC (61, 128, 2028, 4528 mu mol/L) and DLM (16, 30, 100, 300 mu mol/L) with or without a 1 mmol/L FA cocktail in a factorial design. After 24 h, media was harvested to quantify glucose, beta-hydroxybutyrate (BHB), and cells harvested to quantify glycogen, DNA, and gene expression. No interactions between CC and DLM were detected. The potential two-way interaction between CC or DLM and FA was partitioned into three contrasts when P <= 0.20: linear without FA, linear with FA, difference of slope. Fatty acids did not affect glucose or cellular glycogen but increased pyruvate carboxylase (PC), cytosolic and mitochondrial phosphoenolpyruvate carboxykinase (PEPCKc, PEPCKm), and glucose-6-phosphatase (G6PC) expression. Increasing CC decreased glucose but increased cellular glycogen. Expression of PC and PEPCKc was increased by CC during FA treatment. Increasing DLM did not affect metabolites or PC expression, although PEPCKc was marginally decreased. Methionine did not affect G6PC, while CC had a marginal quadratic effect on G6PC. Oxidative and gluconeogenic enzymes appear to respond to FA in primary bovine neonatal hepatocytes. Increased PC and PEPCKc by CC during FA treatment suggest increased gluconeogenic capacity. Changes in G6PC may have shifted glucose-6-phosphate towards cellular glycogen; however, subsequent examination of G6PC protein is needed. Unaltered PC and marginally decreased PEPCKc suggest increased oxidative capacity with DLM, although BHB export was unaltered. The differential regulation supports unique effects of CC and DLM within bovine hepatocytes.	[Chandler, Tawny L.; White, Heather M.] Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	White, HM (corresponding author), Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI 53706 USA.	heather.white@wisc.edu		Chandler, Tawny/0000-0001-6299-9436	Real Science Initiative Grant by Balchem Corporation, New Hampton, NY [MSN169422]	Real Science Initiative Grant by Balchem Corporation, New Hampton, NY	This research was supported by funding provided through the Real Science Initiative Grant by Balchem Corporation (MSN169422), New Hampton, NY (http://www.balchem.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2002, PHYSIOL GENOMICS, V11, P53, DOI 10.1152/physiolgenomics.00108.2001; Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Andersen JB, 2002, J VET MED A, V49, P65, DOI 10.1046/j.1439-0442.2002.jv417.x; ARMENTANO LE, 1991, J DAIRY SCI, V74, P132, DOI 10.3168/jds.S0022-0302(91)78153-8; ARMENTANO LE, 1994, J DAIRY SCI, V77, P2809, DOI 10.3168/jds.S0022-0302(94)77221-0; Artegoitia VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103412; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; BALLARD FJ, 1965, COMP BIOCHEM PHYSIOL, V14, P437, DOI 10.1016/0010-406X(65)90218-5; BALLARD FJ, 1969, FED PROC, V28, P218; Barritt GJ, 1985, PYRUVATE CARBOXYLASE, P147; Batistel F, 2017, J DAIRY SCI, V100, P7455, DOI 10.3168/jds.2017-12689; Berry MN, 1991, LAB TECHNIQUES BIOCH, P121; BERTICS SJ, 1992, J DAIRY SCI, V75, P1914, DOI 10.3168/jds.S0022-0302(92)77951-X; Blum JW, 1999, J DAIRY SCI, V82, P1991, DOI 10.3168/jds.S0022-0302(99)75435-4; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; CadornigaValino C, 1997, J DAIRY SCI, V80, P646, DOI 10.3168/jds.S0022-0302(97)75983-6; Chandler TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171080; DONKIN SS, 1994, AM J PHYSIOL, V266, pR1229, DOI 10.1152/ajpregu.1994.266.4.R1229; DONKIN SS, 1993, J ANIM SCI, V71, P2218, DOI 10.2527/1993.7182218x; DONKIN SS, 1995, J ANIM SCI, V73, P546; Donkin SS, 1997, J ANIM SCI, V75, P3082; DRACKLEY JK, 1992, J DAIRY SCI, V75, P1622, DOI 10.3168/jds.S0022-0302(92)77919-3; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Duske K, 2003, J DAIRY SCI, V86, P1722, DOI [10.3168/jds.S0022-0302(03)73758-8, DOI 10.3168/JDS.S0022-0302(03)73758-8]; Elek P, 2013, ACTA VET HUNG, V61, P59, DOI 10.1556/AVet.2012.053; Elek R, 2008, ANIMAL, V2, P1595, DOI 10.1017/S1751731108002917; Freitas I, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9307064; GALLAGHER CH, 1959, BIOCHEM J, V72, P575, DOI 10.1042/bj0720575; Goselink RMA, 2013, J DAIRY SCI, V96, P1102, DOI 10.3168/jds.2012-5396; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Greenfield RB, 2000, J DAIRY SCI, V83, P1228, DOI 10.3168/jds.S0022-0302(00)74989-7; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hartwell JR, 2001, J DAIRY SCI, V84, P490, DOI 10.3168/jds.S0022-0302(01)74499-2; HOWARTH RE, 1968, J DAIRY SCI, V51, P1270, DOI 10.3168/jds.S0022-0302(68)87170-X; HUNTER SV, 1967, J NUTR, V92, P133, DOI 10.1093/jn/92.1.133; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010; Kohlmeier M., 2015, NUTRIENT METABOLISM, P265, DOI [DOI 10.1016/B978-0-12-387784-0.00008-0, 10.1016/B978-0-12-387784-0.00008-0]; Larsen M, 2013, ANIMAL, V7, P1640, DOI 10.1017/S1751731113001171; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Martinov MV, 2010, BBA-PROTEINS PROTEOM, V1804, P89, DOI 10.1016/j.bbapap.2009.10.004; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; MILLS SE, 1986, J DAIRY SCI, V69, P362, DOI 10.3168/jds.S0022-0302(86)80414-3; MUNCK A, 1964, ARCH BIOCHEM BIOPHYS, V107, P504, DOI 10.1016/0003-9861(64)90308-X; NADKARNI GB, 1960, J BIOL CHEM, V235, P420; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; OBRIEN RM, 1990, DIABETES CARE, V13, P327, DOI 10.2337/diacare.13.3.327; Oksbjerg N, 2000, ANIM SCI, V71, P81, DOI 10.1017/S1357729800054916; Osorio JS, 2016, J DAIRY SCI, V99, P234, DOI 10.3168/jds.2015-10157; Osorio JS, 2014, J DAIRY SCI, V97, P7437, DOI 10.3168/jds.2013-7679; Osorio JS, 2013, J DAIRY SCI, V96, P6248, DOI 10.3168/jds.2012-5790; Overton TR, 1999, J ANIM SCI, V77, P1940; Piepenbrink MS, 2003, J DAIRY SCI, V86, P1722, DOI 10.3168/jds.S0022-0302(03)73758-8; Preynat A, 2010, J DAIRY SCI, V93, P2130, DOI 10.3168/jds.2009-2796; Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Rukkwamsuk T, 1999, J DAIRY SCI, V82, P500, DOI 10.3168/jds.S0022-0302(99)75260-4; Soty M, 2016, J PROTEOME RES, V15, P1342, DOI 10.1021/acs.jproteome.6b00110; Strang BD, 1998, J DAIRY SCI, V81, P728, DOI 10.3168/jds.S0022-0302(98)75629-2; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P256, DOI 10.1016/0003-2697(65)90013-8; Velez JC, 2005, J DAIRY SCI, V88, P2938, DOI 10.3168/jds.S0022-0302(05)72974-X; Weber C, 2013, J DAIRY SCI, V96, P5670, DOI 10.3168/jds.2012-6277; White HM, 2012, J DAIRY SCI, V95, P1249, DOI 10.3168/jds.2011-4644; White HM, 2011, J DAIRY SCI, V94, P3428, DOI 10.3168/jds.2010-3960; White HM, 2011, J ANIM SCI, V89, P1763, DOI 10.2527/jas.2010-3407; White HM, 2015, ANIMALS-BASEL, V5, P793, DOI 10.3390/ani5030384; WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; XUE GP, 1985, BIOCHEM INT, V11, P381; Zenobi MG, 2018, J DAIRY SCI, V101, P5902, DOI 10.3168/jds.2017-13973; Zenobi MG, 2018, J DAIRY SCI, V101, P1088, DOI 10.3168/jds.2017-13327; ZHANG J, 1993, P NATL ACAD SCI USA, V90, P1766, DOI 10.1073/pnas.90.5.1766; ZHANG J, 1995, BIOCHEM J, V306, P205, DOI 10.1042/bj3060205; Zhang Q, 2016, J DAIRY SCI, V99, P8451, DOI 10.3168/jds.2016-11312; Zhang Q, 2016, J DAIRY SCI, V99, P3908, DOI 10.3168/jds.2015-10312; Zhang Q, 2015, J DAIRY SCI, V98, P8698, DOI 10.3168/jds.2015-9590; Zhang QH, 2014, FASEB J, V28; Zhou Z, 2016, J DAIRY SCI, V99, P8716, DOI 10.3168/jds.2015-10525; Zom RLG, 2011, J DAIRY SCI, V94, P4016, DOI 10.3168/jds.2011-4233	84	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217160	10.1371/journal.pone.0217160	http://dx.doi.org/10.1371/journal.pone.0217160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141525	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000041
J	Mella, VSA; McArthur, C; Krockenberger, MB; Frend, R; Crowther, MS				Mella, Valentina S. A.; McArthur, Clare; Krockenberger, Mark B.; Frend, Robert; Crowther, Mathew S.			Needing a drink: Rainfall and temperature drive the use of free water by a threatened arboreal folivore	PLOS ONE			English	Article							KOALA PHASCOLARCTOS-CINEREUS; FIELD METABOLIC-RATE; CLIMATE-CHANGE; FOLIAR CHEMISTRY; FOOD-CONSUMPTION; HABITAT; QUEENSLAND; AUSTRALIA; DROUGHT; RANGE	Arboreal folivores are particularly vulnerable to the impacts of extreme climate change-driven heatwaves and droughts as they rely on leaf moisture to maintain hydration. During these increasingly frequent and intense weather events, leaf water content may not be enough to meet their moisture requirements, potentially leading to large-scale mortality due to dehydration. Water supplementation could be critical for the conservation of these animals. We tested artificial water stations for a threatened arboreal folivore, the koala (Phascolarctos cinereus), as a potential mitigation measure during hot and dry weather in New South Wales, Australia. We provided ground and tree drinkers to koalas and investigated changes in use with season, environmental conditions and foliar moisture. Our study provides first evidence of the regular use of free water by koalas. Koalas used supplemented water extensively throughout the year, even during cooler months. Time spent drinking varied with season and depended on days since last rain and temperature. The more days without rain, the more time koalas spent drinking. When temperature was high, visits to water stations were more frequent, indicating that in hot weather koalas need regular access to free water. Our results suggest that future changes in rainfall regimes and temperature in Australia have the potential to critically affect koala populations. Our conclusions can be applied to many other arboreal folivorous mammals worldwide which rely on leaves for their nutritional and water requirements. Artificial water stations may facilitate the resilience of vulnerable arboreal folivores during heat and drought events and may help mitigate the effects of climate change.	[Mella, Valentina S. A.; McArthur, Clare; Frend, Robert; Crowther, Mathew S.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Krockenberger, Mark B.] Univ Sydney, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Krockenberger, Mark B.] Univ Sydney, Marie Bashir Inst Emerging Infect Dis & Biosecur, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Mella, VSA (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	valentina.mella@sydney.edu.au	Crowther, Mathew/M-7406-2013; Mella, Valentina/AAE-5346-2020	Crowther, Mathew/0000-0001-8968-1161; Mella, Valentina/0000-0001-5577-2487; McArthur, Clare/0000-0002-7867-414X	Australian Research Council Linkage grant [LP140100279]; NSW Office of Environment and Heritage	Australian Research Council Linkage grant(Australian Research Council); NSW Office of Environment and Heritage	The research was partially funded by the Australian Research Council Linkage grant LP140100279 to Mathew Crowther with Shenhua Watermark (http://www.shenhuawatermark.com/) and the NSW Office of Environment and Heritage (https://www.environment.nsw.gov.au/) as Linkage partners in the form of salary for Valentina Simona Alice Mella. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Adams-Hosking C, 2011, WILDLIFE RES, V38, P122, DOI 10.1071/WR10156; Beale PK, 2018, BIOL REV, V93, P674, DOI 10.1111/brv.12364; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Boland DJ, 2006, FOREST TREES AUSTR; BOM, 2018, LAT WEATH OBS GUNN A; Booth G. D., 1994, IDENTIFYING PROXY SE; BRERETON R, 1995, BIOL CONSERV, V72, P339, DOI 10.1016/0006-3207(94)00016-J; Briscoe NJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0235; Clifton Irene Delma, 2007, Australian Mammalogy, V29, P85; Clifton Irene Delma, 2010, Australian Mammalogy, V32, P157, DOI 10.1071/AM10015; Craine JM, 2010, GLOBAL CHANGE BIOL, V16, P2901, DOI 10.1111/j.1365-2486.2009.02060.x; Crowther MS, 2014, ECOGRAPHY, V37, P336, DOI 10.1111/j.1600-0587.2013.00413.x; Dargan JR, 2019, ANIM CONSERV, V22, P543, DOI 10.1111/acv.12487; Davies N, 2014, BIOL CONSERV, V172, P80, DOI 10.1016/j.biocon.2014.02.004; Davies NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079136; DEGABRIELE R, 1979, J COMP PHYSIOL, V134, P293, DOI 10.1007/BF00709996; Degabriele R., 1978, P163; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; DUFF GA, 1994, FUNCT ECOL, V8, P502, DOI 10.2307/2390075; Dunham AE, 2011, GLOBAL CHANGE BIOL, V17, P219, DOI 10.1111/j.1365-2486.2010.02205.x; Ellis W., 2010, Australian Zoologist, V35, P369; ELLIS WAH, 1995, AUST J ZOOL, V43, P59, DOI 10.1071/ZO9950059; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; EVERY KR, 1986, WILDLIFE RES, V13, P517; Fensham RJ, 1999, J APPL ECOL, V36, P1035, DOI 10.1046/j.1365-2664.1999.00460.x; Fernandez CM, 2019, VET MICROBIOL, V231, P264, DOI 10.1016/j.vetmic.2019.02.020; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; GORDON G, 1988, AUST J ECOL, V13, P451, DOI 10.1111/j.1442-9993.1988.tb00993.x; Green K, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P239; Higgins DP, 2005, J COMP PATHOL, V133, P164, DOI 10.1016/j.jcpa.2005.04.005; Hughes L, 1996, GLOBAL ECOL BIOGEOGR, V5, P23, DOI 10.2307/2997467; Hughes TP, 2018, ECOLOGY, V99, P501, DOI 10.1002/ecy.2092; HUME ID, 1993, AUST J ZOOL, V41, P379, DOI 10.1071/ZO9930379; Jackson S., 2015, HDB MAMMALS WORLD, V5, P400; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Jobbins SE, 2012, AUST J ZOOL, V60, P1, DOI 10.1071/ZO12013; Kanowski J, 2001, AUSTRAL ECOL, V26, P165, DOI 10.1046/j.1442-9993.2001.01103.x; KNIGHT MH, 1989, S AFR J WILDL RES, V19, P42; Krockenberger AK, 2012, OECOLOGIA, V168, P889, DOI 10.1007/s00442-011-2146-2; Lawler IR, 1997, OECOLOGIA, V109, P59, DOI 10.1007/s004420050058; Lunney D., 2012, KOALAS CLIMATE CHANG, P150, DOI DOI 10.7882/FS.2012.0221016/J.VETMIC.2013.02.026; Lunney D, 2014, WILDLIFE RES, V41, P22, DOI 10.1071/WR13054; Lunney D, 2009, WILDLIFE RES, V36, P262, DOI 10.1071/WR08079; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Martin R. W., 2008, MAMMALS AUSTR, P198; McAlpine C, 2015, BIOL CONSERV, V192, P226, DOI 10.1016/j.biocon.2015.09.020; McAlpine CA, 2006, BIOL CONSERV, V132, P153, DOI 10.1016/j.biocon.2006.03.021; Mella VSA, 2018, AUST MAMMAL, V40, P103, DOI 10.1071/AM16049; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2015, ANIM PROD SCI, V55, P272, DOI 10.1071/AN14487; Munks SA, 1996, WILDLIFE RES, V23, P185, DOI 10.1071/WR9960185; NAGY KA, 1985, AUST J ZOOL, V33, P655, DOI 10.1071/ZO9850655; Pahl L.I., 1990, P123; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; PHILLIPS B, 1990, KOALAS LITTLE AUSTR; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Pratt A, 1937, CALL KOALA; Reckless HJ, 2017, WILDLIFE RES, V44, P458, DOI 10.1071/WR16163; Roden JS, 1996, GLOBAL CHANGE BIOL, V2, P115, DOI 10.1111/j.1365-2486.1996.tb00056.x; Seabrook L, 2014, DIVERS DISTRIB, V20, P95, DOI 10.1111/ddi.12152; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Speight N, 2019, AUST MAMMAL, V41, P92, DOI [10.1071/am17038, 10.1071/AM17038]; Sullivan BJ, 2003, WILDLIFE RES, V30, P583, DOI 10.1071/WR02036; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; WOODWARD FI, 1991, GLOBAL ECOL BIOGEOGR, V1, P7, DOI 10.2307/2997540; Wu H., 2018, INFLUENCE LEAF CHEM; Wu Huiying, 2012, Australian Zoologist, V36, P93	71	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216964	10.1371/journal.pone.0216964	http://dx.doi.org/10.1371/journal.pone.0216964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141564	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000033
J	Dundon, M; Madden, O; Comizzoli, P				Dundon, Morgan; Madden, Odile; Comizzoli, Pierre			Three-dimensional culture of endometrial cells from domestic cats: A new in vitro platform for assessing plastic toxicity	PLOS ONE			English	Article							LONG-TERM; MODELS; IDENTIFICATION; LEACHABLES; ORGANOIDS; APOPTOSIS; CHEMICALS; MOUSE; ZINC	Plastic polymers can be combined with additives that modify physical properties and stability of the material. However, the biocompatibility of those additives is not well known. The objective of the study was to characterize the impact of zinc stearate-a common additivethrough the development of a novel three-dimensional (3-D) in vitro platform with endometrial cells from domestic cats. Epithelial and stromal cells from adult uteri were isolated and cultured in medium supplemented with 3% Matrigel for two weeks in plastic tissue culture dishes that had been identified as polystyrene with and without zinc stearate by Raman, FTIR, and X-ray fluorescence spectroscopies. Three-dimensional cell structures that were obtained were measured and categorized by shape. Cell viability, proliferation, differentiation, organization, and apoptosis then were assessed by immuno-staining. Results indicated that zinc stearate did not affect 3-D endometrial cell structure morphology, viability, or cellular composition. This first study of a new in vitro platform will be useful for studies testing the influence of other additives, drugs, or exogenous hormones.	[Dundon, Morgan; Comizzoli, Pierre] Natl Zool Pk, Ctr Species Survival, Conservat Biol Inst, Washington, DC 20008 USA; [Dundon, Morgan; Madden, Odile] Smithsonian Museum Conservat Inst, Suitland, MD USA; [Dundon, Morgan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA USA; [Madden, Odile] Getty Conservat Inst, Los Angeles, CA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; University of California System; University of California Riverside	Comizzoli, P (corresponding author), Natl Zool Pk, Ctr Species Survival, Conservat Biol Inst, Washington, DC 20008 USA.	comizzolip@si.edu	Madden, Odile/N-9909-2015	Madden, Odile/0000-0003-2322-2522	Smithsonian Museum Conservation Institute; Smithsonian Conservation Biology Institute	Smithsonian Museum Conservation Institute; Smithsonian Conservation Biology Institute(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute)	M.D's fellowship was funded by the Smithsonian Museum Conservation Institute (https://www.si.edu/mci/) and the Smithsonian Conservation Biology Institute (https://nationalzoo.si.edu/conservation).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], RTECS ZH5200000 ZINC; Arnold JT, 2001, HUM REPROD, V16, P836, DOI 10.1093/humrep/16.5.836; Astashkina A, 2014, ADV DRUG DELIVER REV, V69, P1, DOI 10.1016/j.addr.2014.02.008; Boretto M, 2017, DEVELOPMENT, V144, P1775, DOI 10.1242/dev.148478; Bredhult C, 2009, REPROD TOXICOL, V28, P18, DOI 10.1016/j.reprotox.2009.03.006; Broschard TH, 2016, REGUL TOXICOL PHARM, V81, P201, DOI 10.1016/j.yrtph.2016.08.011; Caserta D, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-37; Chang JY, 2010, PHARM RES-DORDR, V27, P2402, DOI 10.1007/s11095-010-0193-8; Chia SL, 2015, SMALL, V11, P702, DOI 10.1002/smll.201401915; Lima DBC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207317; Deane JA, 2017, BIOL REPROD, V97, P781, DOI 10.1093/biolre/iox139; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Eritja N, 2010, AM J PATHOL, V176, P2722, DOI 10.2353/ajpath.2010.090974; Geravandi S, 2017, CRYOLETTERS, V38, P108; Getachew Paulos, 2016, Toxicology and Environmental Health Sciences, V8, P341, DOI 10.1007/s13530-016-0295-8; Gillespie JL, 2016, MED SCI MONIT BASIC, V22, P91, DOI 10.12659/MSMBR.900656; Groh KJ, 2017, COMPR REV FOOD SCI F, V16, P1123, DOI 10.1111/1541-4337.12280; Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802; Jenke Dennis, 2006, PDA J Pharm Sci Technol, V60, P191; Jenke Dennis, 2010, PDA J Pharm Sci Technol, V64, P200; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Lee PC, 2018, MOL HUM REPROD, V24, P14, DOI 10.1093/molehr/gax059; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Murphy J., 2001, ADDITIVES PLASTICS H; Poncin-Epaillard F, 2012, J FUNCT BIOMATER, V3, P528, DOI 10.3390/jfb3030528; SAUVANT MP, 1994, SCI TOTAL ENVIRON, V156, P159, DOI 10.1016/0048-9697(94)90353-0; Solecki R, 2017, ARCH TOXICOL, V91, P1001, DOI 10.1007/s00204-016-1866-9; Tertemiz F, 2005, BIOL REPROD, V72, P727, DOI 10.1095/biolreprod.104.034975; Tomlinson M, 2005, HUM REPROD, V20, P1751, DOI 10.1093/humrep/deh679; Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516; Watson J, 2009, J BIOMOL SCREEN, V14, P566, DOI 10.1177/1087057109336594	32	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217365	10.1371/journal.pone.0217365	http://dx.doi.org/10.1371/journal.pone.0217365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136609	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300030
J	Holmes, CL; Peyton, CG; Bier, AM; Donlon, TZ; Osman, F; Bartels, CM; Shelef, MA				Holmes, Caitlyn L.; Peyton, Chloe G.; Bier, Amy M.; Donlon, Tobias Z.; Osman, Fauzia; Bartels, Christie M.; Shelef, Miriam A.			Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects	PLOS ONE			English	Article							PNEUMOCOCCAL VACCINES; GENDER-DIFFERENCES; ANTIBODY-RESPONSE; INFLUENZA VACCINE; IMMUNOGENICITY; METHOTREXATE; SEX; DISEASE; SAFETY; IMMUNIZATION	Background The antibody response to pertussis vaccination in rheumatoid arthritis is unknown, a concerning omission given the relatively low efficacy of the pertussis vaccine, a rise in pertussis infections, and a general increased susceptibility to infection in rheumatoid arthritis. Additionally, the contributions from an intrinsically dysregulated immune system in rheumatoid arthritis and immune-suppressing medications to the response to pertussis vaccination is poorly defined. This study examines antibody titers against pertussis in vaccinated rheumatoid arthritis patients and controls as well as evaluates potential contributions from demographic factors, immune suppressing medications, and reactivity against citrullinated pertussis. Methods Serum IgG titers against native and citrullinated pertussis and tetanus were quantified by enzyme-linked immunosorbent assay in rheumatoid arthritis subjects and controls who were vaccinated within 10 years. Titers were compared by t-test and percent immunity by Fisher's exact test. Multivariable logistic regression was used to identify clinical factors that correlate with native pertussis titers. Results Compared to controls, rheumatoid arthritis subjects had lower titers against pertussis, but not tetanus, and reduced immunity to pertussis. These results were even more prominent at 5-10 years post-vaccination, when rheumatoid arthritis patients had 50% lower titers than controls and 2.5x more rheumatoid arthritis subjects were not considered immune to pertussis. Multiple logistic regression demonstrated that female sex and methotrexate use, but not TNF inhibiting medications, correlated with reduced immunity to pertussis. Finally, rheumatoid arthritis patients had higher IgG titers against citrullinated pertussis than native pertussis. Conclusions Pertussis titers are lower in vaccinated rheumatoid arthritis patients with evidence for contributions from female sex, a citrulline-biased immune response, and methotrexate use.	[Holmes, Caitlyn L.; Peyton, Chloe G.; Bier, Amy M.; Donlon, Tobias Z.; Osman, Fauzia; Bartels, Christie M.; Shelef, Miriam A.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Holmes, Caitlyn L.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Shelef, Miriam A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Shelef, MA (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53706 USA.; Shelef, MA (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.	mshelef@medicine.wisc.edu	Bartels, Christie Michels/ABG-4072-2020; Holmes, Caitlyn L./ABH-9798-2020	Bartels, Christie Michels/0000-0001-6523-0374; Holmes, Caitlyn L./0000-0001-5818-148X; Shelef, Miriam/0000-0002-8842-0303	University of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program; Doris Duke Charitable Foundation [2015099]; National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [K08AR065500]; National Institutes of Health, National Heart, Lung, and Blood Institute [T32HL07899]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR065500] Funding Source: NIH RePORTER	University of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the University of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program [https://www.med.wisc.edu/wisconsinpartnership-program/no grant number] and the Doris Duke Charitable Foundation [https://www.ddcf.org/2015099] to MAS. MAS is additionally supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [https://www.niams.nih.gov/K08AR065500].Research by CLH was supported by the National Institutes of Health, National Heart, Lung, and Blood Institute [https://www.nhlbi.nih.gov/T32HL07899].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrisani G, 2013, J CROHNS COLITIS, V7, P301, DOI 10.1016/j.crohns.2012.05.011; Barhamain AS, 2017, OPEN ACCESS RHEUMATO, V9, P139, DOI 10.2147/OARRR.S138830; Brandao AP, 2004, VACCINE, V23, P762, DOI 10.1016/j.vaccine.2004.07.024; Brown PM, 2016, NAT REV RHEUMATOL, V12, P731, DOI 10.1038/nrrheum.2016.175; Caldera F, 2018, DIGEST DIS SCI, V63, P1532, DOI 10.1007/s10620-018-5043-2; Caporuscio S, 2018, CLIN IMMUNOL, V195, P18, DOI 10.1016/j.clim.2018.07.010; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen XQ, 1997, J HEPATOL, V26, P260, DOI 10.1016/S0168-8278(97)80039-6; Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054; Corsiero E, 2016, ANN RHEUM DIS, V75, P1866, DOI 10.1136/annrheumdis-2015-208356; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Damgaard D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203214; DEVEY ME, 1987, CLIN EXP IMMUNOL, V68, P562; Dirix V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/795958; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Elkayam O, 2002, CLIN INFECT DIS, V34, P147, DOI 10.1086/338043; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Fairbanks LD, 1999, BIOCHEM J, V342, P143, DOI 10.1042/0264-6021:3420143; Fedele G, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv051; Ferreira I, 2014, ANN RHEUM DIS, V73, P1446, DOI 10.1136/annrheumdis-2014-205246; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Ge C, 2018, ARTHRITIS RHEUMATOL; Hagihara Y, 2014, J CROHNS COLITIS, V8, P223, DOI 10.1016/j.crohns.2013.08.008; Hua C, 2014, ARTHRIT CARE RES, V66, P1016, DOI 10.1002/acr.22246; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Kaine JL, 2007, J RHEUMATOL, V34, P272; Kapetanovic MC, 2011, ARTHRITIS RHEUM-US, V63, P3723, DOI 10.1002/art.30580; Katz JN, 1997, ARTHRITIS RHEUM, V40, P1594, DOI 10.1002/art.1780400908; Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086; Kilgore PE, 2016, CLIN MICROBIOL REV, V29, P449, DOI 10.1128/CMR.00083-15; Kivitz AJ, 2014, J RHEUMATOL, V41, P648, DOI 10.3899/jrheum.130945; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Krasselt M, 2017, RHEUMATOL INT, V37, P229, DOI 10.1007/s00296-016-3608-y; Mamula P, 2007, CLIN GASTROENTEROL H, V5, P851, DOI 10.1016/j.cgh.2007.02.035; Mease PJ, 2004, J RHEUMATOL, V31, P1356; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Migita K, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002184; Milanetti F, 2014, CLIN EXP IMMUNOL, V177, P287, DOI 10.1111/cei.12292; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; MORRIS CA, 1989, EPIDEMIOL INFECT, V103, P387, DOI 10.1017/S0950268800030740; National Center for Immunization and Respiratory Diseases DoBD, 1922, PERT CAS YEAR 1922 2; Park JK, 2018, ANN RHEUM DIS, V77, P898, DOI 10.1136/annrheumdis-2018-213222; Pasteur S., 2019, ADACEL PACKAGE INSER; Rebernick R, 2018, BIOL PROCED ONLINE, V20, DOI 10.1186/s12575-018-0072-y; RHODES K, 1969, ANN RHEUM DIS, V28, P104, DOI 10.1136/ard.28.2.104; Ribeiro ACM, 2011, ANN RHEUM DIS, V70, P2144, DOI 10.1136/ard.2011.152983; Salemi S, 2010, CLIN IMMUNOL, V134, P113, DOI 10.1016/j.clim.2009.09.014; Shohat T, 2000, ISRAEL MED ASSOC J, V2, P192; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Spengler J, 2015, ARTHRITIS RHEUMATOL, V67, P3135, DOI 10.1002/art.39313; Steen J, 2018, ARTHRITIS RHEUMATOL; Stephen J, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-016-0001-5; Titcombe PJ, 2018, ARTHRITIS RHEUMATOL; Torzsa P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2356-2; Trier NH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22058-6; van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41	59	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217221	10.1371/journal.pone.0217221	http://dx.doi.org/10.1371/journal.pone.0217221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136605	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300022
J	Zacharioudakis, IM; Zervou, FN; Shehadeh, F; Mylonakis, E				Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Shehadeh, Fadi; Mylonakis, Eleftherios			Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department	PLOS ONE			English	Article							ANTIMICROBIAL THERAPY; ANTIBIOTIC-THERAPY; BLOOD; INFECTIONS; PATHOGENS; SURVIVAL; IMPACT	Objectives Sepsis presents a major burden to the emergency department (ED). Because empiric inappropriate antimicrobial therapy (IAAT) is associated with increased mortality, rapid molecular assays may decrease IAAT and improve outcomes. We evaluated the cost-effectiveness of molecular testing as an adjunct to blood cultures in patients with severe sepsis or septic shock evaluated in the ED. Methods We developed a decision analysis model with primary outcome the incremental cost-effectiveness ratio expressed in terms of deaths averted. Costs were dependent on the assay price and the patients' length of stay (LOS). Three base-case scenarios regarding the difference in LOS between patients receiving appropriate (AAT) and IAAT were described. Sensitivity analyses regarding the assay cost and sensitivity, and its ability to guide changes from IAAT to AAT were performed. Results Under baseline assumptions, molecular testing was cost-saving when the LOS differed by 4 days between patients receiving IAAT and AAT (ICER -$7,302/death averted). Our results remained robust in sensitivity analyses for assay sensitivity >= 52%, panel efficiency >= 39%, and assay cost <=$ 270. In the extreme case that the LOS of patients receiving AAT and IAAT was the same, the ICER remained <=$ 20,000/death averted for every studied sensitivity (i.e. 0.5-0.95), panel efficiency >= 34%, and assay cost <=$ 313. For 2 days difference in LOS, the bundle approach was dominant when the assay cost was <=$ 135 and the panel efficiency was >= 77%. Conclusions The incorporation of molecular tests in the management of sepsis in the ED has the potential to improve outcomes and be cost-effective for a wide range of clinical scenarios.	[Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Shehadeh, Fadi; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Infect Dis Div, Providence, RI 02903 USA; [Zacharioudakis, Ioannis M.] NYU, Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; New York University	Zacharioudakis, IM; Mylonakis, E (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Infect Dis Div, Providence, RI 02903 USA.; Zacharioudakis, IM (corresponding author), NYU, Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA.	ioannis.zacharioudakis@nyulangone.org; emylonakis@lifespan.org		Mylonakis, Eleftherios/0000-0002-4624-0777; Shehadeh, Fadi/0000-0002-9552-4004	Boehringer Ingelheim; T2 Biosystems; Sanofi	Boehringer Ingelheim(Boehringer Ingelheim); T2 Biosystems; Sanofi	EM has received grant support from Boehringer Ingelheim, T2 Biosystems and Sanofi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle SE, 2017, J ANTIMICROB CHEMOTH, V72, P299, DOI 10.1093/jac/dkw402; Bureau of Labor Statistics, CPI INFL CALC; Clancy CJ, 2018, CLIN INFECT DIS, V66, P1678, DOI 10.1093/cid/cix1095; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Greco R, 2018, BONE MARROW TRANSPL, V53, P410, DOI 10.1038/s41409-017-0039-7; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Hershey TB, 2017, NEW ENGL J MED, V376, P2311, DOI 10.1056/NEJMp1611928; Jeng K, 2012, J CLIN MICROBIOL, V50, P3287, DOI 10.1128/JCM.00677-12; Khare R, 2014, J CLIN MICROBIOL, V52, P3667, DOI 10.1128/JCM.01637-14; Kothari A, 2014, CLIN INFECT DIS, V59, P272, DOI 10.1093/cid/ciu292; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Marco F, 2017, ENFERM INFEC MICR CL, V35, P586, DOI 10.1016/j.eimc.2017.03.002; Marquet Kristel, 2015, Crit Care, V19, P63, DOI 10.1186/s13054-015-0795-y; Marschall J, 2008, J ANTIMICROB CHEMOTH, V61, P1376, DOI 10.1093/jac/dkn104; Mylonakis E, 2015, CLIN INFECT DIS, V60, P892, DOI 10.1093/cid/ciu959; Opota O, 2015, CLIN MICROBIOL INFEC, V21, P323, DOI 10.1016/j.cmi.2015.02.005; Orszag P, 2014, J CLIN MICROBIOL, V52, P307, DOI 10.1128/JCM.02493-13; Raman G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1123-5; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Riedel S, 2016, CLIN CHEST MED, V37, P191, DOI 10.1016/j.ccm.2016.01.018; Shorr AF, 2008, CRIT CARE MED, V36, P2335, DOI 10.1097/CCM.0b013e31818103ea; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Trinh TD, 2015, INFECT DIS THER, V4, P39, DOI 10.1007/s40121-015-0084-8; Wang HE, 2017, CRIT CARE MED, V45, P1443, DOI 10.1097/CCM.0000000000002538; Wilke MH, 2011, EUR J MED RES, V16, P315, DOI 10.1186/2047-783X-16-7-315; [No title captured]	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217508	10.1371/journal.pone.0217508	http://dx.doi.org/10.1371/journal.pone.0217508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125382	Green Published, Green Submitted, gold			2022-12-26	WOS:000468865700046
J	Ozeir, NM; Huyet, J; Burgevin, MC; Pinson, B; Chesney, F; Remy, JM; Siddiqi, AR; Lupoli, R; Pinon, G; Saint-Marc, C; Gibert, JF; Morales, R; Ceballos-Picot, I; Barouki, R; Daignan-Fornier, B; Olivier-Bandini, A; Auge, F; Nioche, P				Ozeir, N. Mohammad; Huyet, Jessica; Burgevin, Marie-Claude; Pinson, Benoit; Chesney, Francoise; Remy, Jean-Marc; Siddiqi, Abdul Rauf; Lupoli, Roland; Pinon, Grgory; Saint-Marc, Christelle; Gibert, Jean-Francois; Morales, Renaud; Ceballos-Picot, Irene; Barouki, Robert; Daignan-Fornier, Bertrand; Olivier-Bandini, Anne; Auge, Franck; Nioche, Pierre			Structural basis for substrate selectivity and nucleophilic substitution mechanisms in human adenine phosphoribosyltransferase catalyzed reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; purine; protein structure; nucleoside; nucleotide biosynthesis; quantum chemistry; adenine; hypoxanthine; QM; MM calculation; forward and reverse reactions; nucleoside monophosphate	PURINE NUCLEOSIDE PHOSPHORYLASE; CRYSTAL-STRUCTURE; ATOMIC MOTION; NUCLEOTIDES; COMPLEXES; KINETICS; FEATURES; REVEAL; LOOP	The reversible adenine phosphoribosyltransferase enzyme (APRT) is essential for purine homeostasis in prokaryotes and eukaryotes. In humans, APRT (hAPRT) is the only enzyme known to produce AMP in cells from dietary adenine. APRT can also process adenine analogs, which are involved in plant development or neuronal homeostasis. However, the molecular mechanism underlying substrate specificity of APRT and catalysis in both directions of the reaction remains poorly understood. Here we present the crystal structures of hAPRT complexed to three cellular nucleotide analogs (hypoxanthine, IMP, and GMP) that we compare with the phosphate-bound enzyme. We established that binding to hAPRT is substrate shape-specific in the forward reaction, whereas it is base-specific in the reverse reaction. Furthermore, a quantum mechanics/molecular mechanics (QM/MM) analysis suggests that the forward reaction is mainly a nucleophilic substitution of type 2 (S(N)2) with a mix of S(N)1-type molecular mechanism. Based on our structural analysis, a magnesium-assisted S(N)2-type mechanism would be involved in the reverse reaction. These results provide a framework for understanding the molecular mechanism and substrate discrimination in both directions by APRTs. This knowledge can play an instrumental role in the design of inhibitors, such as antiparasitic agents, or adenine-based substrates.	[Ozeir, N. Mohammad; Huyet, Jessica; Lupoli, Roland; Pinon, Grgory; Barouki, Robert; Nioche, Pierre] Univ Paris 05, Ctr Interdisciplinaire Chim Biol Paris, UFR Sci Fondamentales & Biomed, UMR 1124,Sorbonne Paris Cite, F-75006 Paris, France; [Ozeir, N. Mohammad; Huyet, Jessica; Lupoli, Roland; Pinon, Grgory; Barouki, Robert; Nioche, Pierre] INSERM, UMR 1124, F-75006 Paris, France; [Pinon, Grgory; Nioche, Pierre] Univ Paris 05, Struct & Mol Anal Platform, F-75006 Paris, France; [Burgevin, Marie-Claude; Chesney, Francoise; Remy, Jean-Marc; Gibert, Jean-Francois; Morales, Renaud; Olivier-Bandini, Anne; Auge, Franck] Sanofi R&D, Translat Sci Unit, F-91385 Chilly Mazarin, France; [Pinson, Benoit; Saint-Marc, Christelle; Daignan-Fornier, Bertrand] Univ Bordeaux, Inst Biochim & Genet Cellulaires, CNRS UMR 5095, F-33077 Bordeaux, France; [Siddiqi, Abdul Rauf] COMSATS Inst Informat Technol, Dept Biosci, Islamabad 45550, Pakistan; [Ceballos-Picot, Irene; Barouki, Robert] Hop Necker Enfants Malad, AP HP, Lab Biochim Metabol & Proteom, Fac Med Paris Descartes, F-75006 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis; Sanofi France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; COMSATS University Islamabad (CUI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Nioche, P (corresponding author), Univ Paris 05, Ctr Interdisciplinaire Chim Biol Paris, UFR Sci Fondamentales & Biomed, UMR 1124,Sorbonne Paris Cite, F-75006 Paris, France.; Nioche, P (corresponding author), INSERM, UMR 1124, F-75006 Paris, France.; Nioche, P (corresponding author), Univ Paris 05, Struct & Mol Anal Platform, F-75006 Paris, France.; Auge, F (corresponding author), Sanofi R&D, Translat Sci Unit, F-91385 Chilly Mazarin, France.	franck.auge@sanofi.com; pierre.nioche@gmail.com	Gregory, Pinon/AAL-6974-2020	Gregory, Pinon/0000-0002-3895-3320	French National Research Agency [2010-CESA-015]; ARC Foundation; INSERM-University Chair; Sanofi research [116048, EU-TL-2013-003]; Ile de France Region; Paris City Hall	French National Research Agency(French National Research Agency (ANR)); ARC Foundation(Australian Research Council); INSERM-University Chair; Sanofi research; Ile de France Region(Region Ile-de-France); Paris City Hall	This work was supported by French National Research Agency Grant 2010-CESA-015 (to J.H. and P.N.), the ARC Foundation (to M.O.), an INSERM-University Chair (to P.N.), Paris City Hall and Ile de France Region grants (to P.N.), and Sanofi research contracts 116048 (to I.C.-P., B.P., and B.D.-F.) and EU-TL-2013-003 (to P.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; [Anonymous], 2014, QSITE; [Anonymous], 2014, MAESTR; Bashor C, 2002, BIOCHEMISTRY-US, V41, P4020, DOI 10.1021/bi0158730; Beresford RM, 1995, P NZ PLAN P, V48, P89, DOI 10.30843/nzpp.1995.48.11498; Bollee G, 2012, CLIN J AM SOC NEPHRO, V7, P1521, DOI 10.2215/CJN.02320312; Burgess J. P, 2008, TEMPLATE SYNTHESIS M; Chen XY, 1998, BIOCHEMISTRY-US, V37, P11605, DOI 10.1021/bi980990p; Costas ME, 1997, J PHYS CHEM A, V101, P8309, DOI 10.1021/jp970621n; Curto R, 1997, BIOCHEM J, V324, P761, DOI 10.1042/bj3240761; EADS JC, 1994, CELL, V78, P325, DOI 10.1016/0092-8674(94)90301-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Ghanem M, 2009, CHEM BIOL, V16, P971, DOI 10.1016/j.chembiol.2009.07.012; GOITEIN RK, 1978, J BIOL CHEM, V253, P2963; GUTHRIE RD, 1989, ACCOUNTS CHEM RES, V22, P343, DOI 10.1021/ar00166a001; Gutierrez JA, 2009, NAT CHEM BIOL, V5, P251, DOI 10.1038/nchembio.153; Heinonen J.K, 2001, BIOL ROLE INORGANIC, DOI [10.1007/978-1-4615-1433-6, DOI 10.1007/978-1-4615-1433-6]; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Huyet J, 2018, CELL CHEM BIOL, V25, P666, DOI 10.1016/j.chembiol.2018.02.011; Johnson ER, 2010, J AM CHEM SOC, V132, P6498, DOI 10.1021/ja100936w; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; MURRAY AW, 1967, BIOCHEM J, V103, P271, DOI 10.1042/bj1030271; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Otilia C., 2004, METAL MEDIATED TEMPL; Phillips CL, 1999, EMBO J, V18, P3533, DOI 10.1093/emboj/18.13.3533; Schramm VL, 2001, CURR OPIN STRUC BIOL, V11, P657, DOI 10.1016/S0959-440X(01)00269-X; Shi WX, 1999, NAT STRUCT BIOL, V6, P588; Shi WX, 2002, J BIOL CHEM, V277, P39981, DOI 10.1074/jbc.M205596200; Silva CHTP, 2008, J BIOMOL STRUCT DYN, V25, P589, DOI 10.1080/07391102.2008.10507205; Silva M, 2004, BBA-PROTEINS PROTEOM, V1696, P31, DOI 10.1016/j.bbapap.2003.09.003; STEIN RL, 1981, J BIOL CHEM, V256, P767; Suarez J, 2013, CHEM BIOL, V20, P212, DOI 10.1016/j.chembiol.2013.01.009; TUTTLE JV, 1980, J BIOL CHEM, V255, P909; Wang GP, 1999, BIOCHEMISTRY-US, V38, P284, DOI 10.1021/bi982057s; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YUAN L, 1992, BIOCHEMISTRY-US, V31, P806, DOI 10.1021/bi00118a024; Zhang XY, 2013, MOL PLANT, V6, P1661, DOI 10.1093/mp/sst071	41	3	3	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2019	294	32					11980	11991		10.1074/jbc.RA119.009087	http://dx.doi.org/10.1074/jbc.RA119.009087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IV5AV	31160323	Green Published, hybrid			2022-12-26	WOS:000484284500004
J	Kolar, MJ; Konduri, S; Chang, T; Wang, HJ; McNerlin, C; Ohlsson, L; Harrod, M; Siegel, D; Saghatelian, A				Kolar, Matthew J.; Konduri, Srihari; Chang, Tina; Wang, Huijing; McNerlin, Clare; Ohlsson, Lena; Harrod, Magnus; Siegel, Dionicio; Saghatelian, Alan			Linoleic acid esters of hydroxy linoleic acids are anti-inflammatory lipids found in plants and mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid; lipid structure; lipid synthesis; lipid signaling; inflammation; FAHFAs; LAHLAs	FATTY-ACIDS; NITRIC-OXIDE; STEREOSELECTIVE-SYNTHESIS; PHENOLIC-ACIDS; AVENANTHRAMIDES; FAHFAS; ACTIVATION; COX-2; OATS; LPS	Fatty acid esters of hydroxy fatty acids (FAHFAs) are a recently discovered class of biologically active lipids. Here we identify the linoleic acid ester of 13-hydroxy linoleic acid (13-LAHLA) as an anti-inflammatory lipid. An oat oil fraction and FAHFA-enriched extract from this fraction showed anti-inflammatory activity in a lipopolysaccharide-induced cytokine secretion assay. Structural studies identified three LAHLA isomers (15-, 13-, and 9-LAHLA) as being the most abundant FAHFAs in the oat oil fraction. Of these LAHLAs, 13-LAHLA is the most abundant LAHLA isomer in human serum after ingestion of liposomes made of fractionated oat oil, and it is also the most abundant endogenous LAHLA in mouse and human adipose tissue. As a result, we chemically synthesized 13-LAHLA for biological assays. 13-LAHLA suppresses lipopolysaccharide-stimulated secretion of cytokines and expression of pro-inflammatory genes. These studies identify LAHLAs as an evolutionarily conserved lipid with anti-inflammatory activity in mammalian cells.	[Kolar, Matthew J.; Chang, Tina; Saghatelian, Alan] Clayton Fdn Labs Peptide Biol, Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Konduri, Srihari; Wang, Huijing; McNerlin, Clare; Siegel, Dionicio] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Ohlsson, Lena] Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Box 117, S-22100 Lund, Sweden; [Harrod, Magnus] Harrod Res, Frans Persons Vag 6, S-40229 Gothenburg, Sweden; [Kolar, Matthew J.] Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Lund University; University of California System; University of California San Diego	Saghatelian, A (corresponding author), Clayton Fdn Labs Peptide Biol, Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Siegel, D (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	drsiegel@ucsd.edu; asaghatelian@salk.edu	Ohlsson, Lena/AAI-1587-2021; Konduri, Srihari/Q-1030-2019	Konduri, Srihari/0000-0003-1618-3932; Saghatelian, Alan/0000-0002-0427-563X; Kolar, Matthew/0000-0001-8054-9121; Chang, Tina/0000-0002-7079-0226	NIDDK, National Institutes of Health [R01 DK106210, R56 DK110150-01A1, F31 DK112604]; NCI, National Institutes of Health [CA014195]; Ferring Pharmaceuticals Paulsen Chair; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC2DK114785, R56DK110150, R01DK106210] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021815] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ferring Pharmaceuticals Paulsen Chair(Ferring Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIDDK, National Institutes of Health grants R01 DK106210 (to A.S.), R56 DK110150-01A1 (to D.S.), and F31 DK112604 (to A.S.); NCI, National Institutes of Health Grant CA014195 (to M.J.K., T.C., and A.S.), and a Ferring Pharmaceuticals Paulsen Chair (to A.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balas L, 2016, ORG BIOMOL CHEM, V14, P9012, DOI 10.1039/c6ob01597b; CHAN C, 1988, J CHEM SOC CHEM COMM, P971, DOI 10.1039/c39880000971; Chen CY, 2004, J NUTR, V134, P1459, DOI 10.1093/jn/134.6.1459; COLLINS FW, 1989, J AGR FOOD CHEM, V37, P60, DOI 10.1021/jf00085a015; Criquet M, 2012, CLIN COSMET INVESTI, V5, P183, DOI 10.2147/CCID.S31375; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Evans R., 1991, U. S. Patent, Patent No. [5,026,548, 5026548]; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hamberg M, 1998, LIPIDS, V33, P355, DOI 10.1007/s11745-998-0215-9; Harrod M., 2014, U. S. Patent, Patent No. [8,865,923, 8865923]; Hu T, 2018, ANAL BIOANAL CHEM, V410, P7415, DOI 10.1007/s00216-018-1350-x; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kim JB, 2007, BIOL PHARM BULL, V30, P2345, DOI 10.1248/bpb.30.2345; Kolar MJ, 2018, ANAL CHEM, V90, P5358, DOI 10.1021/acs.analchem.8b00503; Kolar MJ, 2016, BIOCHEMISTRY-US, V55, P4636, DOI 10.1021/acs.biochem.6b00565; Kuda O, 2016, DIABETES, V65, P2580, DOI 10.2337/db16-0385; Kurtz Ellen S, 2007, J Drugs Dermatol, V6, P167; Lee J, 2016, J BIOL CHEM, V291, P22207, DOI 10.1074/jbc.M115.703835; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li Z, 2009, CHEM PHYS LIPIDS, V158, P39, DOI 10.1016/j.chemphyslip.2008.12.004; Ma Y, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0104-4; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Mattila P, 2005, J AGR FOOD CHEM, V53, P8290, DOI 10.1021/jf051437z; Moreau RA, 2008, LIPIDS, V43, P533, DOI 10.1007/s11745-008-3181-6; Nelson AT, 2017, J AM CHEM SOC, V139, P4943, DOI 10.1021/jacs.7b01269; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohlsson L, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.24465; Parsons WH, 2016, NAT CHEM BIOL, V12, P367, DOI [10.1038/NCHEMBIO.2051, 10.1038/nchembio.2051]; Peterson DM, 2002, FOOD CHEM, V79, P473, DOI 10.1016/S0308-8146(02)00219-4; RAO AVR, 1985, TETRAHEDRON LETT, V26, P465, DOI 10.1016/S0040-4039(00)61912-3; RAO AVR, 1986, J ORG CHEM, V51, P4158, DOI 10.1021/jo00372a011; Reynertson KA, 2015, J DRUGS DERMATOL, V14, P43; STILLE JK, 1989, TETRAHEDRON LETT, V30, P3645, DOI 10.1016/S0040-4039(01)80470-6; Syed I, 2018, CELL METAB, V27, P419, DOI 10.1016/j.cmet.2018.01.001; YADAV JS, 1992, TETRAHEDRON, V48, P4465, DOI 10.1016/S0040-4020(01)80454-3; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Zhang TJ, 2016, NAT PROTOC, V11, P747, DOI 10.1038/nprot.2016.040; Zhu QF, 2018, ANAL CHEM, V90, P10056, DOI 10.1021/acs.analchem.8b02839	40	41	41	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10698	10707		10.1074/jbc.RA118.006956	http://dx.doi.org/10.1074/jbc.RA118.006956			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31152059	Green Published, hybrid			2022-12-26	WOS:000478717100027
J	Zyla, DS; Prota, AE; Capitani, G; Glockshuber, R				Zyla, Dawid S.; Prota, Andrea E.; Capitani, Guido; Glockshuber, Rudi			Alternative folding to a monomer or homopolymer is a common feature of the type 1 pilus subunit FimA from enteroinvasive bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; X-ray crystallography; Escherichia coli (E; coli); protein structure; protein stability; alternative folding; chaperone-usher pili; FimA; type 1 pilus; urinary tract infections	URINARY-TRACT; DISSOCIATION; STABILITY	Adhesive type 1 pili from enteroinvasive, Gram-negative bacteria mediate attachment to host cells. Up to 3000 copies of the main pilus subunit, FimA, assemble into the filamentous, helical quaternary structure of the pilus rod via a mechanism termed donor-strand complementation, in which the N-terminal extension of each subunit, the donor strand, is inserted into the incomplete immunoglobulin-like fold of the preceding FimA subunit. For FimA from Escherichia coli, it has been previously shown that the protein can also adopt a monomeric, self-complemented conformation in which the donor strand is inserted intramolecularly in the opposite orientation relative to that observed for FimA polymers. Notably, soluble FimA monomers can act as apoptosis inhibitors in epithelial cells after uptake of type 1-piliated pathogens. Here, we show that the FimA orthologues from Escherichia coli, Shigella flexneri, and Salmonella enterica can all fold to form self-complemented monomers. We solved X-ray structures of all three FimA monomers at 0.89-1.69 angstrom resolutions, revealing identical, intramolecular donor-strand complementation mechanisms. Our results also showed that the pseudo-palindromic sequences of the donor strands in all FimA proteins permit their alternative folding possibilities. All FimA monomers proved to be 50-60 kJ/mol less stable against unfolding than their pilus rod-like counterparts (which exhibited very high energy barriers of unfolding and refolding). We conclude that the ability of FimA to adopt an alternative, monomeric state with anti-apoptotic activity is a general feature of FimA proteins of type 1-piliated bacteria.	[Zyla, Dawid S.; Glockshuber, Rudi] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland; [Prota, Andrea E.; Capitani, Guido] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, Forschungsstr 111, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Glockshuber, R (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	rudi@mol.biol.ethz.ch	Prota, Andrea Enrico/R-9526-2019; Żyła, Dawid/AAD-2381-2020	Prota, Andrea Enrico/0000-0003-0875-5339; Żyła, Dawid/0000-0001-8471-469X	Swiss National Science Foundation [310030B_176403/1, 31003A_156304]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 310030B_176403/1 and 31003A_156304 (to R.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen WJ, 2012, CURR OPIN STRUC BIOL, V22, P500, DOI 10.1016/j.sbi.2012.02.001; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Busch A, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2013.0153; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Crespo MD, 2012, NAT CHEM BIOL, V8, P707, DOI [10.1038/NCHEMBIO.1019, 10.1038/nchembio.1019]; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erilov D, 2007, J AM CHEM SOC, V129, P8938, DOI 10.1021/ja0718927; ESHDAT Y, 1981, J BACTERIOL, V148, P308, DOI 10.1128/JB.148.1.308-314.1981; Fersht A., 1999, STRUCTURE MECH PROTE; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Hospenthal MK, 2017, STRUCTURE, V25, P1829, DOI 10.1016/j.str.2017.10.004; Hospenthal MK, 2017, NAT REV MICROBIOL, V15, P365, DOI 10.1038/nrmicro.2017.40; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Nozaki Y, 1972, Methods Enzymol, V26, P43; OHANLEY P, 1985, J CLIN INVEST, V75, P347, DOI 10.1172/JCI111707; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; Puorger C, 2011, J MOL BIOL, V412, P520, DOI 10.1016/j.jmb.2011.07.044; Sauer MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10738; Schilling JD, 2001, J INFECT DIS, V183, pS36, DOI 10.1086/318855; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Spaulding C, 2018, ELIFE, V7, DOI 10.7554/eLife.31662; Sukumaran SK, 2010, MOL CELL, V37, P768, DOI 10.1016/j.molcel.2010.02.015; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; Walczak MJ, 2014, J MOL BIOL, V426, P542, DOI 10.1016/j.jmb.2013.10.029	34	2	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10553	10563		10.1074/jbc.RA119.008610	http://dx.doi.org/10.1074/jbc.RA119.008610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31126987	Green Published, hybrid			2022-12-26	WOS:000478717100015
J	Gastaldi, G; Gomes, D; Schneiter, P; Montet, X; Tappy, L; Clements, S; Negro, F				Gastaldi, Giacomo; Gomes, Diana; Schneiter, Philippe; Montet, Xavier; Tappy, Luc; Clements, Sophie; Negro, Francesco			Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; TYPE-2 DIABETES-MELLITUS; CHRONIC LIVER-DISEASE; QUALITY-OF-LIFE; VIRUS-INFECTION; ADIPOSE-TISSUE; EXTRAHEPATIC MANIFESTATIONS; RECEPTOR SUBSTRATE-1; SELENOPROTEIN P; GROWTH-FACTOR	Background and aims Hepatitis C virus (HCV) infection is associated with insulin resistance, which may lead to type 2 diabetes and its complications. Although HCV infects mainly hepatocytes, it may impair insulin sensitivity at the level of uninfected extrahepatic tissues (muscles and adipose tissue). The aim of this study was to assess whether an interferon-free, antiviral therapy may improve HCV-associated hepatic vs. peripheral insulin sensitivity. Methods In a single-arm exploratory trial, 17 non-diabetic, lean chronic hepatitis C patients without significant fibrosis were enrolled, and 12 completed the study. Patients were treated with a combination of sofosbuvir/ledipasvir and ribavirin for 12 weeks, and were submitted to a 2 step euglycemic hyperinsulinemic clamp with tracers, together with indirect calorimetry measurement, to measure insulin sensitivity before and after 6 weeks of antivirals. A panel of 27 metabolically active cytokines was analyzed at baseline and after therapy-induced viral suppression. Results Clamp analysis performed in 12 patients who achieved complete viral suppression after 6 weeks of therapy showed a significant improvement of the peripheral insulin sensitivity (13.1% [4.6-36.7], p = 0.003), whereas no difference was observed neither in the endogenous glucose production, in lipolysis suppression nor in substrate oxidation. A distinct subset of hepatokines, potentially involved in liver-to-periphery crosstalk, was modified by the antiviral therapy. Conclusion Pharmacological inhibition of HCV improves peripheral (but not hepatic) insulin sensitivity in non-diabetic, lean individuals with chronic hepatitis C without significant fibrosis.	[Gastaldi, Giacomo] Geneva Univ Hosp, Div Endocrinol Diabetol Hypertens & Nutr, Geneva, Switzerland; [Gomes, Diana] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Schneiter, Philippe; Tappy, Luc] Univ Lausanne, Fac Biol & Med, Dept Physiol, Lausanne, Switzerland; [Montet, Xavier] Geneva Univ Hosp, Div Radiol, Geneva, Switzerland; [Clements, Sophie; Negro, Francesco] Geneva Univ Hosp, Div Clin Pathol, Geneva, Switzerland; [Negro, Francesco] Geneva Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Lausanne; University of Geneva; University of Geneva; University of Geneva	Negro, F (corresponding author), Geneva Univ Hosp, Div Clin Pathol, Geneva, Switzerland.; Negro, F (corresponding author), Geneva Univ Hosp, Div Gastroenterol & Hepatol, Geneva, Switzerland.	Francesco.negro@hcuge.ch	Montet, Xavier/GMW-9003-2022; Gastaldi, Giacomo/AAV-8187-2021; gastaldi, giacomo/AAF-9948-2020	gastaldi, giacomo/0000-0001-6327-7451; Gomes, Diana/0000-0002-9342-2557	Gilead Sciences, Inc. Foster City, CA, US; Swiss National Science Foundation [314730-166609]; FLAGS Foundation; Fondation pour la Recherche sur le Diabete, Geneva, Switzerland	Gilead Sciences, Inc. Foster City, CA, US(Gilead Sciences); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FLAGS Foundation; Fondation pour la Recherche sur le Diabete, Geneva, Switzerland	This work was supported by: (FN) Gilead Sciences, Inc. Foster City, CA, US, https://www.gilead.com/; Swiss National Science Foundation (314730-166609 to F.N.), http://www.snf.ch/en/Pages/default.aspx; FLAGS Foundation and the Fondation pour la Recherche sur le Diabete, Geneva, Switzerland, http://www.fondation-diabete.ch/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Gilead Sciences, Inc. Foster City, CA, US, the Swiss National Science Foundation (314730-166609 to F.N.), the FLAGS Foundation and the Fondation pour la Recherche sur le Diabete, Geneva, Switzerland. We thank Dr Nicolas Liaudet (Bioimaging Core Facility, Faculty of Medicine, Geneva) for his help and advice, Dr Annarita Farina (Department of Internal Medicine, Faculty of Medicine, Geneva) for the support provided with the multiplex assays, and the Clinical Research Center, University Hospital of Geneva for its contribution. We gratefully acknowledge the patients who participated in the study.	Aeberli I, 2013, DIABETES CARE, V36, P150, DOI 10.2337/dc12-0540; Aghemo A, 2012, HEPATOLOGY, V56, P1681, DOI 10.1002/hep.25867; Ali SA, 2016, CLIN RES HEPATOL GAS, V40, P465, DOI 10.1016/j.clinre.2015.12.003; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Arase Y, 2009, HEPATOLOGY, V49, P739, DOI 10.1002/hep.22703; Brenachot X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02074-2; Bugianesi E, 2012, J HEPATOL, V56, pS56, DOI 10.1016/S0168-8278(12)60007-5; Butt AA, 2019, GASTROENTEROLOGY, V156, P987, DOI 10.1053/j.gastro.2018.11.022; Cacoub P, 2018, J VIRAL HEPATITIS, V25, P811, DOI 10.1111/jvh.12881; Cacoub P, 2018, GUT, V67, P2025, DOI 10.1136/gutjnl-2018-316234; Carrat F, 2019, LANCET, V393, P1453, DOI 10.1016/S0140-6736(18)32111-1; Clement S, 2008, HEPATOLOGY, V48, P799, DOI 10.1002/hep.22404; Dawood AA, 2017, DIABETES METAB J, V41, P316, DOI 10.4093/dmj.2017.41.4.316; Ebert T, 2009, METABOLISM, V58, P547, DOI 10.1016/j.metabol.2008.11.016; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Fabrizio C, 2017, CLIN MICROBIOL INFEC, V23, P342, DOI 10.1016/j.cmi.2016.09.021; Feng RN, 2014, DIABETES RES CLIN PR, V106, P88, DOI 10.1016/j.diabres.2014.07.026; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Garcia-Alvarez M, 2011, CYTOKINE, V54, P244, DOI 10.1016/j.cyto.2011.03.001; GOODPASTER BH, J APPL PHYSL, V89, P104; Goossens N, 2014, HEPATOLOGY, V59, P2403, DOI 10.1002/hep.26905; Gouthamchandra K, 2014, J GEN VIROL, V95, P1654, DOI 10.1099/vir.0.062430-0; HARGREAVES M, 1991, J APPL PHYSIOL, V70, P194, DOI 10.1152/jappl.1991.70.1.194; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Himoto T, 2013, NUTR RES, V33, P27, DOI 10.1016/j.nutres.2012.11.007; Hoyer D, 2011, DIABETOLOGIA, V54, P2795, DOI 10.1007/s00125-011-2275-5; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Hum J, 2017, DIABETES CARE, V40, P1173, DOI 10.2337/dc17-0485; Jacques C, 2012, J BIOL CHEM, V287, P15100, DOI 10.1074/jbc.M112.350215; Jung CH, 2011, BIOCHEM BIOPH RES CO, V413, P264, DOI 10.1016/j.bbrc.2011.08.083; Kaishima T, 2018, HEPATOL RES, V48, P509, DOI 10.1111/hepr.13053; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2007, AM J GASTROENTEROL, V102, P570, DOI 10.1111/j.1572-0241.2006.01038.x; KELLEY DE, 1991, AM J CLIN NUTR, V54, P509, DOI 10.1093/ajcn/54.3.509; Knobler H, 2003, AM J GASTROENTEROL, V98, P2751, DOI 10.1016/j.amjgastroenterol.2003.06.002; Kukla M, 2010, J VIRAL HEPATITIS, V17, P661, DOI 10.1111/j.1365-2893.2009.01224.x; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Lin YJ, 2017, LIVER INT, V37, P179, DOI 10.1111/liv.13194; Liu WM, 2016, ARCH IMMUNOL THER EX, V64, P371, DOI 10.1007/s00005-016-0395-9; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10227; Mahale P, 2018, GUT, V67, P553, DOI 10.1136/gutjnl-2017-313983; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Mehta SH, 2003, HEPATOLOGY, V38, P50, DOI 10.1053/jhep.2003.50291; Milner KL, 2014, J VIRAL HEPATITIS, V21, P325, DOI 10.1111/jvh.12143; Milner KL, 2010, GASTROENTEROLOGY, V138, P932, DOI 10.1053/j.gastro.2009.11.050; Minehira K, 2004, INT J OBESITY, V28, P1291, DOI 10.1038/sj.ijo.0802760; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Nahon P, 2017, GASTROENTEROLOGY, V152, P142, DOI 10.1053/j.gastro.2016.09.009; Nakamura I, 2018, HEPATOL RES, V48, P855, DOI 10.1111/hepr.13186; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; Pavone P, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.030; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Platanias LC, 1996, J BIOL CHEM, V271, P278, DOI 10.1074/jbc.271.1.278; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2008, J HEPATOL, V48, P721, DOI 10.1016/j.jhep.2007.11.022; Schlevogt B, 2017, Z GASTROENTEROL, V55, P848, DOI 10.1055/s-0043-112656; Schneiter P, 1999, METABOLISM, V48, P1260, DOI 10.1016/S0026-0495(99)90265-2; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Vanni E, 2009, HEPATOLOGY, V50, P697, DOI 10.1002/hep.23031; Wang CS, 2003, AM J EPIDEMIOL, V158, P1154, DOI 10.1093/aje/kwg259; Wasmuth HE, 2008, J HEPATOL, V48, P208, DOI 10.1016/j.jhep.2007.09.008; WHO, 2017, WHO PUBLISHES LIST B; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045; Younossi Z, 2016, GASTROENTEROLOGY, V150, P1599, DOI 10.1053/j.gastro.2016.02.039; Younossi ZM, 2019, LIVER INT, V39, P54, DOI 10.1111/liv.13900; Zanchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109134	74	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217751	10.1371/journal.pone.0217751	http://dx.doi.org/10.1371/journal.pone.0217751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170218	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700052
J	Marsoner, K; Voetsch, A; Lierzer, C; Sodeck, GH; Fruhwald, S; Dapunt, O; Mischinger, HJ; Kornprat, P				Marsoner, Katharina; Voetsch, Andreas; Lierzer, Christoph; Sodeck, Gottfried H.; Fruhwald, Sonja; Dapunt, Otto; Mischinger, Hans Joerg; Kornprat, Peter			Gastrointestinal complications following on-pump cardiac surgery-A propensity matched analysis	PLOS ONE			English	Article							CARDIOPULMONARY BYPASS; BLOOD-FLOW; DETERMINANTS; PREDICTORS	Background Gastrointestinal complications following on-pump cardiac surgery are orphan but serious risk factors for postoperative morbidity and mortality. We aimed to assess incidence, perioperative risk factors, treatment modalities and outcomes. Material and methods A university medical center audit comprised 4883 consecutive patients (median age 69 [interquartile range IQR 60-76] years, 33% female, median logistic EuroScore 5 [IQR 3-11]) undergoing all types of cardiac surgery including surgery on the thoracic aorta; patients undergoing repair of congenital heart disease, implantation of assist devices or cardiac transplantation were excluded. Coronary artery disease was the leading indication for on-pump cardiac surgery (60%), patients undergoing cardiac surgery under urgency or emergency setting were included in analysis. We identified a total of 142 patients with gastrointestinal complications. To identify intra-and postoperative predictors for gastrointestinal complications, we applied a 1: 1 propensity score matching procedure based on a logistic regression model. Results Overall, 30-day mortality for the entire cohort was 5.4%; the incidence of gastrointestinal complications was 2.9% and median time to complication 8 days (IQR 4-12). Acute pancreatitis (n = 41), paralytic ileus (n = 14) and acute cholecystitis (n = 18) were the leading pathologies. Mesenteric ischemia and gastrointestinal bleeding accounted for 16 vs. 18 cases, respectively. While 72 patients (51%) could be managed conservatively, 27 patients required endoscopic/radiological (19%) or surgical intervention (43/142 patients, 30%); overall 30-day mortality was 12.1% (p<0.001). Propensity score matching identified prolonged skin-to-skin times (p = 0.026; Odds Ratio OR 1.003, 95% Confidence Interval CI 1.000-1.007) and extended on-pump periods (p = 0.010; OR 1.006, 95% CI 1.001-1.011) as significant perioperative risk factors. Comment Prolonged skin-to-skin times and extended on-pump periods are important perioperative risk factors regardless of preoperative risk factors.	[Marsoner, Katharina; Lierzer, Christoph; Mischinger, Hans Joerg; Kornprat, Peter] Med Univ Graz, Dept Gen Surg, Graz, Austria; [Voetsch, Andreas; Dapunt, Otto] Med Univ Graz, Dept Cardiac Surg, Graz, Austria; [Voetsch, Andreas] Paracelsus Med Univ, Dept Cardiac Surg, Salzburg, Austria; [Sodeck, Gottfried H.] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Fruhwald, Sonja] Med Univ Graz, Dept Anesthesiol & Intens Care Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Paracelsus Private Medical University; Medical University of Vienna; Medical University of Graz	Kornprat, P (corresponding author), Med Univ Graz, Dept Gen Surg, Graz, Austria.	peter.kornprat@medunigraz.at	, Kornprat/AAH-6353-2019; Vötsch, Andreas/N-5953-2014	Vötsch, Andreas/0000-0001-6841-4208				Abbas SH, 2018, DIGEST SURG, V35, P171, DOI 10.1159/000477780; Byhahn C, 2001, WORLD J SURG, V25, P1140, DOI 10.1007/BF03215861; Chaudhry R, 2017, J CARDIOTHOR VASC AN, V31, P1268, DOI 10.1053/j.jvca.2017.04.013; CHRISTENSON JT, 1994, THORAC CARDIOV SURG, V42, P152, DOI 10.1055/s-2007-1016478; Chung JW, 2013, YONSEI MED J, V54, P154, DOI 10.3349/ymj.2013.54.1.154; D'Ancona G, 2003, TEX HEART I J, V30, P280; FERNANDEZDELCASTILLO C, 1991, NEW ENGL J MED, V325, P382; Filsoufi F, 2007, ANN SURG, V246, P323, DOI 10.1097/SLA.0b013e3180603010; Guillaume A, 2017, SHOCK, V47, P296, DOI 10.1097/SHK.0000000000000720; HUDDY SPJ, 1991, BRIT J SURG, V78, P293, DOI 10.1002/bjs.1800780309; Mangi AA, 2005, ANN SURG, V241, P895, DOI 10.1097/01.sla.0000164173.05762.32; Mayson Sarah E, 2007, Cardiol Rev, V15, P231, DOI 10.1097/CRD.0b013e31813e62bb; MONETA GL, 1985, AM J SURG, V149, P648, DOI 10.1016/S0002-9610(85)80148-3; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nilsson J, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-156; OHRI SK, 1994, ANN THORAC SURG, V57, P1193, DOI 10.1016/0003-4975(94)91355-2; Ohri SK, 2006, PERFUSION-UK, V21, P215, DOI 10.1191/0267659106pf871oa; Poirier B, 2003, J CAN CHIR, V36, P176; Rodriguez R, 2010, J CARDIAC SURG, V25, P188, DOI 10.1111/j.1540-8191.2009.00985.x; Sever K, 2014, ANGIOLOGY, V65, P425, DOI 10.1177/0003319713482357; TAO WK, 1995, J THORAC CARDIOV SUR, V110, P819, DOI 10.1016/S0022-5223(95)70116-8; Viana FF, 2013, ANZ J SURG, V83, P651, DOI 10.1111/ans.12134; Zacharias A, 2000, TEX HEART I J, V27, P93	23	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217874	10.1371/journal.pone.0217874	http://dx.doi.org/10.1371/journal.pone.0217874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166962	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800047
J	Heiferman, MJ; Fawzi, AA				Heiferman, Michael J.; Fawzi, Amani A.			Progression of subclinical choroidal neovascularization in age-related macular degeneration	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; VISUAL-ACUITY; EYES; CHORIOCAPILLARIS; PREVALENCE; ATROPHY; DRUSEN	Purpose To use optical coherence tomography angiography (OCTA) to study longitudinal subclinical choroidal neovascularization (CNV) changes and their correlation with progression to exudation in age-related macular degeneration (AMD). Methods This study included a total of 34 patients with unilateral neovascular AMD who were evaluated prospectively using OCTA to detect subclinical CNV in their fellow eye. Eyes with baseline subclinical CNV were followed with serial OCTA for a minimum of one year (15.2 +/- 3.27 months) to monitor the development of exudation. Results Of the 34 fellow eyes studied, five were found to have baseline subclinical CNV. One of the five cases of baseline subclinical CNV converted to exudative AMD during the follow up period. The average surface area of baseline subclinical CNV on OCTA was 0.131 +/- 0.096 mm(2) which progressed to 0.136 +/- 0.104 mm(2) at the final follow up (P = 0.539). Geographic atrophy grew at a rate of 0.82 +/- 1.20mm(2)/year in four eyes without subclinical CNV and 0.02mm(2)/year in one eye with subclinical CNV. Conclusion and importance The rate of conversion to exudative AMD in eyes with subclinical CNV of 20% in our study is similar to previous reports and suggests the importance of vigilance in these eyes. The lower growth rate of geographic atrophy may suggest a protective effect of subclinical CNV that deserves further study.	[Heiferman, Michael J.; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558	National Institutes of Health [AAF - 1DP3DK108248]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by AAF - 1DP3DK108248, National Institutes of Health (www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Amissah-Arthur KN, 2012, EYE, V26, P394, DOI 10.1038/eye.2011.335; Capuano V, 2017, AM J OPHTHALMOL, V182, P45, DOI 10.1016/j.ajo.2017.07.009; Carnevali A, 2016, AM J OPHTHALMOL, V169, P189, DOI 10.1016/j.ajo.2016.06.042; Chew EY, 2014, JAMA OPHTHALMOL, V132, P272, DOI 10.1001/jamaophthalmol.2013.6636; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Dias JRD, 2018, OPHTHALMOLOGY, V125, P255, DOI 10.1016/j.ophtha.2017.08.030; Fayed A. E., 2018, PREVALENCE SUBCLINIC; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Green W R, 1977, Trans Am Ophthalmol Soc, V75, P180; Hanutsaha P, 1998, OPHTHALMOLOGY, V105, P1632, DOI 10.1016/S0161-6420(98)99030-3; Lamoureux EL, 2011, BRIT J OPHTHALMOL, V95, P666, DOI 10.1136/bjo.2010.185207; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Nesper PL, 2017, AM J OPHTHALMOL, V174, P42, DOI 10.1016/j.ajo.2016.10.005; Palejwala NV, 2015, RETINA-J RET VIT DIS, V35, P2204, DOI 10.1097/IAE.0000000000000867; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Roisman L, 2016, OPHTHALMOLOGY, V123, P1309, DOI 10.1016/j.ophtha.2016.01.044; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Sunness JS, 1999, OPHTHALMOLOGY, V106, P1768, DOI 10.1016/S0161-6420(99)90340-8; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Yanagi Y, 2018, JAMA OPHTHALMOL, V136, P905, DOI 10.1001/jamaophthalmol.2018.2154; Yanagi Y, 2017, INVEST OPHTH VIS SCI, V58, P3488, DOI 10.1167/iovs.16-21167	24	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217805	10.1371/journal.pone.0217805	http://dx.doi.org/10.1371/journal.pone.0217805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163067	Green Submitted, Green Published, gold			2022-12-26	WOS:000470086200037
J	Kaczensky, P; Khaliun, S; Payne, J; Boldgiv, B; Buuveibaatar, B; Walzer, C				Kaczensky, Petra; Khaliun, Sanchir; Payne, John; Boldgiv, Bazartseren; Buuveibaatar, Bayarbaatar; Walzer, Chris			Through the eye of a Gobi khulan - Application of camera collars for ecological research of far-ranging species in remote and highly variable ecosystems	PLOS ONE			English	Article							EQUUS-HEMIONUS; SELECTION; DYNAMICS; BEHAVIOR	The Mongolian Gobi-Eastern Steppe Ecosystem is one of the largest remaining natural drylands and home to a unique assemblage of migratory ungulates. Connectivity and integrity of this ecosystem are at risk if increasing human activities are not carefully planned and regulated. The Gobi part supports the largest remaining population of the Asiatic wild ass (Equus hemionus; locally called "khulan"). Individual khulan roam over areas of thousands of square kilometers and the scale of their movements is among the largest described for terrestrial mammals, making them particularly difficult to monitor. Although GPS satellite telemetry makes it possible to track animals in near-real time and remote sensing provides environmental data at the landscape scale, remotely collected data also harbors the risk of missing important abiotic or biotic environmental variables or life history events. We tested the potential of animal born camera systems ("camera collars") to improve our understanding of the drivers and limitations of khulan movements. Deployment of a camera collar on an adult khulan mare resulted in 7,881 images over a one-year period. Over half of the images showed other khulan and 1,630 images showed enough of the collared khulan to classify the behaviour of the animals seen into several main categories. These khulan images provided us with: i) new insights into important life history events and grouping dynamics, ii) allowed us to calculate time budgets for many more animals than the collared khulan alone, and iii) provided us with a training dataset for calibrating data from accelerometer and tilt sensors in the collar. The images also allowed to document khulan behaviour near infrastructure and to obtain a day-time encounter rate between a specific khulan with semi-nomadic herders and their livestock. Lastly, the images allowed us to ground truth the availability of water by: i) confirming waterpoints predicted from other analyses, ii) detecting new waterpoints, and iii) compare precipitation records for rain and snow from landscape scale climate products with those documented by the camera collar. We discuss the added value of deploying camera collars on a subset of animals in remote, highly variable ecosystems for research and conservation.	[Kaczensky, Petra] Norwegian Inst Nat Res, Trondheim, Norway; [Kaczensky, Petra; Payne, John; Walzer, Chris] Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria; [Khaliun, Sanchir; Boldgiv, Bazartseren] Natl Univ Mongolia, Ecol Grp, Dept Biol, Ulaanbaatar, Mongolia; [Payne, John; Buuveibaatar, Bayarbaatar; Walzer, Chris] Wildlife Conservat Soc, Mongolia Program, Ulaanbaatar, Mongolia	Norwegian Institute Nature Research; University of Veterinary Medicine Vienna; National University of Mongolia	Kaczensky, P (corresponding author), Norwegian Inst Nat Res, Trondheim, Norway.; Kaczensky, P (corresponding author), Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria.	petra.kaczensky@nina.no	Buuveibaatar, Bayarbaatar/AAY-9092-2020; Boldgiv, Bazartseren/I-4754-2013; Bayarbaatar, Buuveibaatar/AAS-5963-2020	Boldgiv, Bazartseren/0000-0003-0015-8142; Sanchir, Khaliun/0000-0002-8964-1642; Walzer, Chris/0000-0002-0437-5147; Kaczensky, Petra/0000-0001-5428-1176; Bayarbaatar, Buuveibaatar/0000-0003-1803-0745	Research Institute of Wildlife Ecology, University of Veterinary Medicine Vienna in part through Austrian Science Fund (FWF) [P24231]; Norwegian Research Council TOPPFORSK project [251112]; Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology	Research Institute of Wildlife Ecology, University of Veterinary Medicine Vienna in part through Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Norwegian Research Council TOPPFORSK project; Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology	Funding for the camera collar and part of the analysis was provided by the Research Institute of Wildlife Ecology, University of Veterinary Medicine Vienna in part through matching funds in context with the Austrian Science Fund (FWF) grant P24231. Manuscript preparation for PK was supported by the Norwegian Research Council TOPPFORSK project 251112. SK and BBo of NUM were supported by the Taylor Family-Asia Foundation Endowed Chair in Ecology and Conservation Biology. Capture and collaring of the khulan happened within the framework of the Oyu Tolgoi LLC Core Biodiversity Monitoring Program, implemented by the Wildlife Conservation Society through a cooperative agreement with Sustainability East Asia LLC. Apart from the roles described, the funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bannikov AG, 1981, THE ASIAN WILD ASS; Batsaikhan N, 2014, CONSERV BIOL, V28, P1736, DOI 10.1111/cobi.12297; Battersby SE, 2013, STORY MAPS CLASSROOM, P62; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Berger J, 2013, CONSERV BIOL, V27, P679, DOI 10.1111/cobi.12100; Brockman CJ, 2017, WILDLIFE SOC B, V41, P88, DOI 10.1002/wsb.733; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Buuveibaatar B, 2017, ORYX, V51, P639, DOI 10.1017/S0030605316000417; Buuveibaatar B, 2016, BIOL CONSERV, V203, P168, DOI 10.1016/j.biocon.2016.09.013; Caravaggi A, 2017, REMOTE SENS ECOL CON, V3, P109, DOI 10.1002/rse2.48; DeMars CA, 2013, ECOL EVOL, V3, P4149, DOI 10.1002/ece3.785; Dietz AJ, 2015, REMOTE SENS LETT, V6, P844, DOI 10.1080/2150704X.2015.1084551; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Gerritsmann H, 2016, J WILDLIFE DIS, V52, P642, DOI 10.7589/2015-07-198; Hughey LF, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0005; Kaczensky P., 2010, Erforschung Biologischer Ressourcen der Mongolei, V11, P291; Kaczensky P., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.EN]; Kaczensky P., 2006, MONGOLIA DISCUSSION; Kaczensky P, 2019, EXPLORATION BIOL RES, V14; Kaczensky Petra, 2015, Open Ecology Journal, V8, P92; Kaczensky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028057; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kroschel M, 2017, ANIMAL BIOTELEMETRY, V5, P10, DOI [10.1186/s40317-017-0125-z, DOI 10.1186/S40317-017-0125-Z]; Linnell JDC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002483; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Lottker P, 2009, WILDLIFE BIOL, V15, P425, DOI 10.2981/08-014; Lyftingsmo E, 2016, THESIS; Milner-Gulland EJ, 2011, ANIMAL MIGRATIONS A; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Mosser AA, 2014, J ANIM ECOL, V83, P916, DOI 10.1111/1365-2656.12187; Nandintsetseg D, 2016, BIOL CONSERV, V204, P313, DOI 10.1016/j.biocon.2016.10.021; Norouzzadeh MS, 2018, P NATL ACAD SCI USA, V115, pE5716, DOI 10.1073/pnas.1719367115; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Rubenstein DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138645; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; St-Louis A, 2017, BEHAVIOUR, V154, P357, DOI 10.1163/1568539X-00003425; Strand O, 2015, MIDT I FLOKKEN; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thompson ID, 2015, CAN J ZOOL, V93, P87, DOI 10.1139/cjz-2014-0140; Thompson ID, 2012, WILDLIFE SOC B, V36, P365, DOI 10.1002/wsb.130; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Tucker MA, 2018, SCIENCE, V359, P466, DOI 10.1126/science.aam9712; von Wehrden H, 2009, PHYTOCOENOLOGIA, V39, P331, DOI 10.1127/0340-269X/2009/0039-0331; Walzer C, 2007, MONGOLIAN J BIOL SCI, V4, P19; Wang MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146725; Watanabe YY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2376; Wilson RP, 2014, FRONT ECOL ENVIRON, V12, P582, DOI 10.1890/140068; Wingard J., 2018, SILENT STEPPE II MON, DOI [10.13140/RG.2.2.18957.03049, DOI 10.13140/RG.2.2.18957.03049]; Wingard J., 2014, UNEPCMSCOP11DOC2332; Zhirnov LV, 1986, THE GREAT GOBI PARK	52	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217772	10.1371/journal.pone.0217772	http://dx.doi.org/10.1371/journal.pone.0217772			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163047	Green Published, Green Submitted, gold			2022-12-26	WOS:000470086200034
J	Wakie, TT; Yee, WL; Neven, LG; Kumar, S				Wakie, Tewodros T.; Yee, Wee L.; Neven, Lisa G.; Kumar, Sunil			Modeling the abundance of two Rhagoletis fly (Diptera: Tephritidae) pests in Washington State, USA	PLOS ONE			English	Article							CHERRY FRUIT-FLY; HOST-PLANT USE; APPLE MAGGOT; POMONELLA DIPTERA; RELATIVE-HUMIDITY; SOIL-MOISTURE; UNITED-STATES; HETEROGENEITY; ESTABLISHMENT; TEMPERATURE	Well-adapted and abundant insect pests can negatively affect agricultural production. We modeled the abundance of two Rhagoletis fly (Diptera: Tephritidae) pests, apple maggot fly, Rhagoletis pomonella (Walsh), and western cherry fruit fly, Rhagoletis indifferens Curran, in Washington State (WA), U. S. A. using biologically relevant environmental variables. We tested the hypothesis that abundance of the two species is influenced by different environmental variables, based on the fact that these two species evolved in different environments, have different host plants, and that R. pomonella is an introduced pest in WA while R. indifferens is native. We collected data on fly and host plant abundance at 61 randomly selected sites across WA in 2015 and 2016. We obtained land-cover, climate, and elevation data from online sources and used these data to derive relevant landscape variables and modeled fly abundance using generalized linear models. For R. pomonella, relatively high winter mean minimum temperature, low elevation, and developed land-cover were the top variables positively related to fly abundance. In contrast, for R. indifferens, the top variables related to greater fly abundance were high Hargreaves climatic moisture and annual heat-moisture deficits (indication of drier habitats), high host plant abundance, and developed land-cover. Our results identify key environmental variables driving Rhagoletis fly abundance in WA and can be used for understanding adaptation of insects to non-native and native habitats and for assisting fly quarantine and management decisions.	[Wakie, Tewodros T.; Yee, Wee L.; Neven, Lisa G.] USDA ARS, Temperate Tree Fruit & Vegetable Res Unit, Wapato, WA 98951 USA; [Kumar, Sunil] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Colorado State University	Wakie, TT (corresponding author), USDA ARS, Temperate Tree Fruit & Vegetable Res Unit, Wapato, WA 98951 USA.	Tewodros.wakie@ars.usda.gov	Kumar, Sunil/A-6730-2009	Neven, Lisa/0000-0003-2391-5652; Wakie, Tewodros/0000-0002-5760-0053	Washington Tree Fruit Research Commission through a grant from the USDA, Foreign Agriculture Service, Technical Assistance for Specialty Crops program [58-5352-1-301]	Washington Tree Fruit Research Commission through a grant from the USDA, Foreign Agriculture Service, Technical Assistance for Specialty Crops program	L.N., W.Y., and S.K. received funding from the Washington Tree Fruit Research Commission (https://www.treefruitresearch.com/), agreement number 58-5352-1-301, through a grant originating from the USDA, Foreign Agriculture Service, Technical Assistance for Specialty Crops program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2018, CLIM ITH; [Anonymous], W CHERRY FRUIT FLY R; [Anonymous], 2018, CLIM HUDS; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Corcos D, 2017, INSECT CONSERV DIVER, V10, P462, DOI 10.1111/icad.12249; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DEAN R W, 1973, Search Agriculture (Geneva New York), V3, P1; Eastwell KC, 2005, FIELD GUIDE SWEET CH; Eide PM, 1949, WASHINGTON STATE AGR, V72, P1; ESRI, 2016, ARCGIS DESKT VERS 10; Evans J.S., 2014, ARCGIS TOOLBOX SURFA; Frick K.E., 1954, WASHINGTON AGR EXPT, V13, P1; Goedickemeier I., 1997, Coenoses, V12, P43; Grez AA, 2014, AGR FOREST ENTOMOL, V16, P382, DOI 10.1111/afe.12068; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); HARGREAVES GH, 1994, J IRRIG DRAIN ENG, V120, P1132, DOI 10.1061/(ASCE)0733-9437(1994)120:6(1132); Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hood GR, 2013, ANN ENTOMOL SOC AM, V106, P59, DOI 10.1603/AN12074; IPPC, 2017, 30 IPPC ISPM FAO UN; JENKS GF, 1971, ANN ASSOC AM GEOGR, V61, P217, DOI 10.1111/j.1467-8306.1971.tb00779.x; JONES SC, 1955, J ECON ENTOMOL, V48, P616, DOI 10.1093/jee/48.5.616; Kumar S, 2009, BIODIVERS CONSERV, V18, P739, DOI 10.1007/s10531-008-9536-8; Kumar S, 2016, J ECON ENTOMOL, V109, P2043, DOI 10.1093/jee/tow166; Kumar S, 2014, J ECON ENTOMOL, V107, P1032, DOI 10.1603/EC14052; Lino LO, 2016, J AGR FOOD CHEM, V64, P4029, DOI 10.1021/acs.jafc.6b00104; Lyons C. P., 1995, TREES SHRUBS FLOWERS; Manosathiyadevan M., 2017, SUSTAINABLE AGR FOOD, P57, DOI DOI 10.1007/978-981-10-6647-4_4; Maxwell SA, 2014, AGR FOREST ENTOMOL, V16, P33, DOI 10.1111/afe.12029; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; McClintock T.C., 1967, OREG HIST QUART, V68, P153; McHugh TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13767; NASS, 2017, VAL WASH 2016 AGR PR, P1; NEILSON WTA, 1964, CAN ENTOMOL, V96, P810, DOI 10.4039/Ent96810-5; NEILSON WTA, 1971, J ECON ENTOMOL, V64, P648, DOI 10.1093/jee/64.3.648; R Core Team, 2013, R LANG ENV STAT COMP; Raghuvanshi Avadhesh Kumar, 2012, Journal of Plant Protection Research, V52, P264, DOI 10.2478/v10045-012-0042-3; Reich RM, 2014, FOREST SCI, V60, P308, DOI 10.5849/forsci.12-092; Schurich JA, 2014, J AM MOSQUITO CONTR, V30, P7, DOI 10.2987/13-6373.1; Senger S.E., 2007, THESIS; Sidder AM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1396; Sim SB, 2017, J ECON ENTOMOL, V110, P2599, DOI 10.1093/jee/tox248; Smith JJ, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P187; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; TROTTIER R, 1979, CAN ENTOMOL, V111, P975, DOI 10.4039/Ent111975-8; USGS, 2012, 100 MET RES EL US; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; West AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117893; Western Regional Climate Center, 2018, CLIM SUMM; WSDA, 2017, 2017 IND CHERR WORKS; WSDA, 2018, PROP RUL CR 102 DEC, P1; Yee WL, 2017, CAN ENTOMOL, V149, P241, DOI 10.4039/tce.2016.49; Yee W. L., 2017, USDA COMPENDIUM FRUI; Yee WL, 2018, ENVIRON ENTOMOL, V47, P457, DOI 10.1093/ee/nvx209; Yee WL, 2015, PAN-PAC ENTOMOL, V91, P39, DOI 10.3956/2014-91.1.039; Yee WL, 2013, CAN ENTOMOL, V145, P317, DOI 10.4039/tce.2013.7; Yee WL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.12401; Yee WL, 2008, PAN-PAC ENTOMOL, V84, P179, DOI 10.3956/2007-49.1; Yee WL, 2008, PAN-PAC ENTOMOL, V84, P163, DOI 10.3956/2007-48.1; Yee WL, 2005, J ENTOMOL SCI, V40, P158, DOI 10.18474/0749-8004-40.2.158; Zhang Y, 2008, COLD REG SCI TECHNOL, V52, P355, DOI 10.1016/j.coldregions.2007.07.001	64	3	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217071	10.1371/journal.pone.0217071	http://dx.doi.org/10.1371/journal.pone.0217071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158239	gold, Green Submitted, Green Published			2022-12-26	WOS:000469915700009
J	Borys, AM; Seweryn, M; Golabek, T; Belch, L; Klimkowska, A; Toton-zuranskal, J; Machlowska, J; Chlosta, P; Okon, K; Wolkow, PP				Borys, Agnieszka M.; Seweryn, Michel; Golabek, Tomasz; Belch, Lukasz; Klimkowska, Agnieszka; Toton-zuranskal, Justyna; Machlowska, Julita; Chlosta, Piotr; Okon, Krzysztof; Wolkow, Pawel P.			Patterns of gene expression characterize T1 and T3 clear cell renal cell carcinoma subtypes	PLOS ONE			English	Article							MOUSE MODEL; PROTEIN; METASTASIS; PROGNOSIS; TARGET; TUMORS; PAX2	Renal carcinoma is the 20th most common cancer worldwide. Clear cell renal cell carcinoma is the most frequent type of renal cancer. Even in patients diagnosed at an early stage, characteristics of disease progression remain heterogeneous. Up-to-date molecular classifications stratify the ccRCC samples into two clusters. We analyzed gene expression in 23 T1 or T3 ccRCC samples. Unsupervised clustering divided this group into three clusters, two of them contained pure T1 or T3 samples while one contained a mixed group. We defined a group of 36 genes that discriminate the mixed cluster. This gene set could be associated with tumor classification into a higher stage and it contained significant number of genes coding for molecular transporters, channel and transmembrane proteins. External data from TCGA used to test our findings confirmed that the expression levels of those 36 genes varied significantly between T1 and T3 tumors. In conclusion, we found a clustering pattern of gene expression, informative for heterogeneity among T1 and T3 tumors of clear cell renal cell carcinoma.	[Borys, Agnieszka M.; Seweryn, Michel; Toton-zuranskal, Justyna; Machlowska, Julita; Wolkow, Pawel P.] Jagiellonian Univ, Med Fac, Ctr Med Genom OMICRON, Med Coll, Krakow, Poland; [Golabek, Tomasz; Belch, Lukasz; Chlosta, Piotr] Jagiellonian Univ, Med Fac, Chair & Dept Urol, Med Coll, Krakow, Poland; [Klimkowska, Agnieszka; Okon, Krzysztof] Jagiellonian Univ, Med Fac, Chair Pathomorphol, Med Coll, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Wolkow, PP (corresponding author), Jagiellonian Univ, Med Fac, Ctr Med Genom OMICRON, Med Coll, Krakow, Poland.	pawel.wolkow@uj.edu.pl	Okon, Krzysztof/D-1345-2011; Wolkow, Pawel/AAI-4222-2021; Totoń-Żurańska, Justyna/AAM-9149-2021; Borys, Agnieszka/AAL-9208-2021	Okon, Krzysztof/0000-0002-1921-5007; Wolkow, Pawel/0000-0002-9322-5545; Totoń-Żurańska, Justyna/0000-0001-5970-238X; Seweryn, Michal/0000-0002-9090-3435; Machlowska, Julita/0000-0001-9951-9248	Jagiellonian University Medical College [K/ZDS/005737]; Ohio Supercomputer Center [PAS0885-2]; PLGrid Infrastructure	Jagiellonian University Medical College; Ohio Supercomputer Center; PLGrid Infrastructure	This work was supported by Statutory Funds No. K/ZDS/005737, Jagiellonian University Medical College, www.uj.edu.pl, to PW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work used the HPC resources provided by the Ohio Supercomputer Center (GRANT #: PAS0885-2). This research was supported in part by PLGrid Infrastructure.	Amin M.B., 2010, AJCC CANC STAGING MA; Astudillo L, 2016, BIOCHIMIE, V125, P267, DOI 10.1016/j.biochi.2015.11.009; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brannon A Rose, 2010, Genes Cancer, V1, P152; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Doberstein K, 2011, CARCINOGENESIS, V32, P1713, DOI 10.1093/carcin/bgr195; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Grunewald TGP, 2012, BIOL CELL, V104, P641, DOI 10.1111/boc.201200027; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Hueber PA, 2008, CANCER LETT, V265, P148, DOI 10.1016/j.canlet.2008.02.016; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Javorhazy A, 2016, J CANCER RES CLIN, V142, P1947, DOI 10.1007/s00432-016-2207-3; Kaminska K, 2015, UROL ONCOL-SEMIN ORI, V33, P476, DOI 10.1016/j.urolonc.2015.07.010; Kirschner KM, 2014, J BIOL CHEM, V289, P24452, DOI 10.1074/jbc.M114.564336; Klatt MG, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1204504; Klatte T, 2008, J UROLOGY, V179, P1719, DOI 10.1016/j.juro.2008.01.018; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Larrinaga G, 2010, REGUL PEPTIDES, V165, P218, DOI 10.1016/j.regpep.2010.07.170; Lin D, 2016, CELL CYCLE, V15, P2414, DOI 10.1080/15384101.2016.1148843; Liu Q, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S5-S7; Lochhead P, 2012, EUR J CANCER, V48, P3405, DOI 10.1016/j.ejca.2012.06.021; Mattu S, 2016, J HEPATOL, V64, P891, DOI 10.1016/j.jhep.2015.11.029; McInnes L., 2018, UMAP UNIFORM MANIFOL, DOI DOI 10.21105/JOSS.00861; Morrissey JJ, 2013, J UROLOGY, V189, P1913, DOI 10.1016/j.juro.2012.11.034; Ning XH, 2016, ONCOL LETT, V11, P4095, DOI 10.3892/ol.2016.4504; Packer LM, 2007, INT J CANCER, V121, P784, DOI 10.1002/ijc.22725; Papadopoulos EI, 2015, CLIN BIOCHEM, V48, P590, DOI 10.1016/j.clinbiochem.2015.02.007; Paule B, 2000, J CLIN PATHOL, V53, P388, DOI 10.1136/jcp.53.5.388; Pietrzak M, 2016, TEST-SPAIN, V25, P654, DOI 10.1007/s11749-016-0489-z; Quaas A, 2015, WORLD J UROL, V33, P1561, DOI 10.1007/s00345-014-1463-6; Riazalhosseini Y, 2016, NAT REV NEPHROL, V12, P655, DOI 10.1038/nrneph.2016.133; Ridge CA, 2014, SEMIN INTERVENT RAD, V31, P3, DOI 10.1055/s-0033-1363837; Sanders Edward, 2015, Oncoscience, V2, P151; Sen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048770; Shantha Kumara Hmc, 2015, Oncoscience, V2, P607; Shoji T, 2009, ATHEROSCLEROSIS, V207, P579, DOI 10.1016/j.atherosclerosis.2009.05.023; Sircar K, 2013, CHIN J CANCER, V32, P303, DOI 10.5732/cjc.012.10136; Steffens S, 2014, EUR J CANCER, V50, P739, DOI 10.1016/j.ejca.2013.11.020; Sun Y, 2014, MOL CELL BIOL, V34, P2409, DOI 10.1128/MCB.00104-14; Takahashi M, 2003, ONCOGENE, V22, P6810, DOI 10.1038/sj.onc.1206869; Takemura Y, 2010, PEDIATR NEPHROL, V25, P1349, DOI 10.1007/s00467-010-1463-8; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Tao QG, 2007, JNCI-J NATL CANCER I, V99, P1668, DOI 10.1093/jnci/djm208; Wang L, 2013, ANAL CELL PATHOL, V36, P93, DOI [10.1155/2013/790698, 10.3233/ACP-130084]; Williamson SR, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.01.001; Yang J, 2013, EUR J CANCER, V49, P1479, DOI 10.1016/j.ejca.2012.10.027; Zand B, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv426; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	52	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216793	10.1371/journal.pone.0216793	http://dx.doi.org/10.1371/journal.pone.0216793			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150395	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100023
J	Sandfort, TGM; Dominguez, K; Kayange, N; Ogendo, A; Panchia, R; Chen, YQ; Chege, W; Cummings, V; Guo, X; Hamilton, EL; Stirratt, M; Eshleman, SH				Sandfort, Theo G. M.; Dominguez, Karen; Kayange, Noel; Ogendo, Arthur; Panchia, Ravindre; Chen, Ying Q.; Chege, Wairimu; Cummings, Vanessa; Guo, Xu; Hamilton, Erica L.; Stirratt, Michael; Eshleman, Susan H.			HIV testing and the HIV care continuum among sub-Saharan African men who have sex with men and transgender women screened for participation in HPTN 075	PLOS ONE			English	Article							KEY POPULATIONS; HIGH PREVALENCE; INFECTION; RISK; INTERVENTIONS; STIGMA; PREVENTION; GAY; MSM; EPIDEMIOLOGY	Throughout the world, men who have sex with men (MSM) are at increased risk for HIV infection compared to heterosexual men. Little is known about awareness of HIV infection and other gaps in the HIV care continuum for MSM, especially in sub-Saharan Africa (SSA). This information is urgently needed to address the HIV epidemic in this population. This study assessed gaps in the HIV care continuum among persons screened for participation in a multi-country prospective study that evaluated the feasibility of recruiting and retaining MSM for HIV prevention studies in SSA (HIV Prevention Trials Network (HPTN) 075, conducted in four cities in Kenya, Malawi, and South Africa). Participants were recruited using site-specific strategies, that included outreach and informal networks. Transgender women (TW) were eligible to participate. During screening, 601 MSM and TW were tested for HIV infection and asked about prior HIV testing, HIV status, engagement in care, and HIV treatment. Viral load testing and retrospective antiretroviral (ARV) drug testing were performed for HIV-infected participants. Most participants (92.2%) had a prior HIV test; 42.1% were last tested >6 months earlier. HIV prevalence was 30.4%. HIV infection was associated with older age and identifying as female or transgender; 43.7% of the HIV-infected participants were newly diagnosed, especially younger persons and persons with a less recent HIV test. Almost a third of previously-diagnosed participants were not linked to care. Most participants (88.7%) in care were on ARV treatment (ART). Only about one-quarter of all HIV-infected participants were virally suppressed. These findings demonstrate substantial prevalence of undiagnosed HIV infection and sub-optimal HIV care engagement among MSM and TW in SSA. Increased HIV testing frequency and better linkage to care represent critical steps in preventing further HIV transmission in this population. Once in care, gaps in the HIV care continuum appear less critical.	[Sandfort, Theo G. M.] Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA; [Dominguez, Karen] UCT Med Sch, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Kayange, Noel] Johns Hopkins Med Coll, Blantyre, Malawi; [Ogendo, Arthur] Kenya Med Res Inst KEMRI CDC, Kisumu, Kenya; [Panchia, Ravindre] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto HPTN CRS, Soweto, South Africa; [Chen, Ying Q.; Guo, Xu] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Chege, Wairimu] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cummings, Vanessa; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Hamilton, Erica L.] FHI, Sci Facilitat Dept, Durham, NC USA; [Stirratt, Michael] NIMH, Div AIDS Res, Bethesda, MD 20892 USA	Columbia University; University of Cape Town; Kenya Medical Research Institute; University of Witwatersrand; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Sandfort, TGM (corresponding author), Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA.	tgs2001@cumc.columbia.edu	Sandfort, Theo/D-1796-2011	Sandfort, Theo/0000-0002-4986-1739; Chen, Ying Qing/0000-0002-2726-3391; Hamilton, Erica L./0000-0003-1174-9263	National Institute of Allergy and Infectious Diseases; National Institute of Mental Health of the National Institutes of Health [UM1AI068619, UM1AI068617, UM1AI068613]; National Institute of Mental Health [P30 MH43520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069518, UM1AI068617, UM1AI068613, UM1AI069453, UM1AI068619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases and the National Institute of Mental Health of the National Institutes of Health under award number UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institute of Mental Health. Sandfort received additional support from the National Institute of Mental Health, P30 MH43520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrinopoulos K, 2015, AIDS BEHAV, V19, P60, DOI 10.1007/s10461-014-0813-0; Arreola S, 2015, AIDS BEHAV, V19, P227, DOI 10.1007/s10461-014-0869-x; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Bowring AL, 2016, AIDS BEHAV, V20, P2243, DOI 10.1007/s10461-015-1281-x; Cao BL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7997; Carroll A, 2017, STATE SPONSORED HOMO; Cock J, 2003, WOMEN STUD INT FORUM, V26, P35, DOI 10.1016/S0277-5395(02)00353-9; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Crowell TA, 2019, ANN EPIDEMIOL, V31, P11, DOI 10.1016/j.annepidem.2018.12.004; Djomand G, 2014, CURR OPIN HIV AIDS, V9, P506, DOI 10.1097/COH.0000000000000090; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Fogel JM, 2019, AIDS BEHAV, V23, P289, DOI 10.1007/s10461-018-2231-1; Freeland R, 2018, AIDS BEHAV, V22, P1614, DOI 10.1007/s10461-017-1975-3; Gelmon L, 2009, KENYA HIV PREVENTION; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hakim A, 2017, SEX TRANSM DIS, V44, P565, DOI 10.1097/OLQ.0000000000000655; Hergenrather KC, 2016, AIDS EDUC PREV, V28, P252, DOI 10.1521/aeap.2016.28.3.252; Hoad Neville Wallace, 2005, SEX POLITICS S AFRIC; Keane J, 2017, AIDS BEHAV, V21, P1745, DOI 10.1007/s10461-016-1532-5; Kellerman S, 2012, EPIDEMIOLOGY HIV EPI; Keshinro B, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21270; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Kohut A, 2013, GLOBAL DIVIDE HOMOSE, P4; Krishnaratne S, 2016, LANCET HIV, V3, pE307, DOI 10.1016/S2352-3018(16)30038-8; Kunzweiler CP, 2017, JAIDS-J ACQ IMM DEF, V76, P241, DOI 10.1097/QAI.0000000000001512; Laar A, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0129-z; Lane T, 2016, JAIDS-J ACQ IMM DEF, V73, P609, DOI 10.1097/QAI.0000000000001162; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Logie CH, 2017, J INT AIDS SOC, V20, DOI [10.7448/IAS.20.01/21422, 10.7448/IAS.20.1.21385, 10.7448/IAS.20.1.21422]; Lyons CE, 2017, JAIDS-J ACQ IMM DEF, V74, pS52, DOI 10.1097/qai.0000000000001209; Maleke K, 2019, GLOB HEALTH PROMOT, V26, P6, DOI 10.1177/1757975917737509; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050691; Mmbaga EJ, 2018, JAIDS-J ACQ IMM DEF, V77, P243, DOI [10.1097/qai.0000000000001593, 10.1097/QAI.0000000000001593]; Mumtaz GR, 2013, SEX TRANSM INFECT, V89, P49, DOI 10.1136/sextrans-2012-050844; Poteat T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002422; Poteat T, 2016, GLOB PUBLIC HEALTH, V11, P835, DOI 10.1080/17441692.2015.1134615; Poteat T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028760; Reid G, 2010, SOC DYNAMICS, V36, P38, DOI 10.1080/02533950903561221; Reisner SL, 2016, CURR OPIN ENDOCRINOL, V23, P198, DOI 10.1097/MED.0000000000000229; Reisner SL, 2014, ARCH SEX BEHAV, V43, P1503, DOI 10.1007/s10508-014-0314-2; Rispel LC, 2011, JAIDS-J ACQ IMM DEF, V57, P69, DOI 10.1097/QAI.0b013e318211b40a; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; Sandfort TGM, 2018, ARCH SEX BEHAV, V47, P2481, DOI 10.1007/s10508-018-1168-9; Sandfort TGM, 2015, AIDS BEHAV, V19, P561, DOI 10.1007/s10461-014-0843-7; Sandfort TGM, 2015, AIDS BEHAV, V19, P2270, DOI 10.1007/s10461-015-1067-1; Sevelius JM, 2016, GLOB PUBLIC HEALTH, V11, P1060, DOI 10.1080/17441692.2016.1154085; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Stahlman S, 2016, J INT AIDS SOC, V19, P5, DOI 10.7448/IAS.19.3.20774; Tanser F, 2014, CURR OPIN HIV AIDS, V9, P115, DOI 10.1097/COH.0000000000000034; Thoreson R, 2011, NOWHERE TURN BLACKMA; Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8; Wirtz AL, 2017, LANCET HIV, V4, pE260, DOI 10.1016/S2352-3018(17)30042-5; Zhang YF, 2018, AIDS, V32, P1301, DOI 10.1097/QAD.0000000000001839	59	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217501	10.1371/journal.pone.0217501	http://dx.doi.org/10.1371/journal.pone.0217501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150447	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100060
J	Zhong, ZM; Zhang, GY; Zhang, HR				Zhong, Zhiming; Zhang, Guangyu; Zhang, Haorui			Impact of diurnal unsymmetrical warming on soil respiration in an agroecological system of the Lhasa region	PLOS ONE			English	Article							ALPINE MEADOW; TIBETAN PLATEAU; GROWING-SEASON; CLIMATIC FACTORS; INCREASED PRECIPITATION; ECOSYSTEM RESPIRATION; MICROBIAL BIOMASS; NITROGEN ADDITION; VEGETATION INDEX; PLANT-PRODUCTION	Purpose The impact of diurnal unsymmetrical rise in temperature on soil respiration (Rs) is not fully understood; thus, we explored such a warming influence on Rs in an agroecological system of the Lhasa. Materials and methods A field warming experiment (C: control; DW: daytime warming; NW: nighttime warming; DW +NW: daytime plus nighttime warming) was carried out in a naked barley ecological system. Results and discussion The DW, NW and DW+ NW treatments dramatically increased soil temperature and decreased soil moisture but did not markedly modify R-s. The effects of DW and NW on soil respiration sensitivity (Q(10)) during the daytime and nighttime were different; they had no effects on daytime Q(10) of R-s, but a significant inhibitory effect on nighttime Q(10) of R-s. Conclusions A diurnal unsymmetrical rise in temperature brought about different results for the Q(10) of Rs but did not cause changes in Rs under different experimental treatments in agroecological systems of the Lhasa.	[Zhong, Zhiming; Zhang, Guangyu; Zhang, Haorui] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Lhasa Plateau Ecosyst Res Stn, Key Lab Ecosystem Network Observat & Modeling, Beijing, Peoples R China; [Zhang, Guangyu; Zhang, Haorui] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, HR (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Lhasa Plateau Ecosyst Res Stn, Key Lab Ecosystem Network Observat & Modeling, Beijing, Peoples R China.; Zhang, HR (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhanghr.18s@igsnrr.ac.cn			National Natural Science Foundation of China [31370458, 31600432, 41571042]; National Key R&D Program of China [2017YFA0604801, 2016YFC0502005]; Youth Innovation Research Team Project [LENOM2016Q0002]; Bingwei Outstanding Young Talents Program of Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences [2018RC202]; Tibet Science and Technology Major Projects of the Pratacultural Industry [XZ201901NA03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Youth Innovation Research Team Project; Bingwei Outstanding Young Talents Program of Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences; Tibet Science and Technology Major Projects of the Pratacultural Industry	The research was sponsored by the National Natural Science Foundation of China [31370458, 31600432, 41571042], National Key R&D Program of China [2017YFA0604801, 2016YFC0502005], Youth Innovation Research Team Project [LENOM2016Q0002], the Bingwei Outstanding Young Talents Program of Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences [2018RC202] and the Tibet Science and Technology Major Projects of the Pratacultural Industry [XZ201901NA03]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai E, 2013, NEW PHYTOL, V199, P441, DOI 10.1111/nph.12252; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Chen J, 2016, AGR FOREST METEOROL, V220, P21, DOI 10.1016/j.agrformet.2016.01.010; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Feng JG, 2017, ATMOS ENVIRON, V150, P181, DOI 10.1016/j.atmosenv.2016.11.060; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fu G., 2010, ACTA ECOL SIN, V30, P264, DOI [10.1016/j.chnaes.2010.08.007, DOI 10.1016/J.CHNAES.2010.08.007]; Fu G, 2019, SCI TOTAL ENVIRON, V650, P2666, DOI 10.1016/j.scitotenv.2018.09.384; Fu G, 2018, AGR FOREST METEOROL, V249, P11, DOI 10.1016/j.agrformet.2017.11.017; Fu G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16645-2; [付刚 Fu Gang], 2017, [生态环境学报, Ecology and Environmental Sciences], V26, P49; Fu G, 2017, APPL SOIL ECOL, V114, P99, DOI 10.1016/j.apsoil.2017.03.008; Fu G, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2387-8; Fu G, 2016, J PLANT GROWTH REGUL, V35, P974, DOI 10.1007/s00344-016-9595-0; Fu G, 2016, CAN J REMOTE SENS, V42, P16, DOI 10.1080/07038992.2016.1131115; Fu G, 2015, J MT SCI-ENGL, V12, P935, DOI 10.1007/s11629-014-3035-z; Fu G, 2015, J PLANT GROWTH REGUL, V34, P57, DOI 10.1007/s00344-014-9442-0; Fu G, 2014, POL J ECOL, V62, P17, DOI 10.3161/104.062.0103; Fu G, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073505; Fu G, 2013, J MT SCI-ENGL, V10, P455, DOI 10.1007/s11629-013-2360-y; Fu G, 2012, APPL SOIL ECOL, V61, P158, DOI 10.1016/j.apsoil.2012.05.002; Fu G, 2012, EUR J SOIL BIOL, V52, P27, DOI 10.1016/j.ejsobi.2012.05.004; HARVEY LDD, 1995, NATURE, V377, P15, DOI 10.1038/377015a0; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Keith H, 1997, PLANT SOIL, V190, P127, DOI 10.1023/A:1004279300622; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Landman W, 2010, S AFR GEOGR J, V92, P86, DOI 10.1080/03736245.2010.480842; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Pan SF, 2015, J GEOGR SCI, V25, P1027, DOI 10.1007/s11442-015-1217-4; Peng P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102265; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Shen ZX, 2016, POL J ECOL, V64, P125, DOI 10.3161/15052249PJE2015.64.1.011; Shen ZX, 2015, APPL SOIL ECOL, V90, P35, DOI 10.1016/j.apsoil.2015.01.015; Shen ZX, 2014, REMOTE SENS-BASEL, V6, P6765, DOI 10.3390/rs6086765; Wan JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148072; Wang J, 2013, BIOL TRACE ELEM RES, V156, P367, DOI 10.1007/s12011-013-9822-5; Wang SH, 2015, POL J ECOL, V63, P424, DOI 10.3161/15052249PJE2015.63.3.012; Wang X, 2014, GLOBAL CHANGE BIOL, V20, P3229, DOI 10.1111/gcb.12620; Wu JS, 2018, REMOTE SENS LETT, V9, P150, DOI [10.1080/2150704X.2017.1407045, 10.1080/2150704x.2017.1407045]; Yang G.H., 1996, PRODUCTIVITY LAND RE, P44; Yu CQ, 2019, SCI TOTAL ENVIRON, V647, P1490, DOI 10.1016/j.scitotenv.2018.08.111; Yu Cheng-Qun, 2014, ScientificWorldJournal, V2014, P152576, DOI 10.1155/2014/152576; Yu CQ, 2019, SCI TOTAL ENVIRON, V655, P814, DOI 10.1016/j.scitotenv.2018.11.309; Zhang XZ, 2015, APPL SOIL ECOL, V87, P32, DOI 10.1016/j.apsoil.2014.11.012; Zhang XZ, 2000, AGR FOREST METEOROL, V102, P207, DOI 10.1016/S0168-1923(00)00093-9; Zhong ZM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1761-0; [周玉科 Zhou Yuke], 2017, [地理与地理信息科学, Geography and Geo-information Science], V33, P64	51	2	2	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217575	10.1371/journal.pone.0217575	http://dx.doi.org/10.1371/journal.pone.0217575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141568	gold, Green Published, Green Submitted			2022-12-26	WOS:000469323000063
J	Luo, C; Wu, MQ; Su, XF; Yu, FY; Brautigan, DL; Chen, JH; Zhou, J				Luo, Chong; Wu, Maoqing; Su, Xuefeng; Yu, Fangyan; Brautigan, David L.; Chen, Jianghua; Zhou, Jing			Protein phosphatase 1 alpha interacts with a novel ciliary targeting sequence of polycystin-1 and regulates polycystin-1 trafficking	FASEB JOURNAL			English	Article						PP1; primary cilium; CTS	PRIMARY CILIUM; KIDNEY-DISEASE; CATALYTIC SUBUNIT; STRUCTURAL BASIS; CELL-CYCLE; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; CALCIUM; COMPLEX	Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disorder causing renal failure. Mutations of polycystic kidney disease 1 (PKD1) account for most ADPKD cases. Defective ciliary localization of polycystin-1 (PC1), a large integral membrane protein encoded by PKD1, underlies the pathogenesis of a subgroup of patients with ADPKD. However, the mechanisms by which PC1 and other ciliary proteins traffic to the primary cilium remain poorly understood. A ciliary targeting sequence (CTS) that resides in ciliary receptors is considered to function in the process. It has been reported that the VxP motif in the intracellular C-terminal tail of PC1 functions as a CTS in an ADP ribosylation factor 4 (Arf4)/ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)-dependent manner. However, other recent studies have revealed that this motif is dispensable for PC1 trafficking to cilia. In this study, we identified a novel CTS consisting of 8 residues (RHKVRFEG) in the PC1 C tail. We found that this motif is sufficient to bind protein phosphatase 1 (PP1)alpha, a ubiquitously expressed phosphatase in the phosphoprotein phosphatase (PPP) family. Mutations in this CTS motif disrupt binding with PP1 alpha and impair ciliary localization of PC1. Additionally, short hairpin RNA-mediated knockdown of PP1 alpha results in reduced ciliary localization of PC1 and elongated cilia, suggesting a role for PP1 alpha in the regulation of ciliary structure and function.-Luo, C., Wu, M., Su, X., Yu, F., Brautigan, D. L., Chen, J., Zhou, J. Protein phosphatase 1 alpha interacts with a novel ciliary targeting sequence of polycystin-1 and regulates polycystin-1 trafficking.	[Luo, Chong; Chen, Jianghua] Zhejiang Univ, Natl Key Clin Dept Kidney Dis, Affiliated Hosp 1, Coll Med,Kidney Dis Ctr,Inst Nephrol, Hangzhou, Zhejiang, Peoples R China; [Luo, Chong; Wu, Maoqing; Su, Xuefeng; Yu, Fangyan; Zhou, Jing] Harvard Med Sch, Brigham & Womens Hosp, Harvard Ctr Polycyst Kidney Dis Res, Renal Div,Dept Med, Boston, MA 02115 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Ctr Cell Signaling, Charlottesville, VA 22908 USA	Zhejiang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Virginia	Chen, JH (corresponding author), Zhejiang Univ, Kidney Dis Ctr, Affiliated Hosp 1, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.; Chen, JH (corresponding author), Zhejiang Univ, Natl Key Clin Dept Kidney Dis, Inst Nephrol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.; Zhou, J (corresponding author), Brigham & Womens Hosp, Harvard Ctr Polycyst Kidney Dis Res, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Zhou, J (corresponding author), Brigham & Womens Hosp, Renal Div, Dept Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Zhou, J (corresponding author), Harvard Med Sch, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	zjukidney@zju.edu.cn; jzhou@bwh.harvard.edu			U.S. National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases [RO1DK099532, R37DK51050]; National Natural Science Foundation of China [81470938, 81770687, 81770752, 81770750]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099532] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the members of the Zhou laboratory and Harvard Center for Polycystic Kidney Disease Research for scientific discussions and support. This work was supported by grants from the U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (RO1DK099532 and R37DK51050 to J.Z.) and by grants from National Natural Science Foundation of China (81470938, 81770687, 81770752, 81770750). The authors declare no conflicts of interest.	Badgandi HB, 2017, J CELL BIOL, V216, P743, DOI 10.1083/jcb.201607095; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Bonnet CS, 2009, HUM MOL GENET, V18, P2166, DOI 10.1093/hmg/ddp149; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; Braun D, 2016, JACC-CARDIOVASC INTE, V9, pe153; Cai YQ, 2014, J CLIN INVEST, V124, P5129, DOI 10.1172/JCI67273; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Chebib FT, 2015, NAT REV NEPHROL, V11, P451, DOI 10.1038/nrneph.2015.39; Chernova MN, 2005, KIDNEY INT, V68, P632, DOI 10.1111/j.1523-1755.2005.00441.x; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Colbran RJ, 1997, J NEUROCHEM, V69, P920; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; DiBella LM, 2009, HUM MOL GENET, V18, P595, DOI 10.1093/hmg/ddn384; Doerr N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161525; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Gainullin VG, 2015, J CLIN INVEST, V125, P607, DOI 10.1172/JCI76972; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Geng L, 2000, BBA-MOL BASIS DIS, V1535, P21, DOI 10.1016/S0925-4439(00)00079-X; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6482; Lesage B, 2011, CURR BIOL, V21, pR898, DOI 10.1016/j.cub.2011.08.063; Li HP, 1999, BIOCHEM BIOPH RES CO, V259, P356, DOI 10.1006/bbrc.1999.0780; Liu PW, 2018, P NATL ACAD SCI USA, V115, pE934, DOI 10.1073/pnas.1713226115; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Mukhopadhyay S, 2017, MOL BIOL CELL, V28, P233, DOI 10.1091/mbc.E16-07-0505; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Parnell SC, 1999, BIOCHEM BIOPH RES CO, V259, P539, DOI 10.1006/bbrc.1999.0810; Parnell SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036798; Pearring JN, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006740; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Rebelo S, 2015, CELL SIGNAL, V27, P2589, DOI 10.1016/j.cellsig.2015.08.007; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2013, HUM MOL GENET, V22, P1924, DOI 10.1093/hmg/ddt031; Su XF, 2015, J CELL SCI, V128, P4063, DOI 10.1242/jcs.160556; Su XF, 2014, HUM MOL GENET, V23, P5441, DOI 10.1093/hmg/ddu267; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Wang SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095630; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xu C, 2007, AM J PHYSIOL-RENAL, V292, pF930, DOI 10.1152/ajprenal.00285.2006; Xu YX, 2016, J AM SOC NEPHROL, V27, P1159, DOI 10.1681/ASN.2014111074; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	63	8	8	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9945	9958		10.1096/fj.201900338R	http://dx.doi.org/10.1096/fj.201900338R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31157564	Green Published, Bronze			2022-12-26	WOS:000482214200020
J	Flores, RR; Carbo, L; Kim, E; Van Meter, M; De Padilla, CML; Zhao, J; Colangelo, D; Yousefzadeh, MJ; Angelini, LA; Zhang, L; Pola, E; Vo, N; Evans, CH; Gambotto, A; Niedernhofer, LJ; Robbins, PD				Flores, Rafael R.; Carbo, Lana; Kim, Eun; Van Meter, Montina; De Padilla, Consuelo M. Lopez; Zhao, Jing; Colangelo, Debora; Yousefzadeh, Matthew J.; Angelini, Luise A.; Zhang, Lei; Pola, Enrico; Nam Vo; Evans, Christopher H.; Gambotto, Andrea; Niedernhofer, Laura J.; Robbins, Paul D.			Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice	FASEB JOURNAL			English	Article						psoriasis; type 1 diabetes; interleukin-23; adenovirus; interleukin-17	INFLAMMATORY SKIN-DISEASE; TRANSGENIC MICE; CUTTING EDGE; IFN-GAMMA; EPIDERMAL HYPERPLASIA; MOUSE MODEL; T-CELLS; KERATINOCYTES; CYTOKINE; LESIONS	Previously, we demonstrated that intratumoral delivery of adenoviral vector encoding single-chain (sc)IL-23 (Ad.scIL-23) was able to induce systemic antitumor immunity. Here, we examined the role of IL-23 in diabetes in nonobese diabetic mice. Intravenous delivery of Ad.scIL-23 did not accelerate the onset of hyperglycemia but instead resulted in the development of psoriatic arthritis. Ad.scIL-23-treated mice developed erythema, scales, and thickening of the skin, as well as intervertebral disc degeneration and extensive synovial hypertrophy and loss of articular cartilage in the knees. Immunological analysis revealed activation of conventional T helper type 17 cells and IL-17-producing gamma delta T cells along with a significant depletion and suppression of T cells in the pancreatic lymph nodes. Furthermore, treatment with anti-IL-17 antibody reduced joint and skin psoriatic arthritis pathologies. Thus, these Ad.scIL-23-treated mice represent a physiologically relevant model of psoriatic arthritis for understanding disease progression and for testing therapeutic approaches.-Flores, R. R., Carbo, L., Kim, E., Van Meter, M., De Padilla, C. M. L., Zhao, J., Colangelo, D., Yousefzadeh, M. J., Angelini, L. A., Zhang, L., Pola, E., Vo, N., Evans, C. H., Gambotto, A., Niedernhofer, L. J., Robbins, P. D. Adenoviral gene transfer of a single-chain IL-23 induces psoriatic arthritis-like symptoms in NOD mice.	[Flores, Rafael R.; Colangelo, Debora; Yousefzadeh, Matthew J.; Angelini, Luise A.; Zhang, Lei; Niedernhofer, Laura J.; Robbins, Paul D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St SE,4-112 Nils Hasselmo Hall, Minneapolis, MN 55455 USA; [Flores, Rafael R.; Colangelo, Debora; Yousefzadeh, Matthew J.; Angelini, Luise A.; Zhang, Lei; Niedernhofer, Laura J.; Robbins, Paul D.] Univ Minnesota, Inst Biol Aging & Metab, Minneapolis, MN USA; [Flores, Rafael R.; Carbo, Lana; Van Meter, Montina; Zhao, Jing; Yousefzadeh, Matthew J.; Angelini, Luise A.; Niedernhofer, Laura J.; Robbins, Paul D.] Scripps Res Inst, Dept Mol Med, Jupiter, FL USA; [Flores, Rafael R.; Carbo, Lana; Van Meter, Montina; Zhao, Jing; Yousefzadeh, Matthew J.; Angelini, Luise A.; Niedernhofer, Laura J.; Robbins, Paul D.] Scripps Res Inst, Ctr Aging, Jupiter, FL USA; [Kim, Eun; Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Nam Vo] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Gambotto, Andrea] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA USA; [De Padilla, Consuelo M. Lopez; Evans, Christopher H.] Mayo Clin, Rehabil Med Res Ctr, Rochester, MN USA; [Pola, Enrico] Univ Cattolica Sacro Cuore, Sch Med, Dept Orthopaed Surg, Agostino Gemelli Univ Hosp, Rome, Italy	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Robbins, PD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St SE,4-112 Nils Hasselmo Hall, Minneapolis, MN 55455 USA.	probbins@umn.edu	ZHANG, LEI/AAV-8848-2020; Colangelo, Debora/ABI-5242-2020	ZHANG, LEI/0000-0001-7409-6090; Yousefzadeh, Negar/0000-0002-2569-5860; Robbins, Paul/0000-0003-1068-7099; Flores, Rafael/0000-0002-5580-6381; Niedernhofer, Laura/0000-0002-1074-1385	U.S. National Institutes of Health (NIH) National Institute on Aging [AG024827, AG044376]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR051456]; Juvenile Diabetes Research Foundation; T32 grant from NIH on Autoimmunity and Immunopathology; University of Pittsburgh's NIH Cancer Center Support Grant [P30 CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044376, P30AG024827] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); T32 grant from NIH on Autoimmunity and Immunopathology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh's NIH Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Biviana Torres (The Scripps Research Institute) for her assistance with flow cytometry and Shannon Howard, Sara McGowan, and Tokio Sano (all from The Scripps Research Institute) for their assistance in collecting and the processing of tissues. The authors acknowledge and extend gratitude to Yuan Yuan Ling (retired, formerly of The Scripps Research Institute) for years of service to science. This work was supported by Grants from the U.S. National Institutes of Health (NIH) National Institute on Aging (AG024827, AG044376), NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR051456), and a program grant from the Juvenile Diabetes Research Foundation to P. D. R. R. R. F. was supported by a T32 grant from NIH on Autoimmunity and Immunopathology. This project used the University of Pittsburgh Cancer Institute Vector Facilities (Pittsburgh, PA, USA) supported by the University of Pittsburgh's NIH Cancer Center Support Grant P30 CA047904. The authors declare no conflicts of interest.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Alleva DG, 2000, DIABETES, V49, P1106, DOI 10.2337/diabetes.49.7.1106; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Atochina O, 2006, EXP DERMATOL, V15, P461, DOI 10.1111/j.1600-0625.2006.00431.x; Baraliakos X., 2012, J RHEUMATOL, V39, P418; BEAMER WG, 1995, BLOOD, V86, P3220; Bellemore SM, 2016, CLIN EXP IMMUNOL, V183, P380, DOI 10.1111/cei.12735; Bellemore SM, 2015, CLIN EXP IMMUNOL, V182, P261, DOI 10.1111/cei.12691; Bilbao R, 2003, GENE THER, V10, P1821, DOI 10.1038/sj.gt.3302084; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Deng YX, 2016, CLIN REV ALLERG IMMU, V50, P377, DOI 10.1007/s12016-016-8535-x; Flores RR, 2015, EUR J IMMUNOL, V45, P3114, DOI 10.1002/eji.201445403; Gambotto A, 1999, CANCER GENE THER, V6, P45, DOI 10.1038/sj.cgt.7700013; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Kerschbaumer A, 2016, WIEN KLIN WOCHENSCHR, V128, P791, DOI 10.1007/s00508-016-1111-9; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Kopp T, 2001, J INVEST DERMATOL, V117, P618, DOI 10.1046/j.1523-1747.2001.01441.x; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kumar P, 2015, CYTOKINE, V71, P366, DOI 10.1016/j.cyto.2014.10.010; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mabuchi T, 2013, J INVEST DERMATOL, V133, P164, DOI 10.1038/jid.2012.260; Mitra A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3781; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; Nitta Y, 2001, J AUTOIMMUN, V16, P97, DOI 10.1006/jaut.2000.0469; Oji V, 2015, CLIN EXP RHEUMATOL, V33, pS14; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Raychaudhuri SP, 2017, J AUTOIMMUN, V76, P21, DOI 10.1016/j.jaut.2016.10.009; Reay J, 2012, CANCER GENE THER, V19, P135, DOI 10.1038/cgt.2011.78; Reay J, 2009, CANCER GENE THER, V16, P776, DOI 10.1038/cgt.2009.27; Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x; Reinert-Hartwall L, 2015, J IMMUNOL, V194, P68, DOI 10.4049/jimmunol.1401653; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Shepherd J, 2004, J INVEST DERMATOL, V122, P665, DOI 10.1111/j.0022-202X.2004.22305.x; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Simpson PB, 2003, J IMMUNOL, V171, P3333, DOI 10.4049/jimmunol.171.7.3333; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Suarez-Farinas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084634; Sundberg JP, 1997, PATHOBIOLOGY, V65, P271, DOI 10.1159/000164138; SUNDBERG JP, 1994, J INVEST DERMATOL, V102, P781, DOI 10.1111/1523-1747.ep12377741; SUNDBERG JP, 1990, J INVEST DERMATOL, V95, pS62, DOI 10.1111/1523-1747.ep12505816; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; Trembleau S, 2003, J IMMUNOL, V170, P5491, DOI 10.4049/jimmunol.170.11.5491; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vo N, 2010, J ORTHOP RES, V28, P1600, DOI 10.1002/jor.21153; Walker LSK, 2016, CLIN EXP IMMUNOL, V183, P16, DOI 10.1111/cei.12672; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	67	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9505	9515		10.1096/fj.201900420R	http://dx.doi.org/10.1096/fj.201900420R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31170010	Green Published			2022-12-26	WOS:000478832900062
J	Ji, JJ; Ge, XY; Chen, YG; Zhu, B; Wu, QA; Zhang, JF; Shan, JJ; Cheng, HB; Shi, LY				Ji, Jianjian; Ge, Xiaoyin; Chen, Yugen; Zhu, Bo; Wu, Qinan; Zhang, Junfeng; Shan, Jinjun; Cheng, Haibo; Shi, Liyun			Daphnetin ameliorates experimental colitis by modulating microbiota composition and T-reg/T(h)17 balance	FASEB JOURNAL			English	Article						gut microbiota; SCFA; colonic immune; SCFA-producing microbiota	CHAIN FATTY-ACIDS; GUT MICROBIOTA; ACTIVATION; TH17; DIFFERENTIATION; HOMEOSTASIS; METABOLITES; CONTRIBUTE; DISEASE; SYSTEM	Inflammatory bowel diseases (IBDs) are characterized by chronic pathologies associated with extensive gut dysbiosis and intestinal inflammation. Hence, endeavors to improve the inflammatory pathology by manipulating gut microbiota are ongoing. Daphnetin (DAPH) is a coumarin derivative extracted from Daphne odora var with anti-inflammatory and immune-regulatory properties that has been widely used in treating inflammatory disorders. Herein, we showed that DAPH remarkably alleviated experimental colitis by reducing colonic inflammation, improving colonic integrity, and reestablishing immune and metabolic homeostasis in the inflicted intestines. Our analysis showed that DAPH modified the composition of gut microbiota and altered the metabolic profiles in dextran sulfate sodium-treated mice. In particular, this agent significantly elevated the abundance of short-chain fatty acid (SCFA)-producing gut microbiota, causatively related with the enhanced development of T-reg cells and the reduced proinflammatory T(h)17 cell differentiation. More critically, the protective effect of DAPH was shown to be transmissible among colitic mice through cohousing or fecal microbiota transplantation, further substantiating the importance of SCFA-producing gut microbiota in DAPH action. We thus for the first time reveal the potential of DAPH in resetting the gut microbiome and reestablishing immune homeostasis in colitic mice, which may have clinical implications for treating IBD.-Ji, J., Ge, X., Chen, Y., Zhu, B., Wu, Q., Zhang, J., Shan, J., Cheng, H., Shi, L. Daphnetin ameliorates experimental colitis by modulating microbiota composition and T-reg/T(h)17 balance.	[Ji, Jianjian; Ge, Xiaoyin; Zhu, Bo; Zhang, Junfeng; Shi, Liyun] Nanjing Univ Chinese Med, Key Lab Inflammat & Immunoregulat, Sch Med & Life Sci, Nanjing, Jiangsu, Peoples R China; [Wu, Qinan] Nanjing Univ Chinese Med, Collaborat Innovat Ctr Chinese Med Resources Indu, Nanjing, Jiangsu, Peoples R China; [Cheng, Haibo] Nanjing Univ Chinese Med, Sch Clin Med 1, Nanjing, Jiangsu, Peoples R China; [Ji, Jianjian; Shan, Jinjun] Nanjing Univ Chinese Med, Jiangsu Key Lab Pediat Resp Dis, Inst Pediat, Nanjing, Jiangsu, Peoples R China; [Chen, Yugen] Nanjing Univ Chinese Med, Dept Colorectal Surg, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Shi, LY (corresponding author), Nanjing Univ Chinese Med, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.	shi_liyun@msn.com		Zhu, Bo/0000-0001-6043-8774; Shi, Liyun/0000-0003-1767-0126	National Natural Scientific Funds [81270066, 81470210, 81770014]; National Key Research and Development Program Project [2012CB911200]; Natural Science Foundation of Jiangsu Province Fund [BK20180825]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Scientific Funds; National Key Research and Development Program Project; Natural Science Foundation of Jiangsu Province Fund(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Scientific Funds (81270066, 81470210, and 81770014), the National Key Research and Development Program Project (2012CB911200), the Natural Science Foundation of Jiangsu Province Fund (BK20180825), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Blazejewski AJ, 2017, CELL REP, V19, P2319, DOI 10.1016/j.celrep.2017.05.058; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chen L, 2017, NAT IMMUNOL, V18, P951, DOI 10.1038/ni0817-951e; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748; Goncalves P, 2018, INFLAMM BOWEL DIS, V24, P558, DOI 10.1093/ibd/izx029; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ji JJ, 2016, CLIN SCI, V130, P1453, DOI 10.1042/CS20160311; Jubair WK, 2018, ARTHRITIS RHEUMATOL, V70, P1220, DOI 10.1002/art.40490; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Luhrs H, 2002, SCAND J GASTROENTERO, V37, P458, DOI 10.1080/003655202317316105; LYON L, 2018, BRAIN 3, V141, DOI DOI 10.1093/BRAIN/AWY017; Ma XL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00987; Malik A, 2018, IMMUNITY, V49, P515, DOI 10.1016/j.immuni.2018.08.024; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Nanjundappa RH, 2017, CELL, V171, P655, DOI 10.1016/j.cell.2017.09.022; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pigneur B, 2016, MUCOSAL IMMUNOL, V9, P1360, DOI 10.1038/mi.2016.67; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott NA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4755; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sordillo JE, 2017, J ALLERGY CLIN IMMUN, V139, P482, DOI 10.1016/j.jaci.2016.08.045; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tu LN, 2012, INT IMMUNOPHARMACOL, V13, P417, DOI 10.1016/j.intimp.2012.04.001; Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201; Wang D, 2016, CNS NEUROSCI THER, V22, P558, DOI 10.1111/cns.12537; Witaicenis A, 2014, PHYTOMEDICINE, V21, P240, DOI 10.1016/j.phymed.2013.09.001; Xiang G, 2018, BIOCHEM PHARMACOL, V150, P150, DOI 10.1016/j.bcp.2018.02.003; Yan H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179586; Yao RF, 2011, EUR J PHARMACOL, V670, P286, DOI 10.1016/j.ejphar.2011.08.019; Yu WW, 2014, INT IMMUNOPHARMACOL, V21, P1, DOI 10.1016/j.intimp.2014.04.005; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zheng L, 2017, J IMMUNOL, V199, P2976, DOI 10.4049/jimmunol.1700105; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172	41	29	31	7	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9308	9322		10.1096/fj.201802659RR	http://dx.doi.org/10.1096/fj.201802659RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145641				2022-12-26	WOS:000478832900048
J	Islam, MS; McDonough, MA; Chowdhury, R; Gault, J; Khan, A; Pires, E; Schofield, CJ				Islam, Md Saiful; McDonough, Michael A.; Chowdhury, Rasheduzzaman; Gault, Joseph; Khan, Amjad; Pires, Elisabete; Schofield, Christopher J.			Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA splicing; dioxygenase; X-ray crystallography; hypoxia; hydroxylysine (Hyl); hydroxylase; enzyme structure; enzyme catalysis; metalloenzyme; substrate specificity; 2-oxoglutarate and iron dependent dioxygenase; C-5 hydroxylysine; JmjC domain-containing protein 6; JMJD6	CONTAINING PROTEIN 6; PHOSPHATIDYLSERINE RECEPTOR; CRYSTAL-STRUCTURE; DOMAIN; HYDROXYLATION; INSIGHTS; BINDING; LYSINE; DEMETHYLATION; METHYLATION	JmjC domain-containing protein 6 (JMJD6) is a 2-oxoglutarate (2OG)-dependent oxygenase linked to various cellular processes, including splicing regulation, histone modification, transcriptional pause release, hypoxia sensing, and cancer. JMJD6 is reported to catalyze hydroxylation of lysine residue(s) of histones, the tumor-suppressor protein p53, and splicing regulatory proteins, including u2 small nuclear ribonucleoprotein auxiliary factor 65-kDa subunit (U2AF65). JMJD6 is also reported to catalyze N-demethylation of N-methylated (both mono- and di-methylated) arginine residues of histones and other proteins, including HSP70 (heat-shock protein 70), estrogen receptor alpha, and RNA helicase A. Here, we report MS- and NMR-based kinetic assays employing purified JMJD6 and multiple substrate fragment sequences, the results of which support the assignment of purified JMJD6 as a lysyl hydroxylase. By contrast, we did not observe N-methyl arginyl N-demethylation with purified JMJD6. Biophysical analyses, including crystallographic analyses of JMJD6(Delta 344-403) in complex with iron and 2OG, supported its assignment as a lysyl hydroxylase rather than an N-methyl arginyl-demethylase. The screening results supported some, but not all, of the assigned JMJD6 substrates and identified other potential JMJD6 substrates. We envision these results will be useful in cellular and biological work on the substrates and functions of JMJD6 and in the development of selective inhibitors of human 2OG oxygenases.	[Islam, Md Saiful; McDonough, Michael A.; Chowdhury, Rasheduzzaman; Gault, Joseph; Khan, Amjad; Pires, Elisabete; Schofield, Christopher J.] Univ Oxford, Dept Chem, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk	; McDonough, Michael/G-2744-2013	Islam, Md. Saiful/0000-0001-9842-0676; Pires, Elisabete/0000-0001-8646-062X; Schofield, Christopher/0000-0002-0290-6565; McDonough, Michael/0000-0003-4664-6942	Wellcome Trust; Cancer Research UK; Biotechnological and Biological Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Biotechnological and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Wellcome Trust, Cancer Research UK, and Biotechnological and Biological Research Council.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguilar JA, 2012, CHEM COMMUN, V48, P811, DOI 10.1039/c1cc16699a; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Alahari S, 2018, J CLIN ENDOCR METAB, V103, P1545, DOI 10.1210/jc.2017-02197; Alahari S, 2015, ENDOCRINOLOGY, V156, P3012, DOI 10.1210/en.2015-1262; Bottger A, 2015, BIOCHEM J, V468, P191, DOI 10.1042/BJ20150278; Bollinger JM, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P95; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chowdhury R, 2014, NATURE, V510, P422, DOI 10.1038/nature13263; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Del Rizzo PA, 2012, MOL CELL BIOL, V32, P4044, DOI 10.1128/MCB.00513-12; Dessau MA, 2011, JOVE-J VIS EXP, DOI 10.3791/2285; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gao WW, 2015, P NATL ACAD SCI USA, V112, pE3327, DOI 10.1073/pnas.1509658112; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hahn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013769; Hamed RB, 2013, NAT PROD REP, V30, P21, DOI 10.1039/c2np20065a; Han G, 2012, J CELL BIOCHEM, V113, P1663, DOI 10.1002/jcb.24035; Hausinger RP, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P1; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hopkinson RJ, 2013, ANGEW CHEM INT EDIT, V52, P7709, DOI 10.1002/anie.201303282; Horita S, 2015, STRUCTURE, V23, P639, DOI 10.1016/j.str.2015.01.014; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724; Lawrence P, 2014, VIROLOGY, V452, P1, DOI 10.1016/j.virol.2013.12.040; Leung IKH, 2013, J MED CHEM, V56, P547, DOI 10.1021/jm301583m; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Mantri M, 2012, FEBS J, V279, P1563, DOI 10.1111/j.1742-4658.2012.08496.x; Mantri M, 2011, CHEMBIOCHEM, V12, P531, DOI 10.1002/cbic.201000641; Mantri M, 2010, J MOL BIOL, V401, P211, DOI 10.1016/j.jmb.2010.05.054; Markolovic S, 2018, NAT CHEM BIOL, V14, P688, DOI 10.1038/s41589-018-0071-y; Markolovic S, 2016, CURR OPIN STRUC BIOL, V41, P62, DOI 10.1016/j.sbi.2016.05.013; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Morton CJ, 1996, STRUCTURE, V4, P705, DOI 10.1016/S0969-2126(96)00076-7; Noma A, 2010, J BIOL CHEM, V285, P34503, DOI 10.1074/jbc.M110.156398; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Tarhonskaya H, 2017, J MOL BIOL, V429, P2895, DOI 10.1016/j.jmb.2017.08.007; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; Tibrewal N, 2007, MOL CELL BIOCHEM, V304, P119, DOI 10.1007/s11010-007-9492-8; Tsai WC, 2017, J BIOL CHEM, V292, P18886, DOI 10.1074/jbc.M117.800706; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Walport LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11974; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilkins SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03410-w; Wilkins SE, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P169; WITKOP B, 1956, EXPERIENTIA, V12, P372, DOI 10.1007/BF02157272; Wolf A, 2013, BIOCHEM J, V453, P357, DOI 10.1042/BJ20130529; Yu L, 2010, CELL RES, V20, P166, DOI 10.1038/cr.2010.8	67	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2019	294	30					11637	11652		10.1074/jbc.RA119.008693	http://dx.doi.org/10.1074/jbc.RA119.008693			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LP	31147442	Green Published, hybrid			2022-12-26	WOS:000478717600024
J	Haymond, A; Dey, D; Carter, R; Dailing, A; Nara, V; Nara, P; Venkatayogi, S; Paige, M; Liotta, L; Luchini, A				Haymond, Amanda; Dey, Douglass; Carter, Rachel; Dailing, Angela; Nara, Vaishnavi; Nara, Pranavi; Venkatayogi, Sravani; Paige, Mikell; Liotta, Lance; Luchini, Alessandra			Protein painting, an optimized MS-based technique, reveals functionally relevant interfaces of the PD-1/PD-L1 complex and the YAP2/ZO-1 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); cell signaling; protein-protein interaction; Yes-associated protein (YAP); structural biology; immune checkpoint inhibitor; PD-L1; programmed cell death protein 1 (PD-1); protein painting; ZO-1	SECONDARY STRUCTURE ANALYSES; CONGO RED; NUCLEAR-LOCALIZATION; PDZ DOMAIN; YAP; TARGETS; ORGANIZATION; MECHANISMS; STABILITY; MOLECULES	Protein-protein interactions lie at the heart of many biological processes and therefore represent promising drug targets. Despite this opportunity, identification of protein-protein interfaces remains challenging. We have previously developed a method that relies on coating protein surfaces with small-molecule dyes to discriminate between solvent-accessible protein surfaces and hidden interface regions. Dye-bound, solvent-accessible protein regions resist trypsin digestion, whereas hidden interface regions are revealed by denaturation and sequenced by MS. The small-molecule dyes bind promiscuously and with high affinity, but their binding mechanism is unknown. Here, we report on the optimization of a novel dye probe used in protein painting, Fast Blue B + naphthionic acid, and show that its affinity for proteins strongly depends on hydrophobic moieties that we call here hydrophobic clamps. We demonstrate the utility of this probe by sequencing the protein-protein interaction regions between the Hippo pathway protein Yes-associated protein 2 (YAP2) and tight junction protein 1 (TJP1 or ZO-1), uncovering interactions via the known binding domain as well as ZO-1's MAGUK domain and YAP's N-terminal proline-rich domain. Additionally, we demonstrate how residues predicted by protein painting are present exclusively in the complex interface and how these residues may guide the development of peptide inhibitors using a case study of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand 1 (PD-L1). Inhibitors designed around the PD-1/PD-L1 interface regions identified via protein painting effectively disrupted complex formation, with the most potent inhibitor having an IC50 of 5 mu m.	[Haymond, Amanda; Dey, Douglass; Carter, Rachel; Dailing, Angela; Venkatayogi, Sravani; Liotta, Lance; Luchini, Alessandra] George Mason Univ, Ctr Appl Proteom & Mol Med, Manassas, VA 20110 USA; [Paige, Mikell] George Mason Univ, Dept Chem & Biochem, Manassas, VA 20110 USA; [Nara, Vaishnavi] Thomas Jefferson High Sch Sci & Technol, Alexandria, VA 22312 USA; [Nara, Pranavi] Univ Pittsburgh, Pittsburgh, PA 15260 USA	George Mason University; George Mason University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Haymond, A (corresponding author), George Mason Univ, Ctr Appl Proteom & Mol Med, Manassas, VA 20110 USA.	ahaymond@gmu.edu	Luchini, Alessandra/M-5340-2014	Luchini, Alessandra/0000-0003-1599-0214; Paige, Mikell/0000-0001-9292-1277; Venkatayogi, Sravani/0000-0001-8976-6827	National Institutes of Health [P41-GM103311]; NATIONAL CANCER INSTITUTE [R33CA206937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We most gratefully acknowledge Dr. Paul Russo and Dr. Weidong Zhou for MS expertise. We also thank Dr. Barney Bishop for assistance with the CD experiments. Protein structure images were generated with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California (San Francisco, CA) with support from National Institutes of Health Grant P41-GM103311.	Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Bruzzoni-Giovanelli H, 2018, DRUG DISCOV TODAY, V23, P272, DOI 10.1016/j.drudis.2017.10.016; Celej MS, 2003, PROTEIN SCI, V12, P1496, DOI 10.1110/ps.0240003; Dailing A, 2015, EXPERT REV PROTEOMIC, V12, P457, DOI 10.1586/14789450.2015.1079487; EDELHOCH H, 1960, J BIOL CHEM, V235, P1326; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Francis DM, 2017, ADV DRUG DELIVER REV, V114, P33, DOI 10.1016/j.addr.2017.04.011; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Gunther S, 2017, IMMUNITY, V47, P510, DOI 10.1016/j.immuni.2017.08.004; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Holden JK, 2018, CANCERS, V10, DOI 10.3390/cancers10030081; Horita S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35297; Iglesias-Bexiga M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113828; Kamath Amrita V, 2016, Drug Discov Today Technol, V21-22, P75, DOI 10.1016/j.ddtec.2016.09.004; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Kobe B, 2008, BIOCHEM SOC T, V36, P1438, DOI 10.1042/BST0361438; Kurochkina Natalya, 2013, Biophys Rev, V5, P29, DOI 10.1007/s12551-012-0081-z; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Li K, 2019, J DRUG TARGET, V27, P244, DOI 10.1080/1061186X.2018.1440400; Luchini A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5413; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Mehta SM, 1998, ANAL BIOCHEM, V263, P248, DOI 10.1006/abio.1998.2805; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Pan LF, 2011, J BIOL CHEM, V286, P40069, DOI 10.1074/jbc.C111.293084; Paris L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2807; Parmar AS, 2009, BIOPHYS J, V97, P590, DOI 10.1016/j.bpj.2009.04.045; PIGORSCH E, 1994, SPECTROCHIM ACTA A, V50, P2145, DOI 10.1016/0584-8539(94)00151-0; Samaranayake H, 2009, ANN MED, V41, P322, DOI 10.1080/07853890802698842; Schumacher B, 2010, ACTA CRYSTALLOGR F, V66, P978, DOI 10.1107/S1744309110025479; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Skalniak L, 2017, ONCOTARGET, V8, P72167, DOI 10.18632/oncotarget.20050; Smilgies DM, 2015, J APPL CRYSTALLOGR, V48, P1604, DOI 10.1107/S1600576715015551; Stefanini S, 1996, ARCH BIOCHEM BIOPHYS, V325, P58, DOI 10.1006/abbi.1996.0007; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002; TAL M, 1985, J BIOL CHEM, V260, P9976; Tan SG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14369; Thermo Scientific, 2010, PROT A280 THERM SCI; Verma Apoorva, 2018, Oncotarget, V9, P8068, DOI 10.18632/oncotarget.23909; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; White AM, 2016, EXPERT OPIN DRUG DIS, V11, P1151, DOI 10.1080/17460441.2016.1245720; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yan ZZ, 2018, MOL VIS, V24, P83; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010; Zhao Zhenjun, 2007, J Biomol Tech, V18, P331	56	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11180	11198		10.1074/jbc.RA118.007310	http://dx.doi.org/10.1074/jbc.RA118.007310			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167787	hybrid, Green Published			2022-12-26	WOS:000478717400011
J	Cragle, CE; MacNicol, MC; Byrum, SD; Hardy, LL; Mackintosh, SG; Richardson, WA; Gray, NK; Childs, GV; Tackett, AJ; MacNicol, AM				Cragle, Chad E.; MacNicol, Melanie C.; Byrum, Stephanie D.; Hardy, Linda L.; Mackintosh, Samuel G.; Richardson, William A.; Gray, Nicola K.; Childs, Gwen, V; Tackett, Alan J.; MacNicol, Angus M.			Musashi interaction with poly(A)-binding protein is required for activation of target mRNA translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; oocyte; translation control; polyadenylation; stem cells; cell plasticity; interactome analysis; Musashi; PABP; self-renewal	BINDING-PROTEIN; STEM-CELLS; CYTOPLASMIC POLYADENYLATION; STIMULATE TRANSLATION; MYELOID-LEUKEMIA; EXPRESSION; REPRESSION; FATE; MOS; INTEGRATION	The Musashi family of mRNA translational regulators controls both physiological and pathological stem cell self-renewal primarily by repressing target mRNAs that promote differentiation. In response to differentiation cues, Musashi can switch from a repressor to an activator of target mRNA translation. However, the molecular events that distinguish Musashi-mediated translational activation from repression are not understood. We have previously reported that Musashi function is required for the maturation of Xenopus oocytes and specifically for translational activation of specific dormant maternal mRNAs. Here, we employed MS to identify cellular factors necessary for Musashi-dependent mRNA translational activation. We report that Musashi1 needs to associate with the embryonic poly(A)-binding protein (ePABP) or the canonical somatic cell poly(A)-binding protein PABPC1 for activation of Musashi target mRNA translation. Co-immunoprecipitation studies demonstrated an increased Musashi1 interaction with ePABP during oocyte maturation. Attenuation of endogenous ePABP activity severely compromised Musashi function, preventing downstream signaling and blocking oocyte maturation. Ectopic expression of either ePABP or PABPC1 restored Musashi-dependent mRNA translational activation and maturation of ePABP-attenuated oocytes. Consistent with these Xenopus findings, PABPC1 remained associated with Musashi under conditions of Musashi target mRNA de-repression and translation during mammalian stem cell differentiation. Because association of Musashi1 with poly(A)-binding proteins has previously been implicated only in repression of Musashi target mRNAs, our findings reveal novel context-dependent roles for the interaction of Musashi with poly(A)-binding protein family members in response to extracellular cues that control cell fate.	[Cragle, Chad E.; MacNicol, Melanie C.; Hardy, Linda L.; Childs, Gwen, V; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, 4301 Markham,Slot 814, Little Rock, AR 72205 USA; [Byrum, Stephanie D.; Childs, Gwen, V] Univ Arkansas Med Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA; [Byrum, Stephanie D.; Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Mackintosh, Samuel G.; Tackett, Alan J.] Univ Arkansas Med Sci, Arkansas Childrens Res Inst, Little Rock, AR 72205 USA; [MacNicol, Angus M.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Richardson, William A.; Gray, Nicola K.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Edinburgh	MacNicol, AM (corresponding author), Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, 4301 Markham,Slot 814, Little Rock, AR 72205 USA.	Angus@UAMS.edu	Childs, Gwen V/H-2648-2013	Childs, Gwen V/0000-0003-3764-1373	National Institutes of Health NCRR; National Center for Advancing Translational Sciences [UL1TR000039, KL2TR000063]; National Institutes of Health NIGMS Grant [P30 GM110702]; BBSRC [BB/J01687X/1] Funding Source: UKRI; MRC [MR/N022556/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD087057, R01HD093461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429, P20GM121293, P30GM110702] Funding Source: NIH RePORTER	National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health NIGMS Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Arkansas for Medical Sciences (UAMS)Translational Research Institute was supported by National Institutes of Health NCRR and National Center for Advancing Translational Sciences Grants UL1TR000039 and KL2TR000063. The University of Arkansas for Medical Sciences Center for Translational Neuroscience was supported by National Institutes of Health NIGMS Grant P30 GM110702. We acknowledge the UAMS Proteomics Facility for mass spectrometric support. A. M. M. acknowledges training received through the advanced course in Proteomics/Bioinformatics held at the Welcome Genome Campus/European Bioinformatics Institute, Cambridge, United Kingdom.	Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Arumugam K, 2012, J BIOL CHEM, V287, P10639, DOI 10.1074/jbc.M111.300681; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Brook M, 2012, BIOCHEM J, V441, P803, DOI 10.1042/BJ20111474; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Cragle C, 2014, J BIOL CHEM, V289, P14239, DOI 10.1074/jbc.M114.548271; Cragle CE, 2014, XENOPUS DEVELOPMENT, P38; de Andres-Aguayo L, 2012, CURR OPIN HEMATOL, V19, P268, DOI 10.1097/MOH.0b013e328353c778; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Fox RG, 2015, ANNU REV CELL DEV BI, V31, P249, DOI 10.1146/annurev-cellbio-100814-125446; Friend K, 2012, BIOCHEM J, V445, P93, DOI 10.1042/BJ20120304; Gorgoni B, 2011, P NATL ACAD SCI USA, V108, P7844, DOI 10.1073/pnas.1017664108; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Horisawa Kenichi, 2010, Biomol Concepts, V1, P59, DOI 10.1515/bmc.2010.005; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Kwon HY, 2015, CELL STEM CELL, V17, P152, DOI 10.1016/j.stem.2015.06.006; Lasko P, 2009, PROG MOL BIOL TRANSL, V90, P211, DOI 10.1016/S1877-1173(09)90006-0; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; Li N, 2015, CELL REP, V13, P2440, DOI 10.1016/j.celrep.2015.11.022; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; MacNicol AM, 2008, BIOCHEM SOC T, V36, P528, DOI 10.1042/BST0360528; MacNicol AM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0064-y; MacNicol MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11917-3; MacNicol MC, 2015, BIOMOLECULES, V5, P1580, DOI 10.3390/biom5031580; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Nagata T, 1999, J MOL BIOL, V287, P315, DOI 10.1006/jmbi.1999.2596; Nakamura Y, 2010, DEV BIOL, V344, P272, DOI 10.1016/j.ydbio.2010.05.006; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Odle AK, 2018, ENDOCRINOLOGY, V159, P883, DOI 10.1210/en.2017-00586; Odle AK, 2018, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00367; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1383106; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Smith AR, 2015, ONCOTARGET, V6, P12558, DOI 10.18632/oncotarget.3726; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; Sutherland JM, 2015, ASIAN J ANDROL, V17, P529, DOI 10.4103/1008-682X.151397; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Voeltz GK, 2001, GENE DEV, V15, P774, DOI 10.1101/gad.872201; Vu LP, 2017, NAT GENET, V49, P866, DOI 10.1038/ng.3854; Wang XY, 2013, ONCOTARGET, V4, P739, DOI 10.18632/oncotarget.1034; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wilkie GS, 2005, MOL CELL BIOL, V25, P2060, DOI 10.1128/MCB.25.5.2060-2071.2005; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	71	14	15	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10969	10986		10.1074/jbc.RA119.007220	http://dx.doi.org/10.1074/jbc.RA119.007220			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31152063	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000478717200019
J	Hirose, S; Hioki, Y; Miyashita, H; Hirade, N; Yoshitake, J; Shibata, T; Kikuchi, R; Matsushita, T; Chikazawa, M; Itakura, M; Zhang, M; Nagata, K; Uchida, K				Hirose, Sayumi; Hioki, Yusuke; Miyashita, Hiroaki; Hirade, Naoya; Yoshitake, Jun; Shibata, Takahiro; Kikuchi, Ryosuke; Matsushita, Tadashi; Chikazawa, Miho; Itakura, Masanori; Zhang, Mimin; Nagata, Koji; Uchida, Koji			Apolipoprotein E binds to and reduces serum levels of DNA-mimicking, pyrrolated proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); apolipoprotein E (apoE); protein-protein interaction; serum; innate immunity; inflammation; damage-associated molecular pattern (DAMP); hyperlipidemia; Lysine N-pyrrolation; N-E-pyrrole-l-lysine	SELF-ASSOCIATION; PRODUCTS; ISOFORMS; HEPARIN; PLASMA; MODEL	Lysine N-pyrrolation, converting lysine residues to N-E-pyrrole-l-lysine, is a recently discovered post-translational modification. This naturally occurring reaction confers electrochemical properties onto proteins that potentially produce an electrical mimic to DNA and result in specificity toward DNA-binding molecules such as anti-DNA autoantibodies. The discovery of this unique covalent protein modification provides a rationale for establishing the molecular mechanism and broad functional significance of the formation and regulation of N-E-pyrrole-l-lysine-containing proteins. In this study, we used microbeads coupled to pyrrolated or nonpyrrolated protein to screen for binding activities of human serum-resident nonimmunoglobin proteins to the pyrrolated proteins. This screen identified apolipoprotein E (apoE) as a protein that innately binds the DNA-mimicking proteins in serum. Using an array of biochemical assays, we observed that the pyrrolated proteins bind to the N-terminal domain of apoE and that oligomeric apoE binds these proteins better than does monomeric apoE. Employing surface plasmon resonance and confocal microscopy, we further observed that apoE deficiency leads to significant accumulation of pyrrolated serum albumin and is associated with an enhanced immune response. These results, along with the observation that apoE facilitates the binding of pyrrolated proteins to cells, suggest that apoE may contribute to the clearance of pyrrolated serum proteins. Our findings uncover apoE as a binding target of pyrrolated proteins, providing a key link connecting covalent protein modification, lipoprotein metabolism, and innate immunity.	[Hirose, Sayumi; Hioki, Yusuke; Miyashita, Hiroaki; Hirade, Naoya; Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Yoshitake, Jun] Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi 4648601, Japan; [Kikuchi, Ryosuke] Nagoya Univ, Dept Med Tech, Nagoya, Aichi 4668560, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi 4668560, Japan; [Chikazawa, Miho; Itakura, Masanori; Zhang, Mimin; Nagata, Koji; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Uchida, Koji] Japan Agcy Med Res & Dev, CREST, Tokyo 1020076, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; University of Tokyo; Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	a-uchida@mail.ecc.u-tokyo.ac.jp	Kikuchi, Ryosuke/AAX-4971-2021; Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Nagata, Koji/0000-0002-4704-0603; Uchida, Koji/0000-0003-3894-5299	Japan Society for the Promotion of Science KAKENHI [20117007, 21248016, 24658122]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 20117007, 21248016, and 24658122. The authors declare that they have no conflicts of interest with the contents of this article.	CARDIN AD, 1986, BIOCHEM BIOPH RES CO, V134, P783, DOI 10.1016/S0006-291X(86)80489-2; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Cohn JS, 1996, ARTERIOSCL THROM VAS, V16, P149, DOI 10.1161/01.ATV.16.1.149; Frieden C, 2017, P NATL ACAD SCI USA, V114, P6292, DOI 10.1073/pnas.1705080114; Garai K, 2011, BIOCHEMISTRY-US, V50, P6356, DOI 10.1021/bi2006702; Garai K, 2011, BIOCHEMISTRY-US, V50, P2550, DOI 10.1021/bi1020106; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; HIDALGO FJ, 1995, CHEM PHYS LIPIDS, V77, P1; HIDALGO FJ, 1993, J BIOL CHEM, V268, P16190; Itakura K, 1998, J ORG CHEM, V63, P185, DOI 10.1021/jo971239+; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Ma ZJ, 2008, CLIN IMMUNOL, V127, P168, DOI 10.1016/j.clim.2008.01.002; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miyashita H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05343; Moellering RE, 2013, SCIENCE, V341, P549, DOI 10.1126/science.1238327; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; PITAS RE, 1980, J BIOL CHEM, V255, P5454; Salomon RG, 1997, CHEM RES TOXICOL, V10, P536, DOI 10.1021/tx960157y; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Theendakara V, 2016, J NEUROSCI, V36, P685, DOI 10.1523/JNEUROSCI.3562-15.2016; Walsh CT, 2006, NAT PROD REP, V23, P517, DOI 10.1039/b605245m; Wang YH, 2012, BIOCHEM BIOPH RES CO, V423, P805, DOI 10.1016/j.bbrc.2012.06.044; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Yamauchi Y, 2008, BIOCHEMISTRY-US, V47, P6702, DOI 10.1021/bi8003999; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhou Y, 1999, BRAIN RES BULL, V49, P173, DOI 10.1016/S0361-9230(99)00052-0	30	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					11035	11045		10.1074/jbc.RA118.006629	http://dx.doi.org/10.1074/jbc.RA118.006629			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31167785	Green Published, hybrid			2022-12-26	WOS:000478717200024
J	Rasmussen, CL; Palarea-Albaladejo, J; Korshoj, M; Gupta, N; Nabe-Nielsen, K; Holtermann, A; Jorgensen, MB				Rasmussen, Charlotte Lund; Palarea-Albaladejo, Javier; Korshoj, Mette; Gupta, Nidhi; Nabe-Nielsen, Kirsten; Holtermann, Andreas; Jorgensen, Marie Birk			Is high aerobic workload at work associated with leisure time physical activity and sedentary behaviour among blue-collar workers? A compositional data analysis based on accelerometer data	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; 20-YEAR INCIDENCE; R-PACKAGE; FITNESS; RISK; VALIDITY; ADULTS; MOVEMENT	Objective This study aimed to investigate the hypothesized negative association between duration of work time spent at a high relative aerobic workload and leisure time movement behaviours among blue-collar workers. Methods This was a cross-sectional study based on heart rate and accelerometer data from 803 blue-collar workers (447 men and 356 women). Relative aerobic workload was measured as percentage of heart rate reserve during work (%HRR). Leisure time movement behaviours were expressed in terms of leisure time spent in sedentary and active behaviours in uninterrupted bouts (i.e. <10 min, >= 10-30 min and >30 min). Compositional regression and isotemporal substitution models were used to assess the association between the predominance of work time spent at >= 40%HRR and leisure time spent in sedentary and active bouts. All analyses were stratified by sex. Results For men, there was no statistically significant association between the predominance of work time spent at >= 40%HRR and leisure time movement behaviours. Among women, the predominance of >= 40%HRR at work was negatively associated with relative leisure time spent in >= 10 min bouts of active behaviour ((beta) over cap =-0.21, p = 0.02) and a theoretical 15 min reallocation of work time from <40%HRR to >= 40%HRR was estimated to decrease active behaviour by 6 min during leisure time. Conclusion Our result highlights the need for considering work-related barriers for an active leisure time in high-risk populations. Longitudinal studies are warranted to disentangle the relationship between physically demanding work characteristics and leisure time movement behaviours in such populations.	[Rasmussen, Charlotte Lund; Korshoj, Mette; Gupta, Nidhi; Nabe-Nielsen, Kirsten; Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Rasmussen, Charlotte Lund; Nabe-Nielsen, Kirsten] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Palarea-Albaladejo, Javier] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Holtermann, Andreas] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Jorgensen, Marie Birk] Univ Copenhagen, Dept Forens Sci, Copenhagen, Denmark	National Research Centre for the Working Environment; University of Copenhagen; James Hutton Institute; University of Southern Denmark; University of Copenhagen	Rasmussen, CL (corresponding author), Natl Res Ctr Working Environm, Copenhagen, Denmark.; Rasmussen, CL (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark.	CLR@nrcwe.dk	Palarea-Albaladejo, Javier/J-5591-2013; Rasmussen, Charlotte Lund/AAP-7065-2020	Palarea-Albaladejo, Javier/0000-0003-0162-669X; Rasmussen, Charlotte Lund/0000-0003-2193-5019; Jorgensen, Marie Birk/0000-0002-1479-2622; Korshoj, Mette/0000-0001-8422-9969	Danish government (Satspulje); Danish Working Environment Research Fund [20175100213]; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); Spanish Ministry of Economy and Competitiveness under the project CODA-RETOS [MTM2015-65016-C2-1(2)-R]	Danish government (Satspulje); Danish Working Environment Research Fund; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); Spanish Ministry of Economy and Competitiveness under the project CODA-RETOS	The work was supported by a grant from the Danish government (Satspulje) and by The Danish Working Environment Research Fund (grant number 20175100213). J. Palarea-Albaladejo was partly supported by the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS) and by the Spanish Ministry of Economy and Competitiveness under the project CODA-RETOS MTM2015-65016-C2-1(2)-R.	Aitchson J., 1986, STAT ANAL COMPOSITIO; Allesoe K, 2015, EUR J PREV CARDIOL, V22, P1601, DOI 10.1177/2047487314554866; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2018, PHYS ACT GUID ADV CO; Arias OE, 2015, J OCCUP ENVIRON MED, V57, P73, DOI 10.1097/JOM.0000000000000303; Astrand PO., 1986, TXB WORK PHYSL, P391; BALL K, 2015, INT J BEHAV NUTR PHY, V12; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Blafoss R, 2019, SCAND J PUBLIC HEALT, V47, P383, DOI 10.1177/1403494818765894; Brage S, 2006, EUR J APPL PHYSIOL, V96, P517, DOI 10.1007/s00421-005-0112-6; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brighenti-Zogg S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154073; Carson V, 2014, PREV MED, V65, P23, DOI 10.1016/j.ypmed.2014.04.005; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Chu AHY, 2013, PREV MED, V57, pS14, DOI 10.1016/j.ypmed.2012.12.011; Clays E, 2014, AM J EPIDEMIOL, V179, P559, DOI 10.1093/aje/kwt294; Clays E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1002; Coenen P, 2018, BRIT J SPORT MED, V52, P1320, DOI 10.1136/bjsports-2017-098540; Efron B., 2003, INTRO BOOTSTRAP; Ekblom-Bak E, 2016, EUR J PREV CARDIOL, V23, P967, DOI 10.1177/2047487315619734; Eng A, 2011, OCCUP ENVIRON MED, V68, P888, DOI 10.1136/oem.2010.064097; Ferrario MM, 2018, HEART, V104, P1165, DOI 10.1136/heartjnl-2017-312594; Fletcher GF, 2018, J AM COLL CARDIOL, V72, P1622, DOI 10.1016/j.jacc.2018.08.2141; Gupta N, 2018, MED SCI SPORT EXER, V50, P2150, DOI 10.1249/MSS.0000000000001680; Gupta N, 2014, INT J ENV RES PUB HE, V11, P5333, DOI 10.3390/ijerph110505333; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Howley ET, 2001, MED SCI SPORT EXER, V33, pS364, DOI 10.1097/00005768-200106001-00005; Hron K, 2012, J APPL STAT, V39, P1115, DOI 10.1080/02664763.2011.644268; Hu G, 2007, ATHEROSCLEROSIS, V194, P490, DOI 10.1016/j.atherosclerosis.2006.08.051; Hu GC, 2014, ASIA-PAC J PUBLIC HE, V26, P604, DOI 10.1177/1010539512471966; Ilmarinen J, 1992, INT J IND ERGON, V10, P53, DOI [10.1016/0169-8141(92)90048-5, DOI 10.1016/0169-8141(92)90048-5]; JORGENSEN MB, 2013, BMC MUSCULOSKEL DIS, V14, P1; Karlqvist L, 2003, EUR J APPL PHYSIOL, V89, P536, DOI 10.1007/s00421-003-0832-4; Karvonen MJ, 1957, ANN MED EXPER FENN, V35, P1; Korshoj M, 2013, ERGONOMICS, V56, P935, DOI 10.1080/00140139.2013.782427; Krause N, 2015, SCAND J WORK ENV HEA, V41, P124, DOI 10.5271/sjweh.3476; Krause N, 2010, SCAND J WORK ENV HEA, V36, P349, DOI 10.5271/sjweh.3077; Kristiansen J, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-27; Lagersted-Olsen J, 2016, SCAND J WORK ENV HEA, V42, P528, DOI 10.5271/sjweh.3591; Li J, 2013, CURR OPIN CARDIOL, V28, P575, DOI 10.1097/HCO.0b013e328364289c; Loprinzi PD, 2013, AM J HEALTH PROMOT, V27, P143, DOI 10.4278/ajhp.110916-QUAN-348; Lunde LK, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040356; Mathiassen SE, 2006, APPL ERGON, V37, P419, DOI 10.1016/j.apergo.2006.04.006; McArdle W.D., 2007, EXERCISE PHYSL ENERG; Mehdi Riazi A., 2016, ROUTLEDGE ENCY RES M, DOI DOI 10.4324/9781315656762; Palarea-Albaladejo J, 2008, COMPUT GEOSCI-UK, V34, P902, DOI 10.1016/j.cageo.2007.09.015; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Palarea-Albaladejo J, 2014, J CHEMOMETR, V28, P585, DOI 10.1002/cem.2621; Pawlowsky-Glahn V., 2015, MODELLING ANAL COMPO, DOI DOI 10.1002/9781119003144; Pawlowsky-Glahn V, 2015, STAT MODEL, V15, DOI 10.1177/1471082X14535526; Pedisic Z, 2017, KINESIOLOGY, V49, P252; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rasmussen CL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071306; Savinainen M, 2004, ERGONOMICS, V47, P1087, DOI 10.1080/00140130410001686357; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Stefelova N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102248; Stemland I, 2015, ERGONOMICS, V58, P953, DOI 10.1080/00140139.2014.998724; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Templ M, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P341; Tomaz SA, 2016, EUR J SPORT SCI, V16, P149, DOI 10.1080/17461391.2014.987323; van den Boogaart KG, 2008, COMPUT GEOSCI-UK, V34, P320, DOI 10.1016/j.cageo.2006.11.017; Vasankari V, 2017, EUR J PREV CARDIOL, V24, P1311, DOI 10.1177/2047487317711048; Wang AL, 2016, SCAND J WORK ENV HEA, V42, P423, DOI 10.5271/sjweh.3580; Wellburn S, 2016, MED SCI SPORT EXER, V48, P641, DOI 10.1249/MSS.0000000000000816; Wolff-Hughes DL, 2015, J PHYS ACT HEALTH, V12, P694, DOI 10.1123/jpah.2013-0463; Wu HC, 2005, ERGONOMICS, V48, P668, DOI 10.1080/00140130500070871	69	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217024	10.1371/journal.pone.0217024	http://dx.doi.org/10.1371/journal.pone.0217024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170169	Green Published, Green Submitted, gold			2022-12-26	WOS:000470263700015
J	Smith, MR; Veneklaas, E; Polania, J; Rao, IM; Beebe, SE; Merchant, A				Smith, Millicent R.; Veneklaas, Erik; Polania, Jose; Rao, Idupulapati M.; Beebe, Stephen E.; Merchant, Andrew			Field drought conditions impact yield but not nutritional quality of the seed in common bean (Phaseolus vulgaris L.)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; RESPONSES; STRESS; VARIABILITY; PHOSPHORUS; RESISTANCE; SELECTION; NITROGEN; GENES; GRAIN	Drought substantially limits seed yield of common bean (Phaseolus vulgaris L.) in the tropics. Understanding the interaction of drought on yield and the nutrient concentration of the seed is vital in order to supply nutrition to the millions of consumers who rely on common bean as a staple crop. Nevertheless, the impact of drought on common bean for both yield and nutrient concentration has not yet been concurrently investigated in a field environment. Using 10 bred lines developed by CIAT and its partners for their improved adaptation to drought and phosphorus deficiency, this study characterised the impact of drought on yield and nutrient concentration for leaf and seed tissue of common bean grown in the field. Drought significantly reduced leaf area (by 50%), harvest index (by 60%), yield (by similar to 70%), seed weight (by similar to 25%) and enriched carbon isotope abundance (delta C-13) in the seed. Within the soluble leaf fraction, drought significantly decreased the concentration of mineral nutrients and amino acids, whereas no negative effect on the concentration of nutrients and amino acids was detected within the seed. Genotypic variation in nutrient concentration in both the leaf and seed tissue was identified and should be explored further to identify traits that may confer tolerance to abiotic stress.	[Smith, Millicent R.; Merchant, Andrew] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney Inst Agr, Sydney, NSW, Australia; [Veneklaas, Erik] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Polania, Jose; Rao, Idupulapati M.; Beebe, Stephen E.] CIAT, Cali, Colombia; [Smith, Millicent R.] Int Crops Res Inst Semi Arid Trop, Patancheru, Telangana, India; [Rao, Idupulapati M.] ARS, Natl Ctr Agr Utilizat Res, Plant Polymer Res Unit, USDA, Peoria, IL USA	University of Sydney; University of Western Australia; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); United States Department of Agriculture (USDA)	Smith, MR (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney Inst Agr, Sydney, NSW, Australia.; Smith, MR (corresponding author), Int Crops Res Inst Semi Arid Trop, Patancheru, Telangana, India.	millicent.smith@cgiar.org	Merchant, Andrew/AAQ-4592-2021; Smith, Millicent/AAB-5602-2020; Merchant, Andrew/C-8689-2011; Veneklaas, Erik J/C-8907-2009; Polania, Jose/Q-2745-2017	Merchant, Andrew/0000-0001-8979-6786; Smith, Millicent/0000-0003-1749-2884; Merchant, Andrew/0000-0001-8979-6786; Veneklaas, Erik J/0000-0002-7030-4056; Polania, Jose/0000-0002-1186-0503	Australian Postgraduate Award; ARC Future Fellowship Scheme; ARC Industrial Transformation Hub [IT140100013]; CGIAR Research Program on Grain Legumes through funds from USAID; USAID	Australian Postgraduate Award(Australian Government); ARC Future Fellowship Scheme(Australian Research Council); ARC Industrial Transformation Hub(Australian Research Council); CGIAR Research Program on Grain Legumes through funds from USAID(CGIAR); USAID(United States Agency for International Development (USAID))	M.R. Smith was the recipient of an Australian Postgraduate Award. A. Merchant was supported by the ARC Future Fellowship Scheme and ARC Industrial Transformation Hub (IT140100013). This work was also partially supported by the CGIAR Research Program on Grain Legumes through funds from USAID.	Andersson MS, 2017, AFRICAN J FOOD AGR N, V17, P11906; Assefa T, 2013, FIELD CROP RES, V148, P24, DOI 10.1016/j.fcr.2013.04.008; Beebe S., 2012, PLANT BREEDING REVIE, V36; Beebe Stephen, 2000, Food and Nutrition Bulletin, V21, P387; Beebe SE, 2008, CROP SCI, V48, P582, DOI 10.2135/cropsci2007.07.0404; Beebe SE, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00035; Behboudian MH, 2001, J SCI FOOD AGR, V81, P1288, DOI 10.1002/jsfa.939; Blum A, 1996, PLANT GROWTH REGUL, V20, P135, DOI 10.1007/BF00024010; Boyer JS, 2007, J EXP BOT, V58, P267, DOI 10.1093/jxb/erl177; Boyer JS, 2010, J EXP BOT, V61, P3493, DOI 10.1093/jxb/erq231; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; Daryanto S, 2017, AGR WATER MANAGE, V179, P18, DOI 10.1016/j.agwat.2016.04.022; Dumschott K, 2017, PHYTOCHEMISTRY, V144, P243, DOI 10.1016/j.phytochem.2017.09.019; Fan MS, 2008, J TRACE ELEM MED BIO, V22, P315, DOI 10.1016/j.jtemb.2008.07.002; FAO, 2017, DAT PULS DRY MATT BA; Food and Agriculture Organisation (FAO), 2003, FOOD EN METH AN CONV; Gous PW, 2015, J I BREWING, V121, P19, DOI 10.1002/jib.187; Gyori Z, 1998, J AGR FOOD CHEM, V46, P3087, DOI 10.1021/jf980060c; Haas JD, 2016, J NUTR, V146, P1586, DOI 10.3945/jn.115.224741; He MZ, 2014, NEW PHYTOL, V204, P924, DOI 10.1111/nph.12952; Liu ZQ, 2013, J CHROMATOGR B, V912, P8, DOI 10.1016/j.jchromb.2012.10.040; Lockhart E, 2016, FUNCT PLANT BIOL, V43, P1149, DOI 10.1071/FP16022; Maillard A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00317; McClean PE, 2011, FUNCT PLANT BIOL, V38, P927, DOI 10.1071/FP11102; Merchant A, 2006, PHYTOCHEMISTRY, V67, P402, DOI 10.1016/j.phytochem.2005.11.027; Merchant A, 2011, FUNCT PLANT BIOL, V38, P934, DOI 10.1071/FP11105; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Pang JY, 2011, PLANT SOIL, V348, P299, DOI 10.1007/s11104-011-0904-x; Passioura J, 2007, J EXP BOT, V58, P113, DOI 10.1093/jxb/erl212; Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144; Polania J, 2017, THEORETICAL EXPT PLA, DOI [10.1104/pp.16.01790, DOI 10.1104/PP.16.01790]; Polania J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00296; Polania J, 2016, EUR J AGRON, V79, P66, DOI 10.1016/j.eja.2016.05.014; Polania J, 2016, EUPHYTICA, V210, P17, DOI 10.1007/s10681-016-1691-5; Polania JA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00660; Popp M, 1996, J EXP BOT, V47, P1469, DOI 10.1093/jxb/47.10.1469; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Rao IM, 2017, J AGR SCI-CAMBRIDGE, V155, P857, DOI 10.1017/S0021859616000915; Singh S.P., 1981, ANN REP BEAN IMPROV, V25, P92; Tardieu F, 1998, J EXP BOT, V49, P419, DOI 10.1093/jexbot/49.suppl_1.419	44	26	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217099	10.1371/journal.pone.0217099	http://dx.doi.org/10.1371/journal.pone.0217099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170187	Green Submitted, Green Published, gold			2022-12-26	WOS:000470263700019
J	Waserstein, G; Parting, C; Cohen, D; Schettler, P; Kinkead, B; Rapaport, MH				Waserstein, Gabriella; Parting, Clyde; Cohen, Debra; Schettler, Pamela; Kinkead, Becky; Rapaport, Mark Hyman			The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUBSYNDROMAL DEPRESSIVE SYMPTOMS; FUNCTIONAL SOMATIC SYNDROMES; SATISFACTION QUESTIONNAIRE; HEALTH; METAANALYSIS; ASSOCIATION; IMPAIRMENT; ENJOYMENT; ANXIETY	In 2008, the NIH launched an undiagnosed diseases program to investigate difficult to diagnose, and typically, multi-system diseases. The objective of this study was to evaluate the presence of psychiatric symptoms or psychiatric diagnoses in a cohort of patients seeking care at the Emory Special Diagnostic Service clinic. We hypothesized that psychiatric symptoms would be prevalent and associated with trauma exposure, and a decreased quality of life and functioning. This is a cross-sectional, retrospective analysis of 247 patients seen between February 7, 2014 and May 31, 2017. The sources for data included the Emory Health History Questionnaire (HHQ) that had the work and social adjustment and quality of life enjoyment and satisfaction questionnaire short form (QLSQ) embedded in it; medical records, and the comprehensive standardized special diagnostic clinic forms. Primary outcomes were presence of any psychiatric symptom, based on report of the symptom on the HHQ or medical record, or presence of a confirmed preexisting psychiatric disorder. Seventy-two percent of patients had at least one psychiatric symptom while 24.3% of patients had a pre-existing psychiatric diagnosis. Patients with any psychiatric symptom had significantly diminished Q-LES-Q scores (45.27 +/- 18.63) versus patients with no psychiatric symptoms (62.01 +/- 21.57, t = 5.60, df = 225, p<0.0001) and they had significantly greater functional disability. Patients with a psychiatric disorder also had significantly diminished Q-LES-Q scores (45.16 17.28) versus those without a psychiatric diagnosis (51.85 21.54, t = 2.11, df = 225, p = 0.036) but did not have significantly increased functional impairment. Both patients with psychiatric symptoms and ones with psychiatric disorders had an increased prevalence of trauma. Psychiatric symptoms are prevalent in patients evaluated for undiagnosed disorders. The presence of any psychiatric symptom, with or without a formal psychiatric diagnosis, significantly decreases quality of life and functioning. This suggests that assessment for psychiatric symptoms should be part of the evaluation of individuals with undiagnosed disorders and may have important diagnostic and treatment implications.	[Waserstein, Gabriella] Emory Univ, Sch Med, Atlanta, GA USA; [Parting, Clyde; Cohen, Debra] Emory Univ, Sch Med, Dept Med, Emory Special Diagnost Serv Clin, Atlanta, GA USA; [Schettler, Pamela; Kinkead, Becky; Rapaport, Mark Hyman] Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Rapaport, MH (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Sch Med, Atlanta, GA 30322 USA.	mrapapo@emory.edu						Afari N, 2014, PSYCHOSOM MED, V76, P2, DOI 10.1097/PSY.0000000000000010; Association AP, 2013, DSM 5 DIAGNOSTIC AND; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Bloss CS, 2015, GENET MED, V17, P995, DOI 10.1038/gim.2015.21; Bobevski I, 2016, PSYCHOSOM MED, V78, P13, DOI 10.1097/PSY.0000000000000252; Bonvanie IJ, 2017, BRIT J PSYCHOL, V108, P318, DOI 10.1111/bjop.12198; Carson A, 2011, J NEUROL NEUROSUR PS, V82, P810, DOI 10.1136/jnnp.2010.220640; Creed FH, 2013, INT J BEHAV MED, V20, P194, DOI 10.1007/s12529-012-9257-y; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; De Hert M, 2018, DIALOGUES CLIN NEURO, V20, P31; Druss Benjamin G, 2011, Synth Proj Res Synth Rep, P1; Eikelboom EM, 2016, J PSYCHOSOM RES, V88, P60, DOI 10.1016/j.jpsychores.2016.07.001; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gahl WA, 2012, DIS MODEL MECH, V5, P3, DOI 10.1242/dmm.009258; Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; HOLM S, 1979, SCAND J STAT, V6, P65; Howland RH, 2008, PSYCHOTHER PSYCHOSOM, V77, P384, DOI 10.1159/000151519; Jiang W, 2011, DEPRESSION HEART DIS; Joustra ML, 2015, J PSYCHOSOM RES, V79, P94, DOI 10.1016/j.jpsychores.2015.05.004; Judd LL, 1996, AM J PSYCHIAT, V153, P1411; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Momsen AH, 2016, PUBLIC HEALTH, V133, P75, DOI 10.1016/j.puhe.2015.10.018; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Nettleton S, 2006, SOC SCI MED, V62, P1167, DOI 10.1016/j.socscimed.2005.07.030; Nettleton S., 2004, SOCIAL THEORY HLTH, V2, P47, DOI DOI 10.1057/PALGRAVE.STH.8700013; Palmer CGS, 2018, J GENET COUNS, V27, P1087, DOI 10.1007/s10897-018-0228-6; Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006; Penning BWJH, 2018, METABOLIC SYNDROME P, V20; Rabkin Judith G, 2008, Curr HIV/AIDS Rep, V5, P163, DOI 10.1007/s11904-008-0025-1; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; Rapaport MH, 1998, J AFFECT DISORDERS, V48, P227, DOI 10.1016/S0165-0327(97)00196-1; Rapaport MH, 2002, AM J PSYCHIAT, V159, P637, DOI 10.1176/appi.ajp.159.4.637; Schechter D, 2007, PSYCHIAT RES, V152, P45, DOI 10.1016/j.psychres.2006.09.008; Spillmann RC, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0623-3; Splinter K, 2018, NEW ENGL J MED, V379, P2131, DOI 10.1056/NEJMoa1714458; Stevanovic D, 2011, J PSYCHIATR MENT HLT, V18, P744, DOI 10.1111/j.1365-2850.2011.01735.x; Stone J, 2009, BRAIN, V132, P2878, DOI 10.1093/brain/awp220; van Dessel N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011142.pub2; Weiss K, 2018, RAMBAM MAIMONIDES ME, V9, DOI 10.5041/RMMJ.10341; Whooley MA, 2013, ANNU REV CLIN PSYCHO, V9, P327, DOI 10.1146/annurev-clinpsy-050212-185526	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216937	10.1371/journal.pone.0216937	http://dx.doi.org/10.1371/journal.pone.0216937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170170	gold, Green Published, Green Submitted			2022-12-26	WOS:000470263700011
J	Chong, SY; Chittleborough, CR; Gregory, T; Lynch, J; Mittinty, M; Smithers, LG				Chong, Shiau Yun; Chittleborough, Catherine Ruth; Gregory, Tess; Lynch, John; Mittinty, Murthy; Smithers, Lisa Gaye			The controlled direct effect of temperament at 2-3 years on cognitive and academic outcomes at 6-7 years	PLOS ONE			English	Article							EFFORTFUL CONTROL; SELF-REGULATION; CHILDRENS; ACHIEVEMENT; SKILLS; PREDICTORS; PERFORMANCE; PRESCHOOL; BEHAVIOR; RATINGS	There is widespread interest in temperament and its impact upon cognitive and academic outcomes. Parents adjust their parenting according to their child's temperament, however, few studies have accounted for parenting while estimating the association between temperament and academic outcomes. We examined the associations between temperament (2-3 years) and cognitive and academic outcomes (6-7 years) when mediation by parenting practices (4-5 years) was held constant, by estimating the controlled direct effect. Participants were from the Longitudinal Study of Australian Children (n = 5107). Cognitive abilities were measured by the Peabody Picture Vocabulary Test (verbal) and the Matrix Reasoning test (non-verbal). Literacy and numeracy were reported by teachers using the Academic Rating Scale. Mothers reported children's temperament using the Short Temperament Scale for Toddlers (subscales: reactivity, approach, and persistence). Parenting practices included items about engagement in activities with children. Marginal structural models with inverse probability of treatment weights were used to estimate the controlled direct effect of temperament, when setting parenting to the mean. All temperament subscales were associated with cognitive abilities, with persistence showing the largest associations with verbal (PPVT; beta = 0.58; 95%CI 0.27, 0.89) and non-verbal (Matrix Reasoning: beta = 0.19; 0.02, 0.34) abilities. Higher persistence was associated with better literacy (beta = 0.08; 0.03, 0.13) and numeracy (beta = 0.08; 0.03, 0.13), and higher reactivity with lower literacy (beta = -0.08; -0.11, -0.05) and numeracy (beta = -0.07; -0.10, -0.04). There was little evidence that temperamental approach influenced literacy or numeracy. Overall, temperament had small associations with cognitive and academic outcomes after accounting for parenting and confounders.	[Chong, Shiau Yun; Chittleborough, Catherine Ruth; Gregory, Tess; Lynch, John; Mittinty, Murthy; Smithers, Lisa Gaye] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Chittleborough, Catherine Ruth; Lynch, John; Mittinty, Murthy; Smithers, Lisa Gaye] Robinson Res Inst, Adelaide, SA, Australia; [Gregory, Tess] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Lynch, John] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England	University of Adelaide; Robinson Research Institute; Telethon Kids Institute; University of Western Australia; University of Bristol	Smithers, LG (corresponding author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.; Smithers, LG (corresponding author), Robinson Res Inst, Adelaide, SA, Australia.	lisa.smithers@adelaide.edu.au	Chittleborough, Catherine/A-7436-2011; Smithers, Lisa/D-1605-2009	Chittleborough, Catherine/0000-0003-3196-7137; Smithers, Lisa/0000-0002-6585-7836; Gregory, Tess/0000-0003-4799-6258	University of Adelaide International Scholarship; Fraser Mustard Centre PhD Scholarship; Australia Fellowship from the National Health and Medical Research Council of Australia [70120]; Australia Fellowship	University of Adelaide International Scholarship; Fraser Mustard Centre PhD Scholarship; Australia Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Fellowship	Dr Chong was funded by a University of Adelaide International Scholarship and a Fraser Mustard Centre PhD Scholarship. During this work, Professor Lynch was supported by an Australia Fellowship from the National Health and Medical Research Council of Australia (70120). Associate Professor Smithers and Dr Mittinty were also supported by funds from the Australia Fellowship awarded to Prof Lynch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association (APA), 2009, APA CONC DICT PSYCH; [Anonymous], TEMPERAMENT CHILDHOO; [Anonymous], 2005, 1 LSAC; Baker CN, 2015, J EDUC PSYCHOL, V107, P805, DOI 10.1037/edu0000008; Banerjee PN, 2007, INFANT BEHAV DEV, V30, P479, DOI 10.1016/j.infbeh.2006.12.001; Bierman KL, 2014, CHILD DEV, V85, P140, DOI 10.1111/cdev.12117; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Blair C, 2015, ANNU REV PSYCHOL, V66, P711, DOI 10.1146/annurev-psych-010814-015221; Byford M, 2012, INT J EPIDEMIOL, V41, P263, DOI 10.1093/ije/dyr188; CAREY WB, 1977, PEDIATRICS, V60, P621; Cheng SY, 2010, J EPIDEMIOL, V20, pS452, DOI 10.2188/jea.JE20090177; Childs G, 2001, BRIT J EDUC PSYCHOL, V71, P303, DOI 10.1348/000709901158532; Dixon WE, 2006, INFANT BEHAV DEV, V29, P342, DOI 10.1016/j.infbeh.2006.01.002; Dixon WE, 2003, INFANT CHILD DEV, V12, P177, DOI 10.1002/icd.283; Dunn L.M., 1981, PEABODY PICTURE VOCA; FULLARD W, 1984, J PEDIATR PSYCHOL, V9, P205, DOI 10.1093/jpepsy/9.2.205; GREENBERG MT, 1995, DEV PSYCHOPATHOL, V7, P117, DOI 10.1017/S0954579400006374; Heckman JJ, 2001, AM ECON REV, V91, P145, DOI 10.1257/aer.91.2.145; Hernan MA, 2004, J EPIDEMIOL COMMUN H, V58, P265, DOI 10.1136/jech.2002.006361; Hernan MA, 2018, CASUAL INFERENCE; Hughes K, 2010, SCHOOL PSYCHOL QUART, V25, P213, DOI 10.1037/a0022070; KEOGH BK, 1982, CIBA F SYMP, V89, P269; LERNER JV, 1985, J CHILD PSYCHOL PSYC, V26, P125, DOI 10.1111/j.1469-7610.1985.tb01633.x; Lipsey M. W., 2012, TRANSLATING STAT REP; MACCOBY EE, 1984, DEV PSYCHOL, V20, P459, DOI 10.1037/0012-1649.20.3.459; MacKenzie MJ, 2013, PEDIATRICS, V132, pE1118, DOI 10.1542/peds.2013-1227; Martin R.P., 1985, J PSYCHOEDUC ASSESS, V3, P131, DOI [DOI 10.1177/073428298500300204, 10.1177/073428298500300204]; National Center for Education Statistics, 2002, 2002135 NCES; Nix RL, 2013, EARLY EDUC DEV, V24, P1000, DOI 10.1080/10409289.2013.825565; PALISIN H, 1986, DEV PSYCHOL, V22, P766, DOI 10.1037/0012-1649.22.6.766; PRIOR M, 1987, INT J BEHAV DEV, V10, P121, DOI 10.1177/016502548701000108; Prior M, 2008, INFANT BEHAV DEV, V31, P270, DOI 10.1016/j.infbeh.2007.11.001; Rabiner D, 2000, J AM ACAD CHILD PSY, V39, P859, DOI 10.1097/00004583-200007000-00014; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Rock D.A., 2002, EARLY CHILDHOOD LONG; Rothman S, 2005, 2 AUSTR I FAM STUD; Rudasill KM, 2010, J SCHOOL PSYCHOL, V48, P113, DOI 10.1016/j.jsp.2009.11.002; Salley BJ, 2007, MERRILL PALMER QUART, V53, P131; Sanson A., 2011, WILEY BLACKWELL HDB, P227, DOI [DOI 10.1002/9781444390933, DOI 10.1002/9781444390933.CH12]; Sawyer ACP, 2015, CHILD CARE HLTH DEV, V41, P744, DOI 10.1111/cch.12208; Smithers LG, 2018, NAT HUM BEHAV, V2, P867, DOI 10.1038/s41562-018-0461-x; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Valiente C, 2010, J EDUC PSYCHOL, V102, P550, DOI 10.1037/a0018992; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20; VanderWeele TJ, 2010, EPIDEMIOLOGY, V21, P540, DOI 10.1097/EDE.0b013e3181df191c; Vassallo S, 2013, AUSTR TEMPERAMENT PR; VAUGHN BE, 1987, DEV PSYCHOL, V23, P152, DOI 10.1037/0012-1649.23.1.152; WACHS TD, 1983, INT J BEHAV DEV, V6, P135, DOI 10.1177/016502548300600202; WEBSTERSTRATTON C, 1982, J CLIN CHILD PSYCHOL, V11, P123, DOI 10.1207/s15374424jccp1102_5; Wechsler D, 1974, WECHSLER INTELLIGENC; West J., 2000, AM KINDERGARTNERS FI	52	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0204189	10.1371/journal.pone.0204189	http://dx.doi.org/10.1371/journal.pone.0204189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163023	Green Submitted, Green Published, gold			2022-12-26	WOS:000470086200001
J	Penningroth, SL; Scott, WD				Penningroth, Suzanna L.; Scott, Walter D.			Age-related differences in the goals and concerns that motivate real-life prospective memory tasks	PLOS ONE			English	Article							AVOIDANCE MOTIVATION; ORIENTATION; INTENTIONS; ADULTHOOD; SELECTION; YOUNG; COMPENSATION; OPTIMIZATION; PERSONALITY; RETRIEVAL	Prospective memory tasks are tasks that one must remember to perform in the future, such as keeping a dentist appointment or locking the door when leaving home. There has been little research to date on the question of what motivates real-life prospective memory tasks, and this is true both generally and within the subfield of aging and prospective memory. In the current study, we investigated whether the prospective memory tasks of younger and older adults were motivated by different personal goals and concerns, a question that has not been addressed in past research. Participants completed a questionnaire on current prospective memory tasks and the higher level goals and concerns that motivated these tasks. In general, younger and older adults reported prospective memory tasks motivated by different goals and concerns that reflected different social age systems or developmental tasks. Specifically, younger adults were more likely to report prospective memory tasks related to goals for education, profession, property, self, and leisure, and related to concerns about education and profession. In contrast, older adults were more likely to report prospective memory tasks related to concerns about world issues and war/terrorism. We also examined prospective memory task motivation more generally as approach motivation (goal-relatedness) and avoidance motivation (concern-relatedness). Both measures showed a gender by age group interaction. That is, older males showed especially low approach motivation and especially high avoidance motivation for their real-life prospective memory tasks. We suggest that a new approach to prospective memory research that incorporates motivational influences would enhance the ecological validity of prospective memory and aging research and may inform more effective memory interventions.	[Penningroth, Suzanna L.; Scott, Walter D.] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Washington State University	Penningroth, SL (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	s.penningroth@wsu.edu						Aberle I, 2010, DEV PSYCHOL, V46, P1444, DOI 10.1037/a0020718; Baltes P.B., 1990, SUCCESSFUL AGING PER, P1, DOI [10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; CANTOR N, 1991, J PERS, V59, P425, DOI 10.1111/j.1467-6494.1991.tb00255.x; Cherry KE, 2001, MEMORY, V9, P177, DOI 10.1080/09658210143000092; Cook GI, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00278; CROSS S, 1991, HUM DEV, V34, P230, DOI 10.1159/000277058; DOBBS AR, 1987, CAN J PSYCHOL, V41, P209, DOI 10.1037/h0084152; Eagly AH, 2000, DEVELOPMENTAL SOCIAL PSYCHOLOGY OF GENDER, P123; Ebner NC, 2006, PSYCHOL AGING, V21, P664, DOI 10.1037/0882-7974.21.4.664; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; Elliot AJ, 1997, J PERS SOC PSYCHOL, V73, P171, DOI 10.1037/0022-3514.73.1.171; Elliot AJ, 2001, J PERS SOC PSYCHOL, V80, P501, DOI 10.1037//0022-3514.80.3.501; Elliot AJ, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P3; Elliot AJ, 2010, J PERS, V78, P865, DOI 10.1111/j.1467-6494.2010.00636.x; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Emmons R. A., 1996, PSYCHOL ACTION LINKI, P313; Emmons RA, GOAL CONCEPTS PERSON, P7; Evans CD, 2009, PSYCHOL WOMEN QUART, V33, P235, DOI 10.1111/j.1471-6402.2009.01493.x; Fishbach A, 2004, J EXP SOC PSYCHOL, V40, P723, DOI 10.1016/j.jesp.2004.04.001; Freeman JE, 2003, INT J PSYCHOL, V38, P215, DOI 10.1080/00207590344000141; Freund AM, 2002, J PERS SOC PSYCHOL, V82, P642, DOI 10.1037//0022-3514.82.4.642; Gilbert SJ, 2015, Q J EXP PSYCHOL, V68, P971, DOI 10.1080/17470218.2014.972963; Gollwitzer P. M., 2008, PROSPECTIVE MEMORY C, P433; Gollwitzer P.M., 1996, PSYCHOL ACTION LINKI; Hagestad G. O., 1985, HDB AGING SOCIAL SCI, P35; Havighurst RJ, 1948, DEV TASKS ED, V3rd; Heckhausen J, 1997, DEV PSYCHOL, V33, P176, DOI 10.1037/0012-1649.33.1.176; Heimerdinger SR, 2008, HUM PERFORM, V21, P383, DOI 10.1080/08959280802347155; Helson R, 2002, J RES PERS, V36, P287, DOI 10.1016/S0092-6566(02)00010-7; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Higgins ET., 1996, PSYCHOL ACTION LINKI, P91; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Ihle A, 2012, AGING NEUROPSYCHOL C, V19, P84, DOI 10.1080/13825585.2011.629288; Kliegel M., 2008, PROSPECTIVE MEMORY C; Kliegel M., 2002, PSYCHOL BEITR, V44, P303; Kruglanski A.W., 1996, PSYCHOL ACTION LINKI, P599; Kruglanski AW, 2002, ADV EXP SOC PSYCHOL, V34, P331, DOI 10.1016/S0065-2601(02)80008-9; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Maylor EA, 2001, PSYCHON B REV, V8, P162, DOI 10.3758/BF03196153; Maylor EA, 2010, Q J EXP PSYCHOL, V63, P442, DOI 10.1080/17470210903469872; McDaniel M. A., 2008, PROSPECTIVE MEMORY C, P141; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Murty VP, 2011, LEARN MEMORY, V18, P712, DOI 10.1101/lm.023549.111; NURMI JE, 1992, PSYCHOL AGING, V7, P194, DOI 10.1037/0882-7974.7.2.194; NURMI JE, 1991, DEV REV, V11, P1, DOI 10.1016/0273-2297(91)90002-6; NURMI JE, 1992, INT J BEHAV DEV, V15, P487, DOI 10.1177/016502549201500404; Ogilvie DM, 2001, BASIC APPL SOC PSYCH, V23, P207, DOI 10.1207/153248301750433768; PATTON GW, 1993, EXP AGING RES, V19, P165, DOI 10.1080/03610739308253929; Penningroth S.L., 2007, PSYCHOL MOTIVATION, p(pp. 115; Penningroth SL, 2005, MEMORY, V13, P711, DOI 10.1080/09658210444000359; Penningroth SL, 2012, PSYCHOL OF MEMORY, P255; Penningroth SL, 2013, APPL COGNITIVE PSYCH, V27, P655, DOI 10.1002/acp.2945; Penningroth SL, 2012, INT J AGING HUM DEV, V74, P87, DOI 10.2190/AG.74.2.a; Phillips L. H., 2008, PROSPECTIVE MEMORY C, P161; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Saajanaho M, 2016, J GERONTOL B-PSYCHOL, V71, P1, DOI 10.1093/geronb/gbu094; Schnitzspahn K, 2018, PSYCHOL RES; Schnitzspahn KM, 2016, MEMORY, V24, P444, DOI 10.1080/09658211.2015.1018276; Shah JY, 2003, J PERS SOC PSYCHOL, V84, P1109, DOI 10.1037/0022-3514.84.6.1109; Sheeran P, 2005, PERS SOC PSYCHOL B, V31, P87, DOI 10.1177/0146167204271308; United States Census Bureau, 2011, STAT COUNT QUICK FAC; Uttl B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193806	68	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0216888	10.1371/journal.pone.0216888	http://dx.doi.org/10.1371/journal.pone.0216888			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158234	Green Published, Green Submitted, gold			2022-12-26	WOS:000469915700003
J	Vetter, SY; Privalov, M; Beisemann, N; Swartman, B; Keil, H; Kirsch, J; Grutzner, PA; Franke, J				Vetter, Sven Y.; Privalov, Maxim; Beisemann, Nils; Swartman, Benedict; Keil, Holger; Kirsch, Joachim; Gruetzner, Paul Alfred; Franke, Jochen			Influence of ankle joint position on angles and distances of the ankle mortise using intraoperative cone beam CT: A cadaveric study	PLOS ONE			English	Article							TIBIOFIBULAR SYNDESMOSIS; COMPUTED-TOMOGRAPHY; FOOT; FRACTURES; ISO-C-3D; ALIGNMENT; FIXATION; SURGERY; IMPACT; CARE	Background The precise anatomical reduction of the ankle mortise is crucial for the clinical outcome in unstable syndesmotic injuries. Intraoperative cone beam computed tomography (CT), in addition to two-dimensional fluoroscopy, provides detailed information about the reduction and implant placement. The aim of this study was to analyze the influence of the joint position on the fibula position in the incisural notch and to determine the inter-and intraindividual anatomical differences in the intact ankle joints. Methods A total of 20 fresh-frozen lower legs disarticulated in the knee joint of 10 individuals were included. The measurements were performed using a cone beam CT. The distances and angles were measured in the standard imaging planes. The mean values of distances and angles were compared during the different joint positions: 10 degrees dorsiflexion, 0 degrees neutral position and 20 degrees plantar flexion. Results The influence of the joint position was on average as follows: The anterior tibiofibular distance was 3.68 mm in 10 degrees dorsiflexion, 3.66 mm (0 degrees neutral position) and 3.59 mm (20 degrees plantar flexion). The posterior tibiofibular distance measured 7.82mm, 7.76mm and 7.82mm. The rotation of the fibula measured ten millimeters proximal the joint line was 1.2 degrees, 1.3 degrees and 1.05 degrees. The fibular rotation determined 4mm was 9.3 degrees, 9.4 degrees and 9.4 degrees. On average, the following intraindividual variations were observed: superior tibiotalar clear space of 0.27mm and 0.15mm medial; and anterior tibiofibular distance of 0.42mm, 0.38mm posterior and 0.24mm in the incisural notch. The proximal angle of the fibular rotation was 0.2 degrees and distal 0.4 degrees. The interindividual variations of the angles and distances exceeded the intraindividual values partly by 3 to 4 fold. Conclusions Within the scope of this study neither the tibiofibular distance, nor the tibiofibular angle changed significantly through the different joint positions. The intraindividual differences were little while the interindividual variations of the parameters were distinctive.	[Vetter, Sven Y.; Privalov, Maxim; Beisemann, Nils; Swartman, Benedict; Keil, Holger; Gruetzner, Paul Alfred; Franke, Jochen] Heidelberg Univ Hosp, BG Trauma Ctr Ludwigshafen, Ludwigshafen, Germany; [Kirsch, Joachim] Heidelberg Univ, Inst Anat & Cell Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Franke, J (corresponding author), Heidelberg Univ Hosp, BG Trauma Ctr Ludwigshafen, Ludwigshafen, Germany.	jochen.franke@bgu-ludwigshafen.de	Keil, Holger/AAE-1264-2020	Keil, Holger/0000-0002-5006-8420; Franke, Jochen/0000-0003-3755-7948				Atesok K, 2007, INJURY, V38, P1163, DOI 10.1016/j.injury.2007.06.014; Barg A, 2018, FOOT ANKLE INT, V39, P376, DOI 10.1177/1071100717740330; Belatti DA, 2014, FOOT ANKLE INT, V35, P334, DOI 10.1177/1071100713519777; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; DESOUZA LJ, 1985, J BONE JOINT SURG AM, V67A, P1066, DOI 10.2106/00004623-198567070-00010; Elgafy H, 2010, SKELETAL RADIOL, V39, P559, DOI 10.1007/s00256-009-0809-4; Franke J, 2013, UNFALLCHIRURG, V116, P185, DOI 10.1007/s00113-013-2359-4; Franke J, 2011, TRAUMA BERUFSKRANKH, V13, P160, DOI 10.1007/s10039-011-1750-z; Franke J, 2012, J BONE JOINT SURG AM, V94A, P1386, DOI 10.2106/JBJS.K.01122; Geerling J, 2009, J TRAUMA, V66, P768, DOI 10.1097/TA.0b013e31816275c7; Grifka J., 2011, ORTHOPADIE UNFALLCHI, VXIII; Hermans JJ, 2010, J ANAT, V217, P633, DOI 10.1111/j.1469-7580.2010.01302.x; Kendoff D, 2009, J TRAUMA, V66, P232, DOI 10.1097/TA.0b013e31815ede5d; Kuo CC, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-131; Lintz F, 2017, FOOT ANKLE INT, V38, P684, DOI 10.1177/1071100717690806; Lintz Francois, 2012, Foot Ankle Surg, V18, P9, DOI 10.1016/j.fas.2011.01.003; Moon SW, 2014, J ORTHOP SCI, V19, P125, DOI 10.1007/s00776-013-0475-1; Nault ML, 2017, FOOT ANKLE INT, V38, P215, DOI 10.1177/1071100716674309; RAMSEY PL, 1976, J BONE JOINT SURG AM, V58, P356, DOI 10.2106/00004623-197658030-00010; Richter M, 2005, J ORTHOP TRAUMA, V19, P259, DOI 10.1097/01.bot.0000151822.10254.db; Richter M, 2009, J ORTHOP TRAUMA, V23, P213, DOI 10.1097/BOT.0b013e31819867f6; Rubberdt A, 2006, UNFALLCHIRURG, V109, P112, DOI 10.1007/s00113-005-1015-z; Scharf H-P, 2011, ORTHOPADIE UNFALLCHI, VXIV; Stephan D, 2014, COMPUT METHOD BIOMEC, V17, P1635, DOI 10.1080/10255842.2012.759564; Summers HD, 2013, J ORTHOP TRAUMA, V27, P196, DOI 10.1097/BOT.0b013e3182694766; Thakore RV, 2015, DISABIL REHABIL, V37, P417, DOI 10.3109/09638288.2014.923525; Thordarson DB, 1997, J BONE JOINT SURG AM, V79A, P1809, DOI 10.2106/00004623-199712000-00006; Tochigi Y, 2006, FOOT ANKLE INT, V27, P82, DOI 10.1177/107110070602700202; Vetter S., 2013, ORTHOP UNFALLCHIR UP, V7, P467, DOI [10.1055/s-0032-1324884, DOI 10.1055/S-0032-1324884]; Vetter SY, 2016, FOOT ANKLE INT, V37, P977, DOI 10.1177/1071100716650532; XENOS JS, 1995, J BONE JOINT SURG AM, V77A, P847, DOI 10.2106/00004623-199506000-00005; Zwaag H, 2015, ADV COMPUT TOMOGR, V4, P9, DOI [10.4236/act.2015.41002, DOI 10.4236/ACT.2015.41002]	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217737	10.1371/journal.pone.0217737	http://dx.doi.org/10.1371/journal.pone.0217737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150469	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100093
J	Kamathewatta, KI; Bushell, RN; Young, ND; Stevenson, MA; Billman-Jacobe, H; Browning, GF; Marenda, MS				Kamathewatta, Kanishka Indiwari; Bushell, Rhys Nathan; Young, Neil David; Stevenson, Mark Anthony; Billman-Jacobe, Helen; Browning, Glenn Francis; Marenda, Marc Serge			Exploration of antibiotic resistance risks in a veterinary teaching hospital with Oxford Nanopore long read sequencing	PLOS ONE			English	Article							GENES; PREVALENCE; INTEGRONS; BACTERIA; COMPLEX; DESIGN	The Oxford Nanopore MinION DNA sequencing device can produce large amounts of long sequences, typically several kilobases, within a few hours. This long read capacity was exploited to detect antimicrobial resistance genes (ARGs) in a large veterinary teaching hospital environment, and to assess their taxonomic origin, genetic organisation and association with mobilisation markers concurrently. Samples were collected on eight occasions between November 2016 and May 2017 (inclusive) in a longitudinal study. Nanopore sequencing was performed on total DNA extracted from the samples after a minimal enrichment step in broth. Many ARGs present in the veterinary hospital environment could potentially confer resistance to antimicrobials widely used in treating infections of companion animals, including aminoglycosides, extended-spectrum beta-lactams, sulphonamides, macrolides, and tetracyclines. High-risk ARGs, defined here as single or multiple ARGs associated with pathogenic bacterial species or with mobile genetic elements, were shared between the intensive care unit (ICU) patient cages, a dedicated laundry trolley and a floor cleaning mop-bucket. By contrast, a floor surface from an office corridor without animal contact and located outside the veterinary hospital did not contain such high-risk ARGs. Relative abundances of high-risk ARGs and co-localisation of these genes on the same sequence read were higher in the laundry trolley and mop bucket samples, compared to the ICU cages, suggesting that amplification of ARGs is likely to occur in the collection points for hospital waste. These findings have prompted the implementation of targeted intervention measures in the veterinary hospital to mitigate the risks of transferring clinically important ARGs between sites and to improve biosecurity practices in the facility.	[Kamathewatta, Kanishka Indiwari; Bushell, Rhys Nathan; Young, Neil David; Marenda, Marc Serge] Univ Melbourne, Fac Vet & Agr Sci, Dept Vet Biosci, Werribee, Vic, Australia; [Stevenson, Mark Anthony; Billman-Jacobe, Helen; Browning, Glenn Francis] Univ Melbourne, Fac Vet & Agr Sci, Dept Vet Biosci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Marenda, MS (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Dept Vet Biosci, Werribee, Vic, Australia.	mmarenda@unimelb.edu.au	Young, Neil David/AAU-4572-2020; Browning, Glenn/P-4459-2014	Young, Neil David/0000-0001-8756-229X; Browning, Glenn/0000-0002-0903-2469; MARENDA, MARC/0000-0001-6778-1110				Benedict KM, 2008, JAVMA-J AM VET MED A, V233, P767, DOI 10.2460/javma.233.5.767; Benitez-Paez A, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0111-z; Birtel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125356; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carver T, 2003, BIOINFORMATICS, V19, P1837, DOI 10.1093/bioinformatics/btg251; Chambers Lindsey, 2015, PLoS One, V10, pe0133764, DOI 10.1371/journal.pone.0133764; Cusco A, 2017, USING MINION CHARACT, DOI [10.1101/167015, DOI 10.1101/167015]; Deng Y, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0100-6; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gillings MR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00004; Girlich D, 2004, ANTIMICROB AGENTS CH, V48, P2043, DOI 10.1128/AAC.48.6.2043-2048.2004; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hayashi H, 2004, MICROBIOL IMMUNOL, V48, P1, DOI 10.1111/j.1348-0421.2004.tb03481.x; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hunt M, 2013, PYTHON3 SCRIPTS MANI; Ito R, 2017, MBIO, V8, DOI 10.1128/mBio.00749-17; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Kraken Wood D., 2014, KRAKEN TAXONOMIC SEQ; Krueger F., 2017, TRIM GALORE; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Leggett R. M., 2017, BIORXIV, DOI [10.1101/180406, DOI 10.1101/180406]; Leggett RM, 2017, J EXP BOT, V68, P5419, DOI 10.1093/jxb/erx289; Legione AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194881; Li CH, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0140-7; Li H, 2016, TOOLKIT PROCESSING S; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; Luby E, 2016, J ENVIRON QUAL, V45, P441, DOI 10.2134/jeq2015.07.0367; Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399; Marx V, 2015, NAT METHODS, V12, P1015, DOI 10.1038/nmeth.3625; Mendonca N, 2009, DIAGN MICR INFEC DIS, V63, P334, DOI 10.1016/j.diagmicrobio.2008.11.005; Moura A, 2012, RES MICROBIOL, V163, P92, DOI 10.1016/j.resmic.2011.10.010; Noyes NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24645; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pitta DW, 2016, FOODBORNE PATHOG DIS, V13, P296, DOI 10.1089/fpd.2015.2092; Rodriguez-Martinez JM, 2013, J ANTIMICROB CHEMOTH, V68, P68, DOI 10.1093/jac/dks377; Rstudio Team, 2019, RSTUDIO INTEGRATED D; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seemann T., 2017, ABRICATE MASS SCREEN; Shin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29681; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Thijs S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00494; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; van der Helm E, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1328; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Walsh TR, 1998, ANTIMICROB AGENTS CH, V42, P436; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Wang FH, 2014, ENVIRON SCI TECHNOL, V48, P9079, DOI 10.1021/es502615e; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weingarten RA, 2018, MBIO, V9, DOI 10.1128/mBio.02011-17; Wichmann F, 2014, MBIO, V5, DOI 10.1128/mBio.01017-13; Wick R., 2017, FAST5 TO FASTQ SIMPL; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xiao L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.161, 10.1038/nmicrobiol.2016.161]; Yuan JY, 2012, J ANTIMICROB CHEMOTH, V67, P1655, DOI 10.1093/jac/dks086; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zarnayova M, 2005, ANTIMICROB AGENTS CH, V49, P3066, DOI 10.1128/AAC.49.7.3066-3069.2005; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	66	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217600	10.1371/journal.pone.0217600	http://dx.doi.org/10.1371/journal.pone.0217600			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145757	Green Published, gold			2022-12-26	WOS:000469425500025
J	Yabe, SG; Nishida, J; Fukuda, S; Takeda, F; Nasiro, K; Yasuda, K; Iwasaki, N; Okochi, H				Yabe, Shigeharu G.; Nishida, Junko; Fukuda, Satsuki; Takeda, Fujie; Nasiro, Kiyoko; Yasuda, Kazuki; Iwasaki, Naoko; Okochi, Hitoshi			Expression of mutant mRNA and protein in pancreatic cells derived from MODY3-iPS cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; LOSS-OF-FUNCTION; TRANSCRIPTION FACTORS; BETA-CELLS; MUTATIONS; GENE; DECAY; HNF-1-ALPHA; INDUCTION	Maturity-onset diabetes of the young (MODY) is a heterozygous monogenic diabetes; more than 14 disease genes have been identified. However, the pathogenesis of MODY is not fully understood because the patients' pancreatic beta cells are inaccessible. To elucidate the pathology of MODY, we established MODY3 patient-derived iPS (MODY3-iPS) cells using non-integrating Sendai virus (SeV) vector and examined the mutant mRNA and protein of HNF1A (Hepatocyte Nuclear factor 1A) after pancreatic lineage differentiation. Our patient had a cytosine insertion in the HNF1A gene (P291fsinsC) causing frameshift and making a premature termination codon (PTC). We confirmed these MODY3-iPS cells possessed the characteristics of pluripotent stem cells. After we differentiated them into pancreatic beta cells, transcripts of HNF1A gene were cloned and sequenced. We found that P291fsinsC mutant transcripts were much less frequent than wild ones, but they increased after adding cycloheximide (CHX) to the medium. These results suggested that mutant mRNA was destroyed by nonsense-mediated mRNA decay (NMD). Moreover, we were not able to detect any band of mutant proteins in pancreatic lineage cells which were differentiated from MODY3-iPSCs by western blot (WB) analysis. A scarcity of the truncated form of mutant protein may indicate that MODY3 might be caused by a haplo-insufficiency effect rather than a dominant negative manner.	[Yabe, Shigeharu G.; Nishida, Junko; Fukuda, Satsuki; Takeda, Fujie; Nasiro, Kiyoko; Okochi, Hitoshi] Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan; [Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Metab Disorders, Tokyo, Japan; [Iwasaki, Naoko] Tokyo Womens Med Univ, Inst Med Genet, Diabet Ctr, Inst Geriatr, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Tokyo Women's Medical University	Yabe, SG; Okochi, H (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Regenerat Med, Tokyo, Japan.	syabe@ri.ncgm.go.jp; hokochi@ri.ncgm.go.jp			National Center for Global Health and Medicine [27A1201, 29A1016]; MEXT [22510214]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the National Center for Global Health and Medicine (27A1201) to HO and (29A1016) to SGY. This work was also partially supported by a Grant-in-Aid (22510214) for Scientific Research from the MEXT to N.I.	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bonnefond A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037423; Braverman-Gross C, 2018, STEM CELL RES, V31, P16, DOI 10.1016/j.scr.2018.06.013; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Ellard S, 2000, HUM MUTAT, V16, P377, DOI 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO;2-2; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gu N, 2004, BIOCHEM BIOPH RES CO, V325, P308, DOI 10.1016/j.bbrc.2004.10.027; Gu N, 2006, BIOCHEM BIOPH RES CO, V346, P1016, DOI 10.1016/j.bbrc.2006.06.010; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hua H, 2013, J CLIN INVEST, V123, P3146, DOI 10.1172/JCI67638; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Iwasaki N, 1998, DIABETES CARE, V21, P2144, DOI 10.2337/diacare.21.12.2144; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Lausen J, 2000, NUCLEIC ACIDS RES, V28, P430, DOI 10.1093/nar/28.2.430; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Okita K, 1999, BIOCHEM BIOPH RES CO, V263, P566, DOI 10.1006/bbrc.1999.1412; Owen KR, 2018, CURR OPIN GENET DEV, V50, P103, DOI 10.1016/j.gde.2018.04.006; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Prudente S, 2015, AM J HUM GENET, V97, P177, DOI 10.1016/j.ajhg.2015.05.011; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sujjitjoon J., 2008, THAI J GENETICS, V1, P93; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teo AKK, 2013, J BIOL CHEM, V288, P5353, DOI 10.1074/jbc.C112.428979; Teo AKK, 2016, STEM CELL REP, V6, P357, DOI 10.1016/j.stemcr.2016.01.007; Timsit J, 2016, CAN J DIABETES, V40, P455, DOI 10.1016/j.jcjd.2015.12.005; Tomura H, 1999, J BIOL CHEM, V274, P12975, DOI 10.1074/jbc.274.19.12975; Usuki F, 2004, ANN NEUROL, V55, P740, DOI 10.1002/ana.20107; Vaxillaire M, 1999, J BIOL CHEM, V274, P35639, DOI 10.1074/jbc.274.50.35639; Vethe H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04979-w; Yabe SG, 2019, INT J DEV BIOL; Yabe SG, 2019, REGEN THER, V10, P69, DOI 10.1016/j.reth.2018.11.003; Yabe SG, 2017, J DIABETES, V9, P168, DOI 10.1111/1753-0407.12400; Yabe SG, 2015, J DIABETES INVEST, V6, P543, DOI 10.1111/jdi.12334; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; Yamagata K, 2003, ENDOCR J, V50, P491, DOI 10.1507/endocrj.50.491; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang Q, 1999, BIOCHEM BIOPH RES CO, V266, P196, DOI 10.1006/bbrc.1999.1747; Yang Q, 2000, DIABETOLOGIA, V43, P520, DOI 10.1007/s001250051338	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217110	10.1371/journal.pone.0217110	http://dx.doi.org/10.1371/journal.pone.0217110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145732	Green Published, Green Submitted, gold			2022-12-26	WOS:000469425500012
J	Krysztofiak, H; Mlynczak, M; Malek, LA; Folga, A; Braksator, W				Krysztofiak, Hubert; Mlynczak, Marcel; Malek, Lukasz A.; Folga, Andrzej; Braksator, Wojciech			Left ventricular mass is underestimated in overweight children because of incorrect body size variable chosen for normalization	PLOS ONE			English	Article							CARDIAC GEOMETRY; BLOOD-PRESSURE; SURFACE AREA; OBESITY; HYPERTROPHY; ADOLESCENTS; IMPACT; ADULTS; ASSOCIATION; LIMITATIONS	Background Left ventricular mass normalization for body size is recommended, but a question remains: what is the best body size variable for this normalization-body surface area, height or lean body mass computed based on a predictive equation? Since body surface area and computed lean body mass are derivatives of body mass, normalizing for them may result in underestimation of left ventricular mass in overweight children. The aim of this study is to indicate which of the body size variables normalize left ventricular mass without underestimating it in overweight children. Methods Left ventricular mass assessed by echocardiography, height and body mass were collected for 464 healthy boys, 5-18 years old. Lean body mass and body surface area were calculated. Left ventricular mass z-scores computed based on reference data, developed for height, body surface area and lean body mass, were compared between overweight and non- overweight children. The next step was a comparison of paired samples of expected left ventricular mass, estimated for each normalizing variable based on two allometric equations-the first developed for overweight children, the second for children of normal body mass. Results The mean of left ventricular mass z-scores is higher in overweight children compared to non-overweight children for normative data based on height (0.36 vs. 0.00) and lower for normative data based on body surface area (-0.64 vs. 0.00). Left ventricular mass estimated normalizing for height, based on the equation for overweight children, is higher in overweight children (128.12 vs. 118.40); however, masses estimated normalizing for body surface area and lean body mass, based on equations for overweight children, are lower in overweight children (109.71 vs. 122.08 and 118.46 vs. 120.56, respectively). Conclusion Normalization for body surface area and for computed lean body mass, but not for height, underestimates left ventricular mass in overweight children.	[Krysztofiak, Hubert] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland; [Krysztofiak, Hubert; Folga, Andrzej] Natl Ctr Sports Med, Warsaw, Poland; [Mlynczak, Marcel] Warsaw Univ Technol, Inst Metrol & Biomed Engn, Fac Mechatron, Warsaw, Poland; [Malek, Lukasz A.] Jozef Pilsudski Univ Phys Educ, Fac Rehabil, Warsaw, Poland; [Braksator, Wojciech] Med Univ Warsaw, Med Fac 2, Dept Sports Cardiol & Noninvas Cardiovasc Imaging, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Warsaw University of Technology; Jozef Pilsudski University Physical Education in Warsaw; Medical University of Warsaw	Krysztofiak, H (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland.; Krysztofiak, H (corresponding author), Natl Ctr Sports Med, Warsaw, Poland.	hkrysztofiak@imdik.pan.pl	Młyńczak, Marcel/L-1509-2016; Krysztofiak, Hubert/L-8083-2019; Braksator, Wojciech/N-2197-2018	Młyńczak, Marcel/0000-0001-8549-7973; Krysztofiak, Hubert/0000-0003-4567-1433; Braksator, Wojciech/0000-0003-2201-4887; Malek, Lukasz/0000-0002-9586-0163				Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; Braley KT, 2017, ECHOCARDIOGR-J CARD, V34, P1029, DOI 10.1111/echo.13565; Cantinotti M, 2014, J AM SOC ECHOCARDIOG, V27, P339, DOI 10.1016/j.echo.2013.12.002; Chinali M, 2006, J AM COLL CARDIOL, V47, P2267, DOI 10.1016/j.jacc.2006.03.004; Chirinos JA, 2010, HYPERTENSION, V56, P91, DOI 10.1161/HYPERTENSIONAHA.110.150250; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Dai S, 2009, AM J PREV MED, V37, pS97, DOI 10.1016/j.amepre.2009.04.011; Dallaire F, 2015, PEDIATR CARDIOL, V36, P667, DOI 10.1007/s00246-014-1063-7; DANIELS SR, 1995, CIRCULATION, V92, P3249, DOI 10.1161/01.CIR.92.11.3249; de Simone G, 2005, AM J HYPERTENS, V18, P191, DOI 10.1016/j.amjhyper.2004.08.032; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Devuyst O, 2014, PERITON DIALYSIS INT, V34, P685, DOI 10.3747/pdi.2014.00272; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Foster BJ, 2016, J AM SOC ECHOCARDIOG, V29, P441, DOI 10.1016/j.echo.2015.12.011; Foster BJ, 2013, J AM SOC ECHOCARDIOG, V26, P410, DOI 10.1016/j.echo.2012.11.018; Foster BJ, 2012, ANN HUM BIOL, V39, P171, DOI 10.3109/03014460.2012.681800; GEORGESON L, 2017, BMJ OPEN SPORT EXERC, V3, DOI DOI 10.1136/BMJSEM-2017; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Ippisch HM, 2008, J AM COLL CARDIOL, V51, P1342, DOI 10.1016/j.jacc.2007.12.029; Janz KF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.5.e63; Jing L, 2017, J CARDIOVASC MAGN R, V19, P1, DOI [10.1186/s12968-016-0318-2, DOI 10.1186/s12968-016-0318-2]; Kharod AM, 2014, PEDIATR CARDIOL, V35, P353, DOI 10.1007/s00246-013-0782-5; Kinoshita N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140573; Kuch B, 2001, J HYPERTENS, V19, P135, DOI 10.1097/00004872-200101000-00018; Lopez L, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006979; Mahgerefteh J, 2016, PEDIATR CARDIOL, V37, P993, DOI 10.1007/s00246-016-1380-0; Majonga ED, 2017, INT J CARDIOL, V248, P409, DOI 10.1016/j.ijcard.2017.06.109; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mangner N, 2014, JACC-CARDIOVASC IMAG, V7, P1198, DOI 10.1016/j.jcmg.2014.08.006; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mawad W, 2013, J AM SOC ECHOCARDIOG, V26, P29, DOI 10.1016/j.echo.2012.09.021; Movahed MR, 2009, OBESITY, V17, P606, DOI 10.1038/oby.2008.563; Movahed MR, 2011, ECHOCARDIOGR-J CARD, V28, P150, DOI 10.1111/j.1540-8175.2010.01289.x; Pettersen MD, 2008, J AM SOC ECHOCARDIOG, V21, P922, DOI 10.1016/j.echo.2008.02.006; Pressler A, 2012, EUR J PREV CARDIOL, V19, P1194, DOI 10.1177/1741826711422455; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Stiefel EC, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116629368; Whalley GA, 2004, J AM COLL CARDIOL, V44, P892, DOI 10.1016/j.jacc.2004.04.051; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Woodiwiss AJ, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0539-z	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217637	10.1371/journal.pone.0217637	http://dx.doi.org/10.1371/journal.pone.0217637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141818	Green Submitted, Green Published, gold			2022-12-26	WOS:000469323000070
J	Solarski, M; Williams, D; Mehrabian, M; Wang, HS; Wille, H; Schmitt-Ulms, G				Solarski, Michael; Williams, Declan; Mehrabian, Mohadeseh; Wang, Hansen; Wille, Holger; Schmitt-Ulms, Gerold			The human brain somatostatin interactome: SST binds selectively to P-type family ATPases	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RECEPTOR SUBTYPES; INDUCED INHIBITION; MOLECULAR-CLONING; PROTEIN COMPLEX; CEREBRAL-CORTEX; CELLS; EXPRESSION; K+; PURIFICATION	Somatostatin (SST) is a cyclic peptide that is understood to inhibit the release of hormones and neurotransmitters from a variety of cells by binding to one of five canonical G protein-coupled SST receptors (SSTR1 to SSTR5). Recently, SST was also observed to interact with the amyloid beta (A beta) peptide and affect its aggregation kinetics, raising the possibility that it may bind other brain proteins. Here we report on an SST interactome analysis that made use of human brain extracts as biological source material and incorporated advanced mass spectrometry workflows for the relative quantitation of SST binding proteins. The analysis revealed SST to predominantly bind several members of the P-type family of ATPases. Subsequent validation experiments confirmed an interaction between SST and the sodium-potassium pump (Na+/K+-ATPase) and identified a tryptophan residue within SST as critical for binding. Functional analyses in three different cell lines indicated that SST might negatively modulate the K+ uptake rate of the Na+/K+-ATPase.	[Solarski, Michael; Williams, Declan; Mehrabian, Mohadeseh; Wang, Hansen; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Ctr, Toronto, ON, Canada; [Wille, Holger] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Wille, Holger] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Alberta; University of Alberta; University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Ctr, Toronto, ON, Canada.; Schmitt-Ulms, G (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	Wille, Holger/C-2280-2008; Wang, Hansen/H-7703-2014	Wille, Holger/0000-0001-5102-8706; Wang, Hansen/0000-0003-4414-3372; Williams, Declan/0000-0002-6754-1624; Schmitt-Ulms, Gerold/0000-0001-6962-0919	Alberta Prion Research Institute [201600028]	Alberta Prion Research Institute	HoW and GS received funding from the Alberta Prion Research Institute (grant number: 201600028). We are grateful to the Rosiak family for their most generous philanthropic support. The mass spectrometry components of this study were enabled through a major donation by the Irwin family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett P, 2003, ENDOCRINE, V20, P255, DOI 10.1385/ENDO:20:3:255; BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X; BEAL MF, 1985, SCIENCE, V229, P289, DOI 10.1126/science.2861661; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; BOSCH J, 1985, CLIN GASTROENTEROL, V14, P169; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; BROWN PJ, 1990, J BIOL CHEM, V265, P17995; BROWN PJ, 1993, J BIOL CHEM, V268, P6668; BRUNO JF, 1992, P NATL ACAD SCI USA, V89, P11151, DOI 10.1073/pnas.89.23.11151; Caplin ME, 2014, NEW ENGL J MED, V371, P1556, DOI 10.1056/NEJMc1409757; Dalm SU, 2017, J NUCL MED, V58, P1609, DOI 10.2967/jnumed.116.189035; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Duran-Prado M, 2008, MOL CELL ENDOCRINOL, V286, P63, DOI 10.1016/j.mce.2007.12.006; EPELBAUM J, 1979, EUR J PHARMACOL, V58, P493, DOI 10.1016/0014-2999(79)90323-6; Epelbaum J, 2009, PROG NEUROBIOL, V89, P153, DOI 10.1016/j.pneurobio.2009.07.002; EPPLER CM, 1992, J BIOL CHEM, V267, P15603; GABRIEL SM, 1993, NEUROSCI LETT, V155, P116, DOI 10.1016/0304-3940(93)90686-F; Gadelha MR, 2017, PITUITARY, V20, P100, DOI 10.1007/s11102-017-0791-0; Gahete MD, 2010, J ALZHEIMERS DIS, V20, P465, DOI 10.3233/JAD-2010-1385; Grisshammer R, 2009, METHOD ENZYMOL, V463, P631, DOI 10.1016/S0076-6879(09)63036-6; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; HE HT, 1989, P NATL ACAD SCI USA, V86, P1480, DOI 10.1073/pnas.86.5.1480; Jamshad M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140171; Jean AHW, 2012, METHODS MOL BIOL, V803, P231, DOI 10.1007/978-1-61779-364-6_16; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; KAUPMANN K, 1995, EMBO J, V14, P727, DOI 10.1002/j.1460-2075.1995.tb07051.x; KAZIRO Y, 1960, P NATL ACAD SCI USA, V46, P1319, DOI 10.1073/pnas.46.10.1319; KIMURA N, 1989, J BIOL CHEM, V264, P7033; KNUHTSEN S, 1990, J BIOL CHEM, V265, P1129; KOCH BD, 1988, J BIOL CHEM, V263, P226; Kockskamper J, 1997, BBA-BIOMEMBRANES, V1325, P197, DOI 10.1016/S0005-2736(96)00259-3; Koltsova SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038032; Kumar U, 2010, CELLULAR PEPTIDE HOR, P97; Li M, 2005, WORLD J SURG, V29, P293, DOI 10.1007/s00268-004-7814-5; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Martel Guillaume, 2012, Front Endocrinol (Lausanne), V3, P154, DOI 10.3389/fendo.2012.00154; Minano C, 2010, GASTROENTEROL CLIN N, V39, P681, DOI 10.1016/j.gtc.2010.08.015; MOLLARD P, 1988, ENDOCRINOLOGY, V123, P721, DOI 10.1210/endo-123-2-721; MORRISON JH, 1985, NATURE, V314, P90, DOI 10.1038/314090a0; OCARROLL AM, 1992, MOL PHARMACOL, V42, P939; Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Piqueras L, 2004, N-S ARCH PHARMACOL, V370, P510, DOI 10.1007/s00210-004-0992-8; RENSDOMIANO S, 1992, J NEUROCHEM, V58, P1987, DOI 10.1111/j.1471-4159.1992.tb10938.x; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; Reynaert H, 2003, ALIMENT PHARM THER, V18, P375, DOI 10.1046/j.1365-2036.2003.01657.x; ROBERTS GW, 1985, NATURE, V314, P92, DOI 10.1038/314092a0; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; SAKAMOTO C, 1988, J BIOL CHEM, V263, P14441; Samson WK, 2008, J BIOL CHEM, V283, P31949, DOI 10.1074/jbc.M804784200; Schmitz B, 2014, HYPERTENSION, V63, P753, DOI 10.1161/HYPERTENSIONAHA.113.02061; SCHONBRUNN A, 1993, ENDOCRINOLOGY, V132, P146, DOI 10.1210/en.132.1.146; Shahidullah M, 2017, INVEST OPHTH VIS SCI, V58, P4447, DOI 10.1167/iovs.17-21600; SHEN LP, 1982, P NATL ACAD SCI-BIOL, V79, P4575, DOI 10.1073/pnas.79.15.4575; SIMS SM, 1991, J PHYSIOL-LONDON, V441, P615, DOI 10.1113/jphysiol.1991.sp018770; Solarski M, 2018, PRION, V12, P1, DOI 10.1080/19336896.2017.1405207; Somvanshi RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085193; Strowski MZ, 2008, MOL CELL ENDOCRINOL, V286, P169, DOI 10.1016/j.mce.2008.02.007; Sun LC, 2011, CURR DRUG DELIV, V8, P2, DOI 10.2174/156720111793663633; Theodoropoulou M, 2013, FRONT NEUROENDOCRIN, V34, P228, DOI 10.1016/j.yfrne.2013.07.005; Tuboly G, 2013, MINI-REV MED CHEM, V13, P34, DOI 10.2174/138955713804484794; Van Grondelle W, 2007, J STRUCT BIOL, V160, P211, DOI 10.1016/j.jsb.2007.08.006; VEBER DF, 1979, NATURE, V280, P512, DOI 10.1038/280512a0; Vepsalainen S, 2007, J NEUROL, V254, P1504, DOI 10.1007/s00415-007-0539-2; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang HS, 2017, ELIFE, V6, DOI 10.7554/eLife.28401; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0; Xue SF, 2009, NEUROSCI LETT, V465, P181, DOI 10.1016/j.neulet.2009.09.002; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251; YAMASHITA N, 1988, P NATL ACAD SCI USA, V85, P4924, DOI 10.1073/pnas.85.13.4924; YAMASHITA N, 1986, P NATL ACAD SCI USA, V83, P6198, DOI 10.1073/pnas.83.16.6198; Yang SK, 2007, CLIN EXP PHARMACOL P, V34, P1221, DOI 10.1111/j.1440-1681.2007.04806.x; Yang SK, 2005, ENDOCRINOLOGY, V146, P4975, DOI 10.1210/en.2005-0696; YASUDA K, 1992, J BIOL CHEM, V267, P20422; Yoshimoto Y, 1999, FEBS LETT, V444, P265, DOI 10.1016/S0014-5793(99)00076-9; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	78	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217392	10.1371/journal.pone.0217392	http://dx.doi.org/10.1371/journal.pone.0217392			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136617	Green Published, Green Submitted, gold			2022-12-26	WOS:000469224300033
J	Bentz, GL; Lowrey, AJ; Home, DC; Nguyen, V; Satterfield, AR; Ross, TD; Harrod, AE; Uchakina, ON; McKallip, RJ				Bentz, Gretchen L.; Lowrey, Angela J.; Home, Dustin C.; Vy Nguyen; Satterfield, Austin R.; Ross, Tabithia D.; Harrod, Abigail E.; Uchakina, Olga N.; McKallip, Robert J.			Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; CONJUGATING ENZYME UBC9; GINKGOLIC ACID; ANTIVIRAL ACTIVITY; KAPOSIS-SARCOMA; GENE-EXPRESSION; KINASE BGLF4; CELL-GROWTH; SUMO; UBIQUITIN	Cellular sumoylation processes are proposed targets for anti-viral and anti-cancer therapies. We reported that Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) dysregulates cellular sumoylation processes, contributing to its oncogenic potential in EBV-associated malignancies. Ginkgolic acid and anacardic acid, known inhibitors of sumoylation, inhibit LMP1-induced protein sumoylation; however, both drugs have adverse effects in hosts. Here we test the effects of glycyrrhizic acid, a medicinal botanical extract with anti-inflammatory, anti-carcinogenic, and anti-viral properties, on cellular sumoylation processes. While glycyrrhizic acid is known to inhibit EBV penetration, its affect on cellular sumoylation processes remains to be documented. We hypothesized that glycyrrhizic acid inhibits cellular sumoylation processes and may be a viable treatment for Epstein-Barr virus-associated malignancies. Results showed that glycyrrhizic acid inhibited sumoylation processes (without affecting ubiquitination processes), limited cell growth, and induced apoptosis in multiple cell lines. Similar to ginkgolic acid; glycyrrhizic acid targeted the first step of the sumoylation process and resulted in low levels of spontaneous EBV reactivation. Glycyrrhizic acid did not affect induced reactivation of the virus, but the presence of the extract did reduce the ability of the produced virus to infect additional cells. Therefore, we propose that glycyrrhizic acid may be a potential therapeutic drug to augment the treatment of EBV-associated lymphoid malignancies.	[Bentz, Gretchen L.; Lowrey, Angela J.; Home, Dustin C.; Vy Nguyen; Satterfield, Austin R.; Ross, Tabithia D.; Harrod, Abigail E.; Uchakina, Olga N.; McKallip, Robert J.] Mercer Univ, Sch Med, Div Biomed Sci, Macon, GA 31207 USA	Mercer University	Bentz, GL (corresponding author), Mercer Univ, Sch Med, Div Biomed Sci, Macon, GA 31207 USA.	bentz_GL@mercer.edu			National Cancer Institute [CA160786]; NATIONAL CANCER INSTITUTE [R00CA160786] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (CA160786 to GLB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2005, BIOCHEM BIOPH RES CO, V336, P22, DOI 10.1016/j.bbrc.2005.08.036; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Afnan Q, 2012, PHYTOMEDICINE, V19, P658, DOI 10.1016/j.phymed.2012.03.007; Ahlemeyer B, 2001, EUR J PHARMACOL, V430, P1, DOI 10.1016/S0014-2999(01)01237-7; Alarcon-Vargas D, 2002, CANCER BIOL THER, V1, P237, DOI 10.4161/cbt.74; BABA M, 1987, ANTIVIR RES, V7, P99, DOI 10.1016/0166-3542(87)90025-8; Baltina LA, 2003, CURR MED CHEM, V10, P155, DOI 10.2174/0929867033368538; Bentz GL, 2015, J VIROL, V89, P7465, DOI 10.1128/JVI.00711-15; Bentz GL, 2012, J VIROL, V86, P12251, DOI 10.1128/JVI.01407-12; Bentz GL, 2011, J VIROL, V85, P10144, DOI 10.1128/JVI.05035-11; Bentz GL, 2010, VIROLOGY, V402, P121, DOI 10.1016/j.virol.2010.03.014; Berg K, 2015, TOXICOLOGY, V327, P47, DOI 10.1016/j.tox.2014.10.001; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006764; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Brennan P, 2001, J BIOL CHEM, V276, P1195, DOI 10.1074/jbc.M005461200; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; CALENDER A, 1990, INT J CANCER, V46, P658, DOI 10.1002/ijc.2910460418; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; Chen L, 2009, XENOBIOTICA, V39, P955, DOI 10.3109/00498250903271997; Cherney BW, 1998, BLOOD, V91, P2491, DOI 10.1182/blood.V91.7.2491.2491_2491_2500; Chueh FS, 2012, ONCOL REP, V28, P2069, DOI 10.3892/or.2012.2029; Cohen JI, 2005, J CLIN INVEST, V115, P591, DOI 10.1172/JCI200524507; Curreli F, 2005, J CLIN INVEST, V115, P642, DOI 10.1172/JCI200523334; De La Cruz-Herrera CF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007176; De Leo Alessandra, 2018, PLoS Pathog, V14, pe1007027, DOI 10.1371/journal.ppat.1007027; Dirmeier U, 2003, CANCER RES, V63, P2982; Duan XY, 2009, ANTI-CANCER AGENT ME, V9, P51, DOI 10.2174/187152009787047716; Erboga M, 2015, RENAL FAILURE, V37, P1492, DOI 10.3109/0886022X.2015.1074521; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Gao LL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00215; Gershburg E, 2007, J VIROL, V81, P5407, DOI 10.1128/JVI.02398-06; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; Hagemeier SR, 2010, J VIROL, V84, P4383, DOI 10.1128/JVI.02369-09; He SQ, 2015, INT J CLIN EXP PATHO, V8, P5175; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; HIRABAYASHI K, 1991, CHEM PHARM BULL, V39, P112; Hirohama M, 2013, ACS CHEM BIOL, V8, P2635, DOI 10.1021/cb400630z; Hostetler BJ, 2017, ANTICANCER RES, V37, P997, DOI 10.21873/anticanres.11409; Huang RY, 2014, CELL PHYSIOL BIOCHEM, V33, P375, DOI 10.1159/000356677; Huang W, 2012, CELL BIOCHEM BIOPHYS, V62, P137, DOI 10.1007/s12013-011-9271-8; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Jamroziak K, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0448-2; Jeong EI, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.428; Jiang L, 2016, AM J TRANSL RES, V8, P1064; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang FB, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008518; Kang H, 2011, J VIROL, V85, P11159, DOI 10.1128/JVI.00720-11; Kao TC, 2014, J AGR FOOD CHEM, V62, P542, DOI 10.1021/jf404939f; Katayama PL, 2017, FASEB J, V31; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Kieser A., 2008, PROTEOMIC IDENTIFICA; Kim KJ, 2013, PHYTOTHER RES, V27, P841, DOI 10.1002/ptr.4800; Klass CM, 2005, CURR OPIN ONCOL, V17, P447, DOI 10.1097/01.cco.0000172823.01190.6c; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Knipscheer Puck, 2009, V497, P201, DOI 10.1007/978-1-59745-566-4_13; Korenaga M, 2011, LIVER INT, V31, P552, DOI 10.1111/j.1478-3231.2011.02469.x; Kroetz Mary B, 2005, Yale J Biol Med, V78, P197; Kukurtchu Bulent, 2012, Akush Ginekol (Sofiia), V51 Suppl 1, P46; Kuwajima H, 1999, YAKUGAKU ZASSHI, V119, P945, DOI 10.1248/yakushi1947.119.12_945; Lampis G, 2001, ANTIVIR CHEM CHEMOTH, V12, P125, DOI 10.1177/095632020101200206; Lee H, 2016, MOLECULES, V21, DOI 10.3390/molecules21081058; Lee M, 2015, ONCOTARGET, V6, P12603, DOI 10.18632/oncotarget.3687; Li HP, 2003, J BIOMED SCI, V10, P490, DOI 10.1159/000072376; Li JY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872139; Li JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006338; Li L, 2016, EXP THER MED, V12, P3381, DOI 10.3892/etm.2016.3768; Li RW, 2012, J VIROL, V86, P5412, DOI 10.1128/JVI.00314-12; Li S, 2014, NEUROL SCI, V35, P1115, DOI 10.1007/s10072-014-1661-4; Lin JC, 2003, ANTIVIR RES, V59, P41, DOI 10.1016/S0166-3542(03)00030-5; Lin JC, 2008, ANTIVIR RES, V79, P6, DOI 10.1016/j.antiviral.2008.01.160; Liu ST, 2006, VIRUS RES, V119, P163, DOI 10.1016/j.virusres.2006.01.004; Liu ZH, 2009, TOXICOL LETT, V187, P131, DOI 10.1016/j.toxlet.2009.02.012; Lowrey AJ, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0183-0; Ma JQ, 2015, INT IMMUNOPHARMACOL, V28, P531, DOI 10.1016/j.intimp.2015.06.036; Mahadevan S, 2008, J FOOD SCI, V73, pR14, DOI 10.1111/j.1750-3841.2007.00597.x; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; Matsuo K, 2001, LEUKEMIA LYMPHOMA, V41, P191, DOI 10.3109/10428190109057970; Miller WE, 1997, J VIROL, V71, P586, DOI 10.1128/JVI.71.1.586-594.1997; Ming LJ, 2013, NAT PROD COMMUN, V8, P415; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Naesens L, 2006, J CLIN VIROL, V37, pS69, DOI 10.1016/S1386-6532(06)70015-4; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; NUMAZAKI K, 1994, TOHOKU J EXP MED, V172, P147, DOI 10.1620/tjem.172.147; NUMAZAKI K, 1994, J LEUKOCYTE BIOL, V55, P24, DOI 10.1002/jlb.55.1.24; Numazaki Kei, 1993, In Vivo (Athens), V7, P477; Orazizadeh M, 2014, CHEM-BIOL INTERACT, V220, P214, DOI 10.1016/j.cbi.2014.07.001; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Park HY, 2004, ARCH PHARM RES, V27, P57, DOI 10.1007/BF02980047; Pattullo V, 2015, WORLD J HEPATOL, V7, P954, DOI 10.4254/wjh.v7.i7.954; POMPEI R, 1980, EXPERIENTIA, V36, P304, DOI 10.1007/BF01952290; POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0; Qu B, 2017, XENOBIOTICA, V47, P290, DOI 10.1080/00498254.2016.1185195; Radwan MA, 2002, J MICROENCAPSUL, V19, P225, DOI 10.1080/02652040110081406; Ramasubramanyan S, 2012, J VIROL, V86, P1809, DOI 10.1128/JVI.06334-11; Salahuddin S, 2019, SCI REPORTS; Salahuddin S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36312-4; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Sekizawa T, 2001, ACTA VIROL, V45, P51; Selyutina OY, 2016, COLLOID SURFACE B, V147, P459, DOI 10.1016/j.colsurfb.2016.08.037; Selyutina OY, 2016, DRUG DELIV, V23, P858, DOI 10.3109/10717544.2014.919544; Shustik C, 2017, ANN HEMATOL, V96, P1185, DOI 10.1007/s00277-017-2982-1; Siegers CP, 1999, PHYTOMEDICINE, V6, P281, DOI 10.1016/S0944-7113(99)80021-X; Sitzia J, 1997, CANCER NURS, V20, P430, DOI 10.1097/00002820-199712000-00007; Son M, 2013, J MICROBIOL, V51, P545, DOI 10.1007/s12275-013-3450-9; Stewart MJ, 2005, J VIROL, V79, P2979, DOI 10.1128/JVI.79.5.2979-2987.2005; Su XT, 2017, BIOMED PHARMACOTHER, V95, P670, DOI 10.1016/j.biopha.2017.08.123; Tabtieng T, 2018, J VIROL, V92; Takemoto M, 2014, J ANTIBIOT, V67, P335, DOI 10.1038/ja.2013.142; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; Torres HA, 2018, HEPATOLOGY, V67, P36, DOI 10.1002/hep.29344; Whitehurst CB, 2009, J VIROL, V83, P4345, DOI 10.1128/JVI.02195-08; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xie YR, 2011, J MED VIROL, V83, P879, DOI 10.1002/jmv.22001; Yang FH, 2015, MOLECULES, V20, P4337, DOI 10.3390/molecules20034337; Yang YC, 2013, J BIOL CHEM, V288, P12866, DOI 10.1074/jbc.M112.413393; Yao QQ, 2017, CHIN J NAT MEDICINES, V15, P375, DOI 10.1016/S1875-5364(17)30058-4; Zhang K, 2017, CELL REP, V21, P3445, DOI 10.1016/j.celrep.2017.11.071	130	12	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217578	10.1371/journal.pone.0217578	http://dx.doi.org/10.1371/journal.pone.0217578			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125383	Green Published, gold, Green Submitted			2022-12-26	WOS:000468865700048
J	Miyake, S; Higuchi, H; Honda-Wakasugi, Y; Fujimoto, M; Kawai, H; Nagatsuka, H; Maeda, S; Miyawaki, T				Miyake, Saki; Higuchi, Hitoshi; Honda-Wakasugi, Yuka; Fujimoto, Maki; Kawai, Hotaka; Nagatsuka, Hitoshi; Maeda, Shigeru; Miyawaki, Takuya			Locally injected ivabradine inhibits carrageenan-induced pain and inflammatory responses via hyperpolarization-activated cyclic nucleotide-gated (HCN) channels	PLOS ONE			English	Article							DIABETIC PERIPHERAL NEUROPATHY; PACEMAKER CHANNELS; ION CHANNELS; FAMILY; DEXMEDETOMIDINE; MECHANISMS; MEDIATORS; PROTEIN; BURDEN; LIFE	Background Recently, attention has been focused on the role of hyperpolarization-activated cyclic nucleotide- gated (HCN) channels in the mechanism of and as a treatment target for neuropathic and inflammatory pain. Ivabradine, a blocker of HCN channels, was demonstrated to have an effect on neuropathic pain in an animal model. Therefore, in the present study, we evaluated the effect of ivabradine on inflammatory pain, and under the hypothesis that ivabradine can directly influence inflammatory responses, we investigated its effect in in vivo and in vitro studies. Methods After approval from our institution, we studied male Sprague-Dawley rats aged 8 weeks. Peripheral inflammation was induced by the subcutaneous injection of carrageenan into the hindpaw of rats. The paw-withdrawal threshold (pain threshold) was evaluated by applying mechanical stimulation to the injected site with von Frey filaments. Ivabradine was subcutaneously injected, combined with carrageenan, and its effect on the pain threshold was evaluated. In addition, we evaluated the effects of ivabradine on the accumulation of leukocytes and TNF-alpha expression in the injected area of rats. Furthermore, we investigated the effects of ivabradine on LPS-stimulated production of TNF-alpha in incubated mouse macrophage-like cells. Results The addition of ivabradine to carrageenan increased the pain threshold lowered by carrageenan injection. Both lamotrigine and forskolin, activators of HCN channels, significantly reversed the inhibitory effect of ivabradine on the pain threshold. Ivabradine inhibited the carrageenan-induced accumulation of leukocytes and TNF-alpha expression in the injected area. Furthermore, ivabradine significantly inhibited LPS-stimulated production of TNFalpha in the incubated cells. Conclusion The results of the present study demonstrated that locally injected ivabradine is effective against carrageenan-induced inflammatory pain via HCN channels. Its effect was considered to involve not only an action on peripheral nerves but also an anti-inflammatory effect.	[Miyake, Saki; Honda-Wakasugi, Yuka; Fujimoto, Maki; Miyawaki, Takuya] Okayama Univ, Dept Dent Anesthesiol & Special Care Dent, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Higuchi, Hitoshi; Maeda, Shigeru] Okayama Univ Hosp, Dept Dent Anesthesiol, Okayama, Japan; [Kawai, Hotaka; Nagatsuka, Hitoshi] Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University; Okayama University; Okayama University	Miyawaki, T (corresponding author), Okayama Univ, Dept Dent Anesthesiol & Special Care Dent, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	miyawaki@md.okayama-u.ac.jp		Miyawaki, Takuya/0000-0002-6378-2623	JSPS (Japan Society for the Promotion of Science) KAKENHI [18K09722]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 18K09722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleman CJM, 2015, DIABETES RES CLIN PR, V109, P215, DOI 10.1016/j.diabres.2015.04.031; Baron Ralf, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79090-7_1; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003; DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103; Doth AH, 2010, PAIN, V149, P338, DOI 10.1016/j.pain.2010.02.034; Emery EC, 2012, TRENDS PHARMACOL SCI, V33, P456, DOI 10.1016/j.tips.2012.04.004; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Honda Y, 2015, EUR J PHARMACOL, V764, P215, DOI 10.1016/j.ejphar.2015.06.054; JAGELS MA, 1994, IMMUNOPHARMACOLOGY, V28, P1, DOI 10.1016/0162-3109(94)90034-5; Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Luo L, 2007, NEUROSCIENCE, V144, P1477, DOI 10.1016/j.neuroscience.2006.10.048; Momin A, 2008, J PHYSIOL-LONDON, V586, P5911, DOI 10.1113/jphysiol.2008.163154; Notomi T, 2015, J BONE MINER RES, V30, P1618, DOI 10.1002/jbmr.2507; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Romanelli MN, 2016, CURR TOP MED CHEM, V16, P1764, DOI 10.2174/1568026616999160315130832; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Sartiani L, 2017, PHARMACOL REV, V69, P354, DOI 10.1124/pr.117.014035; Savelieva I, 2006, ADV CARDIOL, V43, P79, DOI 10.1159/000095430; Schnorr S, 2014, PAIN, V155, P1079, DOI 10.1016/j.pain.2014.02.006; Schomberg D, 2012, ANN NEUROSCI, V19, P125, DOI 10.5214/ans.0972.7531.190309; Sommer C, 2018, PAIN, V159, P595, DOI 10.1097/j.pain.0000000000001122; Sukegawa S, 2014, ANESTH ANALG, V118, P473, DOI 10.1213/ANE.0000000000000060; Takasu K, 2010, PAIN, V151, P87, DOI 10.1016/j.pain.2010.06.020; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Tsantoulas C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam6072; Vinik A, 2013, CLIN THER, V35, P612, DOI 10.1016/j.clinthera.2013.03.008; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Young GT, 2014, PAIN, V155, P1708, DOI 10.1016/j.pain.2014.05.021; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005	39	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217209	10.1371/journal.pone.0217209	http://dx.doi.org/10.1371/journal.pone.0217209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125368	gold, Green Published, Green Submitted			2022-12-26	WOS:000468865700023
J	Song, WW; Qi, NW; Liang, C; Dua, FM; Zha, HH				Song, Wenwen; Qi, Nawei; Liang, Chen; Dua, Fangmeng; Zha, Honghai			Soybean root transcriptome profiling reveals a nonhost resistant response during Heterodera glycines infection	PLOS ONE			English	Article							CYST-NEMATODE; GENE-EXPRESSION; MELOIDOGYNE-INCOGNITA; PHENYLPROPANOID PATHWAY; DISEASE RESISTANCE; NB-ARC; TOMATO; ASSOCIATION; HYPOTAURINE; TAURINE	Heterodera glycines (soybean cyst nematode, SCN) is one of the most devastating pathogens of soybean worldwide. The compatible and in compatible interactions between soybean and SCN have well documented. Nevertheless, the molecular mechanism of a nonhost resistant response in soybean against SCN infection remains obscure. Toward this end, a global transcriptional comparison was conducted between susceptible and resistant reactions of soybean roots infected by taking advantage of finding a new pathotype of SCN (SCNT). The soybean cultivar Lee, which exhibits resistant to SCNT and susceptible to HG 1.2.3.4.7 (SCNs) was utilized in the expriments. The results highlighted a nonhost resistant response of soybean. Transcriptome analysis indicated that the number of differentially expressed genes (DEGs) in the resistant interaction (3746) was much larger than that in the susceptible interaction (602). A great number of genes acting as intrinsic component of membrane, integral component of membrane, cell periphery and plasma membrance were remarkably enriched only in the resistant interaction, while the taurine and hypotaurine, phenylpropanoid pathway, plant-pathogen interaction and transcript factors were modulated in both interactions. This is the first study to examine genes expression patterns in a soybean genotype in response to invasion by a virulent and avirulent SCN population at the transcriptional level, which will provide insights into the complicate molecular mechanism of the nonhost resistant interaction.	[Song, Wenwen; Qi, Nawei; Liang, Chen; Dua, Fangmeng; Zha, Honghai] Qingdao Agr Univ, Coll Plant Hlth & Med, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Shandong, Peoples R China	Qingdao Agricultural University	Zha, HH (corresponding author), Qingdao Agr Univ, Coll Plant Hlth & Med, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Shandong, Peoples R China.	hhzhao618@163.com		Liang, Chen/0000-0002-0139-8140	Special Fund for Agro-Scientific Research in the Public Interest, China [201503114]; Taishan Scholar Foundation of Shandong Province	Special Fund for Agro-Scientific Research in the Public Interest, China; Taishan Scholar Foundation of Shandong Province	This work was financially supported by the Special Fund for Agro-Scientific Research in the Public Interest, China (201503114) and the Taishan Scholar Foundation of Shandong Province.	Alkharouf NW, 2006, PLANTA, V224, P838, DOI 10.1007/s00425-006-0270-8; Boba A, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01951; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Breen S, 2017, TRENDS PLANT SCI, V22, P871, DOI 10.1016/j.tplants.2017.06.013; [程子超 Cheng Zichao], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P387; EDENS RM, 1995, J NEMATOL, V27, P292; Fuller VL, 2007, MOL PLANT PATHOL, V8, P595, DOI 10.1111/J.1364-3703.2007.00416.X; Grove RQ, 2017, FREE RADICAL BIO MED, V108, P575, DOI 10.1016/j.freeradbiomed.2017.04.342; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hosseini P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0300-9; Ibrahim HMM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-220; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jain S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159338; Kandoth PK, 2011, PLANT PHYSIOL, V155, P1960, DOI 10.1104/pp.110.167536; Khan R, 2004, J NEMATOL, V36, P241; Kim Y. H., 1990, Korean Journal of Plant Pathology, V6, P421; Klink VP, 2007, PLANTA, V226, P1389, DOI 10.1007/s00425-007-0581-4; Klink VP, 2009, PLANT MOL BIOL, V71, P525, DOI 10.1007/s11103-009-9539-1; Lavrova VV, 2017, DOKL BIOCHEM BIOPHYS, V476, P306, DOI [10.1134/S1607672917050064, 10.1134/s1607672917050064]; Lee DH, 2015, ADV EXP MED BIOL, V803, P75, DOI 10.1007/978-3-319-15126-7_7; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Ma YS, 2006, J INTEGR PLANT BIOL, V48, P722, DOI 10.1111/j.1744-7909.2006.00256.x; Magnani E, 2018, PLANT CELL, V87, P46; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Mazarei M, 2011, THEOR APPL GENET, V123, P1193, DOI 10.1007/s00122-011-1659-8; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; Noel Gregory R., 1993, Nematologia Brasileira, V17, P103; Pan QL, 2000, GENETICS, V155, P309; Pitari G, 2000, ADV EXP MED BIOL, V483, P157; Puthoff DP, 2007, J EXP BOT, V58, P3407, DOI 10.1093/jxb/erm211; Sekine KT, 2012, MOL PLANT MICROBE IN, V25, P1219, DOI 10.1094/MPMI-11-11-0289; Su JB, 2018, PLANT J, V93, P637, DOI 10.1111/tpj.13798; Tang YH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00306; van Ooijen G, 2008, MOL PLANT, V1, P401, DOI 10.1093/mp/ssn009; Wan JR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1316-8; [王慧敏 Wang Huimin], 2014, [植物保护, Plant Protection], V40, P106; Wen ZF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01087; WRATHER A, 2009, PLANT HLTH PROGR; Wuyts N, 2006, NEMATOLOGY, V8, P89, DOI 10.1163/156854106776179953; Zhang HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09945-0; Zhang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01214; [赵洪海 Zhao Honghai], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P4417; Zhao HongHai, 2013, Acta Phytophylacica Sinica, V40, P529; Zhao M, 2017, BIORXIV	46	8	8	12	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217130	10.1371/journal.pone.0217130	http://dx.doi.org/10.1371/journal.pone.0217130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125369	Green Published, Green Submitted, gold			2022-12-26	WOS:000468865700020
J	Zheng, ZJ; Tan, CL; Chen, YH; Ping, J; Wang, MJ				Zheng, Zhenjiang; Tan, Chunlu; Chen, Yonghua; Ping, Jie; Wang, Mojin			Impact of different surgical procedures on survival outcomes of patients with adenocarcinoma of pancreatic neck	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; R0 RESECTION; OPEN-LABEL; CANCER; GEMCITABINE; PANCREATICODUODENECTOMY; MULTICENTER; MORBIDITY; MORTALITY; INVASION	Background The only curative treatment for pancreatic adenocarcinoma is radical surgical resection. Because of the special anatomic features of pancreatic neck, the selection of optimal surgical procedure for treatment of adenocarcinoma of pancreatic neck has always been a dilemma for surgeons. In this paper, we aim to investigate whether different surgical procedures can affect prognosis in the patient with adenocarcinoma of pancreatic neck. Methods We used the surveillance, epidemiology, and end results database to review patients with adenocarcinoma of pancreatic neck diagnosed between 1998 and 2015. We calculated overall survival (OS) and cancer-specific survival (CSS) of these patients using Kaplan-Meier analysis and Cox regression model. Results Overall, 1443 patients were included in the study, with 12.5% treated with surgical resection. Among them, 30 (18.8%) patients underwent distal pancreatectomy (DP), 105 (65.6%) patients underwent pancreatoduodenectomy (PD), and 25 (15.6%) patients underwent total pancreatectomy (TP). Patients underwent DP were older than these underwent TP (70.5 +/- 10.7 vs. 62.2 +/- 14.1, P = 0.027). Patients underwent TP had higher percentages of nodal metastasis (N1 stage) than these underwent DP (68.0% vs. 34.5%, P = 0.014). The surgical procedures did not significantly affect either OS times (P = 0.924) or CSS times (P = 0.786) in Kaplan-Meier analysis, even if in any subgroup of AJCC stage. The multivariate Cox regression model showed that types of surgery were not associated with OS and CSS. Higher tumor grade and AJCC stage are independent prognostic factors for OS and CSS. No radiotherapy was associated with a worse CSS (HR 1.610, 95% CI 1.016-2.554, P = 0.043). Conclusion Different surgical procedures did not affect prognosis in the patients with adenocarcinoma of pancreatic neck. TP should be performed in carefully selective patients in high-volume pancreatic centers.	[Zheng, Zhenjiang; Tan, Chunlu; Chen, Yonghua] Sichuan Univ, West China Hosp, Dept Pancreat Surg, Chengdu, Sichuan, Peoples R China; [Ping, Jie] Vanderbilt Univ, Med Ctr, Div Epidemiol, Nashville, TN USA; [Wang, Mojin] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Inst Digest Surg, Chengdu, Sichuan, Peoples R China; [Wang, Mojin] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China	Sichuan University; Vanderbilt University; Sichuan University; Sichuan University	Wang, MJ (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Inst Digest Surg, Chengdu, Sichuan, Peoples R China.; Wang, MJ (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.	wangmojin2001@163.com		Ping, Jie/0000-0001-9907-5819	National Health and Family Planning Commission of Chengdu (CN) [2016002]	National Health and Family Planning Commission of Chengdu (CN)	This research was funded by the National Health and Family Planning Commission of Chengdu (CN) (2016002 to ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren-Sandberg A, 2016, DIGEST SURG, V33, P329, DOI 10.1159/000445018; Artinyan A, 2008, HPB, V10, P371, DOI 10.1080/13651820802291233; Bhayani NH, 2014, J GASTROINTEST SURG, V18, P549, DOI 10.1007/s11605-013-2393-0; Bilimoria KY, 2007, ANN SURG, V246, P173, DOI 10.1097/SLA.0b013e3180691579; Boyle J, 2015, J GASTROINTEST ONCOL, V6, P436, DOI 10.3978/j.issn.2078-6891.2015.014; Chen YH, 2014, EUR J MED RES, V19, DOI 10.1186/s40001-014-0042-z; Chen YH, 2013, J AM COLL SURGEONS, V217, pE21, DOI 10.1016/j.jamcollsurg.2013.07.383; Conroy T, 2016, EUR J CANCER, V57, P10, DOI 10.1016/j.ejca.2015.12.026; Del Chiaro M, 2016, UPDATES SURG, V68, P257, DOI 10.1007/s13304-016-0388-6; Desaki R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/219038; Epelboym I, 2014, J SURG RES, V187, P189, DOI 10.1016/j.jss.2013.10.004; Govindarajan A, 2008, ANN SURG ONCOL, V15, P175, DOI 10.1245/s10434-007-9601-7; Hackert T, 2014, LANGENBECK ARCH SURG, V399, P667, DOI 10.1007/s00423-014-1200-z; Hank T, 2018, BRIT J SURG, V105, P1171, DOI 10.1002/bjs.10842; Hartwig W, 2015, ANN SURG, V261, P537, DOI 10.1097/SLA.0000000000000791; Hirono S, 2016, SURGERY, V159, P426, DOI 10.1016/j.surg.2015.07.001; Khorana AA, 2017, J CLIN ONCOL, V35, P2324, DOI 10.1200/JCO.2017.72.4948; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Ling Q, 2017, ONCOTARGET, V8, P15159, DOI 10.18632/oncotarget.14768; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Mollberg N, 2011, ANN SURG, V254, P882, DOI 10.1097/SLA.0b013e31823ac299; Nathan H, 2009, J SURG ONCOL, V99, P87, DOI 10.1002/jso.21189; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Nikfarjam M, 2014, ANZ J SURG, V84, P823, DOI 10.1111/ans.12640; Park Shin-Young, 2014, Korean J Hepatobiliary Pancreat Surg, V18, P77, DOI 10.14701/kjhbps.2014.18.3.77; Reddy S, 2009, ANN SURG, V250, P282, DOI 10.1097/SLA.0b013e3181ae9f93; Roeder F, 2016, WORLD J GASTRO ONCOL, V8, P186, DOI 10.4251/wjgo.v8.i2.186; Ruess DA, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0110-5; Sajjad M, 2018, AM J CLIN ONCOL-CANC, V41, P236, DOI 10.1097/COC.0000000000000261; Santangelo M, 2016, INT J SURG, V28, pS172, DOI 10.1016/j.ijsu.2015.12.046; Satoi S, 2016, PANCREAS, V45, P1003, DOI 10.1097/MPA.0000000000000579; Schmidt CM, 2007, SURGERY, V142, P572, DOI 10.1016/j.surg.2007.07.016; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sinn M, 2017, J CLIN ONCOL, V35, P3330, DOI 10.1200/JCO.2017.72.6463; Song KB, 2015, SURG ENDOSC, V29, P937, DOI 10.1007/s00464-014-3756-7; Strasberg SM, 2012, J GASTROINTEST SURG, V16, P1048, DOI 10.1007/s11605-012-1841-6; Strobel O, 2019, NAT REV CLIN ONCOL, V16, P11, DOI 10.1038/s41571-018-0112-1; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9; Werner J, 2013, NAT REV CLIN ONCOL, V10, P323, DOI 10.1038/nrclinonc.2013.66; Xiong JJ, 2017, INT J SURG, V48, P134, DOI 10.1016/j.ijsu.2017.10.065	40	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217427	10.1371/journal.pone.0217427	http://dx.doi.org/10.1371/journal.pone.0217427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125386	gold, Green Submitted, Green Published			2022-12-26	WOS:000468865700041
J	Volpe, M; Levinton, N; Rosenstein, N; Prag, G; Ben-Aroya, S				Volpe, Marina; Levinton, Nelly; Rosenstein, Nethanel; Prag, Gali; Ben-Aroya, Shay			Regulation of the anaphase promoting complex/cyclosome by the degradation of its unassembled catalytic subunit, Apc11	FASEB JOURNAL			English	Article						ubiquitin proteasome system; mitosis; protein quality control; cell cycle; cohesion	SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; DEGRON SYSTEM; PROTEIN; COMPLEX; YEAST; UBIQUITINATION; IDENTIFICATION; PRINCIPLES; ANEUPLOIDY	One of the challenges encountered by the protein quality control machinery is the need to ensure that members of multiprotein complexes are available in the correct proportions. In this study, we demonstrate that the ubiquitin proteasome system (UPS) mediates the degradation of Apc11, the catalytic core subunit of the anaphase promoting complex/cyclosome (APC/C). In vitro studies have shown that Apc11, together with its E2 enzyme, is sufficient to ubiquitinate substrates independently of the APC/C. Here, we establish that this can occur in living yeast cells. We show that the tight controls regulating the function of the fully assembled APC/C can be circumvented when its substrates are ubiquitinated by the excess levels of Apc11 independently of the assembled complex. We thus suggest that the UPS-mediated degradation of Apc11 is an overlooked mechanism ensuring that proper function of the APC/C is limited to suitably delimited holoenzymes and that an imbalance in protein expression may result in detrimental gain-of-function activity, rather than merely the disruption of protein complex stoichiometry.-Volpe, M., Levinton, N., Rosenstein, N., Prag, G., Ben-Aroya, S. Regulation of the anaphase promoting complex/cyclosome by the degradation of its unassembled catalytic subunit, Apc11.	[Volpe, Marina; Levinton, Nelly; Rosenstein, Nethanel; Ben-Aroya, Shay] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Prag, Gali] Tel Aviv Univ, Dept Biochem & Mol Biol, Tel Aviv, Israel	Bar Ilan University; Tel Aviv University	Ben-Aroya, S (corresponding author), Bar Ilan Univ, Fac Life Sci, Nano Ctr, Bldg 206 Room B-840, IL-52900 Ramat Gan, Israel.	shay.ben-aroya@biu.ac.il						Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Brachmann CB, 1998, YEAST, V14, P115; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; Drouet Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25631-1; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Keren-Kaplan T, 2012, EMBO J, V31, P378, DOI 10.1038/emboj.2011.397; Lev I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003838; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pfleger CM, 2000, GENE DEV, V14, P655; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; SIKORSKI RS, 1989, GENETICS, V122, P19; Sung MK, 2016, ELIFE, V5, DOI 10.7554/eLife.19105; Sung MK, 2016, MOL BIOL CELL, V27, P2642, DOI 10.1091/mbc.E16-05-0290; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zhou JY, 2018, ONCOTARGETS THER, V11, P7125, DOI 10.2147/OTT.S177252	45	3	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9752	9761		10.1096/fj.201802300R	http://dx.doi.org/10.1096/fj.201802300R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162950				2022-12-26	WOS:000482214200006
J	Sudevan, S; Takiura, M; Kubota, Y; Higashitani, N; Cooke, M; Ellwood, RA; Etheridge, T; Szewczyk, NJ; Higashitani, A				Sudevan, Surabhi; Takiura, Mai; Kubota, Yukihiko; Higashitani, Nahoko; Cooke, Michael; Ellwood, Rebecca A.; Etheridge, Timothy; Szewczyk, Nathaniel J.; Higashitani, Atsushi			Mitochondrial dysfunction causes Ca2+ overload and ECM degradation-mediated muscle damage in C. elegans	FASEB JOURNAL			English	Article						Antimycin A; collagen; Furin; DMD; MMP	COLLAGEN-VI; CALCIUM; MATRIX	Mitochondrial dysfunction impairs muscle health and causes subsequent muscle wasting. This study explores the role of mitochondrial dysfunction as an intramuscular signal for the extracellular matrix (ECM)-based proteolysis and, consequentially, muscle cell dystrophy. We found that inhibition of the mitochondrial electron transport chain causes paralysis as well as muscle structural damage in the nematode Caenorhabditis elegans. This was associated with a significant decline in collagen content. Both paralysis and muscle damage could be rescued with collagen IV overexpression, matrix metalloproteinase (MMP), and Furin inhibitors in Antimycin A-treated animal as well as in the C. elegans Duchenne muscular dystrophy model. Additionally, muscle cytosolic calcium increased in the Antimycin A-treated worms, and its down-regulation rescued the muscle damage, suggesting that calcium overload acts as one of the early triggers and activates Furin and MMPs for collagen degradation. In conclusion, we have established ECM degradation as an important pathway of muscle damage.-Sudevan, S., Takiura, M., Kubota, Y., Higashitani, N., Cooke, M., Ellwood, R. A., Etheridge, T., Szewczyk, N. J., Higashitani, A. Mitochondrial dysfunction causes Ca2+ overload and ECM degradation-mediated muscle damage in C. elegans.	[Sudevan, Surabhi; Takiura, Mai; Kubota, Yukihiko; Higashitani, Nahoko; Higashitani, Atsushi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Cooke, Michael; Etheridge, Timothy] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Cooke, Michael; Ellwood, Rebecca A.; Szewczyk, Nathaniel J.] Univ Nottingham, Med Res Council, Nottingham, England; [Cooke, Michael; Ellwood, Rebecca A.; Szewczyk, Nathaniel J.] Univ Nottingham, Arthrit Res United Kingdom ARUK Ctr Musculoskelet, Nottingham, England; [Cooke, Michael; Ellwood, Rebecca A.; Szewczyk, Nathaniel J.] Univ Nottingham, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England	Tohoku University; University of Exeter; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Nottingham; University of Nottingham; University of Nottingham	Kubota, Y (corresponding author), Ritsumeikan Univ, Kusatsu, Japan.; Higashitani, A (corresponding author), Tohoku Univ, Grad Sch Life Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	ahigashi@m.tohoku.ac.jp	Higashitani, Atsushi/AAT-9617-2021	Higashitani, Atsushi/0000-0001-6920-0594; Cooke, Mike/0000-0003-2081-3466; Szewczyk, Nathaniel/0000-0003-4425-9746; Ellwood, Rebecca/0000-0002-0412-7530; Kubota, Yukihiko/0000-0002-8151-9888	U.S. National Institutes of Health (NIH) Office of Research Infrastructure Program [P40OD010440]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [15H05937, 15K21745]; Cross-Ministerial Strategic Innovation Promotion Program [14537491]; Advanced Research and Development Programs for Medical Innovation (AMED-CREST) [16814305]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N015894/1, BB/P025781/1]; UK Space Agency; Science and Technology Facilities Council [ST/R005737/1]; Otsuka Toshimi Foundation; Tohoku University President scholarship; Japan Student Services Organization; BBSRC [BB/P025781/1, BB/N015894/1] Funding Source: UKRI; STFC [2116193] Funding Source: UKRI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Office of Research Infrastructure Program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cross-Ministerial Strategic Innovation Promotion Program; Advanced Research and Development Programs for Medical Innovation (AMED-CREST); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Space Agency; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Otsuka Toshimi Foundation(Otsuka Pharmaceutical); Tohoku University President scholarship; Japan Student Services Organization(Japan Student Services Organization); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NF3620 was kindly provided by Prof. Kiyoji Nishiwaki (Kwansei Gakuin University, Nishinomiya, Japan). Other strains used in this study were provided by the Caenorhabditis Genetics Center funded by the U.S. National Institutes of Health (NIH) Office of Research Infrastructure Program (P40OD010440). Liquid chromatography and tandem mass spectrometry analysis was supported by Drs. Kazuhiko Igarashi and Hiroki Shima. This work was funded in part by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Grants-in-Aid for Scientific Research (KAKENHI) (Grants 15H05937 and 15K21745), the Cross-Ministerial Strategic Innovation Promotion Program (14537491), the Advanced Research and Development Programs for Medical Innovation (AMED-CREST; Grant 16814305), the Biotechnology and Biological Sciences Research Council (BBSRC; Grants BB/N015894/1 and BB/P025781/1), the UK Space Agency, and the Science and Technology Facilities Council (Grant ST/R005737/1). S.S. obtained a scholarship from the Otsuka Toshimi Foundation, the Tohoku University President scholarship, and a scholarship from the Japan Student Services Organization. The authors declare no conflicts of interest.	Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bratcher PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041881; Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247; Cescon M, 2015, J CELL SCI, V128, P3525, DOI 10.1242/jcs.169748; Etheridge T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002471; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hewitt JE, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036137; Higashibata A, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2015.22; Hughes KJ, 2019, P NATL ACAD SCI USA, V116, P3508, DOI 10.1073/pnas.1811379116; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kelly-Worden M., 2014, OPEN J ENDOCRINE MET, V04, P211, DOI [10.4236/ojemd.2014.48020, DOI 10.4236/OJEMD.2014.48020]; Kendall GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005054; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Makowski GS, 2005, CLIN CHIM ACTA, V358, P182, DOI 10.1016/j.cccn.2005.03.012; Mariol MC, 2007, NEUROMUSCULAR DISORD, V17, P56, DOI 10.1016/j.nmd.2006.09.012; Meraz-Cruz N, 2006, MOL HUM REPROD, V12, P633, DOI 10.1093/molehr/gal072; Momma K, 2017, GENETICS, V206, P1985, DOI 10.1534/genetics.117.202747; Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053; Pancha I, 2019, PLANT J, V97, P485, DOI 10.1111/tpj.14136; Schwarz J, 2011, CURR BIOL, V21, pR983, DOI 10.1016/j.cub.2011.10.046; Shephard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024686; Shibata Y, 2016, G3-GENES GENOM GENET, V6, P1449, DOI 10.1534/g3.116.028019; SULSTON JE, 1974, GENETICS, V77, P95; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Timpani CA, 2015, MED HYPOTHESES, V85, P1021, DOI 10.1016/j.mehy.2015.08.015; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Zucchi R, 1997, PHARMACOL REV, V49, P1	33	14	14	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9540	9550		10.1096/fj.201802298R	http://dx.doi.org/10.1096/fj.201802298R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162948	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000478832900065
J	Lessard, CB; Rodriguez, E; Ladd, TB; Minter, LM; Osborne, BA; Miele, L; Golde, TE; Ran, Y				Lessard, Christian B.; Rodriguez, Edgardo; Ladd, Thomas B.; Minter, Lisa M.; Osborne, Barbara A.; Miele, Lucio; Golde, Todd E.; Ran, Yong			Individual and combined presenilin 1 and 2 knockouts reveal that both have highly overlapping functions in HEK293T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						presenilin; inhibitor; gamma-secretase; amyloid-beta (AB); Notch protein; amyloid protein precursor; aspartyl protease; cancer; neurodegeneration; NOTCH	GAMMA-SECRETASE INHIBITORS; ALZHEIMERS-DISEASE; BETA PEPTIDES; IDENTIFICATION; NICASTRIN; APH-1; DISTINCT; SEMAGACESTAT; DEFICIENCY; GENERATION	Presenilins 1 and 2 (PS1 and 2) are the catalytic subunits of gamma-secretase, a multiprotein protease that cleaves amyloid protein precursor and other type I transmembrane proteins. Previous studies with mouse models or cells have indicated differences in PS1 and PS2 functions. We have recently reported that clinical gamma-secretase inhibitors (GSIs), initially developed to manage Alzheimer's disease and now being considered for other therapeutic interventions, are both pharmacologically and functionally distinct. Here, using CRISPR/Cas9-based gene editing, we established human HEK 293T cell lines in which endogenous PS1, PS2, or both have been knocked out. Using these knockout lines to examine differences in PS1- and PS2-mediated cleavage events, we confirmed that PS2 generates more intracellular beta-amyloid than does PS1. Moreover, we observed subtle differences in PS1- and PS2-mediated cleavages of select substrates. In exploring the question of whether differences in activity among clinical GSIs could be attributed to differential inhibition of PS1 or PS2, we noted that select GSIs inhibit PS1 and PS2 activities on specific substrates with slightly different potencies. We also found that endoproteolysis of select PS1 FAD-linked variants in human cells is more efficient than what has been previously reported for mouse cell lines. Overall, these results obtained with HEK293T cells suggest that selective PS1 or PS2 inhibition by a given GSI does not explain the previously observed differences in functional and pharmacological properties among various GSIs.	[Lessard, Christian B.; Ladd, Thomas B.; Golde, Todd E.; Ran, Yong] Univ Florida, Dept Neurosci & Neurol, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Lessard, Christian B.; Ladd, Thomas B.; Golde, Todd E.; Ran, Yong] Univ Florida, Dept Neurosci & Neurol, McKnight Brain Inst, Coll Med, Gainesville, FL 32610 USA; [Rodriguez, Edgardo] Univ Florida, Dept Pharmacol & Therapeut, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Rodriguez, Edgardo] Univ Florida, Dept Pharmacol & Therapeut, McKnight Brain Inst, Gainesville, FL 32610 USA; [Minter, Lisa M.; Osborne, Barbara A.] Univ Massachusetts, Dept Vet & Anim Sci, Ctr Bioact Delivery, Inst Appl Life Sci, Amherst, MA 01003 USA; [Minter, Lisa M.; Osborne, Barbara A.] Univ Massachusetts, Dept Vet & Anim Sci, Ctr Bioact Delivery, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Miele, Lucio] Louisiana State Univ, Dept Genet & Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Golde, TE; Ran, Y (corresponding author), 1275 Ctr Dr,POB 100159, Gainesville, FL 32610 USA.	tgolde@ufl.edu; yran@ufl.edu			NCI, National Institutes of Health [1P01CA166009 01A1]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health Grant 1P01CA166009 01A1 (to B. A. O., L. M., and T. E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Borgegard T, 2012, J NEUROSCI, V32, P17297, DOI 10.1523/JNEUROSCI.1451-12.2012; Cummings J, 2010, BIOL PSYCHIAT, V68, P876, DOI 10.1016/j.biopsych.2010.09.020; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dermaut B, 2000, J NEUROL, V247, P364, DOI 10.1007/s004150050603; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Espinoza I, 2013, ONCOTARGETS THER, V6, P1249, DOI 10.2147/OTT.S36162; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kretner B, 2016, EMBO MOL MED, V8, P458, DOI 10.15252/emmm.201505952; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lee J, 2011, BIOCHEMISTRY-US, V50, P4973, DOI 10.1021/bi200026m; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lessard CB, 2010, P NATL ACAD SCI USA, V107, P21236, DOI 10.1073/pnas.1016284108; Meckler X, 2016, J BIOL CHEM, V291, P12821, DOI 10.1074/jbc.M115.708297; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran Y, 2017, EMBO MOL MED, V9, P950, DOI 10.15252/emmm.201607265; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Samson K, 2010, ANN NEUROL, V68, pA11, DOI 10.1002/ana.22249; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Stanga S, 2018, J CELL MOL MED, V22, P823, DOI 10.1111/jcmm.13364; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; van de Craen M, 1999, FEBS LETT, V445, P149, DOI 10.1016/S0014-5793(99)00108-8; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200	38	8	8	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11276	11285		10.1074/jbc.RA119.008041	http://dx.doi.org/10.1074/jbc.RA119.008041			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167792	Green Published, hybrid			2022-12-26	WOS:000478717400018
J	Wang, H; Pilch, PF; Liu, LB				Wang, Hong; Pilch, Paul F.; Liu, Libin			Cavin-1/PTRF mediates insulin-dependent focal adhesion remodeling and ameliorates high-fat diet-induced inflammatory responses in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; focal adhesion; insulin; adipocyte; lipid raft; inflammation; adipose tissue; osmotic swelling; obesity; cavin-1; focal complex; phosphorylation; PTRF	TRANSCRIPT RELEASE FACTOR; LIPID TRAFFICKING; CELL-ADHESION; POLYMERASE-I; CAVEOLAE; CAVIN; DYNAMICS; PROTEIN; PTRF; PHOSPHORYLATION	Cavin-1/polymerase I and transcript release factor (PTRF) is a requisite component of caveolae, small plasma membrane invaginations that are highly abundant in adipocytes. Cavin-1 is a dynamic molecule whose dissociation from caveolae plays an important role in mechanoprotection and rRNA synthesis. In the former situation, the acute dissociation of cavin-1 from caveolae allows cell membrane expansion that occurs upon insulin-aided lipid uptake into the fat cells. Cavin-1 dissociation from caveolae and membrane flattening alters the cytoskeleton and the interaction of plasma membrane proteins with the extracellular matrix through interactions with focal adhesion structures. Here, using cavin-1 knockout mice, subcellular fractionation, and immunoblotting methods, we addressed the relationship of cavin-1 with focal adhesion complexes following nutritional stimulation. We found that cavin-1 is acutely translocated to focal complex compartments upon insulin stimulation, where it regulates focal complex formation through an interaction with paxillin. We found that loss of cavin-1 impairs focal complex remodeling and focal adhesion formation and causes a mechanical stress response, concomitant with activation of proinflammatory and senescence/apoptosis pathways. We conclude that cavin-1 plays key roles in dynamic remodeling of focal complexes upon metabolic stimulation. This mechanism also underlies the crucial role of caveolae in the long-term healthy expansion of the adipocyte.	[Wang, Hong; Pilch, Paul F.; Liu, Libin] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Pilch, Paul F.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Liu, Libin] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Wang, Hong] Broad Inst, Cambridge, MA 02142 USA	Boston University; Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Liu, LB (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	libin@bu.edu	Liu, Libin/ABH-6019-2020	Liu, Libin/0000-0001-5056-1517	National Institutes of Health [DK-112945]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK-112945 (to P. F. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aboulaich N, 2006, BIOCHEM BIOPH RES CO, V350, P657, DOI 10.1016/j.bbrc.2006.09.094; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Briand N, 2014, DIABETES, V63, P4032, DOI 10.2337/db13-1961; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Cheng JPX, 2015, J CELL BIOL, V211, P53, DOI 10.1083/jcb.201504042; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Ding SY, 2014, J BIOL CHEM, V289, P8473, DOI 10.1074/jbc.M113.546242; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Gambin Y, 2014, ELIFE, V3, DOI 10.7554/eLife.01434; Garcia J, 2017, CURR BIOL, V27, P1982, DOI 10.1016/j.cub.2017.05.035; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Golani G, 2019, DEV CELL, V48, P523, DOI 10.1016/j.devcel.2018.12.005; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hill MM, 2007, TRAFFIC, V8, P1695, DOI 10.1111/j.1600-0854.2007.00653.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; Kleinschmidt EG, 2017, CURR OPIN CELL BIOL, V45, P24, DOI 10.1016/j.ceb.2017.01.003; Lim YW, 2017, CURR BIOL, V27, P1968, DOI 10.1016/j.cub.2017.05.067; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; Liu LB, 2016, ELIFE, V5, DOI 10.7554/eLife.17508; Lo HP, 2015, J CELL BIOL, V210, P833, DOI 10.1083/jcb.201501046; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Martin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046242; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Parton RG, 2018, ANNU REV CELL DEV BI, V34, P111, DOI 10.1146/annurev-cellbio-100617-062737; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Pilch PF, 2011, CLIN LIPIDOL, V6, P49, DOI 10.2217/CLP.10.80; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; Wei Z, 2015, BIOCHEM BIOPH RES CO, V456, P750, DOI 10.1016/j.bbrc.2014.12.035; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yang L, 2017, J BIOL CHEM, V292, P3779, DOI 10.1074/jbc.M116.768499; Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047	52	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10544	10552		10.1074/jbc.RA119.008824	http://dx.doi.org/10.1074/jbc.RA119.008824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31126986	hybrid, Green Published			2022-12-26	WOS:000478717100014
J	Chemaitelly, H; Nagelkerke, N; Omori, R; Abu-Raddad, LJ				Chemaitelly, Hiam; Nagelkerke, Nico; Omori, Ryosuke; Abu-Raddad, Laith J.			Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States	PLOS ONE			English	Article							HIV ACQUISITION; INFECTION; TRENDS; AGE; GLYCOPROTEIN; PREVALENCE; ANTIBODY	Objective Assessing the epidemiological association between herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections in the United States, and characterizing the trends in the standardized HSV-1 and HSV-2 antibody prevalences (seroprevalences), 1999-2016. Methods Source of data was the cross-sectional and nationally-representative biennial surveys of the National Health and Nutrition Examination Survey (NHANES). All nine NHANES rounds for 1999-2016 were included in analysis. Datasets of these rounds were combined and analyzed accounting for survey design and applying weighting procedures. Logistic regressions were used to identify associations with seropositivity. Sensitivity analyses were conducted. Results Odds of HSV-1 infection declined by 2.84% (95% CI: 1.70%-4.00%) annually among men, and by 2.22% (95% CI: 1.23%-3.21%) among women. Declines were highest at younger ages. Odds of HSV-2 infection declined by 2.23% (95% CI: 0.71%-3.82%) annually among men, and by 2.89% (95% CI: 1.57%-4.28%) among women. Odds ratio of the association between HSV-2 and HSV-1 seropositivity was 0.71 (95% CI: 0.60-0.84) for men and 0.81 (95% CI: 0.72-0.91) for women, after adjustment for age, ethnicity, and year. Conclusion HSV-1 and HSV-2 seroprevalences showed a strong declining trend for at least two decades, for both sexes and for the different ethnicities, possibly reflecting improvements in hygiene and living conditions (for HSV-1), and safer sexual behavior (for HSV-2). HSV-1 seroprevalence declines are most pronounced among young individuals. There is evidence for cross protection between the two infections, suggestive of HSV-1 seropositivity being partially protective against HSV-2 infection.	[Chemaitelly, Hiam; Nagelkerke, Nico; Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Qatar, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Doha, Qatar; [Omori, Ryosuke] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med, Dept Healthcare Policy & Res, Ithaca, NY 14850 USA; [Abu-Raddad, Laith J.] Hamad bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hokkaido University; Cornell University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med Qatar, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Doha, Qatar.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med, Dept Healthcare Policy & Res, Ithaca, NY 14850 USA.; Abu-Raddad, LJ (corresponding author), Hamad bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar.	lja2002@qatar-med.cornell.edu	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Chemaitelly, Hiam/0000-0002-8756-6968	NPRP grant from theQatar National Research Fund (a member of Qatar Foundation) [9-040-3-008]; Biomedical Research Program; JST, PRESTO	NPRP grant from theQatar National Research Fund (a member of Qatar Foundation); Biomedical Research Program; JST, PRESTO(Japan Science & Technology Agency (JST))	This publication was made possible by NPRP grant number 9-040-3-008 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The authors are also grateful for pilot funding provided by the Biomedical Research Program and infrastructure support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine in Qatar. JST, PRESTO provided research funding support in the form of salary for RO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'Authors' Contributions' section.	Abu-Raddad LJ, 2010, EPIDEMICS-NETH, V2, P173, DOI 10.1016/j.epidem.2010.08.003; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Alsallaq RA, 2010, SEX TRANSM DIS, V37, P290, DOI 10.1097/OLQ.0b013e3181d3d023; [Anonymous], 2017, NAT HLTH NUTR EX SUR; Ayoub HH, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1285-x; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Catania JA, 1996, HEALTH PSYCHOL, V15, P362; Chaabane S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37833-8; Chandra Anjani, 2011, Natl Health Stat Report, P1; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dickson EL, 2015, EPIDEMIOL INFECT, V143, P1042, DOI 10.1017/S0950268814001538; Fanfair RN, 2013, SEX TRANSM DIS, V40, P860, DOI 10.1097/OLQ.0000000000000043; Fisman DN, 2002, SEX TRANSM DIS, V29, P608, DOI 10.1097/00007435-200210000-00008; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gnann JW, 2016, NEW ENGL J MED, V375, P666, DOI 10.1056/NEJMcp1603178; Gottlieb SL, 2019, VACCINE, V37, P7336, DOI 10.1016/j.vaccine.2017.03.074; Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Haddow Lewis J, 2006, Sex Health, V3, P1, DOI 10.1071/SH05041; Khadr L, 2019, CLIN INFECT DIS, V68, P757, DOI 10.1093/cid/ciy562; Kouyoumjian SP, 2018, AIDS, V32, P1343, DOI [10.1097/QAD.0000000000001828, 10.1097/qad.0000000000001828]; Kraut-Becher JR, 2006, INT J STD AIDS, V17, P378, DOI 10.1258/095646206777323481; LEE FK, 1986, J VIROL METHODS, V14, P111, DOI 10.1016/0166-0934(86)90041-8; LEE FK, 1985, J CLIN MICROBIOL, V22, P641, DOI 10.1128/JCM.22.4.641-644.1985; Lewis RM, 2018, VACCINE, V36, P2567, DOI 10.1016/j.vaccine.2018.03.083; Looker KJ, 2017, LANCET INFECT DIS, V17, P1303, DOI 10.1016/S1473-3099(17)30405-X; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Looker KJ, 2005, SEX TRANSM INFECT, V81, P103, DOI 10.1136/sti.2004.012039; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McQuillan Geraldine, 2018, NCHS Data Brief, P1; Omori R, 2018, SEX TRANSM INFECT, V94, P372, DOI 10.1136/sextrans-2017-053336; Omori R, 2017, AIDS, V31, P1721, DOI [10.1097/QAD.0000000000001542, 10.1097/qad.0000000000001542]; R Core Team, 2018, R LANG ENV STAT COMP; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stanberry LR, 2000, CLIN INFECT DIS, V30, P549, DOI 10.1086/313687; StataCorp, 2013, INVENTORSTATA STAT S; Sukik L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215487; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Weiss H, 2004, HERPES S, V11, p24A; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	48	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0214151	10.1371/journal.pone.0214151	http://dx.doi.org/10.1371/journal.pone.0214151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170140	Green Submitted, Green Published, gold			2022-12-26	WOS:000470263700004
J	Olson, KM; Duron, DI; Womer, D; Fell, R; Streicher, JM				Olson, Keith M.; Duron, David I.; Womer, Daniel; Fell, Ryan; Streicher, John M.			Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids	PLOS ONE			English	Article							MORPHINE ANALGESIA; SIGMA-1 RECEPTORS; BIASED LIGAND; MICE LACKING; IN-VIVO; TOLERANCE; PROTEIN; DISCOVERY; EFFICACY; PAIN	Most clinically used opioids are thought to induce analgesia through activation of the mu opioid receptor (MOR). However, disparities have been observed between the efficacy of opioids in activating the MOR in vitro and in inducing analgesia in vivo. In addition, some clinically used opioids do not produce cross-tolerance with each other, and desensitization produced in vitro does not match tolerance produced in vivo. These disparities suggest that some opioids could be acting through other targets in vivo, but this has not been comprehensively tested. We thus screened 9 clinically relevant opioids (buprenorphine, hydrocodone, hydromorphone, morphine, 0-desmethyl-tramadol, oxycodone, oxymorphone, tapentadol, tramadol) against 9 pain-related receptor targets (MOR, delta opioid receptor [DOR], kappa opioid receptor [KOR], nociceptin receptor [NOP], cannabinoid receptor type 1 [CB1], sigma-1 receptor [al R], and the monoamine transporters [NET/SERT/DAT]) expressed in cells using radioligand binding and functional activity assays. We found several novel interactions, including monoamine transporter activation by buprenorphine and al R binding by hydrocodone and tapentadol. Tail flick anti-nociception experiments with CD-1 mice demonstrated that the monoamine transporter inhibitor duloxetine selectively promoted buprenorphine anti-nociception while producing no effects by itself or in combination with the most MOR-selective drug oxymorphone, providing evidence that these novel interactions could be relevant in vivo. Our findings provide a comprehensive picture of the receptor interaction profiles of clinically relevant opioids, which has not previously been performed. Our findings also suggest novel receptor interactions for future investigation that could explain some of the disparities observed between opioid performance in vitro and in vivo.	[Olson, Keith M.; Duron, David I.; Streicher, John M.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Womer, Daniel; Fell, Ryan] Depomed Inc, Newark, CA USA	University of Arizona	Streicher, JM (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA.	jstreicher@email.arzona.edu		Streicher, John/0000-0002-4173-7362; Olson, Keith/0000-0003-4068-5895	Depomed, Inc.; University of Arizona	Depomed, Inc.; University of Arizona	This work was supported by institutional funds from Depomed, Inc. and the University of Arizona to JMS. The funder (Depomed, Inc.) provided support in the form of salaries for authors DW and RF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Borgelt LM, 2013, PHARMACOTHERAPY, V33, P195, DOI 10.1002/phar.1187; Borgland S, 2001, CLIN EXP PHARMACOL P, V28, P147, DOI 10.1046/j.1440-1681.2001.03418.x; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Castany S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22217-9; CHIEN CC, 1993, EUR J PHARMACOL, V250, pR7, DOI 10.1016/0014-2999(93)90650-7; Corder G, 2017, NAT MED, V23, P164, DOI 10.1038/nm.4262; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dripps IJ, 2018, BRIT J PHARMACOL, V175, P891, DOI 10.1111/bph.14131; Gardell LR, 2002, PAIN, V100, P243, DOI 10.1016/S0304-3959(02)00173-2; Gharagozlou Parham, 2006, BMC Pharmacol, V6, P3, DOI 10.1186/1471-2210-6-3; Gharagozlou P, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-19; Grace PM, 2018, BRAIN BEHAV IMMUN, V72, P45, DOI 10.1016/j.bbi.2017.08.018; Grenald SA, 2017, NEUROPHARMACOLOGY, V116, P59, DOI 10.1016/j.neuropharm.2016.12.008; Hill R, 2018, BRIT J PHARMACOL, V175, P2492, DOI 10.1111/bph.14219; HORAN P, 1992, J PHARMACOL EXP THER, V260, P1237; Kallupi M, 2018, ADDICT BIOL, V23, P585, DOI 10.1111/adb.12513; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; Khroyan TV, 2015, BRIT J PHARMACOL, V172, P668, DOI 10.1111/bph.12796; KNAPP RJ, 1995, FASEB J, V9, P516, DOI 10.1096/fasebj.9.7.7737460; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P206, DOI 10.1016/j.genhosppsych.2008.12.006; Kumar P, 2008, EUR J PHARMACOL, V597, P39, DOI 10.1016/j.ejphar.2008.08.025; Kumar V, 2014, J MED CHEM, V57, P4049, DOI 10.1021/jm401964y; Laggner C, 2005, J MED CHEM, V48, P4754, DOI 10.1021/jm049073+; Learned-Coughlin SM, 2003, BIOL PSYCHIAT, V54, P800, DOI 10.1016/S0006-3223(02)01834-6; Lei W, 2017, J BIOL CHEM, V292, P10414, DOI 10.1074/jbc.M116.769489; Madia PA, 2009, PSYCHOPHARMACOLOGY, V207, P413, DOI 10.1007/s00213-009-1673-6; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Minami K, 2007, J PHARMACOL SCI, V103, P253, DOI 10.1254/jphs.CR0060032; Nielsen CK, 2000, J PHARMACOL EXP THER, V295, P91; Olson KM, 2018, J MED CHEM, V61, P6075, DOI 10.1021/acs.jmedchem.8b00403; Olson KM, 2017, YALE J BIOL MED, V90, P97; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Pawar M, 2007, EUR J PHARMACOL, V563, P92, DOI 10.1016/j.ejphar.2007.01.059; Portoghese PS, 2017, ACS CHEM NEUROSCI, V8, P426, DOI 10.1021/acschemneuro.7b00002; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Ramos-Colon CN, 2016, J MED CHEM, V59, P10291, DOI 10.1021/acs.jmedchem.6b01411; Rossi D, 2017, BIOORGAN MED CHEM, V25, P11, DOI 10.1016/j.bmc.2016.10.005; Schmid CL, 2017, CELL, V171, P1165, DOI 10.1016/j.cell.2017.10.035; Smith HS, 2014, J PAIN RES, V7, P589, DOI 10.2147/JPR.S55782; Stefanucci A, 2017, FUTURE MED CHEM, V9, P859, DOI 10.4155/fmc-2016-0232; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; Tejada MA, 2018, PHARMACOL RES, V131, P224, DOI 10.1016/j.phrs.2018.02.008; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; Viscusi ER, 2016, PAIN, V157, P264, DOI 10.1097/j.pain.0000000000000363; Volpe DA, 2011, REGUL TOXICOL PHARM, V59, P385, DOI 10.1016/j.yrtph.2010.12.007; Weiss RD, 2017, DRUG ALCOHOL DEPEN, V173, pS48, DOI 10.1016/j.drugalcdep.2016.12.001; Xu J, 2015, P NATL ACAD SCI USA, V112, P279, DOI 10.1073/pnas.1419183112; Yang PP, 2016, PHARMACOL RES, V111, P867, DOI 10.1016/j.phrs.2016.05.034; Zhao G, 2010, NEUROCHEM INT, V56, P168, DOI 10.1016/j.neuint.2009.09.015	55	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217371	10.1371/journal.pone.0217371	http://dx.doi.org/10.1371/journal.pone.0217371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170174	Green Submitted, gold, Green Published			2022-12-26	WOS:000470263700027
J	Tanimine, N; Germana, SK; Fan, M; Hippen, K; Blazar, BR; Markmann, JF; Turka, LA; Priyadharshini, B				Tanimine, Naoki; Germana, Sharon K.; Fan, Martin; Hippen, Keli; Blazar, Bruce R.; Markmann, James F.; Turka, Laurence A.; Priyadharshini, Bhavana			Differential effects of 2-deoxy-D-glucose on in vitro expanded human regulatory T cell subsets	PLOS ONE			English	Article							METABOLISM; ACTIVATION; INDUCTION; EXPANSION; RECEPTOR; SIGNALS	Regulatory T cells (Tregs) are required for the maintenance of immune tolerance and adoptive Treg infusion therapy has become a promising approach to suppress immune responses in diseases such as autoimmunity and transplant rejection. However, one critical challenge of Treg therapy is the requirement of in vitro expansion of functionally stable Tregs while preventing either the contamination of T effector and/or emergence of unstable pathogenic Tregs. Recent studies showing distinct metabolic requirements of T effectors and Tregs suggest that manipulation of cell metabolism may be an attractive strategy to achieve this goal. Here we show that human thymically derived Tregs (tTregs) and in vitro induced Tregs (iTregs) from naive T cells engage glycolysis equivalently upon activation. However, inhibiting glucose metabolism via 2-deoxy-D-glucose (2DG) has distinct effects on each of these subsets. While 2DG treatment at the onset of activation significantly reduced the proliferation and expression of suppressive molecules such as ICOS and CTLA-4 in tTregs, its effect on FOXP3 expression was small. In contrast, 2DG treatment during iTreg induction modestly decreased their proliferation but strongly reduced both ICOS and FOXP3 expression. Importantly, both Treg subsets became insensitive to 2DG after day 3 post activation with little effect on either proliferation or FOXP3 expression while T conventional Th0 cells showed reduced proliferation under the same conditions. Moreover, 2DG treatment at day 3 did not impair the suppressive capabilities of Treg subsets. Collectively, these findings suggest that there is a distinct temporal requirement of glycolysis in each of the activated human Treg subsets and T conventional cells. Furthermore, 2DG treatment at the onset as a strategy to impair contaminating T effector cell proliferation is unfavorable for optimal Treg generation as well.	[Tanimine, Naoki; Germana, Sharon K.; Fan, Martin; Markmann, James F.; Turka, Laurence A.; Priyadharshini, Bhavana] Massachusetts Gen Hosp, Dept Surg, Ctr Transplantat Sci, Boston, MA 02114 USA; [Hippen, Keli; Blazar, Bruce R.] Univ Minnesota, Canc Ctr, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplantat, Minneapolis, MN USA; [Turka, Laurence A.; Priyadharshini, Bhavana] Rheos Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities	Priyadharshini, B (corresponding author), Massachusetts Gen Hosp, Dept Surg, Ctr Transplantat Sci, Boston, MA 02114 USA.; Priyadharshini, B (corresponding author), Rheos Med, Boston, MA USA.	bpriyadharshini@rheosrx.com	Tanimine, Naoki/AAQ-5317-2020	Tanimine, Naoki/0000-0003-2744-9097	NIH [P01HL018646]; Naito Foundation; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118979, R01HL056067, P01HL018646] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant P01HL018646 to LAT, Grant for Studying Overseas from The Naito Foundation to NT, and Research Fellowship from The Uehara Memorial Foundation to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelin A., 2017, CELL METAB; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Bluestone JA, 2015, SCI TRANSL MED, V7; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cretenet G, 2016, SCI REP-UK, V6, DOI 10.1038/srep24129; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Gerriets V. A., 2016, NAT IMMUNOL; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Howie D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89160; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Jones N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01516; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017; MATHEW JM, 2018, SCI REP, V8; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Priyadharshini B., 2018, J IMMUNOL; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Renner K, 2015, EUR J IMMUNOL, V45, P2504, DOI 10.1002/eji.201545473; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Tang QZ, 2017, J CLIN INVEST, V127, P2505, DOI 10.1172/JCI90598; Tanimine N., 2017, TRANSPLANTATION; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Xia LY, 2019, CELL METAB, V29, P103, DOI 10.1016/j.cmet.2018.09.020; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	34	13	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217761	10.1371/journal.pone.0217761	http://dx.doi.org/10.1371/journal.pone.0217761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170216	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700054
J	Yi, L; Liu, ZQ; Deng, CF; Li, XH; Wang, K; Deng, K; Mu, Y; Zhu, J; Li, Q; Wang, YP; Dai, L				Yi, Ling; Liu, Zhongqiang; Deng, Changfei; Li, Xiaohong; Wang, Ke; Deng, Kui; Mu, Yi; Zhu, Jun; Li, Qi; Wang, Yanping; Dai, Li			Epidemiological characteristics of holoprosencephaly in China, 2007-2014: A retrospective study based on the national birth defects surveillance system	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; METROPOLITAN ATLANTA; PREVALENCE; PROVINCE; ANOMALIES; GENETICS; CHILDREN; TRENDS	Objective To describe the epidemiology of holoprosencephaly (HPE) in China with special reference to prevalence and associated anomalies. Methods Data were abstracted from the Chinese Birth Defects Monitoring Network for the period 2007-2014. Birth prevalence of HPE were assessed by birth year, fetal/infant sex, maternal age, and maternal residential area. Poisson regressions were used to calculate the crude and adjusted prevalence ratios (PR) and their 95% confidence intervals, and linear chi-square test was used to explore time trend for the prevalence of HPE. Results A total of 1222 HPE cases were identified in 13,284,142 births, yielding an overall prevalence of 0.92 per 10,000 births. The annual prevalence of HPE presented an upward trend (P<0.001), from 0.54 per 10,000 births in 2007 to 1.21 per 10,000 births in 2014. Higher prevalence was found in older maternal-age groups (30-34 years, adjusted PR: 1.19, 95% CI: 1.02-1.40; >= 35 years, adjusted PR: 1.53, 95% CI: 1.26-1.86) in comparison with the maternal-age group of 25 to 29 years. Higher prevalence was also found in infants born to mothers resided in urban areas (adjusted PR: 1.23, 95% CI: 1.08-1.39) and female infants (adjusted PR: 1.30, 95% CI: 1.15-1.47). Conclusions HPE is an important perinatal health issue because of its poor prognosis. This is the first study depicting a picture of epidemiological characteristics of HPE in China, which can provide useful references for future studies.	[Yi, Ling; Deng, Changfei; Li, Xiaohong; Wang, Ke; Deng, Kui; Mu, Yi; Zhu, Jun; Li, Qi; Wang, Yanping; Dai, Li] Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu, Sichuan, Peoples R China; [Yi, Ling; Liu, Zhongqiang; Dai, Li] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Sichuan, Peoples R China; [Liu, Zhongqiang] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Intens Care Unit, Chengdu, Sichuan, Peoples R China; [Dai, Li] Sichuan Univ, Med Big Data Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Dai, L (corresponding author), Sichuan Univ, West China Univ Hosp 2, Natl Ctr Birth Defects Monitoring, Chengdu, Sichuan, Peoples R China.; Dai, L (corresponding author), Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu, Sichuan, Peoples R China.; Dai, L (corresponding author), Sichuan Univ, Med Big Data Ctr, Chengdu, Sichuan, Peoples R China.	daili@scu.edu.cn		Li, Xiaohong/0000-0003-0336-7302	Ministry of Science and Technology of China [2127000074-1]; National Health and Family Planning Commission of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Health and Family Planning Commission of China	This study was funded by a special grant from the Ministry of Science and Technology of China (no. 2127000074-1) and National Health and Family Planning Commission of China.	Agresti A, 2013, CATEGORICAL DATA ANA; Barr M, 1999, AM J MED GENET, V89, P116, DOI 10.1002/(SICI)1096-8628(19990625)89:2<116::AID-AJMG10>3.3.CO;2-W; Bendavid C, 2010, AM J MED GENET C, V154C, P86, DOI 10.1002/ajmg.c.30250; Bullen PJ, 2001, AM J OBSTET GYNECOL, V184, P1256, DOI 10.1067/mob.2001.111071; Chen CP, 2005, GENET COUNSEL, V16, P49; Cohen MM, 2002, AM J MED GENET, V109, P1, DOI 10.1002/ajmg.10258; Crider KS, 2008, AM J MED GENET A, V146A, P820, DOI 10.1002/ajmg.a.32200; Croen LA, 1996, AM J MED GENET, V64, P465, DOI 10.1002/(SICI)1096-8628(19960823)64:3<465::AID-AJMG4>3.0.CO;2-O; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Dai L, 2010, BIRTH DEFECTS RES A, V88, P41, DOI 10.1002/bdra.20607; Deng CF, 2015, PRENATAL DIAG, V35, P311, DOI 10.1002/pd.4516; Dubourg C, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-8; Forrester MB, 2000, PAEDIATR PERINAT EP, V14, P61, DOI 10.1046/j.1365-3016.2000.00211.x; Hu Y H, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P20; ICBDSR, 2013, ANNUAL REPORT 2013 W; Kauvar EF, 2010, CURR OPIN PEDIATR, V22, P687, DOI 10.1097/MOP.0b013e32833f56d5; Leoncini E, 2008, BIRTH DEFECTS RES A, V82, P585, DOI 10.1002/bdra.20479; Levey EB, 2010, AM J MED GENET C, V154C, P183, DOI 10.1002/ajmg.c.30254; Liu JF, 2016, BIRTH DEFECTS RES A, V106, P267, DOI 10.1002/bdra.23486; Miller EA, 2010, AM J MED GENET C, V154C, P62, DOI 10.1002/ajmg.c.30244; MOH, 2003, CHINESE J REPRODUCTI, V2, P14; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; National Bureau of Statistics of China, 2009, RUL COMP STAT ZON CO; National Bureau of Statistics of China, 2016, COND MAT CHILDR HLTH; Olsen CL, 1997, AM J MED GENET, V73, P217, DOI 10.1002/(SICI)1096-8628(19971212)73:2<217::AID-AJMG20>3.0.CO;2-S; Ong S, 2007, PRENATAL DIAG, V27, P340, DOI 10.1002/pd.1677; ORAHILLY R, 1989, TERATOLOGY, V40, P409, DOI 10.1002/tera.1420400502; Orioli IM, 2007, AM J MED GENET A, V143A, P3088, DOI 10.1002/ajmg.a.32104; Orioli IM, 2010, AM J MED GENET C, V154C, P13, DOI 10.1002/ajmg.c.30233; Raam MS, 2011, INDIAN PEDIATR, V48, P457, DOI 10.1007/s13312-011-0078-x; Rasmussen SA, 1996, AM J MED GENET, V66, P320, DOI 10.1002/(SICI)1096-8628(19961218)66:3<320::AID-AJMG16>3.0.CO;2-O; Ren Ai-Guo, 2015, World J Clin Pediatr, V4, P41, DOI 10.5409/wjcp.v4.i3.41; Roessler E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/ajmg.c.30236; Shiota K, 2010, AM J MED GENET C, V154C, P22, DOI 10.1002/ajmg.c.30248; Solomon BD, 2010, AM J MED GENET C, V154C, P146, DOI 10.1002/ajmg.c.30232; Sun G, 2011, WORLD J PEDIATR, V7, P331, DOI 10.1007/s12519-011-0328-y; Szabo N, 2011, J CHILD NEUROL, V26, P1029, DOI 10.1177/0883073811399095; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Tu L, 2012, IRAN J PUBLIC HEALTH, V41, P20; Whiteford ML, 1996, J MED GENET, V33, P578, DOI 10.1136/jmg.33.7.578; Zheng Xiao-ying, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P5	41	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217835	10.1371/journal.pone.0217835	http://dx.doi.org/10.1371/journal.pone.0217835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170204	Green Published, Green Submitted, gold			2022-12-26	WOS:000470263700064
J	Ruiz-Miranda, CR; de Morais, MM; Dietz, LA; Alexandre, BR; Martins, AF; Ferraz, LP; Mickelberg, J; Hankerson, SJ; Dietz, JM				Ruiz-Miranda, Carlos R.; de Morais, Marcio M., Jr.; Dietz, Lou Ann; Alexandre, Brenda Rocha; Martins, Andreia F.; Ferraz, Luis Paulo; Mickelberg, Jennifer; Hankerson, Sarah J.; Dietz, James M.			Estimating population sizes to evaluate progress in conservation of endangered golden lion tamarins (Leontopithecus rosalia)	PLOS ONE			English	Article							LONG CALLS; SUCCESS	Efforts to reverse the decline of endangered golden lion tamarin monkeys have been relatively successful because the Brazilian organization dedicated to the species' conservation (Associac <comma> ao Mico-Leao-Dourado, AMLD) relies on science-based computer modeling to determine the number of tamarins necessary to achieve demographic and genetic goals, and a process of strategic planning to achieve those goals. Accurate estimates of the numbers of tamarins in forest fragments are essential to evaluate progress in achieving goals and adapt strategies as necessary. In this report we present the results of a new method to survey the number of tamarins in the wild, a modification of the point transect with lures procedure. Using this method, we estimate that in 2014 there were approximately 3,700 golden lion tamarins in 41,400 hectares of Atlantic Forest. Of these, 59% are from remnant wild populations, 34% are descendants of captive-born reintroduced animals and 7% are descendants of wild translocated groups. The number of tamarins and amount of forest estimated in this survey exceeded values necessary to meet AMLD's definition of a viable population, determined to be 2,000 tamarins in 25,000 hectares of connected and protected forest. However, the seven forest blocks and their tamarin populations are not yet adequately connected and protected. AMLD's strategic plan to achieve a viable population of golden lion tamarins includes 12 strategies that mitigate these and other threats or contribute directly to the conservation goal. The point transect with lures survey method provides a way to evaluate progress in achieving that goal and adapt strategies as appropriate.	[Ruiz-Miranda, Carlos R.; de Morais, Marcio M., Jr.] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Rio De Janeiro, Brazil; [Ruiz-Miranda, Carlos R.; de Morais, Marcio M., Jr.; Dietz, Lou Ann; Alexandre, Brenda Rocha; Martins, Andreia F.; Ferraz, Luis Paulo; Mickelberg, Jennifer; Dietz, James M.] Assoc Mico Leao Dourado, Rio De Janeiro, Brazil; [Dietz, Lou Ann; Dietz, James M.] Save Golden Lion Tamarin, Silver Spring, MD USA; [Alexandre, Brenda Rocha] Univ Fed Rio de Janeiro, Programa Posgrad Ecol, Dept Ecol, Rio De Janeiro, Brazil; [Alexandre, Brenda Rocha] Univ Fed Fluminense, Inst Geociencias, Campus Praia Vermelha, Rio De Janeiro, Brazil; [Mickelberg, Jennifer] Zoo Atlanta, Atlanta, GA USA; [Hankerson, Sarah J.] Univ St Thomas, Dept Psychol, St Paul, MN USA	Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; University of St Thomas Minnesota	Ruiz-Miranda, CR (corresponding author), Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Rio De Janeiro, Brazil.; Ruiz-Miranda, CR (corresponding author), Assoc Mico Leao Dourado, Rio De Janeiro, Brazil.	cruiz@uenf.br	Ruiz-Miranda, Carlos R/H-7308-2015; Ruiz-Miranda, Carlos R/A-4719-2008	Ruiz-Miranda, Carlos R/0000-0001-7360-0304; Ruiz-Miranda, Carlos R/0000-0001-9786-5315	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Conselho Nacional de Pesquisa (CNPQ) [PQ 309660/2013]; Conservation Food and Health Foundation; Copenhagen Zoo; Disney Conservation Fund; Fundacao Grupo Boticario; Lion Tamarins of Brazil Fund; Philadelphia Zoo; Save the Golden Lion Tamarin; Zoo Atlanta	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservation Food and Health Foundation; Copenhagen Zoo; Disney Conservation Fund; Fundacao Grupo Boticario; Lion Tamarins of Brazil Fund; Philadelphia Zoo; Save the Golden Lion Tamarin; Zoo Atlanta	CRRM was funded by fellowships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and from the Conselho Nacional de Pesquisa (CNPQ) fellowship number PQ 309660/2013. The Associacao Mico Leao Dourado received funds from the Conservation Food and Health Foundation, Copenhagen Zoo, Disney Conservation Fund, Fundacao Grupo Boticario, Lion Tamarins of Brazil Fund, Philadelphia Zoo, Save the Golden Lion Tamarin and Zoo Atlanta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascensao F, 2018, SINGLE ROAD TH UNPUB; Atlantica SM. INPE, 2014, ATL REM FLOR MAT ATL; Atlantica SM. INPE, 2014, ATLAS REMANESCENTES; BAKER AJ, 1993, ANIM BEHAV, V46, P1091, DOI 10.1006/anbe.1993.1299; Baker AJ, 1996, AM J PRIMATOL, V38, P47, DOI 10.1002/(SICI)1098-2345(1996)38:1<47::AID-AJP5>3.0.CO;2-T; Balmford A, 2017, ORYX, V51, P191, DOI 10.1017/S0030605317000096; Bicca-Marques J.C., 2017, SCI ADV, V3, DOI DOI 10.1126/SCIADV.1600946; Buckland ST, 2006, J APPL ECOL, V43, P377, DOI 10.1111/j.1365-2664.2006.01135.x; COIMBRA-FILHO A F, 1973, Primates, V14, P47, DOI 10.1007/BF01730515; Dean W., 1995, With broadax and firebrand: the destruction of the Brazilian Atlantic forest.; DIETZ JM, 1994, AM J PRIMATOL, V34, P115, DOI 10.1002/ajp.1350340204; DIETZ JM, 1993, ANIM BEHAV, V46, P1067, DOI 10.1006/anbe.1993.1297; Dietz L., 1998, CULTURE MISSING ELEM; Dietz Lou Ann Hollingsworth, 1995, P64; Duchiade A., 2018, SCI AM; Estrada A, 2018, PEERJ, V6, DOI 10.7717/peerj.4869; Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946; Grantham HS, 2010, FRONT ECOL ENVIRON, V8, P431, DOI 10.1890/080151; Grativol AD, 2001, CONSERV GENET, V2, P1, DOI 10.1023/A:1011543401239; Grativol AD, 2005, THESIS; Green K., 1980, ASSESSMENT POCO ANTA; Hankerson SJ, 2014, ANIM BEHAV, V96, P87, DOI 10.1016/j.anbehav.2014.07.026; Holst B, 2006, LION TAMARIN POPULAT; Kierulff M, 2014, IUCN RED LIST THREAT; Kierulff M. C. M., 2012, International Zoo Yearbook, V46, P36, DOI 10.1111/j.1748-1090.2012.00170.x; Kierulff Maria Cecilia M., 2002, P271; Kierulff MCM, 2003, AM J PRIMATOL, V59, P29, DOI 10.1002/ajp.10064; Kleiman D.G., 1990, Endangered Species Update, V8, P82; Kleiman D.G., 2002, LION TAMARINS BIOL C; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Margoluis R, 2009, EVAL PROGRAM PLANN, V32, P138, DOI 10.1016/j.evalprogplan.2008.09.007; Matei A, 2006, R SAMPLINGPACKAGE; Mickelberg JL, 2011, LEONTOPITHECUS ROSAL; Miller P, 2005, VERSION 9 50 USERS M; Moraes AM, 2018, BIOL CONSERV, V224, P178, DOI 10.1016/j.biocon.2018.05.023; Moraes AM, 2017, CONSERV GENET, V18, P995, DOI 10.1007/s10592-017-0948-4; Padua Suzana M., 2002, P315; Partnership CM, OPEN STANDARDS PRACT; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Ruiz-Miranda C, 2010, REINTRODUCTION TRANS; Ruiz-Miranda CR, 2002, LION TAMARINS BRAZIL, P256; Ruiz-Miranda CR, 2002, FOLIA PRIMATOL, V718, P1; Russo G, 2009, NATURE, V462, P266, DOI 10.1038/462266a; Sabatini V, 2008, INT J PRIMATOL, V29, P207, DOI 10.1007/s10764-008-9240-2; Sabatini V, 2011, BIOACOUSTICS, V20, P137, DOI 10.1080/09524622.2011.9753640; Savage A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168324; Savage A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1030; Schwartz MW, 2012, BIOL CONSERV, V155, P169, DOI 10.1016/j.biocon.2012.06.014; SEABRA V.S., 2012, ANALISE PAISAGEM APO	49	12	12	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216664	10.1371/journal.pone.0216664	http://dx.doi.org/10.1371/journal.pone.0216664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166940	Green Submitted, gold, Green Published			2022-12-26	WOS:000470087800012
J	Hope, TR; Selnes, P; Rektorova, I; Anderkova, L; Nemcova-Elfmarkova, N; Balazova, Z; Dale, A; Bjornerud, A; Fladby, T				Hope, Tuva R.; Selnes, Per; Rektorova, Irena; Anderkova, Lubomira; Nemcova-Elfmarkova, Nela; Balazova, Zuzana; Dale, Anders; Bjornerud, Atle; Fladby, Tormod			Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; LEWY BODIES; ALZHEIMERS-DISEASE; MOUSE MODEL; BRAIN; DEMENTIA; MICROSTRUCTURE; DEGENERATION; DIAGNOSIS; PATHOLOGY	To meet the need for Parkinson's disease biomarkers and evidence for amount and distribution of pathological changes, MRI diffusion tensor imaging (DTI) has been explored in a number of previous studies. However, conflicting results warrant further investigations. As tissue microstructure, particularly of the grey matter, is heterogeneous, a more precise diffusion model may benefit tissue characterization. The purpose of this study was to analyze the diffusion-based imaging technique restriction spectrum imaging (RSI) and DTI, and their ability to detect microstructural changes within brain regions associated with motor function in Parkinson's disease. Diffusion weighted (DW) MR images of a total of 100 individuals, (46 Parkinson's disease patients and 54 healthy controls) were collected using b-values of 0-4000s/mm(2). Output diffusion-based maps were estimated based on the RSI-model combining the full set of DW-images (Cellular Index (CI), Neurite Density (ND)) and DTI-model combining b = 0 and b = 1000 s/mm(2) (fractional anisotropy (FA), Axial-, Mean-and Radial diffusivity (AD, MD, RD)). All parametric maps were analyzed in a voxel-wise group analysis, with focus on typical brain regions associated with Parkinson's disease pathology. CI, ND and DTI diffusivity metrics (AD, MD, RD) demonstrated the ability to differentiate between groups, with strongest performance within the thalamus, prone to pathology in Parkinson's disease. Our results indicate that RSI may improve the predictive power of diffusion-based MRI, and provide additional information when combined with the standard diffusivity measurements. In the absence of major atrophy, diffusion techniques may reveal microstructural pathology. Our results suggest that protocols for MRI diffusion imaging may be adapted to more sensitive detection of pathology at different sites of the central nervous system.	[Hope, Tuva R.; Bjornerud, Atle] Oslo Univ Hosp, Rikshosp, Div Radiol & Nucl Med, Diagnost Phys, Oslo, Norway; [Selnes, Per; Fladby, Tormod] Akershus Univ Hosp, Dept Neurol, Loerenskog, Norway; [Selnes, Per; Fladby, Tormod] Univ Oslo, Inst Clin Med, Campus Ahus, Oslo, Norway; [Rektorova, Irena; Anderkova, Lubomira; Nemcova-Elfmarkova, Nela; Balazova, Zuzana] Masaryk Univ, Cent European Inst Technol, CEITEC, Brno, Czech Republic; [Rektorova, Irena] Masaryk Univ, Med Fac, Dept Neurol 1, Brno, Czech Republic; [Rektorova, Irena] St Annes Univ Hosp, Brno, Czech Republic; [Dale, Anders] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Dale, Anders] Univ Calif San Diego, Deparment Radiol, La Jolla, CA 92093 USA; [Dale, Anders] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Bjornerud, Atle] Univ Oslo, Dept Phys, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oslo	Hope, TR (corresponding author), Oslo Univ Hosp, Rikshosp, Div Radiol & Nucl Med, Diagnost Phys, Oslo, Norway.	tuvarh@gmail.com	Novakova, Lubomira/AAX-9770-2021; Nemcova Elfmarkova, Nela/GWD-1264-2022; Nemcova Elfmarkova, Nela/GQZ-1872-2022	Novakova, Lubomira/0000-0002-8352-439X; Rektorova, Irena/0000-0002-5455-4573; Fladby, Tormod/0000-0002-9984-9797; Nemcova Elfmarkova, Nela/0000-0001-6181-0320; Selnes, Per/0000-0001-5131-9757	EU-JPND via the Research Council of Norway [237250]; South-Eastern Norway Regional Health Authority [20111093, 2014086]; Research Council of Norway [217780, 226074]; Akershus University Hospital grant; European Regional Development Fund-Project "National infrastructure for biological and medical imaging" [CZ.02.1.01/0.0/0.0/16_013/0001775]	EU-JPND via the Research Council of Norway; South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Akershus University Hospital grant; European Regional Development Fund-Project "National infrastructure for biological and medical imaging"	The work done by TRH, PS and TF was supported by the EU-JPND via the Research Council of Norway [grant number 237250]; South-Eastern Norway Regional Health Authority [grant numbers 20111093, 2014086]; Research Council of Norway [grant numbers 217780, 226074]; Akershus University Hospital grant; the work done by IR, LA, NNW, ZB was supported by the European Regional Development Fund-Project "National infrastructure for biological and medical imaging" [grant number CZ.02.1.01/0.0/0.0/16_013/0001775]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Radaideh AM, 2016, CLIN IMAG, V40, P987, DOI 10.1016/j.clinimag.2016.05.006; Anderkova L, 2017, MOVEMENT DISORDERS; Anderkova L, 2015, J ALZHEIMERS DIS, V48, P251, DOI 10.3233/JAD-150067; Andersson JL, 2007, TR07JA2 FMRIB AN GRO, V2; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Aung Wint Yan, 2013, Imaging Med, V5, P427; Auning E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003976; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boska MD, 2007, NEUROBIOL DIS, V26, P590, DOI 10.1016/j.nbd.2007.02.010; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brunsing RL, 2017, J MAGN RESON IMAGING, V45, P323, DOI 10.1002/jmri.25419; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Carper RA, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00610; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258; Doorn KJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0090-1; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; Halliday GM, 2009, PARKINSONISM RELAT D, V15, pS152, DOI 10.1016/S1353-8020(09)70804-1; Hikishima K, 2015, NEUROSCIENCE, V300, P585, DOI 10.1016/j.neuroscience.2015.05.041; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Khairnar A, 2017, BRAIN BEHAV IMMUN, V61, P197, DOI 10.1016/j.bbi.2016.11.027; Khairnar A, 2016, J NEUROCHEM, V136, P1259, DOI 10.1111/jnc.13500; Khairnar A, 2015, NEUROTOX RES, V28, P281, DOI 10.1007/s12640-015-9537-9; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lanskey JH, 2018, BRAIN, V141, P2545, DOI 10.1093/brain/awy211; Lenfeldt N, 2015, EUR J NEUROL, V22, P1410, DOI 10.1111/ene.12760; Menke RA, 2010, NEUROIMAGE, V52, P1175, DOI 10.1016/j.neuroimage.2010.05.086; Modrego PJ, 2011, ACAD RADIOL, V18, P235, DOI 10.1016/j.acra.2010.09.022; PATT S, 1991, HISTOL HISTOPATHOL, V6, P373; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Planetta PJ, 2013, AM J NEURORADIOL, V34, P74, DOI 10.3174/ajnr.A3178; Prakash BD, 2012, PARKINSONISM RELAT D, V18, P1029, DOI 10.1016/j.parkreldis.2012.05.021; Rektorova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085595; Schuff N, 2015, MOVEMENT DISORD, V30, P1885, DOI 10.1002/mds.26325; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Selnes P, 2017, ANN CLIN TRANSL NEUR, V4, P700, DOI 10.1002/acn3.446; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sowa P, 2019, MULT SCLER J, V25, P687, DOI 10.1177/1352458518765671; Stav AL, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2015.30; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; White NS, 2013, HUM BRAIN MAPP, V34, P327, DOI 10.1002/hbm.21454; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang GH, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/207624	52	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217922	10.1371/journal.pone.0217922	http://dx.doi.org/10.1371/journal.pone.0217922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150514	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100127
J	Jung, YH; Park, Y; Kim, BI; Choi, CW				Jung, Young Hwa; Park, Youngmi; Kim, Beyong Il; Choi, Chang Won			Length at birth z-score is inversely associated with an increased risk of bronchopulmonary dysplasia or death in preterm infants born before 32 gestational weeks: A nationwide cohort study	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; INTRAUTERINE GROWTH-RETARDATION; PATENT DUCTUS-ARTERIOSUS; FETAL ORIGINS; PREDICTORS; MECHANISMS	Objective We investigated whether the extent of fetal growth restriction (FGR) in terms of not only birth weight but length and head circumference at birth is correlated with an increased risk of bronchopulmonary dysplasia (BPD) in preterm infants. Study design A total of 4,940 very low birth weight (VLBW) infants born between 23 and 31 weeks of gestation from 2013 to 2015 who were registered in the Korean Neonatal Network (KNN) database were enrolled. Infants with major congenital malformations and those with incomplete data were excluded. Z-scores for weight, length, and head circumference at birth were calculated from the Fenton 2013 growth curve. Multivariable logistic regression analysis was performed to determine whether the z-score for length at birth was associated with BPD or death before 36 postmenstrual weeks. Results A total of 4,662 VLBW infants were analyzed: 518 infants died before 36 postmenstrual weeks; 1,388 infants developed BPD. Decreased length at birth z-scores were significantly associated with an increased risk of BPD or death when adjusted for covariates (odds ratio (OR) 1.25 per 1-point decrease of length at birth z-score, 95% confidence interval (CI) 1.14-1.37). The association was particularly evident in infants born earlier than 29 weeks of gestation (OR 1.57, 95% CI 1.31-1.89 in infants born at 23-25 weeks; OR 1.24, 95% CI 1.09-1.42 in infants born at 26-28 weeks). Conclusion Length at birth was inversely associated with an increased risk of BPD or death in VLBW infants born earlier than 32 weeks of gestation.	[Jung, Young Hwa; Kim, Beyong Il; Choi, Chang Won] Seoul Natl Univ, Dept Pediat, Bundang Hosp, Seongnam Si, Kyunggi Do, South Korea; [Park, Youngmi] Seoul Natl Univ, Med Res Collaborat Ctr, Bundang Hosp, Seongnam, South Korea; [Kim, Beyong Il; Choi, Chang Won] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, CW (corresponding author), Seoul Natl Univ, Dept Pediat, Bundang Hosp, Seongnam Si, Kyunggi Do, South Korea.; Choi, CW (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.	choic1029@gmail.com		CHOI, CHANG WON/0000-0003-1911-0253	National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A09059577]; Korean Centers for Disease Control and Prevention [2016-ER6307-02]	National Research Foundation of Korea - Ministry of Education; Korean Centers for Disease Control and Prevention	This study was supported by the Basic Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1D1A1A09059577) and also supported by the Research Program funded by the Korean Centers for Disease Control and Prevention (2016-ER6307-02#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barud W, 1991, Ann Univ Mariae Curie Sklodowska Med, V46, P39; Baum M, 2003, CURR OPIN PEDIATR, V15, P166, DOI 10.1097/00008480-200304000-00005; Bose C, 2009, PEDIATRICS, V124, pE450, DOI 10.1542/peds.2008-3249; Bourbon JR, 2010, LUNG BIOL HEALTH DIS, V240, P56; Chang YS, 2015, J KOREAN MED SCI, V30, pS3, DOI 10.3346/jkms.2015.30.S1.S3; Cotten C Michael, 2005, J Perinatol, V25, P650; Feng K, 2011, J KOREAN MED SCI, V26, P1469, DOI 10.3346/jkms.2011.26.11.1469; Friedrich L, 2007, AM J RESP CRIT CARE, V176, P1269, DOI 10.1164/rccm.200703-476OC; Hack M, 1998, EUR J CLIN NUTR, V52, pS65; Hansen AR, 2010, J PEDIATR-US, V156, P532, DOI 10.1016/j.jpeds.2009.10.018; Henderson-Smart DJ, 2006, ARCH DIS CHILD-FETAL, V91, pF40, DOI 10.1136/adc.2005.072264; Jobe AH, 1998, EARLY HUM DEV, V53, P81, DOI 10.1016/S0378-3782(98)00045-0; Jobe AH, 2001, CURR OPIN PEDIATR, V13, P124, DOI 10.1097/00008480-200104000-00006; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Korhonen P, 1999, EARLY HUM DEV, V54, P245, DOI 10.1016/S0378-3782(98)00101-7; Kotecha SJ, 2018, PAEDIATR RESPIR REV, V28, P55, DOI 10.1016/j.prrv.2017.12.001; Lal CV, 2015, CLIN PERINATOL, V42, P739, DOI 10.1016/j.clp.2015.08.004; Lal MK, 2003, PEDIATRICS, V111, P483, DOI 10.1542/peds.111.3.483; MCDONNELL WF, 1991, EUR RESPIR J, V4, P279; Muscedere JG, 1994, AM J RESP CRIT CARE, V66, P2150; O'Shea JE, 2012, PEDIATR RES, V71, P210, DOI 10.1038/pr.2011.27; Redline RW, 2002, PEDIATR RES, V52, P713, DOI 10.1203/00006450-200211000-00017; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Speer CP, 2001, BIOL NEONATE, V79, P205; Tan ZH, 2016, CURR PEDIATR REV, V12, P83, DOI 10.2174/157339631202160506001309; Tauzin L, 2012, ACTA PAEDIATR, V101, P419, DOI 10.1111/j.1651-2227.2011.02550.x; Thureen P.J., 2001, NEOREVIEWS, V2, pe139, DOI DOI 10.1542/neo.2-6-e139; Trembath A, 2012, CLIN PERINATOL, V39, P585, DOI 10.1016/j.clp.2012.06.014; TURNER JA, 1951, PEDIATRICS, V7, P360; Zapletal A, 1987, LUNG FUNCTION CHILDR; Zaw W, 2003, PEDIATRICS, V111, P1273, DOI 10.1542/peds.111.6.1273	34	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217739	10.1371/journal.pone.0217739	http://dx.doi.org/10.1371/journal.pone.0217739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150480	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100094
J	Kuriakose, AE; Hu, WJ; Nguyen, KT; Menon, JU				Kuriakose, Aneetta E.; Hu, Wenjing; Nguyen, Kytai T.; Menon, Jyothi U.			Scaffold-based lung tumor culture on porous PLGA microparticle substrates	PLOS ONE			English	Article							DRUG-DELIVERY; CANCER CELLS; MICROSPHERES; MODEL; BEADS; DOXORUBICIN; RESISTANCE; SYSTEM; GROWTH; TOOL	Scaffold-based cancer cell culture techniques have been gaining prominence especially in the last two decades. These techniques can potentially overcome some of the limitations of current three-dimensional cell culture methods, such as uneven cell distribution, inadequate nutrient diffusion, and uncontrollable size of cell aggregates. Porous scaffolds can provide a convenient support for cell attachment, proliferation and migration, and also allows diffusion of oxygen, nutrients and waste. In this paper, a comparative study was done on porous poly (lactic-co-glycolic acid) (PLGA) microparticles prepared using three porogens-gelatin, sodium bicarbonate (SBC) or novel poly N-isopropylacrylamide [PNIPAAm] particles, as substrates for lung cancer cell culture. These fibronectin-coated, stable particles (19-42 mu m) supported A549 cell attachment at an optimal cell seeding density of 250,000 cells/mg of particles. PLGA-SBC porous particles had comparatively larger, more interconnected pores, and favored greater cell proliferation up to 9 days than their counterparts. This indicates that pore diameters and interconnectivity have direct implications on scaffold-based cell culture compared to substrates with minimally interconnected pores (PLGA-gelatin) or pores of uniform sizes (PLGA-PMPs). Therefore, PLGA-SBC-based tumor models were chosen for preliminary drug screening studies. The greater drug resistance observed in the lung cancer cells grown on porous particles compared to conventional cell monolayers agrees with previous literature, and indicates that the PLGA-SBC porous microparticle substrates are promising for in vitro tumor or tissue development.	[Kuriakose, Aneetta E.; Nguyen, Kytai T.; Menon, Jyothi U.] Univ Texas Arlington, Bioengn Dept, Arlington, TX 76019 USA; [Kuriakose, Aneetta E.; Nguyen, Kytai T.; Menon, Jyothi U.] UT Southwestern Med Ctr, Grad Biomed Engn Program, Dallas, TX 75390 USA; [Hu, Wenjing] Progenitec Inc, Arlington, TX USA; [Menon, Jyothi U.] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Rhode Island	Nguyen, KT; Menon, JU (corresponding author), Univ Texas Arlington, Bioengn Dept, Arlington, TX 76019 USA.; Nguyen, KT; Menon, JU (corresponding author), UT Southwestern Med Ctr, Grad Biomed Engn Program, Dallas, TX 75390 USA.; Menon, JU (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	knguyen@uta.edu; jmenon@uri.edu	Menon, Jyothi/S-9255-2019	Menon, Jyothi/0000-0002-0762-3513	NIH STTR grant [R41 MH106303]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103430]; University of Rhode Island Council for Research award; NIH [T32 HL 134613]; STTR grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	NIH STTR grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); University of Rhode Island Council for Research award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STTR grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported through NIH STTR R41 MH106303 grant to WH and KTN. Progenitec Inc, provided support in the form of salary for author WH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions'. WH provided support in the form of funds to purchase research supplies and reagents, provided resources, and reviewed and edited the manuscript as part of the joint STTR grant with KTN. The work was also funded by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (#P20GM103430) and University of Rhode Island Council for Research award, both to JUM. AK was funded through NIH T32 HL 134613. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrow MG, 2012, EUR J CANCER PREV, V21, P407, DOI 10.1097/CEJ.0b013e32834ef194; Amin ARMR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124218; Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]; Asghar W, 2015, MATER TODAY, V18, P539, DOI 10.1016/j.mattod.2015.05.002; Benien P, 2014, FUTURE ONCOL, V10, P1311, DOI 10.2217/fon.13.274; Blandin Knight Sean, 2017, Open Biol, V7, DOI 10.1098/rsob.170070; Cai YP, 2013, INT J NANOMED, V8, P1111, DOI 10.2147/IJN.S41271; Choi SYC, 2014, ADV DRUG DELIVER REV, V79-80, P222, DOI 10.1016/j.addr.2014.09.009; Choi SW, 2012, J MATER CHEM, V22, P11442, DOI 10.1039/c2jm16019f; Choi SW, 2010, LANGMUIR, V26, P19001, DOI 10.1021/la104206h; Choi SW, 2010, SMALL, V6, P1492, DOI 10.1002/smll.201000544; Choi Y, 2011, B KOREAN CHEM SOC, V32, P867, DOI 10.5012/bkcs.2011.32.3.867; Chou MJ, 2013, J BIOMED MATER RES A, V101, P2862, DOI 10.1002/jbm.a.34594; COLE SPC, 1986, CANCER CHEMOTH PHARM, V17, P259; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Dubiak-Szepietowska M, 2016, TOXICOL APPL PHARM, V294, P78, DOI 10.1016/j.taap.2016.01.016; Edelman MJ, 2001, CANCER CHEMOTH PHARM, V48, P141, DOI 10.1007/s002800000273; El Assal R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39144; Fang JJ, 2014, ACTA BIOMATER, V10, P276, DOI 10.1016/j.actbio.2013.09.002; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Jiang RD, 2010, ROM J MORPHOL EMBRYO, V51, P663; Justin AW, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0768; Kang SW, 2009, BIOMATERIALS, V30, P4227, DOI 10.1016/j.biomaterials.2009.04.025; Ke CJ, 2013, BIOMATERIALS, V34, P1, DOI 10.1016/j.biomaterials.2012.09.023; Kemala T, 2012, ARAB J CHEM, V5, P103, DOI 10.1016/j.arabjc.2010.08.003; Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571; Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031; Knight Eleanor, 2015, J Anat, V227, P746, DOI 10.1111/joa.12257; Kona S, 2012, INT J PHARMACEUT, V423, P516, DOI 10.1016/j.ijpharm.2011.11.043; Koppolu B, 2010, NANOMED-NANOTECHNOL, V6, P355, DOI 10.1016/j.nano.2009.07.008; Lee SH, 2012, ASME FLUID ENG DIV, P253; Lee YS, 2016, MOL THER, V24, P805, DOI 10.1038/mt.2016.22; Leong WY, 2015, TRENDS BIOTECHNOL, V33, P653, DOI 10.1016/j.tibtech.2015.09.003; Libby P, 2010, J NUCL MED, V51, p33S, DOI 10.2967/jnumed.109.069633; LIEBMANN JE, 1993, BRIT J CANCER, V68, P1104, DOI 10.1038/bjc.1993.488; Lim SM, 2009, J BIOMED MATER RES B, V90B, P521, DOI 10.1002/jbm.b.31313; Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]; Martinez-Ramos C, 2015, J BIOMED MATER RES B, V103, P1249, DOI 10.1002/jbm.b.33304; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Meng FB, 2019, ADV MATER, V31, DOI 10.1002/adma.201806899; Menon JU, 2014, ACTA BIOMATER, V10, P2643, DOI 10.1016/j.actbio.2014.01.033; Mitra A, 2013, TRENDS BIOTECHNOL, V31, P347, DOI 10.1016/j.tibtech.2013.03.006; Mittal A, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045001; Movia D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31332-6; Nguyen KT, 2009, J BIOMED MATER RES A, V88A, P1022, DOI 10.1002/jbm.a.31734; Nirmalanandhan VS, 2010, ASSAY DRUG DEV TECHN, V8, P581, DOI 10.1089/adt.2010.0276; Otterson GA, 2010, CLIN CANCER RES, V16, P2466, DOI 10.1158/1078-0432.CCR-09-3015; Parmar N, 2015, TISSUE ENG PART C-ME, V21, P404, DOI [10.1089/ten.tec.2014.0431, 10.1089/ten.TEC.2014.0431]; Pradhan S, 2017, BIOMATERIALS, V115, P141, DOI 10.1016/j.biomaterials.2016.10.052; Privalova AM, 2015, J NANOSCI NANOTECHNO, V15, P4806, DOI 10.1166/jnn.2015.10508; Qutachi O, 2014, ACTA BIOMATER, V10, P5090, DOI 10.1016/j.actbio.2014.08.015; Ravikumar P, 2016, NANOMED-NANOTECHNOL, V12, P811, DOI 10.1016/j.nano.2015.10.004; Ricci C., 2013, OA TISSUE ENG, V1, P1, DOI DOI 10.13172/2052-9643-1-1-607; ROMIJN HJ, 1988, BIOL CELL, V63, P263, DOI 10.1016/0248-4900(88)90116-5; Ruppen J, 2014, LAB CHIP, V14, P1198, DOI 10.1039/c3lc51093j; Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632; Scarpace Sarah L, 2015, Drugs Context, V4, P212289, DOI 10.7573/dic.212289; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sylvester PW, 2011, METHODS MOL BIOL, V716, P157, DOI 10.1007/978-1-61779-012-6_9; Tanaka M, 1997, AM J PHYSIOL-LUNG C, V273, pL1090, DOI 10.1152/ajplung.1997.273.5.L1090; Tocchio A, 2018, ADV MATER, V30, DOI 10.1002/adma.201705034; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wadajkar AS, 2013, BIOMATERIALS, V34, P3618, DOI 10.1016/j.biomaterials.2013.01.062; Wang CH, 2015, RSC ADV, V5, P81445, DOI 10.1039/c5ra15516a; Wang DD, 2016, RSC ADV, V6, P24083, DOI 10.1039/c6ra00229c; Wang M, 2018, ELECTROSPINNING ELEC; Wei DX, 2018, ADV MATER, V30, DOI 10.1002/adma.201802273; Xin YQ, 2013, TOXICOL LETT, V221, P73, DOI 10.1016/j.toxlet.2013.06.215; Xu B, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/3/035018; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yeung P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144139; Yu L, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4918754; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zhang Peilin, 2003, Mol Cancer, V2, P1; Zhang QC, 2012, MAT SCI ENG C-MATER, V32, P2589, DOI 10.1016/j.msec.2012.07.045; Zhang TZ, 2014, COLLOID SURFACE A, V452, P115, DOI 10.1016/j.colsurfa.2014.03.085; Zhao JG, 2014, TUMOR BIOL, V35, P12305, DOI 10.1007/s13277-014-2543-3	82	18	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217640	10.1371/journal.pone.0217640	http://dx.doi.org/10.1371/journal.pone.0217640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150477	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100078
J	Vrbova, E; Grillova, L; Mikalova, L; Pospisilova, P; Strnadel, R; Dastychova, E; Kojanova, M; Kreidlova, M; Vanousova, D; Rob, F; Prochazka, P; Krchnakova, A; Vasku, V; Woznicova, V; Heroldova, MD; Kuklova, I; Zakoucka, H; Smajs, D				Vrbova, Eliska; Grillova, Linda; Mikalova, Lenka; Pospisilova, Petra; Strnadel, Radim; Dastychova, Eliska; Kojanova, Martina; Kreidlova, Miluse; Vanousova, Daniela; Rob, Filip; Prochazka, Premysl; Krchnakova, Alena; Vasku, Vladimir; Woznicova, Vladana; Heroldova, Monika Dvorakova; Kuklova, Ivana; Zakoucka, Hana; Smajs, David			MLST typing of Treponema pallidum subsp. pallidum in the Czech Republic during 2004-2017: Clinical isolates belonged to 25 allelic profiles and harbored 8 novel allelic variants	PLOS ONE			English	Article							SYPHILIS-CAUSING STRAINS; MACROLIDE RESISTANCE; IDENTIFIED GENOTYPES; PREVALENCE; GENE; MUTATIONS; EPIDEMIOLOGY; SURVEILLANCE; ASSOCIATION; PHYLOGENIES	A recently introduced Multilocus Sequence Typing scheme for Treponema pallidum subsp. pallidum was applied to clinical samples collected from 2004 to 2017 from the two largest cities (Prague and Brno) in the Czech Republic. Altogether, a total of 675 samples were tested in this study and 281 of them were found PCR-positive for treponemal DNA and typeable. Most of the typed samples (n = 281) were swabs from primary or secondary syphilis lesions (n = 231), and only a minority were whole blood or tissue samples (n = 50). Swab samples from patients with rapid plasma regain (RPR) values of 1-1024 were more frequently PCR-positive (84.6%) compared to samples from patients with non-reactive RPR test (46.5%; p-value = 0.0001). Out of 281 typeable samples, 136 were fully-typed at all TP0136, TP0548, and TP0705 loci. Among the fully and partially typed samples, 25 different allelic profiles were identified. Altogether, eight novel allelic variants were found among fully (n = 5) and partially (n = 3) typed samples. The distribution of TPA allelic profiles identified in the Czech Republic from 2004 to 2017 revealed a dynamic character with allelic profiles disappearing and emerging over time. While the number of samples with the A2058G mutation was seen to increase (86.7% in 2016/2017), the number of samples harboring the A2059G mutation was found to have decreased over time (3.3% in 2016/2017). In addition, we found several allelic profile associations with macrolide resistance or susceptibility, the gender of patients, as well as patient residence.	[Vrbova, Eliska; Grillova, Linda; Mikalova, Lenka; Pospisilova, Petra; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Strnadel, Radim] Fac Hosp Brno, Dept Dermatovenerol, Brno, Czech Republic; [Dastychova, Eliska; Krchnakova, Alena; Vasku, Vladimir; Woznicova, Vladana; Heroldova, Monika Dvorakova] St Annes Hosp, Fac Med, Dept Med Microbiol, Brno, Czech Republic; [Dastychova, Eliska; Krchnakova, Alena; Vasku, Vladimir; Woznicova, Vladana; Heroldova, Monika Dvorakova] Masaryk Univ, Brno, Czech Republic; [Kojanova, Martina; Kuklova, Ivana] Charles Univ Prague, Fac Med 1, Dept Dermatol, Prague, Czech Republic; [Kreidlova, Miluse] Charles Univ Prague, Fac Med 1, Gen Univ Hosp, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Vanousova, Daniela; Rob, Filip] Charles Univ Prague, Fac Med 2, Dept Dermatovenerol, Prague, Czech Republic; [Prochazka, Premysl] Outpatient STI Clin Medictr, Prague, Czech Republic; [Zakoucka, Hana] Natl Inst Publ Hlth, Natl Reference Lab Diagnost Syphilis, Prague, Czech Republic; [Grillova, Linda] Inst Pasteur, Biol Spirochetes Unit, Paris, France	Masaryk University Brno; University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; National Institute of Public Health (SZU) - Czech Republic; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.	dsmajs@med.muni.cz	Grillova, Linda/AAA-8557-2020; Mikalová, Lenka/AAM-1068-2020; Kojanova, Martina/J-7224-2017	Kojanova, Martina/0000-0001-9890-9965; Pastekova, Lenka/0000-0003-4266-9952; Grillova, Linda/0000-0003-2371-3161	Grant Agency of the Czech Republic [GA17-25455S]; Ministry of Health of the Czech Republic [17-31333A]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by grants from the Grant Agency of the Czech Republic (GA17-25455S) and the Ministry of Health of the Czech Republic (17-31333A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.245; Cejkova D, 2013, J MED MICROBIOL, V62, P196, DOI 10.1099/jmm.0.050658-0; Centurion-Lara A, 2004, MOL MICROBIOL, V52, P1579, DOI 10.1111/j.1365-2958.2004.04086.x; Dai T, 2012, J CLIN MICROBIOL, V50, P3674, DOI 10.1128/JCM.01195-12; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flasarova M., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P105; Flasarova M, 2012, ACTA DERM-VENEREOL, V92, P669, DOI 10.2340/00015555-1335; Vaulet LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172905; Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622; Giacani L, 2018, SEX TRANSM DIS, V45, P237, DOI 10.1097/OLQ.0000000000000741; Godornes C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006113; Grange PA, 2016, SEX TRANSM DIS, V43, P517, DOI 10.1097/OLQ.0000000000000474; Grange PA, 2013, SEX TRANSM DIS, V40, P641, DOI 10.1097/OLQ.0000000000000006; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; Grillova L, 2019, PEERJ, V6, DOI 10.7717/peerj.6182; Grillova L, 2019, J INFECT DIS, V219, P1138, DOI 10.1093/infdis/jiy604; Grillova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200773; Grillova L, 2014, J CLIN MICROBIOL, V52, P3693, DOI 10.1128/JCM.01292-14; Grimes M, 2012, SEX TRANSM DIS, V39, P954, DOI 10.1097/OLQ.0b013e31826ae7a8; Katz KA, 2010, SEX TRANSM DIS, V37, P660, DOI 10.1097/OLQ.0b013e3181e1a77a; Khairullin R, 2016, APMIS, V124, P595, DOI 10.1111/apm.12541; Kojima Y, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01148-18; Kumar S, 2015, MOL BIOL EVOL UNPUB; Li Z, 2017, APMIS, V125, P937, DOI 10.1111/apm.12724; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Matejkova P, 2009, J MED MICROBIOL, V58, P832, DOI 10.1099/jmm.0.007542-0; Mikalova L, 2017, SEX TRANSM DIS, V44, P376, DOI 10.1097/OLQ.0000000000000600; Mikalova L, 2014, SEX TRANSM DIS, V41, P552, DOI 10.1097/OLQ.0000000000000165; Molini BJ, 2016, SEX TRANSM DIS, V43, P579, DOI 10.1097/OLQ.0000000000000486; Nechvatal L, 2014, INT J MED MICROBIOL, V304, P645, DOI 10.1016/j.ijmm.2014.04.007; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Noda AA, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.02.006; Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73; Peng RR, 2012, SEX TRANSM DIS, V39, P42, DOI 10.1097/OLQ.0b013e318232697d; Peng RR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001273; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Pinto M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.190; Pospisilova P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201068; Radolf JD, 2016, NAT REV MICROBIOL, V14, P744, DOI 10.1038/nrmicro.2016.141; Read P, 2016, J CLIN MICROBIOL, V54, P2172, DOI 10.1128/JCM.00959-16; Samajs D, 2015, AM J TROP MED HYG, V93, P678, DOI 10.4269/ajtmh.15-0316; Smajs D., 2016, FORUM IMMUN DIS THER, V7, P181, DOI DOI 10.1615/F0RUMIMMUNDISTHER.2017020184; Smajs D, 2018, INFECT GENET EVOL, V61, P92, DOI 10.1016/j.meegid.2018.03.015; Stamm LV, 2000, ANTIMICROB AGENTS CH, V44, P806, DOI 10.1128/AAC.44.3.806-807.2000; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Strouhal M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006867; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tipple C, 2011, SEX TRANSM INFECT, V87, P486, DOI 10.1136/sextrans-2011-050082; Wu BR, 2014, CLIN MICROBIOL INFEC, V20, P802, DOI 10.1111/1469-0691.12529; Xiao YJ, 2016, SEX TRANSM DIS, V43, P310, DOI 10.1097/OLQ.0000000000000445; Zhang RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175477; Zhu BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159787	52	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217611	10.1371/journal.pone.0217611	http://dx.doi.org/10.1371/journal.pone.0217611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150464	gold, Green Submitted, Green Published			2022-12-26	WOS:000469759100071
J	Li, ZY; Jiang, CH; Yuan, YX				Li, Zaiye; Jiang, Canhua; Yuan, Yongxiang			TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; UP-REGULATION; DOWN-REGULATION; CANCER-CELLS; EXPRESSION; INVASION; PROMOTES; PROLIFERATION; HEAD; PROGRESSION	Objectives The study aimed to investigate the ceRNA network in biological development of Tongue Squamous Cell Carcinoma (TSCC) and to identify novel molecular subtypes of TSCC to screen potential biomarkers for target therapy and prognosis by using integrated genomic analysis based on The Cancer Genome Atlas (TCGA) database. Material and methods Data on gene expressions were downloaded from TCGA and GEO database. Differentially expressed RNAs (DERNAs) were shown by DESeq2 package in R. Functional enrichment analysis of DEmRNAs was performed using clusterprofilers in R. PPI network was established by referring to String website. Survival analysis of DERNAs was carried out by survival package in R. Interactions among mRNAs, miRNAs and lncRNAs were obtained from Starbase v3.0 and used to construct ceRNA network. Consensus Cluster Plus package was applied to identify molecular subtypes. All key genes were validated by comparing them with GEO microarray data. Statistical analyses of clinical features among different subtypes were performed using SPSS 22.0. Results A total of 2907 mRNAs (1366 up-regulated and 1541 down-regulated), 191miRNAs (98 upregulated and 93 down-regulated) and 1831 lncRNAs (1151 up-regulated and 680 downregulated) were identified from tumor and normal tissues. A ceRNA network was successfully constructed and 15 DEmRNAs, 1 DEmiRNA, 2 DElncRNAs associated with prognosis were employed. Furthermore, we firstly identified 2 molecular subtypes, basal and differentiated, and found that differentiated subtype consumed less alcohol and was related to a better overall survival. Conclusion The study constructed a ceRNA network and identified molecular subtypes of TSCC, and our findings provided a novel insight into this intractable cancer and potential therapeutic targets and prognostic indicators.	[Li, Zaiye; Jiang, Canhua; Yuan, Yongxiang] Cent South Univ, Xiangya Hosp, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China	Central South University	Li, ZY (corresponding author), Cent South Univ, Xiangya Hosp, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China.	zaiyl01@163.com		Li, Zaiye/0000-0002-1922-4237				Afsharpad M, 2019, PATHOL ONCOL RES, V25, P191, DOI 10.1007/s12253-017-0313-4; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Cai YY, 2016, MOL MED REP, V13, P4827, DOI 10.3892/mmr.2016.5134; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Cheng XL, 2009, J BIOL CHEM, V284, P30897, DOI 10.1074/jbc.M109.011213; Feng L, 2017, ONCOTARGET, V8, P31521, DOI 10.18632/oncotarget.16358; Gupta B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113385; Hakami F, 2014, BRIT J CANCER, V111, P807, DOI 10.1038/bjc.2014.372; He BX, 2018, J CELL BIOCHEM, V119, P338, DOI 10.1002/jcb.26182; Hernandez-Plata E, 2012, INT J CANCER, V130, P2013, DOI 10.1002/ijc.26210; Hou XF, 2017, WORLD J GASTROENTERO, V23, P1796, DOI 10.3748/wjg.v23.i10.1796; Hu QC, 2019, ORAL ONCOL, V89, P14, DOI 10.1016/j.oraloncology.2018.12.006; Huang SH, 2018, J CELL BIOCHEM, V119, P2248, DOI 10.1002/jcb.26387; Ion Ciuca Marasescu F I, 2018, Curr Health Sci J, V44, P211, DOI 10.12865/CHSJ.44.03.03; Jia LF, 2014, INT J CANCER, V135, P2282, DOI 10.1002/ijc.28667; Jiang HB, 2010, J CANCER RES CLIN, V136, P1295, DOI 10.1007/s00432-010-0780-4; Kazemi-Oula G, 2015, CELL J, V17, P471; Kokemueller H, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-27; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02522-5; Li F, 2018, CLIN CHEM, V64, P1513, DOI 10.1373/clinchem.2018.290569; Li Q, 2015, ONCOL REP, V33, P2354, DOI 10.3892/or.2015.3812; Li SM, 2017, ORAL ONCOL, V73, P1, DOI 10.1016/j.oraloncology.2017.07.026; Liu PY, 2012, INVEST NEW DRUG, V30, P79, DOI 10.1007/s10637-010-9518-z; Liu WH, 2018, BIOMED PHARMACOTHER, V104, P94, DOI 10.1016/j.biopha.2018.05.015; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Lu SX, 2017, CANCER LETT, V402, P71, DOI 10.1016/j.canlet.2017.05.018; Morita Y, 2015, CLIN EXP METASTAS, V32, P739, DOI 10.1007/s10585-015-9741-2; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Nair S, 2016, EUR ARCH OTO-RHINO-L, V273, P3921, DOI 10.1007/s00405-016-4051-0; Nishikawa Y, 2011, ONCOL REP, V26, P587, DOI 10.3892/or.2011.1324; Nohata N, 2016, ORAL ONCOL, V59, P58, DOI 10.1016/j.oraloncology.2016.05.014; Patel F, 2015, INT J DEV BIOL, V59, P357, DOI 10.1387/ijdb.150171wb; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Rastogi B, 2017, CANCER INVEST, V35, P152, DOI 10.1080/07357907.2017.1286669; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shan B, 2014, ONCOL LETT, V8, P345, DOI 10.3892/ol.2014.2110; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simoes-Sousa S, 2016, CELL CYCLE, V15, P1865, DOI 10.1080/15384101.2016.1188239; Song H, 2012, CANCER GENE THER, V19, P875, DOI 10.1038/cgt.2012.77; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Voelxen NF, 2018, CLIN ORAL INVEST, V22, P1033, DOI 10.1007/s00784-017-2185-0; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Wang KT, 2014, MOL MED REP, V9, P273, DOI 10.3892/mmr.2013.1804; Wang ZY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-017-0752-2; Wang ZS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-76; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xiang X, 2015, ONCOTARGET, V6, P22452, DOI 10.18632/oncotarget.4311; Xu K, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4357647; Yin WW, 2016, J CLIN NEUROSCI, V33, P187, DOI 10.1016/j.jocn.2016.04.019; Yu JS, 2016, P NATL ACAD SCI USA, V113, P11549, DOI 10.1073/pnas.1612368113; Zevallos JP, 2019, LARYNGOSCOPE, V129, P154, DOI 10.1002/lary.27340; Zhang R, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0171-2; Zhang TF, 2013, MOL CARCINOGEN, V52, P581, DOI 10.1002/mc.21880; Zhang XA, 2018, CELL MOL BIOL LETT, V23, DOI 10.1186/s11658-018-0120-2; Zhou XL, 2015, MOL MED REP, V12, P885, DOI 10.3892/mmr.2015.3467	58	17	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216834	10.1371/journal.pone.0216834	http://dx.doi.org/10.1371/journal.pone.0216834			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141819	Green Submitted, gold, Green Published			2022-12-26	WOS:000469323000026
J	Havranek, KE; White, LA; Lanchy, JM; Lodmell, JS				Havranek, Katherine E.; White, Luke Adam; Lanchy, Jean-Marc; Lodmell, J. Stephen			Transcriptome profiling in Rift Valley fever virus infected cells reveals modified transcriptional and alternative splicing programs	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NSS PROTEIN; HOST; TFIIH; EXPRESSION; LOCALIZATION; REGULATOR; REPAIR; CLK2; P68	Rift Valley fever virus (RVFV) is a negative-sense RNA virus belonging to the Phenuiviridae family that infects both domestic livestock and humans. The NIAID has designated RVFV as a Category A priority emerging pathogen due to the devastating public health outcomes associated with epidemic outbreaks. However, there is no licensed treatment or vaccine approved for human use. Therefore it is of great interest to understand RVFV pathogenesis in infected hosts in order to facilitate creation of targeted therapies and treatment options. Here we provide insight into the host-pathogen interface in human HEK293 cells during RVFV MP-12 strain infection using high-throughput mRNA sequencing technology. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of differentially expressed genes showed robust innate immune and cytokine-mediated inflammatory pathway activation as well as alterations in pathways associated with fatty acid metabolism and extracellular matrix receptor signaling. We also analyzed the promoter regions of DEGs for patterns in transcription factor binding sites, and found several that are known to act synergistically to impact apoptosis, immunity, metabolism, and cell growth and differentiation. Lastly, we noted dramatic changes in host alternative splicing patterns in genes associated with mRNA decay and surveillance, RNA transport, and DNA repair. This study has improved our understanding of RVFV pathogenesis and has provided novel insight into pathways and signaling modules important for RVFV diagnostics and therapeutic development.	[Havranek, Katherine E.; White, Luke Adam; Lanchy, Jean-Marc; Lodmell, J. Stephen] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Lodmell, J. Stephen] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Lodmell, JS (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.; Lodmell, JS (corresponding author), Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA.	stephen.lodmell@umontana.edu		White, Luke/0000-0003-4548-0661	National Institute of Allergy and Infectious Diseases [R15AI105737]; National Institute of General Medical Sciences [P20GM103546]; NIH [R15AI105737, P20GM103546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI137620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021710] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institute of Allergy and Infectious Diseases (URL: NIH. gov) (grant R15AI105737 to JSL) and National Institute of General Medical Sciences (URL: NIH. gov) (grant P20GM103546) (S. Sprang, P I.; JSL Pilot Project P.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to gratefully acknowledge funding support for this work from NIH grants R15AI105737 to JSL and P20GM103546 (S. Sprang, P.I.; JSL Pilot Project P.I.). We wish to thank Jim Reed and Dr. Scott Wetzel for their gracious help with discussions and analysis of the flow cytometry samples. The following reagent was obtained from the Joel M. Dalrymple-Clarence J. Peters USAMRIID Antibody Collection through BEI Resources, NIAID, NIH: Monoclonal Anti-Rift Valley Fever Virus Gn Glycoprotein, Clone 3C10 (produced in vitro), NR-43186.	Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y; Annese A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22701-2; Aversa R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010121; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Batra R, 2016, NAT STRUCT MOL BIOL, V23, P1101, DOI 10.1038/nsmb.3310; Bauer DLV, 2018, CELL REP, V23, P2119, DOI 10.1016/j.celrep.2018.04.047; Bavelloni A, 2017, ANTICANCER RES, V37, P6511, DOI 10.21873/anticanres.12107; Benferhat R, 2012, J VIROL, V86, P11333, DOI 10.1128/JVI.01549-12; Bing L, 2019, GENOMICS, V111, P242, DOI 10.1016/j.ygeno.2018.11.011; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Blomstrom AL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1538-9; Boudreault S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161914; Brennan B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003922; Coetzer J., 2004, INFECT DIS LIVESTOCK; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; de la Fuente C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191983; De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Di Pietro A, 2013, J VIROL, V87, P4523, DOI 10.1128/JVI.02548-12; Dichmann DS, 2015, CELL REP, V10, P527, DOI 10.1016/j.celrep.2014.12.046; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dupuis-Maurin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118551; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Feng J, 2014, J VIROL, V88, P7987, DOI 10.1128/JVI.00643-14; Frasor J, 2015, MOL CELL ENDOCRINOL, V418, P235, DOI 10.1016/j.mce.2014.09.013; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Glennon NB, 2015, J VIROL, V89, P7550, DOI 10.1128/JVI.00302-15; Guo L, 2018, FUTURE VIROL, V13, P211, DOI 10.2217/fvl-2017-0106; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Han LL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23478-0; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hopkins KC, 2015, P NATL ACAD SCI USA, V112, pE2920, DOI 10.1073/pnas.1418805112; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Indran SV, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00131; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koks S, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00046; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Laine JP, 2006, METHOD ENZYMOL, V408, P246, DOI 10.1016/S0076-6879(06)08015-3; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee YJ, 2018, GENE DEV, V32, P1060, DOI 10.1101/gad.316034.118; Lin L, 2016, HUM MOL GENET, V25, P3454, DOI 10.1093/hmg/ddw187; Lin WS, 2017, MOL MED REP, V16, P2075, DOI 10.3892/mmr.2017.6855; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; Liu Y. X., 2014, J NATL U DEFENCE TEC, V26, P6, DOI DOI 10.1371/J0URNAL.PPAT.1004199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; McCarthy MK, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/236345; McElroy AK, 2012, VIROLOGY, V422, P6, DOI 10.1016/j.virol.2011.09.023; Moore HC, 2011, RNA, V17, P555, DOI 10.1261/rna.2591611; Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020; Narayanan A, 2014, VIROLOGY, V449, P270, DOI 10.1016/j.virol.2013.11.023; Narayanan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020354; Okumu LA, 2010, REPRODUCTION, V140, P143, DOI 10.1530/REP-10-0113; Pinkham C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14800-3; Rossler OG, 2000, NUCLEIC ACIDS RES, V28, P932, DOI 10.1093/nar/28.4.932; Sessions OM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002107; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; Takashima K, 2015, CELL REP, V11, P192, DOI 10.1016/j.celrep.2015.03.027; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Werder RB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0052; Wonderlich Elizabeth R, 2018, J Virol, V92, DOI 10.1128/JVI.01662-17; Yadani FZ, 1999, J VIROL, V73, P5018, DOI 10.1128/JVI.73.6.5018-5025.1999; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida T, 2015, CANCER RES, V75, P1516, DOI 10.1158/0008-5472.CAN-14-2443; Zhong HQ, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-18195-Z, 10.1038/s41598-017-18195-z]	79	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217497	10.1371/journal.pone.0217497	http://dx.doi.org/10.1371/journal.pone.0217497			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136639	Green Published, Green Submitted, gold			2022-12-26	WOS:000469224300045
J	Al-Hameed, S; Benaissa, M; Christensen, H; Mirheidari, B; Blackburn, D; Reuber, M				Al-Hameed, Sabah; Benaissa, Mohammed; Christensen, Heidi; Mirheidari, Bahman; Blackburn, Daniel; Reuber, Markus			A new diagnostic approach for the identification of patients with neurodegenerative cognitive complaints	PLOS ONE			English	Article							SPONTANEOUS SPEECH ANALYSIS; MINI-MENTAL STATE; REVISED ACE-R; ALZHEIMERS-DISEASE; FEATURE-SELECTION; CENTROID FEATURES; DEMENTIA; IMPAIRMENT; CLASSIFICATION; ALGORITHMS	Neurodegenerative diseases causing dementia are known to affect a person's speech and language. Part of the expert assessment in memory clinics therefore routinely focuses on detecting such features. The current outpatient procedures examining patients' verbal and interactional abilities mainly focus on verbal recall, word fluency, and comprehension. By capturing neurodegeneration-associated characteristics in a person's voice, the incorporation of novel methods based on the automatic analysis of speech signals may give us more information about a person's ability to interact which could contribute to the diagnostic process. In this proof-of-principle study, we demonstrate that purely acoustic features, extracted from recordings of patients' answers to a neurologist's questions in a specialist memory clinic can support the initial distinction between patients presenting with cognitive concerns attributable to progressive neurodegenerative disorders (ND) or Functional Memory Disorder (FMD, i.e., subjective memory concerns unassociated with objective cognitive deficits or a risk of progression). The study involved 15 FMD and 15 ND patients where a total of 51 acoustic features were extracted from the recordings. Feature selection was used to identify the most discriminating features which were then used to train five different machine learning classifiers to differentiate between the FMD/ND classes, achieving a mean classification accuracy of 96.2%. The discriminative power of purely acoustic approaches could be integrated into diagnostic pathways for patients presenting with memory concerns and are computationally less demanding than methods focusing on linguistic elements of speech and language that require automatic speech recognition and understanding.	[Al-Hameed, Sabah; Benaissa, Mohammed] Univ Sheffield, Dept Elect & Elect Engn, Sheffield, S Yorkshire, England; [Christensen, Heidi; Mirheidari, Bahman] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England; [Christensen, Heidi] Univ Sheffield, Ctr Assist Technol & Connected Healthcare, Sheffield, S Yorkshire, England; [Blackburn, Daniel] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England; [Reuber, Markus] Univ Sheffield, Royal Hallamshire Hosp, Acad Neurol Unit, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Al-Hameed, S (corresponding author), Univ Sheffield, Dept Elect & Elect Engn, Sheffield, S Yorkshire, England.	ssaal-hameed1@sheffield.ac.uk		Christensen, Heidi/0000-0003-3028-5062; blackburn, daniel/0000-0001-8886-1283; Al-Hameed, Sabah/0000-0003-3617-9906	NIHR Sheffield Biomedical Research Centre (Translational Neuroscience); NIHR Research for Patient Benefit (RfPB) Programme [PB-PG-0211-24079]	NIHR Sheffield Biomedical Research Centre (Translational Neuroscience); NIHR Research for Patient Benefit (RfPB) Programme	We acknowledge the support of the NIHR Sheffield Biomedical Research Centre (Translational Neuroscience) and funder NIHR Research for Patient Benefit (RfPB) Programme: PB-PG-0211-24079-Using Conversation Analysis in the Differential Diagnosis of Memory Problems: a pilot study. 2013-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hameed S., 2017, P INT C BIOINFORMATI, P57, DOI DOI 10.1145/3175587.3175589; Al-Hameed S., 2016, 7 WORKSH SPEECH LANG, P32, DOI [DOI 10.21437/SLPAT.2016-6, 10.21437/SLPAT.2016-6]; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; [Anonymous], 2017, REL STAT WIND; ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730; Bennys K, 2001, NEUROPHYSIOL CLIN, V31, P153, DOI 10.1016/S0987-7053(01)00254-4; Blackburn DJ, 2014, BRIT MED BULL, V112, P71, DOI 10.1093/bmb/ldu029; Boersma Paul, 2002, GLOT INT, V5, P341; Brown RKJ, 2014, RADIOGRAPHICS, V34, P684, DOI 10.1148/rg.343135065; Camargo EE, 2001, J NUCL MED, V42, P611; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Commissaris CJAM, 1998, PATIENT EDUC COUNS, V34, P25, DOI 10.1016/S0738-3991(98)00040-8; DAVIS SB, 1980, IEEE T ACOUST SPEECH, V28, P357, DOI 10.1109/TASSP.1980.1163420; de Cheveigne A, 2002, J ACOUST SOC AM, V111, P1917, DOI 10.1121/1.1458024; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Elsey C, 2015, PATIENT EDUC COUNS, V98, P1071, DOI 10.1016/j.pec.2015.05.021; Faure-Bardon V, 2018, AIDS, V32, P321, DOI 10.1097/QAD.0000000000001681; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraser KC, 2016, J ALZHEIMERS DIS, V49, P407, DOI 10.3233/JAD-150520; Gajic B, 2001, INT CONF ACOUST SPEE, P85, DOI 10.1109/ICASSP.2001.940773; Gayraud F, 2011, CLIN LINGUIST PHONET, V25, P198, DOI 10.3109/02699206.2010.521612; Gosztolya G, 2019, COMPUT SPEECH LANG, V53, P181, DOI 10.1016/j.csl.2018.07.007; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hodge S, 2013, ENGLISH NATL MEMORY; Jarrold W., 2014, P WORKSH COMP LING C, P27, DOI [10.3115/v1/W14-3204, DOI 10.3115/V1/W14-3204]; Jones D, 2016, AGING MENT HEALTH, V20, P500, DOI 10.1080/13607863.2015.1021753; Khan T, 2014, BIOCYBERN BIOMED ENG, V34, P35, DOI 10.1016/j.bbe.2013.10.003; Konig Alexandra, 2015, Alzheimers Dement (Amst), V1, P112, DOI 10.1016/j.dadm.2014.11.012; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larner AJ, 2007, AGE AGEING, V36, P685, DOI 10.1093/ageing/afm112; Laske C, 2015, ALZHEIMERS DEMENT, V11, P561, DOI 10.1016/j.jalz.2014.06.004; Li T, 2004, BIOINFORMATICS, V20, P2429, DOI 10.1093/bioinformatics/bth267; Lopez-de-Ipina K, 2015, COGN COMPUT, V7, P44, DOI 10.1007/s12559-013-9229-9; Lopez-de-Ipina K., 2013, 2013 IEEE 17th International Conference on Intelligent Engineering Systems (INES), P61, DOI 10.1109/INES.2013.6632783; Lopez-de-Ipina K, 2015, COMPUT SPEECH LANG, V30, P43, DOI 10.1016/j.csl.2014.08.002; Lopez-de-Ipina K, 2013, SENSORS-BASEL, V13, P6730, DOI 10.3390/s130506730; MacWhinney B, 2007, CREATING AND DIGITIZING LANGUAGE CORPORA VOLUME 1: SYNCHRONIC DATABASES, P163; Mazzoni D, 1999, AUDACITY; Meilan JJG, 2014, DEMENT GERIATR COGN, V37, P327, DOI 10.1159/000356726; Metternich B, 2009, J PSYCHOSOM RES, V66, P435, DOI 10.1016/j.jpsychores.2008.07.005; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mirheidari B, 2017, INTERSPEECH, P3147, DOI 10.21437/Interspeech.2017-690; Mirheidari B, 2016, INTERSPEECH, P1220, DOI 10.21437/Interspeech.2016-857; Mirheidari B, 2017, J ALZHEIMERS DIS, V58, P373, DOI 10.3233/JAD-160507; Paliwal KK, 1998, INT CONF ACOUST SPEE, P617, DOI 10.1109/ICASSP.1998.675340; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Le N, 2011, SPEECH COMMUN, V53, P540, DOI 10.1016/j.specom.2011.01.005; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Raven J.C., 1958, GUIDE USING COLOURED; Roark B, 2011, IEEE T AUDIO SPEECH, V19, P2081, DOI 10.1109/TASL.2011.2112351; Saenz-Lechon N, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P3667; Satt A, 2013, INTERSPEECH, P1691; Schmidtke K, 2008, AM J GERIAT PSYCHIAT, V16, P981, DOI 10.1097/JGP.0b013e318187ddf9; Singh S, 2001, APHASIOLOGY, V15, P571, DOI 10.1080/02687040143000041; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szatloczki G, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00195; Toth L, 2018, CURR ALZHEIMER RES, V15, P130, DOI 10.2174/1567205014666171121114930; Tsanas A, 2012, IEEE T BIO-MED ENG, V59, P1264, DOI 10.1109/TBME.2012.2183367; Tsanas A, 2010, IEEE T BIO-MED ENG, V57, P884, DOI 10.1109/TBME.2009.2036000; Villarejo A, 2011, NEUROLOGIA, V26, P425, DOI 10.1016/j.nrl.2010.12.002; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; Weiner J, 2016, INTERSPEECH, P1938, DOI 10.21437/Interspeech.2016-100	68	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217388	10.1371/journal.pone.0217388	http://dx.doi.org/10.1371/journal.pone.0217388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125389	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000468865700034
J	Zhang, XZ; Peng, YH; Grace, PM; Metcalf, MD; Kwilasz, AJ; Wang, YB; Zhang, TS; Wu, SR; Selfridge, BR; Portoghese, PS; Rice, KC; Watkins, LR; Hutchinson, MR; Wang, XH				Zhang, Xiaozheng; Peng, Yinghua; Grace, Peter M.; Metcalf, Matthew D.; Kwilasz, Andrew J.; Wang, Yibo; Zhang, Tianshu; Wu, Siru; Selfridge, Brandon R.; Portoghese, Philip S.; Rice, Kenner C.; Watkins, Linda R.; Hutchinson, Mark R.; Wang, Xiaohui			Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling	FASEB JOURNAL			English	Article						norbinaltorphimine; enantioselective modulation; TLR4; MD-2; morphine analgesia	MOLECULAR-DYNAMICS SIMULATIONS; STRUCTURAL BASIS; BINDING MODE; ACTIVATION; (+)-NALTREXONE; DOCKING; SYSTEM; ABUSE	Deregulation of innate immune TLR4 signaling contributes to various diseases including neuropathic pain and drug addiction. Naltrexone is one of the rare TLR4 antagonists with good blood-brain barrier permeability and showing no stereoselectivity for TLR4. By linking 2 naltrexone units through a rigid pyrrole spacer, the bivalent ligand norbinaltorphimine was formed. Interestingly, (+)-norbinaltorphimine [(+)-1] showed similar to 25 times better TLR4 antagonist activity than naltrexone in microglial BV-2 cell line, whereas (-)-norbinaltorphimine [(-)-1] lost TLR4 activity. The enantioselectivity of norbinaltorphimine was further confirmed in primary microglia, astrocytes, and macrophages. The activities of meso isomer of norbinaltorphimine and the molecular dynamic simulation results demonstrate that the stereochemistry of (+)-1 is derived from the (+)-naltrexone pharmacophore. Moreover, (+)-1 significantly increased and prolonged morphine analgesia in vivo. The efficacy of (+)-1 is long lasting. This is the first report showing enantioselective modulation of the innate immune TLR signaling.-Zhang, X., Peng, Y., Grace, P. M., Metcalf, M. D., Kwilasz, A. J., Wang, Y., Zhang, T., Wu, S., Selfridge, B. R., Portoghese, P. S., Rice, K. C., Watkins, L. R., Hutchinson, M. R., Wang, X. Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling.	[Zhang, Xiaozheng; Wang, Yibo; Zhang, Tianshu; Wu, Siru; Wang, Xiaohui] Chinese Acad Sci, Changchun Inst Appl Chem, Biol Chem Lab, Changchun, Jilin, Peoples R China; [Zhang, Xiaozheng; Wang, Yibo; Zhang, Tianshu; Wu, Siru; Wang, Xiaohui] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaozheng; Wang, Xiaohui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Peng, Yinghua] Chinese Acad Agr Sci, Inst Special Wild Econ Anim & Plants, State Key Lab Mol Biol Special Econ Anim, Changchun, Jilin, Peoples R China; [Grace, Peter M.; Kwilasz, Andrew J.; Watkins, Linda R.] Univ Colorado Boulder, Dept Psychol & Neurosci, Ctr Neurosci, Boulder, CO USA; [Metcalf, Matthew D.; Portoghese, Philip S.] Univ Minnesota, Coll Pharm, Dept Med Chem, Minneapolis, MN 55455 USA; [Selfridge, Brandon R.; Rice, Kenner C.] NIDA, Drug Design & Synth Sect, Bethesda, MD 20892 USA; [Selfridge, Brandon R.; Rice, Kenner C.] NIAAA, Bethesda, MD USA; [Hutchinson, Mark R.] Univ Adelaide, Discipline Physiol, Adelaide Med Sch, Adelaide, SA, Australia; [Hutchinson, Mark R.] Univ Adelaide, Australian Res Council ARC, Ctr Excellence Nanoscale Biophoton, Adelaide, SA, Australia; [Wang, Xiaohui] Univ Sci & Technol China, Dept Appl Chem & Engn, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Nanjing University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS; University of Colorado System; University of Colorado Boulder; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Adelaide; University of Adelaide; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, XH (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, 5625 Renmin St, Changchun 130022, Jilin, Peoples R China.	xiaohui.wang@ciac.ac.cn	Hutchinson, Mark/N-1815-2019; zhang, tian/GZK-6001-2022; Grace, Peter/I-5507-2013; Wang, Xiaohui/B-8126-2011	Hutchinson, Mark/0000-0003-2154-5950; Wang, Yibo/0000-0003-1262-4497; Grace, Peter/0000-0002-8999-1220; Zhang, Xiaozheng/0000-0003-2449-057X; Wang, Xiaohui/0000-0002-3415-5612	National Key Research and Development Program of China [2016YFC0800907]; National Natural Science Foundation of China [21850410455, 21750110432, 21877106]; Central Public-interest Scientific Institution Basal Research Fund [1610342016013]; Natural Science Foundation of Jilin Province [20180101021JC]; Open Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University [KF-GN-201601]; U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant [R01 DE017782]; 100 Talents Program of Chinese Academy of Sciences; Young Talents Program of Chinese Academy of Agricultural Sciences; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000530] Funding Source: NIH RePORTER	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public-interest Scientific Institution Basal Research Fund; Natural Science Foundation of Jilin Province; Open Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University; U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant; 100 Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Young Talents Program of Chinese Academy of Agricultural Sciences; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Drug Supply Program of National Institute of Drug Abuse (Bethesda, MD, USA) for providing (-)-norbinaltorphimine. The authors also thank the Network and Coumputing Center, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, National Supercomputer Center of China in Guangzhou and the Computing Center of Jilin Province for the supply of computational resources. This work was supported by the National Key Research and Development Program of China (2016YFC0800907), the National Natural Science Foundation of China (21850410455, 21750110432, 21877106), the 100 Talents Program of Chinese Academy of Sciences, Young Talents Program of Chinese Academy of Agricultural Sciences, Central Public-interest Scientific Institution Basal Research Fund (NO. 1610342016013), Natural Science Foundation of Jilin Province (20180101021JC), Open Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University (Grant No. KF-GN-201601), and U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant R01 DE017782 (to L. R. W.). The authors declare no conflicts of interest.	Bachtell R, 2015, CNS NEUROL DISORD-DR, V14, P692, DOI 10.2174/1871527314666150529132503; BAXTER J, 1981, J OPER RES SOC, V32, P815, DOI 10.2307/2581397; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Blum C, 2008, STUD COMPUT INTELL, V114, P1, DOI 10.1007/978-3-540-78295-7; Coller JK, 2012, PHARMACOL THERAPEUT, V134, P219, DOI 10.1016/j.pharmthera.2012.01.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dennington R., 2016, GAUSSVIEW VERSION 6; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fu WT, 2016, DRUG DES DEV THER, V10, P455, DOI 10.2147/DDDT.S98466; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Ikeda H, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-43; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lacagnina MJ, 2018, PHARMACOL THERAPEUT, V184, P145, DOI 10.1016/j.pharmthera.2017.10.006; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lewis SS, 2010, NEUROSCIENCE, V165, P569, DOI 10.1016/j.neuroscience.2009.10.011; Manning TJ, 1999, J NEUROSCI METH, V91, P73, DOI 10.1016/S0165-0270(99)00083-7; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Neumann H, 2013, NAT NEUROSCI, V16, P253, DOI 10.1038/nn.3338; Northcutt AL, 2015, MOL PSYCHIATR, V20, P1525, DOI 10.1038/mp.2014.177; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PORTOGHESE PS, 1988, J MED CHEM, V31, P836, DOI 10.1021/jm00399a026; PORTOGHESE PS, 1988, J MED CHEM, V31, P1344, DOI 10.1021/jm00402a015; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Selfridge BR, 2015, J MED CHEM, V58, P5038, DOI 10.1021/acs.jmedchem.5b00426; Shah M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39271; Spackova N, 2003, J AM CHEM SOC, V125, P1759, DOI 10.1021/ja025660d; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P16719, DOI 10.1039/c4cp01388c; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theberge FR, 2013, BIOL PSYCHIAT, V73, P729, DOI 10.1016/j.biopsych.2012.12.019; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang X, 2016, BRIT J PHARMACOL, V173, P856, DOI 10.1111/bph.13394; Wang X., 2014, MICROGLIA HLTH DIS, P299; Wang XH, 2013, FASEB J, V27, P2713, DOI 10.1096/fj.12-222992; Wang XH, 2013, CHEM SOC REV, V42, P4859, DOI 10.1039/c3cs60039d; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang Z, 2015, MOL BIOSYST, V11, P1933, DOI 10.1039/c5mb00085h; Watkins LR, 2009, TRENDS PHARMACOL SCI, V30, P581, DOI 10.1016/j.tips.2009.08.002; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zhang T. S., 2016, PROG PHARM SCI, V39, P56; Zhang XZ, 2018, J CHEM INF MODEL, V58, P816, DOI 10.1021/acs.jcim.7b00717; [张晓铮 Zhang Xiaozheng], 2016, [应用化学, Chinese Journal of Applied Chemistry], V33, P876	58	11	12	3	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9577	9587		10.1096/fj.201900173RRR	http://dx.doi.org/10.1096/fj.201900173RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162938	Green Published			2022-12-26	WOS:000478832900068
J	Cortina, ME; Ende, RJ; Bishop, RC; Bayne, C; Derre, I				Cortina, Maria Eugenia; Ende, Rachel J.; Bishop, R. Clayton; Bayne, Charlie; Derre, Isabelle			Chlamydia trachomatis and Chlamydia muridarum spectinomycin resistant vectors and a transcriptional fluorescent reporter to monitor conversion from replicative to infectious bacteria	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ENDOPLASMIC-RETICULUM; DEVELOPMENTAL CYCLE; MUTAGENESIS; EXPRESSION; REVEALS; MODEL; ADENYLTRANSFERASE; TRANSFORMATION; SEQUENCE	Chlamydia trachomatis infections are the leading cause of sexually transmitted infections of bacterial origin. Lower genital tract infections are often asymptomatic, and therefore left untreated, leading to ascending infections that have long-term consequences on female reproductive health. Human pathology can be recapitulated in mice with the mouse adapted strain C. muridarum. Eight years into the post-genetic era, significant advances to expand the Chlamydia genetic toolbox have been made to facilitate the study of this important human pathogen. However, the need for additional tools remains, especially for C. muridarum. Here, we describe a new set of spectinomycin resistant E. coli-Chlamydia shuttle vectors, for C. trachomatis and C. muridarum. These versatile vectors allow for expression and localization studies of Chlamydia effectors, such as Inc proteins, and will be instrumental for mutant complementation studies. In addition, we have exploited the differential expression of specific Chlamydia genes during the developmental cycle to engineer an omcA::gfp fluorescent transcriptional reporter. This novel tool allows for monitoring RB to EB conversion at the bacterial level. Spatiotemporal tracking of GFP expression within individual inclusions revealed that RB to EB conversion initiates in bacteria located at the edge of the inclusion and correlates with the time post initiation of bacterial replication and inclusion size. Comparison between primary and secondary inclusions potentially suggests that the environment in which the inclusions develop influences the timing of conversion. Altogether, the Chlamydia genetic tools described here will benefit the field, as we continue to investigate the molecular mechanisms underlying Chlamydia-host interaction and pathogenesis.	[Cortina, Maria Eugenia; Ende, Rachel J.; Bishop, R. Clayton; Bayne, Charlie; Derre, Isabelle] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA	University of Virginia	Derre, I (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	id8m@virginia.edu		Bayne, Charlie/0000-0003-1870-5298	National Institutes of Health [AI007046, AI101441, AI141841]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101441, T32AI007046, R21AI141841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI007046 to RJE and RCB, and AI101441 and AI141841 to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Aeberhard L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004883; Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; BARRON AL, 1981, J INFECT DIS, V143, P63, DOI 10.1093/infdis/143.1.63; Bauler LD, 2014, J BACTERIOL, V196, P1325, DOI 10.1128/JB.01290-13; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101634; CLARKE IN, 1988, GENE, V71, P307, DOI 10.1016/0378-1119(88)90047-9; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fadel S, 2007, J MED MICROBIOL, V56, P15, DOI 10.1099/jmm.0.46801-0; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Han Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00079; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; JAY F, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/JOURNAL.PPAT.1002258; Keb G, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00479-18; Key CE, 2017, METHODS MOL BIOL, V1498, P163, DOI 10.1007/978-1-4939-6472-7_11; Kokes M, 2015, CELL HOST MICROBE, V17, P716, DOI 10.1016/j.chom.2015.03.014; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Lee JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02432-0; Liu YJ, 2014, J BACTERIOL, V196, P989, DOI 10.1128/JB.01161-13; Lowden Nicole M, 2015, BMC Res Notes, V8, P570, DOI 10.1186/s13104-015-1542-9; Lutter EI, 2013, CELL REP, V3, P1921, DOI 10.1016/j.celrep.2013.04.027; Lutter EI, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/362104; Lyons JM, 2005, J CLIN PATHOL, V58, P397, DOI 10.1136/jcp.2004.021543; Mirrashidi KM, 2015, CELL HOST MICROBE, V18, P109, DOI 10.1016/j.chom.2015.06.004; Mital J, 2015, BIOCHEM BIOPH RES CO, V462, P165, DOI 10.1016/j.bbrc.2015.04.116; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; MOORE ER, 2014, FRONT CELL INFECT MI; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Mueller KE, 2016, MBIO, V7, DOI 10.1128/mBio.01817-15; Mueller KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135295; MURPHY E, 1985, MOL GEN GENET, V200, P33, DOI 10.1007/BF00383309; Nguyen PH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006911; Rosario CJ, 2012, MOL MICROBIOL, V84, P1097, DOI 10.1111/j.1365-2958.2012.08077.x; SARDINIA LM, 1988, J GEN MICROBIOL, V134, P997; Schachter J, 1999, CHLAMYDIA, P139; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Shima K, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00412-18; Sixt BS, 2017, CELL HOST MICROBE, V21, P113, DOI 10.1016/j.chom.2016.12.002; Skilton Rachel J, 2018, Wellcome Open Res, V3, P25, DOI 10.12688/wellcomeopenres.13905.1; Song LH, 2014, PATHOG DIS, V70, P189, DOI 10.1111/2049-632X.12104; Stanhope R, 2017, P NATL ACAD SCI USA, V114, P12039, DOI 10.1073/pnas.1709060114; Wang YB, 2014, PATHOG DIS, V72, P19, DOI 10.1111/2049-632X.12175; Weber MM, 2017, CELL REP, V19, P1406, DOI 10.1016/j.celrep.2017.04.058; Wesolowski J, 2017, MBIO, V8, DOI 10.1128/mBio.02280-16; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Wilson DP, 2006, B MATH BIOL, V68, P161, DOI 10.1007/s11538-005-9024-1; XU S, 2013, BMC RES NOTES, V6	54	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217753	10.1371/journal.pone.0217753	http://dx.doi.org/10.1371/journal.pone.0217753			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170215	gold, Green Submitted, Green Published			2022-12-26	WOS:000470263700053
J	Adedini, SA; Omisakin, OA; Somefun, OD				Adedini, Sunday A.; Omisakin, Olusola Akintoye; Somefun, Oluwaseyi Dolapo			Trends, patterns and determinants of long-acting reversible methods of contraception among women in sub-Saharan Africa	PLOS ONE			English	Article							UNMET NEED; FERTILITY; MORTALITY; PREGNANCIES; COUNTRIES; DEMAND; POOR	Background Method-specific contraceptive prevalence varies widely globally, as huge variations exist in the use of different types of contraception, with short-term methods being the most common methods in sub-Saharan Africa (SSA). Evidence is scanty on the trends, patterns and determinants of long-acting reversible contraceptive (LARC) methods in SSA. This study aimed to address this knowledge gap. Methods Using a pseudo longitudinal research design and descriptive and inferential statistics, we analysed Demographic and Health Survey data of eight countries selected on the basis of contraceptive prevalence rates across SSA. Multinomial logistic regression modelling was used to tease out the predictors of the uptake of LARC methods in the selected countries. Results Findings exhibit a steady but slow upward trend in LARC methods across selected countries, as a marginal increase was recorded in LARC uptake over a 10-year period in many of the selected countries. Results established significant predictors of LARC methods uptake, including fertility-related characteristics, age, level of education, work status, wealth index and exposure to mass media. This study underscored the need to address various barriers to the uptake of LARC methods in SSA. It is recommended that governments at different levels undertake to cover the costs of LARC methods in order to increase access and uptake.	[Adedini, Sunday A.] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa; [Adedini, Sunday A.; Somefun, Oluwaseyi Dolapo] Univ Witwatersrand, Sch Publ Hlth, Programme Demog & Populat Studies, Johannesburg, South Africa; [Adedini, Sunday A.; Somefun, Oluwaseyi Dolapo] Univ Witwatersrand, Sch Social Sci, Programme Demog & Populat Studies, Johannesburg, South Africa; [Omisakin, Olusola Akintoye] Fed Univ, Demog & Social Stat Dept, Birnin Kebbi, Nigeria	South African Medical Research Council; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Adedini, SA (corresponding author), Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa.; Adedini, SA (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Programme Demog & Populat Studies, Johannesburg, South Africa.; Adedini, SA (corresponding author), Univ Witwatersrand, Sch Social Sci, Programme Demog & Populat Studies, Johannesburg, South Africa.	sunday.adedini@gmail.com	Adedini, Sunday/AAM-6790-2021; Adedini, Sunday/GZM-8362-2022	Adedini, Sunday/0000-0003-0378-1941; 				Adebowale SA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-40; Adedini SA, 2015, J HEALTH POPUL NUTR, V33, P187; Adeyanju O., 2017, NIGERIAN URBAN REPRO; Akinyemi A, 2015, GLOBAL HEALTH ACTION, V8, P45, DOI 10.3402/gha.v8.29745; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; [Anonymous], 2015, TRENDS CONTR US WORL; Babalola S, 2015, DEMOGR RES, V33, P211, DOI 10.4054/DemRes.2015.33.8; Bongaarts J, 2017, POPUL DEV REV, V43, P39, DOI 10.1111/j.1728-4457.2016.00164.x; Choi Y, 2015, GLOBAL HEALTH ACTION, V8, P3, DOI 10.3402/gha.v8.29734; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Ezeh AC, 2009, PHILOS T R SOC B, V364, P2991, DOI 10.1098/rstb.2009.0166; Fabic MS, 2015, LANCET, V385, P1928, DOI 10.1016/S0140-6736(14)61055-2; Fekadu H, 2017, J WOMENS HLTH CARE, V6, P2167; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Gillespie D, 2007, B WORLD HEALTH ORGAN, V85, P100, DOI 10.2471/BLT.06.033829; Gribble J, 2008, POPULATION REFERENCE, P8; Gyimah SO, 2012, J RELIG HEALTH, V51, P1359, DOI 10.1007/s10943-011-9478-4; Hasselback L, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2316-y; Imasiku ENS, 2014, J BIOSOC SCI, V46, P294, DOI 10.1017/S0021932013000357; Lipetz C, 2009, J FAM PLAN REPROD H, V35, P75, DOI 10.1783/147118909787931555; Masquelier B, 2018, LANCET GLOB HEALTH, V6, pE1087, DOI [10.1016/S2214-109X(18)30353-X, 10.1016/s2214-109x(18)30353-x]; Mbizvo MT, 2014, BEST PRACT RES CL OB, V28, P931, DOI 10.1016/j.bpobgyn.2014.04.014; Ngo TD, 2017, MATERN CHILD HLTH J, V21, P1734, DOI 10.1007/s10995-016-2014-0; Ochako R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0314-6; Okigbo C, 2017, WORLD MED HEALTH POL, V9, P65, DOI 10.1002/wmh3.215; Onarheim KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150120; Oye-Adeniran Boniface A, 2006, Afr J Reprod Health, V10, P90; Payne JB, 2016, J MIDWIFERY WOM HEAL, V61, P482, DOI 10.1111/jmwh.12425; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Shoupe D, 2016, CONTRACEP REPROD MED, V1, DOI 10.1186/s40834-016-0011-8; Singh S., 2014, ADD COSTS BEN INV SE; Skiles MP, 2015, INT PERSPECT SEX R H, V41, P20, DOI 10.1363/4102015; Starbird E, 2016, GLOB HEALTH-SCI PRAC, V4, P191, DOI 10.9745/GHSP-D-15-00374; Stoddard A, 2011, DRUGS, V71, P969, DOI 10.2165/11591290-000000000-00000; Tibaijuka L, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0382-2; United Nations, 2015, 241 ESAPWP UN; Waggoner MR, 2012, J CHILD ADOL PS NURS, V25, P96, DOI 10.1111/j.1744-6171.2012.00326.x	41	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217574	10.1371/journal.pone.0217574	http://dx.doi.org/10.1371/journal.pone.0217574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163050	gold, Green Published, Green Submitted			2022-12-26	WOS:000470086200019
J	Suh, Y; Park, Y; Kang, D				Suh, Yongyoon; Park, Yongtae; Kang, Daekook			Evaluating mobile services using integrated weighting approach and fuzzy VIKOR	PLOS ONE			English	Article							GROUP DECISION-MAKING; EVIDENTIAL REASONING APPROACH; CUSTOMER SATISFACTION; ATTRIBUTE WEIGHTS; USER INTERFACES; SHANNON ENTROPY; MCDM METHODS; SELECTION; DEMATEL; ADOPTION	Mobile services' rapid evolution and development has meant that their evaluation has become a more and more pressing issue, and from both the practical and theoretical standpoints. The significant previous work in the field of multiple-criteria decision-making based evaluation of mobile services has some practical limitations that should be noted. First, there has been insufficient research that has utilized both objective and subjective weighting. Second, the investigations that have employed Vise Kriterijumska Optimizacija I Kompromisno Resenje (VIKOR), a well known practical tool for use in multi-criteria decision making, did not consider the fuzzy environment. In order to fill these gaps in the literature, the present study developed fuzzy VIKOR for use with an integrated weighting approach that combines subjective and objective weighting to account for mobile services' various characteristics and, thereby, evaluate their quality. For subjective weighting, Decision Making Trial and Evaluation Laboratory (DEMATEL) was employed for simple determination of the weighting and causal relationships. For objective weighting of evaluation criteria, Shannon entropy was utilized. This study has a unique contribution in that it reflects the special circumstances of the mobile service evaluation that have not been considered in the previous studies. Especially, in this study, not only the subjective weighting method but also the objective weighting method are used for more accurate importance weight of evaluation criteria. In the novelty aspect, this is the first study trying to utilize fuzzy VIKOR in concert with a novel combined subjective/objective weighting method in order to integrate objective decision-matrix-derived information with subjective decision-maker preferences. Additionally, a supplemental, empirical mobile-service-evaluation case study was conducted that enables researchers and practitioners to better understand the overall, practical evaluation process. Validation of the case study results by comparison with other, representative multiple-criteria decision-making methods verified the proposed method's robustness.	[Suh, Yongyoon] Pukyong Natl Univ, Dept Safety Engn, Busan, South Korea; [Park, Yongtae] Seoul Natl Univ, Dept Ind Engn, Seoul, South Korea; [Kang, Daekook] Inje Univ, Dept Ind & Management Engn, Gimhae Si, Gyeongsangnam D, South Korea	Pukyong National University; Seoul National University (SNU); Inje University	Kang, D (corresponding author), Inje Univ, Dept Ind & Management Engn, Gimhae Si, Gyeongsangnam D, South Korea.	dkkang@inje.ac.kr			National Research Foundation (NRF) of Korea Grant - Korean Government (MOE) [NRF-2019R1G1A1006073]	National Research Foundation (NRF) of Korea Grant - Korean Government (MOE)	This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MOE) (NRF-2019R1G1A1006073).	Acuna-Carvajal F, 2019, EXPERT SYST APPL, V122, P351, DOI 10.1016/j.eswa.2019.01.030; Alnanih R, 2013, PROCEDIA COMPUT SCI, V21, P390, DOI 10.1016/j.procs.2013.09.051; Asan U, 2018, APPL SOFT COMPUT, V66, P34, DOI 10.1016/j.asoc.2018.01.018; AZAD N., 2013, MANAGEMENT SCI LETT, V3, P1161; Barnes SJ, 2002, INT J INFORM MANAGE, V22, P91, DOI 10.1016/S0268-4012(01)00047-0; Baykasoglu A, 2017, EXPERT SYST APPL, V70, P37, DOI 10.1016/j.eswa.2016.11.001; Blechar J, 2006, EUR J INFORM SYST, V15, P285, DOI 10.1057/palgrave.ejis.3000618; Bowers CP, 2013, INT J HUM-COMPUT ST, V71, P1103, DOI 10.1016/j.ijhcs.2013.08.017; Browne K, 2012, ENTERTAIN COMPUT, V3, P1, DOI 10.1016/j.entcom.2011.06.001; Buyukozkan G, 2008, MATH COMPUT SIMULAT, V77, P464, DOI 10.1016/j.matcom.2007.11.015; Buyukozkan G, 2009, COMPUT STAND INTER, V31, P144, DOI 10.1016/j.csi.2007.11.006; Chang TH, 2014, INFORM SCIENCES, V271, P196, DOI 10.1016/j.ins.2014.02.118; Chen C, 2011, PROCEDIA ENVIRON SCI, V10, P262, DOI 10.1016/j.proenv.2011.09.043; Chen PT, 2010, TECHNOL FORECAST SOC, V77, P678, DOI 10.1016/j.techfore.2009.11.007; Chen S-H, 2008, 2008 INT C MACH LEAR; Chen VYC, 2011, APPL SOFT COMPUT, V11, P265, DOI 10.1016/j.asoc.2009.11.017; Chin KS, 2015, COMPUT IND ENG, V87, P150, DOI 10.1016/j.cie.2015.04.016; Chincholle D, 2002, INT C MOB HUM COMP I; Chong JL, 2011, INT J MOB COMMUN, V9, P1, DOI 10.1504/IJMC.2011.037952; Chou SY, 2008, EUR J OPER RES, V189, P132, DOI 10.1016/j.ejor.2007.05.006; Chou Y-C, 2011, APPL SOFT COMPUTING; Cui L, 2019, J BUS RES, V98, P450, DOI 10.1016/j.jbusres.2018.03.031; Deng H, 2000, COMPUT OPER RES, V27, P963, DOI 10.1016/S0305-0548(99)00069-6; Dijkstra J, 2014, TRANSP RES PROC, V2, P141, DOI 10.1016/j.trpro.2014.09.018; Dincer H, 2013, KYBERNETES, V42, P1072, DOI 10.1108/K-02-2013-0021; Dong MG, 2015, EXPERT SYST APPL, V42, P7846, DOI 10.1016/j.eswa.2015.06.007; Efe B, 2016, APPL SOFT COMPUT, V38, P106, DOI 10.1016/j.asoc.2015.09.037; Fu C, 2015, COMPUT IND ENG, V81, P109, DOI 10.1016/j.cie.2014.12.031; Gou XJ, 2017, INFORM SCIENCES, V388, P225, DOI 10.1016/j.ins.2017.01.033; Gul M, 2019, J SAFETY RES, V69, P135, DOI 10.1016/j.jsr.2019.03.005; Tzeng GH, 2007, EXPERT SYST APPL, V32, P1028, DOI 10.1016/j.eswa.2006.02.004; Hill SR, 2010, INT J MOB COMMUN, V8, P150, DOI 10.1504/IJMC.2010.031445; Itoh N, 2005, INT C SER, DOI [10.1016/j.ics.2005.07.090, DOI 10.1016/J.ICS.2005.07.090]; Jeng DJF, 2012, MANAGE DECIS, V50, P1570, DOI 10.1108/00251741211266697; Kang D, 2016, APPL SOFT COMPUT, V42, P53, DOI 10.1016/j.asoc.2016.01.017; Kang D, 2014, EXPERT SYST APPL, V41, P1041, DOI 10.1016/j.eswa.2013.07.101; Khademi-Zare H, 2010, TELECOMMUN POLICY, V34, P747, DOI 10.1016/j.telpol.2010.10.001; Kim CS, 2010, SERV BUS, V4, P253, DOI 10.1007/s11628-009-0088-0; Kim J, 2014, SERV BUS, V8, P1, DOI 10.1007/s11628-013-0184-z; Kim Y, 2013, APPL MATH MODEL, V37, P9419, DOI 10.1016/j.apm.2013.04.040; Lee HC, 2018, RENEW SUST ENERG REV, V92, P883, DOI 10.1016/j.rser.2018.05.007; Lee PTW, 2012, EXPERT SYST APPL, V39, P5649, DOI 10.1016/j.eswa.2011.11.052; Li XX, 2011, PROCEDIA ENGINEER, V26, DOI 10.1016/j.proeng.2011.11.2410; Li YF, 2019, APPL SOFT COMPUT, V79, P268, DOI 10.1016/j.asoc.2019.03.048; Lin CL, 2016, APPL SOFT COMPUT, V48, P385, DOI 10.1016/j.asoc.2016.05.035; Liu S, 2016, EXPERT SYST APPL, V55, P37, DOI 10.1016/j.eswa.2016.01.059; Lu MT, 2015, SERV BUS, V9, P541, DOI 10.1007/s11628-014-0239-9; Mohsen O, 2017, SAFETY SCI, V92, P160, DOI 10.1016/j.ssci.2016.10.006; Mokhtarian M, 2012, APPL SOFT COMPUT, DOI [10.1016/j.asoc.2011.12.003, DOI 10.1016/J.ASOC.2011.12.003]; Moreno M, 2012, PROCEEDINGS OF THE 4, V14, P74; Narayanamoorthy S, 2019, EXPERT SYST APPL, V121, P28, DOI 10.1016/j.eswa.2018.12.015; Nikou S, 2013, TELECOMMUN POLICY, V37, P915, DOI 10.1016/j.telpol.2012.09.007; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Opricovic S., 1998, THESIS FACULTY CIVIL, V2, P5; Pagani M, 2004, J INTERACT MARK, V18, P46, DOI 10.1002/dir.20011; Ploskas N, 2019, FUZZY SET SYST, V377, P1, DOI 10.1016/j.fss.2019.01.012; Qi JY, 2012, INFORM TECHNOL MANAG, V13, P281, DOI 10.1007/s10799-012-0132-y; Quang NH, 2013, APPL SOFT COMPUTING; Quezada LE, 2018, COMPUT IND ENG, V118, P170, DOI 10.1016/j.cie.2018.02.020; Rao RV, 2008, MATER DESIGN, V29, P1949, DOI 10.1016/j.matdes.2008.04.019; Ren ZL, 2017, INFORM SCIENCES, V388, P1, DOI 10.1016/j.ins.2017.01.024; Shahraki AR, 2011, INDIAN J SCI TECHNOL, V4, P1763; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shemshadi A, 2011, EXPERT SYST APPL, V38, P12160, DOI 10.1016/j.eswa.2011.03.027; Shieh LF, 2014, TECHNOL FORECAST SOC, V87, P80, DOI 10.1016/j.techfore.2013.11.004; Song ML, 2017, COMPUT IND ENG, V112, P99, DOI 10.1016/j.cie.2017.07.023; Suh Y, 2012, INT J MOB COMMUN, V10, P1, DOI 10.1504/IJMC.2012.044520; Teng WC, 2009, TELECOMMUN POLICY, V33, P628, DOI 10.1016/j.telpol.2009.07.002; Tian GD, 2019, J CLEAN PROD, V220, P1088, DOI 10.1016/j.jclepro.2019.01.086; Tian GD, 2017, J CLEAN PROD, V164, P1363, DOI 10.1016/j.jclepro.2017.07.028; Wan SP, 2015, INFORM SCIENCES, V316, P329, DOI 10.1016/j.ins.2015.04.019; Wang H, 2019, J CLEAN PROD, V208, P199, DOI 10.1016/j.jclepro.2018.10.131; Wang Q, 2015, J AIR TRANSP MANAG, V42, P55, DOI 10.1016/j.jairtraman.2014.08.003; Wang TC, 2009, EXPERT SYST APPL, V36, P8980, DOI 10.1016/j.eswa.2008.11.035; Wu SS, 2018, SUSTAIN CITIES SOC, V41, P443, DOI 10.1016/j.scs.2018.05.052; Yoon C, 2015, INFORM TECHNOL MANAG, V16, P139, DOI 10.1007/s10799-014-0202-4; Zadeh L. A., 1978, Fuzzy Sets and Systems, V1, P3, DOI 10.1016/0165-0114(78)90029-5; Zeng SZ, 2019, INFORM SCIENCES, V488, P76, DOI 10.1016/j.ins.2019.03.018; Zhang HH, 2019, INFORM SCIENCES, V481, P491, DOI 10.1016/j.ins.2018.12.071; Zhou T, 2012, INFORM TECHNOL MANAG, V13, P27, DOI 10.1007/s10799-011-0111-8; Zhu B, 2014, EUR J OPER RES, V239, P794, DOI 10.1016/j.ejor.2014.06.019; Zitnick CL, 2004, P 20 C UNC ART INT	82	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217786	10.1371/journal.pone.0217786	http://dx.doi.org/10.1371/journal.pone.0217786			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163061	Green Published, Green Submitted, gold			2022-12-26	WOS:000470086200035
J	Khlebus, E; Kutsenko, V; Meshkov, A; Ershova, A; Kiseleva, A; Shevtsov, A; Shcherbakova, N; Zharikova, A; Lankin, V; Tikhaze, A; Chazova, I; Yarovaya, E; Drapkina, O; Boytsov, S				Khlebus, Eleonora; Kutsenko, Vladimir; Meshkov, Alexey; Ershova, Alexandra; Kiseleva, Anna; Shevtsov, Anton; Shcherbakova, Natalia; Zharikova, Anastasiia; Lankin, Vadim; Tikhaze, Alla; Chazova, Irina; Yarovaya, Elena; Drapkina, Oksana; Boytsov, Sergey			Multiple rare and common variants in APOB gene locus associated with oxidatively modified low-density lipoprotein levels	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; PLASMA-LEVELS; SEQUENCE ALIGNMENT; LIPID-LEVELS; POLYMORPHISMS; MUTATIONS; RISK; CHOLESTEROL	Oxidatively modified low-density lipoproteins (oxLDL) play an important role in the occurrence and progression of atherosclerosis. To identify the genetic factors influencing the oxLDL levels, we have genotyped 776 DNA samples of Russian individuals for 196,725 single-nucleotide polymorphisms (SNPs) using the Cardio-MetaboChip (Illumina, USA) and conducted genome-wide association study (GWAS). Fourteen common variants in the locus including APOB gene were significantly associated with the oxLDL levels (P < 2.18 x 10(-7)). These variants explained only 6% of the variation in the oxLDL levels. Then, we assessed the contribution of rare coding variants of APOB gene to the oxLDL levels. Individuals with the extreme oxLDL levels (48 with the lowest and 48 with the highest values) were selected for targeted sequencing of the region including APOB gene. To evaluate the contribution of the SNPs to the oxLDL levels we used various statistical methods for the association analysis of rare variants: WST, SKAT, and SKAT-O. We revealed that both synonymous and nonsynonymous SNPs affected the oxLDL levels. For the joint analysis of the rare and common variants, we conducted the SKAT-C testing and found a group of 15 SNPs significantly associated with the oxLDL levels (P = 2.14 x 10(-9)). Our results indicate that the oxLDL levels depend on both common and rare variants of the APOB gene.	[Khlebus, Eleonora; Kutsenko, Vladimir; Meshkov, Alexey; Ershova, Alexandra; Kiseleva, Anna; Shcherbakova, Natalia; Zharikova, Anastasiia; Drapkina, Oksana] Minist Healthcare Russian Federat, Fed State Inst, Natl Med Res Ctr Prevent Med, Moscow, Russia; [Khlebus, Eleonora] Moscow Inst Phys & Technol, Moscow, Russia; [Kutsenko, Vladimir; Shevtsov, Anton; Yarovaya, Elena] Lomonosov Moscow State Univ, Moscow, Russia; [Lankin, Vadim; Tikhaze, Alla; Chazova, Irina; Boytsov, Sergey] Minist Healthcare Russian Federat, Fed State Budget Org, Natl Med Res Ctr Cardiol, Moscow, Russia	National Medical Research Center for Therapy & Preventive Medicine; Moscow Institute of Physics & Technology; Lomonosov Moscow State University; National Medical Research Center of Cardiology	Khlebus, E (corresponding author), Minist Healthcare Russian Federat, Fed State Inst, Natl Med Res Ctr Prevent Med, Moscow, Russia.; Khlebus, E (corresponding author), Moscow Inst Phys & Technol, Moscow, Russia.	eleonora.khlebus@phystech.edu	Meshkov, Alexey N/K-1056-2017; Chazova, Irina/B-8688-2017; Shcherbakova, Natalia/U-1290-2019; Drapkina, Oksana/AAE-5376-2021; Khlebus, Eleonora/X-1674-2019; Boytsov, Sergey A/M-4486-2014; Kutsenko, Vladimir/AAB-6974-2019; Zharikova, Anastasiia/ABC-9625-2021; Chazova, Irina/AAK-6581-2021; Drapkina, Oxana/G-8443-2016; Ershova, Alexandra I/J-8772-2017; Kiseleva, Anna/J-8709-2017	Meshkov, Alexey N/0000-0001-5989-6233; Chazova, Irina/0000-0002-9822-4357; Shcherbakova, Natalia/0000-0002-6672-4242; Drapkina, Oksana/0000-0002-4453-8430; Khlebus, Eleonora/0000-0002-8355-8960; Boytsov, Sergey A/0000-0001-6998-8406; Kutsenko, Vladimir/0000-0001-9844-3122; Zharikova, Anastasiia/0000-0003-0723-0493; Chazova, Irina/0000-0002-9822-4357; Drapkina, Oxana/0000-0002-4453-8430; Ershova, Alexandra I/0000-0001-7989-0760; Kiseleva, Anna/0000-0003-4765-8021	Russian Scientific Foundation [14-15-00245]	Russian Scientific Foundation(Russian Science Foundation (RSF))	This research was supported by grant of Russian Scientific Foundation 14-15-00245.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Bustan SA, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-157; Alves AC, 2014, HUM MOL GENET, V23, P1817, DOI 10.1093/hmg/ddt573; Au A, 2017, ATHEROSCLEROSIS, V265, P60, DOI 10.1016/j.atherosclerosis.2017.08.003; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Benn M, 2008, J CLIN ENDOCR METAB, V93, P1038, DOI 10.1210/jc.2007-1365; Bomba L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1212-4; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Bryant EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063469; Burnett John R, 2008, Clin Biochem Rev, V29, P11; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cash TP, 2014, AGING CELL, V13, P1087, DOI 10.1111/acel.12261; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chiou KR, 2012, GENE, V498, P100, DOI 10.1016/j.gene.2012.01.092; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; Chu AY, 2012, CIRC-CARDIOVASC GENE, V5, P676, DOI 10.1161/CIRCGENETICS.112.963314; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Di Pietro N, 2016, VASC PHARMACOL, V84, P1, DOI 10.1016/j.vph.2016.05.013; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Ershova AI, 2012, ULTRASOUND MED BIOL, V38, P417, DOI 10.1016/j.ultrasmedbio.2011.11.014; Rios-Gonzalez BE, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/150358; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fernandez-Higuero JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep18184; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaffney D, 1998, ATHEROSCLEROSIS, V137, P167, DOI 10.1016/S0021-9150(97)00242-6; Gu QL, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20176613, 10.1590/1414-431x20176613]; Gu W, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0125-z; Huijgen R, 2012, HUM MUTAT, V33, P448, DOI 10.1002/humu.21660; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Junyent M, 2010, NUTR METAB CARDIOVAS, V20, P157, DOI 10.1016/j.numecd.2009.03.016; Kanoni S, 2016, HUM MOL GENET, V25, P4094, DOI 10.1093/hmg/ddw227; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; [Хлебус Э.Ю. Khlebus E. YU.], 2017, [Российский кардиологический журнал, Russian Journal of Cardiology, Rossiiskii kardiologicheskii zhurnal], P49, DOI 10.15829/1560-4071-2017-10-49-54; Kim DS, 2013, J LIPID RES, V54, P1512, DOI 10.1194/jlr.P035238; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kulminski AM, 2013, AGING CELL, V12, P237, DOI 10.1111/acel.12046; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lankin VZ, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1081, DOI 10.1134/S0006297907100069; Lankin VZ, 2012, MOL CELL BIOCHEM, V365, P93, DOI 10.1007/s11010-012-1247-5; Lankin V, 2014, MOL CELL BIOCHEM, V395, P241, DOI 10.1007/s11010-014-2131-2; Lankin Vadim Z, 2017, Curr Aging Sci, V10, P18; Lankin VZ, 2003, MOL CELL BIOCHEM, V249, P129, DOI 10.1023/A:1024742907379; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee Seunggeun, 2015, SKAT SNP SET SEQUENC; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao YC, 2008, CLIN BIOCHEM, V41, P306, DOI 10.1016/j.clinbiochem.2007.11.011; Lin WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21824; Linton M., 2015, ROLE LIPIDS LIPOPROT; Liu CQ, 2015, INT J CLIN EXP MED, V8, P16571; Liu XY, 2013, JPN J CLIN ONCOL, V43, P362, DOI 10.1093/jjco/hyt018; Lusis AJ, 2012, TRENDS GENET, V28, P267, DOI 10.1016/j.tig.2012.03.001; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Makela KM, 2013, CIRC-CARDIOVASC GENE, V6, P73, DOI 10.1161/CIRCGENETICS.112.964965; Malovini A, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00017; Maurer F, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14326; Muiya P, 2009, INT J DIABETES MELLI, V1, P16, DOI DOI 10.1016/J.IJDM.2009.05.003; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Peddareddygari Leema Reddy, 2015, Case Rep Genet, V2015, P219691, DOI 10.1155/2015/219691; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; [Прус Ю.А. Prus Y.A.], 2017, [Атеросклероз и дислипидемии, Journal of atherosclerosis and dyslipidemias, Ateroskleroz i dislipidemii], P84; Pullinger CR, 1996, HUM GENET, V98, P678, DOI 10.1007/s004390050283; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radovica-Spalvina I, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0230-x; Reynolds CA, 2010, HUM MOL GENET, V19, P2068, DOI 10.1093/hmg/ddq079; Rytova AI, 2017, RUSS J GENET+, V53, P1091, DOI 10.1134/S1022795417100088; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Starcevic JN, 2014, VASA, V43, P171, DOI 10.1024/0301-1526/a000346; Tada H, 2014, CIRC-CARDIOVASC GENE, V7, P583, DOI 10.1161/CIRCGENETICS.113.000420; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Ung C, 2017, VISION RES, V139, P168, DOI 10.1016/j.visres.2017.03.007; Vandrovcova J, 2013, GENET MED, V15, P948, DOI 10.1038/gim.2013.55; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xiao D, 2015, GENES GENOM, V37, P621, DOI 10.1007/s13258-015-0292-3; Yoshida T, 2009, HYPERTENS RES, V32, P411, DOI 10.1038/hr.2009.22; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhou F, 2018, ONCOTARGET, V9, P2249, DOI 10.18632/oncotarget.23369; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	94	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217620	10.1371/journal.pone.0217620	http://dx.doi.org/10.1371/journal.pone.0217620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150472	Green Published, gold			2022-12-26	WOS:000469759100074
J	Kimm, MA; Gross, C; Dean-Ben, XL; Ron, A; Rummeny, EJ; Lin, HCA; Holtke, C; Razansky, D; Wildgruber, M				Kimm, Melanie A.; Gross, Claudia; Dean-Ben, Xose Luis; Ron, Avihai; Rummeny, Ernst J.; Lin, Hsiao-Chun Amy; Hoeltke, Carsten; Razansky, Daniel; Wildgruber, Moritz			Optoacoustic properties of Doxorubicin - A pilot study	PLOS ONE			English	Article							TOMOGRAPHY MSOT; TUMOR; MODEL; QUANTIFICATION; CHEMOTHERAPY; LIPOSOMES; DYNAMICS; CANCER; TISSUE; LIGHT	Doxorubicin (DOX) is a widely used chemotherapeutic anticancer drug. Its intrinsic fluorescence properties enable investigation of tumor response, drug distribution and metabolism. First phantom studies in vitro showed optoacoustic property of DOX. We therefore aimed to further investigate the optoacoustic properties of DOX in biological tissue in order to explore its potential as theranostic agent. We analysed doxorubicin hydrochloride (Dox center dot HCl) and liposomal encapsulated doxorubicin hydrochloride (Dox center dot Lipo), two common drugs for anticancer treatment in clinical medicine. Optoacoustic measurements revealed a strong signal of both doxorubicin substrates at 488 nm excitation wavelength. Post mortem analysis of intra-tumoral injections of DOX revealed a detectable optoacoustic signal even at three days after the injection. We thereby demonstrate the general feasibility of doxorubicin detection in biological tissue by means of optoacoustic tomography, which could be applied for high resolution imaging at mesoscopic depths dictated by effective penetration of visible light into the biological tissues.	[Kimm, Melanie A.; Gross, Claudia; Rummeny, Ernst J.] Tech Univ Munich, Dept Diagnost & Intervent Radiol, Munich, Germany; [Dean-Ben, Xose Luis; Razansky, Daniel] Univ Zurich, Fac Med, Zurich, Switzerland; [Dean-Ben, Xose Luis; Razansky, Daniel] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Dean-Ben, Xose Luis; Razansky, Daniel] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland; [Dean-Ben, Xose Luis; Razansky, Daniel] Swiss Fed Inst Technol, Dept Informat Technol & Elect Engn, Zurich, Switzerland; [Ron, Avihai; Lin, Hsiao-Chun Amy; Razansky, Daniel] Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Munich, Germany; [Ron, Avihai; Lin, Hsiao-Chun Amy; Razansky, Daniel] TranslaTUM, Ctr Translat Canc Res, Munich, Germany; [Hoeltke, Carsten; Wildgruber, Moritz] Univ Klinikum Munster, Dept Clin Radiol, Translat Res Imaging Ctr, Munster, Germany; [Gross, Claudia] Tech Univ Munich, Inst Pathol, Munich, Germany	Technical University of Munich; University of Geneva; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munster; Technical University of Munich	Wildgruber, M (corresponding author), Univ Klinikum Munster, Dept Clin Radiol, Translat Res Imaging Ctr, Munster, Germany.	moritz.wildgruber@ukmuenster.de	; Razansky, Daniel/B-8590-2015	Kimm, Melanie A./0000-0001-6833-9738; Razansky, Daniel/0000-0001-8676-0964; Lin, Hsiao-Chun Amy/0000-0002-1393-369X; Dean-Ben, Xose Luis/0000-0002-8557-7778				Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Becker A, 2018, EUR RADIOL, V28, P602, DOI 10.1007/s00330-017-5002-x; Blazkova I, 2014, ELECTROPHORESIS, V35, P1040, DOI 10.1002/elps.201300393; Carlson M, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.11.116010; Cook JR, 2011, BIOMED OPT EXPRESS, V2, P3193, DOI 10.1364/BOE.2.003193; CUMMINGS J, 1993, BIOCHEM PHARMACOL, V45, P2550, DOI 10.1016/0006-2952(93)90237-Q; DELANGE JHM, 1992, CYTOMETRY, V13, P571, DOI 10.1002/cyto.990130604; Ding L, 2017, IEEE T MED IMAGING, V36, P1858, DOI 10.1109/TMI.2017.2704019; Diot G, 2017, CLIN CANCER RES, V23, P6912, DOI 10.1158/1078-0432.CCR-16-3200; Dong X, 2017, DRUG DELIV, V24, P641, DOI 10.1080/10717544.2017.1289570; Ehrke MJ, 2000, INT J CANCER, V87, P101, DOI 10.1002/1097-0215(20000701)87:1<101::AID-IJC15>3.0.CO;2-B; Fan Y, 2011, ACTA PHARMACOL SIN, V32, P408, DOI 10.1038/aps.2010.217; Griffin JI, 2017, ACS NANO, V11, P11584, DOI 10.1021/acsnano.7b06524; Han SH, 2015, PROC SPIE, V9419, DOI 10.1117/12.2082439; Ibsen S, 2013, J MASS SPECTROM, V48, P768, DOI 10.1002/jms.3221; Idani H, 2000, INT J CANCER, V88, P645, DOI 10.1002/1097-0215(20001115)88:4<645::AID-IJC20>3.0.CO;2-4; Imai T, 2017, CANCER BIOL THER, V18, P101, DOI 10.1080/15384047.2016.1276137; Jansen K, 2014, ULTRASOUND MED BIOL, V40, P1037, DOI 10.1016/j.ultrasmedbio.2014.01.008; Kauffman Melinda K, 2016, React Oxyg Species (Apex), V2, P432, DOI 10.20455/ros.2016.873; Kress J, 2015, BIOMED OPT EXPRESS, V6, P3546, DOI 10.1364/BOE.6.003546; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lin HCA, 2017, THERANOSTICS, V7, P4470, DOI 10.7150/thno.20616; McNally LR, 2016, CLIN CANCER RES, V22, P3432, DOI 10.1158/1078-0432.CCR-16-0573; Motlagh NSH, 2016, BIOMED OPT EXPRESS, V7, P2400, DOI 10.1364/BOE.7.002400; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Ntziachristos Vasilis, 2013, Recent Results Cancer Res, V187, P133, DOI 10.1007/978-3-642-10853-2_4; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; Omar M, 2015, NEOPLASIA, V17, P208, DOI 10.1016/j.neo.2014.12.010; Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98; Santos MA, 2017, THERANOSTICS, V7, P2718, DOI 10.7150/thno.19662; Stucke-Ring J, 2016, ONCOTARGET, V7, P82458, DOI 10.18632/oncotarget.12559; Tang ZH, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-16; Wong TTW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602168; Yang JM, 2009, OPT LETT, V34, P1591, DOI 10.1364/OL.34.001591	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217576	10.1371/journal.pone.0217576	http://dx.doi.org/10.1371/journal.pone.0217576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150471	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000469759100068
J	Miller, N; Liu, Y; Krivochenitser, R; Rokers, B				Miller, Nathaniel; Liu, Yao; Krivochenitser, Roman; Rokers, Bas			Linking neural and clinical measures of glaucoma with diffusion magnetic resonance imaging (dMRI)	PLOS ONE			English	Article							OPTIC-NERVE; WHITE-MATTER; VISUAL PATHWAYS; TENSOR MRI; CONNECTIVITY; TRACKING; MOUSE	Purpose To link optic nerve (ON) structural properties to clinical markers of glaucoma using advanced, semi-automated diffusion magnetic resonance imaging (dMRI) tractography in human glaucoma patients. Methods We characterized optic neuropathy in patients with unilateral advanced-stage glaucoma (n = 6) using probabilistic dMRI tractography and compared their results to those in healthy controls (n = 6). Results We successfully identified the ONs of glaucoma patients based on dMRI in all patients and confirmed that dMRI measures of the ONs correlated with clinical markers of glaucoma severity. Specifically, we found reduced fractional anisotropy (FA) in the ONs of eyes with advanced, as compared to mild, glaucoma (F(1,10) = 55.474, p < 0.0001, FDR < 0.0005). Furthermore, by comparing the ratios of ON FA in glaucoma patients to those of healthy controls (n = 6), we determined that this difference was beyond that expected from normal anatomical variation (F(1,9) = 20.276, p < 0. 005). Finally, we linked the dMRI measures of ON FA to standard clinical glaucoma measures. ON vertical cup-to-disc ratio (vCD) predicted ON FA (F(1,10) = 11.061, p < 0.01, R-2 = 0.66), retinal nerve fiber layer thickness (RNFL) predicted ON FA (F(1,10) = 11.477, p < 0.01, R-2 = 0.63) and ON FA predicted perceptual deficits (visual field index [VFI]) (F(1,10) = 15.308, p < 0.005, R-2 = 0.52). Conclusion We describe semi-automated methods to detect glaucoma-related structural changes using dMRI and confirm that they correlate with clinical measures of glaucoma.	[Miller, Nathaniel; Rokers, Bas] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Liu, Yao; Krivochenitser, Roman] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Liu, Yao; Rokers, Bas] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA; [Krivochenitser, Roman] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Rokers, B (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.; Rokers, B (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA.	rokers@wisc.edu		Rokers, Bas/0000-0003-0573-5332; LIU, YAO/0000-0002-0700-0148	University of Wisconsin-Madison Undergraduate Academic Awards Office; Wisconsin Alumni Research Foundation; Research to Prevent Blindness	University of Wisconsin-Madison Undergraduate Academic Awards Office; Wisconsin Alumni Research Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This research was supported by grants from University of Wisconsin-Madison Undergraduate Academic Awards Office (NM), the Wisconsin Alumni Research Foundation (BR), and Research to Prevent Blindness (YL and RK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Allen B, 2018, INVEST OPHTH VIS SCI, V59, P921, DOI 10.1167/iovs.17-22930; Allen B, 2015, VISION RES, V114, P48, DOI 10.1016/j.visres.2014.12.021; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolacchi F, 2012, INVEST OPHTH VIS SCI, V53, P4191, DOI 10.1167/iovs.11-9345; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Chang ST, 2014, J GLAUCOMA, V23, P513, DOI 10.1097/IJG.0b013e318294861d; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Davis BM, 2016, ACTA NEUROPATHOL, V132, P807, DOI 10.1007/s00401-016-1609-2; Engelhorn T, 2011, ACAD RADIOL, V18, P764, DOI 10.1016/j.acra.2011.01.014; Frezzotti P, 2016, HUM BRAIN MAPP, V37, P4581, DOI 10.1002/hbm.23330; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Jindal V, 2013, MOL NEUROBIOL, V48, P186, DOI 10.1007/s12035-013-8416-8; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097445; Malania M, 2017, INVEST OPHTH VIS SCI, V58, P2939, DOI 10.1167/iovs.16-21191; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nouraeinejad A, 2016, BINOCULAR VISION ANO; Ohno N, 2015, BRIT J OPHTHALMOL, V99, P1051, DOI 10.1136/bjophthalmol-2014-305809; Ophthalmology AAo, 2015, ICD 10 GLAUC REF GUI; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rokem A, 2017, J VISION, V17, DOI 10.1167/17.2.4; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sidek S, 2014, EUR J RADIOL, V83, P1437, DOI 10.1016/j.ejrad.2014.05.014; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Vu HTV, 2005, BRIT J OPHTHALMOL, V89, P360, DOI 10.1136/bjo.2004.047498; Wang MY, 2013, NEURORADIOLOGY, V55, P493, DOI 10.1007/s00234-013-1133-1; Xu JQ, 2008, NMR BIOMED, V21, P928, DOI 10.1002/nbm.1307; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yoshimine S, 2018, BRAIN STRUCT FUNCT, V223, P3889, DOI 10.1007/s00429-018-1702-5; Zhang YQ, 2012, ACTA OPHTHALMOL, V90, pE295, DOI 10.1111/j.1755-3768.2011.02346.x; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	43	9	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217011	10.1371/journal.pone.0217011	http://dx.doi.org/10.1371/journal.pone.0217011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150402	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100029
J	Morris, MD; Andrew, E; Tan, JY; Maher, L; Hoff, C; Darbes, L; Page, K				Morris, Meghan D.; Andrew, Erin; Tan, Judy Y.; Maher, Lisa; Hoff, Colleen; Darbes, Lynae; Page, Kimberly			Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIV RISK; MALE COUPLES; SEXUAL RISK; USERS; INFECTION; NEEDLE; PREVENTION; PEOPLE; INTERDEPENDENCE	Sharing of injection drug use paraphernalia is a dyadic process linked to the transmission of HIV and hepatitis C virus (HCV). Despite this, limited research exists identifying specific dyadic interpersonal factors driving injecting partners' engagement in needle/syringe and ancillary injecting equipment sharing among young adults. Using semi-structured in-depth interview data collected between 2014 and 2015 from twenty-seven people who inject drugs (PWID), we applied an inductive approach to identify key injection drug-related interpersonal factors and developed a conceptual model integrating the findings based on interdependence theory. Interactions between injecting partners resulted in varying levels of injecting-related trust, cooperation, intimacy, and power. These factors interacted to collectively influence the type and level of risk perceived and enacted by injecting partners. The relationship between these injecting-related interpersonal factors, on the one hand, and risk perception on the other was dynamic and fluctuated between actions that protect the self (person-centered) and those that protect the partnership (partnership-centered). These findings indicate that the interpersonal context exerts substantial influence that shapes risk perception in all types of injecting partnerships. Partnership-focused prevention strategies should consider the dynamics of trust, cooperation, intimacy, and power, in characterizing dyadic risk perceptions and in understanding risky injecting practices among PWID.	[Morris, Meghan D.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Andrew, Erin] Univ Penn, Nursing Sci, Philadelphia, PA 19104 USA; [Tan, Judy Y.] Univ Calif San Francisco, Ctr Aids Prevent Sci, San Francisco, CA 94143 USA; [Maher, Lisa] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Hoff, Colleen] San Francisco State Univ, Ctr Res & Educ Gender & Sexual, San Francisco, CA 94132 USA; [Darbes, Lynae] Univ Michigan, Sch Nursing, Ctr Sexual & Hlth Dispar, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA; [Page, Kimberly] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of California System; University of California San Francisco; University of Pennsylvania; University of California System; University of California San Francisco; University of New South Wales Sydney; Kirby Institute; California State University System; San Francisco State University; University of Michigan System; University of Michigan; University of New Mexico	Morris, MD (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	Meghan.Morris@ucsf.edu		Darbes, Lynae/0000-0003-4738-6812; Morris, Meghan/0000-0003-2762-2953; Maher, Lisa/0000-0001-6020-6519	National Institutes of Health (NIH), University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30-AI027763]; NIH, National Institute on Drug Abuse (NIDA) [R01DA016017]; NIH/NIDA Career Development Award [K01DA037802]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA037802, R01DA016017] Funding Source: NIH RePORTER	National Institutes of Health (NIH), University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research; NIH, National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH/NIDA Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by a grant from the National Institutes of Health (NIH), University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30-AI027763 and NIH, National Institute on Drug Abuse (NIDA) research grant (R01DA016017). MDM is supported through an NIH/NIDA Career Development Award (K01DA037802).	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Albarracin D, 2010, AIDS BEHAV, V14, pS185, DOI 10.1007/s10461-010-9805-x; Gyarmathy VA, 2011, SCAND J INFECT DIS, V43, P32, DOI 10.3109/00365548.2010.513064; Chamaz K., 2006, CONSTRUCTING GROUNDE; Darbes LA, 2014, ARCH SEX BEHAV, V43, P47, DOI 10.1007/s10508-013-0206-x; Dwyer R, 2011, ADDICT RES THEORY, V19, P352, DOI 10.3109/16066359.2011.562619; El-Bassel N, 2015, JAIDS-J ACQ IMM DEF, V69, pS182, DOI 10.1097/QAI.0000000000000628; El-Bassel N, 2014, CURR HIV-AIDS REP, V11, P45, DOI 10.1007/s11904-013-0192-6; Falck RS, 1995, AIDS EDUC PREV, V7, P523; Fraser S, 2004, HEALTH-LONDON, V8, P199, DOI 10.1177/1363459304041070; Fraser S, 2014, DRUG-EDUC PREV POLIC, V21, P88, DOI 10.3109/09687637.2013.776517; GIBSON DR, 1993, INT J ADDICT, V28, P973, DOI 10.3109/10826089309062177; Gyarmathy VA, 2010, AIDS BEHAV, V14, P141, DOI 10.1007/s10461-008-9518-6; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Hoff CC, 2012, AIDS PATIENT CARE ST, V26, P738, DOI 10.1089/apc.2012.0198; Janulis P, 2016, INT J DRUG POLICY, V27, P56, DOI 10.1016/j.drugpo.2015.09.006; Johnson RA, 2002, ADDICTION, V97, P1011, DOI 10.1046/j.1360-0443.2002.00165.x; Kelley H. H, 1978, INTERPERSONAL RELATI; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; Lewis MA, 2006, HEALTH EDUC RES, V21, P488, DOI 10.1093/her/cyh075; Louis GW, 2009, BIOL REPROD, P157; MacRae R, 2000, AIDS CARE, V12, P505, DOI 10.1080/09540120050123909; McMahon JM, 2015, PREV SCI, V16, P341, DOI 10.1007/s11121-014-0540-9; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Morris MD, 2017, SUBSTANCE USE MISUSE; Morris MD, 2017, CLIN INFECT DIS, V64, P860, DOI 10.1093/cid/ciw869; Morris MD, 2015, DRUG ALCOHOL DEPEN, V156, P275, DOI 10.1016/j.drugalcdep.2015.09.025; Morris MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109282; Morse J., 2009, DEV GROUNDED THEORY, V1st; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Rance J, 2018, HEALTH-LONDON, V22, P3, DOI 10.1177/1363459316660859; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2003, DRUG-EDUC PREV POLIC, V10, P303, DOI 10.1080/0968763031000077733; Rhodes T., 1997, RISK THEORY EPIDEMIC, DOI [10.1111/1467-9566.ep10934410, DOI 10.1111/1467-9566.EP10934410]; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2008, ADDICTION, V103, P1593, DOI 10.1111/j.1360-0443.2008.02306.x; Rhodes T, 2017, SOC SCI MED, V180, P125, DOI 10.1016/j.socscimed.2017.03.012; Riehman KS, 2003, DRUG ALCOHOL DEPEN, V70, P1, DOI 10.1016/S0376-8716(02)00332-0; Rusbult C.E., 1996, INTERDEPENDENCE PROC; Shaw SY, 2007, ADDICTION, V102, P1626, DOI 10.1111/j.1360-0443.2007.01940.x; Simmons J, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-7; Starks TJ, 2014, ARCH SEX BEHAV, V43, P139, DOI 10.1007/s10508-013-0216-8; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Strauss A, 1997, GROUNDED THEORY PRAC; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Syvertsen JL, 2013, CULT HEALTH SEX, V15, P540, DOI 10.1080/13691058.2013.773381; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Tracy D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004988; Treloar C, 2016, DRUG ALCOHOL DEPEN, V168, P170, DOI 10.1016/j.drugalcdep.2016.09.010; Treloar C, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0045-2; Unger JB, 2006, ADDICT BEHAV, V31, P1607, DOI 10.1016/j.addbeh.2005.12.007; Wilson H, 2014, DRUG ALCOHOL DEPEN, V144, P274, DOI 10.1016/j.drugalcdep.2014.08.018	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217811	10.1371/journal.pone.0217811	http://dx.doi.org/10.1371/journal.pone.0217811			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA7TI	31150518	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100115
J	Segura, M; Lopez-Gigosos, R; Mariscal-Lopez, E; Gutierrez-Bedmar, M; Mariscal, A				Segura, Marina; Lopez-Gigosos, Rosa; Mariscal-Lopez, Eloisa; Gutierrez-Bedmar, Mario; Mariscal, Alberto			Trends in the travelers' demand for pre-travel medical advice at a Spanish International Vaccination Center between 2000 and 2017	PLOS ONE			English	Article							ECONOMIC-IMPACT; TOURISM; TERRORISM	Crises and disasters affect the numbers of people traveling either for tourism or other reasons. Many studies have been published on the effects of such events on travel, especially on tourism, and based on the arrivals or departures of travelers to or from countries. Our aim was to assess the influence of these events on the demand for pre-travel medical consultation in an International Vaccination Centre (IVC). Data on 94683 international travelers who visited 113529 international destinations attended at the IVC of Malaga (Spain) during 2000-2017 were studied. A descriptive and time series analyses was conducted. The demand to IVC was 3.47 times higher in 2017 than in 2000. The increase has not been the same for all destinations: Travel to South-East Asia and Western Pacific World Health Organization (WHO) regions has multiplied by 10, while in the same period, Africa WHO region has declined from 36% to 20% of total demand. Thailand, India and Brazil were the countries with the highest demand (21% of all pre-travel consultations). We found out three periods, concurrent with some socioeconomic or health events, in which the number of travellers attend decline with respect to the previous years, or the growth was very slow. Growth in the demand for pre-travel medical advice in parallel with a foreseeable increase in the number of travelers is expected. Pre-travel medical services must be adapted to this increase. This study of the trend of demand for pre-travel medical information should new related problems to travel to be identified and quantified, and should assist improvement of policies and programs aimed at care of travelers.	[Segura, Marina; Lopez-Gigosos, Rosa] Port Hlth Author Malaga, Med Serv, Int Vaccinat Ctr, Malaga, Spain; [Lopez-Gigosos, Rosa; Mariscal-Lopez, Eloisa; Gutierrez-Bedmar, Mario; Mariscal, Alberto] Univ Malaga, Fac Med, Dept Publ Hlth & Psychiat, Malaga, Spain	Universidad de Malaga	Lopez-Gigosos, R (corresponding author), Port Hlth Author Malaga, Med Serv, Int Vaccinat Ctr, Malaga, Spain.; Lopez-Gigosos, R (corresponding author), Univ Malaga, Fac Med, Dept Publ Hlth & Psychiat, Malaga, Spain.	roslopgig@uma.es	Gutierrez-Bedmar, Mario/F-2364-2018; Mariscal, Alberto/ABH-5409-2020	Gutierrez-Bedmar, Mario/0000-0003-0898-8212; Mariscal, Alberto/0000-0002-4684-2161; Lopez-gigosos, Rosa/0000-0002-5303-3151; Mariscal-Lopez, Eloisa/0000-0002-5825-8579; Segura Moreno, Marina/0000-0001-8125-7980				Ahlfeldt GM, 2015, JAHRB NATL STAT, V235, P3; AlBattat A. R., 2013, INT BUSINESS RES, V6, P92; Ali A., 2012, CHALLENGES TOURISM C, V6, P1162; [Anonymous], 2016, ITB WORLD TRAV TREND; Arana JE, 2008, ANN TOURISM RES, V35, P299, DOI 10.1016/j.annals.2007.08.003; Bagans L, 2011, CRISES TOURISM IND T; Banki MB, 2016, TOUR MANAG PERSPECT, V18, P141, DOI 10.1016/j.tmp.2016.01.010; Beutels P, 2009, TROP MED INT HEALTH, V14, P85, DOI 10.1111/j.1365-3156.2008.02210.x; Cirer-Costa JC, 2017, TOUR MANAG PERSPECT, V22, P27, DOI 10.1016/j.tmp.2017.01.004; Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007; Harrison LH., 2018, PLOTKINS VACCINES, P619, DOI DOI 10.1016/B978-0-323-35761-6.00038-9; Henderson J. C., 2007, International Journal of Hospitality Management, V26, P228, DOI 10.1016/j.ijhm.2006.02.001; Hurtado TR, 2006, WILD ENVIRON MED, V17, P276, DOI 10.1580/06-WEME-RA-007R.1; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jiang YW, 2019, CURR ISSUES TOUR, V22, P1925, DOI 10.1080/13683500.2017.1408574; Keystone JS, 2013, TRAVEL MED; Ministerio de Sanidad Servicios Sociales e Igualdad, 2017, TAQBL SAL TAMB VIAJ; Novelli M, 2018, ANN TOURISM RES, V70, P76, DOI 10.1016/j.annals.2018.03.006; Pizam A., 2002, Journal of Travel Research, V40, P337, DOI 10.1177/0047287502040003011; Rangel-Buitrago N, 2013, TOURISM MANAGE, V35, P41, DOI 10.1016/j.tourman.2012.05.008; Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862; Ritchie BW, 2014, J TRAVEL RES, V53, P12, DOI 10.1177/0047287513482775; Roure S, 2015, REV CLIN ESP, V215, P439, DOI 10.1016/j.rce.2015.06.006; Stoney RJ, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav015; Suk JE, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25287; UNEP-WTO, 2005, MAK TOUR MOR SUST GU; UNWTO, 2017, UNWTO TOUR HIGHL 201, P1, DOI [10.18111/9789284419029, DOI 10.18111/9789284419029]; UNWTO, 2011, TOUR 2030 GLOB OV AD, DOI DOI 10.18111/9789284414024; Wang YS, 2009, TOURISM MANAGE, V30, P75, DOI 10.1016/j.tourman.2008.04.010; Wilder-Smith Annelies, 2006, Travel Med Infect Dis, V4, P53, DOI 10.1016/j.tmaid.2005.04.004	30	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217588	10.1371/journal.pone.0217588	http://dx.doi.org/10.1371/journal.pone.0217588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA2XG	31145759	Green Published, Green Submitted, gold			2022-12-26	WOS:000469425500024
J	Hom, WW; Tschopp, M; Lin, HA; Nasser, P; Laudier, DM; Hecht, AC; Nicoll, SB; Iatridis, JC				Hom, Warren W.; Tschopp, Melanie; Lin, Huizi A.; Nasser, Philip; Laudier, Damien M.; Hecht, Andrew C.; Nicoll, Steven B.; Iatridis, James C.			Composite biomaterial repair strategy to restore biomechanical function and reduce herniation risk in an ex vivo large animal model of intervertebral disc herniation with varying injury severity	PLOS ONE			English	Article							ANNULUS FIBROSUS REPAIR; CARBOXYMETHYLCELLULOSE HYDROGELS; PUNCTURE INJURY; NEEDLE PUNCTURE; TERM OUTCOMES; LUMBAR DISC; DISKECTOMY; HEIGHT; DEGENERATION; REGENERATION	Back pain commonly arises from intervertebral disc (IVD) damage including annulus fibrosus (AF) defects and nucleus pulposus (NP) loss. Poor IVD healing motivates developing tissue engineering repair strategies. This study evaluated a composite injectable IVD biomaterial repair strategy using carboxymethylcellulose-methylcellulose (CMC-MC) and genipincrosslinked fibrin (FibGen) that mimic NP and AF properties, respectively. Bovine ex vivo caudal IVDs were evaluated in cyclic compression-tension, torsion, and compression-to-failure tests to determine IVD biomechanical properties, height loss, and herniation risk following experimentally-induced severe herniation injury and discectomy (4 mm biopsy defect with 20% NP removed). FibGen with and without CMC-MC had failure strength similar to discectomy injury suggesting no increased risk compared to surgical procedures, yet no biomaterials improved axial or torsional biomechanical properties suggesting they were incapable of adequately restoring AF tension. FibGen had the largest failure strength and was further evaluated in additional discectomy injury models with varying AF defect types (2 mm biopsy, 4 mm cruciate, 4 mm biopsy) and NP removal volume (0%, 20%). All simulated discectomy defects significantly compromised failure strength and biomechanical properties. The 0% NP removal group had mean values of axial biomechanical properties closer to intact levels than defects with 20% NP removed but they were not statistically different and 0% NP removal also decreased failure strength. FibGen with and without CMC-MC failed at super-physiological stress levels above simulated discectomy suggesting repair with these tissue engineered biomaterials may perform better than discectomy alone, although restored biomechanical function may require additional healing with the potential application of these biomaterials as sealants and cell/ drug delivery carriers.	[Hom, Warren W.; Tschopp, Melanie; Nasser, Philip; Laudier, Damien M.; Hecht, Andrew C.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA; [Lin, Huizi A.; Nicoll, Steven B.] CUNY City Coll, Dept Biomed Engn, New York, NY USA	Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; City College of New York (CUNY)	Iatridis, JC (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.	james.iatridis@mssm.edu		Iatridis, James/0000-0002-2186-0590; Hom, Warren/0000-0003-0521-596X	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR057397]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057397] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number R01AR057397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DB, 2016, J BIOMECH, V49, P3407, DOI 10.1016/j.jbiomech.2016.09.009; Amin DB, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029698; Azab WA, 2016, ACTA NEUROCHIR, V158, P749, DOI 10.1007/s00701-016-2743-2; Beckstein JC, 2008, SPINE, V33, pE166, DOI 10.1097/BRS.0b013e318166e001; Bezci SE, 2018, J ORTHOP RES, V36, P2266, DOI 10.1002/jor.23870; Bezci SE, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031416; Borde B, 2015, J BIOMED MATER RES A, V103, P2571, DOI 10.1002/jbm.a.35388; Borem R, 2017, ACTA BIOMATER, V58, P254, DOI 10.1016/j.actbio.2017.06.006; Bowles RD, 2017, BIOMATERIALS, V129, P54, DOI 10.1016/j.biomaterials.2017.03.013; Carragee EJ, 2006, SPINE, V31, P653, DOI 10.1097/01.brs.0000203714.76250.68; Costi JJ, 2008, SPINE, V33, P1731, DOI 10.1097/BRS.0b013e31817bb116; Cruz MA, 2018, TISSUE ENG PT A, V24, P187, DOI [10.1089/ten.tea.2017.0334, 10.1089/ten.TEA.2017.0334]; Deyo RA, 2016, NEW ENGL J MED, V374, P1763, DOI 10.1056/NEJMcp1512658; Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2; Fernandez C, 2016, J BIOMED MATER RES A, V104, P3093, DOI 10.1002/jbm.a.35858; Grunert P, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1105-5; Gullbrand SE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau0670; Guterl CC, 2014, TISSUE ENG PT A, V20, P2536, DOI [10.1089/ten.tea.2012.0714, 10.1089/ten.TEA.2012.0714]; Guterl CC, 2013, EUR CELLS MATER, V25, P1; HAMPTON D, 1989, SPINE, V14, P398, DOI 10.1097/00007632-198904000-00009; Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4; Hu MH, 2018, J ORTHOP RES, V36, P202, DOI 10.1002/jor.23628; HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Jaumard NV, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004493; Laudier D, 2007, J ORTHOP RES, V25, P390, DOI 10.1002/jor.20304; Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P25, DOI 10.22203/eCM.v028a03; Lin HZA, 2016, J BIOMED MATER RES A, V104, P165, DOI 10.1002/jbm.a.35552; Long RG, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032353; Long RG, 2016, ACTA BIOMATER, V30, P116, DOI 10.1016/j.actbio.2015.11.015; Martin JT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15887-4; Masuoka K, 2007, SPINE, V32, P1974, DOI 10.1097/BRS.0b013e318133d591; McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a; MELROSE J, 1992, J ORTHOP RES, V10, P665, DOI 10.1002/jor.1100100509; Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001; Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Reza AT, 2010, ACTA BIOMATER, V6, P179, DOI 10.1016/j.actbio.2009.06.004; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; Scheibler AG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208460; Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28; Sharifi S, 2015, J TISSUE ENG REGEN M, V9, P1120, DOI 10.1002/term.1866; Sherman J, 2010, SPINE J, V10, P108, DOI 10.1016/j.spinee.2009.08.453; Sloan SR, 2017, ACTA BIOMATER, V59, P192, DOI 10.1016/j.actbio.2017.06.045; Varma DM, 2018, EUR CELLS MATER, V35, P300, DOI 10.22203/eCM.v035a21; Varma DM, 2014, ACTA BIOMATER, V10, P4996, DOI 10.1016/j.actbio.2014.08.013; Vergroesen PPA, 2015, SPINE, V40, P622, DOI 10.1097/BRS.0000000000000792; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Yang CH, 2016, EUR SPINE J, V25, P906, DOI 10.1007/s00586-015-4316-0; Yorimitsu E, 2001, SPINE, V26, P652, DOI 10.1097/00007632-200103150-00019	52	15	15	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217357	10.1371/journal.pone.0217357	http://dx.doi.org/10.1371/journal.pone.0217357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136604	gold, Green Published			2022-12-26	WOS:000469224300028
J	Ahern, BM; Levitan, BM; Veeranki, S; Shah, M; Ali, N; Sebastian, A; Su, W; Gong, MC; Li, JY; Stelzer, JE; Andres, DA; Satin, J				Ahern, Brooke M.; Levitan, Bryana M.; Veeranki, Sudhakar; Shah, Mihir; Ali, Nemat; Sebastian, Andrea; Su, Wen; Gong, Ming C.; Li, Jiayang; Stelzer, Julian E.; Andres, Douglas A.; Satin, Jonathan			Myocardial-restricted ablation of the GTPase RAD results in a pro-adaptive heart response in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; cardiomyocyte; GTPase; heart failure; transgenic mice; gene knockout; positive inotrope; RGK GTPase	DEPENDENT CALCIUM-CHANNELS; VASCULAR LESION FORMATION; CA2+ CHANNEL; SARCOPLASMIC-RETICULUM; PHENOTYPE RESISTANT; CARDIAC FIBROSIS; UP-REGULATION; GENE-THERAPY; REM; MUSCLE	Existing therapies to improve heart function target beta-adrenergic receptor (beta-AR) signaling and Ca2+ handling and often lead to adverse outcomes. This underscores an unmet need for positive inotropes that improve heart function without any adverse effects. The GTPase Ras associated with diabetes (RAD) regulates L-type Ca2+ channel (LTCC) current (I-Ca,I-L). Global RAD-knockout mice (gRAD(-/-)) have elevated Ca2+ handling and increased cardiac hypertrophy, but RAD is expressed also in noncardiac tissues, suggesting the possibility that pathological remodeling is due also to noncardiac effects. Here, we engineered a myocardial-restricted inducible RAD-knockout mouse (RAD(Delta/Delta)). Using an array of methods and techniques, including single-cell electrophysiological and calcium transient recordings, echocardiography, and radiotelemetry monitoring, we found that RAD deficiency results in a sustained increase of inotropy without structural or functional remodeling of the heart. I-Ca,I-L was significantly increased, with RAD loss conferring a beta-AR-modulated phenotype on basal I-Ca,I-L. Cardiomyocytes from RAD(Delta/Delta) hearts exhibited enhanced cytosolic Ca2+ handling, increased contractile function, elevated sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2a) expression, and faster lusitropy. These results argue that myocardial RAD ablation promotes a beneficial elevation in Ca2+ dynamics, which would obviate a need for increased beta-AR signaling to improve cardiac function.	[Ahern, Brooke M.; Levitan, Bryana M.; Shah, Mihir; Sebastian, Andrea; Su, Wen; Gong, Ming C.; Satin, Jonathan] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Levitan, Bryana M.] Univ Kentucky, Gill Heart & Vasc Inst, Lexington, KY 40536 USA; [Veeranki, Sudhakar; Ali, Nemat; Andres, Douglas A.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Li, Jiayang; Stelzer, Julian E.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	University of Kentucky; University of Kentucky; University of Kentucky; Case Western Reserve University	Satin, J (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA.; Andres, DA (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	dandres@uky.edu; Jsatin1@uky.edu	ALI, NEMAT/AAK-3922-2020	ALI, NEMAT/0000-0001-6525-4202	Institutional Development Award (IDeA) from NIGMS National Institutes of Health [P20 GM103527]; Saha Cardiovascular Research Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL131782, R01HL114770, R01HL131782, T32HL007567, R01HL146676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527, T32GM118292, T32GM007250] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from NIGMS National Institutes of Health; Saha Cardiovascular Research Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Wendy Katz for histology support provided by an Institutional Development Award (IDeA) from NIGMS National Institutes of Health Grant P20 GM103527. We thank Tanya Seward for surgical support for radiotelemetry in the Physiology Department core facility. The Vevo3100 was supported by The Saha Cardiovascular Research Center.	Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bertero E, 2018, NAT REV CARDIOL, V15, P780, DOI 10.1038/s41569-018-0116-7; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; Bupha-Intr T, 2009, J APPL PHYSIOL, V107, P1105, DOI 10.1152/japplphysiol.00407.2009; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen XW, 2011, J MOL CELL CARDIOL, V50, P460, DOI 10.1016/j.yjmcc.2010.11.012; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Correll RN, 2007, J BIOL CHEM, V282, P28431, DOI 10.1074/jbc.M706176200; Correll RN, 2017, CARDIOVASC RES, V113, P749, DOI 10.1093/cvr/cvx046; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Finlin BS, 2006, J BIOL CHEM, V281, P23557, DOI 10.1074/jbc.M604867200; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Freeman K, 2001, J CLIN INVEST, V107, P967, DOI 10.1172/JCI12083; Fu MG, 2005, CIRCULATION, V111, P1071, DOI 10.1161/01.CIR.0000156439.55349.AD; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Goldhaber JI, 2010, CIRCULATION, V121, P1655, DOI 10.1161/CIRCULATIONAHA.109.899294; Gresham KS, 2017, J APPL PHYSIOL, V122, P520, DOI 10.1152/japplphysiol.00306.2016; Gresham KS, 2016, J PHYSIOL-LONDON, V594, P669, DOI 10.1113/JP270959; Gunton JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039462; Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kobirumaki-Shimozawa F, 2016, J GEN PHYSIOL, V147, P53, DOI 10.1085/jgp.201511484; Levitan BM, 2016, J CARDIOVASC TRANSL, V9, P432, DOI 10.1007/s12265-016-9716-y; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Maack C, 2019, EUR HEART J, V40, P3626, DOI 10.1093/eurheartj/ehy600; Magyar J, 2012, CHANNELS, V6, P166, DOI 10.4161/chan.20192; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; Manning JR, 2018, JACC-BASIC TRANSL SC, V3, P83, DOI 10.1016/j.jacbts.2017.09.004; Manning JR, 2015, AM J PHYSIOL-HEART C, V309, pH336, DOI 10.1152/ajpheart.00389.2015; Manning JR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000459; Mebazaa A, 2011, INTENS CARE MED, V37, P290, DOI 10.1007/s00134-010-2073-4; Muth JN, 1999, J BIOL CHEM, V274, P21503, DOI 10.1074/jbc.274.31.21503; Muth JN, 2001, CIRCULATION, V103, P140; Puckerin AA, 2018, P NATL ACAD SCI USA, V115, P12051, DOI 10.1073/pnas.1811024115; Puhl HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100694; Raake PW, 2012, CIRCULATION, V125, P2108, DOI 10.1161/CIRCULATIONAHA.111.044255; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Satin J., 2017, CARDIAC ELECTROPHYSI, P1424; Schmid E, 2015, NAT MED, V21, P1298, DOI 10.1038/nm.3972; SIPIDO KR, 1995, CIRC RES, V76, P102, DOI 10.1161/01.RES.76.1.102; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Tacon CL, 2012, INTENS CARE MED, V38, P359, DOI 10.1007/s00134-011-2435-6; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Wang Y, 2014, J BIOL CHEM, V289, P14225, DOI 10.1074/jbc.M113.527671; Withers CN, 2017, BONE, V103, P270, DOI 10.1016/j.bone.2017.07.018; Yang TT, 2013, BBA-BIOMEMBRANES, V1828, P1644, DOI 10.1016/j.bbamem.2012.10.005; Zhang J, 2011, CARDIOVASC RES, V91, P90, DOI 10.1093/cvr/cvr068	50	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10913	10927		10.1074/jbc.RA119.008782	http://dx.doi.org/10.1074/jbc.RA119.008782			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31147441	Green Published, hybrid			2022-12-26	WOS:000478717200015
J	Khadka, N; Farquhar, ER; Hill, HE; Shi, W; von Lintig, J; Kiser, PD				Khadka, Nimesh; Farquhar, Erik R.; Hill, Hannah E.; Shi, Wuxian; von Lintig, Johannes; Kiser, Philip D.			Evidence for distinct rate-limiting steps in the cleavage of alkenes by carotenoid cleavage dioxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; iron; crystallography; carotenoid; dioxygenase; non-heme iron; O-2 activation; solvent isotope effect; stilbenoid; X-ray absorption spectroscopy	SOLVENT ISOTOPE; MECHANISM; ENZYME; OXYGENASES; INSIGHTS	Carotenoid cleavage dioxygenases (CCDs) use a nonheme Fe(II) cofactor to split alkene bonds of carotenoid and stilbenoid substrates. The iron centers of CCDs are typically five-coordinate in their resting states, with solvent occupying an exchangeable site. The involvement of this iron-bound solvent in CCD catalysis has not been experimentally addressed, but computational studies suggest two possible roles. 1) Solvent dissociation provides a coordination site for O-2, or 2) solvent remains bound to iron but changes its equilibrium position to allow O-2 binding and potentially acts as a proton source. To test these predictions, we investigated isotope effects (H2O versus D2O) on two stilbenoid-cleaving CCDs, Novosphingobium aromaticivorans oxygenase 2 (NOV2) and Neurospora crassa carotenoid oxygenase 1 (CAO1), using piceatannol as a substrate. NOV2 exhibited an inverse isotope effect (k(H)/k(D) similar to 0.6) in an air-saturated buffer, suggesting that solvent dissociates from iron during the catalytic cycle. By contrast, CAO1 displayed a normal isotope effect (k(H)/k(D) similar to 1.7), suggesting proton transfer in the rate-limiting step. X-ray absorption spectroscopy on NOV2 and CAO1 indicated that the protonation states of the iron ligands are unchanged within pH 6.5-8.5 and that the Fe(II)-aquo bond is minimally altered by substrate binding. We pinpointed the origin of the differential kinetic behaviors of NOV2 and CAO1 to a single amino acid difference near the solvent-binding site of iron, and X-ray crystallography revealed that the substitution alters binding of diffusible ligands to the iron center. We conclude that solvent-iron dissociation and proton transfer are both associated with the CCD catalytic mechanism.	[Khadka, Nimesh; Hill, Hannah E.; von Lintig, Johannes; Kiser, Philip D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Farquhar, Erik R.; Shi, Wuxian] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA; [Farquhar, Erik R.; Shi, Wuxian] Case Western Reserve Univ, Ctr Proteom & Bioinformat, Ctr Synchrotron Biosci, Sch Med, Cleveland, OH 44106 USA; [Kiser, Philip D.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA	Case Western Reserve University; United States Department of Energy (DOE); Brookhaven National Laboratory; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Kiser, PD (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 837 Hlth Sci Rd, Irvine, CA 92617 USA.	pkiser@uci.edu		Farquhar, Erik/0000-0002-6419-038X	National Institutes of Health (NIH) [GM103403, RR029205]; United States Department of Energy (DOE) [DE-AC02-06CH11357]; United States DOE Office of Science [DE-AC02-76SF00515]; NIH [P41-GM-103393, GM111244, EB009998]; DOE Office of Biological and Environmental Research Grant [KP1605010]; DOE Office of Science, Office of Basic Energy Sciences Program [DE-SC0012704 (Grant KC0401040)]; NATIONAL EYE INSTITUTE [R01EY009339, R01EY020551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy (DOE)(United States Department of Energy (DOE)); United States DOE Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research Grant(United States Department of Energy (DOE)); DOE Office of Science, Office of Basic Energy Sciences Program(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work is based in part upon research conducted at the Advanced Photon Source Northeastern Collaborative Access Team beamline 24ID-E supported by National Institutes of Health (NIH) Grants GM103403 and RR029205 and United States Department of Energy (DOE) Contract DE-AC02-06CH11357. Use of SSRL beamlines 7-3 and 9-3 was made possible by the United States DOE Office of Science under Contract DE-AC02-76SF00515 to SLAC National Accelerator Laboratory and NIH Grant P41-GM-103393 (SSRL Structural Molecular Biology Program). Data for this study were measured at beamline 17-ID-2 (FMX) of the National Synchrotron Light Source-II, which is supported by NIH Grant GM111244 and DOE Office of Biological and Environmental Research Grant KP1605010. The NSLS-II is supported in part by the DOE Office of Science, Office of Basic Energy Sciences Program under Contract DE-SC0012704 (Grant KC0401040). The Case Center for Synchrotron Biosciences is supported by NIH Grant EB009998.	Al-Babili S, 2015, ANNU REV PLANT BIOL, V66, P161, DOI 10.1146/annurev-arplant-043014-114759; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Choi EH, 2018, HUM MOL GENET, V27, P2225, DOI 10.1093/hmg/ddy128; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flagg SC, 2012, BIOCHEMISTRY-US, V51, P6654, DOI 10.1021/bi300229y; Gadda G, 2013, FEBS LETT, V587, P2785, DOI 10.1016/j.febslet.2013.04.021; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P926, DOI 10.1271/bbb.57.926; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; KASSEBAUM JW, 1989, J AM CHEM SOC, V111, P2691, DOI 10.1021/ja00189a052; Khadka N, 2017, J AM CHEM SOC, V139, P13518, DOI 10.1021/jacs.7b07311; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kohen Amnon and Limbach Hans Heinrich, 2006, ISOTOPE EFFECTS CHEM, P995; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Loewen PC, 2018, BMC BIOCHEM, V19, DOI 10.1186/s12858-018-0098-4; McAndrew RP, 2016, P NATL ACAD SCI USA, V113, P14324, DOI 10.1073/pnas.1608917113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neidig ML, 2005, CHEM COMMUN, P5843, DOI 10.1039/b510233m; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Scherzinger D, 2006, BIOCHEM J, V398, P361, DOI 10.1042/BJ20060592; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Sui XW, 2018, J BIOL INORG CHEM, V23, P887, DOI 10.1007/s00775-018-1586-0; Sui XW, 2017, BIOCHEMISTRY-US, V56, P2836, DOI 10.1021/acs.biochem.7b00251; Sui XW, 2015, J BIOL CHEM, V290, P30212, DOI 10.1074/jbc.M115.696799; Sui XW, 2014, J BIOL CHEM, V289, P12286, DOI 10.1074/jbc.M114.552836; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Sutherlin KD, 2018, J AM CHEM SOC, V140, P16495, DOI 10.1021/jacs.8b06517; VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268; WEISS PM, 1987, BIOCHEMISTRY-US, V26, P7378, DOI 10.1021/bi00397a027; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wyss A, 2004, J NUTR, V134, p246S, DOI 10.1093/jn/134.1.246S	40	5	5	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10596	10606		10.1074/jbc.RA119.007535	http://dx.doi.org/10.1074/jbc.RA119.007535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138651	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000478717100018
J	Asar, L; Pfefferle, S; Lutgehetmann, M; Hoffmann, A; Katchanov, J; Aepfelbacher, M; Rohde, H; Maurer, FP				Asar, Lucia; Pfefferle, Susanne; Luetgehetmann, Marc; Hoffmann, Armin; Katchanov, Juri; Aepfelbacher, Martin; Rohde, Holger; Maurer, Florian P.			Influence of local epidemiology on the performance of common colistin drug susceptibility testing methods	PLOS ONE			English	Article							RESISTANT PSEUDOMONAS-AERUGINOSA; OUTBREAK; PNEUMONIAE; CRITERIA	Objectives To determine the influence of local spread of clonal strains and testing of follow-up isolates on categorical (CA) and essential agreement rates (EA) of common colistin (COL) drug susceptibility testing methods with the broth microdilution (BMD) reference method. Methods COL MICs were determined for 178 bacterial isolates (Enterobacteriaceae, n = 97; Pseudomonas aeruginosa, n = 81) collected within one year from 64 patients by BMD according to ISO standard 20776-1 (reference method), the SensiTest BMD panel (ST), agar dilution (AD), the VITEK 2 instrument, and gradient diffusion (GD) using antibiotic strips of two and Muller-Hinton agar plates of three manufacturers. CA and EA with BMD were calculated for all isolates and compared to the subset of 68 unique isolates. Results CA ranges were 79.4% to 94.1% for the unique isolateq panel and 89.9% to 96.1% for all tested isolates. EA ranges were 64.7% to 86.8% and 67.4% to 91.0%, respectively. In both panels, EA for all GD assays was lower than 90%. Both lower and higher EA values ranging from-18.3% (MTS on BD agar) to + 6.3% (AD, Vitek 2) were observed in the full one-year sample. Acquisition of colistin resistance under therapy was observed for 3 patients. Conclusions i) Repeat testing and local spread of clonal strains can positively or negatively affect CA and EA, ii) CA is more robust towards local influences than EA, iii) EA of GD and AD methods for COL with the reference BMD method is insufficient.	[Asar, Lucia; Pfefferle, Susanne; Luetgehetmann, Marc; Hoffmann, Armin; Aepfelbacher, Martin; Rohde, Holger; Maurer, Florian P.] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Katchanov, Juri] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany; [Maurer, Florian P.] Leibniz Lung Ctr, Res Ctr Borstel, Borstel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Forschungszentrum Borstel	Maurer, FP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.; Maurer, FP (corresponding author), Leibniz Lung Ctr, Res Ctr Borstel, Borstel, Germany.	f.maurer@uke.de	Maurer, Florian/ABA-1918-2020; Maurer, Florian/Z-5028-2019	Maurer, Florian/0000-0001-8353-5964; Maurer, Florian/0000-0001-8353-5964; Rohde, Holger/0000-0001-8587-4433	German Center for Infection Research (DZIF) [TI 07.003]	German Center for Infection Research (DZIF)	This work was supported by internal funding and a grant by the German Center for Infection Research (DZIF) to LA and FPM (TI 07.003). There was no additional external funding received for this study.	Chabou S., 2016, New Microbes and New Infections, V13, P71, DOI 10.1016/j.nmni.2016.06.017; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Dafopoulou K, 2015, ANTIMICROB AGENTS CH, V59, P4625, DOI 10.1128/AAC.00868-15; European Committee on Antimicrobial Susceptibility Testing (EUCAST), ANT SUSC TEST COL PR; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Gibb AP, 2002, ANTIMICROB AGENTS CH, V46, P255, DOI 10.1128/AAC.46.1.255-258.2002; International Organization for Standardization, 2006, ISO207761 BSI; Katchanov J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195757; Kulengowski B, 2019, CLIN MICROBIOL INFEC, V25, P92, DOI 10.1016/j.cmi.2018.04.008; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Matuschek E, 2018, CLIN MICROBIOL INFEC, V24, P865, DOI 10.1016/j.cmi.2017.11.020; Matuschek E, 2017, ECCMID VIENN, V161; Rebelo AR, 2018, EUROSURVEILLANCE, V23, DOI [10.2807/1560-7917.ES, DOI 10.2807/1560-7917.ES]; Schroter M, 2004, APPL ENVIRON MICROB, V70, P613, DOI 10.1128/AEM.70.1.613-615.2004; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Skov RL, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.9.30155; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Spapen H, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-14; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Zhang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134743	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217468	10.1371/journal.pone.0217468	http://dx.doi.org/10.1371/journal.pone.0217468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170167	Green Published, Green Submitted, gold			2022-12-26	WOS:000470263700033
J	Chambers, C; Kong, GQ; Wei, KL; Kording, K				Chambers, Claire; Kong, Gaiqing; Wei, Kunlin; Kording, Konrad			Pose estimates from online videos show that side-by-side walkers synchronize movement under naturalistic conditions	PLOS ONE			English	Article							INTERPERSONAL COORDINATION; GAIT SYNCHRONIZATION; TREADMILL WALKING; ROCKING; BEAT	Marker-less video-based pose estimation promises to allow us to do movement science on existing video databases. We revisited the old question of how people synchronize their walking using real world data. We thus applied pose estimation to 348 video segments extracted from YouTube videos of people walking in cities. As in previous, more constrained, research, we find a tendency for pairs of people to walk in phase or in anti-phase with each other. Large video databases, along with pose-estimation algorithms, promise answers to many movement questions without experimentally acquiring new data.	[Chambers, Claire; Kong, Gaiqing; Kording, Konrad] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Chambers, Claire; Kong, Gaiqing; Kording, Konrad] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Kong, Gaiqing; Wei, Kunlin] Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China; [Wei, Kunlin] Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China	University of Pennsylvania; University of Pennsylvania; Peking University; Peking University	Chambers, C (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Chambers, C (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	clairenc@seas.upenn.edu	Kording, Konrad/A-1233-2007	Kording, Konrad/0000-0001-8408-4499; Kong, Gaiqing/0000-0002-3142-3730	NIH [5R01NS063399-08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grant 5R01NS063399-08, awarded to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Bode NWF, 2010, P ROY SOC B-BIOL SCI, V277, P3065, DOI 10.1098/rspb.2010.0855; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863, DOI 10.1113/jphysiol.1996.sp021539; Cao Z., 2016, ARXIV161108050; Demos AP, 2012, J EXP PSYCHOL GEN, V141, P49, DOI 10.1037/a0023843; Ducourant T, 2005, NEUROSCI LETT, V389, P6, DOI 10.1016/j.neulet.2005.06.052; Guler RA, 180200434 ARXIV, DOI [10.1109/CVPR.2017.280, DOI 10.1109/CVPR.2017.280]; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; Hreljac A, 2000, J BIOMECH, V33, P783, DOI 10.1016/S0021-9290(00)00014-2; Ingram JN, 2011, PROG BRAIN RES, V191, P3, DOI 10.1016/B978-0-444-53752-2.00016-3; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Krause J, 2002, LIVING GROUPS; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Loper M, 2015, ACM T GRAPHIC, V34, DOI 10.1145/2816795.2818013; Maas AL, 2012, 13TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2012 (INTERSPEECH 2012), VOLS 1-3, P22; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Mickelborough J, 2000, GAIT POSTURE, V11, P32, DOI 10.1016/S0966-6362(99)00050-8; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Nessler JA, 2015, HUM MOVEMENT SCI, V41, P32, DOI 10.1016/j.humov.2015.02.005; Nessler JA, 2011, J APPL BIOMECH, V27, P322, DOI 10.1123/jab.27.4.322; Nessler JA, 2010, GAIT POSTURE, V31, P527, DOI 10.1016/j.gaitpost.2010.01.013; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; Nessler JA, 2009, CHAOS, V19, DOI 10.1063/1.3125762; O'Brien B, 2010, ECOL PSYCHOL, V7413, P37; Ochoa J, 2017, J NEUROPHYSIOL, V118, P2089, DOI 10.1152/jn.00176.2017; Pachi A, 2005, STRUCTURAL ENG, V83, P36, DOI DOI 10.1016/S0141-0296(00)00020-1; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Seethapathi N, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0486; Sylos-Labini F, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00179; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Wei KL, 2018, NAT NEUROSCI, V21, P1146, DOI 10.1038/s41593-018-0215-0; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28; Zivotofsky AZ, 2018, HUM MOVEMENT SCI, V59, P20, DOI 10.1016/j.humov.2018.03.009; Zivotofsky AZ, 2012, HUM MOVEMENT SCI, V31, P1268, DOI 10.1016/j.humov.2012.01.003	39	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217861	10.1371/journal.pone.0217861	http://dx.doi.org/10.1371/journal.pone.0217861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170214	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700071
J	Gou, YP; Wang, G; Quandahor, P; Liu, Q; Liu, CZ				Gou, Yuping; Wang, Guang; Quandahor, Peter; Liu, Qian; Liu, Changzhong			Effects of sex ratio on adult fecundity, longevity and egg hatchability of Bradysia difformis Frey at different temperatures	PLOS ONE			English	Article							DIPTERA; SCIARIDAE; FUNGI	The fungus gnat Bradysia difformis Frey not only attacks edible and medicinal fungi, it also causes the damages to leek, green onion, garlic and other vegetable crops. To confirm the effects of temperature and sex ratio on adult fecundity, longevity and egg hatchability of B. difformis, we assayed the adults survival longevity and numbers of oviposition, as well as egg hatching rate under female-male ratios of 1:1, 1:2, 1:3, 2:1 and 3:1 at 10, 15, 20, 25 and 30 degrees C. Female fecundity and egg hatchability were increased with temperature and peaked at 25 degrees C, which, however, were adverse to adult longevity. Furthermore, female-male ratio of 1:1, 1:2 and 1:3 seemed suitable for female fecundity, of which the sex ratio of 1:1 was the most suitable ratio for its oviposition behavior. These results provide an insight for predicting the population density of B. difformis and offer a literature reference in the effective treatment of harmful insects by controlling and changing the sex ratio artificially.	[Gou, Yuping; Wang, Guang; Quandahor, Peter; Liu, Qian; Liu, Changzhong] Gansu Agr Univ, Coll Plant Protect, Biocontrol Engn Lab Crop Dis & Pests, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Liu, CZ (corresponding author), Gansu Agr Univ, Coll Plant Protect, Biocontrol Engn Lab Crop Dis & Pests, Lanzhou, Gansu, Peoples R China.	liuchzh@gsau.edu.cn		Gou, Yuping/0000-0001-7001-5978	Discipline Construction Fund Project of Gansu Agricultural University [GAU-XKJS-2018-149]; International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology [201303027]	Discipline Construction Fund Project of Gansu Agricultural University; International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology	This study was supported by the Discipline Construction Fund Project of Gansu Agricultural University (GAU-XKJS-2018-149), and International Commonwealth Scientific Research Special Fund-Research and Demonstration of Crop Root Maggot Control Technology (201303027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard RW, 2006, HYDROBIOLOGIA, V568, P403, DOI 10.1007/s10750-006-0200-6; Cao X., 2014, EFFECT DIFFERENT TEM; Dang Zhi-Hong, 2000, Entomological Knowledge, V37, P308; Deng YZ, 2014, STUDY SCREENING PEST; Dong Jun-Feng, 2001, Entomological Knowledge, V38, P173; Fei SM, 2011, J SICHUAN FORESTRY S, V32, P23; Fjerdingstad EJ, 2002, EVOLUTION, V56, P553, DOI 10.1111/j.0014-3820.2002.tb01366.x; Gong Ya-Jun, 2010, Chinese Bulletin of Entomology, V47, P63; [苟玉萍 Gou Yuping], 2015, [植物保护, Plant Protection], V41, P28; [何超 He Chao], 2017, [植物保护, Plant Protection], V43, P62; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hurley BP, 2007, SOUTH HEMISPH FOR J, V69, P103, DOI 10.2989/SHFJ.2007.69.2.5.291; Liu RL, 1983, J SHANXI U NATURAL S, V2, P11; Mei Zeng-Xia, 2004, Acta Entomologica Sinica, V47, P219; Pan Fei, 2014, Huanjing Kunchong Xuebao, V36, P240; Qin Qilian, 2001, Chinese Journal of Biological Control, V17, P155; Shen Deng-Rong, 2009, Acta Entomologica Sinica, V52, P934; Shen Ding, 2008, Electronic Components & Materials, V27, P48; Shi Pei-Jian, 2011, Chinese Journal of Applied Entomology, V48, P1149; Shin S, 2013, MOL ECOL RESOUR, V13, P200, DOI 10.1111/1755-0998.12057; Simon RL, 1994, B ENTOMOL RES, V84, P290; SUNDSTROM L, 1994, NATURE, V367, P266, DOI 10.1038/367266a0; Tao Shu-Xia, 2014, Acta Entomologica Sinica, V57, P616; [姚永生 YAO Yongsheng], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P4351; ZHANG HR, 2008, EDIBLE FUNGI CHINA, V27, P54; Zhang XM, 1994, PEST CONTROL EDIBLE; Zhang Yan-Xia, 2016, Chinese Journal of Applied Entomology, V53, P1184, DOI 10.7679/j.issn.2095-1353.2016.146; Zhang ZhiJun, 2013, Acta Agriculturae Zhejiangensis, V25, P520; Zhang Ziyou, 1990, Scientia Silvae Sinicae, V26, P46; [赵海燕 ZHAO Hai-yan], 2009, [吉林农业科学, Journal of Jilin Agricultural Sciences], V34, P34; Zhao Ya-zhou, 2010, Shengtaixue Zazhi, V29, P1087	31	8	9	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217867	10.1371/journal.pone.0217867	http://dx.doi.org/10.1371/journal.pone.0217867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166959	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800045
J	Gupta, P; Sata, TN; Yadav, AK; Mishra, A; Vats, N; Hossain, MM; Sanal, MG; Venugopal, SK				Gupta, Parul; Sata, Teja Naveen; Yadav, Ajay K.; Mishra, Amit; Vats, Nisha; Hossain, Md. Musa; Sanal, M. G.; Venugopal, Senthil Kumar			TGF-beta induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MICRORNA-181A	Objective To study the role of miRNA-181a and augmenter of liver regeneration in TGF-beta-induced fibrosis in hepatic stellate cells. Methods LX2 cells were treated with 20 ng/ml TGF-beta for 24 h. miRNA-181a, ALR plasmid and empty vectors were transfected using siPORT NeoFx reagent. Cells were harvested after 48 h or 72 h of transfection for protein or RNA analysis. Western blotting was performed for ALR, TGF-beta receptor II (TGF beta-RII), collagen 1A1 (COLL1A1), alpha-smooth muscle cell actin (aSMA), rac1, E-cadherin and beta-actin. Quantitative RT-PCR was performed for ALR, GAPDH, miRNA-181a or 5S rRNA. Results TGF-beta induced the expression of miRNA-181a, which in turn down-regulated ALR thereby induced the fibrosis markers, such as COLL1A1, a-SMA and rac1 in hepatic stellate cells. Over-expression of miRNA-181a down-regulated expression of ALR and up-regulated expression of fibrosis markers. On the other hand, ALR over-expression resulted in a decrease in miRNA-181a expression and fibrosis markers. Over-expression of ALR also inhibited the expression of TGF beta-RII and increased expression E-cadherin. Conclusion TGF-beta induced miRNA-181a, which in turn induced fibrosis, at least in part, by inhibiting ALR. ALR inhibited TGF-beta action by decreasing the expression of TGF-RII, thereby inhibiting miRNA-181a expression and fibrosis markers. ALR could serve as a potential molecule to inhibit liver fibrosis.	[Gupta, Parul; Sata, Teja Naveen; Yadav, Ajay K.; Mishra, Amit; Hossain, Md. Musa; Venugopal, Senthil Kumar] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India; [Vats, Nisha; Sanal, M. G.] Inst Liver & Biliary Sci, Dept Mol & Cellular Med, New Delhi, India	South Asian University (SAU); Institute of Liver & Biliary Sciences (ILBS)	Venugopal, SK (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	drsenthil@sau.ac.in	Girija, Sanal Madhusudana/AAV-2072-2020	Girija, Sanal Madhusudana/0000-0003-0007-5718	Department of Science and Technology; University Grants Commission	Department of Science and Technology(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India)	This work was supported by the Department of Science and Technology, Govt. of India, (SKV); University Grants Commission, Govt. of India (PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen P, 2018, MED SCI MONITOR, V24, P4121, DOI 10.12659/MSM.908056; Davoodian Parivash, 2017, Gastroenterol Hepatol Bed Bench, V10, P112; Gandhi CR, 2015, GASTROENTEROLOGY, V148, P379, DOI 10.1053/j.gastro.2014.10.008; Guo DG, 2016, ACTA BIOCH BIOPH SIN, V48, P840, DOI 10.1093/abbs/gmw068; Gupta P, 2018, HEPATOL RES, V48, P587, DOI 10.1111/hepr.13077; Jiang Joy X, 2013, Curr Pathobiol Rep, V1, P215; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lei ZW, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2017.09.019; Li HH, 2015, INT J ONCOL, V47, P1379, DOI 10.3892/ijo.2015.3144; Meng XM, 2015, ONCOTARGET, V6, P36984, DOI 10.18632/oncotarget.6100; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Nithyamathi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0136709; Ogawa T, 2010, BIOCHEM BIOPH RES CO, V391, P316, DOI 10.1016/j.bbrc.2009.11.056; Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008; Qu F, 2016, ONCOL LETT, V11, P1592, DOI 10.3892/ol.2015.4073; Song M, 2011, BIOCHEM BIOPH RES CO, V415, P152, DOI 10.1016/j.bbrc.2011.10.039; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Torok NJ, 2008, J GASTROENTEROL, V43, P315, DOI 10.1007/s00535-008-2181-x; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang Y, 2017, WORLD J GASTROENTERO, V23, P2330, DOI 10.3748/wjg.v23.i13.2330; You K, 2018, MOL THER-NUCL ACIDS, V12, P57, DOI 10.1016/j.omtn.2018.04.016; Zhiping C, 2017, EUR REV MED PHARMACO, V21, P4835	22	26	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0214534	10.1371/journal.pone.0214534	http://dx.doi.org/10.1371/journal.pone.0214534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166951	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800002
J	Biddlecome, A; Habte, HH; McGrath, KM; Sambanthamoorthy, S; Wurm, M; Sykora, MM; Knobler, CM; Lorenz, IC; Lasaro, M; Elbers, K; Gelbart, WM				Biddlecome, Adam; Habte, Habtom H.; McGrath, Katherine M.; Sambanthamoorthy, Sharmila; Wurm, Melanie; Sykora, Martina M.; Knobler, Charles M.; Lorenz, Ivo C.; Lasaro, Marcio; Elbers, Knut; Gelbart, William M.			Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles	PLOS ONE			English	Article							PHYSICAL PRINCIPLES; ASSEMBLY PATHWAY; NODAMURA-VIRUS; NANOPARTICLES; CAPSIDS	Many mRNA-based vaccines have been investigated for their specific potential to activate dendritic cells (DCs), the highly-specialized antigen-presenting cells of the immune system that play a key role in inducing effective CD4(+) and CD8(+) T-cell responses. In this paper we report a new vaccine/gene delivery platform that demonstrates the benefits of using a self-amplifying ("replicon") mRNA that is protected in a viral-protein capsid. Purified capsid protein from the plant virus Cowpea Chlorotic Mottle Virus (CCMV) is used to in vitro assemble monodisperse virus-like particles (VLPs) containing reporter proteins (e.g., Luciferase or eYFP) or the tandem-repeat model antigen SIINFEKL in RNA gene form, coupled to the RNA-dependent RNA polymerase from the Nodamura insect virus. Incubation of immature DCs with these VLPs results in increased activation of maturation markers - CD80, CD86 and MHC-II - and enhanced RNA replication levels, relative to incubation with unpackaged replicon mRNA. Higher RNA uptake/replication and enhanced DC activation were detected in a dose-dependent manner when the CCMV-VLPs were pre-incubated with anti-CCMV antibodies. In all experiments the expression of maturation markers correlates with the RNA levels of the DCs. Overall, these studies demonstrate that: VLP protection enhances mRNA uptake by DCs; coupling replicons to the gene of interest increases RNA and protein levels in the cell; and the presence of anti-VLP antibodies enhances mRNA levels and activation of DCs in vitro. Finally, preliminary in vivo experiments involving mouse vaccinations with SIIN-FEKL-replicon VLPs indicate a small but significant increase in antigen-specific T cells that are doubly positive for IFN and TFN induction.	[Biddlecome, Adam; Knobler, Charles M.; Gelbart, William M.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Habte, Habtom H.; McGrath, Katherine M.; Sambanthamoorthy, Sharmila; Lasaro, Marcio] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA; [Wurm, Melanie; Sykora, Martina M.] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; [Lorenz, Ivo C.] Triinst Therapeut Discovery Inst, New York, NY USA; [Elbers, Knut] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	University of California System; University of California Los Angeles; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Gelbart, WM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Elbers, K (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.	knut.elbers@boehringer-ingelheim.com; gelbart@chem.ucla.edu			Boehringer-Ingelheim International GmbH [272661]	Boehringer-Ingelheim International GmbH(Boehringer Ingelheim)	This work was supported by Boehringer-Ingelheim International GmbH (https://www.boehringer-ingelheim.com/) as part of its research contract number 272661 with the University of California, Los Angeles, from which AB received salary. No sponsors/funders other than the named authors played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all PLOS ONE policies on sharing data and materials.	A-Cadena-Nava R, 2012, J VIROL, V86, P12271, DOI [10.1128/JVI.01695-12, DOI 10.1128/JVI.01695-12]; Azizgolshani O, 2013, VIROLOGY, V441, P12, DOI 10.1016/j.virol.2013.03.001; Ball L, 2003, U.S. Patent, Patent No. 20030108863; Brito LA, 2014, MOL THER, V22, P2118, DOI 10.1038/mt.2014.133; CARBONE FR, 1992, INT IMMUNOL, V4, P861, DOI 10.1093/intimm/4.8.861; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113; Da Silva DM, 2007, J IMMUNOL, V178, P7587, DOI 10.4049/jimmunol.178.12.7587; Destito G, 2007, CHEM BIOL, V14, P1152, DOI 10.1016/j.chembiol.2007.08.015; Garmann RF, 2016, ACCOUNTS CHEM RES, V49, P48, DOI 10.1021/acs.accounts.5b00350; Garmann RF, 2014, J VIROL, V88, P10472, DOI 10.1128/JVI.01044-14; Garmann RF, 2014, J MOL BIOL, V426, P1050, DOI 10.1016/j.jmb.2013.10.017; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Gitlin L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004529; Hovlid ML, 2012, NANOSCALE, V4, P3698, DOI 10.1039/c2nr30571b; Johnson KL, 2004, J VIROL, V78, P6698, DOI 10.1128/JVI.78.12.6698-6704.2004; Johnson KL, 2003, VIROLOGY, V305, P436, DOI 10.1006/viro.2002.1769; Kemnade JO, 2014, VACCINE, V32, P4228, DOI 10.1016/j.vaccine.2014.04.051; Kovacs EW, 2007, BIOCONJUGATE CHEM, V18, P1140, DOI 10.1021/bc070006e; Lam P, 2018, WIRES NANOMED NANOBI, V10, DOI 10.1002/wnan.1487; Maruggi G, 2019, MOL THERAPY, V27, P1; Rohovie MJ, 2017, BIOENG TRANSL MED, V2, P43, DOI 10.1002/btm2.10049; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schott J, 2010, WIRES RNA, V1, P432, DOI 10.1002/wrna.13; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Stephanopoulos N, 2010, ACS NANO, V4, P6014, DOI 10.1021/nn1014769; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005	27	28	28	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0215031	10.1371/journal.pone.0215031	http://dx.doi.org/10.1371/journal.pone.0215031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163034	Green Published, gold, Green Submitted			2022-12-26	WOS:000470086200004
J	Gebeyehu, E; Nigatu, D; Engidawork, E				Gebeyehu, Endalew; Nigatu, Desalegn; Engidawork, Ephrem			Helicobacter pylori eradication rate of standard triple therapy and factors affecting eradication rate at Bahir Dar city administration, Northwest Ethiopia: A prospective follow up study	PLOS ONE			English	Article							ADULT DYSPEPTIC PATIENTS; TREATMENT FAILURE; INFECTION; CLARITHROMYCIN; AMOXICILLIN; OMEPRAZOLE; MANAGEMENT; 1ST-LINE; EFFICACY; DISEASES	Background Eradication of Helicobacter pylori infection with standard triple therapy has been accepted to curb associated risks of chronic gastritis andpeptic ulcer disease. Objective To assess H. pylori eradication rate of standard triple therapy and patient related factors affecting eradication rate. Methods A facility based prospective follow up study was conducted in Bahir Dar City Administration, Ethiopia, on consented outpatients presented with gastritis and peptic ulcer disease and positive for H. pylori stool antigen test from May 2016 to April 2018. Eradication was confirmed with stool antigen test made after 4-6 weeks of standard triple therapy, comprising of proton pump inhibitor, clarithromycin and amoxicillin. Pre-developed questionnaire and data collection formats were used to collect variables before and after therapy. Bivariate and backward stepwise multivariate logistic regression was used to analyze data. P-value < 0.05 at 95% CI was considered as significant. Results The overall H. pylori eradication rate was 90.3% (379/421). Almost 80% of the patients were urban residents. Mean (+/- SD) age and body weight of patients were 30.63 (+/- 10.74) years and 56.79 (+/- 10.17) kg, respectively. Self-reported adverse drug effects and area of residence of patients were factors affecting eradication rate significantly. Patients with no self-reported adverse drug effect were 3.85 (AOR: 3.85; 95% CI (1.41-5.26)) times more likely to eradicate H. pylori infection compared to those reported adverse effects. Patients living in rural area were 2.7 (AOR: 2.7; 95% CI (1.19-20.0)) times more likely to achieve eradication compared to urban residents. Conclusion H. pylori eradication rate is within the recommended level for clinical practice, indicating that modifications of the standard triple therapy observed in the different healthcare institutions are not evidence-based. Emphasis should be given to adverse drug effects of medications and tailored counseling based on area of residence could have a contribution in improving eradication rate.	[Gebeyehu, Endalew; Engidawork, Ephrem] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Pharmacol, Bahir Dar, Ethiopia; [Gebeyehu, Endalew; Engidawork, Ephrem] Addis Ababa Univ, Dept Pharmacol & Clin Pharm, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia; [Nigatu, Desalegn] Addis Ababa Univ, Coll Med & Hlth Sci, Dept Internal Med, Addis Ababa, Ethiopia	Bahir Dar University; Addis Ababa University; Addis Ababa University	Engidawork, E (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Pharmacol, Bahir Dar, Ethiopia.; Engidawork, E (corresponding author), Addis Ababa Univ, Dept Pharmacol & Clin Pharm, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia.	ephrem.engidawork@aau.edu.et	Engidawork, Ephrem/K-7551-2019	Engidawork, Ephrem/0000-0002-9931-6421	Addis Ababa University; Bahir Dar University	Addis Ababa University; Bahir Dar University	The authors would like to acknowledge Addis Ababa University and Bahir Dar University for funding this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi M, 2008, OBES SURG, V18, P1450, DOI 10.1007/s11695-008-9477-z; Alebie G, 2016, J BACTERIOL MYCOL, V3; [Anonymous], 2014, AUSTIN J NUTR FOOD S; Asrat D, 2004, ETHIOPIAN MED J, V42, P79; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Cho Dong Keun, 2010, Korean J Gastroenterol, V55, P368, DOI 201006254; De Francesco V, 2010, J GASTROINTESTINAL L, V19; Erramouspe J, 2002, J RURAL HEALTH, V18, P311, DOI 10.1111/j.1748-0361.2002.tb00893.x; Figer B, 2017, INDIAN J PHARM SCI, V79, P724, DOI 10.4172/pharmaceutical-sciences.1000285; FOCK KM, ALIMENTARY PHARM THE, V14, P225; Ganorkar P, 2013, INT FOOD RES J, V20; Ghosal N, 2016, J PHARM RES, V10, P351; Gisbert JP, 1996, REV ESP ENFERM DIG, V88, P317; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Goyal A, 2014, J FOOD SCI TECH MYS, V51, P1633, DOI 10.1007/s13197-013-1247-9; Graham DY, 2007, HELICOBACTER, V12, P275, DOI 10.1111/j.1523-5378.2007.00518.x; Graham DY, 2014, CLIN GASTROENTEROL H, V12, P177, DOI 10.1016/j.cgh.2013.05.028; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; GRAHAM DY, 1992, GASTROENTEROLOGY, V102, P493, DOI 10.1016/0016-5085(92)90095-G; Guo Yue, 2016, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V41, P757, DOI 10.11817/j.issn.1672-7347.2016.07.016; Hori K, 2017, CURR DRUG SAF, V12, P103, DOI 10.2174/1574886312666170310100209; Hsu PI, 2005, AM J GASTROENTEROL, V100, P2387, DOI 10.1111/j.1572-0241.2005.00264.x; Kabakambira JD, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0863-2; Kibru D, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0656-3; Lee JY, 2014, DIGEST DIS SCI, V59, P1235, DOI 10.1007/s10620-014-3093-7; Liu RP, 2018, SOUTH MED J, V111, P51, DOI 10.14423/SMJ.0000000000000747; Makristathis A, 1998, J CLIN MICROBIOL, V36, P2772, DOI 10.1128/JCM.36.9.2772-2774.1998; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Mekonnen Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184665; Moayyedi P, 1997, J GASTROENTEROL, V32, P24, DOI 10.1007/BF01213292; O'Connor John P Anthony, 2009, Therap Adv Gastroenterol, V2, P273, DOI 10.1177/1756283X09337342; Pai MP, 2007, PHARMACOTHERAPY, V27, P1081, DOI 10.1592/phco.27.8.1081; Prasertpetmanee S, 2013, HELICOBACTER, V18, P270, DOI 10.1111/hel.12041; Queiroz DMM, 2002, J CLIN GASTROENTEROL, V35, P315, DOI 10.1097/00004836-200210000-00007; Ramas M, 2017, GASTROENT HEPAT-BARC, V40, P658, DOI 10.1016/j.gastrohep.2017.05.017; Shakya Shrestha S, 2016, Kathmandu Univ Med J (KUMJ), V14, P58; Shimoyama T, 2013, WORLD J GASTROENTERO, V19, P8188, DOI 10.3748/wjg.v19.i45.8188; Silva F M, 2001, Rev Hosp Clin Fac Med Sao Paulo, V56, P11; Singh Namrata, 2008, Trop Gastroenterol, V29, P26; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun WH, 2005, WORLD J GASTROENTERO, V11, P2477, DOI 10.3748/wjg.v11.i16.2477; Suzuki T, 2006, AM J MED, V119, P217, DOI 10.1016/j.amjmed.2005.10.003; Tsai CE, 2016, KAOHSIUNG J MED SCI, V32, P397, DOI 10.1016/j.kjms.2016.05.012; Vaira D, 1999, LANCET, V354, P30, DOI 10.1016/S0140-6736(98)08103-3; Wang B, 2014, WORLD J GASTROENTERO, V20, P14973, DOI 10.3748/wjg.v20.i40.14973; Xin YQ, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0491-7; Yoon JH, 2012, WORLD J GASTROENTERO, V18, P6628, DOI 10.3748/wjg.v18.i45.6628	48	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217645	10.1371/journal.pone.0217645	http://dx.doi.org/10.1371/journal.pone.0217645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163069	Green Submitted, Green Published, gold			2022-12-26	WOS:000470086200026
J	Jiwaji, M; Matcher, GF; de Bruyn, MM; Awando, JA; Moodley, H; Waterworth, D; Jarvie, RA; Dorrington, RA				Jiwaji, Meesbah; Matcher, Gwynneth Felicity; de Bruyn, Mart-Mari; Awando, Janet Awino; Moodley, Holisha; Waterworth, Dylan; Jarvie, Rachel Anne; Dorrington, Rosemary Ann			Providence virus: An animal virus that replicates in plants or a plant virus that infects and replicates in animal cells?	PLOS ONE			English	Article							NODAMURA VIRUS; RNA; INSECT; LARVAE	Introduction Emerging viral diseases, most of which are zoonotic, pose a significant threat to global health. There is a critical need to identify potential new viral pathogens and the challenge is to identify the reservoirs from which these viruses might emerge. Deep sequencing of invertebrate transcriptomes has revealed a plethora of viruses, many of which represent novel lineages representing both plant and animal viruses and little is known about the potential threat that these viruses pose. Methods Providence virus, an insect virus, was used to establish a productive infection in Vigna unguiculata (cowpea) plants. Providence virus particles purified from these cowpea plants were used to infect two mammalian cell lines. Findings Here, we present evidence that Providence virus, a non-enveloped insect RNA virus, isolated from a lepidopteran midgut cell line can establish a productive infection in plants as well as in animal cells. The observation that Providence virus can readily infect both plants and mammalian cell culture lines demonstrates the ability of an insect RNA virus to establish productive infections across two kingdoms, in plants and invertebrate and vertebrate animal cell lines. Conclusions The study highlights the potential of phytophagous insects as reservoirs for viral re-assortment and that plants should be considered as reservoirs for emerging viruses that may be potentially pathogenic to humans.	[Jiwaji, Meesbah; Matcher, Gwynneth Felicity; de Bruyn, Mart-Mari; Awando, Janet Awino; Moodley, Holisha; Waterworth, Dylan; Jarvie, Rachel Anne; Dorrington, Rosemary Ann] Rhodes Univ, Dept Biochem & Microbiol, Grahamstown, South Africa	Rhodes University	Jiwaji, M (corresponding author), Rhodes Univ, Dept Biochem & Microbiol, Grahamstown, South Africa.	meesbahjiwaji@gmail.com			Rhodes University Research Committee Research Grant; NRF Emerging Researcher Fellowship [GUN 91468]; TWOS scholarship; NRF Scarce Skills Fellowship	Rhodes University Research Committee Research Grant; NRF Emerging Researcher Fellowship; TWOS scholarship; NRF Scarce Skills Fellowship	This research was supported by a Rhodes University Research Committee Research Grant. MJ was supported by an NRF Emerging Researcher Fellowship (GUN 91468), Janet Awino Awando by a TWOS scholarship and Holisha Moodley by an NRF Scarce Skills Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY L, 1975, J GEN VIROL, V26, P15, DOI 10.1099/0022-1317-26-1-15; Balique F, 2012, J CLIN VIROL, V55, P374, DOI 10.1016/j.jcv.2012.08.012; BALL LA, 1992, J VIROL, V66, P2326, DOI 10.1128/JVI.66.4.2326-2334.1992; Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114; Christian PD, 2001, BIOL CONTROL, V20, P65, DOI 10.1006/bcon.2000.0887; Colson P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010041; Dong XF, 1998, J VIROL, V72, P6024, DOI 10.1128/JVI.72.7.6024-6033.1998; Dorrington R. A., 2011, VIRUS TAXONOMY, P1091; Fan XX, 2015, BIOCHEM BIOPH RES CO, V460, P1035, DOI 10.1016/j.bbrc.2015.03.145; GARZON S, 1990, ARCH VIROL, V113, P165, DOI 10.1007/BF01316670; HANZLIK TN, 1993, J GEN VIROL, V74, P1805, DOI 10.1099/0022-1317-74-9-1805; Jiwaji M, 2016, J GEN VIROL, V97, P2763, DOI 10.1099/jgv.0.000578; Kemenesi G, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00403-16; Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395; Poreddy S, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1149-5; Price BD, 1996, P NATL ACAD SCI USA, V93, P9465, DOI 10.1073/pnas.93.18.9465; Pringle FM, 2003, VIROLOGY, V306, P359, DOI 10.1016/S0042-6822(02)00052-1; Rydell J, 1996, ECOGRAPHY, V19, P62, DOI 10.1111/j.1600-0587.1996.tb00155.x; SCHERER WF, 1968, AM J TROP MED HYG, V17, P120, DOI 10.4269/ajtmh.1968.17.120; SELLING BH, 1990, P NATL ACAD SCI USA, V87, P434, DOI 10.1073/pnas.87.1.434; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Short JR, 2013, J GEN VIROL, V94, P1073, DOI 10.1099/vir.0.047647-0; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Stork J, 2011, VIROLOGY, V409, P338, DOI 10.1016/j.virol.2010.10.015; TESH RB, 1980, J GEN VIROL, V48, P177, DOI 10.1099/0022-1317-48-1-177; Walter CT, 2010, J GEN VIROL, V91, P2826, DOI 10.1099/vir.0.023796-0; Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7	27	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217494	10.1371/journal.pone.0217494	http://dx.doi.org/10.1371/journal.pone.0217494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163039	Green Published, gold, Green Submitted			2022-12-26	WOS:000470086200014
J	Curry, CJ; White, PA; Derr, JN				Curry, Caitlin J.; White, Paula A.; Derr, James N.			Genetic analysis of African lions (Panthera leo) in Zambia support movement across anthropogenic and geographical barriers	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; LINKAGE DISEQUILIBRIUM; RE-IMPLEMENTATION; N-E; SOFTWARE; INFERENCE; PROGRAM; CONSERVATION; RAREFACTION; SOUTHERN	The Luangwa Valley in eastern Zambia is a transverse offshoot of the Great Rift Valley system. This region appears to have an isolating effect as evidenced by suspected endemic subspecies, such as the Cookson's wildebeest and Thornicroft's giraffe. Recent mitochondrial DNA studies demonstrated that African lions in Zambia consist of two highly diverse eastern and western sub-populations. Herein, we report nuclear and mitochondrial DNA results from 409 lions that support this population substructure across Zambia but proposes only partial isolation of the Luangwa Valley with more movement between the populations than previously thought. Population assignment analysis identifies two populations with little evidence of admixture assigning lions to either the eastern or western sub-populations. A high occurrence of private alleles and clear evidence for a Wahlund effect further justify the presence of a highly structured population. But, while mitochondrial DNA analysis still shows little to no matrilineal gene flow (F-ST = 0.53) between sub-populations, microsatellite analysis suggests there is gene flow (F-ST = 0.04) with low but significant isolation-by-distance and an average of 6 migrants per generation. Evidence of isolation-by-distance is also found in factorial correspondence analysis with the Lower Zambezi National Park and eastern corridor clusters overlapping isolated clusters of the Luangwa Valley and western subpopulation. From this evidence, the Luangwa Valley appears separated from the western sub-population with some dispersal through the southern regions of the eastern sub-population. Both the eastern and western sub-populations have high heterozygosity (0.68 and 0.69, respectively) and genetic diversity (0.47 and 0.50, respectively) values, indicative of genetically healthy populations.	[Curry, Caitlin J.; Derr, James N.] Texas A&M Univ, Interdisciplinary Program Genet, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles	Derr, JN (corresponding author), Texas A&M Univ, Interdisciplinary Program Genet, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	jderr@cvm.tamu.edu		Curry, Caitlin/0000-0002-3853-7191	Zambia Wildlife Authority; Professional Hunters Association of Zambia; Safari Hunters and Outfitters Association of Zambia; Boore Family Foundation; Dallas Safari Club; Safari Club International Foundation; Texas AM Foundation	Zambia Wildlife Authority; Professional Hunters Association of Zambia; Safari Hunters and Outfitters Association of Zambia; Boore Family Foundation; Dallas Safari Club; Safari Club International Foundation; Texas AM Foundation	This research has been funded in part by the Zambia Wildlife Authority, Professional Hunters Association of Zambia (www.phazambia.com), Safari Hunters and Outfitters Association of Zambia, the Boore Family Foundation, Dallas Safari Club (biggame. org), Safari Club International Foundation (www.safariclub.org) and the Texas A&M Foundation (txamfoundation. com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; [Anonymous], 2018, SO AFR LION IND M MI; [Anonymous], SEQ VERS 4 8 SEQ AN, P8; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Belkhir K, 2004, 5000 CNRS UMR; Bertola, 2015, GENETIC DIVERSITY LI; Bertola LD, 2012, CHAPTER CONSERVATION; Budowle B, 2009, BIOTECHNIQUES, V46, P339, DOI 10.2144/000113136; Cotterill F.P.D., 2000, BIODIVERSITY ZAMBEZI, P145; Curry CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143827; Curry CJ, 2019, DEV LION MINIS UNPUB; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fennessy J, 2016, CURR BIOL, V26, P2543, DOI 10.1016/j.cub.2016.07.036; Fennessy J, 2013, AFR J ECOL, V51, P635, DOI 10.1111/aje.12085; Garnier-Gere P., 2013, ENCY LIFE SCI ELS, DOI [DOI 10.1002/9780470015902.A0005446.PUB3, 10.1002/9780470015902.a0005446.pub3]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2006, CONS STRAT LION E SO; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kasiki S., 2014, CITES PERIODIC REV S; Kim JH, 2006, GENE, V366, P292, DOI 10.1016/j.gene.2005.08.023; Lindsey PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094109; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Locke M, 2000, QUICK INTRO STRAND S, P1; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Nowell K., 1996, WILD CATS STATUS SUR; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pocock RI, 1897, ANN MAG NAT HIST, V20, P33, DOI [10.1080/00222939708680598, DOI 10.1080/00222939708680598]; Pritchard JK, 2000, GENETICS, V155, P945; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenblatt E, 2016, ECOL EVOL, V6, P3772, DOI 10.1002/ece3.2155; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang J, 2016, HEREDITY, V117, P193, DOI 10.1038/hdy.2016.43; Waples RS, 2016, MOL ECOL, V25, P4689, DOI 10.1111/mec.13814; Waples RS, 2015, J HERED, V106, P1, DOI 10.1093/jhered/esu062; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Zhivotovsky LA, 2015, J HERED, V106, P306, DOI 10.1093/jhered/esv019	55	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217179	10.1371/journal.pone.0217179	http://dx.doi.org/10.1371/journal.pone.0217179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150429	gold, Green Published			2022-12-26	WOS:000469759100034
J	Halamek, J; Leinveber, P; Viscor, I; Smisek, R; Plesinger, F; Vondra, V; Lipoldova, J; Matejkova, M; Jurak, P				Halamek, Josef; Leinveber, Pavel; Viscor, Ivo; Smisek, Radovan; Plesinger, Filip; Vondra, Vlastimil; Lipoldova, Jolene; Matejkova, Magdalena; Jurak, Pavel			The relationship between ECG predictors of cardiac resynchronization therapy benefit	PLOS ONE			English	Article							BUNDLE-BRANCH BLOCK; QRS DURATION; AREA; CRT	Introduction Cardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality and improves cardiac function in patients with left bundle branch block (LBBB). However, about 30% of patients passing the current criteria do not benefit or benefit only a little from CRT. Three predictors of benefit based on different ECG properties were compared: 1) "strict" left bundle branch block classification (SLBBB); 2) QRS area; 3) ventricular electrical delay (VED) which defines the septal-lateral conduction delay. These predictors have never been analyzed concurrently. We analyzed the relationship between them on a subset of 602 records from the MADIT-CRT trial. Methods & results SLBBB classification was performed by two experts; QRS area and VED were computed fully automatically. High-frequency QRS (HFQRS) maps were used to inspect conduction abnormalities. The correlation between SLBBB and other predictors was R = 0.613, 0.523 and 0.390 for VED, QRS area in Z lead, and QRS duration, respectively. Scatter plots were used to pick up disagreement between the predictors. The majority of SLBBB subjects-295 of 330 (89%)-are supposed to respond positively to CRT according to the VED and QRS area, though 93 of 272 (34%) non-SLBBB should also benefit from CRT according to the VED and QRS area. Conclusion SLBBB classification is limited by the proper setting of cut-off values. In addition, it is too " strict" and excludes patients that may benefit from CRT therapy. QRS area and VED are clearly defined parameters. They may be used to optimize biventricular stimulation. Detailed analysis of conduction irregularities with CRT optimization should be based on HFQRS maps.	[Halamek, Josef; Viscor, Ivo; Smisek, Radovan; Plesinger, Filip; Vondra, Vlastimil; Jurak, Pavel] Czech Acad Sci, Inst Sci Instruments, Brno, Czech Republic; [Leinveber, Pavel; Lipoldova, Jolene; Matejkova, Magdalena] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic	Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; St Anne's University Hospital Brno (FNUSA-ICRC)	Halamek, J (corresponding author), Czech Acad Sci, Inst Sci Instruments, Brno, Czech Republic.	josef@isibrno.cz	Plešinger, Filip/G-1449-2014; Matejkova, Magdalena/AAI-7788-2021; Viscor, Ivo/D-3904-2012; Smíšek, Radovan/F-5329-2017; Jurak, Pavel/AAO-3084-2020; Leinveber, Pavel/I-3347-2016; Halamek, Josef/D-5110-2012; Vondra, Vlastimil/D-8086-2013	Plešinger, Filip/0000-0003-2875-3541; Matejkova, Magdalena/0000-0002-9268-7975; Viscor, Ivo/0000-0002-4298-3610; Smíšek, Radovan/0000-0003-0413-3604; Jurak, Pavel/0000-0002-3793-5075; Leinveber, Pavel/0000-0001-7267-4408; Halamek, Josef/0000-0001-8986-796X; Vondra, Vlastimil/0000-0002-5391-0919	Czech Science Foundation [GA17-13830S]; Ministry of Education, Youth and Sports of the Czech Republic [LO1212, LQ1605]; CAS project [RVO: 68081731]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); CAS project(Chinese Academy of Sciences)	The research was supported by Czech Science Foundation, project GA17-13830S and by Ministry of Education, Youth and Sports of the Czech Republic, project LO1212 and LQ1605 and the CAS project RVO: 68081731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KP, 2018, J INTERV CARD ELECTR, V52, P353, DOI 10.1007/s10840-018-0426-z; Arrhythmia C, 2018, NORMALIZATION QRS DU, DOI [10.1161/CIRCEP.118.006767, DOI 10.1161/CIRCEP.118.006767]; Auricchio A, 2014, CONTROVERSIES ARRHYT, P532; Bertaglia E, 2017, PACE, V40, P850, DOI 10.1111/pace.13104; Birgersdotter U, 2018, EFFECT INTERVENTRICU, P1, DOI [10.1161/CIRCEP.117, DOI 10.1161/CIRCEP.117]; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Caputo ML, 2018, INT J CARDIOL, V269, P165, DOI 10.1016/j.ijcard.2018.07.060; Carita P, 2016, INT J CARDIOL, V225, P402, DOI 10.1016/j.ijcard.2016.09.037; Coppola G, 2016, INT J CARDIOL, V221, P450, DOI 10.1016/j.ijcard.2016.06.203; De Pooter J, 2017, J CARDIOVASC ELECTR, V28, P192, DOI 10.1111/jce.13132; Engels EB, 2016, J CARDIOVASC TRANSL, V9, P257, DOI 10.1007/s12265-016-9693-1; Gold MR, 2017, HEART RHYTHM, V14, P1748, DOI 10.1016/j.hrthm.2017.10.016; Gold MR, RATIONALE DESIGN SMA, DOI [10.1111/pace.13459, DOI 10.1111/PACE.13459]; Hussein AA, 2019, YEAR REV CARDIAC ELE, P1, DOI [10.1161/CIRCEP.118.007142, DOI 10.1161/CIRCEP.118.007142]; Jurak P, 2017, J INTERV CARD ELECTR, V49, P245, DOI 10.1007/s10840-017-0268-0; Maass AH, 2018, REFINING SUCCESS CAR, P1, DOI [10.1093/europace/euw445, DOI 10.1093/EUROPACE/EUW445]; Moss AJ, 2005, ANN NONINVAS ELECTRO, V10, P34, DOI 10.1111/j.1542-474X.2005.00073.x; Niederer SA, 2018, INT J CARDIOL, V270, P183, DOI 10.1016/j.ijcard.2018.06.079; Padeletti L, ELECTROCARDIOGRAPHIC, DOI [10.1111/j.1540-8159.2012.03427.x, DOI 10.1111/J.1540-8159.2012.03427.X]; Plesinger F, 2016, PHYSIOL MEAS, V37, pN38, DOI 10.1088/0967-3334/37/7/N38; Plesinger F, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005719; Smisek R, 2019, IFMBE PROC, V68, P435, DOI 10.1007/978-981-10-9038-7_82; Spinale FG, 2019, HEART RHYTHM, V16, P743, DOI 10.1016/j.hrthm.2018.11.026; Strauss DG, 2011, AM J CARDIOL, V107, P927, DOI 10.1016/j.amjcard.2010.11.010; Strik M, 2018, INT J CARDIOL, V270, P143, DOI 10.1016/j.ijcard.2018.06.005; Nguyen UC, 2018, J ELECTROCARDIOL, V51, P457, DOI 10.1016/j.jelectrocard.2018.01.009; van Deursen CJM, 2015, J ELECTROCARDIOL, V48, P45, DOI 10.1016/j.jelectrocard.2014.10.003; van Stipdonk AMW, 2019, INT J CARDIOL, V286, P61, DOI 10.1016/j.ijcard.2019.01.051; Vozda M, 2015, BIOMED SIGNAL PROCES, V19, P23, DOI 10.1016/j.bspc.2015.03.001; Zusterzeel R, 2018, J ELECTROCARDIOL, V51, pS25, DOI 10.1016/j.jelectrocard.2018.08.001	30	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217097	10.1371/journal.pone.0217097	http://dx.doi.org/10.1371/journal.pone.0217097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150418	Green Published, gold			2022-12-26	WOS:000469759100031
J	Kang, TK; Ha, R; Oh, JH; Sunwoo, W				Kang, Tae Kyu; Ha, Ryun; Oh, Jae Hwan; Sunwoo, Woongsang			The potential protective effects of temporal bone pneumatization: A shock absorber in temporal bone fracture	PLOS ONE			English	Article							SECRETORY OTITIS-MEDIA; MASTOID PNEUMATIZATION; CLINICAL CHARACTERISTICS; CLASSIFICATION; ADULTS; MANAGEMENT; SINUS	Objectives We hypothesize that when temporal bone fractures occur, the pneumatic cells in the temporal bone are able to absorb most of the impact force during a traumatic event. This study aims to correlate the degree of pneumatization of the temporal bone with the severity of temporal bone fracture (TBF). Methods Charts and computed tomography scans representing 54 TBFs, diagnosed from 2012 to 2017 at a single tertiary hospital, were retrospectively reviewed. Temporal bone pneumatization (TBP) in the petrous apex and mastoid region was evaluated using previously published classification systems. TBP classifications and fracture types were correlated with TBF complications such as sensorineural hearing loss (SNHL), facial nerve palsy (FNP), and vestibular dysfunction. Results Patients with increased pneumatization of the temporal bone had significantly fewer and less severe SNHL. SNHL more strongly correlated with the degree of pneumatization in the mastoid (P = 0.005) than that in the petrous apex (P = 0.024). On the other hand, the degree of TBP correlated poorly with FNP and vestibular dysfunction. However, the mastoid hypop-neumatization demonstrated significant correlation with otic-capsule violations (P = 0.002). Fractures with otic-capsule violation were 4 times more likely to have vestibular dysfunction (P = 0.043) and 3 times more likely to have SNHL (P = 0.006). FNP was not associated with otic-capsule violating fractures but was 3.5 times more common in comminuted fractures (P = 0.025). Conclusions The degree of temporal bone pneumatization was negatively correlated to the incidence of otic-capsule violation and the severity of hearing impairment in patients with temporal bone fracture. This study substantiated the potential protective effect of temporal bone pneumatization in TBFs.	[Kang, Tae Kyu; Ha, Ryun; Oh, Jae Hwan; Sunwoo, Woongsang] Gachon Univ, Gil Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Incheon, South Korea	Gachon University	Sunwoo, W (corresponding author), Gachon Univ, Gil Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Incheon, South Korea.	sunwoo@gilhospital.com						Alvi A, 1998, OTOLARYNG HEAD NECK, V119, P609, DOI 10.1016/S0194-5998(98)70020-8; Asha'ari ZA, 2012, AURIS NASUS LARYNX, V39, P151, DOI 10.1016/j.anl.2011.02.010; Choi HG, 2015, OTOL NEUROTOL, V36, P1048, DOI 10.1097/MAO.0000000000000662; Cinamon T, 2003, OTOL NEUROTOL, V24, P839, DOI 10.1097/00129492-200311000-00002; Doyle WJ, 2003, OTOLARYNG HEAD NECK, V128, P732, DOI 10.1016/S0194-5998(02)23309-4; Han SJ, 2007, CLIN RADIOL, V62, P1110, DOI 10.1016/j.crad.2007.04.019; HERGILS L, 1990, ACTA OTO-LARYNGOL, V110, P92, DOI 10.3109/00016489009122520; Hill CA, 2008, J HUM EVOL, V55, P682, DOI 10.1016/j.jhevol.2008.03.010; Hill CA, 2011, ANAT REC, V294, P1103, DOI 10.1002/ar.21404; HOHMANN A, 1963, ARCHIV OTOLARYNGOL, V78, P578; Ilea A, 2014, AM J NEURORADIOL, V35, P1398, DOI 10.3174/ajnr.A3887; Ilea A, 2019, EUR ARCH OTO-RHINO-L, V276, P513, DOI 10.1007/s00405-018-5227-6; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Jadhav AB, 2014, OR SURG OR MED OR PA, V117, P376, DOI 10.1016/j.oooo.2013.12.398; Johnson F, 2008, OTOLARYNG CLIN N AM, V41, P597, DOI 10.1016/j.otc.2008.01.006; Kim MB, 2017, J INT ADV OTOL, V13, P374, DOI 10.5152/iao.2017.3424; Lee PH, 2018, J CRANIOFAC SURG, V29, P1842, DOI 10.1097/SCS.0000000000004641; Little SC, 2006, ARCH OTOLARYNGOL, V132, P1300, DOI 10.1001/archotol.132.12.1300; Ljiljana C, 2012, EUR ARCH OTO-RHINO-L, V269, P399, DOI 10.1007/s00405-011-1641-8; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; Mun SK, 2017, INJURY, V48, P2879, DOI 10.1016/j.injury.2017.10.041; Ohlrogge M, 2004, OTOL NEUROTOL, V25, P195, DOI 10.1097/00129492-200403000-00021; Palva T, 1966, Acta Otolaryngol, V62, P237, DOI 10.3109/00016486609119570; SADE J, 1992, EUR ARCH OTO-RHINO-L, V249, P301; SADE J, 1994, EUR ARCH OTO-RHINO-L, V251, P191, DOI 10.1007/BF00628421; Sade J, 1996, ANN OTO RHINOL LARYN, V105, P643, DOI 10.1177/000348949610500810; SADE J, 1979, ARCH OTO-RHINO-LARYN, V225, P39, DOI 10.1007/BF00455874; SADE J, 1976, ANN OTO RHINOL LARYN, V85, P66, DOI 10.1177/00034894760850S214; Sade J, 1997, ANN OTO RHINOL LARYN, V106, P37, DOI 10.1177/000348949710600107; Schubl SD, 2016, INJURY, V47, P1893, DOI 10.1016/j.injury.2016.06.026; 이준희, 2015, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V58, P836, DOI 10.3342/kjorl-hns.2015.58.12.836; TURGUT S, 1992, J LARYNGOL OTOL, V106, P485, DOI 10.1017/S0022215100119942; Vrabec JT, 2002, ACTA OTO-LARYNGOL, V122, P831, DOI 10.1080/0036554021000028085	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217682	10.1371/journal.pone.0217682	http://dx.doi.org/10.1371/journal.pone.0217682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150482	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100084
J	Khalil, HA; Hong, SN; Rouch, JD; Scott, A; Cho, Y; Wang, JF; Lewis, MS; Martine, MG; Dunn, JCY; Stelzner, MG				Khalil, Hassan A.; Hong, Sung Noh; Rouch, Joshua D.; Scott, Andrew; Cho, Yonghoon; Wang, Jiafang; Lewis, Michael S.; Martine, Martin G.; Dunn, James C. Y.; Stelzner, Matthias G.			Intestinal epithelial replacement by transplantation of cultured murine and human cells into the small intestine	PLOS ONE			English	Article							IN-VITRO; STEM-CELLS	Adult intestinal epithelial stem cells are a promising resource for treatment of intestinal epithelial disorders that cause intestinal failure and for intestinal tissue engineering. We developed two different animal models to study the implantation of cultured murine and human intestinal epithelial cells in the less differentiated "spheroid" state and the more differentiated "enteroid" state into the denuded small intestine of mice. Engraftment of donor cells could not be achieved while the recipient intestine remained in continuity. However, we were able to demonstrate successful implantation of murine and human epithelial cells when the graft segment was in a bypassed loop of jejunum. Implantation of donor cells occurred in a random fashion in villus and crypt areas. Engraftment was observed in 75% of recipients for murine and 36% of recipients for human cells. Engrafted spheroid cells differentiated into the full complement of intestinal epithelial cells. These findings demonstrate for the first time successful engraftment into the small bowel which is optimized in a bypassed loop surgical model.	[Khalil, Hassan A.; Rouch, Joshua D.; Scott, Andrew; Cho, Yonghoon; Stelzner, Matthias G.] UCLA, David Geffen Sch Med, Dept Surg, CHS 72-215, Los Angeles, CA 90095 USA; [Hong, Sung Noh; Wang, Jiafang; Martine, Martin G.] Univ Calif Los Angeles, Dept Pediat, Mattel Childrens Hosp, Div Gastroenterol & Nutr, Los Angeles, CA 90024 USA; [Hong, Sung Noh; Wang, Jiafang; Martine, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lewis, Michael S.] VA Greater Los Angeles Hlth Syst, Dept Pathol & Lab Med, Los Angeles, CA USA; [Dunn, James C. Y.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Stelzner, Matthias G.] VA Greater Los Angeles Hlth Syst, Dept Surg, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Stelzner, MG (corresponding author), UCLA, David Geffen Sch Med, Dept Surg, CHS 72-215, Los Angeles, CA 90095 USA.; Stelzner, MG (corresponding author), VA Greater Los Angeles Hlth Syst, Dept Surg, Los Angeles, CA 90073 USA.	stelzner@ucla.edu	Khalil, Hassan A/AAM-7914-2021	Khalil, Hassan A/0000-0002-3835-1290; Dunn, James/0000-0002-6826-7065	Intestinal Stem Cell Consortium - National Institute of Diabetes and Digestive and Kidney; National Institute of Allergy and Infectious Diseases [DK085535]; NIH P30 grant [DK041301]; California Institute of Regenerative Medicine (CIRM) [RT2-01985]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, U01DK085535] Funding Source: NIH RePORTER	Intestinal Stem Cell Consortium - National Institute of Diabetes and Digestive and Kidney; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH P30 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Intestinal Stem Cell Consortium, a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney and the National Institute of Allergy and Infectious Diseases (DK085535) to MGM, JCYD and MGS, an NIH P30 grant (DK041301) to MGM, and the California Institute of Regenerative Medicine (CIRM), RT2-01985, to MGM.	Agopian VG, 2009, J GASTROINTEST SURG, V13, P971, DOI 10.1007/s11605-009-0806-x; Avansino JR, 2006, SURGERY, V140, P423, DOI 10.1016/j.surg.2006.03.012; Avansino JR, 2005, J AM COLL SURGEONS, V201, P710, DOI 10.1016/j.jamcollsurg.2005.06.270; Barthel ER, 2012, REGEN MED, V7, P807, DOI [10.2217/RME.12.91, 10.2217/rme.12.91]; Duro D, 2008, J PEDIATR GASTR NUTR, V47, pS33, DOI 10.1097/MPG.0b013e3181819007; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Fukuda M, 2014, GENE DEV, V28, P1752, DOI 10.1101/gad.245233.114; Hong SN, 2017, STEM CELL TRANSL MED, V6, P666, DOI 10.5966/sctm.2016-0153; Jabaji Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107814; Jabaji Z, 2013, TISSUE ENG PART C-ME, V19, P961, DOI [10.1089/ten.tec.2012.0710, 10.1089/ten.TEC.2012.0710]; Khalil HA, 2016, CELL TISSUE RES, V365, P123, DOI 10.1007/s00441-016-2367-0; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scott A, 2016, J PEDIATR SURG, V51, P995, DOI 10.1016/j.jpedsurg.2016.02.074; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Sugimoto S, 2018, CELL STEM CELL, V22, P171, DOI 10.1016/j.stem.2017.11.012; Thiagarajah JR, 2018, GASTROENTEROLOGY, V154, P2045, DOI 10.1053/j.gastro.2018.03.067; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	21	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216326	10.1371/journal.pone.0216326	http://dx.doi.org/10.1371/journal.pone.0216326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150401	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100018
J	Perez, SM; Biondi, E; Laurita, R; Proto, M; Sarti, F; Gherardi, M; Bertaccini, A; Colombo, V				Perez, Set Madian; Biondi, Enrico; Laurita, Romolo; Proto, Mariarita; Sarti, Fabio; Gherardi, Matteo; Bertaccini, Assunta; Colombo, Vittorio			Plasma activated water as resistance inducer against bacterial leaf spot of tomato	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; BIOLOGICAL-CONTROL; OXIDATIVE BURST; XANTHOMONAS-PERFORANS; DISEASE RESISTANCE; PATHOGEN INFECTION; HYDROGEN-PEROXIDE; SIGNAL NETWORK; PLANT-GROWTH; ETHYLENE	Plant bacterial diseases are routinely managed with scheduled treatments based on heavy metal compounds or on antibiotics; to reduce the negative environmental impact due to the use of such chemical compounds, as pollution or selection of antibiotic resistant pathogens, the integrated control management is required. In the frame of a sustainable agriculture the use of bacterial antagonists, biological agents, plant defence response elicitors or resistant host plant genotypes are the most effective approaches. In this work, cold atmospheric pressure plasma (CAP) was applied to sterile distilled water, inducing the production of a hydrogen peroxide, nitrite and nitrate, and a pH reduction. In particular, an atmospheric pressure dielectric barrier discharge (DBD) has been used to produce plasma activated water (PAW), that was firstly assayed in in vitro experiments and then in planta through application at the root apparatus of tomato plants, against Xanthomonas vesicatoria (Xv), the etiological agent of bacterial leaf spot. Moreover, the transcription abundance of five genes related to the plant defense was investigated in response to PAW treatment. PAW did not show direct antimicrobial activity against Xv in in vitro experiments, but it enhanced the tomato plants defenses. It was effective in reducing the disease severity by giving relative protections of ca. 61, 51 and 38% when applied 1 h, 24 h and 6 days before the experimental inoculation, respectively. In addition, the experiments highlighted the pal gene involvement in response to the PAW treatments and against the pathogen; its transcription levels resulted significantly high from 1 to 48 h until their decrease 192 h after PAW application.	[Perez, Set Madian; Biondi, Enrico; Proto, Mariarita; Sarti, Fabio; Bertaccini, Assunta] Alma Mater Studiorum Univ Bologna, Dept Agr & Food Sci Distal, Plant Pathol, Bologna, Italy; [Perez, Set Madian] Univ OHiggins, Inst Ciencias Agron & Vet, Rancagua, Chile; [Laurita, Romolo; Gherardi, Matteo; Colombo, Vittorio] Alma Mater Studiorum Univ Bologna, Dept Ind Engn DIN, Bologna, Italy; [Gherardi, Matteo; Colombo, Vittorio] Alma Mater Studiorum Univ Bologna, Interdept Ctr Ind Res Adv Mech Engn Applicat & Ma, Bologna, Italy; [Colombo, Vittorio] Alma Mater Studiorum Univ Bologna, Interdept Ctr Ind Res Agrifood, Cesena, Italy	University of Bologna; Universidad de O'Higgins; University of Bologna; University of Bologna; University of Bologna	Biondi, E (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Agr & Food Sci Distal, Plant Pathol, Bologna, Italy.	enrico.biondi3@unibo.it	Gherardi, Matteo/AAX-6106-2021; Laurita, Romolo/U-6968-2017	COLOMBO, VITTORIO/0000-0001-9145-198X; Bertaccini, Assunta/0000-0002-5650-1512; Laurita, Romolo/0000-0003-1744-3329; Perez Fuentealba, Set/0000-0003-3643-0160; GHERARDI, MATTEO/0000-0001-6995-6754; Biondi, Enrico/0000-0002-9310-5236				Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Arasimowicz M, 2007, PLANT SCI, V172, P876, DOI 10.1016/j.plantsci.2007.02.005; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Byrne JM, 2005, BIOL CONTROL, V32, P408, DOI 10.1016/j.biocontrol.2004.12.001; Carson CF, 2002, ANTIMICROB AGENTS CH, V46, P1914, DOI 10.1128/AAC.46.6.1914-1920.2002; Carvalho RAM, 2005, QUIM NOVA, V28, P1006, DOI 10.1590/S0100-40422005000600014; Cellini A, 2014, ANN APPL BIOL, V165, P441, DOI 10.1111/aab.12150; CHAMBERS SC, 1975, AUST J AGR RES, V26, P657, DOI 10.1071/AR9750657; Clinical and Laboratory Standards Institute, 2006, M100S17 CLIN LAB STA; COOKSEY DA, 1993, MOL MICROBIOL, V7, P1, DOI 10.1111/j.1365-2958.1993.tb01091.x; Cortesi R, 2017, J PLANT DIS PROTECT, V124, P269, DOI 10.1007/s41348-016-0055-7; Danve C, 2010, THESIS; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P359, DOI 10.1016/0048-4059(83)90020-6; DYE D. W., 1962, NEW ZEALAND JOUR SCI, V5, P393; El-Hendawy HH, 2005, MICROBIOL RES, V160, P343, DOI 10.1016/j.micres.2005.02.008; Fortunati E, 2019, J SCI FOOD AGR, V99, P986, DOI 10.1002/jsfa.9341; Giovanardi D, 2018, PLANT PATHOL, V67, P1168, DOI 10.1111/ppa.12839; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grant JJ, 2000, PLANT J, V24, P569, DOI 10.1046/j.1365-313x.2000.00902.x; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Jiang JF, 2014, PLASMA SCI TECHNOL, V16, DOI 10.1088/1009-0630/16/1/12; Jiang JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101169; Jones JB, 2000, INT J SYST EVOL MICR, V50, P1211, DOI 10.1099/00207713-50-3-1211; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; Julak J, 2012, PHYS MEDICA, V28, P230, DOI 10.1016/j.ejmp.2011.08.001; Koenraadt H, 2009, ACTA HORTIC, V808, P99, DOI 10.17660/ActaHortic.2009.808.13; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Kostov KG, 2010, SURF COAT TECH, V204, P2954, DOI 10.1016/j.surfcoat.2010.01.052; Kuzniak E, 2000, ACTA PHYSIOL PLANT, V22, P195, DOI 10.1007/s11738-000-0076-4; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Laurita R, 2015, CLIN PLASMA MED, V3, P53, DOI 10.1016/j.cpme.2015.10.001; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Liu CJ, 1999, FUEL PROCESS TECHNOL, V58, P119, DOI 10.1016/S0378-3820(98)00091-5; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Louws FJ, 2001, PLANT DIS, V85, P481, DOI 10.1094/PDIS.2001.85.5.481; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Lund ST, 1998, PLANT CELL, V10, P371, DOI 10.1105/tpc.10.3.371; Mazzaglia A., 2017, NANOTECHNOL AGR FOOD, V96, P115; Michelotti V, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4967-4; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Moreau M, 2007, APPL ENVIRON MICROB, V73, P5904, DOI 10.1128/AEM.00662-07; Moreau M, 2005, J APPL MICROBIOL, V98, P1039, DOI 10.1111/j.1365-2672.2004.02535.x; Murshed R, 2013, PHYSIOL MOL BIOL PLA, V19, P363, DOI 10.1007/s12298-013-0173-7; Nehra V, 2008, INT J ENG-IRAN, V2, P53; Obradovic A, 2005, PLANT DIS, V89, P712, DOI 10.1094/PD-89-0712; Oostendorp M, 2001, EUR J PLANT PATHOL, V107, P19, DOI 10.1023/A:1008760518772; Paret ML, 2013, PHYTOPATHOLOGY, V103, P228, DOI 10.1094/PHYTO-08-12-0183-R; Park DP, 2013, CURR APPL PHYS, V13, pS19, DOI 10.1016/j.cap.2012.12.019; PENG M, 1992, PHYTOPATHOLOGY, V82, P696, DOI 10.1094/Phyto-82-696; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potnis N, 2015, MOL PLANT PATHOL, V16, P907, DOI 10.1111/mpp.12244; Ratti C, 2004, J VIROL METHODS, V122, P95, DOI 10.1016/j.jviromet.2004.08.013; Rep M, 2006, ANNU REV PHYTOPATHOL, V44; Scortichini M., 2013, Bulletin OEPP, V43, P7, DOI 10.1111/epp.12018; Sivachandiran L, 2017, RSC ADV, V7, P1822, DOI 10.1039/c6ra24762h; Suzuki N, 2013, PLANT CELL, V25, P3553, DOI 10.1105/tpc.113.114595; Thaler JS, 2004, PLANT PHYSIOL, V135, P530, DOI 10.1104/pp.104.041566; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Traylor M. J., 2011, J PHYS D, V44, P1; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005	66	23	23	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217788	10.1371/journal.pone.0217788	http://dx.doi.org/10.1371/journal.pone.0217788			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150501	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100109
J	Reinhardt, L; Schwesig, R; Lauenroth, A; Schulze, S; Kurz, E				Reinhardt, Lars; Schwesig, Rene; Lauenroth, Andreas; Schulze, Stephan; Kurz, Eduard			Enhanced sprint performance analysis in soccer: New insights from a GPS-based tracking system	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEMS; ELITE SOCCER; MATCH PERFORMANCE; RUNNING SPEED; ACCELERATION; RELIABILITY; VALIDITY; LEAGUE; STRENGTH; PLAYERS	The aim of this investigation was to establish the validity of a GPS-based tracking system (Polar Team Pro System, PTPS) for estimating sprint performance and to evaluate additional diagnostic indices derived from the temporal course of the movement velocity. Thirty-four male soccer players (20 +/- 4 years) performed a 20 m sprint test measured by timing gates (TG), and while wearing the PTPS. To evaluate the relevance of additional velocity-based parameters to discriminate between faster and slower athletes, the median-split method was applied to the 20-m times. Practical relevance was estimated using standardized mean differences (d) between the subgroups. Differences between the criterion reference (TG) and PTPS for the 10 and 20 m splits did not vary from zero (dt10: -0.01 +/- 0.07 s, P = 0.7, d < -0.1; dt20: -0.01 +/- 0.08 s, P = 0.4, d < -0.2). Although subgroups revealed large differences in their sprint times (d = -2.5), the average accelerations between 5 and 20 km/h as well as 20 and 25 km/h showed merely small effects (d < 0.5). Consequently, analyses of velocity curves derived from PTPS may help to clarify the occurrence of performance in outdoor sports. Thus, training consequences can be drawn which contribute to the differentiation and individualization of sprint training.	[Reinhardt, Lars; Schwesig, Rene; Lauenroth, Andreas; Schulze, Stephan; Kurz, Eduard] Martin Luther Univ Halle Wittenberg, Dept Orthoped & Trauma Surg, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Reinhardt, L (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Orthoped & Trauma Surg, Halle, Saale, Germany.	lars.reinhardt@uk-halle.de						Akenhead R, 2014, J SCI MED SPORT, V17, P562, DOI 10.1016/j.jsams.2013.08.005; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P295, DOI 10.1123/ijspp.6.3.295; Bancroft JB, 2011, SENSORS-BASEL, V11, P6771, DOI 10.3390/s110706771; Barnes C, 2014, INT J SPORTS MED, V35, P1095, DOI 10.1055/s-0034-1375695; Baumgart C, 2018, SPORTS, V6, DOI 10.3390/sports6040161; Bourdon PC, 2017, INT J SPORT PHYSIOL, V12, P161, DOI 10.1123/IJSPP.2017-0208; Brown TD, 2004, J SPORT SCI MED, V3, P203; Buchheit M, 2014, J SPORT SCI, V32, P1906, DOI 10.1080/02640414.2014.965191; Buchheit M, 2012, INT J SPORT PHYSIOL, V7, P76, DOI 10.1123/ijspp.7.1.76; Burgess DJ, 2006, J SCI MED SPORT, V9, P334, DOI 10.1016/j.jsams.2006.01.005; Bush M, 2015, HUM MOVEMENT SCI, V39, P1, DOI 10.1016/j.humov.2014.10.003; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Caron F, 2006, INFORM FUSION, V7, P221, DOI 10.1016/j.inffus.2004.07.002; Castellano J, 2011, J SPORT SCI MED, V10, P233; Cohen J.E., 1988, STAT POWER ANAL BEHA; Comfort P, 2014, J STRENGTH COND RES, V28, P173, DOI 10.1519/JSC.0b013e318291b8c7; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Cummins C, 2013, SPORTS MED, V43, P1025, DOI 10.1007/s40279-013-0069-2; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Di Salvo V, 2010, J SPORT SCI, V28, P1489, DOI 10.1080/02640414.2010.521166; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Gil S, 2018, J SPORT SCI, V36, P1923, DOI 10.1080/02640414.2018.1426346; Gray AJ, 2010, J SPORT SCI, V28, P1319, DOI 10.1080/02640414.2010.504783; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Haugen T, 2016, SPORTS MED, V46, P641, DOI 10.1007/s40279-015-0446-0; Hoppe MW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192708; HRELJAC A, 1995, HUM MOVEMENT SCI, V14, P205, DOI 10.1016/0167-9457(95)00017-M; Ingebrigtsen J, 2014, J STRENGTH COND RES, V28, P942, DOI 10.1519/JSC.0b013e3182a1f861; Jennings Denise, 2010, Int J Sports Physiol Perform, V5, P328; Kawamori N, 2014, J STRENGTH COND RES, V28, P2738, DOI 10.1519/JSC.0b013e3182915ed4; Little T, 2005, J STRENGTH COND RES, V19, P76; Malone JJ, 2017, INT J SPORT PHYSIOL, V12, P18, DOI 10.1123/ijspp.2016-0236; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; Mendez-Villanueva A, 2011, J SPORT SCI, V29, P477, DOI 10.1080/02640414.2010.536248; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Moir G, 2007, SPORT BIOMECH, V6, P285, DOI 10.1080/14763140701489793; Murphy Aron J, 2003, J Sports Sci Med, V2, P144; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Scott MTU, 2016, J STRENGTH COND RES, V30, P1470, DOI 10.1519/JSC.0000000000001221; Sleivert G, 2004, EUR J APPL PHYSIOL, V91, P46, DOI 10.1007/s00421-003-0941-0; Styles WJ, 2016, J STRENGTH COND RES, V30, P1534, DOI 10.1519/JSC.0000000000001243; Sweeting AJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00432; Varley MC, 2013, INT J SPORTS MED, V34, P34, DOI 10.1055/s-0032-1316315; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Vigne G, 2010, INT J SPORTS MED, V31, P304, DOI 10.1055/s-0030-1248320; Waldron M, 2011, J SPORT SCI, V29, P1223, DOI 10.1080/02640414.2011.587445; Yeadon MR, 1999, J SPORT SCI, V17, P249, DOI 10.1080/026404199366154	48	14	14	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217782	10.1371/journal.pone.0217782	http://dx.doi.org/10.1371/journal.pone.0217782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150503	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100106
J	Rubinson, M; Horowitz, I; Naim-Feil, J; Gothelf, D; Levit-Binnun, N; Moses, E				Rubinson, Mica; Horowitz, Itai; Naim-Feil, Jodie; Gothelf, Doron; Levit-Binnun, Nava; Moses, Elisha			Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EVENT-RELATED POTENTIALS; DEFICIT HYPERACTIVITY DISORDER; REACTION-TIME VARIABILITY; RESPONSE-INHIBITION; STIMULANT MEDICATION; CHILDREN; PERFORMANCE; ADOLESCENTS; P300	Methylphenidate (MPH) is a first line drug for attention-deficit/hyperactivity disorder (ADHD), yet the neuronal mechanisms underlying the condition and the treatment are still not fully understood. Previous EEG studies on the effect of MPH in ADHD found changes in evoked response potential (ERP) components that were inconsistent between studies. These inconsistencies highlight the need for a well-designed study which includes multiple baseline sessions and controls for possible fatigue, learning effects and between-days variability. To this end, we employ a double-blind placebo-controlled cross-over study and explore the effect of MPH on the ERP response of subjects with ADHD during a Go/No-Go cognitive task. Our ERP analysis revealed significant differences in ADHD subjects between the placebo and MPH conditions in the frontal-parietal region at 250ms-400ms post stimulus (P3). Additionally, a decrease in the late 650ms-800ms ERP component (LC) is observed in frontal electrodes of ADHD subjects compared to controls. The standard deviation of response time of ADHD subjects was significantly smaller in the MPH condition compared to placebo and correlated with the increased P3 ERP response in the frontoparietal electrodes. We suggest that mental fatigue plays a role in the decrease of the P3 response in the placebo condition compared to pre-placebo, a phenomenon that is significant in ADHD subjects but not in controls, and which is interestingly rectified by MPH.	[Rubinson, Mica; Naim-Feil, Jodie; Moses, Elisha] Weizmann Inst Sci, Dept Phys Complex Syst, Rehovot, Israel; [Horowitz, Itai] Beer Yaacov Ness Ziona Mental Hlth Ctr, Beer Yaagov, Israel; [Horowitz, Itai] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Gothelf, Doron] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Child & Adolescent Psychiat Unit, Tel Hashomer, Israel; [Levit-Binnun, Nava] Sagol Ctr Brain & Mind, Interdisciplinary Ctr, Sch Psychol, Herzliyya, Israel	Weizmann Institute of Science; Tel Aviv University; Chaim Sheba Medical Center; Reichman University	Rubinson, M (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, Rehovot, Israel.	micaboul@gmail.com		Naim-Feil, Jodie/0000-0001-7895-4021	Clore Center for Biological Physics; Israel Science Foundation [1169/11, 1835/16]; Minerva Foundation, Munich, Germany; Sagol Foundation; National Institute of Psychobiology in Israel; National Institute for Psychobiology in Israel [215-18-19]	Clore Center for Biological Physics; Israel Science Foundation(Israel Science Foundation); Minerva Foundation, Munich, Germany; Sagol Foundation; National Institute of Psychobiology in Israel; National Institute for Psychobiology in Israel	Elisha Moses is funded the Clore Center for Biological Physics, the Israel Science Foundation grant 1835/16 and the Minerva Foundation, Munich, Germany. Nava Levit-Binnun is supported by the Israel Science Foundation, grant 1169/11, by the Sagol Foundation and by the National Institute of Psychobiology in Israel. Dr. Itai Horowitz: The National Institute for Psychobiology in Israel -Founded by the Charles E. Smith Family. Grant serial number: 215-18-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht B, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-22; Aron AR, 2003, BIOL PSYCHIAT, V54, P1465, DOI 10.1016/S0006-3223(03)00609-7; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Bioulac S, 2012, EUR J PAEDIATR NEURO, V16, P514, DOI 10.1016/j.ejpn.2012.01.006; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Bonnefond A, 2010, BEHAV BRAIN RES, V211, P185, DOI 10.1016/j.bbr.2010.03.030; Brandeis D, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00018; Brandeis D, 2002, INT C SERIES, V1232, P649, DOI [10.1016/S0531-5131(01)00673-2, DOI 10.1016/S0531-5131(01)00673-2]; Clarke AR, 2002, CLIN NEUROPHYSIOL, V113, P1036, DOI 10.1016/S1388-2457(02)00115-3; Clarke AR, 2002, CLIN NEUROPHYSIOL, V113, P194, DOI 10.1016/S1388-2457(01)00736-2; Davidovitch M, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0971-0; DeFrance JF, 1996, INT J NEUROSCI, V87, P41, DOI 10.3109/00207459608990752; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DUPAUL GJ, 1991, J CLIN CHILD PSYCHOL, V20, P245, DOI 10.1207/s15374424jccp2003_3; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Epstein JN, 2011, NEUROPSYCHOLOGY, V25, P427, DOI 10.1037/a0022155; Epstein JN, 2011, NEUROPSYCHOPHARMACOL, V36, P1060, DOI 10.1038/npp.2010.243; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Faraone SV, 2010, EUR CHILD ADOLES PSY, V19, P353, DOI 10.1007/s00787-009-0054-3; Fox AM, 2000, CLIN NEUROPHYSIOL, V111, P1045, DOI 10.1016/S1388-2457(00)00257-1; Groom MJ, 2008, BIOL PSYCHIAT, V63, P784, DOI 10.1016/j.biopsych.2007.09.018; Groom MJ, 2010, BIOL PSYCHIAT, V67, P624, DOI 10.1016/j.biopsych.2009.09.029; Hermens DF, 2006, EXPERT REV NEUROTHER, V6, P753, DOI 10.1586/14737175.6.5.753; Ilieva IP, 2015, J COGNITIVE NEUROSCI, V27, P1069, DOI 10.1162/jocn_a_00776; Johnstone SJ, 2013, CLIN NEUROPHYSIOL, V124, P644, DOI 10.1016/j.clinph.2012.09.006; Johnstone SJ, 2009, INT J PSYCHOPHYSIOL, V72, P145, DOI 10.1016/j.ijpsycho.2008.11.007; Kato Y, 2009, INT J PSYCHOPHYSIOL, V72, P204, DOI 10.1016/j.ijpsycho.2008.12.008; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; KLORMAN R, 1990, PSYCHOPHYSIOLOGY, V27, P328, DOI 10.1111/j.1469-8986.1990.tb00391.x; KLORMAN R, 1979, PSYCHOPHYSIOLOGY, V16, P23, DOI 10.1111/j.1469-8986.1979.tb01432.x; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Lawrence CA, 2005, PSYCHOPHARMACOLOGY, V183, P81, DOI 10.1007/s00213-005-0144-y; Liotti M, 2007, PSYCHOPHYSIOLOGY, V44, P936, DOI 10.1111/j.1469-8986.2007.00568.x; Liotti M, 2010, BRAIN COGNITION, V72, P228, DOI 10.1016/j.bandc.2009.09.007; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; MICHAEL RL, 1981, PSYCHOPHYSIOLOGY, V18, P665, DOI 10.1111/j.1469-8986.1981.tb01841.x; Mockel T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10113; Naim-Feil J, 2018, BIOL PSYCHIAT-COGN N, V3, P88, DOI 10.1016/j.bpsc.2017.03.017; Naim-Feil J, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5760141; Nandam LS, 2011, BIOL PSYCHIAT, V69, P902, DOI 10.1016/j.biopsych.2010.11.014; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Ogrim G, 2016, CLIN NEUROPHYSIOL, V127, P3277, DOI 10.1016/j.clinph.2016.07.011; PRICHEP LS, 1976, PSYCHOPHYSIOLOGY, V13, P419, DOI 10.1111/j.1469-8986.1976.tb00855.x; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Reimer Bryan, 2007, Traffic Inj Prev, V8, P290, DOI 10.1080/15389580701257842; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosler M, 2010, WORLD J BIOL PSYCHIA, V11, P684, DOI 10.3109/15622975.2010.483249; Sangal RB, 2006, CLIN NEUROPHYSIOL, V117, P1996, DOI 10.1016/j.clinph.2006.06.004; Sangal RB, 2004, CLIN NEUROPHYSIOL, V115, P188, DOI 10.1016/j.clinph.2003.08.023; SKLARE DA, 1984, ELECTROEN CLIN NEURO, V59, P420, DOI 10.1016/0168-5597(84)90043-1; Slopen N, 2012, ARCH GEN PSYCHIAT, V69, P1022, DOI 10.1001/archgenpsychiatry.2012.444; Smith JL, 2004, CLIN NEUROPHYSIOL, V115, P1320, DOI 10.1016/j.clinph.2004.01.008; Strandburg RJ, 1996, BIOL PSYCHIAT, V40, P964, DOI 10.1016/0006-3223(95)00545-5; Sunohara GA, 1999, NEUROPSYCHOPHARMACOL, V21, P218, DOI 10.1016/S0893-133X(99)00023-8; Sur Shravani, 2009, Ind Psychiatry J, V18, P70, DOI 10.4103/0972-6748.57865; TAYLOR MJ, 1993, BIOL PSYCHOL, V36, P139, DOI 10.1016/0301-0511(93)90015-Z; VERBATEN MN, 1994, J ABNORM CHILD PSYCH, V22, P561, DOI 10.1007/BF02168938; Vostanis P, 2006, CURR OPIN PSYCHIATR, V19, P367, DOI 10.1097/01.yco.0000228755.72366.05; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wiersema JR, 2009, J ABNORM CHILD PSYCH, V37, P327, DOI 10.1007/s10802-008-9288-7; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475; Woodman GF, 2010, ATTEN PERCEPT PSYCHO, V72, P2031, DOI 10.3758/APP.72.8.2031	67	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217383	10.1371/journal.pone.0217383	http://dx.doi.org/10.1371/journal.pone.0217383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150439	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100042
J	Sinnige, T; Ciryam, P; Casford, S; Dobson, CM; de Bono, M; Vendruscolo, M				Sinnige, Tessa; Ciryam, Prashanth; Casford, Samuel; Dobson, Christopher M.; de Bono, Mario; Vendruscolo, Michele			Expression of the amyloid-beta peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response	PLOS ONE			English	Article							CARBON-DIOXIDE AVOIDANCE; CAENORHABDITIS-ELEGANS; ALZHEIMERS-DISEASE; OXYGEN; TAU; VULNERABILITY; PROTEOSTASIS; DYSFUNCTION; GLUTAMATE; SYNAPSES	Although the aggregation of the amyloid-beta peptide (A beta) into amyloid fibrils is a well-established hallmark of Alzheimer's disease, the complex mechanisms linking this process to neurodegeneration are still incompletely understood. The nematode worm C. elegans is a valuable model organism through which to study these mechanisms because of its simple nervous system and its relatively short lifespan. Standard A beta-based C. elegans models of Alzheimer's disease are designed to study the toxic effects of the overexpression of A beta in the muscle or nervous systems. However, the wide variety of effects associated with the tissue-level overexpression of A beta makes it difficult to single out and study specific cellular mechanisms related to the onset of Alzheimer's disease. Here, to better understand how to investigate the early events affecting neuronal signalling, we created a C. elegans model expressing A beta 42, the 42-residue form of A beta, from a single-copy gene insertion in just one pair of glutamatergic sensory neurons, the BAG neurons. In behavioural assays, we found that the A beta 42-expressing animals displayed a subtle modulation of the response to CO2, compared to controls. Ca2+ imaging revealed that the BAG neurons in young A beta 42-expressing nematodes were activated more strongly than in control animals, and that neuronal activation remained intact until old age. Taken together, our results suggest that A beta 42-expression in this very subtle model of AD is sufficient to modulate the behavioural response but not strong enough to generate significant neurotoxicity, suggesting that slightly more aggressive perturbations will enable effectively studies of the links between the modulation of a physiological response and its associated neurotoxicity.	[Sinnige, Tessa; Ciryam, Prashanth; Casford, Samuel; Dobson, Christopher M.; Vendruscolo, Michele] Univ Cambridge, Ctr Misfolding Dis, Dept Chem, Cambridge, England; [de Bono, Mario] MRC, Cell Biol Div, Lab Mol Biol, Cambridge, England	University of Cambridge; MRC Laboratory Molecular Biology	Vendruscolo, M (corresponding author), Univ Cambridge, Ctr Misfolding Dis, Dept Chem, Cambridge, England.	mv245@cam.ac.uk	Sinnige, Tessa/Y-7210-2019; Vendruscolo, Michele/F-5901-2012	Vendruscolo, Michele/0000-0002-3616-1610	MRC [MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Chen CC, 2017, NATURE, V542, P43, DOI 10.1038/nature20818; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Dosanjh LE, 2010, J ALZHEIMERS DIS, V19, P681, DOI 10.3233/JAD-2010-1267; Esposito Z, 2013, CNS NEUROSCI THER, V19, P549, DOI 10.1111/cns.12095; Ewald CY, 2012, EXP BRAIN RES, V217, P397, DOI 10.1007/s00221-011-2905-7; Fenk LA, 2015, P NATL ACAD SCI USA, V112, pE3525, DOI 10.1073/pnas.1423808112; Francis PT, 2003, INT J GERIATR PSYCH, V18, pS15, DOI 10.1002/gps.934; Frokjaer-Jensen C, 2014, NAT METHODS, V11, P529, DOI [10.1038/NMETH.2889, 10.1038/nmeth.2889]; Fu HJ, 2019, NAT NEUROSCI, V22, P47, DOI 10.1038/s41593-018-0298-7; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Guillermin ML, 2017, CURR BIOL, V27, P2630, DOI 10.1016/j.cub.2017.07.023; Habchi J, 2017, P NATL ACAD SCI USA, V114, pE200, DOI 10.1073/pnas.1615613114; Habchi J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501244; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Khabirova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102985; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; LINK CD, 1992, GENETICS, V131, P867; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; McColl G, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-57; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Perni M, 2018, J NEUROSCI METH, V306, P57, DOI 10.1016/j.jneumeth.2018.02.005; Revett TJ, 2013, J PSYCHIATR NEUROSCI, V38, P6, DOI 10.1503/jpn.110190; Rice HC, 2019, SCIENCE, V363, P143, DOI 10.1126/science.aao4827; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Soto C., 2013, J NEUROL TRANSL NEUR, V1, P19; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	49	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217746	10.1371/journal.pone.0217746	http://dx.doi.org/10.1371/journal.pone.0217746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150491	Green Published, gold			2022-12-26	WOS:000469759100097
J	Yang, YD; Song, JY; Wang, S; Wang, Y; Song, QY; Dong, YH; Li, CX; Wang, HJ; Ma, J				Yang, Yi-de; Song, Jie-Yun; Wang, Shuo; Wang, Yang; Song, Qi-Ying; Dong, Yan-hui; Li, Chen-Xiong; Wang, Hai-Jun; Ma, Jun			Combined effects of the rs9810888 polymorphism in calcium voltage-gated channel subunit alphal D (CACNA1D) and lifestyle behaviors on blood pressure level among Chinese children	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; GENETIC-VARIANTS; HERITABILITY; ASSOCIATION; SENSITIVITY; COMPONENTS; OBESITY; RISK	Backgrounds A recent GWAS Study found a new locus (rs9810888 in CACNA1D) was associated with blood pressure (BP) in Chinese adults. But whether the association exists in children is unknown. Whether lifestyle behaviors could interact with rs9810888 on BP is not clear. This study aimed to identify the association between rs9810888 and BP in children, and also explore the gene-lifestyle interaction. Methods A case-control study was conducted among 2030 Chinese children aged 7 to 18 years. Genotyping was conducted by using the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Lifestyle behaviors were investigated with questionnaire. Results With adjustment for age, age square, sex, study group and body mass index (BMI), rs9810888 was significantly associated with diastolic BP (DBP) (b = 1.69, p = 0.021) and mean arterial BP (MAP) (b = 1.56, p = 0.010). Stratified analysis showed that the rs9810888 GG genotype carriers had higher DBP than GT/TT carriers (b = 3.78, p = 0.023) in the subgroup having protein intake (meat/fish/soybeans/egg) <twice/day, but not in the subgroup >= twice/day. In addition, in the subgroup with screen time >= 2h/day, the rs9810888 GG genotype carriers had higher DBP than GT/TT carriers (b = 5.49, p = 0.012), but not in the subgroup with screen time<2h/day. For MAP, in the subgroup having either fruits or vegetables < twice/day, the rs9810888 GG genotype carriers had higher MAP than GT/TT carriers (b = 2.64, p = 0.037), but not in the subgroup with both fruits and vegetables intake >= twice/day. Additionally, in the subgroup with screen time >= 2h/day, the rs9810888 GG genotype carriers had higher MAP than GT/TT carriers (b = 4.80, p = 0.017), but not in those with screen time<2h/day. Conclusions The CACNAID rs9810888 polymorphism was significantly associated with DBP and MAP. In addition, unhealthy lifestyle behaviors and rs9810888 GG genotype had combined effects on BP level among Chinese children.	[Yang, Yi-de; Song, Jie-Yun; Wang, Shuo; Dong, Yan-hui; Ma, Jun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China; [Yang, Yi-de] Hunan Normal Univ, Sch Med, Teaching & Researching Off Child & Adolescent Hlt, Key Lab Mol Epidemiol Hunan Prov, Changsha, Hunan, Peoples R China; [Wang, Yang; Song, Qi-Ying; Li, Chen-Xiong; Wang, Hai-Jun] Peking Univ, Hlth Sci Ctr, Dept Maternal & Child Hlth, Beijing, Peoples R China	Peking University; Hunan Normal University; Peking University	Ma, J (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China.; Wang, HJ (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Maternal & Child Hlth, Beijing, Peoples R China.	whjun1@bjmu.edu.cn; majunt@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021; Song, Qiying/AAV-6247-2021	Wang, Haijun/0000-0003-0849-2903; Dong, Yanhui/0000-0003-2519-3200; Yang, Yide/0000-0003-3297-1306	National Natural Science Foundation of China [81673192]; Hunan Provincial Natural Science Foundation of China [2019JJ50376]; Scientific Research Fund of Hunan Provincial Education Department [18C0072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This study was supported by Grants from National Natural Science Foundation of China (81573170, HW, http://www.nsfc.gov.cn/), National Natural Science Foundation of China (81673192, JM, http://www.nsfc.gov.cn/), Hunan Provincial Natural Science Foundation of China (2019JJ50376, YDY) and a Project Supported by Scientific Research Fund of Hunan Provincial Education Department (18C0072, YDY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHIN J EVID BASED PE; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Chen CK, 2008, PROCEEDINGS OF THE 2008 CHINESE CONFERENCE ON PATTERN RECOGNITION (CCPR 2008), P36; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; de Moraes ACF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062006; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Graff M, 2013, PEDIATR OBES, V8, pE74, DOI 10.1111/j.2047-6310.2013.00195.x; Hartman S, 2015, DEV PSYCHOPATHOL, V27, P747, DOI 10.1017/S0954579414000856; Heshmat R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154502; Hottenga JJ, 2005, TWIN RES HUM GENET, V8, P499, DOI 10.1375/183242705774310123; Hruby A, 2018, PUBLIC HEALTH NUTR, V21, P2998, DOI 10.1017/S1368980018001854; Kamide K, 2009, CIRC J, V73, P732, DOI 10.1253/circj.CJ-08-0761; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Li Y, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0489-x; Lin HF, 2005, DIABETOLOGIA, V48, P2006, DOI 10.1007/s00125-005-1892-2; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lu XF, 2015, HUM MOL GENET, V24, P865, DOI 10.1093/hmg/ddu478; MCILHANY ML, 1975, JOHNS HOPKINS MED J, V136, P57; Montasser ME, 2011, AM J HYPERTENS, V24, P1035, DOI 10.1038/ajh.2011.97; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Pomeroy J, 2009, MED SPORT SCI, V54, P110, DOI 10.1159/000235700; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reinbothe TM, 2013, DIABETOLOGIA, V56, P340, DOI 10.1007/s00125-012-2758-z; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2011, NAT REV ENDOCRINOL, V7, P485, DOI 10.1038/nrendo.2011.76; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Smith CE, 2009, ATHEROSCLEROSIS, V206, P500, DOI 10.1016/j.atherosclerosis.2009.03.012; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; Song JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170062; Tardieu Bernard, 1980, ESSENTIALS PRESSURE; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang S, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0352-9; Xi B, 2012, ATHEROSCLEROSIS, V225, P376, DOI 10.1016/j.atherosclerosis.2012.10.027; Yang YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025783; Zhang TH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081055	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0216950	10.1371/journal.pone.0216950	http://dx.doi.org/10.1371/journal.pone.0216950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145748	gold, Green Submitted, Green Published			2022-12-26	WOS:000469425500007
J	Udayanga, L; Ranathunge, T; Iqbal, MCM; Abeyewickreme, W; Hapugoda, M				Udayanga, Lahiru; Ranathunge, Tharaka; Iqbal, M. C. M.; Abeyewickreme, W.; Hapugoda, Menaka			Predatory efficacy of five locally available copepods on Aedes larvae under laboratory settings: An approach towards bio-control of dengue in Sri Lanka	PLOS ONE			English	Article							CYCLOPOID COPEPODS; BIOLOGICAL-CONTROL; MESOCYCLOPS-LONGISETUS; MALARIA VECTOR; COMMUNITY; AEGYPTI; NANOPARTICLES; CRUSTACEA; MOSQUITOS; RESPONSES	Many countries are in search of more effective and sustainable methods for controlling dengue vectors, due to undeniable inefficiencies in chemical and mechanical vector control methods. Bio-control of vectors by copepods is an ideal method of using interactions in the natural ecosystem for vector management, with minimum consequences on the environment. Current study determined the predatory efficacy of five locally abundant copepod species on, Aedes larvae under laboratory conditions. Copepods were collected from the pre-identified locations within the districts of Gampaha and Kandy, and identified morphologically. Individual species of copepods were maintained as separate colonies with Paramecium culture and wheat grain as supplementary food. Five adult copepods of each species was introduced into separate containers with 200 larvae (1st instar) of Aedes aegypti. Number of larvae survived in containers were enumerated at 3 hour intervals within a duration of 24 hours. Each experiment was repeated five times. The same procedure was followed for Ae. albopictus. Significance in the variations among predation rates was evaluated with General Linear Modelling (GLM) followed by Tukey's pair-wise comparison in SPSS (version 23). Significant variations in predation rates of studied copepod species were reported (p<0.05), whereby M. leuckarti indicated the highest followed by M. scrassus, while C. languides indicated the lowest predatory efficacy. The effect of different Aedes larval species on the predation rates of copepods remained significant (p<0.05), even though the effect on predatory efficiency was not significant. Based on the findings, both M. leuckarti and M. scrassus, with the highest predatory efficiencies, could be recommended as potential candidates for biological controlling of Aedes vectors in Sri Lanka.	[Udayanga, Lahiru] Wayamba Univ Sri Lanka, Fac Agr & Plantat Management, Dept Biosyst Engn, Kuliyapitiya, Sri Lanka; [Udayanga, Lahiru; Ranathunge, Tharaka; Hapugoda, Menaka] Univ Kelaniya, Fac Med, Mol Med Unit, Colombo, Sri Lanka; [Iqbal, M. C. M.] Natl Inst Fundamental Studies, Kandy, Sri Lanka; [Abeyewickreme, W.] Sir John Kotelawala Def Univ, Fac Med, Dept Paraclin Sci, Ratmalana, Sri Lanka	Wayamba University of Sri Lanka; University Kelaniya; University of Colombo; National Institute of Fundamental Studies (NIFS); General Sir John Kotelawala Defence University	Hapugoda, M (corresponding author), Univ Kelaniya, Fac Med, Mol Med Unit, Colombo, Sri Lanka.	menakaha@yahoo.com	Iqbal, Mohamed Cassim/AAH-2008-2021; Udayanga, Lahiru/AAM-1831-2021; Iqbal, Mohammed/GYA-1556-2022	Iqbal, Mohamed Cassim/0000-0002-4862-5099; Udayanga, N.W.B.A. Lahiru/0000-0002-5687-989X	National Research Council, Sri Lanka [TO 14-04, <LF> NRC TO 14-04]; International Atomic Energy Agency [IAEA SRL5/047]	National Research Council, Sri Lanka; International Atomic Energy Agency(International Atomic Energy Agency)	Surveillance activities were funded by the National Research Council Funded Dengue Mega Grant (NRC TO 14-04), Sri Lanka.; We acknowledge the National Research Council, Sri Lanka (TO 14-04) for funding and the International Atomic Energy Agency (IAEA SRL5/047) for technical cooperation.	Baldacchino Frederic, 2015, Pest Manag Sci, V71, P1471, DOI 10.1002/ps.4044; Bapna Saroj, 1994, Journal of Communicable Diseases, V26, P39; Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496; Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bock GW, 2005, MIS QUART, V29, P87, DOI 10.2307/25148669; BROWN MD, 1991, J MED ENTOMOL, V28, P618, DOI 10.1093/jmedent/28.5.618; Chitra Thangadurai, 2013, Asian Pacific Journal of Tropical Disease, V3, P111, DOI 10.1016/S2222-1808(13)60054-7; De Roa EZ, 2002, J AM MOSQUITO CONTR, V18, P47; Dessborn L, 2009, HYDROBIOLOGIA, V636, P319, DOI 10.1007/s10750-009-9962-y; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harrison BA, 1973, COMP MORPHOLOGY EARL; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kalimuthu K, 2017, HYDROBIOLOGIA, V785, P359, DOI 10.1007/s10750-016-2943-z; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059; Klerman G, 1994, INTERPERSONAL PSYCHO; Kumar PM, 2012, PARASITOL RES, V111, P609, DOI 10.1007/s00436-012-2876-z; Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LING HU, 1986, LIMNOLOGICAL SURVE 2; MAMARIL A. C., 1978, NAT APPL SCI B, V30, P109; Marten G.G., 1984, Bulletin of the Society of Vector Ecologists, V9, P1; MARTEN GG, 1990, J AM MOSQUITO CONTR, V6, P681; MARTEN GG, 1994, HYDROBIOLOGIA, V293, P491, DOI 10.1007/BF00229976; MARTEN GG, 1997, COPEPOD PRODUCTION A; Mendis A.S., 1962, GUIDE FRESH WATER FA, P42; Micieli MV, 1982, MEM I O CRUZ, V97, P835; Millon A, 2008, OIKOS, V117, P1500, DOI 10.1111/j.0030-1299.2008.16458.x; Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0; Murugan K, 2017, HYDROBIOLOGIA, V797, P335, DOI 10.1007/s10750-017-3196-1; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Paaijmans KP, 2008, INT J BIOMETEOROL, V52, P747, DOI 10.1007/s00484-008-0167-2; Peterson DL, 2013, J BIOGEOGR, V40, P1664, DOI 10.1111/jbi.12107; Ramanibai R, 1998, INDIAN J NAT PROD RE, P208; Ranathunge RMTB, 2018, J VECTOR BORNE DIS; Rey JR, 2004, J VECTOR ECOL, V29, P124; RIVIERE F, 1981, ENTOMOPHAGA, V26, P427, DOI 10.1007/BF02374717; Romano D, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.187427; Romano D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12941-z; Rueda L.M., 2004, PICTORIAL KEYS IDENT; Shad A., 2013, INT J CURR MICROBIOL, V2, P172; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Sirisena PDNN, 2014, INT J INFECT DIS, V19, P6, DOI 10.1016/j.ijid.2013.10.012; Suarez-Rubio M, 2004, J AM MOSQUITO CONTR, V20, P401; TINSON S, 1985, HYDROBIOLOGIA, V127, P257, DOI 10.1007/BF00024230; Udayanga L, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2995-y; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; *WHO, 1992, 15 WHO EXP COMM VECT; Williams-Howze Judith, 1997, Oceanography and Marine Biology an Annual Review, V35, P257; Yasuoka J, 2006, T ROY SOC TROP MED H, V100, P995, DOI 10.1016/j.trstmh.2005.12.014	52	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216140	10.1371/journal.pone.0216140	http://dx.doi.org/10.1371/journal.pone.0216140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136574	Green Published, Green Submitted, gold			2022-12-26	WOS:000469224300003
J	Frydenvang, K; Verkade-Vreeker, MCA; Dohmen, F; Commandeur, JNM; Rafiq, M; Mirza, O; Jorgensen, FS; Geerke, DP				Frydenvang, Karla; Verkade-Vreeker, Marlies C. A.; Dohmen, Floor; Commandeur, Jan N. M.; Rafiq, Maria; Mirza, Osman; Jorgensen, Flemming Steen; Geerke, Daan P.			Structural analysis of Cytochrome P450 BM3 mutant M11 in complex with dithiothreitol	PLOS ONE			English	Article							BINDING; HYDROXYLATION; MECHANISM; PROTEIN; CRYSTALLOGRAPHY; DEGRADATION; VALIDATION; GENERATION; MYOGLOBIN; CYP102A1	The bacterial Cytochrome P450 (CYP) BM3 (CYP102A1) is one of the most active CYP isoforms. BM3 mutants can serve as a model for human drug-metabolizing CYPs and/or as biocatalyst for selective formation of drug metabolites. Hence, molecular and computational biologists have in the last two decades shown strong interest in the discovery and design of novel BM3 variants with optimized activity and selectivity for substrate conversion. This led e.g. to the discovery of mutant M11 that is able to metabolize a variety of drugs and drug-like compounds with relatively high activity. In order to further improve our understanding of CYP binding and reactions, we performed a co-crystallization study of mutant M11 and report here the three-dimensional structure M11 in complex with dithiothreitol (DTT) at a resolution of 2.16 A. The structure shows that DTT can coordinate to the Fe atom in the heme group. UV/Vis spectroscopy and molecular dynamics simulation studies underline this finding and as first structure of the CYP BM3 mutant M11 in complex with a ligand, it offers a basis for structure-based design of novel mutants.	[Frydenvang, Karla; Rafiq, Maria; Mirza, Osman; Jorgensen, Flemming Steen] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Verkade-Vreeker, Marlies C. A.; Dohmen, Floor; Commandeur, Jan N. M.; Geerke, Daan P.] Vrije Univ, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, Amsterdam, Netherlands	University of Copenhagen; Vrije Universiteit Amsterdam	Jorgensen, FS (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark.; Geerke, DP (corresponding author), Vrije Univ, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, Amsterdam, Netherlands.	fsj@sund.ku.dk; d.p.@geerke@vu.nl		Mirza, Osman Asghar/0000-0001-9435-0690; Rafiq, Maria/0000-0001-9118-0788; Jorgensen, Flemming Steen/0000-0001-8040-2998; Geerke, Daan/0000-0002-5262-6166; Commandeur, Jan N.M./0000-0002-2105-971X	Netherlands Organization for Scientific Research (NWO, VIDI grant) [723.012.105]	Netherlands Organization for Scientific Research (NWO, VIDI grant)(Netherlands Organization for Scientific Research (NWO))	DPG acknowledges The Netherlands Organization for Scientific Research (NWO, VIDI grant 723.012.105) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2009, DESM MOL DYN SYST; Arnold FH, 2018, ANGEW CHEM INT EDIT, V57, P4143, DOI 10.1002/anie.201708408; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boerma JS, 2011, CHEM RES TOXICOL, V24, P1263, DOI 10.1021/tx2001515; Bonomo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29468; Capoferri L, 2016, PROTEINS, V84, P383, DOI 10.1002/prot.24985; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Damsten MC, 2008, CHEM-BIOL INTERACT, V171, P96, DOI 10.1016/j.cbi.2007.09.007; DOPPELT P, 1984, CROAT CHEM ACTA, V57, P507; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGLISH DR, 1984, J AM CHEM SOC, V106, P7258, DOI 10.1021/ja00335a074; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gorren ACF, 1997, BIOCHEMISTRY-US, V36, P4360, DOI 10.1021/bi962381s; Grabarczyk DB, 2015, J BIOL CHEM, V290, P9209, DOI 10.1074/jbc.M114.618025; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; He CM, 2013, J INORG BIOCHEM, V122, P38, DOI 10.1016/j.jinorgbio.2013.01.012; Hudson SA, 2012, BIOCHEM SOC T, V40, P573, DOI 10.1042/BST20120062; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirton SB, 2005, PROTEINS, V58, P836, DOI 10.1002/prot.20389; Luirink RA, 2018, J INORG BIOCHEM, V184, P115, DOI 10.1016/j.jinorgbio.2018.04.013; Matsui T, 2010, INORG CHEM, V49, P3602, DOI 10.1021/ic901869t; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nebert DW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0431; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano PR, 2015, CYTOCHROME P450 STRU; Pavlik JW, 2010, INORG CHEM, V49, P1017, DOI 10.1021/ic901853p; Qin J, 2006, BIOCHEMISTRY-US, V45, P3170, DOI 10.1021/bi052171s; Rea V, 2012, BIOCHEMISTRY-US, V51, P750, DOI 10.1021/bi201433h; Reinen J, 2011, DRUG METAB DISPOS, V39, P1568, DOI 10.1124/dmd.111.039461; Roberts AG, 2016, BBA-GEN SUBJECTS, V1860, P669, DOI 10.1016/j.bbagen.2015.12.014; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; SCHAPPACHER M, 1989, INORG CHEM, V28, P4639, DOI 10.1021/ic00325a020; SONO M, 1982, J BIOL CHEM, V257, P8308; Sono M, 2018, J BIOL INORG CHEM, V23, P1085, DOI 10.1007/s00775-018-1611-3; Swanson HI, 2010, DRUG METAB DISPOS, V38, P539, DOI 10.1124/dmd.109.031351; Swartz L, 2006, BIOCHEMISTRY-US, V45, P4421, DOI 10.1021/bi060146w; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; van Vugt-Lussenburg BMA, 2007, J MED CHEM, V50, P455, DOI 10.1021/jm0609061; Venkataraman H, 2012, ADV SYNTH CATAL, V354, P2172, DOI 10.1002/adsc.201200067; Vottero E, 2011, J BIOL INORG CHEM, V16, P899, DOI 10.1007/s00775-011-0789-4; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada T, 2007, BIOCHEMISTRY-US, V46, P8414, DOI 10.1021/bi700605m; Yun CH, 2007, TRENDS BIOTECHNOL, V25, P289, DOI 10.1016/j.tibtech.2007.05.003	49	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217292	10.1371/journal.pone.0217292	http://dx.doi.org/10.1371/journal.pone.0217292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125381	Green Submitted, Green Published, gold			2022-12-26	WOS:000468865700027
J	Petrillo, MG; Oakley, RH; Cidlowski, JA				Petrillo, Maria G.; Oakley, Robert H.; Cidlowski, John A.			beta-Arrestin-1 inhibits glucocorticoid receptor turnover and alters glucocorticoid signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucocorticoid receptor; arrestin; E3 ubiquitin ligase; post-translational modification (PTM); protein stability; glucocorticoid signaling	E3 UBIQUITIN LIGASES; BETA-ARRESTINS; NUCLEAR RECEPTORS; GENE-EXPRESSION; DOWN-REGULATION; CROSS-TALK; PROTEIN; ROLES; DEGRADATION; ACTIVATION	Glucocorticoids are among the most widely used drugs to treat many autoimmune and inflammatory diseases. Although much research has been focused on investigating glucocorticoid activity, it remains unclear how glucocorticoids regulate distinct processes in different cells. Glucocorticoids exert their effects through the glucocorticoid receptor (GR), which, upon glucocorticoid binding, interacts with regulatory proteins, affecting its activity and function. These protein-protein interactions are necessary for the resolution of glucocorticoid-dependent physiological and pharmacological processes. In this study, we discovered a novel protein interaction between the glucocorticoid receptor and beta-arrestin-1, a scaffold protein with a well-established role in G protein-coupled receptor signaling. Using co-immunoprecipitation and in situ proximity ligation assays in A549 cells, we observed that beta-arrestin-1 and unliganded GR interact in the cytoplasm and that, following glucocorticoid binding, the protein complex is found in the nucleus. We show that siRNA-mediated beta-arrestin-1 knockdown alters GR protein turnover by up-regulating the E3 ubiquitin ligase Pellino-1, which catalyzes GR ubiquitination and thereby marks the receptor for proteasomal degradation. The enhanced GR turnover observed in beta-arrestin-1-deficient cells limits the duration of the glucocorticoid response on GR target genes. These results demonstrate that beta-arrestin-1 is a crucial player for the stability of the glucocorticoid receptor. The GR/beta-arrestin-1 interaction uncovered here may help unravel mechanisms that contribute to the cell type-specific activities of glucocorticoids.	[Petrillo, Maria G.; Oakley, Robert H.; Cidlowski, John A.] NIEHS, Signal Transduct Lab, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, NIH, POB 12233,MD F3-07, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	; Cidlowski, John/G-2548-2019	Petrillo, Maria Grazia/0000-0001-5999-9355; Cidlowski, John/0000-0003-1420-0516	Intramural Research Program of the NIEHS, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the NIEHS, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmadzai MM, 2017, ADV IMMUNOL, V136, P279, DOI 10.1016/bs.ai.2017.05.004; ALMLOF T, 1995, J BIOL CHEM, V270, P17535, DOI 10.1074/jbc.270.29.17535; Ayroldi E, 2015, CELL DEATH DIFFER, V22, P118, DOI 10.1038/cdd.2014.129; Bouazza B, 2014, AM J RESP CELL MOL, V50, P301, DOI 10.1165/rcmb.2012-0522OC; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Helzer KT, 2015, J MOL ENDOCRINOL, V54, pR151, DOI 10.1530/JME-14-0308; Hsiao JJ, 2016, J BIOL CHEM, V291, P18818, DOI 10.1074/jbc.M116.732313; Humphries F, 2015, IMMUNOL REV, V266, P93, DOI 10.1111/imr.12306; Ismail A, 2005, IUBMB LIFE, V57, P483, DOI 10.1080/15216540500147163; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Jeon YK, 2017, CELL DEATH DIFFER, V24, P469, DOI 10.1038/cdd.2016.143; Jin W, 2012, CELL MOL IMMUNOL, V9, P113, DOI 10.1038/cmi.2011.60; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kim YS, 2005, ENDOCRINOLOGY, V146, P3133, DOI 10.1210/en.2004-1455; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kommaddi RP, 2013, PROG MOL BIOL TRANSL, V118, P175, DOI 10.1016/B978-0-12-394440-5.00007-3; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Li DW, 2018, CANCER RES, V78, P2897, DOI 10.1158/0008-5472.CAN-17-3531; Malik R, 2012, J BIOL CHEM, V287, P9013, DOI 10.1074/jbc.M111.336792; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Moynagh PN, 2014, NAT REV IMMUNOL, V14, P122, DOI 10.1038/nri3599; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Oakley RH, 2017, J BIOL CHEM, V292, P5825, DOI 10.1074/jbc.M116.758888; Oakley RH, 2012, P NATL ACAD SCI USA, V109, P17591, DOI 10.1073/pnas.1209411109; Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014; OKRET S, 1991, BIOCHIMIE, V73, P51, DOI 10.1016/0300-9084(91)90074-B; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; PALCZEWSKI K, 1994, PROTEIN SCI, V3, P1355, DOI 10.1002/pro.5560030901; Park CW, 2014, BMB REP, V47, P475, DOI 10.5483/BMBRep.2014.47.9.128; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Petta Ioanna, 2016, Microbiol Mol Biol Rev, V80, P495, DOI 10.1128/MMBR.00064-15; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Quinn MA, 2018, CELL REP, V22, P2690, DOI 10.1016/j.celrep.2018.02.041; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SILVA CM, 1994, STEROIDS, V59, P436, DOI 10.1016/0039-128X(94)90013-2; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Simon Jeremy M, 2013, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2126s102; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song Q, 2018, INT J MOL MED, V41, P631, DOI 10.3892/ijmm.2017.3288; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1254, DOI 10.1210/me.2014-1023; Takabe S, 2008, ARCH BIOCHEM BIOPHYS, V475, P1, DOI 10.1016/j.abb.2008.03.036; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Wallace AD, 2010, STEROIDS, V75, P1016, DOI 10.1016/j.steroids.2010.06.015; Wang HB, 2017, P NATL ACAD SCI USA, V114, P11944, DOI 10.1073/pnas.1715742114; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang XJ, 2005, MOL ENDOCRINOL, V19, P1474, DOI 10.1210/me.2004-0383; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; WIRA C, 1970, J BIOL CHEM, V245, P3436; Witchel SF, 2006, NAT CLIN PRACT ENDOC, V2, P621, DOI 10.1038/ncpendmet0323; Wong AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120530; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Yudt MR, 2002, MOL ENDOCRINOL, V16, P1719, DOI 10.1210/me.2002-0106; Zhang MF, 2011, MECH DEVELOP, V128, P368, DOI 10.1016/j.mod.2011.07.003	84	8	9	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11225	11239		10.1074/jbc.RA118.007150	http://dx.doi.org/10.1074/jbc.RA118.007150			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167788	Green Published, hybrid			2022-12-26	WOS:000478717400014
J	Lypova, N; Telang, S; Chesney, J; Imbert-Fernandez, Y				Lypova, Nadiia; Telang, Sucheta; Chesney, Jason; Imbert-Fernandez, Yoannis			Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lung cancer; glycolysis; metabolism; epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); 6-phosphofructo-2-kinase; fructose-2; 6-bisphosphatase; erlotinib; PFKFB3; tumorigenesis; tyrosine kinase inhibitor; small molecule antagonist	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; EARLY PREDICTION; NEVER SMOKERS; PFKFB3; GENE; INHIBITION; PHOSPHORYLATION; EXPRESSION; MUTATIONS	Constitutive activation of the epidermal growth factor receptor (EGFR) because of somatic mutations of the EGFR gene is commonly observed in tumors of non-small cell lung cancer (NSCLC) patients. Consequently, tyrosine kinase inhibitors (TKI) targeting the EGFR are among the most effective therapies for patients with sensitizing EGFR mutations. Clinical responses to the EGFR-targeting TKIs are evaluated through 2-[F-18]fluoro-2-deoxy-glucose ((18)FDG)-PET uptake, which is decreased in patients responding favorably to therapy and is positively correlated with survival. Recent studies have reported that EGFR signaling drives glucose metabolism in NSCLC cells; however, the precise downstream effectors required for this EGFR-driven metabolic effect are largely unknown. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is an essential glycolytic regulator that is consistently overexpressed in lung cancer. Here, we found that PFKFB3 is an essential target of EGFR signaling and that PFKFB3 activation is required for glycolysis stimulation upon EGFR activation. We demonstrate that exposing NSCLC cells harboring either WT or mutated EGFR to EGF rapidly increases PFKFB3 phosphorylation, expression, and activity and that PFKFB3 inhibition markedly reduces the EGF-mediated increase in glycolysis. Furthermore, we found that prolonged NSCLC cell exposure to the TKI erlotinib drives PFKFB3 expression and that chemical PFKFB3 inhibition synergizes with erlotinib in increasing erlotinib's anti-proliferative activity in NSCLC cells. We conclude that PFKFB3 has a key role in mediating glucose metabolism and survival of NSCLC cells in response to EGFR signaling. These results support the potential clinical utility of using PFKFB3 inhibitors in combination with EGFR-TKIs to manage NSCLC.	[Lypova, Nadiia; Telang, Sucheta; Chesney, Jason; Imbert-Fernandez, Yoannis] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Div Med Oncol & Hematol, Louisville, KY 40202 USA	University of Louisville	Chesney, J (corresponding author), 529 S Jackson St, Louisville, KY 40202 USA.; Imbert-Fernandez, Y (corresponding author), 505 S Hancock St, Louisville, KY 40202 USA.	jason.chesney@louisville.edu; yoannis.imbertfernandez@louisville.edu	Lypova, Nadiia/AAH-3405-2021; Lypova, Nadiia/GWR-2435-2022	Lypova, Nadiia/0000-0003-1506-8545; 	Kentucky Lung Cancer Research Program Grant; James Graham Brown Foundation	Kentucky Lung Cancer Research Program Grant; James Graham Brown Foundation	This work was supported by Kentucky Lung Cancer Research Program Grant (to Y. I.-F.) and James Graham Brown Foundation Grant (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Apicella M, 2018, CELL METAB, V28, P848, DOI 10.1016/j.cmet.2018.08.006; Atsumi T, 2002, CANCER RES, V62, P5881; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Cordero-Espinoza L, 2013, J BIOL CHEM, V288, P36020, DOI 10.1074/jbc.M113.510289; Cossu-Rocca P, 2016, AM J CANCER RES, V6, P71; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; De Rosa V, 2015, CLIN CANCER RES, V21, P5110, DOI 10.1158/1078-0432.CCR-15-0375; Dempke WCM, 2015, ANTICANCER RES, V35, P2503; DIAMOND I, 1978, J BIOL CHEM, V253, P866; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Hachemi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087629; Hafner M, 2017, NAT BIOTECHNOL, V35, P500, DOI 10.1038/nbt.3882; Imbert-Fernandez Y, 2014, J BIOL CHEM, V289, P9440, DOI 10.1074/jbc.M113.529990; Kim JH, 2018, CANCER RES, V78, P4482, DOI 10.1158/0008-5472.CAN-18-0117; Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2; Li XL, 2018, MOL CELL BIOCHEM, V445, P123, DOI 10.1007/s11010-017-3258-8; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PF, 2016, THERANOSTICS, V6, P1232, DOI 10.7150/thno.14409; Macdonald-Obermann JL, 2018, J BIOL CHEM, V293, P13401, DOI 10.1074/jbc.RA118.004139; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Manes NP, 2005, ARCH BIOCHEM BIOPHYS, V438, P125, DOI 10.1016/j.abb.2005.04.011; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Minchenko H., 2005, Ukrainskii Biokhimicheskii Zhurnal, V77, P46; Momcilovic M, 2017, CELL REP, V18, P601, DOI 10.1016/j.celrep.2016.12.061; Nan XL, 2017, ONCOTARGET, V8, P75712, DOI 10.18632/oncotarget.20095; Novellasdemunt L, 2012, BIOCHEM J, V442, P345, DOI 10.1042/BJ20111418; Oxnard GR, 2018, JAMA ONCOL, V4, P1527, DOI 10.1001/jamaoncol.2018.2969; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park JH, 2012, BIOCHEM J, V448, P417, DOI 10.1042/BJ20121513; Perez-Soler R., 2004, J CLIN ONCOL, V22, P7026, DOI 10.1200/jco.2004.22.90140.7026; Ranayhossaini DJ, 2014, INT J MOL SCI, V15, P17686, DOI 10.3390/ijms151017686; Ray P, 2016, ONCOTARGET, V7, P68597, DOI 10.18632/oncotarget.11860; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Redman R, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-CT206; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Scagliotti GV, 2015, CANCER TREAT REV, V41, P465, DOI 10.1016/j.ctrv.2015.04.001; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Sunaga N, 2008, LUNG CANCER, V59, P203, DOI 10.1016/j.lungcan.2007.08.012; Tan XJ, 2016, TRENDS CELL BIOL, V26, P352, DOI 10.1016/j.tcb.2015.12.006; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Telang S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-S1-P14; Tiseo M, 2014, CANCER CHEMOTH PHARM, V73, P299, DOI 10.1007/s00280-013-2356-x; Valley CC, 2015, MOL BIOL CELL, V26, P4087, DOI 10.1091/mbc.E15-05-0269; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P887, DOI 10.1042/bj1920887; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; Vivanco I, 2014, BRIT J CANCER, V111, P2033, DOI 10.1038/bjc.2014.461; Wu SG, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0777-1; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zander T, 2011, J CLIN ONCOL, V29, P1701, DOI 10.1200/JCO.2010.32.4939; Zhang L, 2017, ONCOTARGET, V8, P13126, DOI 10.18632/oncotarget.14480	60	16	17	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10530	10543		10.1074/jbc.RA119.007784	http://dx.doi.org/10.1074/jbc.RA119.007784			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31126985	Green Published, hybrid			2022-12-26	WOS:000478717100013
J	Arora, R; Kumar, SN; Sudarshan, S; Fairoze, MN; Kaur, M; Sharma, A; Girdhar, Y; Sreesujatha, RM; Devatkal, SK; Ahlawat, S; Vijh, RK; Manjunatha, SS				Arora, Reena; Kumar, Naveen S.; Sudarshan, S.; Fairoze, Mohamed Nadeem; Kaur, Mandeep; Sharma, Anju; Girdhar, Yashila; Sreesujatha, R. M.; Devatkal, Suresh K.; Ahlawat, Sonika; Vijh, Ramesh Kumar; Manjunatha, S. S.			Transcriptome profiling of longissimus thoracis muscles identifies highly connected differentially expressed genes in meat type sheep of India	PLOS ONE			English	Article							TENDERNESS; RYANODINE; PROTEINS; RNA; FAT; NETWORK; QUALITY; TRAITS; TISSUE; ACIDS	This study describes the muscle transcriptome profile of Bandur breed, a consumer favoured, meat type sheep of India. The transcriptome was compared to the less desirable, unregistered local sheep population, in order to understand the molecular factors related to muscle traits in Indian sheep breeds. Bandur sheep have tender muscles and higher backfat thickness than local sheep. The longissimus thoracis transcriptome profiles of Bandur and local sheep were obtained using RNA sequencing (RNA Seq). The animals were male, non-castrated, with uniform age and reared under similar environment, as well as management conditions. We could identify 568 significantly up-regulated and 538 significantly down-regulated genes in Bandur sheep (p<0.05). Among these, 181 up-regulated and 142 down-regulated genes in Bandur sheep, with a fold change >= 1.5, were considered for further analysis. Significant Gene Ontology terms for the up-regulated dataset in Bandur sheep included transporter activity, substrate specific transmembrane, lipid and fatty acid binding. The down-regulated activities in Bandur sheep were mainly related to RNA degradation, regulation of ERK1 and ERK2 cascades and innate immune response. The MAPK signaling pathway, Adipocytokine signaling pathway and PPAR signaling pathway were enriched for Bandur sheep. The highly connected genes identified by network analysis were CNOT2, CNOT6, HSPB1, HSPA6, MAP3K14 and PPARD, which may be important regulators of energy metabolism, cellular stress and fatty acid metabolism in the skeletal muscles. These key genes affect the CCR4-NOT complex, PPAR and MAPK signaling pathways. The highly connected genes identified in this study, form interesting candidates for further research on muscle traits in Bandur sheep.	[Arora, Reena; Kaur, Mandeep; Sharma, Anju; Girdhar, Yashila; Ahlawat, Sonika; Vijh, Ramesh Kumar] ICAR Natl Bur Anim Genet Resources, Kernel, Haryana, India; [Kumar, Naveen S.; Sudarshan, S.; Fairoze, Mohamed Nadeem; Sreesujatha, R. M.; Manjunatha, S. S.] Karnataka Vet Anim & Fisheries Sci Univ, Bangalore, Karnataka, India; [Devatkal, Suresh K.] ICAR Natl Res Ctr Meat, Hyderabad, Telangana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Meat	Arora, R (corresponding author), ICAR Natl Bur Anim Genet Resources, Kernel, Haryana, India.	rejagati@gmail.com	Ahlawat, Sonika/AAW-9905-2020; ARORA, REENA/AAK-6892-2021; Arora, Reena/AAR-2240-2021		Institute funds of Indian Council of Agricultural Research National Bureau of Animal Genetic Resources (ICAR-NBAGR), Karnal, India	Institute funds of Indian Council of Agricultural Research National Bureau of Animal Genetic Resources (ICAR-NBAGR), Karnal, India	This work was supported by the Institute funds of Indian Council of Agricultural Research National Bureau of Animal Genetic Resources (ICAR-NBAGR), Karnal, India, and not by any external funding.	Acharya R.M., 1982, 30 UN FAO; An QM, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060160; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], [No title captured]; BAHS-Basic Animal Husbandry and Fisheries Statistics, 2017, AHS SER, V18, P1; Berton MP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3232-y; Bhatia S, 2005, ASIAN AUSTRAL J ANIM, V18, P1387, DOI 10.5713/ajas.2005.1387; Bongiorni S, 2016, ANIM GENET, V47, P273, DOI 10.1111/age.12418; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brocker Chad, 2010, Hum Genomics, V4, P411; Cassar-Malek Isabelle, 2016, ScientificWorldJournal, V2016, P2185323, DOI 10.1155/2016/2185323; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Conti A, 1996, BIOCHEM J, V316, P19, DOI 10.1042/bj3160019; DANI NP, 1985, INDIAN J ANIM SCI, V55, P1094; de Huidobro FR, 2005, MEAT SCI, V69, P527, DOI 10.1016/j.meatsci.2004.09.008; Ferguson DM, 2014, ANIM PROD SCI, V54, P464, DOI 10.1071/AN13088; Fischer H, 2006, BIOCHEM BIOPH RES CO, V346, P125, DOI 10.1016/j.bbrc.2006.05.083; Guillemin N, 2011, ANIMAL, V5, P885, DOI 10.1017/S1751731110002612; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Hocquette JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-135; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Jing L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11953; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; KAUFFMAN RG, 1986, MEAT SCI, V18, P307, DOI 10.1016/0309-1740(86)90020-3; KEETON JT, 1983, J FOOD SCI, V48, P878, DOI 10.1111/j.1365-2621.1983.tb14921.x; Kim NK, 2011, J AGR FOOD CHEM, V59, P5657, DOI 10.1021/jf200217j; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857; Kumar NS, 2017, INDIAN J ANIM RES, V2, P1; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobjois V, 2008, ANIM GENET, V39, P147, DOI 10.1111/j.1365-2052.2007.01695.x; Lomiwes D, 2014, MEAT SCI, V96, P26, DOI 10.1016/j.meatsci.2013.06.008; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Ogawa Y, 2000, TRENDS CARDIOVAS MED, V10, P65, DOI 10.1016/S1050-1738(00)00050-5; Paiao FG, 2013, GENET MOL RES, V12, P3017, DOI 10.4238/2013.August.20.3; Picard B, 2014, J AGR FOOD CHEM, V62, P9808, DOI 10.1021/jf501528s; REDDY KS, 1982, INDIAN VET J, V59, P217; Renand G, 2001, MEAT SCI, V59, P49, DOI 10.1016/S0309-1740(01)00051-1; Rodriguez-Ruiz J, 1998, BIOTECHNOL TECH, V12, P689, DOI 10.1023/A:1008812904017; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; SARWAR G, 1993, J CHROMATOGR-BIOMED, V615, P1, DOI 10.1016/0378-4347(93)80286-D; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soam SK, 2008, PARTICIPATORY SOCIOE, P1; Sohn EJ, 2015, CELL PHYSIOL BIOCHEM, V37, P1881, DOI 10.1159/000438549; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Sun LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33586; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YH, 2015, ANIM GENET, V46, P655, DOI 10.1111/age.12338; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Warner RD, 2010, MEAT SCI, V86, P171, DOI 10.1016/j.meatsci.2010.04.042; Xu QL, 2011, CZECH J ANIM SCI, V56, P1, DOI 10.17221/231/2009-CJAS	60	12	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217461	10.1371/journal.pone.0217461	http://dx.doi.org/10.1371/journal.pone.0217461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170190	gold, Green Submitted, Green Published			2022-12-26	WOS:000470263700031
J	Cui, HL; Zhang, YA; Shi, XL; Gong, FF; Xiong, X; Kang, XP; Xing, GM; Li, S				Cui, Huliang; Zhang, Yanan; Shi, Xiaolu; Gong, Feifei; Xiong, Xiong; Kang, Xiuping; Xing, Guoming; Li, Sen			The numerical classification and grading standards of daylily (Hemerocallis) flower color	PLOS ONE			English	Article							ANTIOXIDANT	This study collected 183 Hemerocallis varieties to conduct numerical classification of flower color and provide valuable baseline data and foundational theory for normalization and precision of Hemerocallis. The color CIELab phenotypes were collected via colorimeter (CR-10 Plus), which separately measured three sepal and petal parts (throat, eye and limb). The colors of experimental samples were artificially named by the Royal Horticultural Society Colour Chart (RHSCC). All the data were analyzed using R software. The results showed that the throat was predominantly green-yellow, light yellow and yellow; green-yellow accounted for the largest proportion of sepals (67.76%) and petals (69.40%). The eye was more abundant, and there were significant differences between sepals and petals. The limb was clustered into five color groups (orange, yellow, pink, red and purple); the yellow group had the most varieties for both sepals and petals, containing 57.38% and 55.74%, respectively. Both sepals and petals had significant differences (p<0.0001) in color (LE), redness (a*) and color angle (h) for the throat, eye and limb. However, the difference in CIELab phenotypes between the eye and limb were not significant. According to "Dual Classification", the color classification standard was proposed as a 3-level standard. The color of sepal and petal consistency served as the first standard, and the color of limb was the second standard. The color pattern types of pure, gradual change, watermark and eye spot, served as the third standard. It has been proposed that all the 183 experimental varieties were divided into two categories, five groups and finally four types. This study provides a classification basis and reference for numeric and standardized color phenotype description for Hemerocallis.	[Cui, Huliang; Zhang, Yanan; Shi, Xiaolu; Gong, Feifei; Xiong, Xiong; Kang, Xiuping; Xing, Guoming; Li, Sen] Shanxi Agr Univ, Coll Hort, Taigu, Peoples R China; [Cui, Huliang; Zhang, Yanan; Shi, Xiaolu; Gong, Feifei; Xiong, Xiong; Kang, Xiuping; Xing, Guoming; Li, Sen] Facil Hort Enginering & Technol Ctr Shanxi Prov, Taigu, Peoples R China	Shanxi Agricultural University	Xing, GM; Li, S (corresponding author), Shanxi Agr Univ, Coll Hort, Taigu, Peoples R China.; Xing, GM; Li, S (corresponding author), Facil Hort Enginering & Technol Ctr Shanxi Prov, Taigu, Peoples R China.	xingguoming@163.com; saulisen@163.com			Research Fund for the Doctoral Program of Higher Education of China [20131403110005]; Shanxi Scholarship Council of China [2015-065]; Basic Theory Innovation Project of Shanxi Agricultural University [K4614144]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanxi Scholarship Council of China; Basic Theory Innovation Project of Shanxi Agricultural University	This work was supported by the Research Fund for the Doctoral Program of Higher Education of China (20131403110005 to GX), Shanxi Scholarship Council of China (2015-065 to SL), and Basic Theory Innovation Project of Shanxi Agricultural University (K4614144 to HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHS, 2017, ONL DAYL CULT DIS; Brugliera F, 1999, PLANT J, V19, P441, DOI 10.1046/j.1365-313X.1999.00539.x; Chen J., 1998, ACTA SEDIMENTOL SIN, V16, P5; Chen X. Q., 1997, ACTA PHYTOTAXONOMICA, V35, P311; Du E, 2005, J NW SCI TECHNOLOGY, V10, P85; Fernandes L, 2017, J FOOD COMPOS ANAL, V60, P38, DOI 10.1016/j.jfca.2017.03.017; Fu MR, 2009, FOOD CHEM, V114, P1192, DOI 10.1016/j.foodchem.2008.10.072; GONNET JF, 1993, J HORTIC SCI, V68, P499, DOI 10.1080/00221589.1993.11516378; Graca VC, 2016, IND CROP PROD, V87, P363, DOI 10.1016/j.indcrop.2016.04.058; Hong Yan, 2012, Acta Horticulturae Sinica, V39, P1330; Hsu YW, 2011, FOOD CHEM, V129, P1813, DOI 10.1016/j.foodchem.2011.05.116; Huang X., 2013, THESIS; Kong H., 2001, ACTA BOT BOREAL, V02, P373; Li S., 2016, J SHANXI AGR U, V09, P619, DOI [10.13842/j.cnki.issn1671-8151.2016.09.003, DOI 10.13842/J.CNKI.ISSN1671-8151.2016.09.003]; Liu W, 2017, FOOD RES INT, V102, P493, DOI 10.1016/j.foodres.2017.09.015; Nakatsuka T, 2006, MOL GENET GENOMICS, V275, P231, DOI 10.1007/s00438-005-0083-7; Rodriguez-Enriquez MJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls055; Saito H, 2003, SCI HORTIC-AMSTERDAM, V97, P185, DOI 10.1016/S0304-4238(02)00150-4; Stout A., 1941, HERBERTIA, P95; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tremblay RR, 2017, J PLANT PHYSIOL, V212, P1, DOI 10.1016/j.jplph.2017.01.006; Wang F, 2017, ACTA HORTICULTURAE S, V06, P1125; Wang X., 2014, HEMEROCALLIS, V1st Edn; Xiong Z.T., 1996, ACTA PHYTOTAXON SIN, V34, P586; Zhu H., 2008, THESIS	27	12	18	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216460	10.1371/journal.pone.0216460	http://dx.doi.org/10.1371/journal.pone.0216460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170177	Green Submitted, Green Published, gold			2022-12-26	WOS:000470263700005
J	Liu, QW; Li, H; You, LK; Li, T; Li, LL; Zhou, PK; Bo, XC; Chen, HB; Chen, XH; Hu, Y				Liu, Qiaowei; Li, Hao; You, Lukuan; Li, Tao; Li, Lingling; Zhou, Pingkun; Bo, Xiaochen; Chen, Hebing; Chen, Xiaohua; Hu, Yi			Genome-wide identification and analysis of A-to-I RNA editing events in the malignantly transformed cell lines from bronchial epithelial cell line induced by alpha-particles radiation	PLOS ONE			English	Article							ADENOSINE DEAMINASES; GENE AMPLIFICATION; READ ALIGNMENT; CANCER; SITES; PROMOTES; ADAR1; RADON	Adenosine (A) to inosine (I) RNA editing is the most prevalent RNA editing mechanism in humans and plays critical roles in tumorigenesis. However, the effects of radiation on RNA editing were poorly understood, and a deeper understanding of the radiation-induced cancer is imperative. Here, we analyzed BEP2D (a human bronchial epithelial cell line) and radiation-induced malignantly transformed cell lines with next generation sequencing. By performing an integrated analysis of A-to-I RNA editing, we found that single-nucleotide variants (SNVs) might induce the downregulation of ADAR2 enzymes, and further caused the abnormal occurrence of RNA editing in malignantly transformed cell lines. These editing events were significantly enriched in differentially expressed genes between normal cell line and malignantly transformed cell lines. In addition, oncogenes CTNNB1 and FN1 were highly edited and significantly overexpressed in malignantly transformed cell lines, thus may be responsible for the lung cancer progression. Our work provides a systematic analysis of RNA editing from cell lines derived from human bronchial epithelial cells with high-throughput RNA sequencing and DNA sequencing. Moreover, these results provide further evidence for RNA editing as an important tumorigenesis mechanism.	[Liu, Qiaowei; Li, Hao; You, Lukuan; Li, Tao; Li, Lingling; Hu, Yi] Chinese PLA, Med Sch, Beijing, Peoples R China; [Liu, Qiaowei; You, Lukuan; Li, Tao; Li, Lingling; Hu, Yi] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China; [Liu, Qiaowei; Zhou, Pingkun; Bo, Xiaochen; Chen, Hebing; Chen, Xiaohua] Beijing Inst Radiat Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China	Hu, Y (corresponding author), Chinese PLA, Med Sch, Beijing, Peoples R China.; Hu, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China.; Chen, HB; Chen, XH (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	chb-1012@163.com; chenxh0676@sina.com; huyi0401@aliyun.com	Zhou, Ping-Kun/AAF-3536-2019; Zhou, Ping-Kun/GSJ-3972-2022	Zhou, Ping-Kun/0000-0001-7666-1209; Chen, Hebing/0000-0003-4102-356X; Li, Tao/0000-0002-9038-4794	Innovation Project of People's Liberation Army [16CXZ042, AWS14C002]	Innovation Project of People's Liberation Army	This work was supported by the Innovation Project of People's Liberation Army no. 16CXZ042 to Yi Hu and the Logistics Research Project of People's Liberation Army grant no. AWS14C002 to Xiaohua Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anadon C, 2016, ONCOGENE, V35, P4407, DOI 10.1038/onc.2015.469; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Camero S, 2019, J CANCER RES CLIN, V145, P137, DOI 10.1007/s00432-018-2774-6; Chan THM, 2016, GASTROENTEROLOGY, V151, P637, DOI 10.1053/j.gastro.2016.06.043; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Choi JR, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e207; Choi JR, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0095-2; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ferri GM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061294; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Genovese G, 2012, CELL CYCLE, V11, P2206, DOI 10.4161/cc.20765; Gumireddy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10715; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; John D, 2017, BRIEF BIOINFORM, V18, P993, DOI 10.1093/bib/bbw087; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JC, 2016, MODERN PATHOL, V29, P1335, DOI 10.1038/modpathol.2016.137; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li HB, 2009, J BIOL CHEM, V284, P2012, DOI 10.1074/jbc.M805612200; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Lino AD, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.572; Liu CY, 2014, BIOMED REP, V2, P525, DOI 10.3892/br.2014.268; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Nath N, 2018, HEALTH PHYS, V115, P151, DOI 10.1097/HP.0000000000000880; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Piao CQ, 2001, RADIAT RES, V155, P263, DOI 10.1667/0033-7587(2001)155[0263:GAAMII]2.0.CO;2; Ramaswami G, 2016, METHODS, V107, P42, DOI 10.1016/j.ymeth.2016.05.011; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Reiko S, 2012, GASTROENTEROLOGY, V142, P572, DOI [10.1053/j.gastro.2011.11.041, DOI 10.1053/J.GASTRO.2011.11.041]; Samet JM, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S4; Schroeder MP, 2014, BIOINFORMATICS, V30, pI549, DOI 10.1093/bioinformatics/btu467; Sui JL, 2004, RADIAT ENVIRON BIOPH, V43, P257, DOI 10.1007/s00411-004-0268-1; Sui JL, 2002, B ACAD MILITARY MED, V2, P86; Sun JF, 2002, INT J RADIAT BIOL, V78, P773, DOI 10.1080/09553000210141441; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogeltanz-Holm N, 2018, J ENVIRON RADIOACTIV, V192, P26, DOI 10.1016/j.jenvrad.2018.05.017; Weaver DA, 1997, CARCINOGENESIS, V18, P1251, DOI 10.1093/carcin/18.6.1251; Weiske J, 2007, P NATL ACAD SCI USA, V104, P20344, DOI 10.1073/pnas.0703664105; WILLEY JC, 1991, CANCER RES, V51, P5370; Wu JJ, 2016, CARCINOGENESIS, V37, P511, DOI 10.1093/carcin/bgw029; Yang F, 2017, AGING-US, V9, P2316, DOI 10.18632/aging.101323; Zhan S, 2018, ONCOLOGIST; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]; Zhao YL, 2001, RADIAT RES, V155, P230, DOI 10.1667/0033-7587(2001)155[0230:MORINT]2.0.CO;2	53	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0213047	10.1371/journal.pone.0213047	http://dx.doi.org/10.1371/journal.pone.0213047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158229	gold, Green Published, Green Submitted			2022-12-26	WOS:000469915700001
J	Curry, AS; McPherson, DT; Barlow, AM; Pensa, NW; Reddy, MS; Bellis, SL				Curry, Andrew S.; McPherson, David T.; Barlow, Abby M.; Pensa, Nicholas W.; Reddy, Michael S.; Bellis, Susan L.			Addition of an oligoglutamate domain to bone morphogenic protein 2 confers binding to hydroxyapatite materials and induces osteoblastic signaling	PLOS ONE			English	Article							COLLAGEN-MIMETIC PEPTIDE; BIOACTIVE PEPTIDES; SERUM-PROTEINS; ILIAC CREST; GRAFT; RENATURATION; SUBSTITUTES; DELIVERY; CELLS; SITE	Nonautologous bone grafts have limited osteoinductive potential and thus there is substantial interest in reconstituting these graft materials with osteogenic factors such as bone morphogenic protein 2 (BMP2). However, one limitation of this approach is that BMP2 is typically weakly bound to the graft, which can lead to side effects associated with BMP2 dissemination. In the current study we added a hydroxyapatite (HA)-binding domain onto BMP2 to increase coupling to the graft surface. A sequence consisting of eight glutamate residues (E8) was inserted into the C-terminus of BMP2, and the recombinant protein (rBMP2-E8) was expressed in E. coli. Compared with rBMP2, rBMP2-E8 displayed markedly enhanced binding to HA disks and was better retained on the disks following exposure to vigorous wash steps. Furthermore, rBMP2-E8 was purified using a heparin column, and evaluated for its capacity to stimulate osteoblastic cell signaling. Treatment of SAOS2 cells with rBMP2-E8 induced SMAD 1/5 activation, confirming that the protein retains activity. Collectively these results suggest that the E8 domain serves as an effective tool for improving rBMP2 coupling to graft materials. The increased retention of rBMP2-E8 on the graft surface is expected to prolong BMP2' s osteoinductive activity within the graft site, while simultaneously reducing off-target effects.	[Curry, Andrew S.; Pensa, Nicholas W.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [McPherson, David T.; Barlow, Abby M.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Reddy, Michael S.] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94115 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.; Reddy, MS (corresponding author), Univ Calif San Francisco, Sch Dent, San Francisco, CA 94115 USA.	michael.reddy@ucsf.edu; bellis@uab.edu		Bellis, Susan/0000-0002-5071-527X	National Institutes of Health [R01 DE024670, NRSA F31 DE028164-01]; National Institutes of Health Dental Academic Research Training Program [T32 DE017607]; National Aeronautics and Space Administration (ASGC) [NNX15AJ18H]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024670, F31DE028164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Dental Academic Research Training Program; National Aeronautics and Space Administration (ASGC); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by National Institutes of Health grant R01 DE024670 (S.L.B., M.S.R.). Andrew Curry was supported by the National Institutes of Health Dental Academic Research Training Program T32 DE017607, and Nick Pensa was supported Predoctoral Fellowships from National Aeronautics and Space Administration (ASGC #NNX15AJ18H) and National Institutes of Health (NRSA F31 DE028164-01).	Bain JL, 2015, TISSUE ENG PT A, V21, P2426, DOI [10.1089/ten.TEA.2015.0160, 10.1089/ten.tea.2015.0160]; Bain JL, 2014, INT J ORAL MAX IMPL, V29, P1437, DOI 10.11607/jomi.3759; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Bhatt RA, 2012, HAND CLIN, V28, P457, DOI 10.1016/j.hcl.2012.08.001; Billings PC, 2018, J BIOL CHEM, V293, P14371, DOI 10.1074/jbc.RA118.003191; Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Chenard KE, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601549; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Culpepper BK, 2014, J BIOMED MATER RES A, V102, P1008, DOI 10.1002/jbm.a.34766; Culpepper BK, 2013, BIOMATERIALS, V34, P1506, DOI 10.1016/j.biomaterials.2012.10.046; Culpepper BK, 2010, BIOMATERIALS, V31, P9586, DOI 10.1016/j.biomaterials.2010.08.020; FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006; Fisher DM, 2013, CURR STEM CELL RES T, V8, P260; Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Grabowski G, 2013, J AM ACAD ORTHOP SUR, V21, P51, DOI 10.5435/JAAOS-21-01-51; Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x; Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053; Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338; James AW, 2016, TISSUE ENG PART B-RE, V22, P284, DOI [10.1089/ten.TEB.2015.0357, 10.1089/ten.teb.2015.0357]; Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R; Kim HS, 2017, MAX PLAST RECONSTR S, V39, DOI 10.1186/s40902-017-0138-9; Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114; Long SN, 2006, PROTEIN EXPRES PURIF, V46, P374, DOI 10.1016/j.pep.2005.09.025; Marino JT, 2010, ORTHOP CLIN N AM, V41, P15, DOI 10.1016/j.ocl.2009.08.003; Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; Pensa NW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213592; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Salem D, 2016, J PERIODONTOL, V87, P872, DOI 10.1902/jop.2016.150512; Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006; Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031; Shimer AL, 2009, INJURY, V40, P32; Tannoury CA, 2014, SPINE J, V14, P552, DOI 10.1016/j.spinee.2013.08.060; Vallejo LF, 2004, BIOTECHNOL BIOENG, V85, P601, DOI 10.1002/bit.10906; von Einem S, 2010, PROTEIN EXPRES PURIF, V73, P65, DOI 10.1016/j.pep.2010.03.009; Zhang YH, 2011, PROTEIN EXPRES PURIF, V75, P155, DOI 10.1016/j.pep.2010.07.014	47	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217766	10.1371/journal.pone.0217766	http://dx.doi.org/10.1371/journal.pone.0217766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150531	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100102
J	Allen, P; Calcagni, A; Robson, AG; Claridge, E				Allen, Piers; Calcagni, Antonio; Robson, Anthony G.; Claridge, Ela			Investigating the potential of Zernike polynomials to characterise spatial distribution of macular pigment	PLOS ONE			English	Article							OPTICAL-DENSITY MEASUREMENT; FUNDUS AUTOFLUORESCENCE; QUANTITATIVE-ANALYSIS; EYE DISEASE; AGE; DEGENERATION; CAROTENOIDS; ZEAXANTHIN; LUTEIN; REFLECTANCE	It has been postulated that particular patterns of macular pigment (MP) distribution may be associated with the risk for eye diseases such as age-related macular degeneration (AMD). This work investigates the potential of Zernike polynomials (ZP) to characterise the level and distribution of MP, and their suitability as a representation for analysis of the effects of age and AMD on MP patterns. As the case study, MP distribution maps computed using an experimental method based on fundus reflectance (MRIA) were obtained for ninety volunteers representing three groups: under-fifty without AMD, fifty and over without AMD, and fifty and over with AMD. ZP with 105 coefficients were fitted to the maps using least-squares optimisation and found to represent MP maps accurately (RMSE<10-1). One-way MANOVA analysis carried out on ZP representations showed that the three subject groups have significantly different means (Wilk's Lambda 0.125, p<0.0001). Linear discriminant analysis with leave-one-out scheme resulted in accuracy, sensitivity and specificity of classification according to, respectively, disease status regardless of age (81% all); disease status in the age-matched groups (87%, 88%, 86%); age irrespective of disease status (81%, 83%, 73%); and age for subjects without AMD (83%, 88%, 80%). Mean MP distributions computed from ZP coefficients for the three groups showed more elevated and more peaked MP for the healthy under-fifty group; more irregular and more elevated peripheral levels in over-fifty AMD group than in over-fifty non-AMD group; and moderate radial asymmetry in non-AMD over-50 group. The results suggest that ZP coefficients are capable of accurately representing MP in a way that captures certain spatial patterns of its distribution. Using the ZP representation MP maps could be classified according to both age and disease status with accuracy significantly greater than chance, with peak elevation, pattern irregularity and radial asymmetry identified as important features.	[Allen, Piers; Calcagni, Antonio; Claridge, Ela] Univ Birmingham, Sch Comp Sci, Birmingham, W Midlands, England; [Calcagni, Antonio] Aston Univ, Ophthalm Res Grp, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Calcagni, Antonio; Robson, Anthony G.] Moorfields Eye Hosp NHS Fdn Trust, Dept Electrophysiol, London, England; [Robson, Anthony G.] UCL, Inst Ophthalmol, London, England; [Allen, Piers] Univ Birmingham, Res & Training Ctr Phys Sci Hlth, Birmingham, W Midlands, England	University of Birmingham; Aston University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Birmingham	Claridge, E (corresponding author), Univ Birmingham, Sch Comp Sci, Birmingham, W Midlands, England.	e.claridge@cs.bham.ac.uk		Robson, Anthony/0000-0002-8391-6123; Calcagni, Antonio Salvatore Pio/0000-0002-1446-3546	Dunhill Medical Trust [R116/0509]; Paul & Yuanbi Ramsay Research Fund, University of Birmingham; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	Dunhill Medical Trust(Dunhill Medical Trust); Paul & Yuanbi Ramsay Research Fund, University of Birmingham; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	This work was supported by the Dunhill Medical Trust, grant number R116/0509, (http://dunhillmedical.org.uk) to EC, AC; Paul & Yuanbi Ramsay Research Fund, University of Birmingham to PA. AGR wishes to acknowledge support by the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge contributions that the following colleagues made to the development of the Multispectral Retinal Image Analysis technique and to image data collection: Professor Jonathan M Gibson, Dr Frank Eperjesi, Dr Hannah Bartlett ( Aston University, Birmingham, U.K.), Dr Iain B Styles and Dr Yuan Shen ( University of Birmingham, U.K.). Anthony G Robson wishes to acknowledge support by the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.	Ach T, 2014, INVEST OPHTH VIS SCI, V55, P4832, DOI 10.1167/iovs.14-14802; Agarwal A, 2012, GASS ATLAS MACULAR D; Alabboud I, 2007, EUR C BIOM OPT INT S; Alassane S, 2016, INVEST OPHTH VIS SCI, V57, P4469, DOI 10.1167/iovs.16-19958; ALM A, 1973, EXP EYE RES, V15, P15, DOI 10.1016/0014-4835(73)90185-1; Beatty S, 2008, INVEST OPHTH VIS SCI, V49, P843, DOI 10.1167/iovs.07-1276; Berendschot TT, 2005, EXP EYE RES, V81, P602, DOI 10.1016/j.exer.2005.03.019; Berendschot TTJM, 2004, ARCH BIOCHEM BIOPHYS, V430, P149, DOI 10.1016/j.abb.2004.04.029; Bernstein PS, 2012, INVEST OPHTH VIS SCI, V53, P6178, DOI 10.1167/iovs.12-10275; Bernstein PS, 2010, VISION RES, V50, P716, DOI 10.1016/j.visres.2009.10.014; Bernstein PS, 2004, ARCH BIOCHEM BIOPHYS, V430, P163, DOI 10.1016/j.abb.2004.07.004; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; Calcagni A, 2011, EYE, V25, P1562, DOI 10.1038/eye.2011.202; Chen SF, 2001, CURR EYE RES, V23, P422, DOI 10.1076/ceyr.23.6.422.6963; Chew EY, 2014, JAMA OPHTHALMOL, V132, P142, DOI 10.1001/jamaophthalmol.2013.7376; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Ciulla TA, 2001, OPHTHALMOLOGY, V108, P730, DOI 10.1016/S0161-6420(00)00655-2; Claridge E, 2003, LECT NOTES COMPUT SC, V2732, P306; Ctori I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169520; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Curran-Celentano J, 2001, AM J CLIN NUTR, V74, P796; Degli Esposti S, 2012, INVEST OPHTH VIS SCI, V53, P6568, DOI 10.1167/iovs.12-9756; Delori F, 2011, INVEST OPHTH VIS SCI, V52, P9379, DOI 10.1167/iovs.11-8319; Demirel S, 2014, GRAEF ARCH CLIN EXP, V252, P213, DOI 10.1007/s00417-013-2424-2; Dietzel M, 2011, INVEST OPHTH VIS SCI, V52, P8016, DOI 10.1167/iovs.11-7610; Dysli C, 2017, PROG RETIN EYE RES, V60, P120, DOI 10.1016/j.preteyeres.2017.06.005; Eandi CM, 2017, INVEST OPHTH VIS SCI, V58, P2284, DOI 10.1167/iovs.16-20510; Everdell NL, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478001; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hammond BR, 1996, VISION RES, V36, P2001, DOI 10.1016/0042-6989(95)00290-1; Hammond BR, 2002, INVEST OPHTH VIS SCI, V43, P47; Hammond BR, 1997, J OPT SOC AM A, V14, P1187, DOI 10.1364/JOSAA.14.001187; Howells O, 2011, GRAEF ARCH CLIN EXP, V249, P315, DOI 10.1007/s00417-010-1577-5; Jorgensen JB, 2006, INTRO OPTIMIZATION D; Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122; Lakshminarayanan V, 2011, J MOD OPTIC, V58, P545, DOI 10.1080/09500340.2011.554896; Landrum JT, 2004, ARCH BIOCHEM BIOPHYS, V430, P135, DOI 10.1016/j.abb.2004.07.008; Lima Veronica Castro, 2016, Int J Retina Vitreous, V2, P19; MacKay D. J. C., 1998, Neural Networks and Machine Learning. Proceedings, P133; Meyers KJ, 2014, INVEST OPHTH VIS SCI, V55, P587, DOI 10.1167/iovs.13-13216; Moreland J., 1982, COLOR DEFICIENCIES, V33, P61; Nolan JM, 2007, INVEST OPHTH VIS SCI, V48, P571, DOI 10.1167/iovs.06-0864; Obana A, 2014, GRAEF ARCH CLIN EXP, V252, P1221, DOI 10.1007/s00417-014-2574-x; Preece SJ, 2004, IEEE T PATTERN ANAL, V26, P913, DOI 10.1109/TPAMI.2004.36; Preece SJ, 2002, PHYS MED BIOL, V47, P2863, DOI 10.1088/0031-9155/47/16/303; Preece SJ, 2005, INT C MED IM COMP CO; Putnam CM, 2017, CLIN EXP OPTOM, V100, P333, DOI 10.1111/cxo.12500; Robson AG, 2003, VISION RES, V43, P1765, DOI 10.1016/S0042-6989(03)00280-3; Sauer L, 2018, INVEST OPHTH VIS SCI, V59, P3094, DOI 10.1167/iovs.18-23886; Seth R, 2004, DOC OPHTHALMOL, V108, P197, DOI 10.1007/s10633-004-5182-y; Sharifzadeh M, 2006, J OPT SOC AM A, V23, P2373, DOI 10.1364/JOSAA.23.002373; Shen Y, 2013, P MED IM UND AN 2013, V2013; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P660; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674; Styles IB, 2006, MED IMAGE ANAL, V10, P578, DOI 10.1016/j.media.2006.05.007; Thibos LN, 2002, J REFRACT SURG, V18, pS652; Trieschmann M, 2006, GRAEF ARCH CLIN EXP, V244, P1565, DOI 10.1007/s00417-006-0289-3; Trieschmann M, 2003, GRAEF ARCH CLIN EXP, V241, P1006, DOI 10.1007/s00417-003-0796-4; van de Kraats J, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398925; Van Der Veen RL, 2012, NEW DESKTOP INSTRUME; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; Wolf-Schnurrbusch UEK, 2007, INVEST OPHTH VIS SCI, V48, P3783, DOI 10.1167/iovs.06-1218; Wustemeyer H, 2002, GRAEF ARCH CLIN EXP, V240, P666, DOI 10.1007/s00417-002-0515-6; Wyant J. C., 1992, APPL OPTICS OPTICAL, V11, P28; You QS, 2016, RETINA-J RET VIT DIS, V36, P1381, DOI 10.1097/IAE.0000000000000893; Zeimer M, 2012, INVEST OPHTH VIS SCI, V53, P4852, DOI 10.1167/iovs.12-9713	68	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217265	10.1371/journal.pone.0217265	http://dx.doi.org/10.1371/journal.pone.0217265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125363	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000468865700026
J	Nagayach, A; Singh, A; De Blas, AL; Geller, AI				Nagayach, Aarti; Singh, Anshuman; De Blas, Angel L.; Geller, Alfred, I			Delivery of different genes into pre- and post-synaptic neocortical interneurons connected by GABAergic synapses	PLOS ONE			English	Article							LONG-TERM EXPRESSION; FREE HSV-1 VECTORS; VESICULAR GLUTAMATE TRANSPORTER-1; REGULATED SECRETORY PATHWAY; TYPE-1 PLASMID VECTORS; RAT POSTRHINAL CORTEX; PROTEIN-KINASE-C; GABA-A RECEPTOR; TYROSINE-HYDROXYLASE; FUNCTIONAL ARCHITECTURE	Local neocortical circuits play critical roles in information processing, including synaptic plasticity, circuit physiology, and learning, and GABAergic inhibitory interneurons have key roles in these circuits. Moreover, specific neurological disorders, including schizophrenia and autism, are associated with deficits in GABAergic transmission in these circuits. GABAergic synapses represent a small fraction of neocortical synapses, and are embedded in complex local circuits that contain many neuron and synapse types. Thus, it is challenging to study the physiological roles of GABAergic inhibitory interneurons and their synapses, and to develop treatments for the specific disorders caused by dysfunction at these GABAergic synapses. To these ends, we report a novel technology that can deliver different genes into pre- and post-synaptic neocortical interneurons connected by a GABAergic synapse: First, standard gene transfer into the presynaptic neurons delivers a synthetic peptide neurotransmitter, containing three domains, a dense core vesicle sorting domain, a GABA(A) receptor-binding domain, a single-chain variable fragment anti-GABA(A) beta 2 or beta 3, and the His tag. Second, upon release, this synthetic peptide neurotransmitter binds to GABA(A) receptors on the postsynaptic neurons. Third, as the synthetic peptide neurotransmitter contains the His tag, antibody-mediated, targeted gene transfer using anti-His tag antibodies is selective for these neurons. We established this technology by expressing the synthetic peptide neurotransmitter in GABAergic neurons in the middle layers of postrhinal cortex, and the delivering the postsynaptic vector into connected GABAergic neurons in the upper neocortical layers. Targeted gene transfer was 61% specific for the connected neurons, but untargeted gene transfer was only 21% specific for these neurons. This technology may support studies on the roles of GABAergic inhibitory interneurons in circuit physiology and learning, and support gene therapy treatments for specific disorders associated with deficits at GABAergic synapses.	[Nagayach, Aarti; Singh, Anshuman; Geller, Alfred, I] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Geller, Alfred, I] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA; [Singh, Anshuman] Univ Mississippi, Sch Med, Dept Neurobiol & Anat Sci, Jackson, MS USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Connecticut; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Mississippi	Geller, AI (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA.; Geller, AI (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA.	agelle@lsuhsc.edu	Nagayach, Aarti/AAC-2577-2022; Nagayach, Aarti/ABC-6486-2021	Nagayach, Aarti/0000-0002-3283-5788; Geller, Alfred I/0000-0001-6313-5250	NIH [NS086960]; Research to Prevent Blindness; Lions Eye Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Lions Eye Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grant NS086960 (AIG). Assistance from the Research to Prevent Blindness and the Lions Eye Foundation is gratefully acknowledged.	Agster KL, 2009, HIPPOCAMPUS, V19, P1159, DOI 10.1002/hipo.20578; Bergman I, 2003, VIROLOGY, V316, P337, DOI 10.1016/j.virol.2003.07.010; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Cao HY, 2011, BRAIN RES, V1415, P127, DOI 10.1016/j.brainres.2011.08.010; Cao HY, 2010, BRAIN RES, V1351, P1, DOI 10.1016/j.brainres.2010.06.045; COOL DR, 1994, BIOCHIMIE, V76, P265, DOI 10.1016/0300-9084(94)90156-2; COOL DR, 1995, J BIOL CHEM, V270, P8723, DOI 10.1074/jbc.270.15.8723; Courel M, 2008, J BIOL CHEM, V283, P11807, DOI 10.1074/jbc.M709832200; DEBLAS AL, 1988, J NEUROSCI, V8, P602; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dudai Y., 1989, NEUROBIOLOGY MEMORY; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; EWERT M, 1992, BRAIN RES, V569, P57, DOI 10.1016/0006-8993(92)90368-J; Feng L, 2014, NAT PROTOC, V9, P2425, DOI 10.1038/nprot.2014.166; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; Gao QS, 2007, BRAIN RES, V1130, P1, DOI 10.1016/j.brainres.2006.10.018; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Heller EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039572; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huston J. S., 1991, METHOD ENZYMOL, V203, P46; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Kameda H, 2008, NEUROSCI RES, V61, P79, DOI 10.1016/j.neures.2008.01.014; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kobayashi T, 2003, BBA-GENE STRUCT EXPR, V1628, P156, DOI 10.1016/S0167-4781(03)00138-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kubota Y, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00027; Le Magueresse C, 2013, NEURON, V77, P388, DOI 10.1016/j.neuron.2013.01.011; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Morizono K, 2005, CELL CYCLE, V4, P854, DOI 10.4161/cc.4.7.1789; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Morizono K, 2001, J VIROL, V75, P8016, DOI 10.1128/JVI.75.17.8016-8020.2001; Moskal JR, 2005, NEUROPHARMACOLOGY, V49, P1077, DOI 10.1016/j.neuropharm.2005.06.006; Moskal JR, 2001, CURR DRUG TARGETS, V2, P331, DOI 10.2174/1389450013348399; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Nagayach A, 2019, J MOL NEUROSCIENCE; Nagayach A, 2019, UNPUB; Nagayach A, 2019, BRAIN RES, V1712, P16, DOI 10.1016/j.brainres.2019.01.038; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Ohno K, 1997, NAT BIOTECHNOL, V15, P763, DOI 10.1038/nbt0897-763; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Rasmussen M, 2007, BRAIN RES, V1144, P19, DOI 10.1016/j.brainres.2007.01.125; Ried MU, 2002, J VIROL, V76, P4559, DOI 10.1128/JVI.76.9.4559-4566.2002; SMITH IL, 1992, VIROLOGY, V186, P74, DOI 10.1016/0042-6822(92)90062-T; Song S, 1998, J NEUROSCI, V18, P4119; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Sun M, 2004, HUM GENE THER, V15, P1177, DOI 10.1089/hum.2004.15.1177; Sun M, 1999, HUM GENE THER, V10, P2005, DOI 10.1089/10430349950017365; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tai CK, 2003, HUM GENE THER, V14, P789, DOI 10.1089/104303403765255174; VITORICA J, 1988, J NEUROSCI, V8, P615; Volpers C, 2003, J VIROL, V77, P2093, DOI 10.1128/JVI.77.3.2093-2104.2003; Wang XD, 2005, MOL BRAIN RES, V139, P88, DOI 10.1016/j.molbrainres.2005.05.029; Yang TZ, 2001, MOL BRAIN RES, V90, P1, DOI 10.1016/S0169-328X(01)00059-6; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang GR, 2005, J NEUROSCI, V25, P8468, DOI 10.1523/JNEUROSCI.2271-05.2005; Zhang GR, 2000, MOL BRAIN RES, V84, P17, DOI 10.1016/S0169-328X(00)00197-2; Zhang GR, 2012, HIPPOCAMPUS, V22, P2276, DOI 10.1002/hipo.22045; Zhang GR, 2012, BRAIN RES, V1473, P173, DOI 10.1016/j.brainres.2012.07.024; Zhang GR, 2012, BRAIN RES, V1436, P157, DOI 10.1016/j.brainres.2011.12.011; Zhang GR, 2010, BRAIN RES, V1361, P1, DOI 10.1016/j.brainres.2010.09.030; Zhang GR, 2010, P NATL ACAD SCI USA, V107, P14478, DOI 10.1073/pnas.0912950107	66	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217094	10.1371/journal.pone.0217094	http://dx.doi.org/10.1371/journal.pone.0217094			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125364	Green Published, Green Submitted, gold			2022-12-26	WOS:000468865700018
J	Li, YX; Wang, WZ; Chao, YL; Zhang, FX; Wang, C				Li, Yongxia; Wang, Wenzhe; Chao, Yuelin; Zhang, Fengxao; Wang, Cheng			CTRP13 attenuates vascular calcification by regulating Runx2	FASEB JOURNAL			English	Article						phenotypic switch; mRNA decay; vascular smooth muscle cells; chronic renal failure	MAMMALIAN TARGET; IN-VIVO; ADIPOKINES; DIFFERENTIATION; TRISTETRAPROLIN; INHIBITION; CONVERSION; PROTEINS; FAMILY; CELLS	Vascular calcification is strongly associated with increased cardiovascular mortality and morbidity. C1q/TNF-related protein-13 (CTRP13) is a secreted adipokine that plays important roles in the cardiovascular system. However, the functional role of CTRP13 in the development of vascular calcification has yet to be explored. In this study, we collected blood samples from patients with chronic renal failure (CRF) and from rats with adenine-induced CRF. We found that the serum CTRP13 levels were decreased in patients and rats with CRF and were negatively associated with calcium deposition in the abdominal aorta. Compared to those of the controls, ectopic CTRP13 treatment significantly attenuated the calcium accumulation and alkaline phosphatase activity in the abdominal aorta of CRF rats, and beta-glycerophosphate induced the formation of arterial rings and of vascular smooth muscle cells (VSMCs) and decreased the number of VSMCs that transitioned from a contractile to an osteogenic phenotype. The overexpression of Runx2 blocked CTRP13-reduced VSMC calcification. Mechanistically, CTRP13 repressed the phosphorylation of tristetraprolin (TTP), thereby activating TTP and increasing the TTP binding to the 3 ' untranslated region of the Runx2 mRNA, accelerating the Runx2 mRNA destabilization and degradation. In summary, these findings reveal that CTRP13 regulation is a novel method for the prevention of vascular calcification, representing a novel mechanism of the regulation of Runx2 expression in VSMCs.-Li, Y., Wang, W., Chao, Y., Zhang, F., Wang, C. CTRP13 attenuates vascular calcification by regulating Runx2.	[Li, Yongxia; Wang, Wenzhe; Zhang, Fengxao] Cent Hosp Wuhan, Dept Nephrol, Wuhan, Hubei, Peoples R China; [Wang, Cheng] Huazhong Univ Sci & Technol, Dept Rheumatol, Union Hosp, Tongji Med Coll, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China; [Chao, Yuelin] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Huazhong University of Science & Technology; Nanjing Medical University	Wang, C (corresponding author), Huazhong Univ Sci & Technol, Dept Rheumatol, Union Hosp, Tongji Med Coll, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China.	cwangunion@hust.edu.cn						Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Frasca D, 2007, J IMMUNOL, V179, P918, DOI 10.4049/jimmunol.179.2.918; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Knights AJ, 2014, ADIPOCYTE, V3, P88, DOI 10.4161/adip.27552; Leopold JA, 2015, TRENDS CARDIOVAS MED, V25, P267, DOI 10.1016/j.tcm.2014.10.021; Lu KC, 2014, SCI WORLD J, DOI 10.1155/2014/637065; Lu Y, 2015, INT J CLIN EXP PATHO, V8, P2545; Mancuso P, 2016, IMMUNOTARGETS THER, V5, P47, DOI 10.2147/ITT.S73223; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Nakamura K, 2014, J CARDIOL, V63, P250, DOI 10.1016/j.jjcc.2013.11.006; Palit S, 2014, CURR PHARM DESIGN, V20, P5829, DOI 10.2174/1381612820666140212194926; Paloian NJ, 2014, AM J PHYSIOL-RENAL, V307, pF891, DOI 10.1152/ajprenal.00163.2014; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Wang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09174-1; Wang C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1108-6; Wang C, 2019, FASEB J, V33, P2290, DOI 10.1096/fj.201801267RR; Wang C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0875-4; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Zeadin M, 2009, ARTERIOSCL THROM VAS, V29, P2069, DOI 10.1161/ATVBAHA.109.195255; Zhang J, 2014, BIOSCIENCE REP, V34, P663, DOI 10.1042/BSR20140103; Zhao GX, 2012, KIDNEY INT, V82, P34, DOI 10.1038/ki.2012.40; Zhao Y, 2015, KIDNEY INT, V88, P711, DOI 10.1038/ki.2015.160; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050; Zhou Y, 2014, ARTERIOSCL THROM VAS, V34, P1002, DOI 10.1161/ATVBAHA.114.303301	33	7	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9627	9637		10.1096/fj.201900293RRR	http://dx.doi.org/10.1096/fj.201900293RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145871	Bronze			2022-12-26	WOS:000478832900072
J	Gerlits, O; Kong, XT; Cheng, XL; Wymore, T; Blumenthal, DK; Taylor, P; Radic, Z; Kovalevsky, A				Gerlits, Oksana; Kong, Xiaotian; Cheng, Xiaolin; Wymore, Troy; Blumenthal, Donald K.; Taylor, Palmer; Radic, Zoran; Kovalevsky, Andrey			Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylcholinesterase (AChE); X-ray crystallography; molecular modeling; protein chemical modification; structure-function; oxime reactivator; reactivation mechanism; RS-170B; VX-inhibition	ORGANOPHOSPHOROUS NERVE AGENTS; CRYSTAL-STRUCTURES; NEUTRON CRYSTALLOGRAPHY; MOLECULAR-DYNAMICS; BASIS-SETS; COMPLEX; SITE; DESIGN; INTEGRATION; METABOLITES	Exposure to organophosphorus compounds (OPs) may be fatal if untreated, and a clear and present danger posed by nerve agent OPs has become palpable in recent years. OPs inactivate acetylcholinesterase (AChE) by covalently modifying its catalytic serine. Inhibited AChE cannot hydrolyze the neurotransmitter acetylcholine leading to its build-up at the cholinergic synapses and creating an acute cholinergic crisis. Current antidotes, including oxime reactivators that attack the OP-AChE conjugate to free the active enzyme, are inefficient. Better reactivators are sought, but their design is hampered by a conformationally rigid portrait of AChE extracted exclusively from 100K X-ray crystallography and scarcity of structural knowledge on human AChE (hAChE). Here, we present room temperature X-ray structures of native and VX-phosphonylated hAChE with an imidazole-based oxime reactivator, RS-170B. We discovered that inhibition with VX triggers substantial conformational changes in bound RS-170B from a nonproductive pose (the reactive aldoxime group points away from the VX-bound serine) in the reactivator-only complex to a semi-productive orientation in the VX-modified complex. This observation, supported by concurrent molecular simulations, suggested that the narrow active-site gorge of hAChE may be significantly more dynamic than previously thought, allowing RS-170B to reorient inside the gorge. Furthermore, we found that small molecules can bind in the choline-binding site hindering approach to the phosphorous of VX-bound serine. Our results provide structural and mechanistic perspectives on the reactivation of OP-inhibited hAChE and demonstrate that structural studies at physiologically relevant temperatures can deliver previously overlooked insights applicable for designing next-generation antidotes.	[Gerlits, Oksana] Univ Tennessee, Bredesen Ctr, Knoxville, TN 37996 USA; [Kong, Xiaotian; Cheng, Xiaolin] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Wymore, Troy] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Taylor, Palmer; Radic, Zoran] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kovalevsky, Andrey] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37831 USA	University of Tennessee System; University of Tennessee Knoxville; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; United States Department of Energy (DOE); Oak Ridge National Laboratory	Kovalevsky, A (corresponding author), Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN 37831 USA.	kovalevskyay@ornl.gov		Kovalevsky, Andrey/0000-0003-4459-9142; Blumenthal, Donald/0000-0002-8614-1167; Cheng, Xiaolin/0000-0002-7396-3225	United States DOE [DE-AC02-06CH11357]; Office of Biological and Environmental Research; Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS098998, U01NS083451] Funding Source: NIH RePORTER	United States DOE(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	X-ray crystallographic data presented here were collected at Argonne National Laboratory using Structural Biology Center (SBC) beamline ID19 at the Advanced Photon Source. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract number DE-AC02-06CH11357. The Office of Biological and Environmental Research supported research at the Center for Structural Molecular Biology (CSMB) at ORNL using facilities supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allgardsson A, 2016, P NATL ACAD SCI USA, V113, P5514, DOI 10.1073/pnas.1523362113; Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; Artursson E, 2013, BIOCHEM PHARMACOL, V85, P1389, DOI 10.1016/j.bcp.2013.01.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr JR, 2004, J ANAL TOXICOL, V28, P372, DOI 10.1093/jat/28.5.372; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bester SM, 2018, CHEM RES TOXICOL, V31, P1405, DOI 10.1021/acs.chemrestox.8b00294; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carletti E, 2010, J MED CHEM, V53, P4002, DOI 10.1021/jm901853b; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheung J, 2013, ACS MED CHEM LETT, V4, P1091, DOI 10.1021/ml400304w; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Clifford E. F., 2002, ACTA CRYSTALLOGR D, V58, P1765, DOI [10.1107/S0907444902011642, DOI 10.1107/S0907444902011642]; Cochran R, 2011, J BIOL CHEM, V286, P29718, DOI 10.1074/jbc.M111.264739; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; Dym O, 2016, PROTEIN SCI, V25, P1096, DOI 10.1002/pro.2923; Ekstrom F, 2006, BIOCHEMISTRY-US, V45, P74, DOI 10.1021/bi051286t; Ekstrom FJ, 2007, CLIN PHARMACOL THER, V82, P282, DOI 10.1038/sj.clpt.6100151; Ekstrom F, 2006, BIOCHEM PHARMACOL, V72, P597, DOI 10.1016/j.bcp.2006.05.027; Ekstrom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005957; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franklin MC, 2016, PROTEINS, V84, P1246, DOI 10.1002/prot.25073; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gerlits O, 2017, J MED CHEM, V60, P2018, DOI 10.1021/acs.jmedchem.6b01767; Gorecki L, 2016, ARCH TOXICOL, V90, P2831, DOI 10.1007/s00204-016-1827-3; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hornberg A, 2007, BIOCHEMISTRY-US, V46, P4815, DOI 10.1021/bi0621361; Huang GY, 2014, BIOCHEMISTRY-US, V53, P6725, DOI 10.1021/bi501012v; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Katalinic M, 2018, TOXICOLOGY, V406, P104, DOI 10.1016/j.tox.2018.05.008; Katalinic M, 2012, CROAT CHEM ACTA, V85, P209, DOI 10.5562/cca1815; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kovalevsky A, 2018, STRUCTURE, V26, P383, DOI 10.1016/j.str.2018.01.006; Kovalevsky A, 2016, ANN NY ACAD SCI, V1378, P41, DOI 10.1111/nyas.13128; Kovarik Z, 2015, CHEM RES TOXICOL, V28, P1036, DOI 10.1021/acs.chemrestox.5b00060; KREIMER DI, 1994, BIOCHEMISTRY-US, V33, P14407, DOI 10.1021/bi00252a006; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Legler PM, 2015, ACTA CRYSTALLOGR D, V71, P1788, DOI 10.1107/S1399004715011281; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Millard CB, 1999, J AM CHEM SOC, V121, P9883, DOI 10.1021/ja992704i; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Radic Z, 2010, CHEM-BIOL INTERACT, V187, P163, DOI 10.1016/j.cbi.2010.04.014; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanson B, 2009, J MED CHEM, V52, P7593, DOI 10.1021/jm900433t; Santoni G, 2018, J MED CHEM, V61, P7630, DOI 10.1021/acs.jmedchem.8b00592; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Sit RK, 2014, J MED CHEM, V57, P1378, DOI 10.1021/jm401650z; Solberg Y, 1997, TRENDS PHARMACOL SCI, V18, P183, DOI 10.1016/S0165-6147(97)89540-5; Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tsuchihashi H, 1998, J ANAL TOXICOL, V22, P383, DOI 10.1093/jat/22.5.383; Vandavasi VG, 2018, STRUCTURE, V26, P1645, DOI 10.1016/j.str.2018.08.001; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VELAN B, 1993, BIOCHEM J, V296, P649, DOI 10.1042/bj2960649; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wandhammer M, 2013, CHEM-BIOL INTERACT, V203, P19, DOI 10.1016/j.cbi.2012.08.005; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weber IT, 2013, J MED CHEM, V56, P5631, DOI 10.1021/jm400684f; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Worek F, 2002, ARCH TOXICOL, V76, P523, DOI 10.1007/s00204-002-0375-1; Yang YC, 1996, J ORG CHEM, V61, P8407, DOI 10.1021/jo9614506; Zorbaz T, 2018, CHEM-EUR J, V24, P9675, DOI 10.1002/chem.201801394	79	10	10	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10607	10618		10.1074/jbc.RA119.008725	http://dx.doi.org/10.1074/jbc.RA119.008725			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138650	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000478717100019
J	Yan, YY; Leontovich, AA; Gerdes, MJ; Desai, K; Dong, JH; Sood, A; Santamaria-Pang, A; Mansfield, AS; Chadwick, C; Zhang, R; Nevala, WK; Flotte, TJ; Ginty, F; Markovic, SN				Yan, Yiyi; Leontovich, Alexey A.; Gerdes, Michael J.; Desai, Keyur; Dong, Jinhong; Sood, Anup; Santamaria-Pang, Alberto; Mansfield, Aaron S.; Chadwick, Chrystal; Zhang, Rong; Nevala, Wendy K.; Flotte, Thomas J.; Ginty, Fiona; Markovic, Svetomir N.			Understanding heterogeneous tumor microenvironment in metastatic melanoma	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; EXOME ANALYSIS REVEALS; I ANTIGEN-EXPRESSION; MHC CLASS-I; HLA EXPRESSION; PD-1 BLOCKADE; IPILIMUMAB; CANCER; IMMUNOHISTOCHEMISTRY; DISEASE	A systemic analysis of the tumor-immune interactions within the heterogeneous tumor microenvironment is of particular importance for understanding the antitumor immune response. We used multiplexed immunofluorescence to elucidate cellular spatial interactions and T-cell infiltrations in metastatic melanoma tumor microenvironment. We developed two novel computational approaches that enable infiltration clustering and single cell analysis-cell aggregate algorithm and cell neighborhood analysis algorithm-to reveal and to compare the spatial distribution of various immune cells relative to tumor cell in sub-anatomic tumor microenvironment areas. We showed that the heterogeneous tumor human leukocyte antigen-1 expressions differently affect the magnitude of cytotoxic T-cell infiltration and the distributions of CD20+ B cells and CD4+ FOXP3+ regulatory T cells within and outside of T-cell infiltrated tumor areas. In a cohort of 166 stage III melanoma samples, high tumor human leukocyte antigen-1 expression is required but not sufficient for high T-cell infiltration, with significantly improved overall survival. Our results demonstrate that tumor cells with heterogeneous properties are associated with differential but predictable distributions of immune cells within heterogeneous tumor microenvironment with various biological features and impacts on clinical outcomes. It establishes tools necessary for systematic analysis of the tumor microenvironment, allowing the elucidation of the "homogeneous patterns" within the heterogeneous tumor microenvironment.	[Yan, Yiyi; Mansfield, Aaron S.; Markovic, Svetomir N.] Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA; [Leontovich, Alexey A.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Gerdes, Michael J.; Desai, Keyur; Sood, Anup; Santamaria-Pang, Alberto; Chadwick, Chrystal; Zhang, Rong; Ginty, Fiona] GE Global Res Ctr, Diagnost Imaging & Biomed Technol, Niskayuna, NY USA; [Dong, Jinhong] Mayo Clin, Clin Immunol & Immunotherapeut, Rochester, MN USA; [Nevala, Wendy K.] Mayo Clin, Div Hematol, Rochester, MN USA; [Flotte, Thomas J.] Mayo Clin, Div Anat Pathol, Rochester, MN USA; [Flotte, Thomas J.] Mayo Clin, Div Dermatopathol & Cutaneous Immunopathol, Rochester, MN USA; [Desai, Keyur] Bristol Myers Squibb, Translat Med, Pennington, NJ USA	Mayo Clinic; Mayo Clinic; General Electric; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Bristol-Myers Squibb	Markovic, SN (corresponding author), Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA.	markovic.svetomir@mayo.edu	Mansfield, Aaron/AAQ-8298-2021	Mansfield, Aaron/0000-0002-9483-6903; Ginty, Fiona/0000-0001-6638-683X	NIH [R01 CA174377]; NCI [K12 CA090628]; Mayo Clinic Fraternal Order of Eagles Cancer Research Fund; GE Global Research; NATIONAL CANCER INSTITUTE [K12CA090628, R01CA174377] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Fraternal Order of Eagles Cancer Research Fund; GE Global Research(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Author MJG was supported by NIH R01 CA174377, YY was supported by NCI K12 CA090628 and Mayo Clinic Fraternal Order of Eagles Cancer Research Fund awards during the period of this study. Authors MJG, KD, AS, AS-P, CC, RZ, FG were employees of GE Global Research during the period of this study. GE Global Research provided funds for the research activities. Other than the GE authors, neither GE Research or GE Healthcare played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A.RE, 2016, SPATIAL POINT PATTER, P829, DOI [10.1056/NEJMOA1604958, DOI 10.1056/NEJMOA1604958]; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Carretero R, 2012, INT J CANCER, V131, P387, DOI 10.1002/ijc.26471; Chew SF, 2007, TISSUE ANTIGENS, V69, P248, DOI 10.1111/j.1399-0039.2006.774_2.x; Concha A, 1991, Semin Cancer Biol, V2, P47; GARRIDO F, 1993, IMMUNOL TODAY, V14, P491, DOI 10.1016/0167-5699(93)90264-L; Gerdes MJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00366; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Illian J, 2008, STAT ANAL MODELLING; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Kageshita T, 1999, AM J PATHOL, V154, P745, DOI 10.1016/S0002-9440(10)65321-7; Kitamura H, 2006, CLIN CANCER RES, V12, P4641, DOI 10.1158/1078-0432.CCR-06-0595; Levenson RM, 2015, LAB INVEST, V95, P397, DOI 10.1038/labinvest.2015.2; LEVIN I, 1991, CANCER, V68, P2591, DOI 10.1002/1097-0142(19911215)68:12<2591::AID-CNCR2820681212>3.0.CO;2-L; Madjd Z, 2005, INT J CANCER, V117, P248, DOI 10.1002/ijc.21163; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McKinley ET, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93487; Mendez R, 2007, CANCER IMMUNOL IMMUN, V56, P88, DOI 10.1007/s00262-006-0166-2; Norell H, 2006, CANCER RES, V66, P6387, DOI 10.1158/0008-5472.CAN-06-0029; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087; Sabbatino F, 2016, CLIN CANCER RES, V22, P470, DOI 10.1158/1078-0432.CCR-15-0715; Santamaria-Pang A, 2017, 2017 IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL & HEALTH INFORMATICS (BHI), P121, DOI 10.1109/BHI.2017.7897220; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Shehata M, 2009, BRIT J CANCER, V101, P1321, DOI 10.1038/sj.bjc.6605315; Sood A, US patent, Patent No. [9176032B2, 9176032]; Sood A, US Patent, Patent No. [9,984,199, 9984199]; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Houdt IS, 2008, INT J CANCER, V123, P609, DOI 10.1002/ijc.23543; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Wiegand T., 2014, HDB SPATIAL POIN PAT; Xiao X, 2016, CANCER DISCOV, V6, P546, DOI 10.1158/2159-8290.CD-15-1408; Yamaguchi R, 2012, HUM PATHOL, V43, P1688, DOI 10.1016/j.humpath.2011.12.013; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	46	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216485	10.1371/journal.pone.0216485	http://dx.doi.org/10.1371/journal.pone.0216485			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166985	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800010
J	Almahmoud, K; Abboud, A; Namas, RA; Zamora, R; Sperry, J; Peitzman, AB; Truitt, MS; Gaski, GE; McKinley, TO; Billiar, TR; Vodovotz, Y				Almahmoud, Khalid; Abboud, Andrew; Namas, Rami A.; Zamora, Ruben; Sperry, Jason; Peitzman, Andrew B.; Truitt, Michael S.; Gaski, Greg E.; McKinley, Todd O.; Billiar, Timothy R.; Vodovotz, Yoram			Computational evidence for an early, amplified systemic inflammation program in polytrauma patients with severe extremity injuries	PLOS ONE			English	Article							EARLY TOTAL CARE; MULTIPLE TRAUMA PATIENTS; FEMORAL-SHAFT FRACTURES; BLUNT TRAUMA; OUTCOMES; FIXATION; MEDIATORS; IMPACT; MANAGEMENT; CYTOKINES	Extremity and soft tissue injuries contribute significantly to inflammation and adverse in-hospital outcomes for trauma survivors; accordingly, we examined the complex association between clinical outcomes inflammatory responses in this setting using in silico tools. Two stringently propensity-matched, moderately/severely injured (Injury Severity Score > 16) patient sub-cohorts of similar to 30 patients each were derived retrospectively from a cohort of 472 blunt trauma survivors and segregated based on their degree of extremity injury severity (above or below 3 on the Abbreviated Injury Scale). Serial blood samples were analyzed for 31 plasma inflammatory mediators. In addition to standard statistical analyses, Dynamic Network Analysis (DyNA) and Principal Component Analysis (PCA) were used to model systemic inflammation following trauma. Patients in the severe extremity injury sub-cohort experienced longer intensive care unit length of stay (LOS), total LOS, and days on a mechanical ventilator, with higher Marshall Multiple Organ Dysfunction (MOD) Scores over the first 7 days post-injury as compared to the mild/moderate extremity injury sub-cohort. The higher severity cohort had statistically significant elevated lactate, base deficit, and creatine phosphokinase on first blood draw, along with significant changes in multiple circulating inflammatory mediators. DyNA pointed to a sustained role for type 17 immunity in both sub-cohorts, along with IFN-gamma in the severe extremity injury group. DyNA network complexity increased over 7 days post-injury in the severe injury group, while generally decreasing over this same time period in the mild/moderate injury group. PCA suggested a more robust activation of multiple pathways in the severe extremity injury group as compared to the mild/moderate injury group. These studies thus point to the possibility of self-sustaining inflammation following severe extremity injury vs. resolving inflammation following less severe extremity injury.	[Almahmoud, Khalid; Abboud, Andrew; Namas, Rami A.; Zamora, Ruben; Sperry, Jason; Peitzman, Andrew B.; Billiar, Timothy R.; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Div Trauma & Crit Care Surg, Pittsburgh, PA 15260 USA; [Almahmoud, Khalid; Truitt, Michael S.] Methodist Dallas Hlth Syst, Dept Surg, Dept Grad Med Educ, Dallas, TX USA; [Namas, Rami A.; Zamora, Ruben; Billiar, Timothy R.; Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15260 USA; [Gaski, Greg E.; McKinley, Todd O.] Indiana Univ Sch Med, Dept Orthoped Surg, Indianapolis, IN 46202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington	Vodovotz, Y (corresponding author), Univ Pittsburgh, Dept Surg, Div Trauma & Crit Care Surg, Pittsburgh, PA 15260 USA.; Vodovotz, Y (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Namas, Rami/AAD-5793-2020; Namas, Rami/AAD-5796-2020; Namas, Rami/GZK-4999-2022	Namas, Rami/0000-0002-8582-5321; Namas, Rami/0000-0002-8582-5321; ALMAHMOUD, KHALID/0000-0001-9716-3778; Gaski, Greg/0000-0002-2795-4029; Abboud, Andrew/0000-0003-1527-1535	National Institutes of Health [P50-GM-53789]; Ruth L. Kirschstein National Research Service Award [T32-GM-008516-21]; Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program [W81XWH-18-2-0051, W81XWH-15-PRORP-OCRCA]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grant P50-GM-53789 as well as the Ruth L. Kirschstein National Research Service Award T32-GM-008516-21. This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Defense Medical Research and Development Program under Award No. W81XWH-18-2-0051 and W81XWH-15-PRORP-OCRCA. Opinions, interpretations, conclusions and recommendations are those of the authors and not necessarily endorsed by the Department of Defense.	Abboud A, 2016, CRIT CARE MED, V44, pE1074, DOI 10.1097/CCM.0000000000001951; Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Akkose S, 2007, ADV THER, V24, P955, DOI 10.1007/BF02877699; Almahmoud K, 2015, SHOCK, V44, P101, DOI 10.1097/SHK.0000000000000395; Almahmoud K, 2015, CRIT CARE MED, V43, P1395, DOI 10.1097/CCM.0000000000000964; Andreu-Ballester JC, 2014, INT IMMUNOPHARMACOL, V23, P73, DOI 10.1016/j.intimp.2014.08.015; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Billiar TR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002342; Brakenridge SC, 2018, J TRAUMA ACUTE CARE, V85, P247, DOI [10.1097/TA.0000000000001921, 10.1097/ta.0000000000001921]; BRENNEMAN FD, 1995, J TRAUMA, V39, P320, DOI 10.1097/00005373-199508000-00021; DAY RJ, 1994, MED J AUSTRALIA, V160, P675, DOI 10.5694/j.1326-5377.1994.tb125903.x; DeLong WG, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000130840.64528.1e; Efron PA, 2018, SURGERY, V164, P178, DOI 10.1016/j.surg.2018.04.011; ERTEL W, 1995, J TRAUMA, V39, P879, DOI 10.1097/00005373-199511000-00011; Faist E, 1996, WORLD J SURG, V20, P454, DOI 10.1007/s002689900071; Fulkerson EW, 2009, BULL HOSP JT DIS, V67, P58; Gaski GE, 2018, J ORTHOPAEDIC TRA S1, V2018, pS1; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Giannoudis PV, 2002, CLIN ORTHOP RELAT R, P378, DOI 10.1097/01.blo.00000236813.17269.24; Glance LG, 2009, ARCH SURG-CHICAGO, V144, P326, DOI 10.1001/archsurg.2009.8; Harwood PJ, 2005, J TRAUMA, V58, P446, DOI 10.1097/01.TA.0000153942.28015.77; Hildebrand F, 2005, UNFALLCHIRURG, V108, P793, DOI 10.1007/s00113-005-1005-1; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Horst K, 2016, EUR J TRAUMA EMERG S, V42, P67, DOI 10.1007/s00068-015-0504-1; Huang L, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1193, DOI 10.1134/S0006297917100121; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jawa Randeep S, 2011, J Intensive Care Med, V26, P73, DOI 10.1177/0885066610395679; Katsoulis E, 2006, INJURY, V37, P1133, DOI 10.1016/j.injury.2006.07.017; Lamparello AJ, 2019, J AM COLL SURGEONS, V228, P148, DOI 10.1016/j.jamcollsurg.2018.10.019; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Marshall JC, 1995, CRITICAL CARE MED, V23; McKinley TO, 2018, J ORTHOP TRAUMA, V32, pS1, DOI 10.1097/BOT.0000000000001114; Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Nacionales DC, 2015, J IMMUNOL, V195, P2396, DOI 10.4049/jimmunol.1500984; Namas RA, 2015, ANTIOXID REDOX SIGN, V23, P1370, DOI 10.1089/ars.2015.6398; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Pape HC, 2007, INJURY, V38, P1358, DOI 10.1016/j.injury.2007.09.026; Pape Hans-Christoph, 2005, J Orthop Trauma, V19, P551, DOI 10.1097/01.bot.0000161712.87129.80; Pape HC, 2009, J AM ACAD ORTHOP SUR, V17, P541, DOI 10.5435/00124635-200909000-00001; PAPE HC, 1993, J TRAUMA, V34, P540, DOI 10.1097/00005373-199304000-00010; PAPE HC, 1993, J TRAUMA, V35, P709, DOI 10.1097/00005373-199311000-00010; Pape HC, 2002, J TRAUMA, V53, P452, DOI 10.1097/00005373-200209000-00010; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; Pfeifer R, 2011, PATIENT SAF SURG, V5, DOI 10.1186/1754-9493-5-9; Rose S, 1998, LANGENBECK ARCH SURG, V383, P199, DOI 10.1007/s004230050119; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Tuttle MS, 2009, J TRAUMA, V67, P602, DOI 10.1097/TA.0b013e3181aa21c0; Vallier HA, 2013, J ORTHOP TRAUMA, V27, P543, DOI 10.1097/BOT.0b013e31829efda1; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Vodovotz, 2014, TRANSLATIONAL SYSTEM; Wardle TD, 1999, BRIT MED BULL, V55, P744, DOI 10.1258/0007142991902754; Zaaqoq AM, 2014, CRIT CARE MED, V42, P1487, DOI 10.1097/CCM.0000000000000248; Ziraldo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079804	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217577	10.1371/journal.pone.0217577	http://dx.doi.org/10.1371/journal.pone.0217577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163056	Green Published, Green Submitted, gold			2022-12-26	WOS:000470086200020
J	Tagne, AST; Takembo, CN; Ben-Bolie, HG; Ateba, PO				Tagne, A. S. Tankou; Takembo, C. N.; Ben-Bolie, H. G.; Ateba, P. Owona			Localized nonlinear excitations in diffusive memristor-based neuronal networks	PLOS ONE			English	Article							ELECTRICAL-ACTIVITY; BACKLUND TRANSFORMATION; MODEL	We extend the existing ordinary differential equations modeling neural electrical activity to include the memory effect of electromagnetic induction through magnetic flux, used to describe time varying electromagnetic field. Through the multi-scale expansion in the semi-discrete approximation, we show that the neural network dynamical equations can be governed by the complex Ginzburg-Landau equation. The analytical and numerical envelop soliton of this equation are reported. The results obtained suggest the possibility of collective information processing and sharing in the nervous system, operating in both the spatial and temporal domains in the form of localized modulated waves. The effects of memristive synaptic electromagnetic induction coupling and perturbation on the modulated action potential dynamics examined. Large electromagnetic induction coupling strength may contribute to signal block as the amplitude of modulated waves are observed to decrease. This could help in the development of a chemical brain anaesthesia for some brain pathologies.	[Tagne, A. S. Tankou; Ben-Bolie, H. G.; Ateba, P. Owona] Univ Yaounde I, Dept Phys, Nucl Phys Lab, Fac Sci, Yaounde, Cameroon; [Takembo, C. N.] Univ Yaounde I, Dept Phys, Biophys Lab, Fac Sci, Yaounde, Cameroon	University of Yaounde I; University of Yaounde I	Takembo, CN (corresponding author), Univ Yaounde I, Dept Phys, Biophys Lab, Fac Sci, Yaounde, Cameroon.	takembontahkie@yahoo.com	Takembo, Clovis/AAM-3288-2020					Villacorta-Atienza JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057440; Bao H, 2019, NONLINEAR DYNAM, V95, P43, DOI 10.1007/s11071-018-4549-7; Brunak S, 1990, NEURAL NETWORKS COMP; Coobes S, 2005, PHYS REV LETT, V94, DOI [10.1103/PhysRevLett.94.148102, DOI 10.1103/PHYSREVLETT.94.148102]; Dauxois T, 2006, PHYS SOLITONS; Ermakova EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004454; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gao LN, 2017, NONLINEAR DYNAM, V89, P2233, DOI 10.1007/s11071-017-3581-3; Gu HG, 2015, NONLINEAR DYNAM, V82, P1191, DOI 10.1007/s11071-015-2226-7; Hasegawa A., 1989, SPRINGER TRACT MODER, V116; HINDMARSH JL, 1982, NATURE, V296, P162, DOI 10.1038/296162a0; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Kilpatrick ZP, 2010, PHYSICA D, V239, P547, DOI 10.1016/j.physd.2009.06.003; Lu JQ, 2018, NONLINEAR DYNAM, V91, P1669, DOI 10.1007/s11071-017-3972-5; Lu X, 2016, COMMUN NONLINEAR SCI, V32, P241, DOI 10.1016/j.cnsns.2015.08.008; Lu X, 2016, COMMUN NONLINEAR SCI, V31, P40, DOI 10.1016/j.cnsns.2015.07.007; Lu X, 2015, APPL MATH LETT, V50, P37, DOI 10.1016/j.aml.2015.06.003; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Ma J, 2017, PHYSICA A, V486, P508, DOI 10.1016/j.physa.2017.05.075; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Mvogo A, 2017, PHYS LETT A, V381, P2264, DOI 10.1016/j.physleta.2017.05.020; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Novacek M., 2011, SIMULATION NEURAL IM; Qian Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12333-3; Qu LH, 2018, CHINESE PHYS B, V27, DOI 10.1088/1674-1056/27/11/118707; REMOISSENET M, 1986, PHYS REV B, V33, P2386, DOI 10.1103/PhysRevB.33.2386; ROSE RM, 1989, PROC R SOC SER B-BIO, V237, P267, DOI 10.1098/rspb.1989.0049; Shneider MN, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052713; Stefanescu RA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000219; Takembo CN, 2019, NONLINEAR DYNAM, V96, P1083, DOI 10.1007/s11071-019-04841-w; Takembo CN, 2018, INT J MOD PHYS B, V32, DOI 10.1142/S0217979218501655; Takembo CN, 2018, NONLINEAR DYN; Tchawoua C., 1992, THESIS U YAOUNDE 1; Wu FQ, 2016, SCI REP-UK, V6, DOI 10.1038/s41598-016-0031-2; Xu Y, 2018, NEUROCOMPUTING, V283, P196, DOI 10.1016/j.neucom.2017.12.036; Xu Y, 2017, CHAOS SOLITON FRACT, V104, P435, DOI 10.1016/j.chaos.2017.09.002; Yin YH, 2018, COMPUT MATH APPL, V76, P1275, DOI 10.1016/j.camwa.2018.06.020; Zhang G, 2018, CHAOS SOLITON FRACT, V108, P15, DOI 10.1016/j.chaos.2018.01.017; Zhu JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175039	42	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0214989	10.1371/journal.pone.0214989	http://dx.doi.org/10.1371/journal.pone.0214989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163037	Green Published, Green Submitted, gold			2022-12-26	WOS:000470086200003
J	Venugopala, KN; Chandrashekharappa, S; Pillay, M; Abdallah, HH; Mahomoodally, FM; Bhandary, S; Chopra, D; Attimarad, M; Aldhubiab, BE; Nair, AB; Sreeharsha, N; Morsy, MA; Pottathil, S; Venugopala, R; Odhav, B; Mlisana, K				Venugopala, Katharigatta Narayanaswamy; Chandrashekharappa, Sandeep; Pillay, Melendhran; Abdallah, Hassan H.; Mahomoodally, Fawzi M.; Bhandary, Subhrajyoti; Chopra, Deepak; Attimarad, Mahesh; Aldhubiab, Bandar E.; Nair, Anroop B.; Sreeharsha, Nagaraja; Morsy, Mohamed A.; Pottathil, Shinu; Venugopala, Rashmi; Odhav, Bharti; Mlisana, Koleka			Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; INDOLIZINE ANALOGS; INHIBITORS; DESIGN; RISK	Indolizines are heteroaromatic compounds, and their synthetic analogues have reportedly showed promising pharmacological properties. In this study, a series of synthetic 7-methoxy-indolizine derivatives were synthesised, characterised and evaluated for in vitro whole-cell anti-tuberculosis (TB) screening against susceptible (H37Rv) and multi-drug-resistant (MDR) strains of Mycobacterium tuberculosis (MTB) using the resazurin microplate assay method. The cytotoxicity was evaluated using the MTT assay. In silico molecular-docking study was conducted for compounds 5a-j against enoyl-[acyl-carrier] protein reductase, a key enzyme of the type II fatty acid synthesis that has attracted much interest for the development of novel anti-TB compounds. Thereafter, molecular dynamic (MD) simulation was undertaken for the most active inhibitors. Compounds 5i and 5j with the methoxy functional group at the meta position of the benzoyl group, which was at the third position of the indolizine nucleus, demonstrated encouraging anti-TB activity against MDR strains of MTB at 16 mu g/mL. In silico studies showed binding affinity within the range of 7.07-8.57 kcal/mol, with 5i showing the highest binding affinity. Hydrogen bonding, pi-pi- interactions, and electrostatic interactions were common with the active site. Most of these interactions occurred with the catalytic amino acids (Pro193, Tyr158, Phe149, and Lys165). MD simulation showed that 5j possessed the highest binding affinity toward the enzyme, according to the two calculation methods (MM/PBSA and MM/GBSA). The single-crystal X-ray studies of compounds 5c and 5d revealed that the molecular arrangements in these two structures were mostly guided by C-H center dot center dot center dot O hydrogen-bonded dimeric motifs and C-H center dot center dot center dot N hydrogen bonds, while various secondary interactions ( such as pi center dot center dot center dot pi and C-H center dot center dot center dot F) also contributed to crystal formation. Compounds 5a, 5c, 5i, and 5j exhibited no toxicity up to 500 mu g/mL. In conclusion, 5i and 5j are promising anti-TB compounds that have shown high affinity based on docking and MD simulation results.	[Venugopala, Katharigatta Narayanaswamy; Attimarad, Mahesh; Aldhubiab, Bandar E.; Nair, Anroop B.; Sreeharsha, Nagaraja; Morsy, Mohamed A.] King Faisal Univ, Dept Pharmaceut Sci, Coll Clin Pharm, Al Hasa, Saudi Arabia; [Venugopala, Katharigatta Narayanaswamy; Odhav, Bharti] Durban Univ Technol, Dept Biotechnol & Food Technol, Durban, South Africa; [Chandrashekharappa, Sandeep] GKVK, Inst Stem Cell Biol & Regenerat Med, NCBS, TIFR, Bangalore, Karnataka, India; [Pillay, Melendhran; Mlisana, Koleka] Inkosi Albert Luthuli Cent Hosp, Dept Microbiol, Natl Hlth Lab Serv, KZN Acad Complex, Durban, South Africa; [Abdallah, Hassan H.] Univ Sains Malaysia, Sch Pharm, Nibong Tebal, Penang, Malaysia; [Abdallah, Hassan H.] Salahaddin Univ, Dept Chem, Coll Educ, Erbil, Iraq; [Mahomoodally, Fawzi M.] Univ Mauritius, Dept Hlth Sci, Fac Sci, Reduit, Mauritius; [Bhandary, Subhrajyoti; Chopra, Deepak] Indian Inst Sci Educ & Res Bhopal, Dept Chem, Bhopal, Madhya Pradesh, India; [Morsy, Mohamed A.] Menia Univ, Dept Pharmacol, Fac Med, El Minia, Egypt; [Pottathil, Shinu] King Faisal Univ, Dept Biomed Sci, Coll Clin Pharm, Al Hasa, Saudi Arabia; [Venugopala, Rashmi] Univ KwaZulu Natal, Dept Publ Hlth Med, Howard Coll Campus, Durban, South Africa	King Faisal University; Durban University of Technology; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Universiti Sains Malaysia; Salahaddin University; University of Mauritius; Indian Institute of Science Education & Research (IISER) - Bhopal; Egyptian Knowledge Bank (EKB); Minia University; King Faisal University; University of Kwazulu Natal	Venugopala, KN (corresponding author), King Faisal Univ, Dept Pharmaceut Sci, Coll Clin Pharm, Al Hasa, Saudi Arabia.; Venugopala, KN (corresponding author), Durban Univ Technol, Dept Biotechnol & Food Technol, Durban, South Africa.	kvenugopala@kfu.edu.sa	Chandrashekharappa, Dr. Sandeep/V-8205-2018; Venugopala, Rashmi/AAF-2133-2021; Venugopala, Katharigatta N./M-4030-2016; Abdallah, Hassan H./AEE-4715-2022; Attimarad, Mahesh V/M-4095-2016; Sreeharsha, Nagaraja/P-2189-2019; Nair, Anroop/L-9995-2014; Pottathil, Shinu/AAN-9842-2020; Attimarad, Mahesh/U-9547-2019; Morsy, Mohamed/G-4809-2010; Mlisana, Koleka/N-6204-2013	Chandrashekharappa, Dr. Sandeep/0000-0003-2475-7270; Venugopala, Rashmi/0000-0002-1101-4577; Venugopala, Katharigatta N./0000-0003-0680-1549; Abdallah, Hassan H./0000-0002-9198-0475; Attimarad, Mahesh V/0000-0002-7007-9119; Sreeharsha, Nagaraja/0000-0002-2058-255X; Nair, Anroop/0000-0003-2850-8669; Pottathil, Shinu/0000-0003-4245-0803; Attimarad, Mahesh/0000-0002-7007-9119; Morsy, Mohamed/0000-0002-6752-9094; Mlisana, Koleka/0000-0002-8436-3268	Deanship of Scientific Research, King Faisal University, Kingdom of Saudi Arabia [17122011]	Deanship of Scientific Research, King Faisal University, Kingdom of Saudi Arabia	The authors are grateful to the Deanship of Scientific Research, King Faisal University, Kingdom of Saudi Arabia, for providing financial support (grant number: 17122011).	Baker MA, 2012, CLIN INFECT DIS, V54, P818, DOI 10.1093/cid/cir939; Barry CE, 2015, NAT MED, V21, P211, DOI 10.1038/nm.3823; Bruker Analytical X-ray Systems Inc, 2006, APEX2 VERS 2 US MAN; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Case D., 2015, AMBER, V14; Chandrashekharappa S, 2018, NEW J CHEM, V42, P4893, DOI 10.1039/c7nj05010k; Chandrashekharappa S, 2018, J MOL STRUCT, V1156, P377, DOI 10.1016/j.molstruc.2017.11.131; CINGOLANI GM, 1990, EUR J MED CHEM, V25, P709, DOI 10.1016/0223-5234(90)90138-S; Cox E, 2014, NEW ENGL J MED, V371, P689, DOI 10.1056/NEJMp1314385; DANNHARDT G, 1987, EUR J MED CHEM, V22, P505, DOI 10.1016/0223-5234(87)90290-X; Farrugia L.J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI [DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020, 10.1107/S0021889812029111]; Frisch G. W., 2013, GAUSSIAN 09; Hagishita S, 1996, J MED CHEM, V39, P3636, DOI 10.1021/jm960395q; Hazra A, 2011, EUR J MED CHEM, V46, P2132, DOI 10.1016/j.ejmech.2011.02.066; Hu Y, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4563826; Jaisankar P, 2003, ARKIVOC, P150, DOI 10.3998/ark.5550190.0004.918; Khedr MA, 2018, J BIOMOL STRUCT DYN, V36, P2163, DOI 10.1080/07391102.2017.1345325; Ling LL, 2004, ANTIMICROB AGENTS CH, V48, P1541, DOI 10.1128/AAC.48.5.1541-1547.2004; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Martin A, 2005, INT J TUBERC LUNG D, V9, P901; Mederski W., 2012, U.S. Patent, Patent No. [8(106,067 B2), 8106067, 8106067-B2]; MIDDLEBROOK G, 1977, AM REV RESPIR DIS, V115, P1066; Mishra B. B., 2011, OPPORTUNITY CHALLENG, P1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Narayanaswamy VK, 2013, CHEM BIOL DRUG DES, V81, P219, DOI 10.1111/cbdd.12065; Narayanaswamy VK, 2011, J PEPT SCI, V17, P683, DOI 10.1002/psc.1389; Nasir AI, 1998, BIOORG MED CHEM LETT, V8, P1829, DOI 10.1016/S0960-894X(98)00313-8; Olejnikova P., 2009, SCI PHARM, V77, P216, DOI [DOI 10.3797/scipharm.oephg.21.PO-17, 10.3797/scipharm.oephg.21.PO-17, DOI 10.3797/SCIPHARM.OEPHG.21.PO-17]; Onodera Y, 2001, J ANTIMICROB CHEMOTH, V47, P447, DOI 10.1093/jac/47.4.447; Parida SK, 2015, J INTERN MED, V277, P388, DOI 10.1111/joim.12264; Sandeep C., 2016, J BASIC CLIN PHARM, V8, P49; Sandeep C., 2016, ASIAN J CHEM, V28, P1043, DOI [10.14233/ajchem.2016.19582, DOI 10.14233/AJCHEM.2016.19582]; Sandeep C, 2017, INDIAN J PHARM EDUC, V51, P452, DOI 10.5530/ijper.51.3.73; Sandeep C, 2016, CHEM BIOL DRUG DES, V88, P899, DOI 10.1111/cbdd.12823; Sheldrick G.M., 2014, SADABS; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Siemens, 1995, SMART SYST; Smith SC, 2005, PEST MANAG SCI, V61, P16, DOI 10.1002/ps.980; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; VAUGHT JL, 1990, J PHARMACOL EXP THER, V255, P1; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Venugopala KN, 2019, MED CHEM, V15, P311, DOI 10.2174/1573406414666180703121815; Venugopala KN, 2016, DRUG DES DEV THER, V10, P2681, DOI 10.2147/DDDT.S109760; WHO, 2018, EX SUMM; WHO, 2017, EX SUMM; Zhang R, 2017, RSC ADV, V7, P1480, DOI 10.1039/c6ra25712g	47	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217270	10.1371/journal.pone.0217270	http://dx.doi.org/10.1371/journal.pone.0217270			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163040	Green Submitted, Green Published, gold			2022-12-26	WOS:000470086200010
J	Sileo, KM; Kizito, W; Wanyenze, RK; Chemusto, H; Reed, E; Stockman, JK; Musoke, W; Mukasa, B; Kiene, SM				Sileo, Katelyn M.; Kizito, Williams; Wanyenze, Rhoda K.; Chemusto, Harriet; Reed, Elizabeth; Stockman, Jamila K.; Musoke, William; Mukasa, Barbara; Kiene, Susan M.			Substance use and its effect on antiretroviral treatment adherence among male fisherfolk living with HIV/AIDS in Uganda	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ALCOHOL-CONSUMPTION; FISHING COMMUNITIES; SOUTH-AFRICA; LAKE VICTORIA; HIV CARE; THERAPY; RISK; INTERVENTION; NONADHERENCE	Background Fisherfolk are a most-at-risk population for HIV being prioritized for the scale up of HIV treatment in Uganda. Heavy alcohol use and potential drug use may be a major barrier to treatment adherence for men in this setting. Objective This study examines the prevalence of substance use, and its influence on antiretroviral treatment (ART) adherence, among male fisherfolk on ART in Wakiso District, Uganda. Methods This cross-sectional study included structured questionnaires (N = 300) with men attending HIV clinics near Lake Victoria. Using generalized logistic modeling analyses with a binomial distribution and logit link, we conducted multivariate models to test the association between each alcohol variable (quantity and frequency index, hazardous drinking) and missed pills, adjusting for covariates, and tested for interactions between number of pills prescribed and alcohol variables. Results Thirty-one percent of men reported sub-optimal adherence. Half (46.7%) reported drinking, of which 64.8% met criteria for hazardous drinking. Illicit drug use was low (6%). In the multivariate model, men with greater scores on the alcohol frequency and quantity index were more likely to report missed pills compared to those reporting no drinking (AOR: 1.60, 95% CI: 1.29-1.97). Hazardous drinking had a greater effect on missed ARV doses among men taking twice daily regimens compared to once daily (AOR: 4.91, 95% CI: 1.68-14.37). Conclusions Our findings highlight the need for targeted alcohol-reduction interventions for male fisherfolk on ART who drink at high quantities to improve ART adherence and to prevent the known negative health effects of alcohol for HIV-infected individuals.	[Sileo, Katelyn M.; Reed, Elizabeth; Kiene, Susan M.] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA; [Kizito, Williams; Chemusto, Harriet; Musoke, William; Mukasa, Barbara] Mildmay Uganda, Kampala, Uganda; [Wanyenze, Rhoda K.] Makerere Univ, Makerere Sch Publ Hlth, Kampala, Uganda; [Stockman, Jamila K.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Sileo, Katelyn M.] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT 06510 USA	California State University System; San Diego State University; Makerere University; University of California System; University of California San Diego; Yale University	Sileo, KM (corresponding author), San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA.; Sileo, KM (corresponding author), Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT 06510 USA.	katelyn.sileo@gmail.com	Stockman, Jamila/AAK-8960-2020	Kiene, Susan/0000-0001-8922-5289	National Institute of Health Fogarty International Center [NIH/FIC 5R25TW009343-05]; University of California Global Health Institute [NIH/FIC 5R25TW009343-05]; T32 Predoctoral Fellowship Award on Substance Abuse, HIV, and Related Infections from the National Institute of Drug Abuse [T32 DA023356]; FOGARTY INTERNATIONAL CENTER [D43TW009343, R25TW009343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA023356] Funding Source: NIH RePORTER	National Institute of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of California Global Health Institute; T32 Predoctoral Fellowship Award on Substance Abuse, HIV, and Related Infections from the National Institute of Drug Abuse; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The GloCal Health Fellowship from the National Institute of Health Fogarty International Center and the University of California Global Health Institute awarded to Katelyn Sileo supported this study (NIH/FIC 5R25TW009343-05). Katelyn Sileo was also supported by a T32 Predoctoral Fellowship Award on Substance Abuse, HIV, and Related Infections from the National Institute of Drug Abuse T32 DA023356.	Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Beckham SW, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21106; Bogart LM, 2016, AIDS BEHAV, V20, P2464, DOI 10.1007/s10461-016-1331-z; Braithwaite RS, 2008, ALCOHOL CLIN EXP RES, V32, P1645, DOI 10.1111/j.1530-0277.2008.00732.x; Braithwaite RS, 2010, ALCOHOL RES HEALTH, V33, P280; Carney T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008969.pub3; Chang L. W., 2016, LANCET, V3, P8; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; Hahn JA, 2016, ADDICTION, V111, P272, DOI 10.1111/add.13173; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Howell D.C., 1998, STAT METHODS HUMAN S; Jenkins RA, 2018, AIDS EDUC PREV, V30, P225, DOI 10.1521/aeap.2018.30.3.225; Kader R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125088; Kahler CW, 2017, AIDS BEHAV, V21, P1825, DOI 10.1007/s10461-016-1474-y; Kaner E, 2007, COCHRANE DATABASE SY, V2; Kiwanuka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171200; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; L'Engle KL, 2014, JAIDS-J ACQ IMM DEF, V67, P446, DOI 10.1097/QAI.0000000000000335; Mertens JR, 2014, ALCOHOL ALCOHOLISM, V49, P430, DOI 10.1093/alcalc/agu030; NIDA, NIDA MOD ASSIST V2 0; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parsons JT, 2008, HEALTH PSYCHOL, V27, P628, DOI 10.1037/a0012664; Peltzer K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-699; Pengpid S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-644; Pengpid S, 2013, INT J ENV RES PUB HE, V10, P2043, DOI 10.3390/ijerph10052043; Rendall-Mkosi K, 2013, ADDICTION, V108, P725, DOI 10.1111/add.12081; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Samet JH, 2004, ALCOHOL CLIN EXP RES, V28, P572, DOI 10.1097/01.ALC.0000122103.74491.78; Sankar A, 2007, AIDS BEHAV, V11, P195, DOI 10.1007/s10461-006-9144-0; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Shand T, 2014, IDS BULL-I DEV STUD, V45, P53, DOI 10.1111/1759-5436.12068; Sileo KM, 2019, AIDS CARE, V31, P35, DOI 10.1080/09540121.2018.1524564; Sileo KM, 2016, DRUG ALCOHOL DEPEN, V167, P103, DOI 10.1016/j.drugalcdep.2016.07.028; Sileo KM, 2016, AIDS BEHAV, V20, P537, DOI 10.1007/s10461-015-1077-z; Smolak A, 2014, AIDS CARE, V26, P282, DOI 10.1080/09540121.2013.824541; Swahn MH, 2012, INT J ALCOHOL DRUG R, V1, P13, DOI 10.7895/ijadr.v1i1.84; Truong William R, 2015, P T, V40, P44; Tucker JS, 2003, AM J MED, V114, P573, DOI 10.1016/S0002-9343(03)00093-7; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, P12, DOI 10.1186/1471-2458-12-12; Tumwesigye NM, 2003, GENDER ALCOHOL CULTU; Uganda MOH, 2013, ADD NAT ANT TREATM G; UNAIDS, 2018, COUNTR FACT SHEET UG; UNAIDS, 2014, 90 90 90 AMB TREATM; Wandera B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126236; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2001, ALCOHOL USE DISORDER; World Health Organization, 2016, CONS GUID US ANT DRU	55	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0216892	10.1371/journal.pone.0216892	http://dx.doi.org/10.1371/journal.pone.0216892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA9ZE	31158232	gold, Green Published, Green Submitted			2022-12-26	WOS:000469915700004
J	Fernandes, FS; da Silva, GS; Hilel, AS; Carvalho, AC; Remor, KVT; Schlindwein, AD; Kanis, LA; Martins, DF; Kviecinski, MR				Fernandes, Flavia S.; da Silva, Gustavo S.; Hilel, Alexandre S.; Carvalho, Ana C.; Remor, Karina V. T.; Schlindwein, Aline D.; Kanis, Luiz A.; Martins, Daniel F.; Kviecinski, Maicon R.			Study of the potential adverse effects caused by the dermal application of Dillenia indica L. fruit extract standardized to betulinic acid in rodents	PLOS ONE			English	Article							MEAN CORPUSCULAR VOLUME; PHOTODYNAMIC THERAPY; PASSIFLORA-ALATA; PSORIASIS; TOXICITY; RATS; SAFETY; MICE; ANTIOXIDANT; DERMATITIS	This study aimed to evaluate the potential adverse effects of the dermal administration of Dillenia indica Linnaeus (D. indica) fruit extract in healthy rodents; the extract was standardized to betulinic acid. In the initial phase, the acute effects were evaluated on the skin application site of a single extract dose. A skin irritation test was performed in male Wistar rats (n = 8/group) receiving the extract (50-150 mg/mL) with betulinic acid (0.5-1.5%, respectively). A photosensitivity test was performed in male BALB/c mice (n = 6/group) receiving the extract (150 mg/mL). Afterwards, other BALB/c mice (n = 20, male: female, 1: 1) were used to assess the systemic alterations caused by 14 daily repeated doses (150 mg/mL) by monitoring the effects on mortality, body morphology, behavior, nutrition status, neuromotor reactions, organ morphology and weight, and blood tests. At this time, 0.5 mg/mL clobetasol was used as the positive control. The skin irritation index suggested that negligible skin irritation had occurred, even when the extract was applied to the rat skin at 150 mg/mL. However, the extract acted as a photosensitizer on mouse skin, showing a photosensitizing activity close to that of 10 mg/mL 5-methoxypsoralen. Repeated doses caused no mouse mortality, aggressiveness, piloerection, diarrhea, convulsions, neuromotor alterations or nutrition status changes. The mouse organ weights did not change, and the mice did not have alterations in their blood compositions. Clobetasol caused a reduction in the mononuclear leukocyte numbers. In general, the data suggest that the extract was safe in healthy rodents but indicate that caution should be taken with the photosensitizing activity; in addition, this activity should be further explored as it may be useful for phototherapeutic drug development.	[Fernandes, Flavia S.; da Silva, Gustavo S.; Hilel, Alexandre S.; Carvalho, Ana C.; Remor, Karina V. T.; Schlindwein, Aline D.; Kanis, Luiz A.; Martins, Daniel F.; Kviecinski, Maicon R.] Univ Sul Santa Catarina, Postgrad Program Hlth Sci, Palhoca, SC, Brazil	Universidade do Sul de Santa Catarina	Kviecinski, MR (corresponding author), Univ Sul Santa Catarina, Postgrad Program Hlth Sci, Palhoca, SC, Brazil.	maicon.kviecinski@gmail.com	da Silva, Gustavo Silveira/M-4104-2017; Martins, Daniel Fernandes/J-7125-2014; Martins, Daniel/D-3493-2018	da Silva, Gustavo Silveira/0000-0003-4571-2426; Kviecinski, Maicon Roberto/0000-0002-6703-4040; HILEL, ALEXANDRE/0000-0002-8450-7858; de Souza Fernandes, Flavia/0000-0002-9239-8698; Martins, Daniel/0000-0003-1484-3167				Acesio NO, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8942730; Adeleke GE, 2017, HUM EXP TOXICOL, V36, P734, DOI 10.1177/0960327116661399; Ahad A, 2017, BIOMED PHARMACOTHER, V89, P177, DOI 10.1016/j.biopha.2017.01.164; Alam MB, 2012, INT J PHARMACOL, V8, P243, DOI 10.3923/ijp.2012.243.251; Issa MCA, 2010, AN BRAS DERMATOL, V85, P501, DOI 10.1590/S0365-05962010000400011; Amichai B, 1993, J EUR ACAD DERMATOL, V2, P27, DOI 10.1111/j.1468-3083.1993.tb00006.x; Andris DA, 2006, SEMIOLOGIA BASES PRA; ANVISA (AGENCIA NACIONAL DE VIGILaNCIA SANITaRIA), 2013, GUIA COND EST NAO CL, P1; Apu As, 2010, J Young Pharm, V2, P50, DOI 10.4103/0975-1483.62213; Aregheore EM., 2003, SOUTH PAC J NAT APPL, V21, P51, DOI DOI 10.1071/SP03010; Acevedo JGA, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-281; Bain BJ, 2007, CELULAS SANGUINEAS G; de Mello FB, 2007, LAT AM J PHARM, V26, P191; Bearhop S, 1999, ECOL LETT, V2, P352; Bloom J, 2012, FUNDAMENTOS TOXICOLO, P149; Bobinski F, 2011, NEUROSCIENCE, V194, P337, DOI 10.1016/j.neuroscience.2011.07.075; Bordin D.C.M., 2015, SC, V7, P125, DOI [10.4322/sc.2015.022, DOI 10.4322/SC.2015.022]; Calkosinski I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/972535; Casagrande R, 2006, J PHOTOCH PHOTOBIO B, V84, P21, DOI 10.1016/j.jphotobiol.2006.01.006; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Costa Jessica Pereira, 2012, Revista de Ciencias Farmaceuticas Basica e Aplicada, V33, P421; Council of Scientific and Industrial Research (CSIR), 1952, WEALTH IND DICT IN D, VIII; Craig EA, 2015, J APPL TOXICOL, V35, P729, DOI 10.1002/jat.3036; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; De D, 2007, LEPROSY REV, V78, P401; de Mello JRB, 2010, LAT AM J PHARM, V29, P1431; de Oliveira BH, 2002, PHYTOCHEM ANALYSIS, V13, P95, DOI 10.1002/pca.628; De Souza PA, 2010, REV BRAS FARMACOGN, V20, P922, DOI 10.1590/S0102-695X2010005000042; Jaques JAD, 2012, REDOX REP, V17, P206, DOI 10.1179/1351000212Y.0000000024; Dyer Stephen M., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P423, DOI 10.1016/j.cvex.2008.03.008; Failace RR, 2009, HEMOGRAMA MANUAL INT; Felipe KB, 2014, J ETHNOPHARMACOL, V155, P1492, DOI 10.1016/j.jep.2014.07.040; Fernandez I, 2010, J AM ASSOC LAB ANIM, V49, P202; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; FUJIOKA T, 1994, J NAT PROD, V57, P243, DOI 10.1021/np50104a008; Gagne F, 2014, BIOCHEMICAL ECOTOXICOLOGY: PRINCIPLES AND METHODS, P1; Gandara L, 2014, J PHOTOCH PHOTOBIO B, V133, P55, DOI 10.1016/j.jphotobiol.2014.03.006; Gandhi D, 2013, J APP PHARM SCI, V3, P134, DOI DOI 10.7324/JAPS.2013.31124; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Gordon ML, 1998, CLIN THER, V20, P26, DOI 10.1016/S0149-2918(98)80032-5; GUPTA AK, 1989, J AM ACAD DERMATOL, V20, P1088, DOI 10.1016/S0190-9622(89)70138-9; Gupta RC, 2007, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, P1, DOI 10.5005/jp/books/10078; Han BG, 2008, AM J PHYSIOL-ENDOC M, V295, pE981, DOI 10.1152/ajpendo.90283.2008; Hayes RB, 2001, CHEM-BIOL INTERACT, V135, P455, DOI 10.1016/S0009-2797(01)00182-X; Hoffbrand AV, 2013, FUNDAMENTOS HEMATOLO; Horobin RW, 2011, BIOTECH HISTOCHEM, V86, P36, DOI 10.3109/10520295.2010.515491; IMAI S, 1994, ANTICANCER RES, V14, P933; Jahn AI, 1997, REPROD TOXICOL, V11, P171, DOI 10.1016/S0890-6238(97)00003-8; Khare R, 2013, INDO AM PHARM RES, V3, P6076, DOI [10.1016/j.bcp.2008.07.038, DOI 10.1016/J.BCP.2008.07.038]; Klaasen CD, 2018, CASARETT DOULLS BASI; Klaassen CD., 2012, FUNDAMENTOS TOXICOLO; Kumar D, 2010, PHYTOMEDICINE, V17, P431, DOI 10.1016/j.phymed.2009.07.010; Kumar Sunil, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P570, DOI 10.3736/jcim20110517; Kummer N, 2016, CLIN BIOCHEM, V49, P1078, DOI 10.1016/j.clinbiochem.2016.05.007; Kviecinski M. R., 2016, Revista Brasileira de Plantas Medicinais, V18, P899, DOI 10.1590/1983-084X/0081; Kviecinski MR, 2017, PHARM BIOL, V55, P641, DOI 10.1080/13880209.2016.1266672; LARSEN HOWARD N., 1961, TRANS AMER FISH SOC, V90, P139, DOI 10.1577/1548-8659(1961)90[139:MOTMTW]2.0.CO;2; Lebwohl MG, 2014, J AM ACAD DERMATOL, V70, P871, DOI 10.1016/j.jaad.2013.12.018; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; Liu S, 2014, EUR J PHARM BIOPHARM, V86, P267, DOI 10.1016/j.ejpb.2013.10.001; LOADER S, 1995, AM J HUM GENET, V57, P1724; Lock EA, 1998, TOXICOL PATHOL, V26, P18, DOI 10.1177/019262339802600102; Martens-Lobenhoffer J, 1999, SKIN PHARMACOL APPL, V12, P266, DOI 10.1159/000066251; Matos LC, 2005, MED INTERN, V12, P239; Mccafferty DJ, 2007, MAMMAL REV, V37, P207, DOI 10.1111/j.1365-2907.2007.00111.x; MERSHON MM, 1990, FUND APPL TOXICOL, V15, P622, DOI 10.1016/0272-0590(90)90046-M; Meyer GM, 2016, BIOANALYSIS, V8, P457, DOI 10.4155/bio.16.15; Migliato KF, 2011, WOUNDS, V23, P111; Mueller T, 2001, ANGIOLOGY, V52, P605, DOI 10.1177/000331970105200904; Nelson D, 2011, EUR RESPIR MONOGR, P1, DOI 10.1183/1025448x.10007210; Oliveira R., 2016, HEMOGRAMA COMO FAZER; Parasuraman S, 2011, J PHARMACOL PHARMACO, V2, P74, DOI 10.4103/0976-500X.81895; Rahman MA, 2011, PHARMACOLOGYONLINE, V1, P1247; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Ryan C, 2014, J AM ACAD DERMATOL, V70, P146, DOI 10.1016/j.jaad.2013.08.042; de Oliveira MDSP, 2015, AN BRAS DERMATOL, V90, P9, DOI 10.1590/abd1806-4841.20153038; Schossler D, 2001, ACTA CIR BRAS, V16, P46; Schuhly W, 1999, PLANTA MED, V65, P740, DOI 10.1055/s-1999-14054; Setlik J, 2015, REV SAUDE DESENVOLV, V7, P195; Shara M, 2005, J INORG BIOCHEM, V99, P2161, DOI 10.1016/j.jinorgbio.2005.07.017; Sharma HK, 2001, FITOTERAPIA, V72, P146, DOI 10.1016/S0367-326X(00)00278-1; Sheldon J, 2004, BEST PRACT RES CL RH, V18, P249, DOI 10.1016/j.berh.2004.03.007; SHOME U, 1980, P INDIAN AS-PLANT SC, V89, P91; Silva E. R., 2009, REV BRAS FARM, V90, P211; Simoes C. A. M., 2001, FARMACOGNOSIA PLANTA; SOX HC, 1986, ANN INTERN MED, V104, P515, DOI 10.7326/0003-4819-104-4-515; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; TAMURA J, 1980, Journal of Toxicological Sciences, V5, P177; Vasconcelos J., 2009, REV CIENTIFICA UFPA, V7, P1; Vicentini FTMC, 2010, J PHARM PHARM SCI, V13, P274, DOI 10.18433/J3830G; Vijayalakshmi T, 2000, J ETHNOPHARMACOL, V69, P9, DOI 10.1016/S0378-8741(99)00020-3; WHO, 2004, WHO GUID SAF MON HER, P82; World Health Organization (Who), 2002, IMP PHARM SAF MON ME, DOI [10.1002/0470853093, DOI 10.1002/0470853093]; Yeshwante SB, 2009, J YOUNG PHARM, V1, P63, DOI 10.4103/0975-1483.51885; Yi JN, 2016, PHARMACOL REP, V68, P95, DOI 10.1016/j.pharep.2015.07.003; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Yonezawa Y, 2015, J TOXICOL SCI, V40, P667, DOI 10.2131/jts.40.667; Zohra M., 2014, INT J PHARM SCI RES, V5, P495	98	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217718	10.1371/journal.pone.0217718	http://dx.doi.org/10.1371/journal.pone.0217718			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150479	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100092
J	Rice, SJ; Liu, X; Wang, HG; Belani, CP				Rice, Shawn J.; Liu, Xin; Wang, Hong-Gang; Belani, Chandra P.			EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer	PLOS ONE			English	Article							TUMOR-CELLS; SURVIVAL; ABT-737; EXPRESSION; MARITOCLAX; RESISTANCE; APOPTOSIS; GROWTH; BIM; DISCOVERY	Lung cancer is among the common and deadly cancers. Although the treatment options for late-stage cancer patients have continued to increase in numbers, the overall survival rates for these patients have not shown significant improvement. This highlights the need for new targets and drugs to more effectively treat lung cancer patients. In this study, we characterize the MCL-1 inhibitor maritoclax alone or in combination with a BCL-2/xL inhibitor in a panel of lung cancer cell lines. BCL-2 family proteins, phosphorylated proteins, and apoptosis were monitored following the treatments. We found that maritoclax was effective at inhibiting growth in these lung cancer cells. We also establish that cell lines with EGFR mutations were most sensitive to the combined inhibition of MCL-1 and BCL-2/xL. In addition, a high level of phosphorylated AKT (S473) was identified as a marker for sensitivity to the combination treatment. This work has defined EGFR mutations and AKT phosphorylation as markers for sensitivity to combined MCL-1 and BCL-2/xL targeted therapy and establishes a rationale to explore multiple BCL-2 family members in patients who are refractory to EGFR inhibitor treatment. Our data support the design of a clinical trial that aims to employ inhibitors of the BCL-2 family of proteins in lung cancer patients.	[Rice, Shawn J.; Liu, Xin; Wang, Hong-Gang; Belani, Chandra P.] Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Wang, Hong-Gang] Penn State Coll Med, Dept Pediat, Hershey, PA USA; [Belani, Chandra P.] Penn State Coll Med, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Belani, CP (corresponding author), Penn State Hershey Canc Inst, Hershey, PA 17033 USA.; Belani, CP (corresponding author), Penn State Coll Med, Dept Med, Hershey, PA 17033 USA.	cbelani@psu.edu		Belani, Chandra/0000-0001-5049-5329				Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Costa C, 2014, CLIN CANCER RES, V20, P2001, DOI 10.1158/1078-0432.CCR-13-2233; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; DATTA R, 1995, CELL GROWTH DIFFER, V6, P363; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Doi K, 2014, CANCER BIOL THER, V15, P1077, DOI 10.4161/cbt.29186; Doi K, 2012, J BIOL CHEM, V287, P10224, DOI 10.1074/jbc.M111.334532; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Frederick DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101286; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Howlader N, 2012, AM J EPIDEMIOL, V176, P347, DOI 10.1093/aje/kwr512; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Jeon MY, 2018, MOLECULES, V23, DOI 10.3390/molecules23113030; Kathuria H, 2014, CANCERS, V6, P1157, DOI 10.3390/cancers6021157; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Nalluri S, 2015, CANCER BIOL THER, V16, P276, DOI 10.1080/15384047.2014.1002333; Pandey MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078570; Serasinghe MN, 2015, ONCOGENE, V34, P857, DOI 10.1038/onc.2014.21; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Varadarajan S, 2015, ONCOTARGET, V6, P12668, DOI 10.18632/oncotarget.3706; Wang B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-98; Whitsett TG, 2014, MOL CANCER RES, V12, P550, DOI 10.1158/1541-7786.MCR-13-0458; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217657	10.1371/journal.pone.0217657	http://dx.doi.org/10.1371/journal.pone.0217657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150457	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100081
J	Zhou, LP; Yuan, L; Zhao, BQ; Li, YT; Lin, ZA				Zhou, Liping; Yuan, Liang; Zhao, Bingqiang; Li, Yanting; Lin, Zhian			Structural characteristics of humic acids derived from Chinese weathered coal under different oxidizing conditions	PLOS ONE			English	Article							SIZE-FRACTIONS; LIGNITE; OXIDATION; SUBSTANCES; MATTER; BIOACTIVITY; SORPTION; GROWTH; SOILS; PEAT	Humic acids derived from Chinese weathered coal were oxidized with hydrogen peroxide (H2O2) under various conditions, and their chemical composition and structure were examined. The raw material humic acids (HA) and oxidized humic acids (OHAs) were characterized by elemental analysis and ultraviolet visible (UV-Vis), Fourier transform infrared (FTIR), and solid-state C-13 nuclear magnetic resonance (NMR) spectroscopy. Our results show that aromatic functional groups accounted for more than 70% of the HA and OHAs and there were significant differences in their structures and compositions. Compared to the HA, the average H and N contents of the OHAs decreased by 5.15% and 2.52%, respectively, and the average O content of those of the OHAs increased by 5.30%. The hydrophobicity index (HI) of HA is higher than those of the OHAs. Importantly, in the hypothesis test between the properties and preparation conditions of humic acid using SPSS, the partial eta(2) of the temperature, hydrogen peroxide concentration, liquid-solid ratio, and time were 0.809, 0.771, 0.748 and 0.729, respectively; thus, among the preparation conditions, temperature is the most important factor affecting the humic acids properties.	[Zhou, Liping; Yuan, Liang; Zhao, Bingqiang; Li, Yanting; Lin, Zhian] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr & Rural Affairs, Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Zhao, BQ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr & Rural Affairs, Key Lab Plant Nutr & Fertilizer, Beijing, Peoples R China.	zhaobingqiang@caas.cn			National Key Research and Development Program of China [2016YFD0200402]	National Key Research and Development Program of China	The authors acknowledge the financial support provided by The National Key Research and Development Program of China (2016YFD0200402).	Abakumov EV, 2013, J SOIL SEDIMENT, V13, P491, DOI 10.1007/s11368-012-0579-9; Al Othman ZA, 2011, MOLECULES, V16, P10443, DOI 10.3390/molecules161210443; Al-Faiyz YSS, 2017, ARAB J CHEM, V10, pS839, DOI 10.1016/j.arabjc.2012.12.018; Amir S, 2010, J HAZARD MATER, V177, P524, DOI 10.1016/j.jhazmat.2009.12.064; Canellas LP, 2012, EUR J SOIL SCI, V63, P315, DOI 10.1111/j.1365-2389.2012.01439.x; Canellas LP, 2008, SOIL SCI, V173, P624, DOI 10.1097/SS.0b013e3181847ebf; Canellas LP, 2010, CHEMOSPHERE, V78, P457, DOI 10.1016/j.chemosphere.2009.10.018; Cao XY, 2016, ENVIRON SCI TECHNOL, V50, P1663, DOI 10.1021/acs.est.5b02859; CHEN Y, 1977, SOIL SCI SOC AM J, V41, P352, DOI 10.2136/sssaj1977.03615995004100020037x; Conte P, 2007, CHEMOSPHERE, V69, P1032, DOI 10.1016/j.chemosphere.2007.04.043; de Oliveira LK, 2016, ACS APPL MATER INTER, V8, P1478, DOI 10.1021/acsami.5b10810; Dobbss LB, 2010, J AGR FOOD CHEM, V58, P3681, DOI 10.1021/jf904385c; Doskocil L, 2014, FUEL, V134, P406, DOI 10.1016/j.fuel.2014.06.011; [黄文辉 Huang Wenhui], 2010, [现代地质, Geoscience], V24, P1186; Garcia AC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20798; Garcia-Mina JM, 2006, ORG GEOCHEM, V37, P1960, DOI 10.1016/j.orggeochem.2006.07.027; de Melo BAG, 2016, MAT SCI ENG C-MATER, V62, P967, DOI 10.1016/j.msec.2015.12.001; Griffith S. M., 1989, Humic substances II. In search of structure., P69; Ho KJ, 2003, ARCH TOXICOL, V77, P100, DOI 10.1007/s00204-002-0378-y; Jindo K, 2012, PLANT SOIL, V353, P209, DOI 10.1007/s11104-011-1024-3; Karlsson T, 2010, GEOCHIM COSMOCHIM AC, V74, P30, DOI 10.1016/j.gca.2009.09.023; KIM JI, 1990, FRESEN J ANAL CHEM, V338, P245, DOI 10.1007/BF00323017; Li SX., 2002, HUMIC ACID, V3, P7; Liu FJ, 2013, FUEL, V109, P316, DOI 10.1016/j.fuel.2013.01.020; Lu JH, 2017, ENVIRON POLLUT, V220, P1418, DOI 10.1016/j.envpol.2016.10.092; MALCOLM RE, 1979, SOIL BIOL BIOCHEM, V11, P65, DOI 10.1016/0038-0717(79)90120-2; [МАЛЫШЕНКО НАТАЛЬЯ ВАСИЛЬЕВНА MALYSHENKO N.V.], 2015, [Химия в интересах устойчивого развития, Khimiya v interesakh ustoichivogo razvitiya], V23, P451, DOI 10.15372/KhUR20150415; Mao JD, 2004, ENVIRON SCI TECHNOL, V38, P2680, DOI 10.1021/es034770x; Mao JD, 2007, GEODERMA, V140, P17, DOI 10.1016/j.geoderma.2007.03.014; Mao JD, 2011, ORG GEOCHEM, V42, P891, DOI 10.1016/j.orggeochem.2011.03.023; Mao JD, 2010, GEOCHIM COSMOCHIM AC, V74, P2110, DOI 10.1016/j.gca.2009.12.029; Mathews JP, 2012, FUEL, V96, P1, DOI 10.1016/j.fuel.2011.11.025; Parsons J. W., 1989, HUMIC SUBSTANCES, P99; Pena-Mendez E. M., 2005, J APPL BIOMED, V3, P13, DOI DOI 10.32725/JAB.2005.002; Rajashekhar D, 2017, INT J PURE APP BIOSC, V5, P1254, DOI [10.18782/2320-7051.5454, DOI 10.18782/2320-7051.5454]; Savy D, 2015, MOLECULES, V20, P19958, DOI 10.3390/molecules201119671; SCHNITZER M, 1974, SOIL BIOL BIOCHEM, V6, P1, DOI 10.1016/0038-0717(74)90003-0; Stevenson F. J., 1989, HUMIC SUBSTANCES, VII, P121; Stevenson FJ., 1994, HUMIC CHEM GENESIS C, P236; Tahir MM, 2011, PEDOSPHERE, V21, P124, DOI 10.1016/S1002-0160(10)60087-2; Tang YF, 2017, ACS SUSTAIN CHEM ENG, V5, P10099, DOI 10.1021/acssuschemeng.7b02094; Tao ZY, 1995, TOXICOL ENVIRON CHEM, V49, P45, DOI DOI 10.1080/02772249509358175; Wang XL, 2011, ENVIRON SCI TECHNOL, V45, P9276, DOI 10.1021/es202258q; Wen Y, 2010, SCI TECH INFORM DEV, V33, P65; [武瑞平 WU Rui-ping], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1855; Zhang Q, 2012, J ENVIRON MANAGE, V102, P165, DOI 10.1016/j.jenvman.2011.12.036; Zhang SQ, 2017, CHEMOSPHERE, V166, P334, DOI 10.1016/j.chemosphere.2016.09.095; Zherebtsov SI, 2015, COKE CHEM, V58, P400, DOI 10.3103/S1068364X15100099; Zykova MV, 2018, MOLECULES, V23, DOI 10.3390/molecules23040753	49	17	18	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217469	10.1371/journal.pone.0217469	http://dx.doi.org/10.1371/journal.pone.0217469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150428	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100055
J	De Bari, B; Dixon, JA; Kay, BA; Kondepudi, D				De Bari, Benjamin; Dixon, James A.; Kay, Bruce A.; Kondepudi, Dilip			Oscillatory dynamics of an electrically driven dissipative structure	PLOS ONE			English	Article							ENTROPY PRODUCTION	Physical systems open to a flow of energy can exhibit spontaneous symmetry breaking and self-organization. These nonequilibrium self-organized systems are known as dissipative structures. We study the oscillatory mode of an electrically driven dissipative structure. Our system consists of aluminum beads in shallow oil, which, when subjected to a high voltage, self-organize into connected 'tree' structures. The tree structures serve as pathways for the conduction of charge to ground. This system shows a variety of spatio-temporal behaviors, such as oscillating movement of the tree structures. Utilizing a dynamical systems model of the electromagnetic phenomena, we explore a potential mechanism underlying the system's behavior and use the model to make additional empirical predictions. The model reproduces the oscillatory behavior observed in the real system, and the behavior of the real system is consistent with predictions from the model under various constraints. From the empirical results and the mathematical model, we observe a tendency for the system to select modes of behavior with increased dissipation, or higher rates of entropy production, in accord with the proposed Maximum Entropy Production (MEP) Principle.	[De Bari, Benjamin; Dixon, James A.; Kay, Bruce A.] Univ Connecticut, Ctr Ecol Study Percept & Act, Storrs, CT 06269 USA; [Kondepudi, Dilip] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA	University of Connecticut; Wake Forest University	De Bari, B (corresponding author), Univ Connecticut, Ctr Ecol Study Percept & Act, Storrs, CT 06269 USA.	Benjamin.de_bari@uconn.edu		De Bari, Benjamin/0000-0002-7894-7849	National Science Foundation's INSPIRE Track 1 Program [BCS-1344725]	National Science Foundation's INSPIRE Track 1 Program	This work was supported by a grant from the National Science Foundation's INSPIRE Track 1 Program, Grant number BCS-1344725, awarded to James. Dixon. The funder's website is: https://www.nsf.gov/pubs/2014/nsf14106/nsf14106.jsp.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08323; Dixon J, 2015, WORLD SCI REV    AUG, DOI [10.1142/9789814730617_0009, DOI 10.1142/9789814730617_0009]; Eigen M, 1979, HYPER CYCLE; Endres RG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14485-8; Jun J., 2006, DYNAMICS SELF ORG RA; Kaufmann SA, 1993, ORIGINS ORDER; Kleidon A., 2005, NONEQUILIBRIUM THERM; Kondepudi D, 1998, MODERN THERMODYNAMIC; Kondepudi D, 2017, CHAOS, V27, DOI 10.1063/1.5001195; Kondepudi D, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.050902; Kondepudi D, 2012, ECOL PSYCHOL, V24, P33, DOI 10.1080/10407413.2012.643716; KUGLER PN, 1988, HUM MOVEMENT SCI, V7, P97, DOI 10.1016/0167-9457(88)90009-7; Martyushev LM, 2006, PHYS REP, V426, P1, DOI 10.1016/j.physrep.2005.12.001; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Nicolis G., 1992, NEW PHYS; PRIGOGINE I, 1967, J CHEM PHYS, V46, P3542, DOI 10.1063/1.1841255; Prigogine I., 1961, INTRO THERMODYNAMICS; Rosen R., 2000, ESSAYS LIFE ITSELF; SWENSON R, 1991, Ecological Psychology, V3, P317, DOI 10.1207/s15326969eco0304_2	19	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217305	10.1371/journal.pone.0217305	http://dx.doi.org/10.1371/journal.pone.0217305			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141547	Green Published, Green Submitted, gold			2022-12-26	WOS:000469323000048
J	O'Rourke, JA; Ravichandran, C; Howe, YJ; Mullett, JE; Keary, CJ; Golas, SB; Hureau, AR; McCormick, M; Chung, J; Rose, NR; McDougle, CJ				O'Rourke, Julia A.; Ravichandran, Caitlin; Howe, Yamini J.; Mullett, Jennifer E.; Keary, Christopher J.; Golas, Sara B.; Hureau, Amrita R.; McCormick, Morgan; Chung, Jeanhee; Rose, Noel R.; McDougle, Christopher J.			Accuracy of self-reported history of autoimmune disease: A pilot study	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; RHEUMATOID-ARTHRITIS; FAMILY-HISTORY; QUESTIONNAIRE INFORMATION; MEDICAL-RECORDS; RISK; VALIDITY; POPULATION; PREVALENCE; VALIDATION	Research associating the increased prevalence of familial autoimmunity with neuropsychiatric disorders is reliant upon the ascertainment of history of autoimmune diseases from relatives. To characterize the accuracy of self-report, we compared self-reported diagnoses of 18 autoimmune diseases using an online self-report questionnaire to the electronic medical record (EMR) diagnoses in 1,013 adult (age 18-70 years) patients of a primary care clinic. For the 11 diseases meeting our threshold observed prevalence, we estimated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for selfreported diagnoses under the assumption that EMR-based diagnoses were accurate. Six diseases out of 11 had either sensitivity or PPV below 50%, with the lowest PPV for dermatological and endocrinological diseases. Common errors included incorrectly self-reporting type 2 diabetes mellitus (DM), when type 1 DM was indicated by the EMR, and reporting rheumatoid arthritis when osteoarthritis was indicated by the EMR. Results suggest that ascertainment of familial autoimmunity through self-report contributes to inconsistencies and inaccuracies in studies of autoimmune disease history and that future studies would benefit from incorporating EMR review and biological measures.	[O'Rourke, Julia A.; Ravichandran, Caitlin; Howe, Yamini J.; Mullett, Jennifer E.; Keary, Christopher J.; Golas, Sara B.; Hureau, Amrita R.; McDougle, Christopher J.] Lurie Ctr Autism, Lexington, MA 02421 USA; [O'Rourke, Julia A.; Ravichandran, Caitlin; Howe, Yamini J.; Mullett, Jennifer E.; Keary, Christopher J.; Golas, Sara B.; Hureau, Amrita R.; Chung, Jeanhee; McDougle, Christopher J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [O'Rourke, Julia A.; Ravichandran, Caitlin; Howe, Yamini J.; Keary, Christopher J.; Chung, Jeanhee; Rose, Noel R.; McDougle, Christopher J.] Harvard Med Sch, Boston, MA 02115 USA; [Ravichandran, Caitlin] McLean Hosp, Program Neuropsychiat Res, 115 Mill St, Belmont, MA 02178 USA; [McCormick, Morgan] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Rose, Noel R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Indiana University System; Indiana University Bloomington; Harvard University; Brigham & Women's Hospital	O'Rourke, JA (corresponding author), Lurie Ctr Autism, Lexington, MA 02421 USA.; O'Rourke, JA (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; O'Rourke, JA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	joorourke@mgh.harvard.edu	Ravichandran, Caitlin/AAH-5562-2020	O'Rourke, Julia/0000-0002-5926-1489	Robert and Donna Landreth Family Foundation; Nancy Lurie Marks Family Foundation	Robert and Donna Landreth Family Foundation; Nancy Lurie Marks Family Foundation	This work was supported by the Robert and Donna Landreth Family Foundation. JAO, CR, YJH, JEM, CJK, SBG, ARH, and CJM received this award. It also received support from the Nancy Lurie Marks Family Foundation; JAO, CR, YJH, JEM, CJK, SBG, ARH, and CJM received this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINO N, 1988, BAILLIERE CLIN ENDOC, V2, P591, DOI 10.1016/S0950-351X(88)80055-7; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Barber J, 2010, FAM PRACT, V27, P25, DOI 10.1093/fampra/cmp098; Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; Blatt AJ, 2012, J CLIN ENDOCR METAB, V97, P777, DOI 10.1210/jc.2011-2038; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Burden-Teh E, 2018, BRIT J DERMATOL, V178, P1035, DOI 10.1111/bjd.16104; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chen SW, 2016, BEHAV BRAIN RES, V296, P61, DOI 10.1016/j.bbr.2015.08.035; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481; Cooper GS, 2008, J RHEUMATOL, V35, P2001; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; Cumming R., 1998, HDB PUBLIC HLTH METH; Danielsen K, 2013, BRIT J DERMATOL, V168, P1303, DOI 10.1111/bjd.12230; Deane KD, 2014, NAT REV RHEUMATOL, V10, P212, DOI 10.1038/nrrheum.2014.6; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; Estes ML, 2015, NAT REV NEUROSCI, V16, P469, DOI 10.1038/nrn3978; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Formica MK, 2010, ARTHRIT CARE RES, V62, P235, DOI 10.1002/acr.20073; Fradkin JE, 2012, HEALTH AFFAIR, V31, P12, DOI 10.1377/hlthaff.2011.1150; Genuth SM, 2017, DIABETES AM; Gilvarry CM, 1996, SCHIZOPHR RES, V19, P33, DOI 10.1016/0920-9964(95)00045-3; Hayter SM, 2012, AUTOIMMUN REV, V11, P754, DOI 10.1016/j.autrev.2012.02.001; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Horton M, 2010, NEUROEPIDEMIOLOGY, V35, P83, DOI 10.1159/000311013; Jackson JM, 2014, MENOPAUSE, V21, P861, DOI [10.1097/GME.0000000000000189, 10.1097/gme.0000000000000189]; Karlson EW, 2004, ARTHRITIS RHEUM-US, V50, P3458, DOI 10.1002/art.20621; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813, DOI 10.1093/oxfordjournals.aje.a117078; Kelly-Pumarol IJ, 2018, J CLIN TRANSL SCI, V2, P163, DOI 10.1017/cts.2018.32; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Krakowiak P, 2015, MATERN CHILD HLTH J, V19, P1925, DOI 10.1007/s10995-015-1723-0; Kvien TK, 1996, J RHEUMATOL, V23, P1866; Ling SM, 2000, J RHEUMATOL, V27, P1390; Love TJ, 2011, SEMIN ARTHRITIS RHEU, V40, P413, DOI 10.1016/j.semarthrit.2010.05.002; Lyall K, 2014, J AUTISM DEV DISORD, V44, P1546, DOI 10.1007/s10803-013-2017-2; March L, 2014, BEST PRACT RES CL RH, V28, P353, DOI 10.1016/j.berh.2014.08.002; Mataix-Cols D, 2018, MOL PSYCHIATR, V23, P1652, DOI 10.1038/mp.2017.215; McDougle CJ, 2015, BRAIN RES, V1617, P72, DOI 10.1016/j.brainres.2014.09.048; Merkin SS, 2007, J CLIN EPIDEMIOL, V60, P634, DOI 10.1016/j.jclinepi.2006.09.003; MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537; Mikuls TR, 2002, ARTHRITIS RHEUM, V46, P83, DOI 10.1002/1529-0131(200201)46:1<83::AID-ART10042>3.0.CO;2-D; Modalsli EH, 2016, J INVEST DERMATOL, V136, P323, DOI 10.1038/JID.2015.386; Molloy CA, 2006, J AUTISM DEV DISORD, V36, P317, DOI 10.1007/s10803-005-0071-0; Mouridsen SE, 2007, DEV MED CHILD NEUROL, V49, P429, DOI 10.1111/j.1469-8749.2007.00429.x; Murphy TK, 2010, J NEUROIMMUNOL, V229, P243, DOI 10.1016/j.jneuroim.2010.08.017; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nielsen PR, 2017, J AM ACAD CHILD PSY, V56, P234, DOI 10.1016/j.jaac.2016.12.010; Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Pearce EN, 2003, NEW ENGL J MED, V348, P2646, DOI 10.1056/NEJMra021194; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raza K, 2014, RHEUM DIS CLIN N AM, V40, P569, DOI 10.1016/j.rdc.2014.07.001; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Spinillo A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1076-8; Star VL, 1996, J RHEUMATOL, V23, P1862; Sweeten TL, 2003, PEDIATRICS, V112, pE420, DOI 10.1542/peds.112.5.e420; TRETLI S, 1982, J EPIDEMIOL COMMUN H, V36, P269, DOI 10.1136/jech.36.4.269; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; Videm V, 2017, J RHEUMATOL, V44, P1134, DOI 10.3899/jrheum.161396; Walitt BT, 2008, J RHEUMATOL, V35, P811; Wallia A, 2014, JAMA-J AM MED ASSOC, V311, P2315, DOI 10.1001/jama.2014.5951; Wright P, 1996, SCHIZOPHR RES, V20, P261, DOI 10.1016/0920-9964(96)82950-1; Wu SQ, 2015, NEUROSCI BIOBEHAV R, V55, P322, DOI 10.1016/j.neubiorev.2015.05.004	67	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216526	10.1371/journal.pone.0216526	http://dx.doi.org/10.1371/journal.pone.0216526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141520	Green Published, gold			2022-12-26	WOS:000469323000014
J	Escobar-Turriza, P; Hernandez-Guerrero, R; Poot-Hernandez, AC; Rodriguez-Vazquez, K; Ramirez-Prado, J; Perez-Rueda, E				Escobar-Turriza, Pedro; Hernandez-Guerrero, Rafael; Cesar Poot-Hernandez, Augusto; Rodriguez-Vazquez, Katya; Ramirez-Prado, Jorge; Perez-Rueda, Ernesto			Identification of functional signatures in the metabolism of the three cellular domains of life	PLOS ONE			English	Article							ESCHERICHIA-COLI; EVOLUTION; ORGANIZATION; NETWORKS; PATHWAYS; DATABASE; ORIGIN	In order to identify common and specific enzymatic activities associated with the metabolism of the three cellular domains of life, the conservation and variations between the enzyme contents of Bacteria, Archaea, and Eukarya organisms were evaluated. To this end, the content of enzymes belonging to a particular pathway and their abundance and distribution in 1507 organisms that have been annotated and deposited in the KEGG database were assessed. In addition, we evaluated the consecutive enzymatic reaction pairs obtained from metabolic pathway reactions and transformed into sequences of enzymatic reactions, with catalytic activities encoded in the Enzyme Commission numbers, which are linked by a substrate. Both analyses are complementary: the first considers individual reactions associated with each organism and metabolic map, and the second evaluates the functional associations between pairs of consecutive reactions. From these comparisons, we found a set of five enzymatic reactions that were widely distributed in all the organisms and considered here as universal to Bacteria, Archaea, and Eukarya; whereas 132 pairs out of 3151 reactions were identified as significant, only 5 of them were found to be widely distributed in all the taxonomic divisions. However, these universal reactions are not widely distributed along the metabolic maps, suggesting their dispensability to all metabolic processes. Finally, we found that universal reactions are also associated with ancestral domains, such as those related to phosphorus-containing groups with a phosphate group as acceptor or those related to the ribulose-phosphate binding barrel, triosephosphate isomerase, and D-ribose-5-phosphate isomerase (RpiA) lid domain, among others. Therefore, we consider that this analysis provides clues about the functional constraints associated with the repertoire of enzymatic functions per organism.	[Escobar-Turriza, Pedro; Hernandez-Guerrero, Rafael; Perez-Rueda, Ernesto] Univ Nacl Autonoma Mexico, Unidad Acad Yucatan, Inst Invest Matemat Aplicadas & Sistemas, Merida, Yucatan, Mexico; [Escobar-Turriza, Pedro; Ramirez-Prado, Jorge] Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico; [Cesar Poot-Hernandez, Augusto; Rodriguez-Vazquez, Katya] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ingn Sistemas Computacionales & Automatizac, Ciudad Univ, Ciudad De Mexico, Mexico; [Cesar Poot-Hernandez, Augusto] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Ciudad Univ, Ciudad De Mexico, Mexico; [Perez-Rueda, Ernesto] Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile	Universidad Nacional Autonoma de Mexico; Centro de Investigacion Cientifica de Yucatan; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Mayor	Escobar-Turriza, P; Perez-Rueda, E (corresponding author), Univ Nacl Autonoma Mexico, Unidad Acad Yucatan, Inst Invest Matemat Aplicadas & Sistemas, Merida, Yucatan, Mexico.; Escobar-Turriza, P (corresponding author), Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico.; Perez-Rueda, E (corresponding author), Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile.	pedro.escobar@cicy.mx; ernesto.perez@iimas.unam.mx	Ramirez-Prado, Jorge H/A-3012-2011; Rodriguez-Vázquez, Katya/ABF-4715-2020; Perez-Rueda, Ernesto/D-7468-2016	Ramirez-Prado, Jorge H/0000-0003-2780-5223; Rodriguez-Vázquez, Katya/0000-0002-9413-2762; Perez-Rueda, Ernesto/0000-0002-6879-0673; Escobar Turriza, Pedro Javier/0000-0003-1217-0966; Hernandez Guerrero, Rafael/0000-0003-1096-5968	CONACyT-Mexico [338189]; DGAPA-Universidad Nacional Autonoma de Mexico [IN201117]; CYTED [P918PTE0261]	CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); CYTED	PE-T was supported by a PhD fellowship (338189) from CONACyT-Mexico. DGAPA-Universidad Nacional Autonoma de Mexico (IN201117) and CYTED (P918PTE0261). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva V, 2015, ELIFE, V4, DOI 10.7554/eLife.09410; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Armenta-Medina D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-800; Aziz MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep25058; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Poot-Hernandez AC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2113-0; Diaz-Mejia JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r26; Gonzalez RR, 2000, ESTUAR COAST SHELF S, V51, P507, DOI 10.1006/ecss.2000.0693; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Hernandez-Montes G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r95; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim HS, 2013, J INTEGR BIOINFORMAT, V10, DOI 10.2390/biecoll-jib-2013-214; Laurino P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002396; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; de la Osa JL, 2007, P NATL ACAD SCI USA, V104, P14941, DOI 10.1073/pnas.0706876104; Oates ME, 2015, NUCLEIC ACIDS RES, V43, pD227, DOI 10.1093/nar/gku1041; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Ortegon P, 2015, COMPUT STRUCT BIOTEC, V13, P277, DOI 10.1016/j.csbj.2015.04.001; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Pfeiffer T, 2005, PLOS BIOL, V3, P1269, DOI 10.1371/journal.pbio.0030228; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaeffer RD, 2017, NUCLEIC ACIDS RES, V45, pD296, DOI 10.1093/nar/gkw1137; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Yokobori S, 2016, ARCHAEA, V2016, DOI 10.1155/2016/1802675	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217083	10.1371/journal.pone.0217083	http://dx.doi.org/10.1371/journal.pone.0217083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136618	Green Submitted, Green Published, gold			2022-12-26	WOS:000469224300018
J	Sugihara, Y; Onoue, S; Tashiro, K; Sato, M; Hasegawa, T; Katakura, Y				Sugihara, Yuka; Onoue, Shiori; Tashiro, Kosuke; Sato, Mikako; Hasegawa, Takanori; Katakura, Yoshinori			Carnosine induces intestinal cells to secrete exosomes that activate neuronal cells	PLOS ONE			English	Article							OUTGROWTH; BRAIN	Recently, we showed that imidazole dipeptide such as carnosine contained abundantly in chicken breast meat improves brain function in a double-blind randomized controlled trial. However, the underlying molecular mechanisms remain unknown. Here, we investigated whether carnosine activates intestinal epithelial cells and induces the secretion of factors that activate brain function. We focused on exosomes derived from intestinal epithelial cells as mediators of brain-gut interaction. Results showed that exosomes derived from Caco-2 cells treated with carnosine significantly induced neurite growth in SH-SY5Y cells. To clarify the molecular basis of this finding, we performed integrated analysis of microRNAs (miRNAs) with altered expression in exosomes in response to carnosine treatment and mRNAs with altered expression in target cells in response to exosome treatment to identify related miRNAs and their target genes. The combination of miR-6769-5p and its target gene ATXN1 was found to be involved in the exosome-induced activation of neuronal cells.	[Sugihara, Yuka; Katakura, Yoshinori] Kyushu Univ, Grad Sch Bioresources & Bioenvironm Sci, Nishi Ku, Fukuoka, Fukuoka, Japan; [Onoue, Shiori; Katakura, Yoshinori] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka, Fukuoka, Japan; [Tashiro, Kosuke; Katakura, Yoshinori] Kyushu Univ, Fac Agr, Nishi Ku, Fukuoka, Fukuoka, Japan; [Sato, Mikako; Hasegawa, Takanori] NH Foods Ltd, R&D Ctr, Tsukuba, Ibaraki, Japan	Kyushu University; Kyushu University; Kyushu University; NH Foods Ltd.	Katakura, Y (corresponding author), Kyushu Univ, Grad Sch Bioresources & Bioenvironm Sci, Nishi Ku, Fukuoka, Fukuoka, Japan.; Katakura, Y (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka, Fukuoka, Japan.; Katakura, Y (corresponding author), Kyushu Univ, Fac Agr, Nishi Ku, Fukuoka, Fukuoka, Japan.	katakura@grt.kyushu-u.ac.jp		Katakura, Yoshinori/0000-0002-9678-9602	JSPS KAKENHI (Japan Society for the Promotion of Science) [16K14929]; NH Foods Ltd.; NH Foods Ltd	JSPS KAKENHI (Japan Society for the Promotion of Science); NH Foods Ltd.; NH Foods Ltd	YK awarded JSPS KAKENHI (Japan Society for the Promotion of Science, https://www.jsps.go.jp/, Grant Number: 16K14929). YK received the collaborative research cost from NH Foods Ltd. NH Foods Ltd provided support in the form of salaries for authors [MS, TH], but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.	Asher M, 2016, NEUROSCIENCE, V322, P54, DOI 10.1016/j.neuroscience.2016.02.011; Bellia F, 2014, MOLECULES, V19, P2299, DOI 10.3390/molecules19022299; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Canfran-Duque A, 2014, MOL NUTR FOOD RES, V58, P687, DOI 10.1002/mnfr.201300350; Ding Q, 2018, AGING DIS, V9, P334, DOI 10.14336/AD.2017.0809; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fujii K, 2017, CYTOTECHNOLOGY, V69, P523, DOI 10.1007/s10616-017-0089-0; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Herculano B, 2013, J ALZHEIMERS DIS, V33, P983, DOI 10.3233/JAD-2012-121324; Hisatsune T, 2016, J ALZHEIMERS DIS, V50, P149, DOI 10.3233/JAD-150767; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingram M, 2016, NEURON, V89, P1194, DOI 10.1016/j.neuron.2016.02.011; Kadooka K, 2015, J FUNCT FOODS, V13, P32, DOI 10.1016/j.jff.2014.12.024; Katakura Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111199; Keiser MS, 2015, BRAIN, V138, P3555, DOI 10.1093/brain/awv292; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakai W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33935; Perez-Bermudez P, 2017, EUR J PHARM SCI, V98, P40, DOI 10.1016/j.ejps.2016.09.022; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sale C, 2010, AMINO ACIDS, V39, P321, DOI 10.1007/s00726-009-0443-4; Son DO, 2008, CYTOKINE, V42, P265, DOI 10.1016/j.cyto.2008.02.011; Yamashita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101864; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang Y, 2013, J NEUROSCI, V33, P6885, DOI 10.1523/JNEUROSCI.5180-12.2013	26	15	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217394	10.1371/journal.pone.0217394	http://dx.doi.org/10.1371/journal.pone.0217394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136600	Green Submitted, Green Published, gold			2022-12-26	WOS:000469224300034
J	Tsusaka, T; Makino, B; Ohsawa, R; Ezura, H				Tsusaka, Takahiro; Makino, Bunsho; Ohsawa, Ryo; Ezura, Hiroshi			Genetic and environmental factors influencing the contents of essential oil compounds in Atractylodes lancea	PLOS ONE			English	Article							EXPERIMENTAL STOMACH ULCER; CRUDE DRUG ZHU; IDENTIFICATION; RHIZOMES; QUALITY; ORIGIN	Rhizomes of Atractylodes lancea are used in traditional Japanese medicine (Kampo) and Chinese medicine to treat numerous diseases and disorders because they contain many pharmacologically active compounds. The major active compounds in A. lancea are essential oil compounds such as beta-eudesmol, hinesol, atractylon, and atractylodin. The contents of the compounds in A. lancea exhibit high variability depending on their habitat. We cultivated clonal lines of A. lancea in different years (2016, 2017) and different locations (Hokkaido, Ibaraki) to investigate the influence of genetic and environmental factors on the contents of major compounds, namely, beta-eudesmol, hinesol, atractylon, and atractylodin. Broad sense heritability of beta-eudesmol, hinesol, atractylon, and atractylodin contents were 0.84, 0.77, 0.86, and 0.87, respectively. The effects of interannual variability on the contents of the compounds were lower than those of genotype. In addition, the cultivated environmental factors were assessed by different locations, and the correlations between Hokkaido and Ibaraki grown plants based on beta-eudesmol, hinesol, atractylon, and atractylodin contents were 0.94, 0.94, 1.00, and 0.83, respectively. The results suggest that the contents of beta-eudesmol, hinesol, atractylon, and atractylodin in A. lancea are largely influenced by genetic factors, and clonal propagation could be an effective strategy for obtaining populations with high contents of essential oil compounds. Furthermore, the contents of beta-eudesmol, hinesol, atractylon, and atractylodin in A. lancea exhibited few correlations with rhizome yields. A. lancea cultivars with not only high contents of essential oil compounds but also high rhizome yield could be developed through selective breeding.	[Tsusaka, Takahiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tsusaka, Takahiro] Tsumura & Co, Bot Raw Mat Prod Dept 2, Ami, Ibaraki, Japan; [Makino, Bunsho] Tsumura & Co, Bot Raw Mat Res Labs, Ami, Ibaraki, Japan; [Ohsawa, Ryo; Ezura, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; Tsumura & Company; Tsumura & Company; University of Tsukuba	Tsusaka, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Tsusaka, T (corresponding author), Tsumura & Co, Bot Raw Mat Prod Dept 2, Ami, Ibaraki, Japan.; Ezura, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	tsusaka_takahiro@mail.tsumura.co.jp; ezura.hiroshi.fa@u.tsukuba.ac.jp	Ezura, H/AAO-8184-2021	Tsusaka, Takahiro/0000-0002-4861-0612	Tsumura Co.	Tsumura Co.(Tsumura & Company)	This study was funded by Tsumura & Co. (https://www.tsumura.co.jp/english/).The funder provided support in the form of a salary for TT (First author) and BM (Second author). HE (Last author) and RO (Third author) are supervisors at the University of Tsukuba, to which TT belongs, and there is no funding from Tsumura & Co. The specific roles of these authors have been articulated in the "author contributions" section. Tsumura & Co. was responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2016, JAP PHARM, P1803; BURTON GW, 1953, AGRON J, V45, P478, DOI 10.2134/agronj1953.00021962004500100005x; Chen F, 2017, PLANT CELL TISS ORG, V130, P73, DOI 10.1007/s11240-017-1205-8; Chinese Pharmacopoeia Commission, 2015, CHINESE PHARMACOPOEI, P161; FERREIRA JFS, 1995, PLANTA MED, V61, P351, DOI 10.1055/s-2006-958098; Hong YB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00004; Japan Meteorological Agency, 2019, MET DAT DOWNL; Kaasboll OJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149000; KALTON RR, 1952, AGRON J, V44, P481, DOI 10.2134/agronj1952.00021962004400090007x; Koonrungsesomboon N, 2014, ASIAN PAC J TROP MED, V7, P421, DOI 10.1016/S1995-7645(14)60069-9; KUBO M, 1983, YAKUGAKU ZASSHI, V103, P442, DOI 10.1248/yakushi1947.103.4_442; MCDONALD ED, 1952, AGRON J, V44, P20, DOI 10.2134/agronj1952.00021962004400010007x; Mizukami H, 2000, BIOL PHARM BULL, V23, P589, DOI 10.1248/bpb.23.589; Nakai Y, 2003, J ETHNOPHARMACOL, V84, P51, DOI 10.1016/S0378-8741(02)00260-X; Nishikawa Y., 1975, SYOYAKUGAKU ZASSHI, V29, P139; NOGAMI M, 1986, CHEM PHARM BULL, V34, P3854; Ouyang Z, 2012, REV BRAS FARMACOGN, V22, P957, DOI 10.1590/S0102-695X2012005000051; Ren CG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-128; Shiba M, 2006, BIOL PHARM BULL, V29, P315, DOI 10.1248/bpb.29.315; Sudha G, 2002, PLANT CELL TISS ORG, V71, P181, DOI 10.1023/A:1020336626361; Takeda O, 1996, PLANTA MED, V62, P444, DOI 10.1055/s-2006-957936; Takeda O, 1997, CHEM PHARM BULL, V45, P1527; Takeda Osami, 1995, Natural Medicines, V49, P18; Ukai Y, 2002, GENETIC ANAL QUANTIT; Wang HX, 2008, PHYTOCHEMISTRY, V69, P2088, DOI 10.1016/j.phytochem.2008.04.008; Wang XM, 2015, PHYSIOL PLANTARUM, V153, P30, DOI 10.1111/ppl.12236; Yoshida M, 1998, DESIGN EXPT ANIMAL H, V8th; Yosioka I, 1958, CHEM PHARM BULL, V7, P319, DOI 10.1248/cpb.7.319; Yu F, 2008, FEBS LETT, V582, P565, DOI 10.1016/j.febslet.2008.01.020; Yuan Y, 2009, RUSS J PLANT PHYSL+, V56, P133, DOI 10.1134/S1021443709010191; Zhu SD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42417	31	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217522	10.1371/journal.pone.0217522	http://dx.doi.org/10.1371/journal.pone.0217522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136627	Green Submitted, gold, Green Published			2022-12-26	WOS:000469224300049
J	Numaga-Tomita, T; Shimauchi, T; Oda, S; Tanaka, T; Nishiyama, K; Nishimura, A; Birnbaumer, L; Mori, Y; Nishida, M				Numaga-Tomita, Takuro; Shimauchi, Tsukasa; Oda, Sayaka; Tanaka, Tomohiro; Nishiyama, Kazuhiro; Nishimura, Akiyuki; Birnbaumer, Lutz; Mori, Yasuo; Nishida, Motohiro			TRPC6 regulates phenotypic switching of vascular smooth muscle cells through plasma membrane potential-dependent coupling with PTEN	FASEB JOURNAL			English	Article						VSMCs; phenotype switching; membrane potential; transient receptor potential; Ca2(+) channel	10T1/2 CELLS; CA2+ ENTRY; ACTIVATION; CHANNELS; PROTEIN; DIFFERENTIATION; CONTRACTILE; BETA; EXPRESSION; HYPERFORIN	Vascular smooth muscle cells (VSMCs) play critical roles in the stability and tonic regulation of vascular homeostasis. VSMCs can switch back and forth between highly proliferative synthetic and fully differentiated contractile phenotypes in response to changes in the vessel environment. Although abnormal phenotypic switching of VSMCs is a hallmark of vascular disorders such as atherosclerosis and restenosis after angioplasty, how control of VSMC phenotypic switching is dysregulated in pathologic conditions remains obscure. We found that inhibition of canonical transient receptor potential 6 (TRPC6) channels facilitated contractile differentiation of VSMCs through plasma membrane hyperpolarization. TRPC6-deficient VSMCs exhibited more polarized resting membrane potentials and higher protein kinase B (Akt) activity than wild-type VSMCs in response to TGF-beta 1 stimulation. Ischemic stress elicited by oxygen-glucose deprivation suppressed TGF-beta 1-induced hyperpolarization and VSMC differentiation, but this effect was abolished by TRPC6 deletion. TRPC6-mediated Ca2+ influx and depolarization coordinately promoted the interaction of TRPC6 with lipid phosphatase and tensin homolog deleted from chromosome 10 (PTEN), a negative regulator of Akt activation. Given the marked up-regulation of TRPC6 observed in vascular disorders, our findings suggest that attenuation of TRPC6 channel activity in pathologic VSMCs could be a rational strategy to maintain vascular quality control by fine-tuning of VSMC phenotypic switching.-Numaga-Tomita, T., Shimauchi, T., Oda, S., Tanaka, T., Nishiyama, K., Nishimura, A., Birnbaumer, L., Mori, Y., Nishida, M. TRPC6 regulates phenotypic switching of vascular smooth muscle cells through plasma membrane potential-dependent coupling with PTEN.	[Numaga-Tomita, Takuro; Shimauchi, Tsukasa; Oda, Sayaka; Tanaka, Tomohiro; Nishida, Motohiro] NIPS, Okazaki, Aichi, Japan; [Numaga-Tomita, Takuro; Oda, Sayaka; Tanaka, Tomohiro; Nishida, Motohiro] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi, Japan; [Numaga-Tomita, Takuro; Oda, Sayaka; Nishida, Motohiro] Grad Univ Adv Studies, Sch Life Sci, SOKENDAI, Okazaki, Aichi, Japan; [Shimauchi, Tsukasa; Nishiyama, Kazuhiro; Nishimura, Akiyuki; Nishida, Motohiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka, Fukuoka, Japan; [Shimauchi, Tsukasa] Kyushu Univ, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan; [Birnbaumer, Lutz] NIEHS, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Birnbaumer, Lutz] Catholic Univ Argentina, Inst Biomed Res BIOMED, Buenos Aires, DF, Argentina; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Graduate University for Advanced Studies - Japan; Kyushu University; Kyushu University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kyoto University	Nishida, M (corresponding author), Natl Inst Physiol Sci, Div Cardiocirculatory Signaling, Higashiyama 5-1,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.; Nishida, M (corresponding author), Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Higashiyama 5-1,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	nishida@nips.ac.jp		Nishida, Motohiro/0000-0002-2587-5458; SHIMAUCHI, Tsukasa/0000-0002-9834-4770; Nishiyama, Kazuhiro/0000-0002-6263-3562; sha shi xiang, xiao tian/0000-0003-3901-4760	JSPS KAKENHI [16H05092, 19H03383, 17K15585]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [15K21759, 18H04993]; Ono Medical Research Foundation; Intramural Research Program of the U.S. National Institutes of Health (Bethesda, MD, USA) [ZO1-ES-101684]; Cooperative Study Program of National Institute for Physiological Sciences; Spectrography and Bioimaging Facility, National Institute for Basic Biology Core Research Facilities	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Intramural Research Program of the U.S. National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooperative Study Program of National Institute for Physiological Sciences; Spectrography and Bioimaging Facility, National Institute for Basic Biology Core Research Facilities	The authors thank Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. This research was funded by grants from JSPS KAKENHI [16H05092 and 19H03383 (to M.N.) and 17K15585 (to T.N.-T.)]; Scientific Research on Innovative Areas (Research in a Proposed Research Area 15K21759 "Oxygen Biology" to Y.M. and M.N., and 18H04993 "Living in Space" to T.N.-T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ono Medical Research Foundation (to M.N.); and by the Intramural Research Program of the U.S. National Institutes of Health (Bethesda, MD, USA) (Project ZO1-ES-101684 to L.B.). This work was also supported by the Cooperative Study Program of National Institute for Physiological Sciences and Spectrography and Bioimaging Facility, National Institute for Basic Biology Core Research Facilities. The authors declare no conflicts of interest.	Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Burtenshaw D, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040090; Chiong M, 2013, VASA, V42, P8, DOI 10.1024/0301-1526/a000243; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Fernandez RA, 2015, AM J PHYSIOL-CELL PH, V308, pC581, DOI 10.1152/ajpcell.00202.2014; Frismantiene A, 2018, CELL SIGNAL, V52, P48, DOI 10.1016/j.cellsig.2018.08.019; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Ichikawa J, 2014, BRIT J PHARMACOL, V171, P5280, DOI 10.1111/bph.12840; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Itsuki K, 2014, J GEN PHYSIOL, V143, P183, DOI 10.1085/jgp.201311033; Johansson-Percival A, 2015, CELL REP, V13, P2687, DOI 10.1016/j.celrep.2015.12.004; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Levin M, 2012, BIOESSAYS, V34, P205, DOI 10.1002/bies.201100136; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Malczyk M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00707; Mancarella S, 2013, FASEB J, V27, P893, DOI 10.1096/fj.12-215293; Merlet E, 2013, CARDIOVASC RES, V98, P458, DOI 10.1093/cvr/cvt045; Monet M, 2012, J BIOL CHEM, V287, P17672, DOI 10.1074/jbc.M112.341354; Muto A, 2007, J VASC SURG, V45, p15A, DOI 10.1016/j.jvs.2007.02.061; Nishimura A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac9187; Nishioka K, 2011, ARTERIOSCL THROM VAS, V31, P2278, DOI 10.1161/ATVBAHA.110.221010; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Otsuka H, 2006, ANN VASC SURG, V20, P646, DOI 10.1007/s10016-006-9100-5; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park B, 2010, J VASC SURG, V51, P165, DOI 10.1016/j.jvs.2009.08.045; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Tu P, 2010, J NEUROCHEM, V112, P204, DOI 10.1111/j.1471-4159.2009.06446.x; Waldron GJ, 1999, CLIN EXP PHARMACOL P, V26, P180, DOI 10.1046/j.1440-1681.1999.03006.x; Yao X., 2007, V179, P527; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619	41	18	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9785	9796		10.1096/fj.201802811R	http://dx.doi.org/10.1096/fj.201802811R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162976	Green Published			2022-12-26	WOS:000482214200009
J	Poser, SW; Otto, O; Arps-Forker, C; Ge, Y; Herbig, M; Andree, C; Gruetzmann, K; Adasme, MF; Stodolak, S; Nikolakopoulou, P; Park, DM; Mcintyre, A; Lesche, M; Dahl, A; Lennig, P; Bornstein, SR; Schroeck, E; Klink, B; Leker, RR; Bickle, M; Chrousos, GP; Schroeder, M; Cannistraci, CV; Guck, J; Androutsellis-Theotokis, A				Poser, Steven W.; Otto, Oliver; Arps-Forker, Carina; Ge, Yan; Herbig, Maik; Andree, Cordula; Gruetzmann, Konrad; Adasme, Melissa F.; Stodolak, Szymon; Nikolakopoulou, Polyxeni; Park, Deric M.; Mcintyre, Alan; Lesche, Mathias; Dahl, Andreas; Lennig, Petra; Bornstein, Stefan R.; Schroeck, Evelin; Klink, Barbara; Leker, Ronen R.; Bickle, Marc; Chrousos, George P.; Schroeder, Michael; Cannistraci, Carlo Vittorio; Guck, Jochen; Androutsellis-Theotokis, Andreas			Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery	FASEB JOURNAL			English	Article						signal transduction; glioblastoma; brain tumor; glioma; drug repurposing	MINIMUM CURVILINEARITY; STEM-CELLS; DEFORMABILITY; HES3; EXPRESSION; GROWTH; PROLIFERATION; ACTIVATION; MECHANICS; MIGRATION	Cancer cells can switch between signaling pathways to regulate growth under different conditions. In the tumor microenvironment, this likely helps them evade therapies that target specific pathways. We must identify all possible states and utilize them in drug screening programs. One such state is characterized by expression of the transcription factor Hairy and Enhancer of Split 3 (HES3) and sensitivity to HES3 knockdown, and it can be modeled in vitro. Here, we cultured 3 primary human brain cancer cell lines under 3 different culture conditions that maintain low, medium, and high HES3 expression and characterized gene regulation and mechanical phenotype in these states. We assessed gene expression regulation following HES3 knockdown in the HES3-high conditions. We then employed a commonly used human brain tumor cell line to screen Food and Drug Administration (FDA)-approved compounds that specifically target the HES3-high state. We report that cells from multiple patients behave similarly when placed under distinct culture conditions. We identified 37 FDA-approved compounds that specifically kill cancer cells in the high-HES3-expression conditions. Our work reveals a novel signaling state in cancer, biomarkers, a strategy to identify treatments against it, and a set of putative drugs for potential repurposing.-Poser, S. W., Otto, O., Arps-Forker, C., Ge, Y., Herbig, M., Andree, C., Gruetzmann, K., Adasme, M. F., Stodolak, S., Nikolakopoulou, P., Park, D. M., Mcintyre, A., Lesche, M., Dahl, A., Lennig, P., Bornstein, S. R., Schroeck, E., Klink, B., Leker, R. R., Bickle, M., Chrousos, G. P., Schroeder, M., Cannistraci, C. V., Guck, J., Androutsellis-Theotokis, A. Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery.	[Poser, Steven W.; Arps-Forker, Carina; Nikolakopoulou, Polyxeni; Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas] Tech Univ Dresden, Dept Internal Med 3, Dresden, Germany; [Otto, Oliver; Ge, Yan; Herbig, Maik; Adasme, Melissa F.; Lesche, Mathias; Dahl, Andreas; Schroeder, Michael; Guck, Jochen] Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany; [Ge, Yan; Cannistraci, Carlo Vittorio] Tech Univ Dresden, Biomed Cybernet Grp, Dept Phys, Biotechnol Ctr BIOTEC,CMCB,CSBD, Dresden, Germany; [Lennig, Petra] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Dresden, Germany; [Schroeck, Evelin; Klink, Barbara] Tech Univ Dresden, Inst Clin Genet, Fac Med Carl Gustav Carus, Dresden, Germany; [Andree, Cordula; Bickle, Marc] Max Planck Inst Mol Cell Biol & Genet, Technol Dev Studio, Dresden, Germany; [Gruetzmann, Konrad; Schroeck, Evelin; Klink, Barbara] NCT, Core Unit Mol Tumor Diagnost CMTD, Dresden, Germany; [Gruetzmann, Konrad; Schroeck, Evelin; Klink, Barbara] German Canc Consortium DKTK, Dresden, Germany; [Gruetzmann, Konrad] German Canc Res Ctr, Heidelberg, Germany; [Stodolak, Szymon; Mcintyre, Alan; Androutsellis-Theotokis, Andreas] Univ Nottingham, Div Canc & Stem Cells, Nottingham, England; [Park, Deric M.] Univ Chicago, Dept Neurol, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA; [Park, Deric M.; Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas] Innate Repair, London, England; [Lesche, Mathias; Dahl, Andreas; Androutsellis-Theotokis, Andreas] Ctr Regenerat Therapies Dresden, Dresden, Germany; [Leker, Ronen R.] Hadassah Hebrew Univ Med Ctr, Stroke Unit, Dept Neurol, Stroke Ctr, Jerusalem, Israel; [Leker, Ronen R.] Hadassah Hebrew Univ Med Ctr, Peritz & Chantal Sheinberg Cerebrovasc Res Lab, Jerusalem, Israel; [Chrousos, George P.] Univ Athens, Sch Med, Dept Pediat 1, Athens, Greece; [Chrousos, George P.] Aghia Sophia Childrens Hosp, Athens, Greece; [Cannistraci, Carlo Vittorio] IRCCS Ctr Neurolesi Bonino Pulejo, BBC Lab, Messina, Italy	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Nottingham; University of Chicago; Technische Universitat Dresden; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; IRCCS Bonino Pulejo	Androutsellis-Theotokis, A (corresponding author), Tech Univ Dresden, Univ Klinikum Carl Gustav, Med Klin & Poliklin 3, Haus 27 DINZ,1-OG,Zimmer 1-642,Fetscherstr 74, D-01307 Dresden, Germany.; Androutsellis-Theotokis, A (corresponding author), Tech Univ Dresden, Univ Klinikum Carl Gustav, Zentrum Innere Med, Haus 27 DINZ,1-OG,Zimmer 1-642,Fetscherstr 74, D-01307 Dresden, Germany.	andreas.theotokis@uniklinikum-dresden.de	Nikolakopoulou, Polyxeni/GOV-7024-2022; Dahl, Andreas/E-3783-2017; Herbig, Maik/AAN-4418-2021; Leker, Ronen/ABC-6096-2020; Guck, Jochen/B-4412-2014; Otto, Oliver/Q-9016-2017	Nikolakopoulou, Polyxeni/0000-0002-1695-9545; Dahl, Andreas/0000-0002-2668-8371; Herbig, Maik/0000-0001-7592-7829; Leker, Ronen/0000-0003-4794-0334; Guck, Jochen/0000-0002-1453-6119; Adasme, Melissa/0000-0003-2217-4629; McIntyre, Alan/0000-0002-4791-7292; Poser, Steven/0000-0003-4868-1389; Otto, Oliver/0000-0003-0280-5374; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589; Klink, Barbara/0000-0002-8753-8238	Europaischen Fonds fur regionale Entwicklung (EFRE); Deutsche Forschungsgemeinschaft [KFO249, GU 612/2-2, CRC/Transregio 205/1, IRTG 2251]; Alexander-von-Humboldt Foundation; Sachsisches Ministerium fur Wissenschaft und Kunst [TG70]; Technische Universitat Dresden; TransCampus initiative; MRC [MR/P010334/1] Funding Source: UKRI	Europaischen Fonds fur regionale Entwicklung (EFRE); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Sachsisches Ministerium fur Wissenschaft und Kunst; Technische Universitat Dresden; TransCampus initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to the Microstructure Facility of Biotechnology Center (BIOTEC)/Center for Regenerative Therapies Dresden (CRTD), Technische Universitat Dresden, funded by the Europaischen Fonds fur regionale Entwicklung (EFRE) for the production of real-time deformability cytometry microfluidic chips. The Technische Universitaet Dresden has intellectual property (patented and patent-pending) on aspects described in this manuscript for use in oncology (Inventors: A.A.-T. and S.W.P.). J.G. was supported by the Deutsche Forschungsgemeinschaft (Grant KFO249, GU 612/2-2), the Alexander-von-Humboldt Foundation (Humboldt Professorship), and the Sachsisches Ministerium fur Wissenschaft und Kunst (Grant TG70). O.O. was supported by the Sachsisches Ministerium fur Wissenschaft und Kunst (Grant TG70). C.V.C. was supported by the independent group leader starting grant of the Technische Universitat Dresden. A.A.T. was supported by the Deutsche Forschungsgemeinschaft (Grant SFB 655, "Cells into Tissues," Project A24). A.A.T. and S.R.B. were supported by the Deutsche Forschungsgemeinschaft (Grant CRC/Transregio 205/1 and Grant IRTG 2251). A. A. T. and S. R. B. were supported by the TransCampus initiative between Technische Universitat Dresden and King's College London and the Transcelerator. O.O. is cofounder at Zellmechanik Dresden (http://www.zellmechanik.com).A.A.-T.and S. R. B. are cofounders of Innate Repair (www.innaterepair.com).The authors declare no other conflicts of interest.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; ANDROUTSELLISTH.A, 2010, PLOS ONE, V0005; Bates DM, 2014, IME4 LINEAR MIXED EF; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Behan FM, 2019, NATURE; Brocard E, 2015, ONCOTARGET, V6, P6840, DOI 10.18632/oncotarget.3160; Buchert M, 2016, ONCOGENE, V35, P939, DOI 10.1038/onc.2015.150; Byun S, 2013, P NATL ACAD SCI USA, V110, P7580, DOI 10.1073/pnas.1218806110; Cannistraci CV, 2013, BIOINFORMATICS, V29, P199, DOI 10.1093/bioinformatics/btt208; Cannistraci CV, 2010, BIOINFORMATICS, V26, pi531, DOI 10.1093/bioinformatics/btq376; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fang CQ, 2019, INT J MED SCI, V16, P470, DOI 10.7150/ijms.28139; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Kendall GC, 2018, ELIFE, V7, DOI 10.7554/eLife.33800; Kodack DP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4682; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lautenschlager F, 2009, P NATL ACAD SCI USA, V106, P15696, DOI 10.1073/pnas.0811261106; Li Y, 2017, ONCOTARGET, V8, P39896, DOI 10.18632/oncotarget.16379; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lobe CG, 1997, MECH DEVELOP, V62, P227, DOI 10.1016/S0925-4773(97)00665-5; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo J, 2002, SCIENCE, V298, P425, DOI 10.1126/science.1074549; Masjkur J, 2016, DIABETES, V65, P314, DOI 10.2337/db15-1099; Masjkur J, 2014, J BIOL CHEM, V289, P35503, DOI 10.1074/jbc.M114.590687; Masjkur J, 2014, STEM CELL TRANSL MED, V3, P801, DOI 10.5966/sctm.2013-0211; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mietke A, 2015, BIOPHYS J, V109, P2023, DOI 10.1016/j.bpj.2015.09.006; Mukthavaram R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0627-5; Nikolakopoulou P, 2016, HORM METAB RES, V48, P77, DOI 10.1055/s-0041-111699; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Osanai K, 2017, HUM CELL, V30, P209, DOI 10.1007/s13577-017-0169-7; Otto O, 2015, NAT METHODS, V12, P199, DOI 10.1038/nmeth.3281; Park DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01095; Poser SW, 2015, STEM CELL TRANSL MED, V4, P1251, DOI 10.5966/sctm.2015-0105; Poser SW, 2013, JOVE-J VIS EXP, DOI 10.3791/50880; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Salewski RP, 2013, STEM CELLS DEV, V22, P383, DOI 10.1089/scd.2012.0218; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Toutouna L, 2016, BRAIN RES, V1642, P124, DOI 10.1016/j.brainres.2016.03.014; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang CC, 2012, CLIN CANCER RES, V18, P5008, DOI 10.1158/1078-0432.CCR-12-1379; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P18707, DOI 10.1073/pnas.1209893109; Zheng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep07613	56	3	3	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9235	9249		10.1096/fj.201802603RR	http://dx.doi.org/10.1096/fj.201802603RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145643	Bronze			2022-12-26	WOS:000478832900043
J	Wang, C; Zhang, B; Ratliff, AC; Arrington, J; Chen, JJ; Xiong, Y; Yue, F; Nie, YH; Hu, KP; Jin, W; Tao, WA; Hrycyna, CA; Sun, XB; Kuang, SH				Wang, Chao; Zhang, Bin; Ratliff, Anna C.; Arrington, Justine; Chen, Jingjuan; Xiong, Yan; Yue, Feng; Nie, Yaohui; Hu, Keping; Jin, Wen; Tao, W. Andy; Hrycyna, Christine A.; Sun, Xiaobo; Kuang, Shihuan			Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers	FASEB JOURNAL			English	Article						Mettl21e; Myostatin; non-histone methylation; muscle atrophy; VCP/p97	GENE-EXPRESSION; PROTEIN-SYNTHESIS; MUSCLE; SLOW; CALCINEURIN; METHYLATION; ACTIVATION; MYOSTATIN; IDENTIFICATION; STIMULATION	Skeletal muscles contain heterogeneous myofibers that are different in size and contractile speed, with type IIb myofiber being the largest and fastest. Here, we identify methyltransferase-like 21e (Mettl21e), a member of newly classified nonhistone methyltransferases, as a gene enriched in type IIb myofibers. The expression of Mettl21e was strikingly up-regulated in hypertrophic muscles and during myogenic differentiation in vitro and in vivo. Knockdown (KD) of Mettl21e led to atrophy of cultured myotubes, and targeted mutation of Mettl21e in mice reduced the size of IIb myofibers without affecting the composition of myofiber types. Mass spectrometry and methyltransferase assay revealed that Mettl21e methylated valosin-containing protein (Vcp/p97), a key component of the ubiquitin-proteasome system. KD or knockout of Mettl21e resulted in elevated 26S proteasome activity, and inhibition of proteasome activity prevented atrophy of Mettl21e KD myotubes. These results demonstrate that Mettl21e functions to maintain myofiber size through inhibiting proteasome-mediated protein degradation.-Wang, C., Zhang, B., Ratliff, A. C., Arrington, J., Chen, J., Xiong, Y., Yue, F., Nie, Y., Hu, K., Jin, W., Tao, W. A., Hrycyna, C. A., Sun, X., Kuang, S. Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.	[Wang, Chao; Chen, Jingjuan; Yue, Feng; Nie, Yaohui; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Ratliff, Anna C.; Arrington, Justine; Hrycyna, Christine A.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tao, W. Andy; Hrycyna, Christine A.; Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Zhang, Bin; Xiong, Yan; Hu, Keping; Jin, Wen; Sun, Xiaobo] Chinese Acad Med Sci, Inst Med Plant Dev, Peking Union Med Coll, Beijing, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Wang, C; Kuang, SH (corresponding author), Purdue Univ, 174B Smith Hall,901 West State St, W Lafayette, IN 47907 USA.	wang1438@purdue.edu; skuang@purdue.edu	Wang, Chao/V-8994-2019	Wang, Chao/0000-0002-4051-364X; Arrington, Justine/0000-0003-1511-8805	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR071649]; Innovation Fund for Medical Sciences (CIFMS) from Chinese Academy of Medical Sciences [2016-I2M-1-012]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071649] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Innovation Fund for Medical Sciences (CIFMS) from Chinese Academy of Medical Sciences; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Fengfeng Zhang (ViewSolid Biotech, Beijing, China) for generating the methyltransferase-like 21e knockout mice, Chris Bidwell (Purdue University, West Lafayette, IN, USA) for discussion and sharing Callipyge sheep data, Jessie Ellis (Purdue University) for technical assistance, Jun Wu (Purdue University) and Mary Larimore (Purdue University) for mouse colony maintenance, and members of the Kuang laboratory for valuable comments. This work was supported by a grant from the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (R01AR071649) and Innovation Fund for Medical Sciences (CIFMS) from Chinese Academy of Medical Sciences (2016-I2M-1-012). The authors declare no conflicts of interest.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Bidwell CA, 2014, ANIM GENET, V45, P51, DOI 10.1111/age.12132; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caetano-Anolles K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116828; Carpenter E, 1996, J ANIM SCI, V74, P388; Clemen CS, 2015, BIOCHEM BIOPH RES CO, V463, P1210, DOI 10.1016/j.bbrc.2015.06.086; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; GOLDBERG AL, 1967, NATURE, V216, P1219, DOI 10.1038/2161219a0; Hamey JJ, 2017, MOL CELL PROTEOMICS, V16, P2229, DOI 10.1074/mcp.M116.066308; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Jakobsson ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131426; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Kubik RM, 2018, TRANSL ANIM SCI, V2, pS53, DOI 10.1093/tas/txy053; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee KY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9054; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Ma ZP, 2019, NATURE, V568, P259, DOI 10.1038/s41586-019-1057-y; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Reza MM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01131-0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Stark DA, 2015, J CELL BIOL, V211, P1077, DOI 10.1083/jcb.201502036; TSENG BS, 1994, CELL TISSUE RES, V275, P39, DOI 10.1007/BF00305374; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Wang C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2279; Wang C, 2017, DEVELOPMENT, V144, P235, DOI 10.1242/dev.138099; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Wiederstein JL, 2018, CELL REP, V23, P1342, DOI 10.1016/j.celrep.2018.03.136; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26	50	7	7	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9672	9684		10.1096/fj.201900582R	http://dx.doi.org/10.1096/fj.201900582R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31162944	Green Published			2022-12-26	WOS:000478832900075
J	Espiritu, EB; Jiang, HJ; Moreau-Marquis, S; Sullivan, M; Yan, K; Stolz, DB; Sampson, MG; Hukriede, NA; Swiatecka-Urban, A				Espiritu, Eugenel B.; Jiang, Huajun; Moreau-Marquis, Sophie; Sullivan, Mara; Yan, Kunimasa; Stolz, Donna Beer; Sampson, Matthew G.; Hukriede, Neil A.; Swiatecka-Urban, Agnieszka			The human nephrin (YRSL)-R-1139 motif is essential for podocyte foot process organization and slit diaphragm formation during glomerular development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell culture; cell adhesion; cell surface protein; cell-cell interaction; zebrafish; podocyte; nephrology; endocytosis; clathrin; clathrin-dependent endocytosis; foot processes; nephrin; nephrotic syndrome; slit diaphragm; kidney; glomerulus	TRANSMEMBRANE CONDUCTANCE REGULATOR; CONGENITAL NEPHROTIC SYNDROME; DIABETIC-NEPHROPATHY; ZEBRAFISH PRONEPHROS; PROTEIN; ENDOCYTOSIS; EXPRESSION; L1; MUTATIONS; ADHESION	Nephrin is an immunoglobulin-type cell-adhesion molecule with a key role in the glomerular interpodocyte slit diaphragm. Mutations in the nephrin gene are associated with defects in the slit diaphragm, leading to early-onset nephrotic syndrome, typically resistant to treatment. Although the endocytic trafficking of nephrin is essential for the assembly of the slit diaphragm, nephrin's specific endocytic motifs remain unknown. To search for endocytic motifs, here we performed a multisequence alignment of nephrin and identified a canonical YXXO-type motif, (YRSL)-R-1139, in the nephrin cytoplasmic tail, expressed only in primates. Using site-directed mutagenesis, various biochemical methods, single-plane illumination microscopy, a human podocyte line, and a human nephrin-expressing zebrafish model, we found that (YRSL)-R-1139 is a novel endocytic motif and a structural element for clathrin-mediated nephrin endocytosis that functions as a phosphorylation-sensitive signal. We observed that (YRSL)-R-1139 motif-mediated endocytosis helps to localize nephrin to specialized plasma membrane domains in podocytes and is essential for normal foot process organization into a functional slit diaphragm between neighboring foot processes in zebrafish. The importance of nephrin (YRSL)-R-1139 for healthy podocyte development was supported by population-level analyses of genetic variations at this motif, revealing that such variations are very rare, suggesting that mutations in this motif have autosomal-recessive negative effects on kidney health. These findings expand our understanding of the mechanism underlying nephrin endocytosis and may lead to improved diagnostic tools or therapeutic strategies for managing early-onset, treatment-resistant nephrotic syndrome.	[Espiritu, Eugenel B.; Hukriede, Neil A.] Univ Pittsburgh, Dept Dev Biol, Sch Med, Pittsburgh, PA 15201 USA; [Jiang, Huajun; Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15224 USA; [Moreau-Marquis, Sophie] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Sullivan, Mara; Stolz, Donna Beer] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Dept Nephrol, Sch Med, Pittsburgh, PA 15201 USA; [Yan, Kunimasa] Kyorin Univ, Dept Pediat, Sch Med, Mitaka, Tokyo 1818611, Japan; [Sampson, Matthew G.] Univ Michigan, Sch Med, Dept Pediat Nephrol, Ann Arbor, MI 48109 USA; [Jiang, Huajun] Huazhong Univ Sci & Technol, Union Hosp, Dept Nephrol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyorin University; University of Michigan System; University of Michigan; Huazhong University of Science & Technology	Swiatecka-Urban, A (corresponding author), UPMC Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15201 USA.	asurban@pitt.edu	Swiatecka-Urban, Agnieszka/AAP-6041-2020; Sampson, Matthew/U-4501-2017	Sampson, Matthew/0000-0001-9560-076X; Hukriede, Neil/0000-0002-9655-9030; Swiatecka-Urban, Agnieszka/0000-0002-6575-0334	National Institutes of Health [T32DK061296, P30DK06010, 1S10RR019003-01]; American Heart Association [15GRNT25700019]; NephCure Kidney International Grant [2012-RFE-003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL144539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, T32DK061296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NephCure Kidney International Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants T32DK061296 (to E.B.E.) and P30DK06010 and 1S10RR019003-01 (to N. A. H.), American Heart Association Grant 15GRNT25700019 (to A. S. U.), and NephCure Kidney International Grant 2012-RFE-003 (to A. S. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6; Babayeva S, 2013, J BIOL CHEM, V288, P24035, DOI 10.1074/jbc.M113.452904; Benigni A, 2004, KIDNEY INT, V65, P2193, DOI 10.1111/j.1523-1755.2004.00636.x; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brummendorf T, 2001, CURR OPIN CELL BIOL, V13, P611, DOI 10.1016/S0955-0674(00)00259-3; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cihil KM, 2012, J BIOL CHEM, V287, P15087, DOI 10.1074/jbc.M112.341875; Conti S, 2017, CURR OPIN NEPHROL HY, V26, P148, DOI 10.1097/MNH.0000000000000322; Datta N, 2016, EXP CELL RES, V340, P32, DOI 10.1016/j.yexcr.2015.10.035; DELARUE F, 1991, KIDNEY INT, V40, P906, DOI 10.1038/ki.1991.292; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fornoni A, 2010, DIABETES, V59, P190, DOI 10.2337/db09-0655; Fukuyo Y, 2014, MOL MED REP, V9, P457, DOI 10.3892/mmr.2013.1844; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Haraldsson B, 2009, CURR OPIN NEPHROL HY, V18, P331, DOI 10.1097/MNH.0b013e32832c9dba; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ichimura K, 2013, J HISTOCHEM CYTOCHEM, V61, P313, DOI 10.1369/0022155413477115; Ichimura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045286; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Jeon J, 2012, J BIOL CHEM, V287, P28932, DOI 10.1074/jbc.M112.389452; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 1998, MOL CELL NEUROSCI, V12, P48, DOI 10.1006/mcne.1998.0702; Kapodistria K, 2015, MOL CELL ENDOCRINOL, V400, P112, DOI 10.1016/j.mce.2014.11.003; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JJ, 2007, J AM SOC NEPHROL, V18, P2303, DOI 10.1681/ASN.2006101145; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y; Lenkkeri U, 1999, AM J HUM GENET, V64, P51, DOI 10.1086/302182; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Long KE, 2001, J BIOL CHEM, V276, P1285, DOI 10.1074/jbc.M006658200; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Martin CE, 2018, J AM SOC NEPHROL, V29, P92, DOI 10.1681/ASN.2017030285; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nielsen MS, 2008, TRAFFIC, V9, P980, DOI 10.1111/j.1600-0854.2008.00731.x; Nishimura N, 2009, FRONT BIOSCI-LANDMRK, V14, P2115, DOI 10.2741/3366; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Palmen T, 2001, DIABETOLOGIA, V44, P1274, DOI 10.1007/s001250100641; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schenk H, 2017, CELL TISSUE RES, V369, P127, DOI 10.1007/s00441-017-2593-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schoeb DS, 2010, NEPHROL DIAL TRANSPL, V25, P2970, DOI 10.1093/ndt/gfq088; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shono A, 2009, HUM MOL GENET, V18, P2943, DOI 10.1093/hmg/ddp232; Sugie A, 2010, DEVELOPMENT, V137, P3303, DOI 10.1242/dev.047332; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093999; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00032; Swiatecka-Urban A, 2013, PEDIATR NEPHROL, V28, P1723, DOI 10.1007/s00467-012-2281-y; Takeda Y, 1996, J NEUROCHEM, V66, P2338; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881	75	4	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10773	10788		10.1074/jbc.RA119.008235	http://dx.doi.org/10.1074/jbc.RA119.008235			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31152064	Green Published, hybrid			2022-12-26	WOS:000478717200005
J	Cheng, CH; Chen, HH				Cheng, Ching-Hsue; Chen, Hsien-Hsiu			Sentimental text mining based on an additional features method for text classification	PLOS ONE			English	Article							ONLINE PRODUCT REVIEWS; INTELLIGENCE	Owing to the emergence of the Internet and its rapid growth, people can use mobile devices on many social media platforms (blogs, Facebook forums, etc.), and the platforms provide wellknown websites for people to express and share their daily activities and ideas on global issues. Many consumers utilize product review websites before making a purchase. Many well-known websites are searched for relevant product reviews and experiences of product use. We can easily collect large amounts of structured and unstructured product data and further analyze the data to determine the desired product information. For this reason, many researchers are gradually focusing on sentiment analysis or opinion exploration (opinion mining) and use this technique to extract and analyze customer opinions and emotions. This paper proposes a sentimental text mining method based on an additional features method to enhance accuracy and reduce implementation time and uses singular value decomposition and principal component analysis for data dimension reduction. This study has four contributions: (1) the proposed algorithm for preprocessing the data for sentiment classification, (2) the additional features to enhance the accuracy of the sentiment classification, (3) the application of singular value decomposition and principal component analysis for data dimension reduction, and (4) the design of five modules based on different features, with or without stemming, to compare the performance results. The experimental results show that the proposed method has better accuracy than other methods and that the proposed method can decrease the implementation time.	[Cheng, Ching-Hsue; Chen, Hsien-Hsiu] Natl Yunlin Univ Sci & Tech, Dept Informat Management, Touliu, Yunlin, Taiwan		Cheng, CH (corresponding author), Natl Yunlin Univ Sci & Tech, Dept Informat Management, Touliu, Yunlin, Taiwan.	chcheng@yuntech.edu.tw	Cheng, Ching-Hsue/D-1785-2012	Cheng, Ching-Hsue/0000-0002-5509-6965				Abbasi A, 2011, IEEE T KNOWL DATA EN, V23, P447, DOI 10.1109/TKDE.2010.110; Alfonso J., 2007, P PRIS 2007 FUNCH PO, P59; [Anonymous], 2005, ACM INT C INF KNOWL, DOI DOI 10.1145/1099554.1099714; Archak N, 2011, MANAGE SCI, V57, P1485, DOI 10.1287/mnsc.1110.1370; Bollegala D, 2013, IEEE T KNOWL DATA EN, V25, P1719, DOI 10.1109/TKDE.2012.103; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng C, 2016, AER ADV ENG RES, V75, P150; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Hersh W., 1994, P 17 ANN INT ACM SIG, P192, DOI DOI 10.1007/978-1-4471-2099-5_20; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Kang B, 2016, J PETROL SCI ENG, V141, P114, DOI 10.1016/j.petrol.2016.01.015; Kang D, 2014, EXPERT SYST APPL, V41, P1041, DOI 10.1016/j.eswa.2013.07.101; Lewis D. D., 1998, P EURP C MACH LEARN; Li ST, 2013, KNOWL-BASED SYST, V39, P23, DOI 10.1016/j.knosys.2012.10.005; Li YM, 2013, DECIS SUPPORT SYST, V55, P206, DOI 10.1016/j.dss.2013.01.023; Liu LY, 2005, PROCEEDINGS OF THE 2005 IEEE INTERNATIONAL CONFERENCE ON NATURAL LANGUAGE PROCESSING AND KNOWLEDGE ENGINEERING (IEEE NLP-KE'05), P597; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; McCallum A, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P662; Medhat W, 2014, AIN SHAMS ENG J, V5, P1093, DOI 10.1016/j.asej.2014.04.011; Montoyo A., 2012, SUBJECTIVITY SENTIME; Moraes R, 2013, EXPERT SYST APPL, V40, P621, DOI 10.1016/j.eswa.2012.07.059; Niles I, 2003, IKE'03: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON INFORMATION AND KNOWLEDGE ENGINEERING, VOLS 1 AND 2, P412; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Pang B, 2004, ANN M ASS COMP LING, DOI DOI 10.3115/1218955.1218990; Parmar H., 2014, C INT C INF SCI KER; Rahate Rohini S., 2013, INT J COMPUTER APPL, V84, P24, DOI [10.5120/14573-2697, DOI 10.5120/14573-2697]; Ravi K, 2015, KNOWL-BASED SYST, V89, P14, DOI 10.1016/j.knosys.2015.06.015; Rui HX, 2013, DECIS SUPPORT SYST, V55, P863, DOI 10.1016/j.dss.2012.12.022; Saleh MR, 2011, EXPERT SYST APPL, V38, P14799, DOI 10.1016/j.eswa.2011.05.070; Tan SB, 2009, LECT NOTES COMPUT SC, V5478, P337; Tsytsarau M, 2012, DATA MIN KNOWL DISC, V24, P478, DOI 10.1007/s10618-011-0238-6; Weathers D, 2015, DECIS SUPPORT SYST, V79, P12, DOI 10.1016/j.dss.2015.07.009; Xiao SS, 2016, INFORM MANAGE-AMSTER, V53, P169, DOI 10.1016/j.im.2015.09.010; Yu X, 2014, OPTIK, V125, P1498, DOI 10.1016/j.ijleo.2013.09.013	35	4	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217591	10.1371/journal.pone.0217591	http://dx.doi.org/10.1371/journal.pone.0217591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166975	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800033
J	Bilibio, JP; Monego, HI; Binda, MLA; dos Reis, R				Bilibio, Joao Paolo; Monego, Heleusa Ione; Appel Binda, Marcia Luiza; dos Reis, Ricardo			Menopausal status is associated with a high risk for residual disease after cervical conization with positive margins	PLOS ONE			English	Article							COLD-KNIFE CONIZATION; LARGE LOOP EXCISION; INTRAEPITHELIAL NEOPLASIA; TRANSFORMATION ZONE; UTERINE CERVIX; SEX-HORMONES; LESIONS; PREVENTION; IMMUNITY	Background We aimed to determine demographic and clinicopathological predictors for residual disease in women with cervical intraepithelial neoplasia (CIN 2/3) with endocervical cone margin involvement. Methods and findings A cross-sectional study was conducted. The eligible patients were women who underwent hysterectomy as a treatment option after having a positive endocervical margin for CIN 2/3 in cervix conization specimens from 2000 to 2015. The patients were divided into two groups based on the persistence of CIN 2/3 and absence of CIN 2/3 in hysterectomy specimens. Demographic, clinical and histology information were collected in both groups. A total of 80 patients were eligible for the study; 37 (46.3%) had no persistence of CIN 2/3 and 43 (53.7%) had persistence of CIN 2/3 in the hysterectomy specimens. Demographic, clinical, and cone specimen characteristics, and a visible squamocolumnar junction and type of conization were analyzed as possible risk factors for the presence of residual lesions at hysterectomy, and none of these variables were associated with residual disease. Menopausal status was strongly associated with a high risk of persistent residual disease 81.2% (OR 4.9, CI 1.27-18.9), P = 0.014. In the multivariate analysis, only a menopausal status (P = 0.04) was associated with a high risk of persistent lesions. Conclusion This analysis found that menopausal status exhibited an important association with persistent residual disease. Menopausal women with endocervical margin involvement exhibit a greater than 80% risk of persistent lesions.	[Bilibio, Joao Paolo] Univ Fed Rio Grande do Sul, Postdoctoral Program, Programa Pos Grad Ciencias Med, Porto Alegre, RS, Brazil; [Bilibio, Joao Paolo] Univ Fed Para, Dept Obstet & Gynecol, Belem, Para, Brazil; [Monego, Heleusa Ione; Appel Binda, Marcia Luiza] Univ Fed Rio Grande do Sul, Dept Obstet & Gynecol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [dos Reis, Ricardo] Barretos Canc Hosp, Dept Gynecol Oncol, Sao Paulo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Para; Universidade Federal do Rio Grande do Sul; Hospital de Cancer de Barretos	Bilibio, JP (corresponding author), Univ Fed Rio Grande do Sul, Postdoctoral Program, Programa Pos Grad Ciencias Med, Porto Alegre, RS, Brazil.	joaopaolobilibio@yahoo.com.br	Bilibio, João/AAN-1492-2020	Bilibio, Joao Paolo/0000-0003-4755-170X				Abdi F, 2016, CLIMACTERIC, V19, P234, DOI 10.3109/13697137.2016.1164136; [Anonymous], 2016, J BRAZ CERV CANC SCR; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Ayhan A, 2016, EUR J OBSTET GYN R B, V201, P1, DOI 10.1016/j.ejogrb.2016.03.021; Bae HS, 2013, ACTA OBSTET GYN SCAN, V92, P185, DOI 10.1111/aogs.12025; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Chambo Filho Antonio, 2015, J Clin Med Res, V7, P540, DOI 10.14740/jocmr2171w; Chikazawa K, 2016, J OBSTET GYNAECOL RE, V42, P457, DOI 10.1111/jog.12929; Das N, 2005, GYNECOL ONCOL, V97, P751, DOI 10.1016/j.ygyno.2005.01.003; Melli PPD, 2016, INT J GYNECOL OBSTET, V133, P234, DOI 10.1016/j.ijgo.2015.09.020; El-Nashar SA, 2017, J LOW GENIT TRACT DI, V21, P129, DOI 10.1097/LGT.0000000000000287; FELIX JC, 1994, OBSTET GYNECOL, V84, P996; Fonseca FV, 2011, REV BRAS GINECOL OBS, V33, P334, DOI 10.1590/S0100-72032011001100003; Gardeil F, 1997, OBSTET GYNECOL, V89, P419, DOI 10.1016/S0029-7844(96)00505-4; Kliemann LM, 2012, EUR J OBSTET GYN R B, V165, P342, DOI 10.1016/j.ejogrb.2012.08.016; MAHADEVAN N, 1993, BRIT J OBSTET GYNAEC, V100, P794, DOI 10.1111/j.1471-0528.1993.tb14292.x; Munk AC, 2007, APMIS, V115, P1409, DOI 10.1111/j.1600-0463.2007.00769.x; Papoutsis D, 2013, GYNECOL OBSTET INVES, V75, P163, DOI 10.1159/000345864; Papoutsis D, 2011, IN VIVO, V25, P691; Saslow D, 2012, J LOW GENIT TRACT DI, V16, P175, DOI 10.1097/LGT.0b013e31824ca9d5; Shaco-Levy R, 2014, INT J GYNECOL PATHOL, V33, P83, DOI 10.1097/PGP.0b013e3182763158; Siriaree Sitthicha, 2006, Asian Pac J Cancer Prev, V7, P463; Tasci T, 2015, J LOW GENIT TRACT DI, V19, P115, DOI 10.1097/LGT.0000000000000079; Wira CR, 2014, AM J REPROD IMMUNOL, V72, P236, DOI 10.1111/aji.12252; Xiang LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131790	25	4	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217562	10.1371/journal.pone.0217562	http://dx.doi.org/10.1371/journal.pone.0217562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163055	Green Submitted, gold, Green Published			2022-12-26	WOS:000470086200018
J	Hsouna, H; Abdessalem, R; Boukhris, O; Trabelsi, K; Chtourou, L; Tahri, N; Engel, FA; Shephard, RJ; Chtourou, H				Hsouna, Hsen; Abdessalem, Raouf; Boukhris, Omar; Trabelsi, Khaled; Chtourou, Lassaad; Tahri, Nabil; Engel, Florian A.; Shephard, Roy J.; Chtourou, Hamdi			Short-term maximal performance, alertness, dietary intake, sleep pattern and mood states of physically active young men before, during and after Ramadan observance	PLOS ONE			English	Article							BODY-COMPOSITION; EXERCISE; QUALITY; IMPACT; POWER	Purpose To assess changes in short-term maximal performance, alertness, dietary intake, sleep pattern and mood states of physically active young men before (BR), during and after Ramadan observance. Methods Twelve physically-active men (age: 21.9 +/- 2.4yrs, height: 1.77 +/- 0.09m, body-mass: 72.6 +/- 7.8kg, exercising: >= 3h/week) performed the 5-jump and the digit-cancellation (alertness) tests 15-days BR, on the first (FR) and last 10-days of Ramadan (ER) and 10-days (AR10) and 20-days (AR20) after Ramadan. During each period, sleep pattern (Pittsburgh-Sleep-Quality-Index (PSQI)), mood states (Profile-of-Mood-States (POMS)) and dietary intake were recorded. Results No significant changes in the 5-jump, digit-cancellation test and POMS parameters appeared during and after Ramadan relative to BR. However, the PSQI total score was lower during FR compared to AR10 (p<0.001). Specifically, the subjective sleep quality was lower (i) at BR compared to FR (p<0.05), AR10 (p<0.01) and AR20 (p<0.01) and (ii) at ER and AR20 compared to FR (p<0.05). The sleep duration (i) increased at FR (p<0.05) and (ii) decreased at AR10 (p<0.01) and AR20 (p<0.05) compared to BR. Sleep disturbances were significantly greater (i) at BR compared to FR (p<0.01), ER (p<0.01), AR10 (p<0.05) and AR20 (p<0.05) and (ii) at AR10 and AR20 compared to FR and ER (p<0.05). In terms of diet, the fractional contribution of carbohydrate (%) was lower and the dietary fat content (g) was higher during ER than AR10 and AR20 (p<0.05). Further, the dietary protein (in %) was significantly lower during FR compared to BR (p<0.01), ER (p<0.05), AR10 (p<0.05) and AR20 (p<0.05). Conclusion Ramadan had no-adverse effects on the 5-jump performance, alertness, or mood states in physically active young men. However, the sleep duration was shorter and the sleep quality was improved following compared to during Ramadan. The fractional intake of fat also increased at the expense of carbohydrate during Ramadan, and the protein intake was lower at the beginning of Ramadan than before, at the end of and after Ramadan.	[Hsouna, Hsen; Abdessalem, Raouf; Boukhris, Omar; Trabelsi, Khaled] Univ Sfax, High Inst Sport & Phys Educ, UR15JS01 Educ Motricite Sport & Sante EM2S, Sfax, Tunisia; [Chtourou, Lassaad; Tahri, Nabil] Hedi Chaker Hosp, Dept Gastroenterol & Hepatol, Sfax, Tunisia; [Engel, Florian A.] Heidelberg Univ, Dept Movement & Training, Inst Sport & Sport Sci, Heidelberg, Germany; [Shephard, Roy J.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Chtourou, Hamdi] Univ Sfax, Inst Super Sport & Educ Phys Sfax, Sfax, Tunisia; [Chtourou, Hamdi] Observ Natl Sport, UR18JS01, Act Phys Sport & Sante, Tunis, Tunisia	Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Ruprecht Karls University Heidelberg; University of Toronto; Universite de Sfax	Engel, FA (corresponding author), Heidelberg Univ, Dept Movement & Training, Inst Sport & Sport Sci, Heidelberg, Germany.	florian.engel@issw.uni-heidelberg.de	Chtourou, Hamdi/GVU-1967-2022; Trabelsi, Khaled/ABG-2717-2020; Engel, Florian/AAG-7158-2021	Chtourou, Hamdi/0000-0002-5482-9151; Trabelsi, Khaled/0000-0003-2623-9557; Engel, Florian/0000-0003-0998-2277; Lassaad, Chtourou/0000-0003-1654-5104	Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	We acknowledge and appreciate financial support by Deutsche Forschungsgemeinschaft within the funding program Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.	Abedelmalek Salma, 2011, Asian J Sports Med, V2, P154; Aloui A, 2013, BIOL RHYTHM RES, V44, P869, DOI 10.1080/09291016.2013.780697; Aloui A, 2013, INT J SPORT PHYSIOL, V8, P254, DOI 10.1123/ijspp.8.3.254; Aziz AR, 2017, SPORTS, V5, DOI 10.3390/sports5010004; Aziz AR, 2010, BRIT J SPORT MED, V44, P516, DOI 10.1136/bjsm.2009.070425; Baklouti H, 2017, PHYS THER SPORT, V24, P20, DOI 10.1016/j.ptsp.2016.10.002; Beck TW, 2013, J STRENGTH COND RES, V27, P2323, DOI 10.1519/JSC.0b013e318278eea0; Bouhlel E, 2006, DIABETES METAB, V32, P617, DOI 10.1016/S1262-3636(07)70317-8; Bouhlel E., 2015, OPTIMIZING PHYS PERF; Bouhlel E, 2008, INT J SPORT NUTR EXE, V18, P617, DOI 10.1123/ijsnem.18.6.617; Bouhlel H, 2013, CLIN J SPORT MED, V23, P222, DOI 10.1097/JSM.0b013e318275d213; Boukhris O, 2019, CHRONOBIOL INT, V36, P1, DOI 10.1080/07420528.2018.1513943; Burke LM, 2012, J SPORT SCI, V30, pS21, DOI 10.1080/02640414.2012.680484; Cayrou S., 2003, J THERAPIE COMPORTEM, V13, P83; Chamari K, 2016, BIOL SPORT, V33, P49, DOI 10.5604/20831862.1185888; Chamari K, 2008, J STRENGTH COND RES, V22, P944, DOI 10.1519/JSC.0b013e31816a57c6; Chaouachi A, 2009, J STRENGTH COND RES, V23, P2702, DOI 10.1519/JSC.0b013e3181bc17fc; Chtourou H, 2012, INT J SPORTS MED, V33, P142, DOI 10.1055/s-0031-1286251; Chtourou H, 2015, EFFECTS RAMADAN FAST; Chtourou Hamdi, 2011, Asian J Sports Med, V2, P177; Clark-Carter D., 1997, DOING QUANTITATIVE P; Farooq A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012848; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Girard O, 2012, SCI SPORT, V27, P237, DOI 10.1016/j.scispo.2011.09.006; Hammouda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079873; Hatta T, 2012, PSYCHOLOGIA, V55, P246, DOI 10.2117/psysoc.2012.246; Herrera CP, 2012, J SPORT SCI, V30, pS85, DOI 10.1080/02640414.2012.676666; Kirkendall DT, 2008, J SPORT SCI, V26, P15, DOI 10.1080/02640410802422199; Leiper JB, 2008, J SPORT SCI, V26, P55, DOI 10.1080/02640410802538176; Ramadan J, 2002, MED PRIN PRACT, V11, P41, DOI 10.1159/000066413; Roky R, 2004, ANN NUTR METAB, V48, P296, DOI 10.1159/000081076; Roky R, 2001, J SLEEP RES, V10, P319, DOI 10.1046/j.1365-2869.2001.00269.x; Simpson NS, 2017, SCAND J MED SCI SPOR, V27, P266, DOI 10.1111/sms.12703; Suleiman KH, 2010, WESTERN J NURS RES, V32, P250, DOI 10.1177/0193945909348230; SWEILEH N, 1992, J SPORT MED PHYS FIT, V32, P156; Trabelsi K., 2019, INT J SPORT STUD HLT; Trabelsi Khaled, 2011, Asian J Sports Med, V2, P134; Waterhouse J, 2010, BRIT J SPORT MED, V44, P509, DOI 10.1136/bjsm.2007.071712; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zarrouk N, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0130-2; Zerguini Y, 2007, BRIT J SPORT MED, V41, P398, DOI 10.1136/bjsm.2006.032037	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217851	10.1371/journal.pone.0217851	http://dx.doi.org/10.1371/journal.pone.0217851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163075	Green Submitted, gold, Green Published			2022-12-26	WOS:000470086200040
J	Allen, A; Qin, ACR; Raj, N; Wang, JW; Uddin, S; Yao, Z; Tang, L; Meyers, PA; Taylor, BS; Berger, MF; Yaeger, R; Reidy-Lagunes, D; Pratilas, CA				Allen, Amy; Qin, Alice Can Ran; Raj, Nitya; Wang, Jiawan; Uddin, Sharmeen; Yao, Zhan; Tang, Laura; Meyers, Paul A.; Taylor, Barry S.; Berger, Michael F.; Yaeger, Rona; Reidy-Lagunes, Diane; Pratilas, Christine A.			Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition	PLOS ONE			English	Article							METASTATIC MELANOMA; FEEDBACK INHIBITION; IMPROVED SURVIVAL; MUTANT MELANOMA; OPEN-LABEL; CANCER; SENSITIVITY; PATHWAY; MULTICENTER; DABRAFENIB	The clinical significance of BRAF alterations in well-differentiated (WD) metastatic pancreatic neuroendocrine tumor (panNET) is unknown, but BRAF-mutated panNET could represent a subset characterized by an identifiable and clinically actionable driver. Following the identification of two patients with WD metastatic panNET whose tumors harbored BRAF mutations, we queried the MSK-IMPACT series of 80 patients with WD metastatic panNET for additional mutations in BRAF, and in other genes involved in RAS/RTK/PI3K signaling pathways. BRAF mutations were identified in six samples (7.5%): two tumors harbored V600E mutations, one tumor each expressed K601E, T599K, and T310I mutations, and one tumor expressed both G596D and E451K BRAF. Few additional actionable driver alterations were identified. To determine the ERK activating capability of four BRAF mutations not previously characterized, mutant constructs were tested in model systems. Biochemical characterization of BRAF mutations revealed both high and low activity mutants. Engineered cells expressing BRAF K601E and V600E were used for in vitro drug testing of RAF and MEK inhibitors currently in clinical use. BRAF K601E demonstrated reduced sensitivity to dabrafenib compared to BRAF V600E, but the combination of RAF plus MEK inhibition was effective in cells expressing this mutation. Herein, we describe the clinical course of a patient with BRAF K601E and a patient with BRAF V600E WD metastatic panNET, and the identification of four mutations in BRAF not previously characterized. The combined clinical and biochemical data support a potential role for RAF and MEK inhibitors, or a combination of these, in a selected panNET population.	[Allen, Amy; Qin, Alice Can Ran; Wang, Jiawan; Pratilas, Christine A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA; [Raj, Nitya; Yaeger, Rona; Reidy-Lagunes, Diane] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Uddin, Sharmeen; Yao, Zhan] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Tang, Laura; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Meyers, Paul A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Taylor, Barry S.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA	Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pratilas, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA.	cpratil1@jhmi.edu	Yao, Zhan/AAK-6756-2020	Wang, Jiawan/0000-0002-2137-1826; YAO, ZHAN/0000-0001-5391-5691	National Institutes of Health [K08-CA127350]; Giant Food Pediatric Cancer Fund; Cycle for Survival; National Cancer Institute MSK Cancer Center Core Grant [P30-CA008748]; Center for Molecular Oncology of MSKCC; NATIONAL CANCER INSTITUTE [R01CA204749, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giant Food Pediatric Cancer Fund; Cycle for Survival; National Cancer Institute MSK Cancer Center Core Grant; Center for Molecular Oncology of MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Institutes of Health (K08-CA127350, C.A.P). https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Giant Food Pediatric Cancer Fund (C.A.P.). https://giantfood.com.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cycle for Survival (D.R.-L.). https://www.cycleforsurvival.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Cancer Institute MSK Cancer Center Core Grant (P30-CA008748, B.S.T.). https://www.mskcc.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Center for Molecular Oncology of MSKCC. Center for Molecular Oncology of MSKCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benten D, 2018, MOL CANCER RES, V16, P496, DOI 10.1158/1541-7786.MCR-17-0163; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chenard-Poirier M, 2017, RAS OR RAF MUTATED M; Dummer R, 2017, LANCET ONCOL, V18, P435, DOI 10.1016/S1470-2045(17)30180-8; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hofving T, 2018, ENDOCR-RELAT CANCER, V25, P367, DOI 10.1530/ERC-17-0445; Hyman DM, 2015, DRUG DISCOV TODAY, V20, P1422, DOI 10.1016/j.drudis.2015.08.005; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Leboeuf R, 2008, J CLIN ENDOCR METAB, V93, P2194, DOI 10.1210/jc.2007-2825; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Long GV, 2016, J CLIN ONCOL, V34, P871, DOI 10.1200/JCO.2015.62.9345; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Park C, 2016, ONCOTARGET, V7, P4024, DOI 10.18632/oncotarget.6602; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Raj N, 2018, JCO PRECIS ONCOL, V2, P1, DOI 10.1200/PO.17.00267; Scarpa A, 2017, NATURE, V543, P65, DOI 10.1038/nature21063; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tannapfel A, 2005, AM J CLIN PATHOL, V123, P256, DOI 10.1309/YQBR9C05RU4DD3RN; Vandamme T, 2015, J MOL ENDOCRINOL, V54, P137, DOI 10.1530/JME-14-0304; Vijayvergia N, 2016, BRIT J CANCER, V115, P564, DOI 10.1038/bjc.2016.229; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yao Z, 2017, NATURE, V548, P234, DOI 10.1038/nature23291; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zimmer L, 2014, CLIN CANCER RES, V20, P4251, DOI 10.1158/1078-0432.CCR-14-0341	39	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217399	10.1371/journal.pone.0217399	http://dx.doi.org/10.1371/journal.pone.0217399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158244	Green Published, gold, Green Submitted			2022-12-26	WOS:000469915700015
J	Kageyama, M; Ota, T; Sasaoka, M; Katsuta, O; Shinomiya, K				Kageyama, Masaaki; Ota, Takashi; Sasaoka, Masaaki; Katsuta, Osamu; Shinomiya, Katsuhiko			Chemical proteasome inhibition as a novel animal model of inner retinal degeneration in rats	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NIGRAL DEGENERATION; CELL-DEATH; STRESS; NMDA; IMMUNOPROTEASOME; DEGRADATION; DISCOVERY; COMPLEX; SYSTEM	Chemical proteasome inhibition has been a valuable animal model of neurodegeneration to uncover roles for the ubiquitin-proteasome system in the central nervous system. However, little is known about the effects of chemical proteasome inhibitors on retinal integrity. Therefore, we characterized the effects of structurally different chemical proteasome inhibitors on the retinal morphology and the mechanisms of their action in the normal adult rat eyes. Intravitreal injection of MG-262 and other proteasome inhibitors led to inner retinal degeneration. MG-262-induced inner retinal degeneration was accompanied by reduced proteasome activity, increased poly-ubiquitinated protein levels, and increased positive immunostaining of ubiquitin, 20S proteasome subunit and GADD153/CHOP in the retina. Its retinal degenerative effect was also associated with reduced retinal neurofilament light chain gene expression, reflecting retinal ganglion cell death. MG-262-induced neurofilament light chain downregulation was largely resistant to pharmacological modulation including endoplasmic reticulum stress, apoptosis or MAP kinase inhibitors. Thus, this study provides further evidence of roles for the ubiquitin-proteasome system in the maintenance of the retinal structural integrity. Chemical proteasome inhibition may be used as a novel animal model of inner retinal degeneration, including retinal ganglion cell loss, which warrants further analysis of the molecular mechanisms underlying its retinal degenerative effect.	[Kageyama, Masaaki; Ota, Takashi; Sasaoka, Masaaki] Santen Pharmaceut Co Ltd, Global Alliances & External Res, Nara, Japan; [Katsuta, Osamu; Shinomiya, Katsuhiko] Santen Pharmaceut Co Ltd, Res & Dev Ctr, Nara, Japan	Santen Pharmaceutical Co Ltd; Santen Pharmaceutical Co Ltd	Kageyama, M (corresponding author), Santen Pharmaceut Co Ltd, Global Alliances & External Res, Nara, Japan.	masaaki.kageyama@santen.com		Kageyama, Masaaki/0000-0002-6520-7905; Ota, Takashi/0000-0003-2366-2819				Adams J, 1999, CANCER RES, V59, P2615; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Adekeye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083871; Ando Ryo, 2014, Invest Ophthalmol Vis Sci, V55, P4682, DOI 10.1167/iovs.13-13272; Awai M, 2006, J NEUROCHEM, V96, P43, DOI 10.1111/j.1471-4159.2005.03502.x; Bentea E, 2017, J PARKINSON DIS, V7, P31, DOI 10.3233/JPD-160921; Caldeira MV, 2013, BBA-MOL BASIS DIS, V1832, P263, DOI 10.1016/j.bbadis.2012.10.009; Campello L, 2013, MOL NEUROBIOL, V47, P790, DOI 10.1007/s12035-012-8391-5; Chen FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064262; Chiang WC, 2016, ADV EXP MED BIOL, V854, P185, DOI 10.1007/978-3-319-17121-0_25; Chidlow G, 2003, BRAIN RES, V963, P298, DOI 10.1016/S0006-8993(02)04052-0; Choudhury S, 2014, ADV EXP MED BIOL, V801, P455, DOI 10.1007/978-1-4614-3209-8_58; Cromm PM, 2017, ACS CENTRAL SCI, V3, P830, DOI 10.1021/acscentsci.7b00252; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FLIESLER SJ, 1984, NATURE, V311, P575, DOI 10.1038/311575a0; Gomez-Vicente V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137826; Hu Y, 2012, NEURON, V73, P445, DOI 10.1016/j.neuron.2011.11.026; Hussong SA, 2011, INVEST OPHTH VIS SCI, V52, P714, DOI 10.1167/iovs.10-6032; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kapphahn RJ, 2007, EXP EYE RES, V84, P646, DOI 10.1016/j.exer.2006.12.002; Kikuchi S, 2003, BRAIN RES, V964, P228, DOI 10.1016/S0006-8993(02)04030-1; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kummar S, 2010, EUR J CANCER, V46, P340, DOI 10.1016/j.ejca.2009.10.026; Laabich A, 1999, EXP EYE RES, V68, P703, DOI 10.1006/exer.1999.0664; Laude A, 2010, PROG RETIN EYE RES, V29, P466, DOI 10.1016/j.preteyeres.2010.04.003; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Lobanova ES, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04117-8; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Myeku N, 2018, TRENDS MOL MED, V24, P18, DOI 10.1016/j.molmed.2017.11.006; Nashine S, 2015, INVEST OPHTH VIS SCI, V56, P221, DOI 10.1167/iovs.14-15447; Niu CS, 2009, STEREOT FUNCT NEUROS, V87, P69, DOI 10.1159/000202972; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Perez-Alvarez S, 2009, BRIT J PHARMACOL, V158, P1121, DOI 10.1111/j.1476-5381.2009.00388.x; Rana T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.539; Raynes R, 2016, MOL ASPECTS MED, V50, P41, DOI 10.1016/j.mam.2016.05.001; Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344; Shah SZA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00120; Shimazawa M, 2007, MOL VIS, V13, P578; Shirai Y, 2015, BIOL PHARM BULL, V38, P1076, DOI 10.1248/bpb.b15-00185; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Whittier JE, 2004, J BIOL CHEM, V279, P46135, DOI 10.1074/jbc.M406048200; Yamano T, 2008, J BIOL CHEM, V283, P28060, DOI 10.1074/jbc.M803077200; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zhou D, 2013, TOXICOL APPL PHARM, V273, P401, DOI 10.1016/j.taap.2013.09.018; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	52	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217945	10.1371/journal.pone.0217945	http://dx.doi.org/10.1371/journal.pone.0217945			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150519	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100131
J	McCoy, IE; Chertow, GM; Chang, TIH				McCoy, Ian Ellis; Chertow, Glenn Matthew; Chang, Tara I-Hsin			Patterns of diuretic use in the intensive care unit	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ACUTE KIDNEY INJURY; LOOP DIURETICS; MECHANICAL VENTILATION; CONTINUOUS-INFUSION; ACETAZOLAMIDE; BOLUS; MANAGEMENT; DURATION; THERAPY	Purpose To inform future outcomes research on diuretics, we sought to describe modern patterns of diuretic use in the intensive care unit (ICU), including diuretic type, combination, and dosing. We also investigated two possible quality improvement targets: furosemide dosing in renal impairment and inclusion of an initial bolus with continuous furosemide infusions. Materials and methods In this descriptive study, we retrospectively studied 46,037 adult ICU admissions from a publicly available database of patients in an urban, academic medical center. Results Diuretics were employed in nearly half (49%, 22,569/46,037) of ICU admissions. Mechanical ventilation, a history of heart failure, and admission to the post-cardiac surgery unit were associated with a higher frequency of diuretic use. Combination use of different diuretic classes was uncommon. Patients with severely impaired kidney function were less likely to receive diuretics. Furosemide was by far the most common diuretic given and the initial intravenous dose was only 20 mg in more than half of ICU admissions. Among patients treated with a continuous infusion, 30% did not receive a bolus on the day of infusion initiation. Conclusions Patterns of diuretic use varied by patient-specific factors and by ICU type. Diuretic dosing strategies may be suboptimal.	[McCoy, Ian Ellis; Chertow, Glenn Matthew; Chang, Tara I-Hsin] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA	Stanford University	McCoy, IE (corresponding author), Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA.	imccoy@stanford.edu	McCoy, Ian/AAS-7406-2020	McCoy, Ian/0000-0001-6470-6959; Chertow, Glenn/0000-0002-7599-0534	T-32 grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK007357]; K-24 grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [2K24DK085446]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK085446, T32DK007357] Funding Source: NIH RePORTER	T-32 grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; K-24 grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	IEM was supported by a T-32 grant (5T32DK007357), and GMC was supported by a K-24 grant (2K24DK085446), both from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson R, 2017, ANN AM THORAC SOC, V14, P1086, DOI 10.1513/AnnalsATS.201701-016FR; Alqahtani F, 2014, J CRIT CARE, V29, P10, DOI 10.1016/j.jcrc.2013.03.015; Bagshaw SM, 2007, CONTRIB NEPHROL, V156, P236; Brater DC, 1998, NEW ENGL J MED, V339, P387, DOI 10.1056/NEJM199808063390607; Faisy C, 2016, JAMA-J AM MED ASSOC, V315, P480, DOI 10.1001/jama.2016.0019; Huang A, 2017, CRIT CARE RESUSC, V19, P142; Jentzer JC, 2010, J AM COLL CARDIOL, V56, P1527, DOI 10.1016/j.jacc.2010.06.034; Joannidis M, 2017, INTENS CARE MED, V43, P730, DOI 10.1007/s00134-017-4832-y; Johnson AEW, 2018, J AM MED INFORM ASSN, V25, P32, DOI 10.1093/jamia/ocx084; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Lopez C, 2016, PEDIATR CRIT CARE ME, V17, pE551, DOI 10.1097/PCC.0000000000000971; Michaud CJ, 2017, ANN PHARMACOTHER, V51, P286, DOI 10.1177/1060028016683971; Cervera GR, 2017, PULM PHARMACOL THER, V44, P30, DOI 10.1016/j.pupt.2017.03.002; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RUDY DW, 1991, ANN INTERN MED, V115, P360, DOI 10.7326/0003-4819-115-5-360; Salvador DR, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003178.PUB2; Schrier RW, 2010, CLIN J AM SOC NEPHRO, V5, P733, DOI 10.2215/CJN.00060110; Silbert BI, 2016, CRIT CARE MED, V44, pE923, DOI 10.1097/CCM.0000000000001823; Silva J. R., 2018, CRIMINAL JUSTICE POL, P1, DOI [DOI 10.1097/CCM.0000000000002696, 10.1097/CCM.0000000000002696]; Uchino S, 2004, CRIT CARE MED, V32, P1669, DOI 10.1097/01.CCM.0000132892.51063.2F; Wallet F, 2004, ANN FR ANESTH, V23, P161, DOI 10.1016/j.annfar.2003.12.001; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	22	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217911	10.1371/journal.pone.0217911	http://dx.doi.org/10.1371/journal.pone.0217911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150512	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100126
J	Peytz, NC; Jabbari, R; Bojesen, SE; Nordestgaard, B; Schnohr, P; Prescott, E				Peytz, Nina Caroline; Jabbari, Reza; Bojesen, Stig Egil; Nordestgaard, Boerge; Schnohr, Peter; Prescott, Eva			Physical activity and risk of instant and 28-day case-fatality in myocardial infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; LEISURE-TIME; ALL-CAUSE; EXERCISE; MORTALITY; PROTECTION; ISCHEMIA; IMPACT; CARDIOPROTECTION	Background While physical activity reduces risk of developing myocardial infarction (MI), it is unknown whether a history of physical activity is also protective of fatal arrhythmia and case-fatality in patients who have suffered an acute MI. Methods 104,801 individuals included in 2003-2014 in the Copenhagen General Population Study (CGPS), a prospective population-based study with self-reported leisure time physical activity (LTPA) in three categories measured at baseline, were followed until 2014 through national registries. The 1,517 individuals who suffered a first time MI during follow-up constituted the study population. Outcomes were fatal MI, defined as date of death same as date of MI (including out-of-hospital deaths) and 28-day fatality. Through multivariable analyses the association between baseline LTPA and outcomes were assessed adjusted for CVD risk factors. Results Of 1,517 MI events, 117 (7.7%) were fatal and another 79 (5.6%) lead to death within 28 days. Median time from baseline to MI was 3.6 years (IQR 1.7-5.8). LTPA was associated with lower risk of fatal MI with odds ratios of 0.40 (95% CI: 0.22-0.73) for light and 0.41 (0.22-0.76) for moderate/high LTPA after multivariable adjustment with sedentary LTPA as reference. Age, alcohol-intake, education and smoking were identified as other predictors for fatal MI. We found no association between LTPA and 28-day case fatality. Conclusions Among individuals with MI, those that have engaged in any light or moderate physical activity were more likely to survive their MI. Results are consistent with effect of exercise preconditioning on risk of fatal arrhythmia.	[Peytz, Nina Caroline; Jabbari, Reza; Prescott, Eva] Univ Copenhagen, Bispebjerg Frederiksberg Hosp, Dept Cardiol, Copenhagen, Denmark; [Bojesen, Stig Egil; Nordestgaard, Boerge; Schnohr, Peter; Prescott, Eva] Univ Copenhagen, Herlev Hosp, Copenhagen City Heart Study, Herlev, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Peytz, NC (corresponding author), Univ Copenhagen, Bispebjerg Frederiksberg Hosp, Dept Cardiol, Copenhagen, Denmark.	nina.caroline.peytz.04@regionh.dk	Jabbari, Reza/AAM-6649-2021; Nordestgaard, Borge Gronne/ABF-1310-2020; Prescott, Eva/AAJ-7441-2020	Jabbari, Reza/0000-0002-9432-0632; Bojesen, Stig/0000-0002-4061-4133; Nordestgaard, Borge/0000-0002-1954-7220				Abildstrom SZ, 2003, HEART, V89, P507, DOI 10.1136/heart.89.5.507; Andersson J, 2016, EUR J PREV CARDIOL, V23, P1814, DOI 10.1177/2047487316659574; Armstrong MEG, 2015, CIRCULATION, V131, P721, DOI 10.1161/CIRCULATIONAHA.114.010296; BLAIR SN, 1984, JAMA-J AM MED ASSOC, V252, P487, DOI 10.1001/jama.252.4.487; BOWLES DK, 1992, AM J PHYSIOL, V263, pH804, DOI 10.1152/ajpheart.1992.263.3.H804; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chambless L, 1997, CIRCULATION, V96, P3849; Chiuve SE, 2011, JAMA-J AM MED ASSOC, V306, P62, DOI 10.1001/jama.2011.907; Colak Y, 2015, AM J RESP CRIT CARE, V192, P172, DOI 10.1164/rccm.201502-0302OC; Degano IR, 2015, HEART, V101, P1413, DOI 10.1136/heartjnl-2014-307310; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Domenech R, 2002, CARDIOVASC RES, V55, P561, DOI 10.1016/S0008-6363(02)00334-6; Ejlersen H, 2017, EUR J PREV CARDIOL; Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011; Holtermann A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000556; Jabbari R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001399; Kavouras SA, 2007, MED SCI SPORT EXERC; Lambiase PD, 2003, J AM COLL CARDIOL, V41, P1174, DOI 10.1016/S0735-1097(03)00055-X; Langsted A, 2011, CLIN CHEM, V57, P482, DOI 10.1373/clinchem.2010.157164; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; Lennon SL, 2004, ACTA PHYSIOL SCAND, V182, P161, DOI 10.1111/j.1365-201X.2004.01346.x; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mannsverk J, 2015, CIRCULATION, V133; Marongiu E, 2014, CURR CARDIOL REV, V10, P336, DOI 10.2174/1573403X10666140404110229; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MORRIS JN, 1980, LANCET, V2, P1207; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Piccini JP, 2010, EUR HEART J, V31, P211, DOI 10.1093/eurheartj/ehp425; Quindry JC, 2013, CURR CARDIOL REV, V9, P220, DOI 10.2174/1573403X113099990033; Schnohr P, 2017, EUR J PREV CARDIOL, V24, P1615, DOI 10.1177/2047487317721021; Schnohr P, 2012, EUR J PREV CARDIOL, V19, P73, DOI 10.1177/1741826710393196; Schnohr P, 2009, DAN MED BULL, V56, P40; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Thijssen D, 2017, JAMA CARDIOL, P706, DOI [10.1084/jem.189.11.1699, DOI 10.1084/JEM.189.11.1699]; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217398	10.1371/journal.pone.0217398	http://dx.doi.org/10.1371/journal.pone.0217398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150433	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100043
J	Prabdial-Sing, N; Makhathini, L; Smit, SB; Manamela, MJ; Motaze, NV; Cohen, C; Suchard, MS				Prabdial-Sing, Nishi; Makhathini, Lillian; Smit, Sheilagh Brigitte; Manamela, Morubula Jack; Motaze, Nkengafac Villyen; Cohen, Cheryl; Suchard, Melinda Shelley			Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community- based febrile rash surveillance	PLOS ONE			English	Article							HIV-HBV COINFECTION; VIRUS-INFECTION; BLACK-CHILDREN; PREGNANT-WOMEN; WESTERN CAPE; EPIDEMIOLOGY; VACCINATION; TRANSMISSION; PREVENTION; EXPOSURE	Introduction and methods Hepatitis B is a vaccine preventable disease and is notifiable in South Africa. Hepatitis B vaccination was incorporated into the Expanded Programme on Immunisation in South Africa in 1995. We used a convenience sample from community-based febrile rash surveillance in 2013 to estimate hepatitis B sero-prevalence. Of samples serologically negative for acute measles infection, 450 samples spanning nine provinces of South Africa were tested for hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs) and hepatitis B core antibody (anti-HBc). Results Two children (2/450; 0.4%) tested positive for HBsAg. Three hundred and three children (67.3%) had evidence of vaccine induced immunity. Vaccine induced immunity was present in 80.2% of 1-5 year olds, but only 60.3% of 10-14 year olds. Natural immunity, indicating exposure to circulating hepatitis B, was present in 13/450 (2.9%) children. Conclusion Chronic hepatitis B in South African has decreased in prevalence from highly endemic levels prior to vaccine introduction to approximately 0.4% in this sample, demonstrating impact of a successful vaccination programme 18 years after introduction. Decreased vaccine-induced immunity with increasing age may reflect waning antibody titres over time.	[Prabdial-Sing, Nishi; Makhathini, Lillian; Smit, Sheilagh Brigitte; Manamela, Morubula Jack; Motaze, Nkengafac Villyen; Suchard, Melinda Shelley] NICD, Ctr Vaccines & Immunol, Johannesburg, South Africa; [Prabdial-Sing, Nishi] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Virol, Johannesburg, South Africa; [Motaze, Nkengafac Villyen] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Div Epidemiol & Biostat, Cape Town, South Africa; [Cohen, Cheryl] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Suchard, Melinda Shelley] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Chem Pathol, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Stellenbosch University; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand	Suchard, MS (corresponding author), NICD, Ctr Vaccines & Immunol, Johannesburg, South Africa.; Suchard, MS (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Chem Pathol, Johannesburg, South Africa.	melinda@nicd.ac.za		Suchard, Melinda Shelley/0000-0002-6978-4654	National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa	National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa	The work was funded by the National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.	Amponsah-Dacosta E, 2014, J MED VIROL, V86, P918, DOI 10.1002/jmv.23910; Andersson MI, 2013, VACCINE, V31, P5579, DOI 10.1016/j.vaccine.2013.08.028; [Anonymous], 2012, S AFR NAT HIV PREV I; Ayuk J, 2013, SAMJ S AFR MED J, V103, P330, DOI 10.7196/SAMJ.6304; Bagheri-Jamebozorgi M, 2014, HUM VACC IMMUNOTHER, V10, P3731, DOI 10.4161/hv.34393; Barth H, 2011, J HEPATOL, V54, P844, DOI 10.1016/j.jhep.2010.10.008; Bell TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045750; Boyles TH, 2011, SAMJ S AFR MED J, V101, P470; Burnett RJ, 2007, INT J STD AIDS, V18, P152, DOI 10.1258/095646207780132523; Burnett RJ, 2012, VACCINE, V30, pC45, DOI 10.1016/j.vaccine.2012.02.021; Butler LM, 2010, TROP MED INT HEALTH, V15, P442, DOI 10.1111/j.1365-3156.2010.02474.x; Chotun N, 2015, VACCINE, V33, P4618, DOI 10.1016/j.vaccine.2015.06.076; Di Bisceglie AM, 2010, ANTIVIR THER, V15, P499, DOI 10.3851/IMP1494; Diale Q, 2016, SAMJ S AFR MED J, V106, P97, DOI [10.7196/SAMJ.2016.v106i1.9932, 10.7196/SAMJ.2016.V106I1.9932]; DIBISCEGLIE AM, 1986, BRIT MED J, V292, P1440, DOI 10.1136/bmj.292.6533.1440; Dlamini NR, 2016, SAMJ S AFR MED J, V106, P43, DOI [10.7196/samj.2016.v106i7.10956, 10.7196/SAMJ.2016.v106i7.10956]; DUSHEIKO GM, 1989, S AFR MED J, V75, P473; Firnhaber C, 2008, SAMJ S AFR MED J, V98, P541; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hoffmann C J, 2012, Int J STD AIDS, V23, pe10, DOI 10.1258/ijsa.2009.009340; Hoffmann CJ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18871; Jooste P, 2016, J CLIN VIROL, V85, P71, DOI 10.1016/j.jcv.2016.10.017; KARIM SA, 1988, INT J EPIDEMIOL, V17, P168; KARIM SSA, 1991, INT J EPIDEMIOL, V20, P495, DOI 10.1093/ije/20.2.495; Kew M. C., 2008, Southern African Journal of Epidemiology & Infection, V23, P4; Kew MC, 1996, GUT, V38, pS31, DOI 10.1136/gut.38.Suppl_2.S31; KEW MC, 1973, S AFR MED J, V47, P2419; Leuridan E, 2011, CLIN INFECT DIS, V53, P68, DOI 10.1093/cid/cir270; Lodenyo H, 2000, E AFR MED J, V77, P13; Lu CY, 2004, HEPATOLOGY, V40, P1415, DOI 10.1002/hep.20490; Lukhwareni A, 2009, J MED VIROL, V81, P406, DOI 10.1002/jmv.21418; Mayaphi SH, 2012, SAMJ S AFR MED J, V102, P157, DOI 10.7196/SAMJ.4944; Mdlalose N, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.283; Mendy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058029; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Sadeghi A, 2016, J VIRAL HEPATITIS, V23, P282, DOI 10.1111/jvh.12490; Schillie S, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6701a1; Simani OE, 2009, VACCINE, V27, P146, DOI 10.1016/j.vaccine.2008.10.004; Spengane Z, 2018, SAMJ S AFR MED J, V108, P278, DOI [10.7196/SAMJ.2017.v108i4.12830, 10.7196/SAMJ.2018.v108i4.12830, 10.7196/samj.2018.v108i4.12830]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thumbiran NV, 2014, SAMJ S AFR MED J, V104, P307, DOI [10.7196/samj.7299, 10.7196/SAMJ.7299]; Tsebe KV, 2001, VACCINE, V19, P3919, DOI 10.1016/S0264-410X(01)00120-7; Vardas E, 1999, J MED VIROL, V58, P111, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;111::AID-JMV2&gt;3.0.CO;2-B; Venter WDF, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4353-1; WHO, 2017, WHO WEEKLY EPIDEMIOL, V92, P129; World Health Organization, 2018, SNAK ENV NEGL TROP D, P1; Yousif M, 2014, INT J INFECT DIS, V29, P125, DOI 10.1016/j.ijid.2014.07.002; Zanetti AR, 2005, LANCET, V366, P1379, DOI 10.1016/S0140-6736(05)67568-X	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217415	10.1371/journal.pone.0217415	http://dx.doi.org/10.1371/journal.pone.0217415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150445	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100046
J	Sterchi, M; Faverjon, C; Sarasua, C; Vargas, ME; Berezowski, J; Bernstein, A; Grutter, R; Nathues, H				Sterchi, Martin; Faverjon, Celine; Sarasua, Cristina; Vargas, Maria Elena; Berezowski, John; Bernstein, Abraham; Gruetter, Rolf; Nathues, Heiko			The pig transport network in Switzerland: Structure, patterns, and implications for the transmission of infectious diseases between animal holdings	PLOS ONE			English	Article							LIVESTOCK MOVEMENTS; MOUTH-DISEASE; EPIDEMIC; DYNAMICS; PROTOCOLS; CATTLE	The topology of animal transport networks contributes substantially to how fast and to what extent a disease can transmit between animal holdings. Therefore, public authorities in many countries mandate livestock holdings to report all movements of animals. However, the reported data often does not contain information about the exact sequence of transports, making it impossible to assess the effect of truck sharing and truck contamination on disease transmission. The aim of this study was to analyze the topology of the Swiss pig transport network by means of social network analysis and to assess the implications for disease transmission between animal holdings. In particular, we studied how additional information about transport sequences changes the topology of the contact network. The study is based on the official animal movement database in Switzerland and a sample of transport data from one transport company. The results show that the Swiss pig transport network is highly fragmented, which mitigates the risk of a large-scale disease outbreak. By considering the time sequence of transports, we found that even in the worst case, only 0.34% of all farmpairs were connected within one month. However, both network connectivity and individual connectedness of farms increased if truck sharing and especially truck contamination were considered. Therefore, the extent to which a disease may be transmitted between animal holdings may be underestimated if we only consider data from the official animal movement database. Our results highlight the need for a comprehensive analysis of contacts between farms that includes indirect contacts due to truck sharing and contamination. As the nature of animal transport networks is inherently temporal, we strongly suggest the use of temporal network measures in order to evaluate individual and overall risk of disease transmission through animal transportation.	[Sterchi, Martin; Sarasua, Cristina; Vargas, Maria Elena; Bernstein, Abraham] Univ Zurich, Dept Informat, Zurich, Switzerland; [Sterchi, Martin; Vargas, Maria Elena; Gruetter, Rolf] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Sterchi, Martin] Univ Appl Sci & Arts Northwestern Switzerland FHN, Sch Business, Olten, Switzerland; [Faverjon, Celine; Berezowski, John] Univ Bern, Vet Fac, Vet Publ Hlth Inst, Bern, Switzerland; [Nathues, Heiko] Univ Bern, Vet Fac, Clin Swine, Bern, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Bern; University of Bern	Sterchi, M (corresponding author), Univ Zurich, Dept Informat, Zurich, Switzerland.; Sterchi, M (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.; Sterchi, M (corresponding author), Univ Appl Sci & Arts Northwestern Switzerland FHN, Sch Business, Olten, Switzerland.	sterchi@ifi.uzh.ch	Nathues, Heiko/AAZ-2712-2020	Nathues, Heiko/0000-0002-0285-3731; Faverjon, Celine/0000-0001-6737-1883; Sterchi, Martin/0000-0002-1105-8780; Berezowski, John/0000-0003-3343-908X	Swiss National Science Foundation (SNSF) NRP75 [407540_167303]; University of Applied Sciences and Arts Northwestern Switzerland FHNW; Hasler foundation	Swiss National Science Foundation (SNSF) NRP75; University of Applied Sciences and Arts Northwestern Switzerland FHNW; Hasler foundation	This article is based upon work supported by the Swiss National Science Foundation (SNSF) NRP75, Project no 407540_167303 (http://www.snf.ch/en/researchinFocus/nrp/nfp-75/Pages/default.aspx).In addition, the University of Applied Sciences and Arts Northwestern Switzerland FHNW (www.fhnw.ch) as well as the Hasler foundation (www.haslerstiftung.ch) supported part of the work of MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Beltran-Alcrudo D, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1800-5; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; BLV, 2018, TIERV; Clauset A, 2009, SIAM REV, V38, P3; Dee S, 2004, CAN J VET RES, V68, P208; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2011, REV SCI TECH OIE, V30, P425; Giacomini E, 2018, BMC VET RES, V14, DOI 10.1186/s12917-017-1328-5; Greger M, 2007, BIOSECUR BIOTERROR, V5, P301, DOI 10.1089/bsp.2007.0028; Guinat C, 2018, TRANSBOUND EMERG DIS, V65, pe264, DOI 10.1111/tbed.12748; Guinat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28429; Holme P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046119; Holme P, 2013, F1000PRIME REP, V5; Holme P, 2011, TEMPORAL NETWORKS, P1; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Koher A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151209; Nathues C, 2016, TRANSBOUND EMERG DIS, V63, pE251, DOI 10.1111/tbed.12262; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Riklin AS, 2015, ANTIBIOTIKUMSEINSATZ; Rovira A, 2007, J VET DIAGN INVEST, V19, P492, DOI 10.1177/104063870701900506; Salines M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185858; Scharrer S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0468-8; Smith RP, 2013, PREV VET MED, V108, P167, DOI 10.1016/j.prevetmed.2012.08.011; Swiss Federal Council, 2017, SWISS PLAT; Swiss Federal Council, 2008, TIERSCH; Thakur KK, 2016, TRANSBOUND EMERG DIS, V63, pE14, DOI 10.1111/tbed.12225; Thakur KK, 2017, J SWINE HEALTH PROD, V25, P183; Vidondo B, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1406-3; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	37	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217974	10.1371/journal.pone.0217974	http://dx.doi.org/10.1371/journal.pone.0217974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150524	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000469759100136
J	Li, F; Dong, YZ; Zhang, D; Zhang, XM; Lin, ZJ; Zhang, B				Li, Fan; Dong, Yi-Zhu; Zhang, Dan; Zhang, Xiao-Meng; Lin, Zhi-Jian; Zhang, Bing			Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments	PLOS ONE			English	Article							URIC-ACID; TARGET IDENTIFICATION; METABOLIC SYNDROME; UCSF CHIMERA; WEB SERVER; HYPERURICEMIA; VISUALIZATION; UPDATE; TOOL; PROLIFERATION	As an important part of the comprehensive treatment methods, the urate-lowering Chinese herbs could provide favorable clinical effects on hyperuricemia in its ability to invigorate spleen and remove dampness. Owing to the long-term duration, it brought up the potential adverse reactions (ADRs) and concerns about the drug-induced liver injury from these herbs. To address this problem, the bioinformatics approaches which combined the network pharmacology, computer simulation and molecular biology experiments were undertaken to elucidate the underlying drug-induced liver injury molecular mechanisms of urate-lowering Chinese herbs. Several electronic databases were searched to identify the potential liver injury compounds in published research. Then, the putative target profile of liver injury was predicted, and the interaction network was constructed based on the links between the compounds, corresponding targets and core pathways. Accordingly, the molecular docking simulation was performed to recognize the representative compounds with hepatotoxicity. Finally, the cell experiments were conducted to investigate the biochemical indicators and expression of the crucial protein that were closely associated with liver injury. In conclusion, the current research revealed that the compounds with potential liver injury including diosgenin, baicalin, saikosaponin D, tetrandrine, rutaecarpine and evodiamine from urate-lowering Chinese herbs, could lead to decline the survival rate of L-02 cell, increase the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) in cell-culture medium, enhance the expression of p-p38/p38, while the p38 inhibitor could achieve the trend of regulating and controlling liver injury. These research findings bring further support to the growing evidence that the mechanism of the liver injury induced by the compounds from urate-lowering Chinese herbs may be associated with the activation of p38 alpha.	[Li, Fan; Dong, Yi-Zhu; Zhang, Dan; Zhang, Xiao-Meng; Lin, Zhi-Jian; Zhang, Bing] Beijing Univ Chinese Med, Sch Chinese Materia Med, Dept Clin Chinese Pharm, Beijing, Peoples R China	Beijing University of Chinese Medicine	Zhang, B (corresponding author), Beijing Univ Chinese Med, Sch Chinese Materia Med, Dept Clin Chinese Pharm, Beijing, Peoples R China.	zhangb@bucm.edu.cn						Barbarino JM, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1417; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Billiet Laura, 2014, ISRN Rheumatol, V2014, P852954, DOI 10.1155/2014/852954; Boezio B, 2017, MOL INFORM, V36, DOI 10.1002/minf.201700048; Burley SK, 2017, METHODS MOL BIOL, V1606, P627, DOI 10.1007/978-1-4939-7000-1_26; Cai QY, 2014, MOLECULES, V19, P21168, DOI 10.3390/molecules191221168; Calogiuri Gianfranco, 2013, Inflammation & Allergy Drug Targets, V12, P19; Cao J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010067; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chatterjee B, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0100-z; Chen MF, 2013, J MED FOOD, V16, P793, DOI [10.1091/jmf.2013.2762, 10.1089/jmf.2013.2762]; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Corre I, 2017, ONCOTARGET, V8, P55684, DOI 10.18632/oncotarget.18264; Dai CS, 2016, MOLECULES, V21, DOI 10.3390/molecules21081061; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Gilbert D, 2005, BRIEF BIOINFORM, V6, P194, DOI 10.1093/bib/6.2.194; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Godyn J, 2017, ELECTROPHORESIS, V38, P1268, DOI 10.1002/elps.201600473; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Gonzalez-Teran B, 2016, EMBO J, V35, P536, DOI 10.15252/embj.201591857; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Haw R, 2011, PROTEOMICS, V11, P3598, DOI 10.1002/pmic.201100066; Hong M, 2017, MOLECULES, V22, DOI 10.3390/molecules22040632; Hu YY, 2015, MOLECULES, V20, P6443, DOI 10.3390/molecules20046443; Huang J, 2017, J NANOMATER, V2017, P1, DOI DOI 10.1155/2017/2084621; Jiang Y, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1834-9; Jiang Y, 2017, ONCOL LETT, V13, P4035, DOI 10.3892/ol.2017.6015; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kaufmann P, 2005, HEPATOLOGY, V41, P925, DOI 10.1002/hep.20634; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kojima S, 2017, J CARDIOL, V69, P169, DOI 10.1016/j.jjcc.2016.02.015; Korashy HM, 2011, CHEM RES TOXICOL, V24, P1540, DOI 10.1021/tx200141p; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00080; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Li L, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-122; [李丽玉 Li Liyu], 2015, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V26, P284; Li S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33082; Li XX, 2013, CLIN RHEUMATOL, V32, P943, DOI 10.1007/s10067-013-2274-7; Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300; Luo X, 2018, BRAIN BEHAV IMMUN, V72, P34, DOI 10.1016/j.bbi.2017.11.007; Maharani N, 2016, INT HEART J, V57, P395, DOI 10.1536/ihj.16-192; Malik UZ, 2011, FREE RADICAL BIO MED, V51, P179, DOI 10.1016/j.freeradbiomed.2011.04.004; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; McGill MR, 2016, EXCLI J, V15, P817, DOI 10.17179/excli2016-800; Meng AH, 2016, INT J CHRONIC OBSTR, V11, P909, DOI 10.2147/COPD.S99810; Merriman TR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0609-2; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Multi-Disciplinary Expert Task Force on Hyperuricemia and Its Related Diseases, 2017, Zhonghua Nei Ke Za Zhi, V56, P235, DOI 10.3760/cma.j.issn.0578-1426.2017.03.021; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; Oughtred Rose, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top080754; Pathak Ashish, 2016, Central Nervous System Agents in Medicinal Chemistry, V16, P143, DOI 10.2174/1871524916666151210143347; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi XM, 2013, ACTA PHARMACOL SIN, V34, P1229, DOI 10.1038/aps.2013.62; Qiu L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-664; Rigsby RE, 2016, BIOCHEM MOL BIOL EDU, V44, P433, DOI 10.1002/bmb.20966; Robinson PC, 2015, EXPERT OPIN PHARMACO, V16, P533, DOI 10.1517/14656566.2015.997213; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Sato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030124; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Senior JR, 2012, CLIN PHARMACOL THER, V92, P332, DOI 10.1038/clpt.2012.108; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sreekanth GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149486; Stamp LK, 2016, INTERN MED J, V46, P1075, DOI 10.1111/imj.13173; Su J, 2010, J TRAUMA, V68, P1317, DOI 10.1097/TA.0b013e3181bb9cd3; Sun HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00661-3; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Thornton C. E., 2010, BMC BIOINFORMATICS, V11, P91, DOI DOI 10.1186/1471-2105-11-91; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Tonder Alet, 2015, BMC Res Notes, V8, P47, DOI 10.1186/s13104-015-1000-8; Vilar S, 2017, CURR MED CHEM, V24, P4340, DOI 10.2174/0929867324666170724101448; Wang JB, 2015, FRONT MED-PRC, V9, P457, DOI 10.1007/s11684-015-0417-8; Wang L, 2018, MOL MED REP, V17, P789, DOI 10.3892/mmr.2017.7958; Wang X, 2017, NUCLEIC ACIDS RES, V45, pW356, DOI 10.1093/nar/gkx374; Wang Y, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0190-6; Wen B, 2014, DRUG METAB DISPOS, V42, P1044, DOI 10.1124/dmd.114.057414; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xiao YT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.523; Yang ZH, 2016, INT J MED SCI, V13, P783, DOI 10.7150/ijms.16663; Zhang ZX, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0678-6; Zhou Q, 2014, PLANTA MED, V80, P1259, DOI 10.1055/s-0034-1383048; Zhu JJ, 2014, ANIMAL, V8, P1469, DOI 10.1017/S1751731114001323; Zuo T, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0379-z	87	12	17	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216948	10.1371/journal.pone.0216948	http://dx.doi.org/10.1371/journal.pone.0216948			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141540	Green Submitted, Green Published, gold			2022-12-26	WOS:000469323000031
J	Mulhall, RM; Bennett, DE; Bratcher, HB; Jolley, KA; Bray, JE; O'Lorcain, PP; Cotter, SM; Maiden, MCJ; Cunney, RJ				Mulhall, Robert M.; Bennett, Desiree E.; Bratcher, Holly B.; Jolley, Keith A.; Bray, James E.; O'Lorcain, Piaras P.; Cotter, Suzanne M.; Maiden, Martin C. J.; Cunney, Robert J.			cgMLST characterisation of invasive Neisseria meningitidis serogroup C and W strains associated with increasing disease incidence in the Republic of Ireland	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; IDENTIFICATION; EPIDEMIOLOGY; EMERGENCE; CLUSTER	Introduction and aims Since 2013 MenC and MenW disease incidence and associated mortality rates have increased in the Republic of Ireland. From 2002/2003 to 2012/2013, the average annual MenC incidence was 0.08/100,000, which increased to 0.34/100,000 during 2013/2014 to 2017/18, peaking in 2016/17 (0.72/100,000) with an associated case fatality rate (CFR) of 14.7%. MenW disease incidence has increased each year from 0.02/100,000 in 2013/2014, to 0.29/100,000 in 2017/18, with an associated CFR of 28.6%. We aimed to characterise and relate recent MenC isolates to the previously prevalent MenC:cc11 ET-15 clones, and also characterise and relate recent MenW isolates to the novel ` Hajj' clones. Methods Using WGS we characterised invasive (n = 74, 1997/98 to 2016/17) and carried (n = 16, 2016/17) MenC isolates, and invasive (n = 18, 2010/11 to 2016/17) and carried (n = 15, 2016/17) MenW isolates. Genomes were assembled using VelvethOptimiser and stored on the PubMLST Neisseria Bacterial Isolate Genome Sequence Database. Isolates were compared using the cgMLST approach. Results Most MenC and MenW isolates identified were cc11. A single MenC: cc11 sub- lineage contained the majority (68%, n = 19/28) of recent MenC: cc11 disease isolates and all carried MenC: cc11 isolates, which were interspersed and distinct from the historically significant ET-15 clones. MenW: cc11 study isolates clustered among international examples of both the original UK 2009 MenW: cc11, and novel 2013 MenW: cc11clones. Conclusions We have shown that the majority of recent MenC disease incidence was caused by strain types distinct from the MenC: cc11 ET-15 clone of the late 1990s, which still circulate but have caused only sporadic disease in recent years. We have identified that the same aggressive MenW clone now established in several other European countries, is endemic in the RoI and responsible for the recent MenW incidence increases. This data informed the National immunisation Advisory Committee, who are currently deliberating a vaccine policy change to protect teenagers.	[Mulhall, Robert M.; Bennett, Desiree E.; Cunney, Robert J.] Temple St Childrens Univ Hosp, Irish Meningitis & Sepsis Reference Lab, Dublin, Ireland; [Bratcher, Holly B.; Jolley, Keith A.; Bray, James E.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford, England; [O'Lorcain, Piaras P.; Cotter, Suzanne M.] Hlth Protect & Surveillance Ctr, Dublin, Ireland; [Cunney, Robert J.] Royal Coll Surgeons Ireland, Dept Microbiol, Dublin, Ireland	Childrens University Hospital - Temple Street; University of Oxford; Royal College of Surgeons - Ireland	Mulhall, RM (corresponding author), Temple St Childrens Univ Hosp, Irish Meningitis & Sepsis Reference Lab, Dublin, Ireland.	robert.mulhall@cuh.ie	Maiden, Martin C J/C-5055-2014; Jolley, Keith/ABE-8587-2020	Maiden, Martin C J/0000-0001-6321-5138; Jolley, Keith/0000-0002-0751-0287; Mulhall, Robert/0000-0003-0457-4661; BRAY, JAMES/0000-0003-3554-4254	Health Service Executive (HSE) Population Health, and the National Immunisation Advisory Committee (NIAC), Royal College of Physicians, Dublin; European Union; Wellcome Trust	Health Service Executive (HSE) Population Health, and the National Immunisation Advisory Committee (NIAC), Royal College of Physicians, Dublin; European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded in part by the Health Service Executive (HSE) Population Health, and the National Immunisation Advisory Committee (NIAC), Royal College of Physicians, Dublin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was awarded to RJC, DEB and RMM.; We wish to thank Sandra Morgan and Elizabeth Lynam (IMSRL, Dublin), and Sarah Lamble (Oxford Genomic Centre, Oxford University). The study used the Neisseria MLST website (pubmlst. org/neisseria) developed by Keith Jolley, and supported by the European Union and the Wellcome Trust.	Bassi C, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.28.30574; Bazan JA, 2017, CLIN INFECT DIS, V65, P92, DOI 10.1093/cid/cix215; Bennett DE, 2006, J CLIN MICROBIOL, V44, P1127, DOI 10.1128/JCM.44.3.1127-1131.2006; Bennett DE, 2003, J MED MICROBIOL, V52, P781, DOI 10.1099/jmm.0.05225-0; Borrow R, 2013, VACCINE, V31, P4477, DOI 10.1016/j.vaccine.2013.07.083; Bratcher HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1138; Brundage J, 1987, EVOLUTION MENINGOCOC, P6; Bryant D, 1987, MOL BIOL EVOL, P255; Campbell H, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.12.30175; Campbell H, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.28.21188; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; CAUGANT DA, 1986, J GEN MICROBIOL, V132, P641; Christensen H, 2011, LANCET INFECT DIS, V11, P584; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; Elias J, 2007, J CLIN MICROBIOL, V45, P159, DOI 10.1128/JCM.01322-06; Eriksson L, 2018, J CLIN MICROBIOL, V469, P1; Folaranmi TA, 2017, CLIN INFECT DIS, V65, P756, DOI 10.1093/cid/cix438; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Health Protection Surveillance Centre (HPSC), 1999, ANN EP REP 1999 2016; Hong E, 2018, J INFECTION, V76, P149, DOI 10.1016/j.jinf.2017.10.015; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Knol MJ, 2018, EUROSURVEILLANCE, V12, P1; Koch J, 2016, EUROSURVEILLANCE, V21, P12, DOI 10.2807/1560-7917.ES.2016.21.5.30122; Kratz MM, 2016, EMERG INFECT DIS, V21, P2010; Lucidarme J, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.45.30395; Lucidarme J, 2017, J INFECTION, V75, P95, DOI 10.1016/j.jinf.2017.05.015; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin NV, 2016, COMMUN DIS INTELL Q, V40, P2013; Miglietta A, 2018, EUROSURVEILL, V23; Miglietta A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3598-3; Mustapha MM, 2015, EBIOMEDICINE, V2, P1447, DOI 10.1016/j.ebiom.2015.09.007; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016/j.vaccine.2011.12.062; Pollard AJ, 2001, VACCINE, V19, P1327, DOI 10.1016/S0264-410X(00)00333-9; Russcher A, 2017, EURO SURVEILL, V22; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Safadi MAP, 2015, VACCINE, V33, P6529, DOI 10.1016/j.vaccine.2015.10.055; Smith-Palmer A, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.45.30392; Stefanelli P, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.07.014; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; Trotter CL, 2002, J MED MICROBIOL, V51, P855, DOI 10.1099/0022-1317-51-10-855; Tzeng YL, 2017, P NATL ACAD SCI USA, V114, P4237, DOI 10.1073/pnas.1620971114; Vogel U, 2000, J CLIN MICROBIOL, V38, P941, DOI 10.1128/JCM.38.2.941-942.2000; von Gottberg A, 2008, CLIN INFECT DIS, V46, P377, DOI 10.1086/525260; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216771	10.1371/journal.pone.0216771	http://dx.doi.org/10.1371/journal.pone.0216771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141820	Green Published, Green Submitted, gold			2022-12-26	WOS:000469323000021
J	Staatz, CB; Hardy, R				Staatz, Charis Bridger; Hardy, Rebecca			Number of children and body composition in later life among men and women: Results from a British birth cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MRC NATIONAL-SURVEY; OLD-AGE FINDINGS; PHYSICAL-ACTIVITY; MASS INDEX; RISK-FACTORS; WEIGHT-GAIN; HEALTH; OBESITY; PARITY	Background Although research has found associations between increasing number of children and higher body mass index (BMI), there has been limited research investigating the association with body composition despite abdominal fat being independently associated with cardiovascular and metabolic risk. Most existing research has focussed on women, but investigating the relationship in men can help distinguish biological effects of pregnancy from social pathways related to parenthood. Methods Using the MRC National Survey of Health and Development (NSHD) multiple regression models were applied to test associations between number of children and body composition at age 60-64 years (N = 2229) and body mass index (BMI) and waist circumference (WC) at ages 60-64 and 69 years (N = 2149). Results In adjusted models, associations were observed between increasing numbers of children and increasing fat-adjusted lean mass index in women (p = 0.06). Among men, those with children had 0.59kg (95% CI: 0.15 to 1.02) greater lean mass index than those without and fat: lean mass ratio was greater in those with 4+ children because of their slightly higher mean fat mass. Weak evidence of a higher android: gynoid mass ratio among mothers (0.03, 95% CI: 0.00,0.06, p = 0.1) was observed with no associations with fat mass index, android or gynoid fat mass. Increasing parity in women was associated with increasing BMI at 60-64 years and, more strongly, with increasing BMI at 69 years. Associations among men were also observed more clearly with BMI at 69 years. Conclusion There was little evidence of a consistent association between number of children and body composition in early old age. The strongest associations are observed for lean, rather than fat mass, and in men rather than women, suggesting little evidence of biological effects of pregnancy. The results indicate social pathways associated with parenthood are the likely underlying mechanisms, with suggestion of selection into parenthood among men.	[Staatz, Charis Bridger; Hardy, Rebecca] UCL, MRC Unit Lifelong & Hlth Ageing, Dept Populat Hlth & Expt Med, London, England	University of London; University College London	Staatz, CB (corresponding author), UCL, MRC Unit Lifelong & Hlth Ageing, Dept Populat Hlth & Expt Med, London, England.	charis.staatz.17@ucl.ac.uk	Hardy, Rebecca/AFR-1989-2022	Hardy, Rebecca/0000-0001-9949-0799; Bridger Staatz, Charis/0000-0002-2872-6968	UK Medical research Council [MR/N013867/1, MC_UU_12019/1, MC_UU_12019/2]; MRC [MC_U123092720, 1905200, MC_UU_12019/1, MC_UU_00019/1, MC_UU_12019/2] Funding Source: UKRI	UK Medical research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CBS is supported by a PhD studentship from the UK Medical research Council (MR/N013867/1). The MRC NSHD and RH are supported by the UK Medical Research Council (MC_UU_12019/1, MC_UU_12019/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams B, 2013, OBESITY, V21, P1514, DOI 10.1002/oby.20503; Baker L, 2003, J SURG RES, V115, P325, DOI 10.1016/S0022-4804(03)00215-4; Bann D, 2014, INT J OBESITY, V38, P69, DOI 10.1038/ijo.2013.115; Bellows-Riecken KH, 2008, PREV MED, V46, P99, DOI 10.1016/j.ypmed.2007.08.003; Berge JM, 2011, PEDIATRICS, V127, P881, DOI 10.1542/peds.2010-3218; Blaudeau TE, 2006, INT J OBESITY, V30, P1119, DOI 10.1038/sj.ijo.0803252; Bredella MA, 2010, OBESITY, V18, P2227, DOI 10.1038/oby.2010.5; Brown DM, 2017, SSM-POPUL HLTH, V3, P558, DOI 10.1016/j.ssmph.2017.06.004; Cooper R, 2014, J GERONTOL A-BIOL, V69, P1253, DOI 10.1093/gerona/glu039; Davis EM, 2009, AM J PUBLIC HEALTH, V99, P294, DOI 10.2105/AJPH.2007.132373; Gennaro S, 2000, FAM COMMUNITY HEALTH, V22, P16, DOI 10.1097/00003727-200001000-00004; Gunderson EP, 2008, OBESITY, V16, P1078, DOI 10.1038/oby.2008.40; Guralnik JM, 2009, AGING CLIN EXP RES, V21, P174; Hardy R, 2009, J EPIDEMIOL COMMUN H, V63, P99, DOI 10.1136/jech.2008.076943; Hardy R, 2007, BJOG-INT J OBSTET GY, V114, P721, DOI 10.1111/j.1471-0528.2007.01324.x; Hinton PS, 2001, J AM DIET ASSOC, V101, P1430, DOI 10.1016/S0002-8223(01)00345-5; Hinton PS, 2001, PREDICTORS PREGNANCY, P7; Johnson W, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001828; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Laroche HH, 2007, J AM BOARD FAM MED, V20, P9, DOI 10.3122/jabfm.2007.01.060085; Laroche HH, 2013, J ACAD NUTR DIET, V113, P1504, DOI 10.1016/j.jand.2013.05.022; Laroche HH, 2012, J ACAD NUTR DIET, V112, P832, DOI 10.1016/j.jand.2012.02.024; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Lee SK, 2005, OBES RES, V13, P1263, DOI 10.1038/oby.2005.150; Li WD, 2016, NUTR METAB, P13; Lim U, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.2; Mailey EL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-657; Ngo AD, 2016, BJOG-INT J OBSTET GY, V123, P1311, DOI 10.1111/1471-0528.13729; Nishiwaki Y, 2011, J GERONTOL A-BIOL, V66, P326, DOI 10.1093/gerona/glq227; Okosun IS, 2015, NUTR DIABETES, P5; Ornelas IJ, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-3; Parikh NI, 2012, HUM REPROD, V27, P568, DOI 10.1093/humrep/der400; Pereira MA, 2007, AM J PREV MED, V32, P312, DOI 10.1016/j.amepre.2006.12.017; Reis-Santos B, 2018, BMC PUBLIC HEALTH, P18; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Saito A, 2018, J NUTR SCI, P7; Shen LJ, 2015, SCI REP, P5; Sim JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127860; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; Umberson D, 2011, SOC SCI MED, V73, P1323, DOI 10.1016/j.socscimed.2011.08.014; Vasan SK, 2018, INT J OBESITY, V42, P850, DOI 10.1038/ijo.2017.289; Warin M, 2008, SOCIOL HEALTH ILL, V30, P97, DOI 10.1111/j.1467-9566.2007.01029.x; Weng HLH, 2004, J WOMENS HEALTH, V13, P85, DOI 10.1089/154099904322836492	44	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0209529	10.1371/journal.pone.0209529	http://dx.doi.org/10.1371/journal.pone.0209529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141503	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000001
J	Skrivan, M; Englmaierova, M; Vit, T; Skrivanova, E				Skrivan, Milos; Englmaierova, Michaela; Vit, Tomas; Skrivanova, Eva			Hempseed increases gamma-tocopherol in egg yolks and the breaking strength of tibias in laying hens	PLOS ONE			English	Article							PERFORMANCE; CHEMISTRY; PLASMA; BONE	The effect of hempseed in the diet of laying hens was evaluated at 0, 30, 60 and 90 g/kg concentrations. The aim of the study was to determine the effect of dietary treatment on the performance of hens, the physical characteristics of egg quality, the concentrations of alpha- and gamma-tocopherol and the carotenoid and cholesterol contents of egg yolks, together with the breaking strength of tibial measurements. In light of the obtained results, our study aimed to address the optimal dietary level of hempseed in laying hen diets. Lohmann Brown hens (n = 240) were divided into 4 dietary treatment groups (6 cages per treatment) with 10 hens per cage. The experiment lasted for 12 weeks. The level of nutrients in all diets (wheat-corn) was well balanced. The dietary metabolisable energy was adjusted using rapeseed oil. The addition of 30 g/kg of hempseed to the diet significantly increased (P<0.001) egg production and egg mass. Alpha-tocopherol increased significantly (P = 0.002) only in the case of the 60 g/kg hempseed level (101 mg/kg dry matter (DM) versus 83 mg/kg DM in the control group). In contrast, the level of gamma-tocopherol increased gradually from 11 mg/kg DM in the control to 29, 39 and 43 mg/kg DM at the 30, 60 and 90 g/kg levels of dietary hempseed, respectively. The concentrations of beta carotene, zeaxanthin and lutein in egg yolks were not influenced by the dietary treatment. Hempseed at 90 g/kg (P = 0.036) decreased egg shell thickness without affecting its strength. The addition of hempseed decreased (P<0.001) the cholesterol concentration in the egg yolks in all experimental groups. The addition of 30, 60 and 90 g hempseed increased (P<0.001) the breaking strength of the tibia to 354, 352 and 350 N, respectively, compared to 297 N in the control group. The highest level of hempseed in the diet positively influenced the Ca concentration in the tibia (P = 0.021). The concentration of P in the tibia was negatively affected in the 60 to 90 g/kg hempseed treatments (P<0.001). Eggs are a significant source of alpha-tocopherol. Based on our results, there is a possibility for enrichment of egg yolks with gamma-tocopherol, with all of its associated health benefits, by the addition of hempseed to the diet of laying hens. Another significant benefit of hempseed is its effect on the breaking strength of the tibia, which can help with crucial problems in the commercial breeding of laying hens.	[Skrivan, Milos; Englmaierova, Michaela; Vit, Tomas; Skrivanova, Eva] Inst Anim Sci, Dept Nutr Physiol & Anim Prod Qual, Prague, Czech Republic	Czech Research Institute of Animal Science	Skrivan, M (corresponding author), Inst Anim Sci, Dept Nutr Physiol & Anim Prod Qual, Prague, Czech Republic.	skrivan.milos@vuzv.cz	Skrivanova, Eva/V-6389-2019; Vít, Tomáš/A-9389-2010	Skrivanova, Eva/0000-0001-9336-5436; Englmaierova, Michaela/0000-0003-2752-3170	Ministry of Agriculture of the Czech Republic [MZERO0719]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Ministry of Agriculture of the Czech Republic (Project MZERO0719). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borhanuddin B, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/684510; Budgell KL, 2004, CAN J ANIM SCI, V84, P745, DOI 10.4141/A04-040; Chin KY, 2014, NUTRIENTS, V6, P1424, DOI 10.3390/nu6041424; COONEY RV, 1993, P NATL ACAD SCI USA, V90, P1771, DOI 10.1073/pnas.90.5.1771; Froescheis O, 2000, J CHROMATOGR B, V739, P291, DOI 10.1016/S0378-4347(99)00562-9; Gabet Y, 2017, OSTEOPOROSIS INT, V28, pS124; Goldberg EM, 2012, J FOOD SCI, V77, pS153, DOI 10.1111/j.1750-3841.2012.02626.x; GREGORY NG, 1989, BRIT POULTRY SCI, V30, P555, DOI 10.1080/00071668908417179; Guinazi M, 2009, QUIM NOVA, V32, P2098, DOI 10.1590/S0100-40422009000800021; Halle I, 2013, J VERBRAUCH LEBENSM, V8, P185, DOI 10.1007/s00003-013-0822-3; Hamidi MS, 2012, J BONE MINER RES, V27, P1368, DOI 10.1002/jbmr.1566; Haugh R., 1937, US EGG POULTRY MAGAZ, V43, P522; Haugh R R., 1937, US EGG POULTRY MAGAZ, V43, P572; Jiang Q, 2001, AM J CLIN NUTR, V74, P714; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Kasai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132059; Kriese U, 2004, EUPHYTICA, V137, P339, DOI 10.1023/B:EUPH.0000040473.23941.76; Leger CL, 2000, OCL-OL CORPS GRAS LI, V7, P258, DOI 10.1051/ocl.2000.0258; Neijat M, 2014, POULTRY SCI, V93, P2827, DOI 10.3382/ps.2014-03936; Oomah BD, 2002, FOOD CHEM, V76, P33, DOI 10.1016/S0308-8146(01)00245-X; SAS, 2003, SAS STAT US GUID REL; Sauveur B., 1988, REPROD POULTRY EGG P, P472; Sazmand M, 2018, ELECTRON J GEN MED, V15, DOI 10.29333/ejgm/86195	23	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217509	10.1371/journal.pone.0217509	http://dx.doi.org/10.1371/journal.pone.0217509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136626	Green Submitted, Green Published, gold			2022-12-26	WOS:000469224300048
J	Fontaine, MA; Diane, A; Singh, VP; Mangat, R; Krysa, JA; Nelson, R; Willing, BP; Proctor, SD				Fontaine, Melanie A.; Diane, Abdoulaye; Singh, Vijay P.; Mangat, Rabban; Krysa, Jacqueline A.; Nelson, Randy; Willing, Benjamin P.; Proctor, Spencer D.			4 Low birth weight causes insulin resistance and aberrant intestinal lipid metabolism independent of microbiota abundance in Landrace-Large White pigs	FASEB JOURNAL			English	Article						intrauterine growth restriction; swine; lymphatic lipoproteins; microbiota	HIGH-FAT DIET; DEVELOPMENTAL ORIGINS; GUT MICROBIOTA; CARDIOVASCULAR-DISEASE; OBESITY; GROWTH; MODEL; RISK; OVERPRODUCTION; TRIGLYCERIDES	Low birth weight (LBW) and postnatal nutrition are risk factors for adult metabolic diseases. However, the interactions between LBW, diet, and intestinal lipid absorption and secretion leading to adult metabolic disease remain unclear. The current study determined the impact of LBW on intestinal lipid and carbohydrate metabolism under both control and Western diet (high fat, high fructose, and cholesterol) conditions in 5-wk-old LBW and normal birth weight (NBW) Landrace-Large White x Duroc pigs. A 2-step modified oral glucose and fat challenge test was performed. Mesenteric lymph, jejunal mucosal scrapings, and cecal digesta samples were also collected. LBW offspring were lower in weight and gained less weight per day. LBW pigs on either control or Western diets displayed increased triglyceride (TG) secretion into lymph (P = 0.0135). Western diet-fed LBW pigs developed fasting (P = 0.03) and postprandial (P < 0.05) hypertriglyceridemia, muscle steatosis (P = 0.0072), had higher insulin excursion (P < 0.01), increased jejunal stearoyl-CoA desaturase 1 mRNA and increased hepatic fibrosis (P = 0.0017) compared with NBW piglets. Gut microbiota showed significant dysbiosis on Western diet independent of birth weight. In conclusion, LBW pigs fed a Western diet specifically up-regulate TG absorption and secretion, develop dyslipidemia, muscular steatosis, and display early signs of insulin resistance. Interestingly, this study does not provide evidence of altered intestinal microbiome in LBW pigs contributing to increased severity of metabolic diseases.-Fontaine, M. A., Diane, A., Singh, V. P., Mangat, R., Krysa, J. A., Nelson, R., Willing, B. P., Proctor, S. D. Low birth weight causes insulin resistance and aberrant intestinal lipid metabolism independent of microbiota abundance in Landrace-Large White pigs.	[Fontaine, Melanie A.; Diane, Abdoulaye; Singh, Vijay P.; Mangat, Rabban; Krysa, Jacqueline A.; Nelson, Randy; Proctor, Spencer D.] Univ Alberta, Metab & Cardiovasc Dis Lab, Grp Mol & Cell Biol Lipids, Alberta Diabet & Mazankowski Heart Inst, Edmonton, AB, Canada; [Willing, Benjamin P.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Proctor, SD (corresponding author), Univ Alberta, Alberta Diabet & Mazankowski Heart Inst, Grp Mol & Cell Biol Lipids, 4 002J Li Ka Shing Ctr Hlth Res Innovat,Metab, Edmonton, AB T6G 2E1, Canada.	spencer.proctor@ualberta.ca	Willing, Benjamin/AAA-9650-2019		Alberta Livestock and Meat Agency (ALMA); Alberta Agriculture and Forestry (AAF); Natural Sciences and Engineering Research Council of Canada (NSERC)	Alberta Livestock and Meat Agency (ALMA); Alberta Agriculture and Forestry (AAF); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank Sandra Kelly and Sharon Sokolik (both from the University of Alberta) for technical assistance. Funding support from Alberta Livestock and Meat Agency (ALMA) and Alberta Agriculture and Forestry (AAF) and the Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant (Proctor). The authors declare no conflicts of interest.	Adeli K, 2008, CURR OPIN LIPIDOL, V19, P221, DOI 10.1097/MOL.0b013e3282ffaf82; Al K, 2017, PEERJ, V5, DOI 10.7717/peerj.2840; ALjohani AM, 2017, TRENDS ENDOCRIN MET, V28, P831, DOI 10.1016/j.tem.2017.10.003; Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barker D J, 2001, Med Health Care Philos, V4, P31, DOI 10.1023/A:1009934412988; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Costello EK, 2013, MBIO, V4, DOI 10.1128/mBio.00782-13; Council N.R., 2012, NUTR REQ SWIN; Davis Jeremy E, 2013, ISRN Obes, V2013, P584547, DOI 10.1155/2013/584547; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; Dong XY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-173; Duez H, 2006, ARTERIOSCL THROM VAS, V26, P1357, DOI 10.1161/01.ATV.0000222015.76038.14; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Suarez-Ortegon MF, 2016, WORLD J PEDIATR, V12, P477, DOI 10.1007/s12519-016-0008-z; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005; Field FJ, 2001, J LIPID RES, V42, P1; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; HACK M, 1993, J PEDIATR-US, V122, P887, DOI 10.1016/S0022-3476(09)90012-9; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Halliday HL, 2009, BEST PRACT RES CL OB, V23, P871, DOI 10.1016/j.bpobgyn.2009.06.005; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hyson Dianne, 2003, Curr Atheroscler Rep, V5, P437, DOI 10.1007/s11883-003-0033-y; Jackson KG, 2012, ATHEROSCLEROSIS, V220, P22, DOI 10.1016/j.atherosclerosis.2011.08.012; Jiang ZH, 2008, INT J BIOL SCI, V4, P345, DOI 10.7150/ijbs.4.345; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Li H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00969-0; Lian JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25747; Lim KS, 2015, ASIAN AUSTRAL J ANIM, V28, P151, DOI 10.5713/ajas.14.0529; Liu JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029259; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Myrie SB, 2017, APPL PHYSIOL NUTR ME, V42, P1322, DOI 10.1139/apnm-2017-0311; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Ogden Cynthia L, 2010, NCHS Data Brief, P1; Panasevich MR, 2018, AM J PHYSIOL-ENDOC M, V314, pE78, DOI 10.1152/ajpendo.00015.2017; Pedersen R, 2013, GUT MICROBES, V4, P371, DOI 10.4161/gmic.26108; Pedersen R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-30; PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P154, DOI 10.1055/s-0029-1211159; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Ravandi A, 2000, ARTERIOSCL THROM VAS, V20, P467, DOI 10.1161/01.ATV.20.2.467; Ren J, 2004, ANIM GENET, V35, P255, DOI 10.1111/j.1365-2052.2004.01129.x; Russell JC, 1998, EUR J PHARMACOL, V350, P203, DOI 10.1016/S0014-2999(98)00244-1; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schulz LC, 2010, P NATL ACAD SCI USA, V107, P16757, DOI 10.1073/pnas.1012911107; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Uwiera RR, 2016, JOVE-J VIS EXP, DOI 10.3791/53457; Vaag AA, 2012, DIABETOLOGIA, V55, P2085, DOI 10.1007/s00125-012-2589-y; van Steijn L, 2009, INT J OBESITY, V33, P1326, DOI 10.1038/ijo.2009.154; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; Vine DF, 2007, ATHEROSCLEROSIS, V190, P282, DOI 10.1016/j.atherosclerosis.2006.03.013; Visentin S, 2014, ATHEROSCLEROSIS, V237, P391, DOI 10.1016/j.atherosclerosis.2014.09.027; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yan HL, 2017, EUR J NUTR, V56, P483, DOI 10.1007/s00394-015-1093-9; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	66	11	13	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9250	9262		10.1096/fj.201801302RR	http://dx.doi.org/10.1096/fj.201801302RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31144992	Bronze			2022-12-26	WOS:000478832900044
J	Ikeda, Y; Satoh, A; Horinouchi, Y; Hamano, H; Watanabe, H; Imao, M; Imanishi, M; Zamami, Y; Takechi, K; Izawa-Ishizawa, Y; Miyamoto, L; Hirayama, T; Nagasawa, H; Ishizawa, K; Aihara, KI; Tsuchiya, K; Tamaki, T				Ikeda, Yasumasa; Satoh, Akiho; Horinouchi, Yuya; Hamano, Hirofumi; Watanabe, Hiroaki; Imao, Mizuki; Imanishi, Masaki; Zamami, Yoshito; Takechi, Kenshi; Izawa-Ishizawa, Yuki; Miyamoto, Licht; Hirayama, Tasuku; Nagasawa, Hideko; Ishizawa, Keisuke; Aihara, Ken-Ichi; Tsuchiya, Koichiro; Tamaki, Toshiaki			Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress	FASEB JOURNAL			English	Article						muscle regeneration; muscle differentiation; p38MAPK; ERK1/2	SERUM AMINOTRANSFERASE LEVELS; PROTEIN-KINASE PATHWAY; MUSCLE GENE-EXPRESSION; HUMAN SKELETAL-MUSCLE; SATELLITE CELLS; SARCOPENIC OBESITY; DIFFERENTIATION; REGENERATION; FERRITIN; P38	Skeletal muscle atrophy is caused by disruption in the homeostatic balance of muscle degeneration and regeneration under various pathophysiological conditions. We have previously reported that iron accumulation induces skeletal muscle atrophy via a ubiquitin ligase-dependent pathway. However, the potential effect of iron accumulation on muscle regeneration remains unclear. To examine the effect of iron accumulation on myogenesis, we used a mouse model with cardiotoxin (CTX)-induced muscle regeneration in vivo and C2C12 mouse myoblast cells in vitro. In mice with iron overload, the skeletal muscles exhibited increased oxidative stress and decreased expression of satellite cell markers. Following CTX-induced muscle injury, these mice also displayed delayed muscle regeneration with a decrease in the size of regenerating myofibers, reduced expression of myoblast differentiation markers, and decreased phosphorylation of MAPK signaling pathways. In vitro, iron overload also suppressed the differentiation of C2C12 myoblast cells but the suppression could be reversed by superoxide scavenging using tempol. Excess iron inhibits myogenesis via oxidative stress, leading to an imbalance in skeletal muscle homeostasis.-Ikeda, Y., Satoh, A., Horinouchi, Y., Hamano, H., Watanabe, H., Imao, M., Imanishi, M., Zamami, Y., Takechi, K., Izawa-Ishizawa, Y., Miyamoto, L., Hirayama, T., Nagasawa, H., Ishizawa, K., Aihara, K.-I., Tsuchiya, K., Tamaki, T. Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress.	[Ikeda, Yasumasa; Horinouchi, Yuya; Izawa-Ishizawa, Yuki; Tamaki, Toshiaki] Tokushima Univ, Inst Biomed Sci, Dept Pharmacol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan; [Satoh, Akiho; Imao, Mizuki; Miyamoto, Licht; Tsuchiya, Koichiro] Tokushima Univ, Inst Biomed Sci, Dept Med Pharmacol, Grad Sch, Tokushima, Japan; [Watanabe, Hiroaki; Zamami, Yoshito; Ishizawa, Keisuke] Tokushima Univ, Inst Biomed Sci, Dept Clin Pharmacol, Grad Sch, Tokushima, Japan; [Aihara, Ken-Ichi] Tokushima Univ, Inst Biomed Sci, Dept Community Med Diabet & Metab Disorders, Grad Sch, Tokushima, Japan; [Hamano, Hirofumi; Imanishi, Masaki; Zamami, Yoshito; Ishizawa, Keisuke] Tokushima Univ Hosp, Dept Pharm, Tokushima, Japan; [Takechi, Kenshi] Tokushima Univ Hosp, Clin Trial Ctr Dev Therapeut, Tokushima, Japan; [Hirayama, Tasuku; Nagasawa, Hideko] Gifu Pharmaceut Univ, Lab Pharmaceut & Med Chem, Gifu, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Tokushima University; Tokushima University; Gifu Pharmaceutical University	Ikeda, Y (corresponding author), Tokushima Univ, Inst Biomed Sci, Dept Pharmacol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	yasuike@tokushima-u.ac.jp		Imanishi, Masaki/0000-0003-1305-5943; Hamano, Hirofumi/0000-0002-2231-0179; Ikeda, Yasumasa/0000-0003-4318-7349	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K01716, 18K08480]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Editage (www.editage.jp) for help with English language editing. The authors appreciate the excellent technical advice by the Support Center for Advanced Medical Sciences (Institute of Biomedical Sciences, Tokushima University Graduate School). This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grants (15K01716 and 18K08480 to Y. I.). The authors declare no conflicts of interest.	Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Bross R, 1999, TRENDS ENDOCRIN MET, V10, P194, DOI 10.1016/S1043-2760(98)00143-X; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Camaschella C, 2005, BLOOD, V106, P3710, DOI 10.1182/blood-2005-05-1857; CARTEE GD, 1995, J GERONTOL A-BIOL, V50, P137; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chung JY, 2013, ARCH GERONTOL GERIAT, V56, P270, DOI 10.1016/j.archger.2012.09.007; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cooper RN, 1999, J CELL SCI, V112, P2895; Corbu A, 2010, NEUROL RES, V32, P63, DOI 10.1179/174313209X385725; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; D'Souza DM, 2016, DIABETES, V65, P3053, DOI 10.2337/db15-1577; DeRuisseau KC, 2013, EXP GERONTOL, V48, P1294, DOI 10.1016/j.exger.2013.08.011; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Fernandez E, 2005, CLIN CHEM, V51, P1014, DOI 10.1373/clinchem.2004.047233; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Fu X, 2016, DIABETES, V65, P188, DOI 10.2337/db15-0647; Fulster S, 2013, EUR HEART J, V34, P512, DOI 10.1093/eurheartj/ehs381; Fujimaki Shin, 2016, Biochem Biophys Rep, V8, P6, DOI 10.1016/j.bbrep.2016.07.004; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Gallegly JC, 2004, J APPL PHYSIOL, V97, P1082, DOI 10.1152/japplphysiol.00006.2004; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; GUTTRIDGE DC, 2000, SCIENCE, V289, P2363, DOI [10.1126/sci-ence.289.5488.2363, DOI 10.1126/SCI-ENCE.289.5488.2363, DOI 10.1126/science.289.5488.2363, DOI 10.1126/SCIENCE.289.5488.2363]; Halliday JW, 1996, BIOMETALS, V9, P205, DOI 10.1007/BF00144626; Hamano H, 2018, NEPHROL DIAL TRANSPL, V33, P586, DOI 10.1093/ndt/gfx252; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; HAYASHI H, 1995, J HEPATOL, V22, P268, DOI 10.1016/0168-8278(95)80278-9; HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986; Hirayama T, 2013, CHEM SCI, V4, P1250, DOI 10.1039/c2sc21649c; Horinouchi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29008-2; Houschyar KS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-54; Ikeda Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11089-0; Ikeda Y, 2016, J TRACE ELEM MED BIO, V35, P66, DOI 10.1016/j.jtemb.2016.01.011; Ikeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089355; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; Ishizaka N, 2002, CIRCULATION, V106, P1840, DOI 10.1161/01.CIR.0000031161.77536.02; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090105; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kuo KL, 2014, J AM SOC NEPHROL, V25, P2596, DOI 10.1681/ASN.2013080838; Lee DH, 2006, DIABETES CARE, V29, P1090, DOI 10.2337/DC05-2471; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Lynch G S, 2001, Exerc Sport Sci Rev, V29, P141, DOI 10.1097/00003677-200110000-00002; Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P9, DOI 10.1007/s13539-011-0019-5; Menke A, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-34; Moore DR, 2018, EUR J APPL PHYSIOL, V118, P2225, DOI 10.1007/s00421-018-3954-4; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Nakanishi T, 2010, AM J NEPHROL, V32, P439, DOI 10.1159/000320733; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Oshima K, 2017, LAB INVEST, V97, P555, DOI 10.1038/labinvest.2017.11; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Reardon TF, 2009, EXP PHYSIOL, V94, P720, DOI 10.1113/expphysiol.2008.046045; Renault V, 2002, EXP GERONTOL, V37, P1229, DOI 10.1016/S0531-5565(02)00129-8; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Sawada H, 2015, ARTERIOSCL THROM VAS, V35, P1507, DOI 10.1161/ATVBAHA.115.305586; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sestili P, 2009, MOL NUTR FOOD RES, V53, P1187, DOI 10.1002/mnfr.200800504; Tajima S, 2012, AM J PHYSIOL-ENDOC M, V302, pE77, DOI 10.1152/ajpendo.00033.2011; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	84	12	14	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9551	9564		10.1096/fj.201802724RR	http://dx.doi.org/10.1096/fj.201802724RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145863	Bronze			2022-12-26	WOS:000478832900066
J	Inniss, NL; Prehna, G; Morrison, DA				Inniss, Nicole L.; Prehna, Gerd; Morrison, Donald A.			The pneumococcal sigma(X) activator, ComW, is a DNA-binding protein critical for natural transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus; microbiology; RNA polymerase; DNA transformation; protein structure; bacterial transcription; competence; ComW; pneumococcus; sigma factor	STREPTOCOCCUS-PNEUMONIAE MUTATIONS; COLI RNA-POLYMERASE; GENETIC-TRANSFORMATION; SECONDARY STRUCTURE; BACILLUS-SUBTILIS; CONTROLS COMPETENCE; STRUCTURAL BASIS; IDENTIFICATION; PROMOTER; TRANSCRIPTION	Natural genetic transformation via horizontal gene transfer enables rapid adaptation to dynamic environments and contributes to both antibiotic resistance and vaccine evasion among bacterial populations. In Streptococcus pneumoniae (pneumococcus), transformation occurs when cells enter competence, a transient state in which cells express the competence master regulator, SigX (sigma(Chi)), an alternative sigma factor (sigma), and a competence co-regulator, ComW. Together, ComW and sigma(X) facilitate expression of the genes required for DNA uptake and genetic recombination. SigX activity depends on ComW, as Delta comW cells transcribe late genes and transform at levels 10- and 10,000-fold below that of WT cells, respectively. Previous findings suggest that ComW functions during assembly of the RNA polymerase-sigma(X) holoenzyme to help promote transcription from sigma(X)-targeted promoters. However, it remains unknown how ComW facilitates holoenzyme assembly. As ComW seems to be unique to Gram-positive cocci and has no sequence similarity with known transcriptional activators, here we used Rosetta to generate an ab initio model of pneumococcal ComW's 3D-structure. Using this model as a basis for further biochemical, biophysical, and genetic investigations into the molecular features important for its function, we report that ComW is a predicted globular protein and that it interacts with DNA, independently of DNA sequence. We also identified conserved motifs in ComW and show that key residues in these motifs contribute to DNA binding. Lastly, we provide evidence that ComW's DNA-binding activity is important for transformation in pneumococcus. Our findings begin to fill the gaps in understanding how ComW regulates sigma(Chi) activity during bacterial natural transformation.	[Inniss, Nicole L.; Morrison, Donald A.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Prehna, Gerd] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Manitoba	Morrison, DA (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA.; Prehna, G (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	gerd.prehna@umanitoba.ca; damorris@uic.edu		Inniss, Nicole/0000-0002-1510-7412; Prehna, Gerd/0000-0001-5539-7533	University of Illinois at Chicago through the Abraham Lincoln Fellowship; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [1R03AI128228]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI128228] Funding Source: NIH RePORTER	University of Illinois at Chicago through the Abraham Lincoln Fellowship; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the University of Illinois at Chicago through the Abraham Lincoln Fellowship awarded to NLI, as well as an R03 grant to GP and DAM from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (1R03AI128228). The authors declare that they have no conflicts of interest with the contents of this article.	Andam CP, 2015, INFECT GENET EVOL, V33, P334, DOI 10.1016/j.meegid.2014.11.007; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Banta AB, 2014, J BACTERIOL, V196, P3279, DOI 10.1128/JB.01910-14; Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Campagne S, 2014, NAT STRUCT MOL BIOL, V21, P269, DOI 10.1038/nsmb.2777; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 1998, MOL MICROBIOL, V27, P929, DOI 10.1046/j.1365-2958.1998.00737.x; Cavaliere Paola, 2016, BioMolecular Concepts, V7, P197, DOI 10.1515/bmc-2016-0006; CHAMBERLIN M, 1962, P NATL ACAD SCI USA, V48, P81, DOI 10.1073/pnas.48.1.81; CHANDLER MS, 1988, J BACTERIOL, V170, P3136, DOI 10.1128/jb.170.7.3136-3141.1988; Cheng Q, 1997, MOL MICROBIOL, V23, P683, DOI 10.1046/j.1365-2958.1997.2481617.x; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; Devkota SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174284; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dou Y, 2016, MOL ORAL MICROBIOL, V31, P270, DOI 10.1111/omi.12122; England P, 2008, J BIOL CHEM, V283, P33455, DOI 10.1074/jbc.M807380200; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; Fontaine L, 2013, MOL MICROBIOL, V87, P1113, DOI 10.1111/mmi.12157; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; FOX TD, 1976, J MOL BIOL, V101, P427, DOI 10.1016/0022-2836(76)90157-1; Gao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101229; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goutam K, 2017, NUCLEIC ACIDS RES, V45, P9760, DOI 10.1093/nar/gkx609; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gu D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005645; Havarstein LS, 2010, MOL MICROBIOL, V78, P541, DOI 10.1111/j.1365-2958.2010.07380.x; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Heinrich J, 2009, RES MICROBIOL, V160, P696, DOI 10.1016/j.resmic.2009.08.019; Hill KE, 2002, J MED MICROBIOL, V51, P949, DOI 10.1099/0022-1317-51-11-949; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUI FM, 1991, J BACTERIOL, V173, P372, DOI 10.1128/jb.173.1.372-381.1991; HUI FM, 1995, GENE, V153, P25, DOI 10.1016/0378-1119(94)00841-F; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; JONES CH, 1992, J BACTERIOL, V174, P6815, DOI 10.1128/JB.174.21.6815-6821.1992; JONES CH, 1992, P NATL ACAD SCI USA, V89, P1958, DOI 10.1073/pnas.89.5.1958; JUANG YL, 1995, BIOCHEMISTRY-US, V34, P8465, DOI 10.1021/bi00026a030; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; Khan R, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00038-15; Khan R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04768-5; Konovalova A, 2014, FEMS MICROBIOL REV, V38, P493, DOI 10.1111/1574-6976.12050; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; Li W, 2002, J MOL BIOL, V323, P225, DOI 10.1016/S0022-2836(02)00948-8; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Liu H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0078-1; Luo P, 2004, MOL MICROBIOL, V54, P172, DOI 10.1111/j.1365-2958.2004.04254.x; Luo P, 2003, MOL MICROBIOL, V50, P623, DOI 10.1046/j.1365-2958.2003.03714.x; Luo P, 2003, J BACTERIOL, V185, P349, DOI 10.1128/JB.185.1.349-358.2003; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, P NATL ACAD SCI USA, V106, P21323, DOI 10.1073/pnas.0910006106; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; Martin B, 2013, MOL MICROBIOL, V87, P394, DOI 10.1111/mmi.12104; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Morrison DA, 2000, RES MICROBIOL, V151, P445, DOI 10.1016/S0923-2508(00)00171-6; Murakami KS, 2015, BIOMOLECULES, V5, P848, DOI 10.3390/biom5020848; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nechaev S, 2004, P NATL ACAD SCI USA, V101, P17365, DOI 10.1073/pnas.0408028101; Neiditch MB, 2017, ANNU REV GENET, V51, P311, DOI 10.1146/annurev-genet-120116-023507; Paget MS, 2015, BIOMOLECULES, V5, P1245, DOI 10.3390/biom5031245; Parashar V, 2015, P NATL ACAD SCI USA, V112, P5177, DOI 10.1073/pnas.1500357112; PERO J, 1975, P NATL ACAD SCI USA, V72, P1589, DOI 10.1073/pnas.72.4.1589; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Piotrowski A., 2010, STREPTOCOCCUS PNEUMO; Piotrowski A, 2009, J BACTERIOL, V191, P3359, DOI 10.1128/JB.01750-08; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Qiu J, 2001, J BACTERIOL, V183, P1921, DOI 10.1128/JB.183.6.1921-1927.2001; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Talagas A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005980; TALKINGTON C, 1978, P NATL ACAD SCI USA, V75, P1185, DOI 10.1073/pnas.75.3.1185; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tovpeko Y, 2016, J BACTERIOL, V198, P2370, DOI 10.1128/JB.00354-16; Tovpeko Y, 2014, J BACTERIOL, V196, P3724, DOI 10.1128/JB.01933-14; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Ween O, 1999, MOL MICROBIOL, V33, P817, DOI 10.1046/j.1365-2958.1999.01528.x; Weng LM, 2009, J MICROBIOL METH, V79, P353, DOI 10.1016/j.mimet.2009.10.007; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WILLIAMS KP, 1989, J BACTERIOL, V171, P3579, DOI 10.1128/jb.171.6.3579-3582.1989; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	95	8	8	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11101	11118		10.1074/jbc.RA119.007571	http://dx.doi.org/10.1074/jbc.RA119.007571			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31160340	Green Published, hybrid			2022-12-26	WOS:000478717400005
J	Ma, QY; Liang, MM; Wu, YT; Ding, N; Duan, LL; Yu, T; Bai, Y; Kang, F; Dong, SW; Xu, JZ; Dou, C				Ma, Qinyu; Liang, Mengmeng; Wu, Yutong; Ding, Ning; Duan, Lianli; Yu, Tao; Bai, Yun; Kang, Fei; Dong, Shiwu; Xu, Jianzhong; Dou, Ce			Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoclast; osteoblast; apoptosis; bone; cell differentiation; bone remodeling; cell coupling	ILIAC TRABECULAR BONE; KINETIC-MODEL; VESICLES; CELLS; RECONSTRUCTION; MECHANISMS; RESORPTION; LIGAND; DEATH; SITE	In bone remodeling, after a lifespan of similar to 2 weeks, osteoclasts undergo apoptosis in each bone turnover cycle, resulting in generation of a large number of apoptotic bodies (ABs). However, the biological roles of osteoclast-derived ABs (OC-ABs) in bone remodeling have not been investigated and remain unknown. In this study, we stimulated bone marrow macrophages with receptor activator of NF-kappa B ligand (RANKL) to obtain both preosteoclasts and mature osteoclasts (mOCs). We then used alendronate to induce apoptosis in preosteoclasts and mOCs and generate the respective ABs and used flow cytometry and immunoblotting to characterize the sizes and immunogenic characteristics of the extracted ABs. We show that mOC-ABs are engulfed by preosteoblastic MC3T3-E1 cells and promote the viability of these cells. Among all osteoclast-derived extracellular vesicles, mOC-ABs had the highest osteogenic potency. We further observed that mOC-ABs had the highest vesicular receptor activator of NF-kappa B (RANK) levels among all types of osteoclast-derived extracellular vesicles. Of note, masking of vesicular RANK by soluble RANKL strongly abolished the osteogenic potency of osteoclast-derived ABs. Mechanistically, we found that mOC-ABs induce osteoblast differentiation by activatingPI3K/AKT/mechanistic target of rapamycin (mTOR)/ribosomal protein S6 kinase signaling. In conclusion, OC-ABs promote osteogenic differentiation by stimulating osteoblast differentiation via activation of RANKL reverse signaling. These findings provide important insights into the reversal phase between the bone resorption and formation stages during bone remodeling and identify an AB-dependent cellular signaling mechanism in osteoclast-osteoblast coupling.	[Ma, Qinyu; Wu, Yutong; Duan, Lianli; Yu, Tao; Bai, Yun; Xu, Jianzhong; Dou, Ce] Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Gaotanyan St 30, Chongqing 400038, Peoples R China; [Liang, Mengmeng; Kang, Fei; Dong, Shiwu] Third Mil Med Univ, Southwest Hosp, Dept Biomed Mat Sci, Chongqing 400038, Peoples R China; [Ding, Ning] Gen Hosp Shenyang Mil Area Command, Dept Blood Purificat, Shenyang 110000, Liaoning, Peoples R China; [Dou, Ce] Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD 21205 USA	Army Medical University; Army Medical University; Johns Hopkins University	Xu, JZ; Dou, C (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthoped, Gaotanyan St 30, Chongqing 400038, Peoples R China.	xujianzhong1962@163.com; lance.douce@gmail.com	Duan, Lianli/GQP-3771-2022	Liang, Mengmneg/0000-0002-2200-7487; Ma, Qinyu/0000-0002-3817-6023	Nature Science Foundation of China [81802166]; China Postdoctoral Science Foundation [2017M613315]; TMMU [2017MPRC-04]; China Scholarship Council (CSC)	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); TMMU; China Scholarship Council (CSC)(China Scholarship Council)	This work was funded by the grant from the Nature Science Foundation of China (81802166), first class General Financial Grant from the China Postdoctoral Science Foundation (2017M613315), and TMMU funding for young investigators (2017MPRC-04), as well as postdoc training award (to CD) from the China Scholarship Council (CSC). The authors declare that they have no conflicts of interest with the contents of this article.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Atkin-Smith GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8439; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; BOYCE BF, 1995, ENDOCRINOLOGY, V136, P5751, DOI 10.1210/en.136.12.5751; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Caruso S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01486; Cerri PS, 2005, ANAT REC PART A, V286A, P833, DOI 10.1002/ar.a.20220; Ding N, 2018, J CELL PHYSIOL, V233, P7415, DOI 10.1002/jcp.26587; Dou C, 2016, J CELL PHYSIOL, V231, P558, DOI 10.1002/jcp.24916; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; ERIKSEN EF, 1984, METAB BONE DIS RELAT, V5, P243, DOI 10.1016/0221-8747(84)90066-3; ERIKSEN EF, 1984, METAB BONE DIS RELAT, V5, P235, DOI 10.1016/0221-8747(84)90065-1; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Garcia AJ, 2013, J BONE MINER RES, V28, P283, DOI 10.1002/jbmr.1747; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Hughes DE, 1997, J CLIN PATHOL-MOL PA, V50, P132, DOI 10.1136/mp.50.3.132; Ikebuchi Y, 2018, NATURE, V561, P195, DOI 10.1038/s41586-018-0482-7; Ito M, 1999, BONE, V25, P447, DOI 10.1016/S8756-3282(99)00197-0; Jilka RL, 2003, MED PEDIATR ONCOL, V41, P182, DOI 10.1002/mpo.10334; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MARKS SC, 1985, BONE, V6, P451, DOI 10.1016/8756-3282(85)90223-6; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Sims NA, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00041; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; VAN PT, 1982, CELL TISSUE RES, V225, P283; Wang L, 2015, CELL DEATH DIFFER, V22, P1654, DOI 10.1038/cdd.2015.14; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zirngibl M, 2015, CLIN EXP IMMUNOL, V179, P39, DOI 10.1111/cei.12342	36	27	29	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11240	11247		10.1074/jbc.RA119.007625	http://dx.doi.org/10.1074/jbc.RA119.007625			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167789	Green Published, hybrid			2022-12-26	WOS:000478717400015
J	Bruzzese, DJ; Wagner, DL; Harrison, T; Jogesh, T; Overson, RP; Wickett, NJ; Raguso, RA; Skogen, KA				Bruzzese, Daniel J.; Wagner, David L.; Harrison, Terry; Jogesh, Tania; Overson, Rick P.; Wickett, Norman J.; Raguso, Robert A.; Skogen, Krissa A.			Phylogeny, host use, and diversification in the moth family Momphidae (Lepidoptera: Gelechioidea)	PLOS ONE			English	Article							PALAEOMYSTELLA FLETCHER LEPIDOPTERA; PLANT ASSOCIATIONS; R-PACKAGE; ECOLOGICAL SPECIATION; HERBIVOROUS INSECTS; LIFE-HISTORY; EVOLUTION; DIVERSITY; BUTTERFLIES; PATTERNS	Insect herbivores and their hostplants constitute much of Earth's described biological diversity, but how these often-specialized associations diversify is not fully understood. We combined detailed hostplant data and comparative phylogenetic analyses of the lepidopteran family Momphidae to explore how shifts in the use of hostplant resources, not just hostplant taxon, contribute to the diversification of a phytophagous insect lineage. We inferred two phylogenetic hypotheses emphasizing relationships among species in the nominate genus, Mompha Hubner. A six-gene phylogeny was constructed with reared exemplars and collections from hostplants in the family Onagraceae from western and southwestern USA, and a cytochrome c oxidase subunit 1 (CO1) phylogeny was inferred from collections and publicly available accessions in the Barcode of Life Data System. Species delimitation analyses combined with morphological data revealed ca. 56 undescribed species-level taxa, many of which are hostplant specialists on Onagraceae in the southwestern USA. Our phylogenetic reconstructions divided Momphidae into six major clades: 1) an Onagraceae flower- and fruit-boring Glade, 2) a Melastomataceae-galling Glade, 3) a leafmining Glade A, 4) a leafmining Glade B, 5) a Zapyrastra Meyrick Glade, and 6) a monobasic lineage represented by Mompha eloisella (Clemens). Ancestral trait reconstructions using the COI phylogeny identified leafmining on Onagraceae as the ancestral state for Momphidae. Our study finds that shifts along three hostplant resource axes (plant taxon, plant tissue type, and larval feeding mode) have contributed to the evolutionary success and diversification of momphids.	[Bruzzese, Daniel J.; Wickett, Norman J.; Skogen, Krissa A.] Northwestern Univ, Dept Plant Biol & Conservat, Evanston, IL 60208 USA; [Bruzzese, Daniel J.; Jogesh, Tania; Overson, Rick P.; Wickett, Norman J.; Skogen, Krissa A.] Chicago Bot Garden, Div Plant Sci & Conservat, Glencoe, IL 60022 USA; [Wagner, David L.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Overson, Rick P.] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Raguso, Robert A.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Bruzzese, Daniel J.] Univ Notre Dame, Dept Biol Sci, South Bend, IN 46556 USA	Northwestern University; University of Connecticut; Arizona State University; Arizona State University-Tempe; Cornell University; University of Notre Dame	Bruzzese, DJ (corresponding author), Northwestern Univ, Dept Plant Biol & Conservat, Evanston, IL 60208 USA.; Bruzzese, DJ (corresponding author), Chicago Bot Garden, Div Plant Sci & Conservat, Glencoe, IL 60022 USA.; Bruzzese, DJ (corresponding author), Univ Notre Dame, Dept Biol Sci, South Bend, IN 46556 USA.	dbruzzes@nd.edu	Skogen, Krissa/AAA-3370-2022; Wickett, Norman/AAV-8136-2021	Skogen, Krissa/0000-0002-7868-9632; Wickett, Norman/0000-0003-0944-1956; Overson, Rick/0000-0003-3728-6260; Bruzzese, Daniel/0000-0002-3115-6599	National Science Foundation [DEB 1342873, DEB 1342792]; Plant Biology and Conservation Program at Northwestern University; Hartford Foundation; USFS Co-op Agreement [14-CA-11420004-138]; Chicago Botanic Garden Division of Plant Science and Conservation	National Science Foundation(National Science Foundation (NSF)); Plant Biology and Conservation Program at Northwestern University; Hartford Foundation; USFS Co-op Agreement; Chicago Botanic Garden Division of Plant Science and Conservation	The authors thank the following for funding: National Science Foundation (https://www.nsf.gov/) DEB 1342873 to KAS and NJW, DEB 1342792 to RAR; the Plant Biology and Conservation Program at Northwestern University (https://www.plantbiology.northwestern.edu/) to DJB; USFS Co-op Agreement (https://www.fs.fed.us) 14-CA-11420004-138 to DLW; Richard P. Garmany Fund from the Hartford Foundation (http://www.hfpg.org/) to DLW, and the Chicago Botanic Garden Division of Plant Science and Conservation (https://www.chicagobotanic.org/) to DJB, TJ, RPO, NJW, and KAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Agrawal AA, 2013, AM NAT, V181, pS35, DOI 10.1086/666727; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Althoff DM, 2014, ECOL ENTOMOL, V39, P620, DOI 10.1111/een.12141; Althoff DM, 2012, MOL PHYLOGENET EVOL, V62, P898, DOI 10.1016/j.ympev.2011.11.024; Anstett DN, 2014, ECOLOGY, V95, P2915, DOI 10.1890/13-0932.1; Basilio DS, 2015, REV BRAS ENTOMOL, V59, P188, DOI 10.1016/j.rbe.2015.06.005; Becerra JX, 2015, P NATL ACAD SCI USA, V112, P6098, DOI 10.1073/pnas.1418643112; Becker VO, 2008, REV BRAS ENTOMOL, V52, P647, DOI 10.1590/S0085-56262008000400017; Becker Vitor O., 1999, Revista Brasileira de Zoologia, V16, P141; Bouckaert, 2015, BMODELTEST BAYESIAN, P1, DOI [10.1101/020792, DOI 10.1101/020792]; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Braby MF, 2006, J EVOLUTION BIOL, V19, P1677, DOI 10.1111/j.1420-9101.2006.01109.x; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Calatayud J, 2016, P NATL ACAD SCI USA, V113, P9840, DOI 10.1073/pnas.1608381113; Casquet J, 2012, MOL ECOL RESOUR, V12, P136, DOI 10.1111/j.1755-0998.2011.03073.x; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Clausing G, 2001, AM J BOT, V88, P486, DOI 10.2307/2657114; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Condamine FL, 2018, SYST BIOL, V67, P940, DOI 10.1093/sysbio/syy009; Condon MA, 2008, SCIENCE, V320, P928, DOI 10.1126/science.1155832; Cook JM, 2002, EVOLUTION, V56, P1821, DOI 10.1111/j.0014-3820.2002.tb00196.x; DOAK DF, 1992, ECOLOGY, V73, P2086, DOI 10.2307/1941457; Doorenweerd C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119586; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dugdale JS, 1988, LEPIDOPTERA ANNOTATE; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eiseman CS, 2016, P ENTOMOL SOC WASH, V118, P510, DOI 10.4289/0013-8797.118.4.510; Espeland M, 2015, MOL PHYLOGENET EVOL, V93, P296, DOI 10.1016/j.ympev.2015.08.006; Ezard T, 2009, PACKAGE SPLITS SPECI; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Forbes AA, 2017, EVOLUTION, V71, P1126, DOI 10.1111/evo.13164; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Goldenberg R, 2008, INT J PLANT SCI, V169, P963, DOI 10.1086/589697; Goodman KR, 2012, EVOLUTION, V66, P2798, DOI 10.1111/j.1558-5646.2012.01643.x; Hardy NB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2960; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; HODGES RW, 1992, J NEW YORK ENTOMOL S, V100, P203; Hodges RW, 1999, LEPIDOPTERA MOTHS BU; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imada Y, 2011, P ROY SOC B-BIOL SCI, V278, P3026, DOI 10.1098/rspb.2011.0134; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Johnson MTJ, 2014, NEW PHYTOL, V203, P267, DOI 10.1111/nph.12763; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jousselin E, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-56; Kaila L, 2011, MOL PHYLOGENET EVOL, V61, P801, DOI 10.1016/j.ympev.2011.08.016; Kartesz J.T., 2015, N AM PLANT ATLAS; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawakita A, 2010, P ROY SOC B-BIOL SCI, V277, P2765, DOI 10.1098/rspb.2010.0355; Lafontaine J Donald, 2013, Zookeys, P209, DOI 10.3897/zookeys.264.4441; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lin YP, 2015, ECOL ENTOMOL, V40, P299, DOI 10.1111/een.12191; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; Looney C, 2012, J LEPID SOC, V66, P233; Luz FA, 2014, ZOOKEYS, P97, DOI 10.3897/zookeys.433.7379; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Mayhew PJ, 2018, ENTOMOL EXP APPL, V166, P225, DOI 10.1111/eea.12673; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Miller M.A., 2010, P GAT COMP ENV WORKS; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Moore LM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1819; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; Nafus M.G., 2017, CLIMATE CHANGE RESPO, V4, P4, DOI DOI 10.1186/S40665-017-0032-9; Nakadai R, 2017, ECOL RES, V32, P811, DOI 10.1007/s11284-017-1500-1; Nakadai R, 2016, ECOL EVOL, V6, P4958, DOI 10.1002/ece3.2266; Nakadai R, 2015, ECOL ENTOMOL, V40, P14, DOI 10.1111/een.12148; Nyman T, 2006, EVOLUTION, V60, P1622, DOI 10.1111/j.0014-3820.2006.tb00507.x; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; Ogilvie HA, 2017, MOL BIOL EVOL, V34, P2101, DOI 10.1093/molbev/msx126; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pellmyr O, 2006, SYST ENTOMOL, V31, P1, DOI 10.1111/j.1365-3113.2005.00301.x; Pohl G. R., 2015, Checklist of the Lepidoptera of British Columbia, Canada; Powell J. A., 2009, MOTHS W N AM; POWELL JA, 1980, ANNU REV ENTOMOL, V25, P133, DOI 10.1146/annurev.en.25.010180.001025; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Price PW, 2009, PLANT ANIMAL INTERAC, P3; Rambaut A., 2016, FIGTREE V1 4 3 2006; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; RStudio Team, 2019, RSTUDIO INT DEV R; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shorthouse JD, 2005, BASIC APPL ECOL, V6, P407, DOI 10.1016/j.baae.2005.07.001; Simonato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057192; Sohn JC, 2016, SYST ENTOMOL, V41, P112, DOI 10.1111/syen.12143; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stone GN, 2009, EVOLUTION, V63, P854, DOI 10.1111/j.1558-5646.2008.00604.x; Strong D., 1984, INSECTS PLANTS COMMU; Strutzenberger P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188430; Taylor RS, 2017, MOL ECOL, V26, P3330, DOI 10.1111/mec.14126; Toussaint EFA, 2016, ZOOL J LINN SOC-LOND, V178, P241, DOI 10.1111/zoj.12413; TOWNER HF, 1977, ANN MO BOT GARD, V64, P48, DOI 10.2307/2395236; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wagner DL, 2004, P ENTOMOL SOC WASH, V106, P1; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; White SN, 2016, NORTHEAST NAT, V23, P211, DOI 10.1656/045.023.0203; Wiens JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9370; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Yu H, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1239-5; Zhang B, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1649; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	117	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0207833	10.1371/journal.pone.0207833	http://dx.doi.org/10.1371/journal.pone.0207833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170152	gold, Green Submitted, Green Published			2022-12-26	WOS:000470263700001
J	Kim, KH; Kim, HS; Kang, MS; Park, SS				Kim, Keong-Hwan; Kim, Han-Soo; Kang, Michael Seungcheol; Park, Soo-Sung			Varus shearing force is a main injury mechanism of pediatric trampoline-related injury in addition to compressive axial loading	PLOS ONE			English	Article							CHILDREN; FRACTURE; PATTERNS	Background Many case studies have been published about trampoline-related injury (TRI); however, a comparative study could allow a more specific analysis of the characteristics of TRI, and enable more differentiated approaches to prevent such injuries. We investigated the injury mechanism of TRI in children compared with other pediatric trauma. Methods Of 35,653 children (age 0-18 years) who visited the pediatric emergency department after traumatic injuries from January 2011 to June 2017, 372 patients with TRI (TRI group) were retrospectively identified. Among the remaining 35,281 patients with other trauma (non-TRI group), 372 were 1: 1 matched to the TRI group according to sex, age, injured body part, and body weight (matched-control group). The patients' data, injured site, and injury patterns were compared between the groups. Results The most frequently injured body part was the knee/lower leg in the TRI group and the head in the non-TRI group. The most frequent injury types were fractures in the TRI group and open wounds in the non-TRI group. In the comparison between the TRI and matched-control groups, the most common lower-extremity fractures were proximal tibial fractures with varus angulation in the TRI group and tibial shaft spiral fractures in the matched-control group. For the upper extremities, the risk of lateral condylar humeral fracture was higher in the TRI group. The TRI group presented more physeal involvements. Conclusions The risks of varus stress injury (proximal tibial fracture with varus angulation in lower extremity and lateral condylar humeral fracture in upper extremity) were higher in the TRI group than in matched-control group. Thus, varus shearing force seems to be an important injury mechanism in TRI in addition to compressive force. This varus force may increase the risk of physeal injury by generating additional shear force on the physis.	[Kim, Keong-Hwan; Kang, Michael Seungcheol; Park, Soo-Sung] Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Kim, Keong-Hwan] Kangwon Natl Univ Hosp, Dept Orthopaed Surg, Chuncheon Si, Gangwon Do, South Korea; [Kim, Han-Soo] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kang, MS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea.	kang@amc.seoul.kr		Kang, Michael Seungcheol/0000-0002-0172-2721	Asan Medical Center Children's Hospital, Seoul, Korea [2017-0384]	Asan Medical Center Children's Hospital, Seoul, Korea	This study was supported by a grant (2017-0384) from Asan Medical Center Children's Hospital, Seoul, Korea.	Adams AL, 2013, INJURY PREV, V19, P191, DOI 10.1136/injuryprev-2012-040341; [Anonymous], 1999, Pediatrics, V103, P1053; Ashby K, 2015, AUST NZ J PUBL HEAL, V39, P491, DOI 10.1111/1753-6405.12404; Blumetti FC, 2016, J PEDIATR ORTHOP B, V25, P133, DOI 10.1097/BPB.0000000000000255; BOYER RS, 1986, AM J ROENTGENOL, V146, P83, DOI 10.2214/ajr.146.1.83; Briskin S, 2012, PEDIATRICS, V130, P774, DOI 10.1542/peds.2012-2082; Hurson C, 2007, J PEDIATR ORTHOPED, V27, P729, DOI 10.1097/BPO.0b013e318155ab1; John SD, 1996, RADIOGRAPHICS, V16, P1443, DOI 10.1148/radiographics.16.6.8946546; Kakel R, 2012, ORTHOP TRAUMATOL-SUR, V98, P446, DOI 10.1016/j.otsr.2012.02.007; Kang S, 2015, J ORTHOP TRAUMA, V29, pE253, DOI 10.1097/BOT.0000000000000322; Linakis JG, 2007, ACAD EMERG MED, V14, P539, DOI [10.1197/j.aem.2007.01.018, 10.1111/j.1553-2712.2007.tb01826.x]; McDermott C, 2006, J BONE JOINT SURG BR, V88B, P796, DOI 10.1302/0301-620X.88B6; Monroe KW, 2011, CLIN PEDIATR, V50, P17, DOI 10.1177/0009922810378735; Sandler G, 2011, PEDIATR EMERG CARE, V27, P1052, DOI 10.1097/PEC.0b013e318235e9e0; Smith GA, 1998, PEDIATRICS, V101, P406, DOI 10.1542/peds.101.3.406; Smith GA, 1998, ARCH PEDIAT ADOL MED, V152, P694; Sorenson SB, 2011, AM J PUBLIC HEALTH, V101, pS353, DOI 10.2105/AJPH.2010.300029; Tracy ET, 2013, J PEDIATR SURG, V48, P1384, DOI 10.1016/j.jpedsurg.2013.03.041; Wootton M, 2009, EMERG MED J, V26, P728, DOI 10.1136/emj.2008.069344	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217863	10.1371/journal.pone.0217863	http://dx.doi.org/10.1371/journal.pone.0217863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31167002	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800044
J	Kufa, T; Shubber, Z; MacLeod, W; Takuva, S; Carmona, S; Bor, J; Gorgens, M; Pillay, Y; Puren, A; Eaton, JW; Fraser-Hurt, N				Kufa, Tendesayi; Shubber, Zara; MacLeod, William; Takuva, Simbarashe; Carmona, Sergio; Bor, Jacob; Gorgens, Marelize; Pillay, Yogan; Puren, Adrian; Eaton, Jeffrey W.; Fraser-Hurt, Nicole			CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data	PLOS ONE			English	Article							ADVANCED HIV DISEASE; ART INITIATION; CELL RECOVERY; RISK; COVERAGE; BURDEN	Background We describe CD4 count recovery among HIV positive individuals who initiated antiretroviral therapy (ART) with and without severe immune suppression using complete laboratory data from South Africa's national HIV treatment programme between 2010 and 2014 and discuss implications for CD4 count monitoring. Methods Retrospective analysis of routinely collected laboratory data from South Africa's National Health Laboratory Service (NHLS). A probabilistic record linkage algorithm was used to create a cohort of HIV positive individuals who initiated ART between 2010 and 2014 based on timing of CD4 count and viral load measurements. A CD4 count < 50 copies/mu l at ART initiation was considered severe immunosuppression. A multivariable piecewise mixed-effects linear regression model adjusting for age, gender, year of starting ART, viral suppression in follow up and province was used to predict CD4 counts during follow up. Results 1,070,900 individuals had evidence of starting ART during 2010-2014 and met the criteria for inclusion in the cohort -46.6% starting ART with CD4 < 200 cells/mu l and 10.1% with CD4 < 50 cells/mu l. For individuals with CD4 counts < 200 cells/mu l, predicted CD4 counts > 200 cells/mu l, > 350 cells/mu l and > 500 cells/mu l corresponded with mean follow up durations of 1.5 years (standard deviation [s.d] 1.1), 1.9years (s.d 1.2) and 2.1 years (s.d 1.3 years). For those with CD4 counts < 50 cells/mu l, predicted CD4 count above these threshold corresponded with mean follow up durations of 2.5 years (s.d 0.9 years), 4.4 years (s.d 0.4 years) and 5.0 years (s.d 0.1years) for recovery to the same thresholds. CD4 count recovery varied mostly with duration on ART, CD4 count at the start of ART and gender. Conclusion For individuals starting with ART with severe immunosuppression, CD4 recovery to 200cells/mu l did not occur or took longer than 12 month for significant proportions. CD4 monitoring and interventions recommended for advanced HIV disease should continue until full recovery.	[Kufa, Tendesayi; Puren, Adrian] Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Kufa, Tendesayi] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Shubber, Zara; Gorgens, Marelize; Fraser-Hurt, Nicole] World Bank Grp, Washington, DC USA; [MacLeod, William; Bor, Jacob] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [MacLeod, William] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off HE2RO,Dept Internal, Johannesburg, South Africa; [Takuva, Simbarashe] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Carmona, Sergio] Natl Hlth Lab Serv, Natl Prior Programmes, Johannesburg, South Africa; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa; [Puren, Adrian] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Div Virol, Johannesburg, South Africa; [Eaton, Jeffrey W.] Imperial Coll, Dept Infect Dis Epidemiol, London, England	National Institute for Communicable Diseases (NICD); University of Witwatersrand; The World Bank; Boston University; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; Imperial College London	Kufa, T (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa.; Kufa, T (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	tendesayikc@nicd.ac.za	Pillay, Yogan/AAW-4966-2021; Puren, Adrian/AAC-2065-2020; Takuva, Simba/G-7735-2012	Pillay, Yogan/0000-0003-2700-6181; Puren, Adrian/0000-0001-7531-4010; Takuva, Simba/0000-0001-6030-2359; MacLeod, William/0000-0001-8003-8874; Eaton, Jeffrey/0000-0001-7728-728X; Kufa, Tendesayi/0000-0002-9797-616X	United Kingdom's Department for International Development (DFID); MRC [MR/R015600/1] Funding Source: UKRI	United Kingdom's Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Zara Shubber, Marelize Gorgens and Nicole Fraser-Hurt were funded by the United Kingdom's Department for International Development (DFID). The rest of the authors received no specific funding for the work. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Ballah N. J, 2016, DETERMINANTS CD4 IMM; Carmona S, 2018, CLIN INFECT DIS, V66, pS111, DOI 10.1093/cid/ciy045; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Department of Health Republic of South Africa, 2015, NAT CONS GUID PREV M; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Fatti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100273; Ford N, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20061; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Fox MP, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002589; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Geng EH, 2015, INT J EPIDEMIOL, V44, P251, DOI 10.1093/ije/dyu271; He L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148915; Kanters S, 2014, ANTIVIR THER, V19, P31, DOI 10.3851/IMP2670; Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007; Kroeze S, 2018, AIDS, V32, P1043, DOI [10.1097/QAD.0000000000001801, 10.1097/qad.0000000000001801]; Kwofie Theophilus B, 2015, BMC Res Notes, V8, P413, DOI 10.1186/s13104-015-1406-3; Lahuerta M, 2013, J HEALTH CARE POOR U, V24, P359, DOI 10.1353/hpu.2013.0014; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Means AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164148; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; National Department of Health, 2015, AN BIG DAT BETT TARG; National Department of Health Republic of South Africa, 2004, NAT ANT TREATM GUID; National Department of Health Republic of South Africa, 2016, IMPL UN TEST TREAT S; Osler M, 2018, CLIN INFECT DIS, V66, pS118, DOI 10.1093/cid/cix1140; Patten GE, 2014, CLIN INFECT DIS, V59, P456, DOI 10.1093/cid/ciu288; Simms V, 2018, AIDS; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Waters L, 2011, EXPERT REV ANTI-INFE, V9, P877, DOI [10.1586/eri.11.106, 10.1586/ERI.11.106]	33	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217742	10.1371/journal.pone.0217742	http://dx.doi.org/10.1371/journal.pone.0217742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150489	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100096
J	Tembo, T; Simuyandi, M; Chiyenu, K; Sharma, A; Chilyabanyama, ON; Mbwili-Muleya, C; Mazaba, ML; Chilengi, R				Tembo, Tannia; Simuyandi, Michelo; Chiyenu, Kanema; Sharma, Anjali; Chilyabanyama, Obvious N.; Mbwili-Muleya, Clara; Mazaba, Mazyanga Lucy; Chilengi, Roma			Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia	PLOS ONE			English	Article							MASS VACCINATION; DISEASE	Introduction In 2016, for the very first time, the Ministry of Health in Zambia implemented a reactive outbreak response to control the spread of cholera and vaccinated at-risk populations with a single dose of Shancol-an oral cholera vaccine (OCV). This study aimed to assess the costs of cholera illness and determine the cost-effectiveness of the 2016 vaccination campaign. Methodology From April to June 2017, we conducted a retrospective cost and cost-effectiveness analysis in three peri-urban areas of Lusaka. To estimate costs of illness from a household perspective, a systematic random sample of 189 in-patients confirmed with V. cholera were identified from Cholera Treatment Centre registers and interviewed for out-of-pocket costs. Vaccine delivery and health systems costs were extracted from financial records at the District Health Office and health facilities. The cost of cholera treatment was derived by multiplying the subsidized cost of drugs by the quantity administered to patients during hospitalisation. The cost-effectiveness analysis measured incremental cost-effectiveness ratio-cost per case averted, cost per life saved and cost per DALY averted-for a single dose OCV. Results The mean cost per administered vaccine was US$1.72. Treatment costs per hospitalized episode were US$14.49-US$18.03 for patients <= 15 years old and US$17.66-US$35.16 for older patients. Whereas households incurred costs on non-medical items such as communication, beverages, food and transport during illness, a large proportion of medical costs were borne by the health system. Assuming vaccine effectiveness of 88.9% and 63%, a life expectancy of 62 years and Gross Domestic Product (GDP) per capita of US$1,500, the costs per case averted were estimated US$369-US$532. Costs per life year saved ranged from US$18,515-US$27,976. The total cost per DALY averted was estimated between US $698-US$1,006 for patients. 15 years old and US$666-US$1,000 for older patients. Conclusion Our study determined that reactive vaccination campaign with a single dose of Shancol for cholera control in densely populated areas of Lusaka was cost-effective.	[Tembo, Tannia; Simuyandi, Michelo; Chiyenu, Kanema; Sharma, Anjali; Chilyabanyama, Obvious N.; Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mbwili-Muleya, Clara] Minist Hlth, Lusaka Dist Hlth Off, Lusaka, Zambia; [Mazaba, Mazyanga Lucy] Zambia Natl Publ Hlth Inst, Lusaka, Zambia		Tembo, T (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	tanniatembo@gmail.com	Simuyandi, Michelo/I-5598-2018	Simuyandi, Michelo/0000-0002-7348-2835; Sharma, Anjali/0000-0002-8189-0732; Tembo, Tannia/0000-0003-3800-371X	Centre for Infectious Disease Research in Zambia; Agence de Medecine Preventive	Centre for Infectious Disease Research in Zambia; Agence de Medecine Preventive	This work was partially funded by the Centre for Infectious Disease Research in Zambia (CIDRZ-http://www.cidrz.org/) and Agence de Medecine Preventive (AMP-http://www.who.int/workforcealliance/members_partners/member_list/aamp/en/).CIDRZ designed the data tools, trained field staff, collected and analysed data and prepared the manuscript for publication. AMP provided technical assistance for the study design and development of data collection tools. They also participated in piloting the data tools.	Abubakar A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001901; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Awalime DK, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-017-0182-2; Cavailler P, 2006, VACCINE, V24, P4890, DOI 10.1016/j.vaccine.2005.10.006; Central Statistical Office, 2014, 2010 CENS POP HOUS L; Chaignat CL, 2007, BMC J HLTH POPULATIO, V25; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; Anh DD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001712; Deen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088139; Desai SN, 2016, LANCET GLOB HEALTH, V4, pE223, DOI 10.1016/S2214-109X(16)00037-1; DuBois AE, 2006, EPIDEMIOL INFECT, V134, P1226, DOI 10.1017/S0950268806006273; Ferreras E, 2018, NEW ENGL J MED, V378, P577, DOI 10.1056/NEJMc1711583; Ilboudo PG, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2885-8; Ilboudo PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185041; Ivers LC, 2015, LANCET GLOB HEALTH, V3, pE162, DOI 10.1016/S2214-109X(14)70368-7; IVI WHO DOVE., 2016, CHOLTOOL PLANN COST; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Kar SK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002629; Khan AI, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006652; Khan IA, 2013, VACCINE, V31, P6058, DOI 10.1016/j.vaccine.2013.10.021; Kim SY, 2011, SAMJ S AFR MED J, V101, P659; Kimball AM, 2005, REV SCI TECH OIE, V24, P825, DOI 10.20506/rst.24.3.1619; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-8; Lantagne D., 2017, WASH INTERVENTIONS D; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Medical Stores Limited, 2016, MSL DRUG CAT; Mogasale V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005124; Morgan W, 2017, COSTING ORAL CHOLERA; Olu O, 2013, East Afr Med J, V90, P324; Parker LA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005652; Poncin M, 2018, B WORLD HEALTH ORGAN, V96, P86, DOI 10.2471/BLT.16.189241; Poulos C, 2011, EPIDEMIOLOGY INFECT, V18, P1, DOI DOI 10.1017/S095026881000316X; Qadri F, 2015, LANCET, V386, P1362, DOI 10.1016/S0140-6736(15)61140-0; Rice DP, 1967, AM J PUBLIC HLTH, V57; Sack DA, 2006, J HEALTH POPUL NUTR, V24, P1; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; Schaetti C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001844; Sinyange N, 2018, MORBIDITY MORTALITY, V67; Siziya S, 2017, HLTH PRESS, V2, P6; Taylor DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135676; Teshome S, 2018, HUM VACC IMMUNOTHER, V14, P2427, DOI 10.1080/21645515.2018.1460295; Whittington D, 2017, EC COSTS BENEFITS CH; World Health Organisation, 2017, WHO POS PAP; World Health Organisation, 2008, CHOOD INT AR COST EF; World Health Organization, 2016, WHO PREQ VACC; World Health Organization, 2016, CHOL FACT SHEET; World Health Organization, 2001, MACR HLTH INV HLTH E	48	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0215972	10.1371/journal.pone.0215972	http://dx.doi.org/10.1371/journal.pone.0215972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150406	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100013
J	Maucieri, C; Nicoletto, C; Zanin, G; Birolo, M; Trocino, A; Sambo, P; Borin, M; Xiccato, G				Maucieri, Carmelo; Nicoletto, Carlo; Zanin, Giampaolo; Birolo, Marco; Trocino, Angela; Sambo, Paolo; Borin, Maurizio; Xiccato, Gerolamo			Effect of stocking density of fish on water quality and growth performance of European Carp and leafy vegetables in a low-tech aquaponic system	PLOS ONE			English	Article							CATFISH CLARIAS-GARIEPINUS; COMMON CARP; BODY-COMPOSITION; L.; SUSTAINABILITY; OPTIMIZATION; CHALLENGES; WELFARE; YIELD; PLANT	Aquaponics (AP) is a semi-closed system of food production that combines aquaculture and hydroponics and represents a new agricultural system integrating producers and consumers. The aim of this study was to test the effect of stocking densities (APL, 2.5 kg m(-3); APH, 4.6 kg m(-3)) on water quality, growth performance of the European Carp (Cyprinus carpio L.), and yield of leafy vegetables (catalogna, lettuce, and Swiss Chard) in a low-technology AP pilot system compared to a hydroponic cultivation. The AP daily consumption of water due to evapotranspiration was not different among treatments with an average value of 8.2 L d(-1), equal to 1.37% of the total water content of the system. Dissolved oxygen was significantly (p < 0.05) different among treatments with the lowest median value recorded with the highest stocking density of fish (5.6 mg L-1) and the highest median value in the hydroponic control (8.7 mg L-1). Marketable yield of the vegetables was significantly different among treatments with the highest production in the hydroponic control for catalogna (1.2 kg m(-2)) and in the APL treatment for Swiss Chard (5.3 kg m(-2)). The yield of lettuce did not differ significantly between hydroponic control and APL system (4.0 kg m(-2) on average). The lowest production of vegetables was obtained in the APH system. The final weight (515 g vs. 413 g for APL and APH, respectively), specific growth rate (0.79% d(-1) vs. 0.68% d(-1)), and feed conversion (1.55 vs. 1.86) of European Carp decreased when stocking density increased, whereas total yield of biomass was higher in the APH system (4.45 kg m(-3) vs. 6.88 kg m(-3)). A low mortality (3% on average) was observed in both AP treatments. Overall, the results showed that a low initial stocking density at 2.5 kg m(-3) improved the production of European Carp and of leafy vegetables by maintaining a better water quality in the tested AP system.	[Maucieri, Carmelo; Nicoletto, Carlo; Zanin, Giampaolo; Birolo, Marco; Sambo, Paolo; Borin, Maurizio; Xiccato, Gerolamo] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy; [Trocino, Angela] Univ Padua, Dept Comparat Biomed & Food Sci BCA, Padua, Italy	University of Padua; University of Padua	Nicoletto, C (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Padua, Italy.	carlo.nicoletto@unipd.it	Maucieri, Carmelo/ABF-4069-2020; Zanin, Giampaolo/F-3362-2019; Birolo, Marco/AAH-1905-2019; XICCATO, GEROLAMO/AAR-6788-2020; borin, maurizio/AAY-1399-2021; sambo, Paolo/B-6742-2014	Maucieri, Carmelo/0000-0003-4004-6612; Zanin, Giampaolo/0000-0002-5366-1756; Birolo, Marco/0000-0002-1236-4456; XICCATO, GEROLAMO/0000-0003-4572-3635; borin, maurizio/0000-0002-4074-2098; sambo, Paolo/0000-0003-4348-8838	University of Padova Department of Agronomy, Food, Natural resources, Animals and Environment (DAFNAE) [BIRD 179231]; University of Padova	University of Padova Department of Agronomy, Food, Natural resources, Animals and Environment (DAFNAE); University of Padova	This project was realized through the following fund "Project Acquaponica: nuovi sistemi integrati per un'agricoltura sostenibile - 2017 - prot. BIRD 179231 -University of Padova Department of Agronomy, Food, Natural resources, Animals and Environment (DAFNAE)." The funder (University of Padova) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman S., 2015, THESIS; Ashley PJ, 2007, APPL ANIM BEHAV SCI, V104, P199, DOI 10.1016/j.applanim.2006.09.001; Bassmann B, 2017, WATER-SUI, V9, DOI 10.3390/w9070504; Biswas JK, 2006, AQUACULTURE, V261, P952, DOI 10.1016/j.aquaculture.2006.08.021; Delaide B, 2016, WATER-SUI, V8, DOI 10.3390/w8100467; Ellis T, 2002, J FISH BIOL, V61, P493, DOI [10.1006/jfbi.2002.2057, 10.1111/j.1095-8649.2002.tb00893.x]; Endut A, 2016, DESALIN WATER TREAT, V57, P29531, DOI 10.1080/19443994.2016.1184593; Fallovo C, 2009, J SCI FOOD AGR, V89, P1682, DOI 10.1002/jsfa.3641; Goddek S, 2015, SUSTAINABILITY-BASEL, V7, P4199, DOI 10.3390/su7044199; HACHMANN TL, 2017, CADERNO CIENCIAS AGA, V9, P48; Hambly AC, 2015, WATER RES, V83, P112, DOI 10.1016/j.watres.2015.06.037; Hengsawat K, 1997, AQUACULTURE, V152, P67, DOI 10.1016/S0044-8486(97)00008-2; Hussain T, 2014, J WORLD AQUACULT SOC, V45, P652, DOI 10.1111/jwas.12159; Hussain T, 2015, AQUACULT INT, V23, P369, DOI 10.1007/s10499-014-9821-3; Karakatsouli N, 2010, AQUACULT ENG, V42, P121, DOI 10.1016/j.aquaeng.2010.01.001; Knaus U, 2017, AQUACULTURE, V473, P62, DOI 10.1016/j.aquaculture.2017.01.020; Konig B, 2018, J CLEAN PROD, V180, P232, DOI 10.1016/j.jclepro.2018.01.037; Ku┬nig B., 2016, ECOCYCLES, V2, P26, DOI [10.19040/ecocycles.v2i1.50, DOI 10.19040/ecocycles.v2i1.50]; Lam SS, 2015, INT BIODETER BIODEGR, V102, P107, DOI 10.1016/j.ibiod.2015.03.012; Lee PG, 2000, AQUACULT ENG, V23, P37, DOI 10.1016/S0144-8609(00)00046-7; Lennard WA, 2006, AQUACULT INT, V14, P539, DOI 10.1007/s10499-006-9053-2; Li DP, 2012, FISH PHYSIOL BIOCHEM, V38, P511, DOI 10.1007/s10695-011-9531-y; Losordo TM, 1999, SRAC PUBLICATION, V453, P1; Maucieri C, 2018, ITAL J AGRON, V13, P1, DOI 10.4081/ija.2017.1012; Nicoletto C, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8050075; Nicoletto C, 2013, J SCI FOOD AGR, V93, P1397, DOI 10.1002/jsfa.5906; Oyugi DO, 2012, J THERM BIOL, V37, P89, DOI 10.1016/j.jtherbio.2011.11.005; Palm HW, 2018, AQUACULT INT, V26, P813, DOI 10.1007/s10499-018-0249-z; Palm Harry W., 2014, AACL Bioflux, V7, P162; dos Santos MJPL, 2016, URBAN FOR URBAN GREE, V20, P402, DOI 10.1016/j.ufug.2016.10.004; Pantanella E, 2012, ACTA HORTIC, V927, P887, DOI 10.17660/ActaHortic.2012.927.109; Peteri A., 2004, CULTURED AQUATIC SPE; Qi CL, 2016, J WORLD AQUACULT SOC, V47, P358, DOI 10.1111/jwas.12278; Rakocy J. E., 2006, SRAC Publication - Southern Regional Aquaculture Center, P1; Rakocy J.E., 2012, AQUACULTURE PRODUCTI, P344, DOI [10.1002/9781118250105.CH14, DOI 10.1002/9781118250105.CH14, 10.1002/9781118250105.ch14]; Rakocy JE, 2004, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2004.648.8; Rayhan M.Z., 2018, INT J ENV AGR BIOTEC, V3, P239073, DOI [/10.22161/ijeab/3, DOI 10.22161/IJEAB/3, 10.22161/ijeab/3.2.5, DOI 10.22161/IJEAB/3.2.5]; Refaey MM, 2018, AQUACULTURE, V492, P73, DOI 10.1016/j.aquaculture.2018.04.003; Sammouth S, 2009, AQUACULT ENG, V40, P72, DOI 10.1016/j.aquaeng.2008.11.004; Smith DC, 2001, SCI HORTIC-AMSTERDAM, V91, P393, DOI 10.1016/S0304-4238(01)00273-4; Somerville C., 2014, FAO FISH AQUAC TECH; Tan CX, 2018, TURK J FISH AQUAT SC, V18, P9, DOI 10.4194/1303-2712-v18_1_02; Tyson R. V., 2004, Proceedings of the Florida State Horticultural Society, V117, P79; Tyson RV, 2011, HORTTECHNOLOGY, V21, P6, DOI 10.21273/HORTTECH.21.1.6; Van Woensel L, 10 TECHNOLOGIES WHIC; Villaverde S, 1997, WATER RES, V31, P1180, DOI 10.1016/S0043-1354(96)00376-4; Yildiz HY, 2017, WATER-SUI, V9, DOI 10.3390/w9010013	47	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217561	10.1371/journal.pone.0217561	http://dx.doi.org/10.1371/journal.pone.0217561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145750	Green Published, gold, Green Submitted			2022-12-26	WOS:000469425500023
J	Fan, XY; Zhu, J; Dong, WB; Sun, YD; Lv, C; Guo, BJ; Xu, RG				Fan, Xiangyun; Zhu, Juan; Dong, Wenbin; Sun, Yuandong; Lv, Chao; Guo, Baojian; Xu, Rugen			Comparison of pasting properties measured from the whole grain flour and extracted starch in barley (Hordeum vulgare L.)	PLOS ONE			English	Article							VISCO ANALYZER RVA; PHYSICOCHEMICAL PROPERTIES; MALT; RETROGRADATION; PROTEINS	Pasting properties of barley starch are important characteristics from a processing standpoint. The isolation of starch form barley grains is time consuming thus the whole grain flour is always used. To compare pasting properties of starch with those of the whole grain flour, we used a Rapid Visco Analyser (RVA) to measure pasting properties of three types of samples: grain flour and starches isolated using two different extraction methods. We also investigated compositional, morphological and structural properties of the two starch samples. Significant differences in pasting properties were found among the three sample types, but most of the parameters of pasting properties displayed significant correlations between flour and starch. No significant differences were found in amylose/amylopectin ratio, granule morphology, granule size distribution and crystal structure between starches extracted using two different methods. However, the starch isolated from water homogenization had a higher protein content and lower total starch, amylose and amylopectin contents than the starch extracted with homogenized extraction under alkaline conditions. We concluded that the whole grain flour can be used to predict the pasting properties in breeding programs.	[Fan, Xiangyun; Zhu, Juan; Dong, Wenbin; Sun, Yuandong; Lv, Chao; Guo, Baojian; Xu, Rugen] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Jiangsu Key Lab Crop Genom & Mol Breeding, Key Lab Plant Funct Genom,Agr Coll,Minist Educ, Yangzhou, Jiangsu, Peoples R China; [Fan, Xiangyun; Zhu, Juan; Dong, Wenbin; Sun, Yuandong; Lv, Chao; Guo, Baojian; Xu, Rugen] Yangzhou Univ, Jiangsu Coinnovat Ctr Modern Prod Technol Grain C, Yangzhou, Jiangsu, Peoples R China; [Fan, Xiangyun] Jiangsu Acad Agr Sci, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Inst Food Crops, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Jiangsu Academy of Agricultural Sciences	Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Jiangsu Key Lab Crop Genom & Mol Breeding, Key Lab Plant Funct Genom,Agr Coll,Minist Educ, Yangzhou, Jiangsu, Peoples R China.; Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Coinnovat Ctr Modern Prod Technol Grain C, Yangzhou, Jiangsu, Peoples R China.	rgxu@yzu.edu.cn			National Key Research and Development Program of China [2018YFD1000703, 2018YFD1000700]; National Natural Science Foundation of China [31571648]; National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China [CARS-05]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Key Research and Development Program of China (2018YFD1000703 & 2018YFD1000700), the National Natural Science Foundation of China (Nos. 31571648), the National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China (CARS-05), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	BeMiller JN, 2011, CARBOHYD POLYM, V86, P386, DOI 10.1016/j.carbpol.2011.05.064; Cai JW, 2015, INT J FOOD PROP, V18, P380, DOI 10.1080/10942912.2013.831443; Claver IP, 2010, INT J MOL SCI, V11, P3002, DOI 10.3390/ijms11083002; Cozzolino D, 2016, J FOOD MEAS CHARACT, V10, P474, DOI 10.1007/s11694-016-9326-z; Cozzolino D, 2016, J CEREAL SCI, V70, P282, DOI 10.1016/j.jcs.2016.07.003; Debet MR, 2006, CARBOHYD POLYM, V64, P452, DOI 10.1016/j.carbpol.2005.12.011; Delcour JA, 2010, ANNU REV FOOD SCI T, V1, P87, DOI 10.1146/annurev.food.102308.124211; Dev PM, 1990, METHODS PLANT BIOCH, V2; Fan XY, 2017, J AGR SCI-CAMBRIDGE, V155, P129, DOI 10.1017/S0021859615001331; Fox G, 2014, J I BREWING, V120, P183, DOI 10.1002/jib.137; Fu Z, 2015, STARCH-STARKE, V67, P69, DOI 10.1002/star.201300278; Gupta M, 2010, COMPR REV FOOD SCI F, V9, P318, DOI 10.1111/j.1541-4337.2010.00112.x; Israkarn K, 2014, CARBOHYD POLYM, V105, P34, DOI 10.1016/j.carbpol.2014.01.054; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; Karim AA, 2008, FOOD HYDROCOLLOID, V22, P1044, DOI 10.1016/j.foodhyd.2007.05.011; Kaur B, 2011, FOOD BIOPROD PROCESS, V89, P463, DOI 10.1016/j.fbp.2010.09.003; KIM CS, 1992, J FOOD SCI, V57, P1009, DOI 10.1111/j.1365-2621.1992.tb14344.x; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Lai LN, 2004, J FOOD SCI, V69, pC249, DOI 10.1111/j.1365-2621.2004.tb06324.x; Li WH, 2014, FOOD RES INT, V58, P7, DOI 10.1016/j.foodres.2014.01.053; MacGregor A.W., 1993, BARLEY CHEM TECHNOLO; Sharma P, 2014, J FOOD SCI TECH MYS, V51, P3870, DOI 10.1007/s13197-013-0924-z; Srichuwong S, 2005, CARBOHYD POLYM, V62, P25, DOI 10.1016/j.carbpol.2005.07.003; Wang JM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113559; Wang JM, 2010, GENETICA, V138, P1191, DOI 10.1007/s10709-010-9511-7; Wang P, 2017, STARCH-STARKE, V69, DOI 10.1002/star.201600201; WU YV, 1973, CEREAL CHEM, V50, P481; Zhang GY, 2003, J AGR FOOD CHEM, V51, P2797, DOI 10.1021/jf0300341; Zhou M, 2005, J CEREAL SCI, V41, P31, DOI 10.1016/j.jcs.2004.04.003; Zhou MX, 2008, J CEREAL SCI, V48, P789, DOI 10.1016/j.jcs.2008.05.006; Zhou MX, 1999, J SCI FOOD AGR, V79, P585, DOI 10.1002/(SICI)1097-0010(19990315)79:4<585::AID-JSFA223>3.0.CO;2-0	31	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216978	10.1371/journal.pone.0216978	http://dx.doi.org/10.1371/journal.pone.0216978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141562	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000034
J	Jones, T; Divine, LM; Renner, H; Knowles, S; Lefebvre, KA; Burgess, HK; Wright, C; Parrish, JK				Jones, Timothy; Divine, Lauren M.; Renner, Heather; Knowles, Susan; Lefebvre, Kathi A.; Burgess, Hillary K.; Wright, Charlie; Parrish, Julia K.			Unusual mortality of Tufted puffins (Fratercula cirrhata) in the eastern Bering Sea	PLOS ONE			English	Article							ST-PAUL ISLAND; CLIMATE-CHANGE; MASS-MORTALITY; REPRODUCTIVE-PERFORMANCE; DETECTION PROBABILITIES; BREEDING SEABIRDS; PERSISTENCE RATES; POPULATION TRENDS; PRIBILOF ISLANDS; MOLT STRATEGIES	Mass mortality events are increasing in frequency and magnitude, potentially linked with ongoing climate change. In October 2016 through January 2017, St. Paul Island, Bering Sea, Alaska, experienced a mortality event of alcids (family: Alcidae), with over 350 carcasses recovered. Almost three-quarters of the carcasses were unscavenged, a rate much higher than in baseline surveys (17%), suggesting ongoing deposition and elevated mortality around St Paul over a 2-3 month period. Based on the observation that carcasses were not observed on the neighboring island of St. George, we bounded the at-sea distribution of moribund birds, and estimated all species mortality at 3,150 to 8,800 birds. The event was particularly anomalous given the late fall/ winter timing when low numbers of beached birds are typical. In addition, the predominance of Tufted puffins (Fratercula cirrhata, 79% of carcass finds) and Crested auklets (Aethia cristatella, 11% of carcass finds) was unusual, as these species are nearly absent from long-term baseline surveys. Collected specimens were severely emaciated, suggesting starvation as the ultimate cause of mortality. The majority (95%, N = 245) of Tufted puffins were adults regrowing flight feathers, indicating a potential contribution of molt stress. Immediately prior to this event, shifts in zooplankton community composition and in forage fish distribution and energy density were documented in the eastern Bering Sea following a period of elevated sea surface temperatures, evidence cumulatively suggestive of a bottom-up shift in seabird prey availability. We posit that shifts in prey composition and/ or distribution, combined with the onset of molt, resulted in this mortality event.	[Jones, Timothy; Burgess, Hillary K.; Wright, Charlie; Parrish, Julia K.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Divine, Lauren M.] Aleut Community St Paul Isl Ecosyst Conservat Off, Pribilof Isl, AK USA; [Renner, Heather] US Fish & Wildlife Serv, Alaska Maritime Natl Wildlife Refuge, Homer, AK USA; [Knowles, Susan] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Lefebvre, Kathi A.] NOAA, Environm & Fisheries Sci Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Jones, T (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	timothy.t.jones@gmail.com		Knowles, Susan/0000-0002-0254-6491	National Science Foundation (NSF) EHR/DRL award [1322820]; Washington Department of Fish and Wildlife [13-1435]; NSF [OCE-1314088]	National Science Foundation (NSF) EHR/DRL award; Washington Department of Fish and Wildlife; NSF(National Science Foundation (NSF))	These analyses were supported by the National Science Foundation (NSF) EHR/DRL award 1322820 and Washington Department of Fish and Wildlife award 13-1435, to JKP. Support for algal toxin analyses was provided by NSF OCE-1314088 to KAL and Dr. David Marcinek at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AG, 2016, DEEP-SEA RES PT II, V134, P235, DOI 10.1016/j.dsr2.2015.10.008; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arimitsu M, 2018, AL MAR SCI S 2018 AN; Auth TD, 2018, GLOBAL CHANGE BIOL, V24, P259, DOI 10.1111/gcb.13872; Baduini CL, 2001, FISH OCEANOGR, V10, P117, DOI 10.1046/j.1365-2419.2001.00156.x; Benson AJ, 2002, FISH FISH, V3, P95, DOI 10.1046/j.1467-2979.2002.00078.x; BIBBY CJ, 1977, BIOL CONSERV, V12, P295, DOI 10.1016/0006-3207(77)90048-9; Bond AL, 2013, CONDOR, V115, P348, DOI 10.1525/cond.2013.110062; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Bridge ES, 2004, J EXP BIOL, V207, P3003, DOI 10.1242/jeb.01116; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; Byrd G. Vernon, 2009, Marine Ornithology, V37, P197; Byrd GV, 2005, FISH OCEANOGR, V14, P139; Camphuysen C.J., 1999, ICES Cooperative Research Report, V232, P51; Castege I, 2007, ARDEOLA, V54, P289; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Coyle KO, 2002, PROG OCEANOGR, V55, P177, DOI 10.1016/S0079-6611(02)00077-0; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; Docherty DE, 2004, EMERG INFECT DIS, V10, P907, DOI 10.3201/eid1005.030825; Dorresteijn I, 2012, MAR ECOL PROG SER, V454, P207, DOI 10.3354/meps09372; Duffy-Anderson JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178955; Fey SB, 2015, P NATL ACAD SCI USA, V112, P1083, DOI 10.1073/pnas.1414894112; Flint PL, 1998, MAR POLLUT BULL, V36, P165, DOI 10.1016/S0025-326X(97)00178-1; Ford RG, 1996, AM FISH S S, V18, P684; Ford RG, 2006, ACUTE SEABIRD MORTAL, P46; Ford RG, 2001, UNPUB, P47; Fort J, 2009, J EXP BIOL, V212, P2483, DOI 10.1242/jeb.032300; Fowler AC, 1997, MAR POLLUT BULL, V34, P522, DOI 10.1016/S0025-326X(96)00153-1; Gall AE, 2013, CONT SHELF RES, V67, P96, DOI 10.1016/j.csr.2012.11.004; Gaston AJ, 2009, ENVIRON REV, V17, P267, DOI 10.1139/A09-013; Gould PJ, 1982, FWSOBS8284 US DEP IN, P294; Goyert HF, 2017, BIOL CONSERV, V209, P178, DOI 10.1016/j.biocon.2017.02.011; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; Harris MP, 2014, BIRD STUDY, V61, P182, DOI 10.1080/00063657.2014.909382; Harris MP, 2005, MAR ECOL PROG SER, V297, P283, DOI 10.3354/meps297283; Harris MP, 1996, BIRD STUDY, V43, P220, DOI 10.1080/00063659609461014; Hart CJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4519; HATCH SA, 1987, WILSON BULL, V99, P468; Hickey JJ, 1977, ENV ASSESSMENT ALASK, V2, P96; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Hope Jones P, 1970, Br. Birds, V63, P97; Hunt GL, 2008, DEEP-SEA RES PT II, V55, P1919, DOI 10.1016/j.dsr2.2008.04.032; Hunt GL, 2018, MAR ECOL PROG SER, V593, P209, DOI 10.3354/meps12383; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Hunt GL, 2002, PROG OCEANOGR, V55, P5, DOI 10.1016/S0079-6611(02)00067-8; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; Hunt GL, 1981, E BERING SEA SHELF O, P689; Hyrenbach D, 2013, FWS BERINGIAN SEABIR; Jahncke J, 2008, DEEP-SEA RES PT II, V55, P1809, DOI 10.1016/j.dsr2.2008.04.003; Jones IL, 2002, OECOLOGIA, V133, P38, DOI 10.1007/s00442-002-0991-8; Jones T, 2018, GEOPHYS RES LETT, V45, P3193, DOI 10.1002/2017GL076164; Jones T, 2017, MAR ECOL PROG SER, V579, P111, DOI 10.3354/meps12253; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Kitaysky AS, 2000, J ANIM ECOL, V69, P248, DOI 10.1046/j.1365-2656.2000.00392.x; Kitaysky AS, 2000, MAR ECOL PROG SER, V206, P283, DOI 10.3354/meps206283; Laidre KL, 2015, CONSERV BIOL, V29, P724, DOI 10.1111/cobi.12474; Lee DE, 2007, J ANIM ECOL, V76, P337, DOI 10.1111/j.1365-2656.2007.01198.x; Lefebvre KA, 2016, HARMFUL ALGAE, V55, P13, DOI 10.1016/j.hal.2016.01.007; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Napp JM, 2001, FISH OCEANOGR, V10, P61, DOI 10.1046/j.1365-2419.2001.00155.x; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Parrish J., 2009, BEACHED BIRDS COASST; Parrish JK, 2007, MAR ECOL PROG SER, V352, P275, DOI 10.3354/meps07077; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Piatt JF, 1997, MAR POLLUT BULL, V34, P656, DOI 10.1016/S0025-326X(97)00008-8; Piatt JF, 2002, BIRDS N AM, DOI [10.2173/bna.708, DOI 10.2173/BNA.708]; PIERCE DJ, 1986, AUK, V103, P214; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Pyle P., 2008, IDENTIFICATION GUI 2, P787; Pyle Peter, 2009, Marine Ornithology, V37, P219; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Schacter C., 2017, THESIS, P242; Schacter CR, 2016, PAC SEAB GROUP ANN M, P10; Schneider David C., 1993, Reviews in Fisheries Science, V1, P311; Schreiber EA, 2001, BIOL MARINE BIRDS, P192; Sealy SG, 1968, THESIS, DOI [10.14288/1.0104305, DOI 10.14288/1.0104305]; Shearn-Bochsler V, 2014, J WILDLIFE DIS, V50, P933, DOI 10.7589/2013-11-296; Siddon E, 2018, NPFMC BERING SEA ALE, P230; Sowls A. L., 1978, FWSOBS7878 US DEP IN; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Springer AM, 2014, P NATL ACAD SCI USA, V111, pE1880, DOI 10.1073/pnas.1319089111; Springer AM, 1996, FISH OCEANOGR, V5, P205, DOI 10.1111/j.1365-2419.1996.tb00118.x; Stabeno PJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185464; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Sydeman WJ, 2017, ECOL INDIC, V78, P458, DOI 10.1016/j.ecolind.2017.03.013; Sydeman WJ, 2001, PROG OCEANOGR, V49, P309, DOI 10.1016/S0079-6611(01)00028-3; Thompson CW, 2004, AUK, V121, P35, DOI 10.1642/0004-8038(2004)121[0035:PFMSIT]2.0.CO;2; UNDERWOOD LA, 1984, BIRD STUDY, V31, P79, DOI 10.1080/00063658409476822; VanPelt TI, 1995, MAR POLLUT BULL, V30, P794, DOI 10.1016/0025-326X(95)00072-U; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wiese FK, 2004, J WILDLIFE MANAGE, V68, P627, DOI 10.2193/0022-541X(2004)068[0627:ASMFCO]2.0.CO;2; Wiese FK, 2001, AUK, V118, P1062, DOI 10.1642/0004-8038(2001)118[1062:ESFAND]2.0.CO;2; Wiese Francis K., 2003, Marine Ornithology, V31, P65; Wise MG, 2004, J CLIN MICROBIOL, V42, P329, DOI 10.1128/JCM.42.1.329-338.2004; Wolf SG, 2010, GLOBAL CHANGE BIOL, V16, P1923, DOI 10.1111/j.1365-2486.2010.02194.x; Young RC, 2014, ECOL SOC, V19, DOI 10.5751/ES-07158-190440; Youngren SM, 2018, 201803 AMNWR; Zador S, 2016, NPFMC BERING SEA ALE, P210	103	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0216532	10.1371/journal.pone.0216532	http://dx.doi.org/10.1371/journal.pone.0216532			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141532	Green Submitted, Green Published, gold			2022-12-26	WOS:000469323000015
J	Silva, JLSE; Cruz-Neto, O; Peres, CA; Tabarelli, M; Lopes, AV				Souza e Silva, Jessica Luiza; Cruz-Neto, Oswaldo; Peres, Carlos A.; Tabarelli, Marcelo; Lopes, Ariadna Valentina			Climate change will reduce suitable Caatinga dry forest habitat for endemic plants with disproportionate impacts on specialized reproductive strategies	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FUNCTIONAL TRAITS; TROPICAL FOREST; PROTECTED AREAS; RESPONSES; FUTURE; POLLINATOR; DIVERSITY; TEMPERATURE; PERFORMANCE	Global climate change alters the dynamic of natural ecosystems and directly affects species distributions, persistence and diversity. The impacts of climate change may lead to dramatic changes in biotic interactions, such as pollination and seed dispersal. Life history traits are extremely important to consider the vulnerability of a species to climate change, producing more robust models than those based primarily on species distributions. Here, we hypothesized that rising temperatures and aridity will reduce suitable habitats for the endemic flora of the Caatinga, the most diverse dry tropical forest on Earth. Specifically, species with specialized reproductive traits (e.g. vertebrate pollination, biotic dispersal, obligatory cross-pollination) should be more affected by climate change than those with generalist traits. We performed two ecological niche models (current and future) to simulate the effects of climate change on the distribution area of endemic species in relation to life-history traits. We used the MIROC-ESM and CCSM4 models for both intermediate (RCP4.5) and highest predicted (RCP8.5) GHG emission scenarios, with a resolution of 30' (similar to 1 km(2)). Habitat with high occurrence probability (>80%) of endemic species will be reduced (up to similar to 10% for trees, similar to 13% for non-arboreous, 10-28% for species with any pollination/reproductive system), with the greatest reductions for species with specialized reproductive traits. In addition, the likely concentration of endemic plants in the extreme northeastern portion of the Caatinga, in more mesic areas, coincides with the currently most human-modified areas of the ecosystem, which combined with climate change will further contract suitable habitats of endemic species. In conclusion, plant species endemic to the Caatinga are highly vulnerable to even conservative scenarios of future climate change and may lose much of their climatic envelopes. New protected areas should be located in the northeastern portion of the Caatinga, which hosts a more favorable climate, but is currently exposed to escalating agricultural intensification.	[Souza e Silva, Jessica Luiza] Univ Fed Pernambuco, Dept Bot, Programa Posgrad Biol Vegetal, Recife, PE, Brazil; [Cruz-Neto, Oswaldo; Tabarelli, Marcelo; Lopes, Ariadna Valentina] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil; [Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; University of East Anglia	Lopes, AV (corresponding author), Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil.	avflopes@ufpe.br	Peres, Carlos A./ABE-8361-2020; Neto, Oswaldo OCN Cruz/I-3345-2015; Peres, Carlos A./B-1276-2013; Peres, Carlos Augusto/N-8275-2019; Tabarelli, Marcelo/F-1088-2010; Lopes, Ariadna V/E-8432-2010	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Tabarelli, Marcelo/0000-0001-7573-7216; Lopes, Ariadna V/0000-0001-5750-5913; Silva, Jessica Luiza Souza e/0000-0001-8519-0891	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq [403770/2012-2, 481755/2013-6, 308832/2014-0]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco - FACEPE [IBPG-0774-2.03/13, BCT-0208-2.05/17, APQ-0138-2.05/14]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [001]; Royal Society [NMG/R2/170081]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco - FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Royal Society(Royal Society of London)	The study was funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq (Long-Term Ecological Research Program-PELD/CNPq, grant number: 403770/2012-2 awarded to MT; CNPq/Chamada Universal, grant number: 481755/2013-6 awarded to AVL; PQ/CNPq, grant number: 308832/2014-0 awarded to AVL); the Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco - FACEPE (PhD Fellowship to JLSS, grant number: IBPG-0774-2.03/13; Pos-doc grant to OCN, grant number: BCT-0208-2.05/17, and Programa de Apoio a Nucleos de Excelencia - PRONEX, grant number: APQ-0138-2.05/14 awarded to MT); the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (grant code 001 awarded to JLSS, MT and AVL); Royal Society (Newton Mobility Grant NMG/R2/170081 awarded to CAP, MT, AVF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbSaber A. N, 2003, OS DOMINIOS NATUREZA; Salvatierra LHA, 2017, BIOTROPICA, V49, P753, DOI 10.1111/btp.12459; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Andrade E.M., 2017, CAATINGA LARGEST TRO, P281, DOI [10.1007/978-3-319-68339-3_10, DOI 10.1007/978-3-319-68339-3_10]; [Anonymous], 2004, MATA ATLANTICA ARVOR; Antongiovanni M, 2018, LANDSCAPE ECOL, V33, P1353, DOI 10.1007/s10980-018-0672-6; Arnan X, 2018, SCI TOTAL ENVIRON, V631-632, P429, DOI 10.1016/j.scitotenv.2018.03.037; Arnan X, 2013, ECOGRAPHY, V36, P1182, DOI 10.1111/j.1600-0587.2013.00155.x; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P1511, DOI 10.1111/j.1365-2486.2008.01824.x; Bullock JM, 2001, J APPL ECOL, V38, P253, DOI 10.1046/j.1365-2664.2001.00599.x; Bussotti F, 2015, ENVIRON EXP BOT, V111, P91, DOI 10.1016/j.envexpbot.2014.11.006; Camara T, 2018, J ANIM ECOL, V87, P1022, DOI 10.1111/1365-2656.12820; Cardoso Domingos Benício Oliveira Silva, 2007, Rodriguésia, V58, P379, DOI 10.1590/2175-7860200758212; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Cornelissen T, 2011, NEOTROP ENTOMOL, V40, P155, DOI 10.1590/S1519-566X2011000200001; Costa WF, 2018, BIOL CONSERV, V218, P200, DOI 10.1016/j.biocon.2017.12.034; Dai A. G., 2011, Interdisciplinary Reviews: Climate Change, V2, P45, DOI 10.1002/wcc.81; de Oliveira G, 2012, BIODIVERS CONSERV, V21, P2913, DOI 10.1007/s10531-012-0346-7; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Doi H, 2008, CLIM RES, V36, P181, DOI 10.3354/cr00741; Drumond MA, 2000, AVALIACAO IDENTIFICA; Dyderski MK, 2018, GLOBAL CHANGE BIOL, V24, P1150, DOI 10.1111/gcb.13925; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Endress P. K., 1994, DIVERSITY EVOLUTIONA; ESRI, 2010, ARCGIS DESKT REL 10; FAEGRI K, 1979, P244; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Foden WB, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.551; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Fonseca CR, 2017, CAATINGA THE LARGEST, P429, DOI [10.1007/978-3-319-68339-3_17, DOI 10.1007/978-3-319-68339-3_17]; Frankie G.W., 1983, P411; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Giannini TC, 2017, APIDOLOGIE, V48, P784, DOI 10.1007/s13592-017-0523-5; Girao LC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000908; Gomi T, 2007, ENTOMOL EXP APPL, V125, P179, DOI 10.1111/j.1570-7458.2007.00616.x; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Graeff O., 2015, FITOGEOGRAFIA BRASIL; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kang H, 2003, AM J BOT, V90, P865, DOI 10.3732/ajb.90.6.865; Kingsolver JG, 2011, INTEGR COMP BIOL, V51, P719, DOI 10.1093/icb/icr015; Kumar L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05034-4; Li DL, 2018, GLOBAL CHANGE BIOL, V24, P4095, DOI 10.1111/gcb.14327; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Lopes AV, 2009, BIOL CONSERV, V142, P1154, DOI 10.1016/j.biocon.2009.01.007; Lorenzi H., 2002, ARVORES BRASILEIRAS, V1; Lorenzi H, 2002, ARVORES BRASILEIRAS, V2; Machado IC, 2004, ANN BOT-LONDON, V94, P365, DOI 10.1093/aob/mch152; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Marengo JA, 2011, VARIABILIDADE MUDANC; Marengo JA, 2017, THEOR APPL CLIMATOL, V129, P1189, DOI 10.1007/s00704-016-1840-8; Martinez-Garza C, 2013, FOREST ECOL MANAG, V303, P35, DOI 10.1016/j.foreco.2013.03.046; Mathe A, 1999, MED AROMATIC PLANTS; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Ministerio do Meio Ambiente, 2007, ATL AR SUSC DES BRAS; Moro MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119166; Moro MF, 2014, PHYTOTAXA, V160, P1; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Oyama MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018600; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Pennington RT, 2006, SYST ASSOC SPEC VOL, P1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Prado D., 2003, ECOLOGIA CONSERVACAO, P3, DOI DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Prieto-Torres DA, 2016, GLOBAL CHANGE BIOL, V22, P364, DOI 10.1111/gcb.13090; Proctor M., 1996, NATURAL HIST POLLINA; Pywell RF, 2003, J APPL ECOL, V40, P65, DOI 10.1046/j.1365-2664.2003.00762.x; Queiroz L.P., 2017, CAATINGA LARGEST TRO, P23, DOI [10.1099/ijsem, DOI 10.1007/978-3-319-68339-3_2, 10.1007/978-3-319, DOI 10.1007/978-3-319]; R Core Team, 2016, R LANG ENV STAT COMP; Reyes-Fox M, 2014, NATURE, V510, P259, DOI 10.1038/nature13207; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Richards A. J., 1997; Rito KF, 2017, J ECOL, V105, P828, DOI 10.1111/1365-2745.12712; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Sampaio Everardo V. S. B., 1995, P35, DOI 10.1017/CBO9780511753398.003; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Santos MG, 2014, THEOR EXP PLANT PHYS, V26, P83, DOI 10.1007/s40626-014-0008-0; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Shabani F., 2018, ACTA SCI HUM SOC SCI, V18, P6; Smith SJ, 2015, NAT CLIM CHANGE, V5, P333, DOI 10.1038/nclimate2552; Sobrinho MS, 2016, BIOTROPICA, V48, P586, DOI 10.1111/btp.12334; Specht MJ, 2015, GLOB ECOL CONSERV, V3, P200, DOI 10.1016/j.gecco.2014.12.002; Spjut Richard W., 1994, Memoirs of the New York Botanical Garden, V70, P1; Syphard AD, 2010, J VEG SCI, V21, P177, DOI 10.1111/j.1654-1103.2009.01133.x; Tayleur C, 2015, GLOBAL ECOL BIOGEOGR, V24, P859, DOI 10.1111/geb.12308; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; VANDERPIJL, 1982, PRINCIPLES DISPERSAL; Wasof S, 2013, GLOBAL ECOL BIOGEOGR, V22, P1130, DOI 10.1111/geb.12073; Watanabe S, 2011, GEOSCI MODEL DEV, V4, P845, DOI 10.5194/gmd-4-845-2011; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Ziska L. H., 2014, Invasive species and global climate change, DOI 10.1079/9781780641645.0000	111	33	35	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217028	10.1371/journal.pone.0217028	http://dx.doi.org/10.1371/journal.pone.0217028			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141533	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000469323000036
J	Choi, JA; Ju, HH; Kim, JE; Kim, SK; Jee, D; Lee, J; Park, CK; Paik, SY				Choi, Jin A.; Ju, Hyun-hee; Kim, Ju-Eun; Kim, Seon-Kyu; Jee, Donghyun; Lee, Jiyoung; Park, Chan Kee; Paik, Soon-young			Transcriptional changes after herpes simplex virus type 1 infection in human trabecular meshwork cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ENTRY MEDIATOR; PATHOGENESIS; GLAUCOMA; UVEITIS	Background Herpes simplex virus type 1 (HSV-1) is causative for hypertensive anterior uveitis. Trabecular meshwork (TM) cells, which are the key cells regulating intraocular pressure (IOP), is considered to be the site of inflammation. We explored the profiles of genes expressed in human TM primary cells upon HSV-1 infection. Methods Human TM cells were infected with HSV-1 and total RNA was isolated. The global transcriptional gene network analyses were performed in mock-infected and HSV-1 infected TM cells. Using ingenuity pathway analysis, we determined the key biological networks upon HSV-1 infection. The results of microarray analyses were validated using quantitative PCR. Results TM cells had a high susceptibility to HSV-1 infection. HSV-1 induced transcriptional suppression of many components related to fibrosis in TM cells. The top biological network related to the genes which were significantly altered upon HSV-1 infection was organismal injury and abnormalities involving TGF-beta 1 and PDGF-BB. The results of PCR analyses for selected molecules were found to be in good agreement with the microarray data. HSV-1-infected TM cells showed an 80-fold increase in the expression of PDGF-BB, which was further increased by treatment with TGF-beta 1. HSV-1 also induced a 4-fold increase in the expression of the monocyte chemoattractant protein (MCP)-1, the downstream molecules of PDGF-BB. Conclusions In human TM cells, HSV-1 induced transcriptional suppression of many components related to fibrosis and enhanced expression of both PDGF-BB and MCP-1. Our study may provide a novel mechanism for the pathogenesis of HSV-1 infection in TM cells.	[Choi, Jin A.; Ju, Hyun-hee; Jee, Donghyun; Lee, Jiyoung] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Kim, Ju-Eun; Paik, Soon-young] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea; [Kim, Seon-Kyu] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Catholic University of Korea; Seoul St. Mary's Hospital	Paik, SY (corresponding author), Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea.; Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckpark@catholic.ac.kr; paik@catholic.ac.kr		Kim, Seon-Kyu/0000-0002-4176-5187	Bumsuk Academic Research Fund	Bumsuk Academic Research Fund	This paper was supported by Bumsuk Academic Research Fund in 2018 (Jin A Choi). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2011, J VIROL, V85, P11448, DOI 10.1128/JVI.00678-11; Choi JA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43349; Diskin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044400; GRANSTEIN RD, 1990, J IMMUNOL, V144, P3021; Hoeksema L, 2017, AM J OPHTHALMOL, V181, P55, DOI 10.1016/j.ajo.2017.06.013; HOGAN MJ, 1964, AM J OPHTHALMOL, V57, P551, DOI 10.1016/0002-9394(64)92501-2; Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc; Janjanam J, 2015, MOL BIOL CELL, V26, P4589, DOI 10.1091/mbc.E15-08-0570; Jap A, 2011, CURR OPIN OPHTHALMOL, V22, P483, DOI 10.1097/ICU.0b013e32834be021; Kamakura M, 2008, MICROBES INFECT, V10, P405, DOI 10.1016/j.micinf.2007.12.019; Karaba AH, 2012, P NATL ACAD SCI USA, V109, P20649, DOI 10.1073/pnas.1216967109; Khodarev NN, 1999, P NATL ACAD SCI USA, V96, P12062, DOI 10.1073/pnas.96.21.12062; Kossmann T, 2003, J INFECT DIS, V187, P534, DOI 10.1086/373995; Li YH, 2016, MOL MED REP, V14, P1297, DOI 10.3892/mmr.2016.5366; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; MICHELSON S, 1994, J VIROL, V68, P5730, DOI 10.1128/JVI.68.9.5730-5737.1994; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nie YH, 2008, MOL VIS, V14, P1631; Ohira S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147080; Sng CCA, 2015, PROG BRAIN RES, V221, P243, DOI 10.1016/bs.pbr.2015.06.008; Stamer WD, 2017, EXP EYE RES, V158, P112, DOI 10.1016/j.exer.2016.07.009; Stingley SW, 2000, J VIROL, V74, P9916, DOI 10.1128/JVI.74.21.9916-9927.2000; Suryawanshi A, 2011, J IMMUNOL, V186, P3653, DOI 10.4049/jimmunol.1003239; Takeda S, 2011, INVEST OPHTH VIS SCI, V52, P6729, DOI 10.1167/iovs.11-7805; Terasaka Y, 2010, INVEST OPHTH VIS SCI, V51, P2441, DOI 10.1167/iovs.09-4624; Tiwari V, 2005, J VIROL, V79, P13173, DOI 10.1128/JVI.79.20.13173-13179.2005; TOWNSEND WM, 1971, AM J OPHTHALMOL, V71, P904, DOI 10.1016/0002-9394(71)90265-0; Tumpey TM, 1998, J LEUKOCYTE BIOL, V63, P486, DOI 10.1002/jlb.63.4.486	28	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217567	10.1371/journal.pone.0217567	http://dx.doi.org/10.1371/journal.pone.0217567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136615	Green Submitted, Green Published, gold			2022-12-26	WOS:000469224300052
J	Tsutsumi-Arai, C; Takakusaki, K; Arai, Y; Terada-Ito, C; Takebe, Y; Imamura, T; Ide, S; Tatehara, S; Tokuyama-Toda, R; Wakabayashi, N; Satomura, K				Tsutsumi-Arai, Chiaki; Takakusaki, Kensuke; Arai, Yuki; Terada-Ito, Chika; Takebe, Yusuke; Imamura, Takahiro; Ide, Shinji; Tatehara, Seiko; Tokuyama-Toda, Reiko; Wakabayashi, Noriyuki; Satomura, Kazuhito			Grapefruit seed extract effectively inhibits the Candida albicans biofilms development on polymethyl methacrylate denture-base resin	PLOS ONE			English	Article							ANTIBACTERIAL AGENT; ANTIFUNGAL ACTIVITY; ADHESION; POLYPHENOLS; FLAVONOIDS	This study aimed to investigate the cleansing effects of grapefruit seed extract (GSE) on biofilms of Candida albicans (C. albicans) formed on denture-base resin and the influence of GSE on the mechanical and surface characteristics of the resin. GSE solution diluted with distilled water to 0.1% (0.1% GSE) and 1% (1% GSE) and solutions with Polident (R) denture cleansing tablet dissolved in distilled water (Polident) or in 0.1% GSE solution (0.1% G+P) were prepared as cleansing solutions. Discs of acrylic resin were prepared, and the biofilm of C. albicans was formed on the discs. The discs with the biofilm were treated with each solution for 5 min at 25 degrees C. After the treatment, the biofilm on the discs was analyzed using a colony forming unit (CFU) assay, fluorescence microscopy, and scanning electron microscopy (SEM). In order to assess the persistent cleansing effect, the discs treated with each solution for 5 min were aerobically incubated in Yeast Nitrogen Base medium for another 24 h. After incubation, the persistent effect was assessed by CFU assay. Some specimens of acrylic resin were immersed in each solution for 7 days, and changes in surface roughness (Ra), Vickers hardness (VH), flexural strength (FS), and flexural modulus (FM) were evaluated. As a result, the treatment with 1% GSE for 5 min almost completely eliminated the biofilm formed on the resin; whereas, the treatment with 0.1% GSE, Polident, and 0.1% G+P for 5 min showed a statistically significant inhibitory effect on biofilms. In addition, 0.1% GSE and 0.1% G+P exerted a persistent inhibitory effect on biofilms. Fluorescence microscopy indicated that Polident mainly induced the death of yeast, while the cleansing solutions containing at least 0.1% GSE induced the death of hyphae as well as yeast. SEM also revealed that Polident caused wrinkles, shrinkage, and some deep craters predominantly on the cell surfaces of yeast, while the solutions containing at least 0.1% GSE induced wrinkles, shrinkage, and some damage on cell surfaces of not only yeasts but also hyphae. No significant changes in Ra, VH, FS, or FM were observed after immersion in any of the solutions. Taken together, GSE solution is capable of cleansing C. albicans biofilms on denture-base resin and has a persistent inhibitory effect on biofilm development, without any deteriorations of resin surface.	[Tsutsumi-Arai, Chiaki; Terada-Ito, Chika; Takebe, Yusuke; Imamura, Takahiro; Ide, Shinji; Tatehara, Seiko; Tokuyama-Toda, Reiko; Satomura, Kazuhito] Tsurumi Univ, Dept Oral Med & Stomatol, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Takakusaki, Kensuke; Arai, Yuki; Wakabayashi, Noriyuki] Tokyo Med & Dent Univ, Dept Removable Partial Prosthodont, Grad Sch, Tokyo, Japan	Tsurumi University; Tokyo Medical & Dental University (TMDU)	Tsutsumi-Arai, C (corresponding author), Tsurumi Univ, Dept Oral Med & Stomatol, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa, Japan.	Tsutsumi-c@tsurumi-u.ac.jp	Wakabayashi, N./ABA-2063-2020		JSPS KAKENHI [17K17156]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI, Grant numbers: 17K17156 (https://www.jsps.go.jp/j-grantsinaid/) to CT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2016, SCI REP-UK, V6, DOI 10.1038/srep37867; Alsteens D, 2013, LANGMUIR, V29, P13473, DOI 10.1021/la403237f; Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095; Bahrin LG, 2014, BIOORG MED CHEM LETT, V24, P2315, DOI 10.1016/j.bmcl.2014.03.071; Belofsky G, 2013, J NAT PROD, V76, P915, DOI 10.1021/np4000763; Cao SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032943; Chen M, 2015, MED MYCOL, V53, P194, DOI 10.1093/mmy/myu073; Choi JS, 2014, J FOOD SCI, V79, pM1159, DOI 10.1111/1750-3841.12469; Coulthwaite L, 2007, BRIT J BIOMED SCI, V64, P180, DOI 10.1080/09674845.2007.11732784; Kammers ACE, 2015, J CLIN DIAGN RES, V9, pZC94, DOI 10.7860/JCDR/2015/11261.5975; Felipucci DNB, 2011, J APPL ORAL SCI, V19, P483, DOI 10.1590/S1678-77572011000500008; Felton D, 2011, J PROSTHODONT, V20, pS1, DOI 10.1111/j.1532-849X.2010.00683.x; Freitas-Fernandes FS, 2014, J PROSTHET DENT, V112, P1349, DOI 10.1016/j.prosdent.2014.07.004; Gleiznys Alvydas, 2015, Stomatologija, V17, P54; Hariri BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185203; Heggers JP, 2002, J ALTERN COMPLEM MED, V8, P333, DOI 10.1089/10755530260128023; Hirasawa M, 2018, ARCH ORAL BIOL, V87, P143, DOI 10.1016/j.archoralbio.2017.12.024; Jackson S, 2014, J PROSTHET DENT, V112, P988, DOI 10.1016/j.prosdent.2014.02.003; JAGGER DC, 1995, BRIT DENT J, V178, P413, DOI 10.1038/sj.bdj.4808788; Jung S, 2018, FOOD SCI BIOTECHNOL, V27, P261, DOI 10.1007/s10068-017-0198-8; Kang ST, 2017, KOREAN J FOOD SCI AN, V37, P429, DOI 10.5851/kosfa.2017.37.3.429; Kim JH, 2018, INT J BIOL MACROMOL, V120, P1468, DOI 10.1016/j.ijbiomac.2018.09.160; Kurt A, 2018, J PROSTHODONT, V27, P577, DOI 10.1111/jopr.12539; Lee H, 2015, BBA-BIOMEMBRANES, V1848, P634, DOI 10.1016/j.bbamem.2014.11.016; Liu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108474; Manoharan RK, 2018, MICROB BIOTECHNOL, V11, P1060, DOI 10.1111/1751-7915.13268; Mayahara M, 2014, J INVESTIG CLIN DENT, V5, DOI 10.1111/jicd.12055; Moussa A. R., 2016, J MED SCI, V4, P476, DOI DOI 10.3889/0AMJMS.2016.089; Paranhos HFO, 2007, J ORAL REHABIL, V34, P606, DOI 10.1111/j.1365-2842.2007.01753.x; RADFORD DR, 1993, J DENT, V21, P87, DOI 10.1016/0300-5712(93)90151-F; Reagor L, 2002, J ALTERN COMPLEM MED, V8, P325, DOI 10.1089/10755530260128014; Saito H, 2013, MICROB PATHOGENESIS, V56, P16, DOI 10.1016/j.micpath.2013.01.002; Seleem D, 2017, ARCH ORAL BIOL, V76, P76, DOI 10.1016/j.archoralbio.2016.08.030; Serpa R, 2012, J MED MICROBIOL, V61, P1704, DOI 10.1099/jmm.0.047852-0; Shankar S, 2018, INT J BIOL MACROMOL, V120, P846, DOI 10.1016/j.ijbiomac.2018.09.004; Shankar S, 2018, CARBOHYD POLYM, V196, P92, DOI 10.1016/j.carbpol.2018.04.128; Sharma A, 2014, FUNGAL BIOL-UK, V118, P264, DOI 10.1016/j.funbio.2013.12.006; Sitheeque MAM, 2009, CHEMOTHERAPY, V55, P189, DOI 10.1159/000216836; Tripathi P, 2018, J INDIAN PROSTHODONT, V18, P291, DOI 10.4103/jips.jips_335_17; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Tsutsumi C, 2016, J DENT, V44, P37, DOI 10.1016/j.jdent.2015.11.010; Xie YX, 2015, CURR MED CHEM, V22, P132; Zhou SD, 2011, BIOTECHNOL J, V6, P513, DOI 10.1002/biot.201000254; Zoric N, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1773-5; Zuzarte M, 2012, EUR J CLIN MICROBIOL, V31, P1359, DOI 10.1007/s10096-011-1450-4	45	9	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217496	10.1371/journal.pone.0217496	http://dx.doi.org/10.1371/journal.pone.0217496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136636	Green Published, gold, Green Submitted			2022-12-26	WOS:000469224300044
J	Chen, YY; Deb, DK; Fu, X; Yi, B; Liang, YM; Du, J; He, L; Li, YC				Chen, Yinyin; Deb, Dilip K.; Fu, Xiao; Yi, Bin; Liang, Yumei; Du, Jie; He, Lei; Li, Yan Chun			ATP-citrate lyase is an epigenetic regulator to promote obesity-related kidney injury	FASEB JOURNAL			English	Article						histone acetylation; de novo lipogenesis; obesity; nephropathy	VITAMIN-D-RECEPTOR; DENSITY-LIPOPROTEIN-CHOLESTEROL; ACTIVATED PROTEIN-KINASE; RENAL LIPID-METABOLISM; BODY-MASS INDEX; RESPONSE ELEMENT; HIGH GLUCOSE; TRANSCRIPTION; P300; MICE	Obesity is a leading cause of chronic kidney disease (CKD), but how obesity promotes renal injury remains poorly understood. Here we showed that ATP-citrate lyase (ACL), an enzyme converting citrate to acetyl-CoA, is highly induced in the kidney of overweight or obese patients with CKD and ob/ob BTBR mice. ACL induction is associated with increased ectopic lipid accumulation (ELA), glomerulosclerosis, and albuminuria. Acetyl-CoA is the substrate for de novo lipogenesis as well as for histone acetylation. By raising acetyl-CoA concentration ACL promotes H3K9/14 and H3K27 hyperacetylation leading to up-regulation of several rate-limiting lipogenic enzymes and fibrogenic factors. On the other hand, the excess acetyl-CoA generated as a result of ACL induction provides the substrate for these lipogenic enzymes to drive de novo lipogenesis leading to ELA, a detrimental event toward renal injury. In mesangial cells, ACL is synergistically induced by high glucose, palmitate, and TNF-alpha via NF-kappa B and PKA pathways. Under these conditions, H3K9/14 and H3K27 hyperacetylation, as well as the induction of the lipogenic and fibrogenic proteins, are completely blocked in the presence of an ACL inhibitor. Collectively, these data suggest that ACL is an epigenetic regulator that promotes renal ELA and fibrogenesis leading to renal injury in obesity.-Chen, Y., Deb, D. K., Fu, X., Yi, B., Liang, Y., Du, J., He, L., Li, Y. C. ATP-citrate lyase is an epigenetic regulator to promote obesity-related kidney injury.	[Chen, Yinyin; Deb, Dilip K.; Fu, Xiao; Yi, Bin; Du, Jie; He, Lei; Li, Yan Chun] Univ Chicago, Dept Med, Div Biol Sci, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA; [Chen, Yinyin; Liang, Yumei] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Chen, Yinyin; Liang, Yumei] Hunan Normal Univ, Hunan Prov Peoples Hosp, Lab Kidney Dis, Changsha, Hunan, Peoples R China; [Fu, Xiao] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China; [Yi, Bin] Cent S Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China	University of Chicago; Hunan Normal University; Hunan Normal University; Central South University; Central South University	Li, YC (corresponding author), Univ Chicago, Dept Med, Div Biol Sci, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA.	cyan@medicine.bsd.uchicago.edu		He, Lei/0000-0002-3821-2047	U.S. National Institutes of Health (NIH) National Cancer Institute Grant [CA180087]; NATIONAL CANCER INSTITUTE [R01CA180087] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Kathryn E. Wellen (University of Pennsylvania) for providing the ATP-citrate lyase (ACL) expression plasmid and ACL-short hairpin RNA plasmid and Marc Bissonnette for critically reading the manuscript. This work was supported in part by U.S. National Institutes of Health (NIH) National Cancer Institute Grant CA180087. The authors declare no conflicts of interest.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Ballantyne CM, 2016, AM J CARDIOL, V117, P1928, DOI 10.1016/j.amjcard.2016.03.043; Ballantyne CM, 2013, J AM COLL CARDIOL, V62, P1154, DOI 10.1016/j.jacc.2013.05.050; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Centers for Disease Control and Prevention, 2017, PREVALENCE OBESITY A; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Deb DK, 2017, AM J PHYSIOL-RENAL, V313, pF423, DOI 10.1152/ajprenal.00029.2017; Deb DK, 2017, FASEB J, V31, P2065, DOI 10.1096/fj.201601116R; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gutierrez MJ, 2014, ARTERIOSCL THROM VAS, V34, P676, DOI 10.1161/ATVBAHA.113.302677; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Imamura M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94979; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kong JA, 2010, AM J PATHOL, V177, P622, DOI 10.2353/ajpath.2010.091292; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; McDonnell E, 2016, CELL REP, V17, P1463, DOI 10.1016/j.celrep.2016.10.012; Nakayama K, 2013, J BIOL CHEM, V288, P22584, DOI 10.1074/jbc.M112.421636; Pearce NJ, 1998, BIOCHEM J, V334, P113, DOI 10.1042/bj3340113; Pinkosky SL, 2017, TRENDS MOL MED, V23, P1047, DOI 10.1016/j.molmed.2017.09.001; Pinkosky SL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13457; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Ruan XZ, 2009, NAT REV NEPHROL, V5, P713, DOI 10.1038/nrneph.2009.184; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang YL, 2012, J AM SOC NEPHROL, V23, P1977, DOI 10.1681/ASN.2012040383; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhang ZL, 2008, PROCEEDINGS OF FIRST INTERNATIONAL CONFERENCE OF MODELLING AND SIMULATION, VOL III, P105; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069; ZIYADEH FN, 1994, J CLIN INVEST, V93, P536, DOI 10.1172/JCI117004	49	13	13	4	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9602	9615		10.1096/fj.201900213R	http://dx.doi.org/10.1096/fj.201900213R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31150280	Bronze, Green Published			2022-12-26	WOS:000478832900070
J	Wu, SY; Ma, SM; Yin, XL; Yi, P; Liu, JF				Wu, Shiyong; Ma, Shumin; Yin, Xueliang; Yi, Ping; Liu, Jianfeng			An integrated PKD1-dependent signaling network amplifies IRE1 prosurvival signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); protein kinase D (PKD); c-Jun N-terminal kinase (JNK); cell death; signal transduction; IRE1; MKP1	PROTEIN-KINASE-D; N-TERMINAL KINASE; ER STRESS SENSOR; UNFOLDED PROTEIN; ENDOPLASMIC-RETICULUM; CELL FATE; MESSENGER-RNA; ACTIVATION; APOPTOSIS; JNK1	Following the accumulation of improperly folded proteins in the endoplasmic reticulum (ER), a condition known as ER stress in this compartment triggers an adaptive signaling pathway referred to as the unfolded protein response (UPR). The UPR aims at restoring ER homeostasis; if the ER stress cannot be resolved, apoptosis is triggered. However, the mechanisms responsible for regulating the balance between cell life and death decisions that occur after exposure to ER stress remain unclear. Protein kinase D1 (PKD1) has been reported to initiate protective signaling against oxidative stress or ischemia, two conditions that impinge on the induction of ER stress. In addition, the high levels of expression of PKD1, observed in highly proliferative cancers and tumors with poor prognosis, contribute to enhanced resistance to chemotherapy. In this study, we show that the ER stress inducers tunicamycin and thapsigargin lead to the activation of PKD1 in human prostate cancer PC-3 cells and in hepatoma HepG2 cells through a PKC delta-dependent mechanism. Moreover, our data indicate that PKD1 is required for the stabilization of inositol-requiring enzyme 1 (IRE1) and the subsequent regulation of its activity. PKD1 activation contributes to the phosphorylation of mitogen-activated protein kinase phosphatase 1, resulting in decreased IRE1-mediated c-Jun N-terminal kinase activation. This study unveils the existence of a novel PKD1-dependent prosurvival mechanism that is activated upon ER stress and selectively enhances IRE1 prosurvival signaling.	[Wu, Shiyong; Ma, Shumin; Yin, Xueliang; Yi, Ping; Liu, Jianfeng] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Yi, P; Liu, JF (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	pingy@hust.edu.cn; jfliu@hust.edu.cn		Yi, Ping/0000-0002-6954-102X	National Natural Science Foundation of China [31371423, 81720108031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31371423 and 81720108031. The authors declare that they have no conflicts of interest with the contents of this article.	Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P256, DOI 10.3389/fgene.2013.00256; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Charonis AS, 2017, J CELL MOL MED, V21, P3141, DOI 10.1111/jcmm.13413; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dieterich S, 1996, FEBS LETT, V381, P183, DOI 10.1016/0014-5793(96)00116-0; Eisenberg-Lerner A, 2007, CELL DEATH DIFFER, V14, P1908, DOI 10.1038/sj.cdd.4402212; Eisenberg-Lerner A, 2012, CELL DEATH DIFFER, V19, P788, DOI 10.1038/cdd.2011.149; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Larroque-Cardoso P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.47; Li B, 2013, BIOCHEM J, V452, P139, DOI 10.1042/BJ20121671; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Marza E, 2015, EMBO REP, V16, P332, DOI 10.15252/embr.201439123; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Plastira I, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1024-1; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2012, CELL SIGNALING & MOLECULAR TARGETS IN CANCER, P245, DOI 10.1007/978-1-4614-0730-0_11; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Tavernier SJ, 2017, NAT CELL BIOL, V19, P698, DOI 10.1038/ncb3518; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang HZ, 2015, J CELL SCI, V128, P100, DOI 10.1242/jcs.155101; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Xu XH, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/817604; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	54	3	3	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11119	11130		10.1074/jbc.RA118.003311	http://dx.doi.org/10.1074/jbc.RA118.003311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167779	Green Published, hybrid			2022-12-26	WOS:000478717400006
J	Yang, CP; Zeng, F; Gao, XY; Zhao, SJ; Li, X; Liu, S; Li, N; Deng, CL; Zhang, B; Gong, R				Yang, Chunpeng; Zeng, Fang; Gao, Xinyu; Zhao, Shaojuan; Li, Xuan; Liu, Sheng; Li, Na; Deng, Chenglin; Zhang, Bo; Gong, Rui			Characterization of two engineered dimeric Zika virus envelope proteins as immunogens for neutralizing antibody selection and vaccine design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; vaccine; flavivirus; dimerization; protein structure; dimer; envelope protein; Fc fragment; quaternary epitope; Zika virus; immunogen; neutralizing antibody; vaccine development; Flaviviridae; neurological disease	STRUCTURAL BIOLOGY; DENGUE; MATURATION; POTENT; BRAZIL	The envelope protein of Zika virus (ZIKV) exists as a dimer on the mature viral surface and is an attractive antiviral target because it mediates viral entry. However, recombinant soluble wild-type ZIKV envelope (wtZE) might preferentially exist as monomer (monZE). Recently, it has been shown that the A264C substitution could promote formation of dimeric ZIKV envelope protein (ZE(A264C)), requiring further characterization of purified ZE(A264C) for its potential applications in vaccine development. We also noted that ZE(A264C), connected by disulfide bond, might be different from the noncovalent native envelope dimer on the virion surface. Because the antibody Fc fragment exists as dimer and is widely used for fusion protein construction, here we fused wtZE to human immunoglobulin G1 (IgG1) Fc fragment (ZE-Fc) for noncovalent wtZE dimerization. Using a multistep purification procedure, we separated dimeric ZE(A264C) and ZE-Fc, revealing that they both exhibit typical beta-sheet-rich secondary structures and stabilities similar to those of monZE. The binding activities of monZE, ZE(A264C), and ZE-Fc to neutralizing antibodies targeting different epitopes indicated that ZE(A264C) and ZE-Fc could better mimic the native dimeric status, especially in terms of the formation of tertiary and quaternary epitopes. Both ZE(A264C) and ZE-Fc recognize a ZIKV-sensitive cell line as does monZE, indicating that the two constructs are still functional. Furthermore, a murine immunization assay disclose that ZE(A264C) and ZE-Fc elicit more neutralizing antibody responses than monZE does. These results suggest that the two immunogen candidates ZE(A264C) and ZE-Fc have potential utility for neutralizing antibody selection and vaccine design against ZIKV.	[Yang, Chunpeng; Zeng, Fang; Gao, Xinyu; Zhao, Shaojuan; Li, Xuan; Li, Na; Deng, Chenglin; Zhang, Bo; Gong, Rui] Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China; [Yang, Chunpeng; Zeng, Fang; Gao, Xinyu; Zhao, Shaojuan; Li, Na] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Liu, Sheng] Huazhong Univ Sci & Technol, Key Lab Biomed Photon MOE, Wuhan Natl Lab Optoelect Hubei Bioinformat, Coll Life Sci & Technol,Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China; [Liu, Sheng] Huazhong Univ Sci & Technol, Mol Imaging Key Lab Syst, Coll Life Sci & Technol, Syst Biol Theme,Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Gong, R (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.	gongr@wh.iov.cn			Core Facility and Technical Support, Wuhan Institute of Virology, Chinese Academy of Sciences; Wuhan Institute of Biotechnology; Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety; Wuhan National Bio-Safety Level 4 Lab of the Chinese Academy of Sciences	Core Facility and Technical Support, Wuhan Institute of Virology, Chinese Academy of Sciences; Wuhan Institute of Biotechnology; Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety; Wuhan National Bio-Safety Level 4 Lab of the Chinese Academy of Sciences	We are thankful to the Core Facility and Technical Support, Wuhan Institute of Virology, Chinese Academy of Sciences; Wuhan Institute of Biotechnology; Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety; as well as Wuhan National Bio-Safety Level 4 Lab of the Chinese Academy of Sciences for the support.	Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005; Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3; Blazevic J, 2016, J VIROL, V90, P6365, DOI 10.1128/JVI.00447-16; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5; Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; de Oliveira WK, 2017, LANCET, V390, P861, DOI [10.1016/S0140-6736(17)31368-5, 10.1016/s0140-6736(17)31368-5]; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5; Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8; Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004; Liu LM, 2018, PROTEIN CELL, V9, P15, DOI 10.1007/s13238-017-0408-4; Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553; Medin CL, 2017, ARCH PATHOL LAB MED, V141, P33, DOI 10.5858/arpa.2016-0409-RA; Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166; Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6; Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469; Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001; Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006; Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79; Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406; Yang CP, 2019, VIROL SIN, V34, P168, DOI 10.1007/s12250-019-00093-5; Yang CP, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01860; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Zeng F, 2018, J BIOL CHEM, V293, P19127, DOI 10.1074/jbc.RA118.005367; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	43	5	5	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10638	10648		10.1074/jbc.RA119.007443	http://dx.doi.org/10.1074/jbc.RA119.007443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138647	Green Published, hybrid			2022-12-26	WOS:000478717100022
J	Li, X; Sivaganesan, M; Kelty, CA; Zimmer-Faust, A; Clinton, P; Reichman, JR; Johnson, Y; Matthews, W; Bailey, S; Shanks, OC				Li, Xiang; Sivaganesan, Mano; Kelty, Catherine A.; Zimmer-Faust, Amity; Clinton, Pat; Reichman, Jay R.; Johnson, York; Matthews, William; Bailey, Stephanie; Shanks, Orin C.			Large-scale implementation of standardized quantitative real-time PCR fecal source identification procedures in the Tillamook Bay Watershed	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTEROIDALES GENETIC-MARKERS; BACTERIAL PATHOGENS; POLLUTION; CONTAMINATION; ASSAYS; INDICATORS; SEWAGE; PERFORMANCE; WATERFOWL	Fecal pollution management remains one of the biggest challenges for water quality authorities worldwide. Advanced fecal pollution source identification technologies are now available that can provide quantitative information from many animal groups. As public interest in these methodologies grows, it is vital to use standardized procedures with clearly defined data acceptance metrics and conduct field studies demonstrating the use of these techniques to help resolve real-world water quality challenges. Here we apply recently standardized human-associated qPCR methods with custom data acceptance metrics (HF183/BacR287 and HumM2), along with established procedures for ruminant (Rum2Bac), cattle (CowM2 and CowM3), canine (DG3 and DG37), and avian (GFD) fecal pollution sources to (i) demonstrate the feasibility of implementing standardized qPCR procedures in a largescale field study, and (ii) characterize trends in fecal pollution sources in the research area. A total of 602 water samples were collected over a one-year period at 29 sites along the Trask, Kilchis, and Tillamook rivers and tributaries in the Tillamook Bay Watershed (OR, USA). Host-associated qPCR results were combined with high-resolution geographic information system (GIS) land use and general indicator bacteria (E. cols) measurements to elucidate water quality fecal pollution trends. Results demonstrate the feasibility of implementing standardized fecal source identification qPCR methods with established data acceptance metrics in a large-scale field study leading to new investigative leads suggesting that elevated E. coli levels may be linked to specific pollution sources and land use activities in the Tillamook Bay Watershed.	[Li, Xiang] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Sivaganesan, Mano; Kelty, Catherine A.; Shanks, Orin C.] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Zimmer-Faust, Amity] Southern Calif Coastal Water Res Project, Costa Mesa, CA USA; [Clinton, Pat] US EPA, Off Res & Dev, Newport, OR USA; [Reichman, Jay R.] US EPA, Off Res & Dev, Corvallis, OR USA; [Johnson, York] Oregon Dept Environm Qual & Tillamook Estuaries P, Garibaldi, OR USA; [Matthews, William] Oregon Dept Agr, Salem, OR USA; [Bailey, Stephanie] US EPA, Reg Manchester Lab 10, Port Orchard, WA USA; [Li, Xiang] Southern Univ Sci & Technol, Sch Environm Sci & Engn, Shenzhen, Guangdong, Peoples R China	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; Southern California Coastal Water Research Project; United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; Southern University of Science & Technology	Shanks, OC (corresponding author), US EPA, Off Res & Dev, Cincinnati, OH 45268 USA.	shank.orin@epa.gov		Reichman, Jay/0000-0002-5657-1115; Li, Xiang/0000-0001-6023-8561				Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; Borok A, 2016, ISSUE PAPER REVISION; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao YP, 2018, WATER RES, V128, P148, DOI 10.1016/j.watres.2017.10.071; DeFlorio-Barker S, 2018, ENV HLTH, V17, P1, DOI [10.1186/s12940-017-0345-y, DOI 10.1186/S12940-017-0345-Y]; Devane ML, 2005, J APPL MICROBIOL, V98, P980, DOI 10.1111/j.1365-2672.2005.02541.x; Edge T.A., 2016, APPL ENVIRON MICROB, DOI [10.1128/AEM.01675-01616, DOI 10.1128/AEM.01675-01616]; Ervin JS, 2014, ENVIRON SCI TECHNOL, V48, P9043, DOI 10.1021/es502173s; Ervin JS, 2013, WATER RES, V47, P6873, DOI 10.1016/j.watres.2013.02.060; Fallacara DM, 2004, AVIAN DIS, V48, P759, DOI 10.1637/7185-032904R; Fallacara DM, 2001, AVIAN DIS, V45, P128, DOI 10.2307/1593019; Green HC, 2014, DEV RAPID CANINE FEC; Green HC, 2014, APPL ENVIRON MICROB, V80, P3086, DOI 10.1128/AEM.04137-13; Green HC, 2012, APPL ENVIRON MICROB, V78, P503, DOI 10.1128/AEM.05734-11; Hajj-Mohamad M, 2019, SCI TOTAL ENVIRON, V659, P548, DOI 10.1016/j.scitotenv.2018.12.378; Haugland RA, 2010, SYST APPL MICROBIOL, V33, P348, DOI 10.1016/j.syapm.2010.06.001; Helsel D. R., 2005, NONDETECTS DATA ANAL; Jokinen CC, 2019, WATER RES, V156, P148, DOI 10.1016/j.watres.2019.03.013; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Korajkic A, 2019, INT J ENV RES PUB HE, V15, pE2842; Kundu A, 2013, WATER RES, V47, P6309, DOI 10.1016/j.watres.2013.08.002; Lee CS, 2010, J MICROBIOL METH, V82, P311, DOI 10.1016/j.mimet.2010.07.012; Lee Sherline H, 2002, MMWR Surveill Summ, V51, P1; Lu JR, 2008, APPL ENVIRON MICROB, V74, P3969, DOI 10.1128/AEM.00019-08; Ly DK, 2012, WATER SCI TECHNOL, V66, P2659, DOI 10.2166/wst.2012.496; McMinn BR, 2019, ECOL ENG, V128, P48, DOI 10.1016/j.ecoleng.2018.11.026; Mieszkin S, 2010, J APPL MICROBIOL, V108, P974, DOI 10.1111/j.1365-2672.2009.04499.x; Newell A, 1998, TILLAMOOK BAY ENV CH; ODFW, 2018, BIG GAM POP SURV DAT; Peed LA, 2011, ENVIRON SCI TECHNOL, V45, P5662; Pickard BR, 2015, ECOSYSTEMS SERVICES, V14; Reischer GH, 2007, LETT APPL MICROBIOL, V44, P351, DOI 10.1111/j.1472-765X.2006.02094.x; Reischer GH, 2006, APPL ENVIRON MICROB, V72, P5610, DOI 10.1128/AEM.00364-06; Samadpour N, 2002, J ENVIRON HEALTH, V64, P16; Shanks OC, 2008, APPL ENVIRON MICROB, V74, P745, DOI 10.1128/AEM.01843-07; Shanks OC, 2006, APPL ENVIRON MICROB, V72, P5537, DOI 10.1128/AEM.03059-05; Shanks OC, 2016, APPL ENVIRON MICROB, V82, P2773, DOI 10.1128/AEM.03661-15; Shanks OC, 2014, APPL ENVIRON MICROB, V80, P1588, DOI 10.1128/AEM.03581-13; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Shanks OC, 2010, ENVIRON SCI TECHNOL, V44, P6281, DOI 10.1021/es100311n; Shanks OC, 2010, APPL ENVIRON MICROB, V76, P1359, DOI 10.1128/AEM.02033-09; Shanks OC, 2009, APPL ENVIRON MICROB, V75, P5507, DOI 10.1128/AEM.00305-09; Shibata T, 2010, ENVIRON SCI TECHNOL, V44, P8175, DOI 10.1021/es100884w; Sivaganesan M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-120; Soller JA, 2010, WATER RES, V44, P4674, DOI 10.1016/j.watres.2010.06.049; Stachler E, 2017, ENVIRON SCI TECHNOL, V51, P9146, DOI 10.1021/acs.est.7b02703; Templar HA, 2016, WATER RES, V100, P556, DOI 10.1016/j.watres.2016.05.056; USEPA, 2002, METHOD 1603 ESCHERIC; USEPA, 2019, 1697 USEPA; USEPA, 2012, RECREATIONAL WATER Q; USEPA, 2019, 1696 USEPA; USEPA (United States Environmental Protection Agency), 2004, 833R04001 USEPA; Weidhass J.L., 2011, APPL ENVIRON MICROB, DOI [10.1128/ AEM.02555-02510, DOI 10.1128/AEM.02555-02510]; Wise DR, 2011, J AM WATER RESOUR AS, V47, P1110, DOI 10.1111/j.1752-1688.2011.00580.x; Yampara-Iquise H, 2008, J APPL MICROBIOL, V105, P1686, DOI 10.1111/j.1365-2672.2008.03895.x	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216827	10.1371/journal.pone.0216827	http://dx.doi.org/10.1371/journal.pone.0216827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170166	Green Published, gold			2022-12-26	WOS:000470263700010
J	Hajjar, A; Ergun, MA; Alagoz, O; Rampurwala, M				Hajjar, Ali; Ergun, Mehmet A.; Alagoz, Oguzhan; Rampurwala, Murtuza			Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer	PLOS ONE			English	Article							CHEMOTHERAPY; HEALTH; SURVIVAL	Objectives Adjuvant paclitaxel and trastuzumab has been shown to be an effective regimen with low risk of cancer recurrence and treatment-related toxicities in early-stage node-negative, HER2-positive breast cancer. We investigated the cost-effectiveness of this regimen. Methods A Markov-based microsimulation model with six health states is used to simulate four adjuvant therapy options for women with early-stage node-negative, HER2-positive breast cancer at different age groups. The four treatment arms are 1) adjuvant paclitaxel and trastuzumab (TH), 2) doxorubicin, cyclophosphamide, paclitaxel and trastuzumab (ACTH), 3) docetaxel, carboplatin and trastuzumab (TCH), and 4) no adjuvant trastuzumab (NT). Data from randomized trials were used to estimate treatment efficacy. Societal perspective was used in this cost-effectiveness analysis. Costs were measured in 2016 US dollars (US $) and quality-adjusted life-years (QALYs) was used for health outcomes. Sensitivity analyses were performed to evaluate the impact of uncertainty in parameter estimation. Results We found that 40-year-old women undergoing TH treatment would have an average of 16.17 QALYs for the cost of $ 178,650 when lifetime horizon is used. Compared to NT, TH has incremental cost-effectiveness ratios ranged from $ 10,584 (ages 40-49) to $ 84,981 (age 80+) per additional QALYs. The sensitivity analysis showed that TH is cheaper and leads to higher QALYs compared to both ACTH and TCH for all age groups and time horizons. Conclusions TH is cost-effective for all age groups in the base case scenario and in the sensitivity analysis. In order to reduce the parameter uncertainty, clinical trials with longer follow-up times are needed.	[Hajjar, Ali; Alagoz, Oguzhan] Univ Wisconsin, Dept Ind & Syst Engn, Madison, WI 53706 USA; [Ergun, Mehmet A.] Istanbul Sehir Univ, Dept Ind Engn, Istanbul, Turkey; [Rampurwala, Murtuza] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; Istanbul Sehir University; University of Chicago	Alagoz, O (corresponding author), Univ Wisconsin, Dept Ind & Syst Engn, Madison, WI 53706 USA.	alagoz@engr.wisc.edu	Ergun, Mehmet/AAB-9782-2019; Hjaar, Ali/GSM-9720-2022	Ergun, Mehmet/0000-0002-2480-8077; Alagoz, Oguzhan/0000-0002-5133-1382; Hajjar, Ali/0000-0003-4654-9798	Clinical and Translational Science Awards (CTSA) Program of the National Center for Research Resources (NCRR) - National Institutes of Health (NIH) [2UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	Clinical and Translational Science Awards (CTSA) Program of the National Center for Research Resources (NCRR) - National Institutes of Health (NIH); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research is supported through grant 2UL1TR000427 from the Clinical and Translational Science Awards (CTSA) Program of the National Center for Research Resources (NCRR) - National Institutes of Health (NIH) to OA and AH.	Alagoz O, 2004, MANAGE SCI, V50, P1420, DOI 10.1287/mnsc.1040.0287; Ayvaci MUS, 2013, MED DECIS MAKING, V33, P521, DOI 10.1177/0272989X12470755; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; Fehrenbacher L, 2014, J CLIN ONCOL, V32, P2151, DOI 10.1200/JCO.2013.52.0858; Garrison LR, 2007, CANCER-AM CANCER SOC, V110, P489, DOI 10.1002/cncr.22806; Hedden L, 2012, RADIAT ONCOL, P3, DOI [10.1186/1748-717X-7-3, DOI 10.1186/1748-717X-7-3]; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Kurian AW, 2007, J CLIN ONCOL, V25, P634, DOI 10.1200/JCO.2006.06.3081; Law A. M., 2000, SIMULATION MODELING; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; National Cancer Institute, 2017, COMM TERM CRIT ADV E; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Press MF, 1993, CANC RES, V53; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Skedgel C, 2013, ANN ONCOL, V24, P1834, DOI 10.1093/annonc/mdt069; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stemmler HJ, 2005, ONKOLOGIE, V28, P582, DOI 10.1159/000088296; Thomson Reuters Healthcare Inc, 2010, RED BOOK; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Tolaney SM, 2019, J CLIN ONCOL, V37; Vaz-Luis I, 2014, J CLIN ONCOL, V32, P2142, DOI 10.1200/JCO.2013.53.1608; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Winn AN, 2016, AM J PREV MED, V50, P241, DOI 10.1016/j.amepre.2015.08.009	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217778	10.1371/journal.pone.0217778	http://dx.doi.org/10.1371/journal.pone.0217778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166995	gold, Green Submitted, Green Published			2022-12-26	WOS:000470087800039
J	Rodrigues, R; Danskog, K; Overby, AK; Arnberg, N				Rodrigues, Raquel; Danskog, Katarina; Overby, Anna K.; Arnberg, Niklas			Characterizing the cellular attachment receptor for Langat virus	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; DENGUE VIRUS; HEPARAN-SULFATE; EXPRESSION PROFILES; ENVELOPE PROTEIN; MESSENGER-RNA; DC-SIGN; INFECTION; BINDING; IDENTIFICATION	Tick-borne encephalitis infections have increased the last 30 years. The mortality associated to this viral infection is 0.5 to 30% with a risk of permanent neurological sequelae, however, no therapeutic is currently available. The first steps of virus-cell interaction, such as attachment and entry, are of importance to understand pathogenesis and tropism. Several molecules have been shown to interact with tick-borne encephalitis virus (TBEV) at the plasma membrane surface, yet, no studies have proven that these are specific entry receptors. In this study, we set out to characterize the cellular attachment receptor(s) for TBEV using the naturally attenuated member of the TBEV complex, Langat virus (LGTV), as a model. Inhibiting or cleaving different molecules from the surface of A549 cells, combined with inhibition assays using peptide extracts from high LGTV binding cells, revealed that LGTV attachment to host cells is dependent on plasma membrane proteins, but not on glycans or glycolipids, and suggested that LGTV might use different cellular attachment factors on different cell types. Based on this, we developed a transcriptomic approach to generate a list of candidate attachment and entry receptors. Our findings shed light on the first step of the flavivirus life-cycle and provide candidate receptors that might serve as a starting point for future functional studies to identify the specific attachment and/or entry receptor for LGTV and TBEV.	[Rodrigues, Raquel; Danskog, Katarina; Overby, Anna K.; Arnberg, Niklas] Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden	Umea University	Rodrigues, R (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden.	raquelorodrigues@hotmail.com	Arnberg, Niklas/K-5878-2019	Arnberg, Niklas/0000-0002-7069-6678	Umea Centre for Microbial Research (UCMR) Linnaeus Programme - Umea University; Swedish Research Council [349-2007-8673]	Umea Centre for Microbial Research (UCMR) Linnaeus Programme - Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was performed as a part of the Umea Centre for Microbial Research (UCMR) Linnaeus Programme supported by Umea University and the Swedish Research Council (349-2007-8673).	ABE A, 1995, J LIPID RES, V36, P611; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; BROCKHAUSEN I, 1992, BIOCHEM CELL BIOL, V70, P99, DOI 10.1139/o92-015; BRUNNGRABER EG, 1972, BRAIN RES, V38, P151, DOI 10.1016/0006-8993(72)90596-3; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Ciani L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9302; Condamine T, 2010, J LEUKOCYTE BIOL, V88, P507, DOI 10.1189/jlb.1109738; ENGLUND PT, 1968, BIOCHEMISTRY-US, V7, P163, DOI 10.1021/bi00841a021; Fan WC, 2017, RES VET SCI, V111, P67, DOI 10.1016/j.rvsc.2016.12.007; Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Han HQ, 2001, J MED VIROL, V64, P21, DOI 10.1002/jmv.1012; Han XQ, 2005, J MED VIROL, V77, P249, DOI 10.1002/jmv.20444; Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713; Hirano M, 2014, J GEN VIROL, V95, P849, DOI 10.1099/vir.0.061432-0; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Jolly CL, 2013, ADV EXP MED BIOL, V790, P1, DOI 10.1007/978-1-4614-7651-1_1; Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kollaritsch H, 2012, EXPERT REV VACCINES, V11, P1103, DOI [10.1586/erv.12.86, 10.1586/ERV.12.86]; KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U; KORNFELD R, 1970, J BIOL CHEM, V245, P2536; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P937, DOI 10.1515/bchm2.1976.357.2.937; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P233; Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kupca AM, 2010, TICKS TICK-BORNE DIS, V1, P44, DOI 10.1016/j.ttbdis.2009.11.002; Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9; Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261; Lauer S, 2002, BIOCHEMISTRY-US, V41, P1742, DOI 10.1021/bi0112816; Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006; Letschert S, 2014, ANGEW CHEM INT EDIT, V53, P10921, DOI 10.1002/anie.201406045; Liao XH, 2014, EXP DERMATOL, V23, P195, DOI 10.1111/exd.12340; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu P, 2017, TRAFFIC, V18, P218, DOI 10.1111/tra.12469; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malygin AA, 2010, BIOCH MOSC, V74, P1328; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mittelstaedt T, 2007, GENE, V403, P70, DOI 10.1016/j.gene.2007.08.004; Monath T.P., 1996, FIELDS VIROLOGY, P961; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; NIEDRIG M, 1994, ACTA VIROL, V38, P141; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10; Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069; Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Robertson SJ, 2014, J IMMUNOL, V192, P2744, DOI 10.4049/jimmunol.1302110; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shapoval A N, 1989, Tr Inst Im Pastera, V65, P133; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Taniguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37829; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Terasaki H, 2002, INT J MOL MED, V9, P107; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Upanan S, 2008, J VIROL METHODS, V151, P325, DOI 10.1016/j.jviromet.2008.05.001; Van Raay TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018650; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Wichit S, 2011, MICROBIOL IMMUNOL, V55, P135, DOI 10.1111/j.1348-0421.2010.00293.x; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Zaitsev BN, 2014, J MOL RECOGNIT, V27, P727, DOI 10.1002/jmr.2399	83	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217359	10.1371/journal.pone.0217359	http://dx.doi.org/10.1371/journal.pone.0217359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163044	Green Published, gold, Green Submitted			2022-12-26	WOS:000470086200012
J	Trefan, L; Gartner, A; Alcock, A; Farewell, D; Morgan, J; Fone, D; Paranjothy, S				Trefan, Laszlo; Gartner, Andrea; Alcock, Amy; Farewell, Daniel; Morgan, Jennifer; Fone, David; Paranjothy, Shantini			Epidemiology of alcohol-related emergency hospital admissions in children and adolescents: An e-cohort analysis in Wales in 2006-2011	PLOS ONE			English	Article							INTOXICATED ADOLESCENTS; SOCIOECONOMIC-STATUS; BINGE DRINKING; CONSUMPTION; AGE; LEVEL; ONSET; HARM; VICTIMIZATION; BEHAVIORS	Objective Harmful levels of alcohol consumption in young people are prevalent and of increasing public concern in the western world. Rates of alcohol-related emergency hospital admissions in children and young people between 10 to 17 years were described, and the reasons for these admissions and their association with socio-demographic factors were examined. Methods E-cohort data were extracted from the Secure Anonymised Information Linkage Databank, which contained alcohol-related emergency hospital admissions (N = 2968) from 2006 to 2011 in children and adolescents aged 10 to 17 years in Wales. A generalised linear mixed model was fitted using a log-link with a population offset to the data to calculate incident rate ratios (IRRSs). Results There was a general decreasing trend from 2006 to 2011 in the number and rate of alcohol-related emergency hospital admissions; the mean age of admission was 15.4 (standard deviation 1.4) years. In each of the four youngest age groups (10-13,14,15,16 years), females had higher IRRs than males. Males had slightly higher IRR compared to females only in the oldest age group (17 years). IRRs increased with increasing deprivation. The majority (92%) of the admissions lasted one day and most of the admissions (70%) occured during the last three days of the week with a peak on Saturday. The length of stay in hospital was longer in cases when self-harm were present. Multiple admissions showed high prevalance of serious self-harm cases in females. The number of admissions with injuries and falls were higher for males than females. Conclusion Female children and adolescents were more likely to be admitted to hospital for alcohol-related reasons. These data illustrate the significant burden of alcohol-related harm in young people and highlight the need for interventions and policies that promote safe drinking practices among young people to prevent future alcohol-related harm during the life-course.	[Trefan, Laszlo; Gartner, Andrea; Farewell, Daniel; Fone, David; Paranjothy, Shantini] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales; [Alcock, Amy] Royal Gwent Hosp, Newport, Gwent, Wales; [Morgan, Jennifer] NHS Wales Delivery Unit, Pencoed, Wales	Cardiff University; Royal Gwent Hospital	Trefan, L (corresponding author), Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales.	TrefanL@cardiff.ac.uk		Paranjothy, Shantini/0000-0002-0528-3121; Farewell, Daniel/0000-0002-8871-1653	Economic and Social Research Council; Medical Research Council; Alcohol Research UK [ES/L015471/1]; ESRC [ES/L015471/1] Funding Source: UKRI; MRC [MR/K023233/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alcohol Research UK; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funds from the Economic and Social Research Council, the Medical Research Council and Alcohol Research UK to the ELAStiC Project (ES/L015471/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouthoorn SH, 2011, EUR J PEDIATR, V170, P1023, DOI 10.1007/s00431-011-1394-9; Calabria B, 2011, ADDICTION, V106, P1406, DOI 10.1111/j.1360-0443.2011.03418.x; Champion HLO, 2004, J ADOLESCENT HEALTH, V35, P321, DOI 10.1016/j.jadohealth.2003.09.023; Dawson DA, 2008, ALCOHOL CLIN EXP RES, V32, P2149, DOI 10.1111/j.1530-0277.2008.00806.x; de Looze M, 2015, EUR J PUBLIC HEALTH, V25, P69, DOI 10.1093/eurpub/ckv031; Diestelkamp S, 2015, ADDICT BEHAV, V50, P51, DOI 10.1016/j.addbeh.2015.06.009; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Fone D., 2016, NIHR J LIB, V4, P1, DOI DOI 10.3310/PHR04030; Fone D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-428; Ford D, 2009, BMC HEALTH SERV RES, V9, P24; Gartner A., 2014, ALCOHOL HLTH WALES 2; Green MA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4265-0; Healey C, 2014, INT J DRUG POLICY, V25, P124, DOI 10.1016/j.drugpo.2013.07.008; Hibell B, 2009, ESPAD REPORT 2007 SU; Hibell B., 2012, ESPAD REPORT 2011 SU; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; Holdcraft LC, 2002, ADDICTION, V97, P1025, DOI 10.1046/j.1360-0443.2002.00142.x; Huckle T, 2008, ADDICTION, V103, P1614, DOI 10.1111/j.1360-0443.2008.02318.x; Jefferis BJMH, 2005, ADDICTION, V100, P543, DOI 10.1111/j.1360-0443.2005.01034.x; Jones KH, 2014, J BIOMED INFORM, V50, P196, DOI 10.1016/j.jbi.2014.01.003; Katikireddi SV, 2017, LANCET PUBLIC HEALTH, V2, pE267, DOI 10.1016/S2468-2667(17)30078-6; KIRKWOOD BR, 2003, ESSENTIAL MED STAT, P315; Livingston W, 2018, REV WORKING TOGETHER; Loxley WM, 2005, MED J AUSTRALIA, V182, P54, DOI 10.5694/j.1326-5377.2005.tb06574.x; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Measham F, 2008, HEALTH EDUC, V108, P207, DOI 10.1108/09654280810867088; Moore GF, 2015, J SCHOOL HEALTH, V85, P267, DOI 10.1111/josh.12242; Moore GF, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-6; Nienhuis K., 2019, Nederlands Tijdschrift voor Geneeskunde, V163, pD2384; Pawlowska-Kamieniak A, 2018, ANN AGR ENV MED, V25, P1, DOI 10.5604/12321966.1228397; Peng M, 2018, INT J POPUL DATA SCI, V3, P1; Pitkanen T, 2005, ADDICTION, V100, P652, DOI 10.1111/j.1360-0443.2005.01053.x; R Core Team, 2018, R LANG ENV STAT COMP; Rowland B, 2014, ADDICT BEHAV, V39, P282, DOI 10.1016/j.addbeh.2013.10.001; Shepherd JP, 2006, J ADOLESCENCE, V29, P539, DOI 10.1016/j.adolescence.2006.06.005; Simons-Morton BG, 2009, INT J PUBLIC HEALTH, V54, P199, DOI 10.1007/s00038-009-5411-y; Sindelar H A, 2004, Minerva Pediatr, V56, P291; Swahn MH, 2004, ADDICT BEHAV, V29, P959, DOI 10.1016/j.addbeh.2004.02.043; Toumbourou JW, 2007, LANCET, V369, P1391, DOI 10.1016/S0140-6736(07)60369-9; van Hoof JJ, 2015, J CHILD ADOLES SUBST, V24, P191, DOI 10.1080/1067828X.2013.803943; van Hoof JJ, 2011, J ADOLESCENT HEALTH, V48, P212, DOI 10.1016/j.jadohealth.2010.06.001; van Hoof JJ, 2010, J STUD ALCOHOL DRUGS, V71, P366, DOI 10.15288/jsad.2010.71.366; Van Zanten E, 2013, ALCOHOL CLIN EXP RES, V37, P1188, DOI 10.1111/acer.12090; Wachtel T, 2010, J CLIN NURS, V19, P605, DOI 10.1111/j.1365-2702.2009.03060.x; Warner LA, 2003, SUBST USE MISUSE, V38, P1983, DOI 10.1081/JA-120025123; WHO, 2010, INT STAT CLASS DIS R; Williams S, 2005, BRIT MED J, V330, p115A	47	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217598	10.1371/journal.pone.0217598	http://dx.doi.org/10.1371/journal.pone.0217598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163052	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000470086200024
J	Chan, M; Muriuki, EM; Emery, S; Kanthula, R; Chohan, V; Frenkel, LM; Wald, A; Chohan, B; Overbaugh, J; Roxby, AC				Chan, Mary; Muriuki, Eric Munene; Emery, Sandra; Kanthula, Ruth; Chohan, Vrasha; Frenkel, Lisa M.; Wald, Anna; Chohan, Bhavna; Overbaugh, Julie; Roxby, Alison C.			Correlates of HIV detection among breastfeeding postpartum Kenyan women eligible under Option B	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; VIRAL LOAD; RESISTANT HIV-1; PLUS; PREGNANCY; ADHERENCE; CARE; RETENTION; NEVIRAPINE	Background The Option B+ strategy streamlines delivery of HIV antiretroviral therapy (ART) to pregnant women, but concerns remain about ART treatment adherence and long term outcomes. Methods We conducted a retrospective analysis of a cohort of HIV-positive, postpartum breastfeeding women receiving ART via Option B+ in Nairobi, Kenya. The primary outcome was virologic failure in plasma (HIV RNA >1000 copies/mL), and detection in breast milk (>150 copies/mL) and endocervical secretions (>100 copies/mL) at 2 postpartum timepoints. Correlates of virologic failure were assessed using univariate tests and multivariate logistic regression. Results Of 42 women at 6-14 weeks postpartum, 21.4% of women had HIV RNA detected in plasma; 14.3% in breast milk, and 23.7% in endocervical secretions. At 18-24 weeks postpartum, the percentages were 21.1%, 7.1%, and 14.3%, respectively. Younger maternal age, intent to breastfeed for longer, and later ART start in pregnancy were significantly associated with plasma virologic failure (p < 0.05 for each). Odds of plasma virologic failure at 6-14 weeks postpartum were 1.25 times higher (95% CI 1.04, 1.51) for each increase in week of gestation at ART initiation. Only 3 women had resistance mutations to their regimen. Conclusions Despite months of ART, nearly one-quarter of the women in our cohort did not achieve plasma virologic suppression in the postpartum period. After adjusting for time on ART, earlier ART initiation in pregnancy was significantly associated with plasma suppression. Our findings suggest that postpartum HIV RNA monitoring in Option B+ programs will be needed to achieve elimination of MTCT.	[Chan, Mary; Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Muriuki, Eric Munene] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Emery, Sandra] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Kanthula, Ruth; Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA USA; [Chohan, Vrasha; Frenkel, Lisa M.; Wald, Anna; Roxby, Alison C.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Frenkel, Lisa M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Frenkel, Lisa M.; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Frenkel, Lisa M.; Chohan, Bhavna; Roxby, Alison C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Chohan, Bhavna] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Nairobi; Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Roxby, AC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Roxby, AC (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	aroxby@uw.edu		Roxby, Alison/0000-0001-9449-8062	NICHD [K23 HD071788-01A1]; University of Washington Center for AIDS Research (CFAR) [P30 AI027757]; Fogarty Fellowship - Fogarty International Center; Office of AIDS Research [3R25TW009345]; Gilead Sciences; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR002319]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD071788] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R25TW009345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Washington Center for AIDS Research (CFAR); Fogarty Fellowship - Fogarty International Center; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by K23 HD071788-01A1 (ACR) from NICHD, by a New Investigator Award to ACR from the University of Washington Center for AIDS Research (CFAR) (P30 AI027757), and by a Fogarty Fellowship to EMM, funded by the Fogarty International Center and the Office of AIDS Research (3R25TW009345). EMM also received a travel award from Gilead Sciences. Analysis of HIV drug resistance was performed with assistance of the Clinical and Retrovirology Research Core and the Molecular Profiling and Computational Biology Core of the UW CFAR (P30 AI027757). Study data were collected and managed using REDCap electronic data capture tools hosted at the Institute of Translational Health Sciences, supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1 TR002319). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Beek IA, 2002, J CLIN MICROBIOL, V40, P1413, DOI 10.1128/JCM.40.4.1413-1419.2002; Bispo S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21251; Blish CA, 2012, JAIDS-J ACQ IMM DEF, V61, P436, DOI 10.1097/QAI.0b013e31826c2edd; Council NAC, 2014, KEN AIDS RESP PROGR; Davis NL, 2016, JAIDS-J ACQ IMM DEF, V73, P572, DOI 10.1097/QAI.0000000000001145; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Gill MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168671; Graham SM, 2012, JAIDS-J ACQ IMM DEF, V60, P511, DOI 10.1097/QAI.0b013e31825bd703; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Kamuyango Alfred A, 2014, World J AIDS, V4, P332; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V70, P99, DOI 10.1097/QAI.0000000000000692; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Koss CA, 2017, JAIDS-J ACQ IMM DEF, V74, P279, DOI 10.1097/QAI.0000000000001228; Landes M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3380-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McGrath CJ, 2018, AIDS CARE, V30, P765, DOI 10.1080/09540121.2017.1400642; Micek MA, 2012, J INFECT DIS, V205, P1811, DOI 10.1093/infdis/jis282; Micek MA, 2010, CLIN INFECT DIS, V50, P1405, DOI 10.1086/652151; Mills EJ, 2014, LANCET HIV, V1, pE104, DOI 10.1016/S2352-3018(14)00003-4; Mwau M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183860; Myer L, 2017, HIV MED, V18, P80, DOI 10.1111/hiv.12397; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Ngarina M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0914-z; Okonji JA, 2012, JAIDS-J ACQ IMM DEF, V61, P249, DOI 10.1097/QAI.0b013e318262514f; Panteleeff DD, 2002, J CLIN MICROBIOL, V40, P3929, DOI 10.1128/JCM.40.11.3929-3937.2002; Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2016, FAST TRACK AIDS FREE; UNICEF, 2017, HIV EP CHILDR AD; Westreich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022778; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2015, GUID START ANT THER	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216252	10.1371/journal.pone.0216252	http://dx.doi.org/10.1371/journal.pone.0216252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150396	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100016
J	Esquerda-Canals, G; Marti-Clua, J; Villegas, S				Esquerda-Canals, Gisela; Marti-Clua, Joaquim; Villegas, Sandra			Pharmacokinetic parameters and mechanism of action of an efficient anti-A beta single chain antibody fragment	PLOS ONE			English	Article							TRIPLE-TRANSGENIC MODEL; ALZHEIMERS-DISEASE; VARIABLE FRAGMENT; 3XTG-AD MICE; MOUSE MODEL; AMYLOID DEPOSITION; IMMUNOTHERAPY; IMMUNIZATION; STABILITY; TRIALS	The success of the targeting of amyloid-beta (A beta) oligomers through immunotherapy in Alzheimer's disease (AD) mouse models has not been translated into the clinics. The use of single-chain variable fragments (scFvs) has been proposed to prevent the potential severe effects of full-length mAbs by precluding crystallizable fraction-mediated microglia activation. The efficacy of scFv-h3D6, a bapineuzumab-derived anti-A beta scFv, has been extensively proven. In this work, we compared scFv-h3D6-EL, an elongated variant of the scFv-h3D6, with its original version to assess whether its characteristic higher thermodynamic stability improved its pharmacokinetic parameters. Although scFv-h3D6-EL had a longer half-life than its original version, its absorption from the peritoneal cavity into the systemic compartment was lower than that of the original version. Moreover, we attempted to determine the mechanism underlying the protective effect of scFv-h3D6. We found that scFv-h3D6 showed compartmental distribution and more interestingly crossed the blood-brain barrier. In the brain, scFv-h3D6 was engulfed by glial cells or internalized by A beta peptide-containing neurons in the early phase post-injection, and was colocalized with the A beta peptide almost exclusively in glial cells in the late phase post-injection. A beta peptide levels in the brain decreased simultaneously with an increase in scFv-h3D6 levels. This observation in addition to the increased tumor necrosis factor-a levels in the late phase post-injection suggested that the engulfment of A beta peptide/scFv-h3D6 complex extruded from large neurons by phagocytic cells was the mechanism underlying A beta peptide withdrawal. The mechanism of action of scFv-h3D6 demonstrates the effectivity of A beta-immunotherapy and lays the background for other studies focused on the finding of a treatment for AD.	[Esquerda-Canals, Gisela; Villegas, Sandra] Univ Autonoma Barcelona, Unitat Biociencies, Dept Bioquim & Biol Mol, Prot Design & Immunotherapy Grp, Cerdanyola Del Valles, Spain; [Esquerda-Canals, Gisela; Marti-Clua, Joaquim] Univ Autonoma Barcelona, Unitat Citol & Histol, Dept Biol Cellular Fisiol & Immunol, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Villegas, S (corresponding author), Univ Autonoma Barcelona, Unitat Biociencies, Dept Bioquim & Biol Mol, Prot Design & Immunotherapy Grp, Cerdanyola Del Valles, Spain.	sandra.villegas@uab.cat	Villegas, Sandra/ABF-8206-2021; Villegas, Sandra/D-8789-2011	Villegas, Sandra/0000-0001-8644-4304; Villegas, Sandra/0000-0001-8644-4304	Instituto de Salud Carlos III [FIS-PI113-01330]; Ministerio de Economia, Industria y Competitividad (MINECO) [SAF2017-89613]; Generalitat de Catalunya [2014-PROD00032]; FEDER; PIF-UAB student grant	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia, Industria y Competitividad (MINECO)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); FEDER(European Commission); PIF-UAB student grant	SV received grants from the Instituto de Salud Carlos III [FIS-PI113-01330], the Ministerio de Economia, Industria y Competitividad (MINECO) [SAF2017-89613], & the Generalitat de Catalunya [2014-PROD00032], all three co-funded by FEDER. GEC received a PIF-UAB student grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BENET LZ, 1984, EUR J RESPIR DIS, V65, P45; Boado RJ, 2010, BIOTECHNOL BIOENG, V105, P627, DOI 10.1002/bit.22576; Carroll JC, 2010, BRAIN RES, V1366, P233, DOI 10.1016/j.brainres.2010.10.009; Das P, 2003, J NEUROSCI, V23, P8532; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Esquerda-Canals G, 2017, J ALZHEIMERS DIS, V59, P1079, DOI 10.3233/JAD-170218; Esquerda-Canals G, 2013, MABS-AUSTIN, V5, P660, DOI 10.4161/mabs.25428; Fernandez-Funez P, 2015, HUM MOL GENET, V24, P6093, DOI 10.1093/hmg/ddv321; Franklin K. B. J., 2012, MOUSE BRAIN STEREOTA; Frenkel D, 2000, P NATL ACAD SCI USA, V97, P11455, DOI 10.1073/pnas.97.21.11455; Fuller JP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00235; Garcia-Cabezas MA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00107; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Gimenez-Llort L, 2013, MABS-AUSTIN, V5, P665, DOI 10.4161/mabs.25424; Guell-Bosch J., 2017, DIAGNOSTIC MONITORIT; Guell-Bosch J, 2016, FRONT CLIN DRUG RES, V4, P3; Guell-Bosch J, 2016, NEURODEGENER DIS MAN, V6, P179, DOI 10.2217/nmt-2016-0006; Harrison JR, 2016, BRIT J PSYCHIAT, V208, P1, DOI 10.1192/bjp.bp.115.167569; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Huang L, 2013, INT J MOL SCI, V14, P19109, DOI 10.3390/ijms140919109; Iwata A, 2013, NEUROL CLIN NEUROSCI, V1, P49, DOI 10.1002/ncn3.20; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kou JH, 2011, J ALZHEIMERS DIS, V27, P23, DOI 10.3233/JAD-2011-110230; Lai Aaron Y, 2010, Int J Alzheimers Dis, V2011, P548380, DOI 10.4061/2011/548380; Lee G, 2015, MOL CELLS, V38, P773, DOI 10.14348/molcells.2015.0073; Maier WE, 1997, NEUROCHEM INT, V30, P385, DOI 10.1016/S0197-0186(96)00073-3; Manoutcharian K, 2017, CURR NEUROPHARMACOL, V15, P779, DOI 10.2174/1570159X01666160930121647; Marin-Argany M, 2011, BIOCHEM J, V437, P25, DOI 10.1042/BJ20101712; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Monnier PP, 2013, ANTIBODIES, V2, P193, DOI 10.3390/antib2020193; Montoliu-Gaya L, 2018, BIOCHEM PHARMACOL, V155, P380, DOI 10.1016/j.bcp.2018.07.012; Montoliu-Gaya L, 2017, AMYLOID, V24, P167, DOI 10.1080/13506129.2017.1348347; Montoliu-Gaya L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181480; Montoliu-Gaya L, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.11; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Panza F, 2012, IMMUNOTHERAPY-UK, V4, P213, DOI [10.2217/IMT.11.170, 10.2217/imt.11.170]; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Ramm K, 1999, J MOL BIOL, V290, P535, DOI 10.1006/jmbi.1999.2854; Rivera-Hernandez G, 2013, MABS-AUSTIN, V5, P678, DOI 10.4161/mabs.25382; Robert R, 2012, ARCH BIOCHEM BIOPHYS, V526, P132, DOI 10.1016/j.abb.2012.02.022; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Wang YJ, 2009, NEUROBIOL AGING, V30, P364, DOI 10.1016/j.neurobiolaging.2007.06.013; Watt AD, 2014, ACTA NEUROPATHOL, V127, P803, DOI 10.1007/s00401-014-1290-2; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wisniewski T, 2014, BIOCHEM PHARMACOL, V88, P499, DOI 10.1016/j.bcp.2013.12.020; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217793	10.1371/journal.pone.0217793	http://dx.doi.org/10.1371/journal.pone.0217793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150495	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100112
J	Mokhber, M; Shahrbabak, MM; Sadeghi, M; Shahrbabak, HM; Stella, A; Nicolzzi, E; Williams, JL				Mokhber, Mahdi; Shahrbabak, Mohammad Moradi; Sadeghi, Mostafa; Shahrbabak, Hossein Moradi; Stella, Alessandra; Nicolzzi, Ezequiel; Williams, John L.			Study of whole genome linkage disequilibrium patterns of Iranian water buffalo breeds using the Axiom Buffalo Genotyping 90K Array	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; CATTLE; PREDICTION; SELECTION; PHASE; DNA	Accuracy of genome-wide association studies, and the successful implementation of genomic selection depends on the level of linkage disequilibrium (LD) across the genome and also the persistence of LD phase between populations. In the present study LD between adjacent SNPs and LD decay between SNPs was calculated in three Iranian water buffalo populations. Persistence of LD phase was evaluated across these populations and effective population size (Ne) was estimated from corrected r(2) information. A set of 404 individuals from three Iranian buffalo populations were genotyped with the Axiom Buffalo Genotyping 90K Array. Average r(2) and vertical bar D'vertical bar between adjacent SNP pairs across all chromosomes was 0.27 and 0.66 for AZI, 0.29 and 0.68 for KHU, and 0.32 and 0.72 for MAZ. The LD between the SNPs decreased with increasing physical distance from 100Kb to 1Mb between markers, from 0.234 to 0.018 for AZI, 0.254 to 0.034 for KHU, and 0.297 to 0.119 for MAZ, respectively. These results indicate that a density of 90K SNP is sufficient for genomic analyses relying on long range LD (e.g. GWAS and genomic selection). The persistence of LD phase decreased with increasing marker distances across all the populations, but remained above 0.8 for AZI and KHU for marker distances up to 100Kb. For multi-breed genomic evaluation, the 90K SNP panel is suitable for AZI and KHU buffalo breeds. Estimated effective population sizes for AZI, KHU and MAZ were 477, 212 and 32, respectively, for recent generations. The estimated effective population sizes indicate that the MAZ is at risk and requires careful management.	[Mokhber, Mahdi] Urmia Univ, Fac Agr, Dept Anim Sci, Orumiyeh, Iran; [Shahrbabak, Mohammad Moradi; Sadeghi, Mostafa; Shahrbabak, Hossein Moradi] Univ Tehran, Univ Coll Agr & Nat Resources UTCAN, Fac Agr Sci & Engn, Dept Anim Sci, Karaj, Iran; [Stella, Alessandra; Nicolzzi, Ezequiel] Fdn Parco Tecnol Padano, Lodi, Italy; [Williams, John L.] Univ Adelaide, Sch Anim & Vet Sci, Davies Res Ctr, Roseworthy, SA, Australia	Urmia University; University of Tehran; University of Adelaide	Mokhber, M (corresponding author), Urmia Univ, Fac Agr, Dept Anim Sci, Orumiyeh, Iran.	m.mokhber@urmia.ac.ir	Mokhber, Mahdi/AHC-3549-2022; Stella, Alessandra/AAY-7322-2020; stella, Alessandra/ABB-1952-2021; mokhber, mahdi/AAD-1763-2022; Moradi Shahrbabak, Mohammad/AFQ-9131-2022; stella, Alessandra/AAG-6401-2021	stella, Alessandra/0000-0003-2850-3964; mokhber, mahdi/0000-0002-7184-8426; stella, Alessandra/0000-0003-2850-3964; Williams, John/0000-0001-5188-7957	Iran's Ministry of Agriculture-Jahad [2014-800/91/20, 2014-888, 2014-1049, 2014-92/487, 2014-289, 2014-91/120/1771]; Iranian Buffalo Genomics project; Towsee Kesht va Dam Noandish Alborz Co (Takdna)	Iran's Ministry of Agriculture-Jahad; Iranian Buffalo Genomics project; Towsee Kesht va Dam Noandish Alborz Co (Takdna)	This study was supported by Iranian Buffalo Genomics project with 2014-800/91/20, 2014-888, 2014-1049, 2014-92/487, 2014-289 and 2014-91/120/1771 research grants from Iran's Ministry of Agriculture-Jahad, and Towsee Kesht va Dam Noandish Alborz Co (Takdna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts CC, 2010, GENET MOL RES, V9, P2429, DOI 10.4238/vol9-4gmr1027; Amaral MEJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-631; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bellwood P, 2007, CAMB ARCHAEOL J, V17, P87, DOI 10.1017/S0959774307000078; Bibi F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-50; Biegelmeyer P, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0339-8; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bohmanova J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-421; Borquis RRA, 2014, GENET MOL RES, V13, P4202, DOI 10.4238/2014.June.9.6; Bradley DG, 1999, GENETICS OF CATTLE, P15; Brito LF, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0220-1; Bush WS, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-7; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Calus MP, 2009, BIOMED CENTRAL, P1; Cardoso D, 2015, P 10 WORLD C GEN APP; Colli L, 2018, FRONTIERS GENETICS, V9; Colli L., 2016, WATER BUFFALO GENOMI; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Espigolan R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-305; Flury C, 2010, J ANIM BREED GENET, V127, P339, DOI 10.1111/j.1439-0388.2010.00862.x; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Iamartino D, 2013, BUFFALO GENOME APPL, P151; Iamartino D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185220; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Kierstein G, 2004, MOL PHYLOGENET EVOL, V30, P308, DOI 10.1016/S1055-7903(03)00221-5; LEWONTIN RC, 1964, GENETICS, V49, P49; MAIJALA K, 1992, FAO ANIM PR, V104, P73; Marques E, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-45; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Meuwissen T, 2009, ACTA AGR SCAND A-AN, V59, P71, DOI 10.1080/09064700903118148; Meuwissen THE, 2001, GENETICS, V157, P1819; Mokhber M., 2015, IRANIAN J ANIMAL SCI, V46, P119; Mokhber M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4759-x; Mokry FB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S6; Nagarajan M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-68; Nicolazzi EL, 2014, BIOINFORMATICS, V30, P3118, DOI 10.1093/bioinformatics/btu486; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Przeworski M, 2002, GENETICS, V160, P1179; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Schrooten C, 2000, J DAIRY SCI, V83, P795, DOI 10.3168/jds.S0022-0302(00)74942-3; Silva C, 2010, EXTENT LINKAGE DISEQ; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Stephan W, 2006, GENETICS, V172, P2647, DOI 10.1534/genetics.105.050179; SVED J A, 1971, Theoretical Population Biology, V2, P125; Teare MD, 2002, ANN HUM GENET, V66, P223, DOI 10.1017/S0003480002001082; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Yindee M, 2010, ANIM GENET, V41, P433, DOI 10.1111/j.1365-2052.2010.02020.x	59	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217687	10.1371/journal.pone.0217687	http://dx.doi.org/10.1371/journal.pone.0217687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150486	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100086
J	Nita, A; Hartel, T; Manolache, S; Ciocanea, CM; Miu, IV; Rozylowicz, L				Nita, Andreea; Hartel, Tibor; Manolache, Steluta; Ciocanea, Cristiana M.; Miu, Iulia, V; Rozylowicz, Laurentiu			Who is researching biodiversity hotspots in Eastern Europe? A case study on the grasslands in Romania	PLOS ONE			English	Article							COAUTHORSHIP NETWORKS; WOOD-PASTURES; CONSERVATION; POLICY; ABANDONMENT; PERSPECTIVE; DIVERSITY; CLUSTERS; THREAT; PLANT	European farmlands are vital arenas for socio-ecological sustainability because of their significant land coverage and potential for integrating food production with biodiversity conservation. The knowledge produced by scientific research is a critical ingredient in developing and implementing socio-economically and ecologically sustainable management strategies for farming landscapes. The grasslands of Europe have been managed for millennia. They have exceptional socio-cultural and economic value and are among the most biodiverse ecosystems in the world. The quality of scientific knowledge on them and its potential to address grasslands as complex socio-ecological systems is strongly dependent not only on the creativity and scientific ambition of the researcher, but also on the network around the researcher (including both academic and non-academic sectors). The goal of this study is to map the research network around Romania's grasslands using bibliometrics analysis, a well-developed scientific domain that utilizes network theory to analyze relationships between affiliations networks, co-authorship networks, and co-word analysis. The number of studies targeting grasslands in Romania is increasing, owing mostly to international involvement. However, management of the grasslands is still deficient and the contribution of science to the process is virtually absent. The current research is mainly related to the biological and ecological characteristics of grasslands, with topics related to their management notably absent from internationally visible research, especially in the context of EU Common Agricultural Policies. To increase scientific inquiry and better inform the EU and local policies on grasslands management, Romanian researchers should capitalize on international collaborations and local academic leaders. Our findings can be used to identify research gaps and to improve collaboration and knowledge exchange between practitioners, researchers, policy makers, and stakeholders.	[Nita, Andreea; Hartel, Tibor; Manolache, Steluta; Ciocanea, Cristiana M.; Miu, Iulia, V; Rozylowicz, Laurentiu] Univ Bucharest, Ctr Environm Res & Impact Studies, Bucharest, Romania; [Hartel, Tibor] Babes Bolyai Univ, Dept Biol & Ecol Hungarian, Cluj Napoca, Romania; [Hartel, Tibor] Babes Bolyai Univ, Ctr Syst Biol Biodivers & Bioresources, Cluj Napoca, Romania; [Rozylowicz, Laurentiu] Chelonia Romania, Bucharest, Romania	University of Bucharest; Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Nita, A (corresponding author), Univ Bucharest, Ctr Environm Res & Impact Studies, Bucharest, Romania.	andreea.nita@cc.unibuc.ro	Miu, Iulia Viorica/U-4431-2017; Tibor, Hartel/B-3440-2012; CIOCANEA, CRISTIANA M/E-4859-2017; Nita, Andreea/W-2056-2018; Rozylowicz, Laurentiu/B-4540-2009; Nita, Andreea/AAY-6874-2021	Miu, Iulia Viorica/0000-0002-5060-537X; CIOCANEA, CRISTIANA M/0000-0001-6060-2749; Nita, Andreea/0000-0002-0661-608X; Rozylowicz, Laurentiu/0000-0001-7174-032X; Nita, Andreea/0000-0002-0661-608X; Hartel, Tibor/0000-0002-0469-8923	Romanian National Authority for Scientific Research [PN-III-P4-ID-PCE-2016-0483]	Romanian National Authority for Scientific Research	This work was supported by a grant of the Romanian National Authority for Scientific Research (https://uefiscdi.gov.ro), PN-III-P4-ID-PCE-2016-0483. The work of T. H. is also a contribution to the ERA-FACCE-STACCATO-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, INFORM PROCESS MANAG, V48, P671, DOI 10.1016/j.ipm.2011.09.001; Abson DJ, 2017, AMBIO, V46, P30, DOI 10.1007/s13280-016-0800-y; [Anonymous], 2005, INTRO SOCIAL NETWORK; Azadi H, 2018, INT J DISAST RISK RE, V31, P184, DOI 10.1016/j.ijdrr.2018.05.003; Babai D, 2014, AGR ECOSYST ENVIRON, V182, P123, DOI 10.1016/j.agee.2013.08.018; Balvanera P, 2017, ECOL SOC, V22, DOI 10.5751/ES-08826-220114; Barabasi A.-L., 2016, NETWORK SCI; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j.biocon.2006.04.018; Benton T, 2011, NATURE, V480, P39, DOI 10.1038/480039d; Borgatti S. P., 2018, ANAL SOCIAL NETWORK; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Borgatti S. P., 2002, NETDRAW SOFTWARE NET; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Campos-Arceiz A, 2015, BIOL CONSERV, V186, P22, DOI 10.1016/j.biocon.2015.02.025; Chen CM, 2010, J AM SOC INF SCI TEC, V61, P1386, DOI 10.1002/asi.21309; Cobo MJ, 2011, J AM SOC INF SCI TEC, V62, P1382, DOI 10.1002/asi.21525; Cremene C, 2005, CONSERV BIOL, V19, P1606, DOI 10.1111/j.1523-1739.2005.00084.x; David D, 2018, NATURE, V560, P167, DOI 10.1038/d41586-018-05876-6; Ding Y., 2014, SPSS 211 UYGULAMALI; Dorresteijn Ine, 2015, Ecosystem Health and Sustainability, V1, DOI 10.1890/EHS15-0021.1; Dotsika F, 2017, TECHNOL FORECAST SOC, V119, P114, DOI 10.1016/j.techfore.2017.03.020; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Flor M., CREATING D3 CHORD DI; Gazni A, 2012, J AM SOC INF SCI TEC, V63, P323, DOI 10.1002/asi.21688; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Granieri M., 2012, INNOVATION LAW POLIC; Halada L, 2011, BIODIVERS CONSERV, V20, P2365, DOI 10.1007/s10531-011-9989-z; Hancean MG, 2016, SCI REP-UK, V6, DOI 10.1038/srep36152; Hancean MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113271; Hanspach J, 2014, ECOL SOC, V19, DOI 10.5751/ES-06915-190432; Hartel T, 2018, RANGELAND ECOL MANAG, V71, P536, DOI 10.1016/j.rama.2018.03.006; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Kozak M, 2015, SCIENTOMETRICS, V102, P1101, DOI 10.1007/s11192-014-1439-8; Lescourret F, 2015, CURR OPIN ENV SUST, V14, P68, DOI 10.1016/j.cosust.2015.04.001; Leydesdorff L, 2004, J DOC, V60, P371, DOI 10.1108/00220410410548144; Lomba A, 2014, J ENVIRON MANAGE, V143, P140, DOI 10.1016/j.jenvman.2014.04.029; Manolache S., 2017, EUR J GEOGR, V8, P24; Michielsen M, 2017, APPL VEG SCI, V20, P388, DOI 10.1111/avsc.12300; Miclauș Mihai, 2018, Nature, V558, P189, DOI 10.1038/d41586-018-05390-9; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Patru-Stupariu I, 2017, ECOL INDIC, V80, P363, DOI 10.1016/j.ecolind.2017.05.010; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Peringer A, 2017, ECOL MODEL, V359, P301, DOI 10.1016/j.ecolmodel.2017.06.012; Plieninger T, 2015, BIOL CONSERV, V190, P70, DOI 10.1016/j.biocon.2015.05.014; Plieninger T, 2013, ECOL SOC, V18, DOI 10.5751/ES-05877-180420; Popescu VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113648; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Roellig M, 2018, RANGELAND ECOL MANAG, V71, P526, DOI 10.1016/j.rama.2018.04.004; Rozylowicz L, 2017, J NAT CONSERV, V38, P21, DOI 10.1016/j.jnc.2017.05.005; Ruprecht E, 2006, RESTOR ECOL, V14, P473, DOI 10.1111/j.1526-100X.2006.00155.x; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutcliffe LME, 2015, DIVERS DISTRIB, V21, P722, DOI 10.1111/ddi.12288; Torralba M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2176; Veen P, 2009, GRASSLANDS EUROPE; Wang J, 2016, RES POLICY, V45, P68, DOI 10.1016/j.respol.2015.09.003; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x	57	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217638	10.1371/journal.pone.0217638	http://dx.doi.org/10.1371/journal.pone.0217638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136635	gold, Green Published, Green Submitted			2022-12-26	WOS:000469224300053
J	Zhu, M; Chen, C; Wang, N; Tang, J; Bao, WX				Zhu, Ming; Chen, Chun; Wang, Nian; Tang, Jun; Bao, Wenxia			Gradually focused fine-grained sketch-based image retrieval	PLOS ONE			English	Article								This paper focuses on fine-grained image retrieval based on sketches. Sketches capture detailed information, but their highly abstract nature makes visual comparisons with images more difficult. In spite of the fact that the existing models take into account the fine-grained details, they can not accurately highlight the distinctive local features and ignore the correlation between features. To solve this problem, we design a gradually focused bilinear attention model to extract detailed information more effectively. Specifically, the attention model is to accurately focus on representative local positions, and then use the weighted bilinear coding to find more discriminative feature representations. Finally, the global triplet loss function is used to avoid oversampling or undersampling. The experimental results show that the proposed method outperforms the state-of-the-art sketch-based image retrieval methods.	[Zhu, Ming; Chen, Chun; Wang, Nian; Tang, Jun; Bao, Wenxia] Anhui Univ, Sch Elect & Informat Engn, Hefei, Anhui, Peoples R China	Anhui University	Wang, N (corresponding author), Anhui Univ, Sch Elect & Informat Engn, Hefei, Anhui, Peoples R China.	wn_xlb@ahu.edu.cn	zhu, ming/ABI-2777-2020		National Natural Science Foundation of China [61501003, 61772032, 61401001, 61672032]; National Key RD Project [SQ2018YFC080102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RD Project	This work was supported by the National Natural Science Foundation of China (No. 61501003; 61772032; 61401001; 61672032) to MZ. This work was also supported by the National Key R&D Project SQ2018YFC080102) to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarthi R., 2015, 2015 INT C INN INF E, P1, DOI DOI 10.1109/ICIIECS.2015.7192911; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Feng Z, 2018, CERAM INT, V44, P1059, DOI 10.1016/j.ceramint.2017.10.048; Feng Zheng, 2016, IJCAI, P2399; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hong S, 2005, P ANN INT IEEE EMBS, P6336; Jang SY, 2007, 9TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY: TOWARD NETWORK INNOVATION BEYOND EVOLUTION, VOLS 1-3, P502, DOI 10.1109/ICACT.2007.358404; Jiang T, 2017, IEEE IMAGE PROC, P3690; Kumar BGV, 2016, PROC CVPR IEEE, P5385, DOI 10.1109/CVPR.2016.581; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lei JJ, 2017, IEEE IMAGE PROC, P3685; Li K, 2017, IEEE T IMAGE PROCESS, V26, P5908, DOI 10.1109/TIP.2017.2745106; Lin TY, 2015, IEEE I CONF COMP VIS, P1449, DOI 10.1109/ICCV.2015.170; Liu SL, 2018, INFORM SCIENCES, V424, P235, DOI 10.1016/j.ins.2017.10.010; Matsui Y, 2014, IEEE IMAGE PROC, P3097, DOI 10.1109/ICIP.2014.7025626; Qin Zhou, ARXIV180308580; Saavedra JM, 2014, IEEE IMAGE PROC, P2998, DOI 10.1109/ICIP.2014.7025606; Saintas E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172140; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Seng WC, 2009, INTERNATIONAL CONFERENCE ON FUTURE COMPUTER AND COMMUNICATIONS, PROCEEDINGS, P412, DOI 10.1109/ICFCC.2009.112; Song JF, 2017, IEEE I CONF COMP VIS, P5552, DOI 10.1109/ICCV.2017.592; Song J, 2017, 2017 INTERNATIONAL CONFERENCE ON CULTURE AND COMPUTING (CULTURE AND COMPUTING), P127, DOI 10.1109/Culture.and.Computing.2017.20; Sun X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156327; Yu Q, 2016, PROC CVPR IEEE, P799, DOI 10.1109/CVPR.2016.93; [于谦 Yu Qian], 2015, [高分子通报, Polymer Bulletin], P1; Zhang H., 2017, 2017 IEEE VISUAL COM, P1; Zhang YT, 2016, IEEE T MULTIMEDIA, V18, P1604, DOI 10.1109/TMM.2016.2568138; Zheng F, 2018, IEEE T IMAGE PROCESS, V27, P4302, DOI 10.1109/TIP.2018.2832462; Zhou Bing, 2010, 2010 International Conference on Computer Design and Applications (ICCDA 2010), P332, DOI 10.1109/ICCDA.2010.5540864	30	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217168	10.1371/journal.pone.0217168	http://dx.doi.org/10.1371/journal.pone.0217168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136610	Green Published, Green Submitted, gold			2022-12-26	WOS:000469224300021
J	Karunasinghe, N; Symes, E; Gamage, A; Wang, A; Murray, P; Zhu, ST; Goudie, M; Masters, J; Ferguson, LR				Karunasinghe, Nishi; Symes, Eva; Gamage, Amy; Wang, Alice; Murray, Pam; Zhu, Shuotun; Goudie, Megan; Masters, Jonathan; Ferguson, Lynnette R.			Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBON; ANDROGEN DEPRIVATION THERAPY; BODY-COMPOSITION; PRODRUG PR-104A; RISK; TESTOSTERONE; AKR1C3; GENE; MORTALITY; EXPOSURE	Introduction Aldo-keto reductase 1C3 (AKR1C3) is known for multiple functions including its catalytic activity towards producing extra-testicular androgen. The present study is towards understanding interaction between biological, lifestyle and genetic impacts of AKR1C3 and their influence on clinical factors in a prostate cancer (PC) cohort from New Zealand (NZ). Method Characteristics of 516 PC patients were collected from the Auckland Regional Urology Facility, NZ. These men were genotyped for the AKR1C3 rs12529 single nucleotide polymorphism (SNP). The leukocyte AKR1C3 activity was measured in a sub-cohort. Variability of leukocyte AKR1C3 activity between biological, lifestyle and clinical features as well as correlation between biological and clinical features were assessed with and without genetic stratification. Results The leukocyte AKR1C3 activity was associated with age at diagnosis (0.51 vs 0.34 mu M coumberol units for >69y vs. <= 69y, P = 0.03); and with anatomic stage/prognostic grouping among the AKR1C3 rs12529 CC genotype carriers (0.50 vs 28 mu M coumberol units among low-and high-risk groups respectively, P = 0.02). Significant correlation between leukocyte AKR1C3 activity and age at PC diagnosis was also observed (correlation coefficient 0.20 and P = 0.02). Ever-smoking impacted both age and PSA at PC diagnosis among AKR1C3 rs12529 GG and CG genotype carriers respectively. Age at diagnosis significantly correlated with PSA at diagnosis in the main (correlation coefficient 0.29, and P<0.001) and subcohorts (correlation coefficient 0.24, and P = 0.01); and those carrying the AKR1C3 rs12529 CG and GG genotypes in both the main (correlation coefficient 0.30, and P<0.001 and correlation coefficient 0.35, and P<0.001 respectively) and sub-cohorts (correlation coefficient 0.43, and P<0.001 and correlation coefficient 0.39, and P = 0.06 respectively); but not with those carrying the CC genotype. Conclusions Age dependent PSA thresholds in PC screening could have been valid only in men carrying the AKR1C3 rs12529 CG and GG genotypes in this NZ cohort.	[Karunasinghe, Nishi; Symes, Eva; Gamage, Amy; Wang, Alice; Murray, Pam; Zhu, Shuotun] Univ Auckland, ACSRC, FM&HS, Auckland, New Zealand; [Goudie, Megan; Masters, Jonathan] Auckland City Hosp, Urol Dept, Auckland, New Zealand; [Ferguson, Lynnette R.] Univ Auckland, FM&HS, Auckland, New Zealand	University of Auckland; Auckland City Hospital; University of Auckland	Karunasinghe, N (corresponding author), Univ Auckland, ACSRC, FM&HS, Auckland, New Zealand.	n.karunasinghe@auckland.ac.nz		Karunasinghe, Nishi/0000-0002-6383-4163	A+ Trust, Auckland District Health Board, Auckland, NZ [5461-PG-1204-007]; GoodFellow Trust, Urology Department, Auckland Hospital, Auckland, NZ [+3192]; Cancer Society NZ [10/08]	A+ Trust, Auckland District Health Board, Auckland, NZ; GoodFellow Trust, Urology Department, Auckland Hospital, Auckland, NZ; Cancer Society NZ	Authors wish to acknowledge the following grantees from New Zealand for their support with the study since 2006 -the A+ Trust, Auckland District Health Board, Auckland, NZ (Grant No. 5461-PG-1204-007-JM), the GoodFellow Trust, Urology Department, Auckland Hospital, Auckland, NZ (Grant No. +3192-JM), the Cancer Society NZ (https://cancernz.org.nz/) (Grant No. 10/08-LRF); and the Auckland Northland Cancer Society, NZ (https://auckland-northland.cancernz.org.nz/) (NK). Funders played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Bastian PJ, 2012, EUR UROL, V61, P1096, DOI 10.1016/j.eururo.2012.02.031; Byrns MC, 2012, J STEROID BIOCHEM, V130, P7, DOI 10.1016/j.jsbmb.2011.12.012; Colli-Dula RC, 2018, AQUAT TOXICOL, V201, P162, DOI 10.1016/j.aquatox.2018.06.005; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Fan L, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201500019; Ferguson Lynnette R., 2012, Current Pharmacogenomics & Personalized Medicine, V10, P204; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P108, DOI 10.1016/j.mrfmmm.2010.01.017; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fleshner K, 2017, NAT REV UROL, V14, P26, DOI 10.1038/nrurol.2016.251; Flowers L, 1996, BIOCHEMISTRY-US, V35, P13664, DOI 10.1021/bi961077w; Flowers L, 1997, BIOCHEMISTRY-US, V36, P8640, DOI 10.1021/bi970367p; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Haseen F, 2010, J CANCER SURVIV, V4, P128, DOI 10.1007/s11764-009-0114-1; Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475; Ishizaki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01528; Islami F, 2014, EUR UROL, V66, P1054, DOI 10.1016/j.eururo.2014.08.059; Jakobsson J, 2007, PHARMACOGENOMICS J, V7, P282, DOI 10.1038/sj.tpj.6500419; Jamieson SMF, 2014, BIOCHEM PHARMACOL, V88, P36, DOI 10.1016/j.bcp.2013.12.019; Karunasinghe N, 2015, SCI CANC HLTH DISPAR; Karunasinghe N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199122; Karunasinghe N, 2017, CURR CANCER DRUG TAR, V17, P603, DOI 10.2174/1568009617666170330115722; Karunasinghe N, 2016, BMC UROL, V16, DOI 10.1186/s12894-016-0164-4; Karunasinghe Nishi, 2013, Current Pharmacogenomics & Personalized Medicine, V11, P22; Karunasinghe N, 2012, J NUTRIGENET NUTRIGE, V5, P339, DOI 10.1159/000346279; Karunasinghe N, 2012, GENES NUTR, V7, P179, DOI 10.1007/s12263-011-0259-1; Kim DK, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010113; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Malhotra R, 2013, OBESITY, V21, P1923, DOI 10.1002/oby.20318; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Merriel SWD, 2018, ADV THER, V35, P1285, DOI 10.1007/s12325-018-0766-1; Ministry-of-Health, 2015, CANC NEW REG DEATHS; Nakamura Y, 2009, J CLIN ENDOCR METAB, V94, P2192, DOI 10.1210/jc.2008-2374; Nnabugwu II, 2016, CLIN INTERV AGING, V11, DOI 10.2147/CIA.S98232; O'Reilly MW, 2017, J CLIN ENDOCR METAB, V102, P3327, DOI 10.1210/jc.2017-00947; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Palermo A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060544; Powell K, 2015, CLIN CANCER RES, V21, P2569, DOI 10.1158/1078-0432.CCR-14-2352; Ricciuti A, 2016, J CLIN ENDOCR METAB, V101, P1535, DOI 10.1210/jc.2016-1016; RUBENS R, 1974, J CLIN ENDOCR METAB, V39, P40, DOI 10.1210/jcem-39-1-40; Rybicki BA, 2008, CLIN CANCER RES, V14, P750, DOI 10.1158/1078-0432.CCR-07-0986; Sausville LN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180471; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schulze JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00151; Silventoinen K, 2017, AM J CLIN NUTR, V106, P457, DOI 10.3945/ajcn.117.153643; St Helen G, 2012, CHEM RES TOXICOL, V25, P952, DOI 10.1021/tx300043k; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Tian YT, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-42; Vaidyanathan V, 2017, MOL BIOSYSTEMS, V2017; Vaidyanathan V, 2017, MOL BIOSYST; van Londen GJ, 2008, CRIT REV ONCOL HEMAT, V68, P172, DOI 10.1016/j.critrevonc.2008.06.006; Verma K, 2018, MOL CANCER THER, V17, P1833, DOI 10.1158/1535-7163.MCT-17-1023; Vogt TM, 2003, INT J CANCER, V103, P664, DOI 10.1002/ijc.10866; Wang A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1843-3; Wang JH, 2007, J STEROID BIOCHEM, V107, P100, DOI 10.1016/j.jsbmb.2007.02.009; White DB, 2004, B MAR SCI, V75, P335; Yarney J, 2013, UROL ONCOL-SEMIN ORI, V31, P325, DOI 10.1016/j.urolonc.2011.01.018; Yepuru M, 2013, CLIN CANCER RES, V19, P5613, DOI 10.1158/1078-0432.CCR-13-1151; Yu CC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056667, 10.1371/journal.pone.0054627]	62	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217373	10.1371/journal.pone.0217373	http://dx.doi.org/10.1371/journal.pone.0217373			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125365	Green Published, Green Submitted, gold			2022-12-26	WOS:000468865700033
J	Lee, HI; Lee, J; Hwang, D; Lee, GR; Kim, N; Kwon, M; Lee, H; Piao, D; Kim, HJ; Kim, NY; Kim, HS; Seo, EK; Kang, D; Jeong, W				Lee, Hye In; Lee, Jiae; Hwang, Donghyun; Lee, Gong-Rak; Kim, Narae; Kwon, Minjeong; Lee, Hana; Piao, Donglan; Kim, Hyun Jin; Kim, Nam Young; Kim, Han Sung; Seo, Eun Kyoung; Kang, Dongmin; Jeong, Woojin			Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome function	FASEB JOURNAL			English	Article						bone; integrin; PKC-beta; Atg5	TYROSINE PHOSPHORYLATION; NUCLEAR FACTOR; BONE LOSS; T-CELLS; PROLIFERATION; DYSFUNCTION; BIOGENESIS; MECHANISMS; EXPRESSION; PROTEINS	Excessive osteoclast activity can lead to an imbalance between the synthesis and breakdown of bone, with pathologic consequences that include osteoporosis and periodontitis. Thus, controlling osteoclast differentiation and function has significant therapeutic implications. In this study, we investigated the effects of dehydrocostus lactone (DL) on osteoclast differentiation and activation and elucidated the possible mechanisms underlying these processes. DL suppressed osteoclast differentiation by reducing the expression of the nuclear factor of activated T-cells, cytoplasmic 1. When used to challenge differentiated osteoclasts, DL also effectively inhibited their enlargement and resorption activity, and biochemical approaches revealed that DL attenuates osteoclast activation by inhibiting the migration and lysosome biogenesis and secretion via the down-regulation of integrin beta(3), PKC-beta, and autophagy related 5 expression. Furthermore, DL prevented bone destruction in inflammation- and ovariectomy-induced osteolytic mouse models. These results indicate that DL has therapeutic potential to treat bone diseases caused by excessive or hyperactive osteoclasts.-Lee, H. I., Lee, J., Hwang, D., Lee, G.-R., Kim, N., Kwon, M., Lee, H., Piao, D., Kim, H. J., Kim, N. Y., Kim, H. S., Seo, E. K., Kang, D., Jeong, W. Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome function.	[Lee, Hye In; Lee, Jiae; Lee, Gong-Rak; Kim, Narae; Kwon, Minjeong; Kim, Hyun Jin; Kim, Nam Young; Kang, Dongmin; Jeong, Woojin] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Piao, Donglan; Seo, Eun Kyoung] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Hwang, Donghyun; Lee, Hana; Kim, Han Sung] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea	Ewha Womans University; Ewha Womans University; Yonsei University	Jeong, W (corresponding author), Ewha Womans Univ, Sci Bldg C,Room 211,52 Ewhayeodae Gil, Seoul 03760, South Korea.	jeongw@ewha.ac.kr		Kang, Dongmin/0000-0001-5997-625X; Lee, Hana/0000-0003-0481-0660	National Research Foundation (NRF) - Korean Ministry of Science, ICT, and Future Planning (MSIP) [2017R1A2B2012435, 2012R1A5A1048236, 2019R1C1C1011198, 2018R1D1A1A02049371]	National Research Foundation (NRF) - Korean Ministry of Science, ICT, and Future Planning (MSIP)	This work was supported by the National Research Foundation (NRF) Grants (2017R1A2B2012435, 2012R1A5A1048236, 2019R1C1C1011198, and 2018R1D1A1A02049371) funded by the Korean Ministry of Science, ICT, and Future Planning (MSIP). The authors declare no conflicts of interest.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cai H, 2017, J CELL BIOCHEM, V118, P3381, DOI 10.1002/jcb.25994; Choi EM, 2011, EUR J PHARMACOL, V664, P1, DOI 10.1016/j.ejphar.2011.05.005; Choi EM, 2009, TOXICOL IN VITRO, V23, P862, DOI 10.1016/j.tiv.2009.05.005; Chung YH, 2012, INT J BIOCHEM CELL B, V44, P989, DOI 10.1016/j.biocel.2012.03.007; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Dong GZ, 2015, PHYTOTHER RES, V29, P680, DOI 10.1002/ptr.5299; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hong SE, 2017, FREE RADICAL BIO MED, V112, P191, DOI 10.1016/j.freeradbiomed.2017.07.030; Jeong GS, 2007, EUR J PHARMACOL, V565, P37, DOI 10.1016/j.ejphar.2007.02.053; Jiang EP, 2015, INT J GYNECOL CANCER, V25, P1179, DOI 10.1097/IGC.0000000000000474; Kim EJ, 2012, J MED FOOD, V15, P24, DOI 10.1089/jmf.2011.1735; Kim H, 2013, J IMMUNOL, V190, P1312, DOI 10.4049/jimmunol.1202525; Lacombe J, 2013, CELL CYCLE, V12, P2744, DOI 10.4161/cc.25825; Lee J, 2019, FASEB J, V33, P2026, DOI 10.1096/fj.201800866RR; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Nagai Y, 2013, J BONE MINER RES, V28, P2449, DOI 10.1002/jbmr.1936; Nakamura I, 1998, J BIOL CHEM, V273, P11144, DOI 10.1074/jbc.273.18.11144; Park EJ, 2014, INT IMMUNOPHARMACOL, V22, P332, DOI 10.1016/j.intimp.2014.07.012; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rodan SB, 1997, J ENDOCRINOL, V154, pS47; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Seo MS, 2012, IMMUNOPHARM IMMUNOT, V34, P810, DOI 10.3109/08923973.2012.657799; SHINAR DM, 1993, J BONE MINER RES, V8, P403; Sun XW, 2015, ANTI-CANCER DRUG, V26, P641, DOI 10.1097/CAD.0000000000000229; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang JK, 2017, AM J CANCER RES, V7, P1270	37	16	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9685	9694		10.1096/fj.201900862R	http://dx.doi.org/10.1096/fj.201900862R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31145860	Bronze			2022-12-26	WOS:000478832900076
J	Pazdernik, M; Mares, J; Pilny, J; Sobotka, R				Pazdernik, Marek; Mares, Jan; Pilny, Jan; Sobotka, Roman			The antenna-like domain of the cyanobacterial ferrochelatase can bind chlorophyll and carotenoids in an energy-dissipative configuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant biochemistry; photosynthetic pigment; photosynthesis; chloroplast; membrane protein; heme; carotenoid; chlorophyll; ferrochelatase; light harvesting complex (LHC)-like proteins; pigment binding; Synechocystis	LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II COMPLEX; SYNECHOCYSTIS PCC 6803; TETRAPYRROLE BIOSYNTHESIS; INDUCIBLE PROTEINS; CHELATASE ACTIVITY; LIL3; PHOTOPROTECTION; SUPERFAMILY; EXPRESSION	Ferrochelatase (FeCh) is an essential enzyme catalyzing the synthesis of heme. Interestingly, in cyanobacteria, algae, and plants, FeCh possesses a conserved transmembrane chlorophyll a/b binding (CAB) domain that resembles the first and the third helix of light-harvesting complexes, including a chlorophyll-binding motif. Whether the FeCh CAB domain also binds chlorophyll is unknown. Here, using biochemical and radiolabeled precursor experiments, we found that partially inhibited activity of FeCh in the cyanobacterium Synechocystis PCC 6803 leads to overproduction of chlorophyll molecules that accumulate in the thylakoid membrane and, together with carotenoids, bind to FeCh. We observed that pigments bound to purified FeCh are organized in an energy-dissipative conformation and further show that FeCh can exist in vivo as a monomer or a dimer depending on its own activity. However, pigmented FeCh was purified exclusively as a dimer. Separately expressed and purified FeCH CAB domain contained a pigment composition similar to that of full-length FeCh and retained its quenching properties. Phylogenetic analysis suggested that the CAB domain was acquired by a fusion between FeCh and a single-helix, high light-inducible protein early in the evolution of cyanobacteria. Following this fusion, the FeCh CAB domain with a functional chlorophyll-binding motif was retained in all currently known cyanobacterial genomes except for a single lineage of endosymbiotic cyanobacteria. Our findings indicate that FeCh from Synechocystis exists mostly as a pigment-free monomer in cells but can dimerize, in which case its CAB domain creates a functional pigment-binding segment organized in an energy-dissipating configuration.	[Pazdernik, Marek; Mares, Jan; Pilny, Jan; Sobotka, Roman] Czech Acad Sci, Ctr Algatech, Inst Microbiol, Novohradska 237, Trebon 37981, Czech Republic; [Pazdernik, Marek; Mares, Jan; Sobotka, Roman] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Mares, Jan] Czech Acad Sci, Biol Ctr, Inst Hydrobiol, Ceske Budejovice 37005, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Sobotka, R (corresponding author), Czech Acad Sci, Ctr Algatech, Inst Microbiol, Novohradska 237, Trebon 37981, Czech Republic.	sobotka@alga.cz	Mareš, Jan/B-2395-2009; Sobotka, Roman/J-3077-2014	Mareš, Jan/0000-0002-5745-7023; Pazdernik, Marek/0000-0002-6717-7121; Sobotka, Roman/0000-0001-5909-3879	Czech Science Foundation [17-08755S]; Czech Ministry of Education [LO1416]; University of South Bohemia [04-026/2017]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); University of South Bohemia	This work was supported by Czech Science Foundation Grant 17-08755S and Czech Ministry of Education Project LO1416. This work was also supported by University of South Bohemia Grant 04-026/2017 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamska I, 1999, EUR J BIOCHEM, V260, P453, DOI 10.1046/j.1432-1327.1999.00178.x; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Bucinska L, 2018, PLANT PHYSIOL, V176, P2931, DOI 10.1104/pp.18.00061; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Christodoulou D, 2018, CELL SYST, V6, P569, DOI 10.1016/j.cels.2018.04.009; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Crawford TS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01060; Czarnecki O, 2012, J EXP BOT, V63, P1675, DOI 10.1093/jxb/err437; Dailey HA, 2007, BIOCHEMISTRY-US, V46, P7973, DOI 10.1021/bi700151f; de Armas-Ricard M, 2011, BIOCHEM BIOPH RES CO, V405, P134, DOI 10.1016/j.bbrc.2011.01.013; Engelken J, 2012, ADV PHOTOSYNTH RESP, V33, P265, DOI 10.1007/978-94-007-1533-2_11; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Heddad M, 2012, ADV PHOTOSYNTH RESP, V34, P299, DOI 10.1007/978-94-007-1579-0_14; Hey D, 2018, PLANT PHYSIOL, V177, P1453, DOI 10.1104/pp.18.00540; Hey D, 2017, PLANT PHYSIOL, V174, P1037, DOI 10.1104/pp.17.00505; Hontani Y, 2018, J PHYS CHEM LETT, V9, P1788, DOI 10.1021/acs.jpclett.8b00663; HUANG LQ, 1990, PLANT PHYSIOL, V92, P172, DOI 10.1104/pp.92.1.172; Ikushiro H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32591-z; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kilian O, 2008, MOL PLANT, V1, P155, DOI 10.1093/mp/ssm019; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; Komenda J, 2016, BBA-BIOENERGETICS, V1857, P288, DOI 10.1016/j.bbabio.2015.08.011; Kopecna J, 2015, J BIOL CHEM, V290, P28477, DOI 10.1074/jbc.M115.664987; Koreny L, 2011, PLANT CELL, V23, P3454, DOI 10.1105/tpc.111.089102; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Llansola-Portoles MJ, 2017, J BIOL CHEM, V292, P1396, DOI 10.1074/jbc.M116.753723; Lohscheider JN, 2015, PLANT CELL ENVIRON, V38, P2115, DOI 10.1111/pce.12540; Mares J, 2018, HYDROBIOLOGIA, V811, P19, DOI 10.1007/s10750-017-3373-2; Masoumi A, 2008, MICROBIOL-SGM, V154, P3707, DOI 10.1099/mic.0.2008/018705-0; Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104; Medlock AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135896; Miller MA, 2015, EVOL BIOINFORM, V11, P43, DOI 10.4137/EBO.S21501; Mork-Jansson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133145; Myouga F, 2018, PLANT PHYSIOL, V176, P2277, DOI 10.1104/pp.17.01782; Neilson JAD, 2010, GENOME, V53, P68, DOI [10.1139/G09-081, 10.1139/g09-081]; Niedzwiedzki DM, 2016, BBA-BIOENERGETICS, V1857, P1430, DOI 10.1016/j.bbabio.2016.04.280; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Papenbrock J, 2001, PLANT J, V28, P41, DOI 10.1046/j.1365-313X.2001.01126.x; Papenbrock J, 2000, PLANT PHYSIOL, V122, P1161, DOI 10.1104/pp.122.4.1161; Papenbrock J, 2000, PLANT J, V22, P155, DOI 10.1046/j.1365-313x.2000.00724.x; Pilny J, 2015, BIOPROTOCOL, V5, pe1390, DOI DOI 10.21769/BI0PR0T0C.1390; Rast A, 2015, BBA-BIOENERGETICS, V1847, P821, DOI 10.1016/j.bbabio.2015.01.007; Reisinger V, 2008, FEBS LETT, V582, P1547, DOI 10.1016/j.febslet.2008.03.042; Rochaix JD, 2019, BIOCHEM J, V476, P581, DOI 10.1042/BCJ20180718; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanchez-Baracaldo P, 2017, P NATL ACAD SCI USA, V114, pE7737, DOI 10.1073/pnas.1620089114; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scharfenberg M, 2015, PLANT CELL ENVIRON, V38, P280, DOI 10.1111/pce.12248; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Shipovskov S, 2005, J MOL BIOL, V352, P1081, DOI 10.1016/j.jmb.2005.08.002; Shukla MK, 2018, PHOTOSYNTH RES, V137, P29, DOI 10.1007/s11120-017-0475-7; Sinha RK, 2012, PLANT CELL ENVIRON, V35, P806, DOI 10.1111/j.1365-3040.2011.02454.x; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2014, PHOTOSYNTH RES, V119, P223, DOI 10.1007/s11120-013-9797-2; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; Staleva H, 2015, NAT CHEM BIOL, V11, P287, DOI [10.1038/nchembio.1755, 10.1038/NCHEMBIO.1755]; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055569; Takahashi K, 2014, J BIOL CHEM, V289, P987, DOI 10.1074/jbc.M113.525428; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Terry MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00014; Tichy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00648; Uniacke J, 2007, PLANT CELL, V19, P3640, DOI 10.1105/tpc.107.054882; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Xiong W, 2017, PHOTOSYNTH RES, V131, P267, DOI 10.1007/s11120-016-0316-0; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yuan XJ, 2016, P NATL ACAD SCI USA, V113, pE5144, DOI 10.1073/pnas.1609865113; Zhao L, 2017, PLANT PHYSIOL, V174, P2419, DOI 10.1104/pp.16.01465; Zhou F, 2017, P NATL ACAD SCI USA, V114, P6866, DOI 10.1073/pnas.1705689114	76	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11131	11143		10.1074/jbc.RA119.008434	http://dx.doi.org/10.1074/jbc.RA119.008434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167780	Green Published, hybrid			2022-12-26	WOS:000478717400007
J	Guengerich, FP; Wilkey, CJ; Phan, TTN				Guengerich, F. Peter; Wilkey, Clayton J.; Phan, Thanh T. N.			Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; enzyme kinetics; pre-steady-state kinetics; steroid; enzyme mechanism; steroidogenesis; drug metabolism; conformational selection; CYP; induced fit; P450	INDUCED FIT; ESCHERICHIA-COLI; KINETIC-ANALYSIS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; MOLECULAR-WEIGHT; CAMPHOR BINDING; P-450 REDUCTASE; LIGAND-BINDING; OXIDATION	Cytochrome P450 (P450) enzymes are major catalysts involved in the oxidations of most drugs, steroids, carcinogens, fat-soluble vitamins, and natural products. The binding of substrates to some of the 57 human P450s and other mammalian P450s is more complex than a two-state system and has been proposed to involve mechanisms such as multiple ligand occupancy, induced-fit, and conformational-selection. Here, we used kinetic analysis of binding with multiple concentrations of substrates and computational modeling of these data to discern possible binding modes of several human P450s. We observed that P450 2D6 binds its ligand rolapitant in a mechanism involving conformational-selection. P450 4A11 bound the substrate lauric acid via conformational-selection, as did P450 2C8 with palmitic acid. Binding of the steroid progesterone to P450 21A2 was also best described by a conformational-selection model. Hexyl isonicotinate binding to P450 2E1 could be described by either a conformational-selection or an induced-fit model. Simulation of the binding of the ligands midazolam, bromocriptine, testosterone, and ketoconazole to P450 3A4 was consistent with an induced-fit or a conformational-selection model, but the concentration dependence of binding rates for varying both P450 3A4 and midazolam concentrations revealed discordance in the parameters, indicative of conformational-selection. Binding of the P450s 2C8, 2D6, 3A4, 4A11, and 21A2 was best described by conformational-selection, and P450 2E1 appeared to fit either mode. These findings highlight the complexity of human P450-substrate interactions and that conformational-selection is a dominant feature of many of these interactions.	[Guengerich, F. Peter; Wilkey, Clayton J.; Phan, Thanh T. N.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Phan, Thanh T. N.] Univ N Carolina, Dept Biochem & Biophys, Genet Med Bldg,Bay 3100F,120 Mason Farm Rd, Chapel Hill, NC 27599 USA	Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill	Guengerich, FP (corresponding author), 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Wilkey, Clayton/0000-0001-6062-1093	National Institutes of Health [R01 GM118122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM118122 (to F. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asciutto EK, 2012, BIOCHEMISTRY-US, V51, P3383, DOI 10.1021/bi300007r; BACKES WL, 1985, BIOCHEMISTRY-US, V24, P5130, DOI 10.1021/bi00340a026; Bart AG, 2018, J BIOL CHEM, V293, P19201, DOI 10.1074/jbc.RA118.005588; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Colthart AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22035; Dabrowski MJ, 2002, J AM CHEM SOC, V124, P11866, DOI 10.1021/ja027552x; Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; Fitch William L, 2009, Drug Metab Lett, V3, P191; Follmer AH, 2018, J AM CHEM SOC, V140, P16222, DOI 10.1021/jacs.8b09441; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; GILLAM EMJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P59, DOI 10.1006/abbi.1994.1280; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Glass SM, 2019, DRUG METAB DISPOS, V47, P567, DOI 10.1124/dmd.118.085928; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; Guengerich FP, 2019, J BIOL CHEM, V294, P10028, DOI 10.1074/jbc.RA119.008860; Guengerich FP, 2018, ACS CATAL, V8, P10964, DOI 10.1021/acscatal.8b03401; Guengerich FP, 2018, CHEM REV, V118, P6573, DOI 10.1021/acs.chemrev.8b00031; GUENGERICH FP, 1983, BIOCHEMISTRY-US, V22, P2811, DOI 10.1021/bi00281a007; Guengerich FP, 1996, CRIT REV TOXICOL, V26, P551, DOI 10.3109/10408449609037477; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; GUENGERICH FP, 1979, BIOCHEMISTRY-US, V18, P5442, DOI 10.1021/bi00591a029; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; HILDEBRA.A, 1968, BIOCHEM BIOPH RES CO, V30, P607, DOI 10.1016/0006-291X(68)90555-X; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Imai Y., 1978, CYTOCHROME P450, P37; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Johnson K. A., 2017, 12 NEW ENZ KIN WORKS, P23; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnson KM, 2017, J BIOL CHEM, V292, P13672, DOI 10.1074/jbc.M116.773937; Johnston WA, 2011, J BIOL CHEM, V286, P40750, DOI 10.1074/jbc.M111.300871; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; Kaur P, 2016, J MED CHEM, V59, P4210, DOI 10.1021/acs.jmedchem.5b01146; Kim D, 2014, BIOCHEMISTRY-US, V53, P6161, DOI 10.1021/bi500710e; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; MARDEN MC, 1987, ARCH BIOCHEM BIOPHYS, V253, P100, DOI 10.1016/0003-9861(87)90642-4; Menard A, 2012, CHEMBIOCHEM, V13, P2527, DOI 10.1002/cbic.201200524; MITANI F, 1969, J BIOCHEM-TOKYO, V66, P139, DOI 10.1093/oxfordjournals.jbchem.a129129; MITANI F, 1969, J BIOCHEM-TOKYO, V65, P269; Mueller Ernest J., 1995, P83; OHAVER TC, 1976, ANAL CHEM, V48, P312, DOI 10.1021/ac60366a016; OPRIAN DD, 1979, J BIOL CHEM, V254, P8895; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Parisi G, 2019, FASEB J, V33, P1787, DOI 10.1096/fj.201800450RR; Pearson JT, 2006, BIOCHEMISTRY-US, V45, P6341, DOI 10.1021/bi0600042; Peng CC, 2010, ARCH BIOCHEM BIOPHYS, V497, P68, DOI 10.1016/j.abb.2010.03.011; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Petrunak EM, 2017, DRUG METAB DISPOS, V45, P635, DOI 10.1124/dmd.117.075317; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Poulos T. L., 2015, CYTOCHROME P450 STRU, V4th, P3, DOI DOI 10.1007/978-3-319-12108-6_1; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; REMMER H, 1966, MOL PHARMACOL, V2, P187; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Rendic SP, 2018, DRUG METAB REV, V50, P256, DOI 10.1080/03602532.2018.1483401; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Scott E., 2018, 2018 INT M 22 MICR D; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Tang ZM, 2009, ANAL CHEM, V81, P3071, DOI 10.1021/ac900021a; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Vogt AD, 2014, BIOPHYS CHEM, V186, P13, DOI 10.1016/j.bpc.2013.09.003; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Walsh AA, 2013, J BIOL CHEM, V288, P12932, DOI 10.1074/jbc.M113.452953; Yao H, 2007, PROTEINS, V69, P125, DOI 10.1002/prot.21508; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029	93	26	26	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2019	294	28					10928	10941		10.1074/jbc.RA119.009305	http://dx.doi.org/10.1074/jbc.RA119.009305			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LM	31147443	Green Published, hybrid			2022-12-26	WOS:000478717200016
J	Lee, CF; Dang, A; Hernandez, E; Pong, RC; Chen, B; Sonavane, R; Raj, G; Kapur, P; Lin, HY; Wu, SR; Ko, CJ; Lo, UG; Lee, HY; Hsieh, JT; Lee, MS				Lee, Cheng-Fan; Dang, Andrew; Hernandez, Elizabeth; Pong, Rey-Chen; Chen, Benjamin; Sonavane, Rajni; Raj, Ganesh; Kapur, Payal; Lin, Hsin-Ying; Wu, Shang-Ru; Ko, Chun-Jung; Lo, U-Ging; Lee, Hsin-yu; Hsieh, Jer-Tsong; Lee, Ming-Shyue			Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase	ONCOGENE			English	Article							C-REACTIVE PROTEIN; NF-KAPPA-B; HUMAN OVARIAN-CANCER; GROWTH-FACTOR; MATRIPTASE ACTIVATION; SIGNALING PATHWAY; PLASMA-MEMBRANE; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; MIGRATION	Gram-negative bacteria have been found to be a major population in prostatitis and prostate cancer (PCa) tissues. Lipopolysaccharide (LPS), a major compound of Gram-negative bacteria, with stimulatory activities in some cancer types, but has not been fully studied in PCa. In this study, we examined the effect of LPS on the invasion of PCa cells. Interestingly, LPS can enhance the invasiveness of PCa, but had no significant effect on PCa cell viability. Using protease inhibitor screening and biochemical analyses, matriptase, a member of the membrane-anchored serine protease family, is found to play a key role in LPS-induced PCa cell invasion. Mechanistically, Toll-like receptor 4 (TLR4, LPS receptor)sphingosine kinase 1 (SphK1) signaling underlies LPS-induced matriptase activation and PCa cell invasion. Specifically, LPS induced the S225 phosphorylation of SphK1 and the translocation of SphK1 to plasma membrane, leading to the production of sphingosine 1-phosphate (S1P), ERK1/2 and matriptase activation via S1P receptor 4 (S1PR4). This phenomenon is further validated using the patient-derived explant (PDE) model. Indeed, there is a significant correlation among the elevated SphK1 levels, the Gleason grades of PCa specimens, and the poor survival of PCa patients. Taken together, this study demonstrates a potential impact of LPS on PCa progression. Our results provide not only a new finding of the role of bacterial infection in PCa progression but also potential therapeutic target(s) associated with PCa metastasis.	[Lee, Cheng-Fan; Lin, Hsin-Ying; Wu, Shang-Ru; Ko, Chun-Jung; Lee, Ming-Shyue] Natl Taiwan Univ, Dept Biochem & Mol Biol, Coll Med, Taipei, Taiwan; [Lee, Cheng-Fan; Dang, Andrew; Hernandez, Elizabeth; Pong, Rey-Chen; Sonavane, Rajni; Raj, Ganesh; Lo, U-Ging; Hsieh, Jer-Tsong] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Chen, Benjamin] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Kapur, Payal] Univ Texas Southwestern Med Ctr Dallas, Urol & Pathol, Dallas, TX 75390 USA; [Ko, Chun-Jung] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Lee, Hsin-yu] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan	National Taiwan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; National Taiwan University	Lee, MS (corresponding author), Natl Taiwan Univ, Dept Biochem & Mol Biol, Coll Med, Taipei, Taiwan.; Hsieh, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA.	jt.hsieh@utsouthwestern.edu; mslee2006@ntu.edu.tw	Ko, Chun-Jung/AAA-6187-2022	Ko, Chun-Jung/0000-0001-6565-7060	United States Army [W81XWH-11-1-0491, W81XWH-16-1-0474]; Taiwan National Science Council [NSC 100-2628-B-002-004-MY4]; National Health Research Institutes Grant [NHRI-EX102-9909BC, NHRI-EX106-10401BI]; National Taiwan University [NTU-CESRP-104R7602C4, 107L890504]; Ministry of Science and Technology [MOST 103-2321-B-002-096, MOST 104-2320B-002-044- MY3, MOST 104-2911-I-002-578, MOST 105-2911-I-002-521, MOST 106-2320-B-002-046-MY3]	United States Army(United States Department of DefenseUnited States Army); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes Grant; National Taiwan University(National Taiwan University); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by grants from the United States Army (W81XWH-11-1-0491 and W81XWH-16-1-0474) to Jer-Tsong Hsieh, and by Taiwan National Science Council Grant NSC 100-2628-B-002-004-MY4, Ministry of Science and Technology Grants (MOST 103-2321-B-002-096, MOST 104-2320B-002-044- MY3, MOST 104-2911-I-002-578, MOST 105-2911-I-002-521 and MOST 106-2320-B-002-046-MY3), National Health Research Institutes Grant (NHRI-EX102-9909BC and NHRI-EX106-10401BI), and National Taiwan University Grant NTU-CESRP-104R7602C4 and 107L890504 to Ming-Shyue Lee. We thank Dr. Bink W. Wattenberg at James Graham Brown Cancer Center for SphK1 plasmid, Dr. Ming-Fong Lin at the University of Nebraska Medical Center for human prostate cancer cell lines, Dr. Chen-Yong Lin at the Georgetown University for his gifts of antibodies and I-Wen Huang and Kuan-Jin Yu for their technical supports.	Adams DR, 2016, TRENDS BIOCHEM SCI, V41, P395, DOI 10.1016/j.tibs.2016.02.007; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Asghar MY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196992; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Beach JA, 2016, ONCOTARGET, V7, P4167, DOI 10.18632/oncotarget.6703; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Bi Y, 2014, AM J PATHOL, V184, P2791, DOI 10.1016/j.ajpath.2014.06.023; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Datta A, 2014, ONCOTARGET, V5, P5920, DOI 10.18632/oncotarget.1874; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Devine KM, 2008, GYNECOL ONCOL, V110, P237, DOI 10.1016/j.ygyno.2008.04.013; Fleming JK, 2016, J LIPID RES, V57, P1737, DOI 10.1194/jlr.D068866; Gebhardt C, 2009, J VET EMERG CRIT CAR, V19, P450, DOI 10.1111/j.1476-4431.2009.00462.x; Gonzalez-Reyes S, 2011, CANCER IMMUNOL IMMUN, V60, P217, DOI 10.1007/s00262-010-0931-0; Guo YX, 2015, INT J CLIN EXP MED, V8, P20349; Illuzzi G, 2010, J BIOL CHEM, V285, P18594, DOI 10.1074/jbc.M109.072801; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kalhori V, 2015, MOL CELL ENDOCRINOL, V404, P113, DOI 10.1016/j.mce.2015.01.037; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Ko CJ, 2017, ONCOGENE, V36, P4597, DOI 10.1038/onc.2017.82; Ko CJ, 2015, CANCER RES, V75, P2949, DOI 10.1158/0008-5472.CAN-14-3297; Koh E, 2007, CELL SIGNAL, V19, P1328, DOI 10.1016/j.cellsig.2007.01.005; Lanoix JP, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-183; Lee MS, 2006, J CANC MOL, V2, P183; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lehrer S, 2005, BJU INT, V95, P961, DOI 10.1111/j.1464-410X.2005.05447.x; Li J, 2017, ANAT REC, V300, P1219, DOI 10.1002/ar.23590; Li MH, 2009, CANCER LETT, V276, P171, DOI 10.1016/j.canlet.2008.11.025; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; Lipsky BA, 2010, CLIN INFECT DIS, V50, P1641, DOI 10.1086/652861; Liu XX, 2017, BIOMED PHARMACOTHER, V92, P429, DOI 10.1016/j.biopha.2017.05.102; Ma D, 2017, BIOCHEM BIOPH RES CO, V482, P366, DOI 10.1016/j.bbrc.2016.11.069; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Malavaud B, 2010, EUR J CANCER, V46, P3417, DOI 10.1016/j.ejca.2010.07.053; Miller AV, 2008, MOL CELL BIOL, V28, P4142, DOI 10.1128/MCB.01465-07; Mukhopadhyay P, 2015, BREAST CANCER MANAG, V4, P241, DOI 10.2217/bmt.15.20; Nagahashi M., 2014, BIOMED RES INT, V2014, P1; Nakajima M, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317699133; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Nunes J, 2012, BRIT J CANCER, V106, P909, DOI 10.1038/bjc.2012.14; Ohotski J, 2012, BRIT J CANCER, V106, P1453, DOI 10.1038/bjc.2012.98; Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112; Pchejetski D, 2011, NAT REV UROL, V8, P569, DOI 10.1038/nrurol.2011.117; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Rosenberg AJ, 2015, APPL RADIAT ISOTOPES, V102, P5, DOI 10.1016/j.apradiso.2015.04.010; Salama MF, 2015, FASEB J, V29, P2803, DOI 10.1096/fj.15-270413; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Simons BW, 2015, J PATHOL, V235, P478, DOI 10.1002/path.4472; Sordillo LA, 2016, ANTICANCER RES, V36, P2085; St Hill CA, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00055; Syed SN, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7510496; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Taitt HE, 2018, AM J MENS HEALTH, V12, P1807, DOI 10.1177/1557988318798279; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thamilselvan V, 2002, IN VITRO CELL DEV-AN, V38, P246; Tsai CH, 2014, ONCOGENE, V33, P4643, DOI 10.1038/onc.2013.412; Vaarala MH, 2016, ONCOL LETT, V12, P1149, DOI 10.3892/ol.2016.4702; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang D, 2008, MOL CANCER THER, V7, P1993, DOI 10.1158/1535-7163.MCT-08-0088; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Weichand B, 2017, J EXP MED, V214, P2695, DOI 10.1084/jem.20160392; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wu SR, 2010, AM J PATHOL, V177, P3145, DOI 10.2353/ajpath.2010.100228; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yatomi Y, 2008, BBA-GEN SUBJECTS, V1780, P606, DOI 10.1016/j.bbagen.2007.10.006; Young N, 2009, MOL CANCER RES, V7, P23, DOI 10.1158/1541-7786.MCR-08-0061; Zeng Y, 2016, ONCOL LETT, V12, P379, DOI 10.3892/ol.2016.4661; Zhan ZZ, 2014, AUTOPHAGY, V10, P257, DOI 10.4161/auto.27162; Zhu GW, 2016, CELL PHYSIOL BIOCHEM, V39, P1665, DOI 10.1159/000447868; Ziaee S, 2015, TRANSL ANDROL UROL, V4, P438, DOI 10.3978/j.issn.2223-4683.2015.04.10	80	26	27	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 11	2019	38	28					5580	5598		10.1038/s41388-019-0833-3	http://dx.doi.org/10.1038/s41388-019-0833-3			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IH9RW	31152147				2022-12-26	WOS:000474845100003
J	Loc'h, J; Gerodimos, CA; Rosario, S; Tekpinar, M; Lieber, MR; Delarue, M				Loc'h, Jerome; Gerodimos, Christina A.; Rosario, Sandrine; Tekpinar, Mustafa; Lieber, Michael R.; Delarue, Marc			Structural evidence for an in trans base selection mechanism involving Loop1 in polymerase mu at an NHEJ double-strand break junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA repair; X-ray crystallography; structural biology; DNA damage; non-homologous DNA end joining; double-strand break; DNA bridging; DNA synapsis; DNA polymerase Pol X family; V(D)J recombination; junctional diversity; ternary complex; Pol mu catalytic cycle	TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; XRCC4-DNA LIGASE-IV; HUMAN POL-MU; DNA-POLYMERASE; CRYSTAL-STRUCTURES; RECOMBINATION; VALIDATION; EXPRESSION; INSERTION; COMPLEX	Eukaryotic DNA polymerase (Pol) X family members such as Pol mu and terminal deoxynucleotidyl transferase (TdT) are important components for the nonhomologous DNA end-joining (NHEJ) pathway. TdT participates in a specialized version of NHEJ, V(D)J recombination. It has primarily nontemplated polymerase activity but can take instructions across strands from the downstream dsDNA, and both activities are highly dependent on a structural element called Loop1. However, it is unclear whether Pol mu follows the same mechanism, because the structure of its Loop1 is disordered in available structures. Here, we used a chimeric TdT harboring Loop1 of Pol mu that recapitulated the functional properties of Pol mu in ligation experiments. We solved three crystal structures of this TdT chimera bound to several DNA substrates at 1.96-2.55 angstrom resolutions, including a full DNA double-strand break (DSB) synapsis. We then modeled the full Pol mu sequence in the context of one these complexes. The atomic structure of an NHEJ junction with a Pol X construct that mimics Pol mu in a reconstituted system explained the distinctive properties of Pol mu compared with TdT. The structure suggested a mechanism of base selection relying on Loop1 and taking instructions via the in trans templating base independently of the primer strand. We conclude that our atomic-level structural observations represent a paradigm shift for the mechanism of base selection in the Pol X family of DNA polymerases.	[Loc'h, Jerome; Rosario, Sandrine; Tekpinar, Mustafa; Delarue, Marc] Inst Pasteur, UMR 3528 CNRS, Unite Dynam Structurale Macromol, 25 Rue Dr Roux, F-75015 Paris, France; [Gerodimos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; [Gerodimos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Gerodimos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Gerodimos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci,Sect Mol & Computat Biol, Los Angeles, CA 90033 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Delarue, M (corresponding author), Inst Pasteur, UMR 3528 CNRS, Unite Dynam Structurale Macromol, 25 Rue Dr Roux, F-75015 Paris, France.	marc.delarue@pasteur.fr		Gerodimos, Christina/0000-0002-1787-616X; Lieber, Michael/0000-0003-3700-6345; Tekpinar, Mustafa/0000-0002-0207-0446; Lieber, Michael/0000-0001-8809-0909	Fondation ARC pour la recherche sur la cancer; NATIONAL CANCER INSTITUTE [R01CA100504, R01CA196671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118009] Funding Source: NIH RePORTER	Fondation ARC pour la recherche sur la cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the "Fondation ARC pour la recherche sur la cancer" through a postdoctoral fellowship (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrade P, 2009, P NATL ACAD SCI USA, V106, P16203, DOI 10.1073/pnas.0908492106; Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Azuara C, 2006, NUCLEIC ACIDS RES, V34, pW38, DOI 10.1093/nar/gkl072; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bienstock RJ, 2014, DNA REPAIR, V22, P77, DOI 10.1016/j.dnarep.2014.07.003; Blanc E., 2011, BUSTER VERSION 2 11; Bollum F J, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P347; Brissett NC, 2011, MOL CELL, V41, P221, DOI 10.1016/j.molcel.2010.12.026; Chang HHY, 2016, J BIOL CHEM, V291, P24377, DOI 10.1074/jbc.M116.752329; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esteban V, 2013, DNA REPAIR, V12, P824, DOI 10.1016/j.dnarep.2013.07.007; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Gerodimos CA, 2017, J BIOL CHEM, V292, P13914, DOI 10.1074/jbc.M117.798850; Gouge J, 2015, EMBO J, V34, P1126, DOI 10.15252/embj.201489643; Gouge J, 2013, J MOL BIOL, V425, P4334, DOI 10.1016/j.jmb.2013.07.009; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Heyer Wolf-Dietrich, 2007, Top Curr Genet, V17, P95; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Martin MJ, 2014, NUCLEIC ACIDS RES, V42, P7923, DOI 10.1093/nar/gku475; Juarez R, 2006, NUCLEIC ACIDS RES, V34, P4572, DOI 10.1093/nar/gkl457; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATO KI, 1967, J BIOL CHEM, V242, P2780; LANDAU NR, 1987, MOL CELL BIOL, V7, P3237, DOI 10.1128/MCB.7.9.3237; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Loc'h J, 2018, CURR OPIN STRUC BIOL, V53, P22, DOI 10.1016/j.sbi.2018.03.019; Loc'h J, 2016, STRUCTURE, V24, P1452, DOI 10.1016/j.str.2016.06.014; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahajan KN, 1999, P NATL ACAD SCI USA, V96, P13926, DOI 10.1073/pnas.96.24.13926; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Mickelsen S, 1999, J IMMUNOL, V163, P834; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Moon AF, 2015, P NATL ACAD SCI USA, V112, pE4530, DOI 10.1073/pnas.1505798112; Moon AF, 2014, NAT STRUCT MOL BIOL, V21, P253, DOI 10.1038/nsmb.2766; Nakane S, 2012, J MOL BIOL, V417, P179, DOI 10.1016/j.jmb.2012.01.025; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pryor JM, 2015, P NATL ACAD SCI USA, V112, pE4537, DOI 10.1073/pnas.1505805112; Romain F, 2009, NUCLEIC ACIDS RES, V37, P4642, DOI 10.1093/nar/gkp460; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; THODE S, 1990, CELL, V60, P921, DOI 10.1016/0092-8674(90)90340-K; Waters CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5286; Waters CA, 2014, DNA REPAIR, V17, P39, DOI 10.1016/j.dnarep.2014.02.008; Yang K, 2016, ACTA BIOCH BIOPH SIN, V48, P632, DOI 10.1093/abbs/gmw046	57	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10579	10595		10.1074/jbc.RA119.008739	http://dx.doi.org/10.1074/jbc.RA119.008739			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138645	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000478717100017
J	Kang, J; Dietz, MJ; Li, BY				Kang, Jason; Dietz, Matthew J.; Li, Bingyun			Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTIONS; ANTIBACTERIAL ACTIVITY; RECOMBINANT LL-37; VANCOMYCIN; MODEL; SUSCEPTIBILITY; CYTOTOXICITY; INHIBITION; MECHANISMS; EXPRESSION	Our current challenge in the management of prosthetic joint infection is the eradication of biofilms which has driven the need for improved antimicrobial agents and regimens. In this study, the antimicrobial peptide, LL-37, and silver nanoparticles (AgNPs) were investigated for their antimicrobial efficacies against Staphylococcus aureus (S. aureus), a microorganism commonly implicated in biofilm-related infections. These antimicrobials were compared to conventional antibiotics and combination treatments with rifampin. Using a Centers for Disease Control reactor, 24 h S. aureus biofilms were formed on cobalt-chromium discs and the anti-biofilm activity was determined by quantifying the amount of colony forming units following treatments. We found that LL-37 was the most efficacious antimicrobial agent with a more than 4 log reduction in colony counts. In comparison, silver nanoparticles and conventional antibiotics were not as efficacious, with a less than 1 log reduction in colony counts. Antimicrobial combination treatments with rifampin significantly increased the log reduction for AgNPs and gentamicin, although still significantly less than LL-37 in isolation. Furthermore, kinetic studies revealed the rapid elimination of S. aureus biofilm with LL-37. Collectively, the results of this study demonstrated that LL-37 was an effective agent against S. aureus biofilms and may have potential clinical applications in the eradication of biofilms and treatment of prosthetic joint infection.	[Kang, Jason; Dietz, Matthew J.; Li, Bingyun] West Virginia Univ, Sch Med, Dept Orthopaed, Morgantown, WV 26506 USA	West Virginia University	Dietz, MJ; Li, BY (corresponding author), West Virginia Univ, Sch Med, Dept Orthopaed, Morgantown, WV 26506 USA.	mdietz@hsc.wvu.edu; bill@hsc.wvu.edu	Dietz, Matthew J/ABH-2691-2020		Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program, Discovery Award [W81XWH1810203]; NIH [2U54GM104942-02, 5P20RR016477, U57GM104942, P30GM103488, P20GM109098, P20GM103434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488, P20GM109098, P20GM103434, U54GM104942] Funding Source: NIH RePORTER	Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program, Discovery Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program, Discovery Award under Award No. W81XWH1810203 (BL). In addition, we acknowledge the use of the WVU Shared Research Facilities, we acknowledge the support of NIH grants 2U54GM104942-02, 5P20RR016477, U57GM104942, P30GM103488, P20GM109098, and P20GM103434. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the funding agencies.	Abdelhady W, 2013, ANTIMICROB AGENTS CH, V57, P1447, DOI 10.1128/AAC.02073-12; Andersson DI, 2016, DRUG RESIST UPDATE, V26, P43, DOI 10.1016/j.drup.2016.04.002; [Anonymous], 2018, METH DIL ANT SUSC TE; Bjorstad A, 2009, ANTIMICROB AGENTS CH, V53, P1027, DOI 10.1128/AAC.01310-08; Cargill JS, 2009, J CLIN PATHOL, V62, P1112, DOI 10.1136/jcp.2009.069021; Chennupati SK, 2009, AM J RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261; Ciofu O, 2017, APMIS, V125, P304, DOI 10.1111/apm.12673; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Cochran AR, 2016, J ARTHROPLASTY, V31, pS156, DOI 10.1016/j.arth.2016.03.028; Conlon BP, 2014, BIOESSAYS, V36, P991, DOI 10.1002/bies.201400080; Cox DL, 2003, PEPTIDES, V24, P1741, DOI 10.1016/j.peptides.2003.07.026; Dean SN, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-114; Foster TJ, 2017, FEMS MICROBIOL REV, V41, P430, DOI 10.1093/femsre/fux007; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Gbejuade HO, 2015, ACTA ORTHOP, V86, P147, DOI 10.3109/17453674.2014.966290; Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0; Hamza T, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0207-5; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Huotari K, 2015, ACTA ORTHOP, V86, P321, DOI 10.3109/17453674.2015.1035173; Iarikov D, 2012, CLIN INFECT DIS, V55, P1474, DOI 10.1093/cid/cis735; Inacio MCS, 2017, OSTEOARTHR CARTILAGE, V25, P1797, DOI 10.1016/j.joca.2017.07.022; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kim BS, 2017, 2017 31ST INTERNATIONAL CONFERENCE ON INFORMATION NETWORKING (ICOIN), P63, DOI 10.1109/ICOIN.2017.7899476; Klemm K, 2001, CLIN MICROBIOL INFEC, V7, P28, DOI 10.1046/j.1469-0691.2001.00186.x; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Kurtz SM, 2010, CLIN ORTHOP RELAT R, V468, P52, DOI 10.1007/s11999-009-1013-5; Leszczynska K, 2013, J ANTIMICROB CHEMOTH, V68, P610, DOI 10.1093/jac/dks434; Li YF, 2012, PROTEIN EXPRES PURIF, V81, P201, DOI 10.1016/j.pep.2011.10.011; Lofton H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068875; Luo Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00544; Marschall J, 2013, INT J ANTIMICROB AG, V41, P272, DOI 10.1016/j.ijantimicag.2012.10.023; Martinez-Gutierrez F, 2013, BIOFOULING, V29, P651, DOI 10.1080/08927014.2013.794225; McConoughey SJ, 2014, FUTURE MICROBIOL, V9, P987, DOI [10.2217/fmb.14.64, 10.2217/FMB.14.64]; Mishra B, 2016, ACS MED CHEM LETT, V7, P117, DOI 10.1021/acsmedchemlett.5b00433; Mohamed MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29707; Moon JY, 2006, BBA-BIOMEMBRANES, V1758, P1351, DOI 10.1016/j.bbamem.2006.02.003; Noore J, 2013, ANTIMICROB AGENTS CH, V57, P1283, DOI 10.1128/AAC.01650-12; Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Post V, 2017, J ORTHOP RES, V35, P381, DOI 10.1002/jor.23291; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Saginur R, 2006, ANTIMICROB AGENTS CH, V50, P55, DOI 10.1128/AAC.50.1.55-61.2006; Sall J, 2013, J INNATE IMMUN, V5, P290, DOI 10.1159/000346587; Segev-Zarko L, 2015, BIOCHEM J, V468, P259, DOI 10.1042/BJ20141251; Siqueira MBP, 2015, J BONE JOINT SURG AM, V97A, P1220, DOI 10.2106/JBJS.N.00999; Snyder ADH, 2015, INFECT DIS THER, V4, P51, DOI 10.1007/s40121-014-0055-5; Strempel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082240; Svensson D, 2016, BIOCHEM J, V473, P87, DOI 10.1042/BJ20150798; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Tavares LS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00412; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009	54	41	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0216676	10.1371/journal.pone.0216676	http://dx.doi.org/10.1371/journal.pone.0216676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170191	Green Submitted, gold, Green Published			2022-12-26	WOS:000470263700008
J	Liu, JH; Liu, SS; Deng, XY; Rao, JY; Huang, KY; Xu, GR; Wang, XK				Liu, Jianghong; Liu, Shengshuo; Deng, Xiaoyan; Rao, Jiaoyu; Huang, Kaiyuan; Xu, Gengrui; Wang, Xiaokang			MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1	PLOS ONE			English	Article							UP-REGULATION; PROLIFERATION; STATISTICS; ACTIVATION; CARCINOMA; APOPTOSIS; PATHWAY; TARGET	Non-small cell lung cancer (NSCLC) is the most common cancer worldwide. MicroRNAs have been shown to be correlated with biological processes of various tumors. In this study, we observed that the expression of miR-582-5p was lower in NSCLC tissues than that in para-carcinoma tissues. Ectopic expression of miR-582-5p significantly inhibited NCI-H358 cell proliferation and invasion. Knockdown of miR-582-5p showed the opposite results, with cell growth rate and the invasive capacity of PC-9 cells enhanced. Furthermore, we elucidated that NOTCH1 is a target of miR-582-5p and there is an inverse correlation between miR-582-5p and NOTCH1 expression in NSCLC tissues. Overexpression of NOTCH1 in miR-582-5p-overexpressing NCI-H358 cells could partially reverse the inhibition of cell proliferation and invasion by miR-582-5p. Thus, our research demonstrated that miR-582-5p suppresses NSCLC cell lines' growth and invasion via targeting oncoprotein NOTCH1 and restoration of miR-582-5p might be feasible therapeutic strategy for NSCLC.	[Liu, Jianghong; Huang, Kaiyuan; Xu, Gengrui; Wang, Xiaokang] Shenzhen Longhua Dist Cent Hosp, Dept Pharm, Shenzhen, Peoples R China; [Liu, Shengshuo] Henan Univ, Sch Pharm, Kaifeng, Henan, Peoples R China; [Deng, Xiaoyan] Shenzhen Longhua Dist Cent Hosp, Dept Endocrinol, Shenzhen, Peoples R China; [Rao, Jiaoyu] Jinan Univ, Coll Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China	Henan University; Jinan University	Wang, XK (corresponding author), Shenzhen Longhua Dist Cent Hosp, Dept Pharm, Shenzhen, Peoples R China.	kangtae.wang@yahoo.com	Wang, Xiaokang/GSD-7988-2022	Wang, Xiaokang/0000-0002-4325-9907	Shenzhen Longhua District Science and Technology Innovation Fund Projects [2017032]; Research Project of Traditional Chinese Medicine Bureau of Guangdong Province [20182131]	Shenzhen Longhua District Science and Technology Innovation Fund Projects; Research Project of Traditional Chinese Medicine Bureau of Guangdong Province	This work was supported by grants from the Shenzhen Longhua District Science and Technology Innovation Fund Projects (No. 2017032), and the Research Project of Traditional Chinese Medicine Bureau of Guangdong Province (No. 20182131).	Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; An TH, 2017, MOL NEUROBIOL, V54, P6329, DOI 10.1007/s12035-016-0163-1; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Baumgart A, 2010, CANCER RES, V70, P5368, DOI 10.1158/0008-5472.CAN-09-3763; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen YP, 2012, PLOS ONE, V7; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Floyd DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096239; Hu HQ, 2016, INT J BIOL MARKER, V31, pE270, DOI 10.5301/jbm.5000194; Huang D., 2016, ACTA BIOCH BIOPHYS S, V48; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Jin Y, 2017, EUR REV MED PHARMACO, V21, P5112, DOI 10.26355/eurrev_201711_13827; Li JL, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1139-8; Li LL, 2018, SAUDI J BIOL SCI, V25, P965, DOI 10.1016/j.sjbs.2018.03.007; Licciulli S, 2013, CANCER RES, V73, P5974, DOI 10.1158/0008-5472.CAN-13-1384; Maeno A, 2014, PROSTATE, V74, P1604, DOI 10.1002/pros.22877; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Park JK, 2011, CANCER RES, V71, P7608, DOI 10.1158/0008-5472.CAN-11-1144; Shu ZB, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0984-4; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uchino K, 2013, MOL THER, V21, P610, DOI 10.1038/mt.2012.269; Wang WW, 2017, JPN J CLIN ONCOL, V47, P690, DOI 10.1093/jjco/hyx073; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Xie M, 2012, J CELL BIOCHEM, V113, P1501, DOI 10.1002/jcb.24019; Xu YT, 2018, CANCER SCI, V109, P1055, DOI 10.1111/cas.13539; Zhang HD, 2015, BIOCHEM BIOPH RES CO, V465, P702, DOI 10.1016/j.bbrc.2015.08.053; Zhang X, 2015, CANCER GENE THER, V22, P475, DOI 10.1038/cgt.2015.44	36	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217652	10.1371/journal.pone.0217652	http://dx.doi.org/10.1371/journal.pone.0217652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170211	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700046
J	Wang, JX; Dang, RH; Miyasaka, Y; Hattori, K; Torigoe, D; Okamura, T; Tag-El-Din-Hassan, HT; Morimatsu, M; Mashimo, T; Agui, T				Wang, Jinxi; Dang, Ruihua; Miyasaka, Yoshiki; Hattori, Kousuke; Torigoe, Daisuke; Okamura, Tadashi; Tag-El-Din-Hassan, Hassan T.; Morimatsu, Masami; Mashimo, Tomoji; Agui, Takashi			Null mutation of the endothelin receptor type B gene causes embryonic death in the GK rat	PLOS ONE			English	Article							HIRSCHSPRUNGS-DISEASE; GERMLINE MUTATIONS; GDNF; RET; SEVERITY; DELETION; DEFECTS; SOX10	The Hirschsprung disease (HSCR) is an inherited disease that is controlled by multiple genes and has a complicated genetic mechanism. HSCR patients suffer from various extents of constipation due to dysplasia of the enteric nervous system (ENS), which can be so severe as to cause complete intestinal obstruction. Many genes have been identified as playing causative roles in ENS dysplasia and HSCR, among them the endothelin receptor type B gene (Ednrb) has been identified to play an important role. Mutation of Ednrb causes a series of symptoms that include deafness, pigmentary abnormalities, and aganglionosis. In our previous studies of three rat models carrying the same spotting lethal (sl) mutation on Ednrb, the haplotype of a region on chromosome (Chr) 2 was found to be responsible for the differing severities of the HSCR-like symptoms. To confirm that the haplotype of the responsible region on Chr 2 modifies the severity of aganglionosis caused by Ednrb mutation and to recreate a rat model with severe symptoms, we selected the GK inbred strain, whose haplotype in the responsible region on Chr 2 resembles that of the rat strain in which severe symptoms accompany the Ednrb(sl) mutation. An Ednrb mutation was introduced into the GK rat by crossing with F344-Ednrb(sl) and by genome editing. The null mutation of Ednrb was found to cause embryonic death in F2 progeny possessing the GK haplotype in the responsible region on Chr 2. The results of this study are unexpected, and they provide new clues and animal models that promise to contribute to studies on the genetic regulatory network in the development of ENS and on embryogenesis.	[Wang, Jinxi; Torigoe, Daisuke; Tag-El-Din-Hassan, Hassan T.; Morimatsu, Masami; Agui, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Appl Vet Sci, Lab Anim Sci & Med, Sapporo, Hokkaido, Japan; [Wang, Jinxi; Miyasaka, Yoshiki; Hattori, Kousuke; Mashimo, Tomoji] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Osaka, Japan; [Dang, Ruihua] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Sect Anim Models, Tokyo, Japan; [Tag-El-Din-Hassan, Hassan T.] Mansoura Univ, Fac Agr, Poultry Prod Dept, Mansoura, Egypt; [Torigoe, Daisuke] Kumamoto Univ, Inst Resource Dev & Anal, Div Microbiol & Genet, Kumamoto, Japan	Hokkaido University; Osaka University; Northwest A&F University - China; National Center for Global Health & Medicine - Japan; Egyptian Knowledge Bank (EKB); Mansoura University; Kumamoto University	Agui, T (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Appl Vet Sci, Lab Anim Sci & Med, Sapporo, Hokkaido, Japan.	agui@vetmed.hokudai.ac.jp	EL-Din, Hassan Tag/Y-7984-2019; Morimatsu, Masami/A-6698-2012	Morimatsu, Masami/0000-0003-0740-0157; Agui, Takashi/0000-0001-6203-0502; Miyasaka, Yoshiki/0000-0003-4020-9290	Morinaga Foundation for Health and Nutrition	Morinaga Foundation for Health and Nutrition	This work was supported in part by a grant from the Morinaga Foundation for Health and Nutrition (MM), of which grant number and URL to sponsor's website were not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; BADNER JA, 1990, AM J HUM GENET, V46, P568; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Brooks AS, 2005, CLIN GENET, V67, P6, DOI 10.1111/j.1399-0004.2004.00319.x; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; Chatterjee S, 2016, CELL, V167, P355, DOI 10.1016/j.cell.2016.09.005; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027902; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; Granhall C, 2006, GENETICS, V174, P1565, DOI 10.1534/genetics.106.062208; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Huang JP, 2016, GENE, V575, P144, DOI 10.1016/j.gene.2015.08.051; Huang JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122068; Jiang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021219; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Kusafuka T, 1996, HUM MOL GENET, V5, P347, DOI 10.1093/hmg/5.3.347; LUO Y, 1993, HUM MOL GENET, V2, P1803, DOI 10.1093/hmg/2.11.1803; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; McKeown SJ, 2017, STEM CELL REP, V8, P476, DOI 10.1016/j.stemcr.2016.12.013; Momose K, 2006, MED MOL MORPHOL, V39, P146, DOI 10.1007/s00795-006-0324-9; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Semenova E, 2003, HUM MOL GENET, V12, P1301, DOI 10.1093/hmg/ddg140; Shen L, 2002, AM J HUM GENET, V70, P435, DOI 10.1086/338712; Syrris P, 1999, AM J MED GENET, V87, P69, DOI 10.1002/(SICI)1096-8628(19991105)87:1<69::AID-AJMG14>3.0.CO;2-R; Szymonska I., 2015, J GENET SYNDR GENE T, V6, DOI 10.4172/2157-7412.1000269; Welsh IC, 2000, DEV BIOL, V225, P151, DOI 10.1006/dbio.2000.9814	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217132	10.1371/journal.pone.0217132	http://dx.doi.org/10.1371/journal.pone.0217132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170185	gold, Green Submitted, Green Published			2022-12-26	WOS:000470263700020
J	Miller, KL; Rico, SC; Muletz-Wolz, CR; Campana, MG; McInerney, N; Augustine, L; Frere, C; Peters, AM; Fleischer, RC				Miller, Kyle L.; Rico, Susette Castaneda; Muletz-Wolz, Carly R.; Campana, Michael G.; McInerney, Nancy; Augustine, Lauren; Frere, Celine; Peters, Alan M.; Fleischer, Robert C.			Parthenogenesis in a captive Asian water dragon (Physignathus cocincinus) identified with novel microsatellites	PLOS ONE			English	Article							MOLECULAR-GENETIC EVIDENCE; FACULTATIVE PARTHENOGENESIS; GENOME; SHARK; BOA	Reptiles show varying degrees of facultative parthenogenesis. Here we use genetic methods to determine that an isolated, captive female Asian water dragon produced at least nine offspring via parthenogenesis. We identified microsatellites for the species from shotgun genomic sequences, selected and optimized primer sets, and tested all of the offspring for a set of seven microsatellites that were heterozygous in the mother. We verified that the seven loci showed high levels of polymorphism in four wild Asian water dragons from Vietnam. In all cases, the offspring (unhatched, but developed eggs, or hatched young) had only a single allele at each locus, and contained only alleles present in the mother's genotype (i.e., were homozygous or hemizygous). The probability that our findings resulted from the female mating with one or more males is extremely small, indicating that the offspring were derived from a single female gamete (either alone or via duplication and/or fusion) and implicating parthenogenesis. This is the first documented case of parthenogenesis in the Squamate family Agamidae.	[Miller, Kyle L.; Augustine, Lauren; Peters, Alan M.] Smithsonians Natl Zool Pk, Dept Anim Care Sci, Washington, DC 20008 USA; [Rico, Susette Castaneda; Muletz-Wolz, Carly R.; Campana, Michael G.; McInerney, Nancy; Fleischer, Robert C.] Natl Zool Pk, Ctr Conservat Genom, Smithsonian Conservat Biol Inst, Washington, DC USA; [Rico, Susette Castaneda] George Mason Univ, Fairfax, VA 22030 USA; [Augustine, Lauren] St Louis Zoo, One Govt Dr, St Louis, MO USA; [Frere, Celine] Univ Sunshine Coast, Sippy Downs, Qld, Australia	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University; University of the Sunshine Coast	Miller, KL (corresponding author), Smithsonians Natl Zool Pk, Dept Anim Care Sci, Washington, DC 20008 USA.	millerkl@si.edu	Frere, Celine Henria/B-4905-2013; Frere, Celine Henria/GYJ-3882-2022; Muletz-Wolz, Carly/N-3816-2013	Frere, Celine Henria/0000-0002-9671-2138; Muletz-Wolz, Carly/0000-0001-5047-9601; Campana, Michael/0000-0003-0461-6462	Center for Conservation Genomics	Center for Conservation Genomics	We thank Assistant Curator of Herpetology at the Smithsonian's National Zoo, Matthew Evans for facilitating scheduling and communications with the Center for Conservation Genomics team to ensure this project came to fruition. We also thank National Zoo Herpetology keepers Robin Saunders and Matthew Neff, who collected the first clutch of eggs we suspected were the result of parthenogenesis and ensured their safe transition to the incubator. We appreciate Maya Rao's help with lab work. Funds for lab work were provided by the Center for Conservation Genomics. We thank Robert and Arlene Kogod for their support of the Secretary's Scholar Program. We acknowledge the Ambrose Monell Cryo Collection (AMCC) at the American Museum of Natural History, New York, and the curatorial staff David Dickey, David Kizirian, and Svetlana Katanova for providing samples for our research. Last, we thank female dragon WD-10, also known as Saphira, for providing research materials.	Allen L, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171901; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Booth W, 2016, BIOL J LINN SOC, V118, P172, DOI 10.1111/bij.12744; Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Booth W, 2011, BIOL J LINN SOC, V104, P934, DOI 10.1111/j.1095-8312.2011.01782.x; Booth W, 2011, J HERED, V102, P759, DOI 10.1093/jhered/esr080; Booth W, 2011, BIOL LETTERS, V7, P253, DOI 10.1098/rsbl.2010.0793; Chapman DD, 2008, J FISH BIOL, V73, P1473, DOI 10.1111/j.1095-8649.2008.02018.x; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dudgeon CL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40537; Engelstadter J, 2008, BIOESSAYS, V30, P1138, DOI 10.1002/bies.20833; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Frere CH, 2012, CONSERV GENET RESOUR, V4, P113, DOI 10.1007/s12686-011-9487-3; Georges A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0085-2; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; Kinney ME, 2012, ZOO BIOL, V32; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Portnoy DS, 2014, J FISH BIOL, V85, P502, DOI 10.1111/jfb.12415; Reynolds GR, 2016, BIOL J LINN SOC, V107, P566, DOI [10.1111/jfb.12415, DOI 10.1111/JFB.12415]; Shibata H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189654; Sinclair EA, 2010, EVOLUTION, V64, P1346, DOI 10.1111/j.1558-5646.2009.00893.x; van der Kooi CJ, 2015, CURR BIOL, V25, pR659, DOI 10.1016/j.cub.2015.06.055; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a	28	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217489	10.1371/journal.pone.0217489	http://dx.doi.org/10.1371/journal.pone.0217489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166974	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800031
J	Fleming, PJ; Lopez, WD; Ledon, C; Llanes, M; Waller, A; Harner, M; Martinez, R; Kruger, DJ				Fleming, Paul J.; Lopez, William D.; Ledon, Charo; Llanes, Mikel; Waller, Adreanne; Harner, Melanie; Martinez, Ramiro; Kruger, Daniel J.			I'm going to look for you and take your kids': Reproductive justice in the context of immigration enforcement	PLOS ONE			English	Article							DEPORTATION; HEALTH; SERVICES; COUNTY	Prior research has shown that immigration law enforcement contributes to poor health outcomes-including reproductive health outcomes-among Latinos. Yet no prior research has examined how immigration enforcement might inhibit reproductive justice and limit individual's reproductive autonomy. We utilized data from an existing study that consisted of a partnership with a Latino community in Michigan in which an immigration raid resulted in multiple arrests and deportations midway through data collection. Using cross-sectional survey data (n = 192) where no one was re-interviewed, we used ordinal logistic regression to compare desired pregnancy timing of individuals surveyed prior to and after the raid to determine the impact of an immigration raid on desired timing of next pregnancy. We then used qualitative data-including 21 in-depth interviews and participant observation-collected in the community after the raid to contextualize our findings. Controlling for socio-demographic characteristics, we found that Latinos surveyed in the aftermath of the raid were more likely to report a greater desire to delay childbearing than Latinos surveyed before the raid occurred. Our qualitative data showed that an immigration raid has financial and psychological effects on immigrant families and that a raid may impact reproductive autonomy because people are fearful of these impacts. These finding suggest that current immigration enforcement efforts may influence reproductive decision-making, impede Latinos reproductive autonomy, and that family-friendly immigration policy reform is needed.	[Fleming, Paul J.; Lopez, William D.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Ledon, Charo] Accion Buenos Vecinos, Ypsilanti, MI USA; [Llanes, Mikel] Univ Michigan, Med Sch, Dept Family Med, Ann Arbor, MI 48109 USA; [Waller, Adreanne] Washtenaw Cty Publ Hlth, Ypsilanti, MI USA; [Harner, Melanie; Martinez, Ramiro] Washtenaw Interfaith Coalit Immigrant Rights, Ypsilanti, MI USA; [Kruger, Daniel J.] Univ Michigan, Populat Studies Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fleming, PJ (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.	pauljf@umich.edu	Zweigenthal, Virginia/AAW-6425-2021	Zweigenthal, Virginia/0000-0003-3914-2156; Fleming, Paul/0000-0001-9150-1254	Rackham Graduate School; Center for Research on Ethnicity, Culture, and Health (CRECH) at the University of Michigan; US Housing and Urban Development-Sustainable Communities Project; Michigan Institute for Clinical and Health Research Partnership [2UL1TR000433-06]; Michigan Department of Community Health-Health Equity Capacity Building Project; Washtenaw County Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER	Rackham Graduate School; Center for Research on Ethnicity, Culture, and Health (CRECH) at the University of Michigan; US Housing and Urban Development-Sustainable Communities Project; Michigan Institute for Clinical and Health Research Partnership; Michigan Department of Community Health-Health Equity Capacity Building Project; Washtenaw County Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded in part by Rackham Graduate School and the Center for Research on Ethnicity, Culture, and Health (CRECH) at the University of Michigan, the US Housing and Urban Development-Sustainable Communities Project, Michigan Institute for Clinical and Health Research Partnership (2UL1TR000433-06), Michigan Department of Community Health-Health Equity Capacity Building Project, and Washtenaw County Public Health.	Calvo JM, 2017, AM J PUBLIC HEALTH, V107, P1240, DOI [10.2105/AJPH.2017.303896, 10.2105/ajph.2017.303896]; Castaneda H, 2014, AM BEHAV SCI, V58, P1891, DOI 10.1177/0002764214550290; Cavazos-Rehg PA, 2007, J NATL MED ASSOC, V99, P1126; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Chavez LR, 2012, SOC SCI MED, V74, P887, DOI 10.1016/j.socscimed.2011.05.023; Delva J., 2013, J COMMUNITY POSITIVE, VXIII, P25; Doering-White J, 2016, J INT MIGR INTEGR, V17, P325, DOI 10.1007/s12134-014-0408-7; Doshi M, 2018, AM PUBL HLTH ASS ANN; Dreby J, 2012, J MARRIAGE FAM, V74, P829, DOI 10.1111/j.1741-3737.2012.00989.x; Evans K, 2009, NYU REV LAW SOC CHAN, V33, P561; Fleming P, 2018, DETROIT FREE PRESS; Fleming PJ, 2018, AM PUBL HLTH ASS ANN; Golash-Boza T, 2013, LAT STUD, V11, P271, DOI 10.1057/lst.2013.14; Hacker K, 2012, J HEALTH CARE POOR U, V23, P651, DOI 10.1353/hpu.2012.0052; Hansen R, 2013, STERILIZED BY THE STATE: EUGENICS, RACE, AND THE POPULATION SCARE IN TWENTIETH-CENTURY NORTH AMERICA, P1; Kopan T, 2018, CNN COM; Lopez WD, 2017, J IMMIGR MINOR HEALT, V19, P702, DOI 10.1007/s10903-016-0390-6; Lopez William D., 2018, TRAUMATOLOGY; Maldonado CZ, 2013, ACAD EMERG MED, V20, P155, DOI 10.1111/acem.12079; Medina J., 2017, NY TIMES; Miller ME, 2018, WASHINGTON POST; Novak NL, 2018, AM J PUBLIC HEALTH, V108, P611, DOI 10.2105/AJPH.2018.304369; Novak NL, 2017, INT J EPIDEMIOL, V46, P839, DOI 10.1093/ije/dyw346; Page KR, 2017, NEW ENGL J MED, V376, DOI 10.1056/NEJMp1700829; Partners HI., 2013, FAMILY UNITY FAMILY; Purdy L, 2006, J MED ETHICS, V32, P287, DOI 10.1136/jme.2004.013193; Richards SE., 2018, ATLANTIC; Rohmy, 2016, MUSICA URBANA; Rosenblum M.R., 2014, DEPORTATION DISCRETI; Ross L., 2006, UNDERSTANDING REPROD; Ross Loretta., 2016, UNDIVIDED RIGHTS WOM; Simanski JF, 2014, ANN REPORT OFFICE IM, V1; Stevens Matt, 2018, NY TIMES; Strauss A, 1997, GROUNDED THEORY PRAC; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Sullivan MM, 2005, ADV NURS SCI, V28, P240, DOI 10.1097/00012272-200507000-00006; White K, 2014, J HEALTH CARE POOR U, V25, P1844, DOI 10.1353/hpu.2014.0194	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217898	10.1371/journal.pone.0217898	http://dx.doi.org/10.1371/journal.pone.0217898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2FX	31163074	Green Published, Green Submitted, gold			2022-12-26	WOS:000470086200043
J	Gommers, LMM; Hill, TG; Ashcroft, FM; de Baaij, JHF				Gommers, Lisanne M. M.; Hill, Thomas G.; Ashcroft, Frances M.; de Baaij, Jeroen H. F.			Low extracellular magnesium does not impair glucose-stimulated insulin secretion	PLOS ONE			English	Article							SERUM MAGNESIUM; HYPOMAGNESEMIA; HOMEOSTASIS; IMPROVES; RISK; MG2+; RAT	There is an increasing amount of clinical evidence that hypomagnesemia (serum Mg2+ levels < 0.7 mmol/l) contributes to type 2 diabetes mellitus pathogenesis. Amongst other hypotheses, it has been suggested that Mg2+ deficiency affects insulin secretion. The aim of this study was, therefore, to investigate the acute effects of extracellular Mg2+ on glucose-stimulated insulin secretion in primary mouse islets of Langerhans and the rat insulinoma INS-1 cell line. Here we show that acute lowering of extracellular Mg2+ concentrations from 1.0 mM to 0.5 mM did not affect glucose-stimulated insulin secretion in islets or in insulin-secreting INS-1 cells. The expression of key genes in the insulin secretory pathway (e.g. Gck, Abcc8) was also unchanged in both experimental models. Knockdown of the most abundant Mg2+ channel Trpm7 by siRNAs in INS-1 cells resulted in a 3-fold increase in insulin secretion at stimulatory glucose conditions compared to mock-transfected cells. Our data suggest that insulin secretion is not affected by acute lowering of extracellular Mg2+ concentrations.	[Gommers, Lisanne M. M.; de Baaij, Jeroen H. F.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands; [Gommers, Lisanne M. M.; Hill, Thomas G.; Ashcroft, Frances M.; de Baaij, Jeroen H. F.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Radboud University Nijmegen; University of Oxford	de Baaij, JHF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands.; de Baaij, JHF (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	jeroen.debaaij@radboudumc.nl	Gommers, Lisanne/O-8313-2016; de Baaij, Jeroen/P-5704-2015	de Baaij, Jeroen/0000-0003-2372-8486	Netherlands Organization for Scientific Research [NWO Rubicon 825.14.021, NWO VENI 016.186.012]; Wellcome Trust [884655, 089795]; Dutch Diabetes Research Foundation [2017.81.014]; Royal Society Research Wolfson Merit Award	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission); Dutch Diabetes Research Foundation; Royal Society Research Wolfson Merit Award	This work was supported by grants from the Netherlands Organization for Scientific Research (NWO Rubicon 825.14.021, NWO VENI 016.186.012) and the Wellcome Trust (884655, 089795). Jeroen de Baaij is supported by the Dutch Diabetes Research Foundation (2017.81.014). Frances Ashcroft holds a European Research Council Advanced Investigatorship and a Royal Society Research Wolfson Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWATER I, 1983, Q J EXP PHYSIOL CMS, V68, P233, DOI 10.1113/expphysiol.1983.sp002715; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Cantley J, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0140-6; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Gommers LMM, 2016, DIABETES, V65, P3, DOI 10.2337/db15-1028; Gunther T, 2010, MAGNESIUM RES, V23, P5, DOI 10.1684/mrh.2009.0195; Guerrero-Romero F, 2014, CIR CIR, V82, P282; Guerrero-Romero F, 2011, EUR J CLIN INVEST, V41, P405, DOI 10.1111/j.1365-2362.2010.02422.x; Ishizuka Jin, 1994, Magnesium Research, V7, P17; Kieboom BCT, 2017, DIABETOLOGIA, V60, P843, DOI 10.1007/s00125-017-4224-4; Kurstjens S, 2019, DIABETOLOGIA, V62, P311, DOI 10.1007/s00125-018-4771-3; Kurstjens S, 2018, DIABETOLOGIA, V61, P2030, DOI 10.1007/s00125-018-4680-5; Kurstjens S, 2017, EUR J ENDOCRINOL, V176, P11, DOI 10.1530/EJE-16-0517; LEGRAND C, 1987, METABOLISM, V36, P160, DOI 10.1016/0026-0495(87)90011-4; Mittermeier L, 2019, P NATL ACAD SCI USA, V116, P4706, DOI 10.1073/pnas.1810633116; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; MURAKAMI M, 1992, P SOC EXP BIOL MED, V200, P490; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; PAOLISSO G, 1989, DIABETES CARE, V12, P265, DOI 10.2337/diacare.12.4.265; PAOLISSO G, 1989, ACTA ENDOCRINOL-COP, V121, P16, DOI 10.1530/acta.0.1210016; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Randell EW, 2008, ATHEROSCLEROSIS, V196, P413, DOI 10.1016/j.atherosclerosis.2006.11.024; Reis MAB, 2001, BRIT J NUTR, V85, P549, DOI 10.1079/BJN2000294; Rodriguez-Moran M, 2011, DIABETES-METAB RES, V27, P590, DOI 10.1002/dmrr.1206; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217925	10.1371/journal.pone.0217925	http://dx.doi.org/10.1371/journal.pone.0217925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163064	gold, Green Published, Green Submitted			2022-12-26	WOS:000470086200047
J	Lahlou, G; Rodallec, M; Nguyen, Y; Sterkers, O; Kalamarides, M				Lahlou, Ghizlene; Rodallec, Mathieu; Yann Nguyen; Sterkers, Olivier; Kalamarides, Michel			How to radiologically identify a spontaneous regression of sporadic vestibular schwannoma?	PLOS ONE			English	Article							RADIOSURGERY; MANAGEMENT	Background The natural history of sporadic vestibular schwannoma is unpredictable, with tumors growing, non-growing and even showing spontaneous regression in some rare cases. Objective This retrospective study aims to describe the radiologic signs characterizing and identifying the shrinking vestibular schwannoma. Methods Involution was considered to have occurred if tumor size had decreased by 2 mm or more on its largest diameter. All magnetic resonance imaging scans were reviewed for tumor size, internal auditory meatus size, and tumor characteristics. Volumetric measurements were performed on the first and last scan. Audiometric data were collected at the first and last visit. Results Fourteen patients with a confirmed spontaneous regression were included, with a mean follow-up of 5 +/- 2.6 years. The mean shrinkage rate was 0.9 +/- 0.59 mm/year on 2D measurements, and 0.2 +/- 0.17 cm(3)/year on volumetric measurements, with a relative shrinkage of 40 +/- 16.9%. Two remarkable radiologic features were observed: First, a festooned aspect, defined by multiple curves in the tumor outline, noticed in 12 cases (86%); second, the appearance of cerebrospinal fluid filling the internal auditory meatus, associated with an enlargement of the internal auditory meatus compared to the contralateral side, and observed in 10 out of 13 cases with internal auditory meatus invasion (77%). Those two aspects were associated in 64% of cases. Conclusion These two newly reported radiologic features could help neurosurgeons, oto-neurosurgeons and neuroradiologists to identify a spontaneous vestibular schwannoma involution at first visit. This could allow any treatment to be postponed, monitoring to be more widely spaced, and patients to be reassured.	[Lahlou, Ghizlene; Yann Nguyen; Sterkers, Olivier] Hop La Pitie Salpetriere, AP HP, Dept Otol Auditory Implants & Skull Base Surg, Paris, France; [Lahlou, Ghizlene; Yann Nguyen; Sterkers, Olivier] Sorbonne Univ, INSERM, Minimally Invas & Robot Based Surg Rehabil Hearin, Paris, France; [Rodallec, Mathieu] Ctr Cardiol Nord, Dept Radiol, St Denis, Reunion, France; [Kalamarides, Michel] Hop La Pitie Salpetriere, AP HP, Dept Neurosurg, Paris, France; [Kalamarides, Michel] Sorbonne Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Lahlou, G (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Otol Auditory Implants & Skull Base Surg, Paris, France.; Lahlou, G (corresponding author), Sorbonne Univ, INSERM, Minimally Invas & Robot Based Surg Rehabil Hearin, Paris, France.	ghizlene.lahlou@aphp.fr	Nguyen, Yann/AAX-5740-2020	Nguyen, Yann/0000-0003-4635-0658				Battaglia A, 2006, OTOL NEUROTOL, V27, P705, DOI 10.1097/01.mao.0000226302.59198.87; Ferri GG, 2008, LARYNGOSCOPE, V118, P951, DOI 10.1097/MLG.0b013e31816a8955; Grayeli AB, 2005, ACTA OTO-LARYNGOL, V125, P1063, DOI 10.1080/00016480510038013; Hashimoto S, 2003, KEIO U INT SYMP LIFE, V10, P13; Huang X, 2013, J LARYNGOL OTOL, V127, P739, DOI 10.1017/S0022215113001266; Ikonomidis C, 2015, AUDIOL NEURO-OTOL, V20, P406, DOI 10.1159/000441119; Kirchmann M, 2017, NEUROSURGERY, V80, P49, DOI 10.1227/NEU.0000000000001414; Lees KA, 2018, OTOLARYNGOL HEAD NEC; Lin EP, 2017, AM J NEURORADIOL, P1; Luetje CM, 2000, AM J OTOL, V21, P393, DOI 10.1016/S0196-0709(00)80050-2; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P179; Nakamura H, 2000, AM J NEURORADIOL, V21, P1540; Pollock BE, 1998, J NEUROSURG, V89, P949, DOI 10.3171/jns.1998.89.6.0949; Stangerup SE, 2012, OTOLARYNG CLIN N AM, V45, P257, DOI 10.1016/j.otc.2011.12.008; Tikka T, 2018, OTOL NEUROTOL, V1; Torres R, 2017, OTOLARYNG HEAD NECK, V156, P525, DOI 10.1177/0194599816677711; Wu CC, 2017, J NEUROSURG, V127, P1384, DOI 10.3171/2016.9.JNS161510; Zhang Z, 2016, ACTA OTORHINOLARYNGO, V36, P408, DOI 10.14639/0392-100X-1176	18	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217752	10.1371/journal.pone.0217752	http://dx.doi.org/10.1371/journal.pone.0217752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163048	Green Published, Green Submitted, gold			2022-12-26	WOS:000470086200031
J	Choi, Y; Ahn, KJ; Nam, Y; Jang, J; Shin, NY; Choi, HS; Jung, SL; Kim, BS				Choi, Yangsean; Ahn, Kook Jin; Nam, Yoonho; Jang, Jinhee; Shin, Na-Young; Choi, Hyun Seok; Jung, So-Lyung; Kim, Bum-soo			Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals	PLOS ONE			English	Article							MGMT PROMOTER METHYLATION; IDH MUTATION; SURVIVAL; HETEROGENEITY; TEMOZOLOMIDE; PERFORMANCE; MULTIFORME; RESECTION; EXTENT	Objectives The extent of peritumoral tumor cell infiltrations in glioblastoma contributes to poor prognosis. We aimed to assess additive prognostic value of Minkowski functionals in analyzing heterogeneity of peritumoral hyperintensity on T2WI in glioblastoma patients. Methods Clinical data (age, sex, extent of surgical resection), O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status and pre-operative T2WI of 113 pathologically confirmed glioblastoma patients (from our institution, n = 61; from the Cancer Imaging Archive, n = 52) were retrospectively reviewed. The patients were randomly grouped into a training set (n = 80) and a test set (n = 33). Peritumoral T2 hyperintensity was manually segmented and Minkowski functionals-a texture analysis method capturing heterogeneity of MR images-were computed as a function of 11 grayscale thresholds. The Cox proportional hazards models were fitted with clinical variables, Minkowski functionals features as well as both combined. The risk prediction performances of the Minkowski functionals and combined models were validated on a separate test dataset. The sex-specific survival difference of the entire cohort was analyzed according to MGMT methylation status via Kaplan-Meier survival curves. Results Thirty-three Minkowski features (11 area, 11 perimeter and 11 genus) for each patient were acquired giving a total of 3729 features. Cox regression models fitted with clinical data, Minkowski features, and both combined had incremental concordance indices of 0.577 (P = 0.02), 0.706 (P = 0.02) and 0.714 (P = 0.01) respectively. The prediction error rate of the combined model-having clinical and Minkowski features-was lower than that of Minkowski functionals model (0.135 and 0.161, respectively) when validated on a test No sex-specific survival difference was found according to MGMT methylation status (male, P = 0.2; female, P = 0.22). Conclusions Minkowski functionals features computed from peritumoral hyperintensity can capture heterogeneity of glioblastoma on T2WI and have additive prognostic value in predicting survival, demonstrating their potential in complementing currently available prognostic parameters.	[Choi, Yangsean; Ahn, Kook Jin; Nam, Yoonho; Jang, Jinhee; Shin, Na-Young; Choi, Hyun Seok; Jung, So-Lyung; Kim, Bum-soo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Ahn, KJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	ahn-kj@catholic.ac.kr	KIM, Bum-soo/F-3086-2018; Choi, Yangsean/AAR-5274-2020	KIM, Bum-soo/0000-0002-3870-6813; 				Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Aubry M, 2015, ONCOTARGET, V6, P12094, DOI 10.18632/oncotarget.3297; Booth TC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176528; Canuto HC, 2009, MAGN RESON MED, V61, P1218, DOI 10.1002/mrm.21946; Chaddad A, 2016, IEEE ENG MED BIO, P4035, DOI 10.1109/EMBC.2016.7591612; Chen Y, 2013, ARCH MED RES, V44, P281, DOI 10.1016/j.arcmed.2013.04.004; Chow D, 2018, AM J ROENTGENOL, V210, P30, DOI 10.2214/AJR.17.18754; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Fox MJ, 2016, J MAGN RESON IMAGING, V43, P903, DOI 10.1002/jmri.25057; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Gutenberg A, 2013, BRIT J NEUROSURG, V27, P772, DOI 10.3109/02688697.2013.791664; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kickingereder P, 2018, NEURO-ONCOLOGY, V20, P848, DOI 10.1093/neuonc/nox188; Kickingereder P, 2016, RADIOLOGY, V280, P880, DOI 10.1148/radiol.2016160845; Kolakshyapati M, 2018, J NEUROSURG, V128, P667, DOI 10.3171/2016.10.JNS161694; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Larkin TJ, 2014, MAGN RESON MED, V71, P402, DOI 10.1002/mrm.24644; Lemee JM, 2015, NEURO-ONCOLOGY, V17, P1322, DOI 10.1093/neuonc/nov119; Li HL, 2016, CLIN NEUROL NEUROSUR, V151, P31, DOI 10.1016/j.clineuro.2016.10.004; Liu Y, 2017, AM J NEURORADIOL, V38, P1695, DOI 10.3174/ajnr.A5279; Mazaris P, 2014, CLIN NEUROL NEUROSUR, V120, P103, DOI 10.1016/j.clineuro.2014.03.001; McMillan KM, 2009, J MAGN RESON IMAGING, V29, P251, DOI 10.1002/jmri.21659; Michielsen K, 2001, PHYS REP, V347, P462; Mogensen UB, 2012, J STAT SOFTW, V50, P1; Molenaar RJ, 2014, NEURO-ONCOLOGY, V16, P1263, DOI 10.1093/neuonc/nou005; Ostrom QT, 2015, CANCER TREAT RES, V163, P1, DOI 10.1007/978-3-319-12048-5_1; Park CK, 2011, NEURO-ONCOLOGY, V13, P195, DOI 10.1093/neuonc/noq162; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Prasanna P, 2017, EUR RADIOL, V27, P4188, DOI 10.1007/s00330-016-4637-3; Sanai N, 2009, NEUROTHERAPEUTICS, V6, P478, DOI 10.1016/j.nurt.2009.04.005; Schiffgens S, 2016, ONCOTARGET, V7, P55169, DOI 10.18632/oncotarget.10465; Schoenegger K, 2009, EUR J NEUROL, V16, P874, DOI 10.1111/j.1468-1331.2009.02613.x; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Yang P, 2015, ONCOTARGET, V6, P40896, DOI 10.18632/oncotarget.5683; Yang SH, 2012, J NEURO-ONCOL, V106, P243, DOI 10.1007/s11060-011-0668-4; Yang W, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aao5253	38	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217785	10.1371/journal.pone.0217785	http://dx.doi.org/10.1371/journal.pone.0217785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150499	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100107
J	Kubuga, CK; Abizari, AR; Song, WO				Kubuga, Clement Kubreziga; Abizari, Abdul-Razak; Song, Won O.			Iodine status of reproductive age women and their toddlers in northern Ghana improved through household supply of iodized salt and weekly indigenous meal consumption	PLOS ONE			English	Article							URINARY IODINE; DEFICIENCY; DIGESTION; NUTRITION; TRENDS; MILK	Iodine deficiency (ID) during pregnancy results in pregnancy losses, intrauterine growth retardation, and lower IQ in the offspring. Even after two decades of universal salt iodization (USI) implementation, the efficacy of USI has not been reported in high risk groups in vulnerable regions in Ghana. We aimed to assess and improve ID status in childbearing age women (all lactating women) and their toddlers in northern Ghana, a geographically and socioeconomically vulnerable region. We provided weekly supply of household iodized salt and community-based feeding of native Hibiscus Sabdariffaa leaves meal (HSM) prepared with iodized salt to women and their toddlers in intervention (n = 60) vs. control group (n = 60). At baseline, ID was prevalent in women (36%) and their toddlers (29%). For women, both median UIC values for intervention (57.4 ug/l) and control group (65.1 ug/l) were below the recommended UIC value of 100 ug/l with no significant differences between the two groups (p = 0.2778). At the endpoint, median UIC for the intervention group (123.6 ug/l) was significantly higher (p = 0.008) than the control group (59.7 ug/l). Our results suggest that weekly supply of iodized salt along with the feeding HSM is an effective channel for improving iodine status of economically disadvantaged groups in communities remote from coastal lands. Furthermore, our results suggest that decreased median UIC among lactating mothers does not necessarily imply lower iodine status for their breastfed toddlers. And finally, the observed median UIC<100 ug/l may point to a non-improvement in iodine status for the past decade for Ghana. There is a need to revisit, assess, and ascertain the challenges in preventing populations from attaining the intended benefits of the USI policy in Ghana.	[Kubuga, Clement Kubreziga; Abizari, Abdul-Razak] Univ Dev Studies, Nutr Sci Dept, Tamale, Ghana; [Song, Won O.] Michigan State Univ, Food Sci & Human Nutr Dept, E Lansing, MI 48824 USA	University for Development Studies; Michigan State University	Song, WO (corresponding author), Michigan State Univ, Food Sci & Human Nutr Dept, E Lansing, MI 48824 USA.	song@msu.edu		Song, Won/0000-0002-4372-4215	G Borlaug LEAP; BHEARD	G Borlaug LEAP; BHEARD	This project was mainly funded by G Borlaug LEAP and BHEARD, https://borlaugleap.org/; http://www.canr.msu.edu/bheard/received by CKK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizari A.-R., 2016, PUBLIC HEALTH NUTR, P1; Andersson M, 2007, PUBLIC HEALTH NUTR, V10, P1606, DOI 10.1017/S1368980007361004; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; [Anonymous], 2007, ASS IOD DEF DIS MON; Bath S., 2008, Journal of Human Nutrition and Dietetics, V21, P379, DOI 10.1111/j.1365-277X.2008.00881_9.x; Bath S, 2008, J HUM NUTR DIET, V21, P280; Cappuccio F, 2014, 20 IEA WORLD C EP 17; Cogill B, 2003, ANTHROPOMETRIC INDIC; de Benoist B, 2008, FOOD NUTR BULL, V29, P195, DOI 10.1177/156482650802900305; DELANGE F, 1994, THYROID, V4, P107, DOI 10.1089/thy.1994.4.107; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; Diosady L. L., 1997, Food and Nutrition Bulletin, V18, P388; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Haldimann M, 2015, PUBLIC HEALTH NUTR, V18, P1333, DOI 10.1017/S1368980014002018; Hedayati M, 2007, J CLIN LAB ANAL, V21, P286, DOI 10.1002/jcla.20185; Hedayati M, 2011, CLIN CHEM LAB MED, V49, P281, DOI 10.1515/CCLM.2011.053; Hess S. Y., 2016, PUBLIC HEALTH NUTR, P1; Hollowell JG, 1998, J CLIN ENDOCR METAB, V83, P3401, DOI 10.1210/jc.83.10.3401; Hurrell RF, 1997, EUR J CLIN NUTR, V51, pS9; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Konig F, 2011, J NUTR, V141, P2049, DOI 10.3945/jn.111.144071; Kubuga CK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010198; Lee KW, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060325; Lee KW, 2016, INT J FOOD SCI NUTR, V67, P184, DOI 10.3109/09637486.2016.1144717; Li M, 2006, MED J AUSTRALIA, V184, P307, DOI 10.5694/j.1326-5377.2006.tb00248.x; Lynch SR, 2011, J NUTR, V141, p763S, DOI 10.3945/jn.110.130609; Nazeri P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020180; Nyumuah RO, 2012, FOOD NUTR BULL, V33, pS293, DOI 10.1177/15648265120334S305; Pearce EN, 2013, THYROID, V23, P523, DOI 10.1089/thy.2013.0128; Ross AC, 2014, MODERN NUTR HLTH DIS, V11; Simpong DL, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0119-y; Spybrook J, OPTIMAL DESIGN PLUS, V5, P2012; Vanderpump MPJ, 2012, INT J EPIDEMIOL, V41, P601, DOI 10.1093/ije/dys059; Vanderpump MPJ, 2011, LANCET, V377, P2007, DOI 10.1016/S0140-6736(11)60693-4; World Health Organization, 2004, VIT MIN REQ HUM NUTR; World Health Organization, 2017, ABN DEV IOD DEF; World Health Organization, 2013, UR IOD CONC DET IOD; Zhao JK, 1999, PUBLIC HEALTH NUTR, V2, P173, DOI 10.1017/S1368980099000221; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216931	10.1371/journal.pone.0216931	http://dx.doi.org/10.1371/journal.pone.0216931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150410	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100027
J	Pedruzzi, G; Rouzine, IM				Pedruzzi, Gabriele; Rouzine, Igor M.			Epistasis detectably alters correlations between genomic sites in a narrow parameter window	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMPENSATORY MUTATIONS; BENEFICIAL MUTATIONS; STATISTICAL-METHODS; DRUG-RESISTANCE; HIV-1 PROTEASE; EVOLUTION; SELECTION; FITNESS; LINKAGE	Different genomic sites evolve inter-dependently due to the combined action of epistasis, defined as a non-multiplicative contribution of alleles at different loci to genome fitness, and the physical linkage of different loci in genome. Both epistasis and linkage, partially compensated by recombination, cause correlations between allele frequencies at the loci (linkage disequilibrium, LD). The interaction and competition between epistasis and linkage are not fully understood, nor is their relative sensitivity to recombination. Modeling an adapting population in the presence of random mutation, natural selection, pairwise epistasis, and random genetic drift, we compare the contributions of epistasis and linkage. For this end, we use a panel of haplotype-based measures of LD and their various combinations calculated for epistatic and non-epistatic pairs separately. We compute the optimal percentages of detected and false positive pairs in a one-time sample of a population of moderate size. We demonstrate that true interacting pairs can be told apart in a sufficiently short genome within a narrow window of time and parameters. Outside of this parameter region, unless the population is extremely large, shared ancestry of individual sequences generates pervasive stochastic LD for non-interacting pairs masking true epistatic associations. In the presence of sufficiently strong recombination, linkage effects decrease faster than those of epistasis, and the detection of epistasis improves. We demonstrate that the epistasis component of locus association can be isolated, at a single time point, by averaging haplotype frequencies over multiple independent populations. These results demonstrate the existence of fundamental restrictions on the protocols for detecting true interactions in DNA sequence sets.	[Pedruzzi, Gabriele; Rouzine, Igor M.] Sorbonne Univ, Inst Biol Paris Seine, Lab Biol Computationelle & Quantitat, LCQB, Paris, France	UDICE-French Research Universities; Sorbonne Universite	Rouzine, IM (corresponding author), Sorbonne Univ, Inst Biol Paris Seine, Lab Biol Computationelle & Quantitat, LCQB, Paris, France.	igor.rouzine@sorbonne-universite.fr	Rouzine, Igor M/AFO-3706-2022	Rouzine, Igor M/0000-0002-0744-6705	Agence National de Recherche, France [J16R389]	Agence National de Recherche, France(French National Research Agency (ANR))	Author IMR is funded by Agence National de Recherche, France, grant J16R389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; BARTON NH, 1995, GENETICS, V140, P821; Batorsky R, 2011, P NATL ACAD SCI USA, V108, P5661, DOI 10.1073/pnas.1102036108; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Brunet E, 2008, GENETICS, V179, P603, DOI 10.1534/genetics.107.079319; Bullock JM, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.08.010; Combarros O, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-22; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Desai MM, 2007, GENETICS, V177, P1001, DOI 10.1534/genetics.107.075812; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; FELSENSTEIN J, 1974, GENETICS, V78, P737; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gheorghiu-Svirschevski S, 2007, MOL BIOL EVOL, V24, P574, DOI 10.1093/molbev/msl189; Gonzalez-Ortega E, 2011, ANTIVIR RES, V92, P479, DOI 10.1016/j.antiviral.2011.10.010; Good BH, 2015, GENETICS, V199, P177, DOI 10.1534/genetics.114.172460; Good BH, 2012, P NATL ACAD SCI USA, V109, P4950, DOI 10.1073/pnas.1119910109; Hallatschek O, 2011, P NATL ACAD SCI USA, V108, P1783, DOI 10.1073/pnas.1013529108; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; KIMURA M, 1965, GENETICS, V52, P875; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; Levin BR, 2000, GENETICS, V154, P985; LEWONTIN RC, 1988, GENETICS, V120, P849; McKinney B. A., 2012, Frontiers in Genetics, V2, P109, DOI 10.3389/fgene.2011.00109; McVean GAT, 2000, GENETICS, V155, P929; Neher RA, 2010, GENETICS, V184, P467, DOI 10.1534/genetics.109.109009; Neher RA, 2013, P NATL ACAD SCI USA, V110, P437, DOI 10.1073/pnas.1213113110; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Neher RA, 2009, P NATL ACAD SCI USA, V106, P6866, DOI 10.1073/pnas.0812560106; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Noviello CM, 2011, J VIROL, V85, P4730, DOI 10.1128/JVI.00099-11; Pedruzzi G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006426; Piana S, 2002, PROTEIN SCI, V11, P2393, DOI 10.1110/ps.0206702; Ritchie MD, 2011, ANN HUM GENET, V75, P172, DOI 10.1111/j.1469-1809.2010.00630.x; Rouzine IM, 2008, THEOR POPUL BIOL, V73, P24, DOI 10.1016/j.tpb.2007.10.004; Rouzine IM, 2010, THEOR POPUL BIOL, V77, P189, DOI 10.1016/j.tpb.2010.02.001; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P587, DOI 10.1073/pnas.242719299; Rouzine IM, 2005, GENETICS, V170, P7, DOI 10.1534/genetics.104.029926; Tsimring LS, 1996, PHYS REV LETT, V76, P4440, DOI 10.1103/PhysRevLett.76.4440; Van Steen K, 2012, BRIEF BIOINFORM, V13, P1, DOI 10.1093/bib/bbr012; Walczak AM, 2012, GENETICS, V190, P753, DOI 10.1534/genetics.111.134544; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131; Xiao YH, 2016, CELL HOST MICROBE, V19, P493, DOI 10.1016/j.chom.2016.03.009; Zhang Y, 2011, ANN HUM GENET, V75, P183, DOI 10.1111/j.1469-1809.2010.00621.x; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0214036	10.1371/journal.pone.0214036	http://dx.doi.org/10.1371/journal.pone.0214036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150393	gold, Green Submitted, Green Published			2022-12-26	WOS:000469759100009
J	Andersson, J; Rosell, M; Kockum, K; Lilja-Lund, O; Soderstrom, L; Laurell, K				Andersson, Johanna; Rosell, Michelle; Kockum, Karin; Lilja-Lund, Otto; Soderstrom, Lars; Laurell, Katarina			Prevalence of idiopathic normal pressure hydrocephalus: A prospective, population-based study	PLOS ONE			English	Article							SURGERY; MRI; SCALE	Background Idiopathic normal pressure hydrocephalus (iNPH) causing gait impairment, dementia and urinary incontinence among the elderly, is probably under-diagnosed and under-treated. Despite being known since the 1960s, there is still a lack of prospective, population-based studies on the prevalence of iNPH. Such studies are warranted to minimize selection bias and estimate the true prevalence of the disease. Methods The prevalence of iNPH was determined in a randomly selected sample of residents, aged 65 years and older, in the Swedish county of Jamtland. Out of 1,000 individuals invited to participate, 673 (67.3%) completed a questionnaire with seven questions on iNPH symptoms. A subgroup, with and without self-reported symptoms, participated in clinical and radiological evaluations and were diagnosed according to international guidelines. Measurement of cerebrospinal fluid opening pressure was not performed as it was considered too invasive. Results Those who reported at least two symptoms in the questionnaire (n = 117) and 51 randomly selected individuals with 0-1 symptom participated in further examinations. Out of them, 25 individuals received the diagnosis probable iNPH according to American-European guidelines (except for the criterion of CSF opening pressure) corresponding to a prevalence of 3.7%. The prevalence of iNPH was four times higher among those aged 80 years and older (8.9%) than among those aged 65-79 years (2.1%) (p < 0.001). The difference in prevalence between men (4.6%) and women (2.9%) was not significant (p = 0.24). When iNPH was diagnosed according to the Japanese guidelines the prevalence was 1.5% Conclusions In this prospective, population-based study the prevalence of iNPH was 3.7% among individuals 65 years and older, and more common in the higher age group, 80 years and above. INPH should be increasingly recognized since it is a fairly common condition and an important cause of gait impairment and dementia among the elderly that can be effectively treated by shunt surgery.	[Andersson, Johanna; Rosell, Michelle; Kockum, Karin; Lilja-Lund, Otto; Laurell, Katarina] Umea Univ, Dept Pharmacol & Clin Neurosci, Neurol, Umea, Sweden; [Soderstrom, Lars] Unit Res Dev & Educ, Ostersund, Sweden	Umea University	Andersson, J (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Neurol, Umea, Sweden.	johanna.andersson@umu.se	Lilja-Lund, Otto/ABD-7387-2020	Lilja-Lund, Otto/0000-0001-5857-9287; Laurell, Katarina/0000-0002-7504-8354; Soderstrom, Lars/0000-0002-6474-6501	Region Jamtland Harjedalen; "Visare Norr"; Syskonen Persson; Jamtlands cancer och omvardnadsfond; donation fund "klinisk Neurovetenskap	Region Jamtland Harjedalen; "Visare Norr"; Syskonen Persson; Jamtlands cancer och omvardnadsfond; donation fund "klinisk Neurovetenskap	KL, JA, KK, OLL received governmental funding from Region Jamtland Harjedalen. KL received governmental funding from "Visare Norr". JA, OLL and KK received funding from the donation funds of "Syskonen Persson" and "Jamtlands cancer och omvardnadsfond". JA receiced funding from the donation fund "klinisk Neurovetenskap. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Andersson J, 2017, eNeurologicalSci, V7, P27, DOI 10.1016/j.ensci.2017.04.002; Andren K, 2014, J NEUROL NEUROSUR PS, V85, P806, DOI 10.1136/jnnp-2013-306117; Brean A, 2008, ACTA NEUROL SCAND, V118, P48, DOI 10.1111/j.1600-0404.2007.00982.x; Brean A, 2009, ACTA NEUROL SCAND, V120, P314, DOI 10.1111/j.1600-0404.2009.01250.x; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Factora R, 2008, GERIATRICS-US, V63, P32; Hashimoto M, 2010, FLUIDS BARRIERS CNS, V7, P2, DOI 10.1186/1743-8454-7-18; Hellstrom P, 2012, ACTA NEUROL SCAND, V126, P229, DOI 10.1111/j.1600-0404.2012.01677.x; Hiraoka K, 2008, NEUROL MED-CHIR, V48, P197, DOI 10.2176/nmc.48.197; Iseki C, 2014, J NEUROL SCI, V339, P108, DOI 10.1016/j.jns.2014.01.033; Iseki C, 2009, J NEUROL SCI, V277, P54, DOI 10.1016/j.jns.2008.10.004; Japanese Society of Normal Pressure Hydrocephalus Guidelines Committee. [Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus], 2004, GUID MAN ID NORM PRE; Jaraj D, 2014, NEUROLOGY, V82, P1449, DOI 10.1212/WNL.0000000000000342; Kockum K, 2018, EUR J NEUROL, V25, P569, DOI 10.1111/ene.13555; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Martin-Laez R, 2016, WORLD NEUROSURG, V87, P298, DOI 10.1016/j.wneu.2015.10.069; Martin-Laez R, 2015, WORLD NEUROSURG, V84, P2002, DOI 10.1016/j.wneu.2015.07.005; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; SCB Statistics Sweden, POP STAT; SPAR, SWED POP REG; Sundstrom N, 2017, BRIT J NEUROSURG, V31, P21, DOI 10.1080/02688697.2016.1229749; Tanaka N, 2009, NEUROEPIDEMIOLOGY, V32, P171, DOI 10.1159/000186501; Toma AK, 2013, ACTA NEUROCHIR, V155, P1977, DOI 10.1007/s00701-013-1835-5; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Virhammar J, 2014, J NEUROSURG, V120, P178, DOI 10.3171/2013.8.JNS13575	29	52	54	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217705	10.1371/journal.pone.0217705	http://dx.doi.org/10.1371/journal.pone.0217705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141553	Green Published, Green Submitted, gold			2022-12-26	WOS:000469323000074
J	Tura, H; Licoze, A				Tura, Halkeno; Licoze, Armando			Women's experience of intimate partner violence and uptake of Antenatal Care in Sofala, Mozambique	PLOS ONE			English	Article							HEALTH CONSEQUENCES; PREVALENCE; PREGNANCY; SYMPTOMS; HIV	Intimate partner violence (IPV) is associated with negative physical and mental health outcomes. Although maternal health services, especially antenatal care (ANC), can act as a link to IPV resources, women experiencing IPV likely have reduced uptake of ANC due to social and emotional barriers. Poor ANC uptake can also further exacerbate adverse pregnancy outcomes. However, there is limited research examining the association between IPV and ANC within the context of Mozambique. Using data from a study conducted to assess the impact of membership in savings groups on maternal health service utilization in Mozambique (N = 205), we investigated the association between IPV and uptake of ANC. Pearson chi-square and logistic regression were employed to examine the association between IPV and ANC service utilization. The mean age of the participants was 33.4 years (SD = 11.88). Overall, 47.3%, 83.4%, and 51.7% of the participants reported experiencing IPV, receiving at least one ANC, and four or more ANC, respectively. Women who reported experience of IPV had lower odds of receiving both at least one (AOR 0.31 [95% CI: 0.12-0.82]) and four or more ANC (AOR 0.50 [95% CI: 0.27-0.92]). Women who reported experience of IPV also had lower odds of receiving ANC from skilled personnel (AOR 0.32 [95% CI: 0.10-0.90]). Experience of IPV showed significant association with reduced ANC service utilization among women in the study area. Further study is needed to assess whether the negative association between IPV and ANC service utilization is also a causal relationship, the evidence which will then help guide a comprehensive intervention effort to improve maternal health services use.	[Tura, Halkeno] Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA; [Licoze, Armando] Oasis Mozambique, Sofala, Mozambique	University of Iowa	Tura, H (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA 52242 USA.	halkeno-tura@uiowa.edu	Zweigenthal, Virginia/AAW-6425-2021; Tura, Halkeno T/AAN-4939-2021	Zweigenthal, Virginia/0000-0003-3914-2156; Tura, Robsan/0000-0003-1245-6673	Oasis Mozambique	Oasis Mozambique	This project is funded by Oasis Mozambique The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript..	Allendorf K, 2010, STUD FAMILY PLANN, V41, P263, DOI 10.1111/j.1728-4465.2010.00252.x; [Anonymous], VIOLENCE AGAINST WOM; Antai D, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-56; Betron M., 2015, RECOGNIZING GENDER B; Borwankar R., 2008, GENDER BASED VIOLENC; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Cebola B., 2013, DOMESTIC VIOLENCE BE; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Hatcher AM, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19233; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Khan MN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198833; Koski AD, 2011, J HEALTH POPUL NUTR, V29, P245, DOI 10.3329/jhpn.v29i3.7872; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Mozambique demographic and health survey, 2011, MOZ DEM HLTH SURV 20; Omer K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0380-4; Pallitto CC, 2013, INT J GYNECOL OBSTET, V120, P3, DOI 10.1016/j.ijgo.2012.07.003; Peltzer K, 2013, GEN HOSP PSYCHIAT, V35, P545, DOI 10.1016/j.genhosppsych.2013.04.001; Rees K, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.712; Rutherford A, 2007, J EPIDEMIOL COMMUN H, V61, P676, DOI 10.1136/jech.2005.043711; Sharps PW, 2007, TRAUMA VIOLENCE ABUS, V8, P105, DOI 10.1177/1524838007302594; Stephenson R, 2006, INT FAM PLAN PERSPEC, V32, P201, DOI 10.1363/3220106; Stephenson R, 2016, VIOLENCE AGAINST WOM, V22, P1642, DOI 10.1177/1077801216630148; Sugg N, 2015, MED CLIN N AM, V99, P629, DOI 10.1016/j.mcna.2015.01.012; WHO Department of Reproductive Health and Research London School of Hygiene and Tropical Medicine South African Medical Research Council, 2013, GLOB REG EST VIOL WO, P51; Winter A, 2013, INT J GYNECOL OBSTET, V121, P218, DOI 10.1016/j.ijgo.2012.12.018; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization , 2002, WHO ANT CAR RAND TRA; Zacarias AE, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-35	30	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217407	10.1371/journal.pone.0217407	http://dx.doi.org/10.1371/journal.pone.0217407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125370	Green Published, gold, Green Submitted			2022-12-26	WOS:000468865700037
J	Liu, G; Khanna, V; Kirtane, A; Grill, A; Panyam, J				Liu, Garvey; Khanna, Vidhi; Kirtane, Ameya; Grill, Alex; Panyam, Jayanth			Chemopreventive efficacy of oral curcumin: a prodrug hypothesis	FASEB JOURNAL			English	Article						curcumin glucuronide; beta-glucuronidase; cancer prevention	BETA-GLUCURONIDASE; IN-VITRO; CANCER; VIVO; EXPRESSION; STABILITY; BIOTRANSFORMATION; PHARMACOKINETICS; DOXORUBICIN; ACTIVATION	Oral consumption of curcumin, a natural polyphenol, is associated with reduced incidence of cancer. Yet, a significant amount of the orally dosed compound is eliminated in the feces, and a major fraction of the absorbed compound is metabolized to inactive glucuronides, resulting in poor bioavailability (<1%). It is not known how oral curcumin exhibits chemopreventive activity. We propose curcumin glucuronide is an inflammation-responsive natural prodrug that is converted back to curcumin on demand at the site of action. Our studies show elevated levels of beta-glucuronidase, an enzyme that hydrolyzes the glycosidic bond of glucuronides to generate the parent compound, in human breast cancer. Oral administration of curcumin in mouse tumor models generated significant tumor levels of the polyphenol. Intravenous administration of the glucuronide resulted in the formation of curcumin in the tumor tissue. Chronic daily oral curcumin dosing led to tumor accumulation of curcumin and inhibition of tumor growth in tumor models with high beta-glucuronidase activity. Overall, the study presented here provides preliminary evidence for a novel mechanism of action for orally administered curcumin.-Liu, G., Khanna, V., Kirtane, A., Grill, A., Panyam, J. Chemopreventive efficacy of oral curcumin: a prodrug hypothesis.	[Liu, Garvey; Khanna, Vidhi; Kirtane, Ameya; Grill, Alex; Panyam, Jayanth] Univ Minnesota, Coll Pharm, Dept Pharmaceut, 308 Harvard St SE,Weaver Densford Hall, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Panyam, J (corresponding author), Univ Minnesota, Coll Pharm, Dept Pharmaceut, 308 Harvard St SE,Weaver Densford Hall, Minneapolis, MN 55455 USA.	jpanyam@umn.edu	Kirtane, Ameya/Y-8203-2019	Kirtane, Ameya/0000-0002-3779-0363; Panyam, Jayanth/0000-0002-8656-2244	University of Minnesota; U.S. National Institutes of Health, National Cancer Institute [CA 141996]	University of Minnesota(University of Minnesota System); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge Prof. Yu-Lin Leu of Chia Nan University of Pharmacy and Science (Tainan, Taiwan) for providing us with near-infrared fluorescent difluoromethylphenol-glucuronide probe. The authors thank Brenda Koniar (University of Minnesota, Minneapolis, MN, USA) for assistance with the animal studies and Jim Fischer (University of Minnesota) for assistance with liquid chromatography-mass spectrometry. Supported by a grant-in-aid award from the University of Minnesota and U.S. National Institutes of Health, National Cancer Institute Grant CA 141996 (to J.P.). The authors declare no conflicts of interest.	Arroo RRJ, 2014, PHYTOCHEM REV, V13, P853, DOI 10.1007/s11101-014-9355-3; Bachmeier BE, 2007, CELL PHYSIOL BIOCHEM, V19, P137, DOI 10.1159/000099202; Bertolini F, 2003, CANCER RES, V63, P4342; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bosslet K, 1998, CANCER RES, V58, P1195; Brusselbach S, 2004, METH MOLEC MED, V90, P303; Calogero RA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1745; Cheng TC, 2012, J AM CHEM SOC, V134, P3103, DOI 10.1021/ja209335z; Choi C, 2014, ONCOGENE, V33, P3668, DOI 10.1038/onc.2013.341; Cummings J, 2004, BIOCHEM PHARMACOL, V67, P31, DOI 10.1016/j.bcp.2003.07.019; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Di Carlo E, 1999, LAB INVEST, V79, P1261; Dodds HM, 2002, J PHARMACOL EXP THER, V303, P649, DOI 10.1124/jpet.102.039040; Grill AE, 2014, DRUG DELIV TRANSL RE, V4, P344, DOI 10.1007/s13346-014-0199-6; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Juan TY, 2009, CLIN CANCER RES, V15, P4600, DOI 10.1158/1078-0432.CCR-09-0090; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kazemi-Lomedasht F, 2013, ADV PHARM BULL, V3, P127, DOI 10.5681/apb.2013.021; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Liang GA, 2009, BIOORGAN MED CHEM, V17, P2623, DOI 10.1016/j.bmc.2008.10.044; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; Mohanty C, 2010, BIOMATERIALS, V31, P6597, DOI 10.1016/j.biomaterials.2010.04.062; Murdter TE, 2002, J PHARMACOL EXP THER, V301, P223, DOI 10.1124/jpet.301.1.223; Murdter TE, 1997, CANCER RES, V57, P2440; Nanni P, 2001, J EXP MED, V194, P1195, DOI 10.1084/jem.194.9.1195; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; Pal A, 2014, BIOORGAN MED CHEM, V22, P435, DOI 10.1016/j.bmc.2013.11.006; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Prasad, 1997, J Cardiovasc Pharmacol Ther, V2, P309, DOI 10.1177/107424849700200409; Prijovich ZM, 2009, MOL CANCER THER, V8, P940, DOI 10.1158/1535-7163.MCT-08-0812; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; RAVINDRANATH V, 1981, TOXICOLOGY, V22, P337, DOI 10.1016/0300-483X(81)90027-5; Sabolovic N, 2006, BIOPHARM DRUG DISPOS, V27, P181, DOI 10.1002/bdd.498; Sharan S, 2012, DRUG METAB DISPOS, V40, P1993, DOI 10.1124/dmd.112.046417; Sherwood RF, 1996, ADV DRUG DELIVER REV, V22, P269, DOI 10.1016/S0169-409X(96)00450-4; Shimoi K, 2005, METHOD ENZYMOL, V400, P263, DOI 10.1016/S0076-6879(05)00015-7; Shoji M, 2014, FOOD CHEM, V151, P126, DOI 10.1016/j.foodchem.2013.11.021; Sperker B, 2000, N-S ARCH PHARMACOL, V362, P110, DOI 10.1007/s002100000260; Thompson KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188873; Tomren MA, 2007, INT J PHARM, V338, P27, DOI 10.1016/j.ijpharm.2007.01.013; Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; Yuan L, 2003, MUTAT RES-FUND MOL M, V523, P55, DOI 10.1016/S0027-5107(02)00321-4	45	5	5	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					9453	9465		10.1096/fj.201900166R	http://dx.doi.org/10.1096/fj.201900166R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31136203	Green Published			2022-12-26	WOS:000478832900058
J	Bitra, A; Nemcovicova, I; Picarda, G; Doukov, T; Wang, J; Benedict, CA; Zajonc, DM				Bitra, Aruna; Nemcovicova, Ivana; Picarda, Gaelle; Doukov, Tzanko; Wang, Jing; Benedict, Chris A.; Zajonc, Dirk M.			Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); viral protein; protein-protein interaction; recombinant protein expression; cell-surface receptor; X-ray crystallography	TNF SUPERFAMILY; ENTRY; ACTIVATION; MEMBER; BTLA; GENE; HERPESVIRUSES; LYMPHOTOXIN; PROGRAM; VACCINE	Human cytomegalovirus (HCMV) is a beta-herpesvirus that has co-evolved with the host immune system to establish lifelong persistence. HCMV encodes many immunomodulatory molecules, including the glycoprotein UL144. UL144 is a structural mimic of the tumor necrosis factor receptor superfamily member HVEM (herpesvirus entry mediator), which binds to the various ligands LIGHT, LT alpha, BTLA, CD160, and gD. However, in contrast to HVEM, UL144 only binds BTLA, inhibiting T-cell activation. Here, we report the crystal structure of the UL144-BTLA complex, revealing that UL144 utilizes residues from its N-terminal cysteine-rich domain 1 (CRD1) to interact uniquely with BTLA. The shorter CRD2 loop of UL144 also alters the relative orientation of BTLA binding with both N-terminal CRDs. By employing structure-guided mutagenesis, we have identified a mutant of BTLA (L123A) that interferes with HVEM binding but preserves UL144 interactions. Furthermore, our results illuminate structural differences between UL144 and HVEM that explain its binding selectivity and highlight it as a suitable scaffold for designing superior, immune inhibitory BTLA agonists.	[Bitra, Aruna; Picarda, Gaelle; Wang, Jing; Benedict, Chris A.; Zajonc, Dirk M.] La Jolla Inst Immunol, Div Immune Regulat, La Jolla, CA 92037 USA; [Nemcovicova, Ivana] Slovak Acad Sci, Biomed Res Ctr, SK-84505 Bratislava, Slovakia; [Doukov, Tzanko] SLAC, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Slovak Academy of Sciences; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Ghent University	Zajonc, DM (corresponding author), Pfizer, Canc Immunol Discovery, 10777 Sci Ctr Dr, San Diego, CA 92129 USA.	Dirk.Zajonc@pfizer.com	Nemčovičová, Ivana/I-3477-2013; Nemčovičová, Ivana/ABA-6080-2021	Nemčovičová, Ivana/0000-0003-1733-9986; Nemčovičová, Ivana/0000-0003-1733-9986; Bitra, Aruna/0000-0003-1675-3544; Zajonc, Dirk/0000-0001-7215-1981; Doukov, Tzanko/0000-0001-8625-2572	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health under NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health under NIGMS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Lightsource (SSRL) for access to remote data collection and the SSRL beamline scientists for support. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by the National Institutes of Health under NIGMS Grant P41GM103393. We thank Kyowa Kirin Pharmaceutical Research, La Jolla, CA, for production and purification of recombinant UL144-Fc proteins.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benedict CA, 1999, J IMMUNOL, V162, P6967; Benedict CA, 2013, EXPERT REV VACCINES, V12, P1235, DOI 10.1586/14760584.2013.844653; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavrieli M, 2003, BIOCHEM BIOPH RES CO, V312, P1236, DOI 10.1016/j.bbrc.2003.11.070; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Holzerlandt R, 2002, GENOME RES, V12, P1739, DOI 10.1101/gr.334302; Lurain NS, 1999, J VIROL, V73, P10040, DOI 10.1128/JVI.73.12.10040-10050.1999; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; McFadden G, 2000, CURR OPIN MICROBIOL, V3, P371, DOI 10.1016/S1369-5274(00)00107-7; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson CA, 2008, J IMMUNOL, V180, P940, DOI 10.4049/jimmunol.180.2.940; Nemcovicova I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003224; Picarda G, 2018, J IMMUNOL, V200, P3881, DOI 10.4049/jimmunol.1800171; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Poole E, 2015, MED MICROBIOL IMMUN, V204, P421, DOI 10.1007/s00430-015-0401-6; Poole E, 2013, J VIROL, V87, P4261, DOI 10.1128/JVI.03497-12; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schlfiss MR, 2007, J PEDIATR-US, V151, P564, DOI 10.1016/j.jpeds.2007.07.015; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Sedy JR, 2017, J BIOL CHEM, V292, P21060, DOI 10.1074/jbc.M117.813295; Sedy JR, 2013, J IMMUNOL, V191, P828, DOI 10.4049/jimmunol.1300894; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Ware CF, 2011, CURR OPIN IMMUNOL, V23, P627, DOI 10.1016/j.coi.2011.08.008; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10519	10529		10.1074/jbc.RA119.009199	http://dx.doi.org/10.1074/jbc.RA119.009199			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31126984	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000478717100012
J	Mendez, A; Rojas, DA; Ponce, CA; Bustamante, R; Beltran, CJ; Toledo, J; Garcia-Angulo, VA; Henriquez, M; Vargas, SL				Mendez, Andrea; Rojas, Diego A.; Ponce, Carolina A.; Bustamante, Rebeca; Beltran, Carol J.; Toledo, Jorge; Garcia-Angulo, Victor A.; Henriquez, Mauricio; Vargas, Sergio L.			Primary infection by Pneumocystis induces Notch-independent Clara cell mucin production in rat distal airways	PLOS ONE			English	Article							VALPROIC ACID; MUCOUS METAPLASIA; MUC5AC EXPRESSION; EPITHELIAL-CELLS; PROTEIN; ASTHMA; LUNG; ASSOCIATION; CARINII; MODEL	Clara cells are the main airway secretory cells able to regenerate epithelium in the distal airways through transdifferentiating into goblet cells, a process under negative regulation of the Notch pathway. Pneumocystis is a highly prevalent fungus in humans occurring between 2 and 5 months of age, a period when airways are still developing and respiratory morbidity typically increases. Pneumocystis induces mucus hyperproduction in immunocompetent host airways and whether it can stimulate Clara cells is unknown. Markers of Clara cell secretion and Notch1 activation were investigated in lungs of immunocompetent rats at 40, 60, and 80 days of age during Pneumocystis primary infection with and without Valproic acid (VPA), a Notch inducer. The proportion of rats expressing mucin increased in Pneumocystis-infected rats respect to controls at 60 and 80 days of age. Frequency of distal airways Clara cells was maintained while mRNA levels for the mucin-encoding genes Muc5B and Muc5ac in lung homogenates increased 1.9 and 3.9 times at 60 days of infection (P. = 0.1609 and P. = 0.0001, respectively) and protein levels of the Clara cell marker CC10 decreased in the Pneumocystis-infected rats at 60 and 80 days of age (P. = 0.0118 & P. = 0.0388). CC10 and Muc5b co-localized in distal airway epithelium of Pneumocystis-infected rats at day 60. Co-localization of Muc5b and Ki67 as marker of mitosis in distal airways was not observed suggesting that Muc5b production by Clara cells was independent of mitosis. Notch levels remained similar and no transnucleation of activated Notch associated to Pneumocystis infection was detected. Unexpectedly, mucus was greatly increased at day 80 in Pneumocystis-infected rats receiving VPA suggesting that a Notch-independent mechanism was triggered. Overall, data suggests a Clara to goblet cell transdifferentiation mechanism induced by Pneumocystis and independent of Notch.	[Mendez, Andrea; Rojas, Diego A.; Ponce, Carolina A.; Bustamante, Rebeca; Garcia-Angulo, Victor A.; Vargas, Sergio L.] Univ Chile, Programa Microbiol & Micol, Inst Ciencias Biomed ICBM, Fac Med, Santiago, Chile; [Beltran, Carol J.] Univ Chile, Serv Gastroenterol, Hosp Clin Univ Chile, Santiago, Chile; [Beltran, Carol J.] Univ Chile, Fac Med, Santiago, Chile; [Toledo, Jorge] Univ Chile, Inst Neurociencias Biomed BNI, Lab Anal Imagenes Cient, SCIAN Lab,Fac Med, Santiago, Chile; [Henriquez, Mauricio] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiol & Biofis, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Vargas, SL (corresponding author), Univ Chile, Programa Microbiol & Micol, Inst Ciencias Biomed ICBM, Fac Med, Santiago, Chile.	svargas@med.uchile.cl	Rojas, Diego A./AAT-4173-2021; Vargas, Sergio L/E-5224-2016; Vargas, Sergio/AAC-1072-2022; /L-6849-2013	Rojas, Diego A./0000-0002-5388-1070; Vargas, Sergio/0000-0002-9299-6428; Toledo, Jorge/0000-0001-8678-558X; /0000-0001-7426-586X; Mendez, Andrea/0000-0001-8173-2921	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1140412]; Comision Nacional de Investigacion Cientifica y Tecnologica [ERANet LAC HID0254]; Vicerrectoria de Investigacion y Desarrollo Universidad de Chile grant [ENL 30/19]; Comision Nacional de Investigacion Cientifica y Tecnologica National Scholarship Doctoral Program	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica; Vicerrectoria de Investigacion y Desarrollo Universidad de Chile grant; Comision Nacional de Investigacion Cientifica y Tecnologica National Scholarship Doctoral Program	This work was supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico grant number 1140412 to SLV, Comision Nacional de Investigacion Cientifica y Tecnologica grant ERANet LAC HID0254 to SLV, Vicerrectoria de Investigacion y Desarrollo Universidad de Chile grant ENL 30/19 to SLV, and Comision Nacional de Investigacion Cientifica y Tecnologica National Scholarship Doctoral Program to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsa JA, 2000, RRD ANTIMICROB AG CH, V4, P1; Bobolea I, 2019, J INVEST ALLERG CLIN, V29, P168, DOI 10.18176/jiaci.0361; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Chatpun S, 2011, J TRAUMA, V70, P787, DOI 10.1155/2010/479364; Cui YH, 2011, AM J RHINOL ALLERGY, V25, P145, DOI 10.2500/ajra.2011.25.3596; Dietert K, 2015, HISTOCHEM CELL BIOL, V143, P277, DOI 10.1007/s00418-014-1279-x; Eddens T, 2016, AM J RESP CRIT CARE, V194, P807, DOI 10.1164/rccm.201511-2205OC; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Greenblatt DY, 2007, ONCOLOGIST, V12, P942, DOI 10.1634/theoncologist.12-8-942; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hayashi T, 2004, VIRCHOWS ARCH, V444, P66, DOI 10.1007/s00428-003-0926-8; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Ito T, 2000, DEVELOPMENT, V127, P3913; Iturra PA, 2018, AM J PATHOL, V188, P417, DOI 10.1016/j.ajpath.2017.10.019; Jang S, 2017, FEBS LETT, V591, P393, DOI 10.1002/1873-3468.12544; Kouznetsova I, 2007, AM J RESP CELL MOL, V36, P286, DOI 10.1165/rcmb.2006-0008OC; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morris A, 2004, AM J RESP CRIT CARE, V170, P408, DOI 10.1164/rccm.200401-094OC; Okuda K, 2019, AM J RESP CRIT CARE, V199, P715, DOI 10.1164/rccm.201804-0734OC; Ou-Yang HF, 2013, RESPIRATION, V86, P341, DOI 10.1159/000350647; Perez Francisco J, 2014, Results Immunol, V4, P58, DOI 10.1016/j.rinim.2014.07.001; Phaybouth V, 2006, AM J PHYSIOL-LUNG C, V290, pL222, DOI 10.1152/ajplung.00148.2005; Platta CS, 2008, J SURG RES, V148, P31, DOI 10.1016/j.jss.2008.03.008; Ponce CA, 2010, CLIN INFECT DIS, V50, P347, DOI 10.1086/649868; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reid AT, 2018, PHARMACOL THERAPEUT, V185, P155, DOI 10.1016/j.pharmthera.2017.12.009; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Rogers DF, 2003, INT J BIOCHEM CELL B, V35, P1, DOI 10.1016/S1357-2725(02)00083-3; Rojas DA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39079-4; Schnackenberg LK, 2006, OMICS, V10, P1, DOI 10.1089/omi.2006.10.1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Swain SD, 2012, AM J RESP CELL MOL, V46, P290, DOI 10.1165/rcmb.2011-0154OC; Swain SD, 2011, INFECT IMMUN, V79, P1905, DOI 10.1128/IAI.01273-10; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tsao PN, 2011, DEVELOPMENT, V138, P3533, DOI 10.1242/dev.063727; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Tyner JW, 2006, J CLIN INVEST, V116, P309, DOI 10.1172/JCI25167; Valque H, 2011, HISTOCHEM CELL BIOL, V136, P699, DOI 10.1007/s00418-011-0872-5; van den Berge M, 2011, CHEST, V139, P412, DOI 10.1378/chest.10-1210; Vargas SL, 2013, CLIN INFECT DIS, V56, P171, DOI 10.1093/cid/cis870; Vargas SL, 1999, CLIN INFECT DIS, V29, P1489, DOI 10.1086/313521; VARGAS SL, 1995, J INFECT DIS, V172, P506, DOI 10.1093/infdis/172.2.506; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176; Zheng XF, 2017, EXP CELL RES, V358, P129, DOI 10.1016/j.yexcr.2017.06.006; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	51	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217684	10.1371/journal.pone.0217684	http://dx.doi.org/10.1371/journal.pone.0217684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170201	gold, Green Submitted, Green Published			2022-12-26	WOS:000470263700048
J	Shah, NB; Mitchell, RE; Proctor, ST; Choi, L; DeClercq, J; Jolly, JA; Hemnes, AR; Zuckerman, AD				Shah, Nisha B.; Mitchell, Rhonita E.; Proctor, Stephanie Terry; Choi, Leena; DeClercq, Joshua; Jolly, Jacob A.; Hemnes, Anna R.; Zuckerman, Autumn D.			High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach	PLOS ONE			English	Article							CARE; THERAPY; TRANSITIONS; MANAGEMENT	Phosphodiesterase-5 inhibitors (PDE-5I) have demonstrated improvement in disease symptoms and quality of life for patients with pulmonary arterial hypertension (PAH). Despite these benefits, reported adherence to PDE-5I therapy is sub-optimal. Clinical pharmacists at an integrated practice site are in a unique position to mitigate barriers related to PAH therapy including medication adherence and costs. The primary objective of this study was to assess medication adherence to PDE-5I therapy within an integrated care model at an academic institution. The secondary objective was to assess the impact of out-of-pocket (OOP) cost, frequency of dosing, adverse events (AE) and PAH-related hospitalizations on medication adherence. We performed a retrospective cohort analysis of adult patients with PAH who were prescribed PDE-5I therapy by the center's outpatient pulmonary clinic and who received medication management through the center's specialty pharmacy. We defined optimal medication adherence as proportion of days covered (PDC) >= 80%. Clinical data including AEs and PAH-related hospitalizations were extracted from the electronic medical record, and financial data from pharmacy claims. Of the 131 patients meeting inclusion criteria, 94% achieved optimal adherence of >= 80% PDC. In this study population, 47% of patients experienced an AE and 27% had at least one hospitalization. The median monthly OOP cost was $0.62. Patients with PDC<80% were more likely to report an AE compared to patients with PDC >= 80% (p = 0.002). Hospitalization, OOP cost, and frequency of dosing were not associated with adherence in this cohort. Patients receiving PDE-5I therapy through an integrated model achieved high adherence rates and low OOP costs.	[Shah, Nisha B.; Mitchell, Rhonita E.; Jolly, Jacob A.; Zuckerman, Autumn D.] Vanderbilt Univ, Med Ctr, Vanderbilt Specialty Pharm Serv, Nashville, TN 37235 USA; [Proctor, Stephanie Terry] Huntsville Dist Mem Hosp, Dept Pharm, Huntsville, AL USA; [Choi, Leena; DeClercq, Joshua] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Hemnes, Anna R.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Shah, NB (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Specialty Pharm Serv, Nashville, TN 37235 USA.	nisha.b.shah@vumc.org						Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Bagwell A, 2017, J MANAG CARE SPEC PH, V23, P815, DOI 10.18553/jmcp.2017.23.8.815; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Brantley AF, 2018, AM J HEALTH-SYST PH, V75, pS1, DOI 10.2146/ajhp160652; Burger CD, 2018, J MANAG CARE SPEC PH, V24, P834, DOI 10.18553/jmcp.2018.17391; Burger CD, 2014, CHEST, V146, P1263, DOI 10.1378/chest.14-0193; Cawthon C, 2012, J HEALTH COMMUN, V17, P312, DOI 10.1080/10810730.2012.712619; Copher Ronda, 2012, J Med Econ, V15, P947, DOI 10.3111/13696998.2012.690801; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01889-2018; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Grady D, 2017, PULM CIRC, V8, DOI 10.1177/2045893217743616; Hanson RL, 2014, AM J HEALTH-SYST PH, V71, P463, DOI 10.2146/ajhp130495; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Macaulay Tracy E, 2016, J Pharm Pract, V29, P67, DOI 10.1177/0897190015615902; Mcgoon MD, 2008, MAYO CLIN PROC, V83, P923, DOI 10.4065/83.8.923; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Nau DP, 2012, PROPORTION DAYS COVE, P1; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Taichman DB, 2014, CHEST, V146, P449, DOI 10.1378/chest.14-0793; Waxman Aaron, 2013, J Med Econ, V16, P298, DOI 10.3111/13696998.2012.756399	23	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217798	10.1371/journal.pone.0217798	http://dx.doi.org/10.1371/journal.pone.0217798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170217	Green Published, gold, Green Submitted			2022-12-26	WOS:000470263700057
J	Bychkov, M; Shenkarev, Z; Shulepko, M; Shlepova, O; Kirpichnikov, M; Lyukmanova, E				Bychkov, Maxim; Shenkarev, Zakhar; Shulepko, Mikhail; Shlepova, Olga; Kirpichnikov, Mikhail; Lyukmanova, Ekaterina			Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of alpha 7 nicotinic acetylcholine receptors	PLOS ONE			English	Article							PROTEIN-KINASE-C; BACTERIAL EXPRESSION; P38 MAPK; ACTIVATION; GENE; MECHANISMS; SLURP-1; P53; NEUROMODULATOR; PROLIFERATION	Lynx1 is the first three-finger prototoxin found in the mammalian central nervous system. It is a GPI-anchored protein modulating nicotinic acetylcholine receptors (nAChRs) in the brain. Besides the brain, the Lynx1 protein was found in the lung and kidney. Endogenous Lynx1 controls the nicotine-induced up-regulation of the expression of alpha 7 type nAChRs in lung adenocarcinoma A549 cells as well as the cell growth. Here, we analyzed the Lynx1 expression in the set of human epithelial cells. The Lynx1 expression both at the mRNA and protein level was detected in normal oral keratinocytes, and lung, colon, epidermal, and breast cancer cells, but not in embryonic kidney cells. Co-localization of Lynx1 with alpha 7-nAChRs was revealed in a cell membrane for lung adenocarcinoma A549 and colon carcinoma HT-29 cells, but not for breast adenocarcinoma MCF-7 and epidermoid carcinoma A431 cells. The recombinant water-soluble variant of Lynx1 without a GPI-anchor (wsLynx1) inhibited the growth of A549 cells causing cell cycle arrest via modulation of alpha 7-nAChRs and activation of different intracellular signaling cascades, including PKC/IP3, MAP/ERK, p38, and JNK pathways. A549 cells treatment with ws-Lynx1 resulted in phosphorylation of the proapoptotic tumor suppressor protein p53 and different kinases participated in the regulation of gene transcription, cell growth, adhesion, and differentiation. Externalization of phosphatidylserine, an early apoptosis marker, observed by flow cytometry, confirmed the induction of apoptosis in A549 cells upon the ws-Lynx1 treatment. Our data revealed the ability of ws-Lynx1 to regulate homeostasis of epithelial cancer cells.	[Bychkov, Maxim; Shenkarev, Zakhar; Shulepko, Mikhail; Shlepova, Olga; Lyukmanova, Ekaterina] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Shenkarev, Zakhar; Shlepova, Olga; Lyukmanova, Ekaterina] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia; [Kirpichnikov, Mikhail] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; Lomonosov Moscow State University	Lyukmanova, E (corresponding author), RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Lyukmanova, E (corresponding author), Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia.	ekaterina-lyukmanova@yandex.ru	Shlepova, Olga/AAM-8065-2020; Shenkarev, Zakhar/P-1808-2015	Lyukmanova, Ekaterina/0000-0002-9728-9407; Kirpichnikov, Mikhail/0000-0001-8170-1607; Shenkarev, Zakhar/0000-0003-1383-3522	Russian Science Foundation [17-74-20161]; Russian Foundation of Basic Researches [18-29-01050]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation of Basic Researches(Russian Foundation for Basic Research (RFBR))	The study was supported by the Russian Science Foundation (http://www.rscf.ru/en/, project 17-74-20161 issued to M.S. and M.B.), and the Russian Foundation of Basic Researches (http://www.rfbr.ru/rffi/eng, the study of kinases phosphorylation, project 18-29-01050 issued to E.L., M.B., M.S., Z.S., and M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei MH, 2016, EUR J CANCER, V52, P188, DOI 10.1016/j.ejca.2015.10.003; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; Allan CM, 2016, J INVEST DERMATOL, V136, P436, DOI 10.1016/j.jid.2015.11.003; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Betapudi V, 2016, FASEB J, V30, P3515, DOI 10.1096/fj.201500040; Bilal Erhan, 2010, Genes Cancer, V1, P1063, DOI 10.1177/1947601910395583; Bocharov EV, 2003, APPL MAGN RESON, V24, P247, DOI 10.1007/BF03166664; Bychkov ML, 2018, ACTA NATURAE, V10, P57; Cardinale A, 2012, CRIT REV TOXICOL, V42, P68, DOI 10.3109/10408444.2011.623150; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Cui X, 2007, ONCOGENE, V26, P4253, DOI 10.1038/sj.onc.1210222; da Silva CP, 2000, BBA-MOL CELL RES, V1498, P122, DOI 10.1016/S0167-4889(00)00089-6; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Fu XW, 2015, INT IMMUNOPHARMACOL, V29, P93, DOI 10.1016/j.intimp.2015.05.022; Fu XW, 2012, AM J PHYSIOL-LUNG C, V303, pL661, DOI 10.1152/ajplung.00075.2012; George AA, 2017, FASEB J, V31, P1398, DOI 10.1096/fj.201600733R; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Guo JJ, 2008, CANCER RES, V68, P8473, DOI 10.1158/0008-5472.CAN-08-0131; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Hu YQ, 2015, ONCOL LETT, V10, P1350, DOI 10.3892/ol.2015.3462; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Ishii T, 2004, EUR RESPIR J, V23, P665, DOI 10.1183/09031936.04.00096204; Ji L, 2015, J BIOL CHEM, V290, P11729, DOI 10.1074/jbc.M115.639351; Kim HS, 2011, CLIN CANCER RES, V17, P1713, DOI 10.1158/1078-0432.CCR-10-2081; King JR, 2015, J BIOL CHEM, V290, P20060, DOI 10.1074/jbc.M115.647040; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Kumar S, 1998, J BIOL CHEM, V273, P25654, DOI 10.1074/jbc.273.40.25654; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loughner CL, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0074-2; Lyukmanova E, 2014, ACTA NATURAE, V6, P7; Lyukmanova EN, 2018, BRIT J PHARMACOL, V175, P1973, DOI 10.1111/bph.14194; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Lyukmanova EN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149733; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Min J, 2015, ONCOL REP, V34, P2871, DOI 10.3892/or.2015.4325; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Moriwaki Y, 2015, INT IMMUNOPHARMACOL, V29, P71, DOI 10.1016/j.intimp.2015.05.030; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Nissen NI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199643; Okada M, 2013, ONCOL REP, V30, P1957, DOI 10.3892/or.2013.2655; Parker RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188715; Perez C, 2016, AM J CLIN DERMATOL, V17, P63, DOI 10.1007/s40257-015-0157-1; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Pettersson A., 2008, Autonomic & Autacoid Pharmacology, V28, P109, DOI 10.1111/j.1474-8673.2008.00424.x; Sekhon HS, 2005, CELL TISSUE RES, V320, P287, DOI 10.1007/s00441-005-1077-9; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shulepko MA, 2011, RUSS J BIOORG CHEM+, V37, P543, DOI 10.1134/S1068162011050165; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; Stokes C, 2015, TRENDS PHARMACOL SCI, V36, P514, DOI 10.1016/j.tips.2015.05.002; Summers AE, 2003, LIFE SCI, V72, P2091, DOI 10.1016/S0024-3205(03)00089-4; Suntsova M, 2013, P NATL ACAD SCI USA, V110, P19472, DOI 10.1073/pnas.1318172110; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thomsen MS, 2016, NEUROBIOL AGING, V46, P13, DOI 10.1016/j.neurobiolaging.2016.06.009; Thomsen MS, 2014, BRAIN STRUCT FUNCT, V219, P1923, DOI 10.1007/s00429-013-0611-x; Throm Verena M, 2018, Oncotarget, V9, P11734, DOI 10.18632/oncotarget.24312; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Trombino S, 2004, CANCER RES, V64, P135, DOI 10.1158/0008-5472.CAN-03-1672; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; Tu SH, 2016, ONCOTARGET, V7, P77516, DOI 10.18632/oncotarget.12717; Vasilyeva NA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1702, DOI 10.1134/S0006297917130090; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wenzel U, 2004, CELL PHYSIOL BIOCHEM, V14, P65, DOI 10.1159/000076928; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185	73	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217339	10.1371/journal.pone.0217339	http://dx.doi.org/10.1371/journal.pone.0217339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150435	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100040
J	Kim, WJ; Hur, KY; Park, HW; Lee, SW; Yoo, JY				Kim, Woo-Jong; Hur, Kye-Yeon; Park, Han Wook; Lee, Seung-Woo; Yoo, Joo-Yeon			Pathogenicity of the H1N1 influenza virus enhanced by functional synergy between the NPV100I and NA(D248N) pair	PLOS ONE			English	Article							GENE-EXPRESSION; NUCLEOPROTEIN; COVARIATION; HOST; COEVOLUTION; EMERGENCE; PROTEIN	By comparing and measuring covariations of viral protein sequences from isolates of the 2009 pH1N1 influenza A virus (IAV), specific substitutions that co-occur in the NP-NA pair were identified. To investigate the effect of these co-occurring substitution pairs, the V100I substitution in NP and the D248N substitution in NA were introduced into laboratory-adapted WSN IAVs. The recombinant WSN with the covarying NPV100I-NA(D248N) pair exhibited enhanced pathogenicity, as characterized by increased viral production, increased death and inflammation of host cells, and high mortality in infected mice. Although direct interactions between the NPV100I and NA(D248N) proteins were not detected, the RNA-binding ability of NPV100I was increased, which was further strengthened by NA D248N, in expression-plas-mid-transfected cells. Additionally, the NA D248N protein was frequently recruited within lipid rafts, indirectly affecting the RNA-binding ability of NP as well as viral release. Altogether, our data indicate that the covarying NPV100I-NA(D248N) pair obtained from 2009 pH1N1 IAV sequence information function together to synergistically augment viral assembly and release, which may explain the observed enhanced viral pathogenicity.	[Kim, Woo-Jong; Hur, Kye-Yeon; Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Park, Han Wook; Lee, Seung-Woo] Pohang Univ Sci & Technol POSTECH, Dept Integrat Biosci & Biotechnol, Pohang, South Korea; [Lee, Seung-Woo; Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Organelle Network Res Ctr, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Yoo, JY (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.; Yoo, JY (corresponding author), Pohang Univ Sci & Technol POSTECH, Organelle Network Res Ctr, Pohang, South Korea.	jyoo@postech.ac.kr			National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT) [NRF-2015R1A2A1A10054957, NRF-2017R1A5A1015366, NRF-2015R1A2A1A100549 57, NRF-2017R1A 5A1015366, NRF-2017R1A5A10153 66]	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (NO. NRF-2015R1A2A1A10054957 and NRF-2017R1A5A1015366), Grant number to each author, W.-J. Kim (NO. NRF-2015R1A2A1A100549 57 and NRF-2017R1A5A1015366), J.-Y. Yoo (NO. NRF-2015R1A2A1A10054957 and NRF-2017R1A 5A1015366), H. W. Park (NRF-2017R1A5A10153 66), S.-W. Lee (NRF-2017R1A5A1015366).	Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Brooke CB, 2014, P NATL ACAD SCI USA, V111, P16854, DOI 10.1073/pnas.1415396111; Carrasco M, 2004, TRAFFIC, V5, P979, DOI 10.1111/j.1600-0854.2004.00237.x; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Clark NL, 2012, GENOME RES, V22, P714, DOI 10.1101/gr.132647.111; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Cotter CR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003831; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Jo JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6433; Liang XZ, 2002, J VIROL, V76, P12320, DOI 10.1128/JVI.76.23.12320-12324.2002; Nagata Kyosuke, 1990, J BIOL CHEM, V265; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ohkura T, 2014, J VIROL, V88, P10039, DOI 10.1128/JVI.00586-14; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Radeva G, 2004, BIOCHEM J, V380, P219, DOI 10.1042/BJ20031348; Sharma K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020215; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064439; Talavera D, 2015, MOL BIOL EVOL, V32, P2456, DOI 10.1093/molbev/msv109; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Wolpert David H., 1993, P NATL ACAD SCI USA, V90, P5; Yang ML, 2011, J VIROL, V85, P10010, DOI 10.1128/JVI.00301-11; Yang S, 2009, NUCLEIC ACIDS RES, V37, pD423, DOI 10.1093/nar/gkn881; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000; Zhao ZZ, 2014, J VIROL, V88, P2260, DOI 10.1128/JVI.03024-13; Zhu WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033383	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217691	10.1371/journal.pone.0217691	http://dx.doi.org/10.1371/journal.pone.0217691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150476	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100088
J	Kos, S; Lopes, A; Preat, V; Cemazar, M; Tratar, UL; Ucakar, B; Vanvarenberg, K; Sersa, G; Vandermeulen, G				Kos, Spela; Lopes, Alessandra; Preat, Veronique; Cemazar, Maja; Tratar, Ursa Lampreht; Ucakar, Bernard; Vanvarenberg, Kevin; Sersa, Gregor; Vandermeulen, Gaelle			Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma	PLOS ONE			English	Article							T-CELL RESPONSES; GENE ELECTROTRANSFER; MULTIELECTRODE ARRAY; CHECKPOINT BLOCKADE; VACCINES; SKIN; ELECTROPORATION; COMBINATION; DELIVERY; INHIBITOR	We aimed to explore whether the combination of intradermal DNA vaccination, to boost immune response against melanoma antigens, and immune checkpoint blockade, to alleviate immunosuppression, improves antitumor effectiveness in a murine B16F10 melanoma tumor model. Compared to single treatments, a combination of intradermal DNA vaccination (ovalbumin or gp100 plasmid adjuvanted with IL12 plasmid) and immune checkpoint CTLA-4/PD-1 blockade resulted in a significant delay in tumor growth and prolonged survival of treated mice. Strong activation of the immune response induced by combined treatment resulted in a significant antigen-specific immune response, with elevated production of antigen-specific IgG antibodies and increased intratumoral CD8(+) infiltration. These results indicate a potential application of the combined DNA vaccination and immune checkpoint blockade, specifically, to enhance the efficacy of DNA vaccines and to overcome the resistance to immune checkpoint inhibitors in certain cancer types.	[Kos, Spela; Cemazar, Maja; Tratar, Ursa Lampreht; Sersa, Gregor] Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia; [Lopes, Alessandra; Preat, Veronique; Ucakar, Bernard; Vanvarenberg, Kevin; Vandermeulen, Gaelle] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Brussels, Belgium; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Sersa, Gregor] Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia	Institute of Oncology - Slovenia; Universite Catholique Louvain; University of Primorska; University of Ljubljana	Sersa, G (corresponding author), Inst Oncol Ljubljana, Dept Expt Oncol, Ljubljana, Slovenia.; Preat, V (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Brussels, Belgium.; Sersa, G (corresponding author), Univ Ljubljana, Fac Hlth Sci, Ljubljana, Slovenia.	veronique.preat@uclouvain.be; gsersa@onko-i.si	Cemazar, Maja/K-6182-2013	Cemazar, Maja/0000-0002-1418-1928; Sersa, Gregor/0000-0002-7641-5670	Universite Catholique de Louvain (Louvain Drug Research Institute); Institute of Oncology Ljubljana; state budget of the Slovenian Research Agency [P3-0003]; FIRST spin-off grant from the Walloon Region	Universite Catholique de Louvain (Louvain Drug Research Institute); Institute of Oncology Ljubljana; state budget of the Slovenian Research Agency; FIRST spin-off grant from the Walloon Region	The research is a result of an IL-EFIS Fellowship (European Federation of Immunological Societies), which supported the collaboration between Universite Catholique de Louvain (Louvain Drug Research Institute) and Institute of Oncology Ljubljana (S.K. received the award). The authors acknowledge financial support from the state budget of the Slovenian Research Agency (program no. P3-0003). G.V. is supported by a FIRST spin-off grant from the Walloon Region.; The research is a result of an IL-EFIS Fellowship (European Federation of Immunological Societies), which supported the collaboration between Universite Catholique de Louvain (Louvain Drug Research Institute) and Institute of Oncology Ljubljana. The authors acknowledge financial support from the state budget of the Slovenian Research Agency (program no. P3-0003). G.V. is supported by a FIRST spin-off grant from the Walloon Region. The authors acknowledge Thomas Michiels for providing the Cliniporator and AJE (American Journal Experts) for proofreading the paper.	Ali OA, 2016, CANCER IMMUNOL RES, V4, P95, DOI 10.1158/2326-6066.CIR-14-0126; Bodles-Brakhop AM, 2009, MOL THER, V17, P585, DOI 10.1038/mt.2009.5; Broderick KE, 2014, METHODS MOL BIOL, V1143, P123, DOI 10.1007/978-1-4939-0410-5_8; Cha E, 2012, HUM VACC IMMUNOTHER, V8, P1734, DOI 10.4161/hv.22573; Chiaruttini G, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1294296; Cross RS, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2014.29; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; De Geest BG, 2012, ANGEW CHEM INT EDIT, V51, P3862, DOI 10.1002/anie.201200048; Donate A, 2013, BIOELECTROCHEMISTRY, V94, P1, DOI 10.1016/j.bioelechem.2013.04.004; Donate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019181; Duperret EK, 2018, MOL THER, V26, P435, DOI 10.1016/j.ymthe.2017.11.010; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Gerlini G, 2012, ONCOIMMUNOLOGY, V1, P1655, DOI 10.4161/onci.21991; Gothelf A, 2010, CURR GENE THER, V10, P287, DOI 10.2174/156652310791823443; Gregor PD, 2004, VACCINE, V22, P1700, DOI 10.1016/j.vaccine.2003.10.048; Guo SQ, 2011, J CONTROL RELEASE, V151, P256, DOI 10.1016/j.jconrel.2011.01.014; Heller R, 2015, ADV GENET, V89, P235, DOI 10.1016/bs.adgen.2014.10.006; Heller R, 2010, HUM GENE THER, V21, P357, DOI 10.1089/hum.2009.065; Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407; Karaki S, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040037; Kleponis J, 2015, CANCER BIOL MED, V12, P201, DOI 10.7497/j.issn.2095-3941.2015.0046; Kos S, 2016, IFMBE P; Kos S, 2017, BIOELECTROCHEMISTRY, V114, P33, DOI 10.1016/j.bioelechem.2016.12.002; Kos S, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.65; Lambricht L, 2016, MOL THER, V24, P1686, DOI 10.1038/mt.2016.122; Lambricht L, 2016, EXPERT OPIN DRUG DEL, V13, P295, DOI 10.1517/17425247.2016.1121990; Lechner MG, 2013, J IMMUNOTHER, V36, P477, DOI 10.1097/01.cji.0000436722.46675.4a; Loiacono L, 2017, MEDIAT INFLAMM, V2017, P1; Lopes A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33933-7; Lopes A, 2017, MOL THER-NUCL ACIDS, V8, P404, DOI 10.1016/j.omtn.2017.07.011; Lussier DM, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0067-z; Madan RA, 2012, ONCOIMMUNOLOGY, V1, P1167, DOI 10.4161/onci.20591; Marshall HT, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00315; Martinez-Lostao L, 2015, CLIN CANCER RES, V21, P5047, DOI 10.1158/1078-0432.CCR-15-0685; Mcarthur HL, 2016, CLIN ADV HEMATOL ONC, V14; Naderi Malihe, 2013, Virologica Sinica, V28, P167, DOI 10.1007/s12250-013-3291-z; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Rekoske BT, 2015, CANCER IMMUNOL RES, V3, P946, DOI 10.1158/2326-6066.CIR-14-0206; Sagiv-Barfi I, 2015, P NATL ACAD SCI USA, V112, pE966, DOI 10.1073/pnas.1500712112; Salvadori C, 2017, RADIOL ONCOL, V51, P286, DOI 10.1515/raon-2017-0035; Shi LZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12335; Smith TRF, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.54; SPECTOR SA, 1982, AM J MED, V73, P36, DOI 10.1016/0002-9343(82)90060-2; Stathopoulos A, 2012, ONCOIMMUNOLOGY, V1, P298, DOI 10.4161/onci.19068; Swart M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00233; Vandermeulen G, 2015, VACCINE, V33, P3179, DOI 10.1016/j.vaccine.2015.05.005; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	50	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217762	10.1371/journal.pone.0217762	http://dx.doi.org/10.1371/journal.pone.0217762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150505	Green Published, gold, Green Submitted			2022-12-26	WOS:000469759100100
J	Sakurai, A; Ono, H; Ochi, A; Matsuura, M; Yoshimoto, S; Kishi, S; Murakami, T; Tominaga, T; Nagai, K; Abe, H; Doi, T				Sakurai, Akiko; Ono, Hiroyuki; Ochi, Arisa; Matsuura, Motokazu; Yoshimoto, Sakiya; Kishi, Seiji; Murakami, Taichi; Tominaga, Tatsuya; Nagai, Kojiro; Abe, Hideharu; Doi, Toshio			Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GLOMERULAR INJURY; EXPRESSION; PROTEIN; RECEPTOR; GENE; NEPHRIN; ALBUMIN; NUMBER; MICE	Diabetic nephropathy (DN) is among the most serious complications of diabetes mellitus, and often leads to end-stage renal disease ultimately requiring dialysis or renal transplantation. The loss of podocytes has been reported to have a role in the onset and progression of DN. Here, we addressed the activation mechanism of Smad3 signaling in podocytes. Expression of RII and activation of Smad3 were induced by AGE exposure (P<0.05). Reduction of the activation of RII-Smad3 signaling ameliorated podocyte injuries in Smad3-knockout diabetic mice. The bone morphogenetic protein 4 (BMP4) significantly regulated activation of RII-Smad3 signalings (P<0.05). Moreover, the epithelium-specific transcription factor, Elf3 was induced by AGE stimulation and, subsequently, upregulated RII expression in cultured podocytes. Induction of Elf3 and activation of RII-Smad3 signaling, leading to a decrease in WT1 expression, were observed in podocytes in diabetic human kidneys. Moreover, AGE treatment induced the secretion of Elf3-containing exosomes from cultured podocytes, which was dependent on the activation of the TGF-beta-Smad3 signaling pathway. In addition, exosomal Elf3 protein in urine could be measured only in urinary exosomes from patients with DN. The appearance of urinary exosomal Elf3 protein in patients with DN suggested the existence of irreversible injuries in podocytes. The rate of decline in the estimated Glomerular Filtration Rate (eGFR) after measurement of urinary exosomal Elf3 protein levels in patients with DN (R-2 = 0.7259) might be useful as an early non-invasive marker for podocyte injuries in DN.	[Sakurai, Akiko; Ono, Hiroyuki; Ochi, Arisa; Matsuura, Motokazu; Yoshimoto, Sakiya; Kishi, Seiji; Murakami, Taichi; Tominaga, Tatsuya; Nagai, Kojiro; Abe, Hideharu; Doi, Toshio] Tokushima Univ, Inst Biomed Sci, Dept Nephrol, Grad Sch, Tokushima, Japan	Tokushima University	Abe, H (corresponding author), Tokushima Univ, Inst Biomed Sci, Dept Nephrol, Grad Sch, Tokushima, Japan.	abeabe@tokushima-u.ac.jp			JSPS KAKENHI [18K08245, 18K07415]; AMED [JP17ek0310003]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED(Japan Agency for Medical Research and Development (AMED))	This research was supported by JSPS KAKENHI Grant Number 18K08245 (HA) and 18K07415 (AS) and in part by AMED under Grant Number JP17ek0310003 (HA). There was no additional external funding received for this study. Neither salaries for authors nor any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; Abe H, 2018, J MED INVESTIG, V65, P208, DOI 10.2152/jmi.65.208; Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Araki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31216; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; BOJESTIG M, 1994, NEW ENGL J MED, V330, P15, DOI 10.1056/NEJM199401063300103; Chang J, 2000, ONCOGENE, V19, P151, DOI 10.1038/sj.onc.1203252; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; Currie G, 2014, WORLD J DIABETES, V5, P763, DOI 10.4239/wjd.v5.i6.763; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Massague J, 2000, GENE DEV, V14, P627; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Ono H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28439-1; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Park SH, 2001, ONCOGENE, V20, P1235, DOI 10.1038/sj.onc.1204227; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Sasaki S, 2016, CLIN EXP NEPHROL, V20, P450, DOI 10.1007/s10157-015-1176-1; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; Sun YBY, 2015, KIDNEY INT, V88, P286, DOI 10.1038/ki.2015.121; Tominaga T, 2011, J BIOL CHEM, V286, P20109, DOI 10.1074/jbc.M110.179382; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Wang A, 2015, AM J PHYSIOL-RENAL, V293, pF1657; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; Yoshida N, 2000, MECH DEVELOP, V97, P27, DOI 10.1016/S0925-4773(00)00419-6	31	23	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0216788	10.1371/journal.pone.0216788	http://dx.doi.org/10.1371/journal.pone.0216788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150422	gold, Green Submitted, Green Published			2022-12-26	WOS:000469759100022
J	Saleh, ME; Gadalla, R; Hassan, H; Afifi, A; Gotte, M; El-Shinawi, M; Mohamed, MM; Ibrahim, SA				Saleh, Moshira Ezzat; Gadalla, Ramy; Hassan, Hebatallah; Afifi, Ahmed; Goette, Martin; El-Shinawi, Mohamed; Mohamed, Mona Mostafa; Ibrahim, Sherif Abdelaziz			The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4(+) T cell polarization in inflammatory and non-inflammatory breast cancer patients	PLOS ONE			English	Article							LATENT TGF-BETA; SULFATE BINDING; TH17 CELLS; PROMOTES; EXPRESSION; ACTIVATION; CARCINOMA; IL-17; DIFFERENTIATION; PROTEOGLYCAN	Herein, we aimed to identify the immunomodulatory role of tumor Syndecan-1 (CD138) in the polarization of CD4(+) T helper (Th) subsets isolated from the tumor microenvironment of inflammatory breast cancer (IBC) and non-IBC patients. Lymphocytes and mononuclear cells isolated from the axillary tributaries of non-IBC and IBC patients during modified radical mastectomy were either stimulated with the secretome as indirect co-culture or directly co-cultured with control and Syndecan-1-silenced SUM-149 IBC cells. In addition, peripheral blood mononuclear cells (PBMCs) of normal subjects were used for the direct co-culture. Employing flow cytometry, we analyzed the expression of the intracellular IFN-gamma, IL-4, IL-17, and Foxp3 markers as readout for basal and co-cultured Th-1, Th-2, Th-17, and T-reg CD4(+) subsets, respectively. Our data revealed that IBC displayed a lower basal frequency of Th1 and Th-2 subsets than non-IBC. Syndecan-1-silenced SUM-149 cells significantly upregulated only T-reg subset polarization of normal subjects relative to controls. However, Syndecan-1 silencing significantly enhanced the polarization of Th-17 and T-reg subsets of non-IBC under both direct and indirect conditions and induced only Th1 subset polarization under indirect conditions compared to control. Interestingly, qPCR revealed that there was a negative correlation between Syndecan-1 and each of IL-4, IL-17, and Foxp3 mRNA expression in carcinoma tissues of IBC and that the correlation was reversed in non-IBC. Mechanistically, Syndecan-1 knockdown in SUM-149 cells promoted Th17 cell expansion via upregulation of IL-23 and the Notch ligand DLL4. Overall, this study indicates a low frequency of the circulating antitumor Th1 subset in IBC and suggests that tumor Syndecan-1 silencing enhances ex vivo polarization of CD4(+) Th-17 and T-reg cells of non-IBC, whereby Th17 polarization is possibly mediated via upregulation of IL-23 and DLL4. These findings suggest the immunoregulatory role of tumor Syndecan-1 expression in Th cell polarization that may have therapeutic implications for breast cancer.	[Saleh, Moshira Ezzat; Gadalla, Ramy; Hassan, Hebatallah; Afifi, Ahmed; Mohamed, Mona Mostafa; Ibrahim, Sherif Abdelaziz] Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt; [Goette, Martin] Munster Univ Hosp, Dept Gynecol & Obstet, Munster, Germany; [El-Shinawi, Mohamed] Ain Shams Univ, Fac Med, Dept Gen Surg, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; University of Munster; Egyptian Knowledge Bank (EKB); Ain Shams University	Ibrahim, SA (corresponding author), Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt.	isherif@sci.cu.edu.eg	Gotte, M/Z-5878-2019; Götte, Martin/G-2254-2018	Gotte, M/0000-0003-2360-2496; Götte, Martin/0000-0003-2360-2496; El-Shinawi, Mohamed/0000-0003-3645-2343; Ibrahim, Sherif Abdelaziz/0000-0001-6403-7345	Science and Technology Development Funds (STDF), Egypt [6309]; German Academic Exchange Service (DAAD) [56808461]; H2020 Marie Sklodowska-Curie Actions [645756]	Science and Technology Development Funds (STDF), Egypt(Science and Technology Development Fund (STDF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); H2020 Marie Sklodowska-Curie Actions	This work was supported by Science and Technology Development Funds (STDF), Egypt, Reintegration project ID#6309 (to SAI and HH), German Academic Exchange Service (DAAD) #56808461 Al Tawasul (to SAI and MG), and H2020 Marie Sklodowska-Curie Actions #645756 (to MG and SAI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Al Absi A, 2018, CANCER RES, V78, P5631, DOI 10.1158/0008-5472.CAN-18-0441; Baba F, 2006, BREAST CANCER RES TR, V98, P91, DOI 10.1007/s10549-005-9135-2; Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen Q, 2007, J BIOL CHEM, V282, P26418, DOI 10.1074/jbc.M703341200; Cochaud S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03456; Coutaz M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39117; Dagur Pradeep K, 2015, Curr Protoc Cytom, V73, DOI 10.1002/0471142956.cy0501s73; Dai H, 2015, EUR J IMMUNOL, V45, P3045, DOI 10.1002/eji.201545532; DAUBENER W, 1995, EUR J IMMUNOL, V25, P688, DOI 10.1002/eji.1830250309; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; El-Shinawi M, 2010, ANN SURG ONCOL, V17, P2677, DOI 10.1245/s10434-010-1029-9; Fluhr H, 2011, FERTIL STERIL, V95, P1272, DOI 10.1016/j.fertnstert.2010.04.061; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gao ZM, 2012, INT J CLIN EXP PATHO, V5, P626; Gong GQ, 2017, J HUAZHONG U SCI-MED, V37, P412, DOI 10.1007/s11596-017-1749-1; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gupta S, 2007, ACTA ONCOL, V46, P792, DOI 10.1080/02841860701233443; Hassan H, 2013, FEBS J, V280, P2216, DOI 10.1111/febs.12111; Heijink IH, 2002, IMMUNOLOGY, V107, P316, DOI 10.1046/j.1365-2567.2002.01501.x; Hollmen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09188; Ibrahim AS, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/437971; Ibrahim SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085737; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Ibrahim SA, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0621-z; Jiang XG, 2014, MOL CELL ENDOCRINOL, V382, P673, DOI 10.1016/j.mce.2013.06.003; Kaminska K, 2015, J CELL MOL MED, V19, P283, DOI 10.1111/jcmm.12408; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Li J, 2017, ONCOTARGET, V8, P66656, DOI 10.18632/oncotarget.19105; Lim B, 2018, NAT REV CANCER, V18, P485, DOI 10.1038/s41568-018-0010-y; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Regos E, 2018, MATRIX BIOL, V68-69, P474, DOI 10.1016/j.matbio.2018.02.008; Ren Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0758-4; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Rider CC, 2017, MOLECULES, V22, DOI 10.3390/molecules22050713; Sadir R, 1998, J BIOL CHEM, V273, P10919, DOI 10.1074/jbc.273.18.10919; Shiao SL, 2015, CANCER IMMUNOL RES, V3, P518, DOI 10.1158/2326-6066.CIR-14-0232; Smeets RL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-12; Sousa S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0621-0; Stanley MJ, 1999, AM J CLIN PATHOL, V112, P377; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Stepp MA, 2015, ADV WOUND CARE, V4, P235, DOI 10.1089/wound.2014.0555; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Tindemans I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00419; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wan YSY, 2010, IMMUNOLOGY, V130, P166, DOI 10.1111/j.1365-2567.2010.03289.x; Welte T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/804347; Xiao J, 2011, ARTERIOSCL THROM VAS, V31, P2261, DOI 10.1161/ATVBAHA.111.229609; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Yoon NK, 2010, HUM PATHOL, V41, P1794, DOI 10.1016/j.humpath.2010.06.010; Zhang XL, 2013, J IMMUNOL, V191, P4551, DOI 10.4049/jimmunol.1300931; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	66	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217550	10.1371/journal.pone.0217550	http://dx.doi.org/10.1371/journal.pone.0217550			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145753	Green Submitted, Green Published, gold			2022-12-26	WOS:000469425500021
J	Ku, A; Ravi, N; Yang, MJ; Evander, M; Laurell, T; Lilja, H; Ceder, Y				Ku, Anson; Ravi, Naveen; Yang, Minjun; Evander, Mikael; Laurell, Thomas; Lilja, Hans; Ceder, Yvonne			A urinary extracellular vesicle microRNA biomarker discovery pipeline; from automated extracellular vesicle enrichment by acoustic trapping to microRNA sequencing	PLOS ONE			English	Article							BIASES; IDENTIFICATION	Development of a robust automated platform for enrichment of extracellular vesicles from low sample volume that matches the needs for next-generation sequencing could remove major hurdles for genomic biomarker discovery. Here, we document a protocol for urinary EVs enrichment by utilizing an automated microfluidic system, termed acoustic trap, followed by next-generation sequencing of microRNAs (miRNAs) for biomarker discovery. Specifically, we compared the sequencing output from two small RNA library preparations, NEXTFlex and CATS, using only 130 pg of input total RNA. The samples prepared using NEXTflex was found to contain larger number of unique miRNAs that was the predominant RNA species whereas rRNA was the dominant RNA species in CATS prepared samples. A strong correlation was found between the miRNA expressions of the acoustic trap technical replicate in the NEXTFlex prepared samples, as well as between the acoustic trap and ultracentrifugation enrichment methods. Together, these results demonstrate a robust and automated strategy for biomarker discovery from small volumes of urine.	[Ku, Anson; Lilja, Hans] Lund Univ, Dept Translat Med, Malmo, Sweden; [Ravi, Naveen; Yang, Minjun] Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden; [Evander, Mikael; Laurell, Thomas] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA; [Lilja, Hans] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Ceder, Yvonne] Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden; [Ku, Anson] Lund Univ, Dept Lab Med, Lund, Sweden	Lund University; Lund University; Lund University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Oxford; Lund University; Lund University	Ku, A (corresponding author), Lund Univ, Dept Translat Med, Malmo, Sweden.; Ku, A (corresponding author), Lund Univ, Dept Lab Med, Lund, Sweden.	anson.ku@med.lu.se	Yang, Minjun/AGJ-3201-2022; Lilja, Hans/S-9703-2019; Evander, Mikael/B-6327-2012	Lilja, Hans/0000-0001-5871-7846; ravi, naveen/0000-0002-3849-8487; Yang, Minjun/0000-0002-3324-1498; Evander, Mikael/0000-0002-7572-931X; Ceder, Yvonne/0000-0002-8705-8293	National Institutes of Health/National Cancer Institute (NIH/NCI); Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center [P30 CA008748]; SPORE grant in Prostate Cancer [P50-CA92629]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program in UK; Swedish Cancer Society [CAN 2017/559]; Swedish Research Council [VR-MH] [2016-02974]; NATIONAL CANCER INSTITUTE [P30CA008748, P50CA092629] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center; SPORE grant in Prostate Cancer; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program in UK(National Institute for Health Research (NIHR)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council [VR-MH]; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health/National Cancer Institute (NIH/NCI) with a Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center [P30 CA008748], a SPORE grant in Prostate Cancer to Dr. H. Scher [P50-CA92629], the Sidney Kimmel Center for Prostate and Urologic Cancers, David H. Koch through the Prostate Cancer Foundation. This work was also supported in part by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Program in UK, the Swedish Cancer Society [CAN 2017/559], and the Swedish Research Council [VR-MH project no. 2016-02974].	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Campbell JD, 2015, RNA, V21, P164, DOI 10.1261/rna.046060.114; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Dard-Dascot C, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4491-6; Evander M, 2015, LAB CHIP, V15, P2588, DOI 10.1039/c5lc00290g; Gebert D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4031-9; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hammarstrom B, 2012, LAB CHIP, V12, P4296, DOI 10.1039/c2lc40697g; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Ku A, 2018, ANAL CHEM, V90, P8011, DOI 10.1021/acs.analchem.8b00914; Li M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0502; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066883; Michell DL, 2016, BBA-MOL CELL BIOL L, V1861, P2069, DOI 10.1016/j.bbalip.2016.01.011; Musante L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00149; Nilsson J, 2009, ANAL CHIM ACTA, V649, P141, DOI 10.1016/j.aca.2009.07.017; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Rezeli M, 2016, ANAL CHEM, V88, P8577, DOI 10.1021/acs.analchem.6b01694; Rodriguez M, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0726-4; Royo F, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29497; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	23	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217507	10.1371/journal.pone.0217507	http://dx.doi.org/10.1371/journal.pone.0217507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141544	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000057
J	Shiao, SH; Weng, SC; Luan, LQ; Vicente, MDH; Jiang, XJ; Ng, DKP; Kolli, BK; Chang, KP				Shiao, Shin-Hong; Weng, Shih-Che; Luan, Liqiang; Vicente, Maria da Graca H.; Jiang, Xiong-Jie; Ng, Dennis K. P.; Kolli, Bala Krishna; Chang, Kwang Poo			Novel phthalocyanines activated by dim light for mosquito larva-and cell-inactivation with inference for their potential as broadspectrum photodynamic insecticides	PLOS ONE			English	Article							TRANSGENIC LEISHMANIA; CATIONIC PORPHYRIN; ALPHA-TERTHIENYL; PHOTOSENSITIZERS; TOXICITY; UROPORPHYRIA; PHOTOLYSIS; EFFICACY; THERAPY; VISION	Mosquitoes are significant vectors, responsible for transmitting serious infectious diseases, including the recent epidemics of global significance caused by, for example, Zika, Dengue and Chikungunya viruses. The chemical insecticides in use for mosquito control are toxic and ineffective due to the development of resistance to them. The new approach to reduce mosquito population by releasing genetically modified males to cause female infertility is still under environmental safety evaluation. Photodynamic insecticides (PDI) have long been known as a safe and effective alternative by using dyes as the photosensitizers (PS) for activation with light to generate insecticidal singlet oxygen and reactive oxygen species. This approach warrants re-examination with advances in the chemical synthesis of novel PS, e.g. phthalocyanines (PC). Nine PC were compared with five porphyrin derivatives and two classic PS of halogenated fluoresceins, i. e. cyanosine and rose bengal experimentally for photodynamic treatment (PDT) of the larvae of laboratory-reared Aedes mosquitoes and their cell lines. Groups of 2 nd instar larvae were first exposed overnight to graded concentrations of each PS in the dark followed by their exposure to dim light for up to 7 hours. Larvae of both experimental and control groups were examined hourly for viability based on their motility. Monolayers of mosquito cells were similarly PS-sensitized and exposed briefly to light at the PS-specific excitation wavelengths. Cell viability was assessed by MTT reduction assays. Of the 16 PS examined for photodynamic inactivation of the mosquito larvae, effective are three novel PC, i.e. amino-Si-PC1 and -PC2, anilinium Zn-PC3.4, pyridyloxy SiPC14 and two porphyrin derivatives, i.e. TPPS2 and TMAP. Their EC50 values were determined, all falling in the nanomolar range lower than those of rose bengal and cyanosine. All PS effective in vivo were also found to dose-dependently inactivate mosquito cells photodynamically in vitro, providing cellular basis for their larvicidal activities. The present findings of novel PC with effective photodynamic larvicidal activities provide fresh impetus to the development of PDI with their established advantages in safety and efficacy. Toward that end, the insect cell lines are of value for rapid screening of new PC. The optimal excitability of PC with insect-invisible red light is inferred to have the potential to broaden the range of targetable insect pests.	[Shiao, Shin-Hong; Weng, Shih-Che] Natl Taiwan Univ, Dept Parasitol, Taipei, Taiwan; [Luan, Liqiang; Vicente, Maria da Graca H.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Jiang, Xiong-Jie; Ng, Dennis K. P.] Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China; [Kolli, Bala Krishna; Chang, Kwang Poo] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL 60064 USA	National Taiwan University; Louisiana State University System; Louisiana State University; Chinese University of Hong Kong; Chicago Medical School; Rosalind Franklin University Medical & Science	Shiao, SH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Taipei, Taiwan.; Chang, KP (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL 60064 USA.	shshiao@ntu.edu.tw; kwangpoo.chang@rosalindfranklin.edu		Weng, Shih-Che/0000-0003-3315-9125; SHIAO, SHIN-HONG/0000-0002-7749-7807; Ng, Dennis/0000-0001-9087-960X	NIH/NIAID [AI097830, AI7712375, AI68835]; NIH [R01 CA179902]; NATIONAL CANCER INSTITUTE [R01CA179902] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH/NIAID Grant #AI097830, AI7712375, AI68835 to KPC/BKK; NIH Grant #R01 CA179902 to GHV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani A, 2016, ANTIMICROB AGENTS CH, V60, P2003, DOI 10.1128/AAC.01879-15; Arikawa K, 2017, J PHYSIOL-LONDON, V595, P5457, DOI 10.1113/JP273917; Bayona AMD, 2017, CHEM BIOL DRUG DES, V89, P192, DOI 10.1111/cbdd.12792; Ben Amor T, 2000, INSECT BIOCHEM MOLEC, V30, P915, DOI 10.1016/S0965-1748(00)00072-2; Chang CH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006307; Chang KP, 2018, PROC SPIE, V10479, DOI 10.1117/12.2281437; Chang KP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1674-3; Dondji B, 2005, J MED ENTOMOL, V42, P652, DOI 10.1603/0022-2585(2005)042[0652:AOLAFA]2.0.CO;2; DOSDALL LM, 1992, J AM MOSQUITO CONTR, V8, P166; Dougherty TJ, 2002, PHOTOCHEM PHOTOBIOL, V76, P91, DOI 10.1562/0031-8655(2002)076<0091:TROTPB>2.0.CO;2; DUKE SO, 1994, ACS SYM SER, V559, P1; Dutta S, 2005, ANTIMICROB AGENTS CH, V49, P4474, DOI 10.1128/AAC.49.11.4474-4484.2005; Dutta S, 2008, EUKARYOT CELL, V7, P1146, DOI 10.1128/EC.00365-07; Dutta S, 2012, EUKARYOT CELL, V11, P430, DOI 10.1128/EC.05202-11; Dutta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020786; FABRIS C, 2012, PHOTOCH PHOTOBIO SCI, V11, P294, DOI DOI 10.1039/C1PP05154G; Fabris C, 2012, ACTA TROP, V123, P239, DOI 10.1016/j.actatropica.2012.05.011; Futahashi R, 2016, CURR OPIN INSECT SCI, V17, P32, DOI 10.1016/j.cois.2016.05.014; Guo B, 2017, SLAS TECHNOL, V22, P557, DOI 10.1177/2472630317698633; HASSPIELER BM, 1988, J AM MOSQUITO CONTR, V4, P479; Heitz J.R., 1987, ACS SYM SER, P1; Heitz JR, 1995, ACS SYM SER, V616, P1; HEITZ JR, 1987, ACS SYM SER, V339, P1; Hung CH, 2008, CHEM COMMUN, P978, DOI 10.1039/b714412a; Iqbal Z, 2015, CURR DRUG METAB, V16, P816, DOI 10.2174/1389200217666151120165404; Jiang XJ, 2011, J MED CHEM, V54, P320, DOI 10.1021/jm101253v; JORI G, 1989, CIBA F SYMP, V146, P78; Jori G., 1984, TOPICS PHOTOMEDICINE, P183; Latham JR, 2017, BIOTECHNOL GENET ENG, V33, P62, DOI 10.1080/02648725.2017.1357295; Li HR, 2008, J MED CHEM, V51, P502, DOI 10.1021/jm070781f; Lucantoni L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001434; Lucht JM, 2015, VIRUSES-BASEL, V7, P4254, DOI 10.3390/v7082819; Mangan RL, 2001, J ECON ENTOMOL, V94, P150, DOI 10.1603/0022-0493-94.1.150; NIVSARKAR M, 1991, ARCH INSECT BIOCHEM, V16, P249, DOI 10.1002/arch.940160404; Pavlidi N, 2018, CURR OPIN INSECT SCI, V27, P97, DOI 10.1016/j.cois.2018.04.007; REBEIZ CA, 1995, CRIT REV PLANT SCI, V14, P329, DOI 10.1080/07352689509382363; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; Shaw WR, 2019, NAT MICROBIOL, V4, P20, DOI 10.1038/s41564-018-0214-7; Song RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42058; SPIKES JD, 1986, PHOTOCHEM PHOTOBIOL, V43, P691, DOI 10.1111/j.1751-1097.1986.tb05648.x; Thomas AP, 2012, J MED CHEM, V55, P5110, DOI 10.1021/jm300009q; Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x; Weng SC, 2015, INSECT BIOCHEM MOLEC, V61, P17, DOI 10.1016/j.ibmb.2015.03.010; Winskill P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004156	44	9	9	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217355	10.1371/journal.pone.0217355	http://dx.doi.org/10.1371/journal.pone.0217355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141567	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000053
J	Honda, GS; Pearce, RG; Pham, LL; Setzer, RW; Wetmore, BA; Sipes, NS; Gilbert, J; Franz, B; Thomas, RS; Wambaugh, JF				Honda, Gregory S.; Pearce, Robert G.; Pham, Ly L.; Setzer, R. W.; Wetmore, Barbara A.; Sipes, Nisha S.; Gilbert, Jon; Franz, Briana; Thomas, Russell S.; Wambaugh, John F.			Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions	PLOS ONE			English	Article							ENVIRONMENTAL CHEMICALS; BIOMONITORING DATA; HEPATIC-CLEARANCE; RISK-ASSESSMENT; TOXICITY; MODEL; DOSIMETRY; PREDICTION; EXPOSURE; HEPATOCYTES	Linking in vitro bioactivity and in vivo toxicity on a dose basis enables the use of high-throughput in vitro assays as an alternative to traditional animal studies. In this study, we evaluated assumptions in the use of a high-throughput, physiologically based toxicokinetic (PBTK) model to relate in vitro bioactivity and rat in vivo toxicity data. The fraction unbound in plasma (f(up)) and intrinsic hepatic clearance (Cl-int) were measured for rats (for 67 and 77 chemicals, respectively), combined with f(up) and Cl-int literature data for 97 chemicals, and incorporated in the PBTK model. Of these chemicals, 84 had corresponding in vitro ToxCast bioactivity data and in vivo toxicity data. For each possible comparison of in vitro and in vivo endpoint, the concordance between the in vivo and in vitro data was evaluated by a regression analysis. For a base set of assumptions, the PBTK results were more frequently better associated than either the results from a "random" model parameterization or direct comparison of the "untransformed" values of AC(50) and dose (performed best in 51%, 28%, and 21% of cases, respectively). We also investigated several assumptions in the application of PBTK for IVIVE, including clearance and internal dose selection. One of the better assumptions sets-restrictive clearance and comparing free in vivo venous plasma concentration with free in vitro concentration-outperformed the random and untransformed results in 71% of the in vitro-in vivo endpoint comparisons. These results demonstrate that applying PBTK improves our ability to observe the association between in vitro bioactivity and in vivo toxicity data in general. This suggests that potency values from in vitro screening should be transformed using in vitro-in vivo extrapolation (IVIVE) to build potentially better machine learning and other statistical models for predicting in vivo toxicity in humans.	[Honda, Gregory S.; Pearce, Robert G.; Pham, Ly L.; Setzer, R. W.; Thomas, Russell S.; Wambaugh, John F.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Honda, Gregory S.; Pearce, Robert G.; Pham, Ly L.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Wetmore, Barbara A.] US EPA, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA; [Sipes, Nisha S.] NIEHS, Div Natl Toxicol Program, POB 12233, Res Triangle Pk, NC 27709 USA; [Gilbert, Jon; Franz, Briana] Cyprotex, Watertown, MA USA	United States Environmental Protection Agency; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wambaugh, JF (corresponding author), US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA.	wambaugh.john@epa.gov	Wambaugh, John/AAM-4487-2020	Wambaugh, John/0000-0002-4024-534X; Franz-Jonas, Briana/0000-0002-9513-8234; Pham, Ly/0000-0001-8467-2645; Sipes, Nisha/0000-0003-4203-6426	United States Environmental Protection Agency through its Office of Research and Development; Cyprotex; Research Participation Program at the National Center for Computational Toxicology, U.S. Environmental Protection Agency; National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103318] Funding Source: NIH RePORTER	United States Environmental Protection Agency through its Office of Research and Development(United States Environmental Protection Agency); Cyprotex; Research Participation Program at the National Center for Computational Toxicology, U.S. Environmental Protection Agency; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The United States Environmental Protection Agency through its Office of Research and Development funded and managed the research described here, including funding and management of the work completed by Cyprotex (B. Franz and J. Gilbert) by external contract. Cyprotex provided no independent funding in support of this work. Funding for G. S. Honda, R. Pearce, and L. Pham was supported by the Research Participation Program at the National Center for Computational Toxicology, U.S. Environmental Protection Agency, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and EPA. The National Institute of Environmental Health Sciences provided funding for N. S. Sipes. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2007, TOXICITY TESTING 21; Armitage JM, 2014, ENVIRON SCI TECHNOL, V48, P9770, DOI 10.1021/es501955g; Arnot JA, 2014, ENVIRON SCI TECHNOL, V48, P723, DOI 10.1021/es4029414; Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5, DOI 10.14573/altex.2012.1.003; Blaauboer BJ, 2010, J TOXICOL ENV HEAL B, V13, P242, DOI 10.1080/10937404.2010.483940; Bucher JR, 1996, FUND APPL TOXICOL, V31, P1, DOI 10.1006/faat.1996.0070; Casey WM, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP1655; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coecke S, 2013, TOXICOL IN VITRO, V27, P1570, DOI 10.1016/j.tiv.2012.06.012; EPA U, EST PROGR INT SUIT W; EPA U, INVITRODB; EPA U, EPA U SER; EPA U, TOXREFDB; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Houston JB, 1997, DRUG METAB REV, V29, P891, DOI 10.3109/03602539709002237; Judson R, 2014, BASIC CLIN PHARMACOL, V115, P69, DOI 10.1111/bcpt.12239; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kavlock RJ, 2018, CHEM RES TOXICOL, V31, P287, DOI 10.1021/acs.chemrestox.7b00339; Kilford PJ, 2008, DRUG METABOLISM DISP; Kleinstreuer NC, 2017, CHEM RES TOXICOL, V30, P946, DOI 10.1021/acs.chemrestox.6b00347; Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Liu J, 2015, CHEM RES TOXICOL, V28, P738, DOI 10.1021/tx500501h; Mansouri K, 2018, J CHEMINFORMATICS, V10, DOI 10.1186/s13321-018-0263-1; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074; Naritomi Y, 2003, DRUG METAB DISPOS, V31, P580, DOI 10.1124/dmd.31.5.580; NASEM, 2017, US 21 CENT SCI IMPR; Pearce RG, 2017, J PHARMACOKINET PHAR, V44, P549, DOI 10.1007/s10928-017-9548-7; Pearce RG, 2017, J STAT SOFTW, V79, DOI [10.18637/jss.v079.104, 10.18637/jss.v079.i04]; Pelkonen O, 2007, XENOBIOTICA, V37, P1066, DOI 10.1080/00498250701620726; Ring CL, 2017, ENVIRON INT, V106, P105, DOI 10.1016/j.envint.2017.06.004; Rotroff DM, 2010, TOXICOL SCI, V117, P348, DOI 10.1093/toxsci/kfq220; Sipes NS, 2017, ENVIRON SCI TECHNOL, V51, P10786, DOI 10.1021/acs.est.7b00650; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Sohlenius-Sternbeck AK, 2013, XENOBIOTICA, V43, P671, DOI 10.3109/00498254.2012.755578; Sohlenius-Sternbeck AK, 2012, XENOBIOTICA, V42, P841, DOI 10.3109/00498254.2012.669080; Strope CL, 2018, SCI TOTAL ENVIRON, V615, P150, DOI 10.1016/j.scitotenv.2017.09.033; Tan YM, 2007, J EXPO SCI ENV EPID, V17, P591, DOI 10.1038/sj.jes.7500540; Tan YM, 2006, J TOXICOL ENV HEAL A, V69, P1727, DOI 10.1080/15287390600631367; Thomas RS, 2013, TOXICOL SCI, V136, P4, DOI 10.1093/toxsci/kft178; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; Toutain PL, 2002, J VET PHARMACOL THER, V25, P460, DOI 10.1046/j.1365-2885.2002.00442.x; Wambaugh JF, 2015, TOXICOL SCI, V147, P55, DOI 10.1093/toxsci/kfv118; Waters NJ, 2008, J PHARM SCI-US, V97, P4586, DOI 10.1002/jps.21317; Wetmore BA, 2015, TOXICOL SCI, V148, P121, DOI 10.1093/toxsci/kfv171; Wetmore BA, 2015, TOXICOLOGY, V332, P94, DOI 10.1016/j.tox.2014.05.012; Wetmore BA, 2013, TOXICOL SCI, V132, P327, DOI 10.1093/toxsci/kft012; Wetmore BA, 2012, TOXICOL SCI, V125, P157, DOI 10.1093/toxsci/kfr254; Williams AJ, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0247-6; Wood FL, 2017, DRUG METAB DISPOS, V45, P1178, DOI 10.1124/dmd.117.077040; Yoon M, 2014, TOXICOL IN VITRO, V28, P164, DOI 10.1016/j.tiv.2013.10.023	56	20	20	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217564	10.1371/journal.pone.0217564	http://dx.doi.org/10.1371/journal.pone.0217564			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136631	Green Published, Green Submitted, gold			2022-12-26	WOS:000469224300051
J	Williams, VL; 't Sas-Rolfes, MJ				Williams, Vivienne L.; 't Sas-Rolfes, Michael J.			Born captive: A survey of the lion breeding, keeping and hunting industries in South Africa	PLOS ONE			English	Article								Commercial captive breeding and trade in body parts of threatened wild carnivores is an issue of significant concern to conservation scientists and policy-makers. Following a 2016 decision by Parties to the Convention on International Trade in Endangered Species of Wild Fauna and Flora, South Africa must establish an annual export quota for lion skeletons from captive sources, such that threats to wild lions are mitigated. As input to the quota-setting process, South Africa's Scientific Authority initiated interdisciplinary collaborative research on the captive lion industry and its potential links to wild lion conservation. A National Captive Lion Survey was conducted as one of the inputs to this research; the survey was launched in August 2017 and completed in May 2018. The structured semi-quantitative questionnaire elicited 117 usable responses, representing a substantial proportion of the industry. The survey results clearly illustrate the impact of a USA suspension on trophy imports from captive-bred South African lions, which affected 82% of respondents and economically destabilised the industry. Respondents are adapting in various ways, with many euthanizing lions and becoming increasingly reliant on income from skeleton export sales. With rising consumer demand for lion body parts, notably skulls, the export quota presents a further challenge to the industry, regulators and conservationists alike, with 52% of respondents indicating they would adapt by seeking 'alternative markets' for lion bones if the export quota allocation restricted their business. Recognizing that trade policy toward large carnivores represents a 'wicked problem', we anticipate that these results will inform future deliberations, which must nonetheless also be informed by challenging inclusive engagements with all relevant stakeholders.	[Williams, Vivienne L.; 't Sas-Rolfes, Michael J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; ['t Sas-Rolfes, Michael J.] Univ Oxford, Oxford Martin Programme Illegal Wildlife Trade, Oxford, England	University of Witwatersrand; University of Oxford	Williams, VL (corresponding author), Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	vivienne.williams@wits.ac.za	Sas-Rolfes, Michael t/ABC-7132-2020; Williams, Vivienne Linda/M-1453-2019	Sas-Rolfes, Michael t/0000-0002-2220-6072; Williams, Vivienne Linda/0000-0003-0698-6512	South African National Biodiversity Institute (SANBI); National Research Foundation (NRF) [109303]; School of Animal, Plant & Environmental Sciences (University of the Witwatersrand); Oxford Martin Programme on the Illegal Wildlife Trade (Oxford University); Earthmind	South African National Biodiversity Institute (SANBI); National Research Foundation (NRF); School of Animal, Plant & Environmental Sciences (University of the Witwatersrand); Oxford Martin Programme on the Illegal Wildlife Trade (Oxford University); Earthmind	VLW and MtSR acknowledge funding from the South African National Biodiversity Institute (SANBI). In addition, VLW received support from the National Research Foundation (NRF; Grant No. 109303), and the School of Animal, Plant & Environmental Sciences (University of the Witwatersrand). MtSR acknowledges financial support from the Oxford Martin Programme on the Illegal Wildlife Trade (Oxford University) and Earthmind. With the exception of SANBI having a role in study design only, the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SANBI's only role was in providing a brief on the types of information they wanted collecting, and we designed the questionnaire accordingly.	Bauer H, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12444; Breitenmoser Urs, 2016, Cat News, P3; CITES. Committee 1, 2016, CONS TRAD AFR LION; Coals P, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9020052; Government of Netherlands, 2016, ADD TROPH ADD IMP PR; Gratwicke B, 2008, CONSERV BIOL, V22, P222, DOI 10.1111/j.1523-1739.2007.00802.x; Gregory R, 2009, RISK ANAL, V29, P518, DOI 10.1111/j.1539-6924.2008.01182.x; Hubschle A, 2017, GLOB CRIME, V18, P198, DOI 10.1080/17440572.2017.1345680; Hunter LTB, 2013, ORYX, V47, P19, DOI 10.1017/S0030605312000695; Lindsey P, 2012, S AFR J WILDL RES, V42, P11, DOI 10.3957/056.042.0103; Mkono M, 2018, J SUSTAIN TOUR, V26, P1608, DOI 10.1080/09669582.2018.1489399; Pratt A, 2017, 7903 HC LIB; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Royal S., 2015, COMMUNICATION; Schroeder RA, 2018, AFR STUD REV, V61, P8, DOI 10.1017/asr.2017.94; 't Sas-Rolfes M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa854b; t Sas-Rolfes MJ, 2010, TIGERS WORLD SCI POL, P477; Tjiane M., 2017, COMMUNICATION   1121; US Fish and Service Wildlife, 2015, FED REGISTER, V80, P79999; Van der Merwe Peet, 2017, International Journal of Biodiversity and Conservation, V9, P314; Williams J, 2017, J COMPUT NONLIN DYN, V12, DOI 10.1115/1.4034390; Williams VL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185996; Williams VL, 2015, NATURE, V523, P290, DOI 10.1038/523290a; Williams VL., 2015, BONES CONTENTION ASS; Williams VL, 2017, S AFRICAN LION UNPUB; Woodford DJ, 2016, NEOBIOTA, P63, DOI 10.3897/neobiota.31.10038	26	22	22	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217409	10.1371/journal.pone.0217409	http://dx.doi.org/10.1371/journal.pone.0217409			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136596	Green Submitted, Green Published, gold			2022-12-26	WOS:000469224300036
J	Zakeri, Z; Otte, V; Sipman, H; Malicek, J; Cubas, P; Rico, VJ; Lenzova, V; Svoboda, D; Divakar, PK				Zakeri, Zakieh; Otte, Volker; Sipman, Harrie; Malicek, Jiri; Cubas, Paloma; Rico, Victor J.; Lenzova, Veronika; Svoboda, David; Divakar, Pradeep K.			Discovering cryptic species in the Aspiciliella intermutans complex (Megasporaceae, Ascomycota) - First results using gene concatenation and coalescent-based species tree approaches	PLOS ONE			English	Article							LICHEN-FORMING FUNGI; BAYESIAN-INFERENCE; DELIMITATION; DIVERSITY; DNA; PARMELIACEAE; PHYLOGENY; EXAMPLE; SIMULATIONS; SELECTION	Taxonomic identifications in some groups of lichen-forming fungi have been challenge largely due to the scarcity of taxonomically relevant features and limitations of morphological and chemical characters traditionally used to distinguish closely related taxa. Delineating species boundaries in closely related species or species complexes often requires a range of multisource data sets and comprehensive analytical methods. Here we aim to examine species boundaries in a group of saxicolous lichen forming fungi, the Aspiciliella intermutans complex (Megasporaceae), widespread mainly in the Mediterranean. We gathered DNA sequences of the nuclear ribosomal internal transcribed spacer (nuITS), the nuclear large subunit (nuLSU), the mitochondrial small subunit (mtSSU) ribosomal DNA, and the DNA replication licensing factor MCM7 from 80 samples mostly from Iran, Caucasia, Greece and eastern Europe. We used a combination of phylogenetic strategies and a variety of empirical, sequence-based species delimitation approaches to infer species boundaries in this group. The latter included: the automatic barcode gap discovery (ABGD), the multispecies coalescent approach *BEAST and Bayesian Phylogenetics and Phylogeography (BPP) program. Different species delimitation scenarios were compared using Bayes factors species delimitation analysis. Furthermore, morphological, chemical, ecological and geographical features of the sampled specimens were examined. Our study uncovered cryptic species diversity in A. intermutans and showed that morphology-based taxonomy may be unreliable, underestimating species diversity in this group of lichens. We identified a total of six species-level lineages in the A. intermutans complex using inferences from multiple empirical operational criteria. We found little corroboration between morphological and ecological features with our proposed candidate species, while secondary metabolite data do not corroborate tree topology. The present study on the A. intermutans species-complex indicates that the genus Aspiciliella, as currently circumscribed, is more diverse in Eurasia than previously expected.	[Zakeri, Zakieh; Otte, Volker] Senckenberg Museum Nat Hist, Gorlitz, Germany; [Sipman, Harrie] Bot Garten, Berlin, Germany; [Sipman, Harrie] Bot Museum Berlin Dahlem, Berlin, Germany; [Malicek, Jiri] Czech Acad Sci, Inst Bot, Prohonice, Czech Republic; [Cubas, Paloma; Rico, Victor J.; Divakar, Pradeep K.] Univ Complutense, Fac Farm, Dept Farmacol Farmacognosia & Bot UD Bot, Madrid, Spain; [Lenzova, Veronika; Svoboda, David] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Senckenberg Gesellschaft fur Naturforschung (SGN); Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Complutense University of Madrid; Charles University Prague	Zakeri, Z (corresponding author), Senckenberg Museum Nat Hist, Gorlitz, Germany.	zakieh.zakeri@senckenberg.de	Rico, Víctor J./AAA-2001-2019; Divakar, Pradeep K/E-5603-2014	Divakar, Pradeep K/0000-0002-0300-0124; Malicek, Jiri/0000-0002-3119-8967; Svoboda, David/0000-0002-5619-636X	long-term research development project [RVO 67985939]; Open Access Fund of the Leibniz Association	long-term research development project; Open Access Fund of the Leibniz Association	The work of J. Malicek was supported by the long-term research development project no. RVO 67985939. The publication of this article was funded by the Open Access Fund of the Leibniz Association to Z. Zakeri.	Altermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097556; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Molina MC, 2011, ORG DIVERS EVOL, V11, P331, DOI 10.1007/s13127-011-0060-4; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; Del-Prado R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161031; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FChG Arnold, 1887, VERHANDLUNGEN ZOOLOG, V37, P81; Fletcher T, 2009, ANZSOG MONOGR, P181; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Gutierrez G, 2007, J MOL EVOL, V64, P181, DOI 10.1007/s00239-005-0313-y; Hafellner J., 1995, FRITSCHIANA, V5, P1; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaklitsch W., 2016, SYLLABUS PLANT FAM 1; John V, 2004, HERZOGIA, V17, P157; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kraichak E, 2015, ORG DIVERS EVOL, V15, P447, DOI 10.1007/s13127-015-0219-5; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leavitt S. D, 2010, THESIS; Leavitt S.D., 2015, RECENT ADV LICHENOLO, P11, DOI 10.1007/978-81-322-2235-4_2; Leavitt SD, 2013, LICHENOLOGIST, V45, P553, DOI 10.1017/S0024282913000212; Leavitt SD, 2013, MOL PHYLOGENET EVOL, V66, P138, DOI 10.1016/j.ympev.2012.09.013; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Llimona X., 2001, BOCCONEA, V14, P1; Lucking R, 2014, LICHENOLOGIST, V46, P261, DOI 10.1017/S0024282913000352; Lumbsch H. T., 2007, MYCONET, V13, P1, DOI DOI 10.3158/1557.1; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; McCune B., 2014, MONOGRAPHS N AM LICH, V2, P1; Nimis P. L., 2008, INFORM SYSTEM ITALIA; Nordin A, 2015, PHYTOTAXA, V192, P197, DOI 10.11646/phytotaxa.192.3.6; Nordin A, 2010, MYCOLOGIA, V102, P1339, DOI 10.3852/09-266; NYLANDER W, 1872, FLORA REGENSBURG, V55, P353; Orange A., 2001, MICROCHEMICAL METHOD; Otalora MAG, 2017, FUNGAL BIOL-UK, V121, P222, DOI 10.1016/j.funbio.2016.12.001; Owe-Larsson B, 2007, LICHEN FLORA GREATER, V3, P61; Park SY, 2014, MYCOBIOLOGY, V42, P311, DOI 10.5941/MYCO.2014.42.4.311; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Paukov AG, 2014, I KANT BALTIC FEDERA, V7, P102; Pitard C. J., 1909, B SOC BOT FR, V56, P243; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rannala B, 2017, SYST BIOL, V66, P823, DOI 10.1093/sysbio/syw119; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Sipman HJM., 2002, WILLDENOWIA, V32, P351; THIII Nash, 2007, LICHEN FLORA GREATER, V3; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Werner RG, 1932, CAVANILLESIA, V5, P157; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zakeri Z, 2019, LICHENOLOGIST, V51, P97, DOI 10.1017/S0024282918000476; Zakeri Z, 2017, HERZOGIA, V30, P166, DOI 10.13158/heia.30.1.2017.166; Zakeri Z, 2016, WILLDENOWIA, V46, P245, DOI 10.3372/wi.46.46205; Zoller S, 1999, LICHENOLOGIST, V31, P511	61	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216675	10.1371/journal.pone.0216675	http://dx.doi.org/10.1371/journal.pone.0216675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136587	Green Submitted, Green Published, gold			2022-12-26	WOS:000469224300008
J	Ye, Y; Duah, D				Ye, Yazoume; Duah, Dwomoh			The President's Malaria Initiative contributed to reducing malaria burden in sub-Saharan Africa between 2004 and 2014: Evidence from generalized estimating equation analysis	PLOS ONE			English	Article							CAUSE CHILD-MORTALITY; CONTROL INTERVENTIONS; IMPACT; MALAWI	The President's Malaria Initiative (PMI) launched in 2005 as a key player in malaria prevention and treatment in sub-Saharan Africa (SSA). Several country-specific evaluations have demonstrated great progress in reducing under-five mortality associated with scaling up malaria interventions in PMI priority countries. Documentation of PMI's specific contributions was limited, until the publication of Jakubowski, et al., which used difference-in-difference analysis to show a higher reduction of under-five mortality in PMI-supported countries than in others. To generate more evidence, this study used rigorous statistical analyses to assess the reduction in mortality attributable to PMI support. The study used generalized estimating equations and a series of matching procedures to evaluate the impact of PMI on under-five mortality and on population coverage of insecticide-treated nets (ITNs), indoor residual spraying (IRS), and artemisinin-based combination therapy (ACT) in SSA. The analyses used country-level secondary data and controlled for several country-level characteristics assumed to influence outcome measures of interest, PMI program participation, or both. The Mahalanobis distance metric, with 1: 1 nearest neighbor matching adjusting for bias in population size in the particular country, showed a reduction in under-five mortality by approximately 12 per 1,000 live births (95% Confidence Interval [CI]: 20.6-3.1; p = 0.012). There were statistically significant increases in the population coverage of ITNs, IRS, and ACTs in PMI countries over the implementation period. ITN use in the population was 0.23% higher (95% CI average treatment effect on the treated: 0.17-0.30; p<0.001) in PMI-ecipient countries than in non-PMI countries. The findings show that PMI contributed significantly to increasing the coverage of malaria control interventions and reducing under-five mortality in SSA.	[Ye, Yazoume] ICF, Rockville, MD 20850 USA; [Duah, Dwomoh] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana	University of Ghana	Ye, Y (corresponding author), ICF, Rockville, MD 20850 USA.	Ye@icf.com		Ye, Yazoume/0000-0001-7851-6603	USAID	USAID(United States Agency for International Development (USAID))	YY is working for ICF on a project funded by USAID. However, this study was perform as an independent scientist outside the normal working hours. The study was based on secondary data publicly available. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2016, WORLD MAL REP 2015; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4; DuGoff EH, 2014, HEALTH SERV RES, V49, P284, DOI 10.1111/1475-6773.12090; Eckert E, 2017, AM J TROP MED HYG, V97, P99, DOI 10.4269/ajtmh.17-0281; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Florey LS, 2017, AM J TROP MED HYG, V97, P65, DOI 10.4269/ajtmh.15-0929; Gimnig JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145282; HARRISON DA, 1989, J APPL PSYCHOL, V74, P300, DOI 10.1037/0021-9010.74.2.300; Hershey CL, 2017, AM J TROP MED HYG, V97, P76, DOI 10.4269/ajtmh.17-0203; Hewko, 2002, E EUROPEAN CONSTITUT, V11, P71; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; Iacus SM, 2009, J STAT SOFTW, V30, P1; Jakubowski A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002319; Lambsdorff JG, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P3; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Ye Y, 2017, AM J TROP MED HYG, V97, P9, DOI 10.4269/ajtmh.15-0363	20	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217103	10.1371/journal.pone.0217103	http://dx.doi.org/10.1371/journal.pone.0217103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ5BN	31125380	Green Submitted, Green Published, gold			2022-12-26	WOS:000468865700019
J	Ueda, M; Okada, M; Mizuguchi, M; Kluve-Beckerman, B; Kanenawa, K; Isoguchi, A; Misumi, Y; Tasaki, M; Ueda, A; Kanai, A; Sasaki, R; Masuda, T; Inoue, Y; Nomura, T; Shinriki, S; Shuto, T; Kai, H; Yamashita, T; Matsui, H; Benson, MD; Ando, Y				Ueda, Mitsuharu; Okada, Masamitsu; Mizuguchi, Mineyuki; Kluve-Beckerman, Barbara; Kanenawa, Kyosuke; Isoguchi, Aito; Misumi, Yohei; Tasaki, Masayoshi; Ueda, Akihiko; Kanai, Akinori; Sasaki, Ryoko; Masuda, Teruaki; Inoue, Yasuteru; Nomura, Toshiya; Shinriki, Satoru; Shuto, Tsuyoshi; Kai, Hirofumi; Yamashita, Taro; Matsui, Hirotaka; Benson, Merrill D.; Ando, Yukio			A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; drug screening; drug discovery; protein aggregation; protein conformation; amyloid disrupters; apomorphine hydrochloride; pyrvinium pamoate; transthyretin (TTR)	SENILE SYSTEMIC AMYLOIDOSIS; LIVER-TRANSPLANTATION; POLYNEUROPATHY; MECHANISM; CARDIOMYOPATHY; AGGREGATION; DIFLUNISAL; INHIBITORS; CLEAVAGE; DEPOSITS	Transthyretin (TTR) is a major amyloidogenic protein associated with hereditary (ATTRm) and nonhereditary (ATTRwt) intractable systemic transthyretin amyloidosis. The pathological mechanisms of ATTR-associated amyloid fibril formation are incompletely understood, and there is a need for identifying compounds that target ATTR. C-terminal TTR fragments are often present in amyloid-laden tissues of most patients with ATTR amyloidosis, and on the basis of in vitro studies, these fragments have been proposed to play important roles in amyloid formation. Here, we found that experimentally-formed aggregates of full-length TTR are cleaved into C-terminal fragments, which were also identified in patients' amyloid-laden tissues and in SH-SY5Y neuronal and U87MG glial cells. We observed that a 5-kDa C-terminal fragment of TTR, TTR81-127, is highly amyloidogenic in vitro, even at neutral pH. This fragment formed amyloid deposits and induced apoptosis and inflammatory gene expression also in cultured cells. Using the highly amyloidogenic TTR81-127 fragment, we developed a cell-based high-throughput screening method to discover compounds that disrupt TTR amyloid fibrils. Screening a library of 1280 off-patent drugs, we identified two candidate repositioning drugs, pyrvinium pamoate and apomorphine hydrochloride. Both drugs disrupted patient-derived TTR amyloid fibrils ex vivo, and pyrvinium pamoate also stabilized the tetrameric structure of TTR ex vivo in patient plasma. We conclude that our TTR81-127-based screening method is very useful for discovering therapeutic drugs that directly disrupt amyloid fibrils. We propose that repositioning pyrvinium pamoate and apomorphine hydrochloride as TTR amyloid-disrupting agents may enable evaluation of their clinical utility for managing ATTR amyloidosis.	[Ueda, Mitsuharu; Okada, Masamitsu; Kanenawa, Kyosuke; Isoguchi, Aito; Misumi, Yohei; Tasaki, Masayoshi; Ueda, Akihiko; Masuda, Teruaki; Inoue, Yasuteru; Nomura, Toshiya; Yamashita, Taro; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto 8600811, Japan; [Mizuguchi, Mineyuki] Univ Toyama, Fac Pharm & Pharmaceut Sci, Lab Struct Biol, Toyama 9300194, Japan; [Kluve-Beckerman, Barbara; Benson, Merrill D.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Tasaki, Masayoshi] Kumamoto Univ, Grad Sch Hlth Sci, Dept Morphol & Physiol Sci, Kumamoto 8620976, Japan; [Kanai, Akinori] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima 7348553, Japan; [Sasaki, Ryoko; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan; [Shinriki, Satoru; Matsui, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Lab Med, Kumamoto 8600811, Japan	Kumamoto University; University of Toyama; Indiana University System; Indiana University Bloomington; Kumamoto University; Hiroshima University; Kumamoto University; Kumamoto University	Ueda, M (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto 8600811, Japan.	mitt@rb3.so-net.ne.jp	Matsui, Hirotaka/AED-6669-2022; Ueda, Mitsuharu/Q-8595-2019	Matsui, Hirotaka/0000-0002-6266-3227; 	Japan Society for the Promotion of Science KAKENHI [18K07502, 15K09318, 15H04841, 25870541]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grants 18K07502, 15K09318, 15H04841, and 25870541 and by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adams D, 2018, NEW ENGL J MED, V379, P11, DOI 10.1056/NEJMoa1716153; Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31; Annamalai K, 2016, ANGEW CHEM INT EDIT, V55, P4822, DOI 10.1002/anie.201511524; Barbarino M, 2018, J CELL PHYSIOL, V233, P7391, DOI 10.1002/jcp.26579; Baures PW, 1998, BIOORGAN MED CHEM, V6, P1389, DOI 10.1016/S0968-0896(98)00130-8; BECK JW, 1959, AM J TROP MED HYG, V8, P349, DOI 10.4269/ajtmh.1959.8.349; Benson MD, 2018, NEW ENGL J MED, V379, P22, DOI 10.1056/NEJMoa1716793; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Benson MD, 2018, AMYLOID, V25, P215, DOI 10.1080/13506129.2018.1549825; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Dionisio PA, 2015, NEUROBIOL AGING, V36, P228, DOI 10.1016/j.neurobiolaging.2014.08.034; Ferreira N, 2009, FEBS LETT, V583, P3569, DOI 10.1016/j.febslet.2009.10.062; Giorgetti S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092677; Goncalves NP, 2014, EXP NEUROL, V257, P76, DOI 10.1016/j.expneurol.2014.04.030; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; Higaki JN, 2016, AMYLOID, V23, P86, DOI 10.3109/13506129.2016.1148025; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Katzenschlager R, 2018, LANCET NEUROL, V17, P749, DOI 10.1016/S1474-4422(18)30239-4; Klimtchuk ES, 2018, P NATL ACAD SCI USA, V115, pE6428, DOI 10.1073/pnas.1802977115; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Li B, 2014, CANCER RES, V74, P4811, DOI 10.1158/0008-5472.CAN-14-0317; Macedo B, 2007, MOL MED, V13, P584, DOI 10.2119/2007-00068.Macedo; Mangione PP, 2014, P NATL ACAD SCI USA, V111, P1539, DOI 10.1073/pnas.1317488111; Marcoux J, 2015, EMBO MOL MED, V7, P1337, DOI 10.15252/emmm.201505357; Matsubara K, 2003, PROTEIN EXPRES PURIF, V30, P55, DOI 10.1016/S1046-5928(03)00069-X; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Merlini G, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0034-3; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Misumi Y, 2009, J PATHOL, V219, P481, DOI 10.1002/path.2618; Mitsui T, 2005, BIOSCI BIOTECH BIOCH, V69, P1923, DOI 10.1271/bbb.69.1923; Miyata M, 2010, BIOCHEMISTRY-US, V49, P6104, DOI 10.1021/bi1004409; Mizuguchi M, 2008, PROTEINS, V72, P261, DOI 10.1002/prot.21919; Mizuguchi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4822; Obici L, 2012, AMYLOID, V19, P34, DOI 10.3109/13506129.2012.678508; Oshima T, 2014, J NEUROL NEUROSUR PS, V85, P740, DOI 10.1136/jnnp-2013-305973; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Richards DB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3128; Saelices L, 2018, PROTEIN SCI, V27, P1295, DOI 10.1002/pro.3420; Saelices L, 2015, J BIOL CHEM, V290, P28932, DOI 10.1074/jbc.M115.659912; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sant'Anna R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10787; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; SMITH RV, 1979, RES COMMUN CHEM PATH, V24, P483; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; Sperry BW, 2018, J AM COLL CARDIOL, V72, P2040, DOI 10.1016/j.jacc.2018.07.092; Suenaga G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01775-4; Sueyoshi T, 2011, HUM PATHOL, V42, P1259, DOI 10.1016/j.humpath.2010.11.017; Suhr OB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211983; Tasaki M, 2019, J PATHOL, V247, P444, DOI 10.1002/path.5203; THYLEN C, 1993, EMBO J, V12, P743, DOI 10.1002/j.1460-2075.1993.tb05708.x; Tsuda Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36357-5; Ueda M, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-19; Ueda M, 2011, MODERN PATHOL, V24, P1533, DOI 10.1038/modpathol.2011.117; van den Berg MP, 2019, EUR HEART J, V40, P1287, DOI 10.1093/eurheartj/ehz057; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Yamashita T, 2012, NEUROLOGY, V78, P637, DOI 10.1212/WNL.0b013e318248df18; Yanagisawa A, 2015, MODERN PATHOL, V28, P201, DOI 10.1038/modpathol.2014.102	62	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11259	11275		10.1074/jbc.RA119.007851	http://dx.doi.org/10.1074/jbc.RA119.007851			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167790	Green Published, hybrid			2022-12-26	WOS:000478717400017
J	Farzad, R; Kuhn, DD; Smith, SA; O'Keefe, SF; Ralston, NVC; Neilson, AP; Gatlin, DM				Farzad, Razieh; Kuhn, David D.; Smith, Stephen A.; O'Keefe, Sean F.; Ralston, Nicholas V. C.; Neilson, Andrew P.; Gatlin, Delbert M.			Trace minerals in tilapia fillets: Status in the United States marketplace and selenium supplementation strategy for improving consumer's health	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; INORGANIC SELENIUM; MUSCLE COMPOSITION; NILE TILAPIA; FISH; BIOAVAILABILITY; CONSUMPTION; MERCURY; GROWTH; SELENOMETHIONINE	This goal of this study was to highlight the importance of minerals in the diet of fish for meeting micronutrient requirements in the human diet. First arsenic, calcium, cadmium, copper, iron, molybdenum, magnesium, manganese, sodium, phosphorus, potassium, selenium, and zinc concentrations of twelve commercially available tilapia samples were measured. The nutritional value of fillets in regard to their mineral content were assessed to establish potential health benefits or risks for consumers. The health benefit value of selenium was also calculated. Positive health benefit values indicate that tilapia fillets in the United States marketplace of this study do not pose health risks associated with mercury exposures. Selenium was the trace mineral of interest. After the market study, a seven-week fish feeding trial was conducted to study the influence of organic versus inorganic dietary selenium on Nile tilapia (Oreochromis niloticus). Fish were fed two different diets enriched with the same concentration (0.01g kg(-1)) of selenium in form of inorganic (sodium selenite) or organic (seleno-L-methionine) selenium in triplicate groups. There were no significant differences between growth and biometrics of fish fed different diets (p>0.05). At the end of trial twelve fish from each treatment were collected. Fillets of fish fed organic selenium had selenium concentrations of 0.55 0.01 mu g g(-1) which were significantly (p<0.05) higher than fish fed inorganic selenium at levels of 0.22 +/- 0.008 mu g g(-1) or fish samples from the marketplace with a selenium level of 0.2 0.03 mu g g(-1). Fish fed organic selenium also had significantly higher (p<0.05) plasma and kidney selenium in comparison to fish fed inorganic selenium. No significant differences (p>0.05) were observed in glutathione peroxidase activities in either the plasma or liver of Nile tilapia in the different treatment groups. This study shows that organic selenium is a better option for production of Nile tilapia fillets rich in selenium.	[Farzad, Razieh; Kuhn, David D.; O'Keefe, Sean F.; Neilson, Andrew P.] Virginia Polytech Inst & State Univ, Dept Food Sci & Technol, Blacksburg, VA 24061 USA; [Smith, Stephen A.] Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathol, Blacksburg, VA USA; [Ralston, Nicholas V. C.] Univ North Dakota, Dept Earth Syst Sci & Policy, Grand Forks, ND 58201 USA; [Gatlin, Delbert M.] Texas A&M Univ, Dept Fisheries & Wildlife Sci, College Stn, TX USA	Virginia Polytechnic Institute & State University; University of North Dakota Grand Forks; Texas A&M University System; Texas A&M University College Station	Kuhn, DD (corresponding author), Virginia Polytech Inst & State Univ, Dept Food Sci & Technol, Blacksburg, VA 24061 USA.	davekuhn@vt.edu	OKeefe, Sean F/N-3101-2016; Gatlin, Delbert/AAB-3615-2021	OKeefe, Sean F/0000-0002-2491-7900; Ralston, Nicholas/0000-0001-7686-2932; Kuhn, David/0000-0003-3368-0375	Virginia Tech's College of Agriculture and Life Sciences John Lee Pratt Animal Nutrition Program; Virginia Tech's Interdisciplinary Graduate Education Program (IGEP) water INTERface	Virginia Tech's College of Agriculture and Life Sciences John Lee Pratt Animal Nutrition Program; Virginia Tech's Interdisciplinary Graduate Education Program (IGEP) water INTERface	This study was funded by Virginia Tech's College of Agriculture and Life Sciences John Lee Pratt Animal Nutrition Program and Virginia Tech's Interdisciplinary Graduate Education Program (IGEP) water INTERface.	Allison EH, 2013, INTEGRATING FI UNPUB; [Anonymous], 2018, USDA NAT NUTR DAT ST; AOCS (American Oil Chemists'' Society), 2010, OFFICIAL METHODS REC; APHA AWWA WEF, 2012, STANDARD METHODS EXA, P541; Avella-Garcia C. B., 2014, CURR ENV HLTH REP, V1, P46, DOI DOI 10.1007/s40572-013-0006-4; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Beveridge MCM, 2013, J FISH BIOL, V83, P1067, DOI 10.1111/jfb.12187; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Coppinger RJ, 2001, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, P219; Daniels LA, 1996, BIOL TRACE ELEM RES, V54, P185, DOI 10.1007/BF02784430; Davidson PW, 2011, NEUROTOXICOLOGY, V32, P711, DOI 10.1016/j.neuro.2011.08.003; de la Guardia M, 2015, HDB MINERAL ELEMENTS, DOI [10.1002/9781118654316, DOI 10.1002/9781118654316]; Ed McCurdy GW, 2006, UNMATCHED REMOVAL SP; Eisler Ronald, 1994, Advances in Environmental Science and Technology, V27, P185; Evans P, 2001, BRIT J NUTR, V85, pS67, DOI 10.1079/BJN2000296; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; FDA 1990-2012, NAT MAR FISH SERV SU; Food and Agriculture Organization [FAO], 2018, STAT WORLD FISH AQ C; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; Gillespie S, 2017, GLOB CHALL, V1, DOI 10.1002/gch2.201600002; Golding J, 2017, INT J HYG ENVIR HEAL, V220, P1161, DOI 10.1016/j.ijheh.2017.07.004; Hayat MA, 2000, PRINCIPLES TECHNIQUE, Vxix; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; HLPE, 2014, REP HIGH LEV PAN EXP; International Food Policy Research Institute (IFPRI), 2016, GLOB NUTR REP PROM I; Julvez J, 2016, AM J EPIDEMIOL, V183, P169, DOI 10.1093/aje/kwv195; Kucukbay FZ, 2009, AQUACULT NUTR, V15, P569, DOI 10.1111/j.1365-2095.2008.00624.x; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Le KT, 2014, AQUACULTURE, V420, P57, DOI 10.1016/j.aquaculture.2013.10.034; Lee S, 2016, AQUACULTURE, V464, P153, DOI 10.1016/j.aquaculture.2016.06.027; LI G, 1985, HUM PATHOL, V16, P602, DOI 10.1016/S0046-8177(85)80110-6; Lin YH, 2014, AQUACULTURE, V430, P114, DOI 10.1016/j.aquaculture.2014.03.048; Llop S, 2017, INT J EPIDEMIOL, V46, P827, DOI 10.1093/ije/dyw259; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; Olmedo P, 2013, FOOD CHEM TOXICOL, V62, P299, DOI 10.1016/j.fct.2013.08.076; Pacitti D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144681; Ralston NVC, 2016, BIOL TRACE ELEM RES, V171, P262, DOI 10.1007/s12011-015-0516-z; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; Ralston NVC, 2018, FREE RADICAL BIOL ME; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrauzer GN, 2001, J AM COLL NUTR, V20, P1; Telli GS, 2014, FISH SHELLFISH IMMUN, V39, P305, DOI 10.1016/j.fsi.2014.05.025; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; United States Environmental Protection Agency (USEPA), 2000, EPA GUID DEV FISH AD; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; US Environmental Protection Agency (USEPA), 2007, INT RISK INF SYST AR; US Food and Drug Administration Center for Food Safety and Applied Nutrition, LAB NUTR LAB CLAIMS; USFDA, 2001, FDA CONS ADV; Vieira C, 2011, FOOD CHEM TOXICOL, V49, P923, DOI 10.1016/j.fct.2010.12.016; Wang CL, 1997, AQUACULTURE, V152, P223, DOI 10.1016/S0044-8486(96)01523-2; Wang YB, 2007, ANIM FEED SCI TECH, V134, P243, DOI 10.1016/j.anifeedsci.2006.12.007; Watt, 1973, AGR HDB, V74; Zhou XX, 2009, AQUACULTURE, V291, P78, DOI 10.1016/j.aquaculture.2009.03.007	58	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217043	10.1371/journal.pone.0217043	http://dx.doi.org/10.1371/journal.pone.0217043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170189	Green Submitted, Green Published, gold			2022-12-26	WOS:000470263700016
J	Wang, JF; Wu, Y				Wang, Jianfeng; Wu, Yan			Self-esteem modulates the ERP processing of emotional intensity in happy and angry faces	PLOS ONE			English	Article							ATTENTIONAL RESPONSES; NEGATIVITY BIAS; REJECTION; STIMULI; BRAIN; INFORMATION; FAILURE; STRESS	Previous studies have shown that self-esteem modulates attentional responses to emotional stimuli. However, it is well known that emotional stimuli can vary in intensity. The main objective of the present study was to further investigate self-esteem related emotional intensity processing in happy and anger faces. Event-related potentials (ERPs) were recorded while 27 high-esteem versus 27 low self-esteem participants carried out a visual oddball task, with neutral faces as the standard stimuli and deviant stimuli varying on valence (happy and anger) and intensity (40%, 70%, and 100% emotive) dimensions. The results showed only high self-esteem people, instead of those with low self-esteem, displayed significant emotion intensity effects for 100% than for 70% happy faces in P3 component. On the other hand, only people with low self-esteem exhibited pronounced intensity effects for anger faces in P3 amplitudes. Moreover, only people with low self-esteem displayed significant intensity effects for 100% compared to both 70% and 40% anger stimuli in N2 amplitudes at central sites. These findings indicate that high self-esteem individuals were typically more susceptible to highly as well as mildly positive stimuli yet less reactive to negative stimuli compared with people with low self-esteem.	[Wang, Jianfeng; Wu, Yan] Chengdu Med Coll, Dept Psychol, Chengdu, Sichuan, Peoples R China; [Wang, Jianfeng; Wu, Yan] Chengdu Med Coll, Sichuan Res Ctr Appl Psychol, Chengdu, Sichuan, Peoples R China	Chengdu Medical College; Chengdu Medical College	Wang, JF; Wu, Y (corresponding author), Chengdu Med Coll, Dept Psychol, Chengdu, Sichuan, Peoples R China.; Wang, JF; Wu, Y (corresponding author), Chengdu Med Coll, Sichuan Res Ctr Appl Psychol, Chengdu, Sichuan, Peoples R China.	wjfzy1985@163.com; wuyanzhicheng@163.com			National Natural Science Foundation of China [31700980, 31701001, 31500910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (31700980, 31701001, 31500910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, SELF; Baldwin MW, 1996, J PERS SOC PSYCHOL, V71, P1130, DOI 10.1037/0022-3514.71.6.1130; Boden JM, 2008, DEV PSYCHOPATHOL, V20, P319, DOI 10.1017/S0954579408000151; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Carretie L, 2013, SOC COGN AFFECT NEUR, V8, P764, DOI 10.1093/scan/nss068; Chen J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00376; Daffner KR, 2000, PSYCHOPHYSIOLOGY, V37, P737, DOI 10.1017/S0048577200990814; Dandeneau SP, 2004, J SOC CLIN PSYCHOL, V23, P584, DOI 10.1521/jscp.23.4.584.40306; Dandeneau SD, 2009, CONTEMP EDUC PSYCHOL, V34, P42, DOI 10.1016/j.cedpsych.2008.05.004; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Diener E., 1999, WELL BEING FDN HEDON, P213, DOI DOI 10.1037/0003-066X.61.4.305; Downey G, 1996, J PERS SOC PSYCHOL, V70, P1327, DOI 10.1037/0022-3514.70.6.1327; Ekman P., 1976, PICTURES FACIAL AFFE; Ellis A., 1991, J RATION-EMOT COGN-B, V9, P139, DOI [https://doi.org/10.1007/BF01061227, DOI 10.1007/BF01061227]; Gross J.J., 2007, HDB EMOTION REGULATI, P3; Grundy JG, 2015, SOC NEUROSCI-UK, V10, P100, DOI 10.1080/17470919.2014.965339; Gyurak A, 2007, PSYCHOL SCI, V18, P886, DOI 10.1111/j.1467-9280.2007.01996.x; Holmes A, 2009, COGN AFFECT BEHAV NE, V9, P323, DOI 10.3758/CABN.9.3.323; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Larsen RJ, 2000, PSYCHOL INQ, V11, P129, DOI 10.1207/S15327965PLI1103_01; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leppanen JM, 2007, BRAIN RES, V1166, P103, DOI 10.1016/j.brainres.2007.06.060; Li HJ, 2012, J RES PERS, V46, P459, DOI 10.1016/j.jrp.2012.02.010; Li HJ, 2012, PERS INDIV DIFFER, V53, P947, DOI 10.1016/j.paid.2012.03.004; Luck S. J., 2005, COGNITIVE NEUROSCIEN; Mauss IB, 2007, SOC PERSONAL PSYCHOL, V1, P146, DOI 10.1111/j.1751-9004.2007.00005.x; Murray SL, 2006, PSYCHOL BULL, V132, P641, DOI 10.1037/0033-2909.132.5.641; Murray SL, 2000, J PERS SOC PSYCHOL, V78, P478, DOI 10.1037//0022-3514.78.3.478; Murray SL, 2002, J PERS SOC PSYCHOL, V83, P556, DOI 10.1037//0022-3514.83.3.556; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Pruessner JC, 1999, PERS INDIV DIFFER, V27, P477, DOI 10.1016/S0191-8869(98)00256-6; Ralph JA, 1998, J ABNORM PSYCHOL, V107, P203, DOI 10.1037/0021-843X.107.2.203; Ridout N, 2009, COGNITION EMOTION, V23, P739, DOI 10.1080/02699930802121137; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Sommer KL, 2002, PERS SOC PSYCHOL B, V28, P926, DOI 10.1177/01467202028007006; Sommer KL, 2001, BASIC APPL SOC PSYCH, V23, P225, DOI 10.1207/S15324834BASP2304_1; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Wang JF, 2014, J RES PERS, V50, P90, DOI 10.1016/j.jrp.2014.03.005; Wang JF, 2011, J RES PERS, V45, P441, DOI 10.1016/j.jrp.2011.05.004; WHISMAN MA, 1993, J PERS SOC PSYCHOL, V65, P1054, DOI 10.1037/0022-3514.65.5.1054; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Wood JV, 2003, J PERS SOC PSYCHOL, V85, P566, DOI 10.1037/0022-3514.85.3.566; Young AW, 2002, FACIAL EXPRESSIONS E; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan Jiajin, 2015, Front Behav Neurosci, V9, P98, DOI 10.3389/fnbeh.2015.00098	51	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217844	10.1371/journal.pone.0217844	http://dx.doi.org/10.1371/journal.pone.0217844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB4TA	31170195	gold, Green Published, Green Submitted			2022-12-26	WOS:000470263700069
J	Takada, K; Shimokawa, M; Tanaka, K; Kohashi, K; Haro, A; Osoegawa, A; Tagawa, T; Azuma, K; Okamoto, I; Oda, Y; Mori, M				Takada, Kazuki; Shimokawa, Mototsugu; Tanaka, Kensuke; Kohashi, Kenichi; Haro, Akira; Osoegawa, Atsushi; Tagawa, Tetsuzo; Azuma, Koichi; Okamoto, Isamu; Oda, Yoshinao; Mori, Masaki			Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma	PLOS ONE			English	Article							DEATH-LIGAND 1; INDOLEAMINE 2,3-DIOXYGENASE 1; TO-LYMPHOCYTE RATIO; PD-L2 EXPRESSION; CLINICOPATHOLOGICAL ANALYSIS; PROTEIN EXPRESSION; OPEN-LABEL; CANCER; DOCETAXEL; NIVOLUMAB	We sought to identify peripheral blood markers associated with two immune-related factors -programmed cell death-ligand-2 (PD-L2) and indoleamine 2,3-dioxygenase-1 (IDO1)- that are expressed on tumor cells in primary lung adenocarcinoma (AD) specimens. We randomly selected 448 patients (70%) from 640 consecutive patients with resected stage I-III primary lung AD, who had been treated at that point with surgery alone. Expression of PD-L2 and IDO1 in these patients was assessed by immunohistochemistry, and evaluated with respect to peripheral blood markers measured before surgery, including white blood cells, absolute neutrophil count, absolute lymphocyte count, absolute monocyte count (AMC), absolute eosinophil count (AEC), serum C-reactive protein, and serum lactate dehydrogenase levels. Membrane PD-L2 expression and cytoplasmic IDO1 expression were defined by tumor proportion score (TPS); samples with TPS < 1% were considered negative. Logistic regression models were used to identify variables associated with the immune-related factors. Advanced stage (P = 0.0090), higher AMC (P = 0.0195), and higher AEC (P = 0.0015) were independent predictors of IDO1 expression. PD-L2 expression was not associated with any tested peripheral blood markers. Peripheral blood markers, especially AMC and AEC, could potential predict IDO1 expression in lung AD. This study should be replicated in another cohort; further efforts to explore other biomarkers that predict PD-L2 or IDO1 expression are also warranted.	[Takada, Kazuki; Tanaka, Kensuke; Haro, Akira; Osoegawa, Atsushi; Tagawa, Tetsuzo; Mori, Masaki] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan; [Shimokawa, Mototsugu] Natl Kyushu Canc Ctr, Clin Res Inst, Fukuoka, Fukuoka, Japan; [Kohashi, Kenichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka, Fukuoka, Japan; [Azuma, Koichi] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Fukuoka, Fukuoka, Japan; [Okamoto, Isamu] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Fukuoka, Japan	Kyushu University; Kyushu Cancer Center; Kyushu University; Kurume University; Kyushu University	Takada, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Fukuoka, Japan.	k_takada@surg2.med.kyushu-u.ac.jp		Osoegawa, Atsushi/0000-0002-8327-3631				Akamine T, 2018, SURG ONCOL, V27, P88, DOI 10.1016/j.suronc.2018.01.002; Awad MM, 2018, J CLIN ONCOLOGY OF S, V36; Bagley SJ, 2017, LUNG CANCER, V106, P1, DOI 10.1016/j.lungcan.2017.01.013; Balar AV, 2018, J CLIN ONCOLOGY OF S, V36; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brustugun OT, 2016, J CLIN ONCOLOGY OFFI; Calles A, 2015, J THORAC ONCOL, V10, P1726, DOI 10.1097/JTO.0000000000000687; Casebeer AW, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.30_suppl.46; Cohen EEW, 2018, J CLIN ONCOLOGY OF S, V36; Daud A, 2018, J CLIN ONCOL S, V36; Della Chiesa M, 2006, BLOOD, V108, P4118, DOI 10.1182/blood-2006-06-006700; Diem S, 2017, LUNG CANCER, V111, P176, DOI 10.1016/j.lungcan.2017.07.024; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hui RN, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.TPS9104; Jotte RM, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA9000; Kim MY, 2015, LUNG CANCER, V88, P24, DOI 10.1016/j.lungcan.2015.01.016; Koh J, 2015, MODERN PATHOL, V28, P1154, DOI 10.1038/modpathol.2015.63; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Kozuma Y, 2018, EUR J CANCER, V101, P20, DOI 10.1016/j.ejca.2018.06.020; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Matsubara T, 2019, ANN SURG ONCOL, V26, P1925, DOI 10.1245/s10434-019-07257-3; Okuma Y, 2017, LUNG CANCER, V104, P1, DOI 10.1016/j.lungcan.2016.11.023; PAZARES LG, 2018, J CLIN ONCOL S, V36; Powles T, 2018, J CLIN ONCOLOGY OF S, V36; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Seeber A, 2018, CANCER SCI, V109, P1583, DOI 10.1111/cas.13560; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Takada K, 2019, LUNG CANCER, V128, P26, DOI 10.1016/j.lungcan.2018.12.008; Takada K, 2018, ANTICANCER RES, V38, P5295, DOI 10.21873/anticanres.12856; Takada K, 2017, CANCER MED-US, V6, P2552, DOI 10.1002/cam4.1215; Takada K, 2016, J THORAC ONCOL, V11, P1879, DOI 10.1016/j.jtho.2016.06.006; Takamori S, 2019, ANN SURG ONCOL, V26, P1916, DOI 10.1245/s10434-019-07231-z; Takamori S, 2018, ANTICANCER RES, V38, P5903, DOI 10.21873/anticanres.12934; Takamori S, 2018, ANTICANCER RES, V38, P5897, DOI 10.21873/anticanres.12933; Takamori S, 2018, CLIN LUNG CANCER, V19, P12, DOI 10.1016/j.cllc.2017.06.015; Tanizaki J, 2018, J THORAC ONCOL, V13, P97, DOI 10.1016/j.jtho.2017.10.030; Theate I, 2015, CANCER IMMUNOL RES, V3, P161, DOI 10.1158/2326-6066.CIR-14-0137; Toyokawa G, 2017, CLIN LUNG CANCER, V18, pE375, DOI 10.1016/j.cllc.2017.03.008; Zhai LJ, 2015, CLIN CANCER RES, V21, P5427, DOI 10.1158/1078-0432.CCR-15-0420; Zhang Y, 2014, ONCOTARGETS THER, V7, P567, DOI 10.2147/OTT.S59959	47	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2019	14	6							e0217991	10.1371/journal.pone.0217991	http://dx.doi.org/10.1371/journal.pone.0217991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2FX	31163080	gold, Green Submitted, Green Published			2022-12-26	WOS:000470086200050
J	Crivaro, AN; Mucci, JM; Bonder, CM; Ormazabal, ME; Ceci, R; Simonaro, C; Rozenfeld, PA				Crivaro, Andrea N.; Mucci, Juan M.; Bonder, Constanza M.; Ormazabal, Maximiliano E.; Ceci, Romina; Simonaro, Calogera; Rozenfeld, Paula A.			Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease	PLOS ONE			English	Article							BONE; IMMUNE; SODIUM; CELLS	Gaucher and Fabry diseases are the most prevalent sphingolipidoses. Chronic inflammation is activated in those disorders, which could play a role in pathogenesis. Significant degrees of amelioration occur in patients upon introduction of specific therapies; however, restoration to complete health status is not always achieved. The idea of an adjunctive therapy that targets inflammation may be a suitable option for patients. PPS is a mixture of semisynthetic sulfated polyanions that have been shown to have anti-inflammatory effects in mucopoly-saccharidosis type I and II patients and animal models of type I, IIIA and VI. We hypothesized PPS could be a useful adjunctive therapy to inflammation for Gaucher and Fabry diseases. The objective of this work is to analyze the in vitro effect of PPS on inflammatory cytokines in cellular models of Gaucher and Fabry diseases, and to study its effect in Gaucher disease associated in vitro bone alterations. Cultures of peripheral blood mononuclear cells from Fabry and Gaucher patients were exposed to PPS. The secretion of proinflammatory cytokines was significantly reduced. Peripheral blood cells exposed to PPS from Gaucher patients revealed a reduced tendency to differentiate to osteoclasts. Osteoblasts and osteocytes cell lines were incubated with an inhibitor of glucocerebrosidase, and conditioned media was harvested in order to analyze if those cells secrete factors that induce osteoclastogenesis. Conditioned media from this cell cultures exposed to PPS produced lower numbers of osteoclasts. We could demonstrate PPS is an effective molecule to reduce the production of proinflammatory cytokines in in vitro models of Fabry and Gaucher diseases. Moreover, it was effective at ameliorating bone alterations of in vitro models of Gaucher disease. These results serve as preclinical supportive data to start clinical trials in human patients to analyze the effect of PPS as a potential adjunctive therapy for Fabry and Gaucher diseases.	[Crivaro, Andrea N.; Mucci, Juan M.; Bonder, Constanza M.; Ormazabal, Maximiliano E.; Ceci, Romina; Rozenfeld, Paula A.] Univ Nacl La Plata, CONICET, IIFP, Fac Ciencias Exactas,Dept Ciencias Biol, La Plata, Buenos Aires, Argentina; [Simonaro, Calogera] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Icahn School of Medicine at Mount Sinai	Rozenfeld, PA (corresponding author), Univ Nacl La Plata, CONICET, IIFP, Fac Ciencias Exactas,Dept Ciencias Biol, La Plata, Buenos Aires, Argentina.	paularozenfeld@gmail.com		Ormazabal, Maximiliano Emanuel/0000-0003-0455-5532; , Paula/0000-0002-8138-3087				Beck M, 2018, DEV MED CHILD NEUROL, V60, P13, DOI 10.1111/dmcn.13600; Bondar C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010112; Chen KH, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.10.033; De Francesco PN, 2013, MOL GENET METAB, V109, P93, DOI 10.1016/j.ymgme.2013.02.003; Frohbergh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100882; Fujitsuka H, 2019, MOL GENET METAB REP, V19, DOI 10.1016/j.ymgmr.2019.100455; GRABOWSKI GA, 2009, ONLINE METABOLIC MOL; Grabowski GA, 2017, MOL GENET METAB, V120, P38, DOI 10.1016/j.ymgme.2016.11.388; Grosjean F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204366; Hennermann JB, 2016, J INHERIT METAB DIS, V39, P831, DOI 10.1007/s10545-016-9974-5; Kruger R, 2012, J CHROMATOGR B, V883, P128, DOI 10.1016/j.jchromb.2011.11.020; Kumar V, 2012, ROBBINS BASIC PATHOL; Liao HC, 2017, CLIN CHEM, V63, P1363, DOI 10.1373/clinchem.2016.264952; Mathur A, 2018, J LEUKOCYTE BIOL, V103, P233, DOI 10.1189/jlb.3MR0617-250R; Mori G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/720504; Morishita K, 2011, RHEUMATOLOGY, V50, pV19, DOI 10.1093/rheumatology/ker397; Mucci JM, 2015, BLOOD CELL MOL DIS, V55, P134, DOI 10.1016/j.bcmd.2015.05.009; Nagata M, 2017, P NATL ACAD SCI USA, V114, pE3285, DOI 10.1073/pnas.1618133114; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Okamoto K, 2017, PHYSIOL REV, V97, P1295, DOI 10.1152/physrev.00036.2016; Panicker LM, 2018, HUM MOL GENET, V27, P811, DOI 10.1093/hmg/ddx442; Rigante D, 2017, IMMUNOL LETT, V188, P79, DOI 10.1016/j.imlet.2017.07.004; Rozenfeld P, 2017, MOL GENET METAB, V122, P19, DOI 10.1016/j.ymgme.2017.09.004; Sadhukhan PC, 2002, J UROLOGY, V168, P289, DOI 10.1016/S0022-5347(05)64909-9; Sampson MJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1754-3; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153136; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Stirnemann J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020441; Vistnes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089621; Wijekoon HMS, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1466-4; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Zancan I, 2015, HUM MOL GENET, V24, P1280, DOI 10.1093/hmg/ddu538	35	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217780	10.1371/journal.pone.0217780	http://dx.doi.org/10.1371/journal.pone.0217780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150494	Green Published, Green Submitted, gold			2022-12-26	WOS:000469759100105
J	Lu, CH; Chen, WT; Hsieh, CH; Kuo, YY; Chao, CY				Lu, Chueh-Hsuan; Chen, Wei-Ting; Hsieh, Chih-Hsiung; Kuo, Yu-Yi; Chao, Chih-Yu			Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; CELLULAR-RESPONSES; MILD HYPERTHERMIA; APOPTOSIS; GEMCITABINE; RADIATION; MITOCHONDRIA; INHIBITION; COFFEE; LINE	Hyperthermia (HT) has shown feasibility and potency as an anticancer therapy. Administration of HT in the chemotherapy has previously enhanced the cytotoxicity of drugs against pancreatic cancer. However, the drugs used when conducting these studies are substantially conventional chemotherapeutic agents that may cause unwanted side effects. Additionally, the thermal dosage in the treatment of cancer cells could also probably harm the healthy cells. The purpose of this work was to investigate the potential of the two natural polyphenolic compounds, epigallocatechin gallate (EGCG) and chlorogenic acid (CGA), as heat synergizers in the thermal treatment of the PANC-1 cells. Furthermore, we have introduced a unique strategy entitled the thermal cycling-hyperthermia (TC-HT) that is capable of providing a maximum synergy and minimal side effect with the anticancer compounds. Our results demonstrate that the combination of the TC-HT and the CGA or EGCG markedly exerts the anticancer effect against the PANC-1 cells, while none of the single treatment induced such changes. The synergistic activity was attributed to the cell cycle arrest at the G2/M phase and the induction of the ROS-dependent mitochondria-mediated apoptosis. These findings not only represent the first in vitro thermal synergistic study of natural compounds in the treatment of pancreatic cancer, but also highlight the potential of the TC-HT as an alternative strategy in thermal treatment.	[Lu, Chueh-Hsuan; Chen, Wei-Ting; Hsieh, Chih-Hsiung; Kuo, Yu-Yi; Chao, Chih-Yu] Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan; [Lu, Chueh-Hsuan; Chen, Wei-Ting; Hsieh, Chih-Hsiung; Kuo, Yu-Yi; Chao, Chih-Yu] Natl Taiwan Univ, Biomed & Mol Imaging Ctr, Coll Med, Taipei, Taiwan; [Chao, Chih-Yu] Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chao, CY (corresponding author), Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Biomed & Mol Imaging Ctr, Coll Med, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan.	cychao@phys.ntu.edu.tw	Hsieh, Chih-Hsiung/GMX-1452-2022; Hsieh, Chih-Hsiung/AFI-4085-2022		Ministry of Science and Technology of the Republic of China [MOST 105-2112-M-002-006-MY3]; Ministry of Education of the Republic of China [MOE 106R880708]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan)	This work was supported by grants from Ministry of Science and Technology (MOST 105-2112-M-002-006-MY3 to CYC) and Ministry of Education (MOE 106R880708 to CYC) of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2009, INT J HYPERTHER, V25, P210, DOI 10.1080/02656730802657036; Ahmed K, 2015, APOPTOSIS, V20, P1411, DOI 10.1007/s10495-015-1168-3; Au JLS, 2010, ONCOLOGY-NY, V24, P1155; Bakshandeh-Bath A, 2009, ANTICANCER RES, V29, P3069; Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7; Bimonte Sabrina, 2017, Recenti Progressi in Medicina, V108, P282, DOI 10.1701/2715.27715; Calderwood SK, 2005, INT J HYPERTHER, V21, P713, DOI 10.1080/02656730500340794; Cesna V, 2018, WORLD J GASTROENTERO, V24, P1072, DOI 10.3748/wjg.v24.i10.1072; Cui ZG, 2014, CHEM-BIOL INTERACT, V215, P46, DOI 10.1016/j.cbi.2014.03.005; Cui ZG, 2014, EUR J PHARMACOL, V723, P99, DOI 10.1016/j.ejphar.2013.11.031; Curley SA, 2014, INT J ENV RES PUB HE, V11, P9142, DOI 10.3390/ijerph110909142; DEWEY WC, 1977, RADIOLOGY, V123, P463, DOI 10.1148/123.2.463; DEWEY WC, 1994, INT J HYPERTHER, V10, P457, DOI 10.3109/02656739409009351; Dong J, 2011, WORLD J GASTROENTERO, V17, P1204, DOI 10.3748/wjg.v17.i9.1204; Feng Q, 2006, J JILIN U MED EDITIO; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Fryer RA, 2009, CURR CLIN PHARMACOL, V4, P102, DOI 10.2174/157488409788185007; Gee JR, 2017, CANCER PREV RES, V10, P298, DOI 10.1158/1940-6207.CAPR-16-0167; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hatashita M, 2014, INT J MOL MED, V33, P406, DOI 10.3892/ijmm.2013.1568; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Huang SH, 1999, J CELL BIOCHEM, V75, P327, DOI 10.1002/(SICI)1097-4644(19991101)75:2<327::AID-JCB14>3.3.CO;2-7; Issels RD, 2008, EUR J CANCER, V44, P2546, DOI 10.1016/j.ejca.2008.07.038; JESSUS C, 1992, CELL, V68, P323, DOI 10.1016/0092-8674(92)90473-P; Jin HB, 2018, ONCOL LETT, V16, P6742, DOI 10.3892/ol.2018.9455; Kampinga HH, 2006, INT J HYPERTHER, V22, P191, DOI 10.1080/02656730500532028; Kaur Punit, 2011, Cancers (Basel), V3, P3799, DOI 10.3390/cancers3043799; KIM JH, 1984, CANCER RES, V44, P102; KORCHAK HM, 1982, BIOCHEM BIOPH RES CO, V108, P1495, DOI 10.1016/S0006-291X(82)80076-4; Li XP, 2013, INT J HYPERTHER, V29, P678, DOI 10.3109/02656736.2013.837199; Lim CU, 2006, INT J HYPERTHER, V22, P77, DOI 10.1080/02656730500430538; Min KJ, 2014, INTEGR MED RES, V3, P16, DOI 10.1016/j.imr.2013.12.001; Miyamoto R, 2016, CANCER SCI, V107, P514, DOI 10.1111/cas.12888; Mohamed F, 2003, ANN SURG ONCOL, V10, P463, DOI 10.1245/ASO.2003.08.006; Oei AL, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0462-0; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; OVERGAARD J, 1989, INT J RADIAT ONCOL, V16, P535, DOI 10.1016/0360-3016(89)90470-7; Ponce AM, 2006, INT J HYPERTHER, V22, P205, DOI 10.1080/02656730600582956; RAAPHORST GP, 1979, RADIAT RES, V79, P390, DOI 10.2307/3575104; Refaat T, 2015, BREAST, V24, P418, DOI 10.1016/j.breast.2015.03.008; Richelle M, 2001, J AGR FOOD CHEM, V49, P3438, DOI 10.1021/jf0101410; Rodriguez M, 2018, J CARCINOG MUTAG S, V6; Roti JLR, 2008, INT J HYPERTHER, V24, P3, DOI 10.1080/02656730701769841; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SMINIA P, 1994, INT J HYPERTHER, V10, P1, DOI 10.3109/02656739409009328; Song CW, 2009, INT J HYPERTHER, V25, P91, DOI 10.1080/02656730902744171; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Tschoep-Lechner KE, 2013, INT J HYPERTHER, V29, P8, DOI 10.3109/02656736.2012.740764; Wang K, 2012, INT J HYPERTHER, V28, P645, DOI 10.3109/02656736.2012.713541; Ware MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10508-6; Xu RS, 2015, J ANAL METHODS CHEM, V2015, DOI 10.1155/2015/189328; Yamagata K, 2018, MOL CELL BIOCHEM, V441, P9, DOI 10.1007/s11010-017-3171-1; Zhao HX, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150665; Zhao PJ, 2015, MOL MED REP, V11, P327, DOI 10.3892/mmr.2014.2655	57	17	17	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217676	10.1371/journal.pone.0217676	http://dx.doi.org/10.1371/journal.pone.0217676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150487	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100083
J	Skrabanek, P; Zahradnikova, A				Skrabanek, Pavel; Zahradnikova, Alexandra, Jr.			Automatic assessment of the cardiomyocyte development stages from confocal microscopy images using deep convolutional networks	PLOS ONE			English	Article								Computer assisted image acquisition techniques, including confocal microscopy, require efficient tools for an automatic sorting of vast amount of generated image data. The complexity of the classification process, absence of adequate tools, and insufficient amount of reference data has made the automated processing of images challenging. Mastering of this issue would allow implementation of statistical analysis in research areas such as in research on formation of t-tubules in cardiac myocytes. We developed a system aimed at automatic assessment of cardiomyocyte development stages (SAACS). The system classifies confocal images of cardiomyocytes with fluorescent dye stained sarcolemma. We based SAACS on a densely connected convolutional network (DenseNet) topology. We created a set of labelled source images, proposed an appropriate data augmentation technique and designed a class probability graph. We showed that the DenseNet topology, in combination with the augmentation technique is suitable for the given task, and that high-resolution images are instrumental for image categorization. SAACS, in combination with the automatic high-throughput confocal imaging, will allow application of statistical analysis in the research of the tubular system development or remodelling and loss.	[Skrabanek, Pavel] Brno Univ Technol, Inst Automat & Comp Sci, Brno, Czech Republic; [Zahradnikova, Alexandra, Jr.] Ctr Biosci SAS, Inst Mol Physiol & Genet, Bratislava, Slovakia; [Zahradnikova, Alexandra, Jr.] Biomed Res Ctr SAS, Inst Expt Endocrinol, Dept Cellular Cardiol, Bratislava, Slovakia	Brno University of Technology; SAS Institute Inc; Slovak Academy of Sciences; SAS Institute Inc; Slovak Academy of Sciences	Skrabanek, P (corresponding author), Brno Univ Technol, Inst Automat & Comp Sci, Brno, Czech Republic.	pavel.skrabanek@vut.cz	Škrabánek, Pavel/AAB-5848-2022; Alexandra, Zahradnikova/C-2918-2009	Škrabánek, Pavel/0000-0001-6194-0467; Alexandra, Zahradnikova/0000-0001-5170-118X	national scholarship programme of the Slovak Republic; Slovak Research and Development Agency (SRDA, APVV) [15-0302]; Vedecka grantova agentura Ministerstva skolstva, vedy, vyskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA) [2/0095/15, VEGA 2/0143/17]; Research and Development Operational Program - European Regional Development Fund [ITMS 26230120006]	national scholarship programme of the Slovak Republic; Slovak Research and Development Agency (SRDA, APVV); Vedecka grantova agentura Ministerstva skolstva, vedy, vyskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Research and Development Operational Program - European Regional Development Fund	The work was supported by national scholarship programme of the Slovak Republic (PS), https://www.scholarships.sk/; Slovak Research and Development Agency (SRDA, APVV), 15-0302 (A. Zahradnikova), http://www.apvv.sk/agentura.html?lang=en; Vedecka grantova agentura Ministerstva skolstva, vedy, vyskumu a sportu Slovenskej republiky a Slovenskej akademie vied (VEGA), 2/0095/15 and VEGA 2/0143/17 (AZjr), http://vega.sav.sk/.This publication is also a result of implementation of the project ITMS 26230120006, supported by the Research and Development Operational Program funded by the European Regional Development Fund, https://ec.europa.eu/regional_policy/EN/atlas/programmes/2014-2020/slovakia/2014sk16rfop001.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2018, HIGH THROUGHPUT CALC; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Franzini-Armstrong C., 2018, J GEN PHYSL; Frisk M, 2016, CARDIOVASC RES, V112, P443, DOI 10.1093/cvr/cvw111; Gao ZM, 2017, IEEE J BIOMED HEALTH, V21, P416, DOI 10.1109/JBHI.2016.2526603; Guo A, 2014, BIOPHYS J, V106, P2729, DOI 10.1016/j.bpj.2014.05.013; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Huang G, 2016, LECT NOTES COMPUT SC, V9908, P646, DOI 10.1007/978-3-319-46493-0_39; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Klimas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11542; krabanek P, 2017, SCI PAPERS U PARDU D, V24, P181; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lemnaru C, 2012, LECT NOTES BUS INF P, V102, P35; Louch WE, 2015, J PHYSIOL-LONDON, V593, P1047, DOI 10.1113/jphysiol.2014.274712; Mackova K, 2017, EUR BIOPHYS J BIOPHY, V46, P691, DOI 10.1007/s00249-017-1249-z; Mao HZ, 2017, IEEE COMPUT SOC CONF, P1927, DOI 10.1109/CVPRW.2017.241; Parikh SS, 2017, CIRC RES, V121, P1323, DOI 10.1161/CIRCRESAHA.117.311920; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Ruder S., 2016, ARXIV; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Singh JK, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13540; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Wang SJ, 2016, IEEE IJCNN, P4368, DOI 10.1109/IJCNN.2016.7727770; Xu MJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005746; Xu Y, 2015, INT CONF ACOUST SPEE, P947, DOI 10.1109/ICASSP.2015.7178109; Yu Z, 2018, INFORM SCIENCES, V433, P241, DOI 10.1016/j.ins.2017.12.045; Zahradnikova jr A, 2019, CONFOCAL MICROSCOPY, DOI [10.6084/m9.figshare.8063369, DOI 10.6084/M9.FIGSHARE.8063369]; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang CM, 2017, J MOL CELL CARDIOL, V112, P123, DOI 10.1016/j.yjmcc.2017.08.007	39	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0216720	10.1371/journal.pone.0216720	http://dx.doi.org/10.1371/journal.pone.0216720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145728	Green Published, gold, Green Submitted			2022-12-26	WOS:000469425500004
J	Gesto-Borroto, R; Cardoso-Taketa, A; Yactayo-Chang, JP; Medina-Jimenez, K; Hornung-Leoni, C; Lorence, A; Villarreal, ML				Gesto-Borroto, Reinier; Cardoso-Taketa, Alexandre; Yactayo-Chang, Jessica P.; Medina-Jimenez, Karina; Hornung-Leoni, Claudia; Lorence, Argelia; Luisa Villarreal, Maria			DNA barcoding and TLC as tools to properly identify natural populations of the Mexican medicinal species Galphimia glauca Cav	PLOS ONE			English	Article							HERBAL PRODUCT; LAND PLANTS; AUTHENTICATION; IDENTIFICATION; MALPIGHIACEAE; PHYLOGENY; EVOLUTION	Galphimia glauca is a plant that is endemic to Mexico and has been commonly used since pre-Hispanic times to treat various illnesses, including central nervous system disorders and inflammation. The first studies investigating a natural population of G. glauca in Mexico showed that the plant has anxiolytic and sedative activities in mice and humans. The plant's bioactive compounds were isolated and identified, and they belong to a family of nor-secofriedelanes called galphimines. The integration of DNA barcoding and thin-layer chromatography analysis was performed to clarify whether the botanical classification of the populations in the study, which were collected in different regions of Mexico, as G. glauca was correct or if the populations consist of more than one species of the genus Galphimia. We employed six DNA barcodes (matK, rbcL, rpoC1, psbA-trnH, ITS1 and ITS2) that were analyzed individually and in combination and then compared each other, to indicate differences among the studied populations. In the phylogenetic analysis, ITS1 and ITS2 markers as well as the combination of all DNA regions were the most efficient for discriminating the population studied. The thin-layer chromatography analysis exhibited four principal chemical profiles, one of which corresponded to the populations that produced galphimines. DNA barcoding was consistent and enabled us to differentiate the populations that produce galphimines from those that do not. The results of this investigation suggest that the studied populations belong to at least four different species of the genus Galphimia. The phylogenetic analysis and the thin-layer chromatography chemical profiles were convenient tools for establishing a strong relationship between the genotype and phenotype of the studied populations and could be used for quality control purposes to prepare herbal medicines from plants of the genus Galphimia.	[Gesto-Borroto, Reinier] Univ Autonoma Estado Morelos, Inst Invest Ciencias Basicas & Aplicadas, Ctr Invest Dinam Celular, Ciencias, Cuernavaca, Morelos, Mexico; [Gesto-Borroto, Reinier; Cardoso-Taketa, Alexandre; Luisa Villarreal, Maria] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Lab Invest Plantas Med, Cuernavaca, Morelos, Mexico; [Yactayo-Chang, Jessica P.; Medina-Jimenez, Karina; Lorence, Argelia] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72401 USA; [Hornung-Leoni, Claudia] Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Pachuca, Hidalgo, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; Arkansas State University; Universidad Autonoma del Estado de Hidalgo	Villarreal, ML (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Lab Invest Plantas Med, Cuernavaca, Morelos, Mexico.; Lorence, A (corresponding author), Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72401 USA.	alorence@astate.edu; luisav@uaem.mx	Gesto-Borroto, Reinier/AAM-6038-2021; Taketa, Alexandre Cardoso/AAG-8912-2020	Medina-Jimenez, Karina/0000-0002-4305-7854	CONACYT Ciencia Basica [222714]; CONACYT, Mexico [293307]; Arkansas Bioscience Institute (ABI); Arkansas Research Alliance (ARA)	CONACYT Ciencia Basica; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Arkansas Bioscience Institute (ABI); Arkansas Research Alliance (ARA)	Grant from CONACYT Ciencia Basica (222714) to MLV supported this research and the stay of RG-B at the Arkansas Biosciences Institute, Arkansas State University, Arkansas, USA. RG-B was awarded by CONACYT (293307), Mexico. Research done in AL's Laboratory was supported by funds from the Arkansas Bioscience Institute (ABI) and the Arkansas Research Alliance (ARA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Christiane, 2007, Contributions from the University of Michigan Herbarium, V25, P1; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bolson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143049; Cameron KM, 2001, AM J BOT, V88, P1847, DOI 10.2307/3558361; Cardoso-Taketa AT, 2008, PLANTA MED, V74, P1295, DOI 10.1055/s-2008-1074583; Chao Z, 2014, PHYTOMEDICINE, V21, P1767, DOI 10.1016/j.phymed.2014.09.001; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cordell GA, 2014, PHYTOCHEM LETT, V10, pXXVIII, DOI 10.1016/j.phytol.2014.06.002; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Davis CC, 2004, AM J BOT, V91, P262, DOI 10.3732/ajb.91.2.262; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; Davis CC, 2010, AM J BOT, V97, P2031, DOI 10.3732/ajb.1000146; Estrada E., 1985, JARDIN BOT PLANTAS M; Ferri G, 2015, FORENSIC SCI INT-GEN, V15, P131, DOI 10.1016/j.fsigen.2014.10.005; Ferri G, 2008, FORENS SCI INT-GEN S, V1, P593, DOI 10.1016/j.fsigss.2007.10.023; Ganie Showkat Hussain, 2015, Plant Gene, V4, P83, DOI 10.1016/j.plgene.2015.10.002; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gere J, 2013, ZOOKEYS, P127, DOI 10.3897/zookeys.365.5728; Ghorbani A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175722; Gonzalez-Cortazar M, 2014, PLANTA MED, V80, P90, DOI 10.1055/s-0033-1360150; Han JP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741476; Herrera-Arellano A, 2007, PLANTA MED, V73, P713, DOI 10.1055/s-2007-981539; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knibbe C, 2007, MOL BIOL EVOL, V24, P2344, DOI 10.1093/molbev/msm165; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Kshirsagar Parthraj, 2017, Proceedings of the Indian National Science Academy Part B Biological Sciences, V87, P101, DOI 10.1007/s40011-015-0556-3; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Lu QP, 2014, BIOCHEM SYST ECOL, V52, P20, DOI 10.1016/j.bse.2013.11.002; Michel CI, 2016, J APPL RES MED AROMA, V3, P94, DOI 10.1016/j.jarmap.2016.02.002; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Nei M., 2000, MOL EVOLUTION PHYLOG; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Purushothaman N, 2014, GENET MOL RES, V13, P2959, DOI 10.4238/2014.April.16.4; Raclariu AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01389-w; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sarwat M, 2016, CRIT REV BIOTECHNOL, V36, P191, DOI 10.3109/07388551.2014.947563; Selvaraj Dhivya, 2012, Genomics Proteomics & Bioinformatics, V10, P364, DOI 10.1016/j.gpb.2012.03.002; Sharma A, 2012, J ETHNOPHARMACOL, V144, P371, DOI 10.1016/j.jep.2012.09.022; Sharma A, 2012, J ETHNOPHARMACOL, V141, P964, DOI 10.1016/j.jep.2012.03.033; Taketa ATC, 2004, J NAT PROD, V67, P644, DOI 10.1021/np0304666; Tate JA, 2003, SYST BOT, V28, P723; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tnah LH, 2019, FOOD CONTROL, V95, P318, DOI 10.1016/j.foodcont.2018.08.022; Tokuoka T, 2006, J PLANT RES, V119, P599, DOI 10.1007/s10265-006-0025-4; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vassou SL, 2015, GENE, V559, P86, DOI 10.1016/j.gene.2015.01.025; Wang XC, 2015, MOL ECOL RESOUR, V15, P573, DOI 10.1111/1755-0998.12325; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125574; Zhen Y, 2012, METHODS MOL BIOL, V856, P141, DOI 10.1007/978-1-61779-585-5_6	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217313	10.1371/journal.pone.0217313	http://dx.doi.org/10.1371/journal.pone.0217313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136619	Green Published, Green Submitted, gold			2022-12-26	WOS:000469224300026
J	Siika, A; Liljeqvist, ML; Zommorodi, S; Nilsson, O; Andersson, P; Gasser, TC; Roy, J; Hultgren, R				Siika, Antti; Liljeqvist, Moritz Lindquist; Zommorodi, Sayid; Nilsson, Olga; Andersson, Patricia; Gasser, T. Christian; Roy, Joy; Hultgren, Rebecka			A large proportion of patients with small ruptured abdominal aortic aneurysms are women and have chronic obstructive pulmonary disease	PLOS ONE			English	Article							WALL STRESS; BODY-SIZE; SURVEILLANCE; GROWTH; REPAIR; METAANALYSIS; GENDER; RISK; PREVALENCE; MORPHOLOGY	Objective In a population-based cohort of ruptured abdominal aortic aneurysms (rAAAs), our aim was to investigate clinical, morphological and biomechanical features in patients with small rAAAs. Methods All patients admitted to an emergency department in Stockholm and Gotland, a region with a population of 2.1 million, between 2009-2013 with a CT-verified rupture (n = 192) were included, and morphological measurements were performed. Patients with small rAAAs, maximal diameter (Dmax) <= 60 mm were selected (n = 27), and matched 2: 1 by Dmax, sex and age to intact AAA (iAAAs). For these patients, morphology including volume and finite element analysis-derived biomechanics were assessed. Results The mean Dmax for all rAAAs was 80.8 mm (SD = 18.9 mm), women had smaller Dmax at rupture (73.4 +/- 18.4 mm vs 83.1 +/- 18.5 mm, p = 0.003), and smaller neck and iliac diameters compared to men. Aortic size index (ASI) was similar between men and women (4.1 +/- 3.1 cm/m(2) vs 3.8 +/- 1.0 cm/m(2)). Fourteen percent of all patients ruptured at Dmax <= 60 mm, and a higher proportion of women compared to men ruptured at Dmax <= 60 mm: 27% (12/45) vs. 10% (15/147), p = 0.005. Also, a higher proportion of patients with a chronic obstructive pulmonary disease ruptured at Dmax <= 60 mm (34.6% vs 14.6%, p = 0.026). Supra-renal aortic size index (14.0, IQR 13.3-15.3 vs 12.8, IQR = 11.4-14.0) and peak wall rupture index (PWRI, 0.35 +/- 0.08 vs 0.43 +/- 0.11, p = 0.016) were higher for small rAAAs compared to matched iAAAs. Aortic size index, peak wall stress and aneurysm volume did not differ. Conclusion More than one tenth of ruptures occur at smaller diameters, women continuously suffer an even higher risk of presenting with smaller diameters, and this must be considered in surveillance programs. The increased supra-renal aortic size index and PWRI are potential markers for rupture risk, and patients under surveillance with these markers may benefit from increased attention, and potentially from timely repair.	[Siika, Antti; Liljeqvist, Moritz Lindquist; Zommorodi, Sayid; Nilsson, Olga; Andersson, Patricia; Roy, Joy; Hultgren, Rebecka] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Zommorodi, Sayid] Karolinska Univ Hosp, Dept Reconstruct Plast Surg, Stockholm, Sweden; [Roy, Joy; Hultgren, Rebecka] Karolinska Univ Hosp, Dept Vasc Surg, Stockholm, Sweden; [Gasser, T. Christian] KTH Royal Inst Technol, Dept Solid Mech, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Siika, A (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	antti.siika@ki.se	Hultgren, Rebecka/K-8738-2012	Hultgren, Rebecka/0000-0002-8869-0493; Nilsson, Olga/0000-0002-7670-1677; Saratzis, Athanasios/0000-0002-3399-094X	Swedish Heart-Lung Foundation [20140722, 20130657, 20160266, 20180596]; Swedish Society of Medicine [SLS-174151]; regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council [20150537, 20180072, 20150916, 20180867]; Health, Medicine and Technology (Stockholm County Council) [20150916, 20180867]; Senior Clinical Research Appointment (Stockholm County Council) [20150906]; Karolinska Institutet	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society of Medicine; regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council; Health, Medicine and Technology (Stockholm County Council)(Stockholm County Council); Senior Clinical Research Appointment (Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This research was supported by the Swedish Heart-Lung Foundation (20140722, 20130657, 20160266, 20180596), the Swedish Society of Medicine (SLS-174151), and through the regional Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning [ALF]) between Stockholm County Council (20150537, 20180072, 20150916, 20180867), The Health, Medicine and Technology (Stockholm County Council 20150916, 20180867), Senior Clinical Research Appointment (Stockholm County Council: 20150906), and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Deery SE, 2018, VASC ENDOVASC SURG, V52, P543, DOI 10.1177/1538574418773247; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Dunsmore Sarah E, 2008, Int J Chron Obstruct Pulmon Dis, V3, P113; Erhart P, 2016, J ENDOVASC THER, V23, P115, DOI 10.1177/1526602815612196; Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Forbes TL, 2006, ANN VASC SURG, V20, P564, DOI 10.1007/s10016-006-9079-y; Gasser TC, 2010, EUR J VASC ENDOVASC, V40, P176, DOI 10.1016/j.ejvs.2010.04.003; Ghatwary T, 2012, J ENDOVASC THER, V19, P400, DOI 10.1583/11-3731MR.1; GLOVICZKI P, 1992, J VASC SURG, V15, P851, DOI 10.1016/0741-5214(92)90720-S; Hardman DTA, 1996, J VASC SURG, V23, P123, DOI 10.1016/S0741-5214(05)80042-4; Ho DE., 2011, J STAT SOFTW, V42, P1, DOI DOI 10.18637/JSS.V042.I08; Hultgren R, 2019, BRIT J SURG, V106, P206, DOI 10.1002/bjs.11047; Hultgren R, 2016, WORLD J SURG, V40, P3080, DOI 10.1007/s00268-016-3705-9; Indrakusuma R, 2016, EUR J VASC ENDOVASC, V52, P475, DOI 10.1016/j.ejvs.2016.07.003; Jones GT, 2019, EUR J VASC ENDOVASC, V57, P221, DOI 10.1016/j.ejvs.2018.08.048; Khosla S, 2014, BRIT J SURG, V101, P1350, DOI 10.1002/bjs.9578; Kristmundsson T, 2016, ANN VASC SURG, V31, P18, DOI 10.1016/j.avsg.2015.09.016; Laine MT, 2016, EUR J VASC ENDOVASC, V51, P511, DOI 10.1016/j.ejvs.2015.12.011; Larsson E, 2011, J VASC SURG, V54, P295, DOI 10.1016/j.jvs.2010.12.053; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lederle FA, 2016, JAMA INTERN MED, V176, P1767, DOI 10.1001/jamainternmed.2016.6663; Liljeqvist ML, 2017, J VASC SURG, V65, P1014, DOI 10.1016/j.jvs.2016.10.074; Liljeqvist ML, 2016, J VASC SURG, V63, P1434, DOI 10.1016/j.jvs.2015.11.051; Lo RC, 2014, J VASC SURG, V59, P1209, DOI 10.1016/j.jvs.2013.10.104; Manning BJ, 2009, J VASC SURG, V50, P263, DOI 10.1016/j.jvs.2009.02.243; McCready R A, 1993, Ann Vasc Surg, V7, P225, DOI 10.1007/BF02000246; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Oliver-Williams C, 2018, BRIT J SURG, V105, P68, DOI 10.1002/bjs.10715; Oliver-Williams C, 2019, CIRCULATION, V139, P1371, DOI 10.1161/CIRCULATIONAHA.118.036966; Ouriel K, 2010, J VASC SURG, V51, P1081, DOI 10.1016/j.jvs.2009.10.113; Parkinson F, 2015, J VASC SURG, V61, P1606, DOI 10.1016/j.jvs.2014.10.023; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; R Core Team, 2021, R LANGUAGE ENV STAT; Shang EK, 2013, J VASC SURG, V57, P84, DOI 10.1016/j.jvs.2012.07.002; Takagi H, 2017, INT ANGIOL, V36, P322, DOI 10.23736/S0392-9590.16.03762-7; Thompson SG, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17410; Truijers M, 2007, EUR J VASC ENDOVASC, V33, P401, DOI 10.1016/j.ejvs.2006.10.009; Ulug P, 2016, BRIT J SURG, V103, P1097, DOI 10.1002/bjs.10225; Ulug P, 2017, LANCET, V389, P2482, DOI 10.1016/S0140-6736(17)30639-6; Villard C, 2017, J VASC SURG, V66, P579, DOI 10.1016/j.jvs.2016.02.056; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wanhainen A, 2016, CIRCULATION, V134, P1141, DOI 10.1161/CIRCULATIONAHA.116.022305; Zommorodi S, 2016, J VASC SURG, V64, P949, DOI 10.1016/j.jvs.2016.04.007	45	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216558	10.1371/journal.pone.0216558	http://dx.doi.org/10.1371/journal.pone.0216558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136570	gold, Green Submitted, Green Published			2022-12-26	WOS:000469224300007
J	Shapiro, P				Shapiro, Paul			A promiscuous kinase inhibitor reveals secrets to cancer cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Deregulated kinase signaling networks drive the growth and survival of many cancer cells. However, the genetic complexity and rapidly evolving nature of most cancer cells create challenges when identifying the most relevant kinases to inhibit to achieve optimal therapeutic benefits. A new strategy that takes advantage of a well-characterized multitargeted kinase inhibitor describes a nongenetic approach to tease out key kinases that promote proliferation of specific cancer cell types.	[Shapiro, Paul] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 North Pine St, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Shapiro, P (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 North Pine St, Baltimore, MD 21201 USA.	pshapiro@rx.umaryland.edu						Dai SX, 2016, PEERJ, V4, DOI 10.7717/peerj.1791; Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lovly CM, 2014, CLIN CANCER RES, V20, P2249, DOI 10.1158/1078-0432.CCR-13-1610; Rao S, 2019, J BIOL CHEM, V294, P8664, DOI 10.1074/jbc.RA118.006805; Rao S, 2019, CELL CHEM BIOL, V26, P818, DOI 10.1016/j.chembiol.2019.02.021; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Zi FM, 2018, ONCOL LETT, V15, P683, DOI 10.3892/ol.2017.7412	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8674	8675		10.1074/jbc.H119.009103	http://dx.doi.org/10.1074/jbc.H119.009103			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	31127063	Green Published, hybrid			2022-12-26	WOS:000471108200033
J	Domingues, RMSM; Figueiredo, VC; Leal, MD				Soares Madeira Domingues, Rosa Maria; Figueiredo, Valeska Carvalho; Leal, Maria do Carmo			Prevalence of pre-gestational and gestational smoking and factors associated with smoking cessation during pregnancy, Brazil, 2011-2012	PLOS ONE			English	Article							BIRTH-WEIGHT; RISK-FACTORS; ALCOHOL-USE; TOBACCO USE; WOMEN; ARGENTINA; EXPOSURE	Gestational smoking is associated with various adverse maternal and fetal outcomes. Over the last three decades, despite considerable advances in tobacco control policy in Brazil, gestational smoking has caused a considerable number of fetal deaths and disabilities. The aim of this study is to estimate the prevalence of pre-gestational and gestational smoking and to identify the factors associated with smoking cessation up to the 20 th gestational week. Methods: "Birth in Brazil" was a nationwide hospital-based study conducted from February 2011 to October 2012. Smoking prevalence and smoking cessation during pregnancy was estimated through face-to-face interviews with postpartum women during hospitalization for birth care. We performed multivariate logistic regression to verify the factors associated with smoking cessation up to the 5th month of pregnancy. Results: prevalence of pre-gestational smoking of 16.1% (CI 95% 15.3%-16.9%); prevalence of smoking any time during pregnancy of 9.6% (CI 95% 9.0%-10.3%); and prevalence of smoking cessation up to the 5th month of pregnancy of 56.7% (CI 95% 54.0%-59.4%). The factors associated with smoking cessation were residence in the North, Northeast, and Central-West of Brazil, having received at least one prenatal consultation (OR 3.51 CI 95% 1.85-6.67), more years of schooling (15 or more vs less than 7 years of schooling OR 5.54 CI 95% 2.97-10.34), living with a partner (OR 1.35 CI 95% 1.01-1.79), no children prior to the index pregnancy (OR 2.77 CI 95% 2.13-3.61), and absence of alcohol use (1.74 CI 95% 1.39-2.18) or of suspected alcohol abuse (OR 1.62 CI 95% 1.07-2.45). Conclusion: The estimated smoking rate during pregnancy in Brazil is still high and is associated with factors of increased maternal social vulnerability, which may contribute to the increased occurrence of unfavorable perinatal outcomes.	[Soares Madeira Domingues, Rosa Maria] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DST Aids, Rio De Janeiro, Brazil; [Figueiredo, Valeska Carvalho; Leal, Maria do Carmo] Fundacao Oswaldo Cruz, Dept Epidemiol & Metodos Quantitat Saude, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Domingues, RMSM (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DST Aids, Rio De Janeiro, Brazil.	rosa.domingues@ini.fiocruz.br	Domingues, Rosa/AAS-3606-2020; Figueiredo, Valeska Carvalho/D-4268-2018; Carvalho Figueiredo, Valeska/D-4268-2018	Domingues, Rosa/0000-0001-5722-8127; Figueiredo, Valeska Carvalho/0000-0002-3379-0024; Carvalho Figueiredo, Valeska/0000-0001-8617-5386	National Council of Technological and Scientific Development (CNPq); National School of Public Health, Oswaldo Cruz Foundation (INOVA Project); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)	National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National School of Public Health, Oswaldo Cruz Foundation (INOVA Project); Research Funding Agency of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the funding from the National Council of Technological and Scientific Development (CNPq); the National School of Public Health, Oswaldo Cruz Foundation (INOVA Project); and the Research Funding Agency of the State of Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althabe F, 2008, MEDICINA-BUENOS AIRE, V68, P48; Alves E, 2013, NICOTINE TOB RES, V15, P1598, DOI 10.1093/ntr/ntt026; Ankum WM, 1996, FERTIL STERIL, V65, P1093, DOI 10.1016/S0015-0282(16)58320-4; Berrueta M, 2016, NICOTINE TOB RES, V18, P1116, DOI 10.1093/ntr/ntv145; Bloch M, 2008, AM J PUBLIC HEALTH, V98, P1833, DOI 10.2105/AJPH.2007.117887; Bloch M, 2014, LANCET GLOB HEALTH, V2, pE489, DOI 10.1016/S2214-109X(14)70294-3; Brasil. Ministerio do Planejamento Orcamento e Instituto Brasileiro de Geografia e Estatistica-IBGE. Diretoria de Pesquisas Coordenac de Trabalho e Rendimento. Pesquisa Nacional de Saude do estado de saude, 2014, DIR PESQ COORD TRAB; Castles A, 1999, AM J PREV MED, V16, P208, DOI 10.1016/S0749-3797(98)00089-0; Lopes NMC, 2015, MUNDO SAUDE, V39, P102; Pereira PPD, 2017, NICOTINE TOB RES, V19, P497, DOI 10.1093/ntr/ntw228; David A, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P199; Delpisheh A, 2006, WOMENS HEALTH, V2, P389, DOI 10.2217/17455057.2.3.389; Department of Health, 2003, IMPL GUID MAINSTR GE; Dias-Dame JL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/345430; DIFRANZA JR, 1995, J FAM PRACTICE, V40, P385; Drake P, 2018, CIGARETTE SMOKING PR; EURO-PERISTAT Project with SCPE and EUROCAT, 2013, HLTH CAR PREGN WOM B; Gilbert NL, 2015, J OBSTET GYNAECOL CA, V37, P32, DOI 10.1016/S1701-2163(15)30360-1; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; IBM Corp, 2010, IBM SPSS STAT WINDOW; Kale PL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1737-y; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Lange S, 2018, LANCET GLOB HEALTH, V6, pE769, DOI 10.1016/S2214-109X(18)30223-7; Lange S, 2015, ADDICT BEHAV, V50, P102, DOI 10.1016/j.addbeh.2015.06.018; Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15; de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013; Lucchese R, 2016, ACTA PAUL ENFERM, V29, P325, DOI 10.1590/1982-0194201600045; Marufu TC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1552-5; Ministerio da Saude, 2002, PROGR HUM PRE NAT NA; Moraes CL, 2007, REV SAUDE PUBL, V41, P695, DOI 10.1590/S0034-89102007000500002; Nielsen SS, 2014, ANN EPIDEMIOL, V24, P236, DOI 10.1016/j.annepidem.2013.12.008; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Perez-Franco J, 2015, REV CHIL SALUD PUBLI, V19, P37; Pineles BL, 2014, AM J EPIDEMIOL, V179, P807, DOI 10.1093/aje/kwt334; Portes LH, 2018, CIENC SAUDE COLETIVA, V23, P1837, DOI 10.1590/1413-81232018236.05202018; Portes LH, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00017317; Reis Liane G., 2008, Rev. Bras. Saude Mater. Infant., V8, P217, DOI 10.1590/S1519-38292008000200009; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Riaz M, 2018, ADDICTION, V113, P610, DOI 10.1111/add.14135; Santos IS, 2008, CAD SAUDE PUBLICA, V24, pS381, DOI 10.1590/S0102-311X2008001500003; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; Smedberg J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-213; Stringhini S, 2017, LANCET GLOB HEALTH, V5, pE230, DOI 10.1016/S2214-109X(17)30054-2; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Szklo AS, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00207416, 10.1590/0102-311x00207416]; Szklo AS, 2016, TOB CONTROL, V25, P564, DOI 10.1136/tobaccocontrol-2015-052324; Tong VT, 2013, PUBLIC HEALTH REP, V128, P179, DOI 10.1177/003335491312800308; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; World Health Organization, 2013, WHO REC PREV MAN TOB; Yan J, 2015, MATERN CHILD HLTH J, V19, P447, DOI 10.1007/s10995-014-1516-x	51	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217397	10.1371/journal.pone.0217397	http://dx.doi.org/10.1371/journal.pone.0217397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125373	Green Published, gold, Green Submitted			2022-12-26	WOS:000468865700035
J	van Leersum, CM; Moser, A; van Steenkiste, B; Wolf, JRLM; van der Weijden, T				van Leersum, Catharina M.; Moser, Albine; van Steenkiste, Ben; Wolf, Judith R. L. M.; van der Weijden, Trudy			Getting to grips with the process of decision-making in long-term care. Descriptive cases illustrate the chaotic reality of the construction of preferences	PLOS ONE			English	Article							MENTAL-CAPACITY; LIFE	Background Clients facing decision-making for long-term care are in need of support and accessible information. Construction of preferences, including context and calculations, for clients in long-term care is challenging because of the variability in supply and demand. This study considers clients in four different sectors of long-term care: the nursing and care of the elderly, mental health care, care of people with disabilities, and social care. The aim is to understand the construction of preferences in real-life situations. Method Client choices were investigated by qualitative descriptive research. Data were collected from 16 in-depth interviews and 79 client records. Interviews were conducted with clients and relatives or informal caregivers from different care sectors. The original client records were explored, containing texts, letters, and comments of clients and caregivers. All data were analyzed using thematic analysis. Results Four cases showed how preferences were constructed during the decision-making process. Clients discussed a wide range of challenging aspects that have an impact on the construction of preferences, e.g. previous experiences, current treatment or family situation. This study describes two main characteristics of the construction of preferences: context and calculation. Conclusion Clients face diverse challenges during the decision-making process on long-term care and their construction of preferences is variable. A well-designed tool to support the elicitation of preferences seems beneficial.	[van Leersum, Catharina M.; Moser, Albine; van Steenkiste, Ben; van der Weijden, Trudy] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Med Ctr, Maastricht, Netherlands; [Moser, Albine] Zuyd Univ Appl Sci, Res Ctr Auton & Participat Persons Chron Illness, Heerlen, Netherlands; [Wolf, Judith R. L. M.] Radboud Univ Nijmegen, Impuls Netherlands Ctr Social Care Res, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands	Maastricht University; Radboud University Nijmegen	van Leersum, CM (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Med Ctr, Maastricht, Netherlands.	karin.vanleersum@maastrichtuniversity.nl	Wolf, Judith/H-8122-2014	Wolf, Judith/0000-0001-7106-9142; van Leersum, Catharina/0000-0002-1003-0794; van der weijden, trudy/0000-0002-7469-3781	ZonMw, The Hague, The Netherlands [516012502]	ZonMw, The Hague, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	TvdW received a fund by ZonMw, The Hague, The Netherlands (516012502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boot AWA, 2017, WETEN IS NOG GEEN DO; Bosselaar H., 2013, BOUWPLAATS LOKALE VE; Carter G, 2017, DEMENTIA-LONDON, V16, P79, DOI 10.1177/1471301215581227; Chatfield DA, 2018, NURS CRIT CARE, V23, P82, DOI 10.1111/nicc.12290; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Friesen-Storms JHHM, 2015, INT J NURS STUD, V52, P393, DOI 10.1016/j.ijnurstu.2014.06.012; Guo L, 2016, MANAGE SCI, V62, P2977, DOI 10.1287/mnsc.2015.2290; Habermas Jurgen, THEORY COMMUNICATIVE, P368; Hendrinks M, 2017, VERSLAG TWEEDAAGSE B; Iederin NPCF, 2017, ALS ZORG ONDERSTEUNI; Kahneman D, 2011, ONS FEILBARE DENKEN; Kane RA, 2001, GERONTOLOGIST, V41, P293, DOI 10.1093/geront/41.3.293; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lindquist LA, 2017, PATIENT EDUC COUNS, V100, P1996, DOI 10.1016/j.pec.2017.06.028; McCall N, 2001, WHO WILL PAY LONG TE, P3; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; Nicholson TRJ, 2008, BRIT MED J, V336, P322, DOI 10.1136/bmj.39457.485347.80; Oosterkamp E, 2016, SOCIAALBESTEK, V78, P3, DOI DOI 10.1007/S41196-016-0064-X; SLOVIC P, 1995, AM PSYCHOL, V50, P364, DOI 10.1037/0003-066X.50.5.364; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Tinetti ME, 2016, CLIN GERIATR MED, V32, P261, DOI 10.1016/j.cger.2016.01.012; Turnpenny A, 2015, HEALTH SOC CARE COMM, V23, P349, DOI 10.1111/hsc.12133; Warren C, 2011, WIRES COGN SCI, V2, P193, DOI 10.1002/wcs.98	24	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217338	10.1371/journal.pone.0217338	http://dx.doi.org/10.1371/journal.pone.0217338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125374	Green Published, gold, Green Submitted			2022-12-26	WOS:000468865700029
J	Taoro-Gonzalez, L; Cabrera-Pastor, A; Sancho-Alonso, M; Arenas, YM; Meseguer-Estornell, F; Balzano, T; ElMlili, N; Felipo, V				Taoro-Gonzalez, Lucas; Cabrera-Pastor, Andrea; Sancho-Alonso, Maria; Arenas, Yaiza M.; Meseguer-Estornell, Fernando; Balzano, Tiziano; ElMlili, Nisrin; Felipo, Vicente			Differential role of interleukin-1 beta in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats	FASEB JOURNAL			English	Article						perirhinal cortex; postrhinal cortex; hippocampus; neurotransmission	DEPENDENT-PROTEIN-KINASE; LONG-TERM POTENTIATION; WORKING-MEMORY; HEPATIC-ENCEPHALOPATHY; PREFRONTAL CORTEX; RECOGNITION MEMORY; RECEPTOR TRAFFICKING; AMPA RECEPTORS; IL-1 RECEPTOR; TNF-ALPHA	Activated microglia and increased brain IL-1 beta play a main role in cognitive impairment in much pathology. We studied the role of IL-1 beta in neuroinflammation-induced impairment of the following different types of learning and memory: novel object recognition (NOR), novel object location (NOL), spatial learning, reference memory (RM), and working memory (WM). All these processes are impaired in hyperammonemic rats. We assessed which of these types of learning and memory are restored by blocking the IL-1 receptor in vivo in hyperammonemic rats and the possible mechanisms involved. Blocking the IL-1 receptor reversed microglial activation in the hippocampus, perirhinal cortex, and prefrontal cortex but not in the postrhinal cortex. This was associated with the restoration of NOR and WM but not of tasks involving a spatial component (NOL and RM). This suggests that IL-1 beta would be involved in neuroinflammation-induced nonspatial memory impairment, whereas spatial memory impairment would be IL-1 beta-independent and would be mediated by other proinflammatory factors.-Taoro-Gonzalez, L., Cabrera-Pastor, A., Sancho-Alonso, M., Arenas, Y. M., Meseguer-Estornell, F., Balzano, T., ElMlili, N., Felipo, V. Differential role of interleukin-1 beta in neuroinflammation-induced impairment of spatial and nonspatial memory in hyperammonemic rats.	[Taoro-Gonzalez, Lucas; Cabrera-Pastor, Andrea; Sancho-Alonso, Maria; Arenas, Yaiza M.; Meseguer-Estornell, Fernando; Balzano, Tiziano; ElMlili, Nisrin; Felipo, Vicente] Ctr Invest Principe Felipe, Lab Neurobiol, Valencia, Spain; [Cabrera-Pastor, Andrea] Fdn Invest Hosp Clin, Inst Invest Sanitaria INCLIVA, Valencia, Spain	Prince Felipe Research Center	Cabrera-Pastor, A (corresponding author), Prince Felipe Res Ctr, Carrer Eduardo Primo Yufera 3, Valencia 46012, Spain.	acabrera@cipf.es	Sancho-Alonso, María/AAW-1746-2021; Cabrera-Pastor, Andrea/J-6867-2014; Balzano, Tiziano/C-9344-2018; Taoro-Gonzalez, Lucas/ABH-7479-2020; Felipo, Vicente/A-9265-2014	Sancho-Alonso, María/0000-0002-6469-5441; Cabrera-Pastor, Andrea/0000-0002-0729-1045; Balzano, Tiziano/0000-0001-6523-2206; Felipo, Vicente/0000-0003-3145-9538; Taoro-Gonzalez, Lucas/0000-0002-9175-9578; Meseguer Estornell, Fernando/0000-0002-7925-7874	Ministerio de Educacion, Cultura y Deporte [FPU13/02492]; Ministerio de Ciencia e Innovacion [SAF2014-51851-R]; Conselleria Educacion Generalitat Valenciana [PROMETEOII/2014/033]; European Regional Development Fund (ERDF)	Ministerio de Educacion, Cultura y Deporte(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria Educacion Generalitat Valenciana; European Regional Development Fund (ERDF)(European Commission)	Funding was provided by the Ministerio de Educacion, Cultura y Deporte (FPU13/02492), the Ministerio de Ciencia e Innovacion (SAF2014-51851-R), the Conselleria Educacion Generalitat Valenciana (PROMETEOII/2014/033), and the European Regional Development Fund (ERDF). The authors declare no conflicts of interest.	Ahabrach H, 2010, J NEUROSCI RES, V88, P1605, DOI 10.1002/jnr.22311; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Arias N, 2015, NEUROSCIENCE, V284, P1, DOI 10.1016/j.neuroscience.2014.08.060; Auger ML, 2017, NEUROPHARMACOLOGY, V113, P10, DOI 10.1016/j.neuropharm.2016.09.022; Auger ML, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu013; Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Bajaj JS, 2010, GASTROENTEROLOGY, V138, P2332, DOI 10.1053/j.gastro.2010.02.015; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2006, J NEUROSCI, V26, P3561, DOI 10.1523/JNEUROSCI.3154-05.2006; Basu A, 2002, GLIA, V40, P109, DOI 10.1002/glia.10118; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Bernsen J., 1986, P 8 INT C PATT REC P, P1251; Bialuk I, 2018, BEHAV GENET, V48, P236, DOI 10.1007/s10519-018-9896-0; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Cabrera-Pastor A, 2016, BRAIN BEHAV IMMUN, V57, P360, DOI 10.1016/j.bbi.2016.05.011; Cabrera-Pastor A, 2015, ACS CHEM NEUROSCI, V6, P1913, DOI 10.1021/acschemneuro.5b00212; Chang R, 2017, MOL PHARMACEUT, V14, P2340, DOI 10.1021/acs.molpharmaceut.7b00200; Clausen BH, 2016, ACTA NEUROPATHOL, V131, P775, DOI 10.1007/s00401-016-1541-5; Dadsetan S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00106; Das S, 2017, J NEUROIMMUNOL, V313, P161, DOI 10.1016/j.jneuroim.2017.11.003; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Erceg S, 2005, BRAIN RES, V1036, P115, DOI 10.1016/j.brainres.2004.12.045; Eriksson C, 1999, NEUROSCIENCE, V93, P915, DOI 10.1016/S0306-4522(99)00178-5; FELIPO V, 1988, EUR J BIOCHEM, V176, P567, DOI 10.1111/j.1432-1033.1988.tb14315.x; FELIPO V, 1993, J NEUROCHEM, V60, P1626, DOI 10.1111/j.1471-4159.1993.tb13384.x; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Felipo V, 2012, HEPATOLOGY, V55, P530, DOI 10.1002/hep.24704; Fiore M, 2000, BEHAV BRAIN RES, V112, P165, DOI 10.1016/S0166-4328(00)00180-7; Frank MG, 2012, J NEUROIMMUNOL, V252, P33, DOI 10.1016/j.jneuroim.2012.07.010; Freudenberg F, 2013, HIPPOCAMPUS, V23, P1359, DOI 10.1002/hipo.22184; Garcia-Moreno L, 2005, BRAZ J MED BIOL RES, V38, P127, DOI 10.1590/S0100-879X2005000100019; Glenn MJ, 1998, BEHAV NEUROSCI, V112, P1353, DOI 10.1037/0735-7044.112.6.1353; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Heisler JM, 2015, BRAIN BEHAV IMMUN, V50, P115, DOI 10.1016/j.bbi.2015.06.022; Hernandez-Rabaza V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0505-y; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hryniewicz A, 2007, EUR J PHARMACOL, V577, P219, DOI 10.1016/j.ejphar.2007.08.046; Hueston CM, 2018, BRAIN BEHAV IMMUN, V74, P252, DOI 10.1016/j.bbi.2018.09.015; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Irikura VM, 2002, J IMMUNOL, V169, P393, DOI 10.4049/jimmunol.169.1.393; Kawai H, 2012, J TOXICOL SCI, V37, P1165, DOI 10.2131/jts.37.1165; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Lai AY, 2006, J NEUROIMMUNOL, V175, P97, DOI 10.1016/j.jneuroim.2006.03.001; Lan KM, 2015, TOXICOL LETT, V234, P30, DOI 10.1016/j.toxlet.2015.02.002; Langston RF, 2010, BEHAV BRAIN RES, V215, P275, DOI 10.1016/j.bbr.2010.07.006; Leke R, 2013, METAB BRAIN DIS, V28, P187, DOI 10.1007/s11011-012-9347-1; Lorenz-Guertin JM, 2018, DEV NEUROBIOL, V78, P238, DOI 10.1002/dneu.22536; Mandolesi G, 2013, J NEUROSCI, V33, P12105, DOI 10.1523/JNEUROSCI.5369-12.2013; McQuail JA, 2016, J NEUROSCI, V36, P12537, DOI 10.1523/JNEUROSCI.2332-16.2016; Monaco SA, 2015, NEUROSCI BIOBEHAV R, V56, P127, DOI 10.1016/j.neubiorev.2015.06.022; Monfort P, 2005, J NEUROCHEM, V94, P934, DOI 10.1111/j.1471-4159.2005.03236.x; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Norman G, 2005, BEHAV NEUROSCI, V119, P557, DOI 10.1037/0735-7044.119.2.557; Oberholzer M, 1996, HISTOCHEM CELL BIOL, V105, P333, DOI 10.1007/BF01463655; Osaka M, 2003, NEUROIMAGE, V18, P789, DOI 10.1016/S1053-8119(02)00032-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Sanderson DJ, 2010, NEUROPSYCHOLOGIA, V48, P2303, DOI 10.1016/j.neuropsychologia.2010.03.018; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Smith DM, 2014, NEUROSCI BIOBEHAV R, V40, P52, DOI 10.1016/j.neubiorev.2014.01.005; Song C, 2003, EUR J NEUROSCI, V18, P1739, DOI 10.1046/j.1460-9568.2003.02886.x; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Taoro-Gonzalez L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1082-z; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vann SD, 2000, J NEUROSCI, V20, P2711; Vann SD, 2011, CURR OPIN NEUROBIOL, V21, P440, DOI 10.1016/j.conb.2011.02.002; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Viviani B, 2007, INT REV NEUROBIOL, V82, P247, DOI 10.1016/S0074-7742(07)82013-7; Wang DS, 2012, CELL REP, V2, P488, DOI 10.1016/j.celrep.2012.08.022; Ward MT, 1999, NEUROBIOL AGING, V20, P373, DOI 10.1016/S0197-4580(99)00047-0; Wincott CM, 2014, NEUROBIOL LEARN MEM, V114, P32, DOI 10.1016/j.nlm.2014.04.007; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Zarezadeh M, 2017, EUR J PHARMACOL, V795, P13, DOI 10.1016/j.ejphar.2016.11.051	89	11	11	2	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2019	33	9					9913	9928		10.1096/fj.201900230RR	http://dx.doi.org/10.1096/fj.201900230RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IS5TA	31162953				2022-12-26	WOS:000482214200018
J	Potapenko, E; Negrao, NW; Huang, GZ; Docampo, R				Potapenko, Evgeniy; Negrao, Nuria W.; Huang, Guozhong; Docampo, Roberto			The acidocalcisome inositol-1,4,5-trisphosphate receptor of Trypanosoma brucei is stimulated by luminal polyphosphate hydrolysis products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inositol trisphosphate receptor (InsP3R); Trypanosoma brucei; calcium; calcium channel; organelle; acidocalcisome; DT-40 cells; orthophosphate; pyrophosphate phosphate; inositol-1; 4; 5-trisphosphate receptor; sleeping sickness	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; INTRALUMINAL LOOP PEPTIDE; CHROMOGRANIN-B; IP3 RECEPTORS; TRISPHOSPHATE; CRUZI; GROWTH; DIFFERENTIATION; PYROPHOSPHATASE; PARAMECIUM	Acidocalcisomes are acidic calcium stores rich in polyphosphate (polyP) and are present in trypanosomes and also in a diverse range of other organisms. Ca2+ is released from these organelles through a channel, inositol 1,4,5-trisphosphate receptor (TbIP3R), which is essential for growth and infectivity of the parasite Trypanosoma brucei. However, the mechanism by which TbIP3R controls Ca2+ release is unclear. In this work, we expressed TbIP3R in a chicken B lymphocyte cell line in which the genes for all three vertebrate IP(3)Rs were stably ablated (DT40-3KO). We show that IP3-mediated Ca2+ release depends on Ca2+ but not on ATP concentration and is inhibited by heparin, caffeine, and 2-aminomethoxydiphenyl borate (2-APB). Excised patch clamp recordings from nuclear membranes of DT40 cells expressing only TbIP3R disclosed that luminal inorganic orthophosphate (P-i) or pyrophosphate (PPi), and neutral or alkaline pH can stimulate IP3-generated currents. In contrast, polyP or acidic pH did not induce these currents, and nuclear membranes obtained from cells expressing rat IP3R were unresponsive to polyP or its hydrolysis products. Our results are consistent with the notion that polyP hydrolysis products within acidocalcisomes or alkalinization of their luminal pH activate TbIP3R and Ca2+ release. We conclude that TbIP3R is well-adapted to its role as the major Ca2+ release channel of acidocalcisomes in T. brucei.	[Potapenko, Evgeniy; Negrao, Nuria W.; Huang, Guozhong; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Negrao, Nuria W.; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	rdocampo@uga.edu	Docampo, Roberto/X-9424-2019	Docampo, Roberto/0000-0003-4229-8784	NIAID, National Institutes of Health [AI-108222, T32 AI060546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grants AI-108222 (to R.D.) and T32 AI060546 (to E.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adl SM, 2019, J EUKARYOT MICROBIOL, V66, P4, DOI 10.1111/jeu.12691; Alzayady KJ, 2015, MOL BIOL EVOL, V32, P2236, DOI 10.1093/molbev/msv098; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Choe Chi-Un, 2006, Sci STKE, V2006, pre15; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Galizzi M, 2013, MOL MICROBIOL, V90, P699, DOI 10.1111/mmi.12392; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hashimoto M, 2013, MOL MICROBIOL, V87, P1133, DOI 10.1111/mmi.12155; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Huang GZ, 2013, P NATL ACAD SCI USA, V110, P1887, DOI 10.1073/pnas.1216955110; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Ladenburger EM, 2009, MOL CELL BIOL, V29, P3605, DOI 10.1128/MCB.01592-08; Lander N, 2016, J BIOL CHEM, V291, P25505, DOI 10.1074/jbc.M116.749655; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Li FJ, 2017, AUTOPHAGY, V13, P715, DOI 10.1080/15548627.2017.1280218; LIU CM, 1978, J BIOL CHEM, V253, P5892; Mak DOD, 2000, J GEN PHYSIOL, V115, P241, DOI 10.1085/jgp.115.3.241; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Mak Don-On Daniel, 2013, Cold Spring Harb Protoc, V2013, P787, DOI 10.1101/pdb.top066217; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Rahman T, 2012, BIOCHEM SOC T, V40, P325, DOI 10.1042/BST20110772; Rahman T, 2010, METHOD CELL BIOL, V99, P199, DOI [10.1016/B978-0-12-374841-6.00008-6, 10.1016/S0091-679X(10)99008-0]; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2006, MOL BIOCHEM PARASIT, V150, P249, DOI 10.1016/j.molbiopara.2006.08.010; Rossi AM, 2012, BBA-GEN SUBJECTS, V1820, P1214, DOI 10.1016/j.bbagen.2011.10.004; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saleem H, 2014, BRIT J PHARMACOL, V171, P3298, DOI 10.1111/bph.12685; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Traynor D, 2000, EMBO J, V19, P4846, DOI 10.1093/emboj/19.17.4846; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Yoo SH, 2000, J BIOL CHEM, V275, P12553, DOI 10.1074/jbc.275.17.12553; Yoo SH, 2000, ADV EXP MED BIOL, V482, P83; Yoo SH, 1998, FEBS LETT, V427, P55, DOI 10.1016/S0014-5793(98)00393-7; Yoo SH, 2000, J BIOL CHEM, V275, P30293, DOI 10.1074/jbc.M001204200; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	55	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2019	294	27					10628	10637		10.1074/jbc.RA119.007906	http://dx.doi.org/10.1074/jbc.RA119.007906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LL	31138655	hybrid, Green Published			2022-12-26	WOS:000478717100021
J	Karami, K; Zerehdaran, S; Javadmanesh, A; Shariati, MM; Fallahi, H				Karami, Keyvan; Zerehdaran, Saeed; Javadmanesh, Ali; Shariati, Mohammad Mandi; Fallahi, Hossein			Characterization of bovine (Bos taurus) imprinted genes from genomic to amino acid attributes by data mining approaches	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; DIRECT REPEAT ELEMENT; CODON USAGE; DNA METHYLATION; EXPRESSION LEVELS; X-CHROMOSOME; RNA; GENERATION; GROWTH; H19	Genomic imprinting results in monoallelic expression of genes in mammals and flowering plants. Understanding the function of imprinted genes improves our knowledge of the regulatory processes in the genome. In this study, we have employed classification and clustering algorithms with attribute weighting to specify the unique attributes of both imprinted (monoallelic) and biallelic expressed genes. We have obtained characteristics of 22 known monoallelically expressed (imprinted) and 8 biallelic expressed genes that have been experimentally validated alongside 208 randomly selected genes in bovine (Bos taurus). Attribute weighting methods and various supervised and unsupervised algorithms in machine learning were applied. Unique characteristics were discovered and used to distinguish mono and biallelic expressed genes from each other in bovine. To obtain the accuracy of classification, 10-fold cross-validation with concerning each combination of attribute weighting (feature selection) and machine learning algorithms, was used. Our approach was able to accurately predict mono and biallelic genes using the genomics and proteomics attributes.	[Karami, Keyvan; Zerehdaran, Saeed; Javadmanesh, Ali; Shariati, Mohammad Mandi] Ferdowsi Univ Mashhad, Dept Anim Sci, Fac Agr, Mashhad, Razavi Khorasan, Iran; [Fallahi, Hossein] Razi Univ, Sch Sci, Dept Biol, Kermanshah, Iran	Ferdowsi University Mashhad; Razi University	Zerehdaran, S (corresponding author), Ferdowsi Univ Mashhad, Dept Anim Sci, Fac Agr, Mashhad, Razavi Khorasan, Iran.	zerehdaran@um.ac.ir	Javadmanesh, Ali/P-6065-2015; Karami, Keyvan/AAN-1498-2021; Zerehdaran, Saeed/G-8323-2017	Javadmanesh, Ali/0000-0001-6016-5905; Zerehdaran, Saeed/0000-0002-8073-8798; Fallahi, Hossein/0000-0002-8754-3491; Shariati, Mohammad Mahdi/0000-0003-4136-6634; Karami, Keyvan/0000-0002-1875-6741				Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Akashi H, 2003, GENETICS, V164, P1291; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Angermueller C, 2017, BIORXIV; Armstrong L., 2013, EPIGENETICS; Bai L, 2011, PATTERN RECOGN, V44, P2843, DOI 10.1016/j.patcog.2011.04.024; Barahimipour R, 2015, PLANT J, V84, P704, DOI 10.1111/tpj.13033; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; Beiki AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044164; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen ZY, 2016, EPIGENETICS-US, V11, P501, DOI 10.1080/15592294.2016.1184805; Chen ZY, 2015, P NATL ACAD SCI USA, V112, P4618, DOI 10.1073/pnas.1422088112; Cohen DE, 2007, DEV CELL, V12, P57, DOI 10.1016/j.devcel.2006.11.014; Cowley M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018953; Dahl G.E., 2014, ARXIV; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; EICKHOLT J, 2013, BMC BIOINFORMATICS, V14; Feinberg AP, 2000, CURR TOP MICROBIOL, V249, P87; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hiraoka Y, 2009, GENES CELLS, V14, P499, DOI 10.1111/j.1365-2443.2009.01284.x; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Hosseinzadeh F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040017, 10.1371/annotation/2b218d50-a9d5-45b2-80d0-0e806e530749]; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Imumorin IG, 2012, LIVESTOCK EPIGENETICS, P89; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kelley DR, 2016, GENOME RES, V26, P990, DOI 10.1101/gr.200535.115; Khatib H, 2007, MAMM GENOME, V18, P538, DOI 10.1007/s00335-007-9039-z; Koerner MV, 2010, CURR OPIN GENET DEV, V20, P164, DOI 10.1016/j.gde.2010.01.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leung MKK, 2014, BIOINFORMATICS, V30, P121, DOI 10.1093/bioinformatics/btu277; Lewis A, 2004, MOL CELL BIOL, V24, P5650, DOI 10.1128/MCB.24.13.5650-5656.2004; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; MacQueen J, 1967, PROCEEDINGS OF THE F; Mannens M., 1994, European Journal of Human Genetics, V2, P3; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; McCallum A., 1998, AAAI 98 WORKSH LEARN; Michalski R S., 2013, MACHINE LEARNING ART; Moore GE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0074; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Piedrahita JA, 2011, BIRTH DEFECTS RES A, V91, P682, DOI 10.1002/bdra.20795; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Rainier S, 1993, RELAXATION OF IMPRIN; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reed MR, 2001, MAMM GENOME, V12, P873, DOI 10.1007/s00335-001-2027-9; Rokach L, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P149, DOI 10.1007/978-0-387-09823-4_9; Sharp PM, 1993, CODON USAGE MUTATION; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Sonderby S.K., 2014, ARXIV14127828; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tan SB, 2008, EXPERT SYST APPL, V34, P2622, DOI 10.1016/j.eswa.2007.05.028; Thai KM, 2009, MOL DIVERS, V13, P321, DOI 10.1007/s11030-009-9117-0; Tian FL, 2012, MOL MED REP, V5, P1536, DOI 10.3892/mmr.2012.833; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Uyar A, 2014, CURR OPIN OBSTET GYN, V26, P210, DOI 10.1097/GCO.0000000000000071; Velmurugan T., 2010, Journal of Computer Sciences, V6, P363, DOI 10.3844/jcssp.2010.363.368; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang K, 2015, PROCEEDINGS OF THE 6; Wang LJ, 2006, PLANT MOL BIOL, V61, P699, DOI 10.1007/s11103-006-0041-8; Wang X, 2014, HEREDITY, V113, P156, DOI 10.1038/hdy.2014.18; Wei YJ, 2014, DEVELOPMENT, V141, P2516, DOI 10.1242/dev.105320; Yang XF, 2016, BRIEF FUNCT GENOMICS, V15, P399, DOI 10.1093/bfgp/elw013; Yoon HR, 2002, YONSEI MED J, V43, P557, DOI 10.3349/ymj.2002.43.5.557; Zeng J, 2010, GENOME BIOL EVOL, V2, P770, DOI 10.1093/gbe/evq060; Zeng X, 2004, NEUR NETW 2004 P 200; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]; Zhou ZP, 2016, P NATL ACAD SCI USA, V113, pE6117, DOI 10.1073/pnas.1606724113; Zycinski G, 2011, ENG MED BIOL SOC EMB	81	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217813	10.1371/journal.pone.0217813	http://dx.doi.org/10.1371/journal.pone.0217813			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170205	Green Submitted, gold, Green Published			2022-12-26	WOS:000470263700059
J	Garcia-Melo, JE; Oliveira, C; Silva, GJD; Ochoa-Orrego, LE; Pereira, LHG; Maldonado-Ocampo, JA				Garcia-Melo, Jorge E.; Oliveira, Claudio; Da Costa Silva, Guilherme Jose; Ochoa-Orrego, Luz E.; Garcia Pereira, Luiz Henrique; Maldonado-Ocampo, Javier A.			Species delimitation of neotropical Characins (Stevardiinae): Implications for taxonomy of complex groups	PLOS ONE			English	Article							GENUS BRYCONAMERICUS TELEOSTEI; CHARACIFORMES CHARACIDAE; MAGDALENA BASIN; RIVER; OSTARIOPHYSI; PHYLOGENY; REVISION; MODELS; CLADE; FISH	Accurate species delimitation is crucial for studies of phylogeny, phylogeography, ecology, conservation and biogeography. The limits of species and genera in the Characidae family are controversial due to its uncertain phylogenetic relationships, high level of morphological homoplasy and the use of ambiguous morphological characters for descriptions. Here we establish species boundaries for Bryconamericus, Hemibrycon, Knodus and Eretmobrycon (Stevardiinae: Characidae), previously diagnosed with morphology, using three different barcoding approaches (GMYC, PTP, ABGD). Results revealed that species delimitation was successful by the use of a single-gene approach and by following a workflow in the context of integrative taxonomy, making evident problems and mistakes in the cataloging of Characidae species. Hence, it was possible to infer boundaries at genus level for clusters in the trees (GMYC and PTP) and automatic partitions (ABGD) which were consistent with some of recent taxonomic changes proposed in Characidae. We found that discordance cases between methods were linked to limitations of the methods and associated to putative species cluster closely related, some historically problematic in their diagnosis and identification. Furthermore, we suggested taxonomic changes and possibly new species, revealing a high degree of hidden diversity. Finally, we propose a workflow as a fast, accurate and objective way to delimit species from mitochondrial DNA sequences and to help clarify the classification of this group.	[Garcia-Melo, Jorge E.; Maldonado-Ocampo, Javier A.] Pontificia Univ Javeriana, Lab Ictiol, Unidad Ecol & Sistemat UNESIS, Dept Biol,Fac Ciencias, Bogota, Colombia; [Oliveira, Claudio; Da Costa Silva, Guilherme Jose; Ochoa-Orrego, Luz E.] Univ Estadual Paulista UNESP, Dept Morfol, Inst Biociencias, Campus Botucatu, Botucatu, SP, Brazil; [Da Costa Silva, Guilherme Jose] Univ Santo Amaro, Rua Prof Eneas de Siqueira Neto, Sao Paulo, SP, Brazil; [Garcia Pereira, Luiz Henrique] Univ Fed Integracao Latino Amer UNILA, Ctr Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil; [Garcia-Melo, Jorge E.] Univ Ibague, Programa Biol Ambiental, Fac Ciencias Nat & Matemat, Ibague, Colombia	Pontificia Universidad Javeriana; Universidade Estadual Paulista; Universidade de Santo Amaro (UNISA); Universidade Federal da Integracao Latino-Americana	Garcia-Melo, JE (corresponding author), Pontificia Univ Javeriana, Lab Ictiol, Unidad Ecol & Sistemat UNESIS, Dept Biol,Fac Ciencias, Bogota, Colombia.; Garcia-Melo, JE (corresponding author), Univ Ibague, Programa Biol Ambiental, Fac Ciencias Nat & Matemat, Ibague, Colombia.	jgarcia-m@javeriana.edu.co	García-Melo, Jorge E/AAU-3289-2020; Oliveira, Claudio/D-7713-2012; Garcia Pereira, Luiz Henrique/S-4710-2017	García-Melo, Jorge E/0000-0003-2885-5652; Oliveira, Claudio/0000-0002-7010-8880; Maldonado Ocampo, Javier Alejandro/0000-0003-3024-237X; Garcia Pereira, Luiz Henrique/0000-0001-9435-6347; Ochoa, Luz/0000-0003-4205-8510	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO) [567/2012]; Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana [00006552]; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/17009-2, 2014/26502-3]; Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306054/2006-0]	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO); Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JEGM was supported by the Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas (COLCIENCIAS-COLFUTURO, doctoral fellowship grant 567/2012) (www.colciencias.gov.co).JEGM and JAMO were supported by Vicerrectoria de Investigaciones, Pontificia Universidad Javeriana (Project No 00006552) (www.javeriana.edu.co).CO was also financially supported by the Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants #2010/17009-2 and 2014/26502-3) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq grant #306054/2006-0) (www.fapesp.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210166; Bagley JC, 2015, MULTILOCUS SPECIES D, P1, DOI [10.1371/journal.pone.0121139, DOI 10.1371/JOURNAL.PONE.0121139]; Bertaco VA, 2010, NEOTROP ICHTHYOL, V8, P737, DOI 10.1590/S1679-62252010000400005; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Casciotta JR, 2002, REV SUISSE ZOOL, V109, P155, DOI 10.5962/bhl.part.79584; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Silva José Francisco Pezzi da, 2004, Neotrop. ichthyol., V2, P55, DOI 10.1590/S1679-62252004000200002; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dellicour S, 2018, MOL ECOL RESOUR, V18, P1234, DOI 10.1111/1755-0998.12908; Dos Santos AR, 2012, HEREDITAS, V149, P24, DOI 10.1111/j.1601-5223.2011.02234.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, GENEIOUS V4 8 5; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eschmeyer W. N., 2018, CATALOG FISHES CALIF; Eschmeyer WN, 2018, CATALOG FISHES GENER; Escobar-Camacho D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135569; Ezard T, 2009, SPLITS SPECIES LIMIT, P1; Ferreira KM, 2007, ANALISE FILOGENETICA; FINK W L, 1976, Proceedings of the Biological Society of Washington, V88, P331; Fischer Johanne, 2013, FAO Fisheries and Aquaculture Technical Paper, V585, P3; Fricke R., 2022, ESCHMEYERS CATALOG F; Fujisawa T, 2016, SYST BIOL, V65, P759, DOI 10.1093/sysbio/syw028; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Melo JE, 2018, J FISH BIOL, V92, P1929, DOI 10.1111/jfb.13634; Gery J., 1977, CHARACOIDS WORLD; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han ZL, 2012, 2012 INTERNATIONAL CONFERENCE ON OPTICAL MEMS AND NANOPHOTONICS (OMN), P27, DOI 10.1109/OMEMS.2012.6318785; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jacobs SJ, 2018, MOL ECOL, V27, P2397, DOI 10.1111/mec.14590; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larson ER, 2016, PEERJ, V4, DOI 10.7717/peerj.1915; Lima F. C. T., 2003, CHECK LIST FRESHWATE, P106, DOI DOI 10.1590/S1679-62252003000100003; Malabarba Luiz R., 2000, Ichthyological Exploration of Freshwaters, V11, P315; Malabarba Luiz R., 2003, Comunicacoes do Museu de Ciencias e Tecnologia da PUCRS Serie Zoologia, V16, P67; Malabarba MCSL, 1995, P BIOL SOC WASH, V108, P1; Maldonado-Ocampo JA, 2005, PECES ANDES COLOMBIA; Marcos Mirande J, 2009, Cladistics, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2019, CLADISTICS, V35, P282, DOI 10.1111/cla.12345; Mirande JM, 2013, NEOTROP ICHTHYOL, V11, P747, DOI 10.1590/S1679-62252013000400003; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Mazeti Camila Montoro, 2013, Acta Scientiarum Biological Sciences, V35, P241, DOI 10.4025/actascibiolsci.v35i2.11451; Melo BF, 2016, ZOOL SCR, V45, P650, DOI 10.1111/zsc.12178; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Miquelarena AM, 1999, P BIOL SOC WASH, V112, P523; Miquelarena Amalia M., 1995, Revista Brasileira de Biologia, V55, P559; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; O'Connell KA, 2019, MOL PHYLOGENET EVOL, V134, P1, DOI 10.1016/j.ympev.2019.01.021; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paintner-Marques TR, 2002, HEREDITAS, V137, P107, DOI 10.1034/j.1601-5223.2002.01651.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pereira LHG, 2013, ANALISE DIVERSIDADE; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Piscor D, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-13; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; Roman-Valencia C, 2014, ANIM BIODIV CONSERV, V37, P107; Roman-Valencia C, 2013, ANIM BIODIV CONSERV, V36, P123; Roman-Valencia C, 2010, ANIM BIODIV CONSERV, V33, P195; Roman-Valencia C, 2002, REV BIOL TROP, V50, P173; Roman-Valencia C, 2000, REV BIOL TROP, V48, P449; Roman-Valencia C., 2008, Animal Biodiversity and Conservation, V31, P15; Roman-Valencia C., 2003, MEMORIAS FUNDACION S, V2003, P31; Roman-Valencia C., 2005, MEMORIA FUNDACION SA, V163, P27; Roman-Valencia C., 2003, B MUS REG SCI NAT TO, V31, P447; Roman-Valencia C., 2001, B MUSEUM REGIONALLI, V18, P469; Roman-Valencia C., 2003, REV ASOCIACION COLOM, P17; Roman-Valencia C, 2017, REV INVESTIG, V29, P38, DOI 10.33975/riuq.vol29n1.13; Roman-Valencia C, 2011, REV MEX BIODIVERS, V82, P844; Roman-Valencia C, 2010, REV BIOL TROP, V58, P339; Roman-Valencia C, 2009, CALDASIA, V31, P393; Roman-Valencia C, 2009, REV MEX BIODIVERS, V80, P465; Roman-Valencia C, 2009, REV MEX BIODIVERS, V80, P455; Roman-Valencia Cesar, 2003, Dahlia, V6, P7; Roman-Valencia C, 2008, REV BIOL TROP, V56, P1749; Roman-Valencia Cesar, 2004, Dahlia, V7, P23; Roman-Valencia Cesar, 1999, Actualidades Biologicas (Medellin), V20, P109; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Serra JP, 2006, BIOTA NEOTROP, P6; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Song C, 2018, ZOOL SCR, V47, P311, DOI 10.1111/zsc.12284; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; Taphorn D, 1992, BIOLLANIA, V4, P1; Taylor W. R., 1967, Proceedings of the United States National Museum, V122, P1; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; VARI RP, 1990, P BIOL SOC WASH, V103, P516; White BP, 2014, FRESHW SCI, V33, P338, DOI 10.1086/674982; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2017, MOL ECOL, V26, P3028, DOI 10.1111/mec.14093; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zenker MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148423; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	111	32	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0216786	10.1371/journal.pone.0216786	http://dx.doi.org/10.1371/journal.pone.0216786			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166941	gold, Green Published, Green Submitted			2022-12-26	WOS:000470087800013
J	Pereira, CM; Filev, R; Dubiela, FP; Brandao, BB; Queiroz, CM; Ludwig, RG; Hipolide, D; Longo, BM; Mello, LE; Mori, MA; Castilho, BA				Pereira, Catia M.; Filev, Renato; Dubiela, Francisco P.; Brandao, Bruna B.; Queiroz, Claudio M.; Ludwig, Raissa G.; Hipolide, Debora; Longo, Beatriz M.; Mello, Luiz E.; Mori, Marcelo A.; Castilho, Beatriz A.			The GCN2 inhibitor IMPACT contributes to diet-induced obesity and body temperature control	PLOS ONE			English	Article							PROTEIN-KINASE GCN2; AMINO-ACID CONTROL; EIF2-ALPHA KINASE; BINDING-PROTEIN; GI DOMAIN; ELF2-ALPHA; MOUSE; ASSOCIATION; ACTIVATION; IMPAIRS	IMPACT, a highly conserved protein, is an inhibitor of the eIF2 alpha kinase GCN2. In mammals, it is preferentially expressed in neurons. Knock-down of IMPACT expression in neuronal cells increases basal GCN2 activation and eIF2 alpha phosphorylation and decreases translation initiation. In the mouse brain, IMPACT is particularly abundant in the hypothalamus. Here we describe that the lack of IMPACT in mice affects hypothalamic functions. Impact(-/-) mice (Imp-KO) are viable and have no apparent major phenotypic defect. The hypothalamus in these animals shows increased levels of eIF2 alpha phosphorylation, as expected from the described role of IMPACT in inhibiting GCN2 and from its abundance in this brain region. When fed a normal chow, animals lacking IMPACT weight slightly less than wild-type mice. When fed a high-fat diet, Imp-KO animals gain substantially less weight due to lower food intake when compared to wild-type mice. STAT3 signaling was depressed in Imp-KO animals even though leptin levels were identical to the wild-type mice. This finding supports the observation that Imp-KO mice have defective thermoregulation upon fasting. This phenotype was partially dependent on GCN2, whereas the lean phenotype was independent of GCN2. Taken together, our results indicate that IMPACT contributes to GCN2-dependent and -independent mechanisms involved in the regulation of autonomic functions in response to energy availability.	[Pereira, Catia M.; Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [Filev, Renato; Longo, Beatriz M.; Mello, Luiz E.] Univ Fed Sao Paulo, Dept Physiol, Escola Paulista Med, Sao Paulo, Brazil; [Dubiela, Francisco P.; Hipolide, Debora] Univ Fed Sao Paulo, Dept Psychobiol, Escola Paulista Med, Sao Paulo, Brazil; [Brandao, Bruna B.; Mori, Marcelo A.] Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, Sao Paulo, Brazil; [Queiroz, Claudio M.] Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil; [Ludwig, Raissa G.; Mori, Marcelo A.] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Campinas, SP, Brazil; [Filev, Renato] Univ Fed Sao Paulo, Dept Psychiat, Escola Paulista Med, Sao Paulo, Brazil; [Brandao, Bruna B.] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio Grande do Norte; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Castilho, BA (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	bacastilho@unifesp.br	Hipolide, Debora/AAC-9970-2020; Queiroz, Claudio M/O-9549-2015; Castilho, Beatriz A/C-2503-2012; Brandao, Bruna/AAY-3939-2021; Checchinato, Catia/AAK-8775-2021; Monteiro Longo, Beatriz/D-2216-2012; Mello, Luiz/B-4177-2009; Mori, Marcelo/R-2881-2018	Hipolide, Debora/0000-0001-5657-3447; Queiroz, Claudio M/0000-0001-5573-7702; Castilho, Beatriz A/0000-0003-4509-5237; Brandao, Bruna/0000-0001-8762-6310; Monteiro Longo, Beatriz/0000-0002-2638-8061; Mello, Luiz/0000-0002-6969-1108; Mori, Marcelo/0000-0001-7112-5263; Guimaraes Ludwig, Raissa/0000-0002-8181-8503	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/52047-5, 02/13871-5, 07/53176-8, 12/04079-8]; Conselho Nacional de Pesquisa [309860/2011-3, 478903/2012-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa	Funded by BAC: 09/52047-5 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. http://www.fapesp.br.BAC: 309860/2011-3 and 478903/2012-0 Conselho Nacional de Pesquisa. http://www.cnpq.br.CMP: 02/13871-5 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. http://www.fapesp.br.FPD: 07/53176-8 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. http://www.fapesp.br.BBB: 12/04079-8 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. http://www.fapesp.br.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Cambiaghi TD, 2014, BIOCHEM BIOPH RES CO, V443, P592, DOI 10.1016/j.bbrc.2013.12.021; Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Donnelly N, 2013, CELL MOL LIFE SCI; Ferraz RC, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0301-2; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Garriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Kubota H, 2001, J BIOL CHEM, V276, P17591, DOI 10.1074/jbc.M011793200; Kubota H, 2000, J BIOL CHEM, V275, P20243, DOI 10.1074/jbc.C000262200; Maurin AC, 2014, CELL REP, V6, P438, DOI 10.1016/j.celrep.2014.01.006; Methippara MM, 2009, AM J PHYSIOL-REG I, V296, pR178, DOI 10.1152/ajpregu.90765.2008; Murguia JR, 2012, IUBMB LIFE, V64, P971, DOI 10.1002/iub.1090; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Roffe M, 2013, J BIOL CHEM, V288, P10860, DOI 10.1074/jbc.M113.461970; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sattlegger E, 2011, J BIOL CHEM, V286, P10341, DOI 10.1074/jbc.M110.171587; Silva RC, 2016, J CELL SCI, V129, P4521, DOI 10.1242/jcs.194738; Silva RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131070; Trinh MA, 2013, NEUROBIOL LEARN MEM; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217287	10.1371/journal.pone.0217287	http://dx.doi.org/10.1371/journal.pone.0217287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166980	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800023
J	Ceccarelli, C; De Leo, A; Chieco, P; Zamagni, C; Zamagni, A; Rubino, D; Taffurelli, M; Santini, D				Ceccarelli, Claudio; De Leo, Antonio; Chieco, Pasquale; Zamagni, Claudio; Zamagni, Alice; Rubino, Daniela; Taffurelli, Mario; Santini, Donatella			A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; RECURRENCE SCORE; PROGESTERONE-RECEPTOR; PRIMARY THERAPY; CANCER HIGHLIGHTS; PROGNOSTIC VALUE; LABELING INDEX; EXPRESSION; ASSAY; KI67	Aim Our goal has been to evaluate the importance that the incorporation of Bcl2 in the ER/PGR/Her2/Ki67 bio-profile can have as predictor of the Oncotype Dx categories. Material and methods 156 consecutive cases of HR+/Her2-pN0/1 primary breast carcinoma were sent to the Oncotype Dx test. Immunohistochemical determination of Bcl2/ER/PGR/Ki67/Her2 expression was evaluated for each case. After the selection of the appropriate cut-off values for PGR and Ki67, explorative as well as confirmative statistical analyses were performed to build and validate predictive risk-of-recurrence immunohistochemical only bioprofiles. Results The predictive capacity of these immunohistochemical profiles was compared with both traditional and TAILORx Oncotype Dx risk class classification. This comparison showed that immunohistochemical bio-profiles select those cases not associated with high risk-of-recurrence of disease (luminal-A/B and luminal A/B Bcl2) and those that are instead at high risk and therefore worthy of chemotherapy (luminal-B ki67 and luminal-B Bcl2/Ki67), strongly suggesting to only submit PGR-positive/Bcl2-Ki67 altered cases to Oncotype Dx, thus reducing the number of cases to be tested. Conclusions Our results indicate that the addition of Bcl2 to an immunohistochemical bio-profile definitely improves its predictive capacity to correctly select which cases to send to the Oncotype Dx test. We have also suggested that institutions with a significant number of breast carcinomas sent to the Oncotype Dx test can use these latter to derive their own PGR and Ki67 cutoff values, overcoming the drawbacks of sharing common inter-laboratory values. Validation of these bio-profiles as predictors of the Oncotype Dx categories is ongoing in a prospective series of new cases.	[Ceccarelli, Claudio; De Leo, Antonio] Univ Bologna, St Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy; [Chieco, Pasquale] Univ Bologna, St Orsola Malpighi Hosp, Unified Ctr Biomed Appl Res CRBA, Bologna, Italy; [Zamagni, Claudio; Rubino, Daniela] St Orsola Malpighi Hosp, Dept Hematol & Oncol, Breast Med Oncol Unit, Bologna, Italy; [Zamagni, Alice] St Orsola Malpighi Hosp, Radiat Oncol Unit, Bologna, Italy; [Taffurelli, Mario] Univ Bologna, St Orsola Malpighi Hosp, Dept Med & Surg Sci DIMEC, Bologna, Italy; [Santini, Donatella] St Orsola Malpighi Hosp, Dept Diagnost & Prevent Med, Surg Pathol Unit, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Ceccarelli, C (corresponding author), Univ Bologna, St Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy.	claudio.ceccarelli@unibo.it	Santini, Donatella/AAO-1490-2021; De Leo, Antonio/ADG-3906-2022; Zamagni, Alice/HIR-2414-2022; ceccarelli, claudio/AAS-6105-2020	Santini, Donatella/0000-0002-1692-6348; De Leo, Antonio/0000-0002-3761-5135; Zamagni, Alice/0000-0001-8942-793X; ceccarelli, claudio/0000-0003-0743-2087				Amin MB, 2017, AJCC CANC STAGING MA, V8th, DOI [10.1007/978-3-319-40618-3_2, DOI 10.1007/978-3-319-40618-3_2, 10.1007/978-3-319-40618-3]; Chaudhary Lubna N, 2016, Hematol Oncol Stem Cell Ther, V9, P48, DOI 10.1016/j.hemonc.2015.12.001; Clark BZ, 2013, APPL IMMUNOHISTO M M, V21, P287, DOI 10.1097/PAI.0b013e31826f80c9; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; GEE JMW, 1994, INT J CANCER, V59, P619, DOI 10.1002/ijc.2910590508; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Greenacre M., 1993, MULTIVARIATE ANAL FU; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hanna MG, 2017, INT J BREAST CANCER, V2017, DOI 10.1155/2017/1257078; Harbeck N, 2013, BREAST CARE, V8, P110, DOI 10.1159/000350777; Hwang KT, 2012, INT J CANCER, V131, pE1109, DOI 10.1002/ijc.27539; Jonsdottir K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090642; Kraus JA, 2012, MODERN PATHOL, V25, P869, DOI 10.1038/modpathol.2011.219; Le MG, 1999, INT J CANCER, V84, P562, DOI 10.1002/(SICI)1097-0215(19991222)84:6<562::AID-IJC4>3.0.CO;2-0; Maisonneuve P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3679; Mengel M, 2002, J PATHOL, V198, P292, DOI 10.1002/path.1218; Milburn M, 2013, BREAST J, V19, P357, DOI 10.1111/tbj.12126; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; Orucevic A, 2017, BREAST CANCER RES TR, V163, P51, DOI 10.1007/s10549-017-4170-3; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park MM, 2014, BREAST J, V20, P37, DOI 10.1111/tbj.12223; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Sahebjam S, 2011, BRIT J CANCER, V105, P1342, DOI 10.1038/bjc.2011.402; SHAO J, 1989, ANN STAT, V17, P1176, DOI 10.1214/aos/1176347263; Snekha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190348; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Tang P, 2010, CANCER INVEST, V28, P978, DOI 10.3109/07357907.2010.496754; Trere D, 2007, ANN ONCOL, V18, P1004, DOI 10.1093/annonc/mdm074; Williams DJ, 2011, APPL IMMUNOHISTO M M, V19, P431, DOI 10.1097/PAI.0b013e318206d23d	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217937	10.1371/journal.pone.0217937	http://dx.doi.org/10.1371/journal.pone.0217937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158261	Green Published, Green Submitted, gold			2022-12-26	WOS:000469915700035
J	Fiocca, K; Barrett, M; Waddell, EA; Viveiros, J; McNair, C; O'Donnell, S; Marenda, DR				Fiocca, Katherine; Barrett, Meghan; Waddell, Edward A.; Viveiros, Jennifer; McNair, Cheyenne; O'Donnell, Sean; Marenda, Daniel R.			Mannitol ingestion causes concentration-dependent, sex-biased mortality in adults of the fruit fly (Drosophila melanogaster)	PLOS ONE			English	Article							LIFE-SPAN; SORBITOL DEHYDROGENASE; FEMALE; DIGESTIBILITY; REPRODUCTION; MODULATION; RECEPTORS; NUTRITION; FECUNDITY; SURVIVAL	Mannitol, a sugar alcohol used in commercial food products, has been previously shown to induce sex-biased mortality in female Drosophila melanogaster when ingested at a single concentration (1 M). We hypothesized that sex differences in energy needs, related to reproductive costs, contributed to the increased mortality we observed in females compared to males. To test this, we compared the longevity of actively mating and non-mating flies fed increasing concentrations of mannitol. We also asked whether mannitol-induced mortality was concentration-dependent for both males and females, and if mannitol's sex-biased effects were consistent across concentrations. Females and males both showed concentration-dependent increases in mortality, but female mortality was consistently higher at concentrations of 0.75 M and above. Additionally, fly longevity decreased further for both sexes when housed in mixed sex vials as compared to single sex vials. This suggests that the increased energetic demands of mating and reproduction for both sexes increased the ingestion of mannitol. Finally, larvae raised on mannitol produced expected adult sex ratios, suggesting that sex-biased mortality due to the ingestion of mannitol occurs only in adults. We conclude that sex and reproductive status differences in mannitol ingestion drive sex-biased differences in adult fly mortality.	[Fiocca, Katherine; Barrett, Meghan; Waddell, Edward A.; Viveiros, Jennifer; O'Donnell, Sean; Marenda, Daniel R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [McNair, Cheyenne; O'Donnell, Sean] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Marenda, Daniel R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University	Marenda, DR (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.; Marenda, DR (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA.	dm562@drexel.edu	Barrett, Meghan/AAQ-8194-2020	Viveiros, Jennifer/0000-0002-9785-7371; Fiocca, Katherine/0000-0002-5708-0641; Marenda, Daniel/0000-0001-5388-8793; Barrett, Meghan/0000-0002-1270-4983	Drexel University Office of Research; National Science Foundation	Drexel University Office of Research; National Science Foundation(National Science Foundation (NSF))	Funds from Drexel University Office of Research supported this work (to DRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Some of this material is based upon work supported by (while serving at) the National Science Foundation (for DRM). Any opinion, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Bjork A, 2007, BIOL LETTERS, V3, P517, DOI 10.1098/rsbl.2007.0219; Bretman A, 2013, EVOLUTION, V67, P2413, DOI 10.1111/evo.12125; Carvalho GB, 2006, CURR BIOL, V16, P692, DOI 10.1016/j.cub.2006.02.064; Chakraborty R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020799; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; Diegelmann S, 2017, JOVE-J VIS EXP, DOI 10.3791/55024; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Elhassan E., 2015, COMPREHENSIVE CLIN N, P85; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Freeman EG, 2014, P NATL ACAD SCI USA, V111, P1598, DOI 10.1073/pnas.1311724111; Fujii S, 2015, CURR BIOL, V25, P621, DOI 10.1016/j.cub.2014.12.058; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gnad F, 2006, BIOINFORMATICS, V22, P2577, DOI 10.1093/bioinformatics/btl422; GraphPad Software Inc., 2018, GRAPHPAD PRISM WIND; Grembecka M, 2015, EUR FOOD RES TECHNOL, V241, P1, DOI 10.1007/s00217-015-2437-7; Harrison JF, 2012, ECOL ENVIRON PHYSIOL, P140; Harvanek ZM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0152; IBM, 2016, IBM SPSS STAT WINDOW; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jamieson P.R., 2012, ALTERNATIVE SWEETENE, P333; Kikuta S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207497; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Leech T, 2017, J INSECT PHYSIOL, V102, P12, DOI 10.1016/j.jinsphys.2017.08.008; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; Lindstad RI, 1998, BIOCHEM J, V330, P479; Lints FA, 1998, DROSOPHILA MODEL ORG; Liu X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006277; Luque T, 1998, J BIOL CHEM, V273, P34293, DOI 10.1074/jbc.273.51.34293; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; MANNING A, 1967, ANIM BEHAV, V15, P239, DOI 10.1016/0003-3472(67)90006-1; MARTINEZ G, 1963, J BIOL CHEM, V238, P1598; Matos RC, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S6; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Min X, 2013, ANIM SCI J, V84, P551, DOI 10.1111/asj.12041; NEGM FB, 1979, PLANT PHYSIOL, V64, P69, DOI 10.1104/pp.64.1.69; Nishiyama A, 2009, J NUTR SCI VITAMINOL, V55, P242, DOI 10.3177/jnsv.55.242; Nunney L, 2007, J EVOLUTION BIOL, V20, P141, DOI 10.1111/j.1420-9101.2006.01214.x; O'Donnell S, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew031; ONISHI H, 1968, APPL MICROBIOL, V16, P1847, DOI 10.1128/AEM.16.12.1847-1852.1968; Ozalp P, 2001, J APPL ENTOMOL, V125, P177, DOI 10.1046/j.1439-0418.2001.00528.x; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Saha BC, 2011, APPL MICROBIOL BIOT, V89, P879, DOI 10.1007/s00253-010-2979-3; Shell BC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29813-9; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Somashekar K, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13201; STROMNAES O, 1959, NATURE, V183, P409, DOI 10.1038/183409a0; Systat Software Inc., 2013, SIGMAPLOT WIND VERS; Takada T, 2017, PLOS ONE, V12, P1; Tang SB, 2017, J INSECT PHYSIOL, V101, P178, DOI 10.1016/j.jinsphys.2017.07.015; Uchizono S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172886; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Wallace IS, 2012, BBA-BIOMEMBRANES, V1818, P627, DOI 10.1016/j.bbamem.2011.11.032; Wisotsky Z, 2011, NAT NEUROSCI, V14, P1534, DOI 10.1038/nn.2944; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; Yao CK, 2014, J HUM NUTR DIET, V27, P263, DOI 10.1111/jhn.12144	63	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0213760	10.1371/journal.pone.0213760	http://dx.doi.org/10.1371/journal.pone.0213760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150400	Green Submitted, gold, Green Published			2022-12-26	WOS:000469759100008
J	Ghazvinian, H; Mousavi, SF; Karami, H; Farzin, S; Ehteram, M; Hossain, MS; Fai, CM; Bin Hashim, H; Singh, VP; Ros, FC; Ahmed, AN; Afan, HA; Lai, SH; El-Shafie, A				Ghazvinian, Hamidreza; Mousavi, Sayed-Farhad; Karami, Hojat; Farzin, Saeed; Ehteram, Mohammad; Hossain, Md Shabbir; Fai, Chow Ming; Bin Hashim, Huzaifa; Singh, Vijay P.; Ros, Faizah Che; Ahmed, Ali Najah; Afan, Haitham Abdulmohsin; Lai, Sai Hin; El-Shafie, Ahmed			Integrated support vector regression and an improved particle swarm optimization-based model for solar radiation prediction	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; FIREFLY ALGORITHM; MACHINE; ANN; IRRADIANCE; SVM	Solar energy is a major type of renewable energy, and its estimation is important for decision-makers. This study introduces a new prediction model for solar radiation based on support vector regression (SVR) and the improved particle swarm optimization (IPSO) algorithm. The new version of algorithm attempts to enhance the global search ability for the PSO. In practice, the SVR method has a few parameters that should be determined through a trial-and-error procedure while developing the prediction model. This procedure usually leads to non-optimal choices for these parameters and, hence, poor prediction accuracy. Therefore, there is a need to integrate the SVR model with an optimization algorithm to achieve optimal choices for these parameters. Thus, the IPSO algorithm, as an optimizer is integrated with SVR to obtain optimal values for the SVR parameters. To examine the proposed model, two solar radiation stations, Adana, Antakya and Konya, in Turkey, are considered for this study. In addition, different models have been tested for this prediction, namely, the M5 tree model (M5T), genetic programming (GP), SVR integrated with four different optimization algorithms SVR-PSO, SVR-IPSO, Genetic Algorithm (SVR-GA), FireFly Algorithm (SVR-FFA) and the multivariate adaptive regression (MARS) model. The sensitivity analysis is performed to achieve the highest accuracy level of the prediction by choosing different input parameters. Several performance measuring indices have been considered to examine the efficiency of all the prediction methods. The results show that SVR-IPSO out-performed M5T and MARS.	[Ghazvinian, Hamidreza; Mousavi, Sayed-Farhad; Karami, Hojat; Farzin, Saeed; Ehteram, Mohammad] Semnan Univ, Fac Civil Engn, Dept Water Engn & Hydraul Struct, Semnan, Iran; [Hossain, Md Shabbir] Heriot Watt Univ, Dept Civil Engn, Sch Energy Geosci Infrastruct & Soc, Putrajaya, Malaysia; [Fai, Chow Ming; Ahmed, Ali Najah] Univ Tenaga Nas, Dept Civil Engn, IEI, Selangor, Malaysia; [Bin Hashim, Huzaifa; Afan, Haitham Abdulmohsin; Lai, Sai Hin; El-Shafie, Ahmed] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; [Singh, Vijay P.] Texas A&M Univ, Dept Biol & Agr Engn, Zachry Dept Civil Engn, College Stn, TX USA; [Ros, Faizah Che] UTM, MJIIT, Dept Environm & Green Technol, Kuala Lumpur, Malaysia	Semnan University; Universiti Tenaga Nasional; Universiti Malaya; Texas A&M University System; Texas A&M University College Station; Universiti Teknologi Malaysia	Afan, HA (corresponding author), Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia.	haitham.afan@gmail.com	El-Shafie, Ahmed/J-1799-2014; Ahmed, Ali Najah/J-9456-2017; Afan, Haitham/ABF-2282-2021; Karami, Hojat/AAU-1618-2020; Afan, Haitham Abdulmohsin/G-6932-2018; Hashim, Huzaifa/N-4079-2018; Lai, Sai Hin/H-3164-2018; Ghazvinian, Hamidreza/AAQ-3628-2020; Chow, M. F./I-1811-2016; Farzin, Saeed/AAB-3877-2020	El-Shafie, Ahmed/0000-0001-5018-8505; Ahmed, Ali Najah/0000-0002-5618-6663; Afan, Haitham Abdulmohsin/0000-0002-4957-756X; Hashim, Huzaifa/0000-0001-8780-4025; Lai, Sai Hin/0000-0002-7143-4805; Chow, M. F./0000-0002-0732-5575; Che Ros, Faizah/0000-0001-7263-2531	Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional [RJO 10436494]; University of Malaya [UMRG RP025A-18SUS, BKS008-2016]	Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional; University of Malaya(Universiti Malaya)	The authors would like to appreciate the financial support received from Bold 2025 grant coded RJO 10436494 by Innovation & Research Management Center (iRMC), Universiti Tenaga Nasional and the research grant coded UMRG RP025A-18SUS to AE-S and BKS008-2016 funded by the University of Malaya.	Alfadda A, 2018, SOL ENERGY, V170, P924, DOI 10.1016/j.solener.2018.05.089; Amrouche B, 2014, APPL ENERG, V130, P333, DOI 10.1016/j.apenergy.2014.05.055; Awange JL, 2018, PARTICLE SWARM OPTIM, P167; Belaid S, 2016, ENERG CONVERS MANAGE, V118, P105, DOI 10.1016/j.enconman.2016.03.082; Benmouiza K, 2013, ENERG CONVERS MANAGE, V75, P561, DOI 10.1016/j.enconman.2013.07.003; Bhardwaj S, 2013, SOL ENERGY, V93, P43, DOI 10.1016/j.solener.2013.03.020; Bou-Rabee M, 2017, RENEW SUST ENERG REV, V72, P434, DOI 10.1016/j.rser.2017.01.013; Deo RC, 2016, APPL ENERG, V168, P568, DOI 10.1016/j.apenergy.2016.01.130; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Ibrahim IA, 2017, ENERG CONVERS MANAGE, V138, P413, DOI 10.1016/j.enconman.2017.02.006; Keshtegar B, 2018, RENEW SUST ENERG REV, V81, P330, DOI 10.1016/j.rser.2017.07.054; Khatib T, 2012, RENEW SUST ENERG REV, V16, P2864, DOI 10.1016/j.rser.2012.01.064; Khosravi A, 2018, J CLEAN PROD, V176, P63, DOI 10.1016/j.jclepro.2017.12.065; Kumar N, 2017, INT J RENEWABLE ENER; Landeras G, 2012, ENERG CONVERS MANAGE, V62, P1, DOI 10.1016/j.enconman.2012.03.025; Liu HH, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/6076475; Loghmari I, 2018, RENEW SUST ENERG REV, V82, P837, DOI 10.1016/j.rser.2017.09.092; Lou I, 2015, APPL MATH MODEL, V39, P5907, DOI 10.1016/j.apm.2015.04.001; Meenal R, 2018, RENEW ENERG, V121, P324, DOI 10.1016/j.renene.2017.12.005; Moazenzadeh R, 2018, ENG APPL COMP FLUID, V12, P584, DOI 10.1080/19942060.2018.1482476; Mohammadi K, 2015, ENERG CONVERS MANAGE, V92, P162, DOI 10.1016/j.enconman.2014.12.050; Mohandes MA, 2012, SOL ENERGY, V86, P3137, DOI 10.1016/j.solener.2012.08.005; Notton G, 1991, RENEWABLE ENERGY; Nouiri M, 2018, J INTELL MANUF, V29, P603, DOI 10.1007/s10845-015-1039-3; Olatomiwa L, 2015, SOL ENERGY, V115, P632, DOI 10.1016/j.solener.2015.03.015; Ozgoren M, 2012, EXPERT SYST APPL, V39, P5043, DOI 10.1016/j.eswa.2011.11.036; Premalatha Neelamegam, 2016, J. appl. res. technol, V14, P206, DOI 10.1016/j.jart.2016.05.001; Qazi A, 2015, J CLEAN PROD, V104, P1, DOI 10.1016/j.jclepro.2015.04.041; Qin WM, 2018, RENEW SUST ENERG REV, V81, P579, DOI 10.1016/j.rser.2017.08.037; Quej VH, 2017, J ATMOS SOL-TERR PHY, V155, P62, DOI 10.1016/j.jastp.2017.02.002; Ramezani F, 2015, SOFT COMPUT, V19, P375, DOI 10.1007/s00500-014-1258-0; Renno C, 2016, J CLEAN PROD, V135, P1298, DOI 10.1016/j.jclepro.2016.07.049; Rohani A, 2018, RENEW ENERG, V115, P411, DOI 10.1016/j.renene.2017.08.061; Sengupta M, 2018, RENEW SUST ENERG REV, V89, P51, DOI 10.1016/j.rser.2018.03.003; Shamshirband S, 2016, RENEW SUST ENERG REV, V56, P428, DOI 10.1016/j.rser.2015.11.055; Shang CF, 2018, RENEW ENERG, V127, P269, DOI 10.1016/j.renene.2018.04.067; Tang XY, 2019, CMC-COMPUT MATER CON, V58, P463, DOI 10.32604/cmc.2019.03816; Turkish State Meteorological Service, 2018, MET GEN MUD; Vakili M, 2017, J CLEAN PROD, V141, P1275, DOI 10.1016/j.jclepro.2016.09.145; Vapnik V., 1998, STAT LEARNING THEORY; Voyant C, 2017, RENEW ENERG, V105, P569, DOI 10.1016/j.renene.2016.12.095; Wang LC, 2017, INT J CLIMATOL, V37, P1141, DOI 10.1002/joc.4762; Wang LC, 2016, RENEW SUST ENERG REV, V61, P384, DOI 10.1016/j.rser.2016.04.024; Yadav AK, 2014, RENEW SUST ENERG REV, V33, P772, DOI 10.1016/j.rser.2013.08.055; Zhang S, 2017, PARAMETER ESTIMATION, DOI [10.1016/J.ENCONMAN.2012.03.025, DOI 10.1016/J.ENCONMAN.2012.03.025]; Zhou P, 2016, SCI TOTAL ENVIRON, V543, P591, DOI 10.1016/j.scitotenv.2015.11.063; Zhou YL, 2018, ENERGY, V143, P785, DOI 10.1016/j.energy.2017.11.035	47	22	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217634	10.1371/journal.pone.0217634	http://dx.doi.org/10.1371/journal.pone.0217634			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150467	Green Submitted, Green Published, gold			2022-12-26	WOS:000469759100077
J	MacAskill, MG; Walton, T; Williams, L; Morgan, TEF; Alcaide-Corral, CJ; Dweck, MR; Gray, GA; Newby, DE; Lucatelli, C; Sutherland, A; Pimlott, SL; Tavares, AAS				MacAskill, Mark G.; Walton, Tashfeen; Williams, Lewis; Morgan, Timaeus E. F.; Alcaide-Corral, Carlos Jose; Dweck, Marc R.; Gray, Gillian A.; Newby, David E.; Lucatelli, Christophe; Sutherland, Andrew; Pimlott, Sally L.; Tavares, Adriana A. S.			Kinetic modelling and quantification bias in small animal PET studies with [F-18]AB5186, a novel 18 kDa translocator protein radiotracer	PLOS ONE			English	Article							INPUT FUNCTION; NEUROINFLAMMATION; INFLAMMATION; TSPO; BINDING; NOMENCLATURE; MICROGLIA; TARGET; BLOOD	Introduction Positron Emission Tomography (PET) imaging with selective 18 kDa translocator protein (TSPO) radiotracers has contributed to our understanding on the role of inflammation in disease development and progression. With an increasing number of rodent models of human disease and expansion of the preclinical PET imaging base worldwide, accurate quantification of longitudinal rodent TSPO PET datasets is necessary. This is particularly relevant as TSPO PET quantification relies on invasive blood sampling due to lack of a suitable tissue reference region. Here we investigate the kinetics and quantification bias of a novel TSPO radiotracer [F-18]AB5186 in rats using automatic, manual and image derived input functions. Methods [F-18]AB5186 was administered intravenously and dynamic PET imaging was acquired over 2 hours. Arterial blood was collected manually to derive a population based input function or using an automatic blood sampler to derive a plasma input function. Manually sampled blood was also used to analyze the [F-18]AB5186 radiometabolite profile in plasma and applied to all groups as a population based dataset. Kinetic models were used to estimate distribution volumes (V-T) and [F-18]AB5186 outcome measure bias was determined. Results [F-18]AB5186 distribution in rats was consistent with TSPO expression and at 2 h post-injection 50% of parent compound was still present in plasma. Population based manual sampling methods and image derived input function (IDIF) underestimated V-T by similar to 50% and 88% compared with automatic blood sampling, respectively. The V-T variability was lower when using IDIF versus arterial blood sampling methods and analysis of the Bland-Altman plots showed a good agreement between methods of analysis. Conclusion Quantification of TSPO PET rodent data using image-derived methods, which are more amenable for longitudinal scanning of small animals, yields outcome measures with reduced variability and good agreement, albeit biased, compared with invasive blood sampling methods.	[MacAskill, Mark G.; Walton, Tashfeen; Alcaide-Corral, Carlos Jose; Dweck, Marc R.; Gray, Gillian A.; Newby, David E.; Tavares, Adriana A. S.] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [MacAskill, Mark G.; Walton, Tashfeen; Alcaide-Corral, Carlos Jose; Lucatelli, Christophe; Tavares, Adriana A. S.] Univ Edinburgh, Edinburgh Imaging, Edinburgh, Midlothian, Scotland; [Williams, Lewis; Morgan, Timaeus E. F.; Sutherland, Andrew] Univ Glasgow, Sch Chem, WestCHEM, Glasgow, Lanark, Scotland; [Pimlott, Sally L.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Pimlott, Sally L.] NHS Greater Glasgow & Clyde, West Scotland PET Ctr, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Glasgow; University of Glasgow	Tavares, AAS (corresponding author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.; Tavares, AAS (corresponding author), Univ Edinburgh, Edinburgh Imaging, Edinburgh, Midlothian, Scotland.	adriana.tavares@ed.ac.uk	Dweck, Marc/AAY-1509-2021; Pimlott, Sally Louise/F-8098-2010; Newby, David Ernest/AAB-1364-2019	Pimlott, Sally Louise/0000-0002-8396-3392; Sutherland, Andrew/0000-0001-7907-5766; Tavares, Adriana/0000-0001-7505-9144; Williams, Lewis/0000-0003-2404-1985; Morgan, Timaeus/0000-0003-0220-8879; dweck, marc/0000-0001-9847-5917	British Heart Foundation [BHF PG/16/12/32022, RE/13/3/30183]; Engineering and Physical Sciences Research Council (EPSRC Impact Acceleration Award) [EP/K5039031]; Engineering and Physical Sciences Research Council (DTP studentship) [EP/M506539/1]; MRC [G0701127] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council (EPSRC Impact Acceleration Award); Engineering and Physical Sciences Research Council (DTP studentship); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors greatly acknowledge the British Heart Foundation (BHF PG/16/12/32022 and RE/13/3/30183) and the Engineering and Physical Sciences Research Council (EPSRC Impact Acceleration Award, EP/K5039031 and DTP studentship to TEFM, EP/M506539/1) for providing the funding to support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Baumgartner R, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0366-8; Bird JLE, 2010, ATHEROSCLEROSIS, V210, P388, DOI 10.1016/j.atherosclerosis.2009.11.047; Blair A, 2015, CHEM SCI, V6, P4772, DOI 10.1039/c5sc01647a; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; Boutin H, 2015, EUR J NUCL MED MOL I, V42, P503, DOI 10.1007/s00259-014-2939-8; Chauveau F, 2009, J NUCL MED, V50, P468, DOI 10.2967/jnumed.108.058669; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Fang YHD, 2008, J NUCL MED, V49, P606, DOI 10.2967/jnumed.107.047613; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Gaemperli O, 2012, EUR HEART J, V33, P1902, DOI 10.1093/eurheartj/ehr367; Gerhard A, 2016, CLIN TRANSL IMAGING, V4, P183, DOI 10.1007/s40336-016-0171-1; Gulyas B, 2012, CURR RADIOPHARM, V5, P19, DOI 10.2174/1874471011205010019; Hannestad J, 2012, NEUROIMAGE, V63, P232, DOI 10.1016/j.neuroimage.2012.06.055; Hatori A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045065; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Lanz B, 2014, J NUCL MED, V55, P1380, DOI 10.2967/jnumed.113.127381; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Meyer M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168667; Njiwa JY, 2017, J CEREBR BLOOD F MET, V37, P1251, DOI 10.1177/0271678X16653615; Oh U, 2011, J NEUROIMMUNE PHARM, V6, P354, DOI 10.1007/s11481-010-9243-6; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; Pain F, 2004, J NUCL MED, V45, P1577; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; RAYLMAN RR, 1993, J NUCL MED, V34, P440; Repalli Jayanthi, 2014, Curr Aging Sci, V7, P168; Roeda D, 2012, J FLUORINE CHEM, V134, P107, DOI 10.1016/j.jfluchem.2011.03.020; Roivainen A, 2009, EUR J NUCL MED MOL I, V36, P671, DOI 10.1007/s00259-008-1000-1; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Seki C, 1998, Ann Nucl Med, V12, P7; Thackeray JT, 2018, J AM COLL CARDIOL, V71, P263, DOI 10.1016/j.jacc.2017.11.024; Thackeray JT, 2015, J NUCL MED, V56, P1615, DOI 10.2967/jnumed.115.160820; Warnock G, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-13	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217515	10.1371/journal.pone.0217515	http://dx.doi.org/10.1371/journal.pone.0217515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150436	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000469759100061
J	Shahid, A; Patel, VB; Morton, JS; Stenson, TH; Davidge, ST; Oudit, GY; McMurtry, MS				Shahid, Anmol; Patel, Vaibhav B.; Morton, Jude S.; Stenson, Trevor H.; Davidge, Sandra T.; Oudit, Gavin Y.; McMurtry, Michael S.			Low altitude simulation without hypoxia improves left ventricular function after myocardial infarction by reducing ventricular afterload	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MORTALITY; CARDIOPROTECTION; DYSFUNCTION; METOPROLOL; REDUCTION; STROKE; RATES	Humans have a lower risk of death from myocardial infarction (MI) living at low elevations (<2500 m), which are not high enough to induce hypoxia. Both chronic hypoxia pre-MI, achieved by altitude simulation >5000 m, and intermittent hypobaric hypoxia post-MI can reduce MI size in rodents, and it is believed that hypoxia is the key stimulus. To explore mechanisms beyond hypoxia we studied whether altitude simulation <2500 m would also be associated with reduced infarct size. We performed left-anterior descending artery ligation on C57BL6 mice. Control mice (n = 12) recovered at 754 mmHg (atmospheric pressure, control), and treatment group mice (n = 13) were placed in a hypobaric chamber to recover 3-hours daily at 714 mmHg for 1 week. Echocardiographic evaluation of left ventricular function was performed on Day 0, Day 1 and Day 8. Intermittent hypobaric treatment was associated with a 14.2 +/- 5.3% improvement in ejection fraction for treatment group mice (p<0.01 vs. Day 1), with no change observed in control mice. Cardiac output, stroke volume, and infarct size were also improved in treated mice, but no changes were observed in HIF-1 activation or neovascularization. Next, we studied the acute hemodynamic effects of low altitude stimulation in intact mice breathing 100% oxygen using left ventricular catheterization and recording of pressure-volume loops. Acute reductions in barometric pressure from 754 mmHg to 714 mmHg and 674 mmHg were associated with reduced systemic vascular resistance, increased stroke volume and cardiac output, and no change in blood pressure or heart rate. Ex-vivo vascular function was studied using murine mesenteric artery segments. Acute reductions in barometric pressure were associated with greater vascular distensibility. We conclude that intermittent hypobaric treatment using simulated altitudes <2500 m reduces infarct size and increases ventricular function post-MI, and that these changes are related to altered arterial function and not hypoxia-associated neovascularization.	[Shahid, Anmol; Stenson, Trevor H.; Oudit, Gavin Y.; McMurtry, Michael S.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Patel, Vaibhav B.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada	University of Alberta; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Alberta	McMurtry, MS (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	mcmurtry@ualberta.ca	Patel, Vaibhav/B-4163-2016	Patel, Vaibhav/0000-0001-5917-5962; Stenson, Trevor/0000-0001-7164-1137; Davidge, Sandra/0000-0002-5559-4905	Canadian Institutes of Health Research (Vascular Metabolism and Angiogenesis) [MOP 106515]	Canadian Institutes of Health Research (Vascular Metabolism and Angiogenesis)(Canadian Institutes of Health Research (CIHR))	The work was funded in part by an operating grant awarded to MSM from the Canadian Institutes of Health Research (Vascular Metabolism and Angiogenesis, MOP 106515). The funder's website is: http://www.cihr-irsc.gc.ca.The funder did not play a role in any part of the work.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], 1973, J Appl Physiol, V34, P549; Baibas N, 2005, J EPIDEMIOL COMMUN H, V59, P274, DOI 10.1136/jech.2004.025510; Bale TL, 2004, P NATL ACAD SCI USA, V101, P3697, DOI 10.1073/pnas.0307324101; Blettner M, 2003, INT J CANCER, V106, P946, DOI 10.1002/ijc.11328; BUECHLEY RW, 1979, AM J EPIDEMIOL, V109, P663, DOI 10.1093/oxfordjournals.aje.a112729; COTTRELL JJ, 1988, CHEST, V93, P81, DOI 10.1378/chest.93.1.81; Eltzschig H, 2011, ISCHEMIA REPERFUSION; FABSITZ R, 1980, AM J EPIDEMIOL, V111, P315, DOI 10.1093/oxfordjournals.aje.a112903; Faeh D, 2009, CIRCULATION, V120, P495, DOI 10.1161/CIRCULATIONAHA.108.819250; GORDON RS, 1977, STROKE, V8, P274, DOI 10.1161/01.STR.8.2.274; GREENBERG BH, 1980, CIRCULATION, V61, P1212, DOI 10.1161/01.CIR.61.6.1212; Gros R, 2002, AM J PHYSIOL-HEART C, V282, pH380, DOI 10.1152/ajpheart.2002.282.1.H380; Honig CR, 1988, MODERN CARDIOVASCULA; Humphreys S, 2005, ANAESTHESIA, V60, P458, DOI 10.1111/j.1365-2044.2005.04124.x; Ibanez B, 2013, CIRCULATION, V128, P1495, DOI 10.1161/CIRCULATIONAHA.113.003653; Ibanez B, 2012, AM HEART J, V164, P473, DOI 10.1016/j.ahj.2012.07.020; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kolk Mandy V V, 2009, J Vis Exp, DOI 10.3791/1438; Linnersjo A, 2011, SCAND J WORK ENV HEA, V37, P219, DOI 10.5271/sjweh.3134; Meng Xiang-yan, 2014, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V30, P396; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672; MORTIMER EA, 1977, NEW ENGL J MED, V296, P581, DOI 10.1056/NEJM197703172961101; NICAS M, 1993, INFECT CONT HOSP EP, V14, P619; VOORS AW, 1979, J CHRON DIS, V32, P157, DOI 10.1016/0021-9681(79)90044-4; Wan CX, 2014, J GERIATR CARDIOL, V11, P237, DOI 10.11909/j.issn.1671-5411.2014.03.002; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Winkelmayer WC, 2009, JAMA-J AM MED ASSOC, V301, P508, DOI 10.1001/jama.2009.84; Wu J, 2013, AM J PHYSIOL-HEART C, V305, pH821, DOI 10.1152/ajpheart.00140.2013; Xu WQ, 2011, BASIC RES CARDIOL, V106, P329, DOI 10.1007/s00395-011-0159-y; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; ZANDER R, 1985, ADV EXP MED BIOL, V191, P965	33	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0215814	10.1371/journal.pone.0215814	http://dx.doi.org/10.1371/journal.pone.0215814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150412	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100012
J	Edens, C; Alden, NB; Danila, RN; Fill, MMA; Gacek, P; Muse, A; Parker, E; Poissant, T; Ryan, PA; Smelser, C; Tobin-D'Angelo, M; Schrag, SJ				Edens, Chris; Alden, Nisha B.; Danila, Richard N.; Fill, Mary-Margaret A.; Gacek, Paul; Muse, Alison; Parker, Erin; Poissant, Tasha; Ryan, Patricia A.; Smelser, Chad; Tobin-D'Angelo, Melissa; Schrag, Stephanie J.			Multistate analysis of prospective Legionnaires' disease cluster detection using SaTScan, 2011-2015	PLOS ONE			English	Article							NEW-YORK-CITY; COOLING-TOWER; UNITED-STATES; SURVEILLANCE; OUTBREAKS; LEGIONELLA; CARE	Detection of clusters of Legionnaires' disease, a leading waterborne cause of pneumonia, is challenging. Clusters vary in size and scope, are associated with a diverse range of aerosol producing devices, including exposures such as whirlpool spas and hotel water systems typically associated with travel, and can occur without an easily identified exposure source. Recently, jurisdictions have begun to use SaTScan spatio-temporal analysis software prospectively as part of routine cluster surveillance. We used data collected by the Active Bacterial Core surveillance platform to assess the ability of SaTScan to detect Legionnaires' disease clusters. We found that SaTScan analysis using traditional surveillance data and geocoded residential addresses was unable to detect many common Legionnaires' disease cluster types, such as those associated with travel or a prolonged time between cases. Additionally, signals from an analysis designed to simulate a real-time search for clusters did not align with clusters identified by traditional surveillance methods or a retrospective SaTScan analysis. A geospatial analysis platform better tailored to the unique characteristics of Legionnaires' disease epidemiology would improve cluster detection and decrease time to public health action.	[Edens, Chris; Schrag, Stephanie J.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Alden, Nisha B.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Danila, Richard N.] Minnesota Dept Hlth, St Paul, MN USA; [Fill, Mary-Margaret A.] Tennessee Dept Hlth, Nashville, TN USA; [Gacek, Paul] Connecticut Dept Publ Hlth, Hartford, CT USA; [Muse, Alison] New York State Dept Hlth, Albany, NY USA; [Parker, Erin] Calif Emerging Infect Program, Oakland, CA USA; [Poissant, Tasha] Oregon Hlth Author, Portland, OR USA; [Ryan, Patricia A.] Maryland Dept Hlth, Baltimore, MD USA; [Smelser, Chad] New Mexico Dept Hlth, Santa Fe, NM USA; [Tobin-D'Angelo, Melissa] Georgia Dept Publ Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment; Minnesota Department of Health (MHD); Tennessee Department Health; State University of New York (SUNY) System; California Emerging Infections Program; New Mexico Department of Health	Edens, C (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	wedens@cdc.gov		Edens, William/0000-0002-7563-6201	Emerging Infections Program [FOA: CK17-1701];  [U50CK000482];  [U50CK000483];  [U50CK000488];  [U50CK000485];  [U50CK000487];  [U50CK000490];  [U50CK000489];  [U50CK000486];  [U50CK000484];  [U50CK000491]	Emerging Infections Program; ; ; ; ; ; ; ; ; ; 	This work was federally funded through the Emerging Infections Program cooperative agreement (FOA: CK17-1701). Authors and grant numbers are as follows: EP - U50CK000482; NBA - U50CK000483; PG - U50CK000488; MT - U50CK000485; PAR - U50CK000487; RND - U50CK000490; CS - U50CK000489; AM-U50CK000486; TP - U50CK000484; MAF - U50CK000491. The funders participated in the study design, data collection, analysis of the data, decision to publish, and preparation of the manuscript.	ADDISS DG, 1989, AM J EPIDEMIOL, V130, P557, DOI 10.1093/oxfordjournals.aje.a115370; Agost L, 2016, ARCH ARGENT PEDIATR, V114, P534, DOI 10.5546/aap.2016.eng.534; Bull M, 2012, EUROSURVEILLANCE, V17, P30; Centers for Disease Control and Prevention, NAT OUBTR REP SYST N; Centers for Disease Control and Prevention, NAT NOT DIS SURV SYS; Chen CC, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0072-6; Day SR, 2015, OPEN FORUM INFECT DI, V2, DOI [10.1093/ofid/ofv164, 10.1093/ofid/ofv064]; Demirjian A, 2015, CLIN INFECT DIS, V60, P1596, DOI 10.1093/cid/civ153; Dooling KL, 2015, MMWR-MORBID MORTAL W, V64, P1190, DOI 10.15585/mmwr.mm6442a2; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fitzhenry R, 2017, EMERG INFECT DIS, V23, P1769, DOI 10.3201/eid2311.161584; Garrison LE, 2016, AM J TRANSPLANT, V16, P3049, DOI 10.1111/ajt.14024; Glatman-Freedman A, 2016, J INFECTION, V73, P99, DOI 10.1016/j.jinf.2016.04.038; Greene SK, 2016, EMERG INFECT DIS, V22, P1808, DOI 10.3201/eid2210.160097; Greene SK, 2012, FOODBORNE PATHOG DIS, V9, P431, DOI 10.1089/fpd.2011.1036; Greene SK, 2011, STAT MED, V30, P549, DOI 10.1002/sim.3883; Greig JE, 2004, MED J AUSTRALIA, V180, P566, DOI 10.5694/j.1326-5377.2004.tb06093.x; Huang L, 2008, STAT MED, V27, P5111, DOI 10.1002/sim.3342; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M., SATSCAN V9 4 4 SOFTW; Levin-Rector A, 2015, EMERG INFECT DIS, V21, P265, DOI 10.3201/eid2102.140098; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Mathes RW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184419; McEvoy M, 2000, Commun Dis Public Health, V3, P43; Orkis LT, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268818002789, 10.1017/s095026881800273x]; Palmore TN, 2009, INFECT CONT HOSP EP, V30, P764, DOI 10.1086/598855; Peterson E. R., 2017, ONLINE J PUBLIC HLTH, V9, pe121, DOI DOI 10.5210/0JPHI.V9I1.7705; Rao HX, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2643-y; Sansom P, 2013, STAT MED, V32, P3522, DOI 10.1002/sim.5765; Smith P., 2007, Morbidity and Mortality Weekly Report, V56, P1261; Tang XY, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2357-1; Weiss D, 2017, PUBLIC HEALTH REP, V132, P241, DOI 10.1177/0033354916689620; Yih WK, 2010, PUBLIC HEALTH REP, V125, P111, DOI 10.1177/003335491012500115	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217632	10.1371/journal.pone.0217632	http://dx.doi.org/10.1371/journal.pone.0217632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145765	Green Published, Green Submitted, gold			2022-12-26	WOS:000469425500028
J	Funaro, CF; Schal, C; Vargo, EL				Funaro, Colin F.; Schal, Coby; Vargo, Edward L.			Queen and king recognition in the subterranean termite, Reticulitermes flavipes: Evidence for royal recognition pheromones	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; MODULATORY COMMUNICATION; VIBRATION SIGNAL; ISOPTERA; REPRODUCTIVES; WORKERS; DIFFERENTIATION; DISCRIMINATION; IDENTIFICATION; POPULATION	Royal recognition is a central feature of insect societies, allowing them to maintain the reproductive division of labor and regulate colony demography. Queen recognition has been broadly demonstrated and queen recognition pheromones have been identified in social hymenopterans, and in one termite species. Here we describe behaviors that are elicited in workers and soldiers by neotenic queens and kings of the subterranean termite, Reticulitermes flavipes, and demonstrate the chemical basis for the behavior. Workers and soldiers readily perform a lateral or longitudinal shaking behavior upon antennal contact with queens and kings. When royal cuticular chemicals are transferred to live workers or inert glass dummies, they elicit antennation and shaking in a dose-dependent manner. The striking response to reproductives and their cuticular extracts suggests that royal-specific cuticular compounds act as recognition pheromones and that shaking behavior is a clear and measurable queen and king recognition response in this termite species.	[Funaro, Colin F.; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Vargo, Edward L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Funaro, Colin F.] North Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; University of North Carolina; North Carolina State University	Funaro, CF (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; Funaro, CF (corresponding author), North Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA.	colin.funaro@gmail.com	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358				Amsalem E, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1800; Bagneres AG, 1998, CHEMOECOLOGY, V8, P201, DOI 10.1007/s000490050026; BAGNERES AG, 1991, J CHEM ECOL, V17, P2397, DOI 10.1007/BF00994590; BAGNERES AG, 1990, J CHEM ECOL, V16, P3213, DOI 10.1007/BF00982094; Batista-Pereira LG, 2004, Z NATURFORSCH C, V59, P135; Bignell DE, 2014, BIOL TERMITES MODERN; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; Chung H, 2015, BIOESSAYS, V37, P822, DOI 10.1002/bies.201500014; Darrouzet E, 2014, J INSECT PHYSIOL, V61, P25, DOI 10.1016/j.jinsphys.2013.12.006; Dietemann V, 2003, P NATL ACAD SCI USA, V100, P10341, DOI 10.1073/pnas.1834281100; ESPELIE KE, 1994, J CHEM ECOL, V20, P1677, DOI 10.1007/BF02059889; Evans TA, 2005, P NATL ACAD SCI USA, V102, P3732, DOI 10.1073/pnas.0408649102; Funaro CF, 2018, P NATL ACAD SCI USA, V115, P3888, DOI 10.1073/pnas.1721419115; Hager FA, 2013, J EXP BIOL, V216, P3249, DOI 10.1242/jeb.086991; Haverty MI, 1996, J CHEM ECOL, V22, P1813, DOI 10.1007/BF02028506; Himuro C, 2011, J INSECT PHYSIOL, V57, P962, DOI 10.1016/j.jinsphys.2011.04.012; Holldobler B., 1990, pi; Holman L, 2017, PEERJ, V5, DOI 10.7717/peerj.3332; Holman L, 2016, BEHAV ECOL SOCIOBIOL, V70, P387, DOI 10.1007/s00265-016-2058-6; Holman L, 2010, P ROY SOC B-BIOL SCI, V277, P3793, DOI 10.1098/rspb.2010.0984; Howse P, 1965, INSECTES SOC, V12, P335; HOWSE PE, 1964, ANIM BEHAV, V12, P284, DOI 10.1016/0003-3472(64)90015-6; Hyland KM, 2007, ANIM BEHAV, V73, P541, DOI 10.1016/j.anbehav.2006.10.006; KIRCHNER WH, 1994, PHYSIOL ENTOMOL, V19, P187, DOI 10.1111/j.1365-3032.1994.tb01041.x; Korb J, 2005, NATURWISSENSCHAFTEN, V92, P45, DOI 10.1007/s00114-004-0589-6; Korb J, 2004, BEHAV ECOL SOCIOBIOL, V56, P89, DOI 10.1007/s00265-004-0757-x; Liebig J, 1999, P ROY SOC B-BIOL SCI, V266, P1865, DOI 10.1098/rspb.1999.0858; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Liebig J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1799, DOI 10.1007/s00265-009-0807-5; LIGHT SF, 1951, J EXP ZOOL, V117, P397, DOI 10.1002/jez.1401170302; Luscher M., 1961, INSECT POLYMORPHISM, P57; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Nunes TM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07449; Ohmura W, 2009, SOCIOBIOLOGY, V54, P269; Penick CA, 2013, J INSECT BEHAV, V26, P23, DOI 10.1007/s10905-012-9332-x; Reinhard J, 2002, J INSECT BEHAV, V15, P95, DOI 10.1023/A:1014436313710; ROCCA JR, 1983, TETRAHEDRON LETT, V24, P1889, DOI 10.1016/S0040-4039(00)81798-0; Schneider SS, 2004, APIDOLOGIE, V35, P117, DOI 10.1051/apido:2004006; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Smith AA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0947; Smith AA, 2013, J EXP BIOL, V216, P3917, DOI 10.1242/jeb.089482; Smith AA, 2012, BEHAV ECOL SOCIOBIOL, V66, P1267, DOI 10.1007/s00265-012-1380-x; SU NY, 1991, SOCIOBIOLOGY, V19, P349; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Van Oystaeyen A, 2014, SCIENCE, V343, P287, DOI 10.1126/science.1244899; VANDERMEER RK, 1980, ANN ENTOMOL SOC AM, V73, P609, DOI 10.1093/aesa/73.5.609; Weil T, 2009, NATURWISSENSCHAFTEN, V96, P315, DOI 10.1007/s00114-008-0475-8; WEST MJ, 1967, SCIENCE, V157, P1584, DOI 10.1126/science.157.3796.1584; Whitman JG, 2007, ANN ENTOMOL SOC AM, V100, P763, DOI 10.1603/0013-8746(2007)100[763:ONOSAI]2.0.CO;2; Yamamoto Y, 2012, BEHAV ECOL SOCIOBIOL, V66, P39, DOI 10.1007/s00265-011-1249-4	51	5	5	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0209810	10.1371/journal.pone.0209810	http://dx.doi.org/10.1371/journal.pone.0209810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145770	Green Published, Green Submitted, gold			2022-12-26	WOS:000469425500002
J	Hwang, YJ; Nam, SJ; Chun, W; Kim, SI; Park, SC; Kang, CD; Lee, SJ				Hwang, Young-Jae; Nam, Seung-Joo; Chun, Wanjoo; Kim, Song In; Park, Sung Chul; Kang, Chang Don; Lee, Sung Joon			Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis model	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXHALED BREATH CONDENSATE; NADPH OXIDASE; PATHOGENESIS; INCREASE; SYSTEM; IMMUNE; CELLS; IBD	Background and aim Various drugs have been developed for inflammatory bowel disease (IBD), but still there are limitations in the treatment due to the insufficient responses and significant adverse effects of immunosuppressant. Apocynin is an NADPH-oxidase inhibitor with established safety profiles. We aimed to investigate the protective efficacy of apocynin in IBD using chemical-induced mouse colitis model. Method We induced experimental colitis by administrating 5% dextran sulfate sodium (DSS) to 8-week old BALB/c mouse for 11 days. Apocynin (400 mg/kg) or sulfasalazine (150 mg/kg) were administeredduring7 days. We monitored bodyweight daily and harvested colon and spleen at day 11 to check weight and length. We also examined histopathologic change and pro-, anti-inflammatory cytokines and enzymes from harvested colons (iNOS, COX-2, TNF-alpha, MCP-1, p-NrF2, and HO-1). Result Apocynin significantly alleviated weight reduction induced by DSS treatment (21.64 +/- 0.55 for Apocynin group vs. 20.33 +/- 0.90 for DSS group, p = 0.005). Anti-inflammatory efficacy of apocynin was also shown by the recovery of colon weight and length. Histopathologic examination revealed significantly reduced inflammatory foci and erosions by apocynin treatment. Colonic expression of iNOS, COX-2, TNF-alpha, and MCP-1 was decreased significantly in the apocynin treated group. Anti-inflammatory mediators Nrf2 and HO-1 were activated significantly in apocynin treated mouse. Conclusion Apocynin showed significant anti-inflammatory efficacy against chemically induced colonic inflammation. This study also revealed the unique action of apocynin compared to the currently prescribed drug, sulfasalazine. Given its excellent safety profile and potent efficacy with novel action mechanism, apocynin can be a new therapeutic molecule for the IBD treatment, which can be added to the currently available drugs.	[Hwang, Young-Jae; Nam, Seung-Joo; Park, Sung Chul; Kang, Chang Don; Lee, Sung Joon] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea; [Chun, Wanjoo; Kim, Song In] Kangwon Natl Univ, Sch Med, Dept Pharmacol, Chunchon, South Korea	Kangwon National University; Kangwon National University	Nam, SJ (corresponding author), Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea.	pinetrees@hanmail.net	Park, Sung Chul/AGO-1773-2022; Nam, Seung-Joo/AAD-2495-2022	Park, Sung Chul/0000-0003-3215-6838; Nam, Seung-Joo/0000-0002-0349-0901	2015 Kangwon National University Hospital Grant	2015 Kangwon National University Hospital Grant	This research was funded by a 2015 Kangwon National University Hospital Grant awarded to S-JN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AC, 2005, J INTERF CYTOK RES, V25, P540, DOI 10.1089/jir.2005.25.540; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Cohen BL, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2505; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Gonzalez-Mauraza H, 2014, J PHYSIOL BIOCHEM, V70, P163, DOI 10.1007/s13105-013-0290-3; Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159; Guan QD, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4810258; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kaur J, 2004, MED PRIN PRACT, V13, P26, DOI 10.1159/000074047; Khan WI, 2006, AM J PHYSIOL-GASTR L, V291, pG803, DOI 10.1152/ajpgi.00069.2006; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kinkade K, 2013, INT J MOL SCI, V14, P17017, DOI 10.3390/ijms140817017; Kruse ML, 2016, INFLAMM BOWEL DIS, V22, P2593, DOI 10.1097/MIB.0000000000000925; Kryl'skii ED, 2015, B EXP BIOL MED+, V160, P24, DOI 10.1007/s10517-015-3089-0; Lam G, 2015, CURR MED CHEM, V22, P2100, DOI 10.2174/0929867322666150416095114; Lee SH, 2018, INTEST RES, V16, P26, DOI 10.5217/ir.2018.16.1.26; Marin M, 2013, PLANTA MED, V79, P1392, DOI 10.1055/s-0033-1350710; McLean LP, 2014, EXPERT REV GASTROENT, V8, P223, DOI 10.1586/17474124.2014.881715; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Mouzaoui S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/312484; Naito Y, 2004, ALIMENT PHARM THERAP, V20, P177, DOI 10.1111/j.1365-2036.2004.01992.x; Plevy S, 2007, GASTROENTEROLOGY, V133, P1414, DOI 10.1053/j.gastro.2007.08.035; Ramonaite R, 2014, WORLD J GASTROENTERO, V20, P12533, DOI 10.3748/wjg.v20.i35.12533; REINECKER HC, 1995, GASTROENTEROLOGY, V108, P40, DOI 10.1016/0016-5085(95)90006-3; Reinglas J, 2018, WORLD J GASTROENTERO, V24, P3567, DOI 10.3748/wjg.v24.i32.3567; Sebastian VP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01956; SHARMA ML, 1994, J ETHNOPHARMACOL, V41, P185, DOI 10.1016/0378-8741(94)90031-0; Singh UP, 2016, CYTOKINE, V77, P44, DOI 10.1016/j.cyto.2015.10.008; Stefanska J, 2012, PULM PHARMACOL THER, V25, P343, DOI 10.1016/j.pupt.2012.06.001; Stefanska J, 2012, EXP LUNG RES, V38, P90, DOI 10.3109/01902148.2011.649823; Tian T, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4535194; Wan WYH, 2016, CHEST, V149, P1445, DOI 10.1016/j.chest.2016.01.024	33	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217642	10.1371/journal.pone.0217642	http://dx.doi.org/10.1371/journal.pone.0217642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141554	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000071
J	Karmakar, M; Rodrigues, CHM; Holt, KE; Dunstan, SJ; Denholm, J; Ascher, DB				Karmakar, Malancha; Rodrigues, Carlos H. M.; Holt, Kathryn E.; Dunstan, Sarah J.; Denholm, Justin; Ascher, David B.			Empirical ways to identify novel Bedaquiline resistance mutations in AtpE	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PROTEIN STABILITY; IN-VITRO; ACQUIRED-RESISTANCE; GENETIC-DISEASE; DIARYLQUINOLINE; SYNTHASE; SERVER; MECHANISMS; DELAMANID	Clinical resistance against Bedaquiline, the first new anti-tuberculosis compound with a novel mechanism of action in over 40 years, has already been detected in Mycobacterium tuberculosis. As a new drug, however, there is currently insufficient clinical data to facilitate reliable and timely identification of genomic determinants of resistance. Here we investigate the structural basis for M. tuberculosis associated bedaquiline resistance in the drug target, AtpE. Together with the 9 previously identified resistance-associated variants in AtpE, 54 non-resistance-associated mutations were identified through comparisons of bedaquiline susceptibility across 23 different mycobacterial species. Computational analysis of the structural and functional consequences of these variants revealed that resistance associated variants were mainly localized at the drug binding site, disrupting key interactions with bedaquiline leading to reduced binding affinity. This was used to train a supervised predictive algorithm, which accurately identified likely resistance mutations (93.3% accuracy). Application of this model to circulating variants present in the Asia-Pacific region suggests that current circulating variants are likely to be susceptible to bedaquiline. We have made this model freely available through a user-friendly web interface called SUSPECT-BDQ, StrUctural Susceptibility PrEdiCTion for bedaquiline (http://biosig.unimelb.edu.au/suspect_bdq/). This tool could be useful for the rapid characterization of novel clinical variants, to help guide the effective use of bedaquiline, and to minimize the spread of clinical resistance.	[Karmakar, Malancha; Denholm, Justin] Melbourne Hlth, Victorian TB Program, Melbourne, Vic, Australia; [Karmakar, Malancha; Rodrigues, Carlos H. M.; Holt, Kathryn E.; Ascher, David B.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Karmakar, Malancha; Denholm, Justin] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Karmakar, Malancha; Rodrigues, Carlos H. M.; Ascher, David B.] Baker Heart & Diabet Inst, Struct Biol & Bioinformat, Melbourne, Vic, Australia; [Dunstan, Sarah J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Ascher, David B.] Univ Cambridge, Dept Biochem, Cambridge, England	University of Melbourne; University of Melbourne; University of Melbourne; University of Cambridge	Ascher, DB (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.; Ascher, DB (corresponding author), Baker Heart & Diabet Inst, Struct Biol & Bioinformat, Melbourne, Vic, Australia.; Ascher, DB (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	david.ascher@unimelb.edu.au	Dunstan, Sarah/AAO-9597-2020; Miranda Rodrigues, Carlos Henrique/GRS-2397-2022; Holt, Kathryn E/A-8108-2012; Denholm, Justin/AAD-6010-2019	Miranda Rodrigues, Carlos Henrique/0000-0002-4420-6401; Holt, Kathryn E/0000-0003-3949-2471; Denholm, Justin/0000-0002-9214-6431; Ascher, David/0000-0003-2948-2413; Karmakar, Malancha/0000-0003-0303-2895; Dunstan, Sarah/0000-0001-7873-933X	Melbourne Research Scholarship; Newton Fund RCUK-CONFAP Grant - The Medical Research Council (MRC); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [MR/M026302/1]; Jack Brockhoff Foundation [JBF 4186]; C. J. Martin Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia [APP1072476]; NHMRC Australia [APP1056689]; Victorian Government's OIS Program; MRC [MR/M026302/1] Funding Source: UKRI	Melbourne Research Scholarship; Newton Fund RCUK-CONFAP Grant - The Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Jack Brockhoff Foundation; C. J. Martin Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	M.K was funded by the Melbourne Research Scholarship. D.B.A was funded by a Newton Fund RCUK-CONFAP Grant awarded by The Medical Research Council (MRC) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (MR/M026302/1), the Jack Brockhoff Foundation (JBF 4186, 2016), and a C. J. Martin Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (APP1072476). The Vietnam genomic dataset was funded by a NHMRC Australia grant (APP1056689) to SJD and KEH. This work was supported in part by the Victorian Government's OIS Program. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Ayala DA, 2017, J MED MICROBIOL, V66, P1140, DOI 10.1099/jmm.0.000537; Albanaz ATS, 2017, EXPERT OPIN DRUG DIS, V12, P553, DOI 10.1080/17460441.2017.1322579; Almeida D, 2016, ANTIMICROB AGENTS CH, V60, P4590, DOI 10.1128/AAC.00753-16; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bloemberg GV, 2015, NEW ENGL J MED, V373, P1986, DOI 10.1056/NEJMc1505196; Chahine EB, 2014, ANN PHARMACOTHER, V48, P107, DOI 10.1177/1060028013504087; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Denholm JT, 2018, AM J RESP CRIT CARE, V198, P541, DOI 10.1164/rccm.201712-2572LE; Field SK, 2015, THER ADV CHRONIC DIS, V6, P170, DOI 10.1177/2040622315582325; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hards K, 2015, J ANTIMICROB CHEMOTH, V70, P2028, DOI 10.1093/jac/dkv054; Hawkey J, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000165; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Hoffmann H, 2016, AM J RESP CRIT CARE, V194, P1171, DOI 10.1164/rccm.201605-1065LE; Hoffmann H, 2016, AM J RESP CRIT CARE, V193, P337, DOI 10.1164/rccm.201502-0372LE; Holt KE, 2018, NAT GENET, V50, P849, DOI 10.1038/s41588-018-0117-9; Huitric E, 2010, ANTIMICROB AGENTS CH, V54, P1022, DOI 10.1128/AAC.01611-09; Huitric E, 2007, ANTIMICROB AGENTS CH, V51, P4202, DOI 10.1128/AAC.00181-07; Ji BH, 2006, ANTIMICROB AGENTS CH, V50, P1921, DOI [10.1128/AAC.00052-06, 10.1128/AAC.50.4.1558-1560.2006]; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Lu P, 2014, BBA-BIOENERGETICS, V1837, P1208, DOI 10.1016/j.bbabio.2014.01.022; Pandurangan AP, 2017, BIOCHEM SOC T, V45, P303, DOI 10.1042/BST20160422; Pang Y, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02627-16, 10.1128/aac.02627-16]; Park Y, 2017, ACS INFECT DIS, V3, P18, DOI 10.1021/acsinfecdis.6b00103; Petrella S, 2006, ANTIMICROB AGENTS CH, V50, P2853, DOI 10.1128/AAC.00244-06; Thai PVK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3033-9; Phelan J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0575-9; Pires DEV, 2016, SCI REP-UK, V6, DOI 10.1038/srep29575; Pires DEV, 2016, NUCLEIC ACIDS RES, V44, pW557, DOI 10.1093/nar/gkw390; Pires DEV, 2016, SCI REP-UK, V6, DOI 10.1038/srep19848; Pires DEV, 2015, NUCLEIC ACIDS RES, V43, pD387, DOI 10.1093/nar/gku966; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Portelli S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33370-6; Preiss L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500106; Provost F., 2000, P AAAI 2000 WORKSH I; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Salfinger M, 2015, EUR RESPIR J, V45, P317, DOI 10.1183/09031936.00199814; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Segala E, 2012, ANTIMICROB AGENTS CH, V56, P2326, DOI 10.1128/AAC.06154-11; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh V, 2017, ACS INFECT DIS, V3, P5, DOI 10.1021/acsinfecdis.6b00102; Nguyen TVA, 2018, CLIN INFECT DIS, V66, P1625, DOI 10.1093/cid/cix992; Trapero A, 2018, J MED CHEM, V61, P2806, DOI 10.1021/acs.jmedchem.7b01622; Vedithi SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23423-1; Wager S, 2014, J MACH LEARN RES, V15, P1625; WHO, 2018, WHOCDSTB201825; World Health Organization, 2013, USE BEDAQUILINE TREA; World Health Organization, 2018, RAP COMM KEY CHANG T; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zimenkov DV, 2017, J ANTIMICROB CHEMOTH, V72, P1901, DOI 10.1093/jac/dkx094	55	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217169	10.1371/journal.pone.0217169	http://dx.doi.org/10.1371/journal.pone.0217169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141524	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000469323000043
J	Magallon, J; Chiem, K; Tran, T; Ramirez, MS; Jimenez, V; Tolmasky, ME				Magallon, Jesus; Chiem, Kevin; Tung Tran; Ramirez, Maria S.; Jimenez, Veronica; Tolmasky, Marcelo E.			Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc	PLOS ONE			English	Article							6'-N-ACETYLTRANSFERASE TYPE IB; ACINETOBACTER-BAUMANNII; AMINOGLYCOSIDE RESISTANCE; KLEBSIELLA-PNEUMONIAE; INHIBITION; MECHANISMS; STRAINS; ENZYMES	Gram-negative pathogens resistant to amikacin and other aminoglycosides of clinical relevance usually harbor the 6'-N-acetyltransferase type Ib [AAC(6')-Ib], an enzyme that catalyzes inactivation of the antibiotic by acetylation using acetyl-CoA as donor substrate. Inhibition of the acetylating reaction could be a way to induce phenotypic conversion to susceptibility in these bacteria. We have previously observed that Zn2+ acts as an inhibitor of the enzymatic acetylation of aminoglycosides by AAC(6')-Ib, and in complex with ionophores it effectively reduced the levels of resistance in cellulo. We compared the activity of 8-hydroxyquinoline, three halogenated derivatives, and 5-[N-Methyl-N-Propargylaminomethyl]- 8-Hydroxyquinoline in complex with Zn2+ to inhibit growth of amikacin-resistant Acinetobacter baumannii in the presence of the antibiotic. Two of the compounds, clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) and 5,7-diiodo-8-hydroxyquinoline, showed robust inhibition of growth of the two A. baumannii clinical isolates that produce AAC(6')-Ib. However, none of the combinations had any activity on another amikacin-resistant A. baumannii strain that possesses a different, still unknown mechanism of resistance. Time-kill assays showed that the combination of clioquinol or 5,7-diiodo-8-hydroxyquinoline with Zn2+ and amikacin was bactericidal. Addition of 8-hydroxyquinoline, clioquinol, or 5,7-diiodo-8-hydroxyquinoline, alone or in combination with Zn2+, and amikacin to HEK293 cells did not result in significant toxicity. These results indicate that ionophores in complex with Zn2+ could be developed into potent adjuvants to be used in combination with aminoglycosides to treat Gram-negative pathogens in which resistance is mediated by AAC(6')-Ib and most probably other related aminoglycoside modifying enzymes.	[Magallon, Jesus; Chiem, Kevin; Tung Tran; Ramirez, Maria S.; Jimenez, Veronica; Tolmasky, Marcelo E.] Calif State Univ Fullerton, Coll Nat Sci & Math, Dept Biol Sci, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA	California State University System; California State University Fullerton	Tolmasky, ME (corresponding author), Calif State Univ Fullerton, Coll Nat Sci & Math, Dept Biol Sci, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA.	mtolmasky@fullerton.edu	Tolmasky, Marcelo/AAC-5316-2020	Tolmasky, Marcelo/0000-0002-6298-7811	Public Health Service grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health [2R15AI047115]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI047115] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant 2R15AI047115 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Arivett BA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00212-15; Bareggi SR, 2012, CNS NEUROSCI THER, V18, P41, DOI 10.1111/j.1755-5949.2010.00231.x; Bohlmann L, 2018, MBIO, V9, DOI 10.1128/mBio.02391-18; Castanheira M, 2018, J ANTIMICROB CHEMOTH, V73, P3346, DOI 10.1093/jac/dky344; Chan SH, 2013, ACS MED CHEM LETT, V4, P170, DOI 10.1021/ml300238z; Chandrika NT, 2018, CHEM SOC REV, V47, P1189, DOI 10.1039/c7cs00407a; Chandrika NT, 2016, MEDCHEMCOMM, V7, P50, DOI 10.1039/c5md00453e; Chandrika NT, 2015, ACS MED CHEM LETT, V6, P1134, DOI 10.1021/acsmedchemlett.5b00255; Chiem K, 2018, INT J ANTIMICROB AG, V51, P271, DOI 10.1016/j.ijantimicag.2017.08.002; Chiem K, 2016, MEDCHEMCOMM, V7, P184, DOI 10.1039/c5md00316d; Chiem K, 2015, ANTIMICROB AGENTS CH, V59, P5851, DOI 10.1128/AAC.01106-15; Davies-Sala C, 2015, ANN NY ACAD SCI, V1354, P98, DOI 10.1111/nyas.12755; Garneau-Tsodikova S, 2016, MEDCHEMCOMM, V7, P11, DOI 10.1039/c5md00344j; Guan JM, 2018, CHEMBIOCHEM, V19, P2107, DOI 10.1002/cbic.201800368; Haas M J, 1975, Methods Enzymol, V43, P611; Jackson Alexis, 2016, Biol Methods Protoc, V1; Ju LC, 2018, TRENDS PHARMACOL SCI, V39, P635, DOI 10.1016/j.tips.2018.03.007; Labby KJ, 2013, FUTURE MED CHEM, V5, P1285, DOI 10.4155/fmc.13.80; Li YJ, 2015, ANTIMICROB AGENTS CH, V59, P4148, DOI 10.1128/AAC.00885-15; Lin DL, 2014, ANTIMICROB AGENTS CH, V58, P4238, DOI 10.1128/AAC.00129-14; Lind SE, 2009, TRANSL RES, V154, P153, DOI 10.1016/j.trsl.2009.06.002; Lopez C, 2015, ANTIMICROB AGENTS CH, V59, P5798, DOI 10.1128/AAC.01304-15; Maianti JP, 2016, MEDCHEMCOMM, V7, P170, DOI 10.1039/c5md00429b; Mao X, 2009, LEUKEMIA, V23, P585, DOI 10.1038/leu.2008.232; Mao XL, 2008, TOXICOL LETT, V182, P1, DOI 10.1016/j.toxlet.2008.08.015; Matsushita T, 2019, J AM CHEM SOC, V141, P5051, DOI 10.1021/jacs.9b01693; Papp-Wallace KM, 2016, INFECT DIS CLIN N AM, V30, P441, DOI 10.1016/j.idc.2016.02.007; Petersen PJ, 2006, J ANTIMICROB CHEMOTH, V57, P573, DOI 10.1093/jac/dki477; Ramirez MS, 2017, MOLECULES, V22, DOI 10.3390/molecules22122267; Ramirez MS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00121; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Sarno R, 2003, ANTIMICROB AGENTS CH, V47, P3296, DOI 10.1128/AAC.47.10.3296-3304.2003; Schmidt M, 2015, BIOCONJUGATE CHEM, V26, P1950, DOI 10.1021/acs.bioconjchem.5b00393; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Ramirez MS, 2013, CURR MICROBIOL, V67, P9, DOI 10.1007/s00284-013-0326-5; Bistue AJCS, 2009, P NATL ACAD SCI USA, V106, P13230, DOI 10.1073/pnas.0906529106; Tolmasky ME, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P35; Tolmasky ME, 2017, FRONTIERS CLIN DRUG, P3; Traglia G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35377-5; Traglia G, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01146-14; Traglia GM, 2014, GENOME BIOL EVOL, V6, P2235, DOI 10.1093/gbe/evu176; Tran T, 2018, INT J ANTIMICROB AG, V51, P752, DOI 10.1016/j.ijantimicag.2018.01.019; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Vilacoba E, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01190-14; Vilacoba E, 2013, ANTIMICROB AGENTS CH, V57, P651, DOI 10.1128/AAC.01751-12; Vong K, 2012, MEDCHEMCOMM, V3, P397, DOI [10.1039/c2md00253a, 10.1039/C2MD00253A]; WOLOJ M, 1986, ANTIMICROB AGENTS CH, V29, P315, DOI 10.1128/AAC.29.2.315; Wright GD, 2003, CURR OPIN CHEM BIOL, V7, P563, DOI 10.1016/j.cbpa.2003.08.004; Wright PM, 2014, ANGEW CHEM INT EDIT, V53, P8840, DOI 10.1002/anie.201310843; Zarate SG, 2018, MOLECULES, V23, DOI 10.3390/molecules23020284	50	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217602	10.1371/journal.pone.0217602	http://dx.doi.org/10.1371/journal.pone.0217602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141575	Green Submitted, gold, Green Published			2022-12-26	WOS:000469323000066
J	Miller, EJ; Temple-Smith, MJ; Bilardi, JE				Miller, Ellena J.; Temple-Smith, Meredith J.; Bilardi, Jade E.			'There was just no-one there to acknowledge that it happened to me as well': A qualitative study of male partner's experience of miscarriage	PLOS ONE			English	Article							PREGNANCY LOSS; HEALTH-CARE; WOMEN; GRIEF; SUPPORT; ANXIETY	Miscarriage occurs in up to one in four pregnancies and can be a devastating event affecting both men and women. Unfortunately, the male partner's experience of miscarriage is seldom researched, particularly within Australia. This qualitative study involved semi-structured telephone interviews with 10 Australian men, whose partners miscarried between three months and ten years ago. Participants were recruited through professional networks and support organisations. Interviews explored men's general miscarriage experience and the support received or lacking from both healthcare providers and social networks. Online health seeking behaviour and opinions on online support were also discussed. Data was transcribed verbatim and analysed thematically. Most men described feeling significant grief following miscarriage and felt that there was little acknowledgment of their loss, both from healthcare providers and within their social networks. Feelings of sadness, devastation, powerlessness, fear, shock and a loss of identity were common. All men felt their primary role at the time of miscarriage was to support their partner. Most men did not want to burden their partner with their emotions or grief, and struggled to find people within their social networks to talk to about their loss, leading to feelings of isolation. Overall participants felt there was inadequate support offered to men affected by miscarriage. Men wanted information, informed professionals to talk to and male-orientated support networks. A website was one mechanism suggested by men which could adequately contribute to information and support needs during this time. Men are often greatly affected by miscarriage and yet there is all too often little acknowledgement or support available to them at this time. Men affected by miscarriage want and need further support, including reputable, Australian based information and resources tailored their needs.	[Miller, Ellena J.; Temple-Smith, Meredith J.; Bilardi, Jade E.] Univ Melbourne, Dept Gen Practice, Carlton, Vic, Australia; [Temple-Smith, Meredith J.; Bilardi, Jade E.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Bilardi, Jade E.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	University of Melbourne; Monash University	Bilardi, JE (corresponding author), Univ Melbourne, Dept Gen Practice, Carlton, Vic, Australia.; Bilardi, JE (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia.; Bilardi, JE (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.	jade.bilardi@monash.edu	Zweigenthal, Virginia/AAW-6425-2021	Zweigenthal, Virginia/0000-0003-3914-2156; Bilardi, Jade/0000-0003-0461-2605	National Health and Medical Research Council [1035135]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	JEB is in receipt of a National Health and Medical Research Council Early Career Fellowship Number 1035135 (www.nhmrc.gov.au).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JEB received a partial salary from the funding body to support her postdoctoral studies.	Abboud L, 2005, J REPROD INFANT PSYC, V23, P3, DOI 10.1080/02646830512331330974; Abboud LN, 2003, SOC WORK HEALTH CARE, V36, P37, DOI 10.1300/J010v36n03_03; Armstrong D, 2001, MCN Am J Matern Child Nurs, V26, P147, DOI 10.1097/00005721-200105000-00012; Bellhouse C, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0672-3; Bellhouse C, 2019, WOMEN BIRTH, V32, P137, DOI 10.1016/j.wombi.2018.06.006; Brier N, 2004, BIRTH-ISS PERINAT C, V31, P138, DOI 10.1111/j.0730-7659.2004.00292.x; Brier N, 2008, J WOMENS HEALTH, V17, P451, DOI 10.1089/jwh.2007.0505; Conway K, 2000, BRIT J MED PSYCHOL, V73, P531, DOI 10.1348/000711200160714; CONWAY K, 1995, BRIT J MED PSYCHOL, V68, P259, DOI 10.1111/j.2044-8341.1995.tb01833.x; Cumming GP, 2007, BJOG-INT J OBSTET GY, V114, P1138, DOI 10.1111/j.1471-0528.2007.01452.x; Due C, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1560-9; Farren J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011864; Garfield CF, 2008, AM J LIFESTYLE MED, V2, P474, DOI 10.1177/1559827608323213; Johnson MP, 1996, BRIT J MED PSYCHOL, V69, P313, DOI 10.1111/j.2044-8341.1996.tb01875.x; Khan R A, 2004, Ir Med J, V97, P217; Lok IH, 2007, BEST PRACT RES CL OB, V21, P229, DOI 10.1016/j.bpobgyn.2006.11.007; McCreight BS, 2004, SOCIOL HEALTH ILL, V26, P326, DOI 10.1111/j.1467-9566.2004.00393.x; McLean A, 2013, QUAL SOC WORK, V12, P782, DOI 10.1177/1473325012464099; Meaney S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011382; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; NEUGEBAUER R, 1992, AM J PUBLIC HEALTH, V82, P1332, DOI 10.2105/AJPH.82.10.1332; Obst KL, 2019, MIDWIFERY, V70, P1, DOI 10.1016/j.midw.2018.11.013; Rinehart MS, 2010, PSYCHOTHERAPY, V47, P288, DOI 10.1037/a0021160; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Saunders M, 2009, HEALTH PROMOT J AUST, V20, P92, DOI 10.1071/HE09092; Simmons RK, 2006, SOC SCI MED, V63, P1934, DOI 10.1016/j.socscimed.2006.04.024; Stratton K, 2008, AUST NZ J OBSTET GYN, V48, P5, DOI 10.1111/j.1479-828X.2007.00806.x; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Toedter LJ, 2001, DEATH STUD, V25, P205, DOI 10.1080/074811801750073251; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; WELLS RG, 1991, POSTGRAD MED, V89, P207; Wong MKY, 2003, BRIT J GEN PRACT, V53, P697; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	33	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217395	10.1371/journal.pone.0217395	http://dx.doi.org/10.1371/journal.pone.0217395			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA0CM	31136597	Green Submitted, Green Published, gold			2022-12-26	WOS:000469224300035
J	Grauman, A; Hansson, MG; Puranen, A; James, S; Veldwijk, J				Grauman, Asa; Hansson, Mats G.; Puranen, Arvid; James, Stefan; Veldwijk, Jorien			Short-term mental distress in research participants after receiving cardiovascular risk information	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; HEART-DISEASE	Background Understanding of how cardiovascular risk information influence individuals is critical for the practice of risk assessment and the management of patients with cardiovascular disease. Objectives The objective of this study was to investigate change in mental distress among research participants after undergoing a cardiovascular risk assessment and receiving individual test results. Methods In 2017, a questionnaire measuring mental distress after taking part in a risk assessment was distributed among 615 participants in the Swedish Cardiopulmonary Bio Image Study in Uppsala, Sweden, aged 50-64 years. Outcome measures were re-assessed after three months (30% were lost to follow-up). Results There were no differences in outcomes after three months for participants with normal test results or for participants who were referred to primary health care. Mental distress increased in participants who were referred to the hospital, and were further explained by the fact that these participants were diagnosed with coronary artery stenosis. Conclusions CV risk information can be provided to individuals with lower levels of risk without concerns of inducing mental distress. However, in order to prevent unnecessary worry in contexts similar to this study, one should be prepared for different risk outcomes and plan for support for individuals with higher risk. The increased utility of powerful, yet not fully mature, imaging techniques requires careful considerations extending beyond medical risks and benefits; the clinician must also take into account the risk of mental distress and secure support when necessary.	[Grauman, Asa; Hansson, Mats G.] Uppsala Univ, Ctr Res Eth & Bioeth, Uppsala, Sweden; [Puranen, Arvid] Sunderby Hosp, Lulea, Region Norrbott, Sweden; [James, Stefan] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Veldwijk, Jorien] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Veldwijk, Jorien] Erasmus Univ, Erasmus Choice Modelling Ctr, Rotterdam, Netherlands	Uppsala University; Sunderby Hospital; Uppsala University; Erasmus University Rotterdam; Erasmus University Rotterdam	Grauman, A (corresponding author), Uppsala Univ, Ctr Res Eth & Bioeth, Uppsala, Sweden.	asa.grauman@crb.uu.se	James, Stefan K/J-4554-2014	Veldwijk, Jorien/0000-0003-4822-5068; Grauman, Asa/0000-0002-7293-3411	Swedish Heart and Lung Association [20150049]	Swedish Heart and Lung Association(Swedish Heart-Lung Foundation)	Financially support for this study was provided entirely by a grant from The Swedish Heart and Lung Association grant number: 20150049 (https://www.hjart-lungfonden.se/HLF/Om-Hjart-lungfonden/About-HLF/) to MH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron J, 2000, RISK ANAL, V20, P413, DOI 10.1111/0272-4332.204041; Bergstrom G, 2015, J INTERN MED, V278, P645, DOI 10.1111/joim.12384; CHRISTENSEN B, 1995, SCAND J PRIM HEALTH, V13, P164, DOI 10.3109/02813439508996756; Collins RE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-603; Das Sajal, 2006, Curr Atheroscler Rep, V8, P111, DOI 10.1007/s11883-006-0048-2; Eich E., 2000, COGNITION EMOTION, DOI [10.1080/026999300378996, DOI 10.1080/026999300378996]; Grauman A, 2019, PATIENT EDUC COUNS, V102, P1528, DOI 10.1016/j.pec.2019.03.010; Hagglund M, 2017, STUD HEALTH TECHNOL, V245, P723, DOI 10.3233/978-1-61499-830-3-723; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Jorgensen T, 2009, PREV MED, V48, P242, DOI 10.1016/j.ypmed.2008.12.010; KASH KM, 1992, J NATL CANCER I, V84, P24, DOI 10.1093/jnci/84.1.24; Lokkegaard T, 2015, SCAND J PUBLIC HEALT, V43, P102, DOI 10.1177/1403494814557886; Martensson L, 2017, SKKHL SKALA KOMMUNIK; McNaughton CD, 2015, MED DECIS MAKING, V35, P932, DOI 10.1177/0272989X15581800; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Nielsen AD, 2012, J THORAC IMAG, V27, P202, DOI 10.1097/RTI.0b013e31824752bd; Nielsen KDB, 2005, SCAND J PRIM HEALTH, V23, P233, DOI 10.1080/02813430500336245; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Peters E, 2006, HEALTH PSYCHOL, V25, P144, DOI 10.1037/0278-6133.25.2.144; Piepoli MF, 2016, EUR J PREV CARDIOL, V23, pNP1, DOI 10.1177/2047487316653709; Powers BJ, 2011, AM HEART J, V161, P673, DOI 10.1016/j.ahj.2010.12.021; Sheridan SL, 2010, ARCH INTERN MED, V170, P230, DOI 10.1001/archinternmed.2009.516; Smith AW, 2008, PSYCHO-ONCOL, V17, P767, DOI 10.1002/pon.1291; Tominaga T, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0272-3; Wangdahl JM, 2014, SCAND J PUBLIC HEALT, V42, P25, DOI 10.1177/1403494813500592; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2019	14	5							e0217247	10.1371/journal.pone.0217247	http://dx.doi.org/10.1371/journal.pone.0217247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HZ5BN	31125371	gold, Green Published, Green Submitted			2022-12-26	WOS:000468865700025
J	Convery, O; Gargan, S; Kickham, M; Schroder, M; O'Farrelly, C; Stevenson, NJ				Convery, Orla; Gargan, Siobhan; Kickham, Michelle; Schroder, Martina; O'Farrelly, Cliona; Stevenson, Nigel J.			The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-alpha via signal transducer and activator of transcription (STAT)3 and extracellular signal-regulated kinase (ERK)-mediated induction of suppressor of cytokine signaling (SOCS)3	FASEB JOURNAL			English	Article						inflammation; viral immune evasion; intracellular signaling pathways; immune regulation; JAK-STAT signalling pathway	MESSENGER-RNA STABILITY; KAPPA-B ACTIVATION; CORE PROTEIN; SOCS PROTEINS; UP-REGULATION; PROTEASOMAL DEGRADATION; RAF/MEK/ERK PATHWAY; STAT3 ACTIVATION; ENVELOPE PROTEIN; GENE-EXPRESSION	Viruses use a spectrum of immune evasion strategies that enable infection and replication. The acute phase of hepatitis C virus (HCV) infection is characterized by nonspecific and often mild clinical symptoms, suggesting an immunosuppressive mechanism that, unless symptomatic liver disease presents, allows the virus to remain largely undetected. We previously reported that HCV induced the regulatory protein suppressor of cytokine signaling (SOCS)3, which inhibited TNF-alpha-mediated inflammatory responses. However, the mechanism by which HCV up-regulates SOCS3 remains unknown. Here we show that the HCV protein, p7, enhances both SOCS3 mRNA and protein expression. A p7 inhibitor reduced SOCS3 induction, indicating that p7's ion channel activity was required for optimal up-regulation of SOCS3. Short hairpin RNA and chemical inhibition revealed that both the Janus kinase-signal transducer and activator of transcription (JAK-STAT) and MAPK pathways were required for p7-mediated induction of SOCS3. HCV-p7 expression suppressed TNF-alpha-mediated I kappa B-alpha degradation and subsequent NF-kappa B promoter activity, revealing a new and functional, anti-inflammatory effect of p7. Together, these findings identify a molecular mechanism by which HCV-p7 induces SOCS3 through STAT3 and ERK activation and demonstrate that p7 suppresses proinflammatory responses to TNF-alpha, possibly explaining the lack of inflammatory symptoms observed during early HCV infection.-Convery, O., Gargan, S., Kickham, M., Schroder, M., O'Farrelly, C., Stevenson, N. J. The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-alpha via signal transducer and activator of transcription (STAT)3 and extracellular signal-regulated kinase (ERK)-mediated induction of suppressor of cytokine signaling (SOCS)3.	[Convery, Orla; Gargan, Siobhan; O'Farrelly, Cliona; Stevenson, Nigel J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Med, Dublin, Ireland; [Kickham, Michelle; Schroder, Martina] Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland	Trinity College Dublin; Trinity College Dublin; Maynooth University	Stevenson, NJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Intracellular Immunol Grp, 152-160 Pearse St, Dublin 2, Ireland.	n.stevenson@tcd.ie		Schroeder, Martina/0000-0003-1899-6048; O'Farrelly, Cliona/0000-0002-0616-2874	Trinity College Dublin College Award; Health Research Board [POR-20120-57]; Science Foundation Ireland [12/IA/1667]	Trinity College Dublin College Award; Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors thank Prof. Ralf Bartenschlager (University of Heidelberg, Heidelberg, Germany) for the Jc1 and p7 constructs, Prof. Ron Hay (University of Dundee, Dundee, United Kingdom) for the I kappa B-alpha antibody, and Dr. Andrew MacDonald (Leeds University, Leeds, United Kingdom) for the PRDIV6 (activating protein 1)-regulated firefly luciferase construct. This study was funded by the Trinity College Dublin College Award, Health Research Board (POR-20120-57), and Science Foundation Ireland (12/IA/1667). The authors declare no conflicts of interest.	Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Baker BJ, 2008, GLIA, V56, P1250, DOI 10.1002/glia.20694; Bentham MJ, 2013, J GEN VIROL, V94, P2236, DOI 10.1099/vir.0.054338-0; Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Canfield S, 2005, J IMMUNOL, V174, P2494, DOI 10.4049/jimmunol.174.5.2494; Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Chen YZ, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2159; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Collins AS, 2014, J LEUKOCYTE BIOL, V96, P255, DOI 10.1189/jlb.2A1211-608RRRR; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; Deutsch M, 2013, SAUDI J GASTROENTERO, V19, P81, DOI 10.4103/1319-3767.108479; Duncan SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02431; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Ehlting C, 2015, CELL SIGNAL, V27, P555, DOI 10.1016/j.cellsig.2014.12.016; Fink Karin, 2013, JAKSTAT, V2, pe27521, DOI 10.4161/jkst.27521; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Fried MW, 2008, CLIN GASTROENTEROL H, V6, P503, DOI 10.1016/j.cgh.2008.02.040; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Gatto L, 2004, J BIOL CHEM, V279, P13746, DOI 10.1074/jbc.M308999200; Giambartolomei S, 2001, ONCOGENE, V20, P2606, DOI 10.1038/sj.onc.1204372; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Goossens N, 2015, CLIN MOL HEPATOL, V21, P105, DOI 10.3350/cmh.2015.21.2.105; Hayashi J, 2000, HEPATOLOGY, V32, P958, DOI 10.1053/jhep.2000.19343; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Hsieh MJ, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-74; Huang Y, 2007, GASTROENTEROLOGY, V132, P733, DOI 10.1053/j.gastro.2006.11.045; Huang YL, 2013, MOLECULES, V18, P12987, DOI 10.3390/molecules181012987; Isobe A, 2006, PLACENTA, V27, P912, DOI 10.1016/j.placenta.2005.10.003; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Joo MS, 2005, J VIROL, V79, P7648, DOI 10.1128/JVI.79.12.7648-7657.2005; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kogut MH, 2008, INNATE IMMUN-LONDON, V14, P213, DOI 10.1177/1753425908094416; Kong LB, 2016, ARCH VIROL, V161, P2149, DOI 10.1007/s00705-016-2892-x; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liu D, 2015, MOL CELL BIOL, V35, P2400, DOI 10.1128/MCB.00090-15; Mahony R, 2016, CELL MOL LIFE SCI, V73, P3323, DOI 10.1007/s00018-016-2234-x; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Marusawa H, 1999, J VIROL, V73, P4713, DOI 10.1128/JVI.73.6.4713-4720.1999; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; McCartney EM, 2013, HEPATOLOGY, V58, P1558, DOI 10.1002/hep.26496; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mitchell TJ, 2005, IMMUNOLOGY, V114, P301, DOI 10.1111/j.1365-2567.2005.02091.x; Park KH, 2013, J IMMUNOL, V190, P6550, DOI 10.4049/jimmunol.1202284; Pei RJ, 2011, J GEN VIROL, V92, P2237, DOI 10.1099/vir.0.032581-0; Persico M, 2007, HEPATOLOGY, V46, P1009, DOI 10.1002/hep.21782; Pirvulescu M, 2012, BIOCHEM BIOPH RES CO, V422, P321, DOI 10.1016/j.bbrc.2012.04.159; Qi HF, 2017, P NATL ACAD SCI USA, V114, P2018, DOI 10.1073/pnas.1614623114; Qin H, 2007, J IMMUNOL, V179, P5966, DOI 10.4049/jimmunol.179.9.5966; Rebe Cedric, 2013, JAKSTAT, V2, pe23010, DOI 10.4161/jkst.23010; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sarcar B, 2004, VIROLOGY, V322, P51, DOI 10.1016/j.virol.2004.01.008; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Steen Hakan C, 2013, JAKSTAT, V2, pe25790, DOI 10.4161/jkst.25790; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Stevenson NJ, 2013, FEBS LETT, V587, P1571, DOI 10.1016/j.febslet.2013.03.041; Strebel K, 2014, BBA-BIOMEMBRANES, V1838, P1074, DOI 10.1016/j.bbamem.2013.06.029; Timofeeva OA, 2012, J BIOL CHEM, V287, P14192, DOI 10.1074/jbc.M111.323899; Toshikuni N, 2014, WORLD J GASTROENTERO, V20, P2876, DOI 10.3748/wjg.v20.i11.2876; Tran SC, 2016, J VIROL, V90, P7231, DOI 10.1128/JVI.00326-16; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wetherill LF, 2012, J VIROL, V86, P5341, DOI 10.1128/JVI.06243-11; Wiejak J, 2013, BIOCHEM J, V454, P283, DOI 10.1042/BJ20130481; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yoshida T, 2002, J EXP MED, V196, P641, DOI 10.1084/jem.20012127; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao LJ, 2013, CELL STRESS CHAPERON, V18, P495, DOI 10.1007/s12192-013-0405-3; Zhao LJ, 2006, J LEUKOCYTE BIOL, V80, P424, DOI 10.1189/jlb.0106014; Zhou X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.342; Zhu XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32538	93	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2019	33	8					8732	8744		10.1096/fj.201800629RR	http://dx.doi.org/10.1096/fj.201800629RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IN7AA	31163989	Green Accepted, Green Submitted			2022-12-26	WOS:000478832900004
J	McGuire, CM; Collins, MP; Sun-Wada, G; Wade, Y; Forgac, M				McGuire, Christina M.; Collins, Michael P.; Sun-Wada, GeHong; Wade, Yoh; Forgac, Michael			Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; breast cancer; cell invasion; cell migration; plasma membrane; proton pump; metastasis; a-subunit isoforms; protein trafficking	VACUOLAR H+-ATPASE; AMINO-TERMINAL DOMAIN; CATHEPSIN-B; PLASMA-MEMBRANE; A3 ISOFORM; PROTON TRANSPORT; TUMOR-METASTASIS; EXPRESSION; PH; INVASION	The vacuolar H+-ATPase (V-ATPase) is an ATP-driven proton pump present in various intracellular membranes and at the plasma membrane of specialized cell types. Previous work has reported that plasma membrane V-ATPases are key players in breast cancer cell invasiveness. The two subunit a-isoforms known to target the V-ATPase to the plasma membrane are a3 and a4, and expression of a3 has been shown to correlate with plasma membrane localization of the V-ATPase in various invasive human breast cancer cell lines. Here we analyzed the role of subunit a-isoforms in the invasive mouse breast cancer cell line, 4T1-12B. Quantitation of mRNA levels for each isoform by quantitative RT-PCR revealed that a4 is the dominant isoform expressed in these cells. Using a CRISPR/Cas9-based approach to disrupt the genes encoding each of the four V-ATPase subunit a-isoforms, we found that ablation of only the a4-encoding gene significantly inhibits invasion and migration of 4T1-12B cells. Additionally, cells with disrupted a4 exhibited reduced V-ATPase expression at the leading edge, suggesting that the a4 isoform is primarily responsible for targeting the V-ATPase to the plasma membrane in 4T1-12B cells. These findings suggest that different subunit a-isoforms may direct V-ATPases to the plasma membrane of different invasive breast cancer cell lines. They further suggest that expression of V-ATPases at the cell surface is the primary factor that promotes an invasive cancer cell phenotype.	[McGuire, Christina M.; Collins, Michael P.; Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [McGuire, Christina M.; Forgac, Michael] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Biochem, Boston, MA 02111 USA; [Collins, Michael P.; Forgac, Michael] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Sun-Wada, GeHong] Doshisha Womens Coll, Fac Pharmaceut Sci, Dept Biochem, Kyotanabe, Kyoto 6100395, Japan; [Wade, Yoh] Osaka Univ, Inst Sci & Ind Res, Div Biol Sci, Ibaraki, Osaka 5670047, Japan	Tufts University; Tufts University; Tufts University; Osaka University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	michael.forgac@tufts.edu		Collins, Michael/0000-0002-1806-6775	National Institutes of Health [R01 GM34478]; Breast Cancer Alliance; Tufts University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Alliance; Tufts University	This work was supported by National Institutes of Health Grant R01 GM34478 (to M. F.) and an Exceptional Project Award from the Breast Cancer Alliance (to M. F.) as well as the Sackler Families Collaborative Cancer Biology Award from Tufts University (to M. P. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Avnet S, 2013, BBA-MOL BASIS DIS, V1832, P1105, DOI 10.1016/j.bbadis.2013.04.003; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Capecci J, 2013, J BIOL CHEM, V288, P32731, DOI 10.1074/jbc.M113.503771; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; Cotter K, 2016, ONCOTARGET, V7, P46142, DOI 10.18632/oncotarget.10063; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; Day CP, 2015, CELL, V163, P39, DOI 10.1016/j.cell.2015.08.068; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Feng SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084833; Feng SM, 2013, INT J BIOL SCI, V9, P853, DOI 10.7150/ijbs.6030; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garcia-Garcia A, 2012, BIOTECH HISTOCHEM, V87, P133, DOI 10.3109/10520295.2011.574647; Gleize V, 2012, GLIA, V60, P1004, DOI 10.1002/glia.22332; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gondi CS, 2013, EXPERT OPIN THER TAR, V17, P281, DOI 10.1517/14728222.2013.740461; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hendrix A, 2013, INT J CANCER, V133, P843, DOI 10.1002/ijc.28079; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Kane PM, 2016, ADV EXP MED BIOL, V892, P33, DOI 10.1007/978-3-319-25304-6_3; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kulshrestha A, 2015, ONCOTARGET, V6, P3797, DOI 10.18632/oncotarget.2902; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu PF, 2015, INT J CLIN ONCOL, V20, P725, DOI 10.1007/s10147-015-0782-y; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu XD, 2015, EXP THER MED, V10, P1829, DOI 10.3892/etm.2015.2758; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Marjuki H, 2011, CELL MICROBIOL, V13, P587, DOI 10.1111/j.1462-5822.2010.01556.x; Matsumoto N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24918-7; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; MILLER FR, 1983, INVAS METAST, V3, P22; MILLER FR, 1983, INVAS METAST, V3, P234; Nalla AK, 2010, CANCER GENE THER, V17, P599, DOI 10.1038/cgt.2010.16; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Ohta T, 1996, BRIT J CANCER, V73, P1511, DOI 10.1038/bjc.1996.285; Otero-Rey EM, 2008, ORAL ONCOL, V44, P193, DOI 10.1016/j.oraloncology.2007.02.011; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Perez-Sayans M, 2010, CANCER BIOL THER, V9, P1057, DOI 10.4161/cbt.9.12.11880; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Pulaski BA, 1998, CANCER RES, V58, P1486; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Schempp CM, 2014, MOL CANCER THER, V13, P926, DOI 10.1158/1535-7163.MCT-13-0484; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Soliman M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006820; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Sun-Wada GH, 2013, HISTOL HISTOPATHOL, V28, P805, DOI 10.14670/HH-28.805; Sun-Wada GH, 2011, HYBRIDOMA, V30, P199, DOI 10.1089/hyb.2010.0087; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Xu JY, 2012, CARCINOGENESIS, V33, P2432, DOI 10.1093/carcin/bgs277; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoneda Toshiyuki, 2000, Cancer, V88, P2979, DOI 10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhang SW, 2015, ONCOTARGET, V6, P43508, DOI 10.18632/oncotarget.6180; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	76	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2019	294	29					11248	11258		10.1074/jbc.RA119.007713	http://dx.doi.org/10.1074/jbc.RA119.007713			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5LO	31167791	Green Published, hybrid			2022-12-26	WOS:000478717400016
J	Baker, S; Kessler, E; Darville-Bowleg, L; Merchant, M				Baker, Sarah; Kessler, Ethan; Darville-Bowleg, Lancia; Merchant, Mark			Different mechanisms of serum complement activation in the plasma of common (Chelydra serpentina) and alligator (Macrochelys temminckii) snapping turtles	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; PATHWAY; SYSTEM; TEMPERATURE; THIOESTER; PROTEINS	Reptiles are declining worldwide yet our understanding of their immune function lags far behind other taxa. The innate immune system is the primary mode of defense in reptiles, and the serum complement cascade is its major component. We assessed serum complement activity of plasma in two closely related aquatic turtle species, the common snapping turtle (CST; Chelydra serpentina) and alligator snapping turtle (AST; Macrochelys temminckii). We used a sheep red blood cell (SRBC) hemolysis assay to assess serum complement activity. Although the antibacterial activities of the plasma of these turtle species are similar, the hemolytic activity was much stronger in CST than AST. Treatment with inhibitors of the serum complement cascade indicated differences in the mechanisms of complement activation between the turtle species. We subjected plasma from both turtle species to mannan affinity chromatography and analyzed the eluate with SDS-PAGE, which revealed that plasma from the CSTs contained only small amounts of one C-type lectin protein while the AST plasma contained high concentrations of two C-type lectins (31.0 and 35.9 kDa). Edman degradation analyses confirmed that the two AST proteins contained identical N-terminal sequences. Thus, the CST appears to rely more heavily on the alternative mechanism of serum complement activation, while the AST appears to rely more on the lectin-mediated pathway, which is a pattern recognition response to prokaryotes not activated by the SRBCs. These results are unique in that the use of serum complement pathways are generally assumed to be conserved within clades.	[Baker, Sarah; Kessler, Ethan] Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Darville-Bowleg, Lancia] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Merchant, Mark] McNeese State Univ, Dept Chem, Lake Charles, LA 70605 USA; [Baker, Sarah] Arizona Game & Fish Dept, Phoenix, AZ 85086 USA	Illinois Natural History Survey; H Lee Moffitt Cancer Center & Research Institute; University of Louisiana System; McNeese State University	Baker, S (corresponding author), Illinois Nat Hist Survey, Champaign, IL 61820 USA.; Baker, S (corresponding author), Arizona Game & Fish Dept, Phoenix, AZ 85086 USA.	sbaker@azgfd.gov		Kessler, Ethan/0000-0001-8916-2070	McNeese State University College of Science Endowed Professorship [072]	McNeese State University College of Science Endowed Professorship	Funding for this work was provided by McNeese State University College of Science Endowed Professorship 072 awarded to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTEN KF, 1961, J EXP MED, V114, P29, DOI 10.1084/jem.114.1.29; Baker SJ, 2018, J EXP ZOOL PART A, P1; Beck ML, 2017, J EXP ZOOL PART A, V327, P293, DOI 10.1002/jez.2089; Blom AM, 2003, J BIOL CHEM, V278, P43437, DOI 10.1074/jbc.M306620200; BROWN GP, 1990, CAN J ZOOL, V68, P1659, DOI 10.1139/z90-246; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; DALMASSO AP, 1989, COMPLEMENT INFLAMMAT, V6, P36, DOI 10.1159/000463070; Darville LNF, 2012, COMP BIOCHEM PHYS B, V161, P161, DOI 10.1016/j.cbpb.2011.11.001; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Ernst CH, 2009, TURTLES US CANADA; Ferronato BO, 2009, ZOOLOGIA-CURITIBA, V26, P747, DOI 10.1590/S1984-46702009000400020; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; GORSKI JP, 1980, J BIOL CHEM, V255, P25; Gotze O, 1977, Monogr Allergy, V12, P66; Kilpatrick DC, 2002, TRANSFUSION MED, V12, P335, DOI 10.1046/j.1365-3148.2002.00408.x; KNIGHT TW, 1990, COPEIA, P1067, DOI 10.2307/1446490; Law SKA, 1997, PROTEIN SCI, V6, P263; Li YM, 2012, PEPTIDES, V37, P207, DOI 10.1016/j.peptides.2012.07.001; Lovich JE, 2018, BIOSCIENCE, V68, P771, DOI 10.1093/biosci/biy095; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Merchant M, 2006, COMP BIOCHEM PHYS A, V143, P488, DOI 10.1016/j.cbpa.2006.01.009; Merchant M, 2012, ADV BIOL CHEM, V2, P353, DOI DOI 10.4236/ABC.2012.24043; Merchant M., 2014, INT J BIOCH RES REV, V4, P295, DOI DOI 10.9734/IJBCRI1/2014/7825; Merchant M., 2013, ENTOMOLOGY ORNITHOLO, V2, P110; Merchant M, 2010, VET IMMUNOL IMMUNOP, V133, P165, DOI 10.1016/j.vetimm.2009.07.016; Merchant ME, 2005, COMP BIOCHEM PHYS B, V141, P281, DOI 10.1016/j.cbpc.2005.03.009; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; PANGBURN MK, 1983, ANN NY ACAD SCI, V421, P291, DOI 10.1111/j.1749-6632.1983.tb18116.x; Petersen SV, 2001, MOL IMMUNOL, V38, P133; Porter R R, 1979, Adv Protein Chem, V33, P1, DOI 10.1016/S0065-3233(08)60458-1; PRITCHARD P. C. H., 2006, ALLIGATOR SNAPPING T; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Shaffer HB, 2017, MOL PHYLOGENET EVOL, V115, P7, DOI 10.1016/j.ympev.2017.07.006; Shipman PA, 2008, SOUTHEAST NAT, V7, P331, DOI 10.1656/1528-7092(2008)7[331:SADOTA]2.0.CO;2; Siroski PA, 2010, ZOOL STUD, V49, P64; Turtle Taxonomy Working Group, 2017, Chelonian Research Monographs, V7, P1; WARDLAW ALASTAIR C., 1962, JOUR EXPTL MED, V115, P1231, DOI 10.1084/jem.115.6.1231; Warr GW, 2003, DEV COMP IMMUNOL, V27, P257, DOI 10.1016/S0145-305X(02)00070-8; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; West JM, 2018, GEN COMP ENDOCR, V262, P71, DOI 10.1016/j.ygcen.2018.03.016; WILLIAMSON LU, 1989, J THERM BIOL, V14, P33, DOI 10.1016/0306-4565(89)90027-2; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315	43	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217626	10.1371/journal.pone.0217626	http://dx.doi.org/10.1371/journal.pone.0217626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170203	Green Submitted, gold, Green Published			2022-12-26	WOS:000470263700044
J	Cussell, PJG; Howe, MS; Illingworth, TA; Escalada, MG; Milton, NGN; Paterson, AWJ				Cussell, Peter J. G.; Howe, Michael S.; Illingworth, Thomas A.; Escalada, Margarita Gomez; Milton, Nathaniel G. N.; Paterson, Andrew W. J.			The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA	PLOS ONE			English	Article							FORMYLPEPTIDE RECEPTOR; GROWTH; PROTEINS; INTERNALIZATION; NEUTROPHILS; ROLES	The N-formyl peptide receptors (FPRs) have been identified within neuronal tissues and may serve as yet undetermined functions within the nervous system. The FPRs have been implicated in the progression and invasiveness of neuroblastoma and other cancers. In this study the effects of the synthetic FPR agonist FPRa14, FPR antagonists and FPR knockdown using siRNA on mouse neuroblastoma neuro2a (N2a) cell differentiation plus toxicity were examined. The FPRa14 (1-10 mu M) was found to induce a significant dose-dependent differentiation response in mouse neuroblastoma N2a cells. Interestingly, three distinct differentiated morphologies were observed, with two non-archetypal forms observed at the higher FPRa14 concentrations. These three forms were also observed in the human neuroblastoma cell-lines IMR-32 and SH-SY5Y when exposed to 100 mu M FPRa14. In N2a cells combined knockdown of FPR1 and FPR2 using siRNA inhibited the differentiation response to FPRa14, suggesting involvement of both receptor subtypes. Pre-incubating N2a cultures with the FPR1 antagonists Boc-MLF and cyclosporin H significantly reduced FPRa14-induced differentiation to near baseline levels. Meanwhile, the FPR2 antagonist WRW4 had no significant effect on FPRa14-induced N2a differentiation. These results suggest that the N2a differentiation response observed has an FPR1-dependent component. Toxicity of FPRa14 was only observed at higher concentrations. All three antagonists used blocked FPRa14-induced toxicity, whilst only siRNA knockdown of FPR2 reduced toxicity. This suggests that the toxicity and differentiation involve different mechanisms. The demonstration of neuronal differentiation mediated via FPRs in this study represents a significant finding and suggests a role for FPRs in the CNS. This finding could potentially lead to novel therapies for a range of neurological conditions including neuroblastoma, Alzheimer's disease, Parkinson's disease and neuropathic pain. Furthermore, this could represent a potential avenue for neuronal regeneration therapies.	[Cussell, Peter J. G.; Howe, Michael S.; Illingworth, Thomas A.; Escalada, Margarita Gomez; Milton, Nathaniel G. N.; Paterson, Andrew W. J.] Leeds Beckett Univ, Sch Clin & Appl Sci, Leeds, W Yorkshire, England	Leeds Beckett University	Paterson, AWJ (corresponding author), Leeds Beckett Univ, Sch Clin & Appl Sci, Leeds, W Yorkshire, England.	a.paterson@leedsbeckett.ac.uk	Milton, Nathaniel G N/E-8522-2012; Milton, Nathaniel Gavin Nicolas/GON-7735-2022	Milton, Nathaniel G N/0000-0002-7431-9060; Milton, Nathaniel Gavin Nicolas/0000-0002-7431-9060; Gomez Escalada, Margarita/0000-0002-7374-0048; Paterson, Andrew/0000-0002-3289-8738; Howe, Michael/0000-0002-4905-1920; Cussell, Peter/0000-0001-9494-7921; Illingworth, Thomas/0000-0001-9762-5071	Leeds Beckett University PhD studentship	Leeds Beckett University PhD studentship	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. P.J.G.C. is supported by a Leeds Beckett University PhD studentship.	Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Baracco EE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1139275; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; Boer JC, 2013, BRIT J CANCER, V108, P587, DOI 10.1038/bjc.2012.603; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Cattaneo F, 2010, NEUROCHEM RES, V35, P2018, DOI 10.1007/s11064-010-0301-5; Chang YT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/182303; FINNEY DA, 1983, CYTOMETRY, V4, P54, DOI 10.1002/cyto.990040108; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Haigh CL, 2011, FREE RADICAL BIO MED, V51, P594, DOI 10.1016/j.freeradbiomed.2011.03.035; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; Huang J, 2008, CANCER LETT, V267, P254, DOI 10.1016/j.canlet.2008.03.014; JESAITIS AJ, 1993, EUR J HAEMATOL, V51, P288; JESAITIS AJ, 1984, J CELL BIOL, V98, P1378, DOI 10.1083/jcb.98.4.1378; JESAITIS AJ, 1989, J CELL BIOL, V109, P2783, DOI 10.1083/jcb.109.6.2783; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Li LZ, 2016, J LEUKOCYTE BIOL, V99, P425, DOI 10.1189/jlb.2RI0815-354RR; Li YS, 2013, J MOL MED, V91, P781, DOI 10.1007/s00109-013-1005-5; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Prevete N, 2015, PHARMACOL RES, V102, P184, DOI 10.1016/j.phrs.2015.09.017; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Ries M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0692-6; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Roberts HL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171925; Schepetkin IA, 2007, MOL PHARMACOL, V71, P1061, DOI 10.1124/mol.106.033100; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Snapkov I, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2545-1; Soltys Z, 2005, J NEUROSCI METH, V146, P50, DOI 10.1016/j.jneumeth.2005.01.009; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; Tokay T, 2008, GLIA, V56, P1380, DOI 10.1002/glia.20705; VALE RD, 1982, J CELL BIOL, V94, P710, DOI 10.1083/jcb.94.3.710; Wagener BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147442; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25946; Yan C, 2015, J HEPATOL, V63, P420, DOI 10.1016/j.jhep.2015.03.024; Yang Y, 2011, AM J PATHOL, V179, P1504, DOI 10.1016/j.ajpath.2011.05.059; Yazawa H, 2001, FASEB J, V15, P2454, DOI 10.1096/fj.01-0251com; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00314-5; Zhang L, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078055; Zhou Y, 2005, JNCI-J NATL CANCER I, V97, P823, DOI 10.1093/jnci/dji142; Zou YM, 2016, NEUROPSYCH DIS TREAT, V12, P869, DOI 10.2147/NDT.S104886	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2019	14	6							e0217815	10.1371/journal.pone.0217815	http://dx.doi.org/10.1371/journal.pone.0217815			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB4TA	31170199	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000470263700060
J	Herman, PM; Yuan, AH; Cefalu, MS; Chu, K; Zeng, Q; Marshall, N; Lorenz, KA; Taylor, SL				Herman, Patricia M.; Yuan, Anita H.; Cefalu, Matthew S.; Chu, Karen; Zeng, Qing; Marshall, Nell; Lorenz, Karl A.; Taylor, Stephanie L.			The use of complementary and integrative health approaches for chronic musculoskeletal pain in younger US Veterans: An economic evaluation	PLOS ONE			English	Article							LOW-BACK-PAIN; ALTERNATIVE MEDICINE USE; HIERARCHICAL LINEAR-MODELS; CARE EXPENDITURES; PROPENSITY SCORE; MASSAGE THERAPY; METAANALYSIS; COSTS; MANIPULATION; ACUPUNCTURE	Objectives To estimate the cost-effectiveness to the US Veterans Health Administration (VA) of the use of complementary and integrative health (CIH) approaches by younger Veterans with chronic musculoskeletal disorder (MSD) pain. Perspective VA healthcare system. Methods We used a propensity score-adjusted hierarchical linear modeling (HLM), and 2010-2013 VA administrative data to estimate differences in VA healthcare costs, pain intensity (0-10 numerical rating scale), and opioid use between CIH users and nonusers. We identified CIH use in Veterans' medical records through Current Procedural Terminology, VA workload tracking, and provider-type codes. Results We identified 30,634 younger Veterans with chronic MSD pain as using CIH and 195,424 with no CIH use. CIH users differed from nonusers across all baseline covariates except the Charlson comorbidity index. They also differed on annual pre-CIH-start healthcare costs ($10,729 versus $5,818), pain (4.33 versus 3.76), and opioid use (66.6% versus 54.0%). The HLM results indicated lower annual healthcare costs (-$637; 95% CI: -$1,023, -$247), lower pain (-0.34; -0.40, -0.27), and slightly higher (less than a percentage point) opioid use (0.8; 0.6, 0.9) for CIH users in the year after CIH start. Sensitivity analyses indicated similar results for three most-used CIH approaches (acupuncture, chiropractic care, and massage), but higher costs for those with eight or more CIH visits. Conclusions On average CIH use appears associated with lower healthcare costs and pain and slightly higher opioid use in this population of younger Veterans with chronic musculoskeletal pain. Given the VA's growing interest in the use of CIH, further, more detailed analyses of its impacts are warranted.	[Herman, Patricia M.; Cefalu, Matthew S.] RAND Corp, Santa Monica, CA 90401 USA; [Yuan, Anita H.; Chu, Karen; Taylor, Stephanie L.] VA Greater Los Angeles Healthcare Syst, Ctr Study Healthcare Innovat Implementat & Policy, Los Angeles, CA USA; [Zeng, Qing] VA Washington DC Healthcare Syst, Ctr Hlth & Aging, Washington, DC USA; [Zeng, Qing] George Washington Univ, Biomed Informat Ctr, Washington, DC USA; [Marshall, Nell; Lorenz, Karl A.] VA Palo Alto Healthcare Syst, Ctr Study Innovat Implementat, Menlo Pk, CA USA; [Lorenz, Karl A.] Stanford Sch Med, Palo Alto, CA USA; [Taylor, Stephanie L.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90024 USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of California System; University of California Los Angeles	Herman, PM (corresponding author), RAND Corp, Santa Monica, CA 90401 USA.	pherman@rand.org	TAYLOR, STEPHANIE/GYV-4768-2022	Taylor, Stephanie/0000-0002-3266-1132; Herman, Patricia/0000-0001-5579-5654	Department of Veterans Affairs, Health Services Research and Development Service [1 R01 HX001704-1]	Department of Veterans Affairs, Health Services Research and Development Service(US Department of Veterans Affairs)	All authors were funded under a grant provided by the Department of Veterans Affairs, Health Services Research and Development Service, 1 R01 HX001704-1, Principal Investigator: Dr. Stephanie L Taylor. https://www.research.va.gov/services/hsrd.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2016, APP C CLIN CLASS SOF; [Anonymous], 2018, AHRQ PUB, V18-0033-EF; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Avogo W, 2008, HEALTH EDUC J, V67, P258, DOI 10.1177/0017896908097069; Bolton JE, 1998, J MANIP PHYSIOL THER, V21, P1; Boyd C, 2016, PAIN MED, V17, P1553, DOI 10.1093/pm/pnw100; Bureau of Labor Statistics, 2013, CONS PRIC IND; Caspi O, 2004, MED DECIS MAKING, V24, P64, DOI 10.1177/0272989X03261567; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Clare HA, 2004, AUST J PHYSIOTHER, V50, P209, DOI 10.1016/S0004-9514(14)60110-0; Coulter ID, 2018, SPINE J, V18, P866, DOI 10.1016/j.spinee.2018.01.013; Coulter ID, 2018, PAIN PHYS; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Crawford C, 2016, PAIN MED, V17, P1353, DOI 10.1093/pm/pnw099; Cui DW, 2014, PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON NUCLEAR ENGINEERING - 2013, VOL 3; Denneson LM, 2011, J REHABIL RES DEV, V48, P1119, DOI 10.1682/JRRD.2010.12.0243; Diagnosis and Treatment of Low Back Pain Work Group, 2017, VA DOD CLIN PRACT GU; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; FELDMAN HA, 1988, J APPL PHYSIOL, V64, P1721, DOI 10.1152/jappl.1988.64.4.1721; Furlan AD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/953139; Furlan AD, 2009, SPINE, V34, P1669, DOI 10.1097/BRS.0b013e3181ad7bd6; Gironda RJ, 2007, J REHABIL RES DEV, V44, P223, DOI 10.1682/JRRD.2006.06.0058; Goulet JL, 2016, PAIN, V157, P1696, DOI 10.1097/j.pain.0000000000000567; Grieves B, 2009, J MANIP PHYSIOL THER, V32, P734, DOI 10.1016/j.jmpt.2009.10.001; Haas M, 2014, SPINE J, V14, P1106, DOI 10.1016/j.spinee.2013.07.468; Hadlandsmyth K, 2018, J GEN INTERN MED, V33, P818, DOI 10.1007/s11606-017-4283-8; Haskell SG, 2006, J WOMENS HEALTH, V15, P862, DOI 10.1089/jwh.2006.15.862; Healthcare Analysis & Information Group, 2015, FY 2015 VHA COMPL IN; Healthcare Analysis & Information Group, 2011, 2011 COMPL ALT MED S; Healthcare Analysis & Information Group, 2002, SURV COMPL ALT MED; Heo M, 2003, STAT MED, V22, P1911, DOI 10.1002/sim.1218; Herman PM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001046; Hilton L, 2017, ANN BEHAV MED, V51, P199, DOI 10.1007/s12160-016-9844-2; Imai K, 2014, J R STAT SOC B, V76, P243, DOI 10.1111/rssb.12027; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Johnson ML, 2009, VALUE HEALTH, V12, P1062, DOI 10.1111/j.1524-4733.2009.00602.x; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Kerns RD, 2009, PAIN MED, V10, P1161, DOI 10.1111/j.1526-4637.2009.00722.x; Lam M, 2013, SPINE, V38, P2124, DOI 10.1097/01.brs.0000435025.65564.b7; Legorreta AP, 2004, ARCH INTERN MED, V164, P1985, DOI 10.1001/archinte.164.18.1985; Lind BK, 2010, J ALTERN COMPLEM MED, V16, P411, DOI 10.1089/acm.2009.0261; Lorenz KA, 2009, J AM BOARD FAM MED, V22, P291, DOI 10.3122/jabfm.2009.03.080162; Macey TA, 2011, PAIN MED, V12, P1502, DOI 10.1111/j.1526-4637.2011.01226.x; Machlin SR, 2018, CHARACTERISTICS HLTH; Martin BI, 2012, MED CARE, V50, P1029, DOI 10.1097/MLR.0b013e318269e0b2; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; McEachrane-Gross F Patricia, 2006, BMC Complement Altern Med, V6, P34, DOI 10.1186/1472-6882-6-34; Midboe AM, 2012, TRANSL BEHAV MED, V2, P57, DOI 10.1007/s13142-011-0104-5; Moritz S, 2011, J ALTERN COMPLEM MED, V17, P1015, DOI 10.1089/acm.2010.0619; National Pain Management Coordinating Committee, 2000, PAIN 5 VIT SIGN TOOL; O'Connell AA, 2004, EVAL HEALTH PROF, V27, P119, DOI 10.1177/0163278704264049; Owens JE, 1999, J ALTERN COMPLEM MED, V5, P529, DOI 10.1089/acm.1999.5.529; Perlman AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030248; Phibbs CS, 2003, MED CARE RES REV, V60, p54S, DOI 10.1177/1077558703256725; Posadzki P, 2011, CLIN RHEUMATOL, V30, P1257, DOI 10.1007/s10067-011-1764-8; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rickhi B, 2003, CAN J PSYCHIAT, V48, P475, DOI 10.1177/070674370304800708; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schwehr NA, 2018, ACUPUNCT MED; Sherman KJ, 2014, ANN FAM MED, V12, P112, DOI 10.1370/afm.1602; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Sirois FM, 2002, J ALTERN COMPLEM MED, V8, P127, DOI 10.1089/107555302317371415; Smith M.W., 2010, FEE BASIS DATA GUIDE; Sparber A, 2002, J ALTERN COMPLEM MED, V8, P93, DOI 10.1089/107555302753507230; Swartzman LC, 2002, MED DECIS MAKING, V22, P431, DOI 10.1177/027298902236943; Taylor SL, 2019, J ALTERN COMPLEM MED, V25, P32, DOI 10.1089/acm.2018.0276; Thorne S, 2002, INT J NURS STUD, V39, P671, DOI 10.1016/S0020-7489(02)00005-6; Tian TY, 2013, J AM MED INFORM ASSN, V20, pE275, DOI 10.1136/amiajnl-2013-001856; VA Health Care, 2017, WHOL HLTH LIF EXP VA; VA Health Care, 2018, ENR PRIOR GROUPS WHA; Veterans Health Administration (VHA), 2017, CORP DAT WAR CDW; VHA Office of Patient Centered Care and Cultural Transformation, 2017, WHOL HLTH ITS ALL YO; Wagner TH, 2003, MED CARE RES REV, V60, p15S, DOI 10.1177/1077558703256485; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; Wootton JC, 2001, J ALTERN COMPLEM MED, V7, P715, DOI 10.1089/10755530152755270; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000	79	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217831	10.1371/journal.pone.0217831	http://dx.doi.org/10.1371/journal.pone.0217831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31167005	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800042
J	Onyeaghala, G; Lane, J; Pankratz, N; Nelson, HH; Thyagarajan, B; Walcheck, B; Anderson, KE; Prizment, AE				Onyeaghala, Guillaume; Lane, John; Pankratz, Nathan; Nelson, Heather H.; Thyagarajan, Bharat; Walcheck, Bruce; Anderson, Kristin E.; Prizment, Anna E.			Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SOLUBLE NKG2D LIGANDS; CHAIN-RELATED GENE; HEPATOCELLULAR-CARCINOMA; EXPRESSION; ALLELE; TUMOR; SUSCEPTIBILITY; INCREASE	Background Pancreatic tumor cells may avoid immune surveillance by releasing the transmembrane major histocompatibility complex class I chain-related A (MICA) protein in soluble form (s-MICA). We hypothesized that the presence of the A5.1 polymorphism in the MICA gene, which encodes a truncated MICA protein, is associated with higher s-MICA levels and increased pancreatic cancer risk. Methods MICA alleles and s-MICA levels were measured in 121 pancreatic cancer cases and 419 controls. General linear regression with a log transformation assessed geometric means of s-MICA levels across MICA alleles. Unconditional logistic regression was used to calculate the odds ratio (OR) and 95% confidence intervals (CI) for pancreatic cancer associated with MICA alleles. Results After multivariate adjustment, participants with at least one copy of the A5.1 allele versus no A5.1 allele had 1.35 (95% CI: 1.05-1.74) times greater s-MICA levels (1.65 times higher for cases and 1.28, for controls) and increased risk of pancreatic cancer (OR = 1.91, 95% CI: 1.05-3.48). Conclusions Our study suggests higher risk of pancreatic cancer among those with the MICA A5.1 polymorphism, which may be explained by an increase in s-MICA secretion and impaired immune response. Impact These findings provide further evidence at the genetic and molecular level of the important role of MICA in pancreatic cancer development, and may have important implications with regards to pancreatic cancer screening.	[Onyeaghala, Guillaume; Nelson, Heather H.; Anderson, Kristin E.; Prizment, Anna E.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Lane, John; Pankratz, Nathan; Nelson, Heather H.; Thyagarajan, Bharat; Walcheck, Bruce; Anderson, Kristin E.; Prizment, Anna E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Lane, John; Pankratz, Nathan; Thyagarajan, Bharat] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Walcheck, Bruce] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Prizment, AE (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.; Prizment, AE (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	prizm001@umn.edu		Nelson, Heather/0000-0003-1901-9513; prizment, anna/0000-0001-5924-6871	American Cancer Society [124166-IRG-58-001-55-IRG21]; National Center for Advancing Translational Sciences of the NIH [UL1 TR000114]; National Institutes of Health [R01CA203348]; NATIONAL CANCER INSTITUTE [R01CA203348] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494, KL2TR002492] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research was supported by Institutional Research Grant #124166-IRG-58-001-55-IRG21 from the American Cancer Society (https://www.cancer.org). A.E.Prizment was supported by the National Center for Advancing Translational Sciences of the NIH Award Number UL1 TR000114 (https://www.nih.gov/). B.W. R01CA203348 from the National Institutes of Health (https://www.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2005, CANCER EPIDEM BIOMAR, V14, P2261, DOI 10.1158/1055-9965.EPI-04-0514; Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Chen D, 2014, CARCINOGENESIS, V35, P2633, DOI 10.1093/carcin/bgu215; Chen D, 2013, JNCI-J NATL CANCER I, V105, P624, DOI 10.1093/jnci/djt051; Chitadze G, 2013, SCAND J IMMUNOL, V78, P120, DOI 10.1111/sji.12072; Chitadze G, 2013, INT J CANC; Choy MK, 2003, J MOL EVOL, V57, P38, DOI 10.1007/s00239-002-2444-8; Chung HW, 2013, CANCER-AM CANCER SOC, V119, P233, DOI 10.1002/cncr.27669; Dambrauskas Z, 2014, INT J ONCOL, V44, P99, DOI 10.3892/ijo.2013.2156; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Duan XH, 2011, MED ONCOL, V28, P466, DOI 10.1007/s12032-010-9480-9; Field SF, 2008, DIABETES, V57, P1753, DOI 10.2337/db07-1402; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groth A, 2011, J INNATE IMMUN, V3, P344, DOI 10.1159/000327014; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Isernhagen A, 2016, IMMUNOGENETICS, V68, P109, DOI 10.1007/s00251-015-0884-8; Ji MY, 2015, INT J CLIN EXP MED, V8, P818; Jiang X, 2011, TISSUE ANTIGENS, V78, P143, DOI 10.1111/j.1399-0039.2011.01693.x; Jiang XX, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-62; Kennedy C, 2002, J INVEST DERMATOL, V118, P686, DOI 10.1046/j.1523-1747.2002.01712.x; Kopp R, 2009, J CLIN IMMUNOL, V29, P545, DOI 10.1007/s10875-009-9288-6; Kumar V, 2012, PLOS ONE; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu CJ, 2002, J ORAL PATHOL MED, V31, P323, DOI 10.1034/j.1600-0714.2002.310602.x; Lo PHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061279; Lo SS, 2004, BRIT J CANCER, V90, P1809, DOI 10.1038/sj.bjc.6601750; Marten A, 2006, INT J CANCER, V119, P2359, DOI 10.1002/ijc.22186; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Onyeaghala G, 2017, MOL CARCINOGEN, V56, P2158, DOI 10.1002/mc.22667; Prizment AE, 2011, PANCREAS; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tamaki S, 2008, HUM IMMUNOL, V69, P88, DOI 10.1016/j.humimm.2008.01.010; Tamaki S, 2007, J ORAL PATHOL MED, V36, P351, DOI 10.1111/j.1600-0714.2007.00539.x; Tong HV, 2013, J VIRAL HEPATITIS, V20, P687, DOI 10.1111/jvh.12089; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wu J, 2019, J LEUKOCYTE BIOL; Xu XL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-194; Yang X, 2018, BIOMEDICINE PHARMACO; Zhang JJ, 2014, PANCREAS, V43, P281, DOI 10.1097/MPA.0b013e3182a7c829; Zhang JJ, 2009, NUTR CANCER, V61, P457, DOI 10.1080/01635580902718941; Zhang JJ, 2005, ANN EPIDEMIOL, V15, P500, DOI 10.1016/j.annepidem.2004.11.005; Zhao J, 2011, J GASTROENTEROL HEPA	46	5	5	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217868	10.1371/journal.pone.0217868	http://dx.doi.org/10.1371/journal.pone.0217868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IB2GN	31166958	Green Published, gold, Green Submitted			2022-12-26	WOS:000470087800046
J	Pelaez, I; Ferrera, D; Barjola, P; Fernandes, R; Mercado, F				Pelaez, Irene; Ferrera, David; Barjola, Paloma; Fernandes, Roberto; Mercado, Francisco			Subliminal emotional pictures are capable of modulating early cerebral responses to pain in fibromyalgia	PLOS ONE			English	Article							LASER-EVOKED POTENTIALS; ANTERIOR CINGULATE CORTEX; EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; POSTERIOR CINGULATE; ATTENTIONAL BIAS; SPANISH VERSION; TIME-COURSE; STIMULI; MEMORY	Pain experience involves a complex relationship between sensory and both emotional and cognitive factors, which appear to be mediated by different neural pathways. Previous evidence has shown that whereas conscious processing of unpleasant stimuli enhances pain perception, the influence of emotions on pain under unaware conditions is much less known. The need to better characterise the relationship between pain processing and emotional factors is crucial for dealing with chronic pain conditions. Therefore, the present study aimed to explore the neural correlates relating to the influence of visual masking emotional stimulation on the processing of painful stimuli in chronic pain patients suffering from fibromyalgia (FM). Twenty FM and 22 healthy control (HC) women participated in the study. The experimental masking paradigm consisted of a rapid succession of two types of stimuli, where a masked picture (neutral, negative or pain-related) was followed by a laser stimulus (painful or not painful). LEP activity was recorded at sixty scalp electrodes. An LEP-amplitude approach was used to quantify the main cerebral waves linked to pain response. ANOVAs indicated that the posterior regions of the P1 component were sensitive to experimental manipulation (p<0.05). Specifically, FM patients showed higher amplitudes to painful stimuli preceded by pain-related pictures compared with painful trials preceded by other emotional pictures. The FM group also showed greater amplitudes than those in the HC group in P2a and P2b waves. In addition to the scalp data, at the neural level the posterior cingulate cortex, lingual gyrus and insular cortex showed higher activation in the FM group than in the HC group. Our findings show an early cerebral modulation of pain (as reflected by the P1) in FM patients, suggesting that only pain-related information, even when it is unconsciously perceived, is capable to enhance exogenous (automatic) attention, increasing the neural activity involved in processing painful stimulation. Further research is needed to fully understand unconscious emotional influences on pain in fibromyalgia.	[Pelaez, Irene; Ferrera, David; Barjola, Paloma; Fernandes, Roberto; Mercado, Francisco] Rey Juan Carlos Univ, Fac Hlth Sci, Unit Clin Psychol, Madrid, Spain	Universidad Rey Juan Carlos	Pelaez, I (corresponding author), Rey Juan Carlos Univ, Fac Hlth Sci, Unit Clin Psychol, Madrid, Spain.	irene.pelaez@urjc.es	Pelaéz, Irene/AAT-1399-2020; Ferrera, David/GXZ-8861-2022	Ferrera, David/0000-0002-2367-3051; Fernandes Magalhaes, Roberto/0000-0002-4541-7016; Pelaez, Irene/0000-0001-7635-5068	Ministerior de Economia y Competitividad de Espana [PSI2017-85241-R]; Comunidad de Madrid	Ministerior de Economia y Competitividad de Espana; Comunidad de Madrid(Comunidad de Madrid)	Funded by PSI2017-85241-R from the Ministerior de Economia y Competitividad de Espana and S2015/HUM-3327 EMO-CM from the Comunidad de Madrid The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al'Absi M, 2016, NEUROSCIENCE PAIN ST, DOI [10.1016/C2013-0-16065-5, DOI 10.1016/C2013-0-16065-5]; Ambrose KR, 2012, REUMATISMO, V64, P206, DOI 10.4081/reumatismo.2012.206; Arnold LM, 2008, PATIENT EDUC COUNS, V73, P114, DOI 10.1016/j.pec.2008.06.005; Balconi M, 2012, BRAIN SCI, V2, P85, DOI 10.3390/brainsci2020085; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bellato E, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/426130; Bentley DE, 2003, PAIN, V102, P265, DOI 10.1016/S0304-3959(02)00405-0; Bernat E, 2001, CLIN NEUROPHYSIOL, V112, P159, DOI 10.1016/S1388-2457(00)00445-4; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077; Brown CA, 2014, EUR J NEUROSCI, V39, P663, DOI 10.1111/ejn.12420; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Bubier JA, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00001; Carretie L, 2011, BIOL PSYCHOL, V86, P247, DOI 10.1016/j.biopsycho.2010.12.005; Chen ACN, 1998, PAIN FORUM, V7, P174, DOI 10.1016/S1082-3174(98)70001-7; Cliff N., 1987, ANAL MULTIVARIATE DA; Crofford LJ, 2017, KELLEY FIRESTEINS TX, DOI [10.1016/B978-0-323-31696-5.00052-8, DOI 10.1016/B978-0-323-31696-5.00052-8]; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; Crombez G, 2013, PAIN, V154, P497, DOI 10.1016/j.pain.2012.11.013; de Tommaso M, 2011, J PAIN, V12, P116, DOI 10.1016/j.jpain.2010.06.004; de Tommaso M, 2009, INT J PSYCHOPHYSIOL, V74, P139, DOI 10.1016/j.ijpsycho.2009.08.004; de Wied M, 2001, PAIN, V90, P163, DOI 10.1016/S0304-3959(00)00400-0; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Dien J, 2012, DEV NEUROPSYCHOL, V37, P497, DOI 10.1080/87565641.2012.697503; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Duschek S, 2014, PAIN MED, V15, P603, DOI 10.1111/pme.12360; Duschek S, 2013, BEHAV MED, V39, P11, DOI 10.1080/08964289.2012.708684; Friebel U, 2011, NEUROIMAGE, V58, P1070, DOI 10.1016/j.neuroimage.2011.07.022; GarciaLarrea L, 1997, NEUROREPORT, V8, P3785, DOI 10.1097/00001756-199712010-00026; Glascher J, 2003, J NEUROSCI, V23, P10274; Gomez-Perez L, 2011, J PAIN, V12, P425, DOI 10.1016/j.jpain.2010.08.004; Gonzalez JL, 2010, J PSYCHOSOM RES, V69, P279, DOI 10.1016/j.jpsychores.2010.05.002; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Handy T. C., 2005, EVENT RELATED POTENT, P57; Hinojosa JA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00024; Iannetti GD, 2004, CLIN NEUROPHYSIOL, V115, P2629, DOI 10.1016/j.clinph.2004.05.023; Kamping S, 2013, PAIN, V154, P1846, DOI 10.1016/j.pain.2013.06.003; Kenntner-Mabiala R, 2005, PSYCHOPHYSIOLOGY, V42, P559, DOI 10.1111/j.1469-8986.2005.00310.x; Kenntner-Mabiala R, 2008, BIOL PSYCHOL, V78, P114, DOI 10.1016/j.biopsycho.2008.01.007; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P318, DOI 10.1111/j.1469-8986.2007.00634.x; Klauer KC, 2007, CONSCIOUS COGN, V16, P63, DOI 10.1016/j.concog.2005.12.002; Kugler K., 1999, PHOTOGRAPH SERIES DA, V1; KUNDE V, 1993, ELECTROEN CLIN NEURO, V88, P280, DOI 10.1016/0168-5597(93)90052-Q; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Liu XZ, 2017, BEHAV BRAIN RES, V326, P132, DOI 10.1016/j.bbr.2017.01.037; Loge-Hagen JS, 2019, J AFFECT DISORDERS, V245, P1098, DOI 10.1016/j.jad.2018.12.001; Lorenz J, 1996, EVOKED POTENTIAL, V100, P165, DOI 10.1016/0013-4694(95)00259-6; Low LA, 2012, PAIN RES TREAT, V2012, DOI [10.1155/2012/140832, DOI 10.1155/2012/140832]; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Meerman EE, 2013, INT J BEHAV MED, V20, P627, DOI 10.1007/s12529-012-9270-1; Meerman EE, 2012, J PSYCHOSOM RES, V72, P408, DOI 10.1016/j.jpsychores.2012.02.004; Meerman EE, 2011, J PSYCHOSOM RES, V70, P250, DOI 10.1016/j.jpsychores.2010.08.006; Meerwijk EL, 2013, BRAIN IMAGING BEHAV, V7, P1, DOI 10.1007/s11682-012-9179-y; Mercado F., 2013, FUNCTIONAL BRAIN MAP, DOI [10.5772/56495, DOI 10.5772/56495]; Mercado F, 2013, INT J PSYCHOPHYSIOL, V88, P182, DOI 10.1016/j.ijpsycho.2013.03.017; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; MIRON D, 1989, PAIN, V39, P345, DOI 10.1016/0304-3959(89)90048-1; Montoro CI, 2015, NEUROPSYCHOLOGY, V29, P173, DOI 10.1037/neu0000138; Montoya P, 2005, PSYCHOSOM MED, V67, P957, DOI 10.1097/01.psy.0000188401.55394.18; Mulert C, 2004, EUR ARCH PSY CLIN N, V254, P190, DOI 10.1007/s00406-004-0469-2; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; Pascual-Marqui RD, 2007, DISCRETE 3D DISTRI 1, P1, DOI DOI 10.1016/J.NEULET.2010.09.011; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Pelaez I, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01636; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Reicherts P, 2013, PAIN, V154, P793, DOI 10.1016/j.pain.2013.02.012; Rhudy JL, 2008, PAIN, V136, P250, DOI 10.1016/j.pain.2007.06.031; Rhudy JL, 2005, PSYCHOPHYSIOLOGY, V42, P579, DOI 10.1111/j.1469-8986.2005.00313.x; Rhudy JL, 2001, CURR OPIN PSYCHIATR, V14, P241, DOI 10.1097/00001504-200105000-00012; Ring C, 2013, BIOL PSYCHOL, V93, P373, DOI 10.1016/j.biopsycho.2013.04.006; Rivera J, 2004, CLIN EXP RHEUMATOL, V22, P554; Roelofs J, 2002, EUR J PAIN-LONDON, V6, P273, DOI 10.1053/eujp.2002.0337; Spielberger CD, 2010, CORSINI ENCY PSYCHOL, P1, DOI [10.1002/9780470479216.corpsy0942, DOI 10.1002/9780470479216.CORPSY0943, 10.1002/9780470479216.corpsy0942.1, DOI 10.1002/9780470479216.CORPSY0942.1]; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Swannell ER, 2016, J PAIN, V17, P336, DOI 10.1016/j.jpain.2015.11.004; Tiemann L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035068; Valeriani M, 1996, EVOKED POTENTIAL, V100, P343, DOI 10.1016/0168-5597(96)95625-7; Valeriani M, 2009, CLIN NEUROPHYSIOL, V120, P790, DOI 10.1016/j.clinph.2009.02.162; Van Damme S, 2004, PAIN, V107, P70, DOI 10.1016/j.pain.2003.09.023; van Hooff JC, 2013, ACTA PSYCHOL, V143, P1, DOI 10.1016/j.actpsy.2013.02.001; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x; Walentowska W, 2012, INT J PSYCHOPHYSIOL, V85, P27, DOI 10.1016/j.ijpsycho.2011.12.004; Weiss T, 2003, NEUROSCI LETT, V340, P135, DOI 10.1016/S0304-3940(03)00103-4; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203755	98	6	6	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2019	14	6							e0217909	10.1371/journal.pone.0217909	http://dx.doi.org/10.1371/journal.pone.0217909			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IB2GN	31166997	Green Published, Green Submitted, gold			2022-12-26	WOS:000470087800051
J	Abriola, L; Hoyer, D; Caffrey, CR; Williams, DL; Yoshino, TP; Vermeire, JJ				Abriola, Laura; Hoyer, Denton; Caffrey, Conor R.; Williams, David L.; Yoshino, Timothy P.; Vermeire, Jon J.			Development and optimization of a high-throughput screening method utilizing Ancylostoma ceylanicum egg hatching to identify novel anthelmintics	PLOS ONE			English	Article							DRUG DISCOVERY; HOOKWORM; DISEASE	Hookworms remain a major health burden in the developing world, with hundreds of millions currently afflicted by these blood-feeding parasites. There exists a vital need for the discovery of novel drugs and identification of parasite drug targets for the development of chemotherapies. New drug development requires the identification of compounds that target molecules essential to parasite survival and preclinical testing in robust, standardized animal models of human disease. This process can prove costly and time consuming using conventional, low-throughput methods. We have developed a novel high-throughput screen ( HTS) to identify anthelmintics for the treatment of soil-transmitted helminths. Our high-throughput, plate reader-based assay was used to rapidly assess compound toxicity to Ancylostoma ceylanicum L1 larva. Using this method, we screened 39,568 compounds from several small molecule screening libraries at 10 mu M and identified 830 bioactive compounds that inhibit egg hatching of the human hookworm A. ceylanicum by > 50%. Of these, 132 compounds inhibited hookworm egg hatching by > 90% compared to controls. The nematicidal activities of 268 compounds were verified by retesting in the egg hatching assay and were also tested for toxicity against the human HeLa cell line at 10 mu M. Fifty-nine compounds were verified to inhibit A. ceylanicum egg hatching by > 80% and were < 20% toxic to HeLa cells. Half-maximal inhibitory concentration ( IC50) values were determined for the 59 hit compounds and ranged from 0.05-8.94 mu M. This stringent advancement of compounds was designed to 1) systematically assess the nematicidal activity of novel compounds against the egg stage of A. ceylanicum hookworms in culture and 2) define their chemotherapeutic potential in vivo by evaluating their toxicity to human cells. Information gained from these experiments may directly contribute to the development of new drugs for the treatment of human hookworm disease.	[Abriola, Laura; Hoyer, Denton] Yale Univ, Yale Ctr Mol Discovery, New Haven, CT USA; [Caffrey, Conor R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Williams, David L.] Rush Univ, Med Ctr, Dept Microbial Pathogens & Immun, Chicago, IL 60612 USA; [Yoshino, Timothy P.] Univ Wisconsin, Dept Pathobiol Sci, Cellular & Mol Parasitol Training Program, Madison, WI 53706 USA; [Vermeire, Jon J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	Yale University; University of California System; University of California San Diego; Rush University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco	Vermeire, JJ (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	jon.vermeire@gmail.com		Vermeire, Jon/0000-0001-6073-4071; Abriola, Laura/0000-0002-7304-6531	Yale Center for Molecular Discovery, High-Throughput Screening Pilot Project Award; NIH/NIAID K22 RSDA	Yale Center for Molecular Discovery, High-Throughput Screening Pilot Project Award; NIH/NIAID K22 RSDA	This work was funded by a private Yale-sponsored grant (Yale Center for Molecular Discovery, High-Throughput Screening Pilot Project Award) to JJV and an NIH/NIAID K22 RSDA awarded to JJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bungiro RD, 2001, J INFECT DIS, V183, P1380, DOI 10.1086/319867; Bungiro Richard, 2011, Curr Infect Dis Rep, V13, P210, DOI 10.1007/s11908-011-0182-z; Burns AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8485; Cappello M, 2006, P NATL ACAD SCI USA, V103, P15154, DOI 10.1073/pnas.0607002103; Ellerbrock BR, 2004, J BIOMOL SCREEN, V9, P147, DOI 10.1177/1087057103261038; Garcia-Longoria L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-239; Geary TG, 2015, J PARASITOL, V101, P125, DOI 10.1645/14-703.1; Geiger SM, 2004, CLIN EXP IMMUNOL, V136, P334, DOI 10.1111/j.1365-2249.2004.02449.x; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Lee JA, 2012, J MED CHEM, V55, P4527, DOI 10.1021/jm201649s; Leung CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062166; Loukas A, 2005, FEMS IMMUNOL MED MIC, V43, P115, DOI 10.1016/j.femsim.2004.11.006; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mansour NR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004659; Mendez S, 2005, VACCINE, V23, P3123, DOI 10.1016/j.vaccine.2004.12.022; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; ROBBINS PW, 1988, J BIOL CHEM, V263, P443; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; Weicksel SE, 2016, DEVELOPMENT, V143, P3540, DOI 10.1242/dev.140046; World Health Organization; TDR Disease Reference Group on Helminth Infections, 2013, WHO TECH REP SER, Vxv, P1; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217019	10.1371/journal.pone.0217019	http://dx.doi.org/10.1371/journal.pone.0217019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158236	Green Published, Green Submitted, gold			2022-12-26	WOS:000469915700006
J	Wittauer, EM; Oldhafer, F; Augstein, E; Beetz, O; Kleine, M; Schumacher, C; Sieg, L; Eismann, H; Johanning, K; Bleich, A; Vondran, FWR				Wittauer, Eva-Maria; Oldhafer, Felix; Augstein, Eva; Beetz, Oliver; Kleine, Moritz; Schumacher, Carsten; Sieg, Lion; Eismann, Hendrik; Johanning, Kai; Bleich, Andre; Vondran, Florian Wolfgang Rudolf			Porcine model for the study of liver regeneration enhanced by non-invasive C-13-methacetin breath test (LiMAx test) and permanent portal venous access	PLOS ONE			English	Article							SMALL-FOR-SIZE; HEPATOCYTE TRANSPLANTATION; EXTENDED HEPATECTOMY; RESECTION; PRESSURE; FAILURE; SURVIVAL; REMNANT; MANAGEMENT; CIRRHOSIS	Introduction Despite advances in perioperative management and surgical technique, postoperative liver failure remains a feared complication after hepatic resection. Various supportive treatment options are under current discussion, but lack of structured evaluation. We therefore established a porcine model of major liver resection to study regeneration after partial hepatectomy in a reliable and well-defined pre-clinical setting. Methods Major hepatectomy was performed on seven minipigs with the intention to set up a non-lethal but relevant transient impairment of liver function. For steady postoperative vascular access (e.g. for blood withdrawal, measurement of venous pressure), permanent catheters were implanted into the internal jugular and portal veins, respectively. Animals were followed up for 30 days; clinical and laboratory results were recorded in detail. Monitoring was enhanced by non-invasive determination of the maximum liver function capacity (LiMAx test). Results and conclusions The established porcine model appeared suitable for evaluation of postoperative liver regeneration. Clinical characteristics and progression of liver function impairment as well as subsequent recovery were comparable to courses known from surgery in humans. Laboratory parameters (e.g. liver enzymes, bilirubin, INR, coagulation factor II) showed relevant derangements during postoperative days (POD) 0 to 3 followed by normalization until POD 7. Application of the LiMAx test was feasible in minipigs, again showing values comparable to humans and kinetics in line with obtained laboratory parameters. The exteriorized portal vein catheters enabled intra- and postoperative monitoring of portal venous pressures as well as easy access for blood withdrawal without relevant risk of postoperative complications.	[Wittauer, Eva-Maria; Oldhafer, Felix; Augstein, Eva; Beetz, Oliver; Kleine, Moritz; Vondran, Florian Wolfgang Rudolf] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, ReMediES, Hannover, Germany; [Schumacher, Carsten; Sieg, Lion; Eismann, Hendrik; Johanning, Kai] Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Vondran, FWR (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplant Surg, ReMediES, Hannover, Germany.	vondran.florian@mh-hannover.de	Eismann, Hendrik/GVU-1519-2022	Sieg, Lion/0000-0002-0756-893X	German Research Foundation [SFB 738]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (SFB 738; to FWRV; project C11), http://sfb738.de/startseite-3/sonderforschungsbereich-738.html.	Allard MA, 2013, ANN SURG, V258, P822, DOI 10.1097/SLA.0b013e3182a64b38; Athanasiou A, 2016, J BUON, V21, P1403; Baccarani U, 2005, TRANSPLANT P, V37, P2702, DOI 10.1016/j.transproceed.2005.06.027; Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Bilir BM, 2000, LIVER TRANSPLANT, V6, P32, DOI 10.1016/S1527-6465(00)80030-1; Cammann S, 2017, INT J SURG CASE REP, V39, P140, DOI 10.1016/j.ijscr.2017.08.003; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Eshkenazy Rony, 2014, Hepatobiliary Surg Nutr, V3, P303, DOI 10.3978/j.issn.2304-3881.2014.09.08; Fahrner R, 2014, TRANSPLANTATION, V97, P892, DOI 10.1097/TP.0000000000000045; Fierbinteanu-Braticevici C, 2014, INDIAN J MED RES, V140, P123; Goetze O, 2007, ALIMENT PHARM THER, V26, P305, DOI 10.1111/j.1365-2036.2007.03360.x; Golriz M, 2017, CAN J GASTROENTEROL, V2017, DOI 10.1155/2017/5127178; Gorowska-Kowolik K, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/7397840; Guglielmi A, 2012, DIGEST SURG, V29, P6, DOI 10.1159/000335713; Inayat F, 2016, CUREUS, V8, DOI 10.7759/cureus.884; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Jara M, 2015, J SURG RES, V193, P184, DOI 10.1016/j.jss.2014.07.041; Kaffarnik MF, 2013, CRIT CARE, V17, DOI 10.1186/cc13089; Kaiser GM, 2005, EUR SURG RES, V37, P298, DOI 10.1159/000089241; Kawachi S, 1997, TRANSPLANTATION, V64, P205, DOI 10.1097/00007890-199707270-00004; Kelly DM, 2009, LIVER TRANSPLANT, V15, P1448, DOI 10.1002/lt.21863; Kim DS, 2018, ANN SURG TREAT RES, V94, P118, DOI 10.4174/astr.2018.94.3.118; Laurent C, 2003, BRIT J SURG, V90, P1131, DOI 10.1002/bjs.4202; Lee WC, 2014, TRANSPLANTATION, V97, P890, DOI 10.1097/TP.0000000000000067; Lock JF, 2017, ANN SURG ONCOL, V24, P2447, DOI 10.1245/s10434-017-5887-2; Luca A, 2006, LIVER TRANSPLANT, V12, P1237, DOI 10.1002/lt.20762; LYDTIN H, 1969, Z GESAMTE EXP MED, V149, P279, DOI 10.1007/BF02044484; Matrella E, 2001, ALIMENT PHARM THERAP, V15, P857, DOI 10.1046/j.1365-2036.2001.00996.x; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Moore BA, 2005, CRIT CARE MED, V33, P1317, DOI 10.1097/01.CCM.0000166349.76514.40; Oldhafer F, 2016, PATIENT SAF SURG, V10, DOI 10.1186/s13037-016-0104-y; Otsuka Y, 2007, LIVER TRANSPLANT, V13, P672, DOI 10.1002/lt.20917; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Ray S, 2018, ANN MED SURG, V34, P4, DOI 10.1016/j.amsu.2018.08.012; Rubin T, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027102; Shen XL, 2008, LAB ANIMAL, V37, P41, DOI 10.1038/laban0108-41; Stockmann M, 2009, ANN SURG, V250, P119, DOI 10.1097/SLA.0b013e3181ad85b5; Takada Y, 2004, LIVER TRANSPLANT, V10, P807, DOI 10.1002/lt.20164; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Troisi R, 2005, AM J TRANSPLANT, V5, P1397, DOI 10.1111/j.1600-6143.2005.00850.x; VANLEEUWEN P, 1995, J ANIM PHYSIOL AN N, V73, P38, DOI 10.1111/j.1439-0396.1995.tb00401.x; Vondran FWR, 2018, ANZ J SURG, V88, pE324, DOI 10.1111/ans.13944; Vondran Florian Wolfgang Rudolf, 2016, Case Rep Transplant, V2016, P7074636, DOI 10.1155/2016/7074636; Xia Q, 2008, HEPATOB PANCREAT DIS, V7, P601; Xiang L, 2016, TRANSPL P, V48, P234, DOI 10.1016/j.transproceed.2015.12.026	48	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217488	10.1371/journal.pone.0217488	http://dx.doi.org/10.1371/journal.pone.0217488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150446	gold, Green Submitted, Green Published			2022-12-26	WOS:000469759100057
J	Zhang, QY; Du, YC				Zhang, Qingyang; Du, Yuchun			Model-free feature screening for categorical outcomes: Nonlinear effect detection and false discovery rate control	PLOS ONE			English	Article							GENERALIZED LINEAR-MODELS; VARIABLE SELECTION; T-TEST; MULTIVARIATE; EXPRESSION; TUMOR	Feature screening has become a real prerequisite for the analysis of high-dimensional genomic data, as it is effective in reducing dimensionality and removing redundant features. However, existing methods for feature screening have been mostly relying on the assumptions of linear effects and independence (or weak dependence) between features, which might be inappropriate in real practice. In this paper, we consider the problem of selecting continuous features for a categorical outcome from high-dimensional data. We propose a powerful statistical procedure that consists of two steps, a nonparametric significance test based on edge count and a multiple testing procedure with dependence adjustment for false discovery rate control. The new method presents two novelties. First, the edge-count test directly targets distributional difference between groups, therefore it is sensitive to nonlinear effects. Second, we relax the independence assumption and adapt Efron's procedure to adjust for the dependence between features. The performance of the proposed procedure, in terms of statistical power and false discovery rate, is illustrated by simulated data. We apply the new method to three genomic datasets to identify genes associated with colon, cervical and prostate cancers.	[Zhang, Qingyang] Univ Arkansas, Dept Math Sci, Fayetteville, AR 72701 USA; [Du, Yuchun] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Zhang, QY (corresponding author), Univ Arkansas, Dept Math Sci, Fayetteville, AR 72701 USA.; Du, YC (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	qz008@uark.edu; ydu@uark.edu			Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000	Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000	This study was funded by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2006, INTRO CATEGORICAL DA, DOI [10.1002/0470114754, DOI 10.1002/0470114754]; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y, 1995, P NAT ACAD SCI, V96, P6745; Chen H, 2017, J AM STAT ASSOC, V112, P397, DOI 10.1080/01621459.2016.1147356; Cheriton D., 1976, SIAM Journal on Computing, V5, P724, DOI 10.1137/0205051; CRUTCHER HL, 1975, J APPL METEOROL, V14, P1600, DOI 10.1175/1520-0450(1975)014<1600:ANOTPM>2.0.CO;2; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; Fan J, 2012, J AM STAT ASSOC, V40, P745; FRIEDMAN JH, 1979, ANN STAT, V7, P697, DOI 10.1214/aos/1176344722; Gertheiss J, 2013, STAT, V2, P86, DOI 10.1002/sta4.20; Gonzalez-Gonzalez L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00225; GUCCIARDI PG, 2008, J PHYS C SERIES, V19, DOI DOI 10.1088/0957-4484/19/21/215702; Guo CC, 2017, COMMUN STAT-THEOR M, V46, P2967, DOI 10.1080/03610926.2015.1053940; Jia DS, 2018, CANCER DISCOV, V8, P1422, DOI 10.1158/2159-8290.CD-18-0385; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li GR, 2012, ANN STAT, V40, P1846, DOI 10.1214/12-AOS1024; Li RZ, 2012, J AM STAT ASSOC, V107, P1129, DOI 10.1080/01621459.2012.695654; Li ZL, 2012, CAN J STAT, V40, P745, DOI 10.1002/cjs.11165; Liu WD, 2017, ANN STAT, V45, P2680, DOI 10.1214/17-AOS1539; Liu WD, 2013, ANN STAT, V41, P2948, DOI 10.1214/13-AOS1169; Lu Y, 2005, BIOINFORMATICS, V21, P3105, DOI 10.1093/bioinformatics/bti496; Mariot P, 2000, PROSTATE, V43, P205; Rosenbaum PR, 2005, J ROY STAT SOC B, V67, P515, DOI 10.1111/j.1467-9868.2005.00513.x; Sebban S, 2014, ONCOTARGET, V5, P9214, DOI 10.18632/oncotarget.2400; Shiba-Ishii A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0414-1; Steinskog DJ, 2007, MON WEATHER REV, V135, P1151, DOI 10.1175/MWR3326.1; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2013, J MULTIVARIATE ANAL, V117, P193, DOI 10.1016/j.jmva.2013.02.012; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Tsagris M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2023-7; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Zhang Q, 2017, TECHNICAL REPORT; Zhang Q, 2018, BMC SYST BIOL, V12, P1; Zhang Qingyang, 2014, BMC Syst Biol, V8, P1338, DOI 10.1186/s12918-014-0136-9; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626; Zhou Nina, 2007, Genomics Proteomics & Bioinformatics, V5, P242, DOI 10.1016/S1672-0229(08)60011-X	38	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2019	14	5							e0217463	10.1371/journal.pone.0217463	http://dx.doi.org/10.1371/journal.pone.0217463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA7TI	31150453	gold, Green Published, Green Submitted			2022-12-26	WOS:000469759100054
J	Ryuno, H; Nigo, F; Naguro, I; Sekimizu, K; Kaito, C				Ryuno, Hiroki; Nigo, Fuki; Naguro, Isao; Sekimizu, Kazuhisa; Kaito, Chikara			Staphylococcus aureus aggregation in the plasma fraction of silkworm hemolymph	PLOS ONE			English	Article							BOMBYX-MORI; LIPOTEICHOIC ACID; NODULE FORMATION; BINDING-PROTEIN; CLUMPING FACTOR; COAGULASE; VIRULENCE; RESISTANCE; MODEL; GENE	Staphylococcus aureus formed bacterial aggregates in the plasma fraction of the hemolymph of silkworm, the larva of Bombyx mori, in a growth-dependent manner. The addition of arabinose or galactose inhibited the formation of S. aureus aggregates in the silkworm plasma. Formation of the bacterial aggregates depended on S. aureus genes required for the synthesis of bacterial surface polysaccharides-ypfP and ltaA, which are involved in lipoteichoic acid synthesis, and the tagO gene, which is involved in wall teichoic acid synthesis. These findings suggest that S. aureus forms bacterial aggregates in the silkworm plasma via bacterial surface teichoic acids.	[Ryuno, Hiroki; Naguro, Isao] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Nigo, Fuki; Kaito, Chikara] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Sekimizu, Kazuhisa] Teikyo Univ, Inst Med Mycol, Tokyo, Japan	University of Tokyo; Okayama University; Teikyo University	Kaito, C (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	ckaito@okayama-u.ac.jp	Kaito, Chikara/W-1815-2019	Kaito, Chikara/0000-0002-2895-3386; Naguro, Isao/0000-0002-0338-8026	 [15H04727];  [15H05783];  [19H03466]	; ; 	This work was supported by Grants-in-aid for Scientific Research (CK, 15H04727; KS, 15H05783; CK, 19H03466). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimitsu N, 1999, ANTIMICROB AGENTS CH, V43, P3042, DOI 10.1128/AAC.43.12.3042; Arai I, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12501; BADDOUR LM, 1994, J MED MICROBIOL, V41, P259, DOI 10.1099/00222615-41-4-259; CAWDERY M, 1969, BRIT J EXP PATHOL, V50, P408; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Crossly KB, 1997, STAPHYLOCOCCI HUMAN; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GOLDSTEIN J, 1982, J CLIN MICROBIOL, V15, P848, DOI 10.1128/JCM.15.5.848-851.1982; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; Higgins J, 2006, FEMS MICROBIOL LETT, V258, P290, DOI 10.1111/j.1574-6968.2006.00229.x; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2012, ISJ-INVERT SURVIV J, V9, P163; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2002, FEMS MICROBIOL LETT, V210, P157, DOI 10.1016/S0378-1097(02)00603-1; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2016, DRUG DISCOV THER, V10, P30, DOI 10.5582/ddt.2016.01020; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; KAWABATA S, 1985, J BIOCHEM, V98, P1603, DOI 10.1093/oxfordjournals.jbchem.a135430; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Kochi Y, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw163; KOTANI E, 1995, BBA-GENE STRUCT EXPR, V1260, P245, DOI 10.1016/0167-4781(94)00202-E; Kyuma T, 2015, BIOCHIMIE, V119, P166, DOI 10.1016/j.biochi.2015.10.027; Kyuma T, 2015, FEBS J, V282, P2570, DOI 10.1111/febs.13302; Loeb L, 1904, J MED RES, V10, P407; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; MORI H, 1989, J INVERTEBR PATHOL, V54, P112, DOI 10.1016/0022-2011(89)90147-X; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; MURRAY M, 1959, J BACTERIOL, V78, P450, DOI 10.1128/JB.78.3.450-451.1959; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Omae Y, 2013, J BIOL CHEM, V288, P25542, DOI 10.1074/jbc.M113.495051; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; PHONIMDAENG P, 1990, MOL MICROBIOL, V4, P393, DOI 10.1111/j.1365-2958.1990.tb00606.x; Qian Q, 2007, J CLIN MICROBIOL, V45, P2267, DOI 10.1128/JCM.00369-07; RATCLIFFE NA, 1977, TISSUE CELL, V9, P73, DOI 10.1016/0040-8166(77)90050-7; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Suzuki Asahi, 2011, Journal of Insect Biotechnology and Sericology, V80, P49; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Yoshikai H, 2016, J INFECT DIS, V213, P295, DOI 10.1093/infdis/jiv376	45	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2019	14	5							e0217517	10.1371/journal.pone.0217517	http://dx.doi.org/10.1371/journal.pone.0217517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA2XG	31145754	Green Published, gold, Green Submitted			2022-12-26	WOS:000469425500020
J	Abd Gani, S; Muhammad, SA; Kura, AU; Barahuie, F; Hussein, MZ; Fakurazi, S				Abd Gani, Shafinaz; Muhammad, Suleiman Alhaji; Kura, Aminu Umar; Barahuie, Farahnaz; Hussein, Mohd Zobir; Fakurazi, Sharida			Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice	PLOS ONE			English	Article							FOCAL LESION GROWTH; ZINC-DEFICIENCY; TRACE-METALS; LIVER; CANCER; TUMOR; EXTRACT; BREAST; CELLS; CHEMOPREVENTION	Researchers investigating cancer chemotherapy and management continue to search for agents that selectively kill malignant cells and leave healthy neighboring cells intact. Natural products provide relevant resources for anti-cancer drug discovery. However, the physicochemical properties of these compounds limit their efficient uptake and bioavailability. We introduced a nanocarrier system, namely, zinc-aluminum-layered double hydroxide (ZnAl-LDH) intercalated with protocatechuic acid. In this study, the efficacy and toxicity of protocatechuic acid intercalated in zinc aluminum-layered double hydroxide nanoparticles (PCA-ZnAl) against diethylnitrosamine/phenobarbital (DEN/PB)-induced hepatocellular carcinoma (HCC) in BALB/c mice was evaluated. HCC in male mice was induced by a single-dose intraperitoneal administration of DEN and was promoted by the introduction of PB via drinking water for 12 weeks. HCC induction was confirmed after the DEN/PB introduction period by measurement of the elevated level of serum a-feto protein (AFP). The results showed that the level of alpha-fetoprotein was significantly reduced in PCA-ZnAl (350 +/- 43.90 ng/mL), doxorubicin (DOX) (290 +/- 20.52 ng/mL) and ZnAl-LDH (390 +/- 19.65 ng/mL) treated animals compared to HCC mice treated with normal saline (580.4 +/- 52.04 ng/mL). Superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) levels were significantly increased, whereas the level of lipid peroxidation was significantly decreased in HCC mice treated with DOX, PCA-ZnAl and ZnAl-LDH compared with those in HCC mice treated with saline. Restoration of hepatocyte morphology was observed following treatment that was comparable to that in the normal control group. Deterioration of hepatic cells and a significant increase of aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) were observed in the cancer-induced untreated group compared with that in the groups treated with nanoparticles. The histopathological features of the liver obtained from PCA-ZnAl-treated mice showed a uniform size with a similar distribution of the nuclear-cytoplasmic ratio and nucleus centrally located in the cytoplasm, similar to the normal liver cells. The results underscored the potential of PCA-ZnAl for the treatment of hepatocellular carcinoma.	[Abd Gani, Shafinaz; Muhammad, Suleiman Alhaji; Fakurazi, Sharida] Univ Putra Malaysia, Inst Biosci, Lab Vaccine & Immunotherapeut, Serdang, Selangor, Malaysia; [Abd Gani, Shafinaz] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor, Malaysia; [Kura, Aminu Umar] Bauchi State Univ, Dept Pharmacol, Fac Med, Gadau, Nigeria; [Barahuie, Farahnaz] Univ Sistan & Baluchestan, Fac Ind & Min, Zahedan, Iran; [Hussein, Mohd Zobir] Univ Putra Malaysia, Inst Adv Technol ITMA, Mat Synth & Characterizat Lab, Serdang, Selangor, Malaysia; [Fakurazi, Sharida] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; University of Sistan & Baluchestan; Universiti Putra Malaysia; Universiti Putra Malaysia	Fakurazi, S (corresponding author), Univ Putra Malaysia, Inst Biosci, Lab Vaccine & Immunotherapeut, Serdang, Selangor, Malaysia.; Fakurazi, S (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia.	sharida@upm.edu.my	Muhammad, Suleiman/ABA-3384-2020; Barahuie, Farahnaz/AAG-8428-2019	Barahuie, Farahnaz/0000-0003-4745-6454; FAKURAZI, SHARIDA/0000-0001-8986-876X; Muhammad, Suleiman A./0000-0003-2421-3556	Fundamental research grant scheme from the Ministry of Education, Malaysia [5524841]	Fundamental research grant scheme from the Ministry of Education, Malaysia	This work was funded by Fundamental research grant scheme with grant number 5524841 from the Ministry of Education, Malaysia. The funder has no role in study design, collection and analysis of the data, preparing the manuscripts, and decisions to publish. The researchers have no conflict of interest in designing, obtaining, analyzing and publishing the data. No salary was obtained from the funders of the project.	Afonne, 2002, INDIAN J PHARM, V34, P26; Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; Al-Ebraheem A, 2009, APPL RADIAT ISOTOPES, V67, P470, DOI 10.1016/j.apradiso.2008.06.018; Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Atefipour Narges, 2016, Electron Physician, V8, P2410, DOI 10.19082/2410; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Barahuie F, 2015, J SOLID STATE CHEM, V221, P21, DOI 10.1016/j.jssc.2014.09.001; Beytur A, 2012, ANDROLOGIA, V44, P454, DOI 10.1111/j.1439-0272.2011.01204.x; Bianchi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177995; Bianchi GP, 2000, NUTR RES, V20, P1079, DOI 10.1016/S0271-5317(00)00194-9; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; BISHAYEE A, 1995, BRIT J CANCER, V71, P1214, DOI 10.1038/bjc.1995.236; Bravi F, 2013, CLIN GASTROENTEROL H, V11, P1413, DOI 10.1016/j.cgh.2013.04.039; Cho SK, 2011, DIAGN INTERV RADIOL, V17, P374, DOI 10.4261/1305-3825.DIR.4016-10.1; Choi G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04430; Choi SJ, 2010, J MATER CHEM, V20, P9463, DOI 10.1039/b925831k; COMPORTI M, 1989, CHEM-BIOL INTERACT, V72, P1, DOI 10.1016/0009-2797(89)90016-1; FARBER E, 1990, BIOCHEM PHARMACOL, V39, P1837, DOI 10.1016/0006-2952(90)90599-G; Ferguson Lydia, 2013, Front Endocrinol (Lausanne), V4, P32, DOI 10.3389/fendo.2013.00032; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Giovannini C, 2008, J NUTR BIOCHEM, V19, P118, DOI 10.1016/j.jnutbio.2007.01.010; Gutierrez L, 2009, BBA-MOL BASIS DIS, V1792, P541, DOI 10.1016/j.bbadis.2009.03.007; Hefaiedh Rania, 2013, Tunis Med, V91, P505; HEIDELBERGER C, 1975, ANNU REV BIOCHEM, V44, P79, DOI 10.1146/annurev.bi.44.070175.000455; Jagan S, 2008, MOL CELL BIOCHEM, V319, P51, DOI 10.1007/s11010-008-9876-4; JAMES RC, 1982, BIOCHEM PHARMACOL, V31, P1829, DOI 10.1016/0006-2952(82)90484-1; Jarapala SR, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/201506; Jayaprakash R, 2015, J PHARM BIOALLIED SC, V7, pS40, DOI 10.4103/0975-7406.155791; Kawata T, 2006, BIOL PHARM BULL, V29, P403, DOI 10.1248/bpb.29.403; Klaunig JE, 1999, TOXICOL SCI, V52, P101, DOI 10.1093/toxsci/52.2.101; KLAUNIG JE, 1988, TOXICOL PATHOL, V16, P381, DOI 10.1177/019262338801600310; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kolaja KL, 1997, TOXICOL APPL PHARM, V143, P380, DOI 10.1006/taap.1996.8089; Kushida M, 2011, TOXICOL PATHOL, V39, P776, DOI 10.1177/0192623311409596; Kuthati Y, 2015, APPL CLAY SCI, V112, P100, DOI 10.1016/j.clay.2015.04.018; Lee JS, 2005, INFECT IMMUN, V73, P4399, DOI 10.1128/IAI.73.7.4399-4403.2005; Liccioni A, 2014, DIGEST DIS, V32, P554, DOI 10.1159/000360501; Lin HH, 2011, BRIT J PHARMACOL, V162, P237, DOI 10.1111/j.1476-5381.2010.01022.x; Lin SB, 2012, LIVER CANCER, V1, P144, DOI 10.1159/000343828; Liu CL, 2002, FOOD CHEM TOXICOL, V40, P635, DOI 10.1016/S0278-6915(02)00002-9; Liu ZQ, 2019, J HEPATOL, V70, P674, DOI 10.1016/j.jhep.2018.12.001; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mangray S, 2015, DIGEST DIS SCI, V60, P2868, DOI 10.1007/s10620-015-3854-y; Maronpot RR, 2010, TOXICOL PATHOL, V38, P776, DOI 10.1177/0192623310373778; Masella R, 2004, J NUTR, V134, P785, DOI 10.1093/jn/134.4.785; Masella R, 2012, CURR MED CHEM, V19, P2901; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; OLSSON M, 1977, J EXP MED, V145, P819, DOI 10.1084/jem.145.4.819; Paradis Valerie, 2013, Recent Results Cancer Res, V190, P21, DOI 10.1007/978-3-642-16037-0_2; Patrick Lyn, 2003, Altern Med Rev, V8, P106; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Schwaiblmair Martin, 2012, Open Respir Med J, V6, P63, DOI 10.2174/1874306401206010063; Semaming Y, 2015, EVID-BASED COMPL ALT, V2015, DOI [10.1155/2015/593902, DOI 10.1155/2015/593902]; Sengupta S, 2015, DIGEST DIS SCI, V60, P3130, DOI 10.1007/s10620-015-3613-0; Shaheen N., 2014, OXIDATIVE STRESS DIE; Singh RP, 2000, MOL CELL BIOCHEM, V213, P99, DOI 10.1023/A:1007182913931; Sukowati CHC, 2010, WORLD J HEPATOL, V2, P114, DOI 10.4254/wjh.v2.i3.114; Sun H, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/584728; Sun XD, 2015, J COLLOID INTERF SCI, V459, P264, DOI 10.1016/j.jcis.2015.07.073; TANAKA T, 1993, CANCER RES, V53, P2775; Tashiro-Itoh T, 1997, LIVER, V17, P300; Vargas-Olvera CY, 2012, MOL CELL BIOCHEM, V369, P105, DOI 10.1007/s11010-012-1373-0; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Wadei HM, 2006, CLIN J AM SOC NEPHRO, V1, P1066, DOI 10.2215/CJN.01340406; Wong MCS, 2019, NAT REV GASTRO HEPAT, V16, P57, DOI 10.1038/s41575-018-0055-0; Xiao B, 2014, ONCOL LETT, V7, P23, DOI 10.3892/ol.2013.1651; Yin MC, 2009, J AGR FOOD CHEM, V57, P6468, DOI 10.1021/jf9004466	69	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217009	10.1371/journal.pone.0217009	http://dx.doi.org/10.1371/journal.pone.0217009			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA1LO	31141523	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000469323000035
J	Kaplan, WA; Cardenas, J; Mansilla, C; Tobar, T; Wirtz, VJ				Kaplan, Warren A.; Cardenas, Jorge; Mansilla, Cristian; Tobar, Tatiana; Wirtz, Veronika J.			The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data	PLOS ONE			English	Article							GENERIC MEDICINES; COUNTRIES	Background Affordability is a key barrier to access to medicines. Generic medicines policies can address this barrier and promote access. Successful uptake of generic medicines depends, in part, on ensuring that these products are interchangeable with reference products. Typically, bioequivalence certification is established in order to demonstrate such interchangeability. Objective To study the implementation of the bioequivalence certification policy in Chile. Methods We used Chilean Market Regulatory Authority data for analysis to study the number of products that obtained bioequivalence certification, the time until bioequivalence certification and associated factors to obtain bioequivalence. Results As of January 2017, out of 2,336 products with a valid market authorization containing at least one of the 167 APIs that required BE certification, 1,026 products actually have BE certification (1,026/ 2,336, 43.9% compliance). Where data were available, the time between submission of the market authorization as a bioequivalent product to final authorization by the national medicine regulatory authority for most products varied between 4-6 months. The fraction of all BE products containing a given API out of the total marketed products containing that API varies considerably, e.g. for the API olmesartan there was only a single BE product marketed, the API diclofenac had none. Conclusions Although the implementation of Chile's bioequivalence policy increased the number of bioequivalent products, over 50% of generic products requiring bioequivalence that did not obtain this certification. Also for some of the API none or very few BE products are marketed which limits the success of a substitution policy. Further studies are required to identify the apparent lack of incentives to obtain bioequivalence certification. Studies of sales volumes and prices of the products are needed to identify whether generic products without bioequivalence certification either become bioequivalent or eventually exit the market.	[Kaplan, Warren A.; Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Cardenas, Jorge; Mansilla, Cristian; Tobar, Tatiana] Minist Hlth Santiago, Santiago, Chile	Boston University	Wirtz, VJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.	vwirtz@bu.edu	Wirtz, Veornika/AAG-9712-2019	Kaplan, Warren/0000-0001-6127-4820; Wirtz, Veronika J./0000-0002-0863-8768; Mansilla, Cristian/0000-0003-2377-0094	Pan American Health Organization (PAHO); Alliance for Health Policy and Systems Research; Norwegian Government Agency for Development Cooperation (Norad); Swedish International Development Cooperation Agency (Sida); UK Department for International Development (DFID)	Pan American Health Organization (PAHO); Alliance for Health Policy and Systems Research; Norwegian Government Agency for Development Cooperation (Norad); Swedish International Development Cooperation Agency (Sida); UK Department for International Development (DFID)	This is work undertaken under the auspices of the embedded implementation research initiative supported by the Pan American Health Organization (PAHO) and the Alliance for Health Policy and Systems Research, an international partnership hosted by the World Health Organization (WHO), with support from the Norwegian Government Agency for Development Cooperation (Norad: https://norad.no/en/front/), the Swedish International Development Cooperation Agency (Sidahttps://www.sida.se/English/) and the UK Department for International Development (DFID: https://www.gov.uk/government/organisations/department-for-international-development).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cristian Mansilla, BMJ GLOB HEALTH, DOI [10.1136/bmjgh-2018-000922, DOI 10.1136/BMJGH-2018-000922]; da Fonseca EM, 2015, REV PANAM SALUD PUBL, V37, P113; da Fonseca EM, 2014, POLICY SOC, V33, P65, DOI 10.1016/j.polsoc.2014.03.004; Dylst P, 2013, EXPERT REV PHARM OUT, V13, P59, DOI [10.1586/ERP.12.83, 10.1586/erp.12.83]; European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP), 2010, CPMPEWPQWP140198; Fiscalia Nacional Economica Santiago Chile, 2013, STUD EFF BIOEQ PEN G; Fonseca EM, 2016, REV PANAM SALUD PUBL, V41, P1; Gomes Barra AC, 2011, J GENERIC MED, V2, P72, DOI DOI 10.1177/1741134311411266; Gonzalez C., 2008, J GENERIC MED, V6, P43; Gonzalez PE, 2011, WORKING HLTH POPULAT; Hill S., 2004, EMERGING CHALLENGES; Homedes N, 2005, B WORLD HEALTH ORGAN, V83, P64; Kaplan WA, 2012, HEALTH POLICY, V106, P211, DOI 10.1016/j.healthpol.2012.04.015; Moise P, 2007, OECD HLTH WORKING PA; Moye-Holz D, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0281-1; Organisation for Economic Co-operation and Development, 2014, DAFCOMPGFWD20143 ORG, P3; Shadlen KC, 2013, POLIT SOC, V41, P561, DOI 10.1177/0032329213507552; Storpirtis S, 2014, PHARM POLICY LAW, V16, P22; US Food and Drug Administration, 2018, APPR PROD THER EQ OR; Vogler S, 2012, GABI J, V1, P93, DOI 10.5639/gabij.2012.0102.020; WHO Expert Committee on Specifications for Pharmaceutical Preparations, 40 WHO; World Health Organization, QUAL ASS MED TERM DA; 2006, WHO TECHN REP SER, V936, P1	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2019	14	5							e0217334	10.1371/journal.pone.0217334	http://dx.doi.org/10.1371/journal.pone.0217334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IA1LO	31141565	Green Published, gold, Green Submitted			2022-12-26	WOS:000469323000050
J	Banierink, H; ten Duis, K; de Vries, R; Wendt, K; Heineman, E; Reininga, I; IJpma, F				Banierink, Hester; ten Duis, Kaj; de Vries, Rob; Wendt, Klaus; Heineman, Erik; Reininga, Inge; IJpma, Frank			Pelvic ring injury in the elderly: Fragile patients with substantial mortality rates and long-term physical impairment	PLOS ONE			English	Article							FUNCTION ASSESSMENT QUESTIONNAIRE; FRACTURES; EPIDEMIOLOGY; VALIDITY	Background Pelvic ring injuries in the elderly often occur after low-energy accidents. They may result in prolonged immobilization, complications and an intense rehabilitation process. The aim of this study was to assess mortality, physical functioning and quality of life (QoL) in elderly patients with pelvic ring injuries. Methods A cross-sectional study was performed including all elderly patients (. 65 years) admitted for a pelvic ring injury between 2007-2016. Mortality and survival were evaluated and patient reported outcome measures (PROMs) were used to assess physical functioning (SMFA) and QoL (EQ-5D). These were compared to age-matched normative data from the general Dutch population. Results A total of 153 patients, with a mean age of 79 years (SD 8) at the time of injury, were included in this study. The mortality rate was 20% at 30 days, 27% at 1 year and 41% at 3 years of follow-up. All six patients with a type C fracture died within 30 days. Analyses of the 153 patients showed that increasing age, fracture type C and Injury Severity Score (ISS) were all independent risk factors for mortality. Eventually, after excluding patients that died (N = 78) or were unable to contact (N = 2), 73 patients were eligible for follow-up, of which 53 patients (73%) responded. Mean Short Musculoskeletal Function Assessment (SMFA) scores were respectively 67.4 (function index), 65.2 (bother index), 66.5 (lower extremity), 60.4 (activities of daily living) and 68.2 (emotion). Mean EuroQuol-5D (EQ-5D) score was 0.72. Overall, physical functioning and quality of life were significantly decreased in comparison with normative data from the general population. Conclusion Elderly people who sustain a pelvic ring injury should be considered as a fragile population with substantial mortality rates. The patients who survived demonstrated a substantially lower level of physical functioning and quality of life in comparison with their age-matched peers from the general population.	[Banierink, Hester; ten Duis, Kaj; de Vries, Rob; Wendt, Klaus; Reininga, Inge; IJpma, Frank] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands; [Wendt, Klaus; Reininga, Inge] Northern Netherlands Trauma Registry, Emergency Care Network Northern Netherlands AZNN, Groningen, Netherlands; [Heineman, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands	University of Groningen; University of Groningen	Banierink, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands.	h.banierink@umcg.nl	IJpma, Frank/AAH-6350-2019; Reininga, Inge H.F./H-4250-2013; Heineman, Erik/ABG-9592-2021	Reininga, Inge H.F./0000-0003-1341-845X; 				AO/OTA, 2018, J ORTHOP TRAUMA, V32; Balogh Z, 2007, J TRAUMA, V63, P1066, DOI 10.1097/TA.0b013e3181589fa4; Bible JE, 2013, ORTHOPEDICS, V36, P760, DOI 10.3928/01477447-20130523-21; Butler M, 2011, J BONE JOINT SURG AM, V93A, P1104, DOI [10.2106/JBJSJ.00296, 10.2106/JBJS.J.00296]; Centraal Bureau voor de Statistiek, 2018, LEV GESL LEEFT JAAR; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clement Nicholas D, 2014, Eur J Orthop Surg Traumatol, V24, P1431, DOI 10.1007/s00590-014-1439-7; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; de Graaf MW, 2015, QUAL LIFE RES, V24, P2015, DOI 10.1007/s11136-015-0929-3; de Vries R., 2018, AV TECHN INT OP C 20, P1; Dechert TA, 2009, AM SURGEON, V75, P291; Forni C, 2018, INT ORTHOP, P15; Giesbers H, 2013, WAT ZIJN BELANGRIJKS; Kannus P, 2000, OSTEOPOROSIS INT, V11, P443, DOI 10.1007/s001980070112; MELTON LJ, 1981, CLIN ORTHOP RELAT R, P43; Morris RO, 2000, POSTGRAD MED J, V76, P646, DOI 10.1136/pmj.76.900.646; Mundi S, 2014, ACTA ORTHOP, V85, P54, DOI 10.3109/17453674.2013.878831; Osterhoff G, 1994, PRAXIS, V40, P1195; Reininga IHF, 2012, INJURY, V43, P726, DOI 10.1016/j.injury.2011.07.013; Schmitz P, 2018, INT ORTHOP; Soles GLS, 2012, CURR REV MUSCULOSKE, V5, P222, DOI 10.1007/s12178-012-9128-9; Studer P, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13859; Swiontkowski MF, 1999, J BONE JOINT SURG AM, V81A, P1245, DOI 10.2106/00004623-199909000-00006; Tile M., 2015, FRACTURES PELVIS ACE, V4th ed.; van Dijk WA, 2010, INJURY, V41, P411, DOI 10.1016/j.injury.2009.12.014; Verbeek Diederik O, 2018, Eur J Orthop Surg Traumatol, V28, P197, DOI 10.1007/s00590-017-2044-3; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003	27	16	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0216809	10.1371/journal.pone.0216809	http://dx.doi.org/10.1371/journal.pone.0216809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136589	Green Published, gold, Green Submitted			2022-12-26	WOS:000469224300010
J	Lin, WW; Lin, MH; Zhou, HY; Wu, HM; Li, ZW; Lin, WX				Lin, Weiwei; Lin, Manhong; Zhou, Hongyan; Wu, Hongmiao; Li, Zhaowei; Lin, Wenxiong			The effects of chemical and organic fertilizer usage on rhizosphere soil in tea orchards	PLOS ONE			English	Article							MICROBIAL COMMUNITY; BACTERIAL COMMUNITIES; ACIDIFICATION; ACID; AGRICULTURE; ADSORPTION; MANAGEMENT; IMPACTS; GROWTH; MANURE	Sustainable agriculture is an important global issue. The use of organic fertilizers can enhance crop yield and soil properties while restraining pests and diseases. The objective of this study was to assess the effects of long-term use of chemical and organic fertilizers on tea and rhizosphere soil properties in tea orchards. Inductively coupled plasma mass spectrometry (ICP-MS) and high-throughput sequencing technology analyses were used to investigate heavy metals content and bacterial composition in rhizosphere soils. Our results indicated that organic fertilizer treatment significantly decreased Cu, Pb and Cd contents in rhizosphere soil sample. The results also showed that treatment with organic fertilizer significantly decreased the contents of Cd, Pb and As in tea leaves. Furthermore, organic fertilizer significantly increased the amino acids content of tea and the pH of the soil. The use of organic fertilizer significantly increased in the relative abundance of Burkholderiales, Myxococcales, Streptomycetales, Nitrospirales, Ktedonobacterales, Acidobacteriales, Gemmatimonadales, and Solibacterales, and decreased the abundance of Pseudonocardiales, Frankiales, Rhizobiales, and Xanthomonadales. In conclusion, organic fertilizer can help to shape the microbial composition and recruit beneficial bacteria into the rhizosphere of tea, leading to improved tea quality and reduced heavy metals content in rhizosphere soil and tea leaves.	[Lin, Weiwei; Wu, Hongmiao; Li, Zhaowei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Life Sci, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China; [Lin, Weiwei; Lin, Manhong; Wu, Hongmiao; Li, Zhaowei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Key Lab Crop Ecol & Mol Physiol, Fuzhou, Fujian, Peoples R China; [Lin, Manhong; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China; [Zhou, Hongyan] Fujian Vocat Coll Agr, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Li, ZW; Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China.; Li, ZW; Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Key Lab Crop Ecol & Mol Physiol, Fuzhou, Fujian, Peoples R China.; Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab Genet Breeding & Multiple Utilizat Crops, Minist Educ, Fuzhou, Fujian, Peoples R China.	zhaoweili@fafu.edu.cn; lwx@fafu.edu.cn	Wu, Hongmiao/J-5958-2014	Wu, Hongmiao/0000-0002-9664-0824	National Natural Science Foundation of China [31701329, 81573530]; Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop (Fujian 2011 Program), China [2015-75]; Natural Science Foundation of Fujian Province [2016J01100]; China Postdoral Science Foundation [2015M580560]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop (Fujian 2011 Program), China; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); China Postdoral Science Foundation	This work was supported by: National Natural Science Foundation of China (No. 31701329, 81573530); Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop (Fujian 2011 Program, No. 2015-75, China); the Natural Science Foundation of Fujian Province (No. 2016J01100); and the Project Funded by China Postdoral Science Foundation (No. 2015M580560).; This work was supported by by the National Natural Science Foundation of China (No. 31701329, 81573530), Fujian-Taiwan Joint Innovative Center for Germplasm Resources and Cultivation of Crop (Fujian 2011 Program, No. 2015-75, China), the Natural Science Foundation of Fujian Province (No. 2016J01100), and the Project Funded by China Postdoral Science Foundation (No. 2015M580560).	Ahmad R, 2007, ANN MICROBIOL, V57, P471, DOI 10.1007/BF03175343; Arafat Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081727; Bao SD, 2000, SOIL AGR CHEM ANAL, P263; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Blake L, 2002, PLANT SOIL, V240, P235, DOI 10.1023/A:1015731530498; BOLAN NS, 1991, PLANT SOIL, V134, P53, DOI 10.1007/BF00010717; Carpio IEM, 2014, CARBON, V77, P289, DOI 10.1016/j.carbon.2014.05.032; Chang KH, 2010, SCI HORTIC-AMSTERDAM, V125, P434, DOI 10.1016/j.scienta.2010.04.011; Cheng Y, 2015, PLANT SOIL, V389, P45, DOI 10.1007/s11104-014-2343-y; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DORMAAR JF, 1988, CAN J SOIL SCI, V68, P669, DOI 10.4141/cjss88-064; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gao G., 2001, CHIN J FOOD HYG, V13, P12; Goyal N, 2003, ADV ENVIRON RES, V7, P311, DOI 10.1016/S1093-0191(02)00004-7; Gremion F, 2004, FEMS MICROBIOL ECOL, V48, P273, DOI 10.1016/j.femsec.2004.02.004; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hacquard S, 2016, NEW PHYTOL, V209, P454, DOI 10.1111/nph.13760; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Horrigan L, 2002, ENVIRON HEALTH PERSP, V110, P445, DOI 10.1289/ehp.02110445; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; Kinkel LL, 2012, RES MICROBIOL, V163, P490, DOI 10.1016/j.resmic.2012.07.005; Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112; [兰海霞 LAN Haixia], 2008, [农业环境科学学报, Journal of Agro-Environment Science], V27, P1077; Li YC, 2016, J APPL MICROBIOL, V121, P787, DOI 10.1111/jam.13225; Li Yan-chun, 2018, Yingyong Shengtai Xuebao, V29, P1273, DOI 10.13287/j.1001-9332.201804.036; Li YC, 2017, EUR J SOIL BIOL, V81, P48, DOI 10.1016/j.ejsobi.2017.06.008; Lin B., 2010, FUJIAN J AGR SCI, V25, P90, DOI [DOI 10.19303/J.ISSN.1008-0384.2010.01.018, 10.19303/j.issn.1008-0384.2010.01.018]; LIU L, 1995, PHYTOPATHOLOGY, V85, P1064, DOI 10.1094/Phyto-85-1064; Liu ZA, 2012, NUTR CYCL AGROECOSYS, V93, P297, DOI 10.1007/s10705-012-9517-x; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Nkoa R, 2014, AGRON SUSTAIN DEV, V34, P473, DOI 10.1007/s13593-013-0196-z; Owuor P. O., 2011, International Journal of Tea Science (IJTS), V8, P15; Pansu Marc, 2006, P3; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P516, DOI 10.1016/j.soilbio.2009.11.026; Savci S., 2012, International Journal of Environmental Science and Development, V3, P77; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sun Q., 2017, J CHIN AGR SCI B, V33, P52; Sun RB, 2015, SOIL BIOL BIOCHEM, V88, P9, DOI 10.1016/j.soilbio.2015.05.007; Van VT, 2000, PLANT SOIL, V218, P273, DOI 10.1023/A:1014986916913; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang WW, 2011, POL J ECOL, V59, P37; Wu HM, 2019, AGR ECOSYST ENVIRON, V270, P19, DOI 10.1016/j.agee.2018.10.014; Wu HM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00335; Wu LK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01788; Wu LK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15871; Xu H., 2010, CHIN J SOIL SCI, V41, P1355; Yan XY, 2010, PLANT SOIL, V331, P471, DOI 10.1007/s11104-009-0268-7; Yang SX, 2010, CHEMOSPHERE, V80, P852, DOI 10.1016/j.chemosphere.2010.05.055; Zhang QC, 2012, APPL SOIL ECOL, V57, P1, DOI 10.1016/j.apsoil.2012.02.012; Zhang Qin, 2012, Guizhou Agricultural Sciences, P65; Zhao J, 2012, WORLD J MICROB BIOT, V28, P1967, DOI 10.1007/s11274-011-0999-5; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	54	108	115	48	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2019	14	5							e0217018	10.1371/journal.pone.0217018	http://dx.doi.org/10.1371/journal.pone.0217018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA0CM	31136614	Green Submitted, gold, Green Published			2022-12-26	WOS:000469224300013
J	Matsuno, AK; Gagliardi, TB; Paula, FE; Luna, LKS; Jesus, BLS; Stein, RT; Aragon, DC; Carlotti, APCP; Arruda, E				Matsuno, Alessandra K.; Gagliardi, Talita B.; Paula, Flavia E.; Luna, Luciano K. S.; Jesus, Bruna L. S.; Stein, Renato T.; Aragon, Davi C.; Carlotti, Ana P. C. P.; Arruda, Eurico			Human coronavirus alone or in co-infection with rhinovirus C is a risk factor for severe respiratory disease and admission to the pediatric intensive care unit: A one-year study in Southeast Brazil	PLOS ONE			English	Article							SYNCYTIAL VIRUS; CHILDREN; INFECTIONS	Objective We aimed to assess the profile of respiratory viruses in young children hospitalized for acute lower respiratory tract infection (ALRI) and its association with disease severity, defined as need for pediatric intensive care unit (PICU) admission. Design Prospective observational cohort study. Setting A tertiary-care university hospital in Brazil. Patients Children younger than three years attending the pediatric emergency room with ALRI who were admitted to the hospital. Interventions None. Measurements and main results Nasopharyngeal aspirates were collected from patients from June 1 st, 2008 to May 31 st, 2009within the first 48 hours of hospitalization. Nasopharyngeal aspirates were tested for 17humanrespiratory viruses by molecular and immunofluorescence based assays. Simple and multiple log-binomial regression models were constructed to assess associations of virus type with a need for PICU admission. Age, prematurity, the presence of an underlying disease and congenital heart disease were covariates. Nasopharyngeal aspirates were positive for at least one virus in 236 patients. Rhinoviruses were detected in 85.6% of samples, with a preponderance of rhinovirus C (RV-C) (61.9%). Respiratory syncytial virus was detected in 59.8% and human coronavirus (HCoV) in 11% of the samples. Co-detections of two to five viruses were found in 78% of the patients. The detection of HCoV alone (adjusted relative risk (RR) 2.18; 95% CI 1.15-4.15) or in co-infection with RV-C (adjusted RR 2.37; 95% CI 1.23-4.58) was independently associated with PICU admission. Conclusions The detection of HCoV alone or in co-infection with RV-C was independently associated with PICU admission in young children hospitalized for ALRI.	[Matsuno, Alessandra K.; Aragon, Davi C.; Carlotti, Ana P. C. P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ribeirao Preto, Brazil; [Gagliardi, Talita B.; Paula, Flavia E.; Luna, Luciano K. S.; Jesus, Bruna L. S.; Arruda, Eurico] Univ Sao Paulo, Dept Cell Biol, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil; [Gagliardi, Talita B.; Paula, Flavia E.; Luna, Luciano K. S.; Jesus, Bruna L. S.; Arruda, Eurico] Univ Sao Paulo, Virol Res Ctr, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil; [Stein, Renato T.] Pontificia Univ Catolica Rio Grande do Sul, Dept Pediat, Sch Med, Porto Alegre, RS, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Pontificia Universidade Catolica Do Rio Grande Do Sul	Matsuno, AK (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ribeirao Preto, Brazil.	matsuno@fmrp.usp.br	de Souza Luna, Luciano Kleber/L-1213-2013; Carlotti, Ana PCP/G-4893-2012; de Souza Luna, Luciano Kleber/AAG-6418-2019; Matsuno, Alessandra Kimie/H-9507-2012; Casale Aragon, Davi/R-6604-2016	de Souza Luna, Luciano Kleber/0000-0002-3552-5507; Carlotti, Ana PCP/0000-0003-2760-8801; de Souza Luna, Luciano Kleber/0000-0002-3552-5507; MATSUO, Akiko/0000-0002-6293-5501; Matsuno, Alessandra Kimie/0000-0002-3491-1641; Sasahara, Kazutoshi/0000-0003-2572-0648; Casale Aragon, Davi/0000-0003-1019-3654; STEIN, RENATO/0000-0003-0269-0757; Arruda, Eurico/0000-0002-0978-410X	Abbott Laboratorios do Brasil Ltda; Sao Paulo State Research Foundation (FAPESP); FAEPA - Fundacao de Apoio ao Ensino Pesquisa e Assistencia" ("Foundation of Support to Teaching Research and Assistance) of the University of Sao Paulo Hospital of Ribeirao Preto; Brazilian Research Council (CNPq)	Abbott Laboratorios do Brasil Ltda; Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPA - Fundacao de Apoio ao Ensino Pesquisa e Assistencia" ("Foundation of Support to Teaching Research and Assistance) of the University of Sao Paulo Hospital of Ribeirao Preto; Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AKM and EAN supported mainly by an academic grant from Abbott Laboratorios do Brasil Ltda based on an unrestricted investigatorgenerated proposal. EAN Additional funding was provided by a grant from the Sao Paulo State Research Foundation (FAPESP) and by FAEPA - Fundacao de Apoio ao Ensino Pesquisa e Assistencia"(in English would be "Foundation of Support to Teaching Research and Assistance) of the University of Sao Paulo Hospital of Ribeirao Preto. EA has long standing scholarship support from the Brazilian Research Council (CNPq). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda E, 2014, PEDIATR INFECT DIS J, V33, P997, DOI 10.1097/INF.0000000000000349; Cebey-Lopez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152481; Chu HY, 2016, J PEDIAT INF DIS SOC, V5, P29, DOI 10.1093/jpids/piu099; Cintra OAL, 2001, J MED VIROL, V65, P408, DOI 10.1002/jmv.2049; Costa LF, 2014, PEDIATRICS, V133, pE312, DOI 10.1542/peds.2013-2216; De Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154662; Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06; Fawkner-Corbett DW, 2016, J MED VIROL, V88, P58, DOI 10.1002/jmv.24300; Kelesidis T, 2016, INFECT CONT HOSP EP, V37, P70, DOI 10.1017/ice.2015.226; Lauinger IL, 2013, J CLIN VIROL, V58, P216, DOI 10.1016/j.jcv.2013.06.042; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Legg JP, 2005, PEDIATR INFECT DIS J, V24, P611, DOI 10.1097/01.inf.0000168747.94999.aa; Do LAH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160606; Miyaji Y, 2013, MICROBIOL IMMUNOL, V57, P811, DOI 10.1111/1348-0421.12102; Nathan AM, 2017, PEDIAT RESPIROL CRIT, V1, P46, DOI DOI 10.4103/PRCM.PRCM_2_17; Proenca-Modena JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042136; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Scotta MC, 2016, J CLIN VIROL, V80, P45, DOI 10.1016/j.jcv.2016.04.019; Sonego M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116380; Varghese L, 2018, J PEDIAT INF DIS SOC, V7, P151, DOI 10.1093/jpids/pix027; Walsh EE., 2015, MANDELL BENNETTS PRI, V8th ed., P1948; Wishaupt JO, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2118-6; Zhang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033773	26	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217744	10.1371/journal.pone.0217744	http://dx.doi.org/10.1371/journal.pone.0217744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	31158256	Green Published, gold, Green Submitted			2022-12-26	WOS:000469915700024
J	Matsuoi, A; Sasahara, K; Taguchi, Y; Karasawa, M				Matsuoi, Akiko; Sasahara, Kazutoshi; Taguchi, Yasuhiro; Karasawa, Minoru			Development and validation of the Japanese Moral Foundations Dictionary	PLOS ONE			English	Article								The Moral Foundations Dictionary (MFD) is a useful tool for applying the conceptual framework developed in Moral Foundations Theory and quantifying the moral meanings implicated in the linguistic information people convey. However, the applicability of the MFD is limited because it is available only in English. Translated versions of the MFD are therefore needed to study morality across various cultures, including non-Western cultures. The contribution of this paper is two-fold. We developed the first Japanese version of the MFD (referred to as the J-MFD) using a semi-automated method-this serves as a reference when translating the MFD into other languages. We next tested the validity of the J-MFD by analyzing open-ended written texts about the situations that Japanese participants thought followed and violated the five moral foundations. We found that the J-MFD correctly categorized the Japanese participants' descriptions into the corresponding moral foundations, and that the Moral Foundations Questionnaire (MFQ) scores correlated with the frequency of situations, of total words, and of J-MFD words in the participants' descriptions for the Harm and Fairness foundations. The J-MFD can be used to study morality unique to the Japanese and also multicultural comparisons in moral behavior.	[Matsuoi, Akiko] Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Nagoya, Aichi, Japan; [Sasahara, Kazutoshi] Nagoya Univ, Grad Sch Informat, Dept Complex Syst Sci, Nagoya, Aichi, Japan; [Taguchi, Yasuhiro] Aichi Univ, Sch Letters, Dept Humanities & Social Sci, Toyohashi, Aichi, Japan; [Karasawa, Minoru] Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan; [Sasahara, Kazutoshi] JST, PRESTO, Kawaguchi, Saitama, Japan	Nagoya University; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Sasahara, K (corresponding author), Nagoya Univ, Grad Sch Informat, Dept Complex Syst Sci, Nagoya, Aichi, Japan.; Sasahara, K (corresponding author), JST, PRESTO, Kawaguchi, Saitama, Japan.	sasahara@nagoya-u.jp	de Souza Luna, Luciano Kleber/L-1213-2013; Carlotti, Ana PCP/G-4893-2012; de Souza Luna, Luciano Kleber/AAG-6418-2019; Matsuno, Alessandra Kimie/H-9507-2012; Casale Aragon, Davi/R-6604-2016	de Souza Luna, Luciano Kleber/0000-0002-3552-5507; Carlotti, Ana PCP/0000-0003-2760-8801; de Souza Luna, Luciano Kleber/0000-0002-3552-5507; MATSUO, Akiko/0000-0002-6293-5501; Matsuno, Alessandra Kimie/0000-0002-3491-1641; Sasahara, Kazutoshi/0000-0003-2572-0648; Casale Aragon, Davi/0000-0003-1019-3654; STEIN, RENATO/0000-0003-0269-0757; Arruda, Eurico/0000-0002-0978-410X	JSPS/MEXT KAKENHI [15H03446, JP17H06383, 4903]; JST PRESTO [JPMJPR16D6]; JST CREST [JPMJCR17A4]	JSPS/MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO(Japan Science & Technology Agency (JST)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This research was supported by JSPS/MEXT KAKENHI Grant Numbers 15H03446 and JP17H06383 in #4903, JST PRESTO Grant Number JPMJPR16D6, and JST CREST Grant Number JPMJCR17A4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulbulia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080224; Clifford S, 2015, BEHAV RES METHODS, V47, P1178, DOI 10.3758/s13428-014-0551-2; Davis D, 2015, J PERS SOC PSYCHOL, V110, P56; Dehghani M, 2017, BEHAV RES METHODS, V49, P538, DOI 10.3758/s13428-016-0722-4; Dehghani M, 2016, J EXP PSYCHOL GEN, V145, P366, DOI 10.1037/xge0000139; Fulgoni D, 2016, LREC 2016 - TENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P3730; GOOLSBY JR, 1992, J MARKETING, V56, P55, DOI 10.2307/1252132; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J., 2015, VOLKSWAGEN MORAL PSY; Haidt J, 2008, PERSPECT PSYCHOL SCI, V3, P65, DOI 10.1111/j.1745-6916.2008.00063.x; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Honda S., 2017, B FACULTY ED YAMAGUC, V66, P95; Ji QH, 2015, MEDIA PSYCHOL, V18, P221, DOI 10.1080/15213269.2014.956939; Johnson KA, 2016, PERS INDIV DIFFER, V100, P56, DOI 10.1016/j.paid.2015.12.037; Jones D, 2010, SCIENCE, V328, P1627, DOI 10.1126/science.328.5986.1627; Kanai R., 2013, NOU NI KIZAMARETA MO; Kaur R, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON BIG DATA (BIG DATA), P2505, DOI 10.1109/BigData.2016.7840889; LaBouff JP, 2017, ARCH PSYCHOL RELIG, V39, P263, DOI 10.1163/15736121-12341343; Maekawa K, 2014, LANG RESOUR EVAL, V48, P345, DOI 10.1007/s10579-013-9261-0; Matsumoto K, 2005, P ASS NAT LANG PROC, P145; Mooijman M, 2017, J PERSONALITY SOCIAL; Pennebaker James W, 2001, MAHWAY L ERLBAUM ASS, V71, P2001; Piazza J, 2018, SOCIAL PSYCHOL PERSO, P1; Reed A, 2007, J MARKETING, V71, P178, DOI 10.1509/jmkg.71.1.178; Takamatsu R., 2017, JPN J INTERPERS SOC, V17, P93; Yilmaz O, 2016, PERS INDIV DIFFER, V99, P149, DOI 10.1016/j.paid.2016.04.090	29	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2019	14	3							e0213343	10.1371/journal.pone.0213343	http://dx.doi.org/10.1371/journal.pone.0213343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ1KV	31158256	gold, Green Submitted, Green Published			2022-12-26	WOS:000462157600010
